PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Abdulrahim, MH; McManus, BA; Flint, SR; Coleman, DC				Abdulrahim, Mohammed H.; McManus, Brenda A.; Flint, Stephen R.; Coleman, David C.			Genotyping Candida albicans from Candida Leukoplakia and Non-Candida Leukoplakia Shows No Enrichment of Multilocus Sequence Typing Clades but Enrichment of ABC Genotype C in Candida Leukoplakia	PLOS ONE			English	Article							CHRONIC HYPERPLASTIC CANDIDIASIS; DUBLINIENSIS; IDENTIFICATION; DISORDERS; EBURST	Oral leukoplakias are histopathologically-diagnosed as Candida leukoplakia or non-Candida leukoplakia by the presence or absence of hyphae in the superficial epithelium. Candida leukoplakia lesions have significantly increased malignant potential. Candida albicans is the most prevalent fungal species associated with oral leukoplakia and may contribute to malignant transformation of Candida leukoplakia. To date, no detailed population analysis of C. albicans isolates from oral leukoplakia patients has been undertaken. This study investigated whether specific C. albicans genotypes were associated with Candida leukoplakia and non-Candida leukoplakia in a cohort of Irish patients. Patients with histopathologically-defined Candida leukoplakia (n = 31) or non-Candida leukoplakia (n = 47) were screened for Candida species by culture of oral rinse and lesional swab samples. Selected C. albicans isolates from Candida leukoplakia patients (n = 25), non-Candida leukoplakia patients (n = 19) and oral carriage isolates from age and sex matched healthy subjects without leukoplakia (n = 34) were subjected to multilocus sequence typing (MLST) and ABC genotyping. MLST revealed that the clade distribution of C. albicans from both Candida leukoplakia and non-Candida leukoplakia lesions overlapped with the corresponding clade distributions of oral carriage isolates and global reference isolates from the MLST database indicating no enrichment of leukoplakia-associated clones. Oral leukoplakia isolates were significantly enriched with ABC genotype C (12/44, 27.3%), particularly Candida leukoplakia isolates (9/25, 36%), relative to oral carriage isolates (3/34, 8.8%). Genotype C oral leukoplakia isolates were distributed in MLST clades 1,3,4,5,8,9 and 15, whereas genotype C oral carriage isolates were distributed in MLST clades 4 and 11.	[Abdulrahim, Mohammed H.; Flint, Stephen R.] Univ Dublin, Dublin Dent Univ Hosp, Div Maxillofacial Surg Oral Med & Oral Pathol, Dublin, Ireland; [McManus, Brenda A.; Coleman, David C.] Univ Dublin, Trin Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit,Div Oral Biosci, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Coleman, DC (corresponding author), Univ Dublin, Trin Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit,Div Oral Biosci, Dublin, Ireland.	david.coleman@dental.tcd.ie	Coleman, David C./C-2008-2009; McManus, Brenda/H-8600-2019	Coleman, David C./0000-0003-1797-2888; McManus, Brenda/0000-0003-3969-054X	Dublin Dental University Hospital Microbiology Research Unit	Dublin Dental University Hospital Microbiology Research Unit	This study was supported by the Dublin Dental University Hospital Microbiology Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartie KL, 2001, J CLIN MICROBIOL, V39, P4066, DOI 10.1128/JCM.39.11.4066-4075.2001; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; CAWSON RA, 1968, BRIT J DERMATOL, V80, P9, DOI 10.1111/j.1365-2133.1968.tb11899.x; CAWSON RA, 1966, ORAL SURG ORAL MED O, V22, P582, DOI 10.1016/0030-4220(66)90161-7; Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06; Coleman DC, 1997, AIDS, V11, P557, DOI 10.1097/00002030-199705000-00002; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gainza-Cirauqui ML, 2013, J ORAL PATHOL MED, V42, P243, DOI 10.1111/j.1600-0714.2012.01203.x; HOLMSTRUP P, 1983, ORAL SURG ORAL MED O, V56, P388, DOI 10.1016/0030-4220(83)90349-3; JEPSEN A, 1965, Acta Odontol Scand, V23, P239, DOI 10.3109/00016356509007513; KROGH P, 1987, ORAL SURG ORAL MED O, V63, P48, DOI 10.1016/0030-4220(87)90339-2; KROGH P, 1990, ACTA ODONTOL SCAND, V48, P85, DOI 10.3109/00016359009012738; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LEHNER T, 1964, Trans St Johns Hosp Dermatol Soc, V50, P8; McCullough M, 2002, ORAL ONCOL, V38, P391, DOI 10.1016/S1368-8375(01)00079-3; McCullough MJ, 1999, J CLIN MICROBIOL, V37, P417, DOI 10.1128/JCM.37.2.417-421.1999; McCullough MJ, 1999, CLIN INFECT DIS, V29, P1220, DOI 10.1086/313455; McManus BA, 2012, J CLIN MICROBIOL, V50, P3335, DOI 10.1128/JCM.01532-12; McManus BA, 2011, J CLIN MICROBIOL, V49, P1879, DOI 10.1128/JCM.00026-11; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923, DOI 10.1128/JCM.32.8.1923-1929.1994; ODDS FC, 1988, CANDIDA CANDIDOSIS, P68; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Pincus DH, 1999, J CLIN MICROBIOL, V37, P3533, DOI 10.1128/JCM.37.11.3533-3539.1999; Sitheeque MAM, 2003, CRIT REV ORAL BIOL M, V14, P253, DOI 10.1177/154411130301400403; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; Walker D. M., 1990, Oral candidosis., P184; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; WILLIAMSON DM, 1969, BRIT J DERMATOL, V81, P125, DOI 10.1111/j.1365-2133.1969.tb15992.x; Wrobel L, 2008, EUKARYOT CELL, V7, P1475, DOI 10.1128/EC.00162-08	35	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73738	10.1371/journal.pone.0073738	http://dx.doi.org/10.1371/journal.pone.0073738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058485	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900017
J	Abella, J; Valenciano, A; Perez-Ramos, A; Montoya, P; Morales, J				Abella, Juan; Valenciano, Alberto; Perez-Ramos, Alejandro; Montoya, Plinio; Morales, Jorge			On the Socio-Sexual Behaviour of the Extinct Ursid Indarctos arctoides: An Approach Based on Its Baculum Size and Morphology	PLOS ONE			English	Article							PROMEGANTEREON-OGYGIA FELIDAE; LATE MIOCENE; OS-PENIS; FUNCTIONAL-ANATOMY; COPULATORY-BEHAVIOR; MAMMALIAN BACULUM; SEXUAL-DIMORPHISM; FALSE-THUMB; CARNIVORA; EVOLUTION	The fossil bacula, or os penis, constitutes a rare subject of study due to its scarcity in the fossil record. In the present paper we describe five bacula attributed to the bear Indarctos arctoides Deperet, 1895 from the Batallones-3 site (Madrid Basin, Spain). Both the length and morphology of this fossil bacula enabled us to make interpretative approaches to a series of ecological and ethological characters of this bear. Thus, we suggest that I. arctoides could have had prolonged periods of intromission and/or maintenance of intromission during the post-ejaculatory intervals, a multi-male mating system and large home range sizes and/or lower population density. Its size might also have helped females to choose from among the available males.	[Abella, Juan] Autonomous Univ Barcelona, Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Abella, Juan; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Valenciano, Alberto] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain; [Valenciano, Alberto] UCM, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Perez-Ramos, Alejandro] Univ Valencia, Inst Cavanilles Biodivers & Biol Evolut, Paterna, Spain; [Montoya, Plinio] Univ Valencia, Area Paleontol, Dept Geol, E-46100 Burjassot, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); Complutense University of Madrid; University of Valencia; University of Valencia	Abella, J (corresponding author), Autonomous Univ Barcelona, Inst Catala Paleontol Miquel Crusafont, Edifici ICP,Campus UAB S-N, Barcelona, Spain.	juan.abella@icp.cat	Abella, Juan/AAB-1040-2020; Morales, Jorge/L-1476-2014; Vaquero, Alberto Valenciano/N-8757-2019	Abella, Juan/0000-0002-3433-6093; Morales, Jorge/0000-0001-5170-5754; Vaquero, Alberto Valenciano/0000-0003-1633-2248; Perez-Ramos, Alejandro/0000-0003-1417-4338	Spanish Ministerio de Economia y Competitividad [CGL2011-25754, CGL2011-28681]; JAE-Predoc (CSIC program "Junta para la ampliacion de estudios''); European Social Fund;  [BSCH-UCM910607]	Spanish Ministerio de Economia y Competitividad(Spanish Government); JAE-Predoc (CSIC program "Junta para la ampliacion de estudios''); European Social Fund(European Social Fund (ESF)); 	This study was supported by the Spanish Ministerio de Economia y Competitividad (research project CGL2011-25754 and CGL2011-28681) and the research group BSCH-UCM910607. AV was supported by a JAE-Predoc 2011 (CSIC program "Junta para la ampliacion de estudios''), co-funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella J, 2011, PALEONTOLOGIA EVOLUC, V5, P21; Abella J., 2011, THESIS U AUTONOMA MA; Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; Albayrak I, 2008, TURK J ZOOL, V32, P147; Amstrup SC., 2003, WILD MAMMALS N AM BI, P587; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anton M, 2006, J ANAT, V209, P757, DOI 10.1111/j.1469-7580.2006.00649.x; Baryshnikov GF, 2003, J MAMMAL, V84, P673, DOI 10.1644/1545-1542(2003)084<0673:MVAEOT>2.0.CO;2; BAUMGARDNER DJ, 1982, J MAMMAL, V63, P110, DOI 10.2307/1380677; Blanchard B.M., 1987, BEARS THEIR BIOL MAN, V7, P99, DOI [10.2307/3872615, DOI 10.2307/3872615]; BURT WILLIAM HENRY, 1960, MISC PUBL MUS ZOOL UNIV MICHIGAN, V113, P1; Calvo JP, 2013, SEDIMENTOLOGY, V60, P1681, DOI 10.1111/sed.12048; Dathe H, 1975, GRZIMEKS ANIMAL LIFE, P141; Davis D. D., 1964, Fieldiana Zoology Memoir, V3, P1; DEMASTER DP, 1981, MAMMALIAN SPECIES, V145, P1, DOI DOI 10.2307/3503828; Didier R, 1950, MAMMALIA, V14, P78; DIXSON AF, 1987, AM J PRIMATOL, V13, P51, DOI 10.1002/ajp.1350130107; DIXSON AF, 1995, J ZOOL, V235, P67, DOI 10.1111/j.1469-7998.1995.tb05128.x; Dixson Alan, 2004, Acta Zoologica Sinica, V50, P490; Domingo MS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2138; Dyck MG, 2004, J ZOOL, V264, P105, DOI 10.1017/S0952836904005606; Evans H.E., 2010, MILLERS GUIDE DISSEC, VFourth; Ewer, 1998, CARNIVORES; Ferguson SH, 2004, OIKOS, V105, P255; HARRISON JA, 1982, J PALEONTOL, V56, P1266; Hosken DJ, 2001, BEHAV ECOL SOCIOBIOL, V50, P450; Kelly DA, 2000, J MORPHOL, V244, P69, DOI 10.1002/(SICI)1097-4687(200004)244:1<69::AID-JMOR7>3.0.CO;2-#; KINGSLEY MCS, 1988, CAN J ZOOL, V66, P981, DOI 10.1139/z88-145; Lariviere S, 2003, J MAMMAL, V84, P937, DOI 10.1644/BME-003; Lariviere S, 2002, MAMMAL REV, V32, P283, DOI 10.1046/j.1365-2907.2002.00112.x; Laycock G, 1997, WILDERNESS LEGEND GR; LEFRANC MN, 1987, GRIZZLY BEAR COMPEND; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Lindenfors P, 2002, BEHAV ECOL SOCIOBIOL, V52, P188, DOI 10.1007/s00265-002-0507-x; Lono O, 1970, NOR POLARINST SKR, V149, P1; Matthew WD, 1907, B AM MUS NAT HIST, V23, P169; Miller EH, 2000, J MAMMAL, V81, P134, DOI 10.1644/1545-1542(2000)081<0134:BSGAAI>2.0.CO;2; Miller EH, 2002, ENCY MARINE MAMMALS, P55; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Mohr E., 1963, Zeitschrift fuer Saugietierkunde, V28, P19; Mondolfi E, 1971, DEFENSA NATURALEZA, V1, P31; Morales J., 2004, Geogaceta, V35, P139; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; Morales J., 1992, GEOGACETA, V12, P77; MOREJOHN G V, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P49; MURAKAMI R, 1986, J EMBRYOL EXP MORPH, V92, P133; MURAKAMI R, 1984, DEV GROWTH DIFFER, V26, P419; OHANLON JK, 1986, J COMP PSYCHOL, V100, P178, DOI 10.1037/0735-7036.100.2.178; OLSEN SJ, 1959, J PALEONTOL, V33, P449; Oosthuizen WH, 2000, MAR MAMMAL SCI, V16, P124, DOI 10.1111/j.1748-7692.2000.tb00908.x; PATTERSON BD, 1982, J MAMMAL, V63, P1, DOI 10.2307/1380665; Peigne S, 2008, PALAEONTOLOGY, V51, P943, DOI 10.1111/j.1475-4983.2008.00788.x; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; PEYTON B, 1980, J MAMMAL, V61, P639, DOI 10.2307/1380309; Pozo M., 2004, CUENCA MADRID GEOGAC, V35, P143; Prater S.H., 1965, BOOK INDIAN ANIMALS; Ramm SA, 2007, AM NAT, V169, P360, DOI 10.1086/510688; Romer AS., 1970, VERTEBRATE BODY; Ruth EB, 1934, ANAT REC, V60, P231, DOI 10.1002/ar.1090600209; Salesa MJ, 2008, ZOOL J LINN SOC-LOND, V152, P593, DOI 10.1111/j.1096-3642.2007.00370.x; Salesa MJ, 2012, J SYST PALAEONTOL, V10, P87, DOI 10.1080/14772019.2011.566584; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2006, P NATL ACAD SCI USA, V103, P379, DOI 10.1073/pnas.0504899102; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Scheffer V. B., 1963, Zeitschrift fuer Saugietierkunde, V28, P38; Schenk A, 1995, ANIM BEHAV, V50, P1483, DOI 10.1016/0003-3472(95)80005-0; Schwery Orlando, 2011, Beitraege zur Jagd- und Wildforschung, V36, P605; Servheen C, 1999, STATUS SURVEY BEARS; Siliceo G, 2011, ESTUD GEOL-MADRID, V67, P277, DOI 10.3989/egeol.40605.189; Stirling Ian, 1993, P36; TONER JP, 1987, PHYSIOL BEHAV, V39, P371, DOI 10.1016/0031-9384(87)90237-X; Valenciano A., 2012, 10 ANN M EUR ASS VER, P267; VERRELL PA, 1992, FOLIA PRIMATOL, V59, P114, DOI 10.1159/000156648; VILMANN H, 1979, ANAT ANZEIGER, V146, P483; WILLIAMSASHMAN HG, 1990, PERSPECT BIOL MED, V33, P335; WILLIAMSASHMAN HG, 1991, J STEROID BIOCHEM, V39, P873, DOI 10.1016/0960-0760(91)90344-5	78	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73711	10.1371/journal.pone.0073711	http://dx.doi.org/10.1371/journal.pone.0073711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058484	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900016
J	Halford, MM; Macheda, ML; Parish, CL; Takano, EA; Fox, S; Layton, D; Nice, E; Stacker, SA				Halford, Michael M.; Macheda, Maria L.; Parish, Clare L.; Takano, Elena A.; Fox, Stephen; Layton, Daniel; Nice, Edouard; Stacker, Steven A.			A Fully Human Inhibitory Monoclonal Antibody to the Wnt Receptor RYK	PLOS ONE			English	Article							DROSOPHILA DERAILED RECEPTOR; WNT/PLANAR CELL POLARITY; CENTRAL-NERVOUS-SYSTEM; MEDIATES AXON GROWTH; TYROSINE KINASES; NEURONAL DIFFERENTIATION; CORPUS-CALLOSUM; OVARIAN-CANCER; DRL RECEPTOR; H-RYK	RYK is an unusual member of the receptor tyrosine kinase (RTK) family that is classified as a putative pseudokinase. RYK regulates fundamental biological processes including cell differentiation, migration and target selection, axon outgrowth and pathfinding by transducing signals across the plasma membrane in response to the high affinity binding of Wnt family ligands to its extracellular Wnt inhibitory factor (WIF) domain. Here we report the generation and initial characterization of a fully human inhibitory monoclonal antibody to the human RYK WIF domain. From a naive human single chain fragment variable (scFv) phage display library, we identified anti-RYK WIF domain-specific scFvs then screened for those that could compete with Wnt3a for binding. Production of a fully human IgG(1 kappa) from an inhibitory scFv yielded a monoclonal antibody that inhibits Wnt5a-responsive RYK function in a neurite outgrowth assay. This antibody will have immediate applications for modulating RYK function in a range of settings including development and adult homeostasis, with significant potential for therapeutic use in human pathologies.	[Halford, Michael M.; Macheda, Maria L.; Takano, Elena A.; Fox, Stephen; Stacker, Steven A.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic, Australia; [Halford, Michael M.; Macheda, Maria L.; Stacker, Steven A.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Angiogenesis Lab, Parkville, Vic 3050, Australia; [Parish, Clare L.] Univ Melbourne, Melbourne Brain Ctr, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Layton, Daniel; Nice, Edouard] Monash Univ, Monash Antibody Technol Facil, Clayton, Vic, Australia; [Fox, Stephen; Stacker, Steven A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; Peter Maccallum Cancer Center; University of Melbourne	Stacker, SA (corresponding author), Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic, Australia.	Steven.Stacker@petermac.org	Layton, Daniel S/J-6117-2017; Parish, Clare/A-3380-2014; Fox, Stephen/G-9719-2016	Fox, Stephen/0000-0002-7648-8896; Parish, Clare/0000-0001-8212-9884; Macheda, Maria/0000-0002-8460-2046; Stacker, Steven/0000-0003-4096-9273	National Health and Medical Research Council of Australia (NHMRC); NHMRC; Viertel Senior Medical Research Fellowship, Australia; Pfizer Australia	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Viertel Senior Medical Research Fellowship, Australia; Pfizer Australia(PfizerPfizer Australia)	This work was funded partly by a Program Grant from the National Health and Medical Research Council of Australia (NHMRC) to SAS and an NHMRC Project Grant to CLP. SAS is supported by a Senior Research Fellowship from the NHMRC. CLP is supported by a Viertel Senior Medical Research Fellowship, Australia. SAS would like to acknowledge the support of the Pfizer Australia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2012, J BIOL CHEM, V287, P44518, DOI 10.1074/jbc.M112.414441; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Callahan CA, 1996, DEVELOPMENT, V122, P2761; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Davydova N, 2011, J MOL BIOL, V407, P581, DOI 10.1016/j.jmb.2011.02.009; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deshpande R, 2005, DEV BIOL, V278, P118, DOI 10.1016/j.ydbio.2004.10.020; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003; Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Grillenzoni N, 2007, DEVELOPMENT, V134, P3089, DOI 10.1242/dev.02876; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Harris KE, 2007, DEVELOPMENT, V134, P2017, DOI 10.1242/dev.001164; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hollis ER, 2012, P NATL ACAD SCI USA, V109, P14663, DOI 10.1073/pnas.1206218109; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hutchins BI, 2011, DEV NEUROBIOL, V71, P269, DOI 10.1002/dneu.20846; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Katso RMT, 2000, CLIN CANCER RES, V6, P3271; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kuroda H, 2011, CURR PROTOC CELL BIO, P26; Lahaye LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032297; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li X, 2008, BRAIN RES BULL, V77, P178, DOI 10.1016/j.brainresbull.2008.05.011; Liebl FLW, 2008, DEV NEUROBIOL, V68, P152, DOI 10.1002/dneu.20562; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Macheda M, 2013, RECEPTOR TY IN PRESS; Macheda ML, 2012, J BIOL CHEM, V287, P29312, DOI 10.1074/jbc.M112.362681; Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081; Mikalsen SO, 1998, J BIOL CHEM, V273, P10036, DOI 10.1074/jbc.273.16.10036; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Sakurai M, 2009, J NEUROSCI, V29, P4972, DOI 10.1523/JNEUROSCI.2821-08.2009; Santiago F, 2012, BIOCHEM BIOPH RES CO, V417, P223, DOI 10.1016/j.bbrc.2011.11.089; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; TSANG VCW, 1991, J IMMUNOL METHODS, V138, P291, DOI 10.1016/0022-1759(91)90178-I; Wang XC, 1996, MOL MED, V2, P189, DOI 10.1007/BF03401616; Wang XY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001110; Wouda RR, 2008, DEVELOPMENT, V135, P2277, DOI 10.1242/dev.017319; Wynshaw-Boris A, 2012, CURR TOP DEV BIOL, V101, P213, DOI 10.1016/B978-0-12-394592-1.00007-7; Yao Y, 2007, NAT NEUROSCI, V10, P1423, DOI 10.1038/nn1993; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhong JY, 2011, DEVELOPMENT, V138, P409, DOI 10.1242/dev.061051; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	74	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75447	10.1371/journal.pone.0075447	http://dx.doi.org/10.1371/journal.pone.0075447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058687	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900118
J	Soria, G; Tudela, R; Marquez-Martin, A; Camon, L; Batalle, D; Munoz-Moreno, E; Eixarch, E; Puig, J; Pedraza, S; Vila, E; Prats-Galino, A; Planas, AM				Soria, Guadalupe; Tudela, Raul; Marquez-Martin, Ana; Camon, Lluisa; Batalle, Dafnis; Munoz-Moreno, Emma; Eixarch, Elisenda; Puig, Josep; Pedraza, Salvador; Vila, Elisabet; Prats-Galino, Alberto; Planas, Anna M.			The Ins and Outs of the BCCAo Model for Chronic Hypoperfusion: A Multimodal and Longitudinal MRI Approach	PLOS ONE			English	Article							CAROTID-ARTERY OCCLUSION; CHRONIC CEREBRAL HYPOPERFUSION; BLOOD-BRAIN-BARRIER; SMALL VESSEL DISEASE; VASCULAR COGNITIVE IMPAIRMENT; WHITE-MATTER CHANGES; WORKING-MEMORY; OPTIC-NERVE; RAT-BRAIN; ARTERIOGENESIS	Cerebral hypoperfusion induced by bilateral common carotid artery occlusion (BCCAo) in rodents has been proposed as an experimental model of white matter damage and vascular dementia. However, the histopathological and behavioral alterations reported in this model are variable and a full characterization of the dynamic alterations is not available. Here we implemented a longitudinal multimodal magnetic resonance imaging (MRI) design, including time-of-flight angiography, high resolution T1-weighted images, T2 relaxometry mapping, diffusion tensor imaging, and cerebral blood flow measurements up to 12 weeks after BCCAo or sham-operation in Wistar rats. Changes in MRI were related to behavioral performance in executive function tasks and histopathological alterations in the same animals. MRI frequently (70%) showed various degrees of acute ischemic lesions, ranging from very small to large subcortical infarctions. Independently, delayed MRI changes were also apparent. The patterns of MRI alterations were related to either ischemic necrosis or gliosis. Progressive microstructural changes revealed by diffusion tensor imaging in white matter were confirmed by observation of myelinated fiber degeneration, including severe optic tract degeneration. The latter interfered with the visually cued learning paradigms used to test executive functions. Independently of brain damage, BCCAo induced progressive arteriogenesis in the vertebrobasilar tree, a process that was associated with blood flow recovery after 12 weeks. The structural alterations found in the basilar artery were compatible with compensatory adaptive changes driven by shear stress. In summary, BCCAo in rats induces specific signatures in multimodal MRI that are compatible with various types of histological lesion and with marked adaptive arteriogenesis.	[Soria, Guadalupe; Tudela, Raul] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Expt T MRI Unit, Barcelona, Spain; [Soria, Guadalupe; Camon, Lluisa; Planas, Anna M.] CSIC, Inst Invest Biomed Barcelona, Dept Brain Ischemia & Neurodegenerat, Barcelona, Spain; [Tudela, Raul] Univ Barcelona, Grp Biomed Imaging, CIBER Bioingn Biomat & Nanomed CIBER BBN, Barcelona, Spain; [Marquez-Martin, Ana; Vila, Elisabet] Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, Dept Farmacol Terapeut & Toxicol, Bellaterra, Spain; [Batalle, Dafnis; Munoz-Moreno, Emma; Eixarch, Elisenda] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Puig, Josep] Univ Girona, Hosp Univ Dr Josep Trueta IDIBGI, Dept Radiol, IDI, Girona, Spain; [Prats-Galino, Alberto] Univ Barcelona, Fac Med, Human Anat & Embryol Unit, Lab Surg Neuroanat LSNA, Barcelona 7, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Barcelona	Soria, G (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Expt T MRI Unit, Barcelona, Spain.	gsoriar@clinic.ub.es	Soria, Guadalupe/GXH-4792-2022; Batalle, Dafnis/H-7531-2019; Soria, Guadalupe/AAG-4658-2021; Tudela, Raúl/K-8261-2017; Muñoz-Moreno, Emma/A-2363-2016; Planas, Anna M/J-5991-2014; pedraza, salvador/AAC-1728-2019; Muñoz-Moreno, Emma/ABD-6424-2021; Prats-Galino, Alberto/J-6319-2013	Batalle, Dafnis/0000-0003-2097-979X; Soria, Guadalupe/0000-0002-8344-0479; Tudela, Raúl/0000-0001-5134-4784; Muñoz-Moreno, Emma/0000-0003-2104-7265; Planas, Anna M/0000-0002-6147-1880; pedraza, salvador/0000-0003-2517-4413; Muñoz-Moreno, Emma/0000-0003-2104-7265; Prats-Galino, Alberto/0000-0002-2710-6433; Eixarch, Elisenda/0000-0001-7379-9608	Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion [PS09/00527]; Ministerio de Economia y Competitividad ERANET-NEURON [PRI-PIMNEU-2011-1340]; project ARISE [201024]	Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad ERANET-NEURON; project ARISE	This work was supported by Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion (PS09/00527) and Ministerio de Economia y Competitividad ERANET-NEURON (PRI-PIMNEU-2011-1340) and the FP7/2007-2013 project ARISE (grant agreement number 201024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Boulougouris V, 2009, PSYCHOPHARMACOLOGY, V202, P611, DOI 10.1007/s00213-008-1341-2; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Busch HJ, 2003, J CEREBR BLOOD F MET, V23, P621, DOI 10.1097/01.WCB.0000057741.00152.E4; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Chidlow G, 2009, EXP EYE RES, V88, P426, DOI 10.1016/j.exer.2008.10.015; Choi Bo-Ryoung, 2011, Exp Neurobiol, V20, P92, DOI 10.5607/en.2011.20.2.92; Choy M, 2006, J CEREBR BLOOD F MET, V26, P1066, DOI 10.1038/sj.jcbfm.9600259; COX NH, 1974, J ANAT, V118, P507; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Duelsner A, 2012, J CEREBR BLOOD F MET, V32, P105, DOI 10.1038/jcbfm.2011.113; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Gajendiran M, 2001, NEUROSCIENCE, V105, P139, DOI 10.1016/S0306-4522(01)00163-4; GUARNERI P, 1988, NEUROCHEM RES, V13, P209, DOI 10.1007/BF00971534; Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491; Hainsworth AH, 2012, J NEUROL SCI, V322, P237, DOI 10.1016/j.jns.2012.05.046; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hoefer IE, 2004, CIRC RES, V94, P1179, DOI 10.1161/01.RES.0000126922.18222.F0; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; Kantor O, 2007, ACTA NEUROPATHOL, V113, P549, DOI 10.1007/s00401-007-0204-y; Kitamura A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.033; Kurumatani T, 1998, STROKE, V29, P1058, DOI 10.1161/01.STR.29.5.1058; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Lai SL, 2005, J NEUROL SCI, V238, P101, DOI 10.1016/j.jns.2005.06.012; Lanari A, 2012, FRONT NEUROL NEUROSC, V30, P185, DOI 10.1159/000333639; Liu HX, 2005, MOL BRAIN RES, V139, P169, DOI 10.1016/j.molbrainres.2005.05.014; Marquez-Martin A, 2012, J APPL PHYSIOL, V112, P511, DOI 10.1152/japplphysiol.00998.2011; Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Mulvany MJ, 1999, CARDIOVASC RES, V41, P9, DOI 10.1016/S0008-6363(98)00289-2; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Okamoto Y, 2012, ACTA NEUROPATHOL, V123, P381, DOI 10.1007/s00401-011-0925-9; Ostergaard Leif, 2004, Top Magn Reson Imaging, V15, P3; Otori T, 2003, CLIN EXP PHARMACOL P, V30, P266, DOI 10.1046/j.1440-1681.2003.03825.x; Pappas BA, 1996, BRAIN RES, V708, P50, DOI 10.1016/0006-8993(95)01267-2; Pimentel-Coelho PM, 2013, NEUROBIOL AGING, V34, P679, DOI 10.1016/j.neurobiolaging.2012.06.025; Plaschke K, 2001, BRIT J PHARMACOL, V133, P107, DOI 10.1038/sj.bjp.0704061; Pluta R, 2008, ACT NEUR S, V102, P353, DOI 10.1007/978-3-211-85578-2_67; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Sarti C, 2002, BEHAV BRAIN RES, V136, P13, DOI 10.1016/S0166-4328(02)00090-6; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Schmidt-Kastner R, 2005, BRAIN RES, V1052, P28, DOI 10.1016/j.brainres.2005.06.018; SCHNEIDER LH, 1982, NEUROSCI LETT, V33, P281, DOI 10.1016/0304-3940(82)90385-8; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Ueno M, 2002, J CEREBR BLOOD F MET, V22, P97, DOI 10.1097/00004647-200201000-00012; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Vivo M, 2002, BRAIN RES, V955, P104, DOI 10.1016/S0006-8993(02)03373-5; WAKITA H, 1994, ACTA NEUROPATHOL, V87, P484; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019; Yang YM, 2008, J NEUROSCI METH, V167, P176, DOI 10.1016/j.jneumeth.2007.08.005	60	41	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74631	10.1371/journal.pone.0074631	http://dx.doi.org/10.1371/journal.pone.0074631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058609	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900071
J	Riedy, MD; Keefe, KA				Riedy, Matthew D.; Keefe, Kristen A.			Lack of Increased Immediate Early Gene Expression in Rats Reinstating Cocaine-Seeking Behavior to Discrete Sensory Cues	PLOS ONE			English	Article							DORSOMEDIAL PREFRONTAL CORTEX; MESSENGER-RNA EXPRESSION; C-FOS EXPRESSION; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; DORSAL STRIATUM; DIFFERENTIAL INVOLVEMENT; NUCLEUS-ACCUMBENS; NEURAL ACTIVATION; ETHANOL-SEEKING	Drug-seeking behavior elicited by drug-associated cues contributes to relapse in addiction; however, whether relapse elicited by drug-associated conditioned reinforcers (CR) versus discriminative stimuli (DS) involves distinct or overlapping neuronal populations is unknown. To address this question, we developed a novel cocaine self-administration and cue-induced reinstatement paradigm that exposed the same rats to distinct cocaine-associated CR and DS. Rats were trained to self-administer cocaine in separate sessions. In one, a DS signaled cocaine availability; in the other, cocaine delivery was paired with a different CR. After extinction training and reinstatement testing, where both cues were presented in separate sessions, rats were sacrificed and processed for cellular analysis of temporal activity by fluorescent in situ hybridization (CatFISH) for activity regulated cytoskeleton-associated protein (Arc) mRNA and for radioactive in situ hybridization for Arc and zif268 mRNAs. CatFISH did not reveal significant changes in Arc mRNA expression. Similar results were obtained with radioactive in situ hybridization. We have shown that while rats reinstate drug seeking in response to temporally discrete presentations of distinct drug-associated cues, such reinstatement is not associated with increased transcriptional activation of Arc or zif268 mRNAs, suggesting that expression of these genes may not be necessary for cue-induced reinstatement of drug-seeking behavior.	[Riedy, Matthew D.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; Univ Utah, Program Neurosci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Riedy, MD (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA.	riedy@musc.edu			National Institute on Drug Abuse [DA022447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA022447] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse [DA022447]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JI, 2005, PHARMACOL BIOCHEM BE, V80, P297, DOI 10.1016/j.pbb.2004.12.001; Bailey SR, 2010, ADDICTION, V105, P364, DOI 10.1111/j.1360-0443.2009.02760.x; Barker-Haliski ML, 2012, J NEUROCHEM, V123, P845, DOI 10.1111/jnc.12017; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Buffalari DM, 2011, PSYCHOPHARMACOLOGY, V213, P19, DOI 10.1007/s00213-010-2008-3; Burbassi S, 2008, PSYCHOPHARMACOLOGY, V196, P15, DOI 10.1007/s00213-007-0916-7; Childress A, 1988, NIDA Res Monogr, V81, P74; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Daberkow DP, 2007, EUR J NEUROSCI, V26, P228, DOI 10.1111/j.1460-9568.2007.05630.x; Dayas CV, 2007, BIOL PSYCHIAT, V61, P979, DOI 10.1016/j.biopsych.2006.07.034; Di Ciano P, 2004, EUR J NEUROSCI, V19, P1661, DOI 10.1111/j.1460-9568.2004.03232.x; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feltenstein MW, 2006, BEHAV BRAIN RES, V174, P1, DOI 10.1016/j.bbr.2006.06.039; Fuchs RA, 2004, J NEUROSCI, V24, P6600, DOI 10.1523/JNEUROSCI.1924-04.2004; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Fuchs RA, 2004, PSYCHOPHARMACOLOGY, V176, P459, DOI 10.1007/s00213-004-1895-6; Ghitza UE, 2003, J NEUROSCI, V23, P7239; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hearing MC, 2008, BRAIN STRUCT FUNCT, V213, P215, DOI 10.1007/s00429-008-0182-4; Hearing MC, 2008, PSYCHOPHARMACOLOGY, V198, P77, DOI 10.1007/s00213-008-1090-2; Hearing MC, 2011, INT J NEUROPSYCHOPH, V14, P784, DOI 10.1017/S1461145710001173; Hutcheson DM, 2003, ANN NY ACAD SCI, V1003, P410, DOI 10.1196/annals.1300.038; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Kalivas Peter W, 2004, Curr Psychiatry Rep, V6, P347, DOI 10.1007/s11920-004-0021-0; Kantak KM, 2002, PSYCHOPHARMACOLOGY, V161, P278, DOI 10.1007/s00213-002-1036-z; Keefe KA, 1998, DEV NEUROSCI-BASEL, V20, P216, DOI 10.1159/000017315; Kelly MP, 2003, J NEUROSCI, V23, P6443; Koya E, 2006, J NEUROCHEM, V98, P905, DOI 10.1111/j.1471-4159.2006.03917.x; Lasseter HC, 2009, EUR J NEUROSCI, V30, P1370, DOI 10.1111/j.1460-9568.2009.06906.x; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Radwanska K, 2008, NEUROPSYCHOPHARMACOL, V33, P1835, DOI 10.1038/sj.npp.1301567; Riedy MD, 2009, ADV BEHAV BIOL, P275; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Smith RJ, 2009, EUR J NEUROSCI, V30, P493, DOI 10.1111/j.1460-9568.2009.06844.x; Thomas KL, 2003, EUR J NEUROSCI, V17, P1964, DOI 10.1046/j.1460-9568.2003.02617.x; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Volkow ND, 1997, ANN NY ACAD SCI, V820, P41, DOI 10.1111/j.1749-6632.1997.tb46188.x; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; Yun IA, 2003, NEUROSCIENCE, V121, P747, DOI 10.1016/S0306-4522(03)00531-1; Zavala AR, 2008, SYNAPSE, V62, P421, DOI 10.1002/syn.20502; Zhang FQ, 2005, NEUROSCI LETT, V386, P133, DOI 10.1016/j.neulet.2005.06.008; Zhao Y, 2006, J NEUROSCI, V26, P9967, DOI 10.1523/JNEUROSCI.2384-06.2006; Ziolkowska B, 2011, J NEURAL TRANSM, V118, P877, DOI 10.1007/s00702-011-0583-z	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e72883	10.1371/journal.pone.0072883	http://dx.doi.org/10.1371/journal.pone.0072883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069163	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300003
J	Attri, P; Choi, EH				Attri, Pankaj; Choi, Eun Ha			Influence of Reactive Oxygen Species on the Enzyme Stability and Activity in the Presence of Ionic Liquids	PLOS ONE			English	Article							REFOLDING ADDITIVES; ALPHA-CHYMOTRYPSIN; PLASMA; WATER; UREA	In this paper, we have examined the effect of ammonium and imidazolium based ionic liquids (ILs) on the stability and activity of proteolytic enzyme alpha-chymotrypsin (CT) in the presence of cold atmospheric pressure plasma jet (APPJ). The present work aims to illustrate the state of art implementing the combined action of ILs and APPJ on the enzyme stability and activity. Our circular dichroism (CD), fluorescence and enzyme activity results of CT have revealed that buffer and all studied ILs {triethylammonium hydrogen sulphate (TEAS) from ammonium family and 1-butyl-3-methyl imidazolium chloride ([Bmim][Cl]), 1-methylimidazolium chloride ([Mim][Cl]) from imidazolium family} are notable to act as protective agents against the deleterious action of the APPJ, except triethylammonium dihydrogen phosphate (TEAP) ammonium IL. However, TEAP attenuates strongly the deleterious action of reactive oxygen species (ROS) created by APPJ on native structure of CT. Further, TEAP is able to retain the enzymatic activity after APPJ exposure which is absent in all the other systems. This study provides the first combined effect of APPJ and ILs on biomolecules that may generate many theoretical and experimental opportunities. Through this methodology, we can utilise both enzyme and plasma simultaneously without affecting the enzyme structure and activity on the material surface; which can prove to be applicable in various fields.	[Attri, Pankaj; Choi, Eun Ha] Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea	Kwangwoon University	Attri, P (corresponding author), Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea.	chem.pankaj@gmail.com; ehchoi@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022; Attri, Pankaj/ABE-7522-2020	Choi, Eun Ha/0000-0001-5385-1878; Attri, Pankaj/0000-0002-5036-7877	SRC program of National Research Foundation of Korea (NRF); Korean Government (MEST) [20100029418]; Kwangwoon University	SRC program of National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Kwangwoon University	The authors gratefully acknowledge SRC program of National Research Foundation of Korea (NRF) grant funded by the Korean Government (MEST) (number 20100029418) and in part by Kwangwoon University 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Attri P., 2013, PLOS ONE, V88, DOI [DOI 10.1371/J0URNAL.P0NE.0068970, 10.1371/journal.pone.0068970.]; Attri P, 2013, RSC ADV, V3, P12540, DOI 10.1039/c3ra41277f; Attri P, 2012, RSC ADV, V2, P7146, DOI 10.1039/c2ra20085f; Attri P, 2012, ORG BIOMOL CHEM, V10, P7475, DOI 10.1039/c2ob26001h; Attri P, 2011, J PHYS CHEM B, V115, P10086, DOI 10.1021/jp2059084; Attri P, 2011, PHYS CHEM CHEM PHYS, V13, P6566, DOI 10.1039/c0cp02768e; Attri P, 2010, J PHYS CHEM B, V114, P1471, DOI 10.1021/jp9092332; Baba K, 2010, CHEM COMMUN, V46, P255, DOI 10.1039/b918505d; Baker SN, 2004, CHEM COMMUN, P940, DOI 10.1039/b401304m; Branden C., 1999, INTRO PROTEIN STRUCT; Chen XW, 2010, ANAL METHODS-UK, V2, P1222, DOI 10.1039/c0ay00342e; Chiappe C, 2011, J PHYS CHEM B, V115, P9653, DOI 10.1021/jp2045788; Constantinescu D, 2007, ANGEW CHEM INT EDIT, V46, P8887, DOI 10.1002/anie.200702295; Davis JH, 2004, CHEM LETT, V33, P1072, DOI 10.1246/cl.2004.1072; De Diego T, 2004, BIOTECHNOL BIOENG, V88, P916, DOI 10.1002/bit.20330; Dickerson R.E., 1969, STRUCTURE ACTION PRO; Dudak FC, 2007, P 28 ICPIG PRAG, DOI [10.1021/bp025665e, DOI 10.1021/BP025665E]; El Abedin SZ, 2007, GREEN CHEM, V9, P549, DOI 10.1039/b614520e; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Flores-Fernandez GM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-57; Freemantle M, 2010, INTRODUCTION TO IONIC LIQUIDS, P1; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fujita K, 2005, CHEM COMMUN, P4804, DOI 10.1039/b508238b; Gao CH, 2001, J FOOD SCI, V66, P89; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hardelin L, 2012, J APPL POLYM SCI, V125, P1901, DOI 10.1002/app.36323; Hong YJ, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/C03046; Hong YC, 2006, APPL PHYS LETT, V89; Kumar A, 2012, CHEM REV, V112, P4283, DOI 10.1021/cr2003773; Lange C, 2005, PROTEIN SCI, V14, P2693, DOI 10.1110/ps.051596605; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P158, DOI 10.1109/TPS.2002.1003972; Meiss SA, 2007, CHEMPHYSCHEM, V8, P50, DOI 10.1002/cphc.200600582; O'Connell D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3521502; Ortiz-Costa S, 2002, ARCH BIOCHEM BIOPHYS, V408, P272, DOI 10.1016/S0003-9861(02)00565-9; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001; Ptasinska Sylwia, 2009, Journal of Physics: Conference Series, V194, DOI 10.1088/1742-6596/194/15/152029; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Rather GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049241; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; Rutala WA, 1998, AM J INFECT CONTROL, V26, P393, DOI 10.1016/S0196-6553(98)70034-3; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; Shukla D, 2011, J AM CHEM SOC, V133, P18713, DOI 10.1021/ja205215t; Summers CA, 2000, PROTEIN SCI, V9, P2001, DOI 10.1110/ps.9.10.2001; Takai E, 2012, PLASMA PROCESS POLYM, V9, P77, DOI 10.1002/ppap.201100063; Tang SK, 2012, CHEM SOC REV, V41, P4030, DOI 10.1039/c2cs15362a; van Rantwijk F, 2007, CHEM REV, V107, P2757, DOI 10.1021/cr050946x; Ventura SPM, 2012, GREEN CHEM, V14, P1620, DOI 10.1039/c2gc35197h; Vrikkis RM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3156810; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zhang X, 2008, APPL PHYS LETT, V93	54	51	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75096	10.1371/journal.pone.0075096	http://dx.doi.org/10.1371/journal.pone.0075096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066167	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000149
J	Bullon, P; Battino, M; Varela-Lopez, A; Perez-Lopez, P; Granados-Principal, S; Ramirez-Tortosa, MC; Ochoa, JJ; Cordero, MD; Gonzalez-Alonso, A; Ramirez-Tortosa, CL; Rubini, C; Zizzi, A; Quiles, JL				Bullon, Pedro; Battino, Maurizio; Varela-Lopez, Alfonso; Perez-Lopez, Patricia; Granados-Principal, Sergio; Ramirez-Tortosa, Maria C.; Ochoa, Julio J.; Cordero, Mario D.; Gonzalez-Alonso, Adrian; Ramirez-Tortosa, Cesar L.; Rubini, Corrado; Zizzi, Antonio; Quiles, Jose L.			Diets Based on Virgin Olive Oil or Fish Oil but Not on Sunflower Oil Prevent Age-Related Alveolar Bone Resorption by Mitochondrial-Related Mechanisms	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; OXIDATIVE STRESS; METABOLIC SYNDROME; DNA DELETION; PERIODONTITIS; N-3; INTERLEUKIN-1-BETA; SUPPLEMENTATION; ASSOCIATION; EXPRESSION	Background/Objectives: Aging enhances frequency of chronic diseases like cardiovascular diseases or periodontitis. Here we reproduced an age-dependent model of the periodontium, a fully physiological approach to periodontal conditions, to evaluate the impact of dietary fat type on gingival tissue of young (6 months old) and old (24 months old) rats. Methods/Findings: Animals were fed life-long on diets based on monounsaturated fatty acids (MUFA) as virgin olive oil, n-6 polyunsaturated fatty acids (n-6PUFA), as sunflower oil, or n-3PUFA, as fish oil. Age-related alveolar bone loss was higher in n-6PUFA fed rats, probably as a consequence of the ablation of the cell capacity to adapt to aging. Gene expression analysis suggests that MUFA or n-3PUFA allowed mitochondria to maintain an adequate turnover through induction of biogenesis, autophagy and the antioxidant systems, and avoiding mitochondrial electron transport system alterations. Conclusions: The main finding is that the enhanced alveolar bone loss associated to age may be targeted by an appropriate dietary treatment. The mechanisms involved in this phenomenon are related with an ablation of the cell capacity to adapt to aging. Thus, MUFA or n-3PUFA might allow mitochondrial maintaining turnover through biogenesis or autophagy. They might also be able to induce the corresponding antioxidant systems to counteract age-related oxidative stress, and do not inhibit mitochondrial electron transport chain. From the nutritional and clinical point of view, it is noteworthy that the potential treatments to attenuate alveolar bone loss (a feature of periodontal disease) associated to age could be similar to some of the proposed for the prevention and treatment of cardiovascular diseases, a group of pathologies recently associated with age-related periodontitis.	[Bullon, Pedro] Univ Seville, Sch Dent, Dept Periodontol, Seville, Spain; [Battino, Maurizio] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Varela-Lopez, Alfonso; Perez-Lopez, Patricia; Ochoa, Julio J.; Gonzalez-Alonso, Adrian; Quiles, Jose L.] Univ Granada, Dept Physiol, Inst Nutr & Food Technol Jose Mataix Verdu, Granada, Spain; [Granados-Principal, Sergio; Ramirez-Tortosa, Maria C.] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Biochem & Mol Biol 2, Granada, Spain; [Cordero, Mario D.] Univ Seville, Dept Citol & Histol Normal & Patol, Seville, Spain; [Ramirez-Tortosa, Cesar L.] Complejo Hosp Jaen, Dept Pathol, Jaen, Spain; [Rubini, Corrado; Zizzi, Antonio] Univ Politecn Marche, Dipartimento Sci Biomed Sanita Pubbl, Ancona, Italy	University of Sevilla; Marche Polytechnic University; University of Granada; University of Granada; University of Sevilla; Complejo Hospitalario de Jaen; Marche Polytechnic University	Battino, M (corresponding author), Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy.	m.a.battino@univpm.it	Granados-Principal, Sergio/B-4987-2014; IBIS, PERIODONTAL/I-5076-2016; Quiles, José L./C-6911-2013; Ramírez-Tortosa, César/F-2055-2016; Ochoa, Julio/L-8733-2014; Varela-López, Alfonso/F-8055-2016; Battino, Maurizio/E-6103-2012; Cordero, Mario D./L-8006-2014; Bullon, Pedro/E-6319-2010	Granados-Principal, Sergio/0000-0001-8773-9489; Quiles, José L./0000-0002-9048-9086; Ramírez-Tortosa, César/0000-0002-3302-707X; Ochoa, Julio/0000-0001-8976-6296; Varela-López, Alfonso/0000-0002-0504-5086; Battino, Maurizio/0000-0002-7250-1782; Cordero, Mario D./0000-0003-0151-3644; Bullon, Pedro/0000-0003-4873-4196; Zizzi, Antonio/0000-0001-5253-693X	Spanish Ministry of Education and Science [AGL2008-01057]; Autonomous Government of Andalusia [AGR832]	Spanish Ministry of Education and Science(Spanish Government); Autonomous Government of Andalusia	This study was supported by I+D grants from the Spanish Ministry of Education and Science (AGL2008-01057) and the Autonomous Government of Andalusia (AGR832). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2005, ARCH GERONTOL GERIAT, V40, P225, DOI 10.1016/j.archger.2004.08.005; Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218; Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Benatti BB, 2009, CYTOKINE, V46, P176, DOI 10.1016/j.cyto.2009.01.002; Bendyk A, 2009, J PERIODONTAL RES, V44, P211, DOI 10.1111/j.1600-0765.2008.01108.x; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bullon P, 2009, J DENT RES, V88, P503, DOI 10.1177/0022034509337479; Bullon P, 2011, FREE RADICAL BIO MED, V50, P1336, DOI 10.1016/j.freeradbiomed.2011.02.018; BURT BA, 1994, J AM DENT ASSOC, V125, P273, DOI 10.14219/jada.archive.1994.0034; Campan P, 1997, J CLIN PERIODONTOL, V24, P907, DOI 10.1111/j.1600-051X.1997.tb01210.x; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Eberhard J, 2002, J CLIN PERIODONTOL, V29, P364, DOI 10.1034/j.1600-051X.2002.290413.x; EI-Sharkawy H, 2010, J PERIODONTOL, V81, P1635, DOI 10.1902/jop.2010.090628; Enoki N, 2007, J MOL HISTOL, V38, P321, DOI 10.1007/s10735-007-9105-6; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; Hakansson J, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-32; Harma M, 2004, ACTA OBSTET GYN SCAN, V83, P857, DOI 10.1111/j.0001-6349.2004.00608.x; Iwasaki M, 2010, NUTRITION, V26, P1105, DOI 10.1016/j.nut.2009.09.010; Jarnbring F, 2002, J CLIN PERIODONTOL, V29, P1065, DOI 10.1034/j.1600-051X.2002.291203.x; Jules J, 2010, EXPERT OPIN THER TAR, V14, P923, DOI 10.1517/14728222.2010.511179; Kaye EK, 2010, J AM DIET ASSOC, V110, P1650, DOI 10.1016/j.jada.2010.08.017; Kesavalu L, 2007, ORAL MICROBIOL IMMUN, V22, P232, DOI 10.1111/j.1399-302X.2007.00346.x; LEPAGE G, 1986, J LIPID RES, V27, P114; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Naqvi AZ, 2010, J AM DIET ASSOC, V110, P1669, DOI 10.1016/j.jada.2010.08.009; Nesbitt MJ, 2010, AGING CLIN EXP RES, V22, P238, DOI 10.1007/BF03324802; NEWMAN HN, 1974, BRIT DENT J, V136, P491, DOI 10.1038/sj.bdj.4803220; Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839; Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004; Okamura H, 1999, EXP GERONTOL, V34, P379, DOI 10.1016/S0531-5565(99)00006-6; Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107; Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002; Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096; Quiles JL, 2010, MECH AGEING DEV, V131, P38, DOI 10.1016/j.mad.2009.11.004; Reeves PG, 1997, J NUTR, V127, pS838; Rosenstein ED, 2003, PROSTAG LEUKOTR ESS, V68, P213, DOI 10.1016/S0952-3278(02)00272-7; Santos-Gonzalez M, 2012, AGE, V34, P341, DOI 10.1007/s11357-011-9239-z; Uauy R, 2009, ANN NUTR METAB, V54, P2, DOI 10.1159/000220821; VANDERVELDEN U, 1991, J CLIN PERIODONTOL, V18, P380; Vardar-Sengul S, 2006, J PERIODONTOL, V77, P814, DOI 10.1902/jop.2006.050214; Wada N, 2004, BONE, V35, P629, DOI 10.1016/j.bone.2004.04.023	44	35	36	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74234	10.1371/journal.pone.0074234	http://dx.doi.org/10.1371/journal.pone.0074234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066124	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000106
J	Caetano, S; Mottola, J; Finguerman, F; Goldman, SM; Szejnfeld, J				Caetano, Simone; Mottola Junior, Juvenal; Finguerman, Flora; Goldman, Suzan M.; Szejnfeld, Jacob			Mammographic Assessment of a Geographically Defined Population at a Mastology Referral Hospital in Sao Paulo Brazil	PLOS ONE			English	Article							BREAST-CANCER DETECTION; SCREENING MAMMOGRAPHY; PERFORMANCE BENCHMARKS; DIAGNOSTIC MAMMOGRAPHY; AGE	Objective: To evaluate the results of screening and diagnostic mammography in a geographically defined population attending a regional mastology referral hospital of the State Public Service of Sao Paulo. Methods: A total of 7508 women, who received screening or diagnostic mammography examinations from 06/2004 to 06/2005, with follow-up until 06/2006, were included in this study. Data corresponding to age, the Breast Imaging-Reporting and Data System (BI-RADS), biopsy, surgery and the stage of breast cancer were collected. Five-year survival of patients with breast cancer was posteriorly calculated during this period. Results: This study included a total of 713 diagnostic and 6795 screening mammograms. The average age of the population was 51.2 years, with a BI-RADS end result of 4 and 5 (abnormal) in 1.9% of the screening and 11.4% of the diagnostic mammograms, respectively. All BI-RADS category zero was complemented. Of the 228 nonsurgical biopsies performed (71 CNB, 94 mammotomy and 63 FNAB), 63 (27.6%) biopsies were malignant findings. Among the 33 surgical biopsies, 10 (30.3%) biopsies were malignant findings, and of the 82 surgeries, 55 (67, 1%) procedures showed malignant findings. Seventy-one (0.9%) breast cancers (25/6795 on screening exams and 46/713 on diagnostics) were diagnosed. A total of 28.6% small cancers (<= 10 mm) were observed, with 27% of the cancers in stages zero and I. Approximately 47.6% of the cases showed nodal invasion, and 4.5% of cases were not staged. Overall detection rate of breast cancer was 8.8/1000 (3.2/1000 screening and 61.7/1000 diagnostic). The overall 5-year survival rate of patients with breast cancer in this population was 79.1%. Conclusion: Survival is a key index of the overall effectiveness of health services in the management of patients with cancer. Our results suggest that this approach is feasible and can potentially improve breast cancer outcomes for many women in Sao Paulo.	[Caetano, Simone; Finguerman, Flora; Goldman, Suzan M.; Szejnfeld, Jacob] Fundacao Pesquisa & Estudo Diagnost Imagem FIDI, Sao Paulo, Brazil; [Mottola Junior, Juvenal] Secretaria Saude Estado Sao Paulo, Sao Paulo, Brazil; [Goldman, Suzan M.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Diagnost Imagem, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Goldman, SM (corresponding author), Fundacao Pesquisa & Estudo Diagnost Imagem FIDI, Sao Paulo, Brazil.	smgold@terra.com.br		Caetano, Simone/0000-0002-6442-6540	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto de Pesquisa e Ensino de Medicina Diagnostica e Terapeutica (IPmed)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto de Pesquisa e Ensino de Medicina Diagnostica e Terapeutica (IPmed)	The authors would like to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Instituto de Pesquisa e Ensino de Medicina Diagnostica e Terapeutica (IPmed) for the financial support for data collection and scientific support for data analysis and preparation of the manuscript.	Aguillar VLN, 2003, REV BRASIL MASTOL, V13, P82; Azevedo AC, 2005, RADIOL BRAS, V38, P431; Brasil. Ministerio da Saude. Instituto Nacional de Cancer. SISMAMA, 2010, GLOBO; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; D'Orsi C, 2003, BREAST IMAGING REPOR; Mattos JSD, 2013, ANTICANCER RES, V33, P2651; Duijm LEM, 2009, BRIT J CANCER, V100, P901, DOI 10.1038/sj.bjc.6604954; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; INCA-INSTITUTO NACIONAL DO CANCER JOSE ALENCAR GOMES DA SILVA, 2020, EST 2020 INC CANC BR; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Keen JD, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-40; Kopans DB, 2007, BREAST IMAGING, P121; Leung JWT, 2007, AM J ROENTGENOL, V188, P236, DOI 10.2214/AJR.05.1581; Marchi AA, 2010, REV BRAS GINECOL OBS, V32, P191, DOI 10.1590/S0100-72032010000400007; Milani V, 2007, SAO PAULO MED J, V125, P210, DOI 10.1590/S1516-31802007000400003; Poplack SP, 2000, RADIOLOGY, V217, P832, DOI 10.1148/radiology.217.3.r00dc33832; Puschel K, 2010, CANCER EPIDEM BIOMAR, V19, P2254, DOI 10.1158/1055-9965.EPI-10-0313; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Schell MJ, 2007, RADIOLOGY, V243, P681, DOI 10.1148/radiol.2433060372; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Sohlich RE, 2002, AM J ROENTGENOL, V178, P681, DOI 10.2214/ajr.178.3.1780681; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74270	10.1371/journal.pone.0074270	http://dx.doi.org/10.1371/journal.pone.0074270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066130	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000112
J	Cohen, PJ; Alexander, TJ				Cohen, Philippa Jane; Alexander, Timothy J.			Catch Rates, Composition and Fish Size from Reefs Managed with Periodically-Harvested Closures	PLOS ONE			English	Article							TROCHUS-NILOTICUS GASTROPODA; MARINE RESOURCE-MANAGEMENT; SMALL-SCALE FISHERIES; STRUCTURAL-CHANGE; PREDATORY FISH; FOOD SECURITY; WEST NGGELA; RESERVES; CONSERVATION; COMMUNITY	Periodically-harvested closures are commonly employed within co-management frameworks to help manage small-scale, multi-species fisheries in the Indo-Pacific. Despite their widespread use, the benefits of periodic harvesting strategies for multi-species fisheries have, to date, been largely untested. We examine catch and effort data from four periodically-harvested reef areas and 55 continuously-fished reefs in Solomon Islands. We test the hypothesis that fishing in periodically-harvested closures would yield: (a) higher catch rates, (b) proportionally more short lived, fast growing, sedentary taxa, and (c) larger finfish and invertebrates, compared to catches from reefs continuously open to fishing. Our study showed that catch rates were significantly higher from periodically-harvested closures for gleaning of invertebrates, but not for line and spear fishing. The family level composition of catches did not vary significantly between open reefs and periodically-harvested closures. Fish captured from periodically-harvested closures were slightly larger, but Trochus niloticus were significantly smaller than those from continuously open reefs. In one case of intense and prolonged harvesting, gleaning catch rates significantly declined, suggesting invertebrate stocks were substantially depleted in the early stages of the open period. Our study suggests periodically-harvested closures can have some short term benefits via increasing harvesting efficiency. However, we did not find evidence that the strategy had substantially benefited multi-species fin-fisheries.	[Cohen, Philippa Jane] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cohen, Philippa Jane; Alexander, Timothy J.] WorldFish, Solomon Islands Off, Honiara, Solomon Islands	James Cook University; CGIAR; Worldfish	Cohen, PJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	p.cohen@cgiar.org		Cohen, Philippa/0000-0002-9987-1943	Australian Postgraduate Award; Australian Research Council Discovery Project grant [DP0987537]; Australian Centre for International Agricultural Research grant [FIS/2012/056]; CGIAR Research Program on Aquatic Agricultural Systems	Australian Postgraduate Award(Australian Government); Australian Research Council Discovery Project grant(Australian Research Council); Australian Centre for International Agricultural Research grant(Australian Ctr Intl Agr Res); CGIAR Research Program on Aquatic Agricultural Systems(CGIAR)	This work was supported by an Australian Postgraduate Award, an Australian Research Council Discovery Project grant (DP0987537), an Australian Centre for International Agricultural Research grant (FIS/2012/056) and the CGIAR Research Program on Aquatic Agricultural Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Allee W., 1949, PRINCIPLES ANIMAL EC; Amos MJ, 2003, AQUACULTURE, V218, P235, DOI 10.1016/S0044-8486(02)00511-2; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Bell JD, 2008, OCEAN COAST MANAGE, V51, P589, DOI 10.1016/j.ocecoaman.2008.06.011; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Beverton RJ, 1957, DYNAMICS EXPLOITED F, V19, P533; Botsford LW, 1993, ROTATING SPATIAL HAR, P409; Caddy J.F., 1993, MAR FISH REV, V55, P10; Caddy JF, 1998, SPECIAL PUBLICATION, V125, P359; Carrier J. G., 1987, QUESTION COMMONS CUL, P142; Choat JH, 1996, MAR ECOL PROG SER, V134, P15, DOI 10.3354/meps134015; Christie P, 2004, AM FISH S S, V42, P155; Cinner JE, 2005, CONSERV BIOL, V19, P1714, DOI 10.1111/j.1523-1739.2005.00209.x-i1; Cinner J, 2006, ECOL SOC, V11; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clarke PJ, 2003, AQUACULTURE, V215, P123, DOI 10.1016/S0044-8486(02)00222-3; Cohen P, 2013, GLOBAL ENV IN PRESS; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; DEVLAMING V, 1982, COMP BIOCHEM PHYS A, V73, P31, DOI 10.1016/0300-9629(82)90088-3; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Evans SM, 1997, FISH RES, V31, P83, DOI 10.1016/S0165-7836(97)00011-8; FAO, 2010, MAR FISH RES PAC ISL; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Foale S, 1997, FISH RES, V33, P1, DOI 10.1016/S0165-7836(97)00062-3; Foale S, 1998, OCEAN COAST MANAGE, V40, P187, DOI 10.1016/S0964-5691(98)00044-1; Foale S., 2004, ASIA PAC VIEWP, V45, P373; Foale S., 1998, SPC TRADITIONAL MARI, V9, P2; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Foale S, 2011, FISH FISH, V12, P357, DOI 10.1111/j.1467-2979.2010.00395.x; FROESE R., 2012, FISHBASE; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gendron L, 2002, CAN J FISH AQUAT SCI, V59, P899, DOI 10.1139/F02-068; Gorley C.K., 2006, GETTING STARTED PRIM; Govan H., 2009, SPC TRAD MAR RESOUR, V25, P16; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1760, DOI 10.1139/cjfas-58-9-1760; Hart DR, 2003, FISH B-NOAA, V101, P44; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; Jennings S, 1999, CONSERV BIOL, V13, P1466, DOI 10.1046/j.1523-1739.1999.98324.x; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Kaplan DM, 2010, ECOL LETT, V13, pE10, DOI 10.1111/j.1461-0248.2010.01499.x; Kulbicki M, 2007, J EXP MAR BIOL ECOL, V353, P145, DOI 10.1016/j.jembe.2007.02.021; Lincoln-Smith MP, 2006, CAN J FISH AQUAT SCI, V63, P1251, DOI 10.1139/F06-033; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; MCCALLUM HI, 1988, MATH BIOSCI, V89, P177, DOI 10.1016/0025-5564(88)90098-3; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McLeod E, 2009, COAST MANAGE, V37, P656, DOI 10.1080/08920750903244143; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Myers RA, 2000, CAN J FISH AQUAT SCI, V57, P2357, DOI 10.1139/cjfas-57-12-2357; Nash W, 1995, AITUTAKI TROCHUS FIS; Nash WJ, 1993, NEARSHORE MARINE RES, P710; Palomares MLD, 2012, SEALIFEBASE; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pfister CA, 1996, ECOL APPL, V6, P298, DOI 10.2307/2269573; Pinheiro JC, 2000, MIXED EVECTS MODELS; Rasband W., 2006, IMAGEJ; RICHARDS AH, 1994, MAR POLLUT BULL, V29, P90, DOI 10.1016/0025-326X(94)90431-6; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; SLUCZANOWSKI PR, 1984, CAN J FISH AQUAT SCI, V41, P1008, DOI 10.1139/f84-117; Stoner AW, 2000, MAR ECOL PROG SER, V202, P297, DOI 10.3354/meps202297; Thorburn CC, 2000, WORLD DEV, V28, P1461, DOI 10.1016/S0305-750X(00)00039-5; Valderrama D, 2007, LAND ECON, V83, P86, DOI 10.3368/le.83.1.86; Williams ID, 2006, MAR ECOL PROG SER, V310, P139, DOI 10.3354/meps310139	76	28	29	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73383	10.1371/journal.pone.0073383	http://dx.doi.org/10.1371/journal.pone.0073383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066044	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000324494000025
J	Daniels, IS; OBrien, WG; Nath, V; Zhao, ZY; Lee, CC				Daniels, Isadora Susan; OBrien, William G., III; Nath, Vinay; Zhao, Zhaoyang; Lee, Cheng Chi			AMP Deaminase 3 Deficiency Enhanced 5 '-AMP Induction of Hypometabolism	PLOS ONE			English	Article							HUMAN ERYTHROCYTE; TORPOR; MAMMALS; MICE; INVERTEBRATES; VERTEBRATES; EXPRESSION; ADENOSINE; TISSUES; MODEL	A hypometabolic state can be induced in mice by 5'-AMP administration. Previously we proposed that an underlying mechanism for this hypometabolism is linked to reduced erythrocyte oxygen transport function due to 5'-AMP uptake altering the cellular adenylate equilibrium. To test this hypothesis, we generated mice deficient in adenosine monophosphate deaminase 3 (AMPD3), the key catabolic enzyme for 5'-AMP in erythrocytes. Mice deficient in AMPD3 maintained AMPD activities in all tissues except erythrocytes. Developmentally and morphologically, the Ampd3(-/-) mice were indistinguishable from their wild type siblings. The levels of ATP, ADP but not 5'-AMP in erythrocytes of Ampd3(-/-) mice were significantly elevated. Fasting blood glucose levels of the Ampd3(-/-) mice were comparable to wild type siblings. In comparison to wild type mice, the Ampd3(-/-) mice displayed a deeper hypometabolism with a significantly delayed average arousal time in response to 5'-AMP administration. Together, these findings demonstrate a central role of AMPD3 in the regulation of 5'-AMP mediated hypometabolism and further implicate erythrocytes in this behavioral response.	[Daniels, Isadora Susan; OBrien, William G., III; Nath, Vinay; Zhao, Zhaoyang; Lee, Cheng Chi] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Lee, CC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Cheng.C.Lee@uth.tmc.edu		Daniels, Isadora/0000-0002-1351-2908	NIH [5 DP1 OD000895]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding grant NIH 5 DP1 OD000895. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ARCH JRS, 1978, BIOCHEM J, V174, P965, DOI 10.1042/bj1740965; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bouma HR, 2012, J CELL PHYSIOL, V227, P1285, DOI 10.1002/jcp.22850; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Cheng J, 2012, GENES CELLS, V17, P913, DOI 10.1111/gtc.12006; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; HAYDEN P, 1970, COMP BIOCHEM PHYSIOL, V33, P167, DOI 10.1016/0010-406X(70)90492-5; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; IKEDA S, 1965, TOHOKU J EXP MED, V87, P185, DOI 10.1620/tjem.87.185; Lehninger A L, 1982, PRINCIPLES BIOCH; LOWY BA, 1962, J BIOL CHEM, V237, P1622; LOWY BA, 1970, J BIOL CHEM, V245, P3043; MAHNKEZIZELMAN DK, 1992, J BIOL CHEM, V267, P20866; Maniatis T., 1982, MOL CLONING; Mathews WB, 2005, MOL IMAGING BIOL, V7, P203, DOI 10.1007/s11307-005-4118-6; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; OGASAWARA N, 1982, BIOCHIM BIOPHYS ACTA, V714, P298; OGASAWARA N, 1987, HUM GENET, V75, P15; Pritlove DC, 2006, PLACENTA, V27, P924, DOI 10.1016/j.placenta.2005.08.010; RAFFIN JP, 1991, INT J BIOCHEM, V23, P1069, DOI 10.1016/0020-711X(91)90147-F; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Swoap SJ, 2007, AM J PHYSIOL-REG I, V293, pR468, DOI 10.1152/ajpregu.00888.2006; Tao ZY, 2011, AM J TRANSL RES, V3, P351; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75418	10.1371/journal.pone.0075418	http://dx.doi.org/10.1371/journal.pone.0075418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066180	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000162
J	Giancardo, L; Sona, D; Huang, HP; Sannino, S; Manago, F; Scheggia, D; Papaleo, F; Murino, V				Giancardo, Luca; Sona, Diego; Huang, Huiping; Sannino, Sara; Manago, Francesca; Scheggia, Diego; Papaleo, Francesco; Murino, Vittorio			Automatic Visual Tracking and Social Behaviour Analysis with Multiple Mice	PLOS ONE			English	Article							RODENTS; DENSE	Social interactions are made of complex behavioural actions that might be found in all mammalians, including humans and rodents. Recently, mouse models are increasingly being used in preclinical research to understand the biological basis of social-related pathologies or abnormalities. However, reliable and flexible automatic systems able to precisely quantify social behavioural interactions of multiple mice are still missing. Here, we present a system built on two components. A module able to accurately track the position of multiple interacting mice from videos, regardless of their fur colour or light settings, and a module that automatically characterise social and non-social behaviours. The behavioural analysis is obtained by deriving a new set of specialised spatio-temporal features from the tracker output. These features are further employed by a learning-by-example classifier, which predicts for each frame and for each mouse in the cage one of the behaviours learnt from the examples given by the experimenters. The system is validated on an extensive set of experimental trials involving multiple mice in an open arena. In a first evaluation we compare the classifier output with the independent evaluation of two human graders, obtaining comparable results. Then, we show the applicability of our technique to multiple mice settings, using up to four interacting mice. The system is also compared with a solution recently proposed in the literature that, similarly to us, addresses the problem with a learning-by-examples approach. Finally, we further validated our automatic system to differentiate between C57B/6J (a commonly used reference inbred strain) and BTBR T+tf/J (a mouse model for autism spectrum disorders). Overall, these data demonstrate the validity and effectiveness of this new machine learning system in the detection of social and non-social behaviours in multiple (>2) interacting mice, and its versatility to deal with different experimental settings and scenarios.	[Giancardo, Luca; Sona, Diego; Huang, Huiping; Sannino, Sara; Manago, Francesca; Scheggia, Diego; Papaleo, Francesco; Murino, Vittorio] Ist Italiano Tecnol, Genoa, Italy; [Papaleo, Francesco] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy	Istituto Italiano di Tecnologia - IIT; University of Padua	Giancardo, L (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	luca.giancardo@iit.it; francesco.papaleo@iit.it	Giancardo, Luca/AGY-0035-2022; Scheggia, Diego/AAS-8087-2021; Papaleo, Francesco/AAD-1844-2019; Sona, Diego/A-9667-2014; Managò, Francesca/AAC-1815-2019	Giancardo, Luca/0000-0002-4862-2277; Scheggia, Diego/0000-0003-2586-9717; Papaleo, Francesco/0000-0002-6326-0657; Sona, Diego/0000-0003-2883-5336; Managò, Francesca/0000-0003-3663-6193; Murino, Vittorio/0000-0002-8645-2328	Istituto Italiano di Tecnologia; Marie Curie FP7-Reintegration-Grant [268247]	Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT); Marie Curie FP7-Reintegration-Grant	This research was supported by the Istituto Italiano di Tecnologia and by the Marie Curie FP7-Reintegration-Grant No268247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2011, NATURE, V475, P123, DOI 10.1038/475123a; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Branson K, 2005, PROC CVPR IEEE, P1039; Branson K., 2007, THESIS U CALIFORNIA; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burgos-Artizzu X, 2012, 25 C COMP VIS PATT R; Chang F, 2004, COMPUT VIS IMAGE UND, V93, P206, DOI 10.1016/j.cviu.2003.09.002; Cormen T.H., 2001, INTRO ALGORITHMS; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Dollar P., 2005, Proceedings. 2nd Joint IEEE International Workshop on Visual Surveillance and Performance Evaluation of Tracking and Surveillance (VS-PETS) (IEEE Cat. No. 05EX1178), P65; Gall J, 2011, IEEE T PATTERN ANAL, V33, P2188, DOI 10.1109/TPAMI.2011.70; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; GHEUSI G, 1994, BEHAV PROCESS, V33, P59, DOI 10.1016/0376-6357(94)90060-4; Giancardo L, 2012, 21 INT C PA IN PRESS; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Jhuang H, 2007, IEEE I CONF COMP VIS, P1253; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Khan Z, 2005, IEEE T PATTERN ANAL, V27, P1805, DOI 10.1109/TPAMI.2005.223; Kipp M., 2001, 7 EUR C SPEECH COMM; Klaser A., 2008, BMVC, V275, P1; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kyzar E, 2011, BEHAV BRAIN RES, V225, P426, DOI 10.1016/j.bbr.2011.07.052; Laptev I, 2008, PROC CVPR IEEE, P3222, DOI 10.1109/cvpr.2008.4587756; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Mikolajczyk K, 2008, PROC CVPR IEEE, P2229; Pistori H, 2010, PATTERN RECOGN LETT, V31, P337, DOI 10.1016/j.patrec.2009.05.015; Rapantzikos K, 2009, PROC CVPR IEEE, P1454, DOI 10.1109/CVPRW.2009.5206525; Reddy KK, 2009, IEEE I CONF COMP VIS, P1010, DOI 10.1109/ICCV.2009.5459374; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Willems G, 2008, LECT NOTES COMPUT SC, V5303, P650, DOI 10.1007/978-3-540-88688-4_48; Yang M, 2012, PHYSL BEHAV; Yu T, 2010, P BRIT MACH VIS C, P56	45	52	55	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74557	10.1371/journal.pone.0074557	http://dx.doi.org/10.1371/journal.pone.0074557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066146	Green Published, gold			2022-12-27	WOS:000324494000128
J	Grunau, RE; Cepeda, IL; Chau, CMY; Brummelte, S; Weinberg, J; Lavoie, PM; Ladd, M; Hirschfeld, AF; Russell, E; Koren, G; Van Uum, S; Brant, R; Turvey, SE				Grunau, Ruth E.; Cepeda, Ivan L.; Chau, Cecil M. Y.; Brummelte, Susanne; Weinberg, Joanne; Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Russell, Evan; Koren, Gideon; Van Uum, Stan; Brant, Rollin; Turvey, Stuart E.			Neonatal Pain-Related Stress and NFKBIA Genotype Are Associated with Altered Cortisol Levels in Preterm Boys at School Age	PLOS ONE			English	Article							PRENATAL STRESS; PSYCHOSOCIAL STRESS; PROCEDURAL PAIN; HAIR CORTISOL; INFANTS BORN; BIRTH; LIFE; CHILDHOOD; RESPONSES; REACTIVITY	Neonatal pain-related stress is associated with elevated salivary cortisol levels to age 18 months in children born very preterm, compared to full-term, suggesting early programming effects. Importantly, interactions between immune/inflammatory and neuroendocrine systems may underlie programming effects. We examined whether cortisol changes persist to school age, and if common genetic variants in the promoter region of the NFKBIA gene involved in regulation of immune and inflammatory responses, modify the association between early experience and later life stress as indexed by hair cortisol levels, which provide an integrated index of endogenous HPA axis activity. Cortisol was assayed in hair samples from 128 children (83 born preterm <= 32 weeks gestation and 45 born full-term) without major sensory, motor or cognitive impairments at age 7 years. We found that hair cortisol levels were lower in preterm compared to term-born children. Downregulation of the HPA axis in preterm children without major impairment, seen years after neonatal stress terminated, suggests persistent alteration of stress system programming. Importantly, the etiology was gender-specific such that in preterm boys but not girls, specifically those with the minor allele for NFKBIA rs2233409, lower hair cortisol was associated with greater neonatal pain (number of skin-breaking procedures from birth to term), independent of medical confounders. Moreover, the minor allele (CT or TT) of NFKBIA rs2233409 was associated with higher secretion of inflammatory cytokines, supporting the hypothesis that neonatal pain-related stress may act as a proinflammatory stimulus that induces long-term immune cell activation. These findings are the first evidence that a long-term association between early pain-related stress and cortisol may be mediated by a genetic variants that regulate the activity of NF-kappa B, suggesting possible involvement of stress/inflammatory mechanisms in HPA programming in boys born very preterm.	[Grunau, Ruth E.; Brummelte, Susanne; Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Grunau, Ruth E.; Cepeda, Ivan L.; Chau, Cecil M. Y.; Brummelte, Susanne; Weinberg, Joanne; Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Brant, Rollin; Turvey, Stuart E.] Child & Family Res Inst, Vancouver, BC, Canada; [Russell, Evan; Koren, Gideon; Van Uum, Stan] Univ Western Ontario, London, ON, Canada; [Weinberg, Joanne; Brant, Rollin] Univ British Columbia, Vancouver, BC V6T 1W5, Canada	University of British Columbia; Child & Family Research Institute; Western University (University of Western Ontario); University of British Columbia	Grunau, RE (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.	rgrunau@cw.bc.ca	Koren, Gideon/AAG-7726-2019; Turvey, Stuart/HGV-1191-2022; van Uum, Stan/G-3351-2011	Koren, Gideon/0000-0002-9234-0875; Grunau, Ruth/0000-0002-5428-9212; Cepeda, Ivan Leonardo/0000-0001-9696-4047; Lavoie, Pascal/0000-0002-2205-0362; Weinberg, Joanne/0000-0002-7937-3904; Brant, Rollin/0000-0002-8026-2451; Turvey, Stuart/0000-0003-1599-1065	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health/NICHD [R01 HD039783]; Canadian Institutes of Health Research (CIHR) [MOP86489]; Child and Family Research Institute; Louise and Alan Edwards Postdoctoral Fellowship in Pediatric Pain Research; Canadian Institutes of Health Research (CIHR) Pain in Child Health Strategic Training Initiative; Aubrey J. Tingle Professorship; Michael Smith Foundation for Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039783] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health/NICHD; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute; Louise and Alan Edwards Postdoctoral Fellowship in Pediatric Pain Research; Canadian Institutes of Health Research (CIHR) Pain in Child Health Strategic Training Initiative; Aubrey J. Tingle Professorship; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health/NICHD (http://www.nichd.nih.gov) R01 HD039783 to REG, and the Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca) MOP86489 to REG. REG is supported by a Senior Scientist Award from the Child and Family Research Institute (http://www.cfri.ca). SB was supported by a Louise and Alan Edwards Postdoctoral Fellowship in Pediatric Pain Research (http://painresearchcenter.mcgill.ca) and was a trainee of the Canadian Institutes of Health Research (CIHR) Pain in Child Health Strategic Training Initiative. SET is supported in part by the Aubrey J. Tingle Professorship (http://www.msfhr.org/aubrey-j-tingle-prize) in Pediatric Immunology and a Clinical Research Scholar Award from the Michael Smith Foundation for Health Research (http://www.msfhr.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Bale TL, 2011, STRESS, V14, P348, DOI 10.3109/10253890.2011.586447; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BRUGGEMEIER U, 1991, CELL, V64, P565, DOI 10.1016/0092-8674(91)90240-Y; Buske-Kirschbaum A, 2007, J CLIN ENDOCR METAB, V92, P3429, DOI 10.1210/jc.2006-2223; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Dougherty LR, 2013, J ABNORM CHILD PSYCH, V41, P531, DOI 10.1007/s10802-012-9703-y; Elzinga BM, 2008, PSYCHONEUROENDOCRINO, V33, P227, DOI 10.1016/j.psyneuen.2007.11.004; Fietta P, 2009, PSYCHIAT CLIN NEUROS, V63, P613, DOI 10.1111/j.1440-1819.2009.02005.x; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Grunau RE, 2005, PAIN, V113, P293, DOI 10.1016/j.pain.2004.10.020; Grunau RE, 2000, CLIN J PAIN, V16, P37, DOI 10.1097/00002508-200003000-00007; Grunau RE, 2004, PEDIATRICS, V114, pE77, DOI 10.1542/peds.114.1.e77; Grunau RE, 2001, PEDIATRICS, V107, P105, DOI 10.1542/peds.107.1.105; Grunau RE, 2007, J PEDIATR-US, V150, P151, DOI 10.1016/j.jpeds.2006.10.053; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HINGRE RV, 1994, J CLIN ENDOCR METAB, V78, P266, DOI 10.1210/jc.78.2.266; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Holsti L, 2006, CLIN J PAIN, V22, P757, DOI 10.1097/01.ajp.0000210921.10912.47; Jett PL, 1997, J CLIN ENDOCR METAB, V82, P2921, DOI 10.1210/jc.82.9.2921; Joels M, 2011, PSYCHONEUROENDOCRINO, V36, P406, DOI 10.1016/j.psyneuen.2010.03.004; Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kajantie E, 2002, CLIN ENDOCRINOL, V57, P635, DOI 10.1046/j.1365-2265.2002.01659.x; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Khulan B, 2012, BEST PRACT RES CL EN, V26, P689, DOI 10.1016/j.beem.2012.03.007; Koenig JI, 2011, STRESS, V14, P475, DOI 10.3109/10253890.2011.604879; Korte C, 1996, J PEDIATR-US, V128, P257, DOI 10.1016/S0022-3476(96)70404-3; LaPrairie JL, 2010, FRONT NEUROENDOCRIN, V31, P193, DOI 10.1016/j.yfrne.2010.02.001; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller GE, 2010, PSYCHOL SCI, V21, P848, DOI 10.1177/0956797610370161; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Molina P. E., 2010, ENDOCRINE PHYSL; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Pesonen AK, 2010, PSYCHONEUROENDOCRINO, V35, P758, DOI 10.1016/j.psyneuen.2009.10.017; R Development Core Team, 2008, R LANG ENV STAT COMP; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Sharpley CF, 2012, REV NEUROSCIENCE, V23, P111, DOI 10.1515/RNS.2011.058; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Tukey JW, 1977, EXPLORATORY DATA ANA; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011; Vaghri Z, 2013, PSYCHONEUROENDOCRINO, V38, P331, DOI 10.1016/j.psyneuen.2012.06.009; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Viveros M P, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS217, DOI 10.1016/j.psyneuen.2009.05.015; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Zhang GL, 2011, INFLAMM RES, V60, P11, DOI 10.1007/s00011-010-0216-2	63	66	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73926	10.1371/journal.pone.0073926	http://dx.doi.org/10.1371/journal.pone.0073926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066085	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000067
J	Nakase, J; Inaki, A; Mochizuki, T; Toratani, T; Kosaka, M; Ohashi, Y; Taki, J; Yahata, T; Kinuya, S; Tsuchiya, H				Nakase, Junsuke; Inaki, Anri; Mochizuki, Takafumi; Toratani, Tatsuhiro; Kosaka, Masahiro; Ohashi, Yoshinori; Taki, Junichi; Yahata, Tetsutaro; Kinuya, Seigo; Tsuchiya, Hiroyuki			Whole Body Muscle Activity during the FIFA 11+Program Evaluated by Positron Emission Tomography	PLOS ONE			English	Article							GLUCOSE-UPTAKE; PREVENTING INJURIES; SKELETAL-MUSCLES; HIP; PROGRAM; VALGUS; FORCE; PET	Purpose: This study investigated the effect of the FIFA 11+ warm-up program on whole body muscle activity using positron emission tomography. Methods: Ten healthy male volunteers were divided into a control group and a group that performed injury prevention exercises (The 11+). The subjects of the control group were placed in a sitting position for 20 min and 37 MBq of 18 F-fluorodeoxyglucose (FDG) was injected intravenously. The subjects then remained seated for 45 min. The subjects of the exercise group performed part 2 of the 11+ for 20 min, after which FDG was injected. They then performed part 2 of the 11+ for 20 min, and rested for 25 min in a sitting position. Positron emission tomography-computed tomography images were obtained 50 min after FDG injection in each group. Regions of interest were defined within 30 muscles. The standardized uptake value was calculated to examine the FDG uptake of muscle tissue per unit volume. Results: FDG accumulation within the abdominal rectus, gluteus medius and minimus were significantly higher in the exercise group than in the control group (P < 0.05). Conclusion: The hip abductor muscles and abdominal rectus were active during part 2 of the FIFA 11+ program.	[Nakase, Junsuke; Toratani, Tatsuhiro; Kosaka, Masahiro; Ohashi, Yoshinori; Yahata, Tetsutaro; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Inaki, Anri; Taki, Junichi; Kinuya, Seigo] Kanazawa Univ, Grad Sch Med Sci, Dept Nucl Med Biotracer Med, Kanazawa, Ishikawa, Japan; [Mochizuki, Takafumi] Kanazawa Adv Med Ctr, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Tsuchiya, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	tsuchi@med.kanazawa-u.ac.jp			Japan Sports Medicine Foundation	Japan Sports Medicine Foundation	This research was supported by grants from Japan Sports Medicine Foundation, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojsen-Moller J, 2006, J APPL PHYSIOL, V101, P196, DOI 10.1152/japplphysiol.00004.2006; Bojsen-Moller J, 2010, J APPL PHYSIOL, V109, P1895, DOI 10.1152/japplphysiol.00671.2010; Claiborne TL, 2006, J APPL BIOMECH, V22, P41, DOI 10.1123/jab.22.1.41; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051568; Ford K.R., 2007, MED SCI SPORTS EXERC, V9, pS70; Fujimoto T, 2000, EUR J APPL PHYSIOL, V83, P297, DOI 10.1007/s004210000254; Fujimoto T, 1996, LANCET, V348, P266, DOI 10.1016/S0140-6736(05)65572-9; Grindstaff TL, 2006, J ATHL TRAINING, V41, P450; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; MERO A, 1987, MED SCI SPORT EXER, V19, P266; MONTGOMERY WH, 1994, AM J SPORT MED, V22, P272, DOI 10.1177/036354659402200220; Myer GD, 2008, BRIT J SPORT MED, V42, P614, DOI 10.1136/bjsm.2007.046086; Myer GD, 2006, J STRENGTH COND RES, V20, P345, DOI 10.1519/R-17955.1; Nagano Yasuharu, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P14, DOI 10.1186/1758-2555-3-14; Ohnuma M, 2006, J ORTHOP SCI, V11, P42, DOI 10.1007/s00776-005-0972-y; Oi Naoyuki, 2003, J Orthop Sci, V8, P55, DOI 10.1007/s007760300009; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Pappas GP, 2001, J APPL PHYSIOL, V90, P329, DOI 10.1152/jappl.2001.90.1.329; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Russell KA, 2006, J ATHL TRAINING, V41, P166; Sadoghi P, 2012, J BONE JOINT SURG AM, V94A, P769, DOI 10.2106/JBJS.K.00467; Schmitz RJ, 2002, J SPORT REHABIL, V11, P179, DOI 10.1123/jsr.11.3.179; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P605, DOI 10.1111/j.1600-0838.2007.00703.x; Tai SJ, 2010, CHINESE J PHYSIOL, V53, P91, DOI 10.4077/CJP.2010.AMK016; Tashiro M, 1999, J NUCL MED, V40, P70; Tegnander A, 2008, KNEE SURG SPORT TR A, V16, P194, DOI 10.1007/s00167-007-0403-z	28	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73898	10.1371/journal.pone.0073898	http://dx.doi.org/10.1371/journal.pone.0073898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066082	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000064
J	Ospina-Alvarez, A; Bernal, M; Catalan, IA; Roos, D; Bigot, JL; Palomera, I				Ospina-Alvarez, Andres; Bernal, Miguel; Alberto Catalan, Ignacio; Roos, David; Bigot, Jean-Louis; Palomera, Isabel			Modeling Fish Egg Production and Spatial Distribution from Acoustic Data: A Step Forward into the Analysis of Recruitment	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; INDIVIDUAL-BASED MODEL; MACKEREL SCOMBER-SCOMBRUS; SMALL PELAGIC FISH; EARLY-LIFE-HISTORY; FRESH-WATER INPUT; VERTICAL MIGRATION; MEDITERRANEAN SEA; MARINE POPULATIONS; SOUTHERN BENGUELA	To date, there are numerous transport simulation studies demonstrating the relevance of the hydrodynamics for the advection, dispersion and recruitment of early stages of marine organisms. However, the lack of data has conditioned the use of realistic locations for the model setup and configuration in transport studies. This work (I) demonstrates the key role played by the use of the realistic initial position of the eggs of small pelagic fishes in the analysis of late-larval recruitment in coastal nursery areas and (II) provides a general solution for deriving future egg positions and abundances from adult biomass obtained from acoustic surveys and available fecundity data. Using European anchovy in the NW Mediterranean as a case study, we first analyzed the impact of the initial location, timing, egg buoyancy and diel vertical migration of larvae on the potential late-larval recruitment to coastal areas. The results suggested that prior knowledge of the initial spawning grounds may substantially affect the estimates of potential recruitment. We then integrated biological and acoustics-derived data (the biomass and size structure, sex ratio, a weight-batch fecundity model, mean weight, number of fish and mean spawning) to build a predictive model for interannual egg production. This model was satisfactorily contrasted with field data for two years obtained with the Daily Egg Production Method (DEPM). We discuss our results in the context of the fluctuations of European anchovy egg abundance from 2003 through 2010 in the NW Mediterranean and in terms of the potential applicability of the acoustics-based spatial predictive egg production model.	[Ospina-Alvarez, Andres; Bernal, Miguel; Palomera, Isabel] CSIC, Dept Renewable Marine Resources, Inst Marine Sci, ICM, Barcelona, Spain; [Alberto Catalan, Ignacio] UIB, IMEDEA CSIC, Mediterranean Inst Adv Studies, Dept Ecol & Marine Resources, Esporles, Balearic Island, Spain; [Roos, David; Bigot, Jean-Louis] IFREMER, Sete, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Ifremer	Ospina-Alvarez, A (corresponding author), CSIC, Dept Renewable Marine Resources, Inst Marine Sci, ICM, Barcelona, Spain.	aospina.co@me.com	Catalan, Ignacio/C-5382-2011; Ospina-Alvarez, Andres/M-2556-2014; Palomera, Isabel/L-4769-2014	Catalan, Ignacio/0000-0002-6496-9182; Ospina-Alvarez, Andres/0000-0003-2454-7169; ROOS, David/0000-0003-0273-3585; Palomera, Isabel/0000-0001-5708-168X	project PERSEUS [FP7-287600]; Generalitat de Catalunya; JAE program (Spanish Science and Technology Council, CSIC)	project PERSEUS; Generalitat de Catalunya(Generalitat de Catalunya); JAE program (Spanish Science and Technology Council, CSIC)	This work was supported by project PERSEUS (FP7-287600). Egg samples were obtained from the MPOCAT-DEPM surveys financed by Generalitat de Catalunya. A. Ospina-Alvarez benefited from a PhD grant of the JAE program (Spanish Science and Technology Council, CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa A., 1977, METHODS COMPUTATIONA, V17, P173, DOI DOI 10.1016/B978-0-12-460817-7.50009-4; Barange M, 2013, S AFRICAN J MARINE S, V21, P367; Bartsch J, 2004, FISH OCEANOGR, V13, P380, DOI 10.1111/j.1365-2419.2004.00306.x; Bartsch J, 2001, ECOL MODEL, V138, P127, DOI 10.1016/S0304-3800(00)00398-7; Begon M., 2009, ECOLOGY INDIVIDUALS; Bernal M, 2011, ICES J MAR SCI, V68, P528, DOI 10.1093/icesjms/fsr002; Bernal M, 2011, ICES J MAR SCI, V68, P519, DOI 10.1093/icesjms/fsr001; Bethoux JP, 1999, J MARINE SYST, V20, P33, DOI 10.1016/S0924-7963(98)00069-4; Borchers DL, 1997, CAN J FISH AQUAT SCI, V54, P2727, DOI 10.1139/cjfas-54-12-2727; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Brickman D, 2002, J ATMOS OCEAN TECH, V19, P83, DOI 10.1175/1520-0426(2002)019<0083:LSMICO>2.0.CO;2; Brochier T, 2009, PROG OCEANOGR, V83, P261, DOI 10.1016/j.pocean.2009.07.044; Campbell R, 2013, PROG OCEANOGR, V109, P47, DOI 10.1016/j.pocean.2012.09.005; Catalan IA, 2013, PROG OCEANOGR, V111, P140, DOI 10.1016/j.pocean.2013.02.001; Checkley DM, 1997, FISH OCEANOGR, V6, P58, DOI 10.1046/j.1365-2419.1997.00030.x; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen Robert K., 2002, P149, DOI 10.1016/B978-012615185-5/50010-4; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruzado A, 2002, CONT SHELF RES, V22, P349, DOI 10.1016/S0278-4343(01)00060-7; CURY P, 1994, CAN J FISH AQUAT SCI, V51, P1664, DOI 10.1139/f94-167; DEMARCQ H, 1984, OCEANOL ACTA, V7, P159; DiBacco C, 2001, MAR ECOL PROG SER, V217, P191, DOI 10.3354/meps217191; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; DOHERTY PJ, 1985, ENVIRON BIOL FISH, V12, P81, DOI 10.1007/BF00002761; Doray M, 2010, TECHNICAL REPORT; Farris D. A., 1960, ICES J MAR SCI, V25, P294; Foote K. G., 1987, ICES COOP RES REP; Forget P, 1998, OCEANOL ACTA, V21, P739, DOI 10.1016/S0399-1784(99)80003-6; Forget P, 2007, SENSORS-BASEL, V7, P884, DOI 10.3390/s7060884; Freon P, 2005, B MAR SCI, V76, P385; Garcia A, 1996, SCI MAR, V60, P155; Garcia A, 1998, MAR ECOL PROG SER, V166, P237, DOI 10.3354/meps166237; GASPAR P, 1990, J GEOPHYS RES-OCEANS, V95, P16179, DOI 10.1029/JC095iC09p16179; Gauthier S, 2002, J FISH BIOL, V61, P1135, DOI 10.1006/jfbi.2002.2128; Gerlotto F, 2004, ICES J MAR SCI, V61, P1120, DOI 10.1016/j.icesjms.2004.07.017; Gould S. J., 1989, WONDERFUL LIFE BURGE; Grimm V., 2005, PRINCETON SERIES THE; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Hampton I, 2013, S AFRICAN J MARINE S, V12, P1031; Hare Jonathan A., 1999, Fisheries Oceanography, V8, P57; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hinckley S, 1996, MAR ECOL PROG SER, V139, P47, DOI 10.3354/meps139047; Hinckley S, 2001, ICES J MAR SCI, V58, P1042, DOI 10.1006/jmsc.2001.1096; Hinrichsen HH, 2011, ICES J MAR SCI, V68, P1478, DOI 10.1093/icesjms/fsr056; Huggett J, 2003, MAR ECOL PROG SER, V250, P247, DOI 10.3354/meps250247; Js S, 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, DOI 10.1175/1520-0493(1963)0912.3.CO;2]; King D. P.F., 1978, FISH B S AFR, V10, P37; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lasker R, 1985, NMFS36 NOAA US DEP C; Lazure P, 2008, ADV WATER RESOUR, V31, P233, DOI 10.1016/j.advwatres.2007.06.010; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; LIMA ID, 1995, FISH OCEANOGR, V4, P1, DOI 10.1111/j.1365-2419.1995.tb00057.x; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Lluch-Belda D., 1992, Fisheries Oceanography, V1, P339, DOI 10.1111/j.1365-2419.1992.tb00006.x; Lo N.C.H., 1985, NOAA Technical Report NMFS, V36, P43; Masse J, 1996, ICES J MAR SCI, V53, P155, DOI 10.1006/jmsc.1996.0016; MATLAB, 2011, V 7 12 0 635 R2011A; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Moser HG., 1985, 36 NOAA NMFS US DEP, P43; Mullon C, 2003, FISH OCEANOGR, V12, P396, DOI 10.1046/j.1365-2419.2003.00240.x; Mullon C, 2002, CAN J FISH AQUAT SCI, V59, P910, DOI 10.1139/F02-064; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Natunewicz CC, 2001, MAR ECOL PROG SER, V212, P217, DOI 10.3354/meps212217; Nevitt G., 1998, INTEGR BIOL, V1, P215, DOI [10.1002/(SICI)1520-6602(1998)1:6%3C215:AID-INBI3%3E3.0.CO;2-V, DOI 10.1002/(SICI)1520-6602(1998)1:6<215::AID-INBI3>3.0.C0;2-V]; Nichols J., 2001, DISPERSAL; Nicolle A, 2009, OCEAN DYNAM, V59, P953, DOI 10.1007/s10236-009-0221-6; Ohshimo S, 1996, FISHERIES SCI, V62, P344, DOI 10.2331/fishsci.62.344; Olivar MP, 2001, MAR ECOL PROG SER, V217, P111, DOI 10.3354/meps217111; Ospina-Alvarez A, 2012, ECOL MODEL, V231, P65, DOI 10.1016/j.ecolmodel.2012.02.001; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; PALOMERA I, 1992, MAR ECOL PROG SER, V79, P215; PALOMERA I, 1991, MAR BIOL, V111, P37, DOI 10.1007/BF01986343; PALOMERA I, 1988, MAR BIOL, V99, P283, DOI 10.1007/BF00391991; Palomera I, 2009, EVALUACION POBLACION; Palomera I, 2008, SPAWNING STOCK BIOMA; Palomera I, 1995, RAPP COMM INT MER ME, V34, P252; Palomera I, 1995, AVALUACIO POBLACIONS; Parada C, 2003, FISH OCEANOGR, V12, P170, DOI 10.1046/j.1365-2419.2003.00235.x; Parada C, 2008, AFR J MAR SCI, V30, P437, DOI 10.2989/AJMS.2008.30.3.1.635; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; PARKER K, 1980, FISH B-NOAA, V78, P541; Pepin P, 1997, CAN J FISH AQUAT SCI, V54, P670, DOI 10.1139/cjfas-54-3-670; Pinardi N, 2003, ANN GEOPHYS-GERMANY, V21, P3, DOI 10.5194/angeo-21-3-2003; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Proctor R, 1998, FISH OCEANOGR, V7, P347, DOI 10.1046/j.1365-2419.1998.00077.x; R Core Team, 2021, R LANGUAGE ENV STAT; Regner S, 1996, SCI MAR, V60, P167; Regner S., 1985, ACTA ADRIAT, V26, P113; Reuter H, 2005, ECOL MODEL, V186, P489, DOI 10.1016/j.ecolmodel.2005.02.014; Riveiro I, 2011, HYDROBIOLOGIA, V670, P189, DOI 10.1007/s10750-011-0663-y; Sabates A, 2007, FISH OCEANOGR, V16, P130, DOI 10.1111/j.1365-2419.2006.00416.x; Salat J, 1996, SCI MAR, V60, P21; SHELTON PA, 1993, B MAR SCI, V53, P778; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Smith P.E., 1985, NOAA Technical Report NMFS, V36, P27; Somarakis S, 2004, ICES J MAR SCI, V61, P944, DOI 10.1016/j.icesjms.2004.07.018; Somarakis S, 2010, J PLANKTON RES, V32, P317, DOI 10.1093/plankt/fbp132; Stobutzki IC, 2001, REV FISH BIOL FISHER, V10, P515; SWARTZMAN G, 1992, CAN J FISH AQUAT SCI, V49, P1366, DOI 10.1139/f92-152; Takahashi M, 2005, FISH OCEANOGR, V14, P223, DOI 10.1111/j.1365-2419.2005.00334.x; Takasuka A, 2006, FISH OCEANOGR, V15, P139, DOI 10.1111/j.1365-2419.2005.00385.x; Urtizberea A, 2008, J PLANKTON RES, V30, P1369, DOI 10.1093/plankt/fbn090; van der Molen J, 2007, J SEA RES, V58, P313, DOI 10.1016/j.seares.2007.07.003; Vargas-Yanez M, 2007, J MARINE SYST, V68, P421, DOI 10.1016/j.jmarsys.2007.01.004; Werner FE, 2001, SARSIA, V86, P411, DOI 10.1080/00364827.2001.10420483; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X	110	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73687	10.1371/journal.pone.0073687	http://dx.doi.org/10.1371/journal.pone.0073687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066063	gold, Green Published			2022-12-27	WOS:000324494000045
J	Zhang, L; Stuber, F; Stamer, UM				Zhang, Lan; Stuber, Frank; Stamer, Ulrike M.			Inflammatory Mediators Influence the Expression of Nociceptin and Its Receptor in Human Whole Blood Cultures	PLOS ONE			English	Article							TUMOR NECROSIS FACTOR; FQ GENE-EXPRESSION; ORPHANIN-FQ; MESSENGER-RNA; IMMUNE CELLS; NEURONS; SYSTEM; PAIN; ASTROCYTES; CYTOKINE	Background: Nociceptin/orphanin FQ and its receptor (NOP) are involved in immune responses, inflammation and pain processing. The aim of this study was to investigate the modulation of NOP and prepro-nociceptin (PNoc), the precursor of nociceptin, by inflammatory mediators in human whole blood. Methods: Peripheral blood from healthy volunteers was cultured for 0, 3, 6 and 24 hrs with or without lipopolysaccharide (LPS), tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-10 or interferon (IFN)-gamma. NOP and PNoc mRNA of peripheral white blood cells were detected by quantitative RT-PCR. Cytokine concentrations in supernatants of whole blood cultures were measured using ELISA. In addition, an intervention experiment using anti-cytokine antibodies was conducted to evaluate possible mechanisms involved in the modulation of NOP and PNoc by LPS. The primary goal was to investigate NOP and PNoc mRNA expression in human peripheral blood under inflammatory conditions. Results: LPS significantly suppressed NOP (median area under the mRNA-expression-time curve (1st/3rd quartile): 5.4 (4.6/ 6.6) normalized ratio . hr) and PNoc expression (40.8 (34.4/49.5)) compared to baseline measures (NOP: 22.7 (17.1/25.3); PNoc: 69.9 (58.4/89.2), both p, 0.001). LPS incubation induced cytokine concentrations (TNF-alpha, IL-1 beta, IL-10 and IFN-gamma) in whole blood cultures. Incubation with TNF-alpha, IL-1 beta, IL-10 or IFN-gamma decreased NOP mRNA levels to varying extents (p, 0.05 for all). In contrast, PNoc mRNA expression was decreased by IL-10 only (p = 0.018). The LPS effect on NOP expression could be antagonized by anti-TNF-alpha and anti-IL-1 beta, whereas anti-IL-10 and anti-INF-gamma had no effect. There was no change of PNoc expression when LPS induced cytokines were antagonized by the respective antibodies. Conclusions: LPS as well as cytokines suppress mainly NOP and, in part, PNoc mRNA expression in human whole blood cultures. This may represent a negative feedback loop to the previously described upregulation of cytokines by PNoc.	[Zhang, Lan; Stuber, Frank; Stamer, Ulrike M.] Univ Bern, Inselspital, Dept Anaesthesiol & Pain Med, CH-3010 Bern, Switzerland; [Zhang, Lan; Stuber, Frank; Stamer, Ulrike M.] Univ Bern, Dept Clin Res, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Zhang, L (corresponding author), Univ Bern, Inselspital, Dept Anaesthesiol & Pain Med, CH-3010 Bern, Switzerland.	lan.zhang@dkf.unibe.ch			R. Sackler Research Foundation	R. Sackler Research Foundation	This work was in part supported by a grant of the R. Sackler Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acosta C, 2008, J NEUROSCI RES, V86, P1077, DOI 10.1002/jnr.21565; Anderberg UM, 1998, Z RHEUMATOL, V57, P77; Arjomand J, 2002, J NEUROIMMUNOL, V130, P100, DOI 10.1016/S0165-5728(02)00217-5; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Buzas B, 1999, J NEUROCHEM, V72, P1882, DOI 10.1046/j.1471-4159.1999.0721882.x; Buzas B, 2002, GLIA, V39, P237, DOI 10.1002/glia.10106; Buzas B, 2002, NEUROREPORT, V13, P1707, DOI 10.1097/00001756-200210070-00003; CANNON JG, 1992, CRIT CARE MED, V20, P1414, DOI 10.1097/00003246-199210000-00009; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Chen Y, 2006, J PERIPHER NERV SYST, V11, P232, DOI 10.1111/j.1529-8027.2006.0093.x; Chiou LC, 2007, CURR DRUG TARGETS, V8, P117, DOI 10.2174/138945007779315605; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Fiset MT, 2003, BIOCHEMISTRY-US, V42, P10498, DOI 10.1021/bi0300635; Gavioli Elaine C, 2011, J Amino Acids, V2011, P836569, DOI 10.4061/2011/836569; Goldfarb Y, 2006, J NEUROIMMUNOL, V176, P76, DOI 10.1016/j.jneuroim.2006.04.008; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Ko MH, 2002, NEUROREPORT, V13, P1631, DOI 10.1097/00001756-200209160-00012; Kruger C, 2006, SCHMERZ, V20, P509, DOI 10.1007/s00482-006-0488-1; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Leggett JD, 2009, J NEUROENDOCRINOL, V21, P888, DOI 10.1111/j.1365-2826.2009.01912.x; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Mogil JS, 2001, PHARMACOL REV, V53, P381; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Peluso J, 1998, J NEUROIMMUNOL, V81, P184, DOI 10.1016/S0165-5728(97)00178-1; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Singh SR, 2012, BRIT J ANAESTH, V108, P714; Stamer UM, 2011, BRIT J ANAESTH, V106, P566, DOI 10.1093/bja/aer007; van Crevel R, 1999, J IMMUNOL METHODS, V222, P145, DOI 10.1016/S0022-1759(98)00192-6; Waits PS, 2004, J NEUROIMMUNOL, V149, P110, DOI 10.1016/j.jneuroim.2003.12.018; WICK MJ, 1995, MOL BRAIN RES, V32, P342, DOI 10.1016/0169-328X(95)00096-B; Williams JP, 2008, BRIT J ANAESTH, V100, P810, DOI 10.1093/bja/aen093; Williams JP, 2008, ANESTH ANALG, V106, P865, DOI 10.1213/ane.0b013e3181617646; Williams JP, 2007, ANESTH ANALG, V105, P998, DOI 10.1213/01.ane.0000278865.11991.9d; Witta J, 2003, J NEUROTRAUM, V20, P523, DOI 10.1089/089771503767168456; Zeilhofer HU, 2003, J PHARMACOL EXP THER, V306, P423, DOI 10.1124/jpet.102.046979; Zhao H, 2002, NEUROSCIENCE, V114, P1019, DOI 10.1016/S0306-4522(02)00233-6	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74138	10.1371/journal.pone.0074138	http://dx.doi.org/10.1371/journal.pone.0074138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066107	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000089
J	Bouhassira, D; Letanoux, M; Hartemann, A				Bouhassira, Didier; Letanoux, Martine; Hartemann, Agnes			Chronic Pain with Neuropathic Characteristics in Diabetic Patients: A French Cross-Sectional Study	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; HEALTH SURVEY; PREVALENCE; DIAGNOSIS; SEVERITY; RELIABILITY; COMMUNITY; MELLITUS; TESTS	Objective: Our aim was to estimate the prevalence of distal chronic pain with neuropathic characteristics in patients with type 1 and type 2 diabetes mellitus and its impact on quality of life, mood, anxiety, sleep and healthcare utilization. Methods: In total, 885 patients were screened and 766 diabetic patients (38.7% with type 1 diabetes mellitus, 44.8% women, mean age: 57.2 +/- 14.9 years) were enrolled consecutively over a three-month period in this observational study by 85 diabetes specialists working in a hospital department or in private practice. All the patients completed a series of questionnaires for the detection of chronic pain (i.e. daily pain for more than three months) in the lower limbs and assessment of health-related quality of life (Medical Outcomes Short Form 12 scale), sleep disturbances (MOS sleep scale), depression and anxiety (Hospital Anxiety and Depression scale). Patients with chronic pain were also assessed with the 7-item DN4-interview questionnaire, the monofilament test and the Michigan Neuropathy Screening Instrument (MNSI). Results: The overall prevalence of chronic pain with neuropathic characteristics was 20.3% [95% CI 17.4-23.1]. The MNSI examination score suggested that pain was related to polyneuropathy, in 80.1% of these patients (89.5% of those with bilateral pain). Patients with chronic pain had a poorer quality of life and more sleep disturbances, anxiety and depression than patients without pain and the presence of neuropathic characteristics was predictive of such impairments. Only 38.6% of the patients had received appropriate treatment for neuropathic pain. Conclusions: Chronic pain with neuropathic characteristics concerns one in five diabetic patients, has a significant impact on quality of life and is not adequately managed. The close correlation between the DN4 questionnaire and MNSI results suggests that screening tools for neuropathic pain could be used in daily practice for the identification of painful diabetic polyneuropathy.	[Bouhassira, Didier] CHU Ambroise Pare, APHP, INSERM, U987,Ctr Evaluat & Traitement Douleur, Boulogne, France; [Bouhassira, Didier] Univ Versailles St Quentin, Versailles, France; [Letanoux, Martine] Cherche Midi, Ctr Med, Paris, France; [Hartemann, Agnes] CHU Pitie Salpetriere, Serv Diabetol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bouhassira, D (corresponding author), CHU Ambroise Pare, APHP, INSERM, U987,Ctr Evaluat & Traitement Douleur, Boulogne, France.	didier.bouhassira@inserm.fr	Bouhassira, Didier/Y-8403-2018	Bouhassira, Didier/0000-0001-6446-8719	Pfizer	Pfizer(Pfizer)	This study was supported by Pfizer. The sponsor financed the data collection and statistical analysis of the data, which was performed by an independent clinical research organization (Lincoln), Boulogne, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Attal N, 2011, PAIN, V152, P2836, DOI 10.1016/j.pain.2011.09.014; Benbow SJ, 1998, QJM-INT J MED, V91, P733, DOI 10.1093/qjmed/91.11.733; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Bouhassira D, 2011, PAIN, V152, pS74, DOI 10.1016/j.pain.2010.11.027; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Daousi C, 2004, DIABETIC MED, V21, P976, DOI 10.1111/j.1464-5491.2004.01271.x; Davies M, 2006, DIABETES CARE, V29, P1518, DOI 10.2337/dc05-2228; Erbas T, 2011, J CLIN NEUROPHYSIOL, V28, P51, DOI 10.1097/WNP.0b013e3182051334; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; Halawa MR, 2010, CURR MED RES OPIN, V26, P337, DOI 10.1185/03007990903471940; Hartemann A, 2011, DIABETES METAB, V37, P377, DOI 10.1016/j.diabet.2011.06.003; Jambart S, 2011, J INT MED RES, V39, P366, DOI 10.1177/147323001103900204; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Singleton JR, 2008, J PERIPHER NERV SYST, V13, P218, DOI 10.1111/j.1529-8027.2008.00180.x; Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89; Spallone V, 2012, DIABETIC MED, V29, P578, DOI 10.1111/j.1464-5491.2011.03500.x; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	96	100	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74195	10.1371/journal.pone.0074195	http://dx.doi.org/10.1371/journal.pone.0074195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058527	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400055
J	Jani, BD; Purves, D; Barry, S; Cavanagh, J; McLean, G; Mair, FS				Jani, Bhautesh Dinesh; Purves, David; Barry, Sarah; Cavanagh, Jonathan; McLean, Gary; Mair, Frances S.			Challenges and Implications of Routine Depression Screening for Depression in Chronic Disease and Multimorbidity: A Cross Sectional Study	PLOS ONE			English	Article							CASE-FINDING INSTRUMENTS; QUALITY-OF-CARE; MAJOR DEPRESSION; HOSPITAL ANXIETY; HEART-DISEASE; HEALTH-CARE; ASSOCIATION; PREVALENCE; RISK; EPIDEMIOLOGY	Background: Depression screening in chronic disease is advocated but its impact on routine practice is uncertain. We examine the effects of a programme of incentivised depression screening in chronic disease within a UK primary care setting. Methods and Findings: Cross sectional analysis of anonymised, routinely collected data (2008-9) from family practices in Scotland serving a population of circa 1.8 million. Primary care registered patients with at least one of three chronic diseases, coronary heart disease, diabetes and stroke, underwent incentivised depression screening using the Hospital Anxiety and Depression Score (HADS). 125143 patients were identified with at least one chronic disease. 10670 (8.5%) were under treatment for depression and exempt from screening. Of remaining, HADS were recorded for 35537 (31.1%) patients. 7080 (19.9% of screened) had raised HADS (>= 8); majority had indications of mild depression with HADS between 8 and 10. Over 6 months, 572 (8%) of those with raised HADS (>= 8) were initiated on antidepressants, while 696 (2.4%) patients with normal HADS (<8) were also initiated on antidepressants (relative risk of antidepressant initiation with raised HADS 3.3 (CI 2.97-3.67), p value <0.0001). Of those with multimorbidity who were screened, 24.3% had raised HADS (>= 8). A raised HADS was more likely in females, socioeconomically deprived, multimorbid or younger (18-44) individuals. Females and 45-64 years old were more likely to receive antidepressants. Limitations: retrospective study of routinely collected data. Conclusions: Despite incentivisation, only a minority of patients underwent depression screening, suggesting that systematic depression screening in chronic disease can be difficult to achieve in routine practice. Targeting those at greatest risk such as the multimorbid or using simpler screening methods may be more effective. Raised HADS was associated with higher number of new antidepressant prescriptions which has significant resource implications. The clinical benefits of such screening remain uncertain and merits investigation.	[Jani, Bhautesh Dinesh; Cavanagh, Jonathan; McLean, Gary; Mair, Frances S.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Purves, David; Barry, Sarah] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Mair, FS (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Frances.mair@glasgow.ac.uk		Barry, Sarah J.E./0000-0003-3039-8729; Mair, Frances/0000-0001-9780-1135	BUPA Foundation [TBF/MR/11]	BUPA Foundation	This study was funded by the BUPA Foundation (http://www.bupafoundation.co.uk/), grant number TBF/MR/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; [Anonymous], 2005, IDF CLIN GUID TASK F; [Anonymous], 2010, MULT CHRON COND STRA; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Burroughs H, 2006, FAM PRACT, V23, P369, DOI 10.1093/fampra/cmi115; Burton C., 2012, PSYCHOL MED, P1; Coventry PA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-10; CROXFORD AM, 2013, REINVENTION INT J UN; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Dumesnil H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052429; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Goodyear-Smith FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-76; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Hadidi N, 2009, HEART LUNG, V38, P151, DOI 10.1016/j.hrtlng.2008.05.002; Hansson M, 2009, BRIT J GEN PRACT, V59, P650, DOI 10.3399/bjgp09X454070; Hyde J, 2005, BRIT J GEN PRACT, V55, P846; *INF SERV DIV S, 2013, GEN PRACT QUAL OUTC; *INFORM SERV DIV S, 2012, SCOTT IND MULT DEPR; Joling KJ, 2011, J AFFECT DISORDERS, V133, P522, DOI 10.1016/j.jad.2011.05.001; Karasz A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616373; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lockhart P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593848; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Mercer SW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5559; Mitchell Alex J, 2013, Lancet Oncol, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Munoz-Arroyo R, 2006, BRIT J GEN PRACT, V56, P423; *NAT STAT PUBL SCO, 2013, NAT STAT PUBL SCOTL, V1; Naylor C, 2012, LONG TERM CONDITIONS; *NIH CLIN EXC, 2009, DEPR AD UPD CG 90; *NIH CLIN EXC, 2009, DEPR PEOPL CHRON PHY; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0; Pozuelo L, 2009, CLEV CLIN J MED, V76, P59, DOI 10.3949/ccjm.75a.08011; *R PROJ STAT COMP, 2012, R LANG ENV STAT COMP; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Scheibe S, 2003, J AFFECT DISORDERS, V75, P223, DOI 10.1016/S0165-0327(02)00050-2; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; *STEPS TEAM, 2012, GLASG STEPS; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Yano EM, 2012, J GEN INTERN MED, V27, P331, DOI 10.1007/s11606-011-1904-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74610	10.1371/journal.pone.0074610	http://dx.doi.org/10.1371/journal.pone.0074610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058602	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400087
J	Lin, CW; Chuang, CY; Tang, CH; Chang, JL; Lee, LM; Lee, WJ; Chow, JM; Yang, SF; Chien, MH				Lin, Chiao-Wen; Chuang, Chun-Yi; Tang, Chih-Hsin; Chang, Junn-Liang; Lee, Liang-Ming; Lee, Wei-Jiunn; Chow, Jyh-Ming; Yang, Shun-Fa; Chien, Ming-Hsien			Combined Effects of ICAM-1 Single-Nucleotide Polymorphisms and Environmental Carcinogens on Oral Cancer Susceptibility and Clinicopathologic Development	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SOLUBLE ICAM-1; BREAST-CANCER; INTRACELLULAR DOMAIN; GENE POLYMORPHISMS; TUMOR-GROWTH; EXPRESSION; ASSOCIATION; PROGRESSION; METASTASIS	Background: In Taiwan, oral cancer has causally been associated with environmental carcinogens. Intercellular adhesion molecule (ICAM)-1, a cell adhesion molecule with a key role in inflammation and immunosurveillance, was implicated in carcinogenesis by facilitating instability in the tumor environment. The current study explored the combined effect of ICAM-1 gene polymorphisms and exposure to environmental carcinogens on the susceptibility of developing oral squamous cell carcinoma (OSCC) and the clinicopathological characteristics of the tumors. Methodology and Principal Findings: Four single-nucleotide polymorphisms (SNPs) of the ICAM-1 gene from 595 patients with oral cancer and 561 non-cancer controls were analyzed by a real-time PCR. We found that the ICAM-1 rs5498 polymorphism and the TAGG or TACG haplotype of 4 ICAM-1 SNPs (rs3093030, rs5491, rs281432, and rs5498) combined were associated with oral-cancer susceptibility. Among 727 smokers, ICAM-1 polymorphisms carriers with the betel-nut chewing habit had a 27.49-36.23-fold greater risk of having oral cancer compared to ICAM-1 wild-type (WT) carriers without the betel-nut chewing habit. Among 549 betel-nut chewers, ICAM-1 polymorphisms carriers who smoked had a 9.93-14.27-fold greater risk of having oral cancer compared to those who carried the WT but did not smoke. Finally, patients with oral cancer who had at least 1 T allele of ICAM-1 rs5491 or 1 G allele of rs281432 were at lower risk of developing an advanced clinical stage (III/IV) (p<0.05), compared to those patients with AA or CC homozygotes. Conclusions: Our results suggest that the ICAM-1 rs5498 SNP and either of 2 haplotypes of 4 SNPs combined have potential predictive significance in oral carcinogenesis. Gene-environment interactions of ICAM-1 polymorphisms, smoking, and betel-nut chewing might alter oral-cancer susceptibility. ICAM-1 rs5491 and rs281432 may be applied as factors to predict the clinical stage in OSCC patients.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chuang, Chun-Yi] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chuang, Chun-Yi] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Dept Biotechnol, Coll Hlth Sci, Taichung, Taiwan; [Chang, Junn-Liang] Taoyuan Armed Forces Gen Hosp, Dept Med Management, Tao Yuan, Taiwan; [Chang, Junn-Liang] Natl Def Med Ctr, Sch Med, Dept Pathol, Taipei, Taiwan; [Lee, Liang-Ming; Lee, Wei-Jiunn] Taipei Med Univ, Wan Fan Hosp, Dept Urol, Taipei, Taiwan; [Chow, Jyh-Ming] Taipei Med Univ, Wan Fan Hosp, Dept Internal Med, Hematol Oncol Sect, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; Asia University Taiwan; National Defense Medical Center; Taipei Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; mhchien1976@gmail.com	Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927	Taipei Medical University-Wan Fang Hospital, Taiwan [102 swf03]	Taipei Medical University-Wan Fang Hospital, Taiwan	This study was financially supported by grants from Taipei Medical University-Wan Fang Hospital, Taiwan (no. 102 swf03). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinski SJ, 2008, ATHEROSCLEROSIS, V201, P339, DOI 10.1016/j.atherosclerosis.2008.02.031; Biolchini F, 2005, Minerva Stomatol, V54, P405; Burim RV, 2009, CLIN EXP MED, V9, P157, DOI 10.1007/s10238-009-0040-6; Califano J, 1996, CANCER RES, V56, P2488; Champagne B, 1998, J IMMUNOL, V161, P6398; Chen HK, 2006, HUM GENET, V120, P69, DOI 10.1007/s00439-006-0184-3; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Fujihara Tomofumi, 1999, Gastric Cancer, V2, P221, DOI 10.1007/s101200050067; Gho YS, 2001, CANCER RES, V61, P4253; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Hayes SH, 2009, INT J CLIN EXP PATHO, V2, P553; Hopkins AM, 2004, ADV DRUG DELIVER REV, V56, P763, DOI 10.1016/j.addr.2003.10.043; Hsu LA, 2010, METABOLISM, V59, P1710, DOI 10.1016/j.metabol.2010.04.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; JOHNSON JP, 1989, P NATL ACAD SCI USA, V86, P641, DOI 10.1073/pnas.86.2.641; Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kostler WJ, 2001, CANCER IMMUNOL IMMUN, V50, P483; Lin MH, 2004, ARCH TOXICOL, V78, P167, DOI 10.1007/s00204-003-0524-1; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Liu SY, 2010, ORAL ONCOL, V46, P276, DOI 10.1016/j.oraloncology.2010.01.008; Liu SY, 2005, J FORMOS MED ASSOC, V104, P113; Ma J, 2006, DIABETIC MED, V23, P1093, DOI 10.1111/j.1464-5491.2006.01948.x; Maruo Y, 2002, INT J CANCER, V100, P486, DOI 10.1002/ijc.10514; Melis M, 2003, AM J RESP CRIT CARE, V167, P1131, DOI 10.1164/rccm.200207-654OC; Mendez MP, 2008, AM J PHYSIOL-LUNG C, V294, pL807, DOI 10.1152/ajplung.00398.2007; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Ogawa Y, 1998, CLIN CANCER RES, V4, P31; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Puthothu B, 2006, GENES IMMUN, V7, P322, DOI 10.1038/sj.gene.6364302; REILLY PL, 1995, J IMMUNOL, V155, P529; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sun JJ, 1999, J CANCER RES CLIN, V125, P28, DOI 10.1007/s004320050238; Tachimori A, 2005, EUR J CANCER, V41, P1802, DOI 10.1016/j.ejca.2005.04.036; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tian MM, 2012, WORLD J GASTROENTERO, V18, P368, DOI 10.3748/wjg.v18.i4.368; Usami Y, 2013, INT J CANCER, V133, P568, DOI 10.1002/ijc.28066; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Wuertz B, 2010, OTOLARYNG HEAD NECK, V143, P190; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72940	10.1371/journal.pone.0072940	http://dx.doi.org/10.1371/journal.pone.0072940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069166	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100024
J	Anitua, E; Pascual, C; Perez-Gonzalez, R; Antequera, D; Padilla, S; Orive, G; Carro, E				Anitua, Eduardo; Pascual, Consuelo; Perez-Gonzalez, Rocio; Antequera, Desiree; Padilla, Sabino; Orive, Gorka; Carro, Eva			Intranasal Delivery of Plasma and Platelet Growth Factors Using PRGF-Endoret System Enhances Neurogenesis in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INCREASED HIPPOCAMPAL NEUROGENESIS; VEGF-SECRETING CELLS; DENTATE GYRUS; NEURONAL PROGENITORS; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; BETA PEPTIDES; STEM-CELLS; IN-VITRO	Neurodegeneration together with a reduction in neurogenesis are cardinal features of Alzheimer's disease (AD) induced by a combination of toxic amyloid-beta peptide (A beta) and a loss of trophic factor support. Amelioration of these was assessed with diverse neurotrophins in experimental therapeutic approaches. The aim of this study was to investigate whether intranasal delivery of plasma rich in growth factors (PRGF-Endoret), an autologous pool of morphogens and proteins, could enhance hippocampal neurogenesis and reduce neurodegeneration in an amyloid precursor protein/presenilin-1 (APP/PS1) mouse model. Neurotrophic and neuroprotective actions were firstly evident in primary neuronal cultures, where cell proliferation and survival were augmented by Endoret treatment. Translation of these effects in vivo was assessed in wild type and APP/PS1 mice, where neurogenesis was evaluated using 5-bromodeoxyuridine (BdrU), doublecortin (DCX), and NeuN immunostaining 5 weeks after Endoret administration. The number of BrdU, DCX, and NeuN positive cell was increased after chronic treatment. The number of degenerating neurons, detected with fluoro Jade-B staining was reduced in Endoret-treated APP/PS1 mice at 5 week after intranasal administration. In conclusion, Endoret was able to activate neuronal progenitor cells, enhancing hippocampal neurogenesis, and to reduce A beta-induced neurodegeneration in a mouse model of AD.	[Anitua, Eduardo; Padilla, Sabino; Orive, Gorka] Fdn Eduardo Anitua, Vitoria, Spain; [Pascual, Consuelo; Perez-Gonzalez, Rocio; Antequera, Desiree; Carro, Eva] Inst Invest Hosp 12 Octubre I 12, Neurosci Grp, Madrid, Spain; [Pascual, Consuelo; Perez-Gonzalez, Rocio; Antequera, Desiree; Carro, Eva] Biomed Res Networking Ctr Neurodegenerat Dis CIBE, Madrid, Spain; [Orive, Gorka] Univ Basque Country, Sch Pharm, NanoBioCel Grp, Lab Pharmaceut, Vitoria, Spain; [Orive, Gorka] CIBER BBN, Networking Biomed Res Ctr Bioengn Biomat & Nanome, Vitoria, Spain	Hospital Universitario 12 de Octubre; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Orive, G (corresponding author), Fdn Eduardo Anitua, Vitoria, Spain.	gorka.orive@ehu.es; carroeva@h12o.es	Perez-Gonzalez, Rocio/GQH-7068-2022; Carro, Eva/D-6240-2018; Anitua, Eduardo/O-1154-2018	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Carro, Eva/0000-0002-6504-4579; Anitua, Eduardo/0000-0002-8386-5303; ORIVE, GORKA/0000-0002-0773-300X				Abad MA, 2006, J NEUROSCI, V26, P12735, DOI 10.1523/JNEUROSCI.0575-06.2006; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Alvira-Botero X, 2010, MOL CELL NEUROSCI, V45, P306, DOI 10.1016/j.mcn.2010.07.005; Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010; Anitua E, 2012, J CONTROL RELEASE, V157, P317, DOI 10.1016/j.jconrel.2011.11.011; Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001; Antequera D, 2012, J ALZHEIMERS DIS, V29, P187, DOI 10.3233/JAD-2011-111646; Bir SC, 2011, J VASC RES, V48, P195, DOI 10.1159/000318779; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Ermini FV, 2008, AM J PATHOL, V172, P1520, DOI 10.2353/ajpath.2008.060520; Esteras N, 2012, J ALZHEIMERS DIS, V30, P337, DOI 10.3233/JAD-2012-111967; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Jessberger S, 2009, TRENDS PHARMACOL SCI, V30, P61, DOI 10.1016/j.tips.2008.11.003; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; KAKUDO N, 2013, MED MOL MORPHOL, V23, P4952; Kilian O, 2004, EUR J MED RES, V9, P337; Kokjohn TA, 2011, BBA-MOL BASIS DIS, V1812, P1508, DOI 10.1016/j.bbadis.2011.07.004; Liu Xin-Feng, 2004, J Stroke Cerebrovasc Dis, V13, P16, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.005; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mukaetova-Ladinska EB, 2012, AGE AGEING, V41, P408, DOI 10.1093/ageing/afr171; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Padovani A, 2001, NEUROLOGY, V57, P2243, DOI 10.1212/WNL.57.12.2243; Perez-Gonzalez R, 2011, J ALZHEIMERS DIS, V24, P17, DOI 10.3233/JAD-2011-102070; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Roy NS, 2000, NAT MED, V6, P271; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sanchez M, 2012, ARTHROSCOPY, V28, P1070, DOI 10.1016/j.arthro.2012.05.011; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Skovronsky DM, 2001, J BIOL CHEM, V276, P17036, DOI 10.1074/jbc.M006285200; Spuch C, 2010, BIOMATERIALS, V31, P5608, DOI 10.1016/j.biomaterials.2010.03.042; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Turker S, 2004, PHARM WORLD SCI, V26, P137, DOI 10.1023/B:PHAR.0000026823.82950.ff; Udo H, 2008, J NEUROSCI, V28, P14522, DOI 10.1523/JNEUROSCI.3673-08.2008; Venkatesan A, 2007, CELL MOL LIFE SCI, V64, P2120, DOI 10.1007/s00018-007-7063-5; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang CY, 2011, NEUROPSYCHOPHARMACOL, V36, P1073, DOI 10.1038/npp.2010.245; William H, 2002, DRUG DELIV TECHNOL, V2, P46; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018	62	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73118	10.1371/journal.pone.0073118	http://dx.doi.org/10.1371/journal.pone.0073118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069173	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300008
J	Arnspang, EC; Sundbye, S; Nelson, WJ; Nejsum, LN				Arnspang, Eva C.; Sundbye, Sabrina; Nelson, W. James; Nejsum, Lene N.			Aquaporin-3 and Aquaporin-4 Are Sorted Differently and Separately in the Trans-Golgi Network	PLOS ONE			English	Article							WATER PERMEABILITY; EPITHELIAL-CELLS; PLASMA-MEMBRANE; COLLECTING DUCT; PROTEINS; PATHWAYS; POLARITY; LACKING; SURFACE; ROUTES	Aquaporin-3 (AQP3) and aquaporin-4 (AQP4) are homologous proteins expressed in the basolateral plasma membrane of kidney collecting duct principal cells, where they mediate the exit pathway for apically reabsorbed water. Although both proteins are localized to the same plasma membrane domain, it is unknown if they are sorted together in the Golgi, or arrive in the same or different vesicles at the plasma membrane. We addressed these questions using high resolution deconvolution imaging, spinning disk and laser scanning confocal microscopy of cells expressing AQP3 and AQP4. AQP3 and AQP4 were observed mostly in separate post-Golgi carriers, and spinning disk microscopy showed that most of AQP3 and AQP4 were delivered to the plasma membrane in separate vesicles. In contrast, VSV-G and LDL-R, two well-charcterized basolateral proteins, co-localized to a high degree in the same post-Golgi carriers, indicating that the differential sorting of AQP3 and AQP4 is specific and regulated. Significantly, a chimeric AQP3 containing the AQP4 cytoplasmic tails co-localized with AQP4 in post-Golgi vesicles. These results indicate that AQP3 and AQP4 are separated into different post-Golgi carriers based on different cytoplasmic domain sorting signals, and are then delivered separately to the plasma membrane.	[Arnspang, Eva C.] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Dept Phys Chem & Pharm, Odense M, Denmark; [Arnspang, Eva C.] Univ Southern Denmark, DaMBIC Danish Mol Biomed Imaging Ctr, Odense M, Denmark; [Arnspang, Eva C.; Sundbye, Sabrina; Nejsum, Lene N.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Arnspang, Eva C.; Sundbye, Sabrina; Nejsum, Lene N.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Nelson, W. James; Nejsum, Lene N.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Southern Denmark; University of Southern Denmark; Aarhus University; Aarhus University; Stanford University	Nejsum, LN (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	nejsum@mb.au.dk	Arnspang, Eva C/Y-1132-2018	Arnspang, Eva C/0000-0002-3095-4070; Nejsum, Lene Niemann/0000-0003-4368-8821	National Institutes of Health [R01 GM35527]; Danish Medical Research Foundation; Lundbeck Foundation; Lundbeck Junior Group Leader Fellowship; Danish Natural Research Foundation; DaMBIC (Danish Molecular Biomedical Imaging Center); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Foundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Junior Group Leader Fellowship(Lundbeck Corporation); Danish Natural Research Foundation(Danish Natural Science Research Council); DaMBIC (Danish Molecular Biomedical Imaging Center); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant R01 GM35527 to WJN, and postdoctoral fellowships from the Danish Medical Research Foundation (http://fivu.dk/) and the Lundbeck Foundation (http://www.lundbeckfonden.com/) to LNN, as well as a Lundbeck Junior Group Leader Fellowship (to LNN). The spinning disk was supported by the Danish Natural Research Foundation (http://dg.dk/; to MEMPHYS-Center for Biomembrane Physics) and DaMBIC (Danish Molecular Biomedical Imaging Center) (EAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; BOLL W, 1991, P NATL ACAD SCI USA, V88, P8592, DOI 10.1073/pnas.88.19.8592; Brooks HL, 2003, AM J PHYSIOL-RENAL, V284, pF218, DOI 10.1152/ajprenal.00054.2002; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Fosch H, 2008, CURR OPIN CELL BIOL, V20, P208, DOI 10.1016/j.ceb.2008.01.003; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Lian WN, 2006, J CELL SCI, V119, P11, DOI 10.1242/jcs.02706; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Matsuzaki T, 2001, AM J PHYSIOL-CELL PH, V281, pC55, DOI 10.1152/ajpcell.2001.281.1.C55; Muth TR, 1998, AM J PHYSIOL-CELL PH, V274, pC688, DOI 10.1152/ajpcell.1998.274.3.C688; Nejsum LN, 2009, FRONT BIOSCI-LANDMRK, V14, P1088, DOI 10.2741/3295; Nejsum LN, 2005, CELL MOL LIFE SCI, V62, P1692, DOI 10.1007/s00018-005-4549-x; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Rasband W., 2006, IMAGEJ; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775, DOI 10.1152/ajprenal.1995.269.6.F775; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247	31	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73977	10.1371/journal.pone.0073977	http://dx.doi.org/10.1371/journal.pone.0073977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058510	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900027
J	Meller, CL; Podrabsky, JE				Meller, Camie L.; Podrabsky, Jason E.			Avoidance of Apoptosis in Embryonic Cells of the Annual Killifish Austrofundulus limnaeus Exposed to Anoxia	PLOS ONE			English	Article							DEVELOPMENTAL BIOLOGY; ANNUAL FISHES; STAUROSPORINE; TOLERANCE; DIAPAUSE; SURVIVAL; HEARTS; DEATH; TUNEL	Embryos of the annual killifish Austrofundulus limnaeus have unequalled ability among vertebrates to survive long-term anoxia. Surprisingly, these embryos can survive for months in anoxia despite a large-scale decrease in ATP levels during the initial hours of anoxic exposure. These conditions are known to trigger apoptotic cell death in mammalian cells as a result of ischemia or anoxia. Anoxia-induced induction of apoptosis was investigated in four developmental stages of A. limnaeus that differ in their tolerance of anoxia, and thus may respond to anoxia uniquely. Exposure to staurosporine was used to determine if A. limnaeus cells were competent to enter apoptosis via cues other than anoxia. Apoptotic cells were identified by TUNEL assays and by measuring caspase 3/7 activity. Exposure to 48 hr of anoxia did not induce an increase in TUNEL-positive cells and generally did not lead to an increase in caspase 3/7 activity. However, treatment of anoxic embryos with 10 mu M staurosporine resulted in a significant increase in caspase 3/7 activity in both normoxic and anoxic embryos. These results suggest that apoptosis is avoided in embryos of A. limnaeus following exposure to anoxia at least in part by mechanisms that prevent the activation of caspase 3/7 activity. While this mechanism remains unknown, it may be triggered by a protein kinase that can be experimentally inhibited by staurosporine.	[Meller, Camie L.; Podrabsky, Jason E.] Portland State Univ, Dept Biol, Portland, OR 97207 USA	Portland State University	Podrabsky, JE (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	jpod@pdx.edu		Podrabsky, Jason/0000-0003-1411-8547	National Institutes of Health (NIH) [R01 HL095454]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095454] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant R01 HL095454 to JEP. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Buck LT, 2012, ADV EXP MED BIOL, V758, P71, DOI 10.1007/978-94-007-4584-1_10; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Fergusson-Kolmes L, 2007, J EXP ZOOL PART A, V307A, P419, DOI 10.1002/jez.395; Fleck CC, 2005, AM J PHYSIOL-REG I, V289, pR586, DOI 10.1152/ajpregu.00100.2005; HARA H, 1990, J CEREBR BLOOD F MET, V10, P646, DOI 10.1038/jcbfm.1990.117; Hrbek T, 2005, ZOOTAXA, P1; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; Kockx MM, 1998, AM J PATHOL, V152, P885; Krumschnabel G, 2007, APOPTOSIS, V12, P1755, DOI 10.1007/s10495-007-0103-7; Lesauskaite V, 2004, AM J CLIN PATHOL, V121, P108, DOI 10.1309/7MNN4E8TFAKH3XC9; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LUTZ PL, 1992, ANNU REV PHYSIOL, V54, P601, DOI 10.1146/annurev.physiol.54.1.601; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Melino G, 2001, NATURE, V412, P23, DOI 10.1038/35083653; Meller CL, 2012, J COMP PHYSIOL B, V182, P909, DOI 10.1007/s00360-012-0672-9; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Podrabsky J. E., 2012, ANOXIA, P3, DOI DOI 10.5772/39079; Podrabsky JE, 2007, J EXP BIOL, V210, P2253, DOI 10.1242/jeb.005116; Podrabsky JE, 2012, J EXP ZOOL PART A, V317A, P524, DOI 10.1002/jez.1744; Podrabsky JE, 1998, HYDROBIOLOGIA, V362, P67; Podrabsky JE, 1999, ENVIRON BIOL FISH, V54, P421, DOI 10.1023/A:1007598320759; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310; WOURMS JP, 1972, J EXP ZOOL, V182, P143, DOI 10.1002/jez.1401820202	29	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75837	10.1371/journal.pone.0075837	http://dx.doi.org/10.1371/journal.pone.0075837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058704	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900128
J	Mwanahamuntu, MH; Sahasrabuddhe, VV; Blevins, M; Kapambwe, S; Shepherd, BE; Chibwesha, C; Pfaendler, KS; Mkumba, G; Vwalika, B; Hicks, ML; Vermund, SH; Stringer, JSA; Parham, GP				Mwanahamuntu, Mulindi H.; Sahasrabuddhe, Vikrant V.; Blevins, Meridith; Kapambwe, Sharon; Shepherd, Bryan E.; Chibwesha, Carla; Pfaendler, Krista S.; Mkumba, Gracilia; Vwalika, Belington; Hicks, Michael L.; Vermund, Sten H.; Stringer, Jeffrey S. A.; Parham, Groesbeck P.			Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a 'Screen-And-Treat' Program Integrated with HIV/AIDS Care in Zambia	PLOS ONE			English	Article							HIV-INFECTED WOMEN; VISUAL INSPECTION; PREVENTION SERVICES; ACETIC-ACID; IMPLEMENTATION; PREVALENCE; CERVICOGRAPHY; MANAGEMENT; SEE	Background: In the absence of stand-alone infrastructures for delivering cervical cancer screening services, efforts are underway in sub-Saharan Africa to dovetail screening with ongoing vertical health initiatives like HIV/AIDS care programs. Yet, evidence demonstrating the utilization of cervical cancer prevention services in such integrated programs by women of the general population is lacking. Methods: We analyzed program operations data from the Cervical Cancer Prevention Program in Zambia (CCPPZ), the largest public sector programs of its kind in sub-Saharan Africa. We evaluated patterns of utilization of screening services by HIV serostatus, examined contemporaneous trends in screening outcomes, and used multivariable modeling to identify factors associated with screening test positivity. Results: Between January 2006 and April 2011, CCPPZ services were utilized by 56,247 women who underwent cervical cancer screening with visual inspection with acetic acid (VIA), aided by digital cervicography. The proportion of women accessing these services who were HIV-seropositive declined from 54% to 23% between 2006-2010, which coincided with increasing proportions of HIV-seronegative women (from 22% to 38%) and women whose HIV serostatus was unknown (from 24% to 39%) (all p-for trend <0.001). The rates of VIA screening positivity declined from 47% to 17% during the same period (p-for trend <0.001), and this decline was consistent across all HIV serostatus categories. After adjusting for demographic and sexual/reproductive factors, HIV-seropositive women were more than twice as likely (Odds ratio 2.62, 95% CI 2.49, 2.76) to screen VIA-positive than HIV-seronegative women. Conclusions: This is the first 'real world' demonstration in a public sector implementation program in a sub-Saharan African setting that with successful program scale-up efforts, nurse-led cervical cancer screening programs targeting women with HIV can expand and serve all women, regardless of HIV serostatus. Screening program performance can improve with adequate emphasis on training, quality control, and telemedicine-support for nurse-providers in clinical decision making.	[Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Chibwesha, Carla; Stringer, Jeffrey S. A.; Parham, Groesbeck P.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mwanahamuntu, Mulindi H.; Mkumba, Gracilia; Vwalika, Belington; Stringer, Jeffrey S. A.; Parham, Groesbeck P.] Univ Teaching Hosp, Lusaka, Zambia; [Sahasrabuddhe, Vikrant V.; Blevins, Meridith; Shepherd, Bryan E.; Vermund, Sten H.] Vanderbilt Univ, Nashville, TN 37235 USA; [Chibwesha, Carla; Stringer, Jeffrey S. A.; Parham, Groesbeck P.] Univ N Carolina, Chapel Hill, NC USA; [Pfaendler, Krista S.] Univ Cincinnati, Cincinnati, OH USA; [Hicks, Michael L.] Michigan Canc Inst, Pontiac, MI USA	University of Zambia; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati	Parham, GP (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	groesbeck.parham@cidrz.org	Vermund, Sten/AAD-3592-2020; Stringer, Jeffrey S. A./AAU-2342-2021	Vermund, Sten/0000-0001-7289-8698; Stringer, Jeffrey/0000-0002-9590-7216; Blevins, Meridith/0000-0002-3861-9859	Zambian Ministry of Health, U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC); National Institutes of Health (NIH)/Fogarty International Center (FIC) [D43TW001035, R24007988]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER	Zambian Ministry of Health, U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC); National Institutes of Health (NIH)/Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Zambian Ministry of Health, U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH)/Fogarty International Center (FIC) grants D43TW001035 and R24007988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhadj H, 2013, INT J GYNAECOL OBSTE; Blumenthal PD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.031; Bomfim-Hyppolito S, 2006, INT J GYNECOL OBSTET, V92, P58, DOI 10.1016/j.ijgo.2005.09.016; Casper C, 2011, ANNU REV MED, V62, P157, DOI 10.1146/annurev-med-050409-103711; Chen ZP, 2008, TAIWAN J OBSTET GYNE, V47, P187, DOI 10.1016/S1028-4559(08)60078-9; Chirwa Susan, 2010, Glob Health Promot, V17, P47, DOI 10.1177/1757975910363938; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Ferlay J, 2010, INT J CANC; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Franceschi S, 2010, AIDS, V24, P2570, DOI 10.1097/QAD.0b013e32833f39b2; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; Khodakarami N, 2010, ARCH GYNECOL OBSTET; Little RJA, 2002, STAT ANAL MISSING DA, Vxv; Mahy M, 2012, SEX TRANSM INFECT, V88, pI65, DOI 10.1136/sextrans-2012-050789; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Mwanahamuntu Mulindi H, 2008, Bull World Health Organ, V86, pD; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Parham Groesbeck P., 2010, HIV Therapy, V4, P713, DOI [10.2217/hiv.10.52, 10.2217/HIV.10.52]; Parham GP, 2010, J LOW GENIT TRACT DI, V14, P167, DOI 10.1097/LGT.0b013e3181cd6d5e; Pfaendler KS, 2008, GYNECOL ONCOL, V110, P402, DOI 10.1016/j.ygyno.2008.04.031; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sahasrabuddhe VV, 2012, CANCER PREV RES, V5, P11, DOI 10.1158/1940-6207.CAPR-11-0540; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sylla BS, 2012, INT J CANCER, V130, P245, DOI 10.1002/ijc.26333; White HL, 2012, SOC SCI MED, V74, P1486, DOI 10.1016/j.socscimed.2012.01.028	33	43	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74607	10.1371/journal.pone.0074607	http://dx.doi.org/10.1371/journal.pone.0074607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058599	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900065
J	Sanders, J; Mayford, M; Jeste, D				Sanders, Jeff; Mayford, Mark; Jeste, Dilip			Empathic Fear Responses in Mice Are Triggered by Recognition of a Shared Experience	PLOS ONE			English	Article							OTHERS PAIN; CONGENITAL INSENSITIVITY; PSYCHOPATHIC TENDENCIES; ANTISOCIAL-BEHAVIOR; SOCIAL MODULATION; NEUROBIOLOGY; NEUROSCIENCE; EXPRESSIONS; CHILDREN; EMOTION	Empathy is an important psychological capacity that involves the ability to recognize and share emotions with others. In humans, empathy for others is facilitated by having had a similar prior experience. It increases with the intensity of distress that observers believe is occurring to others, and is associated with acute emotional responses to witnessing others' distress. We sought to develop a relatively simple and fast mouse model of human empathy that resembled these characteristics. We modeled empathy by measuring the freezing of observer mice to observing the footshock of a subject mouse. Observer mice froze to subject footshocks only when they had a similar shock experience 24 hours earlier. Moreover, this freezing increased with the number of footshocks given to the subject and it was accentuated within seconds after footshock delivery. Freezing was not seen in naive observers or in experienced observers that observed a subject who was spared footshock. Observers did not freeze to a subject's footshock when they had experienced a swim stress 24 hours prior, demonstrating a specific effect for shared experience, as opposed to a generalized stressor in eliciting observer mouse freezing. We propose that this two-day experimental protocol resembles many aspects of human empathy in a mouse model that is amenable to transgenic analysis of neural substrates for empathy and its impairment in certain clinical disorders.	[Sanders, Jeff; Jeste, Dilip] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA; [Sanders, Jeff; Jeste, Dilip] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Mayford, Mark] Scripps Res Inst, Dorris Ctr Neurosci, La Jolla, CA 92037 USA; [Jeste, Dilip] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego	Sanders, J (corresponding author), Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA.	jeff.d.sanders@emory.edu		Mayford, Mark/0000-0002-9001-5024	National Institutes of Health [T32 MH019934, DA028300, MH057368]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019934, R01MH057368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants T32 MH019934, DA028300, and MH057368. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Appelbaum PS, 2012, PSYCHIAT SERV, V63, P630, DOI 10.1176/appi.ps.201200630; Atsak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021855; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P3567, DOI 10.1098/rstb.2009.0191; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Blair RJR, 2006, J CHILD PSYCHOL PSYC, V47, P262, DOI 10.1111/j.1469-7610.2006.01596.x; Blair RJR, 2005, J CHILD PSYCHOL PSYC, V46, P327, DOI 10.1111/j.1469-7610.2004.00356.x; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Bredy TW, 2009, LEARN MEMORY, V16, P12, DOI 10.1101/lm.1226009; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Chen W, 2009, BEHAV BRAIN RES, V201, P8, DOI 10.1016/j.bbr.2009.01.019; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; DAVIS CM, 1990, PHYS THER, V70, P707, DOI 10.1093/ptj/70.11.707; Didehbani N, 2012, SCHIZOPHR RES, V142, P246, DOI 10.1016/j.schres.2012.09.010; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Edgar JL, 2011, P ROY SOC B-BIOL SCI, V278, P3129, DOI 10.1098/rspb.2010.2701; Edgar JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031542; Eklund J, 2009, SCAND J PSYCHOL, V50, P65, DOI 10.1111/j.1467-9450.2008.00673.x; Gery I, 2009, PSYCHIAT RES, V165, P252, DOI 10.1016/j.psychres.2007.11.006; Golan O, 2010, J AUTISM DEV DISORD, V40, P269, DOI 10.1007/s10803-009-0862-9; Hein G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022759; Heldt SA, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.022.2009; Jeon D, 2011, CURRENT PROTOCOLS NE; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kimonis ER, 2006, BEHAV SCI LAW, V24, P21, DOI 10.1002/bsl.668; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kurtuncu M, 2005, J NEUROSCI METH, V149, P26, DOI 10.1016/j.jneumeth.2005.04.010; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Maurage P, 2011, ALCOHOL CLIN EXP RES, V35, P1662, DOI 10.1111/j.1530-0277.2011.01512.x; Mendez MF, 2010, J AM ACAD PSYCHIATRY, V38, P318; Mestre-Escriva MV, 2009, SPAN J PSYCHOL, V12, P76, DOI 10.1017/S1138741600001499; Mogil JS, 2012, TRENDS COGN SCI, V16, P143, DOI 10.1016/j.tics.2011.12.012; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Preis MA, 2012, EUR J PAIN, V16, P1311, DOI 10.1002/j.1532-2149.2012.00119.x; Prkachin K M, 2001, Pain Res Manag, V6, P105; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Shirtcliff EA, 2009, BEHAV SCI LAW, V27, P137, DOI 10.1002/bsl.862; Simonoff E, 2004, BRIT J PSYCHIAT, V184, P118, DOI 10.1192/bjp.184.2.118; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sluyter F, 2003, BEHAV GENET, V33, P563, DOI 10.1023/A:1025730901955; Staub E, 2008, AM J ORTHOPSYCHIAT, V78, P267, DOI 10.1037/a0014223; Valsamis B, 2011, JOVE-J VIS EXP, DOI 10.3791/3446; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; Watanabe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023357; Wessely S, 2012, LANCET, V379, P1563, DOI 10.1016/S0140-6736(12)60655-2	50	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74609	10.1371/journal.pone.0074609	http://dx.doi.org/10.1371/journal.pone.0074609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058601	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900067
J	Sedlak, TL; Johnson, BD; Pepine, CJ; Reis, SE; Merz, CNB				Sedlak, Tara L.; Johnson, B. Delia; Pepine, Carl J.; Reis, Steven E.; Merz, C. Noel Bairey			Brachial Artery Constriction during Brachial Artery Reactivity Testing Predicts Major Adverse Clinical Outcomes in Women with Suspected Myocardial Ischemia: Results from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; ENDOTHELIAL FUNCTION; VASCULAR FUNCTION; CORONARY; DISEASE; HEART; DYSFUNCTION; INFORMATION; DILATATION	Background: Limited brachial artery (BA) flow-mediated dilation during brachial artery reactivity testing (BART) has been linked to increased cardiovascular risk. We report on the phenomenon of BA constriction (BAC) following hyperemia. Objectives: To determine whether BAC predicts adverse CV outcomes and/or mortality in the women's ischemic Syndrome Evaluation Study (WISE). Further, as a secondary objective we sought to determine the risk factors associated with BAC. Methods: We performed BART on 377 women with chest pain referred for coronary angiography and followed for a median of 9.5 years. Forearm ischemia was induced with 4 minutes occlusion by a cuff placed distal to the BA and inflated to 40mm Hg > systolic pressure. BAC was defined as > 4.8% artery constriction following release of the cuff. The main outcome was major adverse events (MACE) including all-cause mortality, non-fatal MI, non-fatal stroke, or hospitalization for heart failure. Results: BA diameter change ranged from -20.6% to + 44.9%, and 41 (11%) women experienced BAC. Obstructive CAD and traditional CAD risk factors were not predictive of BAC. Overall, 39% of women with BAC experienced MACE vs. 22% without BAC (p=0.004). In multivariate Cox proportional hazards regression, BAC was a significant independent predictor of MACE (p=0.018) when adjusting for obstructive CAD and traditional risk factors. Conclusions: BAC predicts almost double the risk for major adverse events compared to patients without BAC. This risk was not accounted for by CAD or traditional risk factors. The novel risk marker of BAC requires further investigation in women.	[Sedlak, Tara L.] Vancouver Gen Hosp, Dept Med, Vancouver, BC, Canada; [Johnson, B. Delia; Reis, Steven E.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Pepine, Carl J.] Univ Florida, Dept Med, Gainesville, FL USA; [Merz, C. Noel Bairey] Cedars Sinai Heart Inst, Dept Med, Los Angeles, CA USA	University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Cedars Sinai Medical Center	Merz, CNB (corresponding author), Cedars Sinai Heart Inst, Dept Med, Los Angeles, CA USA.	Noel.BaireyMerz@cshs.org	Reis, Steven E/J-3957-2014	Reis, Steven/0000-0001-8023-0102; Pepine, Carl/0000-0002-6011-681X; Bairey Merz, C. Noel/0000-0002-9933-5155	National Heart, Lung and Blood Institutes [N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164]; National Institute on Aging [U0164829, U01 HL649141, U01 HL649241]; National Center for Research Resources [MO1-RR00425]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; DIVISION OF HEART AND VASCULAR DISEASES [N01HV068161, N01HV068162, N01HV068164, N01HV068163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032631] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by contracts from the National Heart, Lung and Blood Institutes, (nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164); grants U0164829, U01 HL649141, U01 HL649241, T32HL69751, and 1R03AG032631 from the National Institute on Aging; GCRC grant MO1-RR00425 from the National Center for Research Resources; grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; the Edythe L. Broad Women's Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, CA; the Barbara Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, CA; and The Society for Women's Health Research (SWHR), Washington, D. C. The sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.	ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Black MA, 2008, HYPERTENSION, V51, P203, DOI 10.1161/HYPERTENSIONAHA.107.101014; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Gori T, 2010, HEART, V96, P141, DOI 10.1136/hrt.2009.167213; Gori T, 2008, J AM COLL CARDIOL, V51, P1953, DOI 10.1016/j.jacc.2008.01.049; Gori T, 2012, EUR HEART J, V33, P363, DOI 10.1093/eurheartj/ehr361; Holubkov R, 2002, AM HEART J, V143, P802, DOI 10.1067/mhj.2002.121735; Jiang BY, 2011, HYPERTENSION, V57, P1145, DOI 10.1161/HYPERTENSIONAHA.110.163113; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2; Sondergaard E, 2002, AM HEART J, V144, P108, DOI 10.1067/mhj.2002.123147; Teragawa H, 2005, CLIN CARDIOL, V28, P460, DOI 10.1002/clc.4960281004	14	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74585	10.1371/journal.pone.0074585	http://dx.doi.org/10.1371/journal.pone.0074585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058592	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000324695900060
J	Thvilum, M; Brandt, F; Almind, D; Christensen, K; Brix, TH; Hegedus, L				Thvilum, Marianne; Brandt, Frans; Almind, Dorthe; Christensen, Kaare; Brix, Thomas Heiberg; Hegedus, Laszlo			Type and Extent of Somatic Morbidity before and after the Diagnosis of Hypothyroidism. A Nationwide Register Study	PLOS ONE			English	Article							THYROID-DYSFUNCTION; AUTOIMMUNE HYPOTHYROIDISM; CIGARETTE-SMOKING; EXCESS MORTALITY; CANCER-PATIENTS; DISEASE; RISK; HYPERTHYROIDISM; TWIN; COMORBIDITY	Background: Hypothyroidism has been linked with an increased risk of other morbidities, such as cardiovascular diseases and diabetes mellitus. However, the temporal relationship between these diseases and the diagnosis of hypothyroidism is not well illuminated. Such information may provide insight into causal relationships between hypothyroidism and other morbidities. Aim: To investigate the type and extent of somatic morbidity before and after a diagnosis of hypothyroidism. Methods: Observational cohort study. From official Danish health registers, 2822 hypothyroid singletons were identified and matched 1: 4 with non-hypothyroid controls and observed over a mean period of 6 years. Frequency of different morbidities was obtained by person-to-person linking in the registers. Logistic and Cox regression models were used to assess the risk of morbidity before and after the diagnosis of hypothyroidism, respectively. Results: Prior to the diagnosis of hypothyroidism there was a significantly increased risk of being diagnosed with cardiovascular diseases (odds ratio (OR) 1.37; 95% confidence interval (CI): 1.19-1.58), lung diseases (OR 1.25; 95% CI: 1.13-1.39), diabetes mellitus (OR 1.92; 95% CI: 1.61-2.29), as well as malignant diseases (OR 1.24; 95% CI: 1.06-1.45). Following the diagnosis of hypothyroidism there was a significantly increased risk of being diagnosed with cardiovascular diseases (hazard ratio (HR) 1.36; 95% CI: 1.15-1.60); lung diseases (HR 1.51; 95% CI: 1.30-1.75); and diabetes mellitus (HR 1.40; 95% CI: 1.11-1.77). Conclusions: Prior to the diagnosis of hypothyroidism there is an excess risk of being diagnosed with cardiovascular diseases, lung diseases, diabetes mellitus, and malignant diseases. Following the diagnosis of hypothyroidism we demonstrate an increased frequency of cardiovascular diseases, lung diseases, and diabetes mellitus.	[Thvilum, Marianne; Brandt, Frans; Brix, Thomas Heiberg; Hegedus, Laszlo] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense C, Denmark; [Almind, Dorthe; Christensen, Kaare] Univ Southern Denmark, Danish Aging Res Ctr, Odense C, Denmark; [Almind, Dorthe; Christensen, Kaare] Univ Southern Denmark, Danish Twin Registry, Odense C, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense C, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Hegedus, L (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense C, Denmark.	laszlo.hegedus@rsyd.dk	Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292; Pedersen, Dorthe Almind/0000-0001-7758-3791	University of Southern Denmark in Odense; Novo Nordisk Foundation via The School of Endocrinology, University of Southern Denmark in Odense; Novo Nordisk Foundation; National Institute on Aging [P01 AG08761]; NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER	University of Southern Denmark in Odense; Novo Nordisk Foundation via The School of Endocrinology, University of Southern Denmark in Odense; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Marianne Thvilum is enrolled as a PhD-student financed by The University of Southern Denmark in Odense and by the Novo Nordisk Foundation via The School of Endocrinology, University of Southern Denmark in Odense. Dr. Laszlo Hegedus is the recipient of an unrestricted research grant from the Novo Nordisk Foundation. This work was supported by the National Institute on Aging, grant No. P01 AG08761 to Kaare Christensen. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acton RT, 2004, ETHNIC DIS, V14, pS8; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Berkson J, 1946, BIOMETRIC B, V2, P126, DOI DOI 10.2307/3002000; Biondi B, 2004, ENDOCRINE, V24, P1, DOI 10.1385/ENDO:24:1:001; Boelaert K, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.030; Bogazzi F, 2012, J ENDOCRINOL INVEST, V35, P340, DOI 10.3275/8298; Brandt F, 2013, THYROID, V23, P408, DOI 10.1089/thy.2012.0500; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; Brix TH, 2000, J CLIN ENDOCR METAB, V85, P536, DOI 10.1210/jc.85.2.536; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Brix TH, 2012, CLIN ENDOCRINOL, V76, P457, DOI 10.1111/j.1365-2265.2011.04318.x; Carle A, 2006, EUR J ENDOCRINOL, V154, P21, DOI 10.1530/eje.1.02068; Carle A, 2012, CLIN ENDOCRINOL, V77, P764, DOI 10.1111/j.1365-2265.2012.04455.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; D'Alessandro A, 2012, EUR J PREV CARDIOL, V19, P297, DOI 10.1177/1741826711411738; Diez JJ, 2011, EXP CLIN ENDOCR DIAB, V119, P201, DOI 10.1055/s-0031-1271691; Disel U, 2012, MED ONCOL, V29, P3608, DOI 10.1007/s12032-012-0254-4; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Hilberink SR, 2006, PATIENT EDUC COUNS, V61, P449, DOI 10.1016/j.pec.2005.05.012; Ingebrigtsen T, 2010, RESP MED, V104, P1890, DOI 10.1016/j.rmed.2010.05.004; Jenkins RC, 2002, THYROID, V12, P977, DOI 10.1089/105072502320908312; Jorgensen TL, 2012, BRIT J CANCER, V106, P1353, DOI 10.1038/bjc.2012.46; Kahaly GJ, 2000, THYROID, V10, P665, DOI 10.1089/10507250050137743; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; McGue M, 2010, PERSPECT PSYCHOL SCI, V5, P546, DOI 10.1177/1745691610383511; Milla CE, 2012, PAEDIATR RESPIR REV, V13, P23, DOI 10.1016/j.prrv.2011.01.004; PERROS P, 1995, DIABETIC MED, V12, P622, DOI 10.1111/j.1464-5491.1995.tb00553.x; Rothman XJ, 2008, MODERN EPIDEMIOLOGY; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Selmer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7895; Skytthe A, 2011, SCAND J PUBLIC HEALT, V39, P75, DOI 10.1177/1403494810387966; Thomsen AF, 2005, EUR J ENDOCRINOL, V152, P535, DOI 10.1530/eje.1.01894; Thvilum M, 2013, J CLIN ENDOCR METAB, V98, P1069, DOI 10.1210/jc.2012-3375; Thvilum M, 2012, NAT REV ENDOCRINOL, V8, P417, DOI 10.1038/nrendo.2012.29; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	40	56	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75789	10.1371/journal.pone.0075789	http://dx.doi.org/10.1371/journal.pone.0075789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066186	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000168
J	Muto, G; Kotani, H; Kondo, T; Morita, R; Tsuruta, S; Kobayashi, T; Luche, H; Fehling, HJ; Walsh, M; Choi, Y; Yoshimura, A				Muto, Go; Kotani, Hitoshi; Kondo, Taisuke; Morita, Rimpei; Tsuruta, Sanae; Kobayashi, Takashi; Luche, Herve; Fehling, Hans Joerg; Walsh, Matthew; Choi, Yongwon; Yoshimura, Akihiko			TRAF6 Is Essential for Maintenance of Regulatory T Cells That Suppress Th2 Type Autoimmunity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; FOXP3 EXPRESSION; RHEUMATOID-ARTHRITIS; IMMUNE HOMEOSTASIS; C-REL; PLASTICITY; DIFFERENTIATION; GENERATION; INDUCTION; BETA	Regulatory T cells (Tregs) maintain immune homeostasis by limiting inflammatory responses. TRAF6 plays a key role in the regulation of innate and adaptive immunity by mediating signals from various receptors including the T-cell receptor (TCR). T cell-specific deletion of TRAF6 has been shown to induce multiorgan inflammatory disease, but the role of TRAF6 in Tregs remains to be investigated. Here, we generated Treg-specific TRAF6-deficient mice using Foxp3-Cre and TRAF6-flox mice. Treg-specific TRAF6-deficient (cKO) mice developed allergic skin diseases, arthritis, lymphadenopathy and hyper IgE phenotypes. Although TRAF6-deficient Tregs possess similar in vitro suppression activity compared to wild-type Tregs, TRAF6-deficient Tregs did not suppress colitis in lymphopenic mice very efficiently due to reduced number of Foxp3-positive cells. In addition, the fraction of TRAF6-deficient Tregs was reduced compared with wild-type Tregs in female cKO mice without inflammation. Moreover, adoptive transfer of Foxp3(+) Tregs into Rag2(-/-) mice revealed that TRAF6-deficient Tregs converted into Foxp3-cells more rapidly than WT Tregs under lymphopenic conditions. Fate-mapping analysis also revealed that conversion of Tregs from Foxp3(+) to Foxp3(-) (exFoxp3 cells) was accelerated in TRAF6-deficient Tregs. These data indicate that TRAF6 in Tregs plays important roles in the maintenance of Foxp3 in Tregs and in the suppression of pathogenic Th2 type conversion of Tregs.	[Muto, Go; Kotani, Hitoshi; Kondo, Taisuke; Morita, Rimpei; Tsuruta, Sanae; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Kobayashi, Takashi] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Kobayashi, Takashi] Oita Univ, Fac Med, Dept Infect Dis Control, Yufu, Oita, Japan; [Luche, Herve; Fehling, Hans Joerg] Univ Clin, Inst Immunol, Ulm, Germany; [Walsh, Matthew; Choi, Yongwon] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	Keio University; Japan Science & Technology Agency (JST); Oita University; Ulm University; University of Pennsylvania; Pennsylvania Medicine	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	yoshimura@a6.keio.jp	LUCHE, Herve/GLT-1401-2022; Yoshimura, Akihiko/K-5515-2013	Kondo, Taisuke/0000-0002-8545-1251; LUCHE, Herve/0000-0003-4309-8338	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society of the Promotion of Science; Takeda Science Foundation; Uehara Memorial Foundation; Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064909] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society of the Promotion of Science, the Takeda Science Foundation, the Uehara Memorial Foundation, the Mitsubishi Pharma Research Foundation, Kanae Foundation for the Promotion of Medical Science, and the Mochida Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Cejas PJ, 2010, BLOOD, V115, P4750, DOI 10.1182/blood-2009-09-242768; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lee HM, 2011, ADV IMMUNOL, V112, P25, DOI 10.1016/B978-0-12-387827-4.00002-4; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Motegi H, 2011, GENES CELLS, V16, P179, DOI 10.1111/j.1365-2443.2010.01474.x; Murai M, 2010, MUCOSAL IMMUNOL, V3, P443, DOI 10.1038/mi.2010.27; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ohkura N, 2011, TRENDS PHARMACOL SCI, V32, P158, DOI 10.1016/j.tips.2010.12.004; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	37	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74639	10.1371/journal.pone.0074639	http://dx.doi.org/10.1371/journal.pone.0074639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058613	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400091
J	Yuan, HC; Qiu, JG; Liu, LR; Zheng, S; Yang, L; Liu, ZH; Pu, CX; Li, JH; Wei, Q; Han, P				Yuan, Haichao; Qiu, Jianguo; Liu, Liangren; Zheng, Shuo; Yang, Lu; Liu, Zhenghua; Pu, Chunxiao; Li, Jinhong; Wei, Qiang; Han, Ping			Therapeutic Outcome of Fluorescence Cystoscopy Guided Transurethral Resection in Patients with Non-Muscle Invasive Bladder Cancer: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							HEXAMINOLEVULINATE-INDUCED FLUORESCENCE; WHITE-LIGHT CYSTOSCOPY; CARCINOMA IN-SITU; PHOTODYNAMIC DIAGNOSIS; FLEXIBLE CYSTOSCOPY; RECURRENCE; ENDOSCOPY; TUMORS; RISK	Objectives: To conduct a meta-analysis of randomized controlled trials (RCTs) to assess the therapeutic outcome of fluorescence cystoscopy (FC) guided transurethral resection (TUR) in non-muscle invasive bladder cancer (NMIBC). Materials and Methods: Relevant RCTs were identified from electronic database (MEDLINE, Embase and the Cochrane Library). The proceedings of relevant congress were also searched. The primary parameters were recurrence rate, the time to fist recurrence, recurrence free survival rate (RFS) and progression rate. Results: 12 RCTs including 2258 patients, which were identified for analysis in our study. Our study showed that the FC group have lower recurrence rate than the white light cystoscopy (WLC) group with statistically significant difference (OR: 0.5; p<0.00001). The time of the FC group first recurrence delayed significantly 7.39 weeks than WLC group (MD: 7.39 weeks; p<0.0001). There was a statistically significant difference in favor of FC in RFS at 1 yr (HR: 0.69; p<0.00001) and 2 yrs (HR: 0.65; p=0.0004). However, the FC group cannot significantly reduce the rate of progression into muscle invasive bladder cancer compared with the WLC group (OR: 0.85; p=0.39). Conclusions: FC guided TUR was demonstrated to be an effective procedure for delaying recurrence of NMIBC. Unfortunately, FC guided TUR could not significantly decrease the rate of progression into muscle invasive bladder cancer.	[Yuan, Haichao; Liu, Liangren; Zheng, Shuo; Yang, Lu; Liu, Zhenghua; Pu, Chunxiao; Li, Jinhong; Wei, Qiang; Han, Ping] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Sichuan, Peoples R China; [Qiu, Jianguo] Sichuan Univ, West China Hosp, Dept Hepatobiliary Pancreat Surg, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Han, P (corresponding author), Sichuan Univ, West China Hosp, Dept Urol, Guoxue Xiang 37, Chengdu, Sichuan, Peoples R China.	hanpinghxyy@163.com			Natural Science Foundation of China [81200551, 81270841]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by Natural Science Foundation of China (81200551, and 81270841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shukri S. Kh., 2000, Urologiya (Moscow), P48; Babjuk M, 2005, BJU INT, V96, P798, DOI 10.1111/j.1464-410X.2004.05715.x; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Burger M, 2007, EUR UROL, V52, P142, DOI 10.1016/j.eururo.2007.01.064; Daniltchenko DI, 2005, J UROLOGY, V174, P2129, DOI 10.1097/01.ju.0000181814.73466.14; Dragoescu O, 2011, ROM J MORPHOL EMBRYO, V52, P123; Filbeck T, 2002, J UROLOGY, V168, P67, DOI 10.1016/S0022-5347(05)64833-1; Geavlete B, 2012, BJU INT, V109, P549, DOI 10.1111/j.1464-410X.2011.10374.x; Grossman HB, 2012, J UROLOGY, V188, P58, DOI 10.1016/j.juro.2012.03.007; Grossman HB, 2004, J UROLOGY, V171, P69, DOI 10.1016/S0022-5347(18)37525-6; Hermann GG, 2012, SCAND J UROL NEPHROL, V46, P31, DOI 10.3109/00365599.2011.637954; Hermann GG, 2011, BJU INT, V108, pE297, DOI 10.1111/j.1464-410X.2011.10090.x; HERR HW, 1990, J UROLOGY, V144, P1365, DOI 10.1016/S0022-5347(17)39742-2; Higgins J., 2009, COCHRANE HDB SYSTEMA; Isfoss BL, 2011, BJU INT, V108, P1703, DOI 10.1111/j.1464-410X.2011.10485.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jocham D, 2005, J UROLOGY, V174, P862, DOI 10.1097/01.ju.0000169257.19841.2a; Karaolides T, 2012, UROLOGY, V80, P354, DOI 10.1016/j.urology.2012.03.067; Kausch I, 2010, EUR UROL, V57, P595, DOI 10.1016/j.eururo.2009.11.041; Kriegmair M, 2002, J UROLOGY, V168, P475, DOI 10.1016/S0022-5347(05)64661-7; KRIEGMAIR M, 1994, UROLOGY, V44, P836, DOI 10.1016/S0090-4295(94)80167-3; Lerner SP, 2012, UROL ONCOL-SEMIN ORI, V30, P285, DOI 10.1016/j.urolonc.2010.09.009; Loidl W, 2005, EUR UROL, V47, P323, DOI 10.1016/j.eururo.2004.10.025; Malmstrom PU, 2009, SCAND J UROL NEPHROL, V43, P192, DOI 10.1080/00365590902808541; Mowatt G, 2011, INT J TECHNOL ASSESS, V27, P3, DOI 10.1017/S0266462310001364; Riedl CR, 2001, J UROLOGY, V165, P1121, DOI 10.1016/S0022-5347(05)66442-7; Schumacher MC, 2010, EUR UROL, V57, P293, DOI 10.1016/j.eururo.2009.10.030; Shen PF, 2012, BJU INT, V110, pE209, DOI 10.1111/j.1464-410X.2011.10892.x; Stenzl A, 2011, CANCER-AM CANCER SOC, V117, P938, DOI [10.1002/cncr.25523, 10.1590/S1677-55382011000500027]; Stenzl A, 2010, J UROLOGY, V184, P1907, DOI 10.1016/j.juro.2010.06.148; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Witjes JA, 2005, EUR UROL, V47, P319, DOI 10.1016/j.eururo.2004.09.017; Witjes JA, 2004, EUR UROL, V45, P142, DOI 10.1016/j.eururo.2003.09.013	34	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74142	10.1371/journal.pone.0074142	http://dx.doi.org/10.1371/journal.pone.0074142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058522	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400053
J	Collard, M; Ruttle, A; Buchanan, B; O'Brien, MJ				Collard, Mark; Ruttle, April; Buchanan, Briggs; O'Brien, Michael J.			Population Size and Cultural Evolution in Nonindustrial Food-Producing Societies	PLOS ONE			English	Article							DEMOGRAPHY; COMPLEXITY; MODEL	Modeling work suggests that population size affects cultural evolution such that larger populations can be expected to have richer and more complex cultural repertoires than smaller populations. Empirical tests of this hypothesis, however, have yielded conflicting results. Here, we report a study in which we investigated whether the subsistence toolkits of small-scale food-producers are influenced by population size in the manner the hypothesis predicts. We applied simple linear and standard multiple regression analysis to data from 40 nonindustrial farming and pastoralist groups to test the hypothesis. Results were consistent with predictions of the hypothesis: both the richness and the complexity of the toolkits of the food-producers were positively and significantly influenced by population size in the simple linear regression analyses. The multiple regression analyses demonstrated that these relationships are independent of the effects of risk of resource failure, which is the other main factor that has been found to influence toolkit richness and complexity in nonindustrial groups. Thus, our study strongly suggests that population size influences cultural evolution in nonindustrial food-producing populations.	[Collard, Mark; Ruttle, April; Buchanan, Briggs] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; [Collard, Mark; Ruttle, April; Buchanan, Briggs] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs; O'Brien, Michael J.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	Simon Fraser University; Simon Fraser University; University of Missouri System; University of Missouri Columbia	Collard, M (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada.	mcollard@sfu.ca		Buchanan, Briggs/0000-0002-5684-9615; Collard, Mark/0000-0002-2725-4989	Canada Research Chairs Program; Social Sciences and Humanities Research Council; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University; University of Missouri	Canada Research Chairs Program(Canada Research Chairs); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University; University of Missouri	MC is supported by the Canada Research Chairs Program, the Social Sciences and Humanities Research Council, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and Simon Fraser University. AR's work on the study was supported by a Joseph-Armand Bombardier CGS Master's Scholarship from the Social Sciences and Humanities Research Council. BB is supported by the University of Missouri, the Canada Foundation for Innovation, and Simon Fraser University. The opinions expressed in this research are those of the authors and do not necessarily reflect the views of the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY HP, 1960, GEOGR ANN, V42, P1, DOI DOI 10.2307/520173; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Benjamini Y, 2001, ANN STAT, V29, P1165; Boyd R., 1985, CULTURE EVOLUTIONARY; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Collard M., 2008, HDB ARCHAEOLOGICAL T, P203; Collard M., 2005, CAN J ARCHAEOL J CAN, V29, P1; Colwell R., 2009, PRINCETON GUIDE ECOL, P257, DOI DOI 10.1515/9781400833023.257; Durham WH., 1991, COEVOLUTION GENES CU; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J., 2007, OXFORD HDB EVOLUTION, P555, DOI DOI 10.1093/OXFORDHB/9780198568308.013.0038; Henrich Joseph, 2010, INNOVATION CULTURAL, P203; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Kobayashi Y, 2012, THEOR POPUL BIOL, V82, P38, DOI 10.1016/j.tpb.2012.04.001; Lipo CP, 2005, MAPPING OUR ANCESTOR; Lumsden CJ, 1981, GENES MIND CULTURE; Mace R, 2005, EVOLUTION CULTURAL D; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A., 2011, CULTURAL EVOLUTION D; Mesoudi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018239; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; National Oceanic and Atmospheric Administration, 1991, NAT OC ATM ADM HIST; OBrien M. J, 1996, EVOLUTIONARY ARCHAEO; OBrien MJ, 2008, CULTURAL TRANSMISSIO; Oswalt W. H., 1973, HABITAT TECHNOLOGY E; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Premo LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015582; Read D, 2008, AM ANTIQUITY, V73, P599, DOI 10.2307/25470520; Richerson PJ., 2005, NOT GENES ALONE CULT; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Shennan SJ, 2002, GENES MEMES HUMAN HI; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; Tylor E.B., 1881, ANTHR INTRO STUDY MA	35	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72628	10.1371/journal.pone.0072628	http://dx.doi.org/10.1371/journal.pone.0072628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069153	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100013
J	Gunda, DW; Kasang, C; Kidenya, BR; Kabangila, R; Mshana, SE; Kidola, J; Kalluvya, SE; Kongola, GW; Klinker, H				Gunda, Daniel W.; Kasang, Christa; Kidenya, Benson R.; Kabangila, Rodrick; Mshana, Stephen E.; Kidola, Jeremiah; Kalluvya, Samuel E.; Kongola, Gilbert W.; Klinker, Hartwig			Plasma Concentrations of Efavirenz and Nevirapine among HIV-Infected Patients with Immunological Failure Attending a Tertiary Hospital in North-Western Tanzania	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; ROUTINE CLINICAL-PRACTICE; ANTIRETROVIRAL THERAPY; DRUG-INTERACTIONS; HIV-1-INFECTED PATIENTS; MANAGEMENT; INDINAVIR; UGANDA	Background: Sub-therapeutic and supra-therapeutic plasma concentrations of antriretrovirals are the significant causes of treatment failure and toxicity respectively among HIV-infected patients. We conducted this study to determine the pattern of efavirenz and nevirapine plasma drug concentrations among adult HIV-infected patients with immunological failure attending at a tertiary hospital in North-western Tanzania. Materials and Methods: A cross-sectional study was conducted among adult HIV-infected patients with immunological failure who have been on either efavirenz or nevirapine based antiretroviral regimen for more than 6 months. Patients were serially enrolled through routine Care and Treatment Clinic (CTC) activities. Plasma drug concentrations for efavirenz and nevirapine were determined by high performance liquid chromatography (HPLC) and Gas Chromatography (GC) respectively. Demographic, clinical and laboratory data such as viral load and CD4 counts were collected. Data analysis was done using STATA 12. Results: Of the 152 patients with immunological failure enrolled, the sub-therapeutic, therapeutic and supra-therapeutic plasma antiretroviral drug concentrations were found in 43/152 (28.3%), 76/152 (50.0%) and 33/152 (21.7%) respectively. Half of the patients were outside therapeutic window with either sub-therapeutic or supra-therapeutic plasma ARV drug concentrations. There was a significant difference in distribution of ARV adherence (p-value<0.001), NRTI backbone (p-value = 0.039), HIV stage (p-value = 0.026) and viral load (p-value = 0.007) within sub-therapeutic, therapeutic and supratherapeutic ARV plasma drug concentrations. Conclusion: There is a wide inter-individual variability of plasma ARV concentrations among HIV patients with immunological failure, with a large proportion of patients being outside therapeutic window. This variability is significant based on ARV adherence, NRTI backbone, viral load and HIV stage. Routine therapeutic drug monitoring (TDM) could assist identifying these patients early and making timely correction to avoid virological failure, poor immunological outcome and prevent associated drug toxicities. Nonetheless, ARV adherence should be strictly emphasized on HIV patients with immunological failure.	[Gunda, Daniel W.; Kabangila, Rodrick; Kalluvya, Samuel E.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Internal Med, Mwanza, Tanzania; [Kasang, Christa] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Kasang, Christa] Med Miss Inst, Wurzburg, Germany; [Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Biochem & Mol Biol, Mwanza, Tanzania; [Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Microbiol & Immunol, Mwanza, Tanzania; [Kidola, Jeremiah] NIMR, Mwanza Res Ctr, Mwanza, Tanzania; [Kongola, Gilbert W.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Clin Pharmacol, Mwanza, Tanzania; [Klinker, Hartwig] Univ Wurzburg, Dept Internal Med, Div Infect Dis, D-97070 Wurzburg, Germany	University of Wurzburg; National Institute of Medical Research; University of Wurzburg	Kidenya, BR (corresponding author), Catholic Univ Hlth & Allied Sci, Sch Med, Dept Biochem & Mol Biol, Mwanza, Tanzania.	benkidenya@yahoo.com	Klinker, Hartwig/AAC-1134-2021; Kasang, Christa/AAW-5048-2021	Kasang, Christa/0000-0003-0241-0321; Jeremiah, Kidola/0000-0001-7900-9689	Ministry of Health and Social Welfare of Tanzania; University of Wurzburg, Germany	Ministry of Health and Social Welfare of Tanzania; University of Wurzburg, Germany	This work was supported by the Ministry of Health and Social Welfare of Tanzania and the University of Wurzburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EP, 2002, AIDS RES HUM RETROV, V18, P825, DOI 10.1089/08892220260190290; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Alexander CS, 2003, J INFECT DIS, V188, P541, DOI 10.1086/376835; Back D, 2002, AIDS, V16, pS5, DOI 10.1097/00002030-200203001-00002; Best BM, 2007, JAIDS-J ACQ IMM DEF, V46, P433, DOI 10.1097/QAI.0b013e318156f029; Boffito M, 2005, ANTIVIR THER, V10, P469; Bossi P, 2004, HIV MED, V5, P352, DOI 10.1111/j.1468-1293.2004.00234.x; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Clevenbergh P, 2004, CURR HIV RES, V2, P309, DOI 10.2174/1570162043351129; corp GhB-s, 2010, COBAS AMPLIPREP COBA; Dahri K, 2007, CLIN PHARMACOKINET, V46, P109, DOI 10.2165/00003088-200746020-00002; de Maat MMR, 2003, THER DRUG MONIT, V25, P367, DOI 10.1097/00007691-200306000-00018; Dieleman JP, 1999, AIDS, V13, P473, DOI 10.1097/00002030-199903110-00005; Duong M, 2004, HIV CLIN TRIALS, V5, P216, DOI 10.1310/NXJU-9ERQ-ADWW-UC5X; Fabbiani M, 2011, INFECTION, V39, P563, DOI 10.1007/s15010-011-0183-8; Fabbiani M, 2009, J ANTIMICROB CHEMOTH, V64, P109, DOI 10.1093/jac/dkp132; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; Gazzard BG, 1999, INT J CLIN PRACT, V53, P60; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; Khoo SH, 2006, JAIDS-J ACQ IMM DEF, V41, P461, DOI 10.1097/01.qai.0000218345.65434.21; Kiser Jennifer J, 2005, Curr HIV/AIDS Rep, V2, P61, DOI 10.1007/s11904-005-0020-8; Kontorinis N, 2003, SEMIN LIVER DIS, V23, P173; Kredo T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007268.pub2; Langmann P, 2002, J CHROMATOGR B, V767, P69, DOI 10.1016/S0378-4347(01)00528-X; Langmann P, 2001, J CHROMATOGR B, V755, P151, DOI 10.1016/S0378-4347(01)00059-7; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Molto Jose, 2004, J HIV Ther, V9, P75; Murphy RL, 1999, J INFECT DIS, V179, P1116, DOI 10.1086/314703; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Rendon AL, 2005, HIV MED, V6, P360, DOI 10.1111/j.1468-1293.2005.00321.x; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Robertson SM, 2007, EXPERT OPIN PHARMACO, V8, P2947, DOI 10.1517/14656566.8.17.2947; Van Leth F, 2006, AIDS RES HUM RETROV, V22, P232, DOI 10.1089/aid.2006.22.232; van Leth F, 2006, Ned Tijdschr Geneeskd, V150, P1719; Veldkamp AI, 2001, AIDS, V15, P1089, DOI 10.1097/00002030-200106150-00003; Young B, 2005, AIDS PATIENT CARE ST, V19, P286, DOI 10.1089/apc.2005.19.286	39	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75118	10.1371/journal.pone.0075118	http://dx.doi.org/10.1371/journal.pone.0075118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058655	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600128
J	Pretel, E; Camporeale, G; de Prat-Gay, G				Pretel, Esteban; Camporeale, Gabriela; de Prat-Gay, Gonzalo			The Non-Structural NS1 Protein Unique to Respiratory Syncytial Virus: A Two-State Folding Monomer in Quasi-Equilibrium with a Stable Spherical Oligomer	PLOS ONE			English	Article							NF-KAPPA-B; AMYLOID FORMATION; VIRAL ONCOPROTEIN; IN-VITRO; BETA; GENE; BINDING; TRANSCRIPTION; INTERFERONS; SUPPRESSION	Human respiratory syncytial virus (hRSV) is a major infectious agent that cause pediatric respiratory disease worldwide. Considered one of the main virulence factors of hRSV, NS1 is known to suppress type I interferon response and signaling, thus favoring immune evasion. This, together with the fact that NS1 is unique to hRSV among paramyxoviruses, and that has no homology within databases, prompted us to investigate its conformational stability, equilibria and folding. Temperature cooperatively induces conformational changes leading to soluble spherical oligomers (NS1SOs) with amyloid-like or repetitive beta-sheet structures. The onset of the thermal transition is 45 degrees C, and the oligomerization rate is increased by 25-fold from 40 to 46 degrees C. Conformational stability analyzed by chemical perturbation of the NS1 monomer shows a two-state, highly reversible and cooperative unfolding, with a denaturant midpoint of 3.8 M, and a free energy change of 9.6 +/- 0.9 kcal.mol(-1). However, two transitions were observed in the chemical perturbation of NS1SOs: the first, from 2.0 to 3.0 M of denaturant, corresponds to a conformational transition and dissociation of the oligomers to the native monomer, indicating a substantial energy barrier. The second transition (2.0 to 3.5 M denaturant) corresponds to full unfolding of the native NS1 monomer. In addition, different cosolvent perturbations converged on the formation of beta-sheet enriched soluble oligomeric species, with secondary structure resembling those obtained after mild temperature treatment. Thus, a unique protein without homologs, structure or mechanistic information may switch between monomers and oligomers in conditions compatible with the cellular environment and be potentially modulated by crowding or compartmentalization. NS1 may act as a reservoir for increased levels and impact on protein turnover.	[de Prat-Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina; IIBBA CONICET, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	de Prat-Gay, G (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina.	gpg@leloir.org.ar		Prat Gay, Gonzalo/0000-0001-5748-6863	International Centre for Biotechnology (ICGEB) [CRP/ARG10-02]; Consejo Nacional de Promocion cientifica y Tecnologica (CONICET) [11220110100288]; Agencia Nacional de Promocion Cinetifica y Tecnologica [PICT 2011-0721]; CONICET	International Centre for Biotechnology (ICGEB); Consejo Nacional de Promocion cientifica y Tecnologica (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cinetifica y Tecnologica; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the following grants: CRP/ARG10-02 from International Centre for Biotechnology (ICGEB); PIP 2011-2014 Nro:11220110100288, from Consejo Nacional de Promocion cientifica y Tecnologica (CONICET); and PICT 2011-0721, from Agencia Nacional de Promocion Cinetifica y Tecnologica. EP holds a doctoral fellowship from CONICET. GC and GdPG are Career Investigator from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Atreya PL, 1998, J VIROL, V72, P1452, DOI 10.1128/JVI.72.2.1452-1461.1998; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; Bossert B, 2002, J VIROL, V76, P4287, DOI 10.1128/JVI.76.9.4287-4293.2002; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Claes P. D. M., 1992, LASER LIGHT SCATTERI, P66; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Collins PL, 2007, FIELDS VIROLOGY, P1601; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Freire E, 2008, PROTEINS, V70, P450, DOI 10.1002/prot.21580; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P341, DOI 10.1021/bi602457q; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gotoh B, 2001, MICROBIOL IMMUNOL, V45, P787, DOI 10.1111/j.1348-0421.2001.tb01315.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hastie ML, 2012, MOL CELL PROTEOMICS, V11, P108, DOI 10.1074/mcp.M111.015909; Hengst U, 2000, VIRUS GENES, V20, P221, DOI 10.1023/A:1008188527858; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393; Jin H, 2003, VACCINE, V21, P3647, DOI 10.1016/S0264-410X(03)00426-2; Ling Z, 2008, PROTEIN EXPRES PURIF, V57, P261, DOI 10.1016/j.pep.2007.09.017; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; PRIBIC R, 1993, ANAL BIOCHEM, V214, P366, DOI 10.1006/abio.1993.1511; Ramaswamy M, 2006, VIROLOGY, V344, P328, DOI 10.1016/j.virol.2005.09.009; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tan YR, 2013, MOL BIOL REP, V40, P675, DOI 10.1007/s11033-012-2107-9; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Wu WN, 2012, J VIROL, V86, P7777, DOI 10.1128/JVI.00460-12; Xiao SF, 2010, J MOL BIOL, V401, P274, DOI 10.1016/j.jmb.2010.05.070; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74338	10.1371/journal.pone.0074338	http://dx.doi.org/10.1371/journal.pone.0074338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058549	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600089
J	Lasa, A; Garcia, A; Alonso, C; Millet, P; Cornet, M; Cajal, TRY; Baiget, M; Barnadas, A				Lasa, Adriana; Garcia, Arnal; Alonso, Carmen; Millet, Pilar; Cornet, Monica; Ramon y Cajal, Teresa; Baiget, Montserrat; Barnadas, Agusti			Molecular Detection of Peripheral Blood Breast Cancer mRNA Transcripts as a Surrogate Biomarker for Circulating Tumor Cells	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; GENE-EXPRESSION; MARKER; PANEL; SURVIVAL; ASSAY; HER2	Circulating tumor cells (CTCs) are becoming a scientifically recognized indicator of primary tumors and/or metastasis. These cells can now be accurately detected and characterized as the result of technological advances. We analyzed the presence of CTCs in the peripheral blood of patients with metastatic breast cancer by real-time reverse-transcription PCR (RT-qPCR) using a panel of selected genes. The analysis of a single marker, without an EpCAM based enrichment approach, allowed the positive identification of 35% of the metastatic breast cancer patients. The analysis of five genes (SCGB2, TFF1, TFF3, Muc1, KRT20) performed in all the samples increased the detection to 61%. We describe a sensitive, reproducible and easy to implement approach to characterize CTC in patients with metastasic breast cancer.	[Lasa, Adriana; Garcia, Arnal; Cornet, Monica; Baiget, Montserrat] Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona, Spain; [Lasa, Adriana; Garcia, Arnal; Cornet, Monica; Baiget, Montserrat] CIBERER U705, Barcelona, Spain; [Alonso, Carmen; Millet, Pilar; Ramon y Cajal, Teresa; Barnadas, Agusti] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain; [Ramon y Cajal, Teresa; Barnadas, Agusti] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain	Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Lasa, A (corresponding author), Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona, Spain.	alasa@santpau.cat	Lasa, Adriana/H-4745-2017	Lasa, Adriana/0000-0001-9957-9646				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Arya SK, 2013, LAB CHIP, V13, P1995, DOI 10.1039/c3lc00009e; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Gervasoni A, 2008, CANCER LETT, V263, P267, DOI 10.1016/j.canlet.2008.01.003; Grunewald K, 2000, LAB INVEST, V80, P1071, DOI 10.1038/labinvest.3780112; Hauch S, 2007, ANTICANCER RES, V27, P1337; Ignatiadis M, 2008, CLIN CANCER RES, V14, P2593, DOI 10.1158/1078-0432.CCR-07-4758; Kahn HJ, 2000, BREAST CANCER RES TR, V60, P143, DOI 10.1023/A:1006350913243; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; May FEB, 2012, BIOMARK MED, V6, P301, DOI [10.2217/BMM.12.22, 10.2217/bmm.12.22]; Molloy TJ, 2011, BRIT J CANCER, V104, P1913, DOI 10.1038/bjc.2011.164; Molloy TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032426; Mostert B, 2009, CANCER TREAT REV, V35, P463, DOI 10.1016/j.ctrv.2009.03.004; Muller V, 2009, BREAST CANCER RES TR, V117, P535, DOI 10.1007/s10549-008-0276-y; Obermayr E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-666; Pollan M, 2009, JNCI-J NATL CANCER I, V101, P1584, DOI 10.1093/jnci/djp358; Reinholz MM, 2005, CLIN CANCER RES, V11, P3722, DOI 10.1158/1078-0432.CCR-04-1483; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Stathopoulou A, 2002, J CLIN ONCOL, V20, P3404, DOI 10.1200/JCO.2002.08.135; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Van der Auwera I, 2010, BRIT J CANCER, V102, P276, DOI 10.1038/sj.bjc.6605472; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Watson MA, 1999, CANCER RES, V59, P3028; Weigelt B, 2003, BRIT J CANCER, V88, P1091, DOI 10.1038/sj.bjc.6600868; Zach O, 1999, J CLIN ONCOL, V17, P2015, DOI 10.1200/JCO.1999.17.7.2015; Zhao S, 2011, BREAST CANCER RES TR, V130, P809, DOI 10.1007/s10549-011-1379-4	29	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74079	10.1371/journal.pone.0074079	http://dx.doi.org/10.1371/journal.pone.0074079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058517	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900031
J	Loffler, PMG; Groen, J; Dorr, M; Monnard, PA				Loffler, Philipp M. G.; Groen, Joost; Dorr, Mark; Monnard, Pierre-Alain			Sliding over the Blocks in Enzyme-Free RNA Copying - One-Pot Primer Extension in Ice	PLOS ONE			English	Article							TEMPLATE-DIRECTED SYNTHESIS; IN-VITRO SELECTION; HAIRPIN OLIGONUCLEOTIDES; RANDOM COPOLYMERS; NONENZYMATIC OLIGOMERIZATION; ACTIVATED NUCLEOTIDES; EUTECTIC PHASE; NUCLEIC-ACIDS; ORIGIN; EARTH	Template-directed polymerization of RNA in the absence of enzymes is the basis for an information transfer in the 'RNA-world' hypothesis and in novel nucleic acid based technology. Previous investigations established that only cytidine rich strands are efficient templates in bulk aqueous solutions while a few specific sequences completely block the extension of hybridized primers. We show that a eutectic water/ice system can support Pb2+/Mg2+-ion catalyzed extension of a primer across such sequences, i.e. AA, AU and AG, in a one-pot synthesis. Using mixtures of imidazole activated nucleotide 5'-monophosphates, the two first "blocking" residues could be passed during template-directed polymerization, i.e., formation of triply extended products containing a high fraction of faithful copies was demonstrated. Across the AG sequence, a mismatch sequence was formed in similar amounts to the correct product due to U.G wobble pairing. Thus, the template-directed extension occurs both across pyrimidine and purine rich sequences and insertions of pyrimidines did not inhibit the subsequent insertions. Products were mainly formed with 2'-5'-phosphodiester linkages, however, the abundance of 3'-5'-linkages was higher than previously reported for pyrimidine insertions. When enzyme-free, template-directed RNA polymerization is performed in a eutectic water ice environment, various intrinsic reaction limitations observed in bulk solution can then be overcome.	[Loffler, Philipp M. G.; Groen, Joost; Dorr, Mark; Monnard, Pierre-Alain] Univ Southern Denmark, Dept Phys Chem & Pharmaceut Sci, Odense, Denmark; [Groen, Joost] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Dorr, Mark] Ernst Moritz Arndt Univ Greifswald, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany	University of Southern Denmark; Radboud University Nijmegen; Ernst Moritz Arndt Universitat Greifswald	Monnard, PA (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharmaceut Sci, Odense, Denmark.	monnard@sdu.dk	Groen, Joost/I-7828-2012	Groen, Joost/0000-0003-3087-8087; Monnard, Pierre-Alain/0000-0003-4679-3950; Loffler, Philipp/0000-0002-8995-6783	University of Southern Denmark; Danish National Research Foundation; European Community [249032]	University of Southern Denmark; Danish National Research Foundation(Danmarks Grundforskningsfond); European Community(European Commission)	This work was supported by the University of Southern Denmark and the Danish National Research Foundation that supports the Center for Fundamental Living Technology (FLinT) and by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 249032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RL, 1981, PHILOS T R SOC A, V301, P443, DOI 10.1098/rsta.1981.0122; Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; BADA JL, 1994, P NATL ACAD SCI USA, V91, P1248, DOI 10.1073/pnas.91.4.1248; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; Dorr M, 2012, CURR ORG SYNTH, V9, P735, DOI 10.2174/157017912803901691; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hartel C, 2000, HELV CHIM ACTA, V83, P2541, DOI 10.1002/1522-2675(20000906)83:9<2541::AID-HLCA2541>3.0.CO;2-8; Hey M, 2003, HELV CHIM ACTA, V86, P844, DOI 10.1002/hlca.200390084; Huang WH, 2006, J AM CHEM SOC, V128, P8914, DOI 10.1021/ja061782k; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Iizuka T, 2007, PRECAMBRIAN RES, V153, P179, DOI 10.1016/j.precamres.2006.11.017; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; JOYCE GF, 1986, J MOL BIOL, V188, P433, DOI 10.1016/0022-2836(86)90166-X; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; JOYCE GF, 1984, J MOL BIOL, V176, P279, DOI 10.1016/0022-2836(84)90425-X; JOYCE GF, 1988, J MOL BIOL, V202, P677, DOI 10.1016/0022-2836(88)90297-5; Kanavarioti A, 1999, ORIGINS LIFE EVOL B, V29, P473, DOI 10.1023/A:1006540607594; KANAVARIOTI A, 1989, J AM CHEM SOC, V111, P7247, DOI 10.1021/ja00200a053; Kanavarioti A, 2001, ASTROBIOLOGY, V1, P271, DOI 10.1089/15311070152757465; Kervio E, 2010, P NATL ACAD SCI USA, V107, P12074, DOI 10.1073/pnas.0914872107; Kurz M, 1998, HELV CHIM ACTA, V81, P1156, DOI 10.1002/hlca.19980810528; Leu K, 2013, J AM CHEM SOC, V135, P354, DOI 10.1021/ja3095558; LOHRMANN R, 1980, SCIENCE, V208, P1464, DOI 10.1126/science.6247762; Monnard PA, 2003, J AM CHEM SOC, V125, P13734, DOI 10.1021/ja036465h; Monnard PA, 2008, J INORG BIOCHEM, V102, P1104, DOI 10.1016/j.jinorgbio.2008.01.026; Oligo Analyzer, OL AN 3 1; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Prabahar KJ, 1997, J AM CHEM SOC, V119, P4330, DOI 10.1021/ja9700764; Rajamani S, 2010, J AM CHEM SOC, V132, P5880, DOI 10.1021/ja100780p; Rothlingshofer M, 2008, ANGEW CHEM INT EDIT, V47, P6065, DOI 10.1002/anie.200801260; SAWAI H, 1976, J AM CHEM SOC, V98, P7037, DOI 10.1021/ja00438a050; Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v; STRIBLING R, 1991, J MOL EVOL, V32, P282, DOI 10.1007/BF02102185; Thayer JR, 2007, ANAL BIOCHEM, V361, P132, DOI 10.1016/j.ab.2006.10.032; Thayer JR, 2005, ANAL BIOCHEM, V338, P39, DOI 10.1016/j.ab.2004.11.013; Trinks H, 2005, ORIGINS LIFE EVOL B, V35, P429, DOI 10.1007/s11084-005-5009-1; Vaish NK, 2000, NUCLEIC ACIDS RES, V28, P3316, DOI 10.1093/nar/28.17.3316; Vogel SR, 2007, CHEM COMMUN, P1896, DOI 10.1039/b702768k; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Woese C.R., 1967, GENETIC CODE MOL BAS; WU T, 1992, J AM CHEM SOC, V114, P7963, DOI 10.1021/ja00047a001; WU TF, 1992, J AM CHEM SOC, V114, P5496, DOI 10.1021/ja00040a002; WU TF, 1992, J AM CHEM SOC, V114, P317, DOI 10.1021/ja00027a040; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z; Zhao C, 2012, ANAL CHEM, V84, P1157, DOI 10.1021/ac2029387	47	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75617	10.1371/journal.pone.0075617	http://dx.doi.org/10.1371/journal.pone.0075617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058695	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900122
J	Scherpenisse, M; Schepp, RM; Mollers, M; Meijer, CJLM; Berbers, GAM; van der Klis, FRM				Scherpenisse, Mirte; Schepp, Rutger M.; Mollers, Madelief; Meijer, Chris J. L. M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.			Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTIONS; RISK; IMMUNOGENICITY; SEROPREVALENCE; PREVALENCE; EFFICACY; VACCINES; MARKER; SAFETY; ASSAY	Objectives: In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral antibody response that will provide insight in the HPV humoral immune response induced by HPV infection and vaccination. Methods: Cross-reactivity of HPV-specific antibodies induced by infection or vaccination was assessed with VLP16 or 18 inhibition using a VLP-based multiplex immunoassay (MIA) for HPV16, 18, 31, 33, 45, 52 and 58. HPV16/18 specific IgG1-4 subclasses and avidity were determined with the VLP-MIA in sera after HPV infection and after vaccination. Neutralizing antibodies were determined in a small subset of single-seropositive and multi-seropositive naturally derived antibodies. Results: Naturally derived antibodies from single-positive sera were highly genotype-specific as homologue VLP-inhibition percentages varied between 78-94%. In multi-positive sera, cross-reactive antibodies were observed both within and between alpha 7 and alpha 9 species. After vaccination, cross-reactive antibodies were mainly species-specific. Avidity of vaccine-derived HPV-specific antibodies was 3 times higher than that of antibodies induced by HPV infection (p<0.0001). IgG1 and IgG3 were found to be the predominant subclasses observed after HPV infection and vaccination. In the small subset tested, the number of single-positive sera with neutralizing capacity was higher than of multi-positive sera. Conclusion: Naturally derived HPV-specific antibodies from single-positive samples showed different characteristics in terms of cross-reactivity and neutralizing capacity compared with antibodies from multi-positive sera. Post-vaccination, HPV antibody avidity was approximately 3 times higher than antibody avidity induced by HPV infection. Therefore, antibody avidity might be a potential surrogate of protection.	[Scherpenisse, Mirte; Schepp, Rutger M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Mollers, Madelief] Natl Inst Publ Hlth & Environm, Dept Epidemiol & Surveillance, NL-3720 BA Bilthoven, Netherlands; [Scherpenisse, Mirte; Mollers, Madelief; Meijer, Chris J. L. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Scherpenisse, M (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	M.Scherpenisse@amc.uva.nl						Anttila M, 1998, J INFECT DIS, V177, P1614, DOI 10.1086/515298; Braunstein SL, 2011, SEX TRANSM DIS, V38, P385, DOI 10.1097/OLQ.0b013e31820b8eba; Burk RD, 2009, PUBLIC HEALTH GENOM, V12, P281, DOI 10.1159/000214919; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Dauner JG, 2010, VACCINE, V28, P5407, DOI 10.1016/j.vaccine.2010.06.018; De Carvalho N, 2010, VACCINE, V28, P6247, DOI 10.1016/j.vaccine.2010.07.007; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Draper E, 2011, VACCINE, V29, P8585, DOI 10.1016/j.vaccine.2011.09.021; Einstein MH, 2011, HUM VACCINES, V7, P1343, DOI 10.4161/hv.7.12.18281; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Harro CD, 2001, JNCI-J NATL CANCER I, V93, P284, DOI 10.1093/jnci/93.4.284; Heim K, 2007, REPROD SCI, V14, P806, DOI 10.1177/1933719107309546; Ho GYF, 2002, J INFECT DIS, V186, P737, DOI 10.1086/342972; Ho GYF, 2004, CANCER EPIDEM BIOMAR, V13, P110, DOI 10.1158/1055-9965.EPI-03-0191; KEMP TJ, 2012, VACCINE; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Lu BB, 2012, CANCER RES, V72, P676, DOI 10.1158/0008-5472.CAN-11-0751; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Matsumoto K, 1999, BIOCHEM BIOPH RES CO, V258, P128, DOI 10.1006/bbrc.1999.0588; MOLLERS M, 2012, CANC EPIDEMIOL; Namujju Proscovia B, 2011, BMC Res Notes, V4, P170, DOI 10.1186/1756-0500-4-170; Palmroth J, 2010, SCAND J INFECT DIS, V42, P379, DOI 10.3109/00365540903501608; Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x; Rice PS, 1999, REV MED VIROL, V9, P15, DOI 10.1002/(SICI)1099-1654(199901/03)9:1&lt;15::AID-RMV232&gt;3.0.CO;2-Q; ROTELIMARTINS C, 2012, HUM VACCIN J IMMUNOT, P8; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; SCHERPENISSE M, 2012, HUM VACC IMMUNOTHER, V9, P49693; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Sonnex C, 1999, SEX TRANSM INFECT, V75, P317, DOI 10.1136/sti.75.5.317; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; van der Klis FRM, 2009, NETH J MED, V67, P301; Velicer C, 2009, SEX TRANSM DIS, V36, P696, DOI 10.1097/OLQ.0b013e3181ad25ff; Viscidi RP, 1997, CLIN DIAGN LAB IMMUN, V4, P122, DOI 10.1128/CDLI.4.2.122-126.1997; Wentzensen N, 2011, J INFECT DIS, V204, P94, DOI 10.1093/infdis/jir209; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	39	55	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74797	10.1371/journal.pone.0074797	http://dx.doi.org/10.1371/journal.pone.0074797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058629	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900081
J	Verhein, KC; Salituro, FG; Ledeboer, MW; Fryer, AD; Jacoby, DB				Verhein, Kirsten C.; Salituro, Francesco G.; Ledeboer, Mark W.; Fryer, Allison D.; Jacoby, David B.			Dual p38/JNK Mitogen Activated Protein Kinase Inhibitors Prevent Ozone-Induced Airway Hyperreactivity in Guinea Pigs	PLOS ONE			English	Article							P38 MAP KINASE; PULMONARY PARASYMPATHETIC NERVES; M2 MUSCARINIC RECEPTORS; MAJOR BASIC-PROTEIN; CYTOKINE PRODUCTION; SIGNALING PATHWAYS; EPITHELIAL-CELLS; TERMINAL KINASE; SMOOTH-MUSCLE; HYPERRESPONSIVENESS	Ozone exposure causes airway hyperreactivity and increases hospitalizations resulting from pulmonary complications. Ozone reacts with the epithelial lining fluid and airway epithelium to produce reactive oxygen species and lipid peroxidation products, which then activate cell signaling pathways, including the mitogen activated protein kinase (MAPK) pathway. Both p38 and c-Jun NH2 terminal kinase (JNK) are MAPK family members that are activated by cellular stress and inflammation. To test the contribution of both p38 and JNK MAPK to ozone-induced airway hyperreactivity, guinea pigs were pretreated with dual p38 and JNK MAPK inhibitors (30 mg/kg, ip) 60 minutes before exposure to 2 ppm ozone or filtered air for 4 hours. One day later airway reactivity was measured in anesthetized animals. Ozone caused airway hyperreactivity one day post-exposure, and blocking p38 and JNK MAPK completely prevented ozone-induced airway hyperreactivity. Blocking p38 and JNK MAPK also suppressed parasympathetic nerve activity in air exposed animals, suggesting p38 and JNK MAPK contribute to acetylcholine release by airway parasympathetic nerves. Ozone inhibited neuronal M-2 muscarinic receptors and blocking both p38 and JNK prevented M-2 receptor dysfunction. Neutrophil influx into bronchoalveolar lavage was not affected by MAPK inhibitors. Thus p38 and JNK MAPK mediate ozone-induced airway hyperreactivity through multiple mechanisms including prevention of neuronal M-2 receptor dysfunction.	[Verhein, Kirsten C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Fryer, Allison D.; Jacoby, David B.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Salituro, Francesco G.; Ledeboer, Mark W.] Vertex Pharmaceut Inc, Cambridge, MA USA	Oregon Health & Science University; Oregon Health & Science University; Vertex Pharmaceuticals	Verhein, KC (corresponding author), NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA.	verheinkc@niehs.nih.gov	Fryer, Allison/F-2420-2014	Fryer, Allison/0000-0003-1712-9831; Jacoby, David/0000-0003-2195-9512	American Heart Association [0810148Z]; National Institutes of Health [HL55543, ES014601, HL54659, HL071795, RR023424]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055543, R01HL071795, R01HL054659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017592, R01ES014601] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the American Heart Association 0810148Z (to KCV) and the National Institutes of Health HL55543 (to ADF), ES014601 (to ADF), HL54659 (to DBJ), HL071795 (to DBJ), and RR023424 (to DBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Agthong S, 2009, NEUROL RES; Association AL, 2009, STAT AIR REP; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Cho HY, 2007, AM J RESP CRIT CARE, V175, P829, DOI 10.1164/rccm.200509-1527OC; Cui CH, 2002, AM J RESP CELL MOL, V27, P329, DOI 10.1165/rcmb.4762; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Etter PD, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-39; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Foster WM, 2000, J APPL PHYSIOL, V89, P1804, DOI 10.1152/jappl.2000.89.5.1804; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; FRYER AD, 1984, BRIT J PHARMACOL, V83, P973, DOI 10.1111/j.1476-5381.1984.tb16539.x; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; FRYER AD, 1991, J APPL PHYSIOL, V71, P2255, DOI 10.1152/jappl.1991.71.6.2255; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Green C, 1982, ANIMAL ANESTHESIA; Guan ZH, 2003, J NEUROSCI, V23, P7317; Hamilton RF, 1996, AM J RESP CELL MOL, V15, P275, DOI 10.1165/ajrcmb.15.2.8703485; Hiltermann JTN, 1999, FREE RADICAL BIO MED, V27, P1448, DOI 10.1016/S0891-5849(99)00191-4; Hirai S, 2005, GENE EXPR PATTERNS, V5, P517, DOI 10.1016/j.modgep.2004.12.002; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kirichenko A, 1996, TOXICOL APPL PHARM, V141, P416, DOI 10.1006/taap.1996.0307; KREIT JW, 1989, J APPL PHYSIOL, V66, P217, DOI 10.1152/jappl.1989.66.1.217; Kumagai T, 2002, ARCH BIOCHEM BIOPHYS, V397, P240, DOI 10.1006/abbi.2001.2601; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LEE LY, 1977, J APPL PHYSIOL, V43, P626, DOI 10.1152/jappl.1977.43.4.626; Lewis TC, 2005, ENVIRON HEALTH PERSP, V113, P1068, DOI 10.1289/ehp.7533; Li YK, 2003, J NEUROSCI, V23, P1605; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; MITCHELL HW, 1988, BRIT J PHARMACOL, V94, P522, DOI 10.1111/j.1476-5381.1988.tb11556.x; Nath P, 2006, EUR J PHARMACOL, V544, P160, DOI 10.1016/j.ejphar.2006.06.031; Peng Q, 2004, AM J RESP CRIT CARE, V169, P596, DOI 10.1164/rccm.200307-888OC; PRYOR WA, 1992, FREE RADICAL BIO MED, V12, P83, DOI 10.1016/0891-5849(92)90060-T; Rittner HL, 2007, BRAIN BEHAV IMMUN, V21, P1021, DOI 10.1016/j.bbi.2007.05.002; SCHULTHEIS AH, 1994, J APPL PHYSIOL, V76, P1088, DOI 10.1152/jappl.1994.76.3.1088; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Verhein KC, 2008, AM J RESP CELL MOL, V39, P730, DOI 10.1165/rcmb.2008-0045OC; Wagner EM, 1999, J APPL PHYSIOL, V86, P294, DOI 10.1152/jappl.1999.86.1.294; WHITE SR, 1990, AM J PHYSIOL, V259, pL294, DOI 10.1152/ajplung.1990.259.4.L294; Williams AS, 2007, J PHARMACOL EXP THER, V322, P351, DOI 10.1124/jpet.107.121624; Williams AS, 2008, EUR J PHARMACOL, V600, P117, DOI 10.1016/j.ejphar.2008.09.031; Yost BL, 2005, AM J PHYSIOL-LUNG C, V289, pL627, DOI 10.1152/ajplung.00377.2004; Yost BL, 1999, J APPL PHYSIOL, V87, P1272, DOI 10.1152/jappl.1999.87.4.1272	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75351	10.1371/journal.pone.0075351	http://dx.doi.org/10.1371/journal.pone.0075351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058677	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900109
J	Barbacci, A; Lahaye, M; Magnenet, V				Barbacci, Adelin; Lahaye, Marc; Magnenet, Vincent			Another Brick in the Cell Wall: Biosynthesis Dependent Growth Model	PLOS ONE			English	Article							CHARA-CORALLINA; PECTATE CHEMISTRY; MECHANICS; EXPANSION; PLANTS; POLYSACCHARIDES; XYLOGLUCAN; RELAXATION; MOVEMENTS; NETWORKS	Expansive growth of plant cell is conditioned by the cell wall ability to extend irreversibly. This process is possible if (i) a tensile stress is developed in the cell wall due to the coupling effect between turgor pressure and the modulation of its mechanical properties through enzymatic and physicochemical reactions and if (ii) new cell wall elements can be synthesized and assembled to the existing wall. In other words, expansive growth is the result of coupling effects between mechanical, thermal and chemical energy. To have a better understanding of this process, models must describe the interplay between physical or mechanical variable with biological events. In this paper we propose a general unified and theoretical framework to model growth in function of energy forms and their coupling. This framework is based on irreversible thermodynamics. It is then applied to model growth of the internodal cell of Chara corallina modulated by changes in pressure and temperature. The results describe accurately cell growth in term of length increment but also in term of cell pectate biosynthesis and incorporation to the expanding wall. Moreover, the classical growth model based on Lockhart's equation such as the one proposed by Ortega, appears as a particular and restrictive case of the more general growth equation developed in this paper.	[Barbacci, Adelin; Lahaye, Marc] INRA, Biopolymers Interact Assembly UR 1268 BIA, F-44026 Nantes, France; [Magnenet, Vincent] Univ Strasbourg, UMR CNRS 7357, Lab Sci Ingnieur Informat & Imagerie ICube, Illkirch Graffenstaden, France	INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Barbacci, A (corresponding author), INRA, Biopolymers Interact Assembly UR 1268 BIA, F-44026 Nantes, France.	adelin.barbacci@nantes.inra.fr; vmagnenet@unistra.fr	Barbacci, Adelin/G-2634-2016; Barbacci, Adelin/O-1593-2019; LAHAYE, Marc/C-6324-2009	Barbacci, Adelin/0000-0003-3156-272X; Barbacci, Adelin/0000-0003-3156-272X; LAHAYE, Marc/0000-0001-8380-0334	European project Dream [UE FP7-222654-2]; INRA project Impeto	European project Dream; INRA project Impeto	This work was founded by the European project Dream (UE FP7-222654-2) and INRA project Impeto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bastien R, 2013, P NATL ACAD IN PRESS; Boudaoud A, 2010, TRENDS PLANT SCI, V15, P353, DOI 10.1016/j.tplants.2010.04.002; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Callen H.B., 1985, THERMODYNAMICS INTRO; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; COSGROVE DJ, 1985, PLANT PHYSIOL, V78, P347, DOI 10.1104/pp.78.2.347; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Coussy O., 2004, POROMECHANICS; Cunat C, 2001, MECH TIME-DEPEND MAT, V5, P39, DOI 10.1023/A:1009899519935; Dumais J, 2007, CURR OPIN PLANT BIOL, V10, P58, DOI 10.1016/j.pbi.2006.11.014; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; Dyson RJ, 2012, J THEOR BIOL, V307, P125, DOI 10.1016/j.jtbi.2012.04.035; Dyson RJ, 2010, J FLUID MECH, V655, P472, DOI 10.1017/S002211201000100X; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; Hamant O, 2010, NEW PHYTOL, V185, P369, DOI 10.1111/j.1469-8137.2009.03100.x; Kha H, 2010, PLANT PHYSIOL, V152, P774, DOI 10.1104/pp.109.146936; Kroeger JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018549; Lerouxel O, 2006, CURR OPIN PLANT BIOL, V9, P621, DOI 10.1016/j.pbi.2006.09.009; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Moulia B, 2011, SIGNAL COMMUN PLANTS, P269, DOI 10.1007/978-3-642-19091-9_11; Moulia B, 2009, J EXP BOT, V60, P461, DOI 10.1093/jxb/ern341; Mrabet K, 2003, ENG SCI, V45, P42; ORTEGA JKE, 1985, PLANT PHYSIOL, V79, P318, DOI 10.1104/pp.79.1.318; Park YB, 2012, PLANT PHYSIOL, V158, P465, DOI 10.1104/pp.111.189779; Peaucelle A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00121; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pietruszka M, 2012, J THEOR BIOL, V315, P119, DOI 10.1016/j.jtbi.2012.09.016; Prigogine I., 1999, THERMODYNAMIQUE MOTE; Proseus TE, 2008, PLANT CELL ENVIRON, V31, P1147, DOI 10.1111/j.1365-3040.2008.01829.x; Proseus TE, 2007, J EXP BOT, V58, P4283, DOI 10.1093/jxb/erm318; Proseus TE, 2006, J EXP BOT, V57, P3231, DOI 10.1093/jxb/erl087; Proseus TE, 2006, J EXP BOT, V57, P3989, DOI 10.1093/jxb/erl166; RAY PM, 1962, DEV BIOL, V4, P377, DOI 10.1016/0012-1606(62)90049-0; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Thompson DS, 2005, J EXP BOT, V56, P2275, DOI 10.1093/jxb/eri247; Veytsman BA, 1998, BIOPHYS J, V75, P2240, DOI 10.1016/S0006-3495(98)77668-4; Videcoq P, 2013, SOFT MATTER, V9, P5110, DOI 10.1039/c3sm00058c; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Zonia L, 2007, TRENDS PLANT SCI, V12, P90, DOI 10.1016/j.tplants.2007.01.006	42	17	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74400	10.1371/journal.pone.0074400	http://dx.doi.org/10.1371/journal.pone.0074400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066142	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000124
J	Ignatov, D; Malakho, S; Majorov, K; Skvortsov, T; Apt, A; Azhikina, T				Ignatov, Dmitriy; Malakho, Sofia; Majorov, Konstantin; Skvortsov, Timofey; Apt, Alexander; Azhikina, Tatyana			RNA-Seq Analysis of Mycobacterium avium Non-Coding Transcriptome	PLOS ONE			English	Article							SUBSP PARATUBERCULOSIS; TRANSLATION INITIATION; REGULATORY RNA; BOVIS BCG; TUBERCULOSIS; VIRULENCE; BACTERIA; MICE; INFECTION; GENES	Deep sequencing was implemented to study the transcriptional landscape of Mycobacterium avium. High-resolution transcriptome analysis identified the transcription start points for 652 genes. One third of these genes represented leaderless transcripts, whereas the rest of the transcripts had 5' UTRs with the mean length of 83 nt. In addition, the 5' UTRs of 6 genes contained SAM-IV and Ykok types of riboswitches. 87 antisense RNAs and 10 intergenic small RNAs were mapped. 6 intergenic small RNAs, including 4.5S RNA and rnpB, were transcribed at extremely high levels. Although several intergenic sRNAs are conserved in M. avium and M. tuberculosis, both of these species have unique intergenic sRNAs. Moreover, we demonstrated that even conserved small RNAs are regulated differently in these species. Different sets of intergenic sRNAs may underlie differences in physiology between conditionally pathogenic M. avium and highly specialized pathogen M. tuberculosis.	[Ignatov, Dmitriy; Skvortsov, Timofey; Azhikina, Tatyana] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Malakho, Sofia] Ctr Innovat & Technol Biol Act Cpds & Their Appli, Moscow, Russia; [Malakho, Sofia] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Majorov, Konstantin; Apt, Alexander] Cent Inst TB, Moscow, Russia	Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University	Ignatov, D (corresponding author), Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	dima.ignatov@gmail.com	Ignatov, Dmitriy/U-4391-2018; Azhikina, Tatyana/X-8411-2018; Majorov, Konstantin Borisovich/AIE-6667-2022	Ignatov, Dmitriy/0000-0002-2237-974X; Skvortsov, Timofey/0000-0002-4048-6725; Apt, Alexander/0000-0002-3683-3085	Presidium of the Russian Academy of Sciences [NSh 1674.2012.4]; RBRF Grant [12-04-01425]	Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); RBRF Grant	The work was supported by grants from the "Leading Scientific Schools of Russia" (project NSh 1674.2012.4), "Molecular and Cellular Biology" programme of the Presidium of the Russian Academy of Sciences, and by RBRF Grant 12-04-01425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Alexander DC, 2009, J BACTERIOL, V191, P1018, DOI 10.1128/JB.01340-08; Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Arnvig KB, 2010, DRUG DISCOV TODAY DI, V7, pe19; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Dvorska L, 2003, J MICROBIOL METH, V55, P11, DOI 10.1016/S0167-7012(03)00092-7; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Flesselles B, 1999, FEMS MICROBIOL LETT, V177, P237, DOI 10.1111/j.1574-6968.1999.tb13738.x; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, P25; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Heifets L, 2004, SEMIN RESP CRIT CARE, V25, P283, DOI 10.1055/s-2004-829501; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Ignatov DV, 2012, RUSS J BIOORG CHEM+, V38, P447, DOI 10.1134/S1068162012040085; Kondratieva EV, 2007, INFECT IMMUN, V75, P4762, DOI 10.1128/IAI.00482-07; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasa I, 2012, RNA BIOL, V9, P1039, DOI 10.4161/rna.21167; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Milon P, 2012, CRIT REV BIOCHEM MOL, V47, P334, DOI 10.3109/10409238.2012.678284; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIGHTINGALE SD, 1992, J INFECT DIS, V165, P1082, DOI 10.1093/infdis/165.6.1082; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; PEDROSA J, 1994, CLIN EXP IMMUNOL, V98, P210; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Thegerstrom J, 2005, SCAND J INFECT DIS, V37, P15, DOI 10.1080/00365540510026850; THOREL MF, 1990, INT J SYST BACTERIOL, V40, P254, DOI 10.1099/00207713-40-3-254; Torarinsson E, 2008, NUCLEIC ACIDS RES, V36, pW79, DOI 10.1093/nar/gkn275; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; van Coppenraet LESB, 2008, EUR J CLIN MICROBIOL, V27, P293, DOI 10.1007/s10096-007-0440-z; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	52	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74209	10.1371/journal.pone.0074209	http://dx.doi.org/10.1371/journal.pone.0074209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066122	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000104
J	Salazar, JK; Wu, ZC; Yang, WX; Freitag, NE; Tortorello, ML; Wang, H; Zhang, W				Salazar, Joelle K.; Wu, Zhuchun; Yang, Weixu; Freitag, Nancy E.; Tortorello, Mary Lou; Wang, Hui; Zhang, Wei			Roles of a Novel Crp/Fnr Family Transcription Factor Lmo0753 in Soil Survival, Biofilm Production and Surface Attachment to Fresh Produce of Listeria monocytogenes	PLOS ONE			English	Article							ESCHERICHIA-COLI O157/H7; PROCESSING PLANTS; STAINLESS-STEEL; REGULATOR PRFA; UNITED-STATES; VIRULENCE; ILLNESS; MICROORGANISMS; SANITATION; OUTBREAKS	Listeria monocytogenes is a foodborne bacterial pathogen and the causative agent of an infectious disease, listeriosis. L. monocytogenes is ubiquitous in nature and has the ability to persist in food processing environments for extended periods of time by forming biofilms and resisting industrial sanitization. Human listeriosis outbreaks are commonly linked to contaminated dairy products, ready-to-eat meats, and in recent years, fresh produce such as lettuce and cantaloupes. We identified a putative Crp/Fnr family transcription factor Lmo0753 that is highly specific to human-associated genetic lineages of L. monocytogenes. Lmo0753 possesses two conserved functional domains similar to the major virulence regulator PrfA in L. monocytogenes. To determine if Lmo0753 is involved in environmental persistence-related mechanisms, we compared lmo0753 deletion mutants with respective wild type and complementation mutants of two fully sequenced L. monocytogenes genetic lineage II strains 10403S and EGDe for the relative ability of growth under different nutrient availability and temperatures, soil survival, biofilm productivity and attachment to select fresh produce surfaces including romaine lettuce leaves and cantaloupe rinds. Our results collectively suggested that Lmo0753 plays an important role in L. monocytogenes biofilm production and attachment to fresh produce, which may contribute to the environmental persistence and recent emergence of this pathogen in human listeriosis outbreaks linked to fresh produce.	[Salazar, Joelle K.; Wu, Zhuchun; Yang, Weixu; Zhang, Wei] Illinois Inst Technol, Inst Food Safety & Hlth, Bedford Pk, IL USA; [Freitag, Nancy E.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Tortorello, Mary Lou] US FDA, Bedford Pk, IL USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Food Safety Res Ctr, Shanghai, Peoples R China; [Zhang, Wei] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Food & Drug Administration (FDA); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wuhan Polytechnic University	Zhang, W (corresponding author), Illinois Inst Technol, Inst Food Safety & Hlth, Bedford Pk, IL USA.	zhangw@iit.edu			U.S. Food and Drug Administration; Department of Education of Hubei Province	U.S. Food and Drug Administration; Department of Education of Hubei Province	This work was partly supported by the U.S. Food and Drug Administration research funds to the Institute for Food Safety and Health of the Illinois Institute of Technology. This work was also partly supported by the Chu Tian Lecturing Professorship from the Department of Education of Hubei Province to Wuhan Polytechnic University. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autio T, 2002, INT J FOOD MICROBIOL, V77, P83, DOI 10.1016/S0168-1605(02)00055-7; Beuchat L. R., 1998, J FOOD SAFETY; Bortolussi R, 2008, CAN MED ASSOC J, V179, P795, DOI 10.1503/cmaj.081377; BOTZLER R G, 1974, Journal of Wildlife Diseases, V10, P204; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; Carpentier B, 2004, INT J FOOD MICROBIOL, V97, P111, DOI 10.1016/j.ijfoodmicro.2004.03.031; CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Chae MS, 2000, INT J FOOD MICROBIOL, V62, P103, DOI 10.1016/S0168-1605(00)00406-2; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dolin R., 2000, PRINCIPLES PRACTICE, V5th ed.; Ecolab, 2012, TSUN 100 MAT SAF DAT; Ecolab, 2006, EC ANN ITS TSUN 100; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Folsom JP, 2006, J FOOD PROTECT, V69, P826, DOI 10.4315/0362-028X-69.4.826; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gamble R, 2007, APPL ENVIRON MICROB, V73, P5235, DOI 10.1128/AEM.00114-07; Garrec N, 2003, FEMS IMMUNOL MED MIC, V35, P275, DOI 10.1016/S0928-8244(02)00443-1; Gaul LK, 2013, CLIN INFECT DIS, V56, P20, DOI 10.1093/cid/cis817; Gil MI, 2009, INT J FOOD MICROBIOL, V134, P37, DOI 10.1016/j.ijfoodmicro.2009.05.021; Gilbreth SE, 2005, APPL ENVIRON MICROB, V71, P8115, DOI 10.1128/AEM.71.12.8115-8122.2005; Hansen LT, 2011, INT J FOOD MICROBIOL, V146, P88, DOI 10.1016/j.ijfoodmicro.2011.01.032; Hood SK, 1997, INT J FOOD MICROBIOL, V37, P145, DOI 10.1016/S0168-1605(97)00071-8; Jain A, 2007, CRIT REV THER DRUG, V24, P393, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i5.10; Jiang XP, 2004, J FOOD PROTECT, V67, P1676, DOI 10.4315/0362-028X-67.8.1676; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kim J, 2010, J APPL MICROBIOL, V109, P2095, DOI 10.1111/j.1365-2672.2010.04841.x; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Lemon KP, 2010, J BACTERIOL, V192, P3969, DOI 10.1128/JB.00179-10; Lemunier M, 2005, APPL ENVIRON MICROB, V71, P5779, DOI 10.1128/AEM.71.10.5779-5786.2005; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; McLaughlin HP, 2011, ARCH MICROBIOL, V193, P775, DOI 10.1007/s00203-011-0716-7; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Olmez H, 2009, LWT-FOOD SCI TECHNOL, V42, P686, DOI 10.1016/j.lwt.2008.08.001; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Salazar JK, 2013, APPL ENV MI IN PRESS; Salazar Joelle K, 2013, PLoS One, V8, pe57272, DOI 10.1371/journal.pone.0057272; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; WILLIAMS ST, 1985, BACTERIA THEIR NATUR, P81; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Zhou QC, 2011, CURR MICROBIOL, V63, P186, DOI 10.1007/s00284-011-9964-7	52	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75736	10.1371/journal.pone.0075736	http://dx.doi.org/10.1371/journal.pone.0075736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066185	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000167
J	Gupta, S; Kapoor, P; Chaudhary, K; Gautam, A; Kumar, R; Raghava, GPS				Gupta, Sudheer; Kapoor, Pallavi; Chaudhary, Kumardeep; Gautam, Ankur; Kumar, Rahul; Raghava, Gajendra P. S.		Open Source Drug Discovery	In Silico Approach for Predicting Toxicity of Peptides and Proteins	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; EPITOPES; DATABASE; BINDING; TOXINS; DRUGS	Background: Over the past few decades, scientific research has been focused on developing peptide/protein-based therapies to treat various diseases. With the several advantages over small molecules, including high specificity, high penetration, ease of manufacturing, peptides have emerged as promising therapeutic molecules against many diseases. However, one of the bottlenecks in peptide/protein-based therapy is their toxicity. Therefore, in the present study, we developed in silico models for predicting toxicity of peptides and proteins. Description: We obtained toxic peptides having 35 or fewer residues from various databases for developing prediction models. Non-toxic or random peptides were obtained from SwissProt and TrEMBL. It was observed that certain residues like Cys, His, Asn, and Pro are abundant as well as preferred at various positions in toxic peptides. We developed models based on machine learning technique and quantitative matrix using various properties of peptides for predicting toxicity of peptides. The performance of dipeptide-based model in terms of accuracy was 94.50% with MCC 0.88. In addition, various motifs were extracted from the toxic peptides and this information was combined with dipeptide-based model for developing a hybrid model. In order to evaluate the over-optimization of the best model based on dipeptide composition, we evaluated its performance on independent datasets and achieved accuracy around 90%. Based on above study, a web server, ToxinPred has been developed, which would be helpful in predicting (i) toxicity or non-toxicity of peptides, (ii) minimum mutations in peptides for increasing or decreasing their toxicity, and (iii) toxic regions in proteins. Conclusion: ToxinPred is a unique in silico method of its kind, which will be useful in predicting toxicity of peptides/proteins. In addition, it will be useful in designing least toxic peptides and discovering toxic regions in proteins. We hope that the development of ToxinPred will provide momentum to peptide/protein-based drug discovery (http://crdd.osdd.net/raghava/toxinpred/).	[Gupta, Sudheer; Kapoor, Pallavi; Chaudhary, Kumardeep; Gautam, Ankur; Kumar, Rahul; Raghava, Gajendra P. S.] CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Open Source Drug Discovery] CSIR, Open Source Drug Discovery Consortium, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery	Raghava, GPS (corresponding author), CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; Kumar, Rahul/ABB-3530-2020; Chaudhary, Kumardeep/Q-9740-2018; kumar, rahul/GZG-2171-2022	Raghava, Gajendra P.S./0000-0002-8902-2876; Chaudhary, Kumardeep/0000-0002-4117-6403; Kumar, Rahul/0000-0002-6927-5390	Council of Scientific and Industrial Research [GENESIS BSC0121]; Department of Biotechnology (project BTISNET), Govt. of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (project BTISNET), Govt. of India	The authors are thankful to funding agencies Council of Scientific and Industrial Research (project Open Source Drug discovery and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Govt. of India financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bhasin Manoj, 2007, V409, P381, DOI 10.1007/978-1-60327-118-9_28; Boutet Emmanuel, 2007, V406, P89; Chakraborty A, 2012, NUCLEIC ACIDS RES, V40, pD615, DOI 10.1093/nar/gkr942; Chen F, 2012, AMINO ACIDS, V43, P499, DOI 10.1007/s00726-011-1095-8; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; Joachims T, 1999, MAKING LARGE SCALE S, P169; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Lauemoller SL, 2001, TISSUE ANTIGENS, V57, P405, DOI 10.1034/j.1399-0039.2001.057005405.x; Li ZJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S1; Li ZJ, 2010, CURR PHARM DESIGN, V16, P1180, DOI 10.2174/138161210790945913; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Saha Sudipto, 2007, In Silico Biology, V7, P405; Saha Sudipto, 2007, In Silico Biology, V7, P369; Sharma A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01607; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Smolarczyk R, 2009, POSTEP HIG MED DOSW, V63, P360; Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Xiao X, 2006, AMINO ACIDS, V30, P49, DOI 10.1007/s00726-005-0225-6; Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163	30	395	407	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73957	10.1371/journal.pone.0073957	http://dx.doi.org/10.1371/journal.pone.0073957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058508	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400047
J	Uribe, KB; Martin, C; Etxebarria, A; Gonzalez-Bullon, D; Gomez-Bilbao, G; Ostolaza, H				Uribe, Kepa B.; Martin, Cesar; Etxebarria, Aitor; Gonzalez-Bullon, David; Gomez-Bilbao, Geraxane; Ostolaza, Helena			Ca2+ Influx and Tyrosine Kinases Trigger Bordetella Adenylate Cyclase Toxin (ACT) Endocytosis. Cell Physiology and Expression of the CD11b/CD18 Integrin Major Determinants of the Entry Route	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PORE-FORMING TOXINS; ENDOTHELIAL-CELLS; BACILLUS-ANTHRACIS; SIGNALING PATHWAY; PLASMA-MEMBRANE; CALCIUM INFLUX; LIPID RAFTS; CYCLIC-AMP; PERTUSSIS	Humans infected with Bordetella pertussis, the whooping cough bacterium, show evidences of impaired host defenses. This pathogenic bacterium produces a unique adenylate cyclase toxin (ACT) which enters human phagocytes and catalyzes the unregulated formation of cAMP, hampering important bactericidal functions of these immune cells that eventually cause cell death by apoptosis and/or necrosis. Additionally, ACT permeabilizes cells through pore formation in the target cell membrane. Recently, we demonstrated that ACT is internalised into macrophages together with other membrane components, such as the integrin CD11b/CD18 (CR3), its receptor in these immune cells, and GM1. The goal of this study was to determine whether ACT uptake is restricted to receptor-bearing macrophages or on the contrary may also take place into cells devoid of receptor and gain more insights on the signalling involved. Here, we show that ACT is rapidly eliminated from the cell membrane of either CR3-positive as negative cells, though through different entry routes, which depends in part, on the target cell physiology and characteristics. ACT-induced Ca2+ influx and activation of non-receptor Tyr kinases into the target cell appear to be common master denominators in the different endocytic strategies activated by this toxin. Very importantly, we show that, upon incubation with ACT, target cells are capable of repairing the cell membrane, which suggests the mounting of an anti-toxin cell repair-response, very likely involving the toxin elimination from the cell surface.	[Ostolaza, Helena] Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Ostolaza, H (corresponding author), Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, E-48080 Bilbao, Spain.	gbzoseth@ehu.es	Uribe, Kepa B./AGZ-5717-2022; Uribe, Kepa B./AAC-2163-2019; martin, cesar/L-1303-2014; González-Bullón, David/H-6987-2017	Uribe, Kepa B./0000-0002-4502-4853; Uribe, Kepa B./0000-0002-4502-4853; martin, cesar/0000-0002-4087-8729; González-Bullón, David/0000-0001-6641-8782; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministerio de Ciencia y Tecnologia [BFU 2007-62062, BFU 2012-36241]; Basque Government (ETORTEK Program); University of Basque Country (UPV/EHU) [UE06/10]; Bizkaia Biophysics Foundation	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government (ETORTEK Program)(Basque Government); University of Basque Country (UPV/EHU); Bizkaia Biophysics Foundation	This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (Project BFU 2007-62062 and Project BFU 2012-36241), the Basque Government (ETORTEK Program), and the University of Basque Country (UPV/EHU, Project UE06/10). KBU and GG were recipients of a fellowship from the Bizkaia Biophysics Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; BENZ R, 1994, J BIOL CHEM, V269, P27231; Berkowitz S A, 1980, Ann N Y Acad Sci, V356, P360, DOI 10.1111/j.1749-6632.1980.tb29626.x; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Dangoria NS, 1996, J GEN VIROL, V77, P2173, DOI 10.1099/0022-1317-77-9-2173; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Eby JC, 2011, INFECT IMMUN; Eby JC, 2010, J BIOL CHEM, V285, P10662, DOI 10.1074/jbc.M109.089219; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Gray MC, 2011, CELL MICROBIOL, V13, P123, DOI 10.1111/j.1462-5822.2010.01525.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017383; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Paccani SR, 2011, J EXP MED, V208, P1317, DOI 10.1084/jem.20101558; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; SZABO G, 1994, J BIOL CHEM, V269, P22496; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Uribe KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067648; Vogel SS, 1999, P NATL ACAD SCI USA, V96, P5019, DOI 10.1073/pnas.96.9.5019; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250	50	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74248	10.1371/journal.pone.0074248	http://dx.doi.org/10.1371/journal.pone.0074248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058533	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400058
J	Zhang, QQ; Fu, HL; Zhang, H; Xu, FY; Zou, Z; Liu, M; Wang, QX; Miao, MY; Shi, XY				Zhang, Qingqing; Fu, Hailong; Zhang, Hao; Xu, Fengying; Zou, Zui; Liu, Meng; Wang, Quanxing; Miao, Mingyong; Shi, Xueyin			Hydrogen Sulfide Preconditioning Protects Rat Liver against Ischemia/Reperfusion Injury by Activating Akt-GSK-3 beta Signaling and Inhibiting Mitochondrial Permeability Transition	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ATP-DEPENDENT MECHANISM; MOLECULAR-MECHANISMS; MOUSE-LIVER; APOPTOSIS; PATHWAY; CARDIOPROTECTION; GSK-3-BETA; RESECTION; TOXICITY	Hydrogen sulfide (H2S) is the third most common endogenously produced gaseous signaling molecule, but its impact on hepatic ischemia/reperfusion (I/R) injury, especially on mitochondrial function, remains unclear. In this study, rats were randomized into Sham, I/R, ischemia preconditioning (IPC) or sodium hydrosulfide (NaHS, an H2S donor) preconditioning groups. To establish a model of segmental (70%) warm hepatic ischemia, the hepatic artery, left portal vein and median liver lobes were occluded for 60 min and then unclamped to allow reperfusion. Preconditioning with 12.5, 25 or 50 mu mol/kg NaHS prior to the I/R insult significantly increased serum H2S levels, and, similar to IPC, NaHS preconditioning decreased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the plasma and prevented hepatocytes from undergoing I/R-induced necrosis. Moreover, a sub-toxic dose of NaHS (25 mu mol/kg) did not disrupt the systemic hemodynamics but dramatically inhibited mitochondrial permeability transition pore (MPTP) opening and thus prevented mitochondrial-related cell death and apoptosis. Mechanistic studies revealed that NaHS preconditioning markedly increased the expression of phosphorylated protein kinase B (p-Akt), phosphorylated glycogen synthase kinase-3 beta (p-GSK-3 beta) and B-cell lymphoma-2 (Bcl-2) and decreased the release of mitochondrial cytochrome c and cleaved caspase-3/9 levels. Therefore, NaHS administration prior to hepatic I/R ameliorates mitochondrial and hepatocellular damage through the inhibition of MPTP opening and the activation of Akt-GSK-3 beta signaling. Furthermore, this study provides experimental evidence for the clinical use of H2S to reduce liver damage after perioperative I/R injury.	[Zhang, Qingqing; Fu, Hailong; Zhang, Hao; Xu, Fengying; Zou, Zui; Liu, Meng; Shi, Xueyin] Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Wang, Quanxing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Wang, Quanxing] Second Mil Med Univ, Dept Immunol, Shanghai, Peoples R China; [Miao, Mingyong] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Miao, MY (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	miaomy@163.com; shixueyin1128@163.com	zhang, qingqing/GXF-2381-2022; Zhang, Hao/AAK-8111-2020	Zou, Zui/0000-0002-8433-8388	Division of Biomedicine from Science and Technology Commission of Shanghai Municipality (STCSM) [10411951300]; Key Project of the 12th Five-Year Plan of the PLA [BWS12J027]; Scientific Project from the 12th Five-Year Plan of the PLA Medicine Technology [CWS11J026]; Medical Research Projects from STCSM [124119a3601]; Shanghai Municipal Health Bureau [2011227]	Division of Biomedicine from Science and Technology Commission of Shanghai Municipality (STCSM); Key Project of the 12th Five-Year Plan of the PLA; Scientific Project from the 12th Five-Year Plan of the PLA Medicine Technology; Medical Research Projects from STCSM; Shanghai Municipal Health Bureau	This work was partially supported by grants from the Key Medical Research Projects from the Division of Biomedicine from Science and Technology Commission of Shanghai Municipality (STCSM) (10411951300), the Key Project of the 12th Five-Year Plan of the PLA (BWS12J027), the Scientific Project from the 12th Five-Year Plan of the PLA Medicine Technology (CWS11J026), the Medical Research Projects from STCSM (124119a3601), and Projects from the Shanghai Municipal Health Bureau (2011227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Belghiti J, 1999, ANN SURG, V229, P369, DOI 10.1097/00000658-199903000-00010; BHAMBHANI Y, 1991, J APPL PHYSIOL, V71, P1872, DOI 10.1152/jappl.1991.71.5.1872; Bos EM, 2012, TRANSPL INT, V25, P897, DOI 10.1111/j.1432-2277.2012.01514.x; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Couch Louise, 2005, N Z Med J, V118, pU1414; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Friman S, 2009, TRANSPL P, V41, P743, DOI 10.1016/j.transproceed.2009.01.035; Fu HL, 2012, MOL MED, V18, P1128, DOI 10.2119/molmed.2012.00088; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Izuishi K, 2006, HEPATOLOGY, V44, P573, DOI 10.1002/hep.21298; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Kapoor S, 2011, BRIT J SURG, V98, P459, DOI 10.1002/bjs.7441; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; King AL, 2011, EXP PHYSIOL, V96, P840, DOI 10.1113/expphysiol.2011.059725; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lowicka E, 2007, PHARMACOL REP, V59, P4; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; NAGORNEY DM, 1989, SURGERY, V106, P740; Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100; Selzner N, 2003, J HEPATOL, V39, P55, DOI 10.1016/S0168-8278(03)00147-8; Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Simon F, 2008, SHOCK, V30, P359, DOI 10.1097/SHK.0b013e3181674185; Snijder PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063291; Sodha NR, 2008, EUR J CARDIO-THORAC, V33, P906, DOI 10.1016/j.ejcts.2008.01.047; Sun K, 2004, WORLD J GASTROENTERO, V10, P1934; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Varela AT, 2010, MITOCHONDRION, V10, P456, DOI 10.1016/j.mito.2010.04.006; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Webster KA, 2012, FUTUR CARDIOL, V8, P863, DOI [10.2217/FCA.12.58, 10.2217/fca.12.58]; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; YAMAMOTO J, 1994, SURGERY, V115, P303; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	52	52	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74422	10.1371/journal.pone.0074422	http://dx.doi.org/10.1371/journal.pone.0074422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058562	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400075
J	Perucho, J; Casarejos, MJ; Gomez, A; Ruiz, C; Fernandez-Estevez, MA; Munoz, MP; de Yebenes, JG; Mena, MA				Perucho, Juan; Jose Casarejos, Maria; Gomez, Ana; Ruiz, Carolina; Angeles Fernandez-Estevez, Maria; Paz Munoz, Maria; Garcia de Yebenes, Justo; Angeles Mena, Maria			Striatal Infusion of Glial Conditioned Medium Diminishes Huntingtin Pathology in R6/1 Mice	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; TRANSGENIC MOUSE MODEL; MUTANT HUNTINGTIN; NEURODEGENERATIVE DISEASE; NEUROTROPHIC FACTOR; ENRICHED CULTURES; CELL-SURVIVAL; IN-VIVO; L-DOPA; AUTOPHAGY	Huntington's disease is a neurodegenerative disorder caused by an expansion of CAG repeats in the huntingtin gene which produces widespread neuronal and glial pathology. We here investigated the possible therapeutic role of glia or glial products in Huntington's disease using striatal glial conditioned medium (GCM) from fetus mice (E16) continuously infused for 15 and 30 days with osmotic minipumps into the left striatum of R6/1 mice. Animals infused with GCM had significantly less huntingtin inclusions in the ipsilateral cerebral cortex and in the ipsilateral and contralateral striata than mice infused with cerebrospinal fluid. The numbers of DARPP-32 and TH positive neurons were also greater in the ipsilateral but not contralateral striata and substantia nigra, respectively, suggesting a neuroprotective effect of GCM on efferent striatal and nigro-striatal dopamine neurons. GCM increases activity of the autophagic pathway, as shown by the reduction of autophagic substrate, p-62, and the augmentation of LC3 II, Beclin-1 and LAMP-2 protein levels, direct markers of autophagy, in GCM infused mice. GCM also increases BDNF levels. These results suggest that CGM should be further explored as a putative neuroprotective agent in Huntington's disease.	[Perucho, Juan; Jose Casarejos, Maria; Gomez, Ana; Angeles Fernandez-Estevez, Maria; Paz Munoz, Maria; Angeles Mena, Maria] Hosp Ramon & Cajal, Dept Neurobiol, E-28034 Madrid, Spain; [Ruiz, Carolina; Garcia de Yebenes, Justo] Hosp Ramon & Cajal, Dept Neurol, E-28034 Madrid, Spain; [Perucho, Juan; Jose Casarejos, Maria; Gomez, Ana; Ruiz, Carolina; Angeles Fernandez-Estevez, Maria; Paz Munoz, Maria; Garcia de Yebenes, Justo; Angeles Mena, Maria] CIBERNED, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; CIBERNED	Mena, MA (corresponding author), Hosp Ramon & Cajal, Dept Neurobiol, E-28034 Madrid, Spain.	maria.a.mena@hrc.es	Casarejos, María jose/AAA-9629-2019; Fernandez-Estevez, Marian/AAP-4474-2020	Casarejos, María jose/0000-0003-1288-1717; Fernandez-Estevez, Marian/0000-0002-7349-9127	Spanish Ministry of Health; FIS [2010/172]; CIBER [2006/05/0059]; CIBERNED [PI 2010/06]; MICINN [EC-10-098 2011/0035]; CAM [2011/BMD-2308]; CAM	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); FIS(Instituto de Salud Carlos III); CIBER; CIBERNED(Instituto de Salud Carlos III); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CAM; CAM	This study has been supported in part by grants from the Spanish Ministry of Health, FIS 2010/172, CIBER 2006/05/0059, CIBERNED PI 2010/06, MICINN EC-10-098 2011/0035 and CAM 2011/BMD-2308. JP and MAFE have a CAM postdoctoral and an FIS predoctoral fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Bolivar VJ, 2004, BRAIN RES, V1005, P29, DOI 10.1016/j.brainres.2004.01.021; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Casarejos MJ, 2005, J NEUROCHEM, V94, P1005, DOI 10.1111/j.1471-4159.2005.03249.x; Cha JHJ, 1999, PHILOS T R SOC B, V354, P981, DOI 10.1098/rstb.1999.0449; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Bernardo S, 2003, J NEUROSCI RES, V73, P818, DOI 10.1002/jnr.10704; ENGELE J, 1991, J NEUROSCI RES, V30, P359, DOI 10.1002/jnr.490300212; Florez-McClure ML, 2004, J NEUROSCI, V24, P4498, DOI 10.1523/JNEUROSCI.5744-03.2004; Folstein S, 1989, HUNTINGTONS DIS DISO, pX251; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lin X, 2011, INT J BIOL SCI, V7, P1114, DOI 10.7150/ijbs.7.1114; Liot G, 2013, J NEUROSCI, V33, P6298, DOI 10.1523/JNEUROSCI.2033-12.2013; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mena MA, 2002, MOL NEUROBIOL, V25, P245, DOI 10.1385/MN:25:3:245; MENA MA, 1993, NEUROREPORT, V4, P438, DOI 10.1097/00001756-199304000-00025; Mena MA, 1997, J NEURAL TRANSM, V104, P317, DOI 10.1007/BF01277654; Mena MA, 2008, NEUROSCIENTIST, V14, P544, DOI 10.1177/1073858408322839; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1989, AM J HUM GENET, V45, P615; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Pardo B, 1997, BRAIN RES PROTOC, V1, P127, DOI 10.1016/S1385-299X(96)00020-7; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pineda JR, 2005, J NEUROCHEM, V93, P1057, DOI 10.1111/j.1471-4159.2005.03047.x; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Reuss B, 2000, MOL CELL NEUROSCI, V16, P781, DOI 10.1006/mcne.2000.0906; Rojo A, 2002, REV NEUROLOGIA, V34, P1112, DOI 10.33588/rn.3412.2002080; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; Ruiz C, 2012, PLOS CURR, V4; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Yu ZX, 2003, J NEUROSCI, V23, P2193	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73120	10.1371/journal.pone.0073120	http://dx.doi.org/10.1371/journal.pone.0073120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069174	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100030
J	Sun, H; Benardais, K; Stanslowsky, N; Thau-Habermann, N; Hensel, N; Huang, DY; Claus, P; Dengler, R; Stangel, M; Petri, S				Sun, Hui; Benardais, Karelle; Stanslowsky, Nancy; Thau-Habermann, Nadine; Hensel, Niko; Huang, DongYa; Claus, Peter; Dengler, Reinhard; Stangel, Martin; Petri, Susanne			Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS) - In Vitro Evidence from Primary Motor Neuron Cultures, NSC-34 Cells, Astrocytes and Microglia	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; LUMBAR SPINAL-CORD; STEM-CELLS; PARKINSONS-DISEASE; PROLONGS SURVIVAL; UP-REGULATION; RAT MODEL; MICE; TRANSPLANTATION	Administration of mesenchymal stromal cells (MSC) improves functional outcome in the SOD1G93A mouse model of the degenerative motor neuron disorder amyotrophic lateral sclerosis (ALS) as well as in models of other neurological disorders. We have now investigated the effect of the interaction between MSC and motor neurons (derived from both non-transgenic and mutant SOD1G93A transgenic mice), NSC-34 cells and glial cells (astrocytes, microglia) (derived again from both non-transgenic and mutant SOD1G93A ALS transgenic mice) in vitro. In primary motor neurons, NSC-34 cells and astrocytes, MSC conditioned medium (MSC CM) attenuated staurosporine (STS) - induced apoptosis in a concentration-dependent manner. Studying MSC CM-induced expression of neurotrophic factors in astrocytes and NSC-34 cells, we found that glial cell line-derived neurotrophic factor (GDNF) and ciliary neurotrophic factor (CNTF) gene expression in astrocytes were significantly enhanced by MSC CM, with differential responses of non-transgenic and mutant astrocytes. Expression of Vascular Endothelial Growth Factor (VEGF) in NSC-34 cells was significantly upregulated upon MSC CM-treatment. MSC CM significantly reduced the expression of the cytokines TNF alpha and IL-6 and iNOS both in transgenic and non-transgenic astrocytes. Gene expression of the neuroprotective chemokine Fractalkine (CX3CL1) was also upregulated in mutant SOD1G93A transgenic astrocytes by MSC CM treatment. Correspondingly, MSC CM increased the respective receptor, CX3CR1, in mutant SOD1G93A transgenic microglia. Our data demonstrate that MSC modulate motor neuronal and glial response to apoptosis and inflammation. MSC therefore represent an interesting candidate for further preclinical and clinical evaluation in ALS.	[Sun, Hui; Benardais, Karelle; Stanslowsky, Nancy; Thau-Habermann, Nadine; Dengler, Reinhard; Stangel, Martin; Petri, Susanne] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Sun, Hui; Benardais, Karelle; Stanslowsky, Nancy; Thau-Habermann, Nadine; Hensel, Niko; Claus, Peter; Dengler, Reinhard; Stangel, Martin; Petri, Susanne] Ctr Syst Neurosci, Hannover, Germany; [Hensel, Niko; Claus, Peter] Hannover Med Sch, Dept Neuroanat, Hannover, Germany; [Huang, DongYa] Tongji Univ, Dept Neurol, East Hosp, Shanghai 200092, Peoples R China; [Petri, Susanne] Integriertes Forsch & Behandlungszentrum Transpla, Hannover, Germany	Hannover Medical School; Hannover Medical School; Tongji University	Petri, S (corresponding author), Hannover Med Sch, Dept Neurol, Hannover, Germany.	Petri.Susanne@mh-hannover.de	Petri, Susanne/AID-7665-2022; Stangel, Martin/AAH-5345-2020; Claus, Peter/A-7978-2008	Claus, Peter/0000-0003-3824-9445	German Federal Ministry of Education and Research [01EO0802]; Deutsche Forschungsgemeinschaft	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802). The authors acknowledge support for publishing costs by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; Anderson CNG, 1999, J NEUROSCI, V19, P664; Audet JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034932; Boucherie C, 2009, J NEUROSCI RES, V87, P2034, DOI 10.1002/jnr.22038; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen K, 2010, BRAIN STRUCT FUNCT, V214, P219, DOI 10.1007/s00429-009-0226-4; Chen Y, 2008, INT J BIOCHEM CELL B, V40, P815, DOI 10.1016/j.biocel.2008.01.007; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Choi MR, 2010, NEUROSCI LETT, V472, P94, DOI 10.1016/j.neulet.2010.01.054; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; DelaRosa O, 2012, CURR OPIN BIOTECH, V23, P978, DOI 10.1016/j.copbio.2012.05.005; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hiatt K, 2012, J TISSUE ENG REGEN M; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI 10.1517/14712598.8.5.569 ; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Kulshreshtha D, 2011, NEURODEGENER DIS, V8, P322, DOI 10.1159/000323718; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Li W, 2007, EXP NEUROL, V203, P457, DOI 10.1016/j.expneurol.2006.08.028; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nagano I, 2005, NEUROL RES, V27, P768, DOI 10.1179/016164105X39860; Pastor D, 2012, STEM CELL REV REP, V8, P445, DOI 10.1007/s12015-011-9295-x; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; Phul RK, 2000, AMYOTROPH LATERAL SC, V1, P259, DOI 10.1080/14660820050515089; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Ragancokova D, 2009, CELL MOL NEUROBIOL, V29, P1037, DOI 10.1007/s10571-009-9393-3; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Schafer S, 2012, J NEUROIMMUNOL, V249, P40, DOI 10.1016/j.jneuroim.2012.04.018; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Soliman ML, 2013, J NEUROIMMUNE PHARM, V8, P287, DOI 10.1007/s11481-012-9426-4; Sun H, 2013, CELL MOL NEUROBIOL, V33, P347, DOI 10.1007/s10571-012-9900-9; Sun Jing-Jun, 2008, Neurosci Bull, V24, P231, DOI 10.1007/s12264-008-0430-x; Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197; Thau N, 2012, NEUROBIOL DIS, V47, P248, DOI 10.1016/j.nbd.2012.04.008; Tovar-y-Romo LB, 2010, J NEUROCHEM, V115, P1090, DOI 10.1111/j.1471-4159.2010.06766.x; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Wiese S, 2010, NAT PROTOC, V5, P31, DOI 10.1038/nprot.2009.193; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413; Zhou C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-52	70	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72926	10.1371/journal.pone.0072926	http://dx.doi.org/10.1371/journal.pone.0072926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069165	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100023
J	Duan, YY; Brenig, B; Wu, XH; Ren, J; Huang, LS				Duan, Yanyu; Brenig, Bertram; Wu, Xiaohui; Ren, Jun; Huang, Lusheng			The G32E Functional Variant Reduces Activity of PPARD by Nuclear Export and Post-Translational Modification in Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PROLIFERATOR-ACTIVATED RECEPTORS; PROTEASOME SYSTEM CONTROLS; AFFECTING MILK-YIELD; MISSENSE MUTATION; GROWTH; GENE; IDENTIFICATION; EXPRESSION; BINDING	Peroxisome proliferator-activated receptor beta/delta (PPARD) is a crucial and multifaceted determinant of diverse biological functions including lipid metabolism, embryonic development, inflammatory response, wound healing and cancer. Recently, we proposed a novel function of porcine PPARD (sPPARD) in external ear development. A missense mutation (G32E) in an evolutionary conservative domain of sPPARD remarkably increases external ear size in pigs. Here, we investigated the underlying molecular mechanism of the causal mutation at the cellular level. Using a luciferase reporter system, we showed that the G32E substitution reduced transcription activity of sPPARD in a ligand-dependent manner. By comparison of the subcellular localization of wild-type and mutated sPPARD in both PK-15 cells and pinna cartilage-derived primary chondrocytes, we found that the G32E substitution promoted CRM-1 mediated nuclear exportation of sPPARD. With the surface plasmon resonance technology, we further revealed that the G32E substitution had negligible effect on its ligand binding affinity. Finally, we used co-immunoprecipitation and luciferase reporter assays to show that the G32E substitution greatly reduced ubiquitination level by blocking ubiquitination of the crucial A/B domain and consequently decreased transcription activity of sPPARD. Taken together, our findings strongly support that G32E is a functional variant that plays a key role in biological activity of sPPARD, which advances our understanding of the underlying mechanism of sPPARD G32E for ear size in pigs.	[Duan, Yanyu; Ren, Jun; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Duan, Yanyu; Ren, Jun; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Duan, Yanyu; Brenig, Bertram] Univ Gottingen, Inst Vet Med, D-37073 Gottingen, Germany; [Wu, Xiaohui] Fudan Univ, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; University of Gottingen; Fudan University	Ren, J (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	renjunjxau@hotmail.com; lushenghuang@hotmail.com	Ren, Jun/H-9793-2019	Brenig, Bertram/0000-0002-7635-9656	Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Key Research Program of China [2013ZX08006-05]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Research Program of China	This study was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136) and National Key Research Program of China (2013ZX08006-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bidanel JP, 2001, GENET SEL EVOL, V33, P289, DOI 10.1051/gse:2001120; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; de Koning DJ, 1999, GENETICS, V152, P1679; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Genini D, 2007, J BIOL CHEM, V282, P11776, DOI 10.1074/jbc.M609149200; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Jouzeau Jean-Yves, 2008, Journal de la Societe de Biologie, V202, P289, DOI 10.1051/jbio:2008034; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Li YT, 2009, ACTA PHARMACOL SIN, V30, P1351, DOI 10.1038/aps.2009.113; Mao HR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-63; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Perspicace S, 2009, J BIOMOL SCREEN, V14, P337, DOI 10.1177/1087057109332595; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rohrer GA, 1998, J ANIM SCI, V76, P2247; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sato S, 2003, J ANIM SCI, V81, P2938; Scholtysek C, 2013, NATURE MED; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shao YY, 2005, J ORTHOP RES, V23, P1139, DOI 10.1016/j.orthres.2005.02.011; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; von Knethen A, 2010, J CELL SCI, V123, P192, DOI 10.1242/jcs.055475; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Welter JF, 2004, METH MOLEC MED, V100, P129; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	52	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75925	10.1371/journal.pone.0075925	http://dx.doi.org/10.1371/journal.pone.0075925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058710	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900133
J	Pandey, M; Srivastava, AK; D'Souza, SF; Penna, S				Pandey, Manish; Srivastava, Ashish Kumar; D'Souza, Stanislaus Francis; Penna, Suprasanna			Thiourea, a ROS Scavenger, Regulates Source-to-Sink Relationship to Enhance Crop Yield and Oil Content in Brassica juncea (L.)	PLOS ONE			English	Article							MEMBRANE-TRANSPORT; SUCROSE SYNTHESIS; PHOTOSYNTHESIS; TARGET; PLANTS; LEAF; IDENTIFICATION; ACCUMULATION; METABOLISM; COMPONENTS	In the present agricultural scenario, the major thrust is to increase crop productivity so as to ensure sustainability. In an earlier study, foliar application of thiourea (TU; a non physiological thiol based ROS scavenger) has been demonstrated to enhance the stress tolerance and yield of different crops under field condition. Towards this endeavor, present work deals with the effect of TU on photosynthetic efficiency and source-to-sink relationship of Indian mustard (Brassica juncea) for understanding its mode of action. The application of TU increased the efficiency of both PSI and PSII photosystems and vegetative growth of plant. The comparative analysis of sucrose to starch ratio and expression level of sugar transporters confirmed the higher source and sink strength in response to TU treatment. The biochemical evidence in support of this was derived from higher activities of sucrose phosphate synthase and fructose-1,6-bis-phosphatase at source; and sucrose synthase and different classes of invertases at both source and sink. This indicated an overall increase in photoassimilate level at sink. An additional contribution through pod photosynthesis was confirmed through the analysis of phosphoenol pyruvate carboxylase enzyme activity and level of organic acids. The increased photoassimilate level was also co-ordinated with acetyl coA carboxylase mediated oil biosynthesis. All these changes were ultimately reflected in the form of 10 and 20% increase in total yield and oil content, respectively under TU treatment as compared to control. Additionally, no change was observed in oil composition of seeds derived from TU treated plants. The study thus signifies the co-ordinated regulation of key steps of photosynthesis and source-to-sink relationship through the external application of TU resulting in increased crop yield and oil content.	[Pandey, Manish; Srivastava, Ashish Kumar; D'Souza, Stanislaus Francis; Penna, Suprasanna] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Penna, S (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	prasanna@barc.gov.in	PENNA, Suprasanna/AAE-1208-2022	Srivastava, Ashish Kumar/0000-0001-9863-528X; Pandey, Manish/0000-0002-4101-6530	Department of Atomic Energy, India	Department of Atomic Energy, India(Department of Atomic Energy (DAE))	The Department of Atomic Energy, India supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Akbar E., 2009, EUR J SCI RES, V29, P396, DOI DOI 10.1016/j.optlaseng.2014.12.019; Amin AA, 2013, COMMUN SOIL SCI PLAN, V44, P1141, DOI 10.1080/00103624.2012.756006; Aranjuelo I, 2013, J EXP BOT, V64, P1879, DOI 10.1093/jxb/ert081; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Cho MH, 2012, PHOTOSYNTH RES, V111, P261, DOI 10.1007/s11120-012-9720-2; Degenkolbe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063637; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; KELNER MJ, 1990, J BIOL CHEM, V265, P1306; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; Kim YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044493; Li J, 2012, PLANT CELL PHYSIOL, V53, P433, DOI 10.1093/pcp/pcr193; Li ZM, 2012, J EXP BOT, V63, P1155, DOI 10.1093/jxb/err329; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mani F., 2012, Journal of Stress Physiology & Biochemistry, V8, P61; Maurino VG, 2013, J EXP BOT, V64, P743, DOI 10.1093/jxb/ers263; Mondal S, 2011, PLANT BREEDING, V130, P242, DOI 10.1111/j.1439-0523.2010.01787.x; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Nagano T, 2012, J BIOL CHEM, V287, P28697, DOI 10.1074/jbc.M112.378067; Nishi Mathur, 2006, World Journal of Agricultural Sciences, V2, P185; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Pandey M, 2012, J PLANT INTERACT, V7, P143, DOI 10.1080/17429145.2011.561934; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Ruan YL, 2012, MOL PLANT, V5, P763, DOI 10.1093/mp/sss046; Sahu M.P., 2006, RES B RAU BARC, V1, P56; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shahba MA, 2008, CROP SCI, V48, P756, DOI 10.2135/cropsci2007.07.0382; Shekhawat K, 2012, INT J AGRON, V2012, DOI 10.1155/2012/408284; Singh G, 2005, RES B RAU BARC, P1; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Sonnewald U, 2013, PLANT BIOTECHNOL J, V11, P223, DOI 10.1111/pbi.12029; Srivastava AK, 2010, ANN BOT-LONDON, V106, P663, DOI 10.1093/aob/mcq163; Srivastava AK, 2009, ANN BOT-LONDON, V103, P403, DOI 10.1093/aob/mcn229; Srivastava AK, 2011, PLANT PHYSIOL BIOCH, V49, P676, DOI 10.1016/j.plaphy.2011.02.016; Srivastava AK, 2008, ENVIRON EXP BOT, V64, P250, DOI 10.1016/j.envexpbot.2008.03.002; Sun JD, 2011, PLANT CELL ENVIRON, V34, P592, DOI 10.1111/j.1365-3040.2010.02265.x; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; Weber APM, 2013, CURR OPIN BIOTECH, V24, P256, DOI 10.1016/j.copbio.2012.09.010; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Xue GP, 2013, PLANT MOL BIOL, V81, P71, DOI 10.1007/s11103-012-9983-1	47	35	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73921	10.1371/journal.pone.0073921	http://dx.doi.org/10.1371/journal.pone.0073921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058504	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900025
J	Wang, ZH; Zhang, D; Bai, Y; Zhang, YH; Liu, Y; Wu, Y; Lin, XY; Wen, JW; Xu, CM; Li, LF; Liu, B				Wang, Zhen-Hui; Zhang, Di; Bai, Yan; Zhang, Yun-Hong; Liu, Ying; Wu, Ying; Lin, Xiu-Yun; Wen, Jia-Wei; Xu, Chun-Ming; Li, Lin-Feng; Liu, Bao			Genomewide Variation in an Introgression Line of Rice-Zizania Revealed by Whole-Genome re-Sequencing	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; GENE-EXPRESSION; EVOLUTION; HYBRIDIZATION; MOBILIZATION; MUTATIONS; RETROTRANSPOSONS; ALLOPOLYPLOIDY; TRANSCRIPTOME	Background: Hybridization between genetically diverged organisms is known as an important avenue that drives plant genome evolution. The possible outcomes of hybridization would be the occurrences of genetic instabilities in the resultant hybrids. It remained under-investigated however whether pollination by alien pollens of a closely related but sexually "incompatible" species could evoke genomic changes and to what extent it may result in phenotypic novelties in the derived progenies. Methodology/Principal Findings: In this study, we have re-sequenced the genomes of Oryza sativa ssp. japonica cv. Matsumae and one of its derived introgressant RZ35 that was obtained from an introgressive hybridization between Matsumae and Zizania latifolia Griseb. in general, 131 millions 90 base pair (bp) paired-end reads were generated which covered 13.2 and 21.9 folds of the Matsumae and RZ35 genomes, respectively. Relative to Matsumae, a total of 41,724 homozygous single nucleotide polymorphisms (SNPs) and 17,839 homozygous insertions/deletions (indels) were identified in RZ35, of which 3,797 SNPs were nonsynonymous mutations. Furthermore, rampant mobilization of transposable elements (TEs) was found in the RZ35 genome. The results of pathogen inoculation revealed that RZ35 exhibited enhanced resistance to blast relative to Matsumae. Notably, one nonsynonymous mutation was found in the known blast resistance gene Pid3/Pi25 and real-time quantitative (q) RTPCR analysis revealed constitutive up-regulation of its expression, suggesting both altered function and expression of Pid3/Pi25 may be responsible for the enhanced resistance to rice blast by RZ35. Conclusions/Significance: Our results demonstrate that introgressive hybridization by Zizania has provoked genomewide, extensive genomic changes in the rice genome, and some of which have resulted in important phenotypic novelties. These findings suggest that introgressive hybridization by alien pollens of even a sexually incompatible species may represent a potent means to generate novel genetic diversities, and which may have played relevant roles in plant evolution and can be manipulated for crop improvements.	[Wang, Zhen-Hui; Zhang, Di; Bai, Yan; Zhang, Yun-Hong; Liu, Ying; Wu, Ying; Xu, Chun-Ming; Li, Lin-Feng; Liu, Bao] NE Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wang, Zhen-Hui; Zhang, Di; Bai, Yan; Zhang, Yun-Hong; Liu, Ying; Wu, Ying; Xu, Chun-Ming; Li, Lin-Feng; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Wang, Zhen-Hui] Jilin Agr Univ, Fac Agron, Changchun, Peoples R China; [Lin, Xiu-Yun; Wen, Jia-Wei] Jilin Acad Agr Sci, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Jilin Agricultural University; Jilin Academy of Agricultural Sciences	Li, LF (corresponding author), NE Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China.	lilf241@nenu.edu.cn; baoliu@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279; Xu, Chunming/0000-0002-0986-0993	State Key Basic Research and Development Plan of China [2011CB100205]; Programme for Introducing Talents to Universities [B07017]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Programme for Introducing Talents to Universities	This work was supported by the State Key Basic Research and Development Plan of China (2011CB100205), and the Programme for Introducing Talents to Universities (B07017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; ANDERSON RP, 1999, REV ACAD COLOMBIANA, V23; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Boyko A, 2011, MOL PLANT, V4, P1014, DOI 10.1093/mp/ssr022; Brennan AC, 2009, NEW PHYTOL, V183, P702, DOI 10.1111/j.1469-8137.2009.02944.x; Cantu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-408; Chen JQ, 2009, MOL BIOL EVOL, V26, P1523, DOI 10.1093/molbev/msp063; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dong ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062317; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ewens WJ., 2004, THEORETICAL INTRO, V2; Farmer EE, 1998, PLANTA, V206, P167, DOI 10.1007/s004250050388; Fritz RS, 1999, ANNU REV ECOL SYST, V30, P565, DOI 10.1146/annurev.ecolsys.30.1.565; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Ge XH, 2009, ANN BOT-LONDON, V104, P19, DOI 10.1093/aob/mcp099; GENOWAYS HHB, 1993, SPEC PUBL AM SOC MAM; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Hegarty MJ, 2005, MOL ECOL, V14, P2493, DOI 10.1111/j.1365-294X.2005.02608.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Hu ZY, 1996, ARCH BIOCHEM BIOPHYS, V333, P298, DOI 10.1006/abbi.1996.0394; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Husband BC, 2000, P ROY SOC B-BIOL SCI, V267, P217, DOI 10.1098/rspb.2000.0990; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; LIU B, 1999, J GENETICS BREEDING, V53; Liu ZL, 2004, PLANT MOL BIOL, V54, P571, DOI 10.1023/B:PLAN.0000038270.48326.7a; Loewe L, 2010, PHILOS T R SOC B, V365, P1153, DOI 10.1098/rstb.2009.0317; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mou ZL, 2000, PLANT CELL, V12, P405, DOI 10.1105/tpc.12.3.405; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Park S, 2010, MOL GENET GENOMICS, V283, P135, DOI 10.1007/s00438-009-0504-0; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x; Saetre GP, 2013, J EVOLUTION BIOL, V26, P256, DOI 10.1111/jeb.12005; Sakai S, 2013, AM J BOT, V100, P546, DOI 10.3732/ajb.1200359; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; Soltis PS, 2013, J EVOLUTION BIOL, V26, P291, DOI 10.1111/jeb.12095; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Wagner W. H. Jun., 1970, Taxon, P146; Wang H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-63; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wendel JF, 2000, P NATL ACAD SCI USA, V97, P6250, DOI 10.1073/pnas.97.12.6250; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; Whitham TG, 1999, ECOLOGY, V80, P416; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yasuda K, 2013, EUPHYTICA, V192, P17, DOI 10.1007/s10681-012-0810-1; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	76	16	17	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74479	10.1371/journal.pone.0074479	http://dx.doi.org/10.1371/journal.pone.0074479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058573	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900046
J	Brauner, EV; Andersen, ZJ; Andersen, CE; Pedersen, C; Gravesen, P; Ulbak, K; Hertel, O; Loft, S; Raaschou-Nielsen, O				Brauner, Elvira V.; Andersen, Zorana J.; Andersen, Claus E.; Pedersen, Camilla; Gravesen, Peter; Ulbak, Kaare; Hertel, Ole; Loft, Steffen; Raaschou-Nielsen, Ole			Residential Radon and Brain Tumour Incidence in a Danish Cohort	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOS-ANGELES-COUNTY; CANCER INCIDENCE; LUNG-CANCER; RADIATION-EXPOSURE; URANIUM MINERS; DOMESTIC RADON; AIR-POLLUTION; RISK; PARTICLES	Background: Increased brain tumour incidence over recent decades may reflect improved diagnostic methods and clinical practice, but remain unexplained. Although estimated doses are low a relationship between radon and brain tumours may exist. Objective: To investigate the long-term effect of exposure to residential radon on the risk of primary brain tumour in a prospective Danish cohort. Methods: During 1993-1997 we recruited 57,053 persons. We followed each cohort member for cancer occurrence from enrolment until 31 December 2009, identifying 121 primary brain tumour cases. We traced residential addresses from 1 January 1971 until 31 December 2009 and calculated radon concentrations at each address using information from central databases regarding geology and house construction. Cox proportional hazards models were used to estimate incidence rate-ratios (IRR) and 95% confidence intervals (CI) for the risk of primary brain tumours associated with residential radon exposure with adjustment for age, sex, occupation, fruit and vegetable consumption and traffic-related air pollution. Effect modification by air pollution was assessed. Results: Median estimated radon was 40.5 Bq/m(3). The adjusted IRR for primary brain tumour associated with each 100 Bq/m(3) increment in average residential radon levels was 1.96 (95% CI: 1.07; 3.58) and this was exposure-dependently higher over the four radon exposure quartiles. This association was not modified by air pollution. Conclusions: We found significant associations and exposure-response patterns between long-term residential radon exposure radon in a general population and risk of primary brain tumours, adding new knowledge to this field. This finding could be chance and needs to be challenged in future studies.	[Brauner, Elvira V.; Andersen, Zorana J.; Pedersen, Camilla; Raaschou-Nielsen, Ole] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Brauner, Elvira V.] Aalborg Univ, Danish Bldg Res Inst, Aalborg, Denmark; [Andersen, Zorana J.; Loft, Steffen] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, Copenhagen, Denmark; [Andersen, Claus E.] Tech Univ Denmark, Ctr Nucl Technol, Roskilde, Denmark; [Gravesen, Peter] Geol Survey Denmark & Greenland, Copenhagen, Denmark; [Ulbak, Kaare] Natl Inst Radiat Protect, Herlev, Denmark; [Hertel, Ole] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark	Danish Cancer Society; Aalborg University; University of Copenhagen; Technical University of Denmark; Geological Survey Of Denmark & Greenland; Aarhus University	Raaschou-Nielsen, O (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	ole@cancer.dk	Hertel, Ole/L-4346-2013; Andersen, Zorana Jovanovic/P-4983-2014; Raaschou-Nielsen, Ole/GOK-0338-2022; Brauner, Elvira/C-7455-2018	Hertel, Ole/0000-0003-0972-7735; Andersen, Zorana Jovanovic/0000-0003-4138-9828; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Brauner, Elvira/0000-0001-9183-4796; Andersen, Claus E./0000-0002-7356-9607; Pedersen, Camilla/0000-0003-2068-0536; Loft, Steffen/0000-0001-9552-8518	Danish Medical Research Council [09 064754]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Research Grant from The Danish Medical Research Council (Grant number: 09 064754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Jarad F, 1997, RADIAT MEAS, V28, P579, DOI 10.1016/S1350-4487(97)00143-1; Andersen CE, 2007, RADIAT PROT DOSIM, V123, P83, DOI 10.1093/rpd/ncl082; BAIR WJ, 1995, RADIAT PROT DOSIM, V60, P307, DOI 10.1093/oxfordjournals.rpd.a082732; Blowers L, 1997, CANCER CAUSE CONTROL, V8, P5, DOI 10.1023/A:1018437031987; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Braganza MZ, 2012, NEURO-ONCOLOGY, V14, P1316, DOI 10.1093/neuonc/nos208; Brauner EV, 2012, ENVIRON RES, V118, P130, DOI 10.1016/j.envres.2012.05.012; Brauner EV, 2010, CANCER CAUSE CONTROL, V21, P1961, DOI 10.1007/s10552-010-9608-4; BROWNSON RC, 1990, AM J PUBLIC HEALTH, V80, P169, DOI 10.2105/AJPH.80.2.169; BURCH JD, 1987, J NATL CANCER I, V78, P601; Christensen G, 2011, SCAND J PUBLIC HEALT, V39, P106, DOI 10.1177/1403494811399168; Darby S, 2001, ANN ONCOL, V12, P1341, DOI 10.1023/A:1012518223463; DARBY SC, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432448; Davis Faith S, 2007, Expert Rev Anticancer Ther, V7, pS3, DOI 10.1586/14737140.7.12s.S3; Deltour I, 2009, J NATL CANCER I, V101, P1721, DOI 10.1093/jnci/djp415; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; GILES GG, 1994, INT J CANCER, V59, P357, DOI 10.1002/ijc.2910590311; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Harrel F.E., 2001, REGRESSION MODELING; Hu JF, 1999, INT J CANCER, V81, P20, DOI 10.1002/(SICI)1097-0215(19990331)81:1&lt;20::AID-IJC4&gt;3.0.CO;2-2; International Agency for Research on Cancer (IARC), 1988, IARC MONOGRAPHS EVAL, V43; Jensen SS, 2001, TRANSPORT RES D-TR E, V6, P229, DOI 10.1016/S1361-9209(00)00026-2; Kakosimos KE, 2010, ENVIRON CHEM, V7, P485, DOI 10.1071/EN10070; Kendall G. M., 2002, Journal of Radiological Protection, V22, P389, DOI 10.1088/0952-4746/22/4/304; Ketzel M, 2003, ATMOS ENVIRON, V37, P2735, DOI 10.1016/S1352-2310(03)00245-0; Kreuzer M, 2010, RADIAT ENVIRON BIOPH, V49, P177, DOI 10.1007/s00411-009-0249-5; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P838, DOI 10.1016/j.neuro.2011.12.001; LYNGE E, 1990, SCAND J WORK ENV HEA, V16, P3; McKinney PA, 2004, J NEUROL NEUROSUR PS, V75, P12, DOI 10.1136/jnnp.2004.040741; MUIR CS, 1994, CANCER SURV, V20, P369; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Preston DL, 2002, JNCI-J NATL CANCER I, V94, P1555, DOI 10.1093/jnci/94.20.1555; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; Raaschou-Nielsen O, 2008, EPIDEMIOLOGY, V19, P536, DOI 10.1097/EDE.0b013e318176bfcd; Raaschou-Nielsen O, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-67; Schneider T, 2004, ATMOS ENVIRON, V38, P6349, DOI 10.1016/j.atmosenv.2004.08.002; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Tokonami S, 2000, HEALTH PHYS, V78, P74, DOI 10.1097/00004032-200001000-00012; TOMASEK L, 1993, LANCET, V341, P919, DOI 10.1016/0140-6736(93)91212-5; Vacquier B, 2011, RADIAT RES, V176, P796, DOI 10.1667/RR2558.1; Yu KN, 2001, ENVIRON SCI TECHNOL, V35, P2136, DOI 10.1021/es001920k	47	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74435	10.1371/journal.pone.0074435	http://dx.doi.org/10.1371/journal.pone.0074435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066143	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000125
J	Godino, JG; Watkinson, C; Corder, K; Marteau, TM; Sutton, S; Sharp, SJ; Griffin, SJ; van Sluijs, EMF				Godino, Job G.; Watkinson, Clare; Corder, Kirsten; Marteau, Theresa M.; Sutton, Stephen; Sharp, Stephen J.; Griffin, Simon J.; van Sluijs, Esther M. F.			Impact of Personalised Feedback about Physical Activity on Change in Objectively Measured Physical Activity (the FAB Study): A Randomised Controlled Trial	PLOS ONE			English	Article							HEALTH BEHAVIOR-CHANGE; HEART-RATE; PRIMARY-CARE; WEIGHT; ADULTS; STAGE; INTERVENTIONS; ACCELEROMETRY; AWARENESS; EFFICACY	Background: Low levels of physical activity are a major public health concern, and interventions to promote physical activity have had limited success. Whether or not personalised feedback about physical activity following objective measurement motivates behaviour change has yet to be rigorously examined. Methods: And Findings: In a parallel group, open randomised controlled trial, 466 healthy adults aged 32 to 54 years were recruited from the ongoing population-based Fenland Study (Cambridgeshire, UK). Participants were randomised to receive either no feedback until the end of the trial (control group, n=120) or one of three different types of feedback: simple, visual, or contextualised (intervention groups, n=346). The primary outcome was physical activity (physical activity energy expenditure (PAEE) in kJ/kg/day and average body acceleration (ACC) in m/s(2)) measured objectively using a combined heart rate monitor and accelerometer (Actiheart (R)). The main secondary outcomes included self-reported physical activity, intention to increase physical activity, and awareness of physical activity (the agreement between self-rated and objectively measured physical activity). At 8 weeks, 391 (83.9%) participants had complete physical activity data. The intervention had no effect on objectively measured physical activity (PAEE: beta=-0.92, 95% CI=-3.50 to 1.66, p=0.48 and ACC: beta=0.01, 95% CI=-0.00 to 0.02, p=0.21), self-reported physical activity (beta=-0.39, 95% CI=-1.59 to 0.81), or intention to increase physical activity (beta=-0.05, 95% CI=-0.22 to 0.11). However, it was associated with an increase in awareness of physical activity (OR=1.74, 95% CI=1.05 to 2.89). Results did not differ according to the type of feedback. Conclusions: Personalised feedback about physical activity following objective measurement increased awareness but did not result in changes in physical activity in the short term. Measurement and feedback may have a role in promoting behaviour change but are ineffective on their own.	[Godino, Job G.; Watkinson, Clare; Corder, Kirsten; Sharp, Stephen J.; Griffin, Simon J.; van Sluijs, Esther M. F.] Univ Cambridge, Addenbrookes Hosp, MRC, Epidemiol Unit,Inst Metab Sci, Cambridge CB2 2QQ, England; [Corder, Kirsten; Sutton, Stephen; Griffin, Simon J.; van Sluijs, Esther M. F.] Univ Cambridge, Inst Publ Hlth, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England; [Marteau, Theresa M.; Sutton, Stephen; Griffin, Simon J.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England; [Sutton, Stephen] Univ Cambridge, Inst Publ Hlth, Behav Sci Grp, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Griffin, SJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, MRC, Epidemiol Unit,Inst Metab Sci, Cambridge CB2 2QQ, England.	simon.griffin@mrc-epid.cam.ac.uk	; Griffin, Simon/K-3106-2013	Sutton, Stephen/0000-0003-1610-0404; Marteau, Theresa/0000-0003-3025-1129; van Sluijs, Esther/0000-0001-9141-9082; Griffin, Simon/0000-0002-2157-4797	Medical Research Council [MC_U106179474]; European Union (Integrated Project in the Framework Programme 6 of the European-Community) [LSHM-CT-2006-037197]; Department of Health NIHR Programme Grant funding scheme [RP-PG-0606-1259]; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/4, MC_UU_12015/7, MC_UP_1001/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10182, RP-PG-0608-10079, RP-PG-0606-1259, PB-PG-0110-20199] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/7, MC_UU_12015/4, MC_U106179474, MC_UP_1001/2] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (Integrated Project in the Framework Programme 6 of the European-Community); Department of Health NIHR Programme Grant funding scheme; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by The Medical Research Council (MC_U106179474), and was conducted at the MRC Epidemiology Unit in Cambridge, UK. CW and protocol development were supported by the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Programme 6 of the European-Community). SJG receives support from the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1985, EN PROT REQ REP JOIN; Bankhead C R, 2003, Health Technol Assess, V7, P1; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Craig R, 2009, HLTH SURVEY ENGLAND; Crockett RA, 2009, PSYCHOL HEALTH, V24, P333, DOI 10.1080/08870440701813030; *DEP HLTH, 2004, PHYS ACT HLTH IMPR P; *DEP HLTH, 2011, CHANGE4LIFE MOV MOR; *DEP HTLH, 2011, NHS CHOIC LIV WELL; DiClemente CC, 2001, AM J HEALTH BEHAV, V25, P217, DOI 10.5993/AJHB.25.3.8; Gibbons FX, 2005, HEALTH PSYCHOL, V24, P358, DOI 10.1037/0278-6133.24.4.358; Hillsdon M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003180.pub.2; Khan KM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4141; King AC, 2008, AM J PREV MED, V34, P138, DOI 10.1016/j.amepre.2007.09.025; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Kroeze W, 2006, ANN BEHAV MED, V31, P205, DOI 10.1207/s15324796abm3103_2; Kruger J, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-17; Lechner L, 2006, HEALTH PROMOT INT, V21, P104, DOI 10.1093/heapro/dal011; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; McCrady-Spitzer SK, 2010, EXPERT REV MED DEVIC, V7, P201, DOI 10.1586/ERD.09.73; Muller-Riemenschneider F, 2008, PREV MED, V47, P354, DOI 10.1016/j.ypmed.2008.07.006; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Nothwehr F, 2007, HEALTH EDUC RES, V22, P532, DOI 10.1093/her/cyl117; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Proper KI, 2003, BRIT J SPORT MED, V37, P529, DOI 10.1136/bjsm.37.6.529; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; Ronda G, 2001, HEALTH PROMOT INT, V16, P305, DOI 10.1093/heapro/16.4.305; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Shahab L, 2007, BRIT J HEALTH PSYCH, V12, P275, DOI 10.1348/135910706X109684; Shalowitz DI, 2008, PLOS MED, V5, P714, DOI 10.1371/journal.pmed.0050091; Smeets T, 2008, HEALTH EDUC RES, V23, P402, DOI 10.1093/her/cyl101; StataCorp, 2021, STATA STAT SOFTWARE; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Sutton S, 2003, CURR PSYCHOL, V22, P234, DOI 10.1007/s12144-003-1019-1; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; van Sluijs EMF, 2006, J CLIN EPIDEMIOL, V59, P404, DOI 10.1016/j.jclinepi.2005.08.016; van Sluijs EMF, 2004, AM J PREV MED, V26, P330, DOI 10.1016/j.amepre.2003.12.010; Sluijs EMF, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-53; Watkinson C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-68; Watkinson C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-144; Weinstein ND, 1998, HEALTH PSYCHOL, V17, P290, DOI 10.1037/0278-6133.17.3.290; Williams K, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-48	47	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75398	10.1371/journal.pone.0075398	http://dx.doi.org/10.1371/journal.pone.0075398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066178	gold, Green Submitted, Green Published			2022-12-27	WOS:000324494000160
J	Kamp, VM; Langereis, JD; van Aalst, CW; van der Linden, JA; Ulfman, LH; Koenderman, L				Kamp, Vera M.; Langereis, Jeroen D.; van Aalst, Corneli W.; van der Linden, Jan A.; Ulfman, Laurien H.; Koenderman, Leo			Physiological Concentrations of Leptin Do Not Affect Human Neutrophils	PLOS ONE			English	Article							SIGNALING PATHWAYS; OB/OB MICE; CELLS; CHEMOTAXIS; INDUCTION; ACTIVATION; MECHANISMS; RESPONSES; EXPOSURE; WEIGHT	Leptin is an adipokine that is thought to be important in many inflammatory diseases, and is known to influence the function of several leukocyte types. However, no clear consensus is present regarding the responsiveness of neutrophils for this adipokine. In this study a 2D DIGE proteomics approach was used as an unbiased approach to identify leptin-induced effects on neutrophils. Additionally chemotaxis and survival experiments were performed to reproduce results from literature showing putative effects of leptin on these neutrophil responses. Leptin did not induce any significant changes in the proteome provided leptin was added at physiologically relevant concentrations (250 ng). Our leptin batches were biologically active as they induced proliferation in LeptinR expressing Ba/F3 cells. At high concentrations (25000 ng) leptin induced a change in neutrophil proteome. Seventeen differently regulated spots were identified of which twelve could be characterized by mass spectrometry. Two of these identified proteins, SerpinB1 and p40 phox, were chosen for further analysis but leptin-induced expression analyzed by western blot were highly variable. Additionally leptin also induced neutrophil survival at these high concentrations. No leptin-induced chemotaxis of human neutrophils was detected at any concentration. In conclusion, physiological concentrations of leptin do not affect neutrophils. High leptin concentrations induced survival and changes in the neutrophils proteome, but this was most likely mediated by an indirect effect. However, it cannot be ruled out that the effects were mediated by a yet not-identified leptin receptor on human neutrophils.	[Kamp, Vera M.; Langereis, Jeroen D.; van Aalst, Corneli W.; van der Linden, Jan A.; Ulfman, Laurien H.; Koenderman, Leo] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Langereis, Jeroen D.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Koenderman, L (corresponding author), Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands.	L.Koenderman@umcutrecht.nl	Langereis, Jeroen/H-1042-2013; Koenderman, Leo/AAE-7870-2020	Langereis, Jeroen/0000-0001-5317-3202; Koenderman, Leo/0000-0002-5636-6453	Dutch Top Institute Pharma project [T1-201-1]	Dutch Top Institute Pharma project	The research described in this manuscript was funded by a research grant from Dutch Top Institute Pharma project T1-201-1 (Transition of systemic inflammation into multi organ pathology). This is collaboration between three universities: (University medical center Utrecht, University medical center Groningen, and Maastricht University), four pharmaceutical companies (AstraZeneca, GlaxoSmithKline, BV Nycomed BV and Danone Research), and the Dutch government. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Aoshiba K, 1999, BLOOD, V93, P4006, DOI 10.1182/blood.V93.11.4006.411k18_4006_4010; Barr VA, 1999, J BIOL CHEM, V274, P21416, DOI 10.1074/jbc.274.30.21416; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; BRIHEIM G, 1984, INFECT IMMUN, V45, P1; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Cakir B, 2004, PEPTIDES, V25, P95, DOI 10.1016/j.peptides.2003.11.005; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Gruen ML, 2007, AM J PHYSIOL-CELL PH, V293, pC1481, DOI 10.1152/ajpcell.00062.2007; Hsu A, 2007, CLIN EXP IMMUNOL, V150, P332, DOI 10.1111/j.1365-2249.2007.03491.x; Kamp VM, 2012, J LEUKOCYTE BIOL, V92, P1011, DOI 10.1189/jlb.0612273; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Kordonowy LL, 2012, AM J RESP CELL MOL, V47, P120, DOI 10.1165/rcmb.2011-0334OC; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Mancuso P, 2006, AM J RESP CRIT CARE, V173, P212, DOI 10.1164/rccm.200506-909OC; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045; Moore SI, 2003, INFECT IMMUN, V71, P4182, DOI 10.1128/IAI.71.7.4182-4185.2003; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; Ottonello L, 2004, J AM SOC NEPHROL, V15, P2366, DOI 10.1097/01.ASN.0000139321.98029.40; Pini M, 2010, J LEUKOCYTE BIOL, V87, P51, DOI 10.1189/jlb.0309188; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Rafail S, 2008, THROMB RES, V122, P366, DOI 10.1016/j.thromres.2007.12.018; Raver N, 2002, GEN COMP ENDOCR, V126, P52, DOI 10.1006/gcen.2001.7766; Schweizer RC, 1996, J LEUKOCYTE BIOL, V59, P347, DOI 10.1002/jlb.59.3.347; Shore SA, 2009, J APPL PHYSIOL, V107, P1445, DOI 10.1152/japplphysiol.00456.2009; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; SWANSON MJ, 1976, J IMMUNOL METHODS, V13, P191, DOI 10.1016/0022-1759(76)90158-7; Talukdar S, 2012, NATURE MED; Ulfman LH, 2005, J IMMUNOL, V175, P6092, DOI 10.4049/jimmunol.175.9.6092; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Vernooy JHJ, 2010, J IMMUNOL, V184, P7169, DOI 10.4049/jimmunol.0900963; Verploegen S, 2002, EUR J BIOCHEM, V269, P4625, DOI 10.1046/j.1432-1033.2002.03162.x; Yasumatsu R, 2006, AM J PHYSIOL-LUNG C, V291, pL619, DOI 10.1152/ajplung.00507.2005; Zarkesh-Esfahani H, 2004, J IMMUNOL, V172, P1809, DOI 10.4049/jimmunol.172.3.1809	40	11	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73170	10.1371/journal.pone.0073170	http://dx.doi.org/10.1371/journal.pone.0073170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066032	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000013
J	Sanchez-Quintero, MJ; Torres, MJ; Blazquez, AB; Gomez, E; Fernandez, TD; Dona, I; Ariza, A; Andreu, I; Melendez, L; Blanca, M; Mayorga, C				Sanchez-Quintero, Maria J.; Torres, Maria J.; Blazquez, Ana B.; Gomez, Enrique; Fernandez, Tahia D.; Dona, Inmaculada; Ariza, Adriana; Andreu, Inmaculada; Melendez, Lidia; Blanca, Miguel; Mayorga, Cristobalina			Synergistic Effect between Amoxicillin and TLR Ligands on Dendritic Cells from Amoxicillin-Delayed Allergic Patients	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR; HYPERSENSITIVITY REACTIONS; BETA-LACTAMS; T-CELLS; INNATE IMMUNITY; IFN-GAMMA; EXPRESSION; MATURATION; INDUCE; RESPONSES	Amoxicillin, a low-molecular-weight compound, is able to interact with dendritic cells inducing semi-maturation in vitro. Specific antigens and TLR ligands can synergistically interact with dendritic cells (DC), leading to complete maturation and more efficient T-cell stimulation. The aim of the study was to evaluate the synergistic effect of amoxicillin and the TLR2, 4 and 7/8 agonists (PAM, LPS and R848, respectively) in TLR expression, DC maturation and specific T-cell response in patients with delayed-type hypersensitivity (DTH) reactions to amoxicillin. Monocyte-derived DC from 15 patients with DTH to amoxicillin and 15 controls were cultured with amoxicillin in the presence or absence of TLR2, 4 and 7/8 agonists (PAM, LPS and R848, respectively). We studied TLR1-9 gene expression by RT-qPCR, and DC maturation, lymphocyte proliferation and cytokine production by flow cytometry. DC from both patients and controls expressed all TLRs except TLR9. The amoxicillin plus TLR2/4 or TLR7/8 ligands showed significant differences, mainly in patients: AX+PAM+LPS induced a decrease in TLR2 and AX+R848 in TLR2, 4, 7 and 8 mRNA levels. AX+PAM+LPS significantly increased the percentage of maturation in patients (75%) vs. controls (40%) (p=0.036) and T-cell proliferation (80.7% vs. 27.3% of cases; p=0.001). Moreover, the combinations AX+PAM+LPS and AX+R848 produced a significant increase in IL-12p70 during both DC maturation and T-cell proliferation. These results indicate that in amoxicillin-induced maculopapular exanthema, the presence of different TLR agonists could be critical for the induction of the innate and adaptive immune responses and this should be taken into account when evaluating allergic reactions to these drugs.	[Sanchez-Quintero, Maria J.; Blazquez, Ana B.; Gomez, Enrique; Fernandez, Tahia D.; Ariza, Adriana; Melendez, Lidia; Mayorga, Cristobalina] Carlos Haya Hosp IBIMA, Res Lab, Malaga, Spain; [Torres, Maria J.; Dona, Inmaculada; Blanca, Miguel; Mayorga, Cristobalina] Carlos Haya Hosp IBIMA, Allergy Serv, Malaga, Spain; [Andreu, Inmaculada] Univ Politecn Valencia, Valencia, Spain; [Andreu, Inmaculada] Univ Politecn Valencia, Inst Chem Technol UPV CSIC, Valencia, Spain	Universidad de Malaga; Universidad de Malaga; Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia	Mayorga, C (corresponding author), Carlos Haya Hosp IBIMA, Res Lab, Malaga, Spain.	mayorga.lina@gmail.com	Andreu, Inmaculada/I-4150-2015; Veguillas, Adriana Ariza/X-3696-2018; Fernández, Tahia Diana/J-2404-2012; SANCHEZ-QUINTERO, MARIA J/AAS-6771-2020; Mayorga, Cristobalina/D-7167-2018; Mayorga, Lina/FBO-7730-2022; Torres, María José/T-3518-2017; Torres, Maria/GVU-3391-2022	Andreu, Inmaculada/0000-0003-3409-9443; Veguillas, Adriana Ariza/0000-0003-1524-9602; Fernández, Tahia Diana/0000-0003-0625-2156; SANCHEZ-QUINTERO, MARIA J/0000-0002-5638-2920; Mayorga, Cristobalina/0000-0001-8852-8077; Torres, María José/0000-0001-5228-471X; Gomez Alcaide, Enrique/0000-0003-0542-303X	Carlos III [ISCIII PS09/00966, PI12/02481, PI12/02529]; Junta de Andalucia [PI-0199/2007, PI-0180/2008, CTS-7433, CTS 06603]; FIS-Thematic Networks and Co-operative Research Centres: RIRAAF [RD07/0064, RD12/0013]; Instituto de Salud Carlos III; Spanish Health Ministry [RD09/0076/00112]; board of health ministry of Andalusia	Carlos III(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia); FIS-Thematic Networks and Co-operative Research Centres: RIRAAF; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); board of health ministry of Andalusia	This work was supported by grants from: the Carlos III (ISCIII PS09/00966, PI12/02481 and PI12/02529), Junta de Andalucia (PI-0199/2007, PI-0180/2008, CTS-7433 and CTS 06603), and FIS-Thematic Networks and Co-operative Research Centres: RIRAAF (RD07/0064; RD12/0013). The BBSSPA, Carlos Haya Hospital Unit is supported by Instituto de Salud Carlos III, Spanish Health Ministry (Grant no RD09/0076/00112)" and the board of health ministry of Andalusia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Aiba S, 1997, EUR J IMMUNOL, V27, P3031, DOI 10.1002/eji.1830271141; Assier E, 2007, J LEUKOCYTE BIOL, V81, P221, DOI 10.1189/jlb.0705385; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Blanca M, 2009, ALLERGY, V64, P183, DOI [10.1111/j.1398-9995.2008.01924.x, 10.1111/j.1398-9995.2008.01916.x]; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Boisleve F, 2005, TOXICOLOGY, V206, P233, DOI 10.1016/j.tox.2004.08.015; Chaves P, 2010, ALLERGY, V65, P1600, DOI 10.1111/j.1398-9995.2010.02459.x; Cornejo-Garcia JA, 2007, ALLERGY, V62, P1429, DOI 10.1111/j.1398-9995.2007.01542.x; Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fernandez TD, 2008, ALLERGY, V63, P712, DOI 10.1111/j.1398-9995.2007.01607.x; Gomez E, 2012, ANN ALLERG ASTHMA IM, V109, P52, DOI 10.1016/j.anai.2012.05.017; Hoene V, 2006, J LEUKOCYTE BIOL, V80, P1328, DOI 10.1189/jlb.0106011; Hong M, 2009, CLIN EXP IMMUNOL, V156, P40, DOI 10.1111/j.1365-2249.2009.03873.x; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jung TY, 2010, EUR J PHARMACOL, V643, P297, DOI 10.1016/j.ejphar.2010.06.030; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Lombardi V, 2009, J IMMUNOL, V182, P3372, DOI 10.4049/jimmunol.0801969; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Mazzoni A, 2004, J LEUKOCYTE BIOL, V75, P721, DOI 10.1189/jlb.1003482; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Rodriguez-Pena R, 2006, J ALLERGY CLIN IMMUN, V118, P949, DOI 10.1016/j.jaci.2006.07.013; Sanderson JP, 2007, J IMMUNOL, V178, P5533, DOI 10.4049/jimmunol.178.9.5533; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Torres MJ, 2006, INT J IMMUNOPATH PH, V19, P119; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Yawalkar N, 2000, CLIN EXP ALLERGY, V30, P847	35	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74198	10.1371/journal.pone.0074198	http://dx.doi.org/10.1371/journal.pone.0074198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066120	gold, Green Submitted, Green Published			2022-12-27	WOS:000324494000102
J	Sharma, RK; Yolcu, ES; Srivastava, AK; Shirwan, H				Sharma, Rajesh K.; Yolcu, Esma S.; Srivastava, Abhishek K.; Shirwan, Haval			CD4(+) T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models	PLOS ONE			English	Article							THERAPEUTIC CANCER VACCINES; SECONDARY EXPANSION; INTERFERON-GAMMA; ACUTE INFECTION; 4-1BB LIGAND; CUTTING EDGE; EX-VIVO; IN-VIVO; HELP; LYMPHOCYTES	The role of CD4(+) T cells in the generation of therapeutic primary and memory immune responses in cancer diverse immunotherapy settings remains ambiguous. We herein investigated this issue using two vaccine formulations containing a novel costimulatory molecule, SA-4-1BBL, as adjuvant and HPV E7 or survivin (SVN) as tumor associated antigens (TAAs) in two mouse transplantable tumor models; the TC-1 cervical cancer expressing xenogeneic HPV E7 and 3LL lung carcinoma overexpressing autologous SVN. Single vaccination with optimized SA-4-1BBL/TAA formulations resulted in the eradication of 6-day established TC-1 and 3LL tumors in >70% of mice in both models. The in vivo depletion of CD4(+) T cells one day before tumor challenge resulted in compromised vaccine efficacy in both TC-1 (25%) and 3LL (12.5%) tumor models. In marked contrast, depletion of CD4(+) T cells 5 days post-tumor challenge and one day prior to vaccination did not significantly alter the therapeutic efficacy of these vaccines. However, long-term immunological memory was compromised in the 3LL, but not in TC-1 model as a significant number (85.7%) of tumor free-mice succumbed to tumor growth when rechallenged with 3LL cells 60 days after the initial tumor inoculation. Collectively, these results demonstrate the indispensable role CD4(+) T cells play in the generation of therapeutic primary immune responses elicited by SA-4-1BBL/TAA-based vaccines irrespective of the nature of TAAs and establish the importance of CD4+ T cells for long-term immune memory against 3LL tumor expressing self-antigen SVN, but not TC-1 expressing xenogeneic viral antigen E7.	[Shirwan, Haval] Univ Louisville, Inst Cellular Therapeut, Dept Microbiol & Immunol, Louisville, KY 40292 USA; Univ Louisville, James Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Shirwan, H (corresponding author), Univ Louisville, Inst Cellular Therapeut, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	haval.shirwan@louisville.edu	Srivastava, Abhishek/M-7577-2014		National Institutes of Health [R44 AI071618]; KLCRP; W.M. Keck Foundation; Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI071618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KLCRP; W.M. Keck Foundation(W.M. Keck Foundation); Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in parts by grants from the National Institutes of Health (R44 AI071618), KLCRP, W.M. Keck Foundation, and the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Bullock TNJ, 2005, J IMMUNOL, V174, P710, DOI 10.4049/jimmunol.174.2.710; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040970; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Lin CT, 2006, VACCINE, V24, P6199, DOI 10.1016/j.vaccine.2006.05.108; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; Mortarini R, 2003, CANCER RES, V63, P2535; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Schabowsky RH, 2009, EXP MOL PATHOL, V86, P198, DOI 10.1016/j.yexmp.2009.01.010; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sharma RK, 2010, CANCER GENE THER, V17, P730, DOI 10.1038/cgt.2010.29; Sharma RK, 2010, VACCINE, V28, P5794, DOI 10.1016/j.vaccine.2010.06.073; Sharma RK, 2010, CANCER RES, V70, P3945, DOI 10.1158/0008-5472.CAN-09-4480; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Singh NP, 2006, HUM GENE THER, V17, P334, DOI 10.1089/hum.2006.17.334; Singh NP, 2003, CANCER RES, V63, P4067; Srivastava AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048463; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; van den Broeke LT, 2003, J IMMUNOL, V171, P5842, DOI 10.4049/jimmunol.171.11.5842; Velders MP, 2003, INT REV IMMUNOL, V22, P113, DOI 10.1080/08830180305220; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; Weidanz JA, 2006, J IMMUNOL, V177, P5088, DOI 10.4049/jimmunol.177.8.5088; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257	42	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73145	10.1371/journal.pone.0073145	http://dx.doi.org/10.1371/journal.pone.0073145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066030	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000011
J	Song, ZL; Parr, JF; Guo, FS				Song, Zhaoliang; Parr, Jeffrey F.; Guo, Fengshan			Potential of Global Cropland Phytolith Carbon Sink from Optimization of Cropping System and Fertilization	PLOS ONE			English	Article							CLIMATE-CHANGE; FOOD SECURITY; SEQUESTRATION; SILICON; STORAGE; PLANTS; CHINA; SOILS; CYCLE	The occlusion of carbon (C) by phytoliths, the recalcitrant silicified structures deposited within plant tissues, is an important persistent C sink mechanism for croplands and other grass-dominated ecosystems. By constructing a silica content-phytolith content transfer function and calculating the magnitude of phytolith C sink in global croplands with relevant crop production data, this study investigated the present and potential of phytolith C sinks in global croplands and its contribution to the cropland C balance to understand the cropland C cycle and enhance long-term C sequestration in croplands. Our results indicate that the phytolith sink annually sequesters 26.35 +/- 10.22 Tg of carbon dioxide (CO2) and may contribute 40 +/- 18% of the global net cropland soil C sink for 1961-2100. Rice (25%), wheat (19%) and maize (23%) are the dominant contributing crop species to this phytolith C sink. Continentally, the main contributors are Asia (49%), North America (17%) and Europe (16%). The sink has tripled since 1961, mainly due to fertilizer application and irrigation. Cropland phytolith C sinks may be further enhanced by adopting cropland management practices such as optimization of cropping system and fertilization.	[Song, Zhaoliang] Zhejiang Agr & Forestry Univ, Zhejiang Prov Key Lab Cycling Forest Ecosyst & Se, Linan, Zhejiang, Peoples R China; [Song, Zhaoliang; Guo, Fengshan] Zhejiang Agr & Forestry Univ, Sch Environm & Resources, Linan, Zhejiang, Peoples R China; [Song, Zhaoliang] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Guizhou, Peoples R China; [Parr, Jeffrey F.] So Cross Univ, Lismore, NSW 2480, Australia	Zhejiang A&F University; Zhejiang A&F University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Southern Cross University	Song, ZL (corresponding author), Zhejiang Agr & Forestry Univ, Zhejiang Prov Key Lab Cycling Forest Ecosyst & Se, Linan, Zhejiang, Peoples R China.	songzhaoliang78@163.com	Song, Zhaoliang/J-9613-2014	Song, Zhaoliang/0000-0002-2219-5852	National Natural Science Foundation of China [41103042]; Zhejiang Province Key Science and Technology Innovation Team [2010R50030]; Opening Project of State Key Laboratory of Environmental Geochemistry [SKLEG9011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Key Science and Technology Innovation Team; Opening Project of State Key Laboratory of Environmental Geochemistry	The authors are grateful for support from the National Natural Science Foundation of China (Grant No. 41103042), the Zhejiang Province Key Science and Technology Innovation Team (No. 2010R50030), and the Opening Project of State Key Laboratory of Environmental Geochemistry (SKLEG9011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Ding TP, 2008, GEOCHIM COSMOCHIM AC, V72, P5600, DOI 10.1016/j.gca.2008.09.006; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hou XY, 1982, VEGETATION GEOGRAPHY, P188; Houghton R.A., 1995, SOILS GLOBAL CHANGE, P45; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Huang Y, 2007, ECOL APPL, V17, P692, DOI 10.1890/05-1792; IPCC, 2001, CLIMATE CHANGE SCI B; Jansson C, 2010, BIOSCIENCE, V60, P685, DOI 10.1525/bio.2010.60.9.6; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Lal R, 2001, ADV AGRON, V74, P155, DOI 10.1016/S0065-2113(01)74033-3; Li ZM, 2013, PLANT SOIL, V370, P615, DOI 10.1007/s11104-013-1661-9; Meunier JD, 1999, GEOLOGY, V27, P835; Mulholland SC, 1992, PHYTOLITHARIAN NEWSL, V7, P7; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parr J., 2009, Sugar Tech, V11, P17, DOI 10.1007/s12355-009-0003-y; Parr J, 2010, GLOBAL CHANGE BIOL, V16, P2661, DOI 10.1111/j.1365-2486.2009.02118.x; Parr JF, 2011, PLANT SOIL, V342, P165, DOI 10.1007/s11104-010-0680-z; Parr JF, 2005, SOIL BIOL BIOCHEM, V37, P117, DOI 10.1016/j.soilbio.2004.06.013; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Smith P, 2004, EUR J AGRON, V20, P229, DOI 10.1016/j.eja.2003.08.002; Song ZL, 2012, EARTH-SCI REV, V115, P319, DOI 10.1016/j.earscirev.2012.09.006; Song ZL, 2012, GLOBAL CHANGE BIOL, V18, P3647, DOI 10.1111/gcb.12017; WILDING LP, 1967, SCIENCE, V156, P66, DOI 10.1126/science.156.3771.66; Xu X, 1998, RICE FIELD ECOSYSTEM; Zhou Q, 2005, SUGAR CROPS CHINA, V2, P1; Zhu JianChun, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P139; Zuo XX, 2011, CHINESE SCI BULL, V56, P3451, DOI 10.1007/s11434-011-4674-x; [No title captured]	37	34	42	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73747	10.1371/journal.pone.0073747	http://dx.doi.org/10.1371/journal.pone.0073747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066067	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000049
J	Yang, X; Qiu, MT; Hu, JW; Jiang, F; Li, M; Wang, J; Zhang, Q; Yin, R; Xu, L				Yang, Xin; Qiu, Man-Tang; Hu, Jing-Wen; Jiang, Feng; Li, Ming; Wang, Jie; Zhang, Qin; Yin, Rong; Xu, Lin			Association of Interleukin-18 Gene Promoter-607 C > A and-137G > C Polymorphisms with Cancer Risk: A Meta-Analysis of 26 Studies	PLOS ONE			English	Article							IL-18 PROMOTER; SERUM INTERLEUKIN-18; A/C POLYMORPHISM; LUNG-CANCER; CARCINOMA; SUSCEPTIBILITY; CELLS; EXPRESSION; PATHWAY	Background: Evidence suggest that IL-18 gene polymorphisms may be risk factors for several cancers. Increasing studies investigating the association between IL-18 gene promoter polymorphisms (-607 C>A and -137G>C) and cancer risk have yielded conflicting results. Methodology/Principal Findings: We performed a meta-analysis of 26 studies including 4096 cases and 5222 controls. We assessed the strength of the association of IL-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk and performed sub-group analyses by cancer types, ethnicities, source of controls and sample size. The pooled results revealed a significant increased risk of cancer susceptibility for -607 C>A (CA vs. CC: OR = 1.19, 95% CI: 1.04, 1.37, P-heterogeneity = 0.033; CA/AA vs. CC: OR = 1.17, 95% CI: 1.01, 1.34, P-heterogeneity = 0.007), but no significant association for -137 G>C was observed with overall cancer risk. Sub-group analyses revealed that an increased risk of nasopharyngeal carcinoma was both found for -607 C>A (CA/AA vs. CC: OR = 1.32, 95% CI: 1.04, 1.69, P-heterogeneity = 0.823) and -137G>C (GC/CC vs. GG: OR = 1.57, 95% CI: 1.26, 1.96, P-heterogeneity = 0.373). Consistent with the results of the genotyping analyses, the -607A/-137C and -607C/-137C haplotypes were associated with a significantly increased risk of nasopharyngeal carcinoma as compared with the -607C/-137G haplotype (-607A/-137C vs. -607C/-137G: OR = 1.26, 95% CI: 1.13, 1.40; P-heterogeneity = 0.569; -607C/-137C vs. -607C/-137G: OR = 1.14, 95% CI: 1.03, 1.27; P-heterogeneity = 0.775). As for gastrointestinal cancer, we also found that -607 C>A polymorphism was significantly associated with increased cancer risk (CA/AA vs. CC: OR = 1.25, 95% CI: 1.05, 1.50, P-heterogeneity = 0.458). Further sub-group analysis revealed that -137G>C polymorphism contributed to cancer risk in Asians but not in Caucasians (GC/CC vs. GG: OR = 1.31, 95% CI: 1.05, 1.64, P-heterogeneity<0.001). Conclusions: The meta-analysis results suggest that IL-18 gene promoter -607 C>A polymorphism is significantly associated with overall cancer risk, especially in nasopharyngeal carcinoma and gastrointestinal cancer; and the -137 G>C polymorphism is associated with increased overall cancer risk in Asian populations and also significantly increases the risk of nasopharyngeal carcinoma.	[Yang, Xin; Hu, Jing-Wen] Nanjing Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China; [Yang, Xin; Qiu, Man-Tang; Hu, Jing-Wen; Jiang, Feng; Li, Ming; Zhang, Qin; Yin, Rong; Xu, Lin] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Qiu, Man-Tang] Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Wang, Jie] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Sci Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yin, R (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China.	yinhero001@126.com; xulin83cn@gmail.com	Qiu, Mantang/L-8937-2019		National Natural Science Foundation of China [81201830]; Natural Science Foundation of Jiangsu Province, China [BK2010589, BK2011857]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (81201830) and Natural Science Foundation of Jiangsu Province (BK2010589, BK2011857), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asefi V, 2009, J LARYNGOL OTOL, V123, P444, DOI 10.1017/S0022215108003733; Babar M, 2012, AM J GASTROENTEROL, V107, P1331, DOI 10.1038/ajg.2012.134; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOISSEL JP, 1988, EUR J CLIN PHARMACOL, V34, P535, DOI 10.1007/BF00615213; Bushley AW, 2004, GYNECOL ONCOL, V95, P672, DOI 10.1016/j.ygyno.2004.08.024; Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P; Dehaghani AS, 2009, MOL BIOL REP, V36, P2393, DOI 10.1007/s11033-009-9469-7; Du B, 2012, MED J W CHINA, V25, P1683; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eissa Soheir A L, 2005, J Egypt Natl Canc Inst, V17, P51; Farhat K, 2008, CYTOKINE, V43, P132, DOI 10.1016/j.cyto.2008.05.004; Farjadfar A, 2009, ACTA ONCOL, V48, P971, DOI 10.1080/02841860902878145; Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Gunel N, 2002, CANCER-AM CANCER SOC, V95, P663, DOI 10.1002/cncr.10705; Guo Jun-yu, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P400; Haghshenas MR, 2009, J GASTROEN HEPATOL, V24, P1119, DOI 10.1111/j.1440-1746.2009.05791.x; Han Ming-yong, 2004, J Zhejiang Univ Sci, V5, P472, DOI 10.1631/jzus.2004.0472; Iwasaki T, 2002, J IMMUNOTHER, V25, pS52, DOI 10.1097/00002371-200203001-00008; Jaiswal PK, 2013, GENE, V519, P128, DOI 10.1016/j.gene.2013.01.025; Kashef MA, 2008, J REPROD MED, V53, P855; Khalili-Azad T, 2009, NEOPLASMA, V56, P22, DOI 10.4149/neo_2009_01_22; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu JM, 2013, GENET MOL RES, V12, P820, DOI 10.4238/2013.March.15.2; Liu YU, 2007, DNA CELL BIOL, V26, P613, DOI 10.1089/dna.2007.0600; Monroy CM, 2011, MOL CARCINOGEN, V50, P36, DOI 10.1002/mc.20688; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nikiteas N, 2007, ANTICANCER RES, V27, P3849; Nong LG, 2009, DNA CELL BIOL, V28, P507, DOI 10.1089/dna.2009.0912; Okano F, 2000, ANTICANCER RES, V20, P3411; Pan HF, 2011, LUPUS, V20, P945, DOI 10.1177/0961203311400114; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Park S, 2007, CELL MOL IMMUNOL, V4, P329; Pratesi C, 2006, CANCER IMMUNOL IMMUN, V55, P23, DOI 10.1007/s00262-005-0688-z; Qi Tao, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P754; Qiu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050887; Saenz-Lopez P, 2010, HUM IMMUNOL, V71, P309, DOI 10.1016/j.humimm.2009.11.010; Sobti RC, 2008, ONCOL RES, V17, P159, DOI 10.3727/096504008785114156; Srivastava S, 2010, CURR MED CHEM, V17, P3353, DOI 10.2174/092986710793176348; Taheri M, 2012, Prague Med Rep, V113, P217; Thong-Ngam D, 2006, WORLD J GASTROENTERO, V12, P4473, DOI 10.3748/wjg.v12.i28.4473; Tschoeke SK, 2006, CRIT CARE MED, V34, P1225, DOI 10.1097/01.CCM.0000208356.05575.16; Tsuboi K, 2004, CANCER LETT, V205, P207, DOI 10.1016/j.canlet.2003.10.010; Vairaktaris E, 2007, ANTICANCER RES, V27, P4011; Wei YS, 2007, ACTA ONCOL, V46, P1090, DOI 10.1080/02841860701373595; Xia DJ, 2004, CANCER BIOTHER RADIO, V19, P322, DOI 10.1089/1084978041424990; Yang Hong-ling, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1006	47	10	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73671	10.1371/journal.pone.0073671	http://dx.doi.org/10.1371/journal.pone.0073671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066061	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000043
J	Yu, Q; Zhu, SY; Zhou, R; Yi, FM; Bing, YT; Huang, S; Wang, ZX; Wang, CY; Xia, B				Yu, Qiao; Zhu, Siying; Zhou, Rui; Yi, Fengming; Bing, Yuntao; Huang, Sha; Wang, Zixi; Wang, Chunyu; Xia, Bing			Effects of Sinomenine on the Expression of microRNA-155 in 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice	PLOS ONE			English	Article							TIME; MIR-155; PROTEIN; MODEL; RNA	Background: Sinomenine, a pure alkaloid isolated in Chinese medicine from the root of Sinomenium acutum, has been demonstrated to have anti-inflammatory and immunosuppressive effects. MicroRNAs (miRNAs) are gradually being recognized as critical mediators of disease pathogenesis via coordinated regulation of molecular effector pathways. Methodology/Findings: After colitis was induced in mice by instillation of 5% (w/v) 2,4,6-trinitrobenzenesulfonic acid (TNBS), sinomenine at a dose of 100 or 200 mg/kg was orally administered once daily for 7 days. We evaluated body weight, survival rate, diarrhea score, histological score and myeloperoxidase (MPO) activity. The mRNA and protein expression levels of miR-155, c-Maf, TNF-alpha and IFN-gamma were determined by quantitative RT-PCR and immunohistochemistry, respectively. Sinomenine (100 or 200 mg/kg)-treated mice with TNBS-induced colitis were significantly improved in terms of body weight, survival rate, diarrhea score, histological score and MPO activity compared with untreated mice. Both dosages of sinomenine significantly decreased the mRNA and protein expression levels of c-Maf, TNF-alpha and IFN-gamma, which elevated in TNBS-induced colitis. Furthermore, sinomenine at a dose of 200 mg/kg significantly decreased the level of miR-155 expression by 71% (p = 0.025) compared with untreated TNBS-induced colitis in mice. Conclusions/Significance: Our study evaluated the effects and potential mechanisms of sinomenine in the anti-inflammatory response via miRNA-155 in mice with TNBS-induced colitis. Our findings suggest that sinomenine has anti-inflammatory effects on TNBS-induced colitis by down-regulating the levels of miR-155 and several related inflammatory cytokines.	[Yu, Qiao; Zhu, Siying; Zhou, Rui; Yi, Fengming; Huang, Sha; Xia, Bing] Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol Hepatol, Wuhan 430072, Peoples R China; [Yu, Qiao; Zhu, Siying; Zhou, Rui; Yi, Fengming; Bing, Yuntao; Huang, Sha; Wang, Zixi; Wang, Chunyu; Xia, Bing] Hubei Clin Ctr, Wuhan, Peoples R China; [Yu, Qiao; Zhu, Siying; Zhou, Rui; Yi, Fengming; Bing, Yuntao; Huang, Sha; Wang, Zixi; Wang, Chunyu; Xia, Bing] Key Lab Intestinal & Colorectal Dis, Wuhan, Peoples R China	Wuhan University	Xia, B (corresponding author), Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol Hepatol, Wuhan 430072, Peoples R China.	bingxia2004@aliyun.com		Yi, Fengming/0000-0002-9417-644X	Wuhan University Platform Grant; National University Students Innovation Training Project of China [111048674]; Foundamental Research Funds for the Central Universities [201130302020004]; National Natural Science Foundation of China [81070280]	Wuhan University Platform Grant; National University Students Innovation Training Project of China; Foundamental Research Funds for the Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Wuhan University Platform Grant (2012) and National University Students Innovation Training Project of China (No. 111048674), Foundamental Research Funds for the Central Universities (No. 201130302020004) and National Natural Science Foundation of China (No. 81070280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Candinas D, 1996, TRANSPLANTATION, V62, P1855, DOI 10.1097/00007890-199612270-00030; Chan K, 2006, J ETHNOPHARMACOL, V103, P425, DOI 10.1016/j.jep.2005.08.020; Chen DP, 2011, J ETHNOPHARMACOL, V137, P457, DOI 10.1016/j.jep.2011.05.048; Cheng H, 2007, INT IMMUNOPHARMACOL, V7, P604, DOI 10.1016/j.intimp.2007.01.003; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; LIU L, 1994, ARZNEIMITTEL-FORSCH, V44-2, P1223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mark W, 2003, TRANSPLANTATION, V75, P940, DOI 10.1097/01.TP.0000056610.22062.03; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang QX, 2011, INT IMMUNOPHARMACOL, V11, P373, DOI 10.1016/j.intimp.2010.11.018; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu L.-H., 2011, EVID BASED COMPLEMEN, V2011, P525462; Xiang GA, 2009, J SURG ONCOL, V100, P708, DOI 10.1002/jso.21408; Zhou H, 2008, BIOCHEM BIOPH RES CO, V376, P352, DOI 10.1016/j.bbrc.2008.08.153	36	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73757	10.1371/journal.pone.0073757	http://dx.doi.org/10.1371/journal.pone.0073757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066068	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000050
J	Dalton, SJ; Roff, G				Dalton, Steven J.; Roff, George			Spatial and Temporal Patterns of Eastern Australia Subtropical Coral Communities	PLOS ONE			English	Article							ISLANDS-MARINE-RESERVE; LORD HOWE ISLAND; SOLITARY-ISLANDS; CLIMATE-CHANGE; SCLERACTINIAN CORALS; REEF CORALS; GENETIC DIVERSITY; WHITE SYNDROME; RECRUITMENT; RESILIENCE	Despite increases in the frequency and intensity of disturbances on coral reefs over the past few decades, the response of subtropical coral assemblages to climate change is poorly understood. To address this knowledge gap on Australian reefs and provide a baseline for future comparisons, we quantified spatial (10-100's of kilometres) and temporal (decadal) patterns of benthic assemblages across a latitudinal gradient along the east Australian coastline (23.5 degrees S to 31.5 degrees S). Benthic community composition was quantified at six locations from the southern Great Barrier Reef, Queensland (Heron Reef, 23.5 degrees S, 152 degrees E) to northern New South Wales (31 degrees S, 153.1 degrees E) and at Lord Howe Island (31.5 degrees S, 159.1 degrees E). Our results indicate significant latitudinal differences in benthic assemblages, while community composition at some sites was more similar to those hundreds of kilometres away than to that of neighbouring reefs. A general trend was observed with decreasing cover of Acroporidae with increasing latitude, corresponding with an increasing cover of Pocilloporidae and Dendrophylliidae. Heron Reef comprised a high proportion of Acropora corals (43% total coral cover) and coralline algae (44%). In contrast, high-latitude reefs were dominated by mixed coral assemblages (0-52%) and high macroalgal cover (16-27%). Decadal comparisons of high-latitude reefs showed regional stability of benthic assemblages (9 out of 11 assemblages remained stable at > 75% similarity), during a period of warming oceans (0.15-0.24 degrees C per decade). Such temporal stability suggests that eastern Australian subtropical communities may be more resistant than tropical reef communities that have experienced assembly shifts caused by perturbations associated with recent global climate change. Despite the clear differences in the structure of coral assemblages evident in our spatial surveys, we suggest that the temporal stability of high-latitude reefs may provide a limited refuge for tropical coral populations in an increasingly uncertain future.	[Dalton, Steven J.] So Cross Univ, Marine Ecol Res Ctr, Coffs Harbour, NSW, Australia; [Roff, George] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	Southern Cross University; University of Queensland	Dalton, SJ (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Coffs Harbour, NSW, Australia.	steve.dalton@scu.edu.au	Roff, George/ABB-4406-2021; Roff, George/C-8766-2015	Roff, George/0000-0002-2823-0575; Roff, George/0000-0002-2823-0575	University of New England	University of New England	Funding for data collection was provided by the first author's university (University of New England) during his PhD candidature, with some contribution by the Northern Rivers Catchment Management Authority, NSW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Baird AH, 2012, CORAL REEFS, V31, P1063, DOI 10.1007/s00338-012-0928-6; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Beger M., 2011, ECOLOGICAL MANAGEMEN, V12, pe7, DOI DOI 10.1111/J.1442-8903.2011.00573.X; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Dalton SJ, 2006, CORAL REEFS, V25, P37, DOI 10.1007/s00338-005-0039-8; Dalton SJ, 2009, STRESSORS E AUSTR SU; Dalton Steven J., 2011, Diversity, V3, P592, DOI 10.3390/d3040592; Dalton SJ, 2010, PUBLIC HEALTH 21ST C, P187; Davies PL, 2005, EVALUATION APPL SATE; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Dollar Steven J., 2004, Pacific Science, V58, P281, DOI 10.1353/psc.2004.0016; EDGAR RJ, 2003, CORAL BLEACHING SOLI; Environment Australia, 2002, REP STAT CONS LORD H; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; HARRIOTT VJ, 1995, MAR ECOL PROG SER, V123, P155, DOI 10.3354/meps123155; HARRIOTT VJ, 1995, MAR FRESHWATER RES, V46, P457, DOI 10.1071/MF9950457; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; HARRIOTT VJ, 1992, CORAL REEFS, V11, P215, DOI 10.1007/BF00301996; Harriott VJ, 1999, MAR FRESHWATER RES, V50, P299, DOI 10.1071/MF98042; HARRIOTT VJ, 1995, AQUAT CONSERV, V5, P179, DOI 10.1002/aqc.3270050303; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Harrison PL, 1998, CORAL COMMUNITIES FL; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Kiessling W, 2012, P NATL ACAD SCI USA, V109, P21378, DOI 10.1073/pnas.1214037110; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Malcolm HA, 2011, DEEP-SEA RES PT II, V58, P616, DOI 10.1016/j.dsr2.2010.09.030; Manly Hydraulics Laboratory, 2007, NSW OC WAV DAT COLL; Marshell A, 2012, CORAL REEFS, V31, P1093, DOI 10.1007/s00338-012-0931-y; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; NSWMPA, 2010, SEAB HAB MAPP SOL IS; Obura DO, 2005, ESTUAR COAST SHELF S, V63, P353, DOI 10.1016/j.ecss.2004.11.010; Oke PR, 2000, J PHYS OCEANOGR, V30, P512, DOI 10.1175/1520-0485(2000)030<0512:TIUOEA>2.0.CO;2; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Roff G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026829; Roughan M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001833; Rule MR, 2007, MARINE ENV NO NEW S; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; VERON JEN, 1979, AUST J MAR FRESH RES, V30, P203, DOI 10.1071/MF9790203; VERON JEN, 1974, AUST J MAR FRESH RES, V25, P193; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Wilson J, 2005, CORAL REEFS, V24, P418, DOI 10.1007/s00338-005-0033-1; Wilson JR, 1998, MAR BIOL, V131, P339, DOI 10.1007/s002270050327; Wilson JR, 2003, MAR ECOL PROG SER, V260, P115, DOI 10.3354/meps260115; Woodroffe CD, 2006, J COASTAL RES, V22, P188, DOI 10.2112/05A-0014.1	64	22	22	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75873	10.1371/journal.pone.0075873	http://dx.doi.org/10.1371/journal.pone.0075873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058705	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400121
J	Meng, J; Xu, ZX; Guo, J; Yue, YX; Sun, X				Meng, Jing; Xu, Zixiang; Guo, Jing; Yue, Yunxia; Sun, Xiao			Analysis of Enhanced Current-Generating Mechanism of Geobacter sulfurreducens Strain via Model-Driven Metabolism Simulation	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; FLUX BALANCE ANALYSIS; C-TYPE CYTOCHROME; ELECTRON-TRANSFER; EVOLUTION	Microbial fuel cells (MFCs) are a class of ideal technologies that function via anaerobic respiration of electricigens, which bring current generation and environmental restoration together. An in-depth understanding of microbial metabolism is of great importance in engineering microbes to further improve their respiration. We employed flux balance analysis and selected Fe(iii) as a substitute for the electrode to simulate current-generating metabolism of Geobacter sulfurreducens PCA with a fixed acetate uptake rate. Simulation results indicated the fluxes of reactions directing acetate towards dissimilation to generate electrons increased under the suboptimal growth condition, resulting in an increase in the respiration rate and a decrease in the growth rate. The results revealed the competitive relationship between oxidative respiration and cell growth during the metabolism of microbe current generation. The results helped us quantitatively understand why microbes growing slowly have the potential to make good use of fuel in MFCs. At the same time, slow growth does not necessarily result in speedy respiration. Alternative respirations may exist under the same growth state due to redundant pathways in the metabolic network. The big difference between the maximum and minimum respiration mainly results from the total formate secretion. With iterative flux variability analysis, a relatively ideal model of variant of G. sulfurreducens PCA was reconstructed by deleting several enzymes in the wild model, which could reach simultaneous suboptimal growth and maximum respiration. Under this ideal condition, flux towards extracellular electron transfer rather than for biosynthesis is beneficial for the conversion of organic matter to electricity without large accumulations of biomass and electricigens may maximize utilization of limited fuel. Our simulations will provide an insight into the enhanced current-generating mechanism and identify theoretical range of respiration rates for guiding strain improvement in MFCs.	[Meng, Jing; Guo, Jing; Yue, Yunxia; Sun, Xiao] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Xu, Zixiang] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China	Southeast University - China; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Sun, X (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	xsun@seu.edu.cn			Open Research Fund of State Key Laboratory of Bioelectronic, Southeast University; Metabolic network reconstruction of Shewanella loihica PV-4	Open Research Fund of State Key Laboratory of Bioelectronic, Southeast University; Metabolic network reconstruction of Shewanella loihica PV-4	This work was supported by the Open Research Fund of State Key Laboratory of Bioelectronic, Southeast University, Metabolic network reconstruction of Shewanella loihica PV-4 and its application in MFCs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Franks AE, 2010, BIOFUELS-UK, V1, P589, DOI 10.4155/BFS.10.25; Franks AE, 2010, ENERGIES, V3, P899, DOI 10.3390/en3050899; Galushko AS, 2000, ARCH MICROBIOL, V174, P314, DOI 10.1007/s002030000208; Inoue K, 2010, APPL ENVIRON MICROB, V76, P3999, DOI 10.1128/AEM.00027-10; Izallalen M, 2008, METAB ENG, V10, P267, DOI 10.1016/j.ymben.2008.06.005; Leang C, 2013, ENERG ENVIRON SCI, V6, P1901, DOI 10.1039/c3ee40441b; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley D, 2006, SCIENTIST, V20, P46; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mahadevan R, 2011, NAT REV MICROBIOL, V9, P39, DOI 10.1038/nrmicro2456; Malvankar NS, 2012, ENERG ENVIRON SCI, V5, P5790, DOI 10.1039/c2ee03388g; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Strycharz SM, 2011, ENERG ENVIRON SCI, V4, P896, DOI 10.1039/c0ee00260g; Sun J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-15; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Tremblay PL, 2011, ENVIRON MICROBIOL, V13, P13, DOI 10.1111/j.1462-2920.2010.02302.x; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004	25	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73907	10.1371/journal.pone.0073907	http://dx.doi.org/10.1371/journal.pone.0073907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058500	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400040
J	Costa, A; Pazman, C; Sinsimer, KS; Wong, LC; McLeod, I; Yates, J; Haynes, S; Schedl, P				Costa, Alexandre; Pazman, Cecilia; Sinsimer, Kristina S.; Wong, Li Chin; McLeod, Ian; Yates, John, III; Haynes, Susan; Schedl, Paul			Rasputin Functions as a Positive Regulator of Orb in Drosophila Oogenesis	PLOS ONE			English	Article							RNA-BINDING-PROTEIN; FRAGILE-X PROTEIN; MESSENGER-RNA; G3BP; RAS; CPEB; EXPRESSION; GRANULES; HOMOLOG; PHOSPHORYLATION	The determination of cell fate and the establishment of polarity axes during Drosophila oogenesis depend upon pathways that localize mRNAs within the egg chamber and control their on-site translation. One factor that plays a central role in regulating on-site translation of mRNAs is Orb. Orb is a founding member of the conserved CPEB family of RNA-binding proteins. These proteins bind to target sequences in 3' UTRs and regulate mRNA translation by modulating poly(A) tail length. In addition to controlling the translation of axis-determining mRNAs like grk, fs(1)K10, and osk, Orb protein autoregulates its own synthesis by binding to orb mRNA and activating its translation. We have previously shown that Rasputin (Rin), the Drosophila homologue of Ras-GAP SH3 Binding Protein (G3BP), associates with Orb in a messenger ribonucleoprotein (mRNP) complex. Rin is an evolutionarily conserved RNA-binding protein believed to function as a link between Ras signaling and RNA metabolism. Here we show that Orb and Rin form a complex in the female germline. Characterization of a new rin allele shows that rin is essential for oogenesis. Co-localization studies suggest that Orb and Rin form a complex in the oocyte at different stages of oogenesis. This is supported by genetic and biochemical analyses showing that rin functions as a positive regulator in the orb autoregulatory pathway by increasing Orb protein expression. Tandem Mass Spectrometry analysis shows that several canonical stress granule proteins are associated with the Orb-Rin complex suggesting that a conserved mRNP complex regulates localized translation during oogenesis in Drosophila.	[Costa, Alexandre; Sinsimer, Kristina S.; Wong, Li Chin; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Pazman, Cecilia; Haynes, Susan] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [McLeod, Ian; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Schedl, Paul] RAS, Inst Gene Biol, Moscow 117901, Russia	Princeton University; Uniformed Services University of the Health Sciences - USA; Scripps Research Institute; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Schedl, P (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	pschedl@princeton.edu			CNPq, Brazil; Uniformed Services University of the Health Sciences [C071FB, C071GP]; NIH/NICHD; Russian Federation Ministry of Education and Science [14.B25.31.0022];  [P41 RRO11823];  [GM043432];  [RFBR 13-0400761]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Uniformed Services University of the Health Sciences; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Russian Federation Ministry of Education and Science(Ministry of Education and Science, Russian Federation); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AC was supported by a fellowship from CNPq, Brazil. This work was supported by Uniformed Services University of the Health Sciences Intramural grants C071FB and C071GP; initial studies were supported by the Intramural Research Program of the NIH/NICHD. JY would like to acknowledge support from P41 RRO11823. PS would like to acknowledge support from GM043432. PS would also like to acknowledge support from a grant to the Gene Biology Institute by the Russian Federation Ministry of Education and Science (14.B25.31.0022) and from grant #RFBR 13-0400761. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Barnes CJ, 2002, CANCER RES, V62, P1251; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P1159; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Costa M, 1999, NUCLEIC ACIDS RES, V27, P817, DOI 10.1093/nar/27.3.817; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Geng CY, 2007, FLY, V1, P259, DOI 10.4161/fly.5246; Guitard E, 2001, CANCER LETT, V162, P213, DOI 10.1016/S0304-3835(00)00638-8; Hafer N, 2011, GENETICS, V189, P907, DOI 10.1534/genetics.110.123646; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Huynh JR, 2000, DEVELOPMENT, V127, P2785; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kuniyoshi H, 2003, J NEUROGENET, V17, P117, DOI 10.1080/01677060390256459; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1994, MOL CELL BIOL, V14, P2235, DOI 10.1128/MCB.14.4.2235; LANTZ V, 1992, DEVELOPMENT, V115, P75; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Mastushita-Sakai T, 2010, P NATL ACAD SCI USA, V107, P11987, DOI 10.1073/pnas.1004433107; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ortega AD, 2010, J CELL SCI, V123, P2685, DOI 10.1242/jcs.065920; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pazman C, 2000, DEVELOPMENT, V127, P1715; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; ROTH S, 1994, DEVELOPMENT, V120, P2245; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan LH, 2001, DEVELOPMENT, V128, P1159; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wong LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024355	41	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72864	10.1371/journal.pone.0072864	http://dx.doi.org/10.1371/journal.pone.0072864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069162	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100022
J	Grund, LZ; Lopes-Ferreira, M; Lima, C				Grund, Lidiane Zito; Lopes-Ferreira, Monica; Lima, Carla			The Hierarchical Process of Differentiation of Long-Lived Antibody-Secreting Cells Is Dependent on Integrated Signals Derived from Antigen and IL-17A	PLOS ONE			English	Article							MEMORY B-CELLS; PLASMA-CELLS; ACTIVATING FACTOR; EXPRESSION; VACCINE; BAFF; IMMUNITY; TH1; PROLIFERATION; MAINTENANCE	Switched CD19-positive memory B cells purified from mice with chronic immune response against Thalassophryne nattereri venom proteins were cultured with venom or cytokines. Our results confirm the existence of a hierarchic process of differentiation: activated memory B cells progressively acquire increasing levels of CD138 and decreasing levels of CD45R/B220 to finally arrive at ASC with B220(neg) phenotype, which are IgG1-secreting cells. Only Bmem from peritoneal cavity or bone marrow of VTn immunized mice presented the capacity to generate ASC functionally active. IL-17A or IL-21/IL-23/IL-33 improves the ability of venom to induce intracellular IgG of peritoneal derived-ASC. Cognate stimulation with venom and IL-17A is sufficient to down-regulate the expression of CD45R/B220. BAFF-R is up-regulated in splenic or medullar derived-ASC stimulated by venom, CpG or cytokines. Only splenic derived-ASC up-regulate Bcl-2 expression after CpG or the combination of IL-21/IL-23/IL-33 stimulation. Finally, the activation of ASC for IgG1 secretion is triggered by venom proteins in peritoneal cavity and by IL-17A in medullar niche. These results show the importance of the integration of signals downstream of BCR and IL17-A receptors in modulating ASC differentiation, focusing in the microenvironment niche of their generation.	[Lima, Carla] Univ Sao Paulo, Butantan Inst, Special Lab Appl Toxinol CEPID FAPESP, Immunoregulat Unit, Sao Paulo, Brazil; Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Lima, C (corresponding author), Univ Sao Paulo, Butantan Inst, Special Lab Appl Toxinol CEPID FAPESP, Immunoregulat Unit, Sao Paulo, Brazil.	carlalima@butantan.gov.br	Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Lima, Carla/B-6750-2019; Grund, Lidiane/AAJ-1844-2021	Lima, Carla/0000-0002-8161-966X; Grund, Lidiane/0000-0001-6587-0283; Lopes-Ferreira, Monica/0000-0003-0244-7482	FAPESP [2012/50001-0, 2009/53078-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP 2012/50001-0 and 2009/53078-1 CNPQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rish EY, 2013, RHEUMATOLOGY, V52, P1190, DOI 10.1093/rheumatology/ket006; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102; BURDIN N, 1995, J IMMUNOL, V154, P2533; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Cocco C, 2011, J LEUKOCYTE BIOL, V89, P729, DOI 10.1189/jlb.1210660; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; ELENIUS K, 1994, J CELL SCI, V107, P2975; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Fecteau JF, 2009, IMMUNOLOGY, V128, pe353, DOI 10.1111/j.1365-2567.2008.02976.x; Grund LZ, 2006, TOXICON, V48, P499, DOI 10.1016/j.toxicon.2006.06.014; Grund LZ, 2012, CYTOKINE, V59, P335, DOI 10.1016/j.cyto.2012.04.045; HARADA H, 1993, BLOOD, V81, P2658; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hung CY, 2011, INFECT IMMUN, V79, P4511, DOI 10.1128/IAI.05726-11; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Klein U, 2003, ANN NY ACAD SCI, V987, P166, DOI 10.1111/j.1749-6632.2003.tb06045.x; Komegae EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067135; KORSMEYER SJ, 1990, CURR TOP MICROBIOL, V166, P203; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lopes-Ferreira M, 2004, BIOCHEM PHARMACOL, V68, P2151, DOI 10.1016/j.bcp.2004.07.037; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; MATSUMOTO AK, 1991, J EXP MED, V173, P55, DOI 10.1084/jem.173.1.55; McArthur MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038408; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Milovanovic M, 2010, J INVEST DERMATOL, V130, P2621, DOI 10.1038/jid.2010.175; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; Saito T, 2008, IMMUNOBIOLOGY, V213, P545, DOI 10.1016/j.imbio.2008.01.006; Saraiva TC, 2011, INT IMMUNOPHARMACOL, V11, P1546, DOI 10.1016/j.intimp.2011.05.012; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmidt CS, 2012, VACCINE, V30, P7594, DOI 10.1016/j.vaccine.2012.10.038; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shimoda M, 2006, J IMMUNOL, V176, P6503, DOI 10.4049/jimmunol.176.11.6503; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Yasuda T, 2011, SCI SIGNAL, V19, p[4, ra25]; Yasuda T, 2008, CELL CYCLE, V7, P3634, DOI 10.4161/cc.7.23.7103; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	60	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74566	10.1371/journal.pone.0074566	http://dx.doi.org/10.1371/journal.pone.0074566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058589	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900057
J	Zhuang, LP; Zeng, XT; Yang, ZG; Meng, ZQ				Zhuang, Liping; Zeng, Xiantao; Yang, Zongguo; Meng, Zhiqiang			Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HEPATITIS-C; INTRAHEPATIC RECURRENCE; CURATIVE RESECTION; LIVER RESECTION; ALPHA; THERAPY; SURVIVAL; TRIAL; MANAGEMENT; REPLICATION	Background: The effect of interferon(IFN) in the management of hepatocellular carcinoma (HCC) remains controversial, and no clear recommendations have been proposed. Objectives: To evaluate the effect and safety of IFN for HCC. Methods: PubMed, OvidSP, and Cochrane Library were searched from their establishment date until August 30, 2012. Studies that met the inclusion criteria were systematically evaluated and then subjected to meta-analysis. Results: Thirteen randomized control trials (RCTs) involving 1344 patients were eligible for this study. When IFN was used as an adjuvant therapy for HCC patients after curative therapy, the meta-analysis showed that IFN reduced the 1-, 2-, 3-, 4-, and 5-year recurrence rates. Subgroup analysis showed that IFN reduced the 2-, 3-, 4-, and 5-year recurrence rates of hepatitis C viral (HCV)-related HCC. The effect of IFN for on hepatitis B virus(HBV)-related HCC patients could not be determined because of isufficient data. After surgical resection, adjuvant IFN therapy reduced the 4- and 5-recurrence rates. All studies reported that IFN could not improve the overall survival of HCV-realated HCC patients after curative therapies. Only one study showed that IFN was associated with better overall survival in HCC patients after curative therapy and subgroup of HCC patients after surgical resection. Thus, meta-analysis was not performed. Different treatment options were used as control to study the effect of IFN for intermediate and advanced HCC patients, thus meta-analysis was not appropriate. All included studies, except for one, reported that IFN treatment was well tolerated. Conclusions: After curative therapies, adjuvant IFN reduced the recurrence of HCC. IFN did not improve the survival of HCV-related HCC patients after curative therapy. Whether IFN is effective for intermediate and advanced HCC patients could not be determined because of insufficient data. The toxicity of IFN was acceptable.	[Zhuang, Liping; Meng, Zhiqiang] Fudan Univ, Dept Integrat Med, Fudan Univ Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zeng, Xiantao] Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Hubei Province, Peoples R China; [Yang, Zongguo] Fudan Univ, Dept Tradit Chinese Med, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China	Fudan University; Hubei University of Medicine; Fudan University	Meng, ZQ (corresponding author), Fudan Univ, Dept Integrat Med, Fudan Univ Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	mengzhq@gmail.com	Meng, Zhiqiang/ABE-7747-2021; Yang, Zongguo/AAY-4190-2021	Yang, Zongguo/0000-0002-6623-4841; Zhuang, Liping/0000-0003-1998-8250; Zeng, Xian-Tao/0000-0003-1262-725X				Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Brozek J, 2011, GRADEPRO COMPUTER PR; Bruix J, 2010, MANAGEMENT HEPATOCEL; Camma C, 2005, EXPERT OPIN PHARMACO, V6, P399, DOI 10.1517/14656566.6.3.399; Chen LT, 2012, ANN SURG, V255, P8, DOI 10.1097/SLA.0b013e3182363ff9; Chung YH, 2000, CANCER, V88, P1986, DOI 10.1002/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I; DUNK AA, 1986, J HEPATOL, V2, P419, DOI 10.1016/S0168-8278(86)80053-8; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Goldstein D, 1998, CANC J CLIN, V38, P258; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOSHIDA Y, 2008, NEW ENGL J MED, V359, P1; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Jang JW, 2004, J HEPATOL, V41, P427, DOI 10.1016/j.jhep.2004.05.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kianmanesh Reza, 2003, Surg Oncol Clin N Am, V12, P51, DOI 10.1016/S1055-3207(02)00090-X; Kubo S, 2002, BRIT J SURG, V89, P418, DOI 10.1046/j.0007-1323.2001.02054.x; Kubo S, 2001, ANN INTERN MED, V134, P963, DOI 10.7326/0003-4819-134-10-200105150-00010; Kubo S, 2001, ANN SURG, V233, P139, DOI 10.1097/00000658-200101000-00020; LAI CL, 1989, BRIT J CANCER, V60, P928, DOI 10.1038/bjc.1989.392; LAI CL, 1993, HEPATOLOGY, V17, P389; Li MQ, 2009, J GASTROEN HEPATOL, V24, P1437, DOI 10.1111/j.1440-1746.2009.05863.x; Liaw YunFan, 2004, Journal of Gastroenterology and Hepatology, V19, pS128, DOI 10.1111/j.1440-1746.2004.03662.x; Lin SM, 2004, CANCER-AM CANCER SOC, V100, P376, DOI 10.1002/cncr.20004; Llovet JM, 2000, HEPATOLOGY, V31, P54, DOI 10.1002/hep.510310111; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nathan H, 2009, ANN SURG, V249, P799, DOI 10.1097/SLA.0b013e3181a38eb5; Nishiguchi S, 2005, INTERVIROLOGY, V48, P71, DOI 10.1159/000082098; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Park HC, 2011, ONCOLOGY-BASEL, V81, P134, DOI 10.1159/000333276; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poon RTP, 2002, ANN SURG, V236, P602, DOI 10.1097/00000658-200211000-00010; Said A, 2009, MINERVA MED, V100, P51; Shamliyan TA, 2009, ANN INTERN MED, V150, P111, DOI 10.7326/0003-4819-150-2-200901200-00101; Shiratori Y, 2003, ANN INTERN MED, V138, P299, DOI 10.7326/0003-4819-138-4-200302180-00008; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tang ZY, 2001, TANG ZY HEPATOCELLUL; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tomuleasa Ciprian, 2011, Hematol Oncol Stem Cell Ther, V4, P60; Wang L, 2003, J GASTROINTEST SURG, V7, P587, DOI 10.1016/S1091-255X(03)00072-6; World Health Organization, 1979, WHO HDB REP RES CANC, P4000; Zhuang PY, 2010, J CANCER RES CLIN, V136, P1891, DOI 10.1007/s00432-010-0848-1	50	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e61361	10.1371/journal.pone.0061361	http://dx.doi.org/10.1371/journal.pone.0061361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069133	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300001
J	Kumar, A; Patil, D; Rajamohanan, PR; Ahmad, A				Kumar, Ashutosh; Patil, Deepak; Rajamohanan, Pattuparambil Ramanpillai; Ahmad, Absar			Isolation, Purification and Characterization of Vinblastine and Vincristine from Endophytic Fungus Fusarium oxysporum Isolated from Catharanthus roseus	PLOS ONE			English	Article							VINCA ALKALOIDS; TAXOL; CAMPTOTHECIN	Endophytic fungi reside in a symbiotic fashion inside their host plants, mimic their chemistry and interestingly, produce the same natural products as their hosts and are thus being screened for the production of valuable compounds like taxol, camptothecin, podophyllotoxin, etc. Vinblastine and vincristine are excellent anti-cancer drugs but their current production using plants is non-abundant and expensive. In order to make these drugs readily available to the patients at affordable prices, we isolated the endophytic fungi from Catharanthus roseus plant and found a fungus AA-CRL-6 which produces vinblastine and vincristine in appreciable amounts. These drugs were purified by TLC and HPLC and characterized using UV-Vis spectroscopy, ESI-MS, MS/MS and H-1 NMR. One liter of culture filtrate yielded 76 mu g and 67 mu g of vinblastine and vincristine respectively. This endophytic fungal strain was identified as Fusarium oxysporum based upon its cultural and morphological characteristics and internal transcribed spacer (ITS) sequence analysis.	[Kumar, Ashutosh; Ahmad, Absar] Natl Chem Lab, CSIR, Div Biochem Sci, Pune, Maharashtra, India; [Patil, Deepak; Rajamohanan, Pattuparambil Ramanpillai] Natl Chem Lab, CSIR, Cent NMR Facil, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Ahmad, A (corresponding author), Natl Chem Lab, CSIR, Div Biochem Sci, Pune, Maharashtra, India.	a.ahmad@ncl.res.in	Patil, Deepak S/C-5688-2019	Patil, Deepak S/0000-0002-7019-9081	Council of Scientific and Industrial Research (CSIR), New Delhi; Department of Biotechnology, Government of India (New Delhi) [NWP0035 CSIR]	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India (New Delhi)(Department of Biotechnology (DBT) India)	AK thanks the Council of Scientific and Industrial Research (CSIR), New Delhi for Senior Research Fellowship. AA thanks the Department of Biotechnology, Government of India (New Delhi) for the Tata Innovation Fellowship award and financial support through NWP0035 CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIRUDDHA D, 1997, PHYTOCHEMISTRY, V46, P135, DOI DOI 10.1016/S0031-9422(97)00165-9; AZRA AA, 2008, AFR J BIOTECHNOL, V7, P2834; Barthe L, 2002, J CHROMATOGR A, V968, P241, DOI 10.1016/S0021-9673(02)00954-8; Chu IH, 1996, J CHROMATOGR A, V755, P281, DOI 10.1016/S0021-9673(96)00614-0; Deng BW, 2009, WORLD J MICROB BIOT, V25, P139, DOI 10.1007/s11274-008-9876-2; Dennison JB, 2006, DRUG METAB DISPOS, V34, P1317, DOI 10.1124/dmd.106.009902; DUBROVAY Z, 2012, J PHARM BIOMED ANAL, DOI DOI 10.1016/J.JPBA.2012.08.019.AVAILABLE:HTTP://WWW.SCIENCEDIRECT.C0M/SCIENCE/ARTICLE/PII/S0731708512004785; ELENA GG, 1992, J NAT PRODUCTS, V55, P285; Eyberger AL, 2006, J NAT PROD, V69, P1121, DOI 10.1021/np060174f; Favretto D, 2001, RAPID COMMUN MASS SP, V15, P364, DOI 10.1002/rcm.239; Guo B., 1998, J YUNNAN U, V20, P214; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Kharwar RN, 2008, CURR SCI INDIA, V95, P228; Kusari S, 2009, J NAT PROD, V72, P2, DOI 10.1021/np800455b; MIURA Y, 1988, PLANTA MED, P18, DOI 10.1055/s-2006-962321; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; OLAF VT, 1991, J PHARM BIOMED ANAL, V9, P1077, DOI DOI 10.1016/0731-7085(91)80047-D; PAULO RH, 1995, PLANT CELL TISSUE OR, V42, P1; RANGARAJULU SK, 2010, J BIOSCI BIOENG, V110, P541, DOI DOI 10.1016/J.JBI0SC.2010.06.007; SATOSHI Y, 2002, J AM CHEM SOC, V124, P2137, DOI DOI 10.1021/JA0177049; Sreekanth D, 2009, J MICROBIOL BIOTECHN, V19, P1342, DOI 10.4014/jmb.0904.04041; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 1996, MICROBIOL-UK, V142, P435, DOI 10.1099/13500872-142-2-435; Tikhomiroff C, 2002, J CHROMATOGR A, V955, P87, DOI 10.1016/S0021-9673(02)00204-2; Tung CY, 2002, J CHUXIONG NORMAL U, V6, P39; Volkov S., 1996, PHARM CHEM J+, V30, P391, DOI DOI 10.1007/BF02219327; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Yabuta T., 1939, J AGR CHEM SOC JPN, V15, P1209; Zhang LB, 2000, CHIN TRAD HERB DRUGS, V11, P805; Zhou H, 2005, PHYTOCHEM ANALYSIS, V16, P328, DOI 10.1002/pca.852	30	97	104	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e71805	10.1371/journal.pone.0071805	http://dx.doi.org/10.1371/journal.pone.0071805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066024	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000004
J	Naumova, AK; Fayer, S; Leung, J; Boateng, KA; Camerini-Otero, RD; Taketo, T				Naumova, Anna K.; Fayer, Shawn; Leung, Jacky; Boateng, Kingsley A.; Camerini-Otero, R. Daniel; Taketo, Teruko			Dynamics of Response to Asynapsis and Meiotic Silencing in Spermatocytes from Robertsonian Translocation Carriers	PLOS ONE			English	Article							HETEROCHROMATIN FORMATION; CROSSING-OVER; X-CHROMOSOME; CHROMATIN; MICE; BRCA1; INACTIVATION; REPLACEMENT; PROTEINS; SYNAPSIS	Failure of homologous synapsis during meiotic prophase triggers transcriptional repression. Asynapsis of the X and Y chromosomes and their consequent silencing is essential for spermatogenesis. However, asynapsis of portions of autosomes in heterozygous translocation carriers may be detrimental for meiotic progression. In fact, a wide range of phenotypic outcomes from meiotic arrest to normal spermatogenesis have been described and the causes of such a variation remain elusive. To better understand the consequences of asynapsis in male carriers of Robertsonian translocations, we focused on the dynamics of recruitment of markers of asynapsis and meiotic silencing at unsynapsed autosomal trivalents in the spermatocytes of Robertsonian translocation carrier mice. Here we report that the enrichment of breast cancer 1 (BRCA1) and histone gamma H2AX at unsynapsed trivalents declines during the pachytene stage of meiosis and differs from that observed in the sex body. Furthermore, histone variant H3.3S31, which associates with the sex chromosomes in metaphase I/anaphase I spermatocytes, localizes to autosomes in 12% and 31% of nuclei from carriers of one and three translocations, respectively. These data suggest that the proportion of spermatocytes with markers of meiotic silencing of unsynapsed chromatin (MSUC) at trivalents depends on both, the stage of meiosis and the number of translocations. This may explain some of the variability in phenotypic outcomes associated with Robertsonian translocations. In addition our data suggest that the dynamics of response to asynapsis in Robertsonian translocations differs from the response to sex chromosomal asynapsis in the male germ line.	[Naumova, Anna K.; Taketo, Teruko] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Naumova, Anna K.; Fayer, Shawn] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Naumova, Anna K.; Taketo, Teruko] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Leung, Jacky] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Boateng, Kingsley A.; Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD USA; [Taketo, Teruko] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); McGill University	Naumova, AK (corresponding author), McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada.	anna.naoumova@mcgill.ca		Naumova, Anna K./0000-0001-8481-5765; Leung, Jacky/0000-0002-7530-9382	Natural Sciences and Engineering Research Council of Canada Discovery Grants program; McGill University Work Study program; Human Genetics Department of McGill University; NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052033] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada Discovery Grants program(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill University Work Study program; Human Genetics Department of McGill University; NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Natural Sciences and Engineering Research Council of Canada Discovery Grants program (to A.N. and T.T.), the McGill University Work Study program (J.L.), the Human Genetics Department of McGill University (to S.F.); and partly supported by the NIDDK Intramural Research Program (to R.D.C.-O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley T, 2004, CHROMOSOMA, V113, P126, DOI 10.1007/s00412-004-0293-5; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bache I, 2004, EUR J HUM GENET, V12, P993, DOI 10.1038/sj.ejhg.5201263; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; BOGDANOV YF, 1986, CHROMOSOMA, V94, P94, DOI 10.1007/BF00286986; BORODIN PM, 1991, CHROMOSOMA, V101, P252, DOI 10.1007/BF00365157; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Croteau S, 2001, GENESIS, V31, P11, DOI 10.1002/gene.1077; Croteau S, 2005, MAMM GENOME, V16, P127, DOI 10.1007/s00335-004-2434-9; DEBOER P, 1986, CHROMOSOMA, V93, P326, DOI 10.1007/BF00327591; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Golding J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009939; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Heng HHQ, 1996, P NATL ACAD SCI USA, V93, P2795, DOI 10.1073/pnas.93.7.2795; Hirshfeld-Cytron J, 2011, SEMIN REPROD MED, V29, P470, DOI 10.1055/s-0031-1293201; Hoffmann K, 2011, BEST PRACT RES CL EN, V25, P77, DOI 10.1016/j.beem.2010.09.004; Homolka D, 2007, GENOME RES, V17, P1431, DOI 10.1101/gr.6520107; Homolka D, 2012, CHROMOSOMA, V121, P91, DOI 10.1007/s00412-011-0346-5; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; JAAFAR H, 1993, CYTOGENET CELL GENET, V64, P273, DOI 10.1159/000133592; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kim SR, 2002, GENET TEST, V6, P163, DOI 10.1089/109065702761403315; Kovaleva NV, 2005, AM J MED GENET A, V136A, P401, DOI 10.1002/ajmg.a.30815; Lu LY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3105; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; MAHADEVAIAH SK, 1990, CYTOGENET CELL GENET, V53, P26, DOI 10.1159/000132889; Manterola M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000625; Manvelyan M, 2007, INT J MOL MED, V19, P855; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; MITTWOCH U, 1992, CYTOGENET CELL GENET, V59, P274, DOI 10.1159/000133268; Munne S, 2005, CYTOGENET GENOME RES, V111, P305, DOI 10.1159/000086904; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Orsi GA, 2009, INT J DEV BIOL, V53, P231, DOI 10.1387/ijdb.082653go; Page J, 2012, CHROMOSOMA, V121, P307, DOI 10.1007/s00412-012-0364-y; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Royo H, 2013, GENE DEV, V27, P1484, DOI 10.1101/gad.219477.113; Saferali A, 2010, MAMM GENOME, V21, P377, DOI 10.1007/s00335-010-9271-9; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Sciurano R, 2007, HUM REPROD, V22, P142, DOI 10.1093/humrep/del330; SETTERFIELD LA, 1988, J REPROD FERTIL, V82, P369, DOI 10.1530/jrf.0.0820369; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; SPEED RM, 1986, CHROMOSOMA, V93, P267, DOI 10.1007/BF00292748; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Taketo T, 2013, CHROMOSOMA; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Vasco C, 2012, CHROMOSOME RES, V20, P269, DOI 10.1007/s10577-011-9272-x; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410	56	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75970	10.1371/journal.pone.0075970	http://dx.doi.org/10.1371/journal.pone.0075970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066189	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000171
J	Qin, SY; Zhou, Y; Jiang, HX; Hu, BL; Tao, L; Xie, MZ				Qin, Shan-Yu; Zhou, You; Jiang, Hai-Xing; Hu, Bang-Li; Tao, Lin; Xie, Min-zhi			The Association of Diabetes Mellitus with Clinical Outcomes after Coronary Stenting: A Meta-Analysis	PLOS ONE			English	Article							SIROLIMUS-ELUTING STENT; LONG-TERM OUTCOMES; BARE METAL STENTS; INTRAVASCULAR ULTRASOUND; GLYCEMIC CONTROL; RESTENOSIS; DISEASE; IMPACT; REVASCULARIZATION; IMPLANTATION	Background: Previous studies have shown inconsistent results on the association between diabetes mellitus (DM) and some clinical outcomes. We conducted a meta-analysis of observational studies to assess effect of DM on clinical outcomes after coronary stenting. Methods: We searched for studies without language restriction in PubMed, Embase and Cochrane library prior to 2012. The clinical outcomes including in-stent restenosis (ISR), major adverse cardiac events (MACE), stent thrombosis (ST), target lesion revascularization (TLR) and target vessel revascularization (TVR). Adjusted odds ratio (OR), and the corresponding 95% confidence interval (95% CI) was summarized. Results: 55 studies involving 128,084 total patients (38,416 DM patients and 89,668 controls) were eligible for our analysis. Overall, there were significant associations between DM and ISR (OR = 1.70, 95% CI: 1.53-1.89, I-2 = 0.0%), MACE (OR = 1.54, 95% CI: 1.36-1.73, I-2 = 29.0%), ST (OR = 2.01, 95% CI: 1.36-2.97, I-2 = 47.7%), TLR (OR = 1.46, 95% CI: 1.26-1.68, I-2 = 43.3%) as well as TVR (OR = 1.33, 95% CI: 1.17-1.51, I-2 = 48.3). Subgroup analysis showed that the associations were similar between BMS and DES implantation. Moreover, there was no significant association in the ST subgroup after 1-3 years follow-up. Conclusions: Our meta-analysis suggests that after coronary stent implantation, DM is associated with ISR, MACE, ST, TLR and TVR. DM appears to be a vital risk factor of these clinical outcomes.	[Qin, Shan-Yu; Jiang, Hai-Xing; Hu, Bang-Li; Tao, Lin; Xie, Min-zhi] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Zhou, You] Minerva Fdn, Inst Med Res, Helsinki, Finland	Guangxi Medical University	Jiang, HX (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	1391510812@qq.com		ZHOU, YOU/0000-0002-1743-1291				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14; Carson JL, 2002, J AM COLL CARDIOL, V40, P418, DOI 10.1016/S0735-1097(02)01969-1; Corpus RA, 2004, J AM COLL CARDIOL, V43, P8, DOI 10.1016/j.jacc.2003.06.019; Drozd J, 2010, KARDIOL POL, V68, P637; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engel S, 2003, NEW ENGL J MED, V348, P2294; Fath-Ordoubadi F, 2012, AM J CARDIOL, V110, P636, DOI 10.1016/j.amjcard.2012.04.039; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Hong SN, 2007, AM J CARDIOL, V99, P1051, DOI 10.1016/j.amjcard.2006.11.069; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Iijima R, 2007, AM HEART J, V154, P688, DOI 10.1016/j.ahj.2007.06.005; Jensen LO, 2008, AM J CARDIOL, V101, P590, DOI 10.1016/j.amjcard.2007.10.020; Kip KE, 1996, CIRCULATION, V94, P1818, DOI 10.1161/01.CIR.94.8.1818; Kishi Koichi, 2005, J Invasive Cardiol, V17, P14; Kornowski R, 2004, J AM COLL CARDIOL, V43, P15, DOI 10.1016/j.jacc.2003.10.016; Kufner S, 2011, AM HEART J, V162, P740, DOI 10.1016/j.ahj.2011.07.003; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Ma ST, 2011, ACTA CARDIOL, V66, P603, DOI 10.1080/AC.66.5.2131085; Mahmud E, 2008, J AM COLL CARDIOL, V51, P2385, DOI 10.1016/j.jacc.2008.03.028; Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D; Mehran R, 2004, J AM COLL CARDIOL, V43, P1348, DOI 10.1016/j.jacc.2003.04.004; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakamura M, 2010, CIRC J, V74, P2592, DOI 10.1253/circj.CJ-10-0179; Nasu K, 2008, HEART, V94, P429, DOI 10.1136/hrt.2007.118950; Radke PW, 2006, AM J CARDIOL, V98, P1218, DOI 10.1016/j.amjcard.2006.06.015; Rathore S, 2010, EUROINTERVENTION, V5, P841, DOI 10.4244/EIJV5I7A141; Sidhu MS, 2010, J INTERV CARDIOL, V23, P167, DOI 10.1111/j.1540-8183.2010.00537.x; Skowasch D, 2005, HEART, V91, P535, DOI 10.1136/hrt.2004.037317; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Van Belle Eric, 2004, J Invasive Cardiol, V16, P23; Wells G SB, 2013, NEWCASTLE OTTAWA SCA; Zahn R, 2010, J INTERV CARDIOL, V23, P18, DOI 10.1111/j.1540-8183.2009.00513.x; Zhang F, 2010, AM J CARDIOL, V105, P64, DOI 10.1016/j.amjcard.2009.08.652	40	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e72710	10.1371/journal.pone.0072710	http://dx.doi.org/10.1371/journal.pone.0072710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066025	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000006
J	Saito, T; Yano, F; Mori, D; Ohba, S; Hojo, H; Otsu, M; Eto, K; Nakauchi, H; Tanaka, S; Chung, U; Kawaguchi, H				Saito, Taku; Yano, Fumiko; Mori, Daisuke; Ohba, Shinsuke; Hojo, Hironori; Otsu, Makoto; Eto, Koji; Nakauchi, Hiromitsu; Tanaka, Sakae; Chung, Ung-il; Kawaguchi, Hiroshi			Generation of Col2a1-EGFP iPS Cells for Monitoring Chondrogenic Differentiation	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; STEM-CELLS; ENDOCHONDRAL OSSIFICATION; CARTILAGE REPAIR; IN-VIVO; HYPERTROPHY; GENE; SKELETOGENESIS; PROGRESSION; EXPRESSION	Induced pluripotent stem cells (iPSC) are a promising cell source for cartilage regenerative medicine; however, the methods for chondrocyte induction from iPSC are currently developing and not yet sufficient for clinical application. Here, we report the establishment of a fluorescent indicator system for monitoring chondrogenic differentiation from iPSC to simplify screening for effective factors that induce chondrocytes from iPSC. We generated iPSC from embryonic fibroblasts of Col2a1-EGFP transgenic mice by retroviral transduction of Oct4, Sox2, Klf4, and c-Myc. Among the 30 clones of Col2a1-EGFP iPSC we established, two clones showed high expression levels of embryonic stem cell (ESC) marker genes, similar to control ESC. A teratoma formation assay showed that the two clones were pluripotent and differentiated into cell types from all three germ layers. The fluorescent signal was observed during chondrogenic differentiation of the two clones concomitant with the increase in chondrocyte marker expression. In conclusion, Col2a1-EGFP iPSC are useful for monitoring chondrogenic differentiation and will contribute to research in cartilage regenerative medicine.	[Saito, Taku; Mori, Daisuke; Tanaka, Sakae; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan; [Yano, Fumiko; Ohba, Shinsuke; Hojo, Hironori; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Otsu, Makoto; Eto, Koji; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med,Minato Ku, Tokyo, Japan; [Eto, Koji] Kyoto Univ, Clin Applicat Dept, CiRA, Sakyo Ku, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kyoto University	Saito, T (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan.	tasaitou-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; Hojo, Hironori/0000-0003-2245-6853; Ohba, Shinsuke/0000-0002-6874-8539; Otsu, Makoto/0000-0002-9769-0217	Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [25293316, 24592253, 25670851] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research and the Project for Realization of Regenerative Medicine from the Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dhinsa BS, 2012, CURR STEM CELL RES T, V7, P143; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Dozin B, 2002, MATRIX BIOL, V21, P449, DOI 10.1016/S0945-053X(02)00028-8; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kan A, 2009, ARTHRITIS RHEUM-US, V60, P3314, DOI 10.1002/art.24878; Kawaguchi H, 2008, MOL CELLS, V25, P1; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; LONGO UG, 2012, STEM CELLS INT, V2012; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Narcisi R, 2012, J CELL PHYSIOL, V227, P3282, DOI 10.1002/jcp.24024; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Yano F, 2013, ANN RHEUM DIS, V72, P748, DOI 10.1136/annrheumdis-2012-201745; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	27	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74137	10.1371/journal.pone.0074137	http://dx.doi.org/10.1371/journal.pone.0074137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066106	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000088
J	Walcott, MM; Jolly, PE; Ehiri, JE; Funkhouser, E; Kempf, MC; Hickman, D; Aung, M; Zhang, K				Walcott, Melonie M.; Jolly, Pauline E.; Ehiri, John E.; Funkhouser, Ellen; Kempf, Mirjam C.; Hickman, Deborah; Aung, Maung; Zhang, Kui			Factors Associated with the Acceptability of Male Circumcision among Men in Jamaica	PLOS ONE			English	Article							INFANT MALE CIRCUMCISION; HIV PREVENTION; HIV/AIDS; INFECTION; RISK; DETERMINANTS; PREVALENCE; BEHAVIORS; EPIDEMIC; PROVINCE	Objectives: To determine the prevalence of male circumcision (MC) among men in the western region of Jamaica, and to identify factors associated with acceptability of MC for self, infants (<1 year) and older sons (1-17 years). Methods: A cross-sectional, interviewer-administered questionnaire survey of 549 men aged 19-54 years was conducted in the western region of Jamaica. The survey included questions about the acceptance of MC for self, infants, and sons before and after an information session about the benefits of MC in preventing HIV/STI transmission. Logistic regression models were used to identify factors that were associated with acceptability of MC. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were calculated from the models. Results: Fourteen percent of the men reported that they were circumcised. In the multivariable model, which adjusted for age, education, religion and income, there were increased odds of accepting MC for infants/sons among uncircumcised men who accepted MC for self (AOR=8.1; 95% CI = 4.1-15.9), believed they would experience more pleasure during sex if circumcised (AOR=4.0; 95% CI = 2.0-8.2), and reported having no concerns regarding MC (AOR=3.0; 95% CI = 1.8-4.8). Similarly, uncircumcised men who reported no concerns about MC or who believed that they would experience more pleasure during sex if circumcised were more likely to accept MC for self. Conclusion: Providing men with information about MC increased acceptance of MC for self, infants (<17 years) and sons (1-17 years). Since targeted education on the benefits of male circumcision for prevention of HIV/STI can be effective in increasing acceptability of MC, health professionals should be trained, and willing to discuss MC with men in healthcare facilities and in the community.	[Walcott, Melonie M.; Jolly, Pauline E.; Hickman, Deborah] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Ehiri, John E.] Univ Arizona, Div Hlth Promot Sci, Tucson, AZ USA; [Funkhouser, Ellen] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Kempf, Mirjam C.] Univ Alabama Birmingham, Dept Family Child Hlth & Caregiving, Birmingham, AL USA; [Kempf, Mirjam C.] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA; [Aung, Maung] Western Reg Hlth Author, Epidemiol Unit, Jamaica, NY USA; [Zhang, Kui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Arizona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jolly, PE (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.	jollyp@uab.edu			National Centre on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA [T37-MD001448]; Ministry of Health, Jamaica; National Institute on Minority Health and Health Disparities [T37MD001448] Funding Source: NIH RePORTER	National Centre on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA; Ministry of Health, Jamaica; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the Minority Health International Research Training (MHIRT) grant no. T37-MD001448 from the National Centre on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA, and the Ministry of Health, Jamaica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addanki KC, 2008, J INFECT DEV COUNTR, V2, P328; Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; Anderson M, 2009, QUAL HEALTH RES, V19, P1060, DOI 10.1177/1049732309341191; Anderson P., 2012, SOC ECON STUD, V61, P49; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baumgartner JN, 2009, INT PERSPECT SEX R H, V35, P21, DOI 10.1363/ifpp.35.021.09; Binagwaho A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000211; Blank S, 2012, PEDIATRICS, V130, pE756, DOI 10.1542/peds.2012-1990; Brito MO, 2010, AIDS CARE, V22, P1530, DOI 10.1080/09540121.2010.484455; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; de Bruyn G, 2010, EXPERT REV ANTI-INFE, V8, P23, DOI 10.1586/ERI.09.120; Doyle SM, 2010, J UROLOGY, V183, P21, DOI 10.1016/j.juro.2009.09.030; Duncan ND, 2010, W INDIAN MED J, V59, P348; Ekundayo OJ, 2007, THESCIENTIFICWORLDJO, V7, P493, DOI 10.1100/tsw.2007.94; Feng Nan, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P281; Figueroa JP, 2008, W INDIAN MED J, V57, P195; Figueroa JP, 2008, W INDIAN MED J, V57, P562; Figueroa JP, 2005, W INDIAN MED J, V54, P70; Figueroa JP, 2008, CURRENT PERCEPTIONS; Frisch M, 2013, PEDIATRICS, V131, P796, DOI 10.1542/peds.2012-2896; Gasasira RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-134; Gibbison GA, 2007, W INDIAN MED J, V56, P66; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Hossain MR, 2012, CASE REP SURG, V2012, DOI 10.1155/2012/483431; Inciardi JA, 2005, AIDS CARE, V17, pS9, DOI 10.1080/09540120500120955; Ishida K, 2011, INT PERSPECT SEX R H, V37, P6, DOI 10.1363/3700611; Kelly A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-67; Kululanga Lucy I, 2012, Afr J Reprod Health, V16, P145; Lukobo MD, 2007, AIDS CARE, V19, P471, DOI 10.1080/09540120601163250; Manji KP, 2000, ANN TROP PAEDIATR, V20, P101, DOI 10.1080/02724936.2000.11748116; Mavhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032475; Ngalande RC, 2006, AIDS BEHAV, V10, P377, DOI 10.1007/s10461-006-9076-8; Norman Lisa R, 2007, Int J Adolesc Med Health, V19, P199; Norman LR, 2006, HIV MED, V7, P231, DOI 10.1111/j.1468-1293.2006.00368.x; Onyango Monica A, 2010, Afr J Reprod Health, V14, P32; PAHO, 2002, UNGASS WOM VULN HIV; Pan LJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-738; Pierre RB, 2008, W INDIAN MED J, V57, P223; Plummer DC, 2013, SEX RES SOC POLICY, P1; Sansom SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008723; Tarimo EAM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-529; Wamai RG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-49; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Western Regional Health Authority (WRHA), 2008, W REG HLTH AUTH WRHA; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; World Health Organization and UNAIDS, 2011, PROGR SCAL UP MAL CI; Young MR, 2012, PEDIATRICS, V130, pE175, DOI 10.1542/peds.2011-2290	51	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75074	10.1371/journal.pone.0075074	http://dx.doi.org/10.1371/journal.pone.0075074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066164	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000146
J	Spiegel, CN; Bretas, JAC; Peixoto, AA; Vigoder, FM; Bruno, RV; Soares, MJ				Spiegel, Carolina N.; Bretas, Jorge A. C.; Peixoto, Alexandre A.; Vigoder, Felipe M.; Bruno, Rafaela V.; Soares, Maurilio J.			Fine Structure of the Male Reproductive System and Reproductive Behavior of Lutzomyia longipalpis Sandflies (Diptera: Psychodidae: Phlebotominae)	PLOS ONE			English	Article							ACCESSORY-GLAND SECRETIONS; FEMALE CHOICE; ULTRASTRUCTURE; COURTSHIP; LEISHMANIASIS; HYMENOPTERA; POPULATIONS; VECTOR; SPERM	Background: The male reproductive system of insects can have several tissues responsible for the secretion of seminal fluid proteins (SFPs), such as testes, accessory glands, seminal vesicles, ejaculatory duct and ejaculatory bulb. The SFPs are transferred during mating and can induce several physiological and behavioral changes in females, such as increase in oviposition and decrease in sexual receptivity after copulation. The phlebotomine Lutzomyia longipalpis is the main vector of visceral leishmaniasis. Despite its medical importance, little is known about its reproductive biology. Here we present morphological aspects of the male L. longipalpis reproductive system by light, scanning and transmission electron microscopy, and compare the mating frequency of both virgin and previously mated females. Results: The male L. longipalpis reproductive system is comprised by a pair of oval-shaped testes linked to a seminal vesicle by vasa deferentia. It follows an ejaculatory duct with an ejaculatory pump (a large bulb enveloped by muscles and associated to tracheas). The terminal endings of the vasa deferentia are inserted into the seminal vesicle by invaginations of the seminal vesicle wall, which is composed by a single layer of gland cells, with well-developed endoplasmic reticulum profiles and secretion granules. Our data suggest that the seminal vesicle acts both as a spermatozoa reservoir and as an accessory gland. Mating experiments support this hypothesis, revealing a decrease in mating frequency after copulation that indicates the effect of putative SFPs. Conclusion: Ultrastructural features of the L. longipalpis male seminal vesicle indicated its possible role as an accessory gland. Behavioral observations revealed a reduction in mating frequency of copulated females. Together with transcriptome analyses from male sandfly reproductive organs identifying ESTs encoding orthologs of SFPs, these data indicate the presence of putative L. longipalpis SFPs reducing sexual mating frequency of copulated females.	[Spiegel, Carolina N.; Bretas, Jorge A. C.; Peixoto, Alexandre A.; Vigoder, Felipe M.; Bruno, Rafaela V.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, RJ, Brazil; [Spiegel, Carolina N.] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Niteroi, RJ, Brazil; [Peixoto, Alexandre A.; Bruno, Rafaela V.] Inst Nacl Ciencia & Tecnol Entomol Mol CNPq, Rio De Janeiro, Brazil; [Soares, Maurilio J.] Fiocruz MS, Inst Carlos Chagas, Curitiba, PR, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Fundacao Oswaldo Cruz	Spiegel, CN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, RJ, Brazil.	cspiegel@ioc.fiocruz.br	Soares, Maurilio J/I-4627-2016; Bruno, Rafaela/AAQ-7611-2020	Soares, Maurilio J/0000-0001-9701-836X; Bruno, Rafaela/0000-0002-7082-9768; Vigoder, Felipe/0000-0003-1037-8851	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FIOCRUZ; FAPERJ; Howard Hughes Medical Institute (HHMI)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), FIOCRUZ, FAPERJ and Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Azevedo RVDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034495; Baldini F, 2012, PATHOG GLOB HEALTH, V106, P82, DOI 10.1179/2047773212Y.0000000016; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Bray DP, 2007, MED VET ENTOMOL, V21, P332, DOI 10.1111/j.1365-2915.2007.00700.x; Bretman A, 2013, J INSECT PHYSIOL, V59, P824, DOI 10.1016/j.jinsphys.2013.05.011; Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Dallacqua RP, 2003, ANAT HISTOL EMBRYOL, V32, P276, DOI 10.1046/j.1439-0264.2003.00484.x; DALLAI R, 1984, INT J INSECT MORPHOL, V13, P1, DOI 10.1016/0020-7322(84)90027-8; Fausto AM, 2000, TISSUE CELL, V32, P228, DOI 10.1054/tice.2000.0110; Forattini O., 1973, ENTOMOLOGIA MEDICA; GIEBULTOWICZ JM, 1989, SCIENCE, V245, P1098, DOI 10.1126/science.245.4922.1098; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gioti A, 2012, P ROY SOC B-BIOL SCI, V279, P4423, DOI 10.1098/rspb.2012.1634; Helinski MEH, 2012, J INSECT PHYSL; Ilango K, 2005, J BIOSCIENCES, V30, P711, DOI 10.1007/BF02703571; Jones TM, 1998, P ROY SOC B-BIOL SCI, V265, P1651, DOI 10.1098/rspb.1998.0484; Jones TM, 2000, P ROY SOC B-BIOL SCI, V267, P681, DOI 10.1098/rspb.2000.1056; Jones TM, 2001, J INSECT BEHAV, V14, P385, DOI 10.1023/A:1011127514317; Kelly DW, 1997, ANIM BEHAV, V53, P721, DOI 10.1006/anbe.1996.0309; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Lee JJ, 1999, J AM MOSQUITO CONTR, V15, P4; Maroli M., 1991, Parassitologia (Rome), V33, P405; MEIKLE DB, 1990, J INSECT PHYSIOL, V36, P93, DOI 10.1016/0022-1910(90)90179-J; MODI GB, 1983, J MED ENTOMOL, V20, P568, DOI 10.1093/jmedent/20.5.568; Nattero J, 2011, ACTA TROP, V119, P183, DOI 10.1016/j.actatropica.2011.05.015; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; QUICKE DLJ, 1992, ZOOL SCR, V21, P381, DOI 10.1111/j.1463-6409.1992.tb00339.x; RIEMANN JG, 1973, J INSECT PHYSIOL, V19, P213, DOI 10.1016/0022-1910(73)90234-5; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Souza NA, 2009, MED VET ENTOMOL, V23, P287, DOI 10.1111/j.1365-2915.2009.00818.x; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Souza NA, 2008, MEM I OSWALDO CRUZ, V103, P216, DOI 10.1590/S0074-02762008000200017; Spiegel CN, 2005, J INSECT PHYSIOL, V51, P1366, DOI 10.1016/j.jinsphys.2005.08.007; Valdez JM, 2001, ANN ENTOMOL SOC AM, V94, P251, DOI 10.1603/0013-8746(2001)094[0251:UOTTOT]2.0.CO;2; Valenta DT, 2000, MED VET ENTOMOL, V14, P207, DOI 10.1046/j.1365-2915.2000.00225.x; Vitta ACR, 2009, J MED ENTOMOL, V46, P789, DOI 10.1603/033.046.0409; Ward RD, 1988, BIOSYSTEMATICS HAEMA, P258; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Yamane T, 2008, J INSECT PHYSIOL, V54, P1522, DOI 10.1016/j.jinsphys.2008.09.001; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058	44	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74898	10.1371/journal.pone.0074898	http://dx.doi.org/10.1371/journal.pone.0074898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058637	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400099
J	Tripathy, D; Haobam, R; Nair, R; Mohanakumar, KP				Tripathy, Debasmita; Haobam, Reena; Nair, Ranju; Mohanakumar, Kochupurackal P.			Engraftment of Mouse Embryonic Stem Cells Differentiated by Default Leads to Neuroprotection, Behaviour Revival and Astrogliosis in Parkinsonian Rats	PLOS ONE			English	Article							MEDIAN FOREBRAIN-BUNDLE; NEUROTROPHIC FACTOR; IN-VITRO; SUBSTANTIA-NIGRA; DOPAMINE NEURONS; MODEL; TRANSPLANTATION; EXPRESSION; ROTENONE; GENERATION	We report here protection against rotenone-induced behavioural dysfunction, striatal dopamine depletion and nigral neuronal loss, following intra-striatal transplantation of neurons differentiated from murine embryonic stem cells (mES). mES maintained in serum free medium exhibited increase in neuronal, and decrease in stem cell markers by 7th and 10th days as revealed by RT-PCR and immunoblot analyses. Tyrosine hydroxylase, NURR1, PITX3, LMX1b and c-RET mRNA showed a significant higher expression in differentiated cells than in mES. Dopamine level was increased by 3-fold on 10th day as compared to 7 days differentiated cells. Severity of rotenone-induced striatal dopamine loss was attenuated, and amphetamine-induced unilateral rotations were significantly reduced in animals transplanted with 7 days differentiated cells, but not in animals that received undifferentiated ES transplant. However, the ratio of contralateral to ipsilateral swings in elevated body swing test was significantly reduced in both the transplanted groups, as compared to control. Striatal grafts exhibited the presence of tyrosine hydroxylase positive cells, and the percentage of dopaminergic neurons in the substantia nigra was also found to be higher in the ipsilateral side of 7 days and mES grafted animals. Increased expression of CD11b and IBA-1, suggested a significant contribution of these microglia-derived factors in controlling the limited survival of the grafted cells. Astrocytosis in the grafted striatum, and significant increase in the levels of glial cell line derived neurotrophic factor may have contributed to the recovery observed in the hemiparkinsonian rats following transplantation.	[Tripathy, Debasmita; Haobam, Reena; Nair, Ranju; Mohanakumar, Kochupurackal P.] CSIR Indian Inst Chem Biol, Lab Clin & Expt Neurosci, Div Cell Biol & Physiol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Mohanakumar, KP (corresponding author), CSIR Indian Inst Chem Biol, Lab Clin & Expt Neurosci, Div Cell Biol & Physiol, Kolkata, India.	mohankumar@iicb.res.in	Haobam, Reena/AAU-2118-2021; Mohanakumar, Kochupurackal P/ABE-8492-2020	Mohanakumar, Kochupurackal P/0000-0002-4985-1100; Haobam, Reena/0000-0002-2994-9493	Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC); DBT, Govt. of India; project 'Neurodegenerative disorders: Causes and corrections' (miND) under CSIR, Govt. of India [BSC 0115]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); DBT, Govt. of India(Department of Biotechnology (DBT) India); project 'Neurodegenerative disorders: Causes and corrections' (miND) under CSIR, Govt. of India	DT and RN received Council of Scientific and Industrial Research (CSIR), and RH received University Grants Commission (UGC) fellowships. Transplantation biology part of the work was funded by a DBT, Govt. of India project grant, and the differentiation and characterization of stem cells part of the work was funded by the project 'Neurodegenerative disorders: Causes and corrections' (miND; Grant # BSC 0115) under the 12th five year plan program CSIR, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT LE, 1994, EXP NEUROL, V125, P228, DOI 10.1006/exnr.1994.1026; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Barroso-Chinea P, 2005, EUR J NEUROSCI, V21, P1815, DOI 10.1111/j.1460-9568.2005.04024.x; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; Deleidi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019926; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Engberg N, 2010, STEM CELLS, V28, P1498, DOI 10.1002/stem.479; Fathi F, 2010, INDIAN J MED RES, V131, P536; Galpern WR, 1996, CELL TRANSPLANT, V5, P225, DOI 10.1016/0963-6897(95)02030-6; Goren B, 2005, SURG NEUROL, V64, P33, DOI 10.1016/j.surneu.2005.07.038; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Jin HJ, 2010, CELL MOL LIFE SCI, V67, P1845, DOI 10.1007/s00018-010-0292-z; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Ko JY, 2009, MOL THER, V17, P1761, DOI 10.1038/mt.2009.148; Lei ZN, 2011, J NEUROPATH EXP NEUR, V70, P736, DOI 10.1097/NEN.0b013e31822830e5; Lenka N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001349; Li B, 2009, J INNATE IMMUN, V1, P570, DOI 10.1159/000235563; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Lonardo E, 2010, STEM CELLS, V28, P1326, DOI 10.1002/stem.458; Love S, 2005, NAT MED, V11, P703, DOI 10.1038/nm0705-703; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Michel-Monigadon D, 2010, TRANSPLANTATION, V89, P816, DOI 10.1097/TP.0b013e3181cbe041; Morizane A, 2010, J NEUROSCI RES, V88, P3467, DOI 10.1002/jnr.22515; Muralikrishnan D, 1998, FASEB J, V12, P905, DOI 10.1096/fasebj.12.10.905; Nakao N, 2006, BRAIN RES REV, V52, P244, DOI 10.1016/j.brainresrev.2006.03.001; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nizzardo M, 2010, CELL MOL LIFE SCI, V67, P3837, DOI 10.1007/s00018-010-0463-y; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Riebeling C, 2011, TOXICOL IN VITRO, V25, P914, DOI 10.1016/j.tiv.2011.02.013; Rossler R, 2010, NEUROSCIENCE, V170, P417, DOI 10.1016/j.neuroscience.2010.07.023; Rowland JW, 2011, STEM CELLS DEV, V20, P1829, DOI 10.1089/scd.2011.0214; Saravanan KS, 2005, BRAIN RES, V1049, P147, DOI 10.1016/j.brainres.2005.04.051; Shafit-Zagardo B, 1999, J NEUROCHEM, V73, P2531, DOI 10.1046/j.1471-4159.1999.0732531.x; Sindhu KM, 2006, PHARMACOL BIOCHEM BE, V84, P321, DOI 10.1016/j.pbb.2006.05.017; Sindhu KM, 2005, BRAIN RES, V1051, P25, DOI 10.1016/j.brainres.2005.05.051; Steinbeck JA, 2012, CELL MOL LIFE SCI, V69, P461, DOI 10.1007/s00018-011-0759-6; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Wang Y, 2012, STEM CELLS, V30, P169, DOI 10.1002/stem.1000; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xiong NA, 2010, BIOL BLOOD MARROW TR, V16, P1519, DOI 10.1016/j.bbmt.2010.06.004; Zhou HT, 2012, MOL MED REP, V5, P842, DOI 10.3892/mmr.2011.719	55	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72501	10.1371/journal.pone.0072501	http://dx.doi.org/10.1371/journal.pone.0072501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069147	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100008
J	Keuschnigg, J; Karinen, S; Auvinen, K; Irjala, H; Mpindi, JP; Kallioniemi, O; Hautaniemi, S; Jalkanen, S; Salmi, M				Keuschnigg, Johannes; Karinen, Sirkku; Auvinen, Kaisa; Irjala, Heikki; Mpindi, John-Patrick; Kallioniemi, Olli; Hautaniemi, Sampsa; Jalkanen, Sirpa; Salmi, Marko			Plasticity of Blood- and Lymphatic Endothelial Cells and Marker Identification	PLOS ONE			English	Article							PAL-E; PHENOTYPIC HETEROGENEITY; VASCULAR ENDOTHELIUM; GENE-EXPRESSION; TUMOR-GROWTH; ADHESION; ANGIOGENESIS; MOLECULE; TRANSMIGRATION; PROGRESSION	The distinction between lymphatic and blood vessels is biologically fundamental. Here we wanted to rigorously analyze the universal applicability of vascular markers and characteristics of the two widely used vascular model systems human microvascular endothelial cell line-1 (HMEC-1) and telomerase-immortalized microvascular endothelial cell line (TIME). Therefore we studied the protein expression and functional properties of the endothelial cell lines HMEC-1 and TIME by flow cytometry and in vitro flow assays. We then performed microarray analyses of the gene expression in these two cell lines and compared them to primary endothelial cells. Using bioinformatics we then defined 39 new, more universal, endothelial-type specific markers from 47 primary endothelial microarray datasets and validated them using immunohistochemistry with normal and pathological tissues. We surprisingly found that both HMEC-1 and TIME are hybrid blood-and lymphatic cells. In addition, we discovered great discrepancies in the previous identifications of blood-and lymphatic endothelium-specific genes. Hence we identified and validated new, universally applicable vascular markers. Summarizing, the hybrid blood-lymphatic endothelial phenotype of HMEC-1 and TIME is indicative of plasticity in the gene expression of immortalized endothelial cell lines. Moreover, we identified new, stable, vessel-type specific markers for blood-and lymphatic endothelium, useful for basic research and clinical diagnostics.	[Keuschnigg, Johannes; Auvinen, Kaisa; Irjala, Heikki; Jalkanen, Sirpa; Salmi, Marko] Univ Turku, MediCity Res Lab, Turku, Finland; [Keuschnigg, Johannes; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Keuschnigg, Johannes] Turku Doctoral Program Biomed Sci, Turku, Finland; [Karinen, Sirkku; Hautaniemi, Sampsa] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Karinen, Sirkku; Hautaniemi, Sampsa] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland; [Auvinen, Kaisa; Jalkanen, Sirpa; Salmi, Marko] Natl Inst Publ Hlth & Welf, Turku, Finland; [Irjala, Heikki] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Mpindi, John-Patrick; Kallioniemi, Olli] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki, Finland; [Salmi, Marko] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	University of Turku; University of Turku; University of Helsinki; University of Helsinki; University of Turku; University of Helsinki; University of Turku	Salmi, M (corresponding author), Univ Turku, MediCity Res Lab, Turku, Finland.	marko.salmi@utu.fi	Hautaniemi, Sampsa/CAG-0362-2022; Kallioniemi, Olli P/H-5111-2011; Hautaniemi, Sampsa/A-3122-2009	Hautaniemi, Sampsa/0000-0002-7749-2694; Kallioniemi, Olli P/0000-0002-3231-0332; Hautaniemi, Sampsa/0000-0002-7749-2694; Irjala, Heikki/0000-0003-3054-4677	Finnish Academy [118621, 126925, 121584, 124282, 129378, 117787, 41071]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Sigrid Juselius Foundation	Finnish Academy(Academy of Finland); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Finnish Academy (grants 118621, 126925, 121584, 124282, 129378, 117787, and 41071), Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; AIRAS L, 1993, J IMMUNOL, V151, P4228; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136; Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003; Boerma M, 2006, BLOOD COAGUL FIBRIN, V17, P173, DOI 10.1097/01.mbc.0000220237.99843.a1; Borg I, 2010, MODERN MULTIDIMENSIO; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DeSilva U, 1997, GENOME RES, V7, P157, DOI 10.1101/gr.7.2.157; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Ganguly A, 2012, JOVE-J VIS EXP, DOI 10.3791/4032; Grumet M, 1996, SEMIN NEUROSCI, V8, P379, DOI 10.1006/smns.1996.0046; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Irjala H, 2003, EUR J IMMUNOL, V33, P815, DOI 10.1002/eji.200323859; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kang J, 2010, BLOOD, V116, P140, DOI 10.1182/blood-2009-11-252270; Keuschnigg J, 2012, BLOOD, V120, P232, DOI 10.1182/blood-2012-01-406876; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Lane RP, 1996, GENOMICS, V35, P456, DOI 10.1006/geno.1996.0385; Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Oostingh GJ, 2007, J INVEST DERMATOL, V127, P2253, DOI 10.1038/sj.jid.5700828; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P281, DOI 10.1097/PAP.0b013e3182691c2a; Parker WL, 2003, J BONE MINER RES, V18, P289, DOI 10.1359/jbmr.2003.18.2.289; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Pounds S, 2006, BIOINFORMATICS, V22, P1979, DOI 10.1093/bioinformatics/btl328; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71; SERS C, 1994, CANCER RES, V54, P5689; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wu J, 2012, R PACKAGE VERSION 2; Xie SH, 1997, CANCER RES, V57, P2295; Zimmer G, 1999, BIOCHEM J, V341, P277, DOI 10.1042/0264-6021:3410277	53	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74293	10.1371/journal.pone.0074293	http://dx.doi.org/10.1371/journal.pone.0074293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058540	gold, Green Submitted, Green Published			2022-12-27	WOS:000327538600084
J	Moharir, A; Peck, SH; Budden, T; Lee, SY				Moharir, Akshay; Peck, Sun H.; Budden, Theodore; Lee, Stella Y.			The Role of N-Glycosylation in Folding, Trafficking, and Functionality of Lysosomal Protein CLN5	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; TRIPEPTIDYL-PEPTIDASE-I; BATTEN-DISEASE; MUTATIONS; TRANSPORT; STORAGE; IDENTIFICATION; MATURATION; ENDOSOME; JUVENILE	CLN5 is a soluble lysosomal protein with unknown function. Mutations in CLN5 lead to neuronal ceroid lipofuscinosis, a group of inherited neurodegenerative disorders that mainly affect children. CLN5 has eight potential N-glycosylation sites based on the Asn-X-Thr/Ser consensus sequence. Through site-directed mutagenesis of individual asparagine residues to glutamine on each of the N-glycosylation consensus sites, we showed that all eight putative N-glycosylation sites are utilized in vivo. Additionally, localization studies showed that the lack of N-glycosylation on certain sites (N179, N252, N304, or N320) caused CLN5 retention in the endoplasmic reticulum, indicating that glycosylation is important for protein folding. Interestingly, one particular mutant, N401Q, is mislocalized to the Golgi, suggesting that N401 is not important for protein folding but essential for CLN5 trafficking to the lysosome. Finally, we analyzed several patient mutations in which N-glycosylation is affected. The N192S patient mutant is localized to the lysosome, indicating that this mutant has a functional defect in the lysosome. Our results suggest that there are functional differences in various N-glycosylation sites of CLN5 which affect folding, trafficking, and lysosomal function of CLN5.	[Moharir, Akshay; Peck, Sun H.; Budden, Theodore; Lee, Stella Y.] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Kansas State University	Lee, SY (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Ackert Hall, Manhattan, KS 66506 USA.	sylee@ksu.edu	Moharir, Akshay/AAK-7219-2021		National Center for Research Resources [5P20RR016475]; National Institute of General Medical Sciences from the National Institutes of Health [8P20GM103418]; Terry Johnson Center for Basic Cancer Research at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Terry Johnson Center for Basic Cancer Research at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Center for Research Resources (5P20RR016475) and the National Institute of General Medical Sciences (8P20GM103418) from the National Institutes of Health, and Terry Johnson Center for Basic Cancer Research at Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund.	Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bennett MJ, 1999, J INHERIT METAB DIS, V22, P535, DOI 10.1023/A:1005564509027; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cannelli N, 2007, NEUROPEDIATRICS, V38, P46, DOI 10.1055/s-2007-981449; El Haddad S, 2012, ELECTROPHORESIS, V33, P3798, DOI 10.1002/elps.201200472; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Isosomppi J, 2002, HUM MOL GENET, V11, P885, DOI 10.1093/hmg/11.8.885; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; Lebrun AH, 2009, HUM MUTAT, V30, pE651, DOI 10.1002/humu.21010; Mamo A, 2012, MOL CELL BIOL, V32, P1855, DOI 10.1128/MCB.06726-11; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pohl S, 2009, BIOL CHEM, V390, P521, DOI 10.1515/BC.2009.076; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Schmiedt ML, 2010, HUM MUTAT, V31, P356, DOI 10.1002/humu.21195; Schulz A, 2006, J BIOL CHEM, V281, P2784, DOI 10.1074/jbc.M509483200; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; Steinfeld R, 2004, HUM MOL GENET, V13, P2483, DOI 10.1093/hmg/ddh264; Steinfeld R, 2002, AM J MED GENET, V112, P347, DOI 10.1002/ajmg.10660; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; TYYNELA J, 1993, FEBS LETT, V330, P8, DOI 10.1016/0014-5793(93)80908-D; Vesa J, 2002, MOL BIOL CELL, V13, P2410, DOI 10.1091/mbc.E02-01-0031; Woodman PG, 2000, TRAFFIC, V1, P695, DOI 10.1034/j.1600-0854.2000.010902.x; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Xin W, 2010, NEUROLOGY, V74, P565, DOI 10.1212/WNL.0b013e3181cff70d; ZEMAN W, 1969, PEDIATRICS, V44, P570	33	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74299	10.1371/journal.pone.0074299	http://dx.doi.org/10.1371/journal.pone.0074299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058541	Green Published, Green Submitted, gold			2022-12-27	WOS:000327538600085
J	Castellon, E; Martinez, M; Madrigal-Carballo, S; Arias, ML; Vargas, WE; Chavarria, M				Castellon, Erick; Martinez, Maria; Madrigal-Carballo, Sergio; Laura Arias, Maria; Vargas, William E.; Chavarria, Max			Scattering of Light by Colloidal Aluminosilicate Particles Produces the Unusual Sky-Blue Color of Rio Celeste (Tenorio Volcano Complex, Costa Rica)	PLOS ONE			English	Article							KAWAH-IJEN VOLCANO; LA VIEJA VOLCANO; CRATER LAKE; OPTICAL-PROPERTIES; ACID; GEOCHEMISTRY; DISCHARGES; SYSTEMS; METALS; RINCON	Rio Celeste (Sky-Blue River) in Tenorio National Park (Costa Rica), a river that derives from the confluence and mixing of two colorless streams-Rio Buenavista (Buenavista River) and Quebrada Agria (Sour Creek)-is renowned in Costa Rica because it presents an atypical intense sky-blue color. Although various explanations have been proposed for this unusual hue of Rio Celeste, no exhaustive tests have been undertaken; the reasons hence remain unclear. To understand this color phenomenon, we examined the physico-chemical properties of Rio Celeste and of the two streams from which it is derived. Chemical analysis of those streams with ion-exchange chromatography (IC) and inductively coupled plasma atomic emission spectroscopy (ICP-OES) made us discard the hypothesis that the origin of the hue is due to colored chemical species. Our tests revealed that the origin of this coloration phenomenon is physical, due to suspended aluminosilicate particles (with diameters distributed around 566 nm according to a lognormal distribution) that produce Mie scattering. The color originates after mixing of two colorless streams because of the enlargement (by aggregation) of suspended aluminosilicate particles in the Rio Buenavista stream due to a decrease of pH on mixing with the acidic Quebrada Agria. We postulate a chemical mechanism for this process, supported by experimental evidence of dynamic light scattering (DLS), zeta potential measurements, X-ray diffraction and scanning electron microscopy (SEM) with energy-dispersive spectra (EDS). Theoretical modeling of the Mie scattering yielded a strong coincidence between the observed color and the simulated one.	[Castellon, Erick; Chavarria, Max] Univ Costa Rica, Escuela Quim, San Jose, Costa Rica; [Martinez, Maria] Univ Nacl OVSICORI UNA, Observ Vulcanol & Sismol Costa Rica, Heredia, Costa Rica; [Madrigal-Carballo, Sergio] Univ Nacl, Escuela Quim, Lab Polimeros, Heredia, Costa Rica; [Laura Arias, Maria] Univ Costa Rica, Fac Microbiol, San Jose, Costa Rica; [Vargas, William E.] Univ Costa Rica, Escuela Fis, San Jose, Costa Rica; [Vargas, William E.] Univ Costa Rica, Ctr Invest Ciencia & Ingn Mat, San Jose, Costa Rica; [Chavarria, Max] Univ Costa Rica, Ctr Invest Prod Nat CIPRONA, San Jose, Costa Rica	Universidad Costa Rica; Universidad Nacional Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica	Chavarria, M (corresponding author), Univ Costa Rica, Escuela Quim, San Jose, Costa Rica.	max.chavarria@ucr.ac.cr	Chavarria, Max/J-3940-2019	Chavarria, Max/0000-0001-5901-3576; Madrigal-Carballo, Sergio/0000-0002-4444-3001	Vicerrectory of Research of the Universidad of Costa Rica; Institutional Programme on Alternative Energy Sources (PrIFAE) of the Universidad de Costa Rica	Vicerrectory of Research of the Universidad of Costa Rica; Institutional Programme on Alternative Energy Sources (PrIFAE) of the Universidad de Costa Rica	This work was supported by the Vicerrectory of Research of the Universidad of Costa Rica. The authors also acknowledge to the Institutional Programme on Alternative Energy Sources (PrIFAE) of the Universidad de Costa Rica for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado Induni G, 2011, VOLCANES COSTA RICA, P386; BIRD RE, 1983, SOL ENERGY, V30, P563, DOI 10.1016/0038-092X(83)90068-3; Bohren C.F., 2007, ABSORPTION SCATTERIN, P82, DOI DOI 10.1002/9783527618156; Brinker J.C., 1990, SOL GEL SCI PHYS CHE; Campion R, 2012, B VOLCANOL, V74, P1757, DOI 10.1007/s00445-012-0631-z; CHAN S.H., 1989, GEOTHERMICS, V18, P49, DOI [10.1016/0375-6505(89)90009-6, DOI 10.1016/0375-6505(89)90009-6]; DELMELLE P, 1994, GEOCHIM COSMOCHIM AC, V58, P2445, DOI 10.1016/0016-7037(94)90023-X; FARMER VC, 1979, GEOCHIM COSMOCHIM AC, V43, P1417, DOI 10.1016/0016-7037(79)90135-2; GERARDY JM, 1982, PHYS REV B, V25, P4204, DOI 10.1103/PhysRevB.25.4204; GHOSH G, 1994, J LIGHTWAVE TECHNOL, V12, P1338, DOI 10.1109/50.317500; GIGGENBACH WF, 1992, APPL GEOCHEM, V7, P309, DOI 10.1016/0883-2927(92)90022-U; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hartl W, 1999, J CHEM PHYS, V110, P7070, DOI 10.1063/1.478612; Hunt RWG, 2011, WILEY-ISTE, P293; Iler RK, 1979, CHEM SILICA SOLUBILI, P864; Kempter KA, 2000, J VOLCANOL GEOTH RES, V97, P143, DOI 10.1016/S0377-0273(99)00181-X; Klavins M, 2000, SCI TOTAL ENVIRON, V262, P175, DOI 10.1016/S0048-9697(00)00597-0; Lee WKW, 2003, LANGMUIR, V19, P8726, DOI 10.1021/la026127e; MAHER BA, 1986, PHYS EARTH PLANET IN, V42, P76, DOI 10.1016/S0031-9201(86)80010-3; MAHEU B, 1984, APPL OPTICS, V23, P3353, DOI 10.1364/AO.23.003353; Melson WG., 1973, COSTA RICA B, V37, P416, DOI [10.1007/BF02597639, DOI 10.1007/BF02597639]; Ohsawa S, 2002, J VOLCANOL GEOTH RES, V113, P49, DOI 10.1016/S0377-0273(01)00250-5; Ohsawa S, 2010, LIMNOLOGY, V11, P207, DOI 10.1007/s10201-009-0304-6; Onda Yuuji, 2003, Japanese Journal of Limnology, V64, P1; de Zarate DO, 2008, SOLID STATE SCI, V10, P587, DOI 10.1016/j.solidstatesciences.2007.10.014; Oyama Y, 2009, LIMNOLOGY, V10, P47, DOI 10.1007/s10201-009-0260-1; Quinten M, 2011, MIES THEORY, P245; Quinten M, 2011, MIES THEORY SINGLE S; Quinten M, 2011, APPL MIES THEORY OPT, P123; Ridgway J, 2003, APPL GEOCHEM, V18, P283, DOI 10.1016/S0883-2927(02)00126-9; Rymer H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022284; SCHULZE DG, 1979, SOIL SCI SOC AM J, V43, P793, DOI 10.2136/sssaj1979.03615995004300040036x; SHIMONO T, 1983, J CHROMATOGR, V258, P73, DOI 10.1016/S0021-9673(00)96399-4; SMITH RC, 1973, LIMNOL OCEANOGR, V18, P189, DOI 10.4319/lo.1973.18.2.0189; Sriwana T, 2000, J VOLCANOL GEOTH RES, V97, P77, DOI 10.1016/S0377-0273(99)00178-X; Stimac JA, 2004, B VOLCANOL, V66, P149, DOI 10.1007/s00445-003-0300-3; Tassi F, 2005, J VOLCANOL GEOTH RES, V148, P315, DOI 10.1016/j.jvolgeores.2005.05.001; Tassi F, 2009, J LIMNOL, V68, P193, DOI 10.4081/jlimnol.2009.193; van Hinsberg V, 2010, J VOLCANOL GEOTH RES, V196, P169, DOI 10.1016/j.jvolgeores.2010.07.004; Vargas WE, 1998, APPL OPTICS, V37, P2615, DOI 10.1364/AO.37.002615; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400	41	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75165	10.1371/journal.pone.0075165	http://dx.doi.org/10.1371/journal.pone.0075165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058661	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900098
J	Di Giallonardo, F; Zagordi, O; Duport, Y; Leemann, C; Joos, B; Kunzli-Gontarczyk, M; Bruggmann, R; Beerenwinkel, N; Gunthard, HF; Metzner, KJ				Di Giallonardo, Francesca; Zagordi, Osvaldo; Duport, Yannick; Leemann, Christine; Joos, Beda; Kuenzli-Gontarczyk, Marzanna; Bruggmann, Remy; Beerenwinkel, Niko; Guenthard, Huldrych F.; Metzner, Karin J.			Next-Generation Sequencing of HIV-1 RNA Genomes: Determination of Error Rates and Minimizing Artificial Recombination	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; DRUG-RESISTANCE MUTATIONS; TREATMENT-NAIVE; AMPLIFICATION PRODUCTS; DNA RECOMBINATION; DIVERSITY; INFECTION; ACCURACY; POLYMERASE; FREQUENCY	Next-generation sequencing (NGS) is a valuable tool for the detection and quantification of HIV-1 variants in vivo. However, these technologies require detailed characterization and control of artificially induced errors to be applicable for accurate haplotype reconstruction. To investigate the occurrence of substitutions, insertions, and deletions at the individual steps of RT-PCR and NGS, 454 pyrosequencing was performed on amplified and non-amplified HIV-1 genomes. Artificial recombination was explored by mixing five different HIV-1 clonal strains (5-virus-mix) and applying different RT-PCR conditions followed by 454 pyrosequencing. Error rates ranged from 0.04-0.66% and were similar in amplified and non-amplified samples. Discrepancies were observed between forward and reverse reads, indicating that most errors were introduced during the pyrosequencing step. Using the 5-virus-mix, non-optimized, standard RT-PCR conditions introduced artificial recombinants in a fraction of at least 30% of the reads that subsequently led to an underestimation of true haplotype frequencies. We minimized the fraction of recombinants down to 0.9-2.6% by optimized, artifact-reducing RTPCR conditions. This approach enabled correct haplotype reconstruction and frequency estimations consistent with reference data obtained by single genome amplification. RT-PCR conditions are crucial for correct frequency estimation and analysis of haplotypes in heterogeneous virus populations. We developed an RT-PCR procedure to generate NGS data useful for reliable haplotype reconstruction and quantification.	[Di Giallonardo, Francesca; Duport, Yannick; Leemann, Christine; Joos, Beda; Guenthard, Huldrych F.; Metzner, Karin J.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Zagordi, Osvaldo; Beerenwinkel, Niko] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Zagordi, Osvaldo] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Kuenzli-Gontarczyk, Marzanna; Bruggmann, Remy] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Beerenwinkel, Niko] SIB Swiss Inst Bioinformat, Basel, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Institute of Bioinformatics	Metzner, KJ (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	karin.metzner@usz.ch	gunthard, huldrych f/F-1724-2011; Metzner, Karin J/G-5319-2011; Zagordi, Osvaldo/H-2879-2019; Joos, Beda/D-5547-2009	gunthard, huldrych f/0000-0002-1142-6723; Metzner, Karin J/0000-0003-4862-1503; Zagordi, Osvaldo/0000-0002-9082-8607; Joos, Beda/0000-0002-3082-8875; Di Giallonardo, Francesca/0000-0002-8749-4095; Bruggmann, Remy/0000-0001-5629-6363	Swiss National Science Foundation [324700-120793, 310030-141067]; KJM [CR3212-I27017, CR32I2-146331]; clinical research priority program viral infectious diseases; Zurich Primary HIV-infection Study by the university of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); KJM; clinical research priority program viral infectious diseases; Zurich Primary HIV-infection Study by the university of Zurich	This work was supported by the Swiss National Science Foundation [grants number 324700-120793 and 310030-141067 to HFG and KJM and CR3212-I27017 and CR32I2-146331 to NB, HFG and KJM and by the clinical research priority program viral infectious diseases, Zurich Primary HIV-infection Study by the university of Zurich (to HFG)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; BRAKENHOFF RH, 1991, NUCLEIC ACIDS RES, V19, P1949, DOI 10.1093/nar/19.8.1949; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang GW, 1998, J VIROL METHODS, V76, P139, DOI 10.1016/S0166-0934(98)00133-5; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gorzer I, 2010, J VIROL METHODS, V169, P248, DOI 10.1016/j.jviromet.2010.07.040; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2013, J INFECT DIS; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; OLSEN DB, 1989, NUCLEIC ACIDS RES, V17, P9613, DOI 10.1093/nar/17.23.9613; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Rice P., 2000, TRENDS GENETICS, V16; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schlub TE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000766; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Smyth RP, 2010, GENE, V469, P45, DOI 10.1016/j.gene.2010.08.009; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wu LH, 2007, J BIOCHEM MOL BIOL, V40, P172; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	47	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74249	10.1371/journal.pone.0074249	http://dx.doi.org/10.1371/journal.pone.0074249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058534	Green Published, Green Accepted, gold			2022-12-27	WOS:000324695900037
J	Huang, WH; Lin, JL; Lin-Tan, DT; Chen, KH; Hsu, CW; Yen, TH				Huang, Wen-Hung; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Chen, Kuan-Hsing; Hsu, Ching-Wei; Yen, Tzung-Hai			Impact of Living Environment on 2-Year Mortality in Elderly Maintenance Hemodialysis Patients	PLOS ONE			English	Article							CAUSE 1-YEAR MORTALITY; STAGE RENAL-DISEASE; LONG-TERM EXPOSURE; AIR-POLLUTION; DIALYSIS OUTCOMES; STARTING DIALYSIS; PRACTICE PATTERNS; ALL-CAUSE; INFLAMMATION; MALNUTRITION	Background: Studies on risk factors of mortality in elderly patients with hemodialysis usually focus on comorbidities, nutrition, and inflammation. Discussion on the correlation between living environment and mortality of these patients is limited. Methods: A total of 256 elderly hemodialysis patients participated in this 2-year prospective observational study. The subjects were divided into 2 subgroups based on whether they were living in Taipei Basin (n = 63) or not (n = 193). Demographic, hematological, nutritional, inflammatory, biochemical, and dialysis-related data were obtained for cross-sectional analysis. Causes of death and mortality rates were also analyzed for each subgroup. Results: Patients in the basin group had a higher incidence of combined protein-energy wasting and inflammation than those in the around basin group. At the end of the 2-year follow-up, 68 patients had died. Univariate binary logistic regression analysis revealed that a very advanced age, basin group, serum albumin levels, serum creatinine levels, non-anuria, and the complications of stroke and CAD were associated with 2-year mortality. Meanwhile, log high-sensitivity Creactive protein (hs-CRP) levels were not associated with 2-year mortality. Multivariate Cox regression analysis revealed that basin group, serum albumin levels, and the complications of stroke and CAD were significant risk factors for 2-year mortality in these patients. Conclusion: The results of this study indicate that factors such as living in the Taipei Basin with higher air pollutant levels in elderly hemodialysis patients is associated with protein-energy wasting and inflammation, as well as 2-year mortality. These findings suggest that among this population, living environment is as important as comorbidities and nutrition. Furthermore, air pollution should be getting more attention especially in the overcrowding Basin topography.	[Lin, Ja-Liang] Chang Gung Univ, Chang Gung Mem Hosp, Lin Kou Med Ctr, Div Nephrol & Clin Toxicol, Taipei, Taiwan; Sch Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lin, JL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Lin Kou Med Ctr, Div Nephrol & Clin Toxicol, Taipei, Taiwan.	tzunghaiyen@ntu.edu.tw	Yen, Tzung-Hai/AAQ-4525-2020; huang, wen/GXW-0661-2022	Yen, Tzung-Hai/0000-0002-0907-1505; 				Alexeeff SE, 2011, ENVIRON HEALTH PERSP, V119, P481, DOI 10.1289/ehp.1002560; Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Centers for Disease Control and Prevention and National Center for Health Statistics, 2003, 3 NAT HLTH NUTR EX S; Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Dasgupta I, 2007, NAT CLIN PRACT NEPHR, V3, P480, DOI 10.1038/ncpneph0569; Dasgupta I, 2009, SEMIN DIALYSIS, V22, P476, DOI 10.1111/j.1525-139X.2009.00617.x; DAUGIRDAS JT, 1989, INT J ARTIF ORGANS, V12, P420; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dockery DW, 2007, NEW ENGL J MED, V356, P511, DOI 10.1056/NEJMe068274; Gan WQ, 2012, AM J EPIDEMIOL, V175, P898, DOI 10.1093/aje/kwr424; Hsiao CH, 2011, NEPHROL DIAL TRANSPL, V26, P1016, DOI 10.1093/ndt/gfq485; Hsu CW, 2010, NEPHROLOGY, V15, P313, DOI 10.1111/j.1440-1797.2009.01202.x; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jassal V, 1996, NEPHROL DIAL TRANSPL, V11, P1052; Jenq CC, 2009, AM J MED SCI, V337, P188, DOI 10.1097/MAJ.0b013e31818d8bbe; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Mateen FJ, 2011, JAMA-J AM MED ASSOC, V305, P1240, DOI 10.1001/jama.2011.352; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Nascimento MM, 2002, BLOOD PURIFICAT, V20, P454, DOI 10.1159/000063559; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Samet JM, 2011, NEW ENGL J MED, V365, P198, DOI 10.1056/NEJMp1103332; SARGENT JA, 1983, KIDNEY INT, pS19; Sezer S, 2002, NEPHRON, V91, P456, DOI 10.1159/000064287; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tsai SS, 2003, STROKE, V34, P2612, DOI 10.1161/01.STR.0000095564.33543.64; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Yen TH, 2010, THER APHER DIAL, V14, P400, DOI 10.1111/j.1744-9987.2010.00818.x; Yen TH, 2009, AM J MED SCI, V337, P421, DOI 10.1097/MAJ.0b013e31819bbec1	36	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74358	10.1371/journal.pone.0074358	http://dx.doi.org/10.1371/journal.pone.0074358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058552	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900042
J	Balmer, D; Emery, M; Andreux, P; Auwerx, J; Ginet, V; Puyal, J; Schorderet, DF; Roduit, R				Balmer, Delphine; Emery, Martine; Andreux, Penelope; Auwerx, Johan; Ginet, Vanessa; Puyal, Julien; Schorderet, Daniel F.; Roduit, Raphael			Autophagy Defect Is Associated with Low Glucose-Induced Apoptosis in 661W Photoreceptor Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SELF-DIGESTION; DANON-DISEASE; DEATH; STIMULATION; STRESS; BCL-2; LIFE; P62; PHOSPHORYLATION	Glucose is an important metabolic substrate of the retina and diabetic patients have to maintain a strict normoglycemia to avoid diabetes secondary effects, including cardiovascular disease, nephropathy, neuropathy and retinopathy. Others and we recently demonstrated the potential role of hypoglycemia in diabetic retinopathy. We showed acute hypoglycemia to induce retinal cell death both in vivo during an hyperinsulinemic/hypoglycemic clamp and in vitro in 661W photoreceptor cells cultured at low glucose concentration. In the present study, we showed low glucose to induce a decrease of BCL2 and BCL-XL anti-apoptotic proteins expression, leading to an increase of free pro-apoptotic BAX. In parallel, we showed that, in retinal cells, low glucose-induced apoptosis is involved in the process of autophagosomes formation through the AMPK/RAPTOR/mTOR pathway. Moreover, the decrease of LAMP2a expression led to a defect in the autophagosome/lysosome fusion process. Specific inhibition of autophagy, either by 3-methyladenine or by down-regulation of ATG5 or ATG7 proteins expression, increased caspase 3 activation and 661W cell death. We show that low glucose modifies the delicate equilibrium between apoptosis and autophagy. Cells struggled against low nutrient condition-induced apoptosis by starting an autophagic process, which led to cell death when inhibited. We conclude that autophagy defect is associated with low glucose-induced 661W cells death that could play a role in diabetic retinopathy. These results could modify the way of addressing negative effects of hypoglycemia. Short-term modulation of autophagy could be envisioned to treat diabetic patients in order to avoid secondary complications of the disease.	[Balmer, Delphine; Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael] Inst Res Ophthalmol, Sion, Switzerland; [Andreux, Penelope; Auwerx, Johan; Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Fac Life Sci, Lausanne, Switzerland; [Schorderet, Daniel F.; Roduit, Raphael] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Ginet, Vanessa; Puyal, Julien] Univ Lausanne, Dept Neurosci Fondamentales, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Lausanne	Roduit, R (corresponding author), Inst Res Ophthalmol, Sion, Switzerland.	raphael.roduit@irovision.ch	Auwerx, Johan/ABE-9307-2021; Roduit, Raphael/AAC-3890-2021; Puyal, Julien P/G-4210-2018	Roduit, Raphael/0000-0001-7440-2799; Puyal, Julien P/0000-0002-8140-7026; Auwerx, Johan/0000-0002-5065-5393	La Fondation Romande pour la Recherche sur le Diabete; La Fondation Charles-Henri et Ruth ROUFFY; La Fondation Art Vie; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation [310030-130769]; European Research Council; Faculte de Biologie et Medecine (University of Lausanne)	La Fondation Romande pour la Recherche sur le Diabete; La Fondation Charles-Henri et Ruth ROUFFY; La Fondation Art Vie; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Faculte de Biologie et Medecine (University of Lausanne)	RR was supported by "La Fondation Romande pour la Recherche sur le Diabete" (www.fondationromande-diabete.ch) "La Fondation Charles-Henri et Ruth ROUFFY" and "La Fondation Art & Vie"; JA and PA were supported by the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation (www.snf.ch), and the European Research Council (www.erc.europa.eu). JP was supported by grants from the Swiss National Science Foundation (www.snf.ch) (310030-130769) and from the Faculte de Biologie et Medecine (University of Lausanne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar-Wikstrom E, 2013, AUTOPHAGY, V9, P626, DOI 10.4161/auto.23642; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai Y, 2007, FREE RADICAL BIO MED, V42, P64, DOI 10.1016/j.freeradbiomed.2006.09.018; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kume S, 2012, DIABETES, V61, P23, DOI 10.2337/db11-0555; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P2695; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Prall FR, 2006, OPHTHALMOLOGY, V113, P1010, DOI 10.1016/j.ophtha.2006.02.030; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Rodriguez-Navarro J, 2012, P NATL ACAD SCI USA, V109, P14; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Schorderet DF, 2007, ARCH OPHTHALMOL-CHIC, V125, P231, DOI 10.1001/archopht.125.2.231; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Thiadens AAHJ, 2012, GRAEF ARCH CLIN EXP, V250, P769, DOI 10.1007/s00417-011-1857-8; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang Zhao, 2007, Congenit Heart Dis, V2, P404, DOI 10.1111/j.1747-0803.2007.00132.x; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74162	10.1371/journal.pone.0074162	http://dx.doi.org/10.1371/journal.pone.0074162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066113	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000095
J	Chimusa, ER; Daya, M; Moller, M; Ramesar, R; Henn, BM; van Helden, PD; Mulder, NJ; Hoal, EG				Chimusa, Emile R.; Daya, Michelle; Moeller, Marlo; Ramesar, Raj; Henn, Brenna M.; van Helden, Paul D.; Mulder, Nicola J.; Hoal, Eileen G.			Determining Ancestry Proportions in Complex Admixture Scenarios in South Africa Using a Novel Proxy Ancestry Selection Method	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; GENETIC-STRUCTURE; INFERENCE; TOOL	Admixed populations can make an important contribution to the discovery of disease susceptibility genes if the parental populations exhibit substantial variation in susceptibility. Admixture mapping has been used successfully, but is not designed to cope with populations that have more than two or three ancestral populations. The inference of admixture proportions and local ancestry and the imputation of missing genotypes in admixed populations are crucial in both understanding variation in disease and identifying novel disease loci. These inferences make use of reference populations, and accuracy depends on the choice of ancestral populations. Using an insufficient or inaccurate ancestral panel can result in erroneously inferred ancestry and affect the detection power of GWAS and meta-analysis when using imputation. Current algorithms are inadequate for multi-way admixed populations. To address these challenges we developed PROXYANC, an approach to select the best proxy ancestral populations. From the simulation of a multi-way admixed population we demonstrate the capability and accuracy of PROXYANC and illustrate the importance of the choice of ancestry in both estimating admixture proportions and imputing missing genotypes. We applied this approach to a complex, uniquely admixed South African population. Using genome-wide SNP data from over 764 individuals, we accurately estimate the genetic contributions from the best ancestral populations: isiXhosa (33%+/- 0.226), (Sic)Khomani SAN (31%+/- 0.195), European (16%+/- 0.118), Indian (13%+/- 0.094), and Chinese (7%+/- 0.0488). We also demonstrate that the ancestral allele frequency differences correlate with increased linkage disequilibrium in the South African population, which originates from admixture events rather than population bottlenecks. Nomenclature: The collective term for people of mixed ancestry in southern Africa is "Coloured,'' and this is officially recognized in South Africa as a census term, and for self-classification. Whilst we acknowledge that some cultures may use this term in a derogatory manner, these connotations are not present in South Africa, and are certainly not intended here.	[Chimusa, Emile R.; Mulder, Nicola J.] Univ Cape Town, Sch Med, Inst Infect Dis & Mol Med, Computat Biol Grp,Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Daya, Michelle; Moeller, Marlo; van Helden, Paul D.; Hoal, Eileen G.] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa; [Ramesar, Raj] Univ Cape Town, MRC Human Genet Res Unit, Inst Infect Dis & Mol Med, Div Human Genet,Dept Clin Lab Sci,Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Henn, Brenna M.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	University of Cape Town; National Research Foundation - South Africa; Stellenbosch University; University of Cape Town; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hoal, EG (corresponding author), Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa.	egvh@sun.ac.za	Moller, Marlo/AAC-6973-2020; Ramesar, Raj S/I-6941-2015; Emile Rugamika, Chimusa/T-3048-2017	Moller, Marlo/0000-0002-0805-6741; Ramesar, Raj S/0000-0001-5688-1634; Hoal, Eileen/0000-0002-6444-5688; Mulder, Nicola J/0000-0003-4905-0941; Emile Rugamika, Chimusa/0000-0001-8846-2047	MRC Centre for Molecular and Cellular Biology; DST/NRF Centre of Excellence for Biomedical TB Research; Carnegie Corporation Grant; Department of Clinical Laboratory Sciences, University of Cape Town	MRC Centre for Molecular and Cellular Biology; DST/NRF Centre of Excellence for Biomedical TB Research; Carnegie Corporation Grant; Department of Clinical Laboratory Sciences, University of Cape Town	This project was funded by the MRC Centre for Molecular and Cellular Biology and the DST/NRF Centre of Excellence for Biomedical TB Research and supported by a Carnegie Corporation Grant and by the Department of Clinical Laboratory Sciences, University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; BOONZAAIER E. A., 1996, CAPE HERDERS HIST KH; Bray S, 2010, P NATL ACAD SCI USA, V107, P162; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cann HM, 2002, SCIENCE, V296, P261; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Churchhouse C, 2013, GENET EPIDEMIOL, V37, P1, DOI 10.1002/gepi.21692; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Henn B, 2012, NAT COMM, V3, P2140; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Keegan Tim., 1996, COLONIAL S AFRICA OR; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034486; Marchini J, 2008, AM J HUM GENET, V83, P535, DOI 10.1016/j.ajhg.2008.09.007; McKeigue PM, 1997, AM J HUM GENET, V60, P188; MOUNTAIN A, 2003, 1 PEOPLE CAPE LOOK T; Nurse G, 1985, PEOPLES SO AFRICA TH; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Patterson N, 2012, GENET SOC AM, V10; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pickrell K, 2012, NATURE COMMUNICATION, V3, DOI 101038/ncomms2140.; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sankararaman S, 2008, GENOME RES, V18, P668, DOI 10.1101/gr.072751.107; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Seldin MF, 2007, CURR OPIN GENET DEV, V17, P177, DOI 10.1016/j.gde.2007.03.002; Shiheng T, 2001, CHINESE SCI BULLIN, V46, P193; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Tang H, 2007, AM J HUM GENET, V81, P626, DOI 10.1086/520769; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1	43	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73971	10.1371/journal.pone.0073971	http://dx.doi.org/10.1371/journal.pone.0073971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066090	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000072
J	Elgendi, M				Elgendi, Mohamed			Fast QRS Detection with an Optimized Knowledge-Based Method: Evaluation on 11 Standard ECG Databases	PLOS ONE			English	Article							DETECTION ALGORITHM; PHYSIONET	The current state-of-the-art in automatic QRS detection methods show high robustness and almost negligible error rates. In return, the methods are usually based on machine-learning approaches that require sufficient computational resources. However, simple-fast methods can also achieve high detection rates. There is a need to develop numerically efficient algorithms to accommodate the new trend towards battery-driven ECG devices and to analyze long-term recorded signals in a time-efficient manner. A typical QRS detection method has been reduced to a basic approach consisting of two moving averages that are calibrated by a knowledge base using only two parameters. In contrast to high-accuracy methods, the proposed method can be easily implemented in a digital filter design.	Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada	University of Alberta	Elgendi, M (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	moe.elgendi@gmail.com	Elgendi, Mohamed/I-8596-2016	Elgendi, Mohamed/0000-0003-1831-0202	Australian government; Charles Darwin University	Australian government(Australian GovernmentCGIAR); Charles Darwin University	Mohamed Elgendi would like to gratefully acknowledge the Australian government and Charles Darwin University whose generous scholarships facilitated this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane M, 2009, COMPUT METH PROG BIO, V93, P20, DOI 10.1016/j.cmpb.2008.07.010; Afonso VX, 1997, P IEEE EMBS, V18, P1037, DOI 10.1109/IEMBS.1996.652698; Albrecht P, 1983, THESIS MIT BOSTON; Alvarado C, 2005, 2005 2nd International Conference on Electrical & Electronics Engineering (ICEEE), P189, DOI 10.1109/ICEEE.2005.1529605; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Arzeno NM, 2008, IEEE T BIO-MED ENG, V55, P478, DOI 10.1109/TBME.2007.912658; Benitez DS, 2000, COMPUT CARDIOL, V27, P379, DOI 10.1109/CIC.2000.898536; Bonow R, 2004, BRAUNWALDS HEART DIS; Chen HC, 2003, COMPUT CARDIOL, V30, P585; Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012; Clifford G, 2006, ADV METHODS TOOLS EC; Darrington J, 2006, BIOMED SIGNAL PROCES, V1, P169, DOI 10.1016/j.bspc.2006.08.002; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Elgendi M., 2009, INT J HYBRID INF TEC, V2, P65; Elgendi M, 2010, BIOSIGNALS 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, P428; Elgendi M, 2008, CSA 2008: INTERNATIONAL SYMPOSIUM ON COMPUTER SCIENCE AND ITS APPLICATIONS, PROCEEDINGS, P153, DOI 10.1109/CSA.2008.16; Engelse W. A. H., 1979, Computers in Cardiology, P37; Fard PJM, 2008, INT J CARDIOL, V124, P250, DOI 10.1016/j.ijcard.2006.11.236; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Ghaffarl A, 2008, COMPUT ELECTR ENG, V34, P81, DOI 10.1016/j.compeleceng.2007.10.005; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Greenwald S, 1990, THESIS MIT BOSTON; Hamilton P, 2002, COMPUT CARDIOL, V29, P101, DOI 10.1109/CIC.2002.1166717; HAMILTON PS, 1986, IEEE T BIO-MED ENG, V33, P1157, DOI 10.1109/TBME.1986.325695; Iyengar N, 1996, AM J PHYSIOL-REG I, V271, pR1078, DOI 10.1152/ajpregu.1996.271.4.R1078; Lee J, 1997, P IEEE EMBS, V18, P1396, DOI 10.1109/IEMBS.1996.647473; LI CW, 1995, IEEE T BIO-MED ENG, V42, P21, DOI 10.1109/10.362922; LIGTENBERG A, 1983, COMPUT BIOMED RES, V16, P273, DOI 10.1016/0010-4809(83)90027-7; Mahmoodabadi SZ, 2005, PROCEEDINGS OF THE FIFTH IASTED INTERNATIONAL CONFERENCE ON VISUALIZATION, IMAGING, AND IMAGE PROCESSING, P343; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; MOODY G, 1984, COMPUT CARDIOL, V0011; Moody GB, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P505, DOI 10.1109/CIC.2008.4749089; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Moody GB, 2004, COMPUT CARDIOL, V31, P101; Moraes JCTB, 2002, COMPUT CARDIOL, V29, P205, DOI 10.1109/CIC.2002.1166743; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Sahambi JS, 1997, IEEE ENG MED BIOL, V16, P77, DOI 10.1109/51.566158; Silva I, 2011, COMPUT CARDIOL CONF, V38, P273; THAKOR NV, 1983, MED BIOL ENG COMPUT, V21, P343, DOI 10.1007/BF02478504; Tompkins W, 2012, DIGISCOPE; XUE QZ, 1992, IEEE T BIO-MED ENG, V39, P317, DOI 10.1109/10.126604; Zhang F, 2007, 2007 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE, P211, DOI 10.1109/BIOCAS.2007.4463346; Zheng HB, 2008, 2008 10TH IEEE INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES, P169, DOI 10.1109/HEALTH.2008.4600130	46	121	124	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73557	10.1371/journal.pone.0073557	http://dx.doi.org/10.1371/journal.pone.0073557			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066054	gold, Green Submitted, Green Published			2022-12-27	WOS:000324494000035
J	Guo, MJ; Bughio, S; Sun, Y; Zhang, Y; Dong, LL; Dai, XH; Wang, LP				Guo, Mengjie; Bughio, Shamsuddin; Sun, Yong; Zhang, Yu; Dong, Lingling; Dai, Xiaohua; Wang, Liping			Age-Related P-Glycoprotein Expression in the Intestine and Affecting the Pharmacokinetics of Orally Administered Enrofloxacin in Broilers	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE GENE; EFFLUX TRANSPORTERS; ABC TRANSPORTERS; ESCHERICHIA-COLI; DRUG ABSORPTION; TISSUES; CHICKENS; BIOAVAILABILITY; DANOFLOXACIN; MODULATION	Bioavailability is the most important factor for the efficacy of any drug and it is determined by P-glycoprotein (P-gp) expression. Confirmation of P-gp expression during ontogeny is needed for understanding the differences in therapeutic efficacy of any drug in juvenile and adult animals. In this study, Abcb1 mRNA levels in the liver and intestine of broilers during ontogeny were analysed by RT qPCR. Cellular distribution of P-gp was detected by immunohistochemstry. Age-related differences of enrofloxacin pharmacokinetics were also studied. It was found that broilers aged 4 week-old expressed significantly (P < 0.01) higher levels of P-gp mRNA in the liver, jejunum and ileum, than at other ages. However, there was no significant (P > 0.05) age-related difference in the duodenum. Furthermore, the highest and lowest levels of Abcb1 mRNA expression were observed in the jejunum, and duodenum, respectively. P-gp immunoreactivity was detected on the apical surface of the enterocytes and in the bile canalicular membranes of the hepatocytes. Pharmacokinetic analysis revealed that the 8 week-old broilers, when orally administrated enrofloxacin, exhibited significantly higher C-max (1.97 vs. 0.98 mu g.ml(-1), P = 0.009), AUC(14.54 vs. 9.35 mu g.ml(-1).h, P = 0.005) and Ka (1.38 vs. 0.43 h(-1), P = 0.032), as well as lower T-peak (1.78 vs. 3.28 h, P = 0.048) and T-1/2ka (0.6 vs. 1.64 h, P = 0.012) than the 4 week-old broilers. The bioavailability of enrofloxacin in 8 week-old broilers was increased by 15.9%, compared with that in 4 week-old birds. Interestingly, combining verapamil, a P-gp modulator, significantly improved pharmacokinetic behaviour of enrofloxacin in all birds. The results indicate juvenile broilers had a higher expression of P-gp in the intestine, affecting the pharmacokinetics and reducing the bioavailability of oral enrofloxacin in broilers. On the basis of our results, it is recommended that alternative dose regimes are necessary for different ages of broilers for effective therapy.	[Guo, Mengjie; Bughio, Shamsuddin; Sun, Yong; Zhang, Yu; Dong, Lingling; Dai, Xiaohua; Wang, Liping] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, LP (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	wlp71@163.com			National Natural Science Foundation of China [30972220]; Natural Science Foundation of Jiangsu Province of China [BK2012771]; Fundamental Research Funds for the Central Universities [KYZ201105]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported in part by the National Natural Science Foundation of China (No. 30972220), Natural Science Foundation of Jiangsu Province of China (No. BK2012771), the Fundamental Research Funds for the Central Universities (KYZ201105), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AI, 2008, J PHARM SCI-US, V97, P3483, DOI 10.1002/jps.21233; ANADON A, 1995, AM J VET RES, V56, P501; Barnes DM, 2001, COMP BIOCHEM PHYS A, V130, P301, DOI 10.1016/S1095-6433(01)00389-0; Batetta B, 1999, J VASC RES, V36, P261, DOI 10.1159/000025654; Chan LMS, 2004, EUR J PHARM SCI, V21, P25, DOI 10.1016/j.ejps.2003.07.003; Chansiripornchai N, 2002, VET RES COMMUN, V26, P255, DOI 10.1023/A:1016078222398; Charleston B, 1998, ANTIMICROB AGENTS CH, V42, P83, DOI 10.1128/AAC.42.1.83; Conzelman G M, 1987, Proc West Pharmacol Soc, V30, P393; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Demeule M, 1999, FEBS LETT, V442, P208, DOI 10.1016/S0014-5793(98)01663-9; Edelmann HML, 1999, BIOL CHEM, V380, P231, DOI 10.1515/BC.1999.031; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Fromm MF, 1999, CIRCULATION, V99, P552, DOI 10.1161/01.CIR.99.4.552; Giacomini K, 2005, GOODMAN GILMANS PHAR; GOLLAPUDI S, 1995, ONCOL RES, V7, P213; Gyrd-Hansen N, 1994, HE INFLUENCE FEED OR, P242; Hanratty CG, 2000, DRUG AGING, V17, P353, DOI 10.2165/00002512-200017050-00003; Haritova AM, 2007, BIOCHEM PHARMACOL, V73, P752, DOI 10.1016/j.bcp.2006.11.015; Idowu OR, 2004, J PHARMACEUT BIOMED, V35, P143, DOI 10.1016/j.jpba.2004.01.006; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Kamath AV, 1998, J PHARM SCI, V87, P785; Kamath AV, 1998, J PHARM SCI-US, V87, P300, DOI 10.1021/js970290q; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x; Kullak-Ublick GA, 2000, J HEPATOL, V32, P3, DOI 10.1016/S0168-8278(00)80411-0; Kwatra D, 2010, INT J PHARMACEUT, V395, P114, DOI 10.1016/j.ijpharm.2010.05.027; Li RJ, 2011, COMP BIOCHEM PHYS A, V160, P200, DOI 10.1016/j.cbpa.2011.06.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangoni AA, 2007, EXPERT OPIN DRUG MET, V3, P315, DOI 10.1517/17425255.3.3.315; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; MULLER C, 1994, INT J CANCER, V56, P749, DOI 10.1002/ijc.2910560523; Pozzin JF, 1997, J VET PHARM THER S1, V20, P60; Prime-Chapman HM, 2004, J PHARMACOL EXP THER, V311, P476, DOI 10.1124/jpet.104.068775; Pulido MM, 2006, J VET PHARMACOL THER, V29, P279, DOI 10.1111/j.1365-2885.2006.00744.x; Rosati A, 2003, DEV GROWTH DIFFER, V45, P377; Schrickx JA, 2007, BRIT J PHARMACOL, V150, P463, DOI 10.1038/sj.bjp.0706974; Schrickx JA, 2008, EUR J PHARMACOL, V585, P510, DOI 10.1016/j.ejphar.2008.03.014; Seguin MA, 2004, AM J VET RES, V65, P350, DOI 10.2460/ajvr.2004.65.350; Simons FER, 1999, CLIN PHARMACOKINET, V36, P329, DOI 10.2165/00003088-199936050-00003; Sparreboom A, 1997, P NATL ACAD SCI USA, V94, P2031, DOI 10.1073/pnas.94.5.2031; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Takano M, 2006, PHARMACOL THERAPEUT, V109, P137, DOI 10.1016/j.pharmthera.2005.06.005; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; van Montfoort JE, 2003, CURR DRUG METAB, V4, P185, DOI 10.2174/1389200033489460; Warrington JS, 2004, J PHARMACOL EXP THER, V309, P730, DOI 10.1124/jpet.103.061234	45	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74150	10.1371/journal.pone.0074150	http://dx.doi.org/10.1371/journal.pone.0074150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066110	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000092
J	Li, YC; Zhao, LY; Zhu, L; Li, J; Chen, AM				Li, Yongchuan; Zhao, Liangyu; Zhu, Lei; Li, Jing; Chen, Aimin			Internal Fixation Versus Nonoperative Treatment for Displaced 3-Part or 4-Part Proximal Humeral Fractures in Elderly Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							REVERSE SHOULDER PROSTHESIS; UPPER END; EPIDEMIOLOGY; CUFF; ARTHROPLASTY; MULTICENTER; ARTHRITIS; RUPTURE; PLATE; BIAS	Background: A few studies focused on open reduction and internal fixation (ORIF) or nonoperative treatment of displaced 3-part or 4-part proximal humeral fractures in elderly patients have been published, all of whom had a low number of patients. In this meta-analysis of randomized controlled trials (RCTs), we aimed to assess the effect of ORIF or nonoperative treatment of displaced 3-part or 4-part proximal humeral fractures in elderly patients on the clinical outcomes and re-evaluate of the potential benefits of conservative treatment. Methods: We searched PubMed and the Cochrane Central Register of Controlled Trials databases for randomized controlled trials comparing ORIF and nonoperative treatment of displaced 3-part or 4-part proximal humeral fractures in elderly patients. Our outcome measures were the Constant scores. Results: Three randomized controlled trials with a total of 130 patients were identified and analyzed. The overall results based on fixed-effect model did not support the treatment of open reduction and internal fixation to improve the functional outcome when compared with nonoperative treatment for treating elderly patients with displaced 3-part or 4-part proximal humeral fractures (WMD -0.51, 95% CI: -7.25 to 6.22, P = 0.88, I-2 = 0%). Conclusions: Although our meta-analysis did not support the treatment of open reduction and internal fixation to improve the functional outcome when compared with nonoperative treatment for treating elderly patients with displaced 3-part or 4-part proximal humeral fractures, this result must be considered in the context of variable patient demographics. Only a limited recommendation can be made based on current data. Considering the limitations of included studies, a large, well designed trial that incorporates the evaluation of clinically relevant outcomes in participants with different underlying risks of shoulder function is required to more adequately assess the role for ORIF or nonoperative treatment.	[Li, Yongchuan; Zhao, Liangyu; Zhu, Lei; Li, Jing; Chen, Aimin] Second Mil Med Univ, Shanghai Changzheng Hosp, Orthopaed Inst PLA, Dept Orthopaed Trauma Surg, Shanghai, Peoples R China	Naval Medical University	Chen, AM (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Orthopaed Inst PLA, Dept Orthopaed Trauma Surg, Shanghai, Peoples R China.	aiminchen@aliyun.com		Li, Yongchuan/0000-0002-6075-9276	National Natural Science Foundation of China [30973054, 81171161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30973054, 81171161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENGNER U, 1988, CLIN ORTHOP RELAT R, P179; Boileau P, 2005, J SHOULDER ELB SURG, V14, p147S, DOI 10.1016/j.jse.2004.10.006; Boileau P, 2006, J SHOULDER ELB SURG, V15, P527, DOI 10.1016/j.jse.2006.01.003; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Court-Brown CM, 2001, ACTA ORTHOP SCAND, V72, P365, DOI 10.1080/000164701753542023; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fjalestad T, 2012, J ORTHOP TRAUMA, V26, P98, DOI 10.1097/BOT.0b013e31821c2e15; Frankle M, 2005, J BONE JOINT SURG AM, V87A, P1697, DOI 10.2106/JBJS.D.02813; Gaebler C, 2003, ACTA ORTHOP SCAND, V74, P580, DOI 10.1080/00016470310017992; GRAMMONT PM, 1993, ORTHOPEDICS, V16, P65, DOI 10.3928/0147-7447-19930101-11; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; HORAK J, 1975, CLIN ORTHOP RELAT R, P250, DOI 10.1097/00003086-197510000-00032; Iyengar JJ, 2011, J ORTHOP TRAUMA, V25, P612, DOI 10.1097/BOT.0b013e3182008df8; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kontakis G, 2008, J BONE JOINT SURG BR, V90B, P1407, DOI 10.1302/0301-620X.90B11.21070; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; Olerud P, 2011, J SHOULDER ELB SURG, V20, P747, DOI 10.1016/j.jse.2010.12.018; Sirveaux F, 2004, J BONE JOINT SURG BR, V86B, P388, DOI 10.1302/0301-620X.86B3.14024; Sudkamp N, 2009, J BONE JOINT SURG AM, V91A, P1320, DOI 10.2106/JBJS.H.00006; Thalhammer G, 2009, J TRAUMA, V66, P204, DOI 10.1097/TA.0b013e31815ede7b; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Yuksel HY, 2011, J ORTHOP TRAUMA, V25, P588, DOI 10.1097/BOT.0b013e318210ea56; Zyto K, 1997, J BONE JOINT SURG BR, V79B, P412, DOI 10.1302/0301-620X.79B3.7419	25	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75464	10.1371/journal.pone.0075464	http://dx.doi.org/10.1371/journal.pone.0075464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066182	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000164
J	Poongavanam, V; Kongsted, J				Poongavanam, Vasanthanathan; Kongsted, Jacob			Virtual Screening Models for Prediction of HIV-1 RT Associated RNase H Inhibition	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; SMALL-MOLECULE INHIBITORS; RIBONUCLEASE-H; DUAL INHIBITORS; ACTIVE-SITE; DIKETO ACID; PROTEIN; IDENTIFICATION; RESISTANCE; INTEGRASE	The increasing resistance to current therapeutic agents for HIV drug regiment remains a major problem for effective acquired immune deficiency syndrome (AIDS) therapy. Many potential inhibitors have today been developed which inhibits key cellular pathways in the HIV cycle. Inhibition of HIV-1 reverse transcriptase associated ribonuclease H (RNase H) function provides a novel target for anti-HIV chemotherapy. Here we report on the applicability of conceptually different in silico approaches as virtual screening (VS) tools in order to efficiently identify RNase H inhibitors from large chemical databases. The methods used here include machine-learning algorithms (e.g. support vector machine, random forest and kappa nearest neighbor), shape similarity (rapid overlay of chemical structures), pharmacophore, molecular interaction fields-based fingerprints for ligands and protein (FLAP) and flexible ligand docking methods. The results show that receptor-based flexible docking experiments provides good enrichment (80-90%) compared to ligand-based approaches such as FLAP (74%), shape similarity (75%) and random forest (72%). Thus, this study suggests that flexible docking experiments is the model of choice in terms of best retrieval of active from inactive compounds and efficiency and efficacy schemes. Moreover, shape similarity, machine learning and FLAP models could also be used for further validation or filtration in virtual screening processes. The best models could potentially be use for identifying structurally diverse and selective RNase H inhibitors from large chemical databases. In addition, pharmacophore models suggest that the inter-distance between hydrogen bond acceptors play a key role in inhibition of the RNase H domain through metal chelation.	[Poongavanam, Vasanthanathan; Kongsted, Jacob] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark	University of Southern Denmark	Kongsted, J (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark.	kongsted@sdu.dk	Kongsted, Jacob/AAD-3458-2022; Poongavanam, Vasanthanathan/O-3945-2017	Poongavanam, Vasanthanathan/0000-0002-8880-9247; Kongsted, Jacob/0000-0002-7725-2164	Lundbeck Foundation; Danish Councils for Independent Research; Villum Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Councils for Independent Research; Villum Foundation(Villum Fonden)	This work has been supported by the Lundbeck Foundation and the The Danish Councils for Independent Research and the Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SCHROD SUIT; [Anonymous], 2012, GLOB REP UNAIDS REP; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baroni M, 2007, J CHEM INF MODEL, V47, P279, DOI 10.1021/ci600253e; Bean P, 2005, CLIN INFECT DIS, V41, pS96, DOI 10.1086/429504; Billamboz M, 2011, J MED CHEM, V54, P1812, DOI 10.1021/jm1014692; Billamboz M, 2008, J MED CHEM, V51, P7717, DOI 10.1021/jm8007085; Borkow G, 1997, BIOCHEMISTRY-US, V36, P3179, DOI 10.1021/bi9624696; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Darbyshire J, 1995, Drugs, V49 Suppl 1, P1, DOI 10.2165/00003495-199500491-00003; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; De Clercq E, 2002, BBA-MOL BASIS DIS, V1587, P258, DOI 10.1016/S0925-4439(02)00089-3; Di Grandi M, 2010, BIOORG MED CHEM LETT, V20, P398, DOI 10.1016/j.bmcl.2009.10.043; Didierjean J, 2005, ANTIMICROB AGENTS CH, V49, P4884, DOI 10.1128/AAC.49.12.4884-4894.2005; Distinto S, 2012, EUR J MED CHEM, V50, P216, DOI 10.1016/j.ejmech.2012.01.056; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Felts AK, 2011, J CHEM INF MODEL, V51, P1986, DOI 10.1021/ci200194w; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Han LY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-401; Hang JQ, 2007, BIOCHEM BIOPH RES CO, V352, P341, DOI 10.1016/j.bbrc.2006.11.018; Hartman Tracy L, 2012, Mol Biol Int, V2012, P401965, DOI 10.1155/2012/401965; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Ilina Tatiana, 2012, Biology (Basel), V1, P521, DOI 10.3390/biology1030521; Imamichi T, 2004, CURR PHARM DESIGN, V10, P4039, DOI 10.2174/1381612043382440; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Kirschberg TA, 2009, J MED CHEM, V52, P5781, DOI 10.1021/jm900597q; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; Lansdon EB, 2011, ANTIMICROB AGENTS CH, V55, P2905, DOI 10.1128/AAC.01594-10; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Martinez L Joel, 2002, Res Initiat Treat Action, V8, P23; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Parniak MA, 2003, ANAL BIOCHEM, V322, P33, DOI 10.1016/j.ab.2003.06.001; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneider G, 2002, DRUG DISCOV TODAY, V7, P64, DOI 10.1016/S1359-6446(01)02091-8; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Singh N, 2012, J CHEM INF MODEL, V52, P2559, DOI 10.1021/ci300336v; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tramontano E, 2010, CURR MED CHEM, V17, P2837, DOI 10.2174/092986710792065045; Tramontano E, 2005, ANTIVIR RES, V65, P117, DOI 10.1016/j.antiviral.2004.11.002; Vasanthanathan P, 2011, MEDCHEMCOMM, V2, P853, DOI 10.1039/c1md00087j; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039; Williams PD, 2010, BIOORG MED CHEM LETT, V20, P6754, DOI 10.1016/j.bmcl.2010.08.135; Witten I. H., 2005, DATA MINING PRACTICA; Yanagita H, 2011, BIOORGAN MED CHEM, V19, P816, DOI 10.1016/j.bmc.2010.12.011; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zdanowicz MM, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj7005100	60	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73478	10.1371/journal.pone.0073478	http://dx.doi.org/10.1371/journal.pone.0073478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066050	Green Published, gold			2022-12-27	WOS:000324494000031
J	Price, B; McAlpine, CA; Kutt, AS; Ward, D; Phinn, SR; Ludwig, JA				Price, Bronwyn; McAlpine, Clive A.; Kutt, Alex S.; Ward, Doug; Phinn, Stuart R.; Ludwig, John A.			Disentangling How Landscape Spatial and Temporal Heterogeneity Affects Savanna Birds	PLOS ONE			English	Article							VERTEBRATE FAUNA; CLIMATE-CHANGE; SPECIES DISTRIBUTION; LAND-USE; WOODLAND; PATTERN; MODELS; CONSERVATION; MANAGEMENT; VEGETATION	In highly seasonal tropical environments, temporal changes in habitat and resources are a significant determinant of the spatial distribution of species. This study disentangles the effects of spatial and mid to long-term temporal heterogeneity in habitat on the diversity and abundance of savanna birds by testing four competing conceptual models of varying complexity. Focussing on sites in northeast Australia over a 20 year time period, we used ground cover and foliage projected cover surfaces derived from a time series of Landsat Thematic Mapper imagery, rainfall data and site-level vegetation surveys to derive measures of habitat structure at local (1-100 ha) and landscape (100-1000s ha) scales. We used generalised linear models and an information theoretic approach to test the independent effects of spatial and temporal influences on savanna bird diversity and the abundance of eight species with different life-history behaviours. Of four competing models defining influences on assemblages of savanna birds, the most parsimonious included temporal and spatial variability in vegetation cover and site-scale vegetation structure, suggesting savanna bird species respond to spatial and temporal habitat heterogeneity at both the broader landscape scale and at the fine-scale. The relative weight, strength and direction of the explanatory variables changed with each of the eight species, reflecting their different ecology and behavioural traits. This study demonstrates that variations in the spatial pattern of savanna vegetation over periods of 10 to 20 years at the local and landscape scale strongly affect bird diversity and abundance. Thus, it is essential to monitor and manage both spatial and temporal variability in avian habitat to achieve long-term biodiversity outcomes.	[Price, Bronwyn] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Price, Bronwyn; McAlpine, Clive A.; Phinn, Stuart R.] Univ Queensland, Ctr Spatial Environm Res, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Kutt, Alex S.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Kutt, Alex S.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Ward, Doug] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Ludwig, John A.] CSIRO Ecosyst Sci, Atherton, Australia	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Queensland; James Cook University; University of Melbourne; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Price, B (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland.	bronwyn.price@wsl.ch	Kutt, Alex S/B-2020-2008; Phinn, Stuart R/J-8457-2013; Price, Bronwyn/L-3538-2013	Kutt, Alex S/0000-0001-9679-2206; Phinn, Stuart R/0000-0002-2605-6104; Price, Bronwyn/0000-0003-3555-2588; McAlpine, Clive/0000-0003-0457-8144	Australian Research Council (ARC) [DP0667029]; CSIRO's Building Resilient Australian Biodiversity Assets Theme; Australian Government Natural Heritage Trust	Australian Research Council (ARC)(Australian Research Council); CSIRO's Building Resilient Australian Biodiversity Assets Theme; Australian Government Natural Heritage Trust(Australian Government)	This study was funded by the Australian Research Council (ARC http://www.arc.gov.au) Discovery Project DP0667029. Bird survey fieldwork was funded by CSIRO's Building Resilient Australian Biodiversity Assets Theme and the Australian Government Natural Heritage Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bar-Massada A, 2012, ECOGRAPHY, V35, P393, DOI 10.1111/j.1600-0587.2011.07097.x; Barrett G., 2003, AUSTRAL BIRDS; Bonthoux S, 2013, OECOLOGIA, V172, P563, DOI 10.1007/s00442-012-2498-2; Bowen ME, 2009, BIOL CONSERV, V142, P122, DOI 10.1016/j.biocon.2008.10.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chambers LE, 2005, EMU, V105, P1, DOI 10.1071/MU04033; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Danaher TJ, 2004, P 24 ANN IEEE INT GE; Fensham RJ, 2009, GLOBAL CHANGE BIOL, V15, P380, DOI 10.1111/j.1365-2486.2008.01718.x; Fensham RJ, 1999, J APPL ECOL, V36, P1035, DOI 10.1046/j.1365-2664.1999.00460.x; Fischer J, 2006, OIKOS, V112, P473, DOI 10.1111/j.0030-1299.2006.14148.x; Foley JC, 1957, BULLETIN, V47; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Fuhlendorf SD, 2012, RANGELAND ECOL MANAG, V65, P579, DOI 10.2111/REM-D-11-00109.1; Gillanders SN, 2008, PROG PHYS GEOG, V32, P503, DOI 10.1177/0309133308098363; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grossmann EB, 2007, LANDSCAPE ECOL, V22, P43, DOI 10.1007/s10980-007-9113-7; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Higgins P.J., 2001, HDB AUSTR NZ ANTARCT; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; Hockey PAR, 2011, DIVERS DISTRIB, V17, P254, DOI 10.1111/j.1472-4642.2010.00741.x; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kutt AS, 2012, AUSTRAL ECOL, V37, P779, DOI 10.1111/j.1442-9993.2011.02338.x; Kutt AS, 2012, WILDLIFE RES, V39, P386, DOI 10.1071/WR11137; Kutt AS, 2012, RANGELAND J, V34, P173, DOI 10.1071/RJ11049; Kutt AS, 2010, BIODIVERS CONSERV, V19, P2247, DOI 10.1007/s10531-010-9840-y; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Kutt AS, 2011, RANGELAND J, V33, P49, DOI 10.1071/RJ10065; Leyequien E, 2007, INT J APPL EARTH OBS, V9, P1, DOI 10.1016/j.jag.2006.08.002; Ludwig JA, 2007, LANDSCAPE ECOL, V22, P163, DOI 10.1007/s10980-006-9038-6; Mabry CM, 2010, FOREST ECOL MANAG, V260, P42, DOI 10.1016/j.foreco.2010.03.028; Mac Nally R, 1996, AUST J ECOL, V21, P224; Maron M, 2009, EMU, V109, P75, DOI 10.1071/MU08064; Martin TG, 2005, ECOL APPL, V15, P266, DOI 10.1890/03-5400; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Pavey CR, 2009, J ARID ENVIRON, V73, P634, DOI 10.1016/j.jaridenv.2009.01.010; Perry JJ, 2012, EMU, V112, P261, DOI 10.1071/MU12007; Price B, 2010, BIOL CONSERV, V143, P2504, DOI 10.1016/j.biocon.2010.06.017; Price B, 2009, ECOGRAPHY, V32, P745, DOI 10.1111/j.1600-0587.2009.05670.x; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Rolfe JC, 2000, 12 U COLL U NEW S WA; Sattler P., 1999, CONSERVATION STATUS; SCARTH P, 2006, P 13 AUSTR REM SENS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sirami C, 2012, DIVERS DISTRIB, V18, P390, DOI 10.1111/j.1472-4642.2011.00810.x; Smith A., 1994, THIS DORADO AUSTR CE; Sorrensen C, 2009, LAND USE POLICY, V26, P782, DOI 10.1016/j.landusepol.2008.10.007; Tassicker AL, 2006, RANGELAND J, V28, P139, DOI 10.1071/RJ05029; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Venables WN., 2002, MODERN APPL STAT S 4; Ward DP, 2009, LANDSCAPE ECOL, V24, P495, DOI 10.1007/s10980-009-9324-1; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1; Woinarski JCZ, 2005, WILDLIFE RES, V32, P377, DOI 10.1071/WR03008; Woinarski John C. Z., 2000, Pacific Conservation Biology, V6, P61; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001; Yang Z, 2006, P PHARMASUG 2006 BON; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	64	14	14	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74333	10.1371/journal.pone.0074333	http://dx.doi.org/10.1371/journal.pone.0074333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066138	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000324494000120
J	Andreasson, C; Schick, AJ; Pfeiffer, SM; Sarov, M; Stewart, F; Wurst, W; Schick, JA				Andreasson, Claes; Schick, Anna J.; Pfeiffer, Susanne M.; Sarov, Mihail; Stewart, Francis; Wurst, Wolfgang; Schick, Joel A.			Direct Cloning of Isogenic Murine DNA in Yeast and Relevance of Isogenicity for Targeting in Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; GENETIC CORRECTION; SHUTTLE VECTORS; IN-VIVO; MOUSE; GENOME; MUTATIONS; FRAGMENTS	Efficient gene targeting in embryonic stem cells requires that modifying DNA sequences are identical to those in the targeted chromosomal locus. Yet, there is a paucity of isogenic genomic clones for human cell lines and PCR amplification cannot be used in many mutation-sensitive applications. Here, we describe a novel method for the direct cloning of genomic DNA into a targeting vector, pRTVIR, using oligonucleotide-directed homologous recombination in yeast. We demonstrate the applicability of the method by constructing functional targeting vectors for mammalian genes Uhrf1 and Gfap. Whereas the isogenic targeting of the gene Uhrf1 showed a substantial increase in targeting efficiency compared to non-isogenic DNA in mouse E14 cells, E14-derived DNA performed better than the isogenic DNA in JM8 cells for both Uhrf1 and Gfap. Analysis of 70 C57BL/6-derived targeting vectors electroporated in JM8 and E14 cell lines in parallel showed a clear dependence on isogenicity for targeting, but for three genes isogenic DNA was found to be inhibitory. In summary, this study provides a straightforward methodological approach for the direct generation of isogenic gene targeting vectors.	[Andreasson, Claes] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Schick, Anna J.] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Pfeiffer, Susanne M.; Wurst, Wolfgang; Schick, Joel A.] Helmholtz Zentrum Munich, Inst Dev Genet, Munich, Germany; [Pfeiffer, Susanne M.; Wurst, Wolfgang; Schick, Joel A.] Tech Univ Munich, Freising Weihenstephan, Germany; [Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, TransgeneOme Project Grp, Dresden, Germany; [Stewart, Francis] Tech Univ Dresden, BioInnovat Zentrum, D-01062 Dresden, Germany	Stockholm University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Max Planck Society; Technische Universitat Dresden	Schick, JA (corresponding author), Helmholtz Zentrum Munich, Inst Dev Genet, Munich, Germany.	joel.schick@helmholtz-muenchen.de	Stewart, A. Francis/E-7789-2010; Schick, Joel/ABA-3728-2021	Schick, Joel/0000-0002-8623-4910; Andreasson, Claes/0000-0001-8948-0685; Wurst, Wolfgang/0000-0003-4422-7410	European Union within the EUCOMMTOOLS project [HEALTH-F4-2010-261492]; German Ministry of Education and Research within the DIGTOP project [01GS0858]	European Union within the EUCOMMTOOLS project; German Ministry of Education and Research within the DIGTOP project	This work was supported by the European Union within the EUCOMMTOOLS project (HEALTH-F4-2010-261492, to WW) and by the German Ministry of Education and Research within the DIGTOP project (01GS0858, to WW). All responsibilities of this publication are due to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava L, 1999, GENOMICS, V62, P285, DOI 10.1006/geno.1999.6000; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Cheng LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032018; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Falcon AA, 2005, FEMS MICROBIOL LETT, V250, P245, DOI 10.1016/j.femsle.2005.07.018; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Liu Y, 2011, METHODS MOL BIOL, V767, P355, DOI 10.1007/978-1-61779-201-4_26; Meyer M, 2012, P NATL ACAD SCI USA, V109, P9354, DOI 10.1073/pnas.1121203109; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; SIKORSKI RS, 1989, GENETICS, V122, P19; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; SUZUKI K, 1983, J BACTERIOL, V155, P747, DOI 10.1128/JB.155.2.747-754.1983; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; VANDEURSEN J, 1992, NUCLEIC ACIDS RES, V20, P3815, DOI 10.1093/nar/20.15.3815; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	43	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74207	10.1371/journal.pone.0074207	http://dx.doi.org/10.1371/journal.pone.0074207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058528	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400056
J	Barry, SJE; Dinnett, E; Kean, S; Gaw, A; Ford, I				Barry, Sarah J. E.; Dinnett, Eleanor; Kean, Sharon; Gaw, Allan; Ford, Ian			Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study	PLOS ONE			English	Article							COHORT PROFILE; FOLLOW-UP; LINKAGE; HEALTH	Background: Routinely collected electronic patient records are already widely used in epidemiological research. In this work we investigated the potential for using them to identify endpoints in clinical trials. Methods: The events recorded in the West of Scotland Coronary Prevention Study (WOSCOPS), a large clinical trial of pravastatin in middle-aged hypercholesterolaemic men in the 1990s, were compared with those in the record-linked deaths and hospitalisations records routinely collected in Scotland. Results: We matched 99% of fatal study events by date. We showed excellent matching (97%) of the causes of fatal endpoint events and good matching (>80% for first events) of the causes of nonfatal endpoint events with a slightly lower rate of mismatching of record linkage than study events (19% of first study myocardial infarctions (MI) and 4% of first record linkage MIs not matched as MI). We also investigated the matching of non-endpoint events and showed a good level of matching, with >78% of first stroke/TIA events being matched as stroke/TIA. The primary reasons for mismatches were record linkage data recording readmissions for procedures or previous events, differences between the diagnoses in the routinely collected data and the conclusions of the clinical trial expert adjudication committee, events occurring outside Scotland and therefore being missed by record linkage data, miscoding of cardiac events in hospitalisations data as 'unspecified chest pain', some general miscoding in the record linkage data and some record linkage errors. Conclusions: We conclude that routinely collected data could be used for recording cardiovascular endpoints in clinical trials and would give very similar results to rigorously collected clinical trial data, in countries with unified health systems such as Scotland. The endpoint types would need to be carefully thought through and an expert endpoint adjudication committee should be involved.	[Barry, Sarah J. E.; Kean, Sharon; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Dinnett, Eleanor] Greater Glasgow & Clyde Hlth Board, R&D Dept, Glasgow, Lanark, Scotland; [Gaw, Allan] Queens Univ Belfast, Wellcome Trust Wolfson Clin Res Facil, Belfast, Antrim, North Ireland	University of Glasgow; Queens University Belfast	Barry, SJE (corresponding author), Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland.	sarah.barry@glasgow.ac.uk	Ford, Ian/ABE-6145-2020	Barry, Sarah J.E./0000-0003-3039-8729	Wellcome Trust through the Scottish Health Informatics Programme (SHIP) [WT086113]	Wellcome Trust through the Scottish Health Informatics Programme (SHIP)	This work was supported by the Wellcome Trust through the Scottish Health Informatics Programme (SHIP) Grant (Ref WT086113). SHIP is a collaboration between the Universities of Aberdeen, Dundee, Edinburgh, Glasgow and St Andrews and the Information Services Division of NHS Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle PJ, 2009, INT J EPIDEMIOL, V38, P385, DOI 10.1093/ije/dyn087; Clemens Tom, 2009, Health Stat Q, P7; DALE A, 1993, ENVIRON PLANN A, V25, P1387, DOI 10.1068/a251387; Ford I, 1995, J CLIN EPIDEMIOL, V48, P1441; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Hamer M, 2010, ARCH GEN PSYCHIAT, V67, P850, DOI 10.1001/archgenpsychiatry.2010.76; Lawder R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-330; LORD I, 1992, J CLIN EPIDEMIOL, V45, P849, DOI 10.1016/0895-4356(92)90068-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; van Ham M, 2010, J ECON GEOGR, V10, P257, DOI 10.1093/jeg/lbp017	11	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75379	10.1371/journal.pone.0075379	http://dx.doi.org/10.1371/journal.pone.0075379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058681	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324408400113
J	Carless, MA; Kulkarni, H; Kos, MZ; Charlesworth, J; Peralta, JM; Goring, HHH; Curran, JE; Almasy, L; Dyer, TD; Comuzzie, AG; Mahaney, MC; Blangero, J				Carless, Melanie A.; Kulkarni, Hemant; Kos, Mark Z.; Charlesworth, Jac; Peralta, Juan M.; Goering, Harald H. H.; Curran, Joanne E.; Almasy, Laura; Dyer, Thomas D.; Comuzzie, Anthony G.; Mahaney, Michael C.; Blangero, John			Genetic Effects on DNA Methylation and Its Potential Relevance for Obesity in Mexican Americans	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; ADIPOSE-TISSUE; BODY-FAT; EXPRESSION; ADIPOCYTES; MUTATION; DISEASE; BLOOD; AGE; HYPERMETHYLATION	Several studies have identified effects of genetic variation on DNA methylation patterns and associated heritability, with research primarily focused on Caucasian individuals. In this paper, we examine the evidence for genetic effects on DNA methylation in a Mexican American cohort, a population burdened by a high prevalence of obesity. Using an Illumina-based platform and following stringent quality control procedures, we assessed a total of 395 CpG sites in peripheral blood samples obtained from 183 Mexican American individuals for evidence of heritability, proximal genetic regulation and association with age, sex and obesity measures (i.e. waist circumference and body mass index). We identified 16 CpG sites (similar to 4%) that were significantly heritable after Bonferroni correction for multiple testing and 27 CpG sites (similar to 6.9%) that showed evidence of genetic effects. Six CpG sites (similar to 2%) were associated with age, primarily exhibiting positive relationships, including CpG sites in two genes that have been implicated in previous genome-wide methylation studies of age (FZD9 and MYOD1). In addition, we identified significant associations between three CpG sites (similar to 1%) and sex, including DNA methylation in CASP6, a gene that may respond to estradiol treatment, and in HSD17B12, which encodes a sex steroid hormone. Although we did not identify any significant associations between DNA methylation and the obesity measures, several nominally significant results were observed in genes related to adipogenesis, obesity, energy homeostasis and glucose homeostasis (ARHGAP9, CDKN2A, FRZB, HOXA5, JAK3, MEST, NPY, PEG3 and SMARCB1). In conclusion, we were able to replicate several findings from previous studies in our Mexican American cohort, supporting an important role for genetic effects on DNA methylation. In addition, we found a significant influence of age and sex on DNA methylation, and report on trend-level, novel associations between DNA methylation and measures of obesity.	[Carless, Melanie A.; Kulkarni, Hemant; Kos, Mark Z.; Charlesworth, Jac; Peralta, Juan M.; Goering, Harald H. H.; Curran, Joanne E.; Almasy, Laura; Dyer, Thomas D.; Comuzzie, Anthony G.; Mahaney, Michael C.; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Charlesworth, Jac] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia	Texas Biomedical Research Institute; University of Tasmania	Carless, MA (corresponding author), Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA.	mcarless@txbiomedgenetics.org	Kulkarni, Hemant/AEM-5750-2022; Charlesworth, Jac/J-7661-2014; Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019	Charlesworth, Jac/0000-0001-6201-3518; Curran, Joanne/0000-0002-6898-155X; Peralta, Juan Manuel/0000-0002-8811-5579; Carless, Melanie/0000-0001-8350-2302	SEMP RUSS fund of the San Antonio Area Foundation; NIDDK [DK087749]; NIMH [MH0708143, MH078111, MH083824, MH59490]; NHLBI [HL045522]; Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health [C06 RR017515]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029392] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490, R01MH078111, R01MH083824] Funding Source: NIH RePORTER	SEMP RUSS fund of the San Antonio Area Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support for this study was provided by the SEMP RUSS fund of the San Antonio Area Foundation and the NIDDK (DK087749). SNP genotyping and SOLAR is supported by NIMH (MH0708143, MH078111 MH083824, MH59490). Collection of family data and blood samples in the San Antonio Family Heart Study was supported by a NHLBI program project grant (HL045522). This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program Grant Number C06 RR017515 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Blangero J, 2005, HUM BIOL, V77, P541, DOI 10.1353/hub.2006.0003; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Boraska V, 2012, HUM MOL GENET, V21, P4805, DOI 10.1093/hmg/dds304; Breton CV, 2011, EPIGENETICS-US, V6, P895, DOI 10.4161/epi.6.7.15768; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Chen Y.A., 2013, EPIGENETICS, V8; Chen YA, 2011, GENOMICS, V97, P214, DOI 10.1016/j.ygeno.2010.12.004; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Davis S, 2010, METHYLUMI HANDLE ILL; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; El Hajj N, 2012, DIABETES; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Haas BE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-61; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Hu ED, 1998, BIOCHEM BIOPH RES CO, V247, P287, DOI 10.1006/bbrc.1998.8784; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Jannot AS, 2012, EUR J HUM GENET, V20, P917, DOI 10.1038/ejhg.2012.35; Jiang MH, 2008, DIABETOLOGIA, V51, P1525, DOI 10.1007/s00125-008-1034-8; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Karastergiou K, 2013, J CLIN ENDOCR METAB, V98, P362, DOI 10.1210/jc.2012-2953; Kim J, 2007, BBA-MOL BASIS DIS, V1772, P72, DOI 10.1016/j.bbadis.2006.10.004; Kobayashi H, 2013, GENOME RES; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Leblanc Valerie, 2003, Reprod Biol Endocrinol, V1, P59, DOI 10.1186/1477-7827-1-59; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Lohner S, 2013, ANN NUTR METAB, V62, P98, DOI 10.1159/000345599; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Millington GWM, 2008, PHARMACOGENOMICS, V9, P1835, DOI 10.2217/14622416.9.12.1835; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Moss TJ, 2007, MUTAT RES-FUND MOL M, V618, P163, DOI 10.1016/j.mrfmmm.2006.05.038; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Park SY, 2007, J KOREAN MED SCI, V22, P311, DOI 10.3346/jkms.2007.22.2.311; Quon G, 2013, NUCLEIC ACIDS RES, V41, P2095, DOI 10.1093/nar/gks1449; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Romero CX, 2012, ADV PREV MED, V172423; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Shao WJ, 2008, COMPARATIVE MED, V58, P341; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Sobel E, 1996, AM J HUM GENET, V58, P1323; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tiesjema B, 2009, OBESITY, V17, P1448, DOI 10.1038/oby.2008.670; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	77	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73950	10.1371/journal.pone.0073950	http://dx.doi.org/10.1371/journal.pone.0073950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058506	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400045
J	Fillenbaum, GG; Blay, SL; Pieper, CF; King, KE; Andreoli, SB; Gastal, FL				Fillenbaum, Gerda G.; Blay, Sergio L.; Pieper, Carl F.; King, Katherine E.; Andreoli, Sergio B.; Gastal, Fabio L.			The Association of Health and Income in the Elderly: Experience from a Southern State of Brazil	PLOS ONE			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC-STATUS; ETHNIC-DIFFERENCES; FUNCTIONAL STATUS; AMERICAN ADULTS; LATIN-AMERICA; OLDER-ADULTS; LIFE-COURSE; INEQUALITIES; PREVALENCE	Objectives: In high income, developed countries, health status tends to improve as income increases, but primarily through the 50th-66th percentile of income. It is unclear whether the same limitation holds in middle income countries, and for both general assessments of health and specific conditions. Methods: Data were obtained from Brazil, a middle income country. In-person interviews with a representative sample of community residents age >= 60 (N=6963), in the southern state of Rio Grande do Sul, obtained information on demographic characteristics including household income and number of persons supported, general health status (self-rated health, functional status), depression, and seven physician-diagnosed, self-reported health conditions. Analyses used household income (adjusted for number supported and economies of scale) together with higher order income terms, and controlled for demographics and comorbidities, to ascertain nonlinearity between income and general and specific health measures. Results: In fully controlled analyses income was associated with general measures of health (linearly with self-rated health, nonlinearly with functional status). For specific health measures there was a consistent linear association with depression, pulmonary disorders, renal disorders, and sensory impairment. For musculoskeletal, cardiovascular (negative association), and gastrointestinal disorders this association no longer held when comorbidities were controlled. There was no association with diabetes. Conclusion: Contrary to findings in high income countries, the association of household-size-adjusted income with health was generally linear, sometimes negative, and sometimes absent when comorbidities were controlled.	[Fillenbaum, Gerda G.; Pieper, Carl F.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Fillenbaum, Gerda G.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA; [Blay, Sergio L.; Andreoli, Sergio B.] Univ Fed Sao Paulo, Dept Psychiat, Brazil Escola Paulista Med UNIFESP, Sao Paulo, Brazil; [Pieper, Carl F.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [King, Katherine E.] Duke Univ, Dept Sociol, Durham, NC 27706 USA; [Gastal, Fabio L.] Sistema Saude Mae Deus, Project Sci Comm, Porto Alegre, RS, Brazil	Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Universidade Federal de Sao Paulo (UNIFESP); Duke University; Duke University	Blay, SL (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, Brazil Escola Paulista Med UNIFESP, Sao Paulo, Brazil.	blay@uol.com.br	Andreoli, Sergio Baxter/D-9568-2012; Andreoli, Sergio Baxter/M-7112-2019	Andreoli, Sergio Baxter/0000-0002-1976-0881; Andreoli, Sergio Baxter/0000-0002-1976-0881; King, Katherine/0000-0001-8615-1894; Gastal, Fabio/0000-0002-1016-3263; Pieper, Carl/0000-0003-4809-1725	Conselho Estadual do Idoso, Secretaria do Trabalho, Cidadania e Assistencia Social; Governo do Estado do Rio Grande do Sul, National Council for Scientific and Technological Development [CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico]; NATIONAL INSTITUTE ON AGING [P30AG028716, T32AG000029] Funding Source: NIH RePORTER	Conselho Estadual do Idoso, Secretaria do Trabalho, Cidadania e Assistencia Social; Governo do Estado do Rio Grande do Sul, National Council for Scientific and Technological Development [CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Conselho Estadual do Idoso, Secretaria do Trabalho, Cidadania e Assistencia Social; Governo do Estado do Rio Grande do Sul, National Council for Scientific and Technological Development [CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to SLB], research grant [Bolsista de Produtividade em Pesquisa: 300235/2008-9, 306156/2011-3 to SLB], National Institute on Aging [grant numbers 1P30 AG028716 Claude D. Pepper OAIC to GGF and CFP, and 2T32 AG000029-35 to KEK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Barcelo A, 2006, J AGING HEALTH, V18, P224, DOI 10.1177/0898264305285728; Blay SL, 2007, AM J GERIAT PSYCHIAT, V15, P790, DOI 10.1097/JGP.0b013e3180654179; BLAY SL, 1988, J AM GERIATR SOC, V36, P687, DOI 10.1111/j.1532-5415.1988.tb07169.x; Brennan SL, 2009, OSTEOPOROSIS INT, V20, P1487, DOI 10.1007/s00198-008-0822-9; Carvalhais SMM, 2008, INT J SOC PSYCHIATR, V54, P447, DOI 10.1177/0020764008090792; Crimmins EM, 2009, J GERONTOL A-BIOL, V64, P286, DOI 10.1093/gerona/gln010; de Souza Ferreira PHG, 2012, 87 IPCIG; Dowd JB, 2007, INT J EPIDEMIOL, V36, P1214, DOI 10.1093/ije/dym214; Lima-Costa MF, 2012, AM J PUBLIC HEALTH, V102, P1535, DOI 10.2105/AJPH.2012.300765; Fillenbaum GG, 2010, J AGING HEALTH, V22, P362, DOI 10.1177/0898264309359307; Fleischer NL, 2008, J URBAN HEALTH, V85, P923, DOI 10.1007/s11524-008-9319-2; da Costa LMFC, 2008, BRAZ J INFECT DIS, V12, P24, DOI 10.1590/S1413-86702008000100007; Guerra RO, 2008, AGING CLIN EXP RES, V20, P53; Herd P, 2007, J HEALTH SOC BEHAV, V48, P223, DOI 10.1177/002214650704800302; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; HOUSE JS, 1990, MILBANK Q, V68, P383, DOI 10.2307/3350111; HOUSE JS, 1992, SOC STRUCT, P1; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; Kitagawa E.M., 1973, DIFFERENTIAL MORTALI, DOI [10.4159/harvard.9780674188471, DOI 10.4159/HARVARD.9780674188471]; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lima-Costa Maria Fernanda, 2006, Ciênc. saúde coletiva, V11, P941, DOI 10.1590/S1413-81232006000400016; Lima-Costa Maria Fernanda, 2003, Rev Panam Salud Publica, V13, P387, DOI 10.1590/S1020-49892003000500007; Lordan G, 2012, HEALTH ECON, V21, P178, DOI 10.1002/hec.1703; Machlin Steven, 2009, Med Care, V47, P618, DOI 10.1097/MLR.0b013e318195fa79; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2006, SOCIAL DETERMINANTS; Melzer D, 2004, AGE AGEING, V33, P253, DOI 10.1093/ageing/afh075; Palloni A, 2007, J CROSS-CULT GERONTO, V22, P263, DOI 10.1007/s10823-006-9001-7; Parahyba MI, 2008, CIENC SAUDE COLETIVA, V13, P1257, DOI 10.1590/S1413-81232008000400022; Parahyba MI, 2009, AM J PUBLIC HEALTH, V99, P81, DOI 10.2105/AJPH.2007.130708; Patel KV, 2006, J AGING HEALTH, V18, P315, DOI 10.1177/0898264305285653; Peis JR, 2009, VITAL HTLH STAT, V10; Ramsay SE, 2008, ANN EPIDEMIOL, V18, P896, DOI 10.1016/j.annepidem.2008.09.006; Rehkopf DH, 2010, EPIDEMIOLOGY, V21, P38, DOI 10.1097/EDE.0b013e3181c30b89; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Rogers RG., 2000, LIVING DYING US BEHA; Rosero-Bixby L, 2009, J GERONTOL B-PSYCHOL, V64, P105, DOI 10.1093/geronb/gbn004; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Singh-Manoux A, 2007, INT J EPIDEMIOL, V36, P1222, DOI 10.1093/ije/dym170; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Smith JP, 1997, DEMOGRAPHY, V34, P159, DOI 10.2307/2061665; Szwarcwald CL, 2011, AM J PUBLIC HEALTH, V101, P517, DOI 10.2105/AJPH.2010.195453; Szwarcwald Célia Landmann, 2005, Cad. Saúde Pública, V21, pS54, DOI 10.1590/S0102-311X2005000700007; Trujillo AJ, 2009, J AGING HEALTH, V21, P3, DOI 10.1177/0898264308324648; Zimmer Z, 2003, INT J EPIDEMIOL, V32, P1089, DOI 10.1093/ije/dyg254; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73930	10.1371/journal.pone.0073930	http://dx.doi.org/10.1371/journal.pone.0073930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058505	Green Submitted, gold, Green Published			2022-12-27	WOS:000324408400044
J	Mann, ZF; Chang, W; Lee, KY; King, KA; Kelley, MW				Mann, Zoe F.; Chang, Weise; Lee, Kyu Yup; King, Kelly A.; Kelley, Matthew W.			Expression and Function of Scleraxis in the Developing Auditory System	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SCLERAXIS; II COLLAGEN DISTRIBUTION; LOOP-HELIX PROTEINS; INNER-EAR; EXTRACELLULAR-MATRIX; MESSENGER-RNA; CELLULAR-DIFFERENTIATION; TECTORIAL MEMBRANE; GENE; LOCALIZATION	A study of genes expressed in the developing inner ear identified the bHLH transcription factor Scleraxis (Scx) in the developing cochlea. Previous work has demonstrated an essential role for Scx in the differentiation and development of tendons, ligaments and cells of chondrogenic lineage. Expression in the cochlea has been shown previously, however the functional role for Scx in the cochlea is unknown. Using a Scx-GFP reporter mouse line we examined the spatial and temporal patterns of Scx expression in the developing cochlea between embryonic day 13.5 and postnatal day 25. Embryonically, Scx is expressed broadly throughout the cochlear duct and surrounding mesenchyme and at postnatal ages becomes restricted to the inner hair cells and the interdental cells of the spiral limbus. Deletion of Scx results in hearing impairment indicated by elevated auditory brainstem response (ABR) thresholds and diminished distortion product otoacoustic emission (DPOAE) amplitudes, across a range of frequencies. No changes in either gross cochlear morphology or expression of the Scx target genes Col2A, Bmp4 or Sox9 were observed in Scx(-/-) mutants, suggesting that the auditory defects observed in these animals may be a result of unidentified Scx-dependent processes within the cochlea.	[Mann, Zoe F.; Chang, Weise; Kelley, Matthew W.] NIDCD, Lab Cochlear Dev, NIH, Bethesda, MD USA; [Lee, Kyu Yup] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD USA; [King, Kelly A.] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Mann, ZF (corresponding author), NIDCD, Lab Cochlear Dev, NIH, Bethesda, MD USA.	mannz@nidcd.nih.gov		Mann, Zoe/0000-0002-4916-9574	NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was fully funded and supported by the NIH intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitz E, 2003, CELL MOL NEUROBIOL, V23, P315, DOI 10.1023/A:1023636620721; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Bodet E, 2005, ACTA OTORRINOLAR ESP, V56, P139, DOI 10.1016/S0001-6519(05)78588-5; Brown D, 1999, DEVELOPMENT, V126, P4317; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P6103, DOI 10.1128/MCB.11.12.6103; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Choi JY, 2006, HEARING RES, V211, P26, DOI 10.1016/j.heares.2005.08.007; Cosgrove D, 1996, HEARING RES, V97, P54; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Cureoglu S, 2004, LARYNGOSCOPE, V114, P622, DOI 10.1097/00005537-200404000-00006; Dallos P.J., 1996, COCHLEA; Delprat B, 2005, MOL CELL BIOL, V25, P847, DOI 10.1128/MCB.25.2.847-853.2005; Dreiling FJ, 2002, HEARING RES, V166, P181, DOI 10.1016/S0378-5955(02)00313-1; Dreiling FJ, 2002, HEARING RES, V166, P166, DOI 10.1016/S0378-5955(02)00314-3; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; FRENZ DA, 1991, DEV BIOL, V144, P38, DOI 10.1016/0012-1606(91)90476-J; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Gavara N, 2010, NAT METHODS, V7, P650, DOI [10.1038/NMETH.1474, 10.1038/nmeth.1474]; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; HAYASHI M, 1988, DEVELOPMENT, V103, P27; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; ISHIBE T, 1989, LARYNGOSCOPE, V99, P547; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jung TTK, 2003, OTOL NEUROTOL, V24, P682, DOI 10.1097/00129492-200307000-00025; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kelley MW, 2007, INT J DEV BIOL, V51, P571, DOI 10.1387/ijdb.072388mk; Kelley MW, 2009, CURR OPIN OTOLARYNGO, V17, P381, DOI 10.1097/MOO.0b013e3283303347; KHETARPAL U, 1994, HEARING RES, V79, P59, DOI 10.1016/0378-5955(94)90127-9; Kikuchi K, 1965, Acta Otolaryngol, V60, P207, DOI 10.3109/00016486509127003; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kim WY, 2001, DEVELOPMENT, V128, P417; Konrad L, 2000, ENDOCRINOLOGY, V141, P3679, DOI 10.1210/en.141.10.3679; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu Y, 1996, J ENDOCRINOL, V151, P491, DOI 10.1677/joe.0.1510491; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mayne R, 1983, COLLAGENS CARTILAGE; MCPHEE JR, 1986, J EMBRYOL EXP MORPH, V97, P1; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Morsli H, 1998, J NEUROSCI, V18, P3327; Mothe AJ, 2001, HEARING RES, V155, P161, DOI 10.1016/S0378-5955(01)00246-5; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Olson EN, 1996, ANN NY ACAD SCI, V785, P108, DOI 10.1111/j.1749-6632.1996.tb56248.x; Paradies NE, 1998, MECH DEVELOP, V79, P165, DOI 10.1016/S0925-4773(98)00184-1; Poole A, 1997, TXB RHEUMATOLOGY; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Sakaguchi N, 1998, HEARING RES, V118, P114, DOI 10.1016/S0378-5955(98)00022-7; Schaffer LA, 2003, EAR HEARING; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; SLEPECKY NB, 1992, MATRIX, V12, P80, DOI 10.1016/S0934-8832(11)80108-3; SPICER SS, 1990, HEARING RES, V43, P205, DOI 10.1016/0378-5955(90)90229-I; Spicer SS, 1997, HEARING RES, V111, P93, DOI 10.1016/S0378-5955(97)00097-X; SWANN DA, 1972, INVEST OPHTH VISUAL, V11, P735; THALMANN I, 1987, LARYNGOSCOPE, V97, P357; THALMANN I, 1986, ORL J OTO-RHINO-LARY, V48, P107, DOI 10.1159/000275855; Trowe MO, 2010, DEV BIOL, V342, P51, DOI 10.1016/j.ydbio.2010.03.014; Tsuprun V, 1999, HEARING RES, V129, P35, DOI 10.1016/S0378-5955(98)00219-6; Tsuprun V, 2001, HEARING RES, V157, P65, DOI 10.1016/S0378-5955(01)00278-7; VANDEWATER TR, 1987, HEARING RES, V30, P39, DOI 10.1016/0378-5955(87)90181-X; Wang LY, 2011, JARO-J ASSOC RES OTO, V12, P407, DOI 10.1007/s10162-011-0264-5; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Weinberger DG, 1999, LARYNGOSCOPE, V109, P2001, DOI 10.1097/00005537-199912000-00020; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; YOO TJ, 1988, LARYNGOSCOPE, V98, P1255	76	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75521	10.1371/journal.pone.0075521	http://dx.doi.org/10.1371/journal.pone.0075521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058692	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400117
J	Tangena, JAA; Adiamoh, M; D'Alessandro, U; Jarju, L; Jawara, M; Jeffries, D; Malik, N; Nwakanma, D; Kaur, H; Takken, W; Lindsay, SW; Pinder, M				Tangena, Julie-Anne A.; Adiamoh, Majidah; D'Alessandro, Umberto; Jarju, Lamin; Jawara, Musa; Jeffries, David; Malik, Naiela; Nwakanma, Davis; Kaur, Harparkash; Takken, Willem; Lindsay, Steve W.; Pinder, Margaret			Alternative Treatments for Indoor Residual Spraying for Malaria Control in a Village with Pyrethroid- and DDT-Resistant Vectors in The Gambia	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; PIRIMIPHOS-METHYL; MOLECULAR-FORMS; AREA; SUSCEPTIBILITY; PROTECTION; BENDIOCARB; MUTATIONS; COMPLEX	Background: Malaria vector control is threatened by resistance to pyrethroids, the only class of insecticides used for treating bed nets. The second major vector control method is indoor residual spraying with pyrethroids or the organochloride DDT. However, resistance to pyrethroids frequently confers resistance to DDT. Therefore, alternative insecticides are urgently needed. Methodology/Principal Findings: Insecticide resistance and the efficacy of indoor residual spraying with different insecticides was determined in a Gambian village. Resistance of local vectors to pyrethroids and DDT was high (31% and 46% mortality, respectively) while resistance to bendiocarb and pirimiphos methyl was low (88% and 100% mortality, respectively). The vectors were predominantly Anopheles gambiae s.s. with 94% of them having the putative resistant genotype kdr 1014F. Four groups of eight residential compounds were each sprayed with either (1) bendiocarb, a carbamate, (2) DDT, an organochlorine, (3) microencapsulated pirimiphos methyl, an organophosphate, or (4) left unsprayed. All insecticides tested showed high residual activity up to five months after application. Mosquito house entry, estimated by light traps, was similar in all houses with metal roofs, but was significantly less in IRS houses with thatched roofs (p=0.02). Residents participating in focus group discussions indicated that IRS was considered a necessary nuisance and also may decrease the use of long-lasting insecticidal nets. Conclusion/Significance: Bendiocarb and microencapsulated pirimiphos methyl are viable alternatives for indoor residual spraying where resistance to pyrethroids and DDT is high and may assist in the management of pyrethroid resistance.	[Tangena, Julie-Anne A.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Eh Wageningen, Netherlands; [Tangena, Julie-Anne A.] Inst Pasteur Laos, Viangchan, Laos; [Adiamoh, Majidah; D'Alessandro, Umberto; Jawara, Musa; Jeffries, David; Nwakanma, Davis; Pinder, Margaret] MRC Unit, Banjul, Gambia; [D'Alessandro, Umberto] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium; [Jarju, Lamin] Natl Malaria Control Programme, Kanifing, Gambia; [Malik, Naiela; Kaur, Harparkash; Lindsay, Steve W.; Pinder, Margaret] London Sch Hyg & Trop Med, London WC1, England; [Tangena, Julie-Anne A.; Lindsay, Steve W.; Pinder, Margaret] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Wageningen University & Research; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; Durham University	Pinder, M (corresponding author), MRC Unit, Banjul, Gambia.	mpinder@mrc.gm	Pinder, Margaret/AAQ-7129-2020; Tangena, Julie-Anne/L-1053-2019; D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Nwakanma, Davis/0000-0002-6706-6069; Tangena, Julie-Anne/0000-0002-8188-4498; Lindsay, Steve/0000-0002-3461-9050	MRC, United Kingdom [MRC GO900220]; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health, Medical Research Council, UK; Medical Research Council [MC_UP_A900_1119, G0900220, MC_UP_A900_1117] Funding Source: researchfish; MRC [MC_UP_A900_1119, MC_UP_A900_1117, G0900220] Funding Source: UKRI	MRC, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health, Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was financed by the MRC, United Kingdom (www.mrc.ac.uk Grant Reference Number: MRC GO900220) to SWL. SWL received support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security, and Fogarty International Center, National Institutes of Health, Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; ANTHONY N, 1995, FEBS LETT, V368, P461, DOI 10.1016/0014-5793(95)00711-H; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187; Bradley J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-242; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Clarke S, 2001, THESIS COPENHAGEN, P162; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Dabire K, 2012, INSECTICIDES PEST EN; DAS M, 1987, MED VET ENTOMOL, V1, P289, DOI 10.1111/j.1365-2915.1987.tb00357.x; Dawson S., 1993, MANUAL USE FOCUS GRO; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fuseini G, 2011, J MED ENTOMOL, V48, P437, DOI 10.1603/ME09286; GILLIES M. T., 1968, The Anophelinae of Africa south of the Sahara (Ethiopian Zoogeographical Region).; Gillies MT, 1987, PUBL S AFR I MED RES, V55, P1; Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x; HEMINGWAY J, 1995, B ENTOMOL RES, V85, P229, DOI 10.1017/S0007485300034301; Kirby MJ, 2010, AM J TROP MED HYG, V83, P965, DOI 10.4269/ajtmh.2010.10-0311; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; KRUSE C. W., 1950, INDIAN JOUR MALARIOL, V4, P267; Maharaj R, 2004, J MED ENTOMOL, V41, P130, DOI 10.1603/0022-2585-41.1.130; Ndiath MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031943; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; WHO, 2006, GUIDELINES TESTING M; WHO, 2012, GLOBAL PLAN INSECTIC; WHO, 2012, WHO GLOB MAL PROGR, P30; World Health Organization, 2006, PEST THEIR APPL CONT	35	30	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74351	10.1371/journal.pone.0074351	http://dx.doi.org/10.1371/journal.pone.0074351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058551	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000324408400066
J	Vuppalanchi, R; Liang, TB; Goswami, CP; Nalamasu, R; Li, L; Jones, D; Wei, RR; Liu, WQ; Sarasani, V; Janga, SC; Chalasani, N				Vuppalanchi, Raj; Liang, Tiebing; Goswami, Chirayu Pankaj; Nalamasu, Rohit; Li, Lang; Jones, David; Wei, Rongrong; Liu, Wanqing; Sarasani, Vishal; Janga, Sarath Chandra; Chalasani, Naga			Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; HUMAN LIVER-MICROSOMES; NUCLEAR FACTOR 4-ALPHA; CYP3A4 GENE; IN-VITRO; DISEASE; PHARMACOKINETICS; IDENTIFICATION; DETERMINANT; ENZYMES	Background and Aim: Liver cirrhosis is associated with decreased hepatic cytochrome P4503A (CYP3A) activity but the pathogenesis of this phenomenon is not well elucidated. In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis. Methods: Hepatic CYP3A activity and miRNA microarray expression profiles were measured in cirrhotic (n=28) and normal (n=12) liver tissue. Hepatic CYP3A activity was measured via midazolam hydroxylation in human liver microsomes. Additionally, hepatic CYP3A4 protein concentration and the expression of CYP3A4 mRNA were measured. Analyses were conducted to identify miRNAs which were differentially expressed between two groups but also were significantly associated with lower hepatic CYP3A activity. Results: Hepatic CYP3A activity in cirrhotic livers was 1.7-fold lower than in the normal livers (0.28 +/- 0.06 vs. 0.47 +/- 0.07 mL(star)min(-1 star)mg protein(-1) (mean +/- SEM), P=0.02). Six microRNAs (miR-155, miR-454, miR-582-5p, let-7f-1(star), miR-181d, and miR-500) had >1.2-fold increase in cirrhotic livers and also had significant negative correlation with hepatic CYP3A activity (range of r = -0.44 to -0.52, P < 0.05). Notably, miR-155, a known regulator of liver inflammation, had the highest fold increase in cirrhotic livers (2.2-fold, P=4.16E-08) and significantly correlated with hepatic CYP3A activity (r=-0.50, P=0.017). The relative expression (2(-Delta Delta Ct) mean +/- SEM) of hepatic CYP3A4 mRNA was significantly higher in cirrhotic livers (21.76 +/- 2.65 vs. 5.91 +/- 1.29, P=2.04E-07) but their levels did not significantly correlate with hepatic CYP3A activity (r=-0.43, P=0.08). Conclusion: The strong association between certain miRNAs, notably miR-155, and lower hepatic CYP3A activity suggest that altered miRNA expression may regulate hepatic CYP3A activity.	[Vuppalanchi, Raj; Liang, Tiebing; Nalamasu, Rohit; Jones, David; Chalasani, Naga] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Goswami, Chirayu Pankaj; Li, Lang; Sarasani, Vishal; Janga, Sarath Chandra] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Wei, Rongrong; Liu, Wanqing] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chalasani, N (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	nchalasa@iu.edu	Vuppalanchi, Raj/AAI-2481-2021; Sarsani, Vishal/AAF-9312-2020; Vuppalanchi, Raj/AAI-2482-2021	Vuppalanchi, Raj/0000-0003-0637-1577; Sarsani, Vishal/0000-0002-9272-3438; Vuppalanchi, Raj/0000-0003-0637-1577; Liang, Tiebing/0000-0002-8445-3765; Liu, Wanqing/0000-0001-7727-6900; Janga, Sarath Chandra/0000-0001-7351-6268	American Recovery and Reinvestment Act of 2009 (ARRA) [3K24DK069290-05S1]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK069290] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act of 2009 (ARRA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Administrative supplements awarded under the American Recovery and Reinvestment Act of 2009 (ARRA) for 3K24DK069290-05S1 to Dr. Chalasani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2000, BIOINFORMATICS, V16, P743, DOI 10.1093/bioinformatics/16.8.743; Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Chalasani N, 2001, HEPATOLOGY, V34, P1103, DOI 10.1053/jhep.2001.29306; Elbekai RH, 2004, CURR DRUG METAB, V5, P157, DOI 10.2174/1389200043489054; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frye RF, 2006, CLIN PHARMACOL THER, V80, P235, DOI 10.1016/j.clpt.2006.05.006; GEORGE J, 1995, BIOCHEM PHARMACOL, V49, P873, DOI 10.1016/0006-2952(94)00515-N; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; GORSKI JC, 1994, BIOCHEM PHARMACOL, V48, P173, DOI 10.1016/0006-2952(94)90237-2; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; IQBAL S, 1990, J HEPATOL, V11, P37, DOI 10.1016/0168-8278(90)90269-W; Kacevska M, 2012, BIOCHIMIE, V94, P2338, DOI 10.1016/j.biochi.2012.07.013; Klein K, 2012, CLIN PHARMACOL THER, V91, P1044, DOI 10.1038/clpt.2011.336; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Liang TB, 2004, ALCOHOL CLIN EXP RES, V28, P1622, DOI 10.1097/01.ALC.0000145686.79141.57; Liang TB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r11; Liu FJ, 2008, BIOCHEM J, V409, P243, DOI 10.1042/BJ20070613; LOWN K, 1992, CLIN PHARMACOL THER, V51, P229, DOI 10.1038/clpt.1992.17; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; MORGAN DJ, 1995, CLIN PHARMACOKINET, V29, P370, DOI 10.2165/00003088-199529050-00005; Nakajima M, 2011, PHARMACOL THERAPEUT, V131, P330, DOI 10.1016/j.pharmthera.2011.04.009; Pan YZ, 2009, DRUG METAB DISPOS, V37, P2112, DOI 10.1124/dmd.109.027680; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Ramamoorthy A, 2012, DRUG METAB DISPOS, V40, P726, DOI 10.1124/dmd.111.040329; Ramamoorthy Anuradha, 2011, Drug Metab Lett, V5, P126; Rodighiero V, 1999, CLIN PHARMACOKINET, V37, P399, DOI 10.2165/00003088-199937050-00004; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Toriyabe T, 2009, MOL PHARMACOL, V75, P677, DOI 10.1124/mol.108.050575; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030560; Wang ZY, 2013, BBA-GENE REGUL MECH, V1829, P436, DOI 10.1016/j.bbagrm.2012.12.009; Westlind-Johnsson A, 2003, DRUG METAB DISPOS, V31, P755, DOI 10.1124/dmd.31.6.755; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Wrighton SA, 2000, DRUG METAB REV, V32, P339, DOI 10.1081/DMR-100102338; Yang LQ, 2003, WORLD J GASTROENTERO, V9, P359, DOI 10.3748/wjg.v9.i2.359; Zhang SY, 2012, MOL PHARMACOL, V82, P529, DOI 10.1124/mol.112.078386	48	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74471	10.1371/journal.pone.0074471	http://dx.doi.org/10.1371/journal.pone.0074471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058572	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400080
J	Yang, LB; Cai, XD; Zhou, JQ; Chen, SD; Chen, YS; Chen, ZY; Wang, Q; Fang, ZY; Zhou, LM				Yang, Libai; Cai, Xiaodong; Zhou, Jueqian; Chen, Shuda; Chen, Yishu; Chen, Ziyi; Wang, Qian; Fang, Ziyan; Zhou, Liemin			STE20/SPS1-Related Proline/Alanine-Rich Kinase Is Involved in Plasticity of GABA Signaling Function in a Mouse Model of Acquired Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PILOCARPINE MODEL; CL-COTRANSPORTER; INTRACELLULAR CHLORIDE; NKCC1 FUNCTION; SPAK; STRESS; KCC2; PHOSPHORYLATION; HIPPOCAMPUS	The intracellular concentration of chloride ([Cl-](i)) determines the strength and polarity of GABA neurotransmission. STE20/SPS1-related proline/alanine-rich kinase (SPAK) is known as an indirect regulator of [Cl-](i) for its activation of Na-K-2 Cl-co-transporters (NKCC) and inhibition of K-Cl(-)co-transporters (KCC) in many organs. NKCC1 or KCC2 expression changes have been demonstrated previously in the hippocampal neurons of mice with pilocarpine-induced status epilepticus (PISE). However, it remains unclear whether SPAK modulates [Cl-](i) via NKCC1 or KCC2 in the brain. Also, there are no data clearly characterizing SPAK expression in cortical or hippocampal neurons or confirming an association between SPAK and epilepsy. In the present study, we examined SPAK expression and co-expression with NKCC1 and KCC2 in the hippocampal neurons of mice with PISE, and we investigated alterations in SPAK expression in the hippocampus of such mice. Significant increases in SPAK mRNA and protein levels were detected during various stages of PISE in the PISE mice in comparison to levels in age-matched sham (control) and blank treatment (control) mice. SPAK and NKCC1 expression increased in vitro, while KCC2 was down-regulated in hippocampal neurons following hypoxic conditioning. However, SPAK overexpression did not influence the expression levels of NKCC1 or KCC2. Using co-immunoprecipitation, we determined that the intensity of interaction between SPAK and NKCC1 and between SPAK and KCC2 increased markedly after oxygen-deprivation, whereas SPAK overexpression strengthened the relationships. The [Cl-](i) of hippocampal neurons changed in a corresponding manner under the different conditions. Our data suggests that SPAK is involved in the plasticity of GABA signaling function in acquired epilepsy via adjustment of [Cl-](i) in hippocampal neurons.	[Yang, Libai; Cai, Xiaodong; Zhou, Jueqian; Chen, Shuda; Chen, Yishu; Chen, Ziyi; Wang, Qian; Fang, Ziyan; Zhou, Liemin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Libai] Shanxi Acad Med Sci, Dept Neurol, Taiyuan, Shanxi, Peoples R China; [Yang, Libai] Shanxi Dayi Hosp, Taiyuan, Shanxi, Peoples R China; [Cai, Xiaodong] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lmzhou56@163.com			National Natural Science Foundation of China [81071050]; Science and Technology Foundation of Guangdong Province [2008B060600063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guangdong Province	This study was supported by the National Natural Science Foundation of China (No. 81071050, http://www.nsfc.gov.cn/Portal0/default152.htm) and the Science and Technology Foundation of Guangdong Province No. 2008B060600063, http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Benini R, 2011, HIPPOCAMPUS, V21, P702, DOI 10.1002/hipo.20785; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Chen ZY, 2009, BRAIN RES, V1270, P112, DOI 10.1016/j.brainres.2009.03.012; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; ENGBLOM AC, 1993, BIOCHIM BIOPHYS ACTA, V1153, P262, DOI 10.1016/0005-2736(93)90414-U; Flatman PW, 2008, CURR OPIN NEPHROL HY, V17, P186, DOI 10.1097/MNH.0b013e3282f5244e; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Gagnon KB, 2010, J PHYSIOL-LONDON, V588, P3385, DOI 10.1113/jphysiol.2010.191932; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Gagnon KB, 2010, J BIOL CHEM, V285, P14115, DOI 10.1074/jbc.M110.112672; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Huang YS, 2007, METHOD ENZYMOL, V431, P143, DOI 10.1016/S0076-6879(07)31008-2; Huberfeld G, 2008, NEUROCHIRURGIE, V54, P148, DOI 10.1016/j.neuchi.2008.02.004; Irie T, 1998, BRAIN RES, V806, P246, DOI 10.1016/S0006-8993(98)00700-8; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Li XB, 2008, BRAIN RES, V1221, P141, DOI 10.1016/j.brainres.2008.04.047; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher Wolfgang, 2002, Novartis Found Symp, V243, P149; Mathew J, 2011, NEUROCHEM RES, V36, P7, DOI 10.1007/s11064-010-0253-9; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; Smith L, 2008, J BIOL CHEM, V283, P22147, DOI 10.1074/jbc.M801752200; Vallon V, 2008, KIDNEY INT, V74, P1373, DOI 10.1038/ki.2008.477; Viitanen T, 2010, J PHYSIOL-LONDON, V588, P1527, DOI 10.1113/jphysiol.2009.181826; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Xu JH, 2010, NEUROPATH APPL NEURO, V36, P71, DOI 10.1111/j.1365-2990.2009.01044.x; Zhang S, 2009, J NEUROSCI RES, V87, P1135, DOI 10.1002/jnr.21941; Zhang YS, 2011, J CEREBR BLOOD F MET, V31, P572, DOI 10.1038/jcbfm.2010.127; Zhao J, 2012, BRAIN RES, V1447, P1, DOI 10.1016/j.brainres.2012.01.059; Zhu Y, 2010, NEUROGASTROENT MOTIL, V22, P704, DOI 10.1111/j.1365-2982.2010.01501.x	53	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74614	10.1371/journal.pone.0074614	http://dx.doi.org/10.1371/journal.pone.0074614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058604	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400089
J	Blom, H; Ronnlund, D; Scott, L; Westin, L; Widengren, J; Aperia, A; Brismar, H				Blom, Hans; Ronnlund, Daniel; Scott, Lena; Westin, Linda; Widengren, Jerker; Aperia, Anita; Brismar, Hjalmar			Spatial Distribution of DARPP-32 in Dendritic Spines	PLOS ONE			English	Article							DOPAMINE D1 RECEPTORS; REGULATED PHOSPHOPROTEIN; COLOCALIZATION; LOCALIZATION; NEURONS; INTEGRATOR; D-1	The phosphoprotein DARPP-32 (dopamine and cyclic adenosine 3', 5'-monophosphate-regulated phosphoprotein, 32 kDa) is an important component in the molecular regulation of postsynaptic signaling in neostriatum. Despite the importance of this phosphoprotein, there is as yet little known about the nanoscale distribution of DARPP-32. In this study we applied superresolution stimulated emission depletion microscopy (STED) to assess the expression and distribution of DARPP-32 in striatal neurons. Primary culture of striatal neurons were immunofluorescently labeled for DARPP-32 with Alexa-594 and for the dopamine D1 receptor (D1R) with atto-647N. Dual-color STED microscopy revealed discrete localizations of DARPP-32 and D1R in the spine structure, with clustered distributions in both head and neck. Dissected spine structures reveal that the DARPP-32 signal rarely overlapped with the D1R signal. The D1R receptor is positioned in an "aggregated" manner primarily in the spine head and to some extent in the neck, while DARPP-32 forms several neighboring small nanoclusters spanning the whole spine structure. The DARPP-32 clusters have a mean size of 52 +/- 6 nm, which is close to the resolution limit of the microscope and corresponds to the physical size of a few individual phosphoprotein immunocomplexes. Dissection of synaptic proteins using superresolution microscopy gives possibilities to reveal in better detail biologically relevant information, as compared to diffraction-limited microscopy. In this work, the dissected postsynaptic topology of the DARPP-32 phosphoprotein provides strong evidence for a compartmentalized and confined distribution in dendritic spines. The protein topology and the relatively low copy number of phosphoprotein provides a conception of DARPP-32's possibilities to fine-tune the regulation of synaptic signaling, which should have an impact on the performance of the neuronal circuits in which it is expressed.	[Blom, Hans; Scott, Lena; Westin, Linda; Widengren, Jerker; Aperia, Anita; Brismar, Hjalmar] Sci Life Lab, Stockholm, Sweden; [Blom, Hans; Ronnlund, Daniel; Widengren, Jerker; Brismar, Hjalmar] Royal Inst Technol, Dept Appl Phys, Stockholm, Sweden; [Scott, Lena; Westin, Linda; Aperia, Anita; Brismar, Hjalmar] Dept Womens & Childrens Hlth, Solna, Sweden	Royal Institute of Technology	Brismar, H (corresponding author), Sci Life Lab, Stockholm, Sweden.	brismar@kth.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Widengren, Jerker/0000-0003-3200-0374	Swedish Research Council [VR-2006-3197, VR-2007-4582, VR-2010-4270]; Familjen Erling-Perssons Stiftelse; Marta och Gunnar V. Philipson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Familjen Erling-Perssons Stiftelse; Marta och Gunnar V. Philipson Foundation	This work was supported by grants from the Swedish Research Council (VR-2006-3197, VR-2007-4582, VR-2010-4270), Familjen Erling-Perssons Stiftelse, and the Marta och Gunnar V. Philipson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; Blom H, 2012, MICROSC RES TECHNIQ, V75, P220, DOI 10.1002/jemt.21046; Blom H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-16; Dani A, 2010, CURR OPIN NEUROBIOL, V20, P648, DOI 10.1016/j.conb.2010.07.006; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Glausier JR, 2010, NEUROSCIENCE, V167, P428, DOI 10.1016/j.neuroscience.2010.02.014; Gould TJ, 2012, ANNU REV BIOMED ENG, V14, P231, DOI [10.1146/annurev-bioeng-071811-150025, 10.1146/annurev.bioeng-071811-150025]; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Langley KC, 1997, NEUROSCIENCE, V78, P977, DOI 10.1016/S0306-4522(96)00583-0; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; OUIMET CC, 1992, J COMP NEUROL, V323, P209, DOI 10.1002/cne.903230206; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Penrod RD, 2011, J NEUROSCI METH, V200, P1, DOI 10.1016/j.jneumeth.2011.05.029; RAFAEL Y, 2010, DENDRITIC SPINES; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; WALAAS SI, 1984, J NEUROSCI, V4, P84; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; WILSON CJ, 1983, J NEUROSCI, V3, P383; WON L, 1989, J COMP NEUROL, V289, P165, DOI 10.1002/cne.902890114; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056	28	19	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75155	10.1371/journal.pone.0075155	http://dx.doi.org/10.1371/journal.pone.0075155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058659	Green Submitted, Green Published, gold			2022-12-27	WOS:000327538600129
J	Borzova, VA; Markossian, KA; Kara, DA; Chebotareva, NA; Makeeva, VF; Poliansky, NB; Muranov, KO; Kurganov, BI				Borzova, Vera A.; Markossian, Kira A.; Kara, Dmitriy A.; Chebotareva, Natalia A.; Makeeva, Valentina F.; Poliansky, Nikolay B.; Muranov, Konstantin O.; Kurganov, Boris I.			Quantification of Anti-Aggregation Activity of Chaperones: A Test-System Based on Dithiothreitol-Induced Aggregation of Bovine Serum Albumin	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; GLYCOGEN-PHOSPHORYLASE-B; RABBIT SKELETAL-MUSCLE; HEAT-SHOCK PROTEINS; THERMAL AGGREGATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MOLECULAR CHAPERONE; DISULFIDE BONDS; X-RAY; ANALYTICAL ULTRACENTRIFUGATION	The methodology for quantification of the anti-aggregation activity of protein and chemical chaperones has been elaborated. The applicability of this methodology was demonstrated using a test-system based on dithiothreitol-induced aggregation of bovine serum albumin at 45 degrees C as an example. Methods for calculating the initial rate of bovine serum albumin aggregation (v(agg)) have been discussed. The comparison of the dependences of v(agg) on concentrations of intact and cross-linked alpha-crystallin allowed us to make a conclusion that a non-linear character of the dependence of v(agg) on concentration of intact alpha-crystallin was due to the dynamic mobility of the quaternary structure of alpha-crystallin and polydispersity of the alpha-crystallin-target protein complexes. To characterize the anti-aggregation activity of the chemical chaperones (arginine, arginine ethyl ester, arginine amide and proline), the semi-saturation concentration [L](0.5) was used. Among the chemical chaperones studied, arginine ethyl ester and arginine amide reveal the highest anti-aggregation activity ([L](0.5) = 53 and 58 mM, respectively).	[Borzova, Vera A.; Markossian, Kira A.; Chebotareva, Natalia A.; Makeeva, Valentina F.; Kurganov, Boris I.] Russian Acad Sci, Bach Inst Biochem, Dept Mol Org Biol Struct, Moscow, Russia; [Kara, Dmitriy A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biochem, Moscow, Russia; [Poliansky, Nikolay B.; Muranov, Konstantin O.] Russian Acad Sci, Emanuel Inst Biochem Phys, Dept Chem & Biol Proc Kinet, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics	Markossian, KA (corresponding author), Russian Acad Sci, Bach Inst Biochem, Dept Mol Org Biol Struct, Moscow, Russia.	markossian@inbi.ras.ru; kurganov@inbi.ras.ru	Муранов, Константин/AAF-7887-2019; Borzova, Vera/F-4021-2017; Kurganov, Boris/M-1286-2019; Chebotareva, Natalia/X-6019-2018	Borzova, Vera/0000-0003-1544-8804; Chebotareva, Natalia/0000-0002-3505-8777; Kurganov, Boris/0000-0002-2930-2286	Russian Foundation for Basic Research [11-94-00932-a, 11-04-01271-a, 12-04-00545-a]; Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This study was funded by the Russian Foundation for Basic Research (grants 11-94-00932-a, 11-04-01271-a and 12-04-00545-a) and by the Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgar S, 2000, BIOCHEM BIOPH RES CO, V276, P619, DOI 10.1006/bbrc.2000.3518; Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; Ahmad E, 2011, BIOCHIMIE, V93, P793, DOI 10.1016/j.biochi.2010.12.012; [Anonymous], ALLOSTERIC ENZYMES K; [Anonymous], 22412 ISO; Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arora D, 1996, J BIOTECHNOL, V52, P127, DOI 10.1016/S0168-1656(96)01636-7; Augusteyn RC, 2004, EXP EYE RES, V79, P781, DOI 10.1016/j.exer.2004.08.010; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Baldwin AJ, 2012, J AM CHEM SOC, V134, P15343, DOI 10.1021/ja307874r; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bhattacharyya J, 2007, BIOCHEMISTRY-US, V46, P14682, DOI 10.1021/bi701326b; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Borwankar T, 2011, BIOCHEMISTRY-US, V50, P2048, DOI 10.1021/bi1018368; Brahma A, 2005, BBA-PROTEINS PROTEOM, V1751, P159, DOI 10.1016/j.bbapap.2005.06.007; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bumagina Z, 2010, INT J MOL SCI, V11, P4556, DOI 10.3390/ijms11114556; Bumagina ZM, 2010, BIOPHYS CHEM, V146, P108, DOI 10.1016/j.bpc.2009.11.002; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Chaiyasut C., 2001, CHROMATOGRAPHY, V22, P91; Chattopadhyay MK, 2004, J BACTERIOL, V186, P8149, DOI 10.1128/JB.186.23.8149-8152.2004; Chebotareva NA, 2009, DOKL BIOCHEM BIOPHYS, V428, P245, DOI 10.1134/S1607672909050068; CHIOU SH, 1979, INT J PEPT PROT RES, V13, P409; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; David C, 2008, BIOPOLYMERS, V89, P623, DOI 10.1002/bip.20972; DAVIDSON BE, 1967, BIOCHEM J, V104, P473, DOI 10.1042/bj1040473; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ecroyd H, 2008, FEBS J, V275, P935, DOI 10.1111/j.1742-4658.2008.06257.x; Eronina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022154; Eronina TB, 2010, BIOPOLYMERS, V93, P986, DOI 10.1002/bip.21508; Eronina TB, 2010, MACROMOL BIOSCI, V10, P768, DOI 10.1002/mabi.200900396; Eronina TB, 2009, BIOPHYS CHEM, V141, P66, DOI 10.1016/j.bpc.2008.12.007; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Fu XM, 2004, BIOCHEM BIOPH RES CO, V316, P291, DOI 10.1016/j.bbrc.2004.02.053; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gobbo J, 2011, METHODS MOL BIOL, V787, P137, DOI 10.1007/978-1-61779-295-3_11; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Hamada H, 2008, BIOTECHNOL PROGR, V24, P436, DOI 10.1021/bp070350q; HIRAYAMA K, 1990, BIOCHEM BIOPH RES CO, V173, P639, DOI 10.1016/S0006-291X(05)80083-X; HO JX, 1993, EUR J BIOCHEM, V215, P205, DOI 10.1111/j.1432-1033.1993.tb18024.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3; Jackson SE, 2013, TOP CURR CHEM, V328, P69, DOI 10.1007/128_2012_324; KATCHALSKI E, 1957, J AM CHEM SOC, V79, P4096, DOI 10.1021/ja01572a034; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Khanova HA, 2007, BIOPHYS CHEM, V125, P521, DOI 10.1016/j.bpc.2006.11.002; Kim SH, 2006, BIOCHEM CELL BIOL, V84, P30, DOI 10.1139/O05-148; Krivandin A V, 2004, Mol Biol (Mosk), V38, P532; Kumar TKS, 1998, BIOCHEM MOL BIOL INT, V46, P509; Kurganov B.I., 2005, CHEM BIOL KINETICS N, V2, P251; Kurganov BI, 1998, BIOCHEMISTRY-MOSCOW+, V63, P364; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P525, DOI 10.1023/A:1015589926728; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li Y, 2009, J PHYS CHEM B, V113, P7020, DOI 10.1021/jp8083088; Maloletkina OI, 2009, DOKL BIOCHEM BIOPHYS, V427, P199, DOI 10.1134/S1607672909040085; Maloletkina OI, 2012, BIOPHYS CHEM, V163, P11, DOI 10.1016/j.bpc.2012.02.001; Maloletkina OI, 2010, INT J BIOL MACROMOL, V46, P487, DOI 10.1016/j.ijbiomac.2010.03.008; Maloletkina OI, 2010, BIOPHYS CHEM, V148, P121, DOI 10.1016/j.bpc.2010.03.005; Markossian K. A., 2006, P89; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2010, PROTEIN J, V29, P11, DOI 10.1007/s10930-009-9217-9; Markossian KA, 2009, INT J MOL SCI, V10, P1314, DOI 10.3390/ijms10031314; Matsuoka T, 2009, BIOTECHNOL PROGR, V25, P1515, DOI 10.1002/btpr.245; Mayr C, 2000, J BIOL CHEM, V275, P34140, DOI 10.1074/jbc.M005251200; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Moriyama Y, 2008, J PHYS CHEM B, V112, P16585, DOI 10.1021/jp8067624; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Ou WB, 2002, INT J BIOCHEM CELL B, V34, P136, DOI 10.1016/S1357-2725(01)00113-3; Paris G, 2012, BIOPOLYMERS, V97, P889, DOI 10.1002/bip.22096; PETERSEN HA, 1965, J BIOL CHEM, V240, P2503; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Reddy RC, 2005, PROTEIN SCI, V14, P929, DOI 10.1110/ps.041085005; Regini JW, 2010, MOL VIS, V16, P2446; Roman SG, 2012, INT J BIOL MACROMOL, V50, P1341, DOI 10.1016/j.ijbiomac.2012.03.015; Roman SG, 2011, BIOCHEMISTRY-US, V50, P10607, DOI 10.1021/bi201030y; Sabbaghian M, 2009, INT J BIOL MACROMOL, V44, P156, DOI 10.1016/j.ijbiomac.2008.11.011; Samuel D, 2000, PROTEIN SCI, V9, P344; SCHOBERT B, 1978, BIOCHIM BIOPHYS ACTA, V541, P270, DOI 10.1016/0304-4165(78)90400-2; Scientist for Experimental Data Fitting, 1995, MICR WIND VERS 2 0; Sgarbossa A, 2008, FEBS LETT, V582, P3288, DOI 10.1016/j.febslet.2008.08.039; Shah D, 2012, BIOTECHNOL PROGR, V28, P223, DOI 10.1002/btpr.710; SHARMA KK, 1995, EXP EYE RES, V61, P413; Shiraki K, 2005, BIOTECHNOL PROGR, V21, P640, DOI 10.1021/bp049769w; Shiraki K, 2004, EUR J BIOCHEM, V271, P3242, DOI 10.1111/j.1432-1033.2004.04257.x; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; SILONOVA G V, 1969, Molekulyarnaya Biologiya (Moscow), V3, P768; SOGAMI M, 1969, BIOCHEMISTRY-US, V8, P49, DOI 10.1021/bi00829a008; Srinivas V, 2005, MOL VIS, V11, P249; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Srinivas V, 2001, MOL VIS, V7, P114; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; UEKI T, 1985, BIOPHYS CHEM, V23, P115, DOI 10.1016/0301-4622(85)80069-7; Wang CH, 2010, AIP CONF PROC, V1267, P346, DOI 10.1063/1.3482550; Wang KY, 2003, BIOPHYS CHEM, V106, P97, DOI 10.1016/S0301-4622(03)00134-0; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Xia Y, 2007, INT J BIOL MACROMOL, V40, P437, DOI 10.1016/j.ijbiomac.2006.10.004	111	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74367	10.1371/journal.pone.0074367	http://dx.doi.org/10.1371/journal.pone.0074367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058554	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600090
J	Puig, MS; Puigcerver, L; Aznar-Casanova, JA; Super, H				Sole Puig, Maria; Puigcerver, Laura; Antonio Aznar-Casanova, J.; Super, Hans			Difference in Visual Processing Assessed by Eye Vergence Movements	PLOS ONE			English	Article							FIELD DEPENDENCE-INDEPENDENCE; COGNITIVE-STYLE; COVERT ATTENTION; ZOOM LENS; MICROSACCADES; TASK; SELECTION; FIXATION; SHIFTS; GAZE	Orienting visual attention is closely linked to the oculomotor system. For example, a shift of attention is usually followed by a saccadic eye movement and can be revealed by micro saccades. Recently we reported a novel role of another type of eye movement, namely eye vergence, in orienting visual attention. Shifts in visuospatial attention are characterized by the response modulation to a selected target. However, unlike (micro-) saccades, eye vergence movements do not carry spatial information (except for depth) and are thus not specific to a particular visual location. To further understand the role of eye vergence in visual attention, we tested subjects with different perceptual styles. Perceptual style refers to the characteristic way individuals perceive environmental stimuli, and is characterized by a spatial difference (local vs. global) in perceptual processing. We tested field independent (local; FI) and field dependent (global; FD) observers in a cue/no-cue task and a matching task. We found that FI observers responded faster and had stronger modulation in eye vergence in both tasks than FD subjects. The results may suggest that eye vergence modulation may relate to the trade-off between the size of spatial region covered by attention and the processing efficiency of sensory information. Alternatively, vergence modulation may have a role in the switch in cortical state to prepare the visual system for new incoming sensory information. In conclusion, vergence eye movements may be added to the growing list of functions of fixational eye movements in visual perception. However, further studies are needed to elucidate its role.	[Sole Puig, Maria; Puigcerver, Laura; Antonio Aznar-Casanova, J.; Super, Hans] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Antonio Aznar-Casanova, J.; Super, Hans] Univ Barcelona, Inst Brain Cognit & Behav, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain.	hans.super@icrea.cat	/B-3900-2011; Aznar-Casanova, J.Antonio/Z-1011-2019; Puigcerver, Laura/I-1114-2015	/0000-0002-3084-3135; Aznar-Casanova, J.Antonio/0000-0002-3084-3135; Super, Hans/0000-0001-9328-0096; Sole Puig, Maria/0000-0002-4331-3432; Puigcerver, Laura/0000-0002-6443-5869	Spanish Ministry of Education and Science (MICINN) [PSI2010-18139, SAF2009-10367]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (PSI2010-18139 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from the Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Campos JA, 1999, PERCEPT MOTOR SKILL, V88, P236, DOI 10.2466/PMS.88.1.236-239; Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Baillargeon R, 1998, J EXP CHILD PSYCHOL, V70, P143, DOI 10.1006/jecp.1998.2452; BURTON JK, 1995, COMPUT HUM BEHAV, V11, P345, DOI 10.1016/0747-5632(95)80004-R; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; CLARK HT, 1988, PERCEPT MOTOR SKILL, V66, P303, DOI 10.2466/pms.1988.66.1.303; COLOMBO J, 1991, CHILD DEV, V62, P1247, DOI 10.2307/1130804; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; ERKELENS CJ, 1991, EXP BRAIN RES, V87, P671; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Goode PE, 2002, INT J PSYCHOPHYSIOL, V43, P123, DOI 10.1016/S0167-8760(01)00158-1; Guillot A, 2007, ADV HEALTH SCI EDUC, V12, P491, DOI 10.1007/s10459-006-9021-7; Guisande MA, 2007, PSICOTHEMA, V19, P572; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Kirchner T, 1990, ANUARO PSICOLOGIA, V46, P53; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; López Villalobos José Antonio, 2010, Clínica y Salud, V21, P93; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Milne Elizabeth, 2009, Adv Cogn Psychol, V5, P1, DOI 10.2478/v10053-008-0062-8; Miyake A, 2001, MEMORY, V9, P445, DOI 10.1080/09658210143000029; Muller NG, 2003, J NEUROSCI, V23, P3561; Zapata LP, 2013, VISION RES, V86, P15, DOI 10.1016/j.visres.2013.04.005; Rucci M, 2003, J VISION, V3, P852, DOI 10.1167/3.11.18; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052955; Super H, 2003, J NEUROSCI, V23, P3407; TINAJERO C, 1993, PERCEPT MOTOR SKILL, V77, P787, DOI 10.2466/pms.1993.77.3.787; Tsakanikos E, 2006, PERS INDIV DIFFER, V40, P579, DOI 10.1016/j.paid.2005.07.014; Witkin HA, 1981, PSYCHOL ISSUES MONOG, V51; Witkin HA, 1981, TEST FIGURAS ENMASCA	32	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e72041	10.1371/journal.pone.0072041	http://dx.doi.org/10.1371/journal.pone.0072041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223BC	24069140	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300003
J	Farhat, R; Goueslain, L; Wychowski, C; Belouzard, S; Feneant, L; Jackson, CL; Dubuisson, J; Rouille, Y				Farhat, Rayan; Goueslain, Lucie; Wychowski, Czeslaw; Belouzard, Sandrine; Feneant, Lucie; Jackson, Catherine L.; Dubuisson, Jean; Rouille, Yves			Hepatitis C Virus Replication and Golgi Function in Brefeldin A-Resistant Hepatoma-Derived Cells	PLOS ONE			English	Article							EXCHANGE FACTOR GBF1; 4-KINASE III ALPHA; SECRETORY PATHWAY; HUH-7 CELLS; PROTEIN; RNA; NS5A; IDENTIFICATION; COMPLEX; DOMAIN	Recent reports indicate that the replication of hepatitis C virus (HCV) depends on the GBF1-Arf1-COP-I pathway. We generated Huh-7-derived cell lines resistant to brefeldin A (BFA), which is an inhibitor of this pathway. The resistant cell lines could be sorted into two phenotypes regarding BFA-induced toxicity, inhibition of albumin secretion, and inhibition of HCV infection. Two cell lines were more than 100 times more resistant to BFA than the parental Huh-7 cells in these 3 assays. This resistant phenotype was correlated with the presence of a point mutation in the Sec7 domain of GBF1, which is known to impair the binding of BFA. Surprisingly, the morphology of the cis-Golgi of these cells remained sensitive to BFA at concentrations of the drug that allowed albumin secretion, indicating a dichotomy between the phenotypes of secretion and Golgi morphology. Cells of the second group were about 10 times more resistant than parental Huh-7 cells to the BFA-induced toxicity. The EC50 for albumin secretion was only 1.5-1.8 fold higher in these cells than in Huh-7 cells. However their level of secretion in the presence of inhibitory doses of BFA was 5 to 15 times higher. Despite this partially effective secretory pathway in the presence of BFA, the HCV infection was almost as sensitive to BFA as in Huh-7 cells. This suggests that the function of GBF1 in HCV replication does not simply reflect its role of regulator of the secretory pathway of the host cell. Thus, our results confirm the involvement of GBF1 in HCV replication, and suggest that GBF1 might fulfill another function, in addition to the regulation of the secretory pathway, during HCV replication.	[Farhat, Rayan; Wychowski, Czeslaw; Belouzard, Sandrine; Feneant, Lucie; Dubuisson, Jean; Rouille, Yves] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, Inserm U1019,CNRS UMR8204, Lille, France; [Goueslain, Lucie; Jackson, Catherine L.] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS UMR 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Rouille, Y (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, Inserm U1019,CNRS UMR8204, Lille, France.	yves.rouille@ibl.fr	Belouzard, Sandrine/AAX-1584-2021; Rouillé, Yves/P-2405-2016; Belouzard, Sandrine/O-8527-2016; Jackson, Catherine/T-5688-2019; Dubuisson, Jean/E-6813-2016	Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054; Dubuisson, Jean/0000-0003-1626-7693; Rouille, Yves/0000-0003-0788-9271; Jackson, Catherine/0000-0002-0843-145X	French "Agence Nationale de la Recherche sur le Sida et les hepatites virales'' (ANRS); Lebanese association of health and social care; ANRS fellowship; Marie Curie International Reintegration [PIRG-GA-2009-256300]	French "Agence Nationale de la Recherche sur le Sida et les hepatites virales'' (ANRS)(French National Research Agency (ANR)); Lebanese association of health and social care; ANRS fellowship(ANRSFrench National Research Agency (ANR)); Marie Curie International Reintegration(European Commission)	This work was supported by the French "Agence Nationale de la Recherche sur le Sida et les hepatites virales'' (ANRS). R.F. was supported by a fellowship from the Lebanese association of health and social care. L.G. is supported by an ANRS fellowship. S. B. was supported by a Marie Curie International Reintegration Grant (PIRG-GA-2009-256300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2004, J BIOCHEM MOL BIOL, V37, P741; Alsaleh K, 2010, J VIROL, V84, P12515, DOI 10.1128/JVI.01393-10; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2010, CELL MICROBIOL, V12, P1463, DOI 10.1111/j.1462-5822.2010.01482.x; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 2003, BIOCHEM BIOPH RES CO, V303, P160, DOI 10.1016/S0006-291X(03)00316-4; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Dumaresq-Doiron K, 2010, J CELL SCI, V123, P2273, DOI 10.1242/jcs.055798; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Ellong EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021889; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Matto M, 2011, J VIROL, V85, P946, DOI 10.1128/JVI.00753-10; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nevo-Yassaf I, 2012, J VIROL, V86, P6491, DOI 10.1128/JVI.00496-12; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Sklan EH, 2007, J VIROL, V81, P11096, DOI 10.1128/JVI.01249-07; Snooks MJ, 2008, J VIROL, V82, P8733, DOI 10.1128/JVI.00219-08; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Verheije MH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000088; WAGNER M, 1994, J CELL SCI, V107, P933; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Zhang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032135	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74491	10.1371/journal.pone.0074491	http://dx.doi.org/10.1371/journal.pone.0074491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058576	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900048
J	Mason, NWH; Wiser, SK; Richardson, SJ; Thorsen, MJ; Holdaway, RJ; Dray, S; Thomson, FJ; Carswell, FE				Mason, Norman W. H.; Wiser, Susan K.; Richardson, Sarah J.; Thorsen, Michael J.; Holdaway, Robert J.; Dray, Stephane; Thomson, Fiona J.; Carswell, Fiona E.			Functional Traits Reveal Processes Driving Natural Afforestation at Large Spatial Scales	PLOS ONE			English	Article							NEW-ZEALAND; SEED DISPERSAL; PLANT TRAITS; NURSE PLANTS; SPECIES-RICHNESS; ENVIRONMENT RELATIONSHIPS; 4TH-CORNER PROBLEM; FISH COMMUNITIES; ARAUCARIA FOREST; ASSEMBLY RULES	An understanding of the processes governing natural afforestation over large spatial scales is vital for enhancing forest carbon sequestration. Models of tree species occurrence probability in non-forest vegetation could potentially identify the primary variables determining natural afforestation. However, inferring processes governing afforestation using tree species occurrence is potentially problematic, since it is impossible to know whether observed occurrences are due to recruitment or persistence of existing trees following disturbance. Plant functional traits have the potential to reveal the processes by which key environmental and land cover variables influence afforestation. We used 10,061 survey plots to identify the primary environmental and land cover variables influencing tree occurrence probability in non-forest vegetation in New Zealand. We also examined how these variables influenced diversity of functional traits linked to plant ecological strategy and dispersal ability. Mean annual temperature was the most important environmental predictor of tree occurrence. Local woody cover and distance to forest were the most important land cover variables. Relationships between these variables and ecological strategy traits revealed a trade-off between ability to compete for light and colonize sites that were marginal for tree occurrence. Biotically dispersed species occurred less frequently with declining temperature and local woody cover, suggesting that abiotic stress limited their establishment and that biotic dispersal did not increase ability to colonize non-woody vegetation. Functional diversity for ecological strategy traits declined with declining temperature and woody cover and increasing distance to forest. Functional diversity for dispersal traits showed the opposite trend. This suggests that low temperatures and woody cover and high distance to forest may limit tree species establishment through filtering on ecological strategy traits, but not on dispersal traits. This study shows that 'snapshot' survey plot data, combined with functional trait data, may reveal the processes driving tree species establishment in non-forest vegetation over large spatial scales.	[Mason, Norman W. H.] Landcare Res, Hamilton, New Zealand; [Wiser, Susan K.; Richardson, Sarah J.; Holdaway, Robert J.; Thomson, Fiona J.; Carswell, Fiona E.] Landcare Res, Lincoln, New Zealand; [Thorsen, Michael J.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Dray, Stephane] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	Landcare Research - New Zealand; Landcare Research - New Zealand; University of Otago; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Mason, NWH (corresponding author), Landcare Res, Hamilton, New Zealand.	masonn@landcareresearch.co.nz	Richardson, Sarah J/D-3353-2015; Wiser, Susan K./G-1975-2011; Dray, Stéphane/B-4107-2010	Richardson, Sarah J/0000-0002-4097-0381; Wiser, Susan K./0000-0002-8938-8181; Dray, Stéphane/0000-0003-0153-1105	New Zealand Ministry of Primary Industries through SLMACC [CO4X1002]	New Zealand Ministry of Primary Industries through SLMACC	This work was funded by the New Zealand Ministry of Primary Industries through SLMACC fund contract CO4X1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, GLOBAL ECOL BIOGEOGR, V17, P503, DOI 10.1111/j.1466-8238.2008.00386.x; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Bernhardt-Romermann M, 2011, J ECOL, V99, P777, DOI 10.1111/j.1365-2745.2011.01794.x; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Carlucci MB, 2011, COMMUNITY ECOL, V12, P196, DOI 10.1556/ComEc.12.2011.2.7; Castro J, 2002, RESTOR ECOL, V10, P297, DOI 10.1046/j.1526-100X.2002.01022.x; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Duarte LDS, 2006, AUSTRAL ECOL, V31, P520, DOI 10.1111/j.1442-9993.2006.01602.x; Duncan RP, 2001, NEW ZEAL J ECOL, V25, P35; Dymond JR, 2004, REMOTE SENS ENVIRON, V90, P116, DOI 10.1016/j.rse.2003.11.013; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; French DD, 1997, BIOL CONSERV, V79, P133, DOI 10.1016/S0006-3207(96)00104-8; Freschet GT, 2011, GLOBAL ECOL BIOGEOGR, V20, P755, DOI 10.1111/j.1466-8238.2011.00651.x; Gapare N, 2004, NZ LAND COVER DATABA; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hall GMJ, 2006, NEW ZEAL J BOT, V44, P211, DOI 10.1080/0028825X.2006.9513019; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; HURST JM, 2007, RECCE METHOD DESCRIB; Kitzberger T, 2000, ECOLOGY, V81, P1914, DOI 10.1890/0012-9658(2000)081[1914:EOCVOF]2.0.CO;2; Laliberte AC, 2008, J BIOGEOGR, V35, P1989, DOI 10.1111/j.1365-2699.2008.01932.x; Laskurain NA, 2013, J VEG SCI, V24, P320, DOI 10.1111/j.1654-1103.2012.01469.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Leathwick J, 2003, LAND ENV NZ; Leathwick JR, 2001, NEW ZEAL J BOT, V39, P447; Leithead M, 2012, J VEG SCI, V23, P339, DOI 10.1111/j.1654-1103.2011.01351.x; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Maher KA, 2010, J APPL ECOL, V47, P441, DOI 10.1111/j.1365-2664.2010.01779.x; Manly B, 2002, ECOLOGY, V83, P580, DOI 10.2307/2680037; Mason NWH, 2007, OECOLOGIA, V153, P441, DOI 10.1007/s00442-007-0727-x; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Mason NWH, 2012, BIOL CONSERV, V155, P157, DOI 10.1016/j.biocon.2012.05.019; Mason NWH, 2012, J ECOL, V100, P678, DOI [10.1111/j.1365-2745.2012.01965.x, 10.1111/j.1365-2745.2012.01965.X]; Mason NWH, 2011, J VEG SCI, V22, P6, DOI 10.1111/j.1654-1103.2010.01223.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2012, SCI CONSERVATION; McGlone MS, 2010, NEW ZEAL J ECOL, V34, P137; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Ozinga WA, 2004, J ECOL, V92, P767, DOI 10.1111/j.0022-0477.2004.00916.x; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Piao SL, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000014; Pollock ML, 2007, NEW ZEAL J ECOL, V31, P68; Puyravaud JP, 2003, J BIOGEOGR, V30, P1067, DOI 10.1046/j.1365-2699.2003.00882.x; R Core Team, 2020, R LANG ENV STAT COMP; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reay SD, 1999, RESTOR ECOL, V7, P298, DOI 10.1046/j.1526-100X.1999.72023.x; Schleuter D, 2012, GLOBAL ECOL BIOGEOGR, V21, P1083, DOI 10.1111/j.1466-8238.2012.00763.x; Smit C, 2007, OECOLOGIA, V152, P265, DOI 10.1007/s00442-006-0650-6; ter Braak CJF, 2012, ECOLOGY, V93, P1525, DOI 10.1890/12-0126.1; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Thomson FJ, 2010, J ECOL, V98, P1310, DOI 10.1111/j.1365-2745.2010.01724.x; Thorsen MJ, 2009, PERSPECT PLANT ECOL, V11, P285, DOI 10.1016/j.ppees.2009.06.001; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Trotter C, 2005, ANN FOREST SCI, V62, P865, DOI 10.1051/forest:2005077; United Nations Framework Convention on Climate Change (UNFCCC), 1998, KYOT PROT CONV CLIM; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wiser S.K., 1997, 2 PERMANENT PLOT MET; Wiser SK, 2001, NEW ZEAL J ECOL, V25, P1; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x	78	7	7	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75219	10.1371/journal.pone.0075219	http://dx.doi.org/10.1371/journal.pone.0075219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058664	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900100
J	Solanki, AA; LeMieux, MH; Chiu, BCH; Mahmood, U; Hasan, Y; Koshy, M				Solanki, Abhishek A.; LeMieux, Melissa Horoschak; Chiu, Brian C. -H.; Mahmood, Usama; Hasan, Yasmin; Koshy, Matthew			Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy	PLOS ONE			English	Article							2ND MALIGNANT NEOPLASMS; CLINICAL PRESENTATION; DISEASE; RISK; CHEMOTHERAPY; RADIATION; SURVIVORS	Purpose: Radiation therapy (RT) is commonly used as definitive treatment for early-stage nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL). We evaluated the cause-specific survival (CSS), overall survival (OS), and second malignancy (SM) rates in patients with early-stage NLPHL treated with RT. Methods and Materials: Patients with stage I-II NLPHL between 1988 and 2009 who underwent RT were selected from the Surveillance, Epidemiology and End Results database. Univariate analysis (UVA) for CSS and Os was performed using the Kaplan-Meier method and included age, gender, involved site, year of diagnosis, presence of B-symptoms, and extranodal involvement (ENI). Multivariable analysis (MVA) was performed using Cox Proportional Hazards modeling and included the above clinical variables. SM were classified as RT-related or non-RT-related. Freedom from SM and freedom from RT-related SM were determined using the Kaplan-Meier method. Results: The study cohort included 469 patients. Median age was 37 years. The most common involved sites were the head and neck (36%), axilla/arm (26%), and multiple lymph node regions (18%). Sixty-eight percent had stage I disease, 70% were male, 4% had ENI, and 7% had B-symptoms. Median follow-up was 6 years. Ten-year CSS and Os were 98% and 88%, respectively. On UVA, none of the covariates was associated with CSS. Increasing age (p<0.01) and female gender (p<0.01) were associated with worse Os. On MVA, older age (p<0.01), female gender (p=0.04), multiple regions of involvement (p=0.03), stage I disease (p=0.02), and presence of B-symptoms (p=0.02) were associated with worse Os. Ten-year freedom from SM and freedom from RT-related SM were 89% and 99%, respectively. Conclusions: This is the largest series to evaluate the outcomes of stage I-II NLPHL patients treated with RT and found that this patient population has an excellent long-term prognosis and a low rate of RT-related second malignancies.	[Solanki, Abhishek A.; LeMieux, Melissa Horoschak; Hasan, Yasmin; Koshy, Matthew] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Chiu, Brian C. -H.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Mahmood, Usama] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Koshy, Matthew] Univ Illinois Hosp, Dept Radiat Oncol, Chicago, IL USA	University of Chicago; University of Chicago; University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Chicago	Koshy, M (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	mkoshy@radonc.uchicago.edu		Koshy, Matthew/0000-0001-6937-7058				CAHAN WG, 1948, CANCER, V1, P3, DOI 10.1002/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7; Chen RC, 2010, J CLIN ONCOL, V28, P136, DOI 10.1200/JCO.2009.24.0945; Chera BS, 2007, AM J CLIN ONCOL-CANC, V30, P601, DOI 10.1097/COC.0b013e318145b9db; Diehl V, 1999, J CLIN ONCOL, V17, P776, DOI 10.1200/JCO.1999.17.3.776; Hall GW, 2007, BRIT J HAEMATOL, V138, P761, DOI 10.1111/j.1365-2141.2007.06736.x; HANSMANN ML, 1984, J CANCER RES CLIN, V108, P321, DOI 10.1007/BF00390466; HENRYAMAR M, 1991, ANN INTERN MED, V114, P361, DOI 10.7326/0003-4819-114-5-361; MAUCH P, 1978, CANCER-AM CANCER SOC, V42, P1039, DOI 10.1002/1097-0142(197809)42:3<1039::AID-CNCR2820420302>3.0.CO;2-R; MIETTINEN M, 1983, CANCER, V51, P2293, DOI 10.1002/1097-0142(19830615)51:12<2293::AID-CNCR2820511221>3.0.CO;2-X; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; National Cancer Institute, 2012, HEM LYMPH NEOPL CAS; National Comprehensive Cancer Network, 2013, ODGK LYMPH VERS 1 20; Ng AK, 2002, BLOOD, V100, P1989, DOI 10.1182/blood-2002-02-0634; Nogova L, 2008, J CLIN ONCOL, V26, P434, DOI 10.1200/JCO.2007.11.8869; O'Brien MM, 2010, J CLIN ONCOL, V28, P1232, DOI 10.1200/JCO.2009.24.8062; Swerdlow AJ, 2011, J CLIN ONCOL, V29, P4096, DOI 10.1200/JCO.2011.34.8268; TUBIANA M, 1984, CANCER-AM CANCER SOC, V54, P885, DOI 10.1002/1097-0142(19840901)54:5<885::AID-CNCR2820540522>3.0.CO;2-B; Tukenova M, 2010, CANCER EPIDEM BIOMAR, V19, P707, DOI 10.1158/1055-9965.EPI-09-1156; Wirth A, 2005, CANCER-AM CANCER SOC, V104, P1221, DOI 10.1002/cncr.21303	19	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75336	10.1371/journal.pone.0075336	http://dx.doi.org/10.1371/journal.pone.0075336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058675	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900107
J	Tan, ZG; Li, HM; Pan, HW; Zhou, XW; Liu, X; Luo, NN; Hu, W; Li, YZ				Tan, Zaigao; Li, Haoming; Pan, Hongwei; Zhou, Xiuwen; Liu, Xin; Luo, Ningning; Hu, Wei; Li, Yuezhong			Characterization of Four Type IV Pilin Homologues in Stigmatella aurantiaca DSM17044 by Heterologous Expression in Myxococcus xanthus	PLOS ONE			English	Article							FRUITING BODY FORMATION; DEVELOPMENT-SPECIFIC PROTEIN; AERUGINOSA PAK PILIN; SOCIAL MOTILITY; GLIDING MOTILITY; MULTICELLULAR DEVELOPMENT; PSEUDOMONAS-AERUGINOSA; POLYSACCHARIDE PRODUCTION; CHEMOTAXIS HOMOLOGS; SEQUENCE ALIGNMENT	As prokaryotic models for multicellular development, Stigmatella aurantiaca and Myxococcus xanthus share many similarities in terms of social behaviors, such as gliding motility. Our current understanding of myxobacterial grouped-cell motilities comes mainly from the research on M. xanthus, which shows that filamentous type IV pili (TFP), composed of type IV pilin (also called PilA protein) subunits, are the key apparatus for social motility (S-motility). However, little is known about the pilin protein in S. aurantiaca. We cloned and sequenced four genes (pilA(Sa1 similar to 4)) from S. aurantiaca DSM17044 that are homologous to pilA(Mx) (pilA gene in M. xanthus DK1622). The homology and similarities among PilA(Sa) proteins and other myxobacterial homologues were systematically analyzed. To determine their potential biological functions, the four pilA(Sa) genes were expressed in M. xanthus DK10410 (Delta pilA(Mx)), which did not restore S-motility on soft agar or EPS production to host cells. After further analysis of the motile behaviors in a methylcellulose solution, the M. xanthus strains were categorized into three types. YL6101, carrying pilA(Sa1), and YL6104, carrying pilA(Sa4), produced stable but unretractable surface pili; YL6102, carrying pilA(Sa2), produced stable surface pili and exhibited reduced TFP-dependent motility in methylcellulose; YL6103, carrying pilA(Sa3), produced unstable surface pili. Based on these findings, we propose that pilA(Sa2) might be responsible for the type IV pilin production involved in group motility in S. aurantiaca DSM17044. After examining the developmental processes, it was suggested that the expression of PilA(Sa4) protein might have positive effects on the fruiting body formation of M. xanthus DK10410 cells. Moreover, the formation of fruiting body in M. xanthus cells with stable exogenous TFPSa were compensated by mixing them with S. aurantiaca DSM17044 cells. Our results shed some light on the features and functions of type IV pilin homologues in S. aurantiaca.	[Tan, Zaigao; Li, Haoming; Pan, Hongwei; Zhou, Xiuwen; Liu, Xin; Luo, Ningning; Hu, Wei; Li, Yuezhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China	Shandong University	Hu, W (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China.	hw_1@sdu.edu.cn	Li, Hao/GPS-9834-2022; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638; TAN, ZAIGAO/0000-0003-4528-0723	Chinese Natural Science Foundation [30870020, 30825001, 31130004]; Shandong Natural Science Foundation [ZR2012CM003]; SDU Innovation Grant [2012TS007]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); SDU Innovation Grant	This work was financially supported by the Chinese Natural Science Foundation Grants 30870020 (to W. H.), 30825001 and 31130004 (to Y.L.), Shandong Natural Science Foundation Grant ZR2012CM003 (to W. H.) and SDU Innovation Grant 2012TS007 (to W. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD JW, 1988, J BACTERIOL, V170, P5765, DOI 10.1128/jb.170.12.5765-5770.1988; Bates PA, 2001, PROTEINS, P39; Black WP, 2006, MOL MICROBIOL, V61, P447, DOI 10.1111/j.1365-2958.2006.05230.x; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bonner PJ, 2006, MOL MICROBIOL, V61, P1283, DOI 10.1111/j.1365-2958.2006.05298.x; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; CHANG BY, 1992, J BACTERIOL, V174, P5780, DOI 10.1128/jb.174.18.5780-5787.1992; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Cordelieres F, 2005, MANUAL TRACKING PLUG; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Garcia R, 2011, J BACTERIOL, V193, P1930, DOI 10.1128/JB.01091-10; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Goldman B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001329; Gorski L, 2000, J BACTERIOL, V182, P2438, DOI 10.1128/JB.182.9.2438-2444.2000; Green MR, 2012, MOL CLONING LAB MANU, V1; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harlow E., 1988, ANTIBODIES LAB MANUA; Hazes B, 2000, J MOL BIOL, V299, P1005, DOI 10.1006/jmbi.2000.3801; Hazes B, 2008, BBA-BIOMEMBRANES, V1778, P1839, DOI 10.1016/j.bbamem.2008.03.011; Hu W, 2012, FEMS MICROBIOL LETT, V326, P23, DOI 10.1111/j.1574-6968.2011.02430.x; Hu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016102; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; INOUYE S, 1983, J BIOL CHEM, V258, P38; INOUYE S, 1983, P NATL ACAD SCI-BIOL, V80, P6829, DOI 10.1073/pnas.80.22.6829; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; Keizer DW, 2001, J BIOL CHEM, V276, P24186, DOI 10.1074/jbc.M100659200; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li J, 2010, J BACTERIOL, V192, P1875, DOI 10.1128/JB.01458-09; Li YN, 2005, MICROBIOL-SGM, V151, P353, DOI 10.1099/mic.0.27614-0; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; Pan HW, 2009, J BACTERIOL, V191, P2102, DOI 10.1128/JB.01556-08; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Reichenbach H., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_26; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; SHIMKETS L, 1992, P NATL ACAD SCI USA, V89, P9459, DOI 10.1073/pnas.89.20.9459; SHIMKETS LJ, 1986, J BACTERIOL, V166, P837, DOI 10.1128/jb.166.3.837-841.1986; SMITH DR, 1994, J BACTERIOL, V176, P1201, DOI 10.1128/JB.176.4.1201-1205.1994; Stamm I, 2005, MOL MICROBIOL, V56, P1386, DOI 10.1111/j.1365-2958.2005.04640.x; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; VASQUEZ GM, 1985, J BACTERIOL, V163, P515, DOI 10.1128/JB.163.2.515-521.1985; Wang J, 2011, J BACTERIOL, V193, P2122, DOI 10.1128/JB.00041-11; WOMACK BJ, 1989, J BACTERIOL, V171, P6093, DOI 10.1128/jb.171.11.6093-6096.1989; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang Z, 2011, MICROBIOL-SGM, V157, P1920, DOI 10.1099/mic.0.049684-0; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Zhao JY, 2008, APPL ENVIRON MICROB, V74, P1980, DOI 10.1128/AEM.02143-07	61	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75105	10.1371/journal.pone.0075105	http://dx.doi.org/10.1371/journal.pone.0075105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058653	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900094
J	Bergt, S; Guter, A; Grub, A; Wagner, NM; Beltschany, C; Langner, S; Wree, A; Hildebrandt, S; Noldge-Schomburg, G; Vollmar, B; Roesner, JP				Bergt, Stefan; Gueter, Anne; Grub, Andrea; Wagner, Nana-Maria; Beltschany, Claudia; Langner, Soenke; Wree, Andreas; Hildebrandt, Steve; Noeldge-Schomburg, Gabriele; Vollmar, Brigitte; Roesner, Jan P.			Impact of Toll-Like Receptor 2 Deficiency on Survival and Neurological Function after Cardiac Arrest: A Murine Model of Cardiopulmonary Resuscitation	PLOS ONE			English	Article							TLR2; INJURY; REPERFUSION; GUIDELINES; MANAGEMENT; CELLS; CARE	Background: Cardiac arrest (CA) followed by cardiopulmonary resuscitation (CPR) is associated with poor survival rate and neurofunctional outcome. Toll-like receptor 2 (TLR2) plays an important role in conditions of sterile inflammation such as reperfusion injury. Recent data demonstrated beneficial effects of the administration of TLR2-blocking antibodies in ischemia/reperfusion injury. In this study we investigated the role of TLR2 for survival and neurofunctional outcome after CA/CPR in mice. Methods: Female TLR2-deficient (TLR2(-/-)) and wild type (WT) mice were subjected to CA for eight min induced by intravenous injection of potassium chloride and CPR by external chest compression. Upon the beginning of CPR, n = 15 WT mice received 5 mu g/g T2.5 TLR2 inhibiting antibody intravenously while n = 30 TLR2(-/-) and n = 31 WT controls were subjected to injection of normal saline. Survival and neurological outcome were evaluated during a 28-day follow up period. Basic neurological function, balance, coordination and overall motor function as well as spatial learning and memory were investigated, respectively. In a separate set of experiments, six mice per group were analysed for cytokine and corticosterone serum levels eight hours after CA/CPR. Results: TLR2 deficiency and treatment with a TLR2 blocking antibody were associated with increased survival (77% and 80% vs. 51% of WT control; both P < 0.05). Neurofunctional performance was less compromised in TLR2(-/-) and antibody treated mice. Compared to WT and antibody treated mice, TLR2(-/-) mice exhibited reduced IL-6 (both P < 0.05) but not IL-1 beta levels and increased corticosterone plasma concentrations (both P < 0.05). Conclusion: Deficiency or functional blockade of TLR2 is associated with increased survival and improved neurofunctional outcome in a mouse model of CA/CPR. Thus, TLR2 inhibition could provide a novel therapeutic approach for reducing mortality and morbidity after cardiac arrest and cardiopulmonary resuscitation.	[Bergt, Stefan; Gueter, Anne; Grub, Andrea; Wagner, Nana-Maria; Beltschany, Claudia; Noeldge-Schomburg, Gabriele; Roesner, Jan P.] Univ Hosp Rostock, Clin Anaesthesiol & Crit Care Med, Rostock, Germany; [Langner, Soenke] Univ Hosp Greifswald, Inst Neuroradiol, Greifswald, Germany; [Wree, Andreas; Hildebrandt, Steve] Univ Rostock, Dept Anat, D-18055 Rostock, Germany; [Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Bergt, S (corresponding author), Univ Hosp Rostock, Clin Anaesthesiol & Crit Care Med, Rostock, Germany.	stefan.bergt@medizin.uni-rostock.de	Langner, Soenke/ABB-6744-2021; Wagner, Nana-Maria/AAB-3953-2021	Langner, Soenke/0000-0001-7241-1173; Wagner, Nana-Maria/0000-0002-4610-6666				Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Arslan F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704202; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Ben Mkaddem S, 2010, ONCOTARGET, V1, P741, DOI 10.18632/oncotarget.209; Bohacek I, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-191; Bornstein SR, 2004, P NATL ACAD SCI USA, V101, P16695, DOI 10.1073/pnas.0407550101; Bottiger BW, 2002, CRIT CARE MED, V30, P2473, DOI 10.1097/01.CCM.0000034689.78033.E2; DECKER MW, 1989, BRAIN RES, V477, P29, DOI 10.1016/0006-8993(89)91391-7; Farrar CA, 2012, FASEB J, V26, P799, DOI 10.1096/fj.11-195396; Fink K, 2010, CRIT CARE, V14, DOI 10.1186/cc9050; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Koster RW, 2010, RESUSCITATION, V81, pE48, DOI 10.1016/j.resuscitation.2010.08.005; KRMPOTIC L, NEUROSCIENCE; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Menzebach A, 2010, SHOCK, V33, P189, DOI 10.1097/SHK.0b013e3181ad59a3; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Neigh GN, 2004, J CEREBR BLOOD F MET, V24, P372, DOI 10.1097/00004647-200404000-00002; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Norman GJ, 2011, J NEUROSCI, V31, P3446, DOI 10.1523/JNEUROSCI.4558-10.2011; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Puttgen HA, 2009, CURR OPIN CRIT CARE, V15, P118, DOI 10.1097/MCC.0b013e328326077c; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Samborska-Sablik A, 2011, ARCH MED SCI, V7, P619, DOI 10.5114/aoms.2011.24131; Tang CH, 2010, BIOCHEM PHARMACOL, V79, P1648, DOI 10.1016/j.bcp.2010.01.025; Tsai MS, 2007, AM J EMERG MED, V25, P318, DOI 10.1016/j.ajem.2006.12.007; Varon J, 2007, AM J EMERG MED, V25, P376, DOI 10.1016/j.ajem.2006.12.023; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157; Ziegler G, 2011, J CEREBR BLOOD F MET, V31, P757, DOI 10.1038/jcbfm.2010.161	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74944	10.1371/journal.pone.0074944	http://dx.doi.org/10.1371/journal.pone.0074944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066159	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000141
J	Tran, DA; Ngo, AD; Shakeshaft, A; Wilson, DP; Doran, C; Zhang, L				Dam Anh Tran; Anh Duc Ngo; Shakeshaft, Anthony; Wilson, David P.; Doran, Christopher; Zhang, Lei			Trends in and Determinants of Loss to Follow Up and Early Mortality in a Rapid Expansion of the Antiretroviral Treatment Program in Vietnam: Findings from 13 Outpatient Clinics	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; INJECTING DRUG-USERS; SOUTH-AFRICA; TREATMENT OUTCOMES; TREATMENT SERVICE; THERAPY PROGRAMS; COHORT ANALYSIS; SCALE-UP; RETENTION; INITIATION	Background: This study aims to describe the trends in and determinants of six month mortality and loss to follow up (LTFU) during 2005-2009 in 13 outpatient clinics in Vietnam. Method: Data were obtained from clinical records of 3,449 Vietnamese HIV/AIDS patients aged 18 years or older who initiated ART between 1 January 2005 and 31 December 2009. Mantel-Haenszel chi-square test, log rank test were conducted to examine the trends of baseline characteristics, six month mortality and LTFU. Cox proportional hazards regression models were performed to compute hazard ratio (HR) and 95% Confidence Interval (CI). Results: Though there was a declining trend, the incidence of six month mortality and LTFU remained as high as 6% and 15%, respectively. Characteristics associated with six month mortality were gender (HR females versus males 0.54, 95% CI: 0.34-0.85), years of initiation (HR 2009 versus 2005 0.54, 95% CI: 0.41-0.80), low baseline CD4 (HR 350-500 cells/mm(3) versus <50 cells/mm(3) 0.26, 95% CI: 0.18-0.52), low baseline BMI (one unit increase: HR 0.96, 95% CI: 0.94-0.97), co-infection with TB (HR 1.61, 95% CI: 1.46-1.95), history of injecting drugs (HR 1.58, 95% CI: 1.31-1.78). Characteristics associated with LTFU were younger age (one year younger: HR 0.97, 95% CI: 0.95-0.98), males (HR females versus males 0.82, 95% CI: 0.63-0.95), and poor adherence (HR 0.55, 95% CI: 0.13-0.87). Conclusions: To reduce early mortality, special attention is required to ensure timely access to ART services, particularly for patients at higher risk. Patients at risk for LTFU after ART initiation should be targeted through enhancing treatment counselling and improving patient tracing system at ART clinics.	[Dam Anh Tran; Wilson, David P.; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Dam Anh Tran; Shakeshaft, Anthony] Univ New S Wales, Natl Drug Alcohol Res Ctr, Sydney, NSW, Australia; [Anh Duc Ngo] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Doran, Christopher] Univ Newcastle, Hunter Med Res Ctr, Newcastle, NSW 2300, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of South Australia; Hunter Medical Research Institute; University of Newcastle	Tran, DA (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	d.tran@unsw.edu.au; lzhang@kirby.unsw.edu.au	Shakeshaft, Anthony/U-4637-2017; Zhang, Lei/D-4039-2011	Shakeshaft, Anthony/0000-0002-5472-0930; Zhang, Lei/0000-0003-2343-084X; Tran, Anh Dam/0000-0001-8677-4637	University of Queensland	University of Queensland(University of Queensland)	The authors appreciate the support provided by Professor Anh Vu Le, The Head of Hanoi School of Public Health. The authors are grateful for the technical assistance supported by Professor Peter Hill, the University of Queensland.	Ahonkhai AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032993; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Tran BX, 2012, AIDS BEHAV, V16, P1988, DOI 10.1007/s10461-012-0271-5; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Conseil A, 2010, HEALTH POLICY PLANN, V25, pi32, DOI 10.1093/heapol/czq055; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Tran DA, 2013, HIV CLIN TRIALS, V14, P21, DOI [10.1410/hct1401-21, 10.1310/hct1401-21]; Tran DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051289; Cuong DD, 2012, SCAND J INFECT DIS, V44, P201, DOI 10.3109/00365548.2011.631937; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Go VF, 2011, SUBST USE MISUSE, V46, P381, DOI 10.3109/10826084.2010.505147; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Maher L, 2007, INT J DRUG POLICY, V18, P296, DOI 10.1016/j.drugpo.2006.12.006; Martinson N, 2007, 14 C RETR OPP INF LO; Ministry of Health, 2007, NAT HIV AIDS CAR TRE; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Schumacher CM, 2009, INT J DRUG POLICY, V20, P352, DOI 10.1016/j.drugpo.2008.09.006; Steele KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020010; Tam V, 2011, AIDS CARE; Vietnam Administration for HIV/AIDS Control [VAAC], 2010, PREL RES NAT EV CLIN; Vietnam Administration for HIV/AIDS Control [VAAC], 2005, VIETN HIV AIDS EST P; Vu MQ, 2011, ADDICTION, V106, P583, DOI 10.1111/j.1360-0443.2010.03175.x; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	42	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73181	10.1371/journal.pone.0073181	http://dx.doi.org/10.1371/journal.pone.0073181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066035	Green Published, gold, Green Accepted			2022-12-27	WOS:000324494000016
J	de Lima, RF; Olmos, F; Dallimer, M; Atkinson, PW; Barlow, J				de Lima, Ricardo Faustino; Olmos, Fabio; Dallimer, Martin; Atkinson, Philip W.; Barlow, Jos			Can REDD plus Help the Conservation of Restricted-Range Island Species? Insights from the Endemism Hotspot of Sao Tome	PLOS ONE			English	Article							REDUCING EMISSIONS; CARBON STORAGE; FOREST BIOMASS; BIODIVERSITY; DEFORESTATION; GUINEA; GULF	REDD+ aims to offset greenhouse gas emissions through "Reduced Emissions from Deforestation and forest Degradation". Some authors suggest that REDD+ can bring additional benefits for biodiversity, namely for the conservation of extinction-prone restricted-range species. Here, we assess this claim, using Sao Tome Island (Democratic Republic of Sao Tome and Principe) as a case study. We quantified the abundance of bird and tree species, and calculated the aboveground carbon stocks across a gradient of land-use intensity. We found a strong spatial congruence between carbon and the presence and abundance of endemic species, supporting the potential of REDD+ to protect these taxa. We then assessed if REDD+ could help protect the forests of Sao Tome and Principe. To do so, we used OSIRIS simulations to predict country-level deforestation under two different REDD+ designs. These simulations showed that REDD+ could promote the loss of forests in Sao Tome and Principe through leakage. This happened even when additional payments for biodiversity were included in the simulations, and despite Sao Tome and Principe having the fourth highest carbon stocks per land area and the second highest biodiversity values according to the OSIRIS database. These results show weaknesses of OSIRIS as a planning tool, and demonstrate that the benefits that REDD+ might bring for biodiversity are strongly dependent on its careful implementation. We recommend that payment for ecosystem services programmes such as REDD+ develop safeguards to ensure that biodiversity co-benefits are met and perverse outcomes are avoided across all tropical countries. In particular, we advise specific safeguards regarding the conservation of extinction-prone groups, such as island restricted-range species.	[de Lima, Ricardo Faustino; Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [de Lima, Ricardo Faustino] Assoc Mt Pico, Mt Cafe, Me Zochi, Sao Tome & Prin; [Olmos, Fabio] Permian Brasil, Sao Paulo, Brazil; [Dallimer, Martin] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Atkinson, Philip W.] British Trust Ornithol, The Nunnery, Thetford, England	Lancaster University; University of Copenhagen; British Trust for Ornithology	de Lima, RF (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England.	rfaustinol@gmail.com	Barlow, Jos/E-7861-2014; Barlow, Jos/HGE-9486-2022; de Lima, Ricardo/C-2826-2011; Atkinson, Philip/B-8975-2009; Dallimer, Martin/I-1547-2019	de Lima, Ricardo/0000-0002-0184-3945; Dallimer, Martin/0000-0001-8120-3309; Atkinson, Philip/0000-0002-0838-557X	Portuguese government's "Fundacao para a Ciencia e a Tecnologia" [SFRH/BD/36812/2007]; Rufford Small Grant [50.04.09]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Portuguese government's "Fundacao para a Ciencia e a Tecnologia"; Rufford Small Grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by RFdL's PhD grant (SFRH/BD/36812/2007) from the Portuguese government's "Fundacao para a Ciencia e a Tecnologia" (http://www.fct.pt/index.phtml.en). Field work was supported by a Rufford Small Grant (50.04.09 - http://www.ruffordsmallgrants.org/rsg/projects/ricardo_de_lima). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; [Anonymous], 2012, UN C SUST DEV; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Barker T, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P25; BDPA, 1985, POT AGR REP DEM SAO; Bond I., 2009, INCENTIVES SUSTAIN F; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Busch J, 2010, OPEN SOURCE IMPACTS; Busch J, 2011, CONSERV LETT, V4, P101, DOI 10.1111/j.1755-263X.2010.00150.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; COLWELL RK., 2009, ESTIMATES VERSION 8; DELIMA RF, 2012, THESIS; DINIZ MA, 2002, GARCIA ORTA, V15, P1; Epple C., 2011, MAKING BIODIVERSITY; Exell AW, 1944, CATALOGUE VASCULAR P; FIGUEIREDO E, 1994, BIODIVERS CONSERV, V3, P785, DOI 10.1007/BF00129658; Figueiredo E, 2011, BOTHALIA, V41, P41, DOI 10.4102/abc.v41i1.34; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hatanaka N, 2011, GLOBAL ECOL BIOGEOGR, V20, P260, DOI 10.1111/j.1466-8238.2010.00591.x; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Husch B., 2003, FOREST MENSURATION, V4th; Interforest, 1990, REP DEM SAO TOM PRIN; IUCN, 2011, 2011 IUCN RED LIST T; Jones P.J., 1991, CONSERVACAO ECOSSIST; JONES PJ, 1994, BIODIVERS CONSERV, V3, P772, DOI 10.1007/BF00129657; Jones PJ, 2006, BIRDS SAO TOME PRINC; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Lindenmayer DB, 2012, CONSERV LETT, V5, P28, DOI 10.1111/j.1755-263X.2011.00213.x; Loehle C, 2012, DIVERS DISTRIB, V18, P84, DOI 10.1111/j.1472-4642.2011.00856.x; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Perez R, 2005, METODOLOGIA EMPLEADA; PISTORIUS T., 2011, GREENING REDD CHALLE; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Salgueiro A, 2002, PROPOSTA PLANO NACL; Salgueiro A, 2001, PROPOSTA PLANO NACL; SILVA H. L., 1958, Garcia de Orta, V6, P61; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; UN, 2011, ANN REP EX BOARD CLE; United Nations, 1993, UN CONV BIOL DIV; United Nations Framework Convention on Climate Change (UNFCCC), 2014, UN FRAM CONV CLIM CH; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Walker, 2005, SOURCEBOOK LAND USE; Waltert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016238; White D., 2011, ESTIMATING OPPORTUNI; Zanne AE, 2011, GLOBAL WOOD DENSITY	55	2	2	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74148	10.1371/journal.pone.0074148	http://dx.doi.org/10.1371/journal.pone.0074148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066109	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324494000091
J	Mukherjee, S; Rigaud, S; Seok, SC; Fu, G; Prochenka, A; Dworkin, M; Gascoigne, NRJ; Vieland, VJ; Sauer, K; Das, J				Mukherjee, Sayak; Rigaud, Stephanie; Seok, Sang-Cheol; Fu, Guo; Prochenka, Agnieszka; Dworkin, Michael; Gascoigne, Nicholas R. J.; Vieland, Veronica J.; Sauer, Karsten; Das, Jayajit			In Silico Modeling of Itk Activation Kinetics in Thymocytes Suggests Competing Positive and Negative IP4 Mediated Feedbacks Increase Robustness	PLOS ONE			English	Article							INTERMOLECULAR SELF-ASSOCIATION; PLECKSTRIN HOMOLOGY DOMAINS; CD4(+) T-CELLS; STATISTICAL-MECHANICS; THYMIC SELECTION; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; BIOLOGICAL ROBUSTNESS; INFORMATION THEORY; GENE-EXPRESSION; BINDING	The inositol-phosphate messenger inositol(1,3,4,5) tetrakisphosphate (IP4) is essential for thymocyte positive selection by regulating plasma-membrane association of the protein tyrosine kinase Itk downstream of the T cell receptor (TCR). IP4 can act as a soluble analog of the phosphoinositide 3-kinase (PI3K) membrane lipid product phosphatidylinositol(3,4,5) trisphosphate (PIP3). PIP3 recruits signaling proteins such as Itk to cellular membranes by binding to PH and other domains. In thymocytes, low-dose IP4 binding to the Itk PH domain surprisingly promoted and high-dose IP4 inhibited PIP3 binding of Itk PH domains. However, the mechanisms that underlie the regulation of membrane recruitment of Itk by IP4 and PIP3 remain unclear. The distinct Itk PH domain ability to oligomerize is consistent with a cooperative-allosteric mode of IP4 action. However, other possibilities cannot be ruled out due to difficulties in quantitatively measuring the interactions between Itk, IP4 and PIP3, and in generating non-oligomerizing Itk PH domain mutants. This has hindered a full mechanistic understanding of how IP4 controls Itk function. By combining experimentally measured kinetics of PLC gamma 1 phosphorylation by Itk with in silico modeling of multiple Itk signaling circuits and a maximum entropy (MaxEnt) based computational approach, we show that those in silico models which are most robust against variations of protein and lipid expression levels and kinetic rates at the single cell level share a cooperative-allosteric mode of Itk regulation by IP4 involving oligomeric Itk PH domains at the plasma membrane. This identifies MaxEnt as an excellent tool for quantifying robustness for complex TCR signaling circuits and provides testable predictions to further elucidate a controversial mechanism of PIP3 signaling.	[Mukherjee, Sayak; Seok, Sang-Cheol; Prochenka, Agnieszka; Dworkin, Michael; Vieland, Veronica J.; Das, Jayajit] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH USA; [Vieland, Veronica J.; Das, Jayajit] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Das, Jayajit] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Vieland, Veronica J.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Dworkin, Michael] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Das, Jayajit] Ohio State Univ, Biophys Grad Program, Columbus, OH 43210 USA; [Rigaud, Stephanie; Fu, Guo; Gascoigne, Nicholas R. J.; Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Prochenka, Agnieszka] Polish Acad Sci, Inst Comp Sci, PL-00901 Warsaw, Poland	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Scripps Research Institute; Polish Academy of Sciences; Institute of Computer Science of the Polish Academy of Sciences	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ksauer@scripps.edu; Jayajit.Das@nationwidechildrens.org	Das, Jayajit/AAD-8502-2022	Das, Jayajit/0000-0001-9649-4698; Dworkin, Michael/0000-0002-2364-9510	Research Institute at Nationwide Childrens Hospital; NIH grant [AI070845, MH086117]; Leukemia and Lymphoma Society Scholar Award [1440-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK094173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785, R01GM065230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086117] Funding Source: NIH RePORTER	Research Institute at Nationwide Childrens Hospital; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the Research Institute at Nationwide Childrens Hospital to J.D., NIH grant AI070845 and The Leukemia and Lymphoma Society Scholar Award 1440-11 to K.S, and NIH grant MH086117 to V.J.V. Part of this work was supported by NIH grant AI070845 to K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Cohen S. D., 1996, Computers in Physics, V10, P138; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Cover T.M., 2006, ELEMENTS INFORM THEO, Vxxiii; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; HAMANN JR, 1970, J THEOR BIOL, V28, P175, DOI 10.1016/0022-5193(70)90050-0; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Huang YH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002428; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Irvine R, 2007, SCIENCE, V316, P845, DOI 10.1126/science.1143339; Jaynes E. T., 2003, PROBABILITY THEORY L, Vxxix; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kim J, 2007, PLOS COMPUT BIOL, V3, P2190, DOI 10.1371/journal.pcbi.0030218; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kullback S., 1968, INFORM THEORY STAT; Laederach A, 2003, J MOL BIOL, V329, P1011, DOI 10.1016/S0022-2836(03)00531-X; Landau L. D, 1958, STAT PHYS; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Min L, 2010, J IMMUNOL, V184, P4228, DOI 10.4049/jimmunol.0901908; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moran AE, 2012, IMMUNOLOGY, V135, P261, DOI 10.1111/j.1365-2567.2011.03547.x; NGv Kampen, 1992, STOCHASTIC PROCESSES, Vxiv; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; Okoh MP, 1999, BIOCHEM BIOPH RES CO, V265, P151, DOI 10.1006/bbrc.1999.1407; Phillips R, 2009, PHYS BIOL CELL, Vxxiv; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; Qi Q, 2009, J BIOL CHEM, V284, P29882, DOI 10.1074/jbc.M109.003129; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Sauer K, 2013, BLOOD, V121, P286, DOI 10.1182/blood-2012-05-429241; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Schell MJ, 2010, CELL MOL LIFE SCI, V67, P1755, DOI 10.1007/s00018-009-0238-5; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Severin A, 2009, J MOL BIOL, V387, P726, DOI 10.1016/j.jmb.2009.02.012; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Stritesky G.L., 2011, ANN REV IMMUNOL; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Xu T. R. R., 2010, SCI SIG, V3, P134; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014	70	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73937	10.1371/journal.pone.0073937	http://dx.doi.org/10.1371/journal.pone.0073937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066087	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000069
J	Safdar, H; Cleuren, ACA; Cheung, KL; Gonzalez, FJ; Vos, HL; Inoue, Y; Reitsma, PH; van Vlijmen, BJM				Safdar, Huma; Cleuren, Audrey C. A.; Cheung, Ka Lei; Gonzalez, Frank J.; Vos, Hans L.; Inoue, Yusuke; Reitsma, Pieter H.; van Vlijmen, Bart J. M.			Regulation of the F11, Klkb1, Cyp4v3 Gene Cluster in Livers of Metabolically Challenged Mice	PLOS ONE			English	Article							BLOOD-COAGULATION FACTOR; ESTROGEN-RECEPTOR-ALPHA; HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; DEEP-VEIN THROMBOSIS; ACTIVATED FACTOR-XII; FACTOR 4-ALPHA; EXPRESSION; PREKALLIKREIN; HNF-4-ALPHA; LOCUS	Single nucleotide polymorphisms (SNPs) in a 4q35.2 locus that harbors the coagulation factor XI (F11), prekallikrein (KLKB1), and a cytochrome P450 family member (CYP4V2) genes are associated with deep venous thrombosis (DVT). These SNPs exert their effect on DVT by modifying the circulating levels of FXI. However, SNPs associated with DVT were not necessarily all in F11, but also in KLKB1 and CYP4V2. Here, we searched for evidence for common regulatory elements within the 4q35.2 locus, outside the F11 gene, that might control FXI plasma levels and/or DVT risk. To this end, we investigated the regulation of the orthologous mouse gene cluster under several metabolic conditions that impact mouse hepatic F11 transcription. In livers of mice in which HNF4 alpha, a key transcription factor controlling F11, was ablated, or reduced by siRNA, a strong decrease in hepatic F11 transcript levels was observed that correlated with Cyp4v3 (mouse orthologue of CYP4V2), but not by Klkb1 levels. Estrogens induced hepatic F11 and Cyp4v3, but not Klkb1 transcript levels, whereas thyroid hormone strongly induced hepatic F11 transcript levels, and reduced Cyp4v3, leaving Klkb1 levels unaffected. Mice fed a high-fat diet also had elevated F11 transcription, markedly paralleled by an induction of Klkb1 and Cyp4v3 expression. We conclude that within the mouse F11, Klkb1, Cyp4v3 gene cluster, F11 and Cyp4v3 frequently display striking parallel transcriptional responses suggesting the presence of shared regulatory elements.	[Safdar, Huma; Cleuren, Audrey C. A.; Cheung, Ka Lei; Vos, Hans L.; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Safdar, Huma; Cleuren, Audrey C. A.; Cheung, Ka Lei; Vos, Hans L.; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA; [Inoue, Yusuke] Gunma Univ, Grad Sch Engn, Dept Chem & Chem Biol, Kiryu, Gunma, Japan	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gunma University	Safdar, H (corresponding author), Leiden Univ Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	h.safdar@lumc.nl	Inoue, Yusuke/O-6207-2018; Cleuren, Audrey/AAV-3684-2021	Inoue, Yusuke/0000-0002-9710-7482; Safdar, Huma/0000-0002-0716-3895	Dutch Organization for Scientific Research (NWO-TOP) [40-00812-98-07-045]; Netherlands Heart Foundation [2006B0045]	Dutch Organization for Scientific Research (NWO-TOP); Netherlands Heart Foundation(Netherlands Heart Foundation)	This project is financially supported by the Dutch Organization for Scientific Research (NWO-TOP Grant #40-00812-98-07-045). The research of Audrey C.A. Cleuren was supported by grant 2006B0045 from the Netherlands Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; Gailani D, 2009, J THROMB HAEMOST, V7, P75, DOI 10.1111/j.1538-7836.2009.03414.x; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Hanniman EA, 2006, J LIPID RES, V47, P2503, DOI 10.1194/jlr.M600303-JLR200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Lai TYY, 2010, INVEST OPHTH VIS SCI, V51, P1092, DOI 10.1167/iovs.09-3665; Laugerette F, 2012, AM J PHYSIOL-ENDOC M, V302, pE374, DOI 10.1152/ajpendo.00314.2011; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rojkjaer R, 1999, IMMUNOPHARMACOLOGY, V43, P109, DOI 10.1016/S0162-3109(99)00069-7; Safdar H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038104; SCHOUSBOE I, 1990, EUR J BIOCHEM, V193, P495, DOI 10.1111/j.1432-1033.1990.tb19364.x; Selva DM, 2009, J MOL ENDOCRINOL, V43, P19, DOI 10.1677/JME-09-0025; Tarumi T, 2002, J BIOL CHEM, V277, P18510, DOI 10.1074/jbc.M201886200	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74637	10.1371/journal.pone.0074637	http://dx.doi.org/10.1371/journal.pone.0074637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066149	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000131
J	Seta, N; Okazaki, Y; Miyazaki, H; Kato, T; Kuwana, M				Seta, Noriyuki; Okazaki, Yuka; Miyazaki, Hiroshi; Kato, Takashi; Kuwana, Masataka			Platelet-Derived Stromal Cell-Derived Factor-1 Is Required for the Transformation of Circulating Monocytes into Multipotential Cells	PLOS ONE			English	Article							BONE-MARROW; PERIPHERAL-BLOOD; PROGENITOR CELLS; SDF-1; MOBILIZATION; CXCR4	Background: We previously described a primitive cell population derived from human circulating CD14(+) monocytes, named monocyte-derived multipotential cells (MOMCs), which are capable of differentiating into mesenchymal and endothelial lineages. To generate MOMCs in vitro, monocytes are required to bind to fibronectin and be exposed to soluble factor(s) derived from circulating CD14(-) cells. The present study was conducted to identify factors that induce MOMC differentiation. Methods: We cultured CD14(+) monocytes on fibronectin in the presence or absence of platelets, CD14(-) peripheral blood mononuclear cells, platelet-conditioned medium, or candidate MOMC differentiation factors. The transformation of monocytes into MOMCs was assessed by the presence of spindle-shaped adherent cells, CD34 expression, and the potential to differentiate in vitro into mesenchymal and endothelial lineages. Results: The presence of platelets or platelet-conditioned medium was required to generate MOMCs from monocytes. A screening of candidate platelet-derived soluble factors identified stromal cell-derived factor (SDF)-1 as a requirement for generating MOMCs. Blocking an interaction between SDF-1 and its receptor CXCR4 inhibited MOMC generation, further confirming SDF-1's critical role in this process. Finally, circulating MOMC precursors were found to reside in the CD14(+)CXCR4(high) cell population. Conclusion: The interaction of SDF-1 with CXCR4 is essential for the transformation of circulating monocytes into MOMCs.	[Seta, Noriyuki; Okazaki, Yuka; Kato, Takashi; Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Miyazaki, Hiroshi] Kyowa Hakko Kirin Co Ltd, Div Res, Innovat Drug Res Labs, Takasaki, Gunma, Japan; [Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan	Keio University; Kyowa Kirin Ltd; Waseda University	Kuwana, M (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan.	kuwanam@z5.keio.jp	Kuwana, Masataka/L-2918-2013; Seta, Noriyuki/L-2844-2013		New Energy and Industrial Technology Development Organization in Japan	New Energy and Industrial Technology Development Organization in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Hattori H, 2012, J NEUROSCI RES, V90, P479, DOI 10.1002/jnr.22755; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Kodama H, 2006, IMMUNOL CELL BIOL, V84, P209, DOI 10.1111/j.1440-1711.2006.01424.x; Kodama H, 2005, STEM CELLS DEV, V14, P676, DOI 10.1089/scd.2005.14.676; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Romagnani P, 2005, CIRC RES, V97, P314, DOI 10.1161/01.RES.0000177670.72216.9b; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41; Seta N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/820827; Seta N, 2010, EXP HEMATOL, V38, P557, DOI 10.1016/j.exphem.2010.03.015; Sharma M, 2011, STEM CELLS DEV, V20, P933, DOI 10.1089/scd.2010.0263; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Yamaguchi Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3180; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	27	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74246	10.1371/journal.pone.0074246	http://dx.doi.org/10.1371/journal.pone.0074246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066125	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000107
J	Vassallo, A; Vaccaro, MC; De Tommasi, N; Dal Piaz, F; Leone, A				Vassallo, Antonio; Vaccaro, Maria Carmela; De Tommasi, Nunziatina; Dal Piaz, Fabrizio; Leone, Antonella			Identification of the Plant Compound Geraniin as a Novel Hsp90 Inhibitor	PLOS ONE			English	Article							BREAST-CANCER; TUMOR-CELLS; IN-VITRO; COMPLEX; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; APOPTOSIS; PROTEINS; TARGET; 17-AAG; LABEL	Besides its function in normal cellular growth, the molecular chaperone heat shock protein 90 (Hsp90) binds to a large number of client proteins required for promoting cancer cell growth and/or survival. In an effort to discover new small molecules able to inhibit the Hsp90 ATPase and chaperoning activities, we screened, by a surface plasmon resonance assay, a small library including different plant polyphenols. The ellagitannin geraniin, was identified as the most promising molecule, showing a binding affinity to Hsp90 alpha similar to that of 17-(allylamino)-17-demethoxygeldanamycin (17AGG). Geraniin was able to inhibit in vitro the Hsp90 alpha ATPase activity in a dose-dependent manner, with an inhibitory efficiency comparable to that measured for 17-AAG. In addition, this compound compromised the chaperone activity of Hsp90 alpha, monitored by the citrate synthase thermal induced aggregation assay. Geraniin decreased the viability of HeLa and Jurkat cell lines and caused an arrest in G(2)/M phase. We also proved that following exposure to different concentrations of geraniin, the level of expression of the client proteins c-Raf, pAkt, and EGFR was strongly down-regulated in both the cell lines. These results, along with the finding that geraniin did not exert any appreciable cytotoxicity on normal cells, encourage further studies on this compound as a promising chemical scaffold for the design of new Hsp90 inhibitors.	[Vassallo, Antonio] Univ Basilicata, Dipartimento Sci, I-85100 Potenza, Italy; [Vaccaro, Maria Carmela; De Tommasi, Nunziatina; Dal Piaz, Fabrizio; Leone, Antonella] Univ Salerno, Dipartimento Farm, Fisciano, Italy	University of Basilicata; University of Salerno	Dal Piaz, F (corresponding author), Univ Salerno, Dipartimento Farm, Fisciano, Italy.	fdalpiaz@unisa.it	Vassallo, Antonio/R-4508-2019; De Tommasi, Nunziatina/A-7768-2011; Dal Piaz, Fabrizio/D-1843-2010	Vassallo, Antonio/0000-0001-7937-3309; De Tommasi, Nunziatina/0000-0003-1707-4156; Dal Piaz, Fabrizio/0000-0002-8643-5018; Multhoff, Gabriele/0000-0002-2616-3137; Vaccaro, Maria Carmela/0000-0002-5194-2650				Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Bisht KS, 2003, CANCER RES, V63, P8984; Brandt GEL, 2008, J MED CHEM, V51, P6495, DOI 10.1021/jm8007486; Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Dal Piaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043316; Dal Piaz F, 2012, PHYTOCHEMISTRY, V75, P78, DOI 10.1016/j.phytochem.2011.12.002; Dal Piaz F, 2010, CHEMBIOCHEM, V11, P818, DOI 10.1002/cbic.200900721; Faiella L, 2012, MOL BIOSYST, V8, P2637, DOI 10.1039/c2mb25171j; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Holzbeierlein JM, 2010, CURR ONCOL REP, V12, P95, DOI 10.1007/s11912-010-0086-3; Ito H, 2011, PLANTA MED, V77, P1110, DOI 10.1055/s-0030-1270749; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kummar S, 2010, EUR J CANCER, V46, P340, DOI 10.1016/j.ejca.2009.10.026; Lee JC, 2008, MOL NUTR FOOD RES, V52, P655, DOI 10.1002/mnfr.200700381; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munster PN, 2001, CANCER RES, V61, P2945; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Okuda T, 1995, Fortschr Chem Org Naturst, V66, P1; Orru S, 1999, PROTEIN SCI, V8, P1445, DOI 10.1110/ps.8.7.1445; Piper PW, 2011, PHARMACEUTICALS, V4, P1400, DOI 10.3390/ph4111400; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Saif MW, 2013, CANCER CHEMOTH PHARM, V71, P1345, DOI 10.1007/s00280-013-2134-9; Shelton SN, 2009, MOL PHARM, V76, DOI [10.1124/mol.109.058545, DOI 10.1124/M0L.109.058545]; Solit DB, 2006, CURR TOP MED CHEM, V6, P1205, DOI 10.2174/156802606777812068; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang RE, 2011, CURR MED CHEM, V18, P4250; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yang YJ, 2012, BIOORG MED CHEM LETT, V22, P2209, DOI 10.1016/j.bmcl.2012.01.102; Yin ZY, 2009, BIOCHEMISTRY-US, V48, P336, DOI 10.1021/bi801637q; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484	37	26	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74266	10.1371/journal.pone.0074266	http://dx.doi.org/10.1371/journal.pone.0074266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066128	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000110
J	Zhao, ZB; Wang, L; Wen, Z; Ayaz-Guner, S; Wang, YD; Ahlquist, P; Xu, W				Zhao, Zibo; Wang, Lu; Wen, Zhi; Ayaz-guner, Serife; Wang, Yidan; Ahlquist, Paul; Xu, Wei			Systematic Analyses of the Cytotoxic Effects of Compound 11a, a Putative Synthetic Agonist of Photoreceptor-Specific Nuclear Receptor (PNR), in Cancer Cell Lines	PLOS ONE			English	Article							S-CONE SYNDROME; ANTICANCER DRUG SCREEN; COUP-TF; RETINOIC ACID; DIVERSE PANEL; NR2E3; EXPRESSION; INDUCTION; ASSAY; GENE	Photoreceptor cell-specific receptor (PNR/NR2E3) is an orphan nuclear receptor that plays a critical role in retinal development and photoreceptor maintenance. The disease-causing mutations in PNR have a pleiotropic effect resulting in varying retinal diseases. Recently, PNR has been implicated in control of cellular functions in cancer cells. PNR was reported to be a novel regulator of ER alpha expression in breast cancer cells, and high PNR expression correlates with favorable response to tamoxifen treatment. Moreover, PNR was shown to increase p53 stability in HeLa cells, implying that PNR may be a therapeutic target in this and other cancers that retain a wild type p53 gene. To facilitate further understanding of PNR functions in cancer, we characterized compound 11a, a synthetic, putative PNR agonist in several cell-based assays. Interestingly, we showed that 11a failed to activate PNR and its cytotoxicity was independent of PNR expression, excluding PNR as a mediator for 11a cytotoxicity. Systematic analyses of the cytotoxic effects of 11a in NCI-60 cell lines revealed a strong positive correlation of cytotoxicity with p53 status, i.e., p53 wild type cell lines were significantly more sensitive to 11a than p53 mutated or null cell lines. Furthermore, using HCT116 p53+/+ and p53-/- isogenic cell lines we revealed that the mechanism of 11a-induced cytotoxicity occurred through G(1)/S phase cell cycle arrest rather than apoptosis. In conclusion, we observed a correlation of 11a sensitivity with p53 status but not with PNR expression, suggesting that tumors expressing wild type p53 might be responsive to this compound.	[Zhao, Zibo; Wang, Lu; Ayaz-guner, Serife; Wang, Yidan; Ahlquist, Paul; Xu, Wei] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Ahlquist, Paul] Univ Wisconsin, Morgridge Inst Res, Madison, WI USA; [Wen, Zhi] Univ Wisconsin, Dept Oncol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Xu, W (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	wxu@oncology.wisc.edu	Ayaz-Guner, Serife/K-4139-2019; AYAZ-GUNER, Serife/ABE-6237-2020; Zhao, Zibo/GWQ-3444-2022	Ayaz-Guner, Serife/0000-0002-1052-0961; Wen, Zhi/0000-0002-0170-622X	National Institutes of Health [CA125387]; NIH [CA22443]; DOD ERA of HOPE Scholar Award [W81XWYH-11-1-0237]; NATIONAL CANCER INSTITUTE [R01CA125387, P01CA022443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ERA of HOPE Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project is supported by National Institutes of Health CA125387 to WX, NIH grant CA22443 to PA and DOD ERA of HOPE Scholar Award W81XWYH-11-1-0237 to WX. PA is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; Connick JH, 2002, BIOCHEM SOC T, V30, P786, DOI 10.1042/bst0300786; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gerber S, 2000, HUM GENET, V107, P276, DOI 10.1007/s004390000350; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Jackson A, 1998, GENOMICS, V50, P34, DOI 10.1006/geno.1998.5270; Jeong JH, 2010, MOL CANCER THER, V9, P2102, DOI 10.1158/1535-7163.MCT-09-1159; Kapitskaya M, 2006, ASSAY DRUG DEV TECHN, V4, P253, DOI 10.1089/adt.2006.4.253; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lepley DM, 1997, MOL CARCINOGEN, V19, P74, DOI 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Litchfield LM, 2012, J MOL ENDOCRINOL, V49, pR135, DOI 10.1530/JME-12-0144; Litchfield LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038278; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mollema NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017494; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Nakamura M, 2002, AM J OPHTHALMOL, V133, P575, DOI 10.1016/S0002-9394(01)01428-3; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; OCHENG HB, 2004, INVEST OPHTH VIS SCI, V45, P2807; OConnor PM, 1997, CANCER RES, V57, P4285; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; Parker GJ, 2000, J BIOMOL SCREEN, V5, P77, DOI 10.1177/108705710000500204; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Qin Q, 2013, J OCUL PHARMACOL TH, V29, P298, DOI 10.1089/jop.2012.0135; QIU Y, 1995, GENOMICS, V29, P240, DOI 10.1006/geno.1995.1237; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; STINSON SF, 1992, ANTICANCER RES, V12, P1035; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tenbaum S, 1997, INT J BIOCHEM CELL B, V29, P1325, DOI 10.1016/S1357-2725(97)00087-3; Webber AL, 2008, EXP EYE RES, V87, P35, DOI 10.1016/j.exer.2008.04.006; Wen Z, 2012, MOL CELL BIOL, V32, P26, DOI 10.1128/MCB.05513-11; Wolkenberg SE, 2006, BIOORG MED CHEM LETT, V16, P5001, DOI 10.1016/j.bmcl.2006.07.056; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Zhou GC, 2001, METHODS, V25, P54, DOI 10.1006/meth.2001.1215	61	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75198	10.1371/journal.pone.0075198	http://dx.doi.org/10.1371/journal.pone.0075198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066170	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000152
J	Aritua, V; Achor, D; Gmitter, FG; Albrigo, G; Wang, N				Aritua, Valente; Achor, Diann; Gmitter, Frederick G.; Albrigo, Gene; Wang, Nian			Transcriptional and Microscopic Analyses of Citrus Stem and Root Responses to Candidatus Liberibacter asiaticus Infection	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; GENE-EXPRESSION; HUANGLONGBING DISEASE; SWEET ORANGE; SALICYLIC-ACID; SINENSIS; FAMILY; RESISTANCE; FRUIT; RICE	Huanglongbing (HLB) is the most destructive disease that affects citrus worldwide. The disease has been associated with Candidatus Liberibacter. HLB diseased citrus plants develop a multitude of symptoms including zinc and copper deficiencies, blotchy mottle, corky veins, stunting, and twig dieback. Ca. L. asiaticus infection also seriously affects the roots. Previous study focused on gene expression of leaves and fruit to Ca. L. asiaticus infection. In this study, we compared the gene expression levels of stems and roots of healthy plants with those in Ca. L. asiaticus infected plants using microarrays. Affymetrix microarray analysis showed a total of 988 genes were significantly altered in expression, of which 885 were in the stems, and 111 in the roots. Of these, 551 and 56 were up-regulated, while 334 and 55 were down-regulated in the stem and root samples of HLB diseased trees compared to healthy plants, respectively. Dramatic differences in the transcriptional responses were observed between citrus stems and roots to Ca. L. asiaticus infection, with only 8 genes affected in both the roots and stems. The affected genes are involved in diverse cellular functions, including carbohydrate metabolism, cell wall biogenesis, biotic and abiotic stress responses, signaling and transcriptional factors, transportation, cell organization, protein modification and degradation, development, hormone signaling, metal handling, and redox. Microscopy analysis showed the depletion of starch in the roots of the infected plants but not in healthy plants. Collapse and thickening of cell walls were observed in HLB affected roots, but not as severe as in the stems. This study provides insight into the host response of the stems and roots to Ca. L. asiaticus infection.	[Aritua, Valente; Wang, Nian] Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Achor, Diann] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Gmitter, Frederick G.; Albrigo, Gene] Univ Florida, Citrus Res & Educ Ctr, Dept Hort Sci, Lake Alfred, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wang, N (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL USA.	nianwang@ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This work was supported by the Citrus Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achor D. S., 2010, Plant Pathology Journal (Faisalabad), V9, P56; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Alleva K, 2012, FEBS LETT, V586, P2991, DOI 10.1016/j.febslet.2012.06.013; Baldwin E, 2010, J AGR FOOD CHEM, V58, P1247, DOI 10.1021/jf9031958; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bove JM, 2006, J PLANT PATHOL, V88, P7; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Dagulo L, 2010, J FOOD SCI, V75, pC199, DOI 10.1111/j.1750-3841.2009.01495.x; Darley CP, 2001, PLANT MOL BIOL, V47, P179, DOI 10.1023/A:1010687600670; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fan J, 2012, MOL PLANT MICROBE IN, V25, P1396, DOI 10.1094/MPMI-06-12-0150-R; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; Gray-Mitsumune M, 2004, PLANT PHYSIOL, V135, P1552, DOI 10.1104/pp.104.039321; Gray-Mitsumunel M, 2004, PLANT BIOLOGY, V6, P47, DOI 10.1055/s-2003-44747; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Jang JY, 2012, PLANT SIGNAL BEHAV, V7, P1180, DOI 10.4161/psb.21178; Johnson E, 2012, PHYTOPATHOLOGY, V102, P59; Keegstra K, 2006, SCIENCE, V311, P1872, DOI 10.1126/science.1125938; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kovi M, 2011, THEOR APPL GENET, V123, P705, DOI 10.1007/s00122-011-1620-x; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Liao HL, 2012, J EXP BOT, V63, P3307, DOI 10.1093/jxb/ers070; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Molina-Hidalgo FJ, 2013, J EXP BOT, V64, P1471, DOI 10.1093/jxb/ers386; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Ogata T, 2008, P 1 INT RES C HUANGL, P184; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rosales R, 2011, J PLANT GROWTH REGUL, V30, P312, DOI 10.1007/s00344-011-9193-0; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Schneider H., 1981, STAIN PROCED, V4th, P315; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P8433, DOI 10.1073/pnas.92.18.8433; Seifert GJ, 2010, PLANT PHYSIOL, V153, P467, DOI 10.1104/pp.110.153940; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teakle GR, 2002, PLANT MOL BIOL, V50, P43, DOI 10.1023/A:1016062325584; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Verica JA, 2003, PLANT PHYSIOL, V133, P1732, DOI 10.1104/pp.103.028530; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Wang N, 2013, PHYTOPATHOLOGY; Wang WH, 2012, NEW PHYTOL, V193, P432, DOI 10.1111/j.1469-8137.2011.03929.x; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yool AJ, 2012, MOL ASPECTS MED, V33, P553, DOI 10.1016/j.mam.2012.02.001; Zheng ZL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-27; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	75	100	104	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73742	10.1371/journal.pone.0073742	http://dx.doi.org/10.1371/journal.pone.0073742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058486	gold, Green Submitted, Green Published			2022-12-27	WOS:000324408400033
J	Kucera, T; Otyepka, M; Matuskova, A; Samad, A; Kutejova, E; Janata, J				Kucera, Tomas; Otyepka, Michal; Matuskova, Anna; Samad, Abdul; Kutejova, Eva; Janata, Jiri			A Computational Study of the Glycine-Rich Loop of Mitochondrial Processing Peptidase	PLOS ONE			English	Article							ALPHA-SUBUNIT; BETA-SUBUNIT; CRYSTAL-STRUCTURES; PROTEIN IMPORT; CORE COMPLEX; BINDING; SEQUENCES; TRANSLOCATION; MEMBRANE; CLEAVAGE	An all atomic, non-restrained molecular dynamics (MD) simulation in explicit water was used to study in detail the structural features of the highly conserved glycine-rich loop (GRL) of the a-subunit of the yeast mitochondrial processing peptidase (MPP) and its importance for the tertiary and quaternary conformation of MPP. Wild-type and GRL-deleted MPP structures were studied using non-restrained MD simulations, both in the presence and the absence of a substrate in the peptidase active site. Targeted MD simulations were employed to study the mechanism of substrate translocation from the GRL to the active site. We demonstrate that the natural conformational flexibility of the GRL is crucial for the substrate translocation process from outside the enzyme towards the MPP active site. We show that the a-helical conformation of the substrate is important not only during its initial interaction with MPP (i.e. substrate recognition), but also later, at least during the first third of the substrate translocation trajectory. Further, we show that the substrate remains in contact with the GRL during the whole first half of the translocation trajectory and that hydrophobic interactions play a major role. Finally, we conclude that the GRL acts as a precisely balanced structural element, holding the MPP subunits in a partially closed conformation regardless the presence or absence of a substrate in the active site.	[Kucera, Tomas; Matuskova, Anna; Samad, Abdul; Kutejova, Eva; Janata, Jiri] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Kucera, Tomas] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic; [Otyepka, Michal] Palacky Univ, Fac Sci, Dept Phys Chem, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Kutejova, Eva] Slovak Acad Sci, Inst Mol Biol, Bratislava 84251, Slovakia	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Palacky University Olomouc; Slovak Academy of Sciences	Janata, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	janata@biomed.cas.cz	Kutejova, Eva/AAI-2544-2021; Samad, Abdul/K-6531-2014; Otyepka, Michal/A-5922-2008; Janata, Jiri/K-4554-2014; Otyepka, Michal/D-1220-2017; Kutejova, Eva/K-6550-2014	Kutejova, Eva/0000-0002-0973-679X; Otyepka, Michal/0000-0002-1066-5677; Janata, Jiri/0000-0002-4582-2062; Otyepka, Michal/0000-0002-1066-5677; Kutejova, Eva/0000-0002-0973-679X	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; Czech Science Foundation [P208/12/G016]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by grants No. CZ.1.07/2.3.00/20.0055 and CZ.1.07/2.3.00/30.0003 of the Ministry of Education, Youth and Sports of the Czech Republic. MO thanks the Czech Science Foundation (project P208/12/G016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Aleshin AE, 2009, STRUCTURE, V17, P1465, DOI 10.1016/j.str.2009.09.009; Amata O, 2011, J AM CHEM SOC, V133, P17824, DOI 10.1021/ja207065v; Bolhuis A, 2000, MOL BIOL EVOL, V17, P198, DOI 10.1093/oxfordjournals.molbev.a026232; BRAUN HP, 1995, TRENDS BIOCHEM SCI, V20, P171, DOI 10.1016/S0968-0004(00)88999-9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CERKASOVOVA A, 1976, Folia Parasitologica (Ceske Budejovice), V23, P33; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dvorakova-Hola K, 2010, J MOL BIOL, V396, P1197, DOI 10.1016/j.jmb.2009.12.054; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gakh O, 2001, ARCH BIOCHEM BIOPHYS, V385, P392, DOI 10.1006/abbi.2000.2167; GELI V, 1990, J BIOL CHEM, V265, P19216; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Janata J, 2004, BIOCHEM BIOPH RES CO, V316, P211, DOI 10.1016/j.bbrc.2004.02.025; KITADA S, 1995, J BIOCHEM-TOKYO, V117, P1148, DOI 10.1093/oxfordjournals.jbchem.a124836; Kitada S, 2007, J BACTERIOL, V189, P844, DOI 10.1128/JB.01261-06; Komuro Y, 2013, J PHYS CHEM B, V117, P2864, DOI 10.1021/jp400113e; Luciano P, 1997, J MOL BIOL, V272, P213, DOI 10.1006/jmbi.1997.1231; Maruyama Y, 2011, J MOL BIOL, V407, P180, DOI 10.1016/j.jmb.2011.01.038; Nagao Y, 2000, J BIOL CHEM, V275, P34552, DOI 10.1074/jbc.M003110200; Nishino TG, 2007, J BIOCHEM, V141, P889, DOI 10.1093/jb/mvm095; Ohtsuka J, 2009, PROTEINS, V75, P774, DOI 10.1002/prot.22365; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; Schrodinger L., 2020, PYMOL; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Striebel HM, 1996, ARCH BIOCHEM BIOPHYS, V335, P211, DOI 10.1006/abbi.1996.0500; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74518	10.1371/journal.pone.0074518	http://dx.doi.org/10.1371/journal.pone.0074518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058582	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400082
J	Lewis, MJ; Frohnen, P; Ibarrondo, FJ; Reed, D; Iyer, V; Ng, HL; Elliott, J; Yang, OO; Anton, P				Lewis, Martha J.; Frohnen, Patricia; Ibarrondo, F. Javier; Reed, Diane; Iyer, Varun; Ng, Hwee L.; Elliott, Julie; Yang, Otto O.; Anton, Peter			HIV-1 Nef Sequence and Functional Compartmentalization in the Gut Is Not Due to Differential Cytotoxic T Lymphocyte Selective Pressure	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COMPLEX CLASS-I; FEMALE GENITAL-TRACT; LONG-TERM SURVIVORS; CD4 DOWN-REGULATION; BLOOD-BANK COHORT; VIRAL INFECTIVITY; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; CELL RESPONSES	The gut is the largest lymphoid organ in the body and a site of active HIV-1 replication and immune surveillance. The gut is a reservoir of persistent infection in some individuals with fully suppressed plasma viremia on combination antiretroviral therapy (cART) although the cause of this persistence is unknown. The HIV-1 accessory protein Nef contributes to persistence through multiple functions including immune evasion and increasing infectivity. Previous studies showed that Nef's function is shaped by cytotoxic T lymphocyte (CTL) responses and that there are distinct populations of Nef within tissue compartments. We asked whether Nef's sequence and/or function are compartmentalized in the gut and how compartmentalization relates to local CTL immune responses. Primary nef quasispecies from paired plasma and sigmoid colon biopsies from chronically infected subjects not on therapy were sequenced and cloned into Env(-) Vpu(-) pseudotyped reporter viruses. CTL responses were mapped by IFN-gamma ELISpot using expanded CD8+ cells from blood and gut with pools of overlapping peptides covering the entire HIV proteome. CD4 and MHC Class I Nef-mediated downregulation was measured by flow cytometry. Multiple tests indicated compartmentalization of nef sequences in 5 of 8 subjects. There was also compartmentalization of function with MHC Class I downregulation relatively well preserved, but significant loss of CD4 downregulation specifically by gut quasispecies in 5 of 7 subjects. There was no compartmentalization of CTL responses in 6 of 8 subjects, and the selective pressure on quasispecies correlated with the magnitude CTL response regardless of location. These results demonstrate that Nef adapts via diverse pathways to local selective pressures within gut mucosa, which may be predominated by factors other than CTL responses such as target cell availability. The finding of a functionally distinct population within gut mucosa offers some insight into how HIV-1 may persist in the gut despite fully suppressed plasma viremia on cART.	[Lewis, Martha J.; Frohnen, Patricia; Reed, Diane; Iyer, Varun; Ng, Hwee L.; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA; [Ibarrondo, F. Javier; Elliott, Julie; Anton, Peter] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Lewis, Martha J.; Frohnen, Patricia; Ibarrondo, F. Javier; Reed, Diane; Iyer, Varun; Ng, Hwee L.; Elliott, Julie; Yang, Otto O.; Anton, Peter] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, MJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA.	malewis@mednet.ucla.edu			NIH [AI083083, AI028697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083083, P30AI028697] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI083083 and AI028697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Ali A, 2009, J VIROL METHODS, V161, P297, DOI 10.1016/j.jviromet.2009.07.006; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Alvarado JJ, 2013, 20 C RETR OPP INF AT; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Anton PA, 2001, J VIROL METHODS, V95, P65, DOI 10.1016/S0166-0934(01)00295-6; Borderia AV, 2007, EVOLUTION, V61, P272, DOI 10.1111/j.1558-5646.2007.00025.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Bull ME, 2013, J INFECT DIS, V207, P1206, DOI 10.1093/infdis/jit016; Bull ME, 2009, J VIROL, V83, P6020, DOI 10.1128/JVI.02664-08; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135; de Oliveira T, 2008, 15 C RETR OPP INF BO; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; Dyer WB, 1997, AIDS, V11, P1565, DOI 10.1097/00002030-199713000-00004; Felsenstein J., 1989, CLADISTICS, V5; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Franken P, 1997, PROTEIN SCI, V6, P2681; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geffin R, 2000, AIDS RES HUM RETROV, V16, P1855, DOI 10.1089/08892220050195810; Gray LR, 2011, J NEUROVIROL, V17, P82, DOI 10.1007/s13365-010-0001-6; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; Imamichi H, 2011, J INFECT DIS, V204, P309, DOI 10.1093/infdis/jir259; JAMIESON BD, 1994, J VIROL, V68, P3478, DOI 10.1128/JVI.68.6.3478-3485.1994; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; Lewis MJ, 2008, J IMMUNOL, V180, P4075, DOI 10.4049/jimmunol.180.6.4075; Lewis MJ, 2012, J VIROL, V86, P7126, DOI 10.1128/JVI.00878-12; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Musey L, 2003, J VIROL, V77, P291, DOI 10.1128/JVI.77.1.291-300.2003; Noviello CM, 2007, J VIROL, V81, P4776, DOI 10.1128/JVI.01793-06; Oelrichs R, 1998, AIDS RES HUM RETROV, V14, P811, DOI 10.1089/aid.1998.14.811; Olivieri KC, 2010, AIDS RES HUM RETROV, V26, P495, DOI 10.1089/aid.2009.0257; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ritola K, 2005, J VIROL, V79, P10830, DOI 10.1128/JVI.79.16.10830-10834.2005; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shacklett BL, 2010, CURR OPIN HIV AIDS, V5, P128, DOI 10.1097/COH.0b013e328335c178; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; SLATKIN M, 1989, GENETICS, V123, P603; Swigut T, 2004, J VIROL, V78, P13335, DOI 10.1128/JVI.78.23.13335-13344.2004; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; WONG JT, 1991, CLIN IMMUNOL IMMUNOP, V58, P236, DOI 10.1016/0090-1229(91)90139-2; Yang OO, 2002, J VIROL, V76, P1626, DOI 10.1128/JVI.76.4.1626-1631.2002; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06	60	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75620	10.1371/journal.pone.0075620	http://dx.doi.org/10.1371/journal.pone.0075620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058696	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400118
J	Tanveer, A; Allen, SM; Jackson, KE; Charan, M; Ralph, SA; Habib, S				Tanveer, Aiman; Allen, Stacey M.; Jackson, Katherine E.; Charan, Manish; Ralph, Stuart A.; Habib, Saman			An FtsH Protease Is Recruited to the Mitochondrion of Plasmodium falciparum	PLOS ONE			English	Article							M-AAA PROTEASE; BLOOD STAGES; MEMBRANE; PROTEINS; APICOPLAST; GENE; ATP; LOCALIZATION; ATPASES; TOXOPLASMA	The two organelles, apicoplast and mitochondrion, of the malaria parasite Plasmodium falciparum have unique morphology in liver and blood stages; they undergo complex branching and looping prior to division and segregation into daughter merozoites. Little is known about the molecular processes and proteins involved in organelle biogenesis in the parasite. We report the identification of an AAA+/FtsH protease homolog (PfFtsH1) that exhibits ATP- and Zn2+-dependent protease activity. PfFtsH1 undergoes processing, forms oligomeric assemblies, and is associated with the membrane fraction of the parasite cell. Generation of a transfectant parasite line with hemagglutinin-tagged PfFtsH1, and immunofluorescence assay with anti-PfFtsH1 Ab demonstrated that the protein localises to P. falciparum mitochondria. Phylogenetic analysis and the single transmembrane region identifiable in PfFtsH1 suggest that it is an i-AAA like inner mitochondrial membrane protein. Expression of PfFtsH1 in Escherichia coli converted a fraction of bacterial cells into division-defective filamentous forms implying a sequestering effect of the Plasmodium factor on the bacterial homolog, indicative of functional conservation with EcFtsH. These results identify a membrane-associated mitochondrial AAA+/FtsH protease as a candidate regulatory protein for organelle biogenesis in P. falciparum.	[Tanveer, Aiman; Charan, Manish; Habib, Saman] Cent Drug Res Inst, CSIR, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India; [Allen, Stacey M.; Jackson, Katherine E.; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Melbourne	Habib, S (corresponding author), Cent Drug Res Inst, CSIR, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India.	saman.habib@gmail.com	Charan, Manish/T-1789-2019; Ralph, Stuart/C-8590-2014	Charan, Manish/0000-0003-4648-8112; Ralph, Stuart/0000-0003-0114-7808	Council of Scientific and Industrial Research, Government of India (CSIR); CSIR Network Project [NWP-0038]; CSIR Network Project (SPLendid); Australian Research Council [FT0990350]	Council of Scientific and Industrial Research, Government of India (CSIR); CSIR Network Project(Council of Scientific & Industrial Research (CSIR) - India); CSIR Network Project (SPLendid); Australian Research Council(Australian Research Council)	AT received a research fellowship from the Council of Scientific and Industrial Research, Government of India (CSIR; http://www.csir.res.in/home.asp). This work was supported by CSIR Network Project (NWP-0038 and SPLendid) grants to SH. SAR is supported by an Australian Research Council Future Fellowship (FT0990350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 1999, BIOCHEMISTRY-US, V38, P11693, DOI 10.1021/bi991177c; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485, DOI 10.1074/jbc.270.40.23485; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; BEGG KJ, 1992, J BACTERIOL, V174, P2416, DOI 10.1128/JB.174.7.2416-2417.1992; Bruckner RC, 2003, BIOCHEMISTRY-US, V42, P10843, DOI 10.1021/bi034516h; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; DEBOER PAJ, 1990, ANNU REV GENET, V24, P249, DOI 10.1146/annurev.genet.24.1.249; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Dunn CD, 2008, MOL BIOL CELL, V19, P5387, DOI 10.1091/mbc.E08-01-0103; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Esseiva AC, 2004, J BIOL CHEM, V279, P42363, DOI 10.1074/jbc.M404519200; FEAGIN JE, 1992, MOL BIOCHEM PARASIT, V52, P145, DOI 10.1016/0166-6851(92)90046-M; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HIROTA Y, 1968, COLD SPRING HARB SYM, V33, P677, DOI 10.1101/SQB.1968.033.01.077; Hodges M, 2005, MOL BIOCHEM PARASIT, V143, P29, DOI 10.1016/j.molbiopara.2005.05.004; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Itoh R, 1999, PLANT MOL BIOL, V41, P321, DOI 10.1023/A:1006369104530; Janska H, 2005, PHYSIOL PLANTARUM, V123, P399, DOI 10.1111/j.1399-3054.2004.00439.x; Janska H, 2013, BBA-MOL CELL RES, V1833, P381, DOI 10.1016/j.bbamcr.2012.03.016; Jayasekera MMK, 2000, ARCH BIOCHEM BIOPHYS, V380, P103, DOI 10.1006/abbi.2000.1903; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Karata K, 2001, MOL MICROBIOL, V39, P890, DOI 10.1046/j.1365-2958.2001.02301.x; Karnataki A, 2007, TRAFFIC, V8, P1543, DOI 10.1111/j.1600-0854.2007.00637.x; Karnataki A, 2009, MOL BIOCHEM PARASIT, V166, P126, DOI 10.1016/j.molbiopara.2009.03.004; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Krungkrai J, 2004, PARASITOLOGY, V129, P511, DOI 10.1017/S0031182004005888; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Marbach PAS, 2001, GENET MOL BIOL, V24, P183, DOI 10.1590/S1415-47572001000100025; Matsuzaki M, 2001, PROTOPLASMA, V218, P180, DOI 10.1007/BF01306607; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Mi-Ichi F, 2003, ADV EXP MED BIOL, V531, P117; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Neuwald AF, 1999, GENOME RES, V9, P27; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; OGURA T, 1991, RES MICROBIOL, V142, P279, DOI 10.1016/0923-2508(91)90041-8; Okamoto N, 2009, EUKARYOT CELL, V8, P128, DOI 10.1128/EC.00267-08; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Piechota J, 2010, J BIOL CHEM, V285, P12512, DOI 10.1074/jbc.M109.063644; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Reisinger V, 2006, PROTEOMICS, P6, DOI 10.1002/pmic.200600553; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Saikawa N, 2002, BIOCHEMISTRY-US, V41, P1861, DOI 10.1021/bi015748o; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shotland Y, 2000, J MOL BIOL, V299, P953, DOI 10.1006/jmbi.2000.3767; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; TOMOYASU T, 1993, J BACTERIOL, V175, P1344, DOI 10.1128/JB.175.5.1344-1351.1993; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya Akhil B., 2004, Current Drug Targets - Infectious Disorders, V4, P11, DOI 10.2174/1568005043480907; Vaishnava S, 2006, MOL MICROBIOL, V61, P1380, DOI 10.1111/j.1365-2958.2006.05343.x; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Varadharajan S, 2004, BIOCHEM J, V384, P429, DOI 10.1042/BJ20040952; Varadharajan S, 2002, BIOCHEM J, V367, P321, DOI 10.1042/BJ20020834; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138	92	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74408	10.1371/journal.pone.0074408	http://dx.doi.org/10.1371/journal.pone.0074408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058559	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400072
J	Xia, CH; Lu, E; Zeng, J; Gong, XH				Xia, Chun-hong; Lu, Eric; Zeng, Jing; Gong, Xiaohua			Deletion of LRP5 in VLDLR Knockout Mice Inhibits Retinal Neovascularization	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; SUBRETINAL NEOVASCULARIZATION; LIPOPROTEIN RECEPTOR; VASCULAR DEVELOPMENT; MOUSE MODEL; ANGIOGENESIS; EXPRESSION; MUTATIONS; DENSITY	The development and maintenance of retinal vasculature require a precise balance between pro-angiogenic and anti-angiogenic factors. However, mechanisms underlying normal homeostasis of retinal vasculature and pathological changes of disrupted retinal vessel development are not fully understood. Recent studies of the low-density lipoprotein receptor-related protein 5 (LRP5) and the very low-density lipoprotein receptor (VLDLR) mutant mice indicate that LRP5 mediates a pro-angiogenic signal while VLDLR mediates an anti-angiogenic signal in retinal vasculature. Mice with a loss of LRP5 display underdeveloped intraretinal vasculature associated with endothelial cell (EC) clustering and failed EC migration into deep retinal layers. In contrast, VLDLR knockout mice show overgrown intraretinal vasculature and subretinal neovascularization. To understand the mechanisms for the opposite retinal vascular abnormalities between LRP5 and VLDLR mutant mice and to test how a loss of LRP5 perturbs subretinal neovascularization caused by a loss of VLDLR, we have generated and characterized the retinal vasculature in LRP5/VLDLR double knockout (DKO) mice. Our data show that DKO mice develop substantial EC clustering without subretinal neovascularization. The absence of subretinal neovascularization in DKO mice is associated with inhibited migration of ECs into the photoreceptor cell layer. In addition, the transcription level of Slc38a5, which encodes a Muller cell specific glutamine transporter, is significantly reduced in DKO mice, similar to previously reported changes in LRP5 single knockout mice. Thus, LRP5 signaling is a prerequisite for neovascularization in VLDLR knockout mice. LRP5 may be an effective target for inhibiting intraretinal neovascularization.	[Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gong, XH (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	xgong@berkeley.edu			East Bay Community Foundation; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER	East Bay Community Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a grant from the East Bay Community Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030203; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Jiang AH, 2009, INVEST OPHTH VIS SCI, V50, P844, DOI 10.1167/iovs.08-2447; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kirillova I, 2007, DEV BIOL, V311, P449, DOI 10.1016/j.ydbio.2007.08.056; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Nikopoulos K, 2010, HUM MUTAT, V31, P656, DOI 10.1002/humu.21250; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Takahashi S, 2003, MOL CELL BIOCHEM, V248, P121, DOI 10.1023/A:1024184201941; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Umapathy NS, 2005, INVEST OPHTH VIS SCI, V46, P3980, DOI 10.1167/iovs.05-0488; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xia CH, 2011, INVEST OPHTH VIS SCI, V52, P6572, DOI 10.1167/iovs.10-7082; Xia CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011676; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75186	10.1371/journal.pone.0075186	http://dx.doi.org/10.1371/journal.pone.0075186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058663	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400111
J	Davidich, MI; Bornholdt, S				Davidich, Maria I.; Bornholdt, Stefan			Boolean Network Model Predicts Knockout Mutant Phenotypes of Fission Yeast	PLOS ONE			English	Article							CELL-CYCLE; MATHEMATICAL-MODEL; S-PHASE; DYNAMICS; PROMOTES; MITOSIS; G(1); PHOSPHORYLATION; PROGRESSION; REGULATOR	Boolean networks (or: networks of switches) are extremely simple mathematical models of biochemical signaling networks. Under certain circumstances, Boolean networks, despite their simplicity, are capable of predicting dynamical activation patterns of gene regulatory networks in living cells. For example, the temporal sequence of cell cycle activation patterns in yeasts S. pombe and S. cerevisiae are faithfully reproduced by Boolean network models. An interesting question is whether this simple model class could also predict a more complex cellular phenomenology as, for example, the cell cycle dynamics under various knockout mutants instead of the wild type dynamics, only. Here we show that a Boolean network model for the cell cycle control network of yeast S. pombe correctly predicts viability of a large number of known mutants. So far this had been left to the more detailed differential equation models of the biochemical kinetics of the yeast cell cycle network and was commonly thought to be out of reach for models as simplistic as Boolean networks. The new results support our vision that Boolean networks may complement other mathematical models in systems biology to a larger extent than expected so far, and may fill a gap where simplicity of the model and a preference for an overall dynamical blueprint of cellular regulation, instead of biochemical details, are in the focus.	[Davidich, Maria I.; Bornholdt, Stefan] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany	University of Bremen	Bornholdt, S (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	bornholdt@itp.uni-bremen.de			Deutsche Forschungsgemeinschaft [INST 144/242-1 FUGG]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was in part supported by the Deutsche Forschungsgemeinschaft under contract No. INST 144/242-1 FUGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Buck V, 2003, J CELL SCI, V116, P4263; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Csikasz-Nagy A, 2008, ADV EXP MED BIOL, V641, P88; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Davidich M, 2008, J THEOR BIOL, V255, P269, DOI 10.1016/j.jtbi.2008.07.020; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; Gupta S, 2007, J THEOR BIOL, V244, P463, DOI 10.1016/j.jtbi.2006.08.014; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Li B, 2010, J THEOR BIOL, V264, P771, DOI 10.1016/j.jtbi.2010.03.023; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Martin-Castellanos C, 1996, EMBO J, V15, P839, DOI 10.1002/j.1460-2075.1996.tb00419.x; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; MILLAR JBA, 1992, EMBO J, V11, P4933, DOI 10.1002/j.1460-2075.1992.tb05600.x; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; Moriya H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.91; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; PARIS J, 1994, J CELL SCI, V107, P615; Romanel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029716; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Rybarsch M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026114; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Thi QCL, 2006, PERIODICA POLYTEC CE, V50, P81; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Villani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017703; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442; Yamaguchi S, 2000, EMBO J, V19, P3968, DOI 10.1093/emboj/19.15.3968; Zanudo JGT, 2011, INTEL SYST REF LIBR, V11, P113, DOI 10.1007/978-3-642-19621-8_6	57	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e71786	10.1371/journal.pone.0071786	http://dx.doi.org/10.1371/journal.pone.0071786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069138	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300002
J	Edin, S; Wikberg, ML; Rutegard, J; Oldenborg, PA; Palmqvist, R				Edin, Sofia; Wikberg, Maria L.; Rutegard, Jorgen; Oldenborg, Per-Arne; Palmqvist, Richard			Phenotypic Skewing of Macrophages In Vitro by Secreted Factors from Colorectal Cancer Cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INFILTRATING MACROPHAGES; T-CELLS; SURVIVAL; INFLAMMATION; PROGRESSION; ACTIVATION; RESOLUTION; FRONT	Macrophages are cells with many important functions in both innate and adaptive immune responses and have been shown to play a complex role in tumor progression since they harbour both tumor preventing (M1 macrophages) and tumor promoting (M2 macrophages) activities. In many human cancers, infiltrating macrophages have been associated with a poor patient prognosis, and therefore suggested to be mainly of an M2 phenotype. However, we and others have previously shown that increased macrophage density in colorectal cancer (CRC) instead is correlated with an improved prognosis. It is an intriguing question if the different roles played by macrophages in various cancers could be explained by variations in the balance between M1 and M2 macrophage attributes, driven by tumor- or organ-specific factors in the tumor microenvironment of individual cancers. Here, we utilized an in vitro cell culture system of macrophage differentiation to compare differences and similarities in the phenotype (morphology, antigen-presentation, migration, endocytosis, and expression of cytokine and chemokine genes) between M1/M2 and tumor activated macrophages (TAMs), that could explain the positive role of macrophages in CRC. We found that secreted factors from CRC cells induced TAMs of a "mixed" M1/M2 phenotype, which in turn could contribute to a "good inflammatory response". This suggests that re-education of macrophages might allow for important therapeutic advances in the treatment of human cancer.	[Edin, Sofia; Wikberg, Maria L.; Palmqvist, Richard] Umea Univ, Dept Med Biosci, Umea, Sweden; [Rutegard, Jorgen] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Oldenborg, Per-Arne] Umea Univ, Dept Integrat Med Biol, Sect Histol & Cell Biol, Umea, Sweden	Umea University; Umea University; Umea University	Edin, S (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	sofia.edin@medbio.umu.se			Swedish Cancer Society [CAN 2011/839]; Swedish Research Council [B03488901]; County Council of Vasterbotten, Sweden [VLL-132981]; Cancer Research Foundation in Northern Sweden [AMP 10-655]; Tore Nilssons Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten, Sweden; Cancer Research Foundation in Northern Sweden; Tore Nilssons Foundation	This study was supported by grants from the Swedish Cancer Society (Grant no. CAN 2011/839, Palmqvist) (www.cancerfonden.se); Swedish Research Council (Grant no. B03488901, Palmqvist) (www.vr.se); Cutting-Edge Research Grant from the County Council of Vasterbotten, Sweden (Grant no. VLL-132981, Palmqvist); Cancer Research Foundation in Northern Sweden (Grant no. AMP 10-655, Edin) (www.cancerforskningsfonden.se); and Tore Nilssons Foundation (Edin) (www.torenilssonsstiftelse.nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Balkwill Frances R., 1992, Progress in Growth Factor Research, V4, P121, DOI 10.1016/0955-2235(92)90027-F; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Lackner C, 2004, VIRCHOWS ARCH, V445, P160, DOI 10.1007/s00428-004-1051-z; Lanca T, 2012, ONCOIMMUNOLOGY, V1, P717, DOI 10.4161/onci.20068; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Nielsen HJ, 1999, J PATHOL, V189, P487, DOI 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I; Ong SM, 2012, EUR J IMMUNOL, V42, P89, DOI 10.1002/eji.201141825; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Richards CH, 2012, BRIT J CANCER, V106, P2010, DOI 10.1038/bjc.2012.211; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schmieder A, 2012, SEMIN CANCER BIOL, V22, P289, DOI 10.1016/j.semcancer.2012.02.002; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Weber B, 2009, SEMIN IMMUNOPATHOL, V31, P171, DOI 10.1007/s00281-009-0156-5; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13	30	55	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74982	10.1371/journal.pone.0074982	http://dx.doi.org/10.1371/journal.pone.0074982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058644	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900089
J	Lemke, S; Muller, C; Lipke, E; Uhl, G; Hildebrandt, JP				Lemke, Sarah; Mueller, Christian; Lipke, Elisabeth; Uhl, Gabriele; Hildebrandt, Jan-Peter			May Salivary Gland Secretory Proteins from Hematophagous Leeches (Hirudo verbana) Reach Pharmacologically Relevant Concentrations in the Vertebrate Host?	PLOS ONE			English	Article							MEDICINAL LEECH; INHIBITORS; THROMBIN; BINDING	Saliva of hematophagous leeches (Hirudo sp.) contains bioactive proteins which allow the leech proper feeding and storage of ingested blood, but may also exert effects in the host. Leech therapy is used to treat many different ailments in humans, although only a small fraction of salivary proteins are characterized yet. Moreover, we do not know whether complete transfer of salivary proteins stored in the unicellular salivary glands in a leech to the host during feeding may generate concentrations that are sufficiently high to affect physiological processes in the host. Our 3D reconstruction of a portion of internal leech tissue from histological sections revealed that one leech contains approx. 37,000 salivary gland cells. Using tissue slices from pig liver and mouse skeletal muscle for reference, we obtained data for protein densities in leech salivary gland cells. As individual salivary cells are voluminous (67,000 mu m(3)) and the stored proteins are densely packed (approx. 500 mg/mu m(3)), we extrapolated that a single leech may contain up to 1.2 mg of salivary proteins. Analyzing protein extracts of unfed or fed leeches by 2D electrophoresis, we calculated the relative molar amounts of individual salivary proteins in the mass range of 17-60 kDa which may be released from a single leech during feeding. Distribution of these salivary proteins in the host (assumed plasma volume of 5 l) may result in concentrations of individual compounds between 3 and 236 pmol/l. Such concentrations seem sufficiently high to exert biochemical interactions with target molecules in the host.	[Lemke, Sarah; Mueller, Christian; Lipke, Elisabeth; Uhl, Gabriele; Hildebrandt, Jan-Peter] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Hildebrandt, JP (corresponding author), Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany.	jph@uni-greifswald.de	Müller, Christian/AAE-3806-2021	Uhl, Gabriele/0000-0001-8758-7913; Hildebrandt, Jan-Peter/0000-0001-7827-8481				ASCENZI P, 1992, J MOL BIOL, V225, P177, DOI 10.1016/0022-2836(92)91034-M; ASCENZI P, 1995, MOL ASPECTS MED, V16, P215, DOI 10.1016/0098-2997(95)00002-X; Baskova IP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P219, DOI 10.1134/S0006297907020137; Baskova IP, 2004, BIOCHEMISTRY-MOSCOW+, V69, P770, DOI 10.1023/B:BIRY.0000040202.21965.2a; Baskova IP, 2001, BIOCHEMISTRY-MOSCOW+, V66, P703, DOI 10.1023/A:1010223325313; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAMAS D, 1974, Archives de Zoologie Experimentale et Generale, V115, P279; DAMAS D, 1972, Archives de Zoologie Experimentale et Generale, V113, P401; Gabe M., 1968, TECHNIQUES HISTOLOGI; Greinacher A, 2008, THROMB HAEMOSTASIS, V99, P819, DOI 10.1160/TH07-11-0693; Hach W, 2005, GEFASSCHIRURGIE, V10, P195, DOI 10.1007/s00772-005-0396-1; Haycraft J. B., 1884, P ROY SOC LOND B BIO, V36, P478, DOI [10.1098/rspl.1883.0135, DOI 10.1098/RSPL.1883.0135]; Hildebrandt JP, 2011, NATURWISSENSCHAFTEN, V98, P995, DOI 10.1007/s00114-011-0859-z; LENT CM, 1988, J EXP BIOL, V137, P513; MANN KH, 1962, LEECHES HIRUDINEA; MARSHALL CG, 1988, J EXP BIOL, V137, P89; Min GS, 2010, J PARASITOL, V96, P1211, DOI 10.1645/GE-2496.1; Nowak G, 2007, THROMB HAEMOSTASIS, V98, P116, DOI 10.1160/Th07-05-0364; OPPLER P, 1904, THESIS U BERN; Pilcher H, 2004, NATURE, V432, P10, DOI 10.1038/432010a; Riede F, 2010, J DTSCH DERMATOL GES, V8, P881, DOI 10.1111/j.1610-0387.2010.07473.x; Rigbi M, 1996, SEMIN THROMB HEMOST, V22, P273, DOI 10.1055/s-2007-999019; Sawyer RT, 1986, LEECH BIOL BEHAV 2 F; STONE SR, 1991, BIOCHEMISTRY-US, V30, P3950, DOI 10.1021/bi00230a021; Whitaker IS, 2004, BRIT J PLAST SURG, V57, P348, DOI 10.1016/j.bjps.2003.12.016; Yanes O, 2005, MOL CELL PROTEOMICS, V4, P1602, DOI 10.1074/mcp.M500145-MCP200; Zaidi SMA, 2011, ALTERN MED REV, V16, P59	28	9	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73809	10.1371/journal.pone.0073809	http://dx.doi.org/10.1371/journal.pone.0073809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058492	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900022
J	Zhang, Y; Hermanson, ME; Eddinger, TJ				Zhang, Yu; Hermanson, Meghan E.; Eddinger, Thomas J.			Tonic and Phasic Smooth Muscle Contraction Is Not Regulated by the PKC alpha - CPI-17 Pathway in Swine Stomach Antrum and Fundus	PLOS ONE			English	Article							PROTEIN-KINASE-C; CROSS-BRIDGE PHOSPHORYLATION; SCAFFOLDING DOMAIN PEPTIDE; LIGHT-CHAIN PHOSPHATASE; SIGNAL-TRANSDUCTION; MYOSIN PHOSPHATASE; CALCIUM SENSITIVITY; ANCHORING PROTEINS; MAMMALIAN-TISSUES; CA2+ SENSITIVITY	Regulation of myosin light chain phosphatase (MLCP) via protein kinase C (PKC) and the 17 kDa PKC-potentiated inhibitor of myosin light chain phosphatase (CPI-17) has been reported as a Ca2+ sensitization signaling pathway in smooth muscle (SM), and thus may be involved in tonic vs. phasic contractions. This study examined the protein expression and spatial-temporal distribution of PKC alpha and CPI-17 in intact SM tissues. KCl or carbachol (CCh) stimulation of tonic stomach fundus SM generates a sustained contraction while the phasic stomach antrum generates a transient contraction. In addition, the tonic fundus generates greater relative force than phasic antrum with 1 mu M phorbol 12, 13-dibutyrate (PDBu) stimulation which is reported to activate the PKC alpha - CPI-17 pathway. Western blot analyses demonstrated that this contractile difference was not caused by a difference in the protein expression of PKC alpha or CPI-17 between these two tissues. Immunohistochemical results show that the distribution of PKC alpha in the longitudinal and circular layers of the fundus and antrum do not differ, being predominantly localized near the SM cell plasma membrane. Stimulation of either tissue with 1 mu M PDBu or 1 mu M CCh does not alter this peripheral PKC alpha distribution. There are no differences between these two tissues for the CPI-17 distribution, but unlike the PKC alpha distribution, CPI-17 appears to be diffusely distributed throughout the cytoplasm under relaxed tissue conditions but shifts to a primarily peripheral distribution at the plasma membrane with stimulation of the tissues with 1 mu M PDBu or 1 mu M CCh. Results from double labeling show that neither PKC alpha nor CPI-17 co-localize at the adherens junction (vinculin/talin) at the membrane but they do co-localize with each other and with caveoli (caveolin) at the membrane. This lack of difference suggests that the PKC alpha - CPI-17 pathway is not responsible for the tonic vs. phasic contractions observed in stomach fundus and antrum.	[Zhang, Yu; Eddinger, Thomas J.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Hermanson, Meghan E.] Bradley Univ, Dept Biol, Peoria, IL 61625 USA	Marquette University; Bradley University	Eddinger, TJ (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	thomas.eddinger@marquette.edu			National Science Foundation (NSF), Biological Sciences Department; Graduate School, Marquette University	National Science Foundation (NSF), Biological Sciences Department(National Science Foundation (NSF)); Graduate School, Marquette University	This work was supported by the National Science Foundation (NSF), Biological Sciences Department and Graduate School, Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON FT, 1975, J MOL BIOL, V98, P17, DOI 10.1016/S0022-2836(75)80098-2; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Bitar KN, 2002, J APPL PHYSIOL, V92, P41, DOI 10.1152/jappl.2002.92.1.41; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen XS, 2008, AM J PHYSIOL-HEART C, V295, pH2172, DOI 10.1152/ajpheart.91437.2007; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; DONG LQ, 1993, CELL GROWTH DIFFER, V4, P793; Eddinger TJ, 2007, AM J PHYSIOL-GASTR L, V292, pG684, DOI 10.1152/ajpgi.00277.2006; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; Eddinger TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC1379, DOI 10.1152/ajpcell.00193.2005; EDDINGER TJ, 1993, CELL MOTIL CYTOSKEL, V25, P358, DOI 10.1002/cm.970250406; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; GIULIAN GG, 1983, ANAL BIOCHEM, V129, P277, DOI 10.1016/0003-2697(83)90551-1; Hai CM, 2005, J APPL PHYSIOL, V98, P1356, DOI 10.1152/japplphysiol.00834.2004; HAI CM, 1988, AM J PHYSIOL, V254, pC99, DOI 10.1152/ajpcell.1988.254.1.C99; Haller H, 1998, ACTA PHYSIOL SCAND, V164, P599; HALLER H, 1990, BIOCHEM J, V270, P375, DOI 10.1042/bj2700375; Han SJ, 2006, AM J PHYSIOL-HEART C, V291, pH138, DOI 10.1152/ajpheart.00977.2005; Hayashi Y, 2001, J BIOL CHEM, V276, P39858, DOI 10.1074/jbc.M107302200; Herrera AM, 2005, J CELL SCI, V118, P2381, DOI 10.1242/jcs.02368; HIMPENS B, 1988, J GEN PHYSIOL, V92, P713, DOI 10.1085/jgp.92.6.713; Huang Q, 2013, AM J PHYSIOL-CELL PH, V304, pC194, DOI 10.1152/ajpcell.00280.2012; Huster M, 2010, FASEB J, V24, P2651, DOI 10.1096/fj.09-149856; Ibitayo AI, 1999, AM J PHYSIOL-GASTR L, V277, pG445, DOI 10.1152/ajpgi.1999.277.2.G445; INOUE M, 1977, J BIOL CHEM, V252, P7610; Khromov A, 1998, BIOPHYS J, V75, P1926, DOI 10.1016/S0006-3495(98)77633-7; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; Kolosova IA, 2004, AM J PHYSIOL-LUNG C, V287, pL970, DOI 10.1152/ajplung.00398.2003; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Li C, 2002, ACTA PHYSIOL SCAND, V174, P237, DOI 10.1046/j.1365-201x.2002.00945.x; Li L, 1998, J PHYSIOL-LONDON, V508, P871, DOI 10.1111/j.1469-7793.1998.871bp.x; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Meininger GA, 1999, BIOPHYS J, V77, P973, DOI 10.1016/S0006-3495(99)76948-1; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morano I, 2003, J MOL MED-JMM, V81, P481, DOI 10.1007/s00109-003-0451-x; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nelson CP, 2008, AM J PHYSIOL-CELL PH, V295, pC1590; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NIXON GF, 1994, J MUSCLE RES CELL M, V15, P682, DOI 10.1007/BF00121075; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; RASMUSSEN H, 1987, FASEB J, V1, P177, DOI 10.1096/fasebj.1.3.3040504; Rattan S, 2010, GASTROENTEROLOGY, V138, P13, DOI 10.1053/j.gastro.2009.11.016; Ratz PH, 2005, AM J PHYSIOL-CELL PH, V288, pC769, DOI 10.1152/ajpcell.00529.2004; RATZ PH, 1989, AM J PHYSIOL, V256, pC96, DOI 10.1152/ajpcell.1989.256.1.C96; Rhee AY, 2006, PFLUG ARCH EUR J PHY, V452, P766, DOI 10.1007/s00424-006-0091-4; Sakai H, 2005, AM J PHYSIOL-LUNG C, V289, pL925, DOI 10.1152/ajplung.00054.2005; Santana LF, 2009, J MOL CELL CARDIOL, V47, P436, DOI 10.1016/j.yjmcc.2009.07.008; SECREST RJ, 1991, J PHARMACOL EXP THER, V256, P103; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SMALL JV, 1995, BIOESSAYS, V17, P785, DOI 10.1002/bies.950170908; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; SOMLYO AP, 1968, PHARMACOL REV, V20, P197; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1985, EXPERIENTIA, V41, P841, DOI 10.1007/BF01970000; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; SUTHERLAND C, 1989, J BIOL CHEM, V264, P578; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; Szymanski PT, 1997, J BIOL CHEM, V272, P11142; Taggart MJ, 1999, EXP CELL RES, V251, P92, DOI 10.1006/excr.1999.4565; Taggart MJ, 2000, EXP CELL RES, V258, P72, DOI 10.1006/excr.2000.4891; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x	74	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74608	10.1371/journal.pone.0074608	http://dx.doi.org/10.1371/journal.pone.0074608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058600	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900066
J	Chen, GQ; He, YH; Qiang, S				Chen, Guo-Qi; He, Yun-He; Qiang, Sheng			Increasing Seriousness of Plant Invasions in Croplands of Eastern China in Relation to Changing Farming Practices: A Case Study	PLOS ONE			English	Article							GLYPHOSATE-RESISTANT WEEDS; OAT AVENA-FATUA; SEED DISPERSAL; CLIMATE-CHANGE; EXPANSION; SYSTEMS; POPULATION; DIVERSITY; ECOLOGY; MODELS	Arable areas are commonly susceptible to alien plant invasion because they experience dramatic environmental influences and intense anthropogenic activity. However, the limited reports on relevant factors in plant invasion of croplands have addressed single or a few invasive species and environmental factors. To elucidate key factors affecting plant invasions in croplands, we analyzed the relationship between 11 effective factors and changes in composition of alien plants, using field surveys of crop fields in Anhui Province conducted during 1987-1990 (historical dataset) and 2005-2010 (recent dataset), when rapid urbanization was occurring in China. We found that in the past few decades, the dominance and richness of alien plant populations approximately doubled, despite differences among the 4 regions of Anhui Province. Among the 38 alien invasive plant species observed in the sites, the dominance values of 11 species increased significantly, while the dominance of 4 species decreased significantly. The quantity of chemical fertilizer and herbicide applied, population density, agricultural machinery use, traffic frequency, and annual mean temperature were significantly related to increased richness and annual dominance values of alien plant species. Our findings suggest that the increase in alien plant invasions during the past few decades is primarily a result of increased application of chemical fertilizer and herbicides.	[Chen, Guo-Qi; He, Yun-He; Qiang, Sheng] Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China; [He, Yun-He] Zhejiang Agr & Forestry Univ, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang A&F University	Qiang, S (corresponding author), Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China.	wrl@njau.edu.cn	Qiang, Sheng/A-6161-2012		National Basic Research and Development Program [2009CB1192]; China National Natural Science Foundation [31070482]; Graduate Student Research and Innovation Program of Jiangsu Province [CXZZ11.0647]; 111 Project [B07030]	National Basic Research and Development Program(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Graduate Student Research and Innovation Program of Jiangsu Province; 111 Project(Ministry of Education, China - 111 Project)	This research was supported by National Basic Research and Development Program (2009CB1192), China National Natural Science Foundation (31070482), Graduate Student Research and Innovation Program of Jiangsu Province (CXZZ11.0647) and the 111 Project (B07030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckie HJ, 1999, WEED TECHNOL, V13, P612, DOI 10.1017/S0890037X00046297; Blanco-Moreno JM, 2004, WEED RES, V44, P375, DOI 10.1111/j.1365-3180.2004.00412.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Clements DR, 2004, AGR ECOSYST ENVIRON, V104, P379, DOI 10.1016/j.agee.2004.03.003; DeGasperis BG, 2007, ECOLOGY, V88, P3115, DOI 10.1890/06-2014.1; Dekker J, 1997, WEED SCI, V45, P357, DOI 10.1017/S0043174500092985; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; [丁一汇 Ding Yihui], 2004, [气象学报, Acta Meteorologica Sinica], V62, P228; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Freckleton RP, 2009, WEED RES, V49, P225, DOI 10.1111/j.1365-3180.2009.00694.x; Gavier-Pizarro GI, 2010, ECOL APPL, V20, P1913, DOI 10.1890/09-2168.1; Graziani A, 2009, AQUAT BOT, V90, P78, DOI 10.1016/j.aquabot.2008.06.003; He JR, 2008, ANHUI AGR SCI B, V14, P41; Holm LG, 1979, GEOGRAPHICAL ATLAW; HRAC, 2012, INT SURVEY HERBICIDE; Hu YZ, 2010, ANHUI AGR SCI B, V16, P143; Huang QQ, 2011, WEED RES, V51, P534, DOI 10.1111/j.1365-3180.2011.00868.x; Huang Y, 2005, AGR ECOSYST ENVIRON, V105, P181, DOI 10.1016/j.agee.2004.04.004; Jose-Maria L, 2010, J APPL ECOL, V47, P832, DOI 10.1111/j.1365-2664.2010.01822.x; Kovacs-Hostyanszki A, 2011, APPL VEG SCI, V14, P40, DOI 10.1111/j.1654-109X.2010.01098.x; LI YH, 1998, WEED FLORA CHINA; McDonald A, 2009, AGR ECOSYST ENVIRON, V130, P131, DOI 10.1016/j.agee.2008.12.007; Mueller TC, 2003, J AGR FOOD CHEM, V51, P680, DOI 10.1021/jf026006k; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Nandula VK, 1999, WEED SCI, V47, P486, DOI 10.1017/S0043174500092158; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Perez A, 2003, WEED RES, V43, P12, DOI 10.1046/j.1365-3180.2003.00311.x; Petit S, 2011, AGRON SUSTAIN DEV, V31, P309, DOI 10.1051/agro/2010020; Ponce C, 2011, AGR ECOSYST ENVIRON, V141, P193, DOI 10.1016/j.agee.2011.02.030; Powles SB, 2008, PEST MANAG SCI, V64, P360, DOI 10.1002/ps.1525; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Price JN, 2011, OECOLOGIA, V167, P759, DOI 10.1007/s00442-011-2027-8; Qiang S, 2005, J INTEGR PLANT BIOL, V47, P1193, DOI 10.1111/j.1744-7909.2005.00131.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Seastedt T, 2007, NATURE, V446, P985, DOI 10.1038/446985a; Seipel T, 2012, GLOBAL ECOL BIOGEOGR, V21, P236, DOI 10.1111/j.1466-8238.2011.00664.x; Shirtliffe SJ, 2005, WEED SCI, V53, P465, DOI 10.1614/WS-03-109R2; Song AY, 2011, ANHUI AGR SCI B, V17, P33; Statistics Bureau of Anhui Province, 1991, STAT BUR ANH PROV AN; Thomas AG, 2011, WEED RES, V51, P41, DOI 10.1111/j.1365-3180.2010.00821.x; Touchette BW, 2010, BIOL INVASIONS, V12, P893, DOI 10.1007/s10530-009-9510-8; Vila-Aiub MM, 2008, PEST MANAG SCI, V64, P366, DOI 10.1002/ps.1488; Wang N, 2009, PLANT BIOLOGY, V11, P483, DOI 10.1111/j.1438-8677.2008.00133.x; Wang R, 2011, NEW PHYTOL, V191, P828, DOI 10.1111/j.1469-8137.2011.03720.x; Wei YB, 2012, ANHUI AGR SCI B, V18, P68; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wu JingLun, 2000, Chinese Journal of Rice Science, V14, P37; Xie J, 2011, P NATL ACAD SCI USA, V108, pE1381, DOI 10.1073/pnas.1111043108; Xie WS, 2011, METEOROLOGICAL SCI T, P160; [许信旺 XU Xinwang], 2011, [农业环境科学学报, Journal of Agro-Environment Science], V30, P1755; Yu EL, 2010, ANHUI AGR SCI B, V16, P172; Zhang BW, 2002, PESTICIDE, V41, P12; Zhang QY, 2003, PLANT PROTECTION TEC, V23, P34; Zhang R, 2011, PLOS ONE, V6; Zhang Ze Pu, 2003, Weed Biology and Management, V3, P197, DOI 10.1046/j.1444-6162.2003.00105.x; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zuo Ran-ling, 2007, Zhongguo Shuidao Kexue, V21, P417	59	8	12	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74136	10.1371/journal.pone.0074136	http://dx.doi.org/10.1371/journal.pone.0074136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066105	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000087
J	Dror, N; Mandel, M; Lavie, G				Dror, Naama; Mandel, Mathilda; Lavie, Gad			Unique Anti-Glioblastoma Activities of Hypericin Are at the Crossroad of Biochemical and Epigenetic Events and Culminate in Tumor Cell Differentiation	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; DNA METHYLATION; CANCER; HSP90; METHYLTRANSFERASES; EXPRESSION; MECHANISM	Failure of conventional therapies to alleviate glioblastoma (GBM) fosters search for novel therapeutic strategies. These include epigenetic modulators as histone deacetylase inhibitors (HDACi), which relax abnormally compact tumor cell chromatin organization, enabling cells to overcome blockage in differentiation. However, in clinical settings, HDACi efficacy is confined to subsets of hematologic malignancies. We reasoned that molecules targeting multiple epigenetic mechanisms may exhibit superior anti-cancer activities. We focused on the redox perylene-quinone Hypericin (HYP) and showed that HYP targets Hsp90 for polyubiquitination, degradation and inactivation. Hsp90 is implicated in mediating inheritable epigenetic modifications transferable to progeny. We therefore examined if HYP can induce epigenetic alterations in GBM cells and show here that HYP indeed, targets multiple mechanisms in human glioblastoma tumor cell lines via unique manners. These elicit major epigenetic signature changes in key developmentally regulated genes. HYP induces neuroglial tumor cell differentiation modulating the cytoarchitecture, neuroglial differentiation antigen expression and causes exit from cell proliferation cycles. Such activities characterize HDACi however HYP is not an HDAC inhibitor. Instead, HYP effectively down-regulates expression of Class-I HDACs, creating marked deficiencies in HDACs cellular contents, leading to histones H3 and H4 hyperacetylation. Expression of EZH2, the Polycomb repressor complex-2 catalytic subunit, which trimethylates histone H3K27 is also suppressed. The resulting histone hyperacetylation and diminished H3K27-trimethylation relax chromatin structure, activating gene transcription including differentiation-promoting genes. DNMT profiles are also modulated increasing global DNA methylation. HYP induces unique epigenetic down-regulations of HDACs, EZH2 and DNMTs, remodeling chromatin structure and culminating in tumor cell differentiation. These modulations generate clinically significant anti-GBM effects obtained in a clinical trial performed in patients with recurrent, progressive disease. Despite this advanced disease stage, patients responded to HYP, displaying stable disease and partial responses; patients on compassionate therapy survived for up to 34 months. Hypericin may constitute a novel anti-glioblastoma therapeutic paradigm.	[Dror, Naama; Lavie, Gad] Tel Aviv Univ, Sackler Sch Med, Dept Cellular & Dev Biol, IL-69978 Tel Aviv, Israel; [Mandel, Mathilda; Lavie, Gad] Chaim Sheba Med Ctr, Ctr Blood, IL-52621 Tel Hashomer, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Lavie, G (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cellular & Dev Biol, IL-69978 Tel Aviv, Israel.	gad.lavie@sheba.health.gov.il			Israel Cancer Association [20090033, 20122012]; Maratier Foundation; Elsa and Leo Abramson Foundation, Tel Aviv University	Israel Cancer Association; Maratier Foundation; Elsa and Leo Abramson Foundation, Tel Aviv University	This research was funded by the Israel Cancer Association, grants 20090033 thanks to a contribution by Rick and Rita Weinstein, Israel Cancer Association Grant 20122012 and two competitive grants from: The Maratier Foundation and the Elsa and Leo Abramson Foundation, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Barliya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022849; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Blank M, 2003, CANCER RES, V63, P8241; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Campos B, 2011, CANCER SCI, V102, P387, DOI 10.1111/j.1349-7006.2010.01792.x; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; Couldwell WT, 2011, CANCER-AM CANCER SOC, V117, P4905, DOI 10.1002/cncr.26123; Crea F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-265; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; GERSON F, 1995, J AM CHEM SOC, V117, P11861, DOI 10.1021/ja00153a007; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; KEISARI Y, 1992, J IMMUNOL METHODS, V146, P155, DOI 10.1016/0022-1759(92)90224-H; Kim JI, 1998, ARCH PHARM RES, V21, P41, DOI 10.1007/BF03216751; Kreth S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017156; Lavie Gad, 2005, Angiogenesis, V8, P35, DOI 10.1007/s10456-005-3828-3; Lee KT, 1999, BIOL PHARM BULL, V22, P1271, DOI 10.1248/bpb.22.1271; Li WJ, 2011, BIOCHEM BIOPH RES CO, V416, P372, DOI 10.1016/j.bbrc.2011.11.045; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; Moss TJ, 2007, MUTAT RES-FUND MOL M, V618, P163, DOI 10.1016/j.mrfmmm.2006.05.038; Rajan P, 1998, J NEUROSCI, V18, P3620; REDEPENNING J, 1993, PHOTOCHEM PHOTOBIOL, V58, P532, DOI 10.1111/j.1751-1097.1993.tb04927.x; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wong KSK, 2006, CELL RES, V16, P742, DOI 10.1038/sj.cr.7310090; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	40	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73625	10.1371/journal.pone.0073625	http://dx.doi.org/10.1371/journal.pone.0073625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066060	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000041
J	Guan, SJ; Ma, JJ; Zhang, Y; Gao, YG; Zhang, YY; Zhang, X; Wang, N; Xie, Y; Wang, JY; Zhang, JP; Chu, L				Guan, Shengjiang; Ma, Juanjuan; Zhang, Ying; Gao, Yonggang; Zhang, Yuanyuan; Zhang, Xuan; Wang, Na; Xie, Yun; Wang, Jiangyan; Zhang, Jianping; Chu, Li			Danshen (Salvia miltiorrhiza) Injection Suppresses Kidney Injury Induced by Iron Overload in Mice	PLOS ONE			English	Article							RAT CORONARY-ARTERY; CALCIUM-CHANNELS; LITHOSPERMATE-B; ACID-B; INHIBITION; METABOLISM; CHEMISTRY; CARDIOMYOCYTES; APOPTOSIS; EXTRACT	Objectives: Excessive iron can accumulate in the kidney and induce tissue damage. Danshen (Salvia miltiorrhiza) injection is a traditional Chinese medicinal preparation used for preventing and treating chronic renal failure. The aim of the present study was to evaluate the effects of treatment with Danshen injection on iron overload-induced kidney damage. Methods: Mice were mock-treated with saline (control group) or given a single dose of iron dextran without treatment (iron overload group, 50 mg/kg/day for 2 weeks) or with daily treatments of low-dose Danshen (3 g/kg/day), high-dose Danshen (6 g/kg/day) or deferoxamine (100 mg/kg/day). Results: Treatment of iron-overloaded mice with Danshen injection led to significant improvements of body weight and decreased iron levels in the kidney. Danshen injection treatment also reduced concentrations of blood urea nitrogen, creatinine and malondialdehyde and enhanced glutathione peroxidase and superoxide dismutase activities. Histopathological examinations showed that Danshen injection ameliorated pathological changes and reduced iron deposition in kidneys of iron overloaded mice. Furthermore, the treatment was demonstrated to suppress apoptosis in nephrocytes. Conclusions: These results indicated that Danshen injection exerted significant renal protective effects in iron-overloaded mice, which were closely associated with the decrease of iron deposition and suppression of lipid peroxidation and apoptosis in the kidney.	[Guan, Shengjiang; Ma, Juanjuan; Zhang, Ying; Gao, Yonggang; Zhang, Yuanyuan; Zhang, Xuan; Wang, Na; Xie, Yun; Zhang, Jianping; Chu, Li] Hebei Med Univ, Sch Basic Med, Dept Pharmacol, Shijiazhuang, Peoples R China; [Wang, Jiangyan] Bethune Mil Med Coll, Dept Biochem, Shijiazhuang, Peoples R China	Hebei Medical University	Zhang, JP (corresponding author), Hebei Med Univ, Sch Basic Med, Dept Pharmacol, Shijiazhuang, Peoples R China.	zhangjianping14@126.com; chuli0614@126.com	zhang, yuanyuan/GYA-4428-2022		Nature Fund of Hebei Province, China [C2011206025]; Fund of Hebei Science and Technology Bureau [10276105D-2]	Nature Fund of Hebei Province, China; Fund of Hebei Science and Technology Bureau	This work was supported by the Nature Fund of Hebei Province, China (No. C2011206025) and the Fund of Hebei Science and Technology Bureau (No. 10276105D-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; ALREFAIE FN, 1992, BLOOD, V80, P593; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Berdoukas V, 2012, J BLOOD MED, V3, P119, DOI 10.2147/JBM.S27400; Cao CM, 2003, LIFE SCI, V72, P2451, DOI 10.1016/S0024-3205(03)00142-5; Chen CG, 2006, ACTA PHARMACOL SIN, V27, P217, DOI 10.1111/j.1745-7254.2006.00225.x; DILLARD CJ, 1984, LIPIDS, V19, P127, DOI 10.1007/BF02534503; Fraga CG, 2002, TOXICOLOGY, V180, P23, DOI 10.1016/S0300-483X(02)00379-7; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Galleano M, 1997, TOXICOLOGY, V124, P73, DOI 10.1016/S0300-483X(97)00135-2; Gambling L, 2002, BIOL REPROD, V66, P516, DOI 10.1095/biolreprod66.2.516; Gao YG, 2013, J ETHNOPHARMACOL, V145, P254, DOI 10.1016/j.jep.2012.10.060; Geisser P, 1997, Met Based Drugs, V4, P137, DOI 10.1155/MBD.1997.137; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Katafuchi R, 1998, CLIN NEPHROL, V49, P1; Kudo H, 2008, TOXICOLOGY, V246, P143, DOI 10.1016/j.tox.2008.01.004; Lam FFY, 2006, EUR J PHARMACOL, V553, P240, DOI 10.1016/j.ejphar.2006.09.030; Lam FFY, 2007, VASC PHARMACOL, V46, P271, DOI 10.1016/j.vph.2006.10.011; Lee TY, 2006, J PHARM PHARMACOL, V58, P659, DOI 10.1211/jpp.58.5.0011; LI JL, 1987, CANCER RES, V47, P1867; Miyajima H, 1997, ANN NEUROL, V41, P404, DOI 10.1002/ana.410410318; Ong-ajyooth L, 1998, NEPHRON, V78, P156, DOI 10.1159/000044904; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; PARKS RR, 1994, LARYNGOSCOPE, V104, P1389; SHIH W, 1988, KIDNEY INT, V33, P1113, DOI 10.1038/ki.1988.119; Soung DY, 2003, J PHARM PHARMACOL, V55, P1427, DOI 10.1211/0022357021891; Tsushima RG, 1999, CIRC RES, V84, P1302, DOI 10.1161/01.RES.84.11.1302; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Zhang Y, 2013, J ETHNOPHARMACOL, V148, P671, DOI 10.1016/j.jep.2013.05.028; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zou C, 2012, J ALTERN COMPLEM MED, V18, P394, DOI 10.1089/acm.2011.0041	33	26	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74318	10.1371/journal.pone.0074318	http://dx.doi.org/10.1371/journal.pone.0074318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066136	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000118
J	Hendrickx, A; Pierrot, N; Tasiaux, B; Schakman, O; Brion, JP; Kienlen-Campard, P; De Smet, C; Octave, JN				Hendrickx, Aurelie; Pierrot, Nathalie; Tasiaux, Bernadette; Schakman, Olivier; Brion, Jean-Pierre; Kienlen-Campard, Pascal; De Smet, Charles; Octave, Jean-Noel			Epigenetic Induction of EGR-1 Expression by the Amyloid Precursor Protein during Exposure to Novelty	PLOS ONE			English	Article							APP INTRACELLULAR DOMAIN; GENE-EXPRESSION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; TRANSGENIC MICE; AICD; PHOSPHORYLATION; NEPRILYSIN; MEMORIES; RECONSOLIDATION	Following transcriptome comparison of primary cultures isolated from brain of mice expressing or not the amyloid precursor protein APP, we found transcription of the EGR-1 gene to be regulated by APP. In primary cultures of cortical neurons, APP significantly down regulated EGR-1 expression at both mRNA and protein levels in a gamma-secretase independent manner. The intracellular domain of APP did not interact with EGR-1 gene promoter, but enrichment of acetylated histone H4 at the EGR-1 promoter region was measured in APP-/- neurons, as well as in brain of APP-/- mice, in which increase in EGR-1 expression was also measured. These results argue for an important function of APP in the epigenetic regulation of EGR-1 gene transcription both in vitro and in vivo. In APP-/- mice, constitutive overexpression of EGR-1 in brain impaired epigenetic induction of this early transcriptional regulator during exposure to novelty. Altogether, these results indicate an important function of APP in the epigenetic regulation of the transcription of EGR-1, known to be important for memory formation.	[Hendrickx, Aurelie; Pierrot, Nathalie; Tasiaux, Bernadette; Schakman, Olivier; Kienlen-Campard, Pascal; Octave, Jean-Noel] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Brion, Jean-Pierre] Univ Libre Brussels, Lab Histol & Neuropathol, Brussels, Belgium; [De Smet, Charles] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles; Universite Catholique Louvain	Octave, JN (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	jean-noel.octave@uclouvain.be	Brion, Jean-Pierre/C-6467-2009	Brion, Jean-Pierre/0000-0002-1917-775X; Kienlen-Campard, Pascal/0000-0003-1086-2942	Belgian Fonds pour la Recherche Scientifique (FNRS-FRS); Belgian FRIA; Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy; Belgian Fonds de la Recherche Scientifique Medicale; Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRMA); Programme d'excellence "Marshall" Diane convention	Belgian Fonds pour la Recherche Scientifique (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS); Belgian FRIA(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRMA); Programme d'excellence "Marshall" Diane convention	This work was supported by the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS) and FRIA, by Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy, The Belgian Fonds de la Recherche Scientifique Medicale, the Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRMA) and the Programme d'excellence "Marshall" Diane convention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bauer C, 2011, J ALZHEIMERS DIS, V27, P511, DOI 10.3233/JAD-2011-110746; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cao X, 2001, SCIENCE, V293, P1436; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hong Y, 2012, INT J CANCER, V130, P775, DOI 10.1002/ijc.26028; Huysseune S, 2009, FASEB J, V23, P4158, DOI 10.1096/fj.09-140012; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Morel M, 2012, ACTA NEUROPATHOL, V123, P71, DOI 10.1007/s00401-011-0901-4; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Renbaum P, 2003, GENE, V318, P113, DOI 10.1016/S0378-1119(03)00766-2; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sarantis K, 2012, NEUROCHEM INT, V60, P55, DOI 10.1016/j.neuint.2011.10.018; Vermeiren C, 2005, NEUROCHEM INT, V46, P137, DOI 10.1016/j.neuint.2004.08.004; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Xu XA, 2011, EMBO REP, V12, P216, DOI 10.1038/embor.2010.210; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	36	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74305	10.1371/journal.pone.0074305	http://dx.doi.org/10.1371/journal.pone.0074305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066134	gold, Green Submitted, Green Published			2022-12-27	WOS:000324494000116
J	Nexo, BA; Hansen, B; Nissen, KK; Gundestrup, L; Terkelsen, T; Villesen, P; Bahrami, S; Petersen, T; Pedersen, FS; Laska, MJ				Nexo, Bjorn A.; Hansen, Bettina; Nissen, Kari K.; Gundestrup, Lisa; Terkelsen, Thorkild; Villesen, Palle; Bahrami, Shervin; Petersen, Thor; Pedersen, Finn S.; Laska, Magdalena J.			Restriction Genes for Retroviruses Influence the Risk of Multiple Sclerosis	PLOS ONE			English	Article							ENDOGENOUS RETROVIRUS; FAMILY-MEMBERS; VIRUS; EXPRESSION; SUSCEPTIBILITY; IDENTIFICATION; INFECTION	We recently described that the autoimmune, central nervous system disease, multiple sclerosis ( MS), is genetically associated with the human endogenous retroviral locus, HERV-Fc1, in Scandinavians. A number of dominant human genes encoding factors that restrict retrovirus replication have been known for a long time. Today human restriction genes for retroviruses include amongst others TRIMs, APOBEC3s, BST2 and TREXs. We have therefore looked for a role of these retroviral restriction genes in MS using genetic epidemiology. We here report that markers in two TRIMs, TRIM5 and TRIM22 and a marker in BST2, associated statistically with the risk of getting MS, while markers in or near APOBEC3s and TREXs showed little or no effect. This indicates that the two TRIMs and BST2 influence the risk of disease and thus supports the hypothesis of a viral involvement.	[Nexo, Bjorn A.; Hansen, Bettina; Nissen, Kari K.; Gundestrup, Lisa; Terkelsen, Thorkild; Laska, Magdalena J.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Villesen, Palle] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Bahrami, Shervin] SKAUvaccines, Aarhus C, Denmark; [Petersen, Thor] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Pedersen, Finn S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Nexo, BA (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.	nexo@hum-gen.au.dk	Terkelsen, Thorkild/Z-3905-2019	Terkelsen, Thorkild/0000-0003-2435-1043; Bahrami, Shervin/0000-0002-2244-3668; Laska, Magdalena Janina/0000-0001-5188-3446; Villesen, Palle/0000-0001-7589-8781; Petersen, Thor/0000-0001-5633-2600; Gundestrup, Lisa/0000-0001-6474-0882	Lundbeck Foundation; Danish Sclerosis Society; Warwara Larsens Fond	Lundbeck Foundation(Lundbeckfonden); Danish Sclerosis Society; Warwara Larsens Fond	This work was supported by the Lundbeck Foundation, The Danish Sclerosis Society, and Warwara Larsens Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Chahwan C, 2012, CLIN GENET, V81, P413, DOI 10.1111/j.1399-0004.2011.01825.x; Christensen T, 1998, LANCET, V352, P1033, DOI 10.1016/S0140-6736(05)60075-X; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Hansen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026438; Hilditch L, 2011, P NATL ACAD SCI USA, V108, P5771, DOI 10.1073/pnas.1100118108; Ilinskaya A, 2013, VIROLOGY, V436, P201, DOI 10.1016/j.virol.2012.11.012; Imahashi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00250; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Le Tortorec A, 2011, VIRUSES-BASEL, V3, P520, DOI 10.3390/v3050520; Maruszak H, 2011, EUR J NEUROL, V18, pE110, DOI 10.1111/j.1468-1331.2011.03430.x; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Nexo BA, 2013, EPIDEMIOLOGY, V24, P331, DOI 10.1097/EDE.0b013e318281e48a; Passerini LD, 2006, J VIROL, V80, P2100, DOI 10.1128/JVI.80.5.2100-2105.2006; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; PINCUS T, 1971, J EXP MED, V133, P1234, DOI 10.1084/jem.133.6.1234; Rahm N, 2012, CURR OPIN HIV AIDS, V7, P180, DOI 10.1097/COH.0b013e32835048e1	22	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74063	10.1371/journal.pone.0074063	http://dx.doi.org/10.1371/journal.pone.0074063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066097	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000079
J	Braem, S; Duthoo, W; Notebaert, W				Braem, Senne; Duthoo, Wout; Notebaert, Wim			Punishment Sensitivity Predicts the Impact of Punishment on Cognitive Control	PLOS ONE			English	Article							MOTIVATIONAL INFLUENCES; BEHAVIORAL-INHIBITION; HEART-RATE; CONFLICT; REWARD; ACTIVATION; ADAPTATION; STROOP; MECHANISMS; COMPONENTS	Cognitive control theories predict enhanced conflict adaptation after punishment. However, no such effect was found in previous work. In the present study, we demonstrate in a flanker task how behavioural adjustments following punishment signals are highly dependent on punishment sensitivity (as measured by the Behavioural Inhibition System (BIS) scale): Whereas low punishment-sensitive participants do show increased conflict adaptation after punishment, high punishment-sensitive participants show no such modulation. Interestingly, participants with a high punishment-sensitivity showed an overall reaction time increase after punishments. Our results stress the role of individual differences in explaining motivational modulations of cognitive control.	[Braem, Senne; Duthoo, Wout; Notebaert, Wim] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Braem, S (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	Senne.Braem@UGent.be		Braem, Senne/0000-0002-2619-8225	Research Foundation Flanders (FWO) [G.0098.09N, 3F009109]	Research Foundation Flanders (FWO)(FWO)	SB and WN (grant G.0098.09N), as well as WD (grant 3F009109), were supported by the Research Foundation Flanders (FWO) (http://www.fwo.be/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boksem MAS, 2008, BIOL PSYCHOL, V79, P185, DOI 10.1016/j.biopsycho.2008.04.010; Boksem MAS, 2006, BRAIN RES, V1101, P92, DOI 10.1016/j.brainres.2006.05.004; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braem S, 2012, COGNITION, V125, P324, DOI 10.1016/j.cognition.2012.07.015; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cavanagh JF, 2011, SOC COGN AFFECT NEUR, V6, P311, DOI 10.1093/scan/nsq041; Chiew KS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00279; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; De Pascalis V, 2010, CLIN NEUROPHYSIOL, V121, P60, DOI 10.1016/j.clinph.2009.10.004; Dreisbach G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00342; Dreisbach G, 2012, BRAIN COGNITION, V78, P94, DOI 10.1016/j.bandc.2011.12.003; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fritz J, 2013, COGN AFFECT BEHAV NE, V13, P311, DOI 10.3758/s13415-012-0147-1; Gendolla G.H.E., 2000, REV GEN PSYCHOL, V4, P378, DOI DOI 10.1037/1089-2680.4.4.378; Gomez R, 1997, PERS INDIV DIFFER, V23, P305, DOI 10.1016/S0191-8869(97)00031-7; Grant AM, 2011, PERSPECT PSYCHOL SCI, V6, P61, DOI 10.1177/1745691610393523; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hickey C, 2011, VIS COGN, V19, P117, DOI 10.1080/13506285.2010.503946; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hills T, 2011, CURR DIR PSYCHOL SCI, V20, P373, DOI 10.1177/0963721411418300; Houtman F, 2012, J COGN PSYCHOL, V24, P278, DOI 10.1080/20445911.2011.617301; Johnson SL, 2003, J PSYCHOPATHOL BEHAV, V25, P25, DOI 10.1023/A:1022247919288; Jorm AF, 1999, PERS INDIV DIFFER, V26, P49; Kanske P, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00042; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Kuhbandner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029287; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; Meiran N, 2011, PSYCHIAT RES, V185, P149, DOI 10.1016/j.psychres.2010.04.044; Muhle-Karbe PS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00450; Notebaert W, 2011, ACTA PSYCHOL, V136, P212, DOI 10.1016/j.actpsy.2010.05.006; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI 10.3758/CABN.10.2.270; Padmala S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00192; Poy R, 2004, PERS INDIV DIFFER, V36, P1471, DOI 10.1016/S0191-8869(03)00242-3; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Schouppe N, 2012, Q J EXP PSYCHOL, V65, P1052, DOI 10.1080/17470218.2012.685080; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Sturmer B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00335; TRANEL DT, 1983, PSYCHOPHYSIOLOGY, V20, P652, DOI 10.1111/j.1469-8986.1983.tb00933.x; van Steenbergen H, 2012, BIOL PSYCHOL, V90, P234, DOI 10.1016/j.biopsycho.2012.03.018; van Steenbergen H, 2012, COGN AFFECT BEHAV NE, V12, P280, DOI 10.3758/s13415-011-0078-2; van Steenbergen H, 2010, PSYCHOL SCI, V21, P1629, DOI 10.1177/0956797610385951; van Steenbergen H, 2009, PSYCHOL SCI, V20, P1473, DOI 10.1111/j.1467-9280.2009.02470.x; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	55	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74106	10.1371/journal.pone.0074106	http://dx.doi.org/10.1371/journal.pone.0074106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058520	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400052
J	Michal, M; Koechel, A; Canterino, M; Adler, J; Reiner, I; Vossel, G; Beutel, ME; Gamer, M				Michal, Matthias; Koechel, Ansgar; Canterino, Marco; Adler, Julia; Reiner, Iris; Vossel, Gerhard; Beutel, Manfred E.; Gamer, Matthias			Depersonalization Disorder: Disconnection of Cognitive Evaluation from Autonomic Responses to Emotional Stimuli	PLOS ONE			English	Article							CAMBRIDGE DEPERSONALIZATION; CLINICAL-FEATURES; MINDFULNESS; SCALE; SELF; LABILITY; THERAPY; ANXIETY; VERSION; UNREAL	Background: Patients with depersonalization disorder (DPD) typically complain about emotional detachment. Previous studies found reduced autonomic responsiveness to emotional stimuli for DPD patients as compared to patients with anxiety disorders. We aimed to investigate autonomic responsiveness to emotional auditory stimuli of DPD patients as compared to patient controls. Furthermore, we examined the modulatory effect of mindful breathing on these responses as well as on depersonalization intensity. Methods: 22 DPD patients and 15 patient controls balanced for severity of depression and anxiety, age, sex and education, were compared regarding 1) electrodermal and heart rate data during a resting period, and 2) autonomic responses and cognitive appraisal of standardized acoustic affective stimuli in two conditions (normal listening and mindful breathing). Results: DPD patients rated the emotional sounds as significantly more neutral as compared to patient controls and standardized norm ratings. At the same time, however, they responded more strongly to acoustic emotional stimuli and their electrodermal response pattern was more modulated by valence and arousal as compared to patient controls. Mindful breathing reduced severity of depersonalization in DPD patients and increased the arousal modulation of electrodermal responses in the whole sample. Finally, DPD patients showed an increased electrodermal lability in the rest period as compared to patient controls. Conclusions: These findings demonstrated that the cognitive evaluation of emotional sounds in DPD patients is disconnected from their autonomic responses to those emotional stimuli. The increased electrodermal lability in DPD may reflect increased introversion and cognitive control of emotional impulses. The findings have important psychotherapeutic implications.	[Michal, Matthias; Koechel, Ansgar; Adler, Julia; Reiner, Iris; Beutel, Manfred E.] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Canterino, Marco] Univ Med Ctr, Mainz, Germany; [Vossel, Gerhard] Johannes Gutenberg Univ Mainz, Inst Psychol, Dept Gen & Expt Psychol, D-55122 Mainz, Germany; [Gamer, Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Michal, M (corresponding author), Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	michal@uni-mainz.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038	Interdisciplinary Research Center for Neurosciences for the Center for Neuroscience at Mainz University	Interdisciplinary Research Center for Neurosciences for the Center for Neuroscience at Mainz University	This study was in part supported by a grant from the Interdisciplinary Research Center for Neurosciences for the Center for Neuroscience at Mainz University (http://www.ifzn.uni-mainz.de/eng/321.php). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JG, 2005, COPING TRAUMA HOPE U; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baker D, 2003, BRIT J PSYCHIAT, V182, P428, DOI 10.1192/bjp.182.5.428; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Bradley M.M., 2007, B3 U FLOR; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Camm AJ, 1996, EUR HEART J, V17, P354; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Crider A, 2008, APPL PSYCHOPHYS BIOF, V33, P141, DOI 10.1007/s10484-008-9057-y; DAVID AS, 2007, OVERCOMING DEPERSONA; Farb NAS, 2012, CAN J PSYCHIAT, V57, P70, DOI 10.1177/070674371205700203; FENICHEL O, 1945, PSYCHOANALYTIC STUDY; Gast U., 2000, SKID D STRUKTURIERTE; Giesbrecht T, 2010, PSYCHIAT RES, V177, P342, DOI 10.1016/j.psychres.2010.03.010; Hunter ECM, 2003, BEHAV RES THER, V41, P1451, DOI 10.1016/S0005-7967(03)00066-4; JACOBSON E, 1959, J AM PSYCHOANAL ASS, V7, P581, DOI 10.1177/000306515900700401; Jensen HH, 1996, SCAND J PSYCHOL, V37, P103, DOI 10.1111/j.1467-9450.1996.tb00643.x; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Lambert MV, 2001, PSYCHOPATHOLOGY, V34, P259, DOI 10.1159/000049319; Lerner Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006230; Medford N, 2003, ADDICTION, V98, P1731, DOI 10.1111/j.1360-0443.2003.00548.x; MEDFORD N, 2005, ADV PSYCHIAT TREATME, V11, P92, DOI DOI 10.1192/APT.11.2.92; Medford N, 2012, EMOT REV, V4, P139, DOI 10.1177/1754073911430135; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Michal M, 2006, PSYCHOPATHOLOGY, V39, P192, DOI 10.1159/000093523; Michal M, 2005, PSYCHOTHERAPEUT, V50, P328, DOI 10.1007/s00278-005-0436-z; Michal M, 2004, PSYCHOTHER PSYCH MED, V54, P367, DOI 10.1055/s-2004-828296; MICHAL M, 2012, DEPERSONALISATION DE; Michal M, 2007, J NERV MENT DIS, V195, P693, DOI 10.1097/NMD.0b013e31811f4492; Michal M, 2011, J AFFECT DISORDERS, V128, P106, DOI 10.1016/j.jad.2010.06.033; Mula M, 2010, COMPR PSYCHIAT, V51, P187, DOI 10.1016/j.comppsych.2009.03.009; Phillips ML, 2001, PSYCHIAT RES-NEUROIM, V108, P145, DOI 10.1016/S0925-4927(01)00119-6; Schilder P, 1939, Bull N Y Acad Med, V15, P258; Schilder P., 1953, MED PSYCHOL; SCHILDER P, 1935, IMAGE APPEARANCE BOD, P1059; Schoenberg PLA, 2012, J TRAUMA DISSOCIATIO, V13, P311, DOI 10.1080/15299732.2011.606742; Sierra M, 1998, BIOL PSYCHIAT, V44, P898, DOI 10.1016/S0006-3223(98)00015-8; Sierra M, 2002, ARCH GEN PSYCHIAT, V59, P833, DOI 10.1001/archpsyc.59.9.833; Sierra M, 2000, PSYCHIAT RES, V93, P153, DOI 10.1016/S0165-1781(00)00100-1; Sierra M., 2009, DEPERSONALIZATION NE; Sierra M, 2006, PSYCHIAT RES, V145, P225, DOI 10.1016/j.psychres.2005.05.022; Sierra M, 2012, PSYCHIAT RES, V197, P123, DOI 10.1016/j.psychres.2011.12.017; Sierra M, 2011, CONSCIOUS COGN, V20, P99, DOI 10.1016/j.concog.2010.10.018; Simeon D, 2004, CNS DRUGS, V18, P343, DOI 10.2165/00023210-200418060-00002; Simeon D, 2003, J CLIN PSYCHIAT, V64, P990, DOI 10.4088/JCP.v64n0903; Simeon D, 2009, J NERV MENT DIS, V197, P492, DOI 10.1097/NMD.0b013e3181aaef6b; Sipe WEB, 2012, CAN J PSYCHIAT, V57, P63, DOI 10.1177/070674371205700202; Spiegel D, 2011, DEPRESS ANXIETY, V28, pE17, DOI 10.1002/da.20923; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein DJ, 2009, CNS SPECTRUMS, V14, P467, DOI 10.1017/S109285290002352X; Velden M., 1987, J PSYCHOPHYSIOL; VENABLES PH, 1980, TECHNIQUES PSYCHOPHY, P2; VOSSEL G, 1990, INT J PSYCHOPHYSIOL, V10, P69, DOI 10.1016/0167-8760(90)90047-H	59	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74331	10.1371/journal.pone.0074331	http://dx.doi.org/10.1371/journal.pone.0074331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058547	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400065
J	Rath, SL; Senapati, S				Rath, Soumya Lipsa; Senapati, Sanjib			Molecular Basis of Differential Selectivity of Cyclobutyl-Substituted Imidazole Inhibitors against CDKs: Insights for Rational Drug Design	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; ACTIVATION; MECHANISM; ROSCOVITINE; DYNAMICS; BINDING; SIMULATIONS; SPECIFICITY; FAMILY; POTENT	Cyclin-dependent kinases (CDKs) belong to the CMGC subfamily of protein kinases and play crucial roles in eukaryotic cell division cycle. At least seven different CDKs have been reported to be implicated in the cell cycle regulation in vertebrates. These CDKs are highly homologous and contain a conserved catalytic core. This makes the design of inhibitors specific for a particular CDK difficult. There is, however, growing need for CDK5 specific inhibitors to treat various neurodegenerative diseases. Recently, cis-substituted cyclobutyl-4-aminoimidazole inhibitors have been identified as potent CDK5 inhibitors that gave up to 30-fold selectivity over CDK2. Available IC50 values also indicate a higher potency of this class of inhibitors over commercially available drugs, such as roscovitine. To understand the molecular basis of higher potency and selectivity of these inhibitors, here, we present molecular dynamics simulation results of CDK5/p25 and CDK2/CyclinE complexed with a series of cyclobutyl-substituted imidazole inhibitors and roscovitine. The atomic details of the stereospecificity and selectivity of these inhibitors are obtained from energetics and binding characteristics to the CDK binding pocket. The study not only complements the experimental findings, but also provides a wealth of detailed information that could help the structure-based drug designing processes.	[Rath, Soumya Lipsa; Senapati, Sanjib] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Senapati, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	sanjibs@iitm.ac.in	Rath, Soumya Lipsa/AGD-5056-2022	Rath, Soumya Lipsa/0000-0003-0767-3016	Department of Biotechnology (DBT), Government of India [BT/01/COE/07/04]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors acknowledge Department of Biotechnology (DBT), Government of India for financial support (grant number BT/01/COE/07/04). The computer resources of Computer Centre, IIT Madras are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Case D.A., 2022, AMBER 2020; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Diaz-Padilla I, 2009, INVEST NEW DRUG, V27, P586, DOI 10.1007/s10637-009-9236-6; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frisch M.J., 2016, GAUSSIAN16 REV B01; Hao GF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010742; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; Mapelli M, 2003, NEUROSIGNALS, V12, P164, DOI 10.1159/000074617; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; RADZIOANDZELM E, 1995, STRUCTURE, V3, P1135; Russo AA, 1993, NATURE, V3, P696; Singh G, 2008, BIOCHEMISTRY-US, V47, P10657, DOI 10.1021/bi8006725; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zhang B, 2007, BIOCHEMISTRY-US, V46, P10841, DOI 10.1021/bi700890t; Zhang B, 2007, J MOL MODEL, V13, P79, DOI 10.1007/s00894-006-0127-x	42	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73836	10.1371/journal.pone.0073836	http://dx.doi.org/10.1371/journal.pone.0073836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058495	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400036
J	Thompson, JW; Dave, KR; Saul, I; Narayanan, SV; Perez-Pinzon, MA				Thompson, John W.; Dave, Kunjan R.; Saul, Isabel; Narayanan, Srinivasan V.; Perez-Pinzon, Miguel A.			Epsilon PKC Increases Brain Mitochondrial SIRT1 Protein Levels via Heat Shock Protein 90 following Ischemic Preconditioning in Rats	PLOS ONE			English	Article							KINASE-C TRANSLOCATION; CALORIE RESTRICTION; REPERFUSION INJURY; CEREBRAL-ISCHEMIA; TOLERANCE; TARGETS; ACTIVATION; HSP90; PGC-1-ALPHA; MICE	Ischemic preconditioning is a neuroprotective mechanism whereby a sublethal ischemic exposure is protective against a subsequent lethal ischemic attack. We previously demonstrated that SIRT1, a nuclear localized stress-activated deacetylase, is vital for ischemic preconditioning neuroprotection. However, a recent study demonstrated that SIRT1 can also localize to the mitochondria. Mitochondrial localized SIRT1 may allow for a direct protection of mitochondria following ischemic preconditioning. The objective of this study was to determine whether ischemic preconditioning increases brain mitochondrial SIRT1 protein levels and to determine the role of PKC epsilon and HSP90 in targeting SIRT1 to the mitochondria. Here we report that preconditioning rats, with 2 min of global cerebral ischemia, induces a delayed increase in non-synaptic mitochondrial SIRT1 protein levels which was not observed in synaptic mitochondria. This increase in mitochondrial SIRT1 protein was found to occur only in neuronal cells and was mediated by PKC epsilon activation. Inhibition of HSP90, a protein chaperone involved in mitochondrial protein import, prevented preconditioning induced increases in mitochondrial SIRT1 and PKC epsilon protein. Our work provides new insights into a possible direct role of SIRT1 in modulating mitochondrial function under both normal and stress conditions, and to a possible role of mitochondrial SIRT1 in activating preconditioning induced ischemic tolerance.	[Thompson, John W.; Dave, Kunjan R.; Saul, Isabel; Narayanan, Srinivasan V.; Perez-Pinzon, Miguel A.] Univ Miami, Miller Sch Med, Dept Neurol, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA	University of Miami	Perez-Pinzon, MA (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Cerebral Vasc Dis Res Labs, Miami, FL 33136 USA.	perezpinzon@miami.edu			National Institutes of Health [NS45676-01, NS054147-01, NS34773, NS073779]; American Heart Association, Greater Southeast Affiliate; NIH [NS080344-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045676, F31NS080344, R01NS034773, R01NS054147, R01NS073779, R55NS034773, R29NS034773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Greater Southeast Affiliate(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS45676-01, NS054147-01 and NS34773 (to M. A. P. P.), and NS073779 (to K. R. D.), by a Postdoctoral award from the American Heart Association, Greater Southeast Affiliate (to J.W.T.) and by a NIH F31 Predoctoral award NS080344-01 (to S.V.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bernaudin M, 2002, J BIOL CHEM, V277, P39728, DOI 10.1074/jbc.M204619200; Bright R, 2008, NEUROSCI LETT, V441, P120, DOI 10.1016/j.neulet.2008.05.080; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clark D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047792; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Dave KR, 2008, J NEUROSCI, V28, P4172, DOI 10.1523/JNEUROSCI.5471-07.2008; de Oliveira RM, 2010, CURR DRUG TARGETS, V11, P1270; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; GASS P, 1994, NEUROSCI LETT, V182, P188, DOI 10.1016/0304-3940(94)90794-3; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Hou JL, 2010, CURR NEUROVASC RES, V7, P95, DOI 10.2174/156720210791184899; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; ITOH H, 1993, INT J BIOCHEM, V25, P93; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jia J, 2007, J NEUROSURG ANESTH, V19, P18, DOI 10.1097/01.ana.0000211020.88431.e2; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kim E, 2007, NEUROSCIENCE, V145, P931, DOI 10.1016/j.neuroscience.2006.12.063; Kim EJ, 2008, J CEREBR BLOOD F MET, V28, P1329, DOI 10.1038/jcbfm.2008.26; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Nadtochiy SM, 2011, AM J PHYSIOL-HEART C, V301, pH1506, DOI 10.1152/ajpheart.00587.2011; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Raval AP, 2007, BRAIN RES, V1184, P345, DOI 10.1016/j.brainres.2007.09.073; Raval AP, 2006, J CEREBR BLOOD F MET, V26, P1141, DOI 10.1038/sj.jcbfm.9600262; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Stagliano NE, 1999, J CEREBR BLOOD F MET, V19, P757, DOI 10.1097/00004647-199907000-00005; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tong C, 2012, FASEB J; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022	52	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75753	10.1371/journal.pone.0075753	http://dx.doi.org/10.1371/journal.pone.0075753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058702	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400120
J	Zhou, TT; Dong, ZT; Setlow, P; Li, YQ				Zhou, Tingting; Dong, Zhiyang; Setlow, Peter; Li, Yong-qing			Kinetics of Germination of Individual Spores of Geobacillus stearothermophilus as Measured by Raman Spectroscopy and Differential Interference Contrast Microscopy	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPORES; SPOVA PROTEINS; PHASE-CONTRAST; CEREUS; ACID; INACTIVATION; ACTIVATION; MEGATERIUM; MECHANISM; ENZYMES	Geobacillus stearothermophilus is a gram-positive, thermophilic bacterium, spores of which are very heat resistant. Raman spectroscopy and differential interference contrast microscopy were used to monitor the kinetics of germination of individual spores of G. stearothermophilus at different temperatures, and major conclusions from this work were as follows. 1) The CaDPA level of individual G. stearothermophilus spores was similar to that of Bacillus spores. However, the Raman spectra of protein amide bands suggested there are differences in protein structure in spores of G. stearothermophilus and Bacillus species. 2) During nutrient germination of G. stearothermophilus spores, CaDPA was released beginning after a lag time (T-lag) between addition of nutrient germinants and initiation of CaDPA release. CaDPA release was complete at T-release, and Delta T-release (T-release - T-lag) was 1-2 min. 3) Activation by heat or sodium nitrite was essential for efficient nutrient germination of G. stearothermophilus spores, primarily by decreasing T-lag values. 4) Values of T-lag and T-release were heterogeneous among individual spores, but Delta T-release values were relatively constant. 5) Temperature had major effects on nutrient germination of G. stearothermophilus spores, as at temperatures below 65 degrees C, average T-lag values increased significantly. 6) G. stearothermophilus spore germination with exogenous CaDPA or dodecylamine was fastest at 65 degrees C, with longer T-lag values at lower temperatures. 7) Decoating of G. stearothermophilus spores slowed nutrient germination slightly and CaDPA germination significantly, but increased dodecylamine germination markedly. These results indicate that the dynamics and heterogeneity of the germination of individual G. stearothermophilus spores are generally similar to that of Bacillus species.	[Zhou, Tingting; Dong, Zhiyang] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Setlow, Peter] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA; [Zhou, Tingting; Li, Yong-qing] E Carolina Univ, Dept Phys, Greenville, NC 27858 USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Connecticut; University of North Carolina; East Carolina University	Li, YQ (corresponding author), E Carolina Univ, Dept Phys, Greenville, NC 27858 USA.	liy@ecu.edu			Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory; U.S. Army Research Office [W911F-09-1-0286]; National Natural Science Foundation of China [31228001]; National High Technology Research and Development Program of China [2012AA092103]	Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory; U.S. Army Research Office; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	Authors PS and YL acknowledge support by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286. Authors TZ and ZD also acknowledge support by a grant from the National Natural Science Foundation of China (No. 31228001) and a grant from the National High Technology Research and Development Program of China (No. 2012AA092103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1980, J APPL BACTERIOL, V49, P527, DOI 10.1111/j.1365-2672.1980.tb04727.x; Bagyan I, 1998, GENE, V212, P179, DOI 10.1016/S0378-1119(98)00172-3; BENEVIDES JM, 1983, NUCLEIC ACIDS RES, V11, P5747, DOI 10.1093/nar/11.16.5747; Benevides JM, 1997, BIOPHYS J, V72, P2748, DOI 10.1016/S0006-3495(97)78917-3; Burgess SA, 2010, INT J FOOD MICROBIOL, V144, P215, DOI 10.1016/j.ijfoodmicro.2010.09.027; Chalmers J.M., 2002, HDB VIBRATIONAL SPEC, V5, P3426; Chen D, 2006, ANAL CHEM, V78, P6936, DOI 10.1021/ac061090e; Clements MO, 1998, J BACTERIOL, V180, P6729, DOI 10.1128/JB.180.24.6729-6735.1998; Coleman WH, 2010, LETT APPL MICROBIOL, V50, P507, DOI 10.1111/j.1472-765X.2010.02827.x; Coleman WH, 2007, J BACTERIOL, V189, P8458, DOI 10.1128/JB.01242-07; Cowan AE, 2003, P NATL ACAD SCI USA, V100, P4209, DOI 10.1073/pnas.0636762100; FEEHERRY F, 1987, APPL ENVIRON MICROB, V53, P365, DOI 10.1128/AEM.53.2.365-370.1987; FOERSTER HF, 1983, ARCH MICROBIOL, V134, P175, DOI 10.1007/BF00407754; FOERSTER HF, 1985, ARCH MICROBIOL, V142, P185, DOI 10.1007/BF00447065; GERHARDT P, 1989, REGULATION OF PROCARYOTIC DEVELOPMENT, P43; Heffron JD, 2010, J BACTERIOL, V192, P763, DOI 10.1128/JB.01380-09; Huang SS, 2007, J BACTERIOL, V189, P4681, DOI 10.1128/JB.00282-07; Kong LB, 2011, NAT PROTOC, V6, P625, DOI 10.1038/nprot.2011.307; Kong LB, 2010, ANAL CHEM, V82, P3840, DOI 10.1021/ac1003322; LOSHON CA, 1986, J BACTERIOL, V167, P168, DOI 10.1128/jb.167.1.168-173.1986; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Pelczar PL, 2007, J BACTERIOL, V189, P1090, DOI 10.1128/JB.01606-06; Peng LX, 2009, ANAL CHEM, V81, P4035, DOI 10.1021/ac900250x; Prevost S, 2010, CURR MICROBIOL, V61, P525, DOI 10.1007/s00284-010-9648-8; Setlow B, 2003, J APPL MICROBIOL, V95, P637, DOI 10.1046/j.1365-2672.2003.02015.x; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; Setlow B, 2009, J APPL MICROBIOL, V107, P318, DOI 10.1111/j.1365-2672.2009.04210.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Setlow P, 2012, FOOD MICROBIOLOGY FU, V4th, P45; Setlow P, 2012, BACTERIAL SPORES: CURRENT RESEARCH AND APPLICATIONS, P199; Vepachedu VR, 2007, J BACTERIOL, V189, P1565, DOI 10.1128/JB.01613-06; Wang GW, 2011, J BACTERIOL, V193, P2301, DOI 10.1128/JB.00122-11; WILLIAMS RW, 1980, FEBS LETT, V115, P306, DOI 10.1016/0014-5793(80)81193-8; Zhang PF, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3494567; Zhang PF, 2010, APPL ENVIRON MICROB, V76, P1796, DOI 10.1128/AEM.02851-09; Zhang PF, 2009, OPT EXPRESS, V17, P16480, DOI 10.1364/OE.17.016480	41	16	17	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74987	10.1371/journal.pone.0074987	http://dx.doi.org/10.1371/journal.pone.0074987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058645	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400104
J	Laner-Plamberger, S; Wolff, F; Kaser-Eichberger, A; Swierczynski, S; Hauser-Kronberger, C; Frischauf, AM; Eichberger, T				Laner-Plamberger, Sandra; Wolff, Florian; Kaser-Eichberger, Alexandra; Swierczynski, Stefan; Hauser-Kronberger, Cornelia; Frischauf, Anna-Maria; Eichberger, Thomas			Hedgehog/GLI Signaling Activates Suppressor of Cytokine Signaling 1 (SOCS1) in Epidermal and Neural Tumor Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INTERFERON-GAMMA; HUMAN KERATINOCYTES; GENE-EXPRESSION; JAK/STAT PATHWAY; GLI1 EXPRESSION; TRANSGENIC MICE; HUMAN-MELANOMA; HUMAN HOMOLOG; STEM-CELLS	Sustained hedgehog (Hh) signaling mediated by the GLI transcription factors is implicated in many types of cancer. Identification of Hh/GLI target genes modulating the activity of other pathways involved in tumor development promise to open new ways for better understanding of tumor development and maintenance. Here we show that SOCS1 is a direct target of Hh/GLI signaling in human keratinocytes and medulloblastoma cells. SOCS1 is a potent inhibitor of interferon gamma (IFN-y)/STAT1 signaling. IFN-y/STAT1 signaling can induce cell cycle arrest, apoptosis and anti-tumor immunity. The transcription factors GLI1 and GLI2 activate the SOCS1 promoter, which contains five putative GLI binding sites, and GLI2 binding to the promoter was shown by chromatin immunoprecipitation. Consistent with a role of GLI in SOCS1 regulation, STAT1 phosphorylation is reduced in cells with active Hh/GLI signaling and IFN-y/STAT1 target gene activation is decreased. Furthermore, IFN-y signaling is restored by shRNA mediated knock down of SOCS1. Here, we identify SOCS1 as a novel Hh/GLI target gene, indicating a negative role of Hh/GLI pathway in IFN-y/STAT1 signaling.	[Laner-Plamberger, Sandra; Wolff, Florian; Kaser-Eichberger, Alexandra; Frischauf, Anna-Maria; Eichberger, Thomas] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Laner-Plamberger, Sandra] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Blood Grp Serol & Transfus Med, Salzburg, Austria; [Laner-Plamberger, Sandra] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Kaser-Eichberger, Alexandra] Paracelsus Med Univ, Univ Hosp, Dept Ophthalmol, Salzburg, Austria; [Hauser-Kronberger, Cornelia] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Pathol, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Laner-Plamberger, S (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	s.laner-plamberger@salk.at	Laner-Plamberger, Sandra/AFP-1191-2022; Wolff, Florian/L-4090-2015	Laner-Plamberger, Sandra/0000-0002-1416-6023; Wolff, Florian/0000-0001-7271-0317; Kaser-Eichberger, Alexandra/0000-0002-6115-5036	Austrian Genome Project GEN-AU; University of Salzburg priority program "Biosciences and Health"; "ICA" doctoral program; Austrian Science Fund	Austrian Genome Project GEN-AU; University of Salzburg priority program "Biosciences and Health"; "ICA" doctoral program; Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Genome Project GEN-AU and the University of Salzburg priority program "Biosciences and Health". FW was supported by the "ICA" doctoral program funded by the Austrian Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Albanesi C, 2002, ANN NY ACAD SCI, V973, P79, DOI 10.1111/j.1749-6632.2002.tb04610.x; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Scutti JAB, 2011, TRANSL ONCOL, V4, P101, DOI 10.1593/tlo.10250; Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546; Chen CY, 2003, GENE CHROMOSOME CANC, V37, P300, DOI 10.1002/gcc.10222; Chong MMW, 2004, J IMMUNOL, V172, P5714, DOI 10.4049/jimmunol.172.9.5714; Cohen MM, 2010, AM J MED GENET A, V152A, P1875, DOI 10.1002/ajmg.a.32909; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Davey GM, 2006, TISSUE ANTIGENS, V67, P1, DOI 10.1111/j.1399-0039.2005.00532.x; Eichberger T, 2008, J BIOL CHEM, V283, P12426, DOI 10.1074/jbc.M707117200; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Fujimoto M, 2000, J IMMUNOL, V165, P1799, DOI 10.4049/jimmunol.165.4.1799; Gallet A, 2011, TRENDS CELL BIOL, V21, P238, DOI 10.1016/j.tcb.2010.12.005; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ilangumaran S, 2003, IMMUNOL REV, V192, P196, DOI 10.1034/j.1600-065X.2003.00020.x; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kasper Maria, 2007, V397, P67; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kogerman P, 2002, ONCOGENE, V21, P6007, DOI 10.1038/sj.onc.1205865; Kooy AJW, 1998, J PATHOL, V184, P169; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lesinski GB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-142; Li Z, 2004, J INVEST DERMATOL, V123, P737, DOI 10.1111/j.0022-202X.2004.23408.x; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sun L, 2010, BRAIN BEHAV IMMUN, V24, P220, DOI 10.1016/j.bbi.2009.09.016; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; TAYLOR RS, 1990, J AM ACAD DERMATOL, V22, P721; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Teider N, 2010, NEURO-ONCOLOGY, V12, P1244, DOI 10.1093/neuonc/noq091; To KF, 2004, BRIT J CANCER, V91, P1335, DOI 10.1038/sj.bjc.6602133; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Umeda H, 2010, EXP CLIN ENDOCR DIAB, V118, P692, DOI 10.1055/s-0030-1254151; Venkataraman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010748; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020; Yu CR, 2011, INVEST OPHTH VIS SCI, V52, P6978, DOI 10.1167/iovs.11-7688; Zhou JH, 2004, J IMMUNOL, V173, P7622, DOI 10.4049/jimmunol.173.12.7622; Zitzmann K, 2007, CANCER RES, V67, P5025, DOI 10.1158/0008-5472.CAN-06-2575	75	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75317	10.1371/journal.pone.0075317	http://dx.doi.org/10.1371/journal.pone.0075317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058673	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600136
J	Ali, A; Khowaja, AR; Bashir, MZ; Aziz, F; Mustafa, S; Zaidi, A				Ali, Asad; Khowaja, Asif Raza; Bashir, Maaman Zahoor; Aziz, Fatima; Mustafa, Sultan; Zaidi, Anita			Role of Human Metapneumovirus, Influenza A Virus and Respiratory Syncytial Virus in Causing WHO-Defined Severe Pneumonia in Children in a Developing Country	PLOS ONE			English	Article							YOUNG-CHILDREN; TRACT INFECTIONS; ETIOLOGY; PCR	Objective: The role of respiratory viruses in causing severe, life threatening pneumonia in children in developing countries is not well established. Our study aims to determine the role of human metapneumovirus (HMPV), influenza A virus and respiratory syncytial virus (RSV) in children, aged 6 weeks to 2 years, hospitalized with WHO defined severe pneumonia (tachypnea plus any general danger sign or chest in-drawing) at a public sector hospital in Karachi, Pakistan. Methods: This study was conducted from November 2010 to September 2011 at Abbassi Shaheed Hospital, a large public tertiary care hospital in Karachi, Pakistan. Children admitted with WHO-defined severe pneumonia were enrolled and throat swabs were obtained to detect respiratory viruses using real time RT-PCR. Chest x-rays of all subjects were obtained and independently interpreted by two radiologists to diagnose radiologic pneumonia. Results: 169 children were enrolled. HMPV was detected in 24 (14.2%), influenza A virus in 9 (5.3%) and RSV in 30 (17.8%) children admitted with severe pneumonia. Of 9 patients with influenza A, 8 tested positive for H1N1. Viral etiology was found in 18% of radiologically confirmed pneumonia. HMPV infections peaked in February and April, influenza A was prevalent in January, June and November and RSV infections were most prevalent from June to September. Conclusion: HMPV, influenza A and RSV are common causes of WHO-defined severe pneumonia in hospitalized children in Karachi. Knowledge regarding the viral etiology of pediatric pneumonia and individual viral seasonality can help in the recommendation and implementation of appropriate management strategies.	[Ali, Asad; Khowaja, Asif Raza; Bashir, Maaman Zahoor; Aziz, Fatima; Zaidi, Anita] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Mustafa, Sultan] Abbasi Shaheed Hosp, Karachi, Pakistan	Aga Khan University	Ali, A (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	asad.ali@aku.edu; anita.zaidi@aku.edu	Aziz, Fatima/O-9104-2018	Aziz, Fatima/0000-0002-9836-9142; Ali, Syed Asad/0000-0001-5274-7665	FIC/NIH [1R01TW008126]; NIH from NCATS/NIH [UL1 TR000445]; FOGARTY INTERNATIONAL CENTER [R01TW008126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grant 1R01TW008126 from FIC/NIH, titled 'Burden of Influenza and RSV in Children in Pakistan' (PI Asad Ali). Data was stored and managed using the REDCap electronic data capture tool, funded by an NIH grant UL1 TR000445 from NCATS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, STAND INT CHEST RAD; [Anonymous], 2008, PAK DEM HLTH SURV 20; [Anonymous], 2012, LEV TRENDS CHILD MOR; [Anonymous], 2005, HDB INT MAN CHILDH I; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Caracciolo S, 2008, PEDIATR INFECT DIS J, V27, P406, DOI 10.1097/INF.0b013e318162a164; Clara W, 2012, B WORLD HEALTH ORGAN, V90, P756, DOI 10.2471/BLT.11.098202; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; JOHN TJ, 1991, REV INFECT DIS, V13, pS463; Mentel R, 2003, J MED MICROBIOL, V52, P893, DOI 10.1099/jmm.0.05290-0; Nokes D J, 2007, PERSPECTIVES MED VIR, P183; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Pang T, 2007, T ROY SOC TROP MED H, V101, P856, DOI 10.1016/j.trstmh.2007.04.014; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Torzillo P, 1999, PEDIATR INFECT DIS J, V18, P714, DOI 10.1097/00006454-199908000-00012; Turner C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050100; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf	21	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74756	10.1371/journal.pone.0074756	http://dx.doi.org/10.1371/journal.pone.0074756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058625	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900079
J	Brar, SS; Petrovich, RM; Williams, JG; Mason, JM				Brar, Sukhdev S.; Petrovich, Robert M.; Williams, Jason G.; Mason, James M.			Phosphorylation at Serines 216 and 221 Is Important for Drosophila HeT-A Gag Protein Stability	PLOS ONE			English	Article							IN-VIVO; CYCLOPHILIN; TELOMERES; TRANSPORT; HIV; UBIQUITINATION; MYRISTYLATION; PHOSPHATASES; INFECTION; KINASES	Telomeres from Drosophila appear to be very different from those of other organisms - in size and the mechanism of their maintenance. In the absence of the enzyme telomerase, Drosophila telomeres are maintained by retrotransposition of three elements, HeT-A, TART, and TAHRE, but details of their transposition mechanisms are not known. Here we characterized some biochemical characteristics of the HeT-A Gag protein encoded by the HeT-A element to understand this mechanism. The HeT-A Gag protein when overexpressed in S2 cells was localized to the nucleus but was resistant to high salt, detergents and nuclease extraction treatments. Analysis of the HeT-A Gag protein by tandem mass spectrophotometry revealed that serines 216 and 221 are phosphorylated. Substituting these serines with alanine or aspartic acid by site-directed mutagenesis did not result in any changes in HeT-A Gag translocation across the nucleus, suggesting that phosphorylation of these sites is not associated with HeT-A Gag translocation, but time course experiments showed that these phosphorylation sites are important for Gag-protein stability.	[Brar, Sukhdev S.; Mason, James M.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Petrovich, Robert M.; Williams, Jason G.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mason, JM (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.	masonj@niehs.nih.gov			NIH, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102487, ZICES102488] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	ANDERSON SK, 1993, P NATL ACAD SCI USA, V90, P542, DOI 10.1073/pnas.90.2.542; Biessmann H, 1997, Ciba Found Symp, V211, P53; Biessmann H, 1997, CHROMOSOMA, V106, P63, DOI 10.1007/s004120050225; Blackburn EH, 1995, TELOMERES, P396; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Coffin J, 1997, RETROVIRUSES; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DANILEVSKAYA ON, 1994, P NATL ACAD SCI USA, V91, P6679, DOI 10.1073/pnas.91.14.6679; Dubourg B, 2004, J BIOL CHEM, V279, P22322, DOI 10.1074/jbc.M400736200; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GALLAY P, 1995, CELL, V80, P379, DOI 10.1016/0092-8674(95)90488-3; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; Halestrap AP, 2008, BBA-BIOENERGETICS, V1777, pS76, DOI 10.1016/j.bbabio.2008.05.298; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; JANS DA, 1995, BIOCHEM J, V311, P705, DOI 10.1042/bj3110705; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kahn T, 2000, MOL CELL BIOL, V20, P7634, DOI 10.1128/MCB.20.20.7634-7642.2000; Kantidze OL, 2009, BIOESSAYS, V31, P278, DOI 10.1002/bies.200800165; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; LODISH HF, 1991, J BIOL CHEM, V266, P14835; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Maki CG, 1996, CANCER RES, V56, P2649; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Pardue ML, 1999, CHROMOSOMA, V108, P73, DOI 10.1007/s004120050354; Pardue ML, 1996, TRENDS GENET, V12, P48, DOI 10.1016/0168-9525(96)81399-0; Pardue ML, 2002, MOBILE DNA, P870; Pawson T, 2000, GENE DEV, V14, P1027; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; REIN A, 1986, P NATL ACAD SCI USA, V83, P7246, DOI 10.1073/pnas.83.19.7246; RHEE SS, 1987, J VIROL, V61, P1045, DOI 10.1128/JVI.61.4.1045-1053.1987; Sjakste N, 2012, GENE, V492, P54, DOI 10.1016/j.gene.2011.09.019; Sjakste N, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1240, DOI 10.1134/S0006297910100056; STAMNES M A, 1992, Trends in Cell Biology, V2, P272, DOI 10.1016/0962-8924(92)90200-7; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Teigelkamp S, 1998, RNA, V4, P127; Wang P, 2005, GENOME BIOL, P6; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75381	10.1371/journal.pone.0075381	http://dx.doi.org/10.1371/journal.pone.0075381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058682	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900113
J	Castano, AG; de Nanclares, GP; Madariaga, L; Aguirre, M; Madrid, A; Nadal, I; Navarro, M; Lucas, E; Fijo, J; Espino, M; Espitaletta, Z; Castano, L; Ariceta, G				Garcia Castano, Alejandro; de Nanclares, Gustavo Perez; Madariaga, Leire; Aguirre, Mireia; Madrid, Alvaro; Nadal, Inmaculada; Navarro, Mercedes; Lucas, Elena; Fijo, Julia; Espino, Mar; Espitaletta, Zilac; Castano, Luis; Ariceta, Gema		RenalTube Grp	Genetics of Type III Bartter Syndrome in Spain, Proposed Diagnostic Algorithm	PLOS ONE			English	Article							CHLORIDE CHANNEL GENE; HYPOKALEMIC ALKALOSIS; CLCNKB GENE; MUTATIONS; GITELMAN; HYPERCALCIURIA; DEAFNESS; KIDNEY	The p.Ala204Thr mutation (exon 7) of the CLCNKB gene is a "founder" mutation that causes most of type III Bartter syndrome cases in Spain. We performed genetic analysis of the CLCNKB gene, which encodes for the chloride channel protein ClC-Kb, in a cohort of 26 affected patients from 23 families. The diagnostic algorithm was: first, detection of the p.Ala204Thr mutation; second, detecting large deletions or duplications by Multiplex Ligation-dependent Probe Amplification and Quantitative Multiplex PCR of Short Fluorescent Fragments; and third, sequencing of the coding and flanking regions of the whole CLCNKB gene. In our genetic diagnosis, 20 families presented with the p.Ala204Thr mutation. Of those, 15 patients (15 families) were homozygous (57.7% of overall patients). Another 8 patients (5 families) were compound heterozygous for the founder mutation together with a second one. Thus, 3 patients (2 siblings) presented with the c. -19-?_2053+? del deletion (comprising the entire gene); one patient carried the p.Val170Met mutation (exon 6); and 4 patients (3 siblings) presented with the novel p.Glu442Gly mutation (exon 14). On the other hand, another two patients carried two novel mutations in compound heterozygosis: one presented the p.Ile398_Thr401del mutation (exon 12) associated with the c. -19-?_2053+? del deletion, and the other one carried the c.1756+1G>A splice-site mutation (exon 16) as well as the already described p.Ala210Val change (exon 7). One case turned out to be negative in our genetic screening. In addition, 51 relatives were found to be heterozygous carriers of the described CLCNKB mutations. In conclusion, different mutations cause type III Bartter syndrome in Spain. The high prevalence of the p.Ala204Thr in Spanish families thus justifies an initial screen for this mutation. However, should it not be detected further investigation of the CLCNKB gene is warranted in clinically diagnosed families.	[Garcia Castano, Alejandro; de Nanclares, Gustavo Perez; Castano, Luis] Cruces Univ Hosp, Res Unit, Bizkaia, Spain; [Madariaga, Leire; Aguirre, Mireia] Cruces Univ Hosp, Bizkaia, Spain; [Madariaga, Leire; Castano, Luis] Univ Basque Country UPV EHU, Sch Med & Odontol, Dept Pediat, Bizkaia, Spain; [Ariceta, Gema] Materno Infantil Vall dHebron Hosp, Barcelona, Spain; [Nadal, Inmaculada] Virgen del Camino Hosp, Pamplona, Spain; [Navarro, Mercedes] La Paz Univ Hosp, Madrid, Spain; [Lucas, Elena] Manises Hosp, Valencia, Spain; [Fijo, Julia] Virgen del Rocio Hosp, Seville, Spain; [Espino, Mar] Fdn Alcorcon Univ Hosp, Madrid, Spain; [Espitaletta, Zilac] San Ignacio Univ Hosp, Bogota, Colombia; Asturias Cent Univ Hosp, Oviedo, Asturias, Spain; [RenalTube Grp] Nuestra Senora Candelaria Univ Hosp, Tenerife, Canarias, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces; University of Basque Country; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario La Paz; Virgen del Rocio University Hospital; Alcorcon Foundation University Hospital; Hospital Universitario San Ignacio; Central University Hospital Asturias	Castano, AG (corresponding author), Cruces Univ Hosp, Res Unit, Bizkaia, Spain.	gariceta@vhebron.net	alvarez, victoria/ABC-7891-2021; García, Alejandro/AAA-6023-2020; Madariaga, Leire/B-5220-2019; alvarez, victoria/GXV-1088-2022	alvarez, victoria/0000-0002-1916-2523; Madariaga, Leire/0000-0002-4032-9842; alvarez, victoria/0000-0002-1916-2523; ESPITALETA, ZILAC/0000-0003-4710-386X; Madrid, Alvaro/0000-0002-5942-8488; Castano, Luis/0000-0003-0437-9401; Perez de Nanclares, Gustavo/0000-0002-1692-8976; Claverie-Martin, Felix/0000-0003-2468-3267; Mejia Gaviria, Natalia/0000-0003-3650-2785	FIS of the Instituto de Salud Carlos III, Madrid, Spain [PI09/90888, PI11/01412]; Eitb Maratoia-Bioef [BIO08/ER/020]; Basque Foundation for Health Innovation and Research (BIOEF, from the Basque Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa)	FIS of the Instituto de Salud Carlos III, Madrid, Spain; Eitb Maratoia-Bioef; Basque Foundation for Health Innovation and Research (BIOEF, from the Basque Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa)	This study was supported by two grants (PI09/90888 and PI11/01412) from the FIS of the Instituto de Salud Carlos III, Madrid, Spain, and the Eitb Maratoia-Bioef (BIO08/ER/020) the Basque Foundation for Health Innovation and Research (BIOEF, from the Basque Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2001, J PHYSIOL-LONDON, V534, P745, DOI 10.1111/j.1469-7793.2001.00745.x; BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Dong Y, 2010, CHINESE MED J-PEKING, V123, P3151, DOI 10.3760/cma.j.issn.0366-6999.2010.21.037; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Ellison DH, 2000, AM J PHYSIOL-RENAL, V279, pF616, DOI 10.1152/ajprenal.2000.279.4.F616; Fukuyama S, 2003, KIDNEY INT, V64, P808, DOI 10.1046/j.1523-1755.2003.00163.x; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; Jeck N, 2000, PEDIATR RES, V48, P754, DOI 10.1203/00006450-200012000-00009; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Nozu K, 2007, PEDIATR RES, V62, P364, DOI 10.1203/PDR.0b013e318123fb90; Proesmans W, 1997, EUR J PEDIATR, V156, P669, DOI 10.1007/s004310050688; Rodriguez-Soriano J, 2005, PEDIATR NEPHROL, V20, P891, DOI 10.1007/s00467-005-1867-z; Rodriguez-Soriano J, 1998, PEDIATR NEPHROL, V12, P315, DOI 10.1007/s004670050461; Rodriguez-Soriano J, 1999, PEDIATRICS, V103, P663, DOI 10.1542/peds.103.3.663; RODRIGUEZSORIANO J, 1981, KIDNEY INT, V20, P700, DOI 10.1038/ki.1981.199; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; SEYBERTH HW, 1985, J PEDIATR-US, V107, P694, DOI 10.1016/S0022-3476(85)80395-4; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; TAKEUCHI Y, 1995, KIDNEY INT, V48, P1497, DOI 10.1038/ki.1995.439; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Vargas-Poussou R, 2011, J AM SOC NEPHROL, V22, P693, DOI 10.1681/ASN.2010090907; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Yu Y, 2010, CLIN GENET, V77, P155, DOI 10.1111/j.1399-0004.2009.01288.x; Zelikovic I, 2003, KIDNEY INT, V63, P24, DOI 10.1046/j.1523-1755.2003.00730.x	30	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74673	10.1371/journal.pone.0074673	http://dx.doi.org/10.1371/journal.pone.0074673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058621	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900076
J	He, B; Wu, JP; Xu, JK; Day, RE; Kirk, TB				He, Bo; Wu, Jian Ping; Xu, Jiake; Day, Robert E.; Kirk, Thomas Brett			Microstructural and Compositional Features of the Fibrous and Hyaline Cartilage on the Medial Tibial Plateau Imply a Unique Role for the Hopping Locomotion of Kangaroo	PLOS ONE			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; ELASTIC FIBERS; MICROSCOPY; PROTEOGLYCANS; MECHANICS; COLLAGEN; MODULUS; NETWORK	Hopping provides efficient and energy saving locomotion for kangaroos, but it results in great forces in the knee joints. A previous study has suggested that a unique fibrous cartilage in the central region of the tibial cartilage could serve to decrease the peak stresses generated within kangaroo tibiofemoral joints. However, the influences of the microstructure, composition and mechanical properties of the central fibrous and peripheral hyaline cartilage on the function of the knee joints are still to be defined. The present study showed that the fibrous cartilage was thicker and had a lower chondrocyte density than the hyaline cartilage. Despite having a higher PG content in the middle and deep zones, the fibrous cartilage had an inferior compressive strength compared to the peripheral hyaline cartilage. The fibrous cartilage had a complex three dimensional collagen meshwork with collagen bundles parallel to the surface in the superficial zone, and with collagen bundles both parallel and perpendicular to the surface in the middle and deep zones. The collagen in the hyaline cartilage displayed a typical Benninghoff structure, with collagen fibres parallel to the surface in the superficial zone and collagen fibres perpendicular to the surface in the deep zone. Elastin fibres were found throughout the entire tissue depth of the fibrous cartilage and displayed a similar alignment to the adjacent collagen bundles. In comparison, the elastin fibres in the hyaline cartilage were confined within the superficial zone. This study examined for the first time the fibrillary structure, PG content and compressive properties of the central fibrous cartilage pad and peripheral hyaline cartilage within the kangaroo medial tibial plateau. It provided insights into the microstructure and composition of the fibrous and peripheral hyaline cartilage in relation to the unique mechanical properties of the tissues to provide for the normal activities of kangaroos.	[He, Bo; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Crawley, Australia; [Wu, Jian Ping; Kirk, Thomas Brett] Curtin Univ, Dept Mech Engn, Bentley, WA, Australia; [Day, Robert E.] Royal Perth Hosp, Dept Med Engn & Phys, Perth, WA, Australia	University of Western Australia; Curtin University; Royal Perth Hospital; University of Western Australia	Kirk, TB (corresponding author), Curtin Univ, Dept Mech Engn, Bentley, WA, Australia.	brett.kirk@curtin.edu.au	Day, Robert/O-6379-2019; Kirk, Thomas B/H-5323-2012; Day, Robert E/B-5325-2016; Wu, Jian-Ping/U-9687-2018	Day, Robert/0000-0003-3442-2298; Kirk, Thomas B/0000-0002-3825-583X; Day, Robert E/0000-0003-3442-2298; Xu, Jiake/0000-0003-2021-8309; Wu, Jian-Ping/0000-0003-4725-2398	National Natural Science Foundation of China [81228013]; Medical & Health Research Infrastructure Fund of Western Australia -Round 15 (JX); Australia NHMRC fellowship [ID404179]; RPH Medical Research Foundation Equipment Grant (RED)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical & Health Research Infrastructure Fund of Western Australia -Round 15 (JX); Australia NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia); RPH Medical Research Foundation Equipment Grant (RED)	This study was also supported by a grant from the National Natural Science Foundation of China (NSFC No. 81228013) (JX), Medical & Health Research Infrastructure Fund of Western Australia -Round 15 (JX), a ward of Australia NHMRC fellowship (ID404179 JP Wu) and RPH Medical Research Foundation Equipment Grant (RED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DAWSON TJ, 1973, NATURE, V246, P313, DOI 10.1038/246313a0; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; FUSS FK, 1994, ANAT REC, V238, P297, DOI 10.1002/ar.1092380303; KEMPSON GE, 1971, J BIOMECH, V4, P239, DOI 10.1016/0021-9290(71)90030-3; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kielty CM, 2002, J CELL SCI, V115, P2817; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Mansfield J, 2009, J ANAT, V215, P682, DOI 10.1111/j.1469-7580.2009.01149.x; Metcalfe K, 2000, EUR J HUM GENET, V8, P955, DOI 10.1038/sj.ejhg.5200564; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9; OLDBERG A, 1990, BIOCHEM SOC T, V18, P789, DOI 10.1042/bst0180789; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Ranstam J, 2012, OSTEOARTHR CARTILAGE, V20, P473, DOI 10.1016/j.joca.2012.02.011; Ranstam J, 2002, ACTA ORTHOP SCAND, V73, P447, DOI 10.1080/00016470216327; Ricard C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821421; Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404; Screen HRC, 2005, ANN BIOMED ENG, V33, P1090, DOI 10.1007/s10439-005-5777-9; Smith LJ, 2008, ANN BIOMED ENG, V36, P214, DOI 10.1007/s10439-007-9421-8; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Werkmeister E, 2010, PHOTOCHEM PHOTOBIOL, V86, P302, DOI 10.1111/j.1751-1097.2009.00648.x; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Yeh AT, 2005, OSTEOARTHR CARTILAGE, V13, P345, DOI 10.1016/j.joca.2004.12.007; Yu J, 2010, J ANAT, V216, P533, DOI 10.1111/j.1469-7580.2009.01207.x	29	12	12	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74303	10.1371/journal.pone.0074303	http://dx.doi.org/10.1371/journal.pone.0074303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058543	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900039
J	Shen, YZ; Wang, ZY; Lu, HZ; Wang, JR; Chen, J; Liu, L; Zhang, RF; Zheng, YF				Shen, Yinzhong; Wang, Zhenyan; Lu, Hongzhou; Wang, Jiangrong; Chen, Jun; Liu, Li; Zhang, Renfang; Zheng, Yufang			Prevalence of Anemia among Adults with Newly Diagnosed HIV/AIDS in China	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; AIDS; INDIVIDUALS; COHORT; WOMEN	Background: The prevalence of anemia among antiretroviral-naive HIV-infected patients in China has not been well characterized. We conducted a cross-sectional study to estimate the prevalence of anemia among Chinese adults with newly diagnosed HIV/AIDS. Methods: One thousand nine hundred and forty-eight newly diagnosed HIV-infected patients in China were selected during 2009 and 2010. Serum samples obtained from each individual were collected to measure hemoglobin levels. Demographics and medical histories were recorded. Factors associated with the presence of anemia were analysed by logistic regression. Results: Among the 1948 patients, 75.8% were male. Median age was 40 years (range: 18-80 years). The overall prevalence of anemia among HIV-infected patients was 51.9% (51.5% among men, 53.2% among women). The prevalences of mild anemia, of moderate anemia, of severe anemia were 32.4%, 17.0%, and 2.5%, respectively. The prevalence of anemia was higher among ethnic minority patients than among the Han patients (70.9% versus 45.9%). The prevalence of anemia increased with increasing age (49.6%, 53.5% and 60.1% among patients who were 18-39, 40-59, and >= 60 years of age respectively) and with decreasing CD4 count (14.0%, 22.4%, 50.7%, and 74.6% among patients with CD4 count of >= 350, 200-349, 50-199, and <50 cells/mm(3) respectively). The logistic regression analysis showed that older age, lower CD4 count and minority ethnicity were significantly associated with an increased risk of anemia. Conclusions: Anemia is highly prevalent among Chinese adults with newly diagnosed HIV/AIDS, but severe anemia is less prevalent in this population. Older age, lower CD4 count and minority ethnicity are associated with an increased risk of anemia.	[Shen, Yinzhong; Wang, Zhenyan; Lu, Hongzhou; Wang, Jiangrong; Chen, Jun; Liu, Li; Zhang, Renfang; Zheng, Yufang] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China	Fudan University	Lu, HZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China.	luhongzhou@fudan.edu.cn	Chen, Jun/K-2085-2012	Chen, Jun/0000-0002-3850-4875	Ministry of Science and Technolgy, the People's Republic of China [2012ZX10001-003, 2011ZX09302-016]	Ministry of Science and Technolgy, the People's Republic of China	This work was supported by Key Research grants from the Ministry of Science and Technolgy, the People's Republic of China (NO: 2012ZX10001-003, 2011ZX09302-016). Website: http://www.most.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastos K, 2004, JAIDS-J ACQ IMM DEF, V35, P383, DOI 10.1097/00126334-200404010-00008; BELLO JL, 1990, AM J HEMATOL, V33, P230, DOI 10.1002/ajh.2830330403; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Cleveland RP, 1996, BLOOD, V87, P2275, DOI 10.1182/blood.V87.6.2275.bloodjournal8762275; Erhabor O, 2005, Niger J Med, V14, P33; Gonzalez Lucia, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P485, DOI 10.1016/S2221-1691(12)60081-1; Mata-Marin Jose A, 2010, BMC Res Notes, V3, P230, DOI 10.1186/1756-0500-3-230; Meidani M, 2012, J RES MED SCI, V17, P138; Mildvan D, 2007, CURR MED RES OPIN, V23, P343, DOI 10.1185/030079906X162683; Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Munyazesa E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001600; Omoregie R, 2009, Tanzan J Health Res, V11, P1; Parinitha SS, 2012, AUSTRALAS MED J, V5, P157, DOI [10.4066/AMJ.20121008, 10.4066/AMJ.2012.100]; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; Semba RD, 2001, J ACQ IMMUN DEF SYND, V26, P315, DOI 10.1097/00126334-200104010-00003; SPIVAK JL, 1989, JAMA-J AM MED ASSOC, V261, P3104, DOI 10.1001/jama.261.21.3104; Subbaraman R, 2009, INT J STD AIDS, V20, P489, DOI 10.1258/ijsa.2008.008370; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Wills Todd S, 2004, AIDS Read, V14, P305; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x	22	23	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73807	10.1371/journal.pone.0073807	http://dx.doi.org/10.1371/journal.pone.0073807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058490	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900020
J	Hanincova, K; Mukherjee, P; Ogden, NH; Margos, G; Wormser, GP; Reed, KD; Meece, JK; Vandermause, MF; Schwartz, I				Hanincova, Klara; Mukherjee, Priyanka; Ogden, Nicholas H.; Margos, Gabriele; Wormser, Gary P.; Reed, Kurt D.; Meece, Jennifer K.; Vandermause, Mary F.; Schwartz, Ira			Multilocus Sequence Typing of Borrelia burgdorferi Suggests Existence of Lineages with Differential Pathogenic Properties in Humans	PLOS ONE			English	Article							FREQUENCY-DEPENDENT SELECTION; FRAGMENT LENGTH POLYMORPHISM; IXODES-SCAPULARIS TICKS; PROTEIN-C GENE; SENSU-STRICTO; LYME-DISEASE; HEMATOGENOUS DISSEMINATION; STREPTOCOCCUS-PNEUMONIAE; METHICILLIN-RESISTANT; PEROMYSCUS-LEUCOPUS	The clinical manifestations of Lyme disease, caused by Borrelia burgdorferi, vary considerably in different patients, possibly due to infection by strains with varying pathogenicity. Both rRNA intergenic spacer and ospC typing methods have proven to be useful tools for categorizing B. burgdorferi strains that vary in their tendency to disseminate in humans. Neither method, however, is suitable for inferring intraspecific relationships among strains that are important for understanding the evolution of pathogenicity and the geographic spread of disease. In this study, multilocus sequence typing (MLST) was employed to investigate the population structure of B. burgdorferi recovered from human Lyme disease patients. A total of 146 clinical isolates from patients in New York and Wisconsin were divided into 53 sequence types (STs). A goeBURST analysis, that also included previously published STs from the northeastern and upper Midwestern US and adjoining areas of Canada, identified 11 major and 3 minor clonal complexes, as well as 14 singletons. The data revealed that patients from New York and Wisconsin were infected with two distinct, but genetically and phylogenetically closely related, populations of B. burgdorferi. Importantly, the data suggest the existence of B. burgdorferi lineages with differential capabilities for dissemination in humans. Interestingly, the data also indicate that MLST is better able to predict the outcome of localized or disseminated infection than is ospC typing.	[Hanincova, Klara; Mukherjee, Priyanka; Schwartz, Ira] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Zoonoses Div, Ctr Food Borne Environm & Zoonot Infect Dis, Ottawa, ON, Canada; [Margos, Gabriele] Univ Munich, Inst Infect Dis & Zoonoses, Oberschleissheim, Germany; [Margos, Gabriele] Bavarian Hlth & Food Safety Author, Natl Reference Ctr Borrelia, Oberschleissheim, Germany; [Wormser, Gary P.] New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA; [Reed, Kurt D.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Meece, Jennifer K.; Vandermause, Mary F.] Marshfield Clin Res Fdn, Marshfield, WI USA	New York Medical College; Public Health Agency of Canada; University of Munich; Bavarian Health & Food Safety Authority; New York Medical College; University of Wisconsin System; University of Wisconsin Madison	Hanincova, K (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	klara.hanincova@gmail.com		MARGOS, Gabriele/0000-0001-5304-9615	National Institutes of Health [AR41511, AI45801]; William and Sylvia Silberstein Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Sylvia Silberstein Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health (AR41511 and AI45801) and the William and Sylvia Silberstein Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Attie O, 2007, INFECT GENET EVOL, V7, P1, DOI 10.1016/j.meegid.2006.02.008; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; Brisson D, 2010, EMERG INFECT DIS, V16, P911, DOI 10.3201/eid1606.090329; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Center of Disease Control and Prevention, 2012, LYM DIS US; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Dennis David T., 2002, P251, DOI 10.1079/9780851996325.0251; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Dykhuizen DE, 2001, TRENDS MICROBIOL, V9, P344, DOI 10.1016/S0966-842X(01)02066-2; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; FALCO RC, 1988, AM J EPIDEMIOL, V128, P1146; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamer SA, 2011, APPL ENVIRON MICROB, V77, P1999, DOI 10.1128/AEM.02479-10; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P5008, DOI 10.1128/AEM.00479-08; Haven J, 2011, GENETICS, V189, P951, DOI 10.1534/genetics.111.130773; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Kurtenbach K., 2010, BACTERIAL POPULATION; Lin T, 2002, J CLIN MICROBIOL, V40, P2572, DOI 10.1128/JCM.40.7.2572-2583.2002; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; MITCHELL PD, 1993, AM J CLIN PATHOL, V99, P104, DOI 10.1093/ajcp/99.1.104; Nadelman RB, 2012, NEW ENGL J MED, V367, P1883, DOI 10.1056/NEJMoa1114362; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiu WG, 2008, EMERG INFECT DIS, V14, P1097, DOI 10.3201/eid/1407.070880; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Qiu WG, 2002, GENETICS, V160, P833; Qiu WG, 1997, HEREDITAS, V127, P203, DOI 10.1111/j.1601-5223.1997.00203.x; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Strle K, 2011, AM J PATHOL, V178, P2726, DOI 10.1016/j.ajpath.2011.02.018; Swanson KI, 2008, VECTOR-BORNE ZOONOT, V8, P397, DOI 10.1089/vbz.2007.0222; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terekhova D, 2006, J BACTERIOL, V188, P6124, DOI 10.1128/JB.00459-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Travinsky B, 2010, EMERG INFECT DIS, V16, P1147, DOI 10.3201/eid1607.091452; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Vitorino LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004002; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wang GQ, 1999, FEMS MICROBIOL LETT, V177, P289, DOI 10.1111/j.1574-6968.1999.tb13745.x; Wang GQ, 2004, INFECT IMMUN, V72, P6702, DOI 10.1128/IAI.72.11.6702-6706.2004; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; Wang IN, 1999, GENETICS, V151, P15; Wareing DRA, 2003, LETT APPL MICROBIOL, V36, P106, DOI 10.1046/j.1472-765X.2003.01270.x; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, WIEN KLIN WOCHENSCHR, V118, P634, DOI 10.1007/s00508-006-0688-9; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Zhou JJ, 2000, J CLIN MICROBIOL, V38, P977, DOI 10.1128/JCM.38.3.977-986.2000	75	74	74	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73066	10.1371/journal.pone.0073066	http://dx.doi.org/10.1371/journal.pone.0073066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069170	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300005
J	Pani, G; Samari, N; Quintens, R; de Saint-Georges, L; Meloni, M; Baatout, S; Van Oostveldt, P; Benotmane, MA				Pani, Giuseppe; Samari, Nada; Quintens, Roel; de Saint-Georges, Louis; Meloni, MariAntonia; Baatout, Sarah; Van Oostveldt, Patrick; Benotmane, Mohammed Abderrafi			Morphological and Physiological Changes in Mature In Vitro Neuronal Networks towards Exposure to Short-, Middle- or Long-Term Simulated Microgravity	PLOS ONE			English	Article							SYNAPSE FORMATION; SPACE-FLIGHT; CELL-CULTURE; GLIAL-CELLS; CYTOSKELETON; GRAVITY; NEUROPLASTICITY; APOPTOSIS; HYPERGRAVITY; PLASTICITY	One of the objectives of the current international space programmes is to investigate the possible effects of the space environment on the crew health. The aim of this work was to assess the particular effects of simulated microgravity on mature primary neuronal networks and specially their plasticity and connectivity. For this purpose, primary mouse neurons were first grown for 10 days as a dense network before being placed in the Random Positioning Machine (RPM), simulating microgravity. These cultures were then used to investigate the impact of short- (1 h), middle- (24 h) and long-term (10 days) exposure to microgravity at the level of neurite network density, cell morphology and motility as well as cytoskeleton properties in established two-dimensional mature neuronal networks. Image processing analysis of dense neuronal networks exposed to simulated microgravity and their subsequent recovery under ground conditions revealed different neuronal responses depending on the duration period of exposure. After short- and middle- term exposures to simulated microgravity, changes in neurite network, neuron morphology and viability were observed with significant alterations followed by fast recovery processes. Long exposure to simulated microgravity revealed a high adaptation of single neurons to the new gravity conditions as well as a partial adaptation of neuronal networks. This latter was concomitant to an increase of apoptosis. However, neurons and neuronal networks exposed for long-term to simulated microgravity required longer recovery time to re-adapt to the ground gravity. In conclusion, a clear modulation in neuronal plasticity was evidenced through morphological and physiological changes in primary neuronal cultures during and after simulated microgravity exposure. These changes were dependent on the duration of exposure to microgravity.	[Pani, Giuseppe; Samari, Nada; Quintens, Roel; de Saint-Georges, Louis; Baatout, Sarah; Benotmane, Mohammed Abderrafi] SCK CEN, Belgian Nucl Res Ctr, Mol & Cellular Biol Expert Grp, Radiobiol Unit, Mol, Belgium; [Pani, Giuseppe; Baatout, Sarah; Van Oostveldt, Patrick] Univ Ghent, Dept Mol Biotechnol, Lab Biochem & Mol Cytol, B-9000 Ghent, Belgium; [Meloni, MariAntonia] Univ Sassari, Dept Physiol Biochem & Cellular Sci, I-07100 Sassari, Italy	Belgian Nuclear Research Centre (SCK-CEN); Ghent University; University of Sassari	Benotmane, MA (corresponding author), SCK CEN, Belgian Nucl Res Ctr, Mol & Cellular Biol Expert Grp, Radiobiol Unit, Mol, Belgium.	abenotma@sckcen.be	Quintens, Roel/G-5339-2017	Quintens, Roel/0000-0002-4359-3403; Benotmane, Rafi/0000-0002-8985-1578; PANI, GIUSEPPE/0000-0001-5198-8205; Baatout, Sarah/0000-0001-8110-751X	3 PRODEX/ESA [C90-303, C90-391, CO-90-11-2801-02]; Sardinian Government; "Master & Back'' grant , SCK*CEN-UGent PhD grant [AF-DR-A2008-67]	3 PRODEX/ESA; Sardinian Government(Regione Sardegna); "Master & Back'' grant , SCK*CEN-UGent PhD grant	This research was financially supported by 3 PRODEX/ESA contracts (C90-303, C90-391 and CO-90-11-2801-02). G. Pani was financially supported by the Sardinian Government with the "Master & Back'' grant (AF-DR-A2008-67) as well as by SCK*CEN-UGent PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts J R, 1985, Physiologist, V28, pS81; Anken RH, 2002, ADV SPACE RES-SERIES, V30, P843, DOI 10.1016/S0273-1177(01)00643-3; Babakova L L, 2008, Aviakosm Ekolog Med, V42, P31; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Battista Natalia, 2007, J Gravit Physiol, V14, pP131; Blaber E, 2010, ASTROBIOLOGY, V10, P463, DOI 10.1089/ast.2009.0415; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; Cogoli A, 1997, Adv Space Biol Med, V6, P33, DOI 10.1016/S1569-2574(08)60077-5; COGOLI A, 1993, J LEUKOCYTE BIOL, V54, P259, DOI 10.1002/jlb.54.3.259; Cogoli Augusto, 1993, Environmental Medicine (Nagoya), V37, P107; Crestini A, 2004, IN VITRO CELL DEV-AN, V40, P159; Flight MH, 2013, NAT REV NEUROSCI, V14, P306, DOI 10.1038/nrn3485; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Fuchs H S, 1980, Riv Med Aeronaut Spaz, V43, P332; GRUENER R, 1991, AVIAT SPACE ENVIR MD, V62, P1159; GRUENER R, 1990, AM J PHYSIOL, V258, pC489, DOI 10.1152/ajpcell.1990.258.3.C489; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; Infanger M, 2006, CELL TISSUE RES, V324, P267, DOI 10.1007/s00441-005-0142-8; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Kim JA, 2002, NEUROPHARMACOLOGY, V42, P1109, DOI 10.1016/S0028-3908(02)00052-7; Krasnov I B, 1994, Adv Space Biol Med, V4, P85; Lai PY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051906; Lucassen PJ, 2004, BIOL PSYCHIAT, V55, P789, DOI 10.1016/j.biopsych.2003.12.014; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; MOORE TP, 1987, AVIAT SPACE ENVIR MD, V58, pA91; Narro ML, 2007, BRAIN RES, V1138, P57, DOI 10.1016/j.brainres.2006.10.094; NEWBERG AB, 1994, AVIAT SPACE ENVIR MD, V65, P562; NICOGOSSIAN A, 1988, ACTA ASTRONAUT, V17, P195, DOI 10.1016/0094-5765(88)90022-7; OBrien PJ, 1997, LAB ANIM SCI, V47, P486; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Ponti G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002366; Popko J, 2009, CYTOM PART A, V75A, P371, DOI 10.1002/cyto.a.20660; RILEY DA, 1990, FASEB J, V4, P84, DOI 10.1096/fasebj.4.1.2153085; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Ross MD, 2005, J VESTIBUL RES-EQUIL, V15, P17; Santucci D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040112; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sciola L, 1999, ADV SPACE RES, V24, P801, DOI 10.1016/S0273-1177(99)00078-2; SHAW CA, 1994, BRAIN RES REV, V19, P241, DOI 10.1016/0165-0173(94)90014-0; Slenzka K, 2003, ADV SPACE RES-SERIES, V31, P1595, DOI 10.1016/S0273-1177(03)00011-5; Sun XQ, 2009, BEHAV BRAIN RES, V199, P197, DOI 10.1016/j.bbr.2008.11.035; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Uzbay T, 2012, MARMARA PHARM J, V16, P65, DOI 10.12991/201216404; Vazquez ME, 1998, ADV SPACE RES-SERIES, V22, P171, DOI 10.1016/S0273-1177(98)80009-4; Vein AA, 2009, CEPHALALGIA, V29, P683, DOI 10.1111/j.1468-2982.2008.01775.x; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	50	28	31	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73857	10.1371/journal.pone.0073857	http://dx.doi.org/10.1371/journal.pone.0073857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066080	Green Published, gold			2022-12-27	WOS:000324494000062
J	Turner, EA; Kroeger, GL; Arnold, MC; Thornton, BL; Di Giulio, RT; Meyer, JN				Turner, Elena A.; Kroeger, Gretchen L.; Arnold, Mariah C.; Thornton, B. Lila; Di Giulio, Richard T.; Meyer, Joel N.			Assessing Different Mechanisms of Toxicity in Mountaintop Removal/Valley Fill Coal Mining-Affected Watershed Samples Using Caenorhabditis elegans	PLOS ONE			English	Article							TRANSGENIC NEMATODES; VALLEY FILLS; SELENIUM; STRESS; CADMIUM; MACROINVERTEBRATES; INDUCTION; RESPONSES; PATHWAY; SULFATE	Mountaintop removal-valley fill coal mining has been associated with a variety of impacts on ecosystem and human health, in particular reductions in the biodiversity of receiving streams. However, effluents emerging from valley fills contain a complex mixture of chemicals including metals, metalloids, and salts, and it is not clear which of these are the most important drivers of toxicity. We found that streamwater and sediment samples collected from mine-impacted streams of the Upper Mud River in West Virginia inhibited the growth of the nematode Caenorhabditis elegans. Next, we took advantage of genetic and transgenic tools available in this model organism to test the hypotheses that the toxicity could be attributed to metals, selenium, oxidative stress, or osmotic stress. Our results indicate that in general, the toxicity of streamwater to C. elegans was attributable to osmotic stress, while the toxicity of sediments resulted mostly from metals or metalloids.	[Turner, Elena A.; Kroeger, Gretchen L.; Arnold, Mariah C.; Thornton, B. Lila; Di Giulio, Richard T.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	joel.meyer@duke.edu	; Meyer, Joel/G-9836-2017	Thornton, Luka/0000-0003-2185-6281; Meyer, Joel/0000-0003-1219-0983	Foundation for the Carolinas	Foundation for the Carolinas	Funding was provided by the Foundation for the Carolinas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2007, J AM WATER RESOUR AS, V43, P41, DOI 10.1111/j.1752-1688.2007.00005.x; Anbalagan C, 2012, ECOTOXICOLOGY, V21, P439, DOI 10.1007/s10646-011-0804-0; Arnold MC, 2013, ARCH ENVIRON CON TOX, V65, P224, DOI 10.1007/s00244-013-9905-5; Au C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007792; Bernhardt ES, 2012, ENVIRON SCI TECHNOL, V46, P8115, DOI 10.1021/es301144q; Borgmann U, 1996, ARCH ENVIRON CON TOX, V30, P356; Buchwalter DB, 2008, P NATL ACAD SCI USA, V105, P8321, DOI 10.1073/pnas.0801686105; CHAPMAN PM, 1986, ENVIRON TOXICOL CHEM, V5, P957, DOI 10.1002/etc.5620051104; Conley JM, 2011, ECOTOXICOLOGY, V20, P1840, DOI 10.1007/s10646-011-0722-1; Conley JM, 2009, ENVIRON SCI TECHNOL, V43, P7952, DOI 10.1021/es9016377; Cormier SM, 2013, ENVIRON TOXICOL CHEM, V32, P296, DOI 10.1002/etc.2055; Cormier SM, 2013, ENVIRON TOXICOL CHEM, V32, P277, DOI 10.1002/etc.2059; Debruyn AMH, 2007, ENVIRON SCI TECHNOL, V41, P1766, DOI 10.1021/es062253j; Dennis JL, 1997, AQUAT TOXICOL, V40, P37, DOI 10.1016/S0166-445X(97)00043-X; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Dittman EK, 2010, ENVIRON SCI TECHNOL, V44, P9182, DOI 10.1021/es1022043; EISLER R, 2000, HDB CHEM RISK ASSESS, V3, P1649; Estevez AO, 2012, NEUROTOXICOLOGY, V33, P1021, DOI 10.1016/j.neuro.2012.04.019; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; GANTHER HE, 1962, J NUTR, V77, P408, DOI 10.1093/jn/77.4.408; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Ghose MK, 2007, ENVIRON MONIT ASSESS, V130, P17, DOI 10.1007/s10661-006-9448-6; Griffith MB, 2012, SCI TOTAL ENVIRON, V417, P1, DOI 10.1016/j.scitotenv.2011.12.042; Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051; Hartman KJ, 2005, HYDROBIOLOGIA, V532, P91, DOI 10.1007/s10750-004-9019-1; Hitt NP, 2010, ECOHEALTH, V7, P91, DOI 10.1007/s10393-010-0297-y; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; IWAI N, 1988, ARCH TOXICOL, V62, P447, DOI 10.1007/BF00288348; Koga M, 2000, EMBO J, V19, P5148, DOI 10.1093/emboj/19.19.5148; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li WH, 2011, FOOD CHEM TOXICOL, V49, P812, DOI 10.1016/j.fct.2010.12.002; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Luoma SN, 2009, ENVIRON SCI TECHNOL, V43, P8483, DOI 10.1021/es900828h; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1311, DOI 10.1897/08-496.1; Malaj E, 2012, ENVIRON TOXICOL CHEM, V31, P1754, DOI 10.1002/etc.1868; Martinez-Finley EJ, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/895236; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Mutwakil MHAZ, 1997, ARCH ENVIRON CON TOX, V32, P146, DOI 10.1007/s002449900167; North M, 2010, INT J MOL SCI, V11, P4796, DOI 10.3390/ijms11124796; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Power RS, 1999, ARCH ENVIRON CON TOX, V37, P503, DOI 10.1007/s002449900545; Sasakura C, 1998, J INORG BIOCHEM, V71, P159, DOI 10.1016/S0162-0134(98)10048-X; Simmons DBD, 2005, ENVIRON TOXICOL CHEM, V24, P1331, DOI 10.1897/04-176R.1; Simmons DBD, 2011, ENVIRON TOXICOL CHEM, V30, P469, DOI 10.1002/etc.392; Smith ME, 1997, ENVIRON TOXICOL CHEM, V16, P1229, DOI [10.1897/1551-5028(1997)016&lt;1229:ARRWFT&gt;2.3.CO;2, 10.1002/etc.5620160618]; Soucek DJ, 2005, ENVIRON TOXICOL CHEM, V24, P1204, DOI 10.1897/04-142.1; Spain SM, 2004, ANAL BIOANAL CHEM, V378, P1561, DOI 10.1007/s00216-003-2415-y; Stiernagle T, 1999, C ELEGANS PRACTICAL, P59; Swain SC, 2004, J MOL BIOL, V341, P951, DOI 10.1016/j.jmb.2004.06.050; Traunspurger W, 1997, ENVIRON TOXICOL CHEM, V16, P245, DOI [10.1897/1551-5028(1997)016&lt;0245:EAOASW&gt;2.3.CO;2, 10.1002/etc.5620160221]; USEPA, 2011, EPA600R609138F; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t	59	21	21	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75329	10.1371/journal.pone.0075329	http://dx.doi.org/10.1371/journal.pone.0075329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066176	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000158
J	Van der Fels-Klerx, HJ; van Asselt, ED; Madsen, MS; Olesen, JE				Van der Fels-Klerx, H. J.; van Asselt, Esther D.; Madsen, Marianne S.; Olesen, Jorgen E.			Impact of Climate Change Effects on Contamination of Cereal Grains with Deoxynivalenol	PLOS ONE			English	Article							WINTER-WHEAT; LAND-USE; SCENARIOS; EUROPE; AGRICULTURE; VALUES; MAIZE; MODEL; TIME	Climate change is expected to aggravate feed and food safety problems of crops; however, quantitative estimates are scarce. This study aimed to estimate impacts of climate change effects on deoxynivalenol contamination of wheat and maize grown in the Netherlands by 2040. Quantitative modelling was applied, considering both direct effects of changing climate on toxin contamination and indirect effects via shifts in crop phenology. Climate change projections for the IPCC A1B emission scenario were used for the scenario period 2031-2050 relative to the baseline period of 1975-1994. Climatic data from two different global and regional climate model combinations were used. A weather generator was applied for downscaling climate data to local conditions. Crop phenology models and prediction models for DON contamination used, each for winter wheat and grain maize. Results showed that flowering and full maturity of both wheat and maize will advance with future climate. Flowering advanced on average 5 and 11 days for wheat, and 7 and 14 days for maize (two climate model combinations). Full maturity was on average 10 and 17 days earlier for wheat, and 19 and 36 days earlier for maize. On the country level, contamination of wheat with deoxynivalenol decreased slightly, but not significantly. Variability between regions was large, and individual regions showed a significant increase in deoxynivalenol concentrations. For maize, an overall decrease in deoxynivalenol contamination was projected, which was significant for one climate model combination, but not significant for the other one. In general, results disagree with previous reported expectations of increased feed and food safety hazards under climate change. This study illustrated the relevance of using quantitative models to estimate the impacts of climate change effects on food safety, and of considering both direct and indirect effects when assessing climate change impacts on crops and related food safety hazards.	[Van der Fels-Klerx, H. J.; van Asselt, Esther D.] Univ Wageningen & Res Ctr, RIKILT Wageningen UR, Wageningen, Netherlands; [Madsen, Marianne S.] Danish Meteorol Inst, Danish Climate Ctr, Copenhagen, Denmark; [Olesen, Jorgen E.] Aarhus Univ, Dept Agroecol, Tjele, Denmark	Wageningen University & Research; Danish Meteorological Institute DMI; Aarhus University	Van der Fels-Klerx, HJ (corresponding author), Univ Wageningen & Res Ctr, RIKILT Wageningen UR, Wageningen, Netherlands.	ine.vanderfels@wur.nl	Olesen, Jørgen/Y-2857-2019; Olesen, Jørgen E/C-2905-2016	Olesen, Jørgen/0000-0002-6639-1273; Olesen, Jørgen E/0000-0002-6639-1273; Madsen, Marianne/0000-0003-3153-5537	Dutch Ministry of Economic Affairs; Nordic Innovation Centre; EU [505539]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Nordic Innovation Centre; EU(European Commission)	The authors acknowledge financial support for this study from the Dutch Ministry of Economic Affairs and the Nordic Innovation Centre. The ENSEMBLES data used in this work was funded by the EU FP6 Integrated Project ENSEMBLES (Contract number 505539) whose support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROW EM, 1995, FORESTRY, V68, P349, DOI 10.1093/forestry/68.4.349; Bindi M, 2011, REG ENVIRON CHANGE, V11, pS151, DOI 10.1007/s10113-010-0173-x; Cesaraccio C, 2001, INT J BIOMETEOROL, V45, P161; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Doohan FM, 2003, EUR J PLANT PATHOL, V109, P755, DOI 10.1023/A:1026090626994; Elsgaard L, 2012, FOOD ADDIT CONTAM A, V29, P1514, DOI 10.1080/19440049.2012.700953; Falloon P, 2010, SCI TOTAL ENVIRON, V408, P5667, DOI 10.1016/j.scitotenv.2009.05.002; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Harrison PA, 1996, CLIMATE RES, V7, P225, DOI 10.3354/cr007225; Hooker DC, 2005, CAN J PLANT PATHOL, V27, P347; Isebaert S, 2009, J PHYTOPATHOL, V157, P108, DOI 10.1111/j.1439-0434.2008.01443.x; Madgwick JW, 2011, EUR J PLANT PATHOL, V130, P117, DOI 10.1007/s10658-010-9739-1; Madsen MS, 2012, FOOD ADDIT CONTAM A, V29, P1502, DOI 10.1080/19440049.2012.712059; Maracchi G, 2005, CLIMATIC CHANGE, V70, P117, DOI 10.1007/s10584-005-5939-7; Miraglia M, 2009, FOOD CHEM TOXICOL, V47, P1009, DOI 10.1016/j.fct.2009.02.005; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Olesen JE, 2012, FOOD ADDIT CONTAM A, V29, P1527, DOI 10.1080/19440049.2012.712060; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9; Paterson RRM, 2011, FOOD RES INT, V44, P2555, DOI 10.1016/j.foodres.2011.05.038; Paterson RRM, 2010, FOOD RES INT, V43, P1902, DOI 10.1016/j.foodres.2009.07.010; Peltonen-Sainio P, 2009, AGR FOOD SCI, V18, P171, DOI 10.2137/145960609790059479; Pestka JJ, 2010, WORLD MYCOTOXIN J, V3, P323, DOI 10.3920/WMJ2010.1247; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; ROSSO L, 1993, J THEOR BIOL, V162, P447, DOI 10.1006/jtbi.1993.1099; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; Schaafsma AW, 2001, CAN J PLANT PATHOL, V23, P279, DOI 10.1080/07060660109506941; Semenov MA, 1998, CLIMATE RES, V10, P95, DOI 10.3354/cr010095; Semenov MA, 2009, J R SOC INTERFACE, V6, P343, DOI 10.1098/rsif.2008.0285; Solomon S., 2007, PHYS SCI BASIS WORKI; Tirado MC, 2010, FOOD RES INT, V43, P1745, DOI 10.1016/j.foodres.2010.07.003; Trnka M, 2011, GLOBAL CHANGE BIOL, V17, P2298, DOI 10.1111/j.1365-2486.2011.02396.x; Turner PC, 2010, WORLD MYCOTOXIN J, V3, P315, DOI 10.3920/WMJ2010.1242; van Asselt ED, 2012, FOOD ADDIT CONTAM A, V29, P1572, DOI 10.1080/19440049.2012.688877; Van Asselt ED, 2012, FOOD ADDIT CONTAM A, V29, P1556, DOI 10.1080/19440049.2012.689997; van der Fels-Klerx HJ, 2012, FOOD ADDIT CONTAM A, V29, P1647, DOI 10.1080/19440049.2012.714080; van der Fels-Klerx HJ, 2012, FOOD ADDIT CONTAM A, V29, P1593, DOI 10.1080/19440049.2012.691555; van der Fels-Klerx HJ, 2012, J FOOD PROTECT, V75, P1099, DOI 10.4315/0362-028X.JFP-11-435; Van Der Fels-Klerx HJ, 2010, FOOD ADDIT CONTAM A, V27, P636, DOI 10.1080/19440040903571762; Van der Fels-Klerx HJ, 2012, FOODS ADD CONTAM, V29, P1556, DOI [10.1080/19440049.2012.689997, DOI 10.1080/19440049.2012.689997.PUBMED:22738407]; Van der Fels-Klerx HJ, 2011, EUR S INT ASS FOOD P; Van der Linden P., 2009, ENSEMBLES CLIMATE CH; Waichler SR, 2003, J HYDROMETEOROL, V4, P251, DOI 10.1175/1525-7541(2003)4<251:DOHMVF>2.0.CO;2	46	20	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73602	10.1371/journal.pone.0073602	http://dx.doi.org/10.1371/journal.pone.0073602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066059	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000040
J	West, J; Blystad, I; Engstrom, M; Warntjes, JBM; Lundberg, P				West, Janne; Blystad, Ida; Engstrom, Maria; Warntjes, Jan B. M.; Lundberg, Peter			Application of Quantitative MRI for Brain Tissue Segmentation at 1.5 T and 3.0 T Field Strengths	PLOS ONE			English	Article							AUTOMATED SEGMENTATION; MULTIPLE-SCLEROSIS; STEADY-STATE; T-1; RELAXATION; IMAGES; VOLUME; MODEL; TIME; QUANTIFICATION	Background: Brain tissue segmentation of white matter (WM), grey matter (GM), and cerebrospinal fluid (CSF) are important in neuroradiological applications. Quantitative Mri (qMRI) allows segmentation based on physical tissue properties, and the dependencies on MR scanner settings are removed. Brain tissue groups into clusters in the three dimensional space formed by the qMRI parameters R-1, R-2 and PD, and partial volume voxels are intermediate in this space. The qMRI parameters, however, depend on the main magnetic field strength. Therefore, longitudinal studies can be seriously limited by system upgrades. The aim of this work was to apply one recently described brain tissue segmentation method, based on qMRI, at both 1.5 T and 3.0 T field strengths, and to investigate similarities and differences. Methods: In vivo qMRI measurements were performed on 10 healthy subjects using both 1.5 T and 3.0 T MR scanners. The brain tissue segmentation method was applied for both 1.5 T and 3.0 T and volumes of WM, GM, CSF and brain parenchymal fraction (BPF) were calculated on both field strengths. Repeatability was calculated for each scanner and a General Linear Model was used to examine the effect of field strength. Voxel-wise t-tests were also performed to evaluate regional differences. Results: Statistically significant differences were found between 1.5 T and 3.0 T for WM, GM, CSF and BPF (p<0.001). Analyses of main effects showed that WM was underestimated, while GM and CSF were overestimated on 1.5 T compared to 3.0 T. The mean differences between 1.5 T and 3.0 T were -66 mL WM, 40 mL GM, 29 mL CSF and -1.99% BPF. Voxel-wise t-tests revealed regional differences of WM and GM in deep brain structures, cerebellum and brain stem. Conclusions: Most of the brain was identically classified at the two field strengths, although some regional differences were observed.	[West, Janne; Blystad, Ida; Engstrom, Maria; Warntjes, Jan B. M.; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden; [West, Janne; Blystad, Ida; Engstrom, Maria; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth, UHL Cty Council Ostergotland, Linkoping, Sweden; [Warntjes, Jan B. M.] Linkoping Univ, Dept Med & Hlth, Div Clin Physiol, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University	West, J (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden.	janne.west@liu.se	Lundberg, Peter/AGD-9679-2022; West, Janne/H-3681-2019	West, Janne/0000-0001-8369-0075; Engstrom, Maria/0000-0002-2167-2450	University Hospital Research Funds, Linkoping University; National Research Council (VR/NT)	University Hospital Research Funds, Linkoping University; National Research Council (VR/NT)(Swedish Research Council)	Research funding and support for this project that was obtained from University Hospital Research Funds, Linkoping University and the National Research Council (VR/NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano B, 1997, MAGNET RESON MED, V37, P84, DOI 10.1002/mrm.1910370113; Andersen AH, 2002, J NEUROSCI METH, V122, P13, DOI 10.1016/S0165-0270(02)00273-X; Barnes J, 2009, HIPPOCAMPUS, V19, P510, DOI 10.1002/hipo.20617; Bland JM, 1996, BRIT MED J, V313, P744; BONAR DC, 1993, J COMPUT ASSIST TOMO, V17, P461, DOI 10.1097/00004728-199305000-00024; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; Bozzali M, 2008, MAGN RESON IMAGING, V26, P1065, DOI 10.1016/j.mri.2008.01.044; CHOI HS, 1991, IEEE T MED IMAGING, V10, P395, DOI 10.1109/42.97590; Clare S, 2001, MAGNET RESON MED, V45, P630, DOI 10.1002/mrm.1085; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Groeneveld RA, 1984, STATISTICIAN, V33, P9; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hocq A, 2009, CONTRAST MEDIA MOL I, V4, P157, DOI 10.1002/cmmi.275; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; JACKSON EF, 1994, JMRI-J MAGN RESON IM, V4, P692, DOI 10.1002/jmri.1880040512; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; KIKINIS R, 1992, JMRI-J MAGN RESON IM, V2, P619, DOI 10.1002/jmri.1880020603; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Neeb H, 2006, NEUROIMAGE, V31, P1156, DOI 10.1016/j.neuroimage.2005.12.063; Pfefferbaum A, 2012, NEUROIMAGE, V60, P940, DOI 10.1016/j.neuroimage.2012.01.092; Rovira A, 2008, EUR J RADIOL, V67, P409, DOI 10.1016/j.ejrad.2008.02.044; Schenck JF, 1995, J NEUROL SCI, V134, P10, DOI 10.1016/0022-510X(95)00203-E; Schmidt-Wilcke Tobias, 2008, Curr Rheumatol Rep, V10, P467; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes JBM, 2007, MAGN RESON MED, V57, P528, DOI 10.1002/mrm.21165; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhu DC, 2005, MAGNET RESON MED, V54, P725, DOI 10.1002/mrm.20602; Zipp F, 2009, J NEUROL SCI, V287, pS24, DOI 10.1016/S0022-510X(09)71297-3	35	19	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74795	10.1371/journal.pone.0074795	http://dx.doi.org/10.1371/journal.pone.0074795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066153	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000135
J	Rajatonirina, S; Razanajatovo, NH; Ratsima, EH; Orelle, A; Ratovoson, R; Andrianirina, ZZ; Andriatahina, T; Ramparany, L; Herindrainy, P; Randrianirina, F; Heraud, JM; Richard, V				Rajatonirina, Soatiana; Razanajatovo, Norosoa Harline; Ratsima, Elisoa Hariniana; Orelle, Arnaud; Ratovoson, Rila; Andrianirina, Zo Zafitsara; Andriatahina, Todisoa; Ramparany, Lovasoa; Herindrainy, Perlinot; Randrianirina, Frederique; Heraud, Jean-Michel; Richard, Vincent			Outcome Risk Factors during Respiratory Infections in a Paediatric Ward in Antananarivo, Madagascar 2010-2012	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TRACT INFECTIONS; ETIOLOGY; CHILDREN; MANAGEMENT; MALNUTRITION; DEATHS	Background: Acute respiratory infections are a leading cause of infectious disease-related morbidity, hospitalisation and mortality among children worldwide, and particularly in developing countries. In these low-income countries, most patients with acute respiratory infection (ARI), whether it is mild or severe, are still treated empirically. The aim of the study was to evaluate the risk factors associated with the evolution and outcome of respiratory illnesses in patients aged under 5 years old. Materials and Methods: We conducted a prospective study in a paediatric ward in Antananarivo from November 2010 to July 2012 including patients under 5 years old suffering from respiratory infections. We collected demographic, socioeconomic, clinical and epidemiological data, and samples for laboratory analysis. Deaths, rapid progression to respiratory distress during hospitalisation, and hospitalisation for more than 10 days were considered as severe outcomes. We used multivariate analysis to study the effects of co-infections. Results: From November 2010 to July 2012, a total of 290 patients were enrolled. Co-infection was found in 192 patients (70%). Co-infections were more frequent in children under 36 months, with a significant difference for the 19-24 month-old group (OR: 8.0). Sixty-nine percent (230/290) of the patients recovered fully and without any severe outcome during hospitalisation; the outcome was scored as severe for 60 children and nine patients (3%) died. Risk factors significantly associated with worsening evolution during hospitalisation (severe outcome) were admission at age under 6 months (OR = 5.3), comorbidity (OR = 4.6) and low household income (OR = 4.1). Conclusion: Co-mordidity, low-income and age under 6 months increase the risk of severe outcome for children infected by numerous respiratory pathogens. These results highlight the need for implementation of targeted public health policy to reduce the contribution of respiratory diseases to childhood morbidity and mortality in low income countries.	[Rajatonirina, Soatiana; Ratovoson, Rila; Herindrainy, Perlinot] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Razanajatovo, Norosoa Harline; Orelle, Arnaud; Heraud, Jean-Michel] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Ratsima, Elisoa Hariniana; Ramparany, Lovasoa; Randrianirina, Frederique] Inst Pasteur Madagascar, Ctr Biol Clin, Antananarivo, Madagascar; [Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal; [Andrianirina, Zo Zafitsara] Ctr Hosp Soavinandriana, Pediat Ward, Antananarivo, Madagascar; [Andriatahina, Todisoa] Ctr Hosp Dist Niveau 2, Pediat Ward, Moramanga, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Rajatonirina, S (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	soatiana@pasteur.mg	Heraud, Jean-Michel/O-1464-2013	Heraud, Jean-Michel/0000-0003-1107-0859; Vincent, RICHARD/0000-0002-6961-1753; Herindrainy, Perlinot/0000-0002-5146-8100; Ratovoson, Rila/0000-0002-3867-6343	Centers for Disease Control and Prevention [U51/IP000327-02]; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000327] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by the Centers for Disease Control and Prevention [Cooperative Agreement Number: U51/IP000327-02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; BALLARD TJ, 1995, J TROP PEDIATRICS, V41, P8, DOI 10.1093/tropej/41.1.8; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; British Thoracic Society Standards of Care Committee, 2002, THORAX, V57, P1, DOI DOI 10.1136/THX.57.SUPPL_1.I1; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1016; Chong YP, 2010, INFECT CHEMOTHER, V42, P397, DOI 10.3947/ic.2010.42.6.397; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Duke T, 2005, ARCH DIS CHILD-FETAL, V90, P211, DOI 10.1136/adc.2003.048108; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Johnson AWBR, 2008, J NATL MED ASSOC, V100, P370, DOI 10.1016/S0027-9684(15)31269-4; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Naheed A, 2009, CLIN INFECT DIS, V48, pS82, DOI 10.1086/596485; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; O'Callaghan-Gordo C, 2011, TROP MED INT HEALTH, V16, P1054, DOI 10.1111/j.1365-3156.2011.02811.x; R Core Team, 2020, R LANG ENV STAT COMP; Rajatonirina S, 2013, EPIDEMIOL INFECT, V141, P745, DOI 10.1017/S0950268812001215; Randremanana RV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-21; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruohola A, 2000, J ALLERGY CLIN IMMUN, V106, P467, DOI 10.1067/mai.2000.108912; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Shibli F, 2010, ISR MED ASSOC J, V12, P477; Soares J. L., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P12; Societe Francaise de Microbiologie, 2010, REMIC, P93; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; WHO, CDC PROT REALT RTPCR; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	36	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72839	10.1371/journal.pone.0072839	http://dx.doi.org/10.1371/journal.pone.0072839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069161	Green Published, gold			2022-12-27	WOS:000326240100021
J	Chary, P; Beard, WA; Wilson, SH; Lloyd, S				Chary, Parvathi; Beard, William A.; Wilson, Samuel H.; Lloyd, Stephen			Inhibition of HIV-1 Reverse Transcriptase-Catalyzed Synthesis by Intercalated DNA Benzo[a]Pyrene 7,8-Dihydrodiol-9,10-Epoxide Adducts	PLOS ONE			English	Article							DEOXYADENOSINE N-6-AMINO GROUP; VERTICAL-SCANNING MUTAGENESIS; POLYMERASE ACTIVE-SITE; NMR SOLUTION STRUCTURE; DG MISMATCH OPPOSITE; GROOVE BINDING TRACK; CODON 61 SEQUENCE; CRYSTAL-STRUCTURES; MINOR-GROOVE; ANGSTROM RESOLUTION	To aid in the characterization of the relationship of structure and function for human immunodeficiency virus type-1 reverse transcriptase (HIV-1 RT), this investigation utilized DNAs containing benzo[a] pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE)-modified primers and templates as a probe of the architecture of this complex. BPDE lesions that differed in their stereochemistry around the C-10 position were covalently linked to N-6-adenine and positioned in either the primer or template strand of a duplex template-primer. HIV-1 RT exhibited a stereoisomer-specific and strand-specific difference in replication when the BPDE-lesion was placed in the template versus the primer strand. When the C10R-BPDE adduct was positioned in the primer strand in duplex DNA, 5 nucleotides from the 3 end of the primer terminus, HIV-1 RT could not fully replicate the template, producing truncated products; this block to further synthesis did not affect rates of dissociation or DNA binding affinity. Additionally, when the adducts were in the same relative position, but located in the template strand, similar truncated products were observed with both the C10R and C10S BPDE adducts. These data suggest that the presence of covalently-linked intercalative DNA adducts distant from the active site can lead to termination of DNA synthesis catalyzed by HIV-1 RT.	[Chary, Parvathi; Lloyd, Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Dept Mol & Med Genet, Portland, OR 97201 USA	Oregon Health & Science University	Lloyd, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Dept Mol & Med Genet, Portland, OR 97201 USA.	lloydst@ohsu.edu	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Lloyd, R. Stephen/0000-0001-7273-372X	NIH [P01 CA160032, P01 ES05355]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-ES050158, Z01-ES050161]; National Institutes of Health [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA177547, U19CA105010, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050161, Z01ES050158, ZIAES050161, ZIAES050158, P01ES005355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by NIH P01 CA160032 and P01 ES05355 to R.S.L. and Research Project Numbers Z01-ES050158 and Z01-ES050161 to S.H.W. in the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences, and was in association with the National Institutes of Health Grant 1U19CA105010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra VK, 2006, P NATL ACAD SCI USA, V103, P17231, DOI 10.1073/pnas.0605069103; Beard WA, 1998, J BIOL CHEM, V273, P30435, DOI 10.1074/jbc.273.46.30435; Beard WA, 1996, J BIOL CHEM, V271, P12213, DOI 10.1074/jbc.271.21.12213; BEARD WA, 1994, J BIOL CHEM, V269, P28091; Beard WA, 1995, METHOD ENZYMOL, V262, P98; BEARD WA, 1993, BIOCHEMISTRY-US, V32, P9745, DOI 10.1021/bi00088a029; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Chary P, 1996, CHEM RES TOXICOL, V9, P409, DOI 10.1021/tx950012b; Chary P, 1997, J BIOL CHEM, V272, P5805, DOI 10.1074/jbc.272.9.5805; CHARY P, 1995, NUCLEIC ACIDS RES, V23, P1398, DOI 10.1093/nar/23.8.1398; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Forgacs E, 1997, J BIOL CHEM, V272, P8525, DOI 10.1074/jbc.272.13.8525; HARRIS CM, 1991, J AM CHEM SOC, V113, P4328, DOI 10.1021/ja00011a044; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIM SJ, 1995, BIOORGAN MED CHEM, V3, P811, DOI 10.1016/0968-0896(95)00065-O; Latham GJ, 2000, J BIOL CHEM, V275, P15025, DOI 10.1074/jbc.M000279200; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHURTER EJ, 1995, BIOCHEMISTRY-US, V34, P9009, DOI 10.1021/bi00028a009; Schwartz JL, 1997, BIOCHEMISTRY-US, V36, P11069, DOI 10.1021/bi971306u; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Yan SX, 2001, J AM CHEM SOC, V123, P7054, DOI 10.1021/ja0043035; YEH HJC, 1995, BIOCHEMISTRY-US, V34, P13570, DOI 10.1021/bi00041a037; Zegar IS, 1998, BIOCHEMISTRY-US, V37, P16516, DOI 10.1021/bi9817616; Zegar IS, 1996, BIOCHEMISTRY-US, V35, P6212, DOI 10.1021/bi9524732	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e72131					10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069141	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300004
J	Giovannetti, A; Maselli, A; Colasanti, T; Rosato, E; Salsano, F; Pisarri, S; Mezzaroma, I; Malorni, W; Ortona, E; Pierdominici, M				Giovannetti, Antonello; Maselli, Angela; Colasanti, Tania; Rosato, Edoardo; Salsano, Felice; Pisarri, Simonetta; Mezzaroma, Ivano; Malorni, Walter; Ortona, Elena; Pierdominici, Marina			Autoantibodies to Estrogen Receptor a in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression	PLOS ONE			English	Article							REGULATORY T-CELLS; LUPUS-ERYTHEMATOSUS; DISEASE-ACTIVITY; TGF-BETA; SCLERODERMA; SKIN; AUTOIMMUNITY; FIBROBLASTS; LYMPHOCYTES; EXPRESSION	Systemic sclerosis (SSc) is a multisystem autoimmune disease of unknown etiology characterized by inflammation, autoantibody production, and fibrosis. It predominantly affects women, this suggesting that female sex hormones such as estrogens may play a role in disease pathogenesis. However, up to date, the role of estrogens in SSc has been scarcely explored. The activity of estrogens is mediated either by transcription activity of the intracellular estrogen receptors (ER), ER alpha and ER beta, or by membrane-associated ER. Since the presence of autoantibodies to ERa and their role as estrogen agonists interfering with T lymphocyte homeostasis were demonstrated in other autoimmune diseases, we wanted to ascertain whether anti-ERa antibodies were detectable in sera from patients with SSc. We detected anti-ERa antibody serum immunoreactivity in 42% of patients with SSc (30 out of 71 analyzed). Importantly, a significant association was found between anti-ERa antibody values and key clinical parameters of disease activity and severity. Fittingly, anti-ERa antibody levels were also significantly associated with alterations of immunological features of SSc patients, including increased T cell apoptotic susceptibility and changes in T regulatory cells (Treg) homeostasis. In particular, the percentage of activated Treg (CD4(+) CD45RA(-) FoxP3(bright) CD25(bright)) was significantly higher in anti-ERa antibody positive patients than in anti-ERa antibody negative patients. Taken together our data clearly indicate that anti-ERa antibodies, probably via the involvement of membrane-associated ER, can represent: i) promising markers for SSc progression but, also, ii) functional modulators of the SSc patients' immune system.	[Giovannetti, Antonello; Rosato, Edoardo; Salsano, Felice; Pisarri, Simonetta; Mezzaroma, Ivano] Univ Roma La Sapienza, Div Clin Immunol, Dept Clin Med, Rome, Italy; [Maselli, Angela; Colasanti, Tania; Ortona, Elena; Pierdominici, Marina] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Colasanti, Tania] IRCCS San Raffaele Pisana, Rome, Italy; [Malorni, Walter] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Malorni, Walter; Ortona, Elena] San Raffaele Pisana, Laquila, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); IRCCS San Raffaele Pisana; Istituto Superiore di Sanita (ISS)	Giovannetti, A (corresponding author), Univ Roma La Sapienza, Div Clin Immunol, Dept Clin Med, Rome, Italy.	antonello.giovannetti@uniroma1.it	Malorni, Walter/G-5874-2016; COLASANTI, Tania/AAF-4074-2022; COLASANTI, Tania/AFI-8434-2022; Pierdominici, Marina/J-6436-2016; ortona, elena/J-6395-2016	COLASANTI, Tania/0000-0002-4413-1817; COLASANTI, Tania/0000-0002-4413-1817; Pierdominici, Marina/0000-0002-6372-3754; malorni, walter/0000-0002-1223-7000; Rosato, Edoardo/0000-0002-7417-8093; ortona, elena/0000-0001-9845-8105	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by the Italian Ministry of Health (U7A grant to EO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Colasanti T, 2012, ARTHRITIS RHEUM-US, V64, P778, DOI 10.1002/art.33400; Cutolo M, 2000, J RHEUMATOL, V27, P155; Cutolo M, 2010, ANN NY ACAD SCI, V1193, P36, DOI 10.1111/j.1749-6632.2009.05383.x; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Giovannetti A, 2010, CLIN IMMUNOL, V137, P122, DOI 10.1016/j.clim.2010.06.004; Gu YS, 2008, SEMIN ARTHRITIS RHEU, V38, P132, DOI 10.1016/j.semarthrit.2007.10.010; Kalogerou A, 2005, ANN RHEUM DIS, V64, P1233, DOI 10.1136/ard.2004.027094; Karpuzoglu E, 2011, CLIN REV ALLERG IMMU, V40, P16, DOI 10.1007/s12016-009-8188-0; Kim JR, 2012, J KOREAN MED SCI, V27, P1009, DOI 10.3346/jkms.2012.27.9.1009; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064531; Mathian A, 2012, ANN RHEUM DIS, V71, P1227, DOI 10.1136/annrheumdis-2011-200709; Mendelsohn ME, 2010, J CLIN INVEST, V120, P2277, DOI 10.1172/JCI43756; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pierdominici M, 2010, IMMUNOL LETT, V132, P79, DOI 10.1016/j.imlet.2010.06.003; Racanelli V, 2011, AUTOIMMUN REV, V10, P503, DOI 10.1016/j.autrev.2011.03.001; Rao PE, 2005, J IMMUNOL, V174, P1446, DOI 10.4049/jimmunol.174.3.1446; Rider V, 2001, INT IMMUNOPHARMACOL, V1, P1009, DOI 10.1016/S1567-5769(01)00046-7; Sakkas LI, 2004, ARTHRITIS RHEUM-US, V50, P1721, DOI 10.1002/art.20315; Soldano S, 2009, ANN RHEUM DIS, V68, P599, DOI 10.1136/ard.2008.097378; Soldano S, 2010, ANN NY ACAD SCI, V1193, P25, DOI 10.1111/j.1749-6632.2009.05296.x; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592; van Bon L, 2011, CURR OPIN RHEUMATOL, V23, P505, DOI 10.1097/BOR.0b013e32834b0dac; XU SW, 1994, ARTHRITIS RHEUM-US, V37, P1689, DOI 10.1002/art.1780371119	31	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74332	10.1371/journal.pone.0074332	http://dx.doi.org/10.1371/journal.pone.0074332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058548	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900040
J	Janesch, B; Koerdt, A; Messner, P; Schaffer, C				Janesch, Bettina; Koerdt, Andrea; Messner, Paul; Schaeffer, Christina			The S-Layer Homology Domain-Containing Protein SlhA from Paenibacillus alvei CCM 2051(T) Is Important for Swarming and Biofilm Formation	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CELL-SURFACE DISPLAY; BACILLUS-SUBTILIS; WALL POLYMERS; BINDING; POLYSACCHARIDE; GLYCOSYLATION; MECHANISMS; COMPONENTS; CELLULOSE	Background: Swarming and biofilm formation have been studied for a variety of bacteria. While this is well investigated for Gram-negative bacteria, less is known about Gram-positive bacteria, including Paenibacillus alvei, a secondary invader of diseased honeybee colonies infected with Mellssococcus pluton, the causative agent of European foulbrood (EFB). Methodology: Paenibacillus alvei CCM 2051(T) is a Gram-positive bacterium which was recently shown to employ Slayer homology (SLH) domains as cell wall targeting modules to display proteins on its cell surface. This study deals with the newly identified 1335-amino acid protein SlhA from P. alvei which carries at the C-terminus three consecutive SLH-motifs containing the predicted binding sequences SRGE, VRQD, and LRGD instead of the common TRAE motif. Based on the proof of cell surface location of SlhA by fluorescence microscopy using a SlhA-GFP chimera, the binding mechanism was investigated in an in vitro assay. To unravel a putative function of the SlhA protein, a knockout mutant was constructed. Experimental data indicated that one SLH domain is sufficient for anchoring of SlhA to the cell surface, and the SLH domains of SlhA recognize both the peptidoglycan and the secondary cell wall polymer in vitro. This is in agreement with previous data from the S-layer protein SpaA, pinpointing a wider utilization of that mechanism for cell surface display of proteins in P. alvei. Compared to the wildtype bacterium Delta slhA revealed changed colony morphology, loss of swarming motility and impaired biofilm formation. The phenotype was similar to that of the flagella knockout Delta hag, possibly due to reduced EPS production influencing the functionality of the flagella of Delta slhA. Conclusion: This study demonstrates the involvement of the SLH domain-containing protein SlhA in swarming and biofilm formation of P. alvei CCM 2051(T).	[Janesch, Bettina; Koerdt, Andrea; Messner, Paul; Schaeffer, Christina] Univ Bodenkultur Wien, Dept Nanobiotechnol, Nanoglycobiol Unit, A-1180 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Messner, P (corresponding author), Univ Bodenkultur Wien, Dept Nanobiotechnol, Nanoglycobiol Unit, A-1180 Vienna, Austria.	paul.messner@boku.ac.at; christina.schaeffer@boku.ac.at	Schäffer, Christina/V-3404-2018; Messner, Paul/Q-5345-2017	Schäffer, Christina/0000-0003-1613-7258; Messner, Paul/0000-0002-3246-5801; Koerdt, Andrea/0000-0002-9214-6183; Janesch, Bettina/0000-0002-3010-7955	Austrian Science Fund [P20745-B11, P21954-B20]; Hochschuljubilaumsstiftung der Stadt Wien [H 2136/2010]; Austrian Science Fund (FWF) [M 1492, P 21954] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Hochschuljubilaumsstiftung der Stadt Wien; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support came from the Austrian Science Fund, projects P20745-B11 (to P. M.) and P21954-B20 (to C. S.) (http://www.fwf.ac.at/), and the Hochschuljubilaumsstiftung der Stadt Wien, project H 2136/2010 (to B.J.) (http://www.wien.gv.at/amtshelfer/kultur/archiv/forschung/hochschuljubilaeumsstiftung.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; Cairns LS, 2013, MOL MICROBIOL; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Chauvaux S, 1999, J BACTERIOL, V181, P2455, DOI 10.1128/JB.181.8.2455-2458.1999; Cohen I, 2000, PHYSICA A, V286, P321, DOI 10.1016/S0378-4371(00)00335-6; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; DEKKER NP, 1991, J ELECTRON MICR TECH, V19, P461, DOI 10.1002/jemt.1060190408; Djukic M, 2012, J BACTERIOL, V194, P6365, DOI 10.1128/JB.01698-12; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Guldal Cemile G, 2006, J Vis Exp, P64, DOI 10.3791/64; Huber C, 2005, MOL MICROBIOL, V55, P197, DOI 10.1111/j.1365-2958.2004.04351.x; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; Janesch B, 2013, J BACTERIOL, V195, P565, DOI 10.1128/JB.01487-12; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kern VJ, 2012, J BACTERIOL, V194, P3833, DOI 10.1128/JB.00402-12; Kim YG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-119; Kosugi A, 2002, J BACTERIOL, V184, P884, DOI 10.1128/jb.184.4.884-888.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Mader C, 2004, J BACTERIOL, V186, P1758, DOI 10.1128/JB.186.6.1758-1768.2004; May A, 2006, ARCH MICROBIOL, V185, P263, DOI 10.1007/s00203-006-0092-x; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Mesnage S, 1999, MOL MICROBIOL, V31, P927, DOI 10.1046/j.1365-2958.1999.01232.x; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; MESSNER P, 1986, J BACTERIOL, V166, P1046, DOI 10.1128/jb.166.3.1046-1054.1986; Messner P, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P53, DOI 10.1007/978-3-642-05062-6_2; Morikawa M, 2006, J BIOSCI BIOENG, V101, P1, DOI 10.1263/jbb.101.1; Nagorska K, 2010, J APPL GENET, V51, P369, DOI 10.1007/BF03208867; Najafi AR, 2011, COLLOID SURFACE B, V82, P33, DOI 10.1016/j.colsurfb.2010.08.010; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; PAUL JH, 1982, APPL ENVIRON MICROB, V43, P939, DOI 10.1128/AEM.43.4.939-944.1982; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Ries W, 1997, J BACTERIOL, V179, P3892, DOI 10.1128/jb.179.12.3892-3898.1997; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schaffer C, 2000, GLYCOCONJUGATE J, V17, P681, DOI 10.1023/A:1011062302889; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Vishnu C, 2006, ENZYME MICROB TECH, V38, P545, DOI 10.1016/j.enzmictec.2005.07.010; Voegel TM, 2010, MICROBIOL-SGM, V156, P2172, DOI 10.1099/mic.0.037564-0; Wang YT, 2013, J BACTERIOL, V195, P596, DOI 10.1128/JB.02005-12; Yegorenkova IV, 2011, CURR MICROBIOL, V62, P1554, DOI 10.1007/s00284-011-9896-2; Zarschler K, 2010, CARBOHYD RES, V345, P1422, DOI 10.1016/j.carres.2010.04.010; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035; Zarschler K, 2009, APPL ENVIRON MICROB, V75, P3077, DOI 10.1128/AEM.00087-09; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	58	15	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e76566	10.1371/journal.pone.0076566	http://dx.doi.org/10.1371/journal.pone.0076566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058714	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900137
J	Jiang, ZY; Sheng, X; Xu, CY; Li, WW; Chang, XX; Sun, LY; Yang, XB; Yu, LF				Jiang, Zhao-Yan; Sheng, Xia; Xu, Chen-Ying; Li, Wei-Wei; Chang, Xian-Xing; Sun, Lu-Ying; Yang, Xiao-Bo; Yu, Li-Fen			Gallbladder Gallstone Disease Is Associated with Newly Diagnosed Coronary Artery Atherosclerotic Disease: A Cross-Sectional Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HIGH-DENSITY-LIPOPROTEINS; HEART-DISEASE; METABOLIC SYNDROME; CHOLESTEROL; RISK; CHOLELITHIASIS; EPIDEMIOLOGY; ABCG8; FRAMINGHAM	Background and Aims: The association between gallstone disease and coronary artery atherosclerotic disease (CAD) remains unclear. To clarify their relationship, patients with CAD newly diagnosed by coronary angiography were investigated in this cross-sectional study. Methods: The study cohort consisted of 1,270 patients undergoing coronary angiography for the first time between January 2007 and September 2011. Patients with >= 50% diameter stenosis in any major coronary artery on coronary angiography were defined as being CAD positive (n = 766) and those with no stenosis as CAD negative (n = 504). Multivariate logistic regression was used to investigate the relationship between gallstone disease and CAD. The odds ratios (OR) of factors associated with CAD were calculated. In addition, CAD-positive and CAD-negative patients were matched one-to-one by age, gender and metabolic syndrome (MetS), and the association between gallbladder disease and CAD was determined. Results: The prevalence of gallstone disease was significantly higher in CAD-positive than in CAD negative patients (149/766 [19.5%] vs 57/504 [11.3%], P<0.01). Gallstone disease was significantly associated with CAD (adjusted OR = 1.59, 95% confidence interval [CI] 1.10-2.31). Following matched pairing of 320 patients per group, gallstone disease remained significantly associated with CAD (adjusted OR = 1.69, 95% CI: 1.08-2.65). Conclusion: Gallstone disease is strongly associated with CAD diagnosed by coronary angiography.	[Jiang, Zhao-Yan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg,Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China; [Xu, Chen-Ying; Li, Wei-Wei; Chang, Xian-Xing; Sun, Lu-Ying; Yang, Xiao-Bo; Yu, Li-Fen] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Sheng, Xia] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Serv Sci, Div Biostat, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Yu, LF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China.	yu-lifen@hotmail.com			Natural Science Foundation of China [30872973, 81070367]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (No 30872973 and 81070367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Allison T, 1996, MAYO CLIN PROC, V71, P43; Arslan U, 2007, CORONARY ARTERY DIS, V18, P433, DOI 10.1097/MCA.0b013e3282583c0d; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; BORTNICHAK EA, 1985, AM J EPIDEMIOL, V121, P19, DOI 10.1093/oxfordjournals.aje.a113978; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Cariati A, 2013, INDIAN J SURG, DOI [10.1007/s12262-12013-10847-y, DOI 10.1007/S12262-12013-10847-Y]; Chen LY, 2012, WORLD J GASTROENTERO, V18, P4215, DOI 10.3748/wjg.v18.i31.4215; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; EMOND M, 1994, CIRCULATION, V90, P2645, DOI 10.1161/01.CIR.90.6.2645; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9; FRIEDMAN GD, 1968, CIRCULATION, V38, P533, DOI 10.1161/01.CIR.38.3.533; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gonzalez-Perez A, 2007, PHARMACOEPIDEM DR S, V16, P524, DOI 10.1002/pds.1346; Jiang ZY, 2008, J LIPID RES, V49, P464, DOI 10.1194/jlr.M700295-JLR200; Jorgensen Torben, 2005, Ugeskr Laeger, V167, P2610; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kim Jung Mi, 2007, Korean J Gastroenterol, V50, P183; Koeijvoets KCMC, 2009, ATHEROSCLEROSIS, V204, P453, DOI 10.1016/j.atherosclerosis.2008.09.018; Koller T, 2012, SCAND J GASTROENTERO, V47, P197, DOI 10.3109/00365521.2011.643481; KONO S, 1988, INT J EPIDEMIOL, V17, P82, DOI 10.1093/ije/17.1.82; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Mendez-Sanchez N, 2005, AM J GASTROENTEROL, V100, P827, DOI 10.1111/j.1572-0241.2005.41214.x; Mendez-Sanchez N, 2008, LIVER INT, V28, P402, DOI 10.1111/j.1478-3231.2007.01632.x; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Misciagna G, 1996, EUR J GASTROEN HEPAT, V8, P585, DOI 10.1097/00042737-199606000-00017; PATTERSON HA, 1954, ANN SURG, V139, P683, DOI 10.1097/00000658-195405000-00017; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Robins SJ, 1997, J CLIN INVEST, V99, P380, DOI 10.1172/JCI119170; Ruhl CE, 2013, AM J GASTROENTEROL, V108, P952, DOI 10.1038/ajg.2013.70; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; Su KSN, 2012, J BIOL CHEM; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007; Xue P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045849; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007; Zeng Q, 2012, EUR J GASTROEN HEPAT, V24, P1459, DOI 10.1097/MEG.0b013e3283583d13	47	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75400	10.1371/journal.pone.0075400	http://dx.doi.org/10.1371/journal.pone.0075400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058685	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900116
J	Klemenhagen, KC; O'Brien, SP; Brody, DL				Klemenhagen, Kristen C.; O'Brien, Scott P.; Brody, David L.			Repetitive Concussive Traumatic Brain Injury Interacts with Post-Injury Foot Shock Stress to Worsen Social and Depression-Like Behavior in Mice	PLOS ONE			English	Article							TAIL-SUSPENSION TEST; ANTIDEPRESSANT ACTIVITY; RECURRENT CONCUSSION; DISORDER; MODEL; OXYTOCIN; MOUSE; RISK; RECOGNITION; EXPRESSION	The debilitating effects of repetitive concussive traumatic brain injury (rcTBI) have been increasingly recognized in both military and civilian populations. rcTBI may result in significant neurological, cognitive, and affective sequelae, and is often followed by physical and/or psychological post-injury stressors that may exacerbate the effects of the injury and prolong the recovery period for injured patients. However, the consequences of post-injury stressors and their subsequent effects on social and emotional behavior in the context of rcTBI have been relatively little studied in animal models. Here, we use a mouse model of rcTBI with two closed-skull blunt impacts 24 hours apart and social and emotional behavior testing to examine the consequences of a stressor (foot shock fear conditioning) following brain injury (rcTBI). rcTBI alone did not affect cued or contextual fear conditioning or extinction compared to uninjured sham animals. In the sucrose preference test, rcTBI animals had decreased preference for sucrose, an anhedonia-like behavior, regardless of whether they experienced foot shock stress or were non-shocked controls. However, rcTBI and post-injury foot shock stress had synergistic effects in tests of social recognition and depression-like behavior. In the social recognition test, animals with both injury and shock were more impaired than either nonshocked injured mice or shocked but uninjured mice. In the tail suspension test, injured mice had increased depression-like behavior compared with uninjured mice, and shock stress worsened the depression-like behavior only in the injured mice with no effect in the uninjured mice. These results provide a model of subtle emotional behavioral deficits after combined concussive brain injury and stress, and may provide a platform for testing treatment and prevention strategies for social behavior deficits and mood disorders that are tailored to patients with traumatic brain injury.	[Klemenhagen, Kristen C.; O'Brien, Scott P.; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Brody, David L.] Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL)	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			National Institutes of Health (NIH) [R01-NS065069]; Department of Defense; Health South Research; Alafi Neuroimaging Laboratory; Hope Center for Neurological Disorders; NIH Neuroscience Blueprint Center Core [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065069, P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Health South Research; Alafi Neuroimaging Laboratory; Hope Center for Neurological Disorders; NIH Neuroscience Blueprint Center Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01-NS065069, The Department of Defense, and a Health South Research Grant to DLB. This work was also supported by the Alafi Neuroimaging Laboratory, the Hope Center for Neurological Disorders, and NIH Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Boscarino JA, 2012, J NERV MENT DIS, V200, P740, DOI 10.1097/NMD.0b013e318266b5ea; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Compton RJ, 2008, EMOTION, V8, P684, DOI 10.1037/a0012910; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Couch Y, 2013, BRAIN BEHAV IMMUN, V29, P136, DOI 10.1016/j.bbi.2012.12.017; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; DENNIS M, 2012, J INT NEUROPSYCH SOC, V19, P1; Ducottet C, 2004, BEHAV BRAIN RES, V155, P291, DOI 10.1016/j.bbr.2004.04.020; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Karelina K, 2011, PSYCHOSOM MED, V73, P67, DOI 10.1097/PSY.0b013e3182002116; Kavaliers M, 2004, GENES BRAIN BEHAV, V3, P189, DOI 10.1111/j.1601-183x.2004.00068.x; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kercmar J, 2011, BEHAV BRAIN RES, V216, P647, DOI 10.1016/j.bbr.2010.09.007; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KLEMENHAGEN KC, 2013, DRYAD DIGITAL REPOSI, DOI DOI 10.5061/DRYADV1T54; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lad HV, 2007, MAMM GENOME, V18, P482, DOI 10.1007/s00335-007-9029-1; Litvin Y, 2011, PHYSIOL BEHAV, V103, P393, DOI 10.1016/j.physbeh.2011.03.007; Liu XQ, 2003, BRAIN RES BULL, V60, P223, DOI 10.1016/S0361-9230(03)00033-9; MacPherson P, 2008, BRAIN RES, V1210, P179, DOI 10.1016/j.brainres.2008.03.008; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Research Council, 2011, GUIDE CARE USE LAB A; O'Leary OF, 2009, NEUROMETHODS, V42, P119, DOI 10.1007/978-1-60761-303-9_7; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019965; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Reboussin DM, 2000, CONTROL CLIN TRIALS, V21, P190, DOI 10.1016/S0197-2456(00)00057-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savignac HM, 2011, NEUROSCIENCE, V192, P524, DOI 10.1016/j.neuroscience.2011.04.054; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Skopp Nancy A, 2012, MSMR, V19, P7; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strekalova T, 2010, PROG NEURO-PSYCHOPH, V34, P348, DOI 10.1016/j.pnpbp.2009.12.014; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	64	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74510	10.1371/journal.pone.0074510	http://dx.doi.org/10.1371/journal.pone.0074510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058581	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900052
J	Siebel, A; Cubillos-Rojas, M; Santos, RC; Schneider, T; Bonan, CD; Bartrons, R; Ventura, F; de Oliveira, JR; Rosa, JL				Siebel, Anna; Cubillos-Rojas, Monica; Santos, Roberto Christ; Schneider, Taiane; Bonan, Carla Denise; Bartrons, Ramon; Ventura, Francesc; de Oliveira, Jarbas Rodrigues; Luis Rosa, Jose			Contribution of S6K1/MAPK Signaling Pathways in the Response to Oxidative Stress: Activation of RSK and MSK by Hydrogen Peroxide	PLOS ONE			English	Article							MAMMALIAN TARGET; P53; CROSSROADS; APOPTOSIS; RAPAMYCIN; MTORC1	Cells respond to different kind of stress through the coordinated activation of signaling pathways such as MAPK or p53. To find which molecular mechanisms are involved, we need to understand their cell adaptation. The ribosomal protein, S6 kinase 1 (S6K1), is a common downstream target of signaling by hormonal or nutritional stress. Here, we investigated the initial contribution of S6K1/MAPK signaling pathways in the cell response to oxidative stress produced by hydrogen peroxide (H2O2). To analyze S6K1 activation, we used the commercial anti-phospho-Thr389-S6K1 antibody most frequently mentioned in the bibliography. We found that this antibody detected an 80-90 kDa protein that was rapidly phosphorylated in response to H2O2 in several human cells. Unexpectedly, this phosphorylation was insensitive to both mTOR and PI3K inhibitors, and knock-down experiments showed that this protein was not S6K1. RSK and MSK proteins were candidate targets of this phosphorylation. We demonstrated that H2O2 stimulated phosphorylation of RSK and MSK kinases at residues that are homologous to Thr389 in S6K1. This phosphorylation required the activity of either p38 or ERK MAP kinases. Kinase assays showed activation of RSK and MSK by H2O2. Experiments with mouse embryonic fibroblasts from p38 animals' knockout confirmed these observations. Altogether, these findings show that the S6K1 signaling pathway is not activated under these conditions, clarify previous observations probably misinterpreted by non-specific detection of proteins RSK and MSK by the anti-phospho-Thr389-S6K1 antibody, and demonstrate the specific activation of MAPK signaling pathways through ERK/p38/RSK/MSK by H2O2.	[Siebel, Anna; Cubillos-Rojas, Monica; Schneider, Taiane; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, Hosp Llobregat, Barcelona, Spain; [Siebel, Anna; Bonan, Carla Denise] Pontificia Univ Catolica Rio Grande do Sul, PUCRS, Fac Biociencias, Lab Neuroquim & Psicofarmacol, Porto Alegre, RS, Brazil; [de Oliveira, Jarbas Rodrigues] Pontificia Univ Catolica Rio Grande do Sul, PUCRS, Fac Biociencias, Lab Biofis Celular & Inflamacao, Porto Alegre, RS, Brazil; [Santos, Roberto Christ] UNIFRA, Ctr Univ Franciscano, Lab Microbiol Clin, Santa Maria, RS, Brazil	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Rosa, JL (corresponding author), Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, Hosp Llobregat, Campus Bellvitge, Barcelona, Spain.	joseluisrosa@ub.edu	Santos, Roberto/G-2472-2012; Ventura, Francesc/ABG-2285-2020; Siebel, Anna Maria/Y-7933-2019; Schneider, Taiane/J-4650-2017; Bonan, Carla Denise/J-7899-2015; Siebel, Anna M/D-1020-2013; Rosa, Jose Luis/K-6685-2014; Ventura, Francesc/K-9700-2014	Santos, Roberto/0000-0002-0533-3483; Ventura, Francesc/0000-0001-9673-9405; Siebel, Anna Maria/0000-0002-7896-1456; Schneider, Taiane/0000-0003-3090-4070; Bonan, Carla Denise/0000-0001-9715-6244; Siebel, Anna M/0000-0002-7896-1456; Rosa, Jose Luis/0000-0002-6161-5688; Ventura, Francesc/0000-0001-9673-9405; Bartrons, Ramon/0000-0001-9349-5847	MICINN (Ministerio de Ciencia e Innovacion) [BFU2011-22498, PHB2008-0080-PC]; ISCIII (Instituto de Salud Carlos III) (RETIC), Spain [RD06/0020]; CAPES/DGU, Brazil [190/09]	MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII (Instituto de Salud Carlos III) (RETIC), Spain(Instituto de Salud Carlos III); CAPES/DGU, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by grants from MICINN (Ministerio de Ciencia e Innovacion) (BFU2011-22498 and PHB2008-0080-PC) and ISCIII (Instituto de Salud Carlos III) (RETIC, RD06/0020) in Spain, and from CAPES/DGU (190/09) in Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Lanni C, 2012, FREE RADICAL BIO MED, V52, P1727, DOI 10.1016/j.freeradbiomed.2012.02.034; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Runchel C, 2011, ANTIOXID REDOX SIGN, V15, P205, DOI 10.1089/ars.2010.3733; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122	25	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75523	10.1371/journal.pone.0075523	http://dx.doi.org/10.1371/journal.pone.0075523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058693	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900120
J	Buenestado, A; Chaumais, MC; Grassin-Delyle, S; Risse, PA; Naline, E; Longchampt, E; Tenor, H; Devillier, P				Buenestado, Amparo; Chaumais, Marie-Camille; Grassin-Delyle, Stanislas; Risse, Paul-Andre; Naline, Emmanuel; Longchampt, Elisabeth; Tenor, Hermann; Devillier, Philippe			Roflumilast Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha and Chemokine Production by Human Lung Parenchyma	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BETA(2)-ADRENOCEPTOR AGONISTS; PHOSPHODIESTERASE-4 INHIBITOR; PDE4 INHIBITORS; INHALED CORTICOSTEROIDS; CAMP-PHOSPHODIESTERASE; ADENOSINE RECEPTORS; CYTOKINE PRODUCTION; INDUCED SPUTUM; CELL-LINE	Background: Roflumilast is the first phosphodiesterase-4 (PDE4) inhibitor to have been approved for the treatment of COPD. The anti-inflammatory profile of PDE4 inhibitors has not yet been explored in human lung tissues. We investigated the effects of roflumilast and its active metabolite roflumilast-N-oxide on the lipopolysaccharide (LPS)-induced release of tumor necrosis factor-alpha (TNF-alpha) and chemokines by human lung parenchymal explants. We also investigated roflumilast's interaction with the long-acting beta(2)-agonist formoterol. Methods: Explants from 25 patients undergoing surgical lung resection were incubated with Roflumilast, Roflumilast-N-oxide and formoterol and stimulated with LPS. Levels of TNF-alpha, chemokines (in the culture supernatants) and cyclic adenosine monophosphate (in tissue homogenates) were determined with appropriate immunoassays. Results: Roflumilast and Roflumilast-N-oxide concentration-dependently reduced the release of TNF-alpha and chemokines CCL2, CCL3, CCL4, CXCL9 and CXCL10 from LPS-stimulated human lung explants, whereas CXCL1, CXCL5 and CXCL8 release was not altered. Formoterol (10 nM) partially decreased the release of the same cytokines and significantly increased the inhibitory effect of roflumilast on the release of the cytokines. Conclusions: In human lung parenchymal explants, roflumilast and roflumilast-N-oxide reduced the LPS-induced release of TNF-alpha and chemokines involved in the recruitment of monocytes and T-cells but not those involved in the recruitment of neutrophils. Addition of formoterol to roflumilast provided superior in vitro anti-inflammatory activity, which may translate into greater efficacy in COPD.	[Buenestado, Amparo; Chaumais, Marie-Camille; Grassin-Delyle, Stanislas; Risse, Paul-Andre; Naline, Emmanuel; Devillier, Philippe] Univ Versailles St Quentin En Yvelines, Lab Pulm Pharmacol UPRES EA220, Suresnes, France; [Longchampt, Elisabeth] Foch Hosp, Dept Pathol, Suresnes, France; [Tenor, Hermann] Nycomed GmbH, Constance, Germany	UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; Nycomed GmbH	Devillier, P (corresponding author), Univ Versailles St Quentin En Yvelines, Lab Pulm Pharmacol UPRES EA220, Suresnes, France.	p.devillier@hopital-foch.org	Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432; Chaumais, Marie-Camille/0000-0002-1217-8442	Nycomed; Conseil Regional d'Ile-de-France, under its Domaine d'Interet Majeur - Sante Environnement program	Nycomed; Conseil Regional d'Ile-de-France, under its Domaine d'Interet Majeur - Sante Environnement program(Region Ile-de-France)	This study was sponsored in part by Nycomed. AB received a post-doctoral fellowship from the Conseil Regional d'Ile-de-France, under its Domaine d'Interet Majeur - Sante Environnement program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifano M, 2010, EUR RESPIR REV, V19, P7, DOI 10.1183/09059180.00008009; Au BT, 1998, BRIT J PHARMACOL, V123, P1260, DOI 10.1038/sj.bjp.0701723; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Bateman ED, 2011, EUR RESPIR J, V38, P553, DOI 10.1183/09031936.00178710; Bethke TD, 2007, J CLIN PHARMACOL, V47, P26, DOI 10.1177/0091270006294529; Bouyssou T, 2010, J PHARMACOL EXP THER, V334, P53, DOI 10.1124/jpet.110.167007; Bryn T, 2006, J IMMUNOL, V176, P7361, DOI 10.4049/jimmunol.176.12.7361; Buenestado A, 2012, BRIT J PHARMACOL, V165, P1877, DOI 10.1111/j.1476-5381.2011.01667.x; Buenestado A, 2010, BRIT J PHARMACOL, V159, P1304, DOI 10.1111/j.1476-5381.2009.00614.x; Capelli A, 1999, EUR RESPIR J, V14, P160, DOI 10.1034/j.1399-3003.1999.14a27.x; Chung KF, 2009, EUR J CLIN PHARMACOL, V65, P853, DOI 10.1007/s00228-009-0682-z; Costa C, 2008, CHEST, V133, P26, DOI 10.1378/chest.07-0393; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Donnelly LE, 2010, EUR RESPIR J, V36, P178, DOI 10.1183/09031936.00158008; FANN YD, 1986, PROSTAGLANDINS, V31, P361, DOI 10.1016/0090-6980(86)90060-2; Flanagan PG, 2001, J CLIN PATHOL, V54, P107, DOI 10.1136/jcp.54.2.107; Fotheringham JA, 2004, EUR J PHARMACOL, V497, P87, DOI 10.1016/j.ejphar.2004.06.029; Gamble E, 2003, AM J RESP CRIT CARE, V168, P976, DOI 10.1164/rccm.200212-1490OC; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hackett TL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-47; Hallsworth MP, 2001, BRIT J PHARMACOL, V132, P729, DOI 10.1038/sj.bjp.0703866; HATZELMANN A, 1995, BRIT J PHARMACOL, V114, P821, DOI 10.1111/j.1476-5381.1995.tb13278.x; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hohlfeld JM, 2008, PULM PHARMACOL THER, V21, P616, DOI 10.1016/j.pupt.2008.02.002; Holden NS, 2010, BRIT J PHARMACOL, V160, P410, DOI 10.1111/j.1476-5381.2010.00708.x; Hung CH, 2008, EUR RESPIR J, V31, P1313, DOI 10.1183/09031936.00121406; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Keravis Therese, 2005, V307, P63; Kharitonov Sergei A., 2007, V14, P83, DOI 10.1159/000107056; Kochetkova M, 1995, BIOCHEM PHARMACOL, V50, P2033, DOI 10.1016/0006-2952(95)02104-3; Kohyama T, 2002, AM J RESP CELL MOL, V26, P694, DOI 10.1165/ajrcmb.26.6.4743; Kreckler LM, 2009, J PHARMACOL EXP THER, V331, P1051, DOI 10.1124/jpet.109.157651; Lahu G, 2010, CLIN PHARMACOKINET, V49, P589, DOI 10.2165/11536600-000000000-00000; Martin TR, 1997, AM J RESP CRIT CARE, V155, P937, DOI 10.1164/ajrccm.155.3.9117029; Martorana Piero A, 2008, BMC Pulm Med, V8, P17, DOI 10.1186/1471-2466-8-17; MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427; Mitsuta K, 2001, CHEST, V120, P1175, DOI 10.1378/chest.120.4.1175; Nys M, 2003, NITRIC OXIDE-BIOL CH, V9, P33, DOI 10.1016/j.niox.2003.07.001; Parameswaran GI, 2011, CHEST, V140, P611, DOI 10.1378/chest.10-2760; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Rodrigo GJ, 2009, CHEST, V136, P1029, DOI 10.1378/chest.09-0821; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; SELDON PM, 1995, MOL PHARMACOL, V48, P747; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Spoelstra FM, 2002, THORAX, V57, P237, DOI 10.1136/thorax.57.3.237; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tannheimer SL, 2012, PULM PHARMACOL THER, V25, P178, DOI 10.1016/j.pupt.2012.01.003; Tashkin DP, 2010, NEW ENGL J MED, V363, P1183, DOI 10.1056/NEJMe1008184; Tenor H, 2002, BRIT J PHARMACOL, V135, P609, DOI 10.1038/sj.bjp.0704480; TORPHY TJ, 1992, J PHARMACOL EXP THER, V263, P1195; Traves SL, 2002, THORAX, V57, P590, DOI 10.1136/thorax.57.7.590; Yoshimura T, 1997, GEN PHARMACOL-VASC S, V29, P633, DOI 10.1016/S0306-3623(96)00580-0; Yougbare I, 2011, AM J PHYSIOL-LUNG C, V301, pL441, DOI 10.1152/ajplung.00407.2010; Zhang HB, 1999, AM J RESP CRIT CARE, V160, P1703, DOI 10.1164/ajrccm.160.5.9903068	59	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74640	10.1371/journal.pone.0074640	http://dx.doi.org/10.1371/journal.pone.0074640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066150	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000132
J	Buettner, PG; Westcott, DA; Maclean, J; Brown, L; McKeown, A; Johnson, A; Wilson, K; Blair, D; Luly, J; Skerratt, L; Muller, R; Speare, R				Buettner, Petra G.; Westcott, David A.; Maclean, Jennefer; Brown, Lawrence; McKeown, Adam; Johnson, Ashleigh; Wilson, Karen; Blair, David; Luly, Jonathan; Skerratt, Lee; Muller, Reinhold; Speare, Richard			Tick Paralysis in Spectacled Flying-Foxes (Pteropus conspicillatus) in North Queensland, Australia: Impact of a Ground-Dwelling Ectoparasite Finding an Arboreal Host	PLOS ONE			English	Article							IXODES-HOLOCYCLUS; POPULATION DECLINES; INFECTIOUS-DISEASE; EASTERN AUSTRALIA; DYNAMICS; ACARI; CHYTRIDIOMYCOSIS; DISTRIBUTIONS; CONSERVATION; EXTINCTION	When a parasite finds a new wildlife host, impacts can be significant. In the late 1980s populations of Spectacled Flying-foxes (SFF) (Pteropus conspicillatus), a species confined, in Australia, to north Queensland became infected by paralysis tick (Ixodes holocyclus), resulting in mortality. This Pteropus-tick relationship was new to Australia. Curiously, the relationship was confined to several camps on the Atherton Tableland, north Queensland. It was hypothesised that an introduced plant, wild tobacco (Solanum mauritianum), had facilitated this new host-tick interaction. This study quantifies the impact of tick paralysis on SFF and investigates the relationship with climate. Retrospective analysis was carried out on records from the Tolga Bat Hospital for 1998-2010. Juvenile mortality rates were correlated to climate data using vector auto-regression. Mortality rates due to tick paralysis ranged between 11.6 per 10,000 bats in 2003 and 102.5 in 2009; more female than male adult bats were affected. Juvenile mortality rates were negatively correlated with the total rainfall in January to March and July to September of the same year while a positive correlation of these quarterly total rainfalls existed with the total population. All tick affected camps of SFF were located in the 80% core range of S. mauritianum. This initial analysis justifies further exploration of how an exotic plant might alter the relationship between a formerly ground-dwelling parasite and an arboreal host.	[Buettner, Petra G.; Brown, Lawrence; Wilson, Karen; Skerratt, Lee; Muller, Reinhold; Speare, Richard] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Westcott, David A.; McKeown, Adam] CSIRO Ecosyst Sci, Atherton, Qld, Australia; [Westcott, David A.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Sch Earth & Environm Sci, Cairns, Australia; [Westcott, David A.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Australia; [Maclean, Jennefer; Johnson, Ashleigh] Tolga Bat Hosp, Atherton, Australia; [Blair, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Luly, Jonathan] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Buettner, Petra G.; Muller, Reinhold; Speare, Richard] Trop Hlth Solut Pty Ltd, Townsville, Qld, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University; James Cook University; James Cook University	Buettner, PG (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	petra.buttner@jcu.edu.au	McKeown, Adam/D-3170-2011; Blair, David/O-2786-2019; Skerratt, Lee Francis/L-2797-2013; Westcott, David A/G-5559-2010	Blair, David/0000-0002-4658-3251; Speare, Rick/0000-0002-9993-1213; Skerratt, Lee/0000-0003-3471-7512; Brown, Lawrence/0000-0002-5940-1840	James Cook University, Townsville, Australia	James Cook University, Townsville, Australia	This study was supported by a collaborative research grant from James Cook University, Townsville, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEYEYE OA, 1991, J MED ENTOMOL, V28, P45, DOI 10.1093/jmedent/28.1.45; Alexander KA, 2010, COMP IMMUNOL MICROB, V33, P249, DOI 10.1016/j.cimid.2008.10.005; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Australian Bureau of Meteorology, 2010, KAIR RES STAT; Beeton N, 2011, J APPL ECOL, V48, P1315, DOI 10.1111/j.1365-2664.2011.02060.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Birt P, 2000, P WORKSH ASS STAT GR, P78; Brandt P., 2007, MULTIPLE TIME SERIES; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Campbell FE, 2003, AUST VET J, V81, P328, DOI 10.1111/j.1751-0813.2003.tb11505.x; Civitello DJ, 2008, J MED ENTOMOL, V45, P867, DOI 10.1603/0022-2585(2008)45[867:EGIRSO]2.0.CO;2; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Dennis AJ, 2006, OECOLOGIA, V149, P620, DOI 10.1007/s00442-006-0475-3; DOUBE BM, 1975, AUST VET J, V51, P511, DOI 10.1111/j.1751-0813.1975.tb06901.x; Duncan AM, 1999, ACTION PLAN AUSTR BA; Eggert C., 1994, THESIS SO CROSS U LI; Estrada-Pena A, 2008, PARASITOLOGICAL R S1, pS87; EVERIST SL, 1981, POISONOUS PLANTS AUS; Fox S. J, 2006, THESIS J COOK U TOWN; Fox S, 2008, WILDLIFE RES, V35, P417, DOI 10.1071/WR07127; Fox S, 2012, TERRA AUSTRALIS, V34, P459; Freeman A, 2006, MONITORING REPORT AN; Freeman A, 2003, MONITORING REPORT AN; Garnett S, 1999, REPORT CENSUS SPECTA; Garnett S, 1998, RESULTS 1 SPECTACLED; Garnett Stephen, 1999, Australian Zoologist, V31, P38; Gaydos JK, 2004, BIOL CONSERV, V117, P253, DOI 10.1016/j.biocon.2003.07.004; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Hall Spencer R., 2008, P223; Hall-Mendelin S, 2011, ANN TROP MED PARASIT, V105, P95, DOI 10.1179/136485911X12899838413628; HARRISON J. L., 1962, AUSTRALIAN JOUR ZOOL, V10, P45, DOI 10.1071/ZO9620045; Hayden S, 1992, POPULATION ESTIMATES; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Inokuma H, 2003, ANN NY ACAD SCI, V990, P357, DOI 10.1111/j.1749-6632.2003.tb07390.x; Jackson J, 2007, AUST VET J, V85, P420, DOI 10.1111/j.1751-0813.2007.00183.x; Klose S, 2009, BEHAV ECOL SOCIOBIOL, V63, P371, DOI 10.1007/s00265-008-0671-8; Low T., 2002, NEW NATURE WINNERS L; Lynch M, 2011, J WILDLIFE DIS, V47, P555, DOI 10.7589/0090-3558-47.3.555; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McCallum H, 2012, PHILOS T R SOC B, V367, P2828, DOI 10.1098/rstb.2012.0224; McIlwee A. P., 2002, Australian Zoologist, V32, P76; Moorhouse DE, 1981, ANIMALS TOXINS MAN H; Oxer D. T., 1942, Australian Veterinary Journal, V18, P194, DOI 10.1111/j.1751-0813.1942.tb06360.x; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Parsons JG, 2006, AUST J ZOOL, V54, P417, DOI 10.1071/ZO06092; Pioz M, 2008, OECOLOGIA, V155, P691, DOI 10.1007/s00442-007-0942-5; Queensland Government, 2010, WILD TOB SOL MAUR FA; Queensland Herbarium, 2010, QUEENSL HERB DAT HER; Richards GC, 1990, AUST MAMMAL, V13, P1; Ross I. C., 1924, Parasitology Cambridge, V16, P365, DOI 10.1017/S0031182000020254; ROSS I. CLUNIES, 1926, PARASITOL, V18, P410, DOI 10.1017/S0031182000005424; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Shilton LA, 2008, AUSTRAL ECOL, V33, P549, DOI 10.1111/j.1442-9993.2008.01910.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Song S, 2011, INT J PARASITOL, V41, P871, DOI 10.1016/j.ijpara.2011.03.008; SPENCER HJ, 1991, WILDLIFE RES, V18, P463, DOI 10.1071/WR9910463; Sullivan S, 2002, REPORT QPWS CAIRNS A; Swei A, 2012, VECTOR-BORNE ZOONOT, V12, P623, DOI 10.1089/vbz.2011.0783; Tolga Bat Hospital, 2012, TOLG BAT HOSP BATT A; Van Tassel T, 1995, BATS, V1, P13; Westcott D.A., 2008, LIVING DYNAMIC TROPI, P210; Westcott D. A., 2001, SPECTACLED FLYING FO; Westcott DA, 2004, WILDLIFE RES, V31, P551, DOI 10.1071/WR03091; Westcott DA, 2012, ECOL APPL, V22, P374, DOI 10.1890/11-0132.1; Whybird O, 2000, SPECTACLED FLYING SU; Whybird O, 2002, AUSTR BAT SOC NEWSLE, V18, P15; Whybird O, 2001, SPECTACLED FLYING SU; Woebeser GA, 2006, ESSENTIALS DIS WILD, P139; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Young S, 2012, DIS AQUAT ORGAN, V98, P1, DOI 10.3354/dao02416	70	12	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73078	10.1371/journal.pone.0073078	http://dx.doi.org/10.1371/journal.pone.0073078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066028	Green Published, gold, Green Accepted			2022-12-27	WOS:000324494000009
J	Wu, ZH; Hao, RZ; Li, P; Zhang, XA; Liu, N; Qiu, SF; Wang, LG; Wang, Y; Xue, WZ; Liu, K; Yang, G; Cui, JJ; Zhang, CF; Song, HB				Wu, Zhihao; Hao, Rongzhang; Li, Peng; Zhang, Xiaoai; Liu, Nan; Qiu, Shaofu; Wang, Ligui; Wang, Yong; Xue, Wenzhong; Liu, Kun; Yang, Guang; Cui, Jiajun; Zhang, Chuanfu; Song, Hongbin			MicroRNA Expression Profile of Mouse Lung Infected with 2009 Pandemic H1N1 Influenza Virus	PLOS ONE			English	Article							SWINE-ORIGIN H1N1; LARGE GENE LISTS; A VIRUSES; IN-VITRO; CELLS; REPLICATION; REASSORTANT; VIRULENCE; GENOMICS; TARGETS	MicroRNAs have been implicated in the regulation of gene expression of various biological processes in a post-transcriptional manner under physiological and pathological conditions including host responses to viral infections. The 2009 pandemic H1N1 influenza virus is an emerging reassortant strain of swine, human and bird influenza virus that can cause mild to severe illness and even death. To further understand the molecular pathogenesis of the 2009 pandemic H1N1 influenza virus, we profiled cellular microRNAs of lungs from BALB/c mice infected with wild-type 2009 pandemic influenza virus A/Beijing/501/2009 (H1N1) (hereafter referred to as BJ501) and mouse-adapted influenza virus A/Puerto Rico/8/1934 (H1N1) (hereafter referred to as PR8) for comparison. Microarray analysis showed both the influenza virus BJ501 and PR8 infection induced strain-and temporal-specific microRNA expression patterns and that their infection caused a group of common and distinct differentially expressed microRNAs. Characteristically, more differentially expressed microRNAs were aroused on day 5 post infection than on day 2 and more up-regulated differentially expressed microRNAs were provoked than the down-regulated for both strains of influenza virus. Finally, 47 differentially expressed microRNAs were obtained for the infection of both strains of H1N1 influenza virus with 29 for influenza virus BJ501 and 43 for PR8. Among them, 15 microRNAs had no reported function, while 32 including miR-155 and miR-233 are known to play important roles in cancer, immunity and antiviral activity. Pathway enrichment analyses of the predicted targets revealed that the transforming growth factor-beta (TGF-beta) signaling pathway was the key cellular pathway associated with the differentially expressed miRNAs during influenza virus PR8 or BJ501 infection. To our knowledge, this is the first report of microRNA expression profiles of the 2009 pandemic H1N1 influenza virus in a mouse model, and our findings might offer novel therapy targets for influenza virus infection.	[Wu, Zhihao; Hao, Rongzhang; Li, Peng; Liu, Nan; Qiu, Shaofu; Wang, Ligui; Wang, Yong; Xue, Wenzhong; Yang, Guang; Cui, Jiajun; Zhang, Chuanfu; Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Zhang, Xiaoai; Liu, Kun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Beijing Institute of Microbiology & Epidemiology	Zhang, CF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China.	hnzcf@126.com; hongbinsong@263.net	Qiu, Shaofu/CAJ-0602-2022	Liu, Wei/0000-0002-9302-8170	National Natural Science Foundation of China [81000723]; Mega-Projects of Science and Technology Research [2012ZX10004215, 2012ZX10004801, 2013ZX10004218, 2013ZX10004607]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-Projects of Science and Technology Research	This work was supported by the National Natural Science Foundation of China (81000723) and by the Mega-Projects of Science and Technology Research (2012ZX10004215, 2012ZX10004801, 2013ZX10004218, 2013ZX10004607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Cline TD, 2011, J VIROL, V85, P12262, DOI 10.1128/JVI.05582-11; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jones KS, 2005, J IMMUNOL, V174, P4262, DOI 10.4049/jimmunol.174.7.4262; Lam WY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-344; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2011, VIROLOGY, V421, P105, DOI 10.1016/j.virol.2011.09.011; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Neumann G, 2001, VIROLOGY, V287, P243, DOI 10.1006/viro.2001.1008; Pan XB, 2012, J GASTROEN HEPATOL, V27, P805, DOI 10.1111/j.1440-1746.2011.06979.x; Rangrez AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047807; Rogers JV, 2012, VIRAL IMMUNOL, V25, P3, DOI 10.1089/vim.2011.0047; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Skovgaard K, 2013, INNATE IMMUN; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Sun SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-52; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278; Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512; Wen Y, 2011, J INVEST ALLERG CLIN, V21, P44; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046184; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Zhao PS, 2012, MICROB PATHOGENESIS, V52, P47, DOI 10.1016/j.micpath.2011.10.001	42	26	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74190	10.1371/journal.pone.0074190	http://dx.doi.org/10.1371/journal.pone.0074190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066118	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000100
J	Zhong, JG; Yuan, JH; Chong, V; Wang, Z; Xu, J; Ding, ZX				Zhong, Jianguo; Yuan, Jianhua; Chong, Vincent; Wang, Zhen; Xu, Jian; Ding, Zhongxiang			The Clinical Application of One-Stop Examination with 640-Slice Volume CT for Nutcracker Syndrome	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; 320-DETECTOR ROW CT; DYNAMIC CT; PERFUSION; DIAGNOSIS; LIVER; EXPERIENCE; ABDOMEN	Background: To investigate the relationship between the level of left renal vein (LRV) compression and changes in the perfusion of the left kidney in patients with nutcracker syndrome (NCS) by one-stop whole-organ perfusion imaging of bilateral kidneys using 640-slice volume CT. Methods: Twelve patients, clinically diagnosed with NCS, were subjected to one-stop examination of kidneys. Angiography and whole-organ perfusion imaging of bilateral kidneys were conducted, and the compression segment of LRV was demonstrated and measured. Information including the results of whole-organ perfusion images of both kidneys in 12 patients was collected. Results of epigastrium dynamic volume scanning by 640-slice volume CT were collected for 12 patients as control group. Left and right renal cortexes were chosen as regions of interest (ROI), and their perfusion values were measured. Results: The perfusion values of the left and right renal cortexes in the control group were 323.8 ml.min-(1).100 ml(-1) and 322.9 ml.min(-1).100 ml(-1), respectively. The difference was not statistically significant (t = 1.388, P = 0.193). For NCS patients, the perfusion values of the left and right renal cortexes were 350.8 ml.min(-1).100 ml(-1) and 391.1 ml.min-(1).100 ml(-1), respectively. Significantly decreased value was observed in left renal cortex compared to that of the right renal cortex, with the mean decrease of 40.3 ml.min(-1).100 ml(-1), and the difference was statistically significant (t = 24.204, P = 0.001). Conclusion: As a non-invasive functional imaging technique, whole-organ perfusion imaging of kidneys can be used to evaluate the organ and tissue perfusion status and to accurately reflect the hemodynamic changes of the left renal cortex in the patients with NCS. Whole organ perfusion imaging may also provide the basis for quantitative diagnosis and clinical interventions of NCS.	[Zhong, Jianguo; Yuan, Jianhua; Wang, Zhen; Xu, Jian; Ding, Zhongxiang] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Chong, Vincent] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Diagnost Imaging, Singapore 117595, Singapore	Zhejiang Provincial People's Hospital; National University of Singapore	Ding, ZX (corresponding author), Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China.	hangzhoudzx73@126.com						Dawson P, 1994, INVEST RADIOL, V28, P79; Fu WJ, 2006, INT J UROL, V13, P870, DOI 10.1111/j.1442-2042.2006.01430.x; Fu WJ, 2004, CHINESE MED J-PEKING, V117, P1873; Kanda T, 2012, EUR J RADIOL, V81, P2470, DOI 10.1016/j.ejrad.2011.10.009; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Kim KW, 2011, EUR J RADIOL, V80, P648, DOI 10.1016/j.ejrad.2010.08.044; Kim SH, 1996, RADIOLOGY, V198, P93, DOI 10.1148/radiology.198.1.8539413; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Nakashige A, 2004, BRIT J RADIOL, V77, P728, DOI 10.1259/bjr/41168942; Pandharipande PV, 2005, RADIOLOGY, V234, P661, DOI 10.1148/radiol.2343031362; Paul JF, 2001, RADIOLOGY, V221, P261, DOI 10.1148/radiol.2211001558; Shin JI, 2007, PEDIATR NEPHROL, V22, P409, DOI 10.1007/s00467-006-0319-8; SHOKEIR AA, 1994, BRIT J UROL, V74, P139, DOI 10.1111/j.1464-410X.1994.tb16574.x; Tsushima Y, 2002, RADIOLOGY, V224, P613, DOI 10.1148/radiol.2242011819; Zhang HK, 2007, ANN VASC SURG, V21, P198, DOI 10.1016/j.avsg.2006.10.021	15	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74365	10.1371/journal.pone.0074365	http://dx.doi.org/10.1371/journal.pone.0074365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066141	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000123
J	Allegretti, YL; Bondar, C; Guzman, L; Rua, EC; Chopita, N; Fuertes, M; Zwirner, NW; Chirdo, FG				Allegretti, Yessica L.; Bondar, Constanza; Guzman, Luciana; Cueto Rua, Eduardo; Chopita, Nestor; Fuertes, Mercedes; Zwirner, Norberto W.; Chirdo, Fernando G.			Broad MICA/B Expression in the Small Bowel Mucosa: A Link between Cellular Stress and Celiac Disease	PLOS ONE			English	Article							MHC-CLASS-I; ACTIVATED T-LYMPHOCYTES; SMALL-INTESTINAL MUCOSA; OXIDATIVE STRESS; EPITHELIAL-CELLS; IMMUNE-RESPONSE; CHAIN-A; NKG2D; GLIADIN; LIGANDS	The MICA/B genes (MHC class I chain related genes A and B) encode for non conventional class I HLA molecules which have no role in antigen presentation. MICA/B are up-regulated by different stress conditions such as heat-shock, oxidative stress, neoplasic transformation and viral infection. Particularly, MICA/B are expressed in enterocytes where they can mediate enterocyte apoptosis when recognised by the activating NKG2D receptor present on intraepithelial lymphocytes. This mechanism was suggested to play a major pathogenic role in active celiac disease (CD). Due to the importance of MICA/B in CD pathogenesis we studied their expression in duodenal tissue from CD patients. By immunofluorescence confocal microscopy and flow cytometry we established that MICA/B was mainly intracellularly located in enterocytes. In addition, we identified MICA/B+ T cells in both the intraepithelial and lamina propria compartments. We also found MICA/B+ B cells, plasma cells and some macrophages in the lamina propria. The pattern of MICA/B staining in mucosal tissue in severe enteropathy was similar to that found in in vitro models of cellular stress. In such models, MICA/B were located in stress granules that are associated to the oxidative and ER stress response observed in active CD enteropathy. Our results suggest that expression of MICA/B in the intestinal	[Allegretti, Yessica L.; Bondar, Constanza; Chirdo, Fernando G.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina; [Guzman, Luciana; Cueto Rua, Eduardo] Hosp Ninos Sor Maria Ludovica, Serv Gastroenterol, La Plata, Buenos Aires, Argentina; [Chopita, Nestor] Hosp San Martin La Plata, Serv Gastroenterol, La Plata, Buenos Aires, Argentina; [Fuertes, Mercedes; Zwirner, Norberto W.] Consejo Nacl Invest Cient & Tecn CONICET, Lab Fisiopatol Inmunidad Innata, IBYME, Buenos Aires, DF, Argentina; [Fuertes, Mercedes] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Zwirner, Norberto W.] Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina	National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires	Chirdo, FG (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina.	fchirdo@biol.unlp.edu.ar	Chirdo, Fernando/AAL-7928-2020; Zwirner, Norberto/AAI-8961-2020	Fuertes, Mercedes Beatriz/0000-0002-2734-1468; Chirdo, Fernando/0000-0002-7099-9142; Zwirner, Norberto/0000-0001-7098-359X	Fundacion Ciencias Exactas; Facultad de Ciencias Exactas; Universidad Nacional de La Plata	Fundacion Ciencias Exactas; Facultad de Ciencias Exactas; Universidad Nacional de La Plata(National University of La Plata)	The funders, Fundacion Ciencias Exactas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Adolph TE, 2012, DIGEST DIS, V30, P341, DOI 10.1159/000338121; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Bernardo D, 2008, CLIN EXP IMMUNOL, V154, P64, DOI 10.1111/j.1365-2249.2008.03743.x; Caputo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045209; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Daniels I, 2005, CLIN CHIM ACTA, V356, P134, DOI 10.1016/j.cccn.2005.01.029; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Ebert EC, 2005, IMMUNOLOGY, V115, P118, DOI 10.1111/j.1365-2567.2005.02132.x; Ferretti G, 2012, NUTRIENTS, V4, P243, DOI 10.3390/nu4040243; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Gulow K, 2002, J CELL SCI, V115, P2443; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Iltanen S, 1999, AUTOIMMUNITY, V31, P125, DOI 10.3109/08916939908994056; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Martin-Pagola A, 2004, IMMUNOGENETICS, V56, P549, DOI 10.1007/s00251-004-0724-8; Martin-Pagola A, 2003, J CLIN IMMUNOL, V23, P498, DOI 10.1023/B:JOCI.0000010426.16956.cc; Matusali G, 2013, FASEB J, V27, P2440, DOI 10.1096/fj.12-223057; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Molinero LL, 2003, J LEUKOCYTE BIOL, V73, P815, DOI 10.1189/jlb.0602329; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Ostberg JR, 2002, INT J HYPERTHER, V18, P552, DOI 10.1080/02656730210166168; Rivabene R, 1999, BBA-MOL BASIS DIS, V1453, P152, DOI 10.1016/S0925-4439(98)00095-7; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Stastny P, 2006, HUM IMMUNOL, V67, P141, DOI 10.1016/j.humimm.2006.02.019; Stojiljkovic V, 2009, CLIN BIOCHEM, V42, P1431, DOI 10.1016/j.clinbiochem.2009.06.009; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x	43	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73658	10.1371/journal.pone.0073658	http://dx.doi.org/10.1371/journal.pone.0073658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058482	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400031
J	Huo, YL; Luo, T; Guccione, JM; Teague, SD; Tan, WC; Navia, JA; Kassab, GS				Huo, Yunlong; Luo, Tong; Guccione, Julius M.; Teague, Shawn D.; Tan, Wenchang; Navia, Jose A.; Kassab, Ghassan S.			Mild Anastomotic Stenosis in Patient-Specific CABG Model May Enhance Graft Patency: A New Hypothesis	PLOS ONE			English	Article							CORONARY ARTERIAL TREE; LONG-TERM PATENCY; BYPASS GRAFT; INTIMAL HYPERPLASIA; NEOINTIMAL HYPERPLASIA; VEIN GRAFTS; BLOOD-FLOW; DISTAL ANASTOMOSES; SAPHENOUS-VEIN; WALL SHEAR	It is well known that flow patterns at the anastomosis of coronary artery bypass graft (CABG) are complex and may affect the long-term patency. Various attempts at optimal designs of anastomosis have not improved long-term patency. Here, we hypothesize that mild anastomotic stenosis (area stenosis of about 40-60%) may be adaptive to enhance the hemodynamic conditions, which may contribute to slower progression of atherosclerosis. We further hypothesize that proximal/distal sites to the stenosis have converse changes that may be a risk factor for the diffuse expansion of atherosclerosis from the site of stenosis. Twelve (12) patient-specific models with various stenotic degrees were extracted from computed tomography images using a validated segmentation software package. A 3-D finite element model was used to compute flow patterns including wall shear stress (WSS) and its spatial and temporal gradients (WSS gradient, WSSG, and oscillatory shear index, OSI). The flow simulations showed that mild anastomotic stenosis significantly increased WSS (> 15 dynes.cm(-2)) and decreased OSI (< 0.02) to result in a more uniform distribution of hemodynamic parameters inside anastomosis albeit proximal/distal sites to the stenosis have a decrease of WSS (< 4 dynes.cm(-2)). These findings have significant implications for graft adaptation and long-term patency.	[Huo, Yunlong; Tan, Wenchang] Peking Univ, Coll Engn, Beijing, Peoples R China; [Huo, Yunlong; Tan, Wenchang] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing, Peoples R China; [Luo, Tong; Kassab, Ghassan S.] Indiana Univ Purdue Univ Indianapolis, Indianapolis, IN USA; [Teague, Shawn D.; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA; [Guccione, Julius M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Navia, Jose A.] Austral Univ, Buenos Aires, DF, Argentina	Peking University; Peking University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; Austral University	Kassab, GS (corresponding author), Indiana Univ Purdue Univ Indianapolis, Indianapolis, IN USA.	gkassab@iupui.edu	Tan, Wenchang/I-9949-2014; Huo, Yunlong/N-8155-2013	Huo, Yunlong/0000-0003-4121-3224	National Institute of Health-National Heart, Lung, and Blood Institute [HL092048, HL086400, HL077921]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077921, R01HL086400, R01HL092048] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by the National Institute of Health-National Heart, Lung, and Blood Institute Grants HL092048 (to GSK), HL086400, HL077921 (to JMG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung SCP, 2010, AUSTRALAS PHYS ENG S, V33, P319, DOI 10.1007/s13246-010-0050-4; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; DILLEY RJ, 1988, ARCH SURG-CHICAGO, V123, P691; FEI DY, 1994, J BIOMECH ENG-T ASME, V116, P331, DOI 10.1115/1.2895739; FITZGIBBON GM, 1991, J AM COLL CARDIOL, V17, P1075, DOI 10.1016/0735-1097(91)90834-V; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; FUJIWARA T, 1988, CIRCULATION, V78, P1210, DOI 10.1161/01.CIR.78.5.1210; Giordana S, 2005, J BIOMECH ENG-T ASME, V127, P1087, DOI 10.1115/1.2073507; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; Huo Y, 2004, INT J HEAT MASS TRAN, V47, P3533, DOI 10.1016/j.ijheatmasstransfer.2004.01.021; Huo Y, 2013, RADIOLOGY, DOI [10.1148/radiol.13122181, DOI 10.1148/RADI0L.13122181]; Huo Y, 2005, FINITE ELEMENT MODEL; Huo Y, 2007, AM J PHYSIOL-HEART C, V293, pH2959, DOI 10.1152/ajpheart.00586.2007; Huo YL, 2012, J R SOC INTERFACE, V9, P1325, DOI 10.1098/rsif.2011.0605; Huo Y, 2012, J BIOMECH, V45, P1273, DOI 10.1016/j.jbiomech.2012.01.033; Huo YL, 2009, J BIOMECH, V42, P594, DOI 10.1016/j.jbiomech.2008.12.011; Jiang ZH, 2007, AM J PHYSIOL-HEART C, V293, pH482, DOI 10.1152/ajpheart.01372.2006; Jiang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH1200, DOI 10.1152/ajpheart.00268.2009; KALAN JM, 1990, AM HEART J, V119, P1164, DOI 10.1016/S0002-8703(05)80249-2; Kassab GS, 2006, ANNU REV BIOMED ENG, V8, P499, DOI 10.1146/annurev.bioeng.8.010506.105023; Kent KC, 2004, ANN VASC SURG, V18, P135, DOI 10.1007/s10016-004-0019-4; KEYNTON RS, 1991, J BIOMECH ENG-T ASME, V113, P458, DOI 10.1115/1.2895427; Keynton RS, 2001, J BIOMECH ENG-T ASME, V123, P464, DOI 10.1115/1.1389461; Kleinstreuer C, 2001, CRIT REV BIOMED ENG, V29, P1, DOI 10.1615/CritRevBiomedEng.v29.i1.10; Lei M, 1997, J VASC SURG, V25, P637, DOI 10.1016/S0741-5214(97)70289-1; Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040; Li W, 2002, J HYDRAULIC ENG, V10, P7; Loth F, 2008, ANNU REV FLUID MECH, V40, P367, DOI 10.1146/annurev.fluid.40.111406.102119; MADRAS PN, 1981, SURGERY, V90, P922; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Parang P, 2009, CAN J CARDIOL, V25, pE57, DOI 10.1016/S0828-282X(09)70486-6; Qi Y, 2005, CHINA WATER RESOURCE, V11, P29; RITTGERS SE, 1978, CIRC RES, V42, P792, DOI 10.1161/01.RES.42.6.792; Spray T L, 1977, Cardiovasc Clin, V8, P11; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Tu JY, 2011, J MED IMAG HEALTH IN, V1, P116, DOI 10.1166/jmihi.2011.1018; UREN NG, 1994, NEW ENGL J MED, V330, P1782, DOI 10.1056/NEJM199406233302503; Weman SM, 1999, INT J LEGAL MED, V112, P107, DOI 10.1007/s004140050211; Wischgoll T, 2008, ANN BIOMED ENG, V36, P356, DOI 10.1007/s10439-008-9443-x; Wischgoll T, 2009, AM J PHYSIOL-HEART C, V297, pH1949, DOI 10.1152/ajpheart.00093.2009; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6; Wong KKL, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500012; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Wu JX, 2009, AM J PHYSIOL-HEART C, V297, pH1194, DOI 10.1152/ajpheart.00703.2009; Zhang LS, 2002, J VASC SURG, V36, P824, DOI 10.1067/mva.2002.126308	47	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73769	10.1371/journal.pone.0073769	http://dx.doi.org/10.1371/journal.pone.0073769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058488	gold, Green Published			2022-12-27	WOS:000324408400034
J	Kim, J; Nakamura, T; Kikuchi, H; Sasaki, T; Yamamoto, Y				Kim, Jinhyuk; Nakamura, Toru; Kikuchi, Hiroe; Sasaki, Tsukasa; Yamamoto, Yoshiharu			Co-Variation of Depressive Mood and Locomotor Dynamics Evaluated by Ecological Momentary Assessment in Healthy Humans	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; FATIGUE; EXPERIENCE; STRESS; RISK; FLUCTUATIONS; ASSOCIATIONS; ANTECEDENTS; SYMPTOMS; ANXIETY	Computerized ecological momentary assessment (EMA) is widely accepted as a "gold standard" method for capturing momentary symptoms repeatedly experienced in daily life. Although many studies have addressed the within-individual temporal variations in momentary symptoms compared with simultaneously measured external criteria, their concurrent associations, specifically with continuous physiological measures, have not been rigorously examined. Therefore, in the present study, we first examined the variations in momentary symptoms by validating the associations among self-reported symptoms measured simultaneously (depressive mood, anxious mood, and fatigue) and then investigated covariant properties between the symptoms (especially, depressive mood) and local statistics of locomotor activity as the external objective criteria obtained continuously. Healthy subjects (N = 85) from three different populations (adolescents, undergraduates, and office workers) wore a watch-type computer device equipped with EMA software for recording the momentary symptoms experienced by the subjects. Locomotor activity data were also continuously obtained by using an actigraph built into the device. Multilevel modeling analysis confirmed convergent associations by showing positive correlations among momentary symptoms. The increased intermittency of locomotor activity, characterized by a combination of reduced activity with occasional bursts, appeared concurrently with the worsening of depressive mood. Further, this association remained statistically unchanged across groups regardless of group differences in age, lifestyle, and occupation. These results indicate that the temporal variations in the momentary symptoms are not random but reflect the underlying changes in psychophysiological variables in daily life. In addition, our findings on the concurrent changes in depressive mood and locomotor activity may contribute to the continuous estimation of changes in depressive mood and early detection of depressive disorders.	[Kim, Jinhyuk; Nakamura, Toru; Sasaki, Tsukasa; Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Kikuchi, Hiroe] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychosomat Res, Tokyo, Japan	University of Tokyo; National Center for Neurology & Psychiatry - Japan	Yamamoto, Y (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	yamamoto@p.u-tokyo.ac.jp	Kim, Jinhyuk/AAD-2082-2020	KIM, JIN HYUK/0000-0003-4218-1631; nakamura, toru/0000-0002-5340-6333; Yamamoto, Yoshiharu/0000-0002-1132-0355	Ministry of Education, Culture, Sports, Science and Technology [22650157, 23240094, 23700795]; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23240094, 25870183] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by Grants-in-Aid for Exploratory Research [22650157], Scientific Research (A) [23240094] (to Y.Y.), and Young Scientists (B) [23700795] (to T.N.) from the Ministry of Education, Culture, Sports, Science and Technology and by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (to Y.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; Benjamini Y, 2001, ANN STAT, V29, P1165; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Bleil ME, 2008, PSYCHOSOM MED, V70, P328, DOI 10.1097/PSY.0b013e31816baefa; Burton C, 2013, J AFFECT DISORDERS, V145, P21, DOI 10.1016/j.jad.2012.07.001; CAMACHO TC, 1991, AM J EPIDEMIOL, V134, P220, DOI 10.1093/oxfordjournals.aje.a116074; Chandra S, 2011, DRUG ALCOHOL DEPEN, V117, P118, DOI 10.1016/j.drugalcdep.2010.12.027; Conner TS, 2012, PSYCHOSOM MED, V74, P327, DOI 10.1097/PSY.0b013e3182546f18; Damasio A, 2004, LOOKING SPINOZA JOY; Demyttenaere K, 2005, INT J NEUROPSYCHOPH, V8, P93, DOI 10.1017/S1461145704004729; Dunton GF, 2009, ANN BEHAV MED, V38, P249, DOI 10.1007/s12160-009-9141-4; Friedberg F, 2008, INT J BEHAV MED, V15, P29, DOI [10.1007/BF03003071, 10.1080/10705500701783850]; Fukui I, 1997, JPN J BEHAV THER, V23, P83, DOI 10.24468/jjbt.23.2_; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Indic P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038761; Jahng S, 2011, J ABNORM PSYCHOL, V120, P572, DOI 10.1037/a0024686; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kamarck TW, 2005, J PERS, V73, P1749, DOI 10.1111/j.0022-3506.2005.00365.x; Kennedy Sidney H, 2008, Dialogues Clin Neurosci, V10, P271; Kikuchi H, 2007, CEPHALALGIA, V27, P1236, DOI 10.1111/j.1468-2982.2007.01436.x; Kim J, 2013, BRIT J HEALTH PSYCH, V18, P155, DOI 10.1111/bjhp.12000; Kimhy D, 2006, J PSYCHIATR RES, V40, P221, DOI 10.1016/j.jpsychires.2005.09.007; Kumar S, 2013, COMPUTER, V46, P28, DOI 10.1109/MC.2012.392; Lindwall M, 2011, HEALTH PSYCHOL, V30, P453, DOI 10.1037/a0023268; LINHART H, 1988, S AFR STAT J, V22, P153; McColl E, 2004, GUT, V53, P49, DOI 10.1136/gut.2003.034355; Muraven M, 2005, PSYCHOL ADDICT BEHAV, V19, P140, DOI 10.1037/0893-164X.19.2.140; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Ritz T, 2010, J PSYCHOSOM RES, V69, P341, DOI 10.1016/j.jpsychores.2010.05.004; Robles TF, 2011, BIOL PSYCHOL, V86, P50, DOI 10.1016/j.biopsycho.2010.10.006; Sano W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043539; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Shiffman S, 2007, DRUG ALCOHOL DEPEN, V91, P159, DOI 10.1016/j.drugalcdep.2007.05.017; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Skapinakis P, 2003, AM J PSYCHIAT, V160, P785, DOI 10.1176/appi.ajp.160.4.785; Smith TW, 2012, HEALTH PSYCHOL, V31, P763, DOI 10.1037/a0026947; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Stavrakakis N, 2012, J ADOLESCENT HEALTH, V50, P503, DOI 10.1016/j.jadohealth.2011.09.004; Steptoe A, 2007, PSYCHONEUROENDOCRINO, V32, P56, DOI 10.1016/j.psyneuen.2006.10.001; Steptoe A, 2011, PSYCHOL AGING, V26, P956, DOI 10.1037/a0023303; Stone AA, 1997, ARTHRIT CARE RES, V10, P185, DOI 10.1002/art.1790100306; Stone AA, 2004, PAIN, V107, P61, DOI 10.1016/j.pain.2003.09.020; Stone AA, 2002, BMJ-BRIT MED J, V324, P1193, DOI 10.1136/bmj.324.7347.1193; Stone AA, 2007, SCI REAL TIME DATA C; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Tchekmedyian NS, 2003, CANCER-AM CANCER SOC, V98, P198, DOI 10.1002/cncr.11463; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; Teicher MH, 1997, ARCH GEN PSYCHIAT, V54, P124; Thewissen V, 2008, J ABNORM PSYCHOL, V117, P143, DOI 10.1037/0021-843X.117.1.143; Thieme K, 2004, PSYCHOSOM MED, V66, P837, DOI 10.1097/01.psy.0000146329.63158.40; Tylee A, 1999, INT CLIN PSYCHOPHARM, V14, P139, DOI 10.1097/00004850-199905002-00001; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; Volkers AC, 2003, J AFFECT DISORDERS, V76, P23, DOI 10.1016/S0165-0327(02)00066-6; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Wichers M, 2012, HEALTH PSYCHOL, V31, P135, DOI 10.1037/a0025688	62	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74979	10.1371/journal.pone.0074979	http://dx.doi.org/10.1371/journal.pone.0074979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058642	gold, Green Submitted, Green Published			2022-12-27	WOS:000324408400102
J	Szpakowicz, A; Pepinski, W; Waszkiewicz, E; Maciorkowska, D; Skawronska, M; Niemcunowicz-Janica, A; Milewski, R; Dobrzycki, S; Musial, WJ; Kaminski, KA				Szpakowicz, Anna; Pepinski, Witold; Waszkiewicz, Ewa; Maciorkowska, Dominika; Skawronska, Malgorzata; Niemcunowicz-Janica, Anna; Milewski, Robert; Dobrzycki, Slawomir; Musial, Wlodzimierz Jerzy; Kaminski, Karol Adam			RETRACTED: Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction (Retracted article. See vol. 9, e95513, 2014)	PLOS ONE			English	Article; Retracted Publication							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; CHROMOSOME 9P21; VARIANT; ONSET; DEATH	Objective: The rs1333049, rs10757278 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus that are associated with prevalence of acute coronary syndromes (ACS). The rs1333049 SNP was also associated with cardiac outcome 6 months post ACS. No data concerning their association with long term prognosis after myocardial infarction is available. The aim of our study was to investigate the association of the 9p21.3 locus with 5-year overall mortality in patients with ST-elevation myocardial infarction (STEMI) treated invasively. Materials and Methods: We performed a retrospective analysis of data collected prospectively in a registry of consecutive patients with STEMI treated with primary PCI. Genotyping was performed with a TaqMan method. The analyzed end-point was total 5-year mortality. Results: The study group comprised 589 patients: 25.3% of females (n = 149), mean age 62.4 +/- 11.9 years, total 5-year mortality 16.6% (n = 98). When all the study group was analyzed, no significant differences in mortality were found between the genotypes. However, in high-risk patients (Grace risk score >= 155 points, n = 238), low-risk homozygotes had significantly better 5-year survival compared to other genotypes. The hazard ratio associated with high-risk genotype (high-risk homozygote or heterozygote) was: HR = 2.9 (95% CI 1.4-6.1) for the rs4977574 polymorphism, HR = 2.6 (1.25-5.3) for the rs1333049 one and HR = 2.35 (1.2-4.6) for the rs10757278 one (Cox proportional hazards model). Conclusions: The 9p21.3 locus is associated with 5-year mortality in high-risk patients with STEMI. This finding, due to very high effect size, could potentially be applied into clinical practice, if appropriate methods are elaborated.	[Szpakowicz, Anna; Waszkiewicz, Ewa; Musial, Wlodzimierz Jerzy; Kaminski, Karol Adam] Med Univ Bialystok, Dept Cardiol, Bialystok, Poland; [Pepinski, Witold; Skawronska, Malgorzata; Niemcunowicz-Janica, Anna] Med Univ Bialystok, Dept Forens Med, Bialystok, Poland; [Maciorkowska, Dominika; Dobrzycki, Slawomir] Med Univ Bialystok, Dept Invas Cardiol, Bialystok, Poland; [Milewski, Robert] Med Univ Bialystok, Dept Stat & Med Informat, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Kaminski, KA (corresponding author), Med Univ Bialystok, Dept Cardiol, Bialystok, Poland.	fizklin@wp.pl	Kaminski, Karol A./J-4515-2014; Niemcunowicz-Janica, Anna/ABH-1454-2021; Milewski, Robert/S-6539-2018; Szpakowicz, Anna/T-4059-2018; Pepiński, Witold/U-9250-2018; Tarasiuk, Ewa/Y-1757-2018; Skawrońska, Małgorzata/U-9251-2018	Kaminski, Karol A./0000-0002-9465-2581; Niemcunowicz-Janica, Anna/0000-0003-2807-8312; Milewski, Robert/0000-0001-6241-8283; Szpakowicz, Anna/0000-0002-4665-5227; Pepiński, Witold/0000-0003-1244-2247; Tarasiuk, Ewa/0000-0002-0614-1352; Skawrońska, Małgorzata/0000-0002-1237-4240	National Science Center, Poland [N N 402 529139]	National Science Center, Poland(National Science Centre, Poland)	This work was supported by National Science Center, Poland [N N 402 529139]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissino D, 2011, J AM COLL CARDIOL, V58, P426, DOI 10.1016/j.jacc.2010.11.075; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Buysschaert I, 2010, EUR HEART J, V31, P1132, DOI 10.1093/eurheartj/ehq053; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; Cugino D, 2012, NUTR METAB CARDIOVAS, V22, P619, DOI 10.1016/j.numecd.2010.11.010; Ellis KL, 2010, CIRC-CARDIOVASC GENE, V3, P286, DOI 10.1161/CIRCGENETICS.109.917443; Gioli-Pereira L, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-61; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koch W, 2011, ATHEROSCLEROSIS, V217, P220, DOI 10.1016/j.atherosclerosis.2011.03.014; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Nambi V, 2012, ATHEROSCLEROSIS, V222, P135, DOI 10.1016/j.atherosclerosis.2012.01.028; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Patel RS, 2010, EUR HEART J, V31, P3017, DOI 10.1093/eurheartj/ehq272; Peng WH, 2009, CLIN CHEM LAB MED, V47, P917, DOI 10.1515/CCLM.2009.215; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheffold T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-9; Schmid M, 2000, ONCOGENE, V19, P5747, DOI 10.1038/sj.onc.1203942; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Wang W, 2011, CHINESE MED J-PEKING, V124, P66, DOI [10.3760/cma.j.issn.0366-6999.2011.01.013, 10.3901/JME.2011.08.066]; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	29	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72333	10.1371/journal.pone.0072333	http://dx.doi.org/10.1371/journal.pone.0072333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069144	Green Published, gold			2022-12-27	WOS:000326240100005
J	Tekiela, DR; Barney, JN				Tekiela, Daniel R.; Barney, Jacob N.			Quantifying Microstegium vimineum Seed Movement by Non-Riparian Water Dispersal Using an Ultraviolet-Marking Based Recapture Method	PLOS ONE			English	Article							CANOPY DECIDUOUS FORESTS; INVASIVE GRASS; SPREAD; DYNAMICS; LITTER; ESTABLISHMENT; DISTURBANCE; ECOSYSTEMS; VIABILITY; EXPANSION	Microstegium vimineum is a shade tolerant annual C-4 invasive grass in the Eastern US, which has been shown to negatively impact species diversity and succession in hardwood forests. To date, empirical studies have shown that population expansion is limited to <1 m yr(-1), which is largely driven by gravity dispersal. However, this likely does not fully account for all mechanisms of population-scale dispersal as we observe greater rates of population expansion. Though water, both riparian and non-riparian water (i.e., ephemeral overland flow), have been speculated mechanisms for M. vimineum dispersal, few studies have empirically tested this hypothesis. We designed an experiment along the slopes of a Southwest Virginia hardwood forest to test the role of non-riparian water on local seed dispersal. We developed a seed marking technique by coating each seed with an ultraviolet (UV) powder that did not affect buoyancy to aid in situ seed recapture. Additionally, a new image analysis protocol was developed to automate seed identification from UV photos. Total seed mobility (summation of individual seed movement within each transect) was positively correlated with precipitation. Over a period of one month with 52.32 mm of precipitation, the maximum dispersal distance of any single recaptured seed was 2.4 m, and the average distance of dispersed seed was 0.21 +/- 0.04 m. This is the first quantitative evidence of non-riparian water dispersal in a forest understory, which accounts for an additional pathway of population expansion.	[Tekiela, Daniel R.; Barney, Jacob N.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Tekiela, DR (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	tekiela2@vt.edu	Barney, Jacob/C-2412-2008	Barney, Jacob/0000-0003-2949-5003				Adams SN, 2009, BIOL CONSERV, V142, P1003, DOI 10.1016/j.biocon.2009.01.009; Aguiar MR, 1997, ECOLOGY, V78, P93, DOI 10.1890/0012-9658(1997)078[0093:SDCTDO]2.0.CO;2; Bauer JT, 2011, AM MIDL NAT, V165, P105, DOI 10.1674/0003-0031-165.1.105; BOSSARD CC, 1990, ECOLOGY, V71, P2370, DOI 10.2307/1938647; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Chambers JC, 2000, ECOL APPL, V10, P1400, DOI 10.2307/2641294; Chambert S, 2009, RIVER RES APPL, V25, P48, DOI 10.1002/rra.1093; Cheplick GP, 2005, J TORREY BOT SOC, V132, P214, DOI 10.3159/1095-5674(2005)132[214:BPARAI]2.0.CO;2; Christen DC, 2009, BIOL INVASIONS, V11, P453, DOI 10.1007/s10530-008-9262-x; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; EDWARDS AL, 1994, B TORREY BOT CLUB, V121, P160, DOI 10.2307/2997168; Emmerson L, 2010, AUSTRAL ECOL, V35, P906, DOI 10.1111/j.1442-9993.2009.02097.x; Eschtruth AK, 2011, ECOLOGY, V92, P1314, DOI 10.1890/10-0857.1; FAIRBROTHERS DE, 1972, B TORREY BOT CLUB, V99, P97, DOI 10.2307/2484205; Flory SL, 2007, NAT AREA J, V27, P124, DOI 10.3375/0885-8608(2007)27[124:ELTAIS]2.0.CO;2; Flory SL, 2010, OECOLOGIA, V164, P1029, DOI 10.1007/s00442-010-1697-y; Groves JH, 2009, RIVER RES APPL, V25, P582, DOI 10.1002/rra.1229; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Huebner CD, 2010, BIOL INVASIONS, V12, P2069, DOI 10.1007/s10530-009-9609-y; Huebner CD, 2010, BIOL INVASIONS, V12, P2081, DOI 10.1007/s10530-009-9610-5; Hull JA, 2010, MICROSTEGIUM VIMINEU; Johansson ME, 1996, J VEG SCI, V7, P593, DOI 10.2307/3236309; Judge CA, 2005, JAPANESE STILTGRASS; Kaproth MA, 2008, FOREST SCI, V54, P490; Kowarik I, 2008, PLANT ECOL, V198, P241, DOI 10.1007/s11258-008-9398-x; Kuppinger D., 2000, CHIQUAPIN, V8, P21; Lehnhoff EA, 2008, INVAS PLANT SCI MANA, V1, P319, DOI 10.1614/IPSM-08-065.1; Leicht SA, 2005, J TORREY BOT SOC, V132, P573, DOI 10.3159/1095-5674(2005)132[573:ATCAOJ]2.0.CO;2; Marshall JM, 2008, BIOL INVASIONS, V10, P531, DOI 10.1007/s10530-007-9149-2; Marshall JM, 2009, J TORREY BOT SOC, V136, P342, DOI 10.3159/09-RA-006.1; Mehrhoff LJ, 2000, J TORREY BOT SOC, V127, P251, DOI 10.2307/3088762; Merritt DM, 2002, ECOL APPL, V12, P1071, DOI 10.1890/1051-0761(2002)012[1071:PGHARH]2.0.CO;2; Miller NP, 2010, DIVERS DISTRIB, V16, P816, DOI 10.1111/j.1472-4642.2010.00690.x; Oswalt CM, 2007, FOREST ECOL MANAG, V249, P199, DOI 10.1016/j.foreco.2007.05.007; Pergl J, 2011, DIVERS DISTRIB, V17, P725, DOI 10.1111/j.1472-4642.2011.00771.x; Rauschert ESJ, 2010, BIOL INVASIONS, V12, P563, DOI 10.1007/s10530-009-9463-y; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Romanello GA, 2009, MICROSTEGIUM VIMINEU; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schramm JW, 2012, RHODORA, V114, P1; Schramm JW, 2010, BIOL INVASIONS, V12, P3195, DOI 10.1007/s10530-010-9711-1; Soomers H, 2010, FRESHWATER BIOL, V55, P2032, DOI 10.1111/j.1365-2427.2010.02460.x; Thorne BL, 1996, ENVIRON ENTOMOL, V25, P938, DOI 10.1093/ee/25.5.938; van den Broek T, 2005, J VEG SCI, V16, P579, DOI 10.1111/j.1654-1103.2005.tb02399.x; van Es SR H, DEP CROP SOIL SCI RE, VR03-01; Warren RJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00181.1; Warren RJ, 2011, BIOL INVASIONS, V13, P471, DOI 10.1007/s10530-010-9842-4; WINTER K, 1982, PLANT SCI LETT, V24, P311, DOI 10.1016/0304-4211(82)90027-X	49	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e63811	10.1371/journal.pone.0063811	http://dx.doi.org/10.1371/journal.pone.0063811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069134	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100001
J	Marques, JT; Pereira, MJR; Marques, TA; Santos, CD; Santana, J; Beja, P; Palmeirim, JM				Marques, Joao Tiago; Ramos Pereira, Maria J.; Marques, Tiago A.; Santos, Carlos David; Santana, Joana; Beja, Pedro; Palmeirim, Jorge M.			Optimizing Sampling Design to Deal with Mist-Net Avoidance in Amazonian Birds and Bats	PLOS ONE			English	Article							VERTICAL STRATIFICATION; INSECTIVOROUS BATS; SPECIES RICHNESS; FOREST; VEGETATION; ABUNDANCE; HABITATS	Mist netting is a widely used technique to sample bird and bat assemblages. However, captures often decline with time because animals learn and avoid the locations of nets. This avoidance or net shyness can substantially decrease sampling efficiency. We quantified the day-to-day decline in captures of Amazonian birds and bats with mist nets set at the same location for four consecutive days. We also evaluated how net avoidance influences the efficiency of surveys under different logistic scenarios using re-sampling techniques. Net avoidance caused substantial declines in bird and bat captures, although more accentuated in the latter. Most of the decline occurred between the first and second days of netting: 28% in birds and 47% in bats. Captures of commoner species were more affected. The numbers of species detected also declined. Moving nets daily to minimize the avoidance effect increased captures by 30% in birds and 70% in bats. However, moving the location of nets may cause a reduction in netting time and captures. When moving the nets caused the loss of one netting day it was no longer advantageous to move the nets frequently. In bird surveys that could even decrease the number of individuals captured and species detected. Net avoidance can greatly affect sampling efficiency but adjustments in survey design can minimize this. Whenever nets can be moved without losing netting time and the objective is to capture many individuals, they should be moved daily. If the main objective is to survey species present then nets should still be moved for bats, but not for birds. However, if relocating nets causes a significant loss of netting time, moving them to reduce effects of shyness will not improve sampling efficiency in either group. Overall, our findings can improve the design of mist netting sampling strategies in other tropical areas.	[Marques, Joao Tiago; Palmeirim, Jorge M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Dept Biol Anim, Lisbon, Portugal; [Marques, Joao Tiago; Ramos Pereira, Maria J.] Inst Desenvolvimento Sustentavel Mamiraua, Tefe, Amazonas, Brazil; [Ramos Pereira, Maria J.; Santos, Carlos David] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Ramos Pereira, Maria J.; Santos, Carlos David] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Marques, Tiago A.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, The Observ, Buchanan Gardens, Fife, Scotland; [Santos, Carlos David] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Santos, Carlos David; Santana, Joana] ERENA SA, Lisbon, Portugal; [Beja, Pedro] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal	Universidade de Lisboa; Universidade de Aveiro; Universidade de Aveiro; University of St Andrews; Max Planck Society; Universidade do Porto	Marques, JT (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Dept Biol Anim, Lisbon, Portugal.	jtiagomarques@gmail.com	Beja, Pedro/A-7851-2008; Marques, Tiago A/A-5530-2010; Palmeirim, Jorge M/A-1323-2014; Marques, Tiago A./M-3253-2019; Pereira, Maria João Ramos/AAH-9411-2021; Ramos Pereira, Maria João/P-6221-2014; Santana, Joana Figueiredo/C-5941-2009; Marques, J. Tiago/AAV-9300-2021; Santos, Carlos/E-5881-2013	Beja, Pedro/0000-0001-8164-0760; Marques, Tiago A/0000-0002-2581-1972; Palmeirim, Jorge M/0000-0003-4734-8162; Marques, Tiago A./0000-0002-2581-1972; Pereira, Maria João Ramos/0000-0002-9365-5166; Ramos Pereira, Maria João/0000-0002-9365-5166; Santana, Joana Figueiredo/0000-0002-4100-8012; Santos, Carlos/0000-0001-5693-9795	Fundacao para a Ciencia e Tecnologia -FCT [POCI-PPCDT/BIA-BDE/60710/2004]; European Regional Development Fund; Bat Conservation International; FCT fellowship [SFRH/BD/22829/2005]; Fundacao Luis de Molina; FCT fellowships [SFRH/BD/19620/2004, SFRH/BPD/72845/2010, SFRH/BD/63566/2009]; FCT [OE/MAT/UI0006/2011]	Fundacao para a Ciencia e Tecnologia -FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund(European Commission); Bat Conservation International; FCT fellowship(Portuguese Foundation for Science and Technology); Fundacao Luis de Molina; FCT fellowships(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The project was mostly funded by Fundacao para a Ciencia e Tecnologia -FCT (POCI-PPCDT/BIA-BDE/60710/2004, co-financed by the European Regional Development Fund) and by a Bat Conservation International grant. J.T.M. was supported by FCT fellowship SFRH/BD/22829/2005 and Fundacao Luis de Molina, M.J.R.P. by FCT fellowships SFRH/BD/19620/2004 and SFRH/BPD/72845/2010 and J.S. by FCT fellowship SFRH/BD/63566/2009. T.A.M. was partially sponsored by FCT under the project Pest OE/MAT/UI0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2012, METHODS ECOL EVOL, V3, P992, DOI 10.1111/j.2041-210X.2012.00244.x; AYRES JM, 1993, MATAS VARZEA MAMIRAU; Barnett AA, 2006, ACTA CHIROPTEROL, V8, P103, DOI 10.3161/1733-5329(2006)8[103:BOJNPC]2.0.CO;2; Beja P, 2010, BIODIVERS CONSERV, V19, P129, DOI 10.1007/s10531-009-9711-6; Bierregaard R.O. Jr, 1990, P217; Blake JG, 2009, BIOTROPICA, V41, P85, DOI 10.1111/j.1744-7429.2008.00445.x; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Carter GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010808; Catry P, 1999, OSTRICH, V70, P134, DOI 10.1080/00306525.1999.9634528; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Colwell RK, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Esberard CEL, 2006, REV BRAS ZOOL, V23, P1093, DOI 10.1590/S0101-81752006000400016; ESTRADA A, 1993, ECOGRAPHY, V16, P309, DOI 10.1111/j.1600-0587.1993.tb00220.x; Estrada-Villegas S, 2010, BIOL CONSERV, V143, P597, DOI 10.1016/j.biocon.2009.11.009; Faaborg John, 2004, Studies in Avian Biology, P144; FENTON MB, 1992, BIOTROPICA, V24, P440, DOI 10.2307/2388615; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Findley JS, 1995, BATS COMMUNITY PRESP; Fleming T.H., 1988, SHORT TAILED FRUIT B; Gotelli Nicholas J., 2011, P39; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handford CR., 1991, DEMOGRAPHY NATURAL H, P1; Hardin JW., 2002, GEN ESTIMATING EQUAT; Henry M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023773; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Karr J.R., 1981, Studies in Avian Biology, P62; Karr J.R., 1981, Studies in Avian Biology, P548; KARR JR, 1977, AUK, V94, P240; Kingston Tigga, 2009, P195; Kunz T.H., 1988, P1; Kunz TH, 2009, ECOLOGICAL BEHAV MET; Larsen RJ, 2007, ACTA CHIROPTEROL, V9, P423, DOI 10.3161/1733-5329(2007)9[423:MNBSAC]2.0.CO;2; LEMKE TO, 1984, ECOLOGY, V65, P538, DOI 10.2307/1941416; Lim BK, 2001, J TROP ECOL, V17, P647, DOI 10.1017/S0266467401001481; MACARTHUR RH, 1974, P NATL ACAD SCI USA, V71, P3230, DOI 10.1073/pnas.71.8.3230; MacSwiney MC, 2008, J APPL ECOL, V45, P1364, DOI 10.1111/j.1365-2664.2008.01531.x; Meyer CFJ, 2011, J APPL ECOL, V48, P777, DOI 10.1111/j.1365-2664.2011.01976.x; PALMEIRIM J, 1985, BIOTROPICA, V17, P82, DOI 10.2307/2388385; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; Pereira MJR, 2010, CURR ZOOL, V56, P469, DOI 10.1093/czoolo/56.4.469; Pereira MJR, 2009, J ANIM ECOL, V78, P1163, DOI 10.1111/j.1365-2656.2009.01591.x; Ratcliffe JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P157, DOI 10.1007/s00265-005-0912-z; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Robbins LW, 2008, NORTHEAST NAT, V15, P275, DOI 10.1656/1092-6194(2008)15[275:ETEOTS]2.0.CO;2; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V237, P1; Skalak SL, 2012, METHODS ECOL EVOL, V3, P490, DOI 10.1111/j.2041-210X.2011.00177.x; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; Spotswood EN, 2012, METHODS ECOL EVOL, V3, P29, DOI 10.1111/j.2041-210X.2011.00123.x; Stahlschmidt P, 2012, METHODS ECOL EVOL, V3, P503, DOI 10.1111/j.2041-210X.2012.00188.x; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Walther BA, 2002, J ORNITHOL, V143, P64, DOI 10.1007/BF02465460; Whitman Andrew A., 2004, Studies in Avian Biology, P161; Wiens J.A., 1992, ECOLOGY BIRD COMMUNI; Wright GS, 2011, ANIM BEHAV, V82, P1075, DOI 10.1016/j.anbehav.2011.07.044	58	34	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74505	10.1371/journal.pone.0074505	http://dx.doi.org/10.1371/journal.pone.0074505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058579	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900050
J	Obeidat, M; Miller, S; Probert, K; Billington, CK; Henry, AP; Hodge, E; Nelson, CP; Stewart, CE; Swan, C; Wain, LV; Artigas, MS; Melen, E; Ushey, K; Hao, K; Lamontagne, M; Bosse, Y; Postma, DS; Tobin, MD; Sayers, I; Hall, IP				Obeidat, Ma'en; Miller, Suzanne; Probert, Kelly; Billington, Charlotte K.; Henry, Amanda P.; Hodge, Emily; Nelson, Carl P.; Stewart, Ceri E.; Swan, Caroline; Wain, Louise V.; Artigas, Maria Soler; Melen, Erik; Ushey, Kevin; Hao, Ke; Lamontagne, Maxime; Bosse, Yohan; Postma, Dirkje S.; Tobin, Martin D.; Sayers, Ian; Hall, Ian P.			GSTCD and INTS12 Regulation and Expression in the Human Lung	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TRANSCRIPTION FACTOR-BINDING; GENOME-WIDE ANALYSIS; BIDIRECTIONAL PROMOTERS; DISTINCT CLASSES; FOLLOW-UP; LOCI; ASSOCIATION; INTEGRATOR; ANNOTATION	Genome-Wide Association Study (GWAS) meta-analyses have identified a strong association signal for lung function, which maps to a region on 4q24 containing two oppositely transcribed genes: glutathione S-transferase, C-terminal domain containing (GSTCD) and integrator complex subunit 12 (INTS12). Both genes were found to be expressed in a range of human airway cell types. The promoter regions and transcription start sites were determined in mRNA from human lung and a novel splice variant was identified for each gene. We obtained the following evidence for GSTCD and INTS12 co-regulation and expression: (i) correlated mRNA expression was observed both via Q-PCR and in a lung expression quantitative trait loci (eQTL) study, (ii) induction of both GSTCD and INTS12 mRNA expression in human airway smooth muscle cells was seen in response to TGF beta 1, (iii) a lung eQTL study revealed that both GSTCD and INTS12 mRNA levels positively correlate with percent predicted FEV1, and (iv) FEV1 GWAS associated SNPs in 4q24 were found to act as an eQTL for INTS12 in a number of tissues. In fixed sections of human lung tissue, GSTCD protein expression was ubiquitous, whereas INTS12 expression was predominantly in epithelial cells and pneumocytes. During human fetal lung development, GSTCD protein expression was observed to be highest at the earlier pseudoglandular stage (10-12 weeks) compared with the later canalicular stage (17-19 weeks), whereas INTS12 expression levels did not alter throughout these stages. Knowledge of the transcriptional and translational regulation and expression of GSTCD and INTS12 provides important insights into the potential role of these genes in determining lung function. Future work is warranted to fully define the functions of INTS12 and GSTCD.	[Obeidat, Ma'en; Miller, Suzanne; Probert, Kelly; Billington, Charlotte K.; Henry, Amanda P.; Hodge, Emily; Nelson, Carl P.; Stewart, Ceri E.; Swan, Caroline; Sayers, Ian; Hall, Ian P.] Univ Nottingham, Queens Med Ctr, Div Resp Med, Nottingham NG7 2RD, England; [Wain, Louise V.; Artigas, Maria Soler; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Melen, Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Melen, Erik] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden; [Obeidat, Ma'en; Ushey, Kevin] Univ British Columbia, James Hogg Res Ctr, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Hao, Ke] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY USA; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Lamontagne, Maxime; Bosse, Yohan] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1K 7P4, Canada; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Tobin, Martin D.] Glenfield Hosp, Natl Inst Hlth Res, Leicester Resp Biomed Res Unit, Leicester, Leics, England	University of Nottingham; University of Leicester; Karolinska Institutet; Karolinska Institutet; University of British Columbia; Icahn School of Medicine at Mount Sinai; Laval University; Laval University; University of Groningen; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Hall, IP (corresponding author), Univ Nottingham, Queens Med Ctr, Div Resp Med, Nottingham NG7 2RD, England.	ian.hall@nottingham.ac.uk	Artigas, María Soler/L-6529-2013; Nelson, Carl/H-6782-2014	Artigas, María Soler/0000-0002-3213-1107; Nelson, Carl/0000-0003-1034-140X; Henry, Amanda/0000-0001-6299-7676; Hall, Ian/0000-0001-9933-3216; Miller, Suzanne/0000-0001-8508-1871; Stewart, Ceri/0000-0002-6214-2237; Sayers, Ian/0000-0001-5601-5410; Lamontagne, Maxime/0000-0001-6674-4983; Tobin, Martin/0000-0002-3596-7874; Wain, Louise/0000-0003-4951-1867	Medical Research Council [G1000861]; Medical Research Council Senior Clinical Fellowship [G0902313]; Pfizer; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council (ALF); MRC [G0700089, G0902313, MC_PC_15004, G1000861] Funding Source: UKRI; Medical Research Council [G0902313, MC_PC_15004, G0700089] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work performed at the University of Nottingham and included in this manuscript was funded by the Medical Research Council (G1000861). Martin D. Tobin holds a Medical Research Council Senior Clinical Fellowship (G0902313) (www.MRC.ac.uk). The resequencing study performed at the Univserity of Leicester was funded by Pfizer. Yohan Bosse is a research scholar from the Heart and Stroke Foundation of Canada. Erik Melen has received funding from The Swedish Research Council, The Swedish Heart-Lung Foundation and Stockholm County Council (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Board PG, 2013, BIOCHIM BIOPHYS ACTA; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Chen JD, 2013, J BIOL CHEM, V288, P4867, DOI 10.1074/jbc.M112.425892; Chi RJ, 2008, J BIOL CHEM, V283, P20959, DOI 10.1074/jbc.M709621200; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hardin M, 2012, AM J RESP CELL MOL, V47, P203, DOI 10.1165/rcmb.2012-0011OC; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Labeit S, 2006, J MOL BIOL, V362, P664, DOI 10.1016/j.jmb.2006.07.077; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Liu BC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S2; Liu B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-168; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Ng YK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-42; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Prele Cecilia M, 2012, Proc Am Thorac Soc, V9, P177, DOI 10.1513/pats.201201-007AW; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Soler Artigas M, 2011, AM J RESP CRIT CARE; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	43	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74630	10.1371/journal.pone.0074630	http://dx.doi.org/10.1371/journal.pone.0074630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058608	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900070
J	Risom, L; Christoffersen, L; Daugaard-Jensen, J; Hove, HD; Andersen, HS; Andresen, BS; Kreiborg, S; Duno, M				Risom, Lotte; Christoffersen, Line; Daugaard-Jensen, Jette; Hove, Hanne Dahlgaard; Andersen, Henriette Skovgaard; Andresen, Brage Storstein; Kreiborg, Sven; Duno, Morten			Identification of Six Novel PTH1R Mutations in Families with a History of Primary Failure of Tooth Eruption	PLOS ONE			English	Article							HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; INACTIVATING MUTATION; RECEPTOR; SEQUENCE; PROTEIN; ABSENCE; PTHRP	Primary Failure of tooth Eruption (PFE) is a non-syndromic disorder which can be caused by mutations in the parathyroid hormone receptor 1 gene (PTH1R). Traditionally, the disorder has been identified clinically based on post-emergent failure of eruption of permanent molars. However, patients with PTH1R mutations will not benefit from surgical and/or orthodontic treatment and it is therefore clinically important to establish whether a given failure of tooth eruption is caused by a PTH1R defect or not. We analyzed the PTH1R gene in six patients clinically diagnosed with PFE, all of which had undergone surgical and/or orthodontic interventions, and identified novel PTH1R mutations in all. Four of the six mutations were predicted to abolish correct mRNA maturation either through introduction of premature stop codons (c.947C>A and c.1082G>A), or by altering correct mRNA splicing (c.544-26_544-23del and c.989G>T). The latter was validated by transfection of minigenes. The six novel mutations expand the mutation spectrum for PFE from eight to 14 pathogenic mutations. Loss-of-function mutations in PTH1R are also associated with recessively inherited Blomstrand chondrodysplasia. We compiled all published PTH1R mutations and identified a mutational overlap between Blomstrand chondrodysplasia and PFE. The results suggest that a genetic approach to preclinical diagnosis will have important implication for surgical and orthodontic treatment of patients with failure of tooth eruption.	[Risom, Lotte; Christoffersen, Line; Hove, Hanne Dahlgaard; Duno, Morten] Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Daugaard-Jensen, Jette] Univ Copenhagen Hosp, Ctr Rare Oral Dis, DK-2100 Copenhagen, Denmark; [Andersen, Henriette Skovgaard; Andresen, Brage Storstein] Univ Southern Denmark, Odense, Denmark; [Kreiborg, Sven] Univ Copenhagen, Dept Paediat Dent & Clin Genet, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of Copenhagen	Risom, L (corresponding author), Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.	lotte.risom@rh.regionh.dk	Andresen, Brage/D-2515-2012	Andresen, Brage/0000-0001-7488-3035				Baccetti T, 2000, AM J ORTHOD DENTOFAC, V118, P608, DOI 10.1067/mod.2000.97938; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Datta NS, 2010, J ENDOCRINOL, V207, P355, DOI 10.1677/JOE-10-0227; Decker E, 2008, AM J HUM GENET, V83, P781, DOI 10.1016/j.ajhg.2008.11.006; Doktor TK, 2011, HUM MUTAT, V32, P220, DOI 10.1002/humu.21419; Duchatelet S, 2005, HUM MOL GENET, V14, P1, DOI 10.1093/hmg/ddi001; Frazier-Bowers Sylvia A, 2010, Semin Orthod, V16, P180; Frazier-Bowers SA, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.019; Frazier-Bowers SA, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.09.038; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hoogendam J, 2007, J CLIN ENDOCR METAB, V92, P1088, DOI 10.1210/jc.2006-0300; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Karperien M, 1999, J CLIN ENDOCR METAB, V84, P3713, DOI 10.1210/jc.84.10.3713; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Marks SC, 1997, TXB COLOR ATLAS TOOT, V1st, P19; Proffit WR, 2009, ORTHOD CRANIOFAC RES, V12, P59, DOI 10.1111/j.1601-6343.2009.01438.x; PROFFIT WR, 1981, AM J ORTHOD DENTOFAC, V80, P173, DOI 10.1016/0002-9416(81)90217-7; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Stellzig-Eisenhauer A, 2010, J OROFAC ORTHOP, V71, P6, DOI 10.1007/s00056-010-0908-9; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; Yamaguchi T, 2011, J BONE MINER RES, V26, P1655, DOI 10.1002/jbmr.385; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang P, 1998, J CLIN ENDOCR METAB, V83, P3365, DOI 10.1210/jc.83.9.3373	27	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74601	10.1371/journal.pone.0074601	http://dx.doi.org/10.1371/journal.pone.0074601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058597	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900063
J	Heimann, M; Girotto, V; Legrenzi, P; Bonnefon, JF				Heimann, Marco; Girotto, Vittorio; Legrenzi, Paolo; Bonnefon, Jean-Francois			Decision Makers Use Norms, Not Cost-Benefit Analysis, When Choosing to Conceal or Reveal Unfair Rewards	PLOS ONE			English	Article							PSYCHOLOGY; MODESTY; HONESTY; VALUES	We introduce the Conceal or Reveal Dilemma, in which individuals receive unfair benefits, and must decide whether to conceal or to reveal this unfair advantage. This dilemma has two important characteristics: it does not lend itself easily to cost-benefit analysis, neither to the application of any strong universal norm. As a consequence, it is ideally suited to the study of interindividual and intercultural variations in moral-economic norms. In this paper we focus on interindividual variations, and we report four studies showing that individuals cannot be swayed by financial incentives to conceal or to reveal, and follow instead fixed, idiosyncratic strategies. We discuss how this result can be extended to individual and cultural variations in the tendency to display or to hide unfair rewards.	[Heimann, Marco] Univ Toulouse, Inst Adm Entreprises, Toulouse, France; [Heimann, Marco; Bonnefon, Jean-Francois] Univ Toulouse, Lab Cognit Langues Langage Ergon, Toulouse, France; [Girotto, Vittorio] Univ IUAV Venice, Dipartimento Culture Progetto, Venice, Italy; [Legrenzi, Paolo] Univ Ca Foscari Venice, Dipartimento Filosofia & Beni Culturali, Venice, Italy; [Bonnefon, Jean-Francois] CNRS, Toulouse, France	Universite de Toulouse; Universite de Toulouse; IUAV University Venice; Universita Ca Foscari Venezia; Centre National de la Recherche Scientifique (CNRS)	Heimann, M (corresponding author), Univ Toulouse, Inst Adm Entreprises, Toulouse, France.	marcoheimann@gmail.com		Bonnefon, Jean-Francois/0000-0002-4959-188X	Swiss AMP; Global- Ca' Foscari Foundation	Swiss AMP; Global- Ca' Foscari Foundation	This work was partially supported by the Swiss & Global- Ca' Foscari Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ariely D., 2012, HONEST TRUTH DISHONE; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Baron J, 1997, ORGAN BEHAV HUM DEC, V70, P1, DOI 10.1006/obhd.1997.2690; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Bennis WM, 2010, PERSPECT PSYCHOL SCI, V5, P187, DOI 10.1177/1745691610362354; Berns GS, 2012, PHILOS T R SOC B, V367, P754, DOI 10.1098/rstb.2011.0262; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Camerer C, 1999, P NATL ACAD SCI USA, V96, P10575, DOI 10.1073/pnas.96.19.10575; Cameron CA, 2012, J MORAL EDUC, V41, P61, DOI 10.1080/03057240.2011.617414; Chen SXH, 2009, J CROSS CULT PSYCHOL, V40, P603, DOI 10.1177/0022022108330992; Cohen-Charash Y, 2007, J APPL PSYCHOL, V92, P666, DOI 10.1037/0021-9010.92.3.666; Fiske AP, 1997, POLIT PSYCHOL, V18, P255, DOI 10.1111/0162-895X.00058; Gibson R, 2012, AM EC REV; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hilbig BE, 2013, J EXP SOC PSYCHOL, V49, P263, DOI 10.1016/j.jesp.2012.11.010; Kurman J, 2001, ASIAN J SOC PSYCHOL, V4, P225, DOI 10.1111/1467-839X.00087; Kurman J, 2004, J CROSS CULTURAL PSY, V5, P496; Lundquist T, 2009, J ECON BEHAV ORGAN, V70, P81, DOI 10.1016/j.jebo.2009.02.010; Moran S., 2008, NEGOT CONFL MANAG R, V1, P3, DOI DOI 10.1111/J.1750-4716.2007.00002.X; Ohtsubo Y, 2010, EVOL HUM BEHAV, V31, P259, DOI 10.1016/j.evolhumbehav.2009.12.007; Rabin M, 1998, J ECON LIT, V36, P11; Rai TS, 2011, PSYCHOL REV, V118, P57, DOI 10.1037/a0021867; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Ritov I, 1999, ORGAN BEHAV HUM DEC, V79, P79, DOI 10.1006/obhd.1999.2839; Shalvi S, 2012, PSYCHOL SCI, V23, P1264, DOI 10.1177/0956797612443835; Shalvi S, 2011, BRIT J MANAGE, V22, pS16, DOI 10.1111/j.1467-8551.2010.00709.x; Smith RH, 2007, PSYCHOL BULL, V133, P46, DOI 10.1037/0033-2909.133.1.46; Sunstein CR, 2005, BEHAV BRAIN SCI, V28, P531, DOI 10.1017/S0140525X05000099; Tetlock PE, 2003, TRENDS COGN SCI, V7, P320, DOI 10.1016/S1364-6613(03)00135-9; van de Ven N, 2010, PSYCHOL SCI, V21, P1671, DOI 10.1177/0956797610385352; Wang CS, 2009, PSYCHOL SCI, V20, P634, DOI 10.1111/j.1467-9280.2009.02344.x; Watve MG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-345	33	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73223	10.1371/journal.pone.0073223	http://dx.doi.org/10.1371/journal.pone.0073223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066040	gold, Green Submitted, Green Published			2022-12-27	WOS:000324494000021
J	Horacio, AN; Diamantino-Miranda, J; Aguiar, SI; Ramirez, M; Melo-Cristino, J				Horacio, Andreia N.; Diamantino-Miranda, Jorge; Aguiar, Sandra I.; Ramirez, Mario; Melo-Cristino, Jose		Portuguese Grp Study Streptococcal	The Majority of Adult Pneumococcal Invasive Infections in Portugal Are Still Potentially Vaccine Preventable in Spite of Significant Declines of Serotypes 1 and 5	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPES; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; TEMPORAL TRENDS; TYPING METHODS; OLDER-ADULTS; DISEASE; PROGRAM; SURVEILLANCE; RESISTANCE	In Portugal, pneumococcal conjugate vaccines have been administered to children outside of the national immunization plan since 2001. We determined the serotype and antimicrobial susceptibility of 1265 isolates responsible for adult invasive pneumococcal infections (IPD) between 2009 and 2011 and compared the results with previously published data from 1999 to 2008. Serotypes 3 (12.6%), 7F (10.0%), 19A (9.1%), 14 (8.4%), 1 (6.9%) and 8 (6.2%) were the most frequent and together accounted for 53.2% of adult IPD. Serotypes 1 and 5 declined significantly while serotype 34, not included in any vaccine, increased. Taken together, the serotypes included in the 13-valent conjugate vaccine (PCV13) peaked among adult IPD isolates in 2008 (70.2%) and declined since then reaching 53.5% in 2011. The decline in the serotypes included in the 23-valent polysaccharide vaccine since 2007 was also significant but much more modest with 79.2% of the isolates causing IPD in 2011 expressing these serotypes. Since the changes in serotypes causing IPD in adults coincided with the 10-valent and PCV13 introduction in children, it is unlikely that vaccination triggered these changes although it may have accelerated them. The proportion of IPD caused by serotypes included in the 7-valent conjugate vaccine remained stable (19.0%). Both penicillin non-susceptibility and erythromycin resistance increased in the study period, with serotypes 14 and 19A accounting for the majority of resistant isolates.	[Horacio, Andreia N.; Diamantino-Miranda, Jorge; Aguiar, Sandra I.; Ramirez, Mario; Melo-Cristino, Jose; Portuguese Grp Study Streptococcal] Univ Lisbon, Fac Med, Inst Microbiol, Inst Mol Med, P-1699 Lisbon, Portugal	Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Microbiol, Inst Mol Med, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Ramirez, Mario/B-4993-2008; Aguiar, Sandra Isabel Rodrigues/A-3500-2009; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Aguiar, Sandra Isabel Rodrigues/0000-0002-3041-383X; Melo-Cristino, Jose A G/0000-0001-8643-1722; Tome, Rui/0000-0001-5381-2705; Miranda, Jorge/0000-0001-9128-2047; Goncalves, Elsa/0000-0003-2789-7068	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81205/2011, SFRH/BD/81766/2011, SFRH/BPD/78376/2011, PTDC/DTPEPI/1759/2012]; Pfizer; Glaxo SmithKline	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Pfizer(Pfizer); Glaxo SmithKline(GlaxoSmithKline)	A.N. Horacio, J. Diamantino-Miranda and S.I. Aguiar were supported by grants SFRH/BD/81205/2011, SFRH/BD/81766/2011, SFRH/BPD/78376/2011, respectively, from Fundacao para a Ciencia e Tecnologia, Portugal. This work was partially supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/DTPEPI/1759/2012) and unrestricted research grants from Pfizer and Glaxo SmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUS S; Clinical and Laboratory Standards Institute, 2011, PERF STAND ANT SUS S; Demczuk WHB, 2012, CAN J MICROBIOL, V58, P1008, DOI [10.1139/W2012-073, 10.1139/w2012-073]; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Grabenstein JD, 2012, CLIN INFECT DIS, V55, P255, DOI 10.1093/cid/cis354; Grau I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042595; Haeseker MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051860; Hak E, 2008, NETH J MED, V66, P378; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Ingels H, 2012, VACCINE, V30, P3944, DOI 10.1016/j.vaccine.2012.03.060; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Marimon JM, 2009, CLIN MICROBIOL INFEC, V15, P875, DOI 10.1111/j.1469-0691.2009.02883.x; Melo-Cristino J, 2003, MICROB DRUG RESIST, V9, P73, DOI 10.1089/107662903764736364; Michel JP, 2010, EUR GERIATR MED, V1, P155, DOI 10.1016/j.eurger.2010.03.013; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Muhammad Riyadh D, 2013, Clin Infect Dis, V56, pe59, DOI 10.1093/cid/cis971; Musher DM, 2011, CLIN INFECT DIS, V52, P633, DOI 10.1093/cid/ciq207; Paradiso PR, 2012, CLIN INFECT DIS, V55, P259, DOI 10.1093/cid/cis359; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Picazo J, 2013, PEDIAT INFE IN PRESS; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Regev-Yochay G, 2013, VACCINE, V31, P2387, DOI 10.1016/j.vaccine.2013.02.059; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Rosen JB, 2011, CLIN INFECT DIS, V53, P137, DOI 10.1093/cid/cir326; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Serrano I, 2004, CLIN MICROBIOL INFEC, V10, P652, DOI 10.1111/j.1469-0691.2004.00869.x; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Truck J, 2012, CLIN INFECT DIS, V55, P1577, DOI 10.1093/cid/cis700; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Vestrheim DF, 2012, CLIN VACCINE IMMUNOL, V19, P443, DOI 10.1128/CVI.05563-11	41	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73704	10.1371/journal.pone.0073704	http://dx.doi.org/10.1371/journal.pone.0073704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066064	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000046
J	Lucherini, OM; Obici, L; Ferracin, M; Fulci, V; McDermott, MF; Merlini, G; Muscari, I; Magnotti, F; Dickie, LJ; Galeazzi, M; Negrini, M; Baldari, CT; Cimaz, R; Cantarini, L				Lucherini, Orso Maria; Obici, Laura; Ferracin, Manuela; Fulci, Valerio; McDermott, Michael F.; Merlini, Giampaolo; Muscari, Isabella; Magnotti, Flora; Dickie, Laura J.; Galeazzi, Mauro; Negrini, Massimo; Baldari, Cosima Tatiana; Cimaz, Rolando; Cantarini, Luca			First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)	PLOS ONE			English	Article							TNF RECEPTOR; AUTOINFLAMMATORY SYNDROMES; RECURRENT PERICARDITIS; EXCELLENT RESPONSE; TNFRSF1A; ETANERCEPT; MUTATIONS; ANAKINRA; HETEROGENEITY; COMPLICATIONS	Tumor necrosis factor-receptor associated periodic syndrome (TRAPS) is a rare autosomal dominant autoinflammatory disorder characterized by recurrent episodes of long-lasting fever and inflammation in different regions of the body, such as the musculo-skeletal system, skin, gastrointestinal tract, serosal membranes and eye. Our aims were to evaluate circulating microRNAs (miRNAs) levels in patients with TRAPS, in comparison to controls without inflammatory diseases, and to correlate their levels with parameters of disease activity and/or disease severity. Expression levels of circulating miRNAs were measured by Agilent microarrays in 29 serum samples from 15 TRAPS patients carrying mutations known to be associated with high disease penetrance and from 8 controls without inflammatory diseases. Differentially expressed and clinically relevant miRNAs were detected using GeneSpring GX software. We identified a 6 miRNAs signature able to discriminate TRAPS from controls. Moreover, 4 miRNAs were differentially expressed between patients treated with the interleukin (IL)-1 receptor antagonist, anakinra, and untreated patients. Of these, miR-92a-3p and miR-150-3p expression was found to be significantly reduced in untreated patients, while their expression levels were similar to controls in samples obtained during anakinra treatment. MiR-92b levels were inversely correlated with the number of fever attacks/year during the 1st year from the index attack of TRAPS, while miR-377-5p levels were positively correlated with serum amyloid A (SAA) circulating levels. Our data suggest that serum miRNA levels show a baseline pattern in TRAPS, and may serve as potential markers of response to therapeutic intervention.	[Lucherini, Orso Maria; Muscari, Isabella; Magnotti, Flora; Galeazzi, Mauro; Cantarini, Luca] Univ Siena, Policlin Le Scotte, Rheumatol Unit, Res Ctr Syst Autoimmune & Autoinflammatory Dis, I-53100 Siena, Italy; [Obici, Laura; Merlini, Giampaolo] Univ Pavia, Fdn IRCCS Policlin San Matteo, Amyloid Res & Treatment Ctr, I-27100 Pavia, Italy; [Obici, Laura; Merlini, Giampaolo] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Dept Morphol Surg & Expt Med, Pathol Sect, I-44100 Ferrara, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Lab Technol Adv Therapies LTTA, I-44100 Ferrara, Italy; [Fulci, Valerio] Univ Roma La Sapienza, Sez Genet Mol, Dipartimento Biotecnol Cellulari & Ematol, I-00185 Rome, Italy; [McDermott, Michael F.; Dickie, Laura J.] Inst Rheumat & Musculoskeletal Med LIRMM, NIHR Leeds Musculoskeletal Biomed Res Unit NIHR L, Leeds, W Yorkshire, England; [Baldari, Cosima Tatiana] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Cimaz, Rolando] Anna Meyer Childrens Hosp, Rheumatol Unit, Dept Pediat, Florence, Italy; [Cimaz, Rolando] Univ Florence, Florence, Italy	University of Siena; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Ferrara; University of Ferrara; Sapienza University Rome; University of Siena; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence	Cantarini, L (corresponding author), Univ Siena, Policlin Le Scotte, Rheumatol Unit, Res Ctr Syst Autoimmune & Autoinflammatory Dis, Via Laterina 8, I-53100 Siena, Italy.	cantariniluca@hotmail.com	Merlini, Giampaolo/A-3817-2008; McDermott, Michael/S-8490-2019; Obici, Laura/AAC-3060-2019; CIMAZ, Rolando/AAA-9058-2019; Fulci, Valerio/J-1963-2015; McDermott, Michael Francis/GZM-5330-2022; Negrini, Massimo/J-2377-2016; Ferracin, Manuela/K-2097-2016; Magnotti, Flora/G-7309-2019; Cantarini, Luca/K-5658-2014	Merlini, Giampaolo/0000-0001-7680-3254; McDermott, Michael/0000-0002-1015-0745; Obici, Laura/0000-0001-7468-700X; CIMAZ, Rolando/0000-0002-3260-4226; Fulci, Valerio/0000-0002-1173-585X; Negrini, Massimo/0000-0002-0007-1920; Ferracin, Manuela/0000-0002-1595-6887; Magnotti, Flora/0000-0002-3803-9934; Cantarini, Luca/0000-0002-7352-1275; Lucherini, Orso Maria/0000-0002-3314-0814; Baldari, Cosima/0000-0002-4414-6744	Associazione Italiana per la Ricerca sul Cancro [MFAG11676]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by funding from Associazione Italiana per la Ricerca sul Cancro to M.F. (MFAG11676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganna E, 2003, ARTHRITIS RHEUM-US, V48, P2632, DOI 10.1002/art.11215; Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arostegui JI, 2005, EUR J PEDIATR, V164, P13, DOI 10.1007/s00431-004-1563-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brizi MG, 2012, ANN INTERN MED, V156, P907, DOI 10.7326/0003-4819-156-12-201206190-00027; Bulua AC, 2012, ARTHRITIS RHEUM-US, V64, P908, DOI 10.1002/art.33416; Cantarini L, 2011, INT J IMMUNOPATH PH, V24, P695, DOI 10.1177/039463201102400315; Cantarini L, 2010, CLIN EXP RHEUMATOL, V28, P802; Cantarini L, 2010, CLIN EXP RHEUMATOL, V28, P405; Cantarini L, 2012, AUTOIMMUN REV, V12, P38, DOI 10.1016/j.autrev.2012.07.020; Cantarini L, 2012, CLIN RES CARDIOL, V101, P525, DOI 10.1007/s00392-012-0422-8; Cantarini L, 2012, RHEUMATOL INT, V32, P4015, DOI 10.1007/s00296-010-1512-4; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Ceribelli A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3377; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; D'Osualdo A, 2006, ARTHRITIS RHEUM-US, V54, P998, DOI 10.1002/art.21657; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; de Menthiere CS, 2003, NUCLEIC ACIDS RES, V31, P282, DOI 10.1093/nar/gkg031; Dode C, 2002, ARTHRITIS RHEUM-US, V46, P2181, DOI 10.1002/art.10429; Drewe E, 2003, RHEUMATOLOGY, V42, P235, DOI 10.1093/rheumatology/keg070; Ferracin M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-123; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1516, DOI 10.1002/art.23475; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hull KM, 2002, MEDICINE, V81, P349, DOI 10.1097/00005792-200209000-00002; Intine RV, 2012, CURR DIABETES REP, V12, P551, DOI 10.1007/s11892-012-0302-7; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Jacobelli S, 2007, RHEUMATOLOGY, V46, P1211, DOI 10.1093/rheumatology/kel298; Jakob P, 2012, CIRCULATION, V126, P2962, DOI 10.1161/CIRCULATIONAHA.112.093906; Jesus AA, 2008, EUR J PEDIATR, V167, P1421, DOI 10.1007/s00431-008-0685-2; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Machlin ES, 2012, CURR GENE THER, V12, P301, DOI 10.2174/156652312802083558; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Nowlan ML, 2006, RHEUMATOLOGY, V45, P31, DOI 10.1093/rheumatology/kei090; Obici L, 2012, AUTOIMMUN REV, V12, P14, DOI 10.1016/j.autrev.2012.07.016; Obici L, 2011, ANN RHEUM DIS, V70, P1511, DOI 10.1136/ard.2010.143438; Ravet N, 2006, ANN RHEUM DIS, V65, P1158, DOI 10.1136/ard.2005.048611; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Stojanov S, 2008, ANN RHEUM DIS, V67, P1292, DOI 10.1136/ard.2007.079376; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Ter Haar N, 2012, ANN RHEUM DIS; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	45	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73443	10.1371/journal.pone.0073443	http://dx.doi.org/10.1371/journal.pone.0073443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066048	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000029
J	Muller, S; Quast, T; Schroder, A; Hucke, S; Klotz, L; Jantsch, J; Gerzer, R; Hemmersbach, R; Kolanus, W				Mueller, Silke; Quast, Thomas; Schroeder, Agnes; Hucke, Stephanie; Klotz, Luisa; Jantsch, Jonathan; Gerzer, Rupert; Hemmersbach, Ruth; Kolanus, Waldemar			Salt-Dependent Chemotaxis of Macrophages	PLOS ONE			English	Article							BINDING PROTEIN; MIGRATION; TRANSCRIPTION; ELEMENT; HYPERTONICITY; EXPRESSION; NFAT5	Besides their role in immune system host defense, there is growing evidence that macrophages may also be important regulators of salt homeostasis and blood pressure by a TonEBP-VEGF-C dependent buffering mechanism. As macrophages are known to accumulate in the skin of rats fed under high salt diet conditions and are pivotal for removal of high salt storage, the question arose how macrophages sense sites of high sodium storage. Interestingly, we observed that macrophage-like RAW264.7 cells, murine bone marrow-derived macrophages and peritoneal macrophages recognize NaCl hypertonicity as a chemotactic stimulus and migrate in the direction of excess salt concentration by using an in vitro transwell migration assay. While RAW264.7 cells migrated toward NaCl in a dose-dependent fashion, no migratory response toward isotonic or hypotonic media controls, or other osmo-active agents, e. g. urea or mannitol, could be detected. Interestingly, we could not establish a specific role of the osmoprotective transcription factor TonEBP in regulating salt-dependent chemotaxis, since the specific migration of bone marrow-derived macrophages following RNAi of TonEBP toward NaCl was not altered. Although the underlying mechanism remains unidentified, these data point to a thus far unappreciated role for NaCl-dependent chemotaxis of macrophages in the clearance of excess salt, and suggest the existence of novel NaCl sensor/effector circuits, which are independent of the TonEBP system.	[Mueller, Silke; Gerzer, Rupert; Hemmersbach, Ruth] German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany; [Quast, Thomas; Kolanus, Waldemar] Univ Bonn, Lab Mol Immunol, Life & Med Sci LIMES Inst, Bonn, Germany; [Schroeder, Agnes] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Hucke, Stephanie; Klotz, Luisa] Univ Munster, Clin Neurol Inflammatory Disorders Cent Nervous S, D-48149 Munster, Germany; [Jantsch, Jonathan] Univ Hosp Erlangen, Microbiol Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Jantsch, Jonathan] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	Helmholtz Association; German Aerospace Centre (DLR); University of Bonn; University of Erlangen Nuremberg; University of Munster; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Kolanus, W (corresponding author), Univ Bonn, Lab Mol Immunol, Life & Med Sci LIMES Inst, Bonn, Germany.	wkolanus@uni-bonn.de	Klotz, Luisa/HCI-7635-2022; Schröder, Agnes/AHC-9286-2022	Thul, Silke/0000-0003-4158-464X	Deutsche Forschungsgemeinschaft (DFG) [SFB704]; Helmholtz Space Life Sciences Research School (SpaceLife) Scholarship; Helmholtz Association; German Aerospace Center (DLR)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Space Life Sciences Research School (SpaceLife) Scholarship; Helmholtz Association(Helmholtz Association); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB704). The first author received a Helmholtz Space Life Sciences Research School (SpaceLife) Scholarship. SpaceLife is funded in equal parts by the Helmholtz Association and the German Aerospace Center (DLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Gerzer R, 2005, CURR PHARM BIOTECHNO, V6, P299, DOI 10.2174/1389201054553662; Halterman JA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00313; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kostyk AG, 2006, AM J PATHOL, V169, P12, DOI 10.2353/ajpath.2006.051042; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Slagman MCJ, 2012, NEPHROL DIAL TRANSPL, V27, P978, DOI 10.1093/ndt/gfr402; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003	21	53	55	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73439	10.1371/journal.pone.0073439	http://dx.doi.org/10.1371/journal.pone.0073439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066047	Green Published, gold			2022-12-27	WOS:000324494000028
J	Ramamoorthy, V; Dhingra, S; Kincaid, A; Shantappa, S; Feng, XH; Calvo, AM				Ramamoorthy, Vellaisamy; Dhingra, Sourabh; Kincaid, Alexander; Shantappa, Sourabha; Feng, Xuehuan; Calvo, Ana M.			The Putative C2H2 Transcription Factor MtfA Is a Novel Regulator of Secondary Metabolism and Morphogenesis in Aspergillus nidulans	PLOS ONE			English	Article							VELVET-LIKE COMPLEX; PENICILLIN BIOSYNTHESIS; SEXUAL DEVELOPMENT; CONIDIOPHORE DEVELOPMENT; IMPORTIN-ALPHA; LOCUS CONSISTS; GENE; VEA; PROTEIN; AFLATOXIN	Secondary metabolism in the model fungus Aspergillus nidulans is controlled by the conserved global regulator VeA, which also governs morphological differentiation. Among the secondary metabolites regulated by VeA is the mycotoxin sterigmatocystin (ST). The presence of VeA is necessary for the biosynthesis of this carcinogenic compound. We identified a revertant mutant able to synthesize ST intermediates in the absence of VeA. The point mutation occurred at the coding region of a gene encoding a novel putative C2H2 zinc finger domain transcription factor that we denominated mtfA. The A. nidulans mtfA gene product localizes at nuclei independently of the illumination regime. Deletion of the mtfA gene restores mycotoxin biosynthesis in the absence of veA, but drastically reduced mycotoxin production when mtfA gene expression was altered, by deletion or overexpression, in A. nidulans strains with a veA wild-type allele. Our study revealed that mtfA regulates ST production by affecting the expression of the specific ST gene cluster activator aflR. Importantly, mtfA is also a regulator of other secondary metabolism gene clusters, such as genes responsible for the synthesis of terrequinone and penicillin. As in the case of ST, deletion or overexpression of mtfA was also detrimental for the expression of terrequinone genes. Deletion of mtfA also decreased the expression of the genes in the penicillin gene cluster, reducing penicillin production. However, in this case, over-expression of mtfA enhanced the transcription of penicillin genes, increasing penicillin production more than 5 fold with respect to the control. Importantly, in addition to its effect on secondary metabolism, mtfA also affects asexual and sexual development in A. nidulans. Deletion of mtfA results in a reduction of conidiation and sexual stage. We found mtfA putative orthologs conserved in other fungal species.	[Ramamoorthy, Vellaisamy; Dhingra, Sourabh; Kincaid, Alexander; Shantappa, Sourabha; Feng, Xuehuan; Calvo, Ana M.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Northern Illinois University	Calvo, AM (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	amcalvo@niu.edu		Vellaisamy, Ramamoorthy/0000-0002-3551-8040	National Institutes of Health (NIH) [1R15AI081232]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI081232] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health (NIH) grant 1R15AI081232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adrio JL, 2003, INT MICROBIOL, V6, P191, DOI 10.1007/s10123-003-0133-0; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Araujo-Bazan L, 2009, FUNGAL GENET BIOL, V46, P506, DOI 10.1016/j.fgb.2009.03.006; Balibar CJ, 2007, NAT CHEM BIOL, V3, P584, DOI 10.1038/nchembio.2007.20; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Borneman AR, 2001, GENETICS, V157, P1003; Bouhired S, 2007, FUNGAL GENET BIOL, V44, P1134, DOI 10.1016/j.fgb.2006.12.010; Boykin LM, 2010, MOL PHYLOGENET EVOL, V54, P687, DOI 10.1016/j.ympev.2009.11.016; Brakhage AA, 2004, ADV BIOCHEM ENG BIOT, V88, P45, DOI 10.1007/b99257; BRAKHAGE AA, 1992, J BACTERIOL, V174, P3789, DOI 10.1128/JB.174.11.3789-3799.1992; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Brakhage AA, 2009, PHYTOCHEMISTRY, V70, P1801, DOI 10.1016/j.phytochem.2009.09.011; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Cole RJ, 1981, HDB TOXIC FUNGAL MET; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Duran R. M., 2009, Open Mycology Journal, V3, P27, DOI 10.2174/1874437000903010027; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; Laskowski-Peak MC, 2012, FUNGAL GENET BIOL, V49, P838, DOI 10.1016/j.fgb.2012.07.001; MACCABE AP, 1990, EMBO J, V9, P279, DOI 10.1002/j.1460-2075.1990.tb08106.x; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Osherov N, 2000, GENETICS, V155, P647; Ozcengiz G, 2012, RECENT ADV BIOSYNTHE, DOI [10.1016/j.biotechadv.2012.12.001, DOI 10.1016/J.BI0TECHADV.2012.12.001]; Payne GA, 1998, ANNU REV PHYTOPATHOL, V36, P329, DOI 10.1146/annurev.phyto.36.1.329; Payne GA, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P157; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; PRADE RA, 1993, EMBO J, V12, P2439, DOI 10.1002/j.1460-2075.1993.tb05898.x; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Ramamoorthy V, 2012, MOL MICROBIOL, V85, P795, DOI 10.1111/j.1365-2958.2012.08142.x; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; SAMBROOK J, 2003, MOL CLONING LAB MANU; Schneider P, 2008, FUNGAL GENET BIOL, V45, P302, DOI 10.1016/j.fgb.2007.09.004; Shaaban M, 2010, FUNGAL GENET BIOL, V47, P423, DOI 10.1016/j.fgb.2010.02.006; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Sprote P, 2007, ARCH MICROBIOL, V188, P69, DOI 10.1007/s00203-007-0224-y; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; Strauss J, 2011, FUNGAL GENET BIOL, V48, P62, DOI 10.1016/j.fgb.2010.07.009; Sweeney MJ, 1999, FEMS MICROBIOL LETT, V175, P149, DOI 10.1111/j.1574-6968.1999.tb13614.x; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Vallim MA, 2000, MOL MICROBIOL, V36, P290, DOI 10.1046/j.1365-2958.2000.01874.x; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Woloshuk CP, 2013, FEMS MICROBIOL REV, V37, P94, DOI 10.1111/1574-6976.12009; Xing BG, 2008, MINI-REV MED CHEM, V8, P455, DOI 10.2174/138955708784223558; Yager L N, 1992, Biotechnology, V23, P19; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	70	44	44	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74122	10.1371/journal.pone.0074122	http://dx.doi.org/10.1371/journal.pone.0074122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066102	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000084
J	Szczesny, B; Olah, G; Walker, DK; Volpi, E; Rasmussen, BB; Szabo, C; Mitra, S				Szczesny, Bartosz; Olah, Gabor; Walker, Dillon K.; Volpi, Elena; Rasmussen, Blake B.; Szabo, Csaba; Mitra, Sankar			Deficiency in Repair of the Mitochondrial Genome Sensitizes Proliferating Myoblasts to Oxidative Damage	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE-GAMMA; SINGLE-STRAND BREAKS; DIFFERENTIATED MUSCLE-CELLS; SKELETAL-MUSCLE; NUCLEAR-DNA; ENDONUCLEASE-G; ADAPTIVE RESPONSE; SATELLITE CELLS; ABASIC SITES	Reactive oxygen species (ROS), generated as a by-product of mitochondrial oxidative phosphorylation, are particularly damaging to the genome of skeletal muscle because of their high oxygen consumption. Proliferating myoblasts play a key role during muscle regeneration by undergoing myogenic differentiation to fuse and restore damaged muscle. This process is severely impaired during aging and in muscular dystrophies. In this study, we investigated the role of oxidatively damaged DNA and its repair in the mitochondrial genome of proliferating skeletal muscle progenitor myoblasts cells and their terminally differentiated product, myotubes. Using the C2C12 cell line as a well-established model for skeletal muscle differentiation, we show that myoblasts are highly sensitive to ROS-mediated DNA damage, particularly in the mitochondrial genome, due to deficiency in 5' end processing at the DNA strand breaks. Ectopic expression of the mitochondrial-specific 5' exonuclease, EXOG, a key DNA base excision/single strand break repair (BER/SSBR) enzyme, in myoblasts but not in myotubes, improves the cell's resistance to oxidative challenge. We linked loss of myoblast viability by activation of apoptosis with deficiency in the repair of the mitochondrial genome. Moreover, the process of myoblast differentiation increases mitochondrial biogenesis and the level of total glutathione. We speculate that our data may provide a mechanistic explanation for depletion of proliferating muscle precursor cells during the development of sarcopenia, and skeletal muscle dystrophies.	[Szczesny, Bartosz; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Walker, Dillon K.; Rasmussen, Blake B.] Univ Texas Med Branch, Dept Nutr & Metab, Galveston, TX 77555 USA; [Volpi, Elena] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Olah, Gabor; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Szczesny, B (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	baszczes@utmb.edu	Szabo, Csaba/ABG-2644-2021; Volpi, Elena/I-4459-2012	Volpi, Elena/0000-0001-8776-0384; Rasmussen, Blake/0000-0001-7854-5375	National Institutes of Health [NIA P30 AG02483, NIAMS R01 AR049877, 2P50 GM060338, NCI R01 CA53791]; NATIONAL CANCER INSTITUTE [R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002483, P30AG024832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants NIA P30 AG02483 (to EV), NIAMS R01 AR049877 (to BBR), 2P50 GM060338 (to CS) and NCI R01 CA53791 (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BOLDEN A, 1977, J BIOL CHEM, V252, P3351; BROWN RH, 1995, CURR OPIN NEUROL, V8, P373, DOI 10.1097/00019052-199510000-00009; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Canitrot Y, 1999, ONCOGENE, V18, P2676, DOI 10.1038/sj.onc.1202619; Chatterjee A, 2008, ONCOGENE, V27, P3710, DOI 10.1038/onc.2008.3; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Ding Y, 2008, AM J PATHOL, V172, P1529, DOI 10.2353/ajpath.2008.070429; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Dupont-Versteegden EE, 2006, WORLD J GASTROENTERO, V12, P7463, DOI 10.3748/wjg.v12.i46.7463; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Figueiredo PA, 2008, BIOGERONTOLOGY, V9, P67, DOI 10.1007/s10522-007-9121-7; Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Frangini M, 2013, J BIOL CHEM, V288, P5624, DOI 10.1074/jbc.M112.441147; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005; Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Hubscher U, 2011, CURR OPIN CHEM BIOL, V15, P627, DOI 10.1016/j.cbpa.2011.08.009; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Jackson MJ, 2011, J PHYSIOL-LONDON, V589, P2139, DOI 10.1113/jphysiol.2011.206623; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kaneko M, 1998, TOXICOL LETT, V99, P15, DOI 10.1016/S0378-4274(98)00132-5; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Kieper J, 2010, PROTEIN EXPRES PURIF, V73, P99, DOI 10.1016/j.pep.2010.04.001; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kumar S, 2009, LIFE SCI, V84, P328, DOI 10.1016/j.lfs.2008.12.016; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lanza IR, 2010, ACTA PHYSIOL, V199, P529, DOI 10.1111/j.1748-1716.2010.02124.x; Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201; Liu M, 2013, J MOL CELL CARDIOL, V54, P25, DOI 10.1016/j.yjmcc.2012.10.011; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Lyons CN, 2004, BIOCHEM CELL BIOL, V82, P391, DOI 10.1139/O04-040; Malinska D, 2012, MITOCHONDRION, V12, P144, DOI 10.1016/j.mito.2011.06.015; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Marzetti E, 2012, GERONTOLOGY, V58, P99, DOI 10.1159/000330064; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Plumb LA, 2004, METH MOLEC MED, V88, P165; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200; Rachek LI, 2006, DIABETES, V55, P1022, DOI 10.2337/diabetes.55.04.06.db05-0865; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Rebelo AP, 2011, J INHERIT METAB DIS, V34, P941, DOI 10.1007/s10545-011-9330-8; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Salucci S, 2010, MICRON, V41, P966, DOI 10.1016/j.micron.2010.07.002; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wagner AE, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/835970; Walker DK, 2012, MUSCLE NERVE, V46, P51, DOI 10.1002/mus.23266; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	109	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75201	10.1371/journal.pone.0075201	http://dx.doi.org/10.1371/journal.pone.0075201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066171	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000153
J	Bhatnagar, P; Barron-Casella, E; Bean, CJ; Milton, JN; Baldwin, CT; Steinberg, MH; DeBaun, M; Casella, JF; Arking, DE				Bhatnagar, Pallav; Barron-Casella, Emily; Bean, Christopher J.; Milton, Jacqueline N.; Baldwin, Clinton T.; Steinberg, Martin H.; DeBaun, Michael; Casella, James F.; Arking, Dan E.			Genome-Wide Meta-Analysis of Systolic Blood Pressure in Children with Sickle Cell Disease	PLOS ONE			English	Article							ASSOCIATION; HYPERTENSION; DOPAMINE; LOCI; VARIANTS; INFARCTS; LINKAGE; DESIGN; ADULTS; COMMON	In pediatric sickle cell disease (SCD) patients, it has been reported that higher systolic blood pressure (SBP) is associated with increased risk of a silent cerebral infarction (SCI). SCI is a major cause of neurologic morbidity in children with SCD, and blood pressure is a potential modulator of clinical manifestations of SCD; however, the risk factors underlying these complications are not well characterized. The aim of this study was to identify genetic variants that influence SBP in an African American population in the setting of SCD, and explore the use of SBP as an endo-phenotype for SCI. We conducted a genome-wide meta-analysis for SBP using two SCD cohorts, as well as a candidate screen based on published SBP loci. A total of 1,617 patients were analyzed, and while no SNP reached genome-wide significance (P-value<5.0x10(-8)), a number of suggestive candidate loci were identified. The most significant SNP, rs7952106 (P-value=8.57x10(-7)), was in the DRD2 locus on chromosome 11. In a gene-based association analysis, MIR4301 (micro-RNA4301), which resides in an intron of DRD2, was the most significant gene (P-value=5.2x10(-5)). Examining 27 of the previously reported SBP associated SNPs, 4 SNPs were nominally significant. A genetic risk score was constructed to assess the aggregated genetic effect of the published SBP variants, demonstrating a significant association (P=0.05). In addition, we also assessed whether these variants are associated with SCI, validating the use of SBP as an endo-phenotype for SCI. Three SNPs were nominally associated, and only rs2357790 (5' CACNB2) was significant for both SBP and SCI. None of these SNPs retained significance after Bonferroni correction. Taken together, our results suggest the importance of DRD2 genetic variation in the modulation of SBP, and extend the aggregated importance of previously reported SNPs in the modulation of SBP in an African American cohort, more specifically in children with SCD.	[Bhatnagar, Pallav; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Barron-Casella, Emily; Casella, James F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Bean, Christopher J.] Ctr Dis Control & Prevent, Clin & Mol Hemostasis Lab Branch, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Milton, Jacqueline N.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Baldwin, Clinton T.; Steinberg, Martin H.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [DeBaun, Michael] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Johns Hopkins University; Johns Hopkins University; Centers for Disease Control & Prevention - USA; Boston University; Boston University; Vanderbilt University	Casella, JF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA.	jcasella@jhmi.edu; arking@jhmi.edu		Bean, Christopher/0000-0001-7433-9769; Steinberg, Martin/0000-0001-8800-8020	National Heart, Lung and Blood Institute (NHLBI) [U54HL090515, 5R01HL091759]; National Institute of Neurological Disorders and Stroke (NINDS) [NIH-NINDS 5U01-NS042804-03];  [5T32 HL007501];  [R01 HL 87681];  [R01 068970];  [RC2 HL 101212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101212, U54HL090515, T32HL007501, R01HL091759, R01HL087681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS042804] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) (Award Number: U54HL090515, 5R01HL091759) and the National Institute of Neurological Disorders and Stroke (NINDS) (NIH-NINDS 5U01-NS042804-03). This work was also supported by 5T32 HL007501 (J.N.M.) and R01 HL 87681, R01 068970 and RC2 HL 101212 (M. H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Armando I, 2007, HYPERTENSION, V49, P672, DOI 10.1161/01.HYP.0000254486.00883.3d; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; BALFOUR IC, 1988, AM J CARDIOL, V61, P395, DOI 10.1016/0002-9149(88)90952-6; Ballas SK, 2010, AM J HEMATOL, V85, P6, DOI 10.1002/ajh.21550; Bernaudin F, 2011, BLOOD, V117, P1130, DOI 10.1182/blood-2010-06-293514; Casella JF, 2010, PEDIATR HEMAT ONCOL, V27, P69, DOI 10.3109/08880010903360367; CORNONIHUNTLEY J, 1989, ARCH INTERN MED, V149, P780, DOI 10.1001/archinte.149.4.780; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; DEJONG PE, 1982, ARCH INTERN MED, V142, P1239, DOI 10.1001/archinte.142.6.1239; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Driss A, 2009, GENOM INSIGHTS, V2, P23; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franklin SS, 1997, CIRCULATION, V96, P308; GASTON M, 1982, AM J PEDIAT HEMATOL, V4, P197; GRELL GAC, 1981, LANCET, V2, P1166; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; HATCH FE, 1989, AM J HYPERTENS, V2, P2, DOI 10.1093/ajh/2.1.2; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; HOMI J, 1993, ARCH INTERN MED, V153, P1233, DOI 10.1001/archinte.153.10.1233; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; JOHNSON CS, 1981, ARCH INTERN MED, V141, P891, DOI 10.1001/archinte.141.7.891; Jose PA, 2003, NEPHRON PHYSIOL, V95, P19, DOI DOI 10.1159/000073676; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kwiatkowski JL, 2009, BRIT J HAEMATOL, V146, P300, DOI 10.1111/j.1365-2141.2009.07753.x; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moser FG, 1996, AM J NEURORADIOL, V17, P965; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RODGERS GP, 1993, AM J MED SCI, V305, P150, DOI 10.1097/00000441-199303000-00004; Safar ME, 2008, J HYPERTENS, V26, P1903, DOI 10.1097/HJH.0b013e32830b8937; San M., 2011, INT J ANGIOL, V7, P185, DOI [10.1007/BF01617389, DOI 10.1007/BF01617389.PUBMED:9585446]; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; STAMLER J, 1976, JAMA-J AM MED ASSOC, V235, P2299, DOI 10.1001/jama.235.21.2299; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; TROY BL, 1972, CIRCULATION, V45, P602, DOI 10.1161/01.CIR.45.3.602; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725; 1977, JAMA-J AM MED ASSOC, V237, P2385, DOI DOI 10.1001/JAMA.237.22.2385	51	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74193	10.1371/journal.pone.0074193	http://dx.doi.org/10.1371/journal.pone.0074193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058526	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400054
J	Karachaliou, N; Papadaki, C; Lagoudaki, E; Trypaki, M; Sfakianaki, M; Koutsopoulos, A; Mavroudis, D; Stathopoulos, E; Georgoulias, V; Souglakos, J				Karachaliou, Niki; Papadaki, Chara; Lagoudaki, Eleni; Trypaki, Maria; Sfakianaki, Maria; Koutsopoulos, Anastasios; Mavroudis, Dimitris; Stathopoulos, Efstathios; Georgoulias, Vassilis; Souglakos, John			Predictive Value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPO-IIA, TOPOIIB and C-MYC Genes in Patients with Small Cell Lung Cancer (SCLC) Who Received First Line Therapy with Cisplatin and Etoposide	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PYRUVATE-KINASE; EXCISION-REPAIR; CHEMOTHERAPY; RESISTANCE; CARCINOMA; ALPHA; SENSITIVITY; MECHANISM; PROTEIN	Background: The aim of the study was to evaluate the predictive value of genes involved in the action of cisplatin-etoposide in Small Cell Lung Cancer (SCLC). Methods: 184 SCLC patients' primary tumour samples were analyzed for ERCCI, BRCA1, ATP7B, PKM2 TOPOI, TOPOIIA, TOPOIIB and C-MYC mRNA expression. All patients were treated with cisplatin-etoposide. Results: The patients' median age was 63 years and 120 (65%) had extended stage, 75 (41%) had increased LDH serum levels and 131 (71%) an ECOG performance status was 0-1. Patients with limited stage, whose tumours expressed high ERCC1 (p=0.028), PKM2 (p=0.046), TOPOI (p=0.008), TOPOIIA (p=0.002) and TOPOIIB (p<0.001) mRNA had a shorter Progression Free Survival (PFS). In limited stage patients, high expression of ERCC1 (p=0.014), PKM2 (p=0.026), TOPOIIA (p=0.021) and TOPOIIB (p=0.019) was correlated with decreased median overall survival (mOS) while in patients with extended stage, only high TOPOIIB expression had a negative impact on Os (p=0.035). The favorable expression signature expression signature (low expression of ERCC1, PKM2, TOPOIIA and TOPOIIB) was correlated with significantly better PFS and Os in both LS-SCLC (p<0.001 and p=0.007, respectively) and ES-SCLC (p=0.007 and (p=0.011, respectively) group. The unfavorable expression signature was an independent predictor for poor PFS (HR: 3.18; p=0.002 and HR: 3.14; p=0.021) and Os (HR: 4.35; p=0.001 and HR: 3.32; p=0.019) in both limited and extended stage, respectively. Conclusions: Single gene's expression analysis as well as the integrated analysis of ERCC1, PKM2, TOPOIIA and TOPOIIB may predict treatment outcome in patients with SCLC. These findings should be further validated in a prospective study.	[Karachaliou, Niki; Papadaki, Chara; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Lab Tumour Cell Biol, Iraklion, Crete, Greece; [Karachaliou, Niki; Trypaki, Maria; Sfakianaki, Maria; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Lagoudaki, Eleni; Koutsopoulos, Anastasios; Stathopoulos, Efstathios] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Souglakos, J (corresponding author), Univ Crete, Sch Med, Lab Tumour Cell Biol, Iraklion, Crete, Greece.	georgsec@med.uoc.gr	Koutsopoulos, Anastasios/AAO-9498-2020	Koutsopoulos, Anastasios/0000-0002-8430-7565; PAPADAKI, CHARA/0000-0002-4591-3757	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO); HeSMO fellowship	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO); HeSMO fellowship	This study was partially supported by grants from the Cretan Association for Biomedical Research (CABR) and the Hellenic Society of Medical Oncology (HeSMO). NK is a recipient of a HeSMO fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amarasena IU, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006849.pub2; Bepler G, 2005, LUNG CANCER-J IASLC, V50, pS13, DOI 10.1016/S0169-5002(05)81553-3; Bonanno L, 2011, DRUGS, V71, P2231, DOI 10.2165/11597700-000000000-00000; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Ceppi P, 2008, J THORAC ONCOL, V3, P583, DOI 10.1097/JTO.0b013e3181734f24; Chiappori AA, 2010, J THORAC ONCOL, V5, P484, DOI 10.1097/JTO.0b013e3181ccb27b; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Dingemans AMC, 1999, CLIN CANCER RES, V5, P2048; Furuta T, 2002, CANCER RES, V62, P4899; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Guinee DG, 1996, CANCER, V78, P729; Guo WH, 2011, J CANCER RES CLIN, V137, P65, DOI 10.1007/s00432-010-0860-5; HUSAIN I, 1994, CANCER RES, V54, P539; Janne PA, 2002, CANCER-AM CANCER SOC, V95, P1528, DOI 10.1002/cncr.10841; JOHNSON BE, 1988, CANCER RES, V48, P5163; KAUFMANN SH, 1994, BLOOD, V83, P517; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Lawson MH, 2011, CANCER RES, V71, P4877, DOI 10.1158/0008-5472.CAN-11-0080; Lee HW, 2008, LUNG CANCER, V59, P95, DOI 10.1016/j.lungcan.2007.07.023; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Martinez-Balibrea E, 2009, MOL CANCER THER, V8, P771, DOI 10.1158/1535-7163.MCT-08-0882; Metro G, 2012, EXPERT OPIN EMERG DR, V17, P31, DOI 10.1517/14728214.2012.656588; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Nakagawa T, 2008, ONCOL REP, V20, P265, DOI 10.3892/or_00000002; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Papadaki C, 2011, BRIT J CANCER, V104, P316, DOI 10.1038/sj.bjc.6606027; PAPADAKI C, 2009, IMP C RT; Papadaki C, 2012, J THORAC ONCOL, V7, P663, DOI 10.1097/JTO.0b013e318244bdd4; PRINS J, 1993, ANTICANCER RES, V13, P1373; Sereno M, 2012, INT J ONCOL, V40, P2104, DOI 10.3892/ijo.2012.1378; Surowiak P, 2006, HISTOL HISTOPATHOL, V21, P713, DOI 10.14670/HH-21.713; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Viktorsson K, 2005, BIOCHEM BIOPH RES CO, V331, P868, DOI 10.1016/j.bbrc.2005.03.192; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V	38	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74611	10.1371/journal.pone.0074611	http://dx.doi.org/10.1371/journal.pone.0074611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058603	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400088
J	Pinto, PR; McIntyre, T; Ferrero, R; Almeida, A; Araujo-Soares, V				Pinto, Patricia R.; McIntyre, Teresa; Ferrero, Ramon; Almeida, Armando; Araujo-Soares, Vera			Risk Factors for Moderate and Severe Persistent Pain in Patients Undergoing Total Knee and Hip Arthroplasty: A Prospective Predictive Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; COMMON-SENSE MODEL; POSTSURGICAL PAIN; ILLNESS PERCEPTIONS; POSTOPERATIVE PAIN; UNITED-STATES; PRIMARY-CARE; REPLACEMENT; SURGERY; OSTEOARTHRITIS	Persistent post-surgical pain (PPSP) is a major clinical problem with significant individual, social and health care costs. The aim of this study was to examine the joint role of demographic, clinical and psychological risk factors in the development of moderate and severe PPSP after Total Knee and Hip Arthroplasty (TKA and THA, respectively). This was a prospective study wherein a consecutive sample of 92 patients were assessed 24 hours before (T1), 48 hours after (T2) and 4-6 months (T3) after surgery. Hierarchical logistic regression analyses were performed to identify predictors of moderate and severe levels of PPSP. Four to six months after TKA and THA, 54 patients (58.7%) reported none or mild pain (Numerical Rating Scale: NRS <= 3), whereas 38 (41.3%) reported moderate to severe pain (NRS > 3). In the final multivariate hierarchical logistic regression analyses, illness representations concerning the condition leading to surgery (osteoarthritis), such as a chronic timeline perception of the disease, emerged as a significant predictor of PPSP. Additionally, post-surgical anxiety also showed a predictive role in the development of PPSP. Pre-surgical pain was the most significant clinical predictive factor and, as expected, undergoing TKA was associated with greater odds of PPSP development than THA. The findings on PPSP predictors after major joint arthroplasties can guide clinical practice in terms of considering cognitive and emotional factors, together with clinical factors, in planning acute pain management before and after surgery.	[Pinto, Patricia R.; Almeida, Armando] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Pinto, Patricia R.; Almeida, Armando] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Pinto, Patricia R.; Araujo-Soares, Vera] Newcastle Univ, Hlth Psychol Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McIntyre, Teresa] Univ Houston, TIMES, Houston, TX USA; [McIntyre, Teresa] Univ Houston, Dept Psychol, Houston, TX USA; [Ferrero, Ramon] Alto Ave Hosp Ctr, Orthoped Unit, Guimaraes, Portugal; [Araujo-Soares, Vera] Newcastle Univ, Fac Med Sci, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Universidade do Minho; Newcastle University - UK; University of Houston System; University of Houston; University of Houston System; University of Houston; Newcastle University - UK	Araujo-Soares, V (corresponding author), Newcastle Univ, Hlth Psychol Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	vera.araujo-soares@ncl.ac.uk	Araujo-Soares, Vera/ABF-8144-2021; Pinto, Patrícia J R/AAA-6721-2020; Almeida, Armando/H-5122-2011; Araujo-Soares, Vera/F-1806-2015	Araujo-Soares, Vera/0000-0003-4044-2527; Pinto, Patrícia J R/0000-0003-3428-5801; Almeida, Armando/0000-0002-6233-4693; Araujo-Soares, Vera/0000-0003-4044-2527; McIntyre, Teresa/0000-0002-0746-0830	Portuguese Foundation of Science and Technology [SFRH/BD/36368/2007]; COMPETE; FEDER;  [PTDC/SAU-NEU/108557/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/108557/2008] Funding Source: FCT	Portuguese Foundation of Science and Technology(Portuguese Foundation for Science and Technology); COMPETE; FEDER(European Commission); ; Fundação para a Ciência e a Tecnologia	This work was supported by a Project grant (PTDC/SAU-NEU/108557/2008) and by a PhD grant (SFRH/BD/36368/2007) from the Portuguese Foundation of Science and Technology, COMPETE and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bisgaard T, 2005, SCAND J GASTROENTERO, V40, P1358, DOI 10.1080/00365520510023675; Bodian CA, 2001, ANESTHESIOLOGY, V95, P1356, DOI 10.1097/00000542-200112000-00013; Botha-Scheepers S, 2008, OSTEOARTHR CARTILAGE, V14, P1104; Brander VA, 2003, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000092983.12414.e9; Brander V, 2007, CLIN ORTHOP RELAT R, P21, DOI 10.1097/BLO.0b013e318126c032; Brandsborg B, 2007, ANESTHESIOLOGY, V106, P1003, DOI 10.1097/01.anes.0000265161.39932.e8; Bruehl S, 2004, PAIN: PSYCHOLOGICAL PERSPECTIVES, P245; Buvanendran A, 2010, ANESTH ANALG, V110, P199, DOI 10.1213/ANE.0b013e3181c4273a; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dihle A, 2006, CLIN J PAIN, V22, P617, DOI 10.1097/01.ajp.0000210905.57546.c1; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Ebrahimpour PB, 2011, J ARTHROPLASTY, V26, P133, DOI 10.1016/j.arth.2011.04.011; Eisenach JC, 2008, PAIN, V140, P87, DOI 10.1016/j.pain.2008.07.011; Faller H, 2003, GEN HOSP PSYCHIAT, V25, P372, DOI 10.1016/S0163-8343(03)00062-8; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Forsythe ME, 2008, PAIN RES MANAG, V13, P335, DOI 10.1155/2008/730951; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; Frostholm L, 2007, J PSYCHOSOM RES, V62, P129, DOI 10.1016/j.jpsychores.2006.09.003; Gerbershagen HJ, 2009, EUR J PAIN, V13, P1054, DOI 10.1016/j.ejpain.2008.11.020; Gerbershagen HJ, 2009, EUR J PAIN, V13, P853, DOI 10.1016/j.ejpain.2008.10.001; Goncalves L, 2008, EXP NEUROL, V213, P48, DOI 10.1016/j.expneurol.2008.04.043; GRAVER V, 1995, J PSYCHOSOM RES, V39, P465, DOI 10.1016/0022-3999(94)00148-X; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hamel MB, 2008, ARCH INTERN MED, V168, P1430, DOI 10.1001/archinte.168.13.1430; Hanley MA, 2007, J PAIN, V8, P102, DOI 10.1016/j.jpain.2006.06.004; Hartrick Craig T, 2003, Pain Pract, V3, P310; Haythornthwaite JA, 1998, J UROLOGY, V160, P1761, DOI 10.1016/S0022-5347(01)62400-5; Hermele Sandy, 2007, Psychol Health Med, V12, P580, DOI 10.1080/13548500601162705; Hudak PL, 2002, MED DECIS MAKING, V22, P272, DOI 10.1177/02789X02022003009; Johnston Marie, 1993, Annals of Behavioral Medicine, V15, P245; Jones CA, 2000, J RHEUMATOL, V27, P1745; Jones CA, 2003, PHYS THER, V83, P696, DOI 10.1093/ptj/83.8.696; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2010, ANESTHESIOLOGY, V112, P514, DOI 10.1097/ALN.0b013e3181cf423d; Kosek E, 2000, EUR J PAIN, V4, P229, DOI 10.1053/eujp.2000.0175; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Leventhal H, 1991, MENTAL REPRESENTATIO, P247, DOI DOI 10.1007/978-1-4613-9074-9_11; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Linsell L, 2006, J PUBLIC HEALTH-UK, V28, P267, DOI 10.1093/pubmed/fdl020; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Lundblad H, 2008, J BONE JOINT SURG BR, V90B, P166, DOI 10.1302/0301-620X.90B2.19640; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; McCarthy SC, 2003, PSYCHOL HEALTH, V18, P109, DOI 10.1080/0887044031000080674; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Moss-Morris R, 2007, CLIN J PAIN, V23, P558, DOI 10.1097/AJP.0b013e318093fcab; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Nikolajsen L, 2006, ACTA ANAESTH SCAND, V50, P495, DOI 10.1111/j.1399-6576.2006.00976.x; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; Nilsdotter AK, 2001, ANN RHEUM DIS, V60, P228, DOI 10.1136/ard.60.3.228; ODRISCOLL SL, 1974, BMJ-BRIT MED J, V3, P714, DOI 10.1136/bmj.3.5933.714; Orbell S, 1998, SOC SCI MED, V47, P93, DOI 10.1016/S0277-9536(97)10132-0; Perkins F, 2003, TECH REG ANESTH PAIN, V7, P122; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Petrie KJ, 1996, BRIT MED J, V312, P1191; Pinto PR, 2013, J PAIN, V14, P502, DOI 10.1016/j.jpain.2012.12.020; Pinto PR, 2012, J PAIN, V13, P1045, DOI 10.1016/j.jpain.2012.07.014; Pinto-Ribeiro F, 2008, BRAIN RES, V1197, P63, DOI 10.1016/j.brainres.2007.12.038; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Puolakka PAE, 2010, EUR J ANAESTH, V27, P455, DOI 10.1097/EJA.0b013e328335b31c; Riley JL, 1997, CLIN J PAIN, V13, P156, DOI 10.1097/00002508-199706000-00010; Rolfson O, 2009, J BONE JOINT SURG BR, V91B, P157, DOI 10.1302/0301-620X.91B2.20765; Rozema H, 2009, PSYCHO-ONCOLOGY, V18, P849, DOI 10.1002/pon.1488; Salmon P, 2001, ARCH PHYS MED REHAB, V82, P360, DOI 10.1053/apmr.2001.21522; Schaible HG, 2006, ANN NY ACAD SCI, V966, P343; Scharloo M, 2005, HEAD NECK-J SCI SPEC, V27, P857, DOI 10.1002/hed.20251; Singh JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-90; Sjoling M, 2003, PATIENT EDUC COUNS, V51, P169, DOI 10.1016/S0738-3991(02)00191-X; Sniehotta FF, 2010, PSYCHOL HEALTH, V25, P839, DOI 10.1080/08870440902915915; Stoddard JA, 2005, J CLIN PSYCHOL MED S, V12, P99, DOI 10.1007/s10880-005-3269-6; Sullivan M, 2011, PAIN, V152, P2287, DOI 10.1016/j.pain.2011.06.014; Vaughan R, 2003, BRIT J HEALTH PSYCH, V8, P287, DOI 10.1348/135910703322370860; Vissers MM, 2012, SEMIN ARTHRITIS RHEU, V41, P576, DOI 10.1016/j.semarthrit.2011.07.003; Vuorenmaa M, 2008, J REHABIL MED, V40, P570, DOI 10.2340/16501977-0213; WATSONJONES R, 1956, J BONE JOINT SURG BR, V38, P353, DOI 10.1302/0301-620X.38B1.353; Wylde V, 2007, KNEE, V14, P417, DOI 10.1016/j.knee.2007.06.001; Wylde V, 2011, PAIN, V152, P566, DOI 10.1016/j.pain.2010.11.023; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	76	78	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73917	10.1371/journal.pone.0073917	http://dx.doi.org/10.1371/journal.pone.0073917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058502	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400042
J	Waldmann, A; Schubert, D; Katalinic, A				Waldmann, Annika; Schubert, Daniel; Katalinic, Alexander			Normative Data of the EORTC QLQ-C30 For the German Population: A Population-Based Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; CANCER; HEALTH; QUESTIONNAIRE; AGE	Aim: The aim of the present study was to generate up-to-date normative data for health-related quality of life (QoL) measured with the "European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30)" in a random sample of the population in Northern Germany. Methods: We conducted a population-based survey of a random sample of 10,000 persons aged 16 years or older. The postal questionnaire included questions regarding lifetime prevalence of common diseases and quality of life. EORTC QLQ-C30 scales were scored according to standard procedures. The results were stratified for age and sex. Results: The questionnaire was completed by 4,684 (47%) of 9,928 eligible persons. Mean age of the participants was 51.7 years (standard deviation: 18.5) and 57% were females. Missing values for the EORTC QLQ-C30 scales and items were sparse (minimum: 0.2%, maximum: 1.5%). Self-reported health related QoL varied by age and sex. Generally, men reported better functioning and fewer symptoms than women. In both sexes function declined and symptoms increased with increasing age. Symptoms most frequently reported were fatigue, pain and insomnia. Compared to the German reference data published in 2001 our participants scored more than 10 points higher on the latter three scales/items. The most frequently reported diseases were hypertension (36%), hyperlipidemia (26%) and arthritis (30%). Lifetime prevalence of depression was 16% in women and 11% in men. Conclusion: Our study participants are representative for the German general population with regard to age, sex and education. Of special interest is the high proportion of participants reporting depression which is also mirrored by high fatigue, pain and insomnia scores. The normative data provided should be used as comparison health-related QoL data when evaluating the QoL in German cancer patients.	[Waldmann, Annika; Schubert, Daniel; Katalinic, Alexander] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Katalinic, Alexander] Univ Lubeck, Inst Canc Epidemiol, Lubeck, Germany	University of Lubeck; University of Lubeck	Waldmann, A (corresponding author), Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany.	Annika.Waldmann@uksh.de	Waldmann, Annika/A-2700-2016; Katalinic, Alexander/D-2512-2010	Waldmann, Annika/0000-0002-5909-9936; Katalinic, Alexander/0000-0003-0490-1554	Druckerei Radtke; Luebeck	Druckerei Radtke; Luebeck	We thank Druckerei Radtke, Luebeck, for supporting our study by bearing the printing costs for our questionnaires [ http://www.radtke-druck.de/, last accessed: 09th March 2013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bundesagentur fur Arbeit, 2013, STAT NACH REG BUND L; Creavin ST, 2010, EUR J PAIN, V14, P327, DOI 10.1016/j.ejpain.2009.05.010; Derogar M, 2012, ACTA ONCOL, V51, P10, DOI 10.3109/0284186X.2011.614636; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fayers PM, 2001, EUR J CANCER, V37, P1331, DOI 10.1016/S0959-8049(01)00127-7; Federal Health Monitoring [Gesundheitsberichterstattung des Bundes], 2013, INF SYST FED HLTH MO; Fuchs J, 2012, KRANKHEITSPRAVALENZE, P576; GEKID, 2013, INT ATL INZ MORT; Hansestadt Luebeck, 2012, STAT JB 2011; Hjermstad MJ, 1998, EUR J CANCER, V34, P1381, DOI 10.1016/S0959-8049(98)00136-1; Koch-Institut Robert, 2009, ROB KOCH I BEITR GES; Kopp I, 2004, INFLAMM RES, V53, pS130, DOI 10.1007/s00011-004-0361-6; Kurth BM, 2012, BUNDESGESUNDHEITSBLA, V55, P980, DOI 10.1007/s00103-012-1504-5; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Quality EORTCof Life Group, 2013, QUAL LIF GROUP QLQ C; RKI GEKID, 2012, KREBS DEUTSCHL 2007; Robert Koch-Institut, 2013, ROB KOCH I BEITR GES, P93; Schwarz R, 2001, EUR J CANCER, V37, P1345, DOI 10.1016/S0959-8049(00)00447-0; Scott NW, 2007, QUAL LIFE RES, V16, P115, DOI 10.1007/s11136-006-9120-1; Statistische Aemter des Bundes und der Lander, 2013, ARM; Stifterverband fur die Deutsche Wissenschaft e.V, 2013, STADT WISS; Stifterverband fur die Deutsche Wissenschaft e.V, 2013, STIFT DTSCH WISS; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P667, DOI 10.1016/j.ejca.2010.11.004; Wong WS, 2012, J PSYCHOSOM RES, V73, P28, DOI 10.1016/j.jpsychores.2012.04.011; Yun YH, 2007, J CLIN EPIDEMIOL, V60, P1164, DOI 10.1016/j.jclinepi.2006.12.014	26	54	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74149	10.1371/journal.pone.0074149	http://dx.doi.org/10.1371/journal.pone.0074149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058523	gold, Green Published, Green Submitted			2022-12-27	WOS:000327538600073
J	Babayan, A; Hannemann, J; Spotter, J; Muller, V; Pantel, K; Joosse, SA				Babayan, Anna; Hannemann, Juliane; Spoetter, Julia; Mueller, Volkmar; Pantel, Klaus; Joosse, Simon A.			Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; ENDOCRINE RESISTANCE; PROGNOSTIC VALUE; ER; MECHANISMS; SUBTYPES; PROGRESSION; MUTATIONS; PATHWAYS; THERAPY	Background: Endocrine treatment is the most preferable systemic treatment in metastatic breast cancer patients that have had an estrogen receptor (ER) positive primary tumor or metastatic lesions, however, approximately 20% of these patients do not benefit from the therapy and demonstrate further metastatic progress. One reason for failure of endocrine therapy might be the heterogeneity of ER expression in tumor cells spreading from the primary tumor to distant sites which is reflected in detectable circulating tumor cells (CTCs). Methods: A sensitive and specific staining protocol for ER, keratin 8/18/19, CD45 was established. Peripheral blood from 35 metastatic breast cancer patients with ER-positive primary tumors was tested for the presence of CTCs. Keratin 8/18/19 and DAPI positive but CD45 negative cells were classified as CTCs and evaluated for ER staining. Subsequently, eight individual CTCs from four index patients (2 CTCs per patient) were isolated and underwent whole genome amplification and ESR1 gene mutation analysis. Results: CTCs were detected in blood of 16 from 35 analyzed patients (46%), with a median of 3 CTCs/7.5 ml. In total, ER-negative CTCs were detected in 11/16 (69%) of the CTC positive cases, including blood samples with only ER-negative CTCs (19%) and samples with both ER-positive and ER-negative CTCs (50%). No correlation was found between the intensity and/or percentage of ER staining in the primary tumor with the number and ER status of CTCs of the same patient. ESR1 gene mutations were not found. Conclusion: CTCs frequently lack ER expression in metastatic breast cancer patients with ER-positive primary tumors and show a considerable intra-patient heterogeneity, which may reflect a mechanism to escape endocrine therapy. Provided single cell analysis did not support a role of ESR1 mutations in this process.	[Babayan, Anna; Hannemann, Juliane; Spoetter, Julia; Pantel, Klaus; Joosse, Simon A.] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Mueller, Volkmar] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pantel, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	pantel@uke.de; s.joosse@uke.de	Joosse, Simon/ABC-2470-2020	Joosse, Simon/0000-0002-4296-5615	Roggenbuck-Stiftung; ERC [ERC-2010-AdG_2010317, 269081]; BMBF [01ES0724]; Research Promotion Fund of the Medical Faculty UKE	Roggenbuck-Stiftung; ERC(European Research Council (ERC)European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); Research Promotion Fund of the Medical Faculty UKE	This research was supported by the Roggenbuck-Stiftung. KP was supported by ERC advanced investigator grant: ERC-2010-AdG_2010317, grant agreement number 269081, DISSECT; and BMBF grant 01ES0724, Metfinder. SJ was supported by the Research Promotion Fund of the Medical Faculty UKE (FFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aktas B, 2011, GYNECOL ONCOL, V122, P356, DOI 10.1016/j.ygyno.2011.04.039; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Bock C, 2012, TRANSL ONCOL, V5, P475, DOI 10.1593/tlo.12310; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Cardoso F, 2011, ANN ONCOL, V22, pvi25, DOI 10.1093/annonc/mdr372; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; CURTIT E, 2013, ONCOLOGIST THEONCOLO, DOI DOI 10.1634/THE0NC0L0GIST.2012-0350; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Esserman LJ, 2005, BREAST CANCER RES, V7, pR1153, DOI 10.1186/bcr1342; Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082; Fehm T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2349; Fehm T, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1869; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hannemann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026362; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Ignatiadis M, 2007, J CLIN ONCOL, V25, P5194, DOI 10.1200/JCO.2007.11.7762; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Joosse SA, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3181-c2; KARNIK PS, 1994, CANCER RES, V54, P349; Kohlberger PD, 1999, ANTICANCER RES, V19, P2189; Kurbel S, 2005, MED HYPOTHESES, V64, P1182, DOI 10.1016/j.mehy.2004.09.026; Lianidou ES, 2011, CLIN CHEM, V57, P1242, DOI 10.1373/clinchem.2011.165068; Ligthart ST, 2013, ANN ONCOL, V24, P1231, DOI 10.1093/annonc/mds625; Loi S, 2008, EUR J CANCER, V44, P2813, DOI 10.1016/j.ejca.2008.09.012; Lonning PE, 2013, ENDOCR-RELAT CANCER, V20, pR183, DOI 10.1530/ERC-13-0099; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; MCCARTY KS, 1986, CANCER RES, V46, P4244; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nadal R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3180; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Rack Brigitte, 2012, Recent Results Cancer Res, V195, P179, DOI 10.1007/978-3-642-28160-0_16; REMMELE W, 1987, PATHOLOGE, V8, P138; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Swaby RF, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-43; Tewes M, 2009, BREAST CANCER RES TR, V115, P581, DOI 10.1007/s10549-008-0143-x; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van de Ven S, 2011, CANCER TREAT REV, V37, P422, DOI 10.1016/j.ctrv.2010.11.006; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587	54	104	108	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75038	10.1371/journal.pone.0075038	http://dx.doi.org/10.1371/journal.pone.0075038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058649	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900091
J	Gao, YZ; Giese, M; Gao, Q; Brueck, H; Sheng, LX; Yang, HJ				Gao, Ying Z.; Giese, Marcus; Gao, Qiang; Brueck, Holger; Sheng, Lian X.; Yang, Hai J.			Community Level Offset of Rain Use- and Transpiration Efficiency for a Heavily Grazed Ecosystem in Inner Mongolia Grassland	PLOS ONE			English	Article							WATER-USE-EFFICIENCY; SEMIARID STEPPE; CLEISTOGENES-SQUARROSA; SPECIES-DIVERSITY; LOCAL SCALE; LAND-USE; PRODUCTIVITY; GROWTH; DEGRADATION; DEFOLIATION	Water use efficiency (WUE) is a key indicator to assess ecosystem adaptation to water stress. Rain use efficiency (RUE) is usually used as a proxy for WUE due to lack of transpiration data. Furthermore, RUE based on aboveground primary productivity (RUEANPP) is used to evaluate whole plant water use because root production data is often missing as well. However, it is controversial as to whether RUE is a reliable parameter to elucidate transpiration efficiency (TE), and whether RUEANPP is a suitable proxy for RUE of the whole plant basis. The experiment was conducted at three differently managed sites in the Inner Mongolia steppe: a site fenced since 1979 (UG79), a winter grazing site (WG) and a heavily grazed site (HG). Site HG had consistent lowest RUEANPP and RUE based on total net primary productivity (RUENPP). RUEANPP is a relatively good proxy at sites UG79 and WG, but less reliable for site HG. Similarly, RUEANPP is good predictor of transpiration efficiency based on aboveground net primary productivity (TEANPP) at sites UG79 and WG but not for site HG. However, if total net primary productivity is considered, RUENPP is good predictor of transpiration efficiency based on total net primary productivity (TENPP) for all sites. Although our measurements indicate decreased plant transpiration and consequentially decreasing RUE under heavy grazing, productivity was relatively compensated for with a higher TE. This offset between RUE and TE was even enhanced under water limited conditions and more evident when belowground net primary productivity (BNNP) was included. These findings suggest that BNPP should be considered when studies fucus on WUE of more intensively used grasslands. The consideration of the whole plant perspective and "real" WUE would partially revise our picture of system performance and therefore might affect the discussion on the C-sequestration and resilience potential of ecosystems.	[Gao, Ying Z.; Yang, Hai J.] NE Normal Univ, Key Lab Vegetat Ecol, Changchun, Jilin, Peoples R China; [Gao, Ying Z.; Giese, Marcus; Brueck, Holger] Univ Hohenheim, Inst Crop Prod & Agroecol Trop & Subtrop, Stuttgart, Baden Wurttembe, Germany; [Gao, Qiang] Jilin Agr Univ, Coll Resources & Environm, Changchun, Jilin, Peoples R China; [Sheng, Lian X.] NE Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Jilin, Peoples R China	Northeast Normal University - China; University Hohenheim; Jilin Agricultural University; Northeast Normal University - China	Yang, HJ (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Changchun, Jilin, Peoples R China.	Yang@nenu.edu.cn			National Natural Science Foundation of China (NSFC) [31270444, 30970509]; National Program on Key Basic Research Project [2012CB722202]; Deutsche Forschungsgemeinschaft (DFG) [SA 359/30-1]; Jilin Province Science and Technology Development Plan [20125096]; GrassNet project; German Academic Exchange Service (DAAD)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project(National Basic Research Program of China); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Jilin Province Science and Technology Development Plan; GrassNet project; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the National Natural Science Foundation of China (NSFC, 31270444, 30970509), the National Program on Key Basic Research Project (2012CB722202) and the Deutsche Forschungsgemeinschaft (DFG, SA 359/30-1) and partially supported by the Jilin Province Science and Technology Development Plan (20125096). Furthermore, the authors would like to mention the support of the GrassNet project funded by the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 1994, GRASSLAND CHINA, V6, P21; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Biondini ME, 1998, ECOL APPL, V8, P469, DOI 10.1890/1051-0761(1998)008[0469:GIAEPI]2.0.CO;2; Brueck H, 2010, PLANT SOIL, V328, P495, DOI 10.1007/s11104-009-0128-5; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Chinese Academy of Sciences: Integrative expedition Team to Inner Monogolia and Ningxia, 1985, VEG INN MONG; Emmerich WE, 2007, RANGELAND ECOL MANAG, V60, P464, DOI 10.2111/1551-5028(2007)60[464:EWUEIA]2.0.CO;2; Feddes R. A., 1978, SIMULATION FIELD WAT; Gao YZ, 2009, ECOL RES, V24, P627, DOI 10.1007/s11284-008-0532-y; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YZ, 2007, J PLANT NUTR SOIL SC, V170, P115, DOI 10.1002/jpln.200625104; Gao YZ, 2011, OECOLOGIA, V165, P855, DOI 10.1007/s00442-010-1890-z; Giese M, 2013, ECOL MONOGR, V83, P195, DOI 10.1890/12-0114.1; Giese M, 2011, PLANT SOIL, V340, P157, DOI 10.1007/s11104-010-0509-9; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Katoh K, 1998, PLANT ECOL, V139, P133, DOI 10.1023/A:1009719604815; Krummelbein J, 2006, ADV GEOECOL, V38, P93; LEHOUEROU HN, 1984, J ARID ENVIRON, V7, P213; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Ludwig J., 1997, LANDSCAPE ECOLOGY FU; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; Miehe S, 2010, J APPL ECOL, V47, P692, DOI 10.1111/j.1365-2664.2010.01815.x; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; MILCHUNAS DG, 1994, J RANGE MANAGE, V47, P133, DOI 10.2307/4002821; Oesterheld M, 2001, J VEG SCI, V12, P137, DOI 10.1111/j.1654-1103.2001.tb02624.x; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; SALA OE, 1982, OECOLOGIA, V53, P301, DOI 10.1007/BF00389004; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Simunek J, 1998, IGWMCTPS70 COL SCH M; Snyman HA, 2005, J ARID ENVIRON, V60, P457, DOI 10.1016/j.jaridenv.2004.06.006; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; VANDERMAAREL E, 1989, OIKOS, V56, P364, DOI 10.2307/3565622; Varnamkhasti AS, 1995, J VEG SCI, V6, P787, DOI 10.2307/3236392; Wang SP, 2001, ACTA BOT SIN, V43, P413; Zhao Y, 2010, SOIL TILL RES, V109, P75, DOI 10.1016/j.still.2010.04.005; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x	42	4	7	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74841	10.1371/journal.pone.0074841	http://dx.doi.org/10.1371/journal.pone.0074841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058632	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900083
J	Kiss, A; Lucio, M; Fildier, A; Buisson, C; Schmitt-Kopplin, P; Cren-Olive, C				Kiss, Agneta; Lucio, Marianna; Fildier, Aurelie; Buisson, Corinne; Schmitt-Kopplin, Philippe; Cren-Olive, Cecile			Doping Control Using High and Ultra-High Resolution Mass Spectrometry Based Non-Targeted Metabolomics-A Case Study of Salbutamol and Budesonide Abuse	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; HUMAN URINE; MUSCLE STRENGTH; PERFORMANCE; EXERCISE; METABONOMICS; METABOLITES; AGONIST; HMDB; KEGG	We have detected differences in metabolite levels between doped athletes, clean athletes, and volunteers (non athletes). This outcome is obtained by comparing results of measurements from two analytical platforms: UHPLC-QTOF/MS and FT-ICR/MS. Twenty-seven urine samples tested positive for glucocorticoids or beta-2-agonists and twenty samples coming from volunteers and clean athletes were analyzed with the two different mass spectrometry approaches using both positive and negative electrospray ionization modes. Urine is a highly complex matrix containing thousands of metabolites having different chemical properties and a high dynamic range. We used multivariate analysis techniques to unravel this huge data set. Thus, the several groups we created were studied by Principal Components Analysis (PCA) and Partial Least Square regression (PLS-DA and OPLS) in the search of discriminating m/z values. The selected variables were annotated and placed on pathway by using MassTRIX.	[Kiss, Agneta; Fildier, Aurelie; Cren-Olive, Cecile] Inst Sci Analyt, UMR, EquipeTRACES, Villeurbanne, France; [Lucio, Marianna; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Buisson, Corinne] Agence Francaise Lutte Dopage, Dept Anal, Chatenay Malabry, France; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Cren-Olive, C (corresponding author), Inst Sci Analyt, UMR, EquipeTRACES, Villeurbanne, France.	c.cren@sca.cnrs.fr	Schmitt-Kopplin, Philippe/H-6271-2011	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098	Rhone-Alpes Regional Council for the PhD funding; Procope Program for the Franco-German collaboration; French Anti-Doping Agency	Rhone-Alpes Regional Council for the PhD funding; Procope Program for the Franco-German collaboration; French Anti-Doping Agency	The authors would like to thank the Rhone-Alpes Regional Council for the PhD funding, the Procope Program for the Franco-German collaboration, and the French Anti-Doping Agency for the urine samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anizan S, 2012, J MASS SPECTROM, V47, P131, DOI 10.1002/jms.2035; Badoud F, 2011, FORENSIC SCI INT, V213, P49, DOI 10.1016/j.forsciint.2011.07.024; Bastos ML, 1997, J VET PHARMACOL THER, V20, P33, DOI 10.1046/j.1365-2885.1997.00046.x; Boyard-Kieken F, 2011, J SEP SCI, V34, P3493, DOI 10.1002/jssc.201100223; Broad EM, 2011, INT J SPORT NUTR EXE, V21, P385, DOI 10.1123/ijsnem.21.5.385; BRYAN J, 2007, PHARM J, V279, P404; Burns SF, 2012, INT J SPORT NUTR EXE, V22, P47, DOI 10.1123/ijsnem.22.1.47; DELBARRIO AS, 1995, ANN NUTR METAB, V39, P317, DOI 10.1159/000177879; Deventer K, 2006, J PHARMACEUT BIOMED, V42, P474, DOI 10.1016/j.jpba.2006.05.016; Fonville JM, 2010, J CHEMOMETR, V24, P636, DOI 10.1002/cem.1359; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Gika HG, 2008, J CHROMATOGR A, V1189, P314, DOI 10.1016/j.chroma.2007.10.066; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kiss A, 2011, TALANTA, V83, P1769, DOI 10.1016/j.talanta.2010.10.030; Kohler M, 2010, PROTEOM CLIN APPL, V4, P568, DOI 10.1002/prca.200900209; Lucio M, 2010, HDB MOL MICROBIAL EC; Lucio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013317; Manach C, 2009, MOL NUTR FOOD RES, V53, P1303, DOI 10.1002/mnfr.200800516; MARTINEAU L, 1992, CLIN SCI, V83, P615, DOI 10.1042/cs0830615; McNiven EMS, 2011, J NUTR BIOCHEM, V22, P995, DOI 10.1016/j.jnutbio.2011.05.016; Nordstrom A, 2010, J NEUROIMMUNE PHARM, V5, P4, DOI 10.1007/s11481-009-9156-4; PAETSCH PR, 1991, J NEUROCHEM, V56, P2027, DOI 10.1111/j.1471-4159.1991.tb03462.x; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van Baak MA, 2000, MED SCI SPORT EXER, V32, P1300, DOI 10.1097/00005768-200007000-00018; Ventura R, 2000, THER DRUG MONIT, V22, P277, DOI 10.1097/00007691-200006000-00008; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Waterman DS, 2009, BIOANALYSIS, V1, P1559, DOI 10.4155/BIO.09.143; Wishart DS, 2008, DRUGS R&D, V9, P307, DOI 10.2165/00126839-200809050-00002; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Zhang J, 2012, J PHARMACEUT BIOMED, V66, P287, DOI 10.1016/j.jpba.2012.03.045	39	25	26	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74584	10.1371/journal.pone.0074584	http://dx.doi.org/10.1371/journal.pone.0074584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058591	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900059
J	MacRae, T; Sargeant, T; Lemieux, S; Hebert, J; Deneault, E; Sauvageau, G				MacRae, Tara; Sargeant, Tobias; Lemieux, Sebastien; Hebert, Josee; Deneault, Eric; Sauvageau, Guy			RNA-Seq Reveals Spliceosome and Proteasome Genes as Most Consistent Transcripts in Human Cancer Cells	PLOS ONE			English	Article							HUMAN ADULT; EXPRESSION; NORMALIZATION; SELECTION; PCR	Accurate quantification of gene expression by qRT-PCR relies on normalization against a consistently expressed control gene. However, control genes in common use often vary greatly between samples, especially in cancer. The advent of Next Generation Sequencing technology offers the possibility to better select control genes with the least cell to cell variability in steady state transcript levels. Here we analyze the transcriptomes of 55 leukemia samples to identify the most consistent genes. This list is enriched for components of the proteasome (ex. PSMA1) and spliceosome (ex. SF3B2), and also includes the translation initiation factor EIF4H, and many heterogeneous nuclear ribonucleoprotein genes (ex. HNRNPL). We have validated the consistency of our new control genes in 1933 cancer and normal tissues using publically available RNA-seq data, and their usefulness in qRT-PCR analysis is clearly demonstrated.	[MacRae, Tara; Sargeant, Tobias; Lemieux, Sebastien; Hebert, Josee; Deneault, Eric; Sauvageau, Guy] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Sargeant, Tobias] Univ Melbourne, Div Mol Med, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Sargeant, Tobias] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Lemieux, Sebastien] Univ Montreal, Dept Comp Sci & Operat Res, Montreal, PQ, Canada; [Hebert, Josee; Sauvageau, Guy] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Hebert, Josee; Sauvageau, Guy] Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H1T 2M4, Canada; [Hebert, Josee; Sauvageau, Guy] Hop Maison Neuve Rosemont, Leukemia Cell Bank Quebec, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	guy.sauvageau@umontreal.ca		Sargeant, Tobias/0000-0002-0909-7182; Sauvageau, Guy/0000-0002-4333-7266	Genome Quebec; Genome Canada; NHMRC [1016647]	Genome Quebec; Genome Canada(Genome Canada); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from Genome Quebec (http://www.genomequebec.com/en) and Genome Canada (http://www.genomecanada.ca) to GS, JH, SL and Brian Wilhelm. TS's work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. TS's research was supported by an NHMRC Program Grant (1016647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Smith RD, 2003, BIOTECHNIQUES, V34, P88, DOI 10.2144/03341st05; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016	23	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e72884	10.1371/journal.pone.0072884	http://dx.doi.org/10.1371/journal.pone.0072884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069164	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300004
J	Goldfarb, L; Levy, S				Goldfarb, Liat; Levy, Sharon			Counting within the Subitizing Range: The Effect of Number of Distractors on the Perception of Subset Items	PLOS ONE			English	Article							ATTENTION; OBJECTS; DISCRIMINATION; INTEGRATION; SEARCH	When exploring the mechanisms involved in perceiving numbers we must distinguish between two types of numbers: subset numbers (e.g., perceiving "2" when two plates and one cup are displayed on a table) and the total number of items (e.g., perceiving "3" objects in the previous example). Combining feature perception theories with number perception theories, the current paper explores the mechanisms involved in the perception of small numbers in feature-defined subsets. The paper introduces several theories for how subset items can be represented and examines an important prediction of those theories: Will the number of distractors affect the perception of small subset items? In two experiments, we found that the response time (RT) for counting small target items that differ from their distractors by a single feature was faster when there were few distractors compared to many distractors. This was found for different types of distractors: distractors within and outside the subitizing range. Only when distractors were organized in a specific pattern, allowing distractor grouping, the increase in the number of distractors did not affect target counting. The current study suggests that even when performing simple counting of subset targets, the enumeration process can begin only once the locations of the targets have been identified and the targets' shape is bound to these locations. This pre-counting procedure depends on the number of individual locations occupied by the distractors. These findings are further discussed within the context of the object file theory.	[Goldfarb, Liat; Levy, Sharon] Univ Haifa, Dept Learning Disabil, EJ Safra Brain Res Ctr Study Learning Disabil, IL-31999 Haifa, Israel	University of Haifa	Goldfarb, L (corresponding author), Univ Haifa, Dept Learning Disabil, EJ Safra Brain Res Ctr Study Learning Disabil, IL-31999 Haifa, Israel.	goldfarb@edu.haifa.ac.il						Beran MJ, 2007, J EXP PSYCHOL-ANIM B, V33, P42, DOI 10.1037/0097-7403.33.1.42; Burr DC, 2010, J VISION, V10, DOI 10.1167/10.6.20; Butterworth B., 1999, WHAT COUNTS EVERY BR; Egeth HE, 2008, VIS COGN, V16, P463, DOI 10.1080/13506280801937939; Feldman J, 1999, ACTA PSYCHOL, V102, P137, DOI 10.1016/S0001-6918(98)00054-7; Gilchrist ID, 1996, COGNITIVE NEUROPSYCH, V13, P1223, DOI 10.1080/026432996381737; Goldfarb L, 2013, SUBSET ENUMERATION L; Goldfarb L, 2013, PSYCHOL SCI, V24, P266, DOI 10.1177/0956797612459761; Goldfarb L, 2011, PSYCHON B REV, V18, P1042, DOI 10.3758/s13423-011-0135-4; Goldfarb L, 2011, PSYCHON B REV, V18, P877, DOI 10.3758/s13423-011-0123-8; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Huang L, 2007, SCIENCE, V317, P823, DOI 10.1126/science.1143515; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Olivers CNL, 2008, VIS COGN, V16, P439, DOI 10.1080/13506280701825861; Pepperberg IM, 2006, J COMP PSYCHOL, V120, P1, DOI 10.1037/0735-7036.120.1.1; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2003, P ROY SOC B-BIOL SCI, V270, P1237, DOI 10.1098/rspb.2003.2356; Poiese P, 2008, VIS COGN, V16, P474, DOI 10.1080/13506280801969676; ROCK I, 1990, SCI AM, V263, P84, DOI 10.1038/scientificamerican1290-84; Schleifer P, 2011, DEVELOPMENTAL SCI, V14, P280, DOI 10.1111/j.1467-7687.2010.00976.x; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; TRICK LM, 1993, J EXP PSYCHOL HUMAN, V19, P331, DOI 10.1037/0096-1523.19.2.331; Vetter P, 2011, J COGNITIVE NEUROSCI, V23, P728, DOI 10.1162/jocn.2010.21472; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Ward R., 1994, VIS COGN, V1, P101, DOI DOI 10.1080/13506289408402295; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	34	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74152	10.1371/journal.pone.0074152	http://dx.doi.org/10.1371/journal.pone.0074152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066111	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000093
J	Llera-Herrera, R; Garcia-Gasca, A; Abreu-Goodger, C; Huvet, A; Ibarra, AM				Llera-Herrera, Raul; Garcia-Gasca, Alejandra; Abreu-Goodger, Cei; Huvet, Arnaud; Ibarra, Ana M.			Identification of Male Gametogenesis Expressed Genes from the Scallop Nodipecten subnodosus by Suppressive Subtraction Hybridization and Pyrosequencing	PLOS ONE			English	Article							RNA-BINDING PROTEIN; OYSTER CRASSOSTREA-GIGAS; HERMAPHRODITE GERM-LINE; VENTRICOSUS SOWERBY II; EXON JUNCTION COMPLEX; SEX DETERMINATION; ARGOPECTEN-VENTRICOSUS; PACIFIC OYSTER; NEGATIVE CORRELATION; CHECKPOINT CONTROL	Despite the great advances in sequencing technologies, genomic and transcriptomic information for marine non-model species with ecological, evolutionary, and economical interest is still scarce. In this work we aimed to identify genes expressed during spermatogenesis in the functional hermaphrodite scallop Nodipecten subnodosus (Mollusca: Bivalvia: Pectinidae), with the purpose of obtaining a panel of genes that would allow for the study of differentially transcribed genes between diploid and triploid scallops in the context of meiotic arrest and reproductive sterility. Because our aim was to isolate genes involved in meiosis and other testis maturation-related processes, we generated suppressive subtractive hybridization libraries of testis vs. inactive gonad. We obtained 352 and 177 ESTs by clone sequencing, and using pyrosequencing (454-Roche) we maximized the identified ESTs to 34,276 reads. A total of 1,153 genes from the testis library had a blastx hit and GO annotation, including genes specific for meiosis, spermatogenesis, sex-differentiation, and transposable elements. Some of the identified meiosis genes function in chromosome pairing (scp2, scp3), recombination and DNA repair (dmc1, rad51, ccnb1ip1/hei10), and meiotic checkpoints (rad1, hormad1, dtl/cdt2). Gene expression analyses in different gametogenic stages in both sexual regions of the gonad of meiosis genes confirmed that the expression was specific or increased towards the maturing testis. Spermatogenesis genes included known testis-specific ones (kelch-10, shippo1, adad1), with some of these known to be associated to sterility. Sex differentiation genes included one of the most conserved genes at the bottom of the sex-determination cascade (dmrt1). Transcript from transposable elements, reverse transcriptase, and transposases in this library evidenced that transposition is an active process during spermatogenesis in N. subnodosus. In relation to the inactive library, we identified 833 transcripts with functional annotation related to activation of the transcription and translation machinery, as well as to germline control and maintenance.	[Llera-Herrera, Raul; Ibarra, Ana M.] Ctr Invest Biol Noroeste, Aquaculture Genet & Breeding Lab, La Paz, Baja California, Mexico; [Garcia-Gasca, Alejandra] Ctr Invest Alimentac & Desarrollo, Mazatlan, Sinaloa, Mexico; [Abreu-Goodger, Cei] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad Langebio, Guanajuato, Mexico; [Huvet, Arnaud] IFREMER, Ctr Bretagne, Lab Sci Environm Marin, Plouzane, France	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Ibarra, AM (corresponding author), Ctr Invest Biol Noroeste, Aquaculture Genet & Breeding Lab, La Paz, Baja California, Mexico.	aibarra@cibnor.mx	García-Gasca, Alejandra/A-5279-2013; Ibarra, Ana M/D-8616-2011; Abreu-Goodger, Cei/A-1268-2010	García-Gasca, Alejandra/0000-0002-4496-2434; Abreu-Goodger, Cei/0000-0001-8302-9893; Llera-Herrera, Raul/0000-0001-9873-9732; Huvet, Arnaud/0000-0001-6912-881X; Ibarra, Ana M/0000-0002-3003-2180	CIBNOR [AC0.16]; CONACyT [204031, 133388];  [CONACYT-CB-2011-1];  [166573]	CIBNOR; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ; 	This work was funded by CIBNOR (grant AC0.16) and CONACYT-CB-2011-1 (grant 166573). The first author is a Ph.D. student, financially supported by a CONACyT fellowship (number 204031). CAG wishes to thank CONACyT for a young investigator grant (number 133388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SK, 1986, BIOL BULL, V170, P198, DOI 10.2307/1541803; ALLEN SK, 1986, J EXP MAR BIOL ECOL, V102, P197, DOI 10.1016/0022-0981(86)90176-0; Arellano-Martinez M, 2004, J SHELLFISH RES, V23, P723; Arellano-Martinez M, 2011, AQUAC RES, V42, P571, DOI 10.1111/j.1365-2109.2010.02652.x; Bailis JM, 2000, MOL CELL BIOL, V20, P4838, DOI 10.1128/MCB.20.13.4838-4848.2000; Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Bao JQ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095463; de Carvalho GAB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-153; Beninger Peter G., 2006, Developments in Aquaculture and Fisheries Science, V35, P123; Bhandari RK, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099663; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Bui LC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-155; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao WX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-26; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Chauhan S, 2012, CELL MOL LIFE SCI, V69, P3835, DOI 10.1007/s00018-012-1050-1; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Chiba T, 2007, MAMM GENOME, V18, P105, DOI 10.1007/s00335-006-0119-2; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Connolly CM, 2005, DEV BIOL, V278, P13, DOI 10.1016/j.ydbio.2004.10.009; Cox ES, 1996, J EXP MAR BIOL ECOL, V197, P101, DOI 10.1016/0022-0981(95)00147-6; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; de Carvalho CE, 2002, BIOL REPROD, V66, P785, DOI 10.1095/biolreprod66.3.785; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Domagala Alina, 2004, Reprod Biol Endocrinol, V2, P11, DOI 10.1186/1477-7827-2-11; Du C, 1998, MOL CELL, V2, P741, DOI 10.1016/S1097-2765(00)80289-0; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo XM, 1997, GENOME, V40, P397, DOI 10.1139/g97-053; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Ibarra A., 2011, BIOL CULTIVO MOLUSCO, P135; Ibarra AM, 2006, MOL ECOL NOTES, V6, P153, DOI 10.1111/j.1471-8286.2005.01173.x; Ishibashi R, 2002, DEV BIOL, V244, P37, DOI 10.1006/dbio.2002.0590; IVANOV VA, 1991, EMBO J, V10, P2489, DOI 10.1002/j.1460-2075.1991.tb07788.x; Kawano T, 2004, MECH DEVELOP, V121, P27, DOI 10.1016/j.mod.2003.11.003; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; KOMARU A, 1988, AQUACULTURE, V69, P201, DOI 10.1016/0044-8486(88)90329-8; Lalli E, 2003, MOL ENDOCRINOL, V17, P1445, DOI 10.1210/me.2003-0159; Lalli E, 2003, J CELL SCI, V116, P441, DOI 10.1242/jcs.00249; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson MJ, 2008, GENE, V407, P54, DOI 10.1016/j.gene.2007.09.017; Lee MH, 2011, P NATL ACAD SCI USA, V108, P9125, DOI 10.1073/pnas.1106027108; Leelatanawit R, 2008, BMB REP, V41, P796, DOI 10.5483/BMBRep.2008.41.11.796; Leitao A, 2001, AQUACULTURE, V193, P39, DOI 10.1016/S0044-8486(00)00488-9; Li WQ, 2000, DEV BIOL, V218, P172, DOI 10.1006/dbio.1999.9593; Li WX, 2006, CELL RES, V16, P402, DOI 10.1038/sj.cr.7310052; Li XC, 2009, HEREDITY, V102, P24, DOI 10.1038/hdy.2008.84; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liang G, 2004, CELL RES, V14, P507, DOI 10.1038/sj.cr.7290254; Llera-Herrera R, 2012, MAR GENOM, V6, P33, DOI 10.1016/j.margen.2012.03.003; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Maldonado-Amparo R, 2004, AQUACULTURE, V235, P185, DOI 10.1016/j.aquaculture.2003.12.014; Maldonado-Amparo R, 2002, J SHELLFISH RES, V21, P597; Maldonado-Amparo R, 2002, J SHELLFISH RES, V21, P93; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; McAndrew CW, 2009, CELL CYCLE, V8, P66, DOI 10.4161/cc.8.1.7451; McDermott SR, 2010, PHILOS T R SOC B, V365, P1265, DOI 10.1098/rstb.2009.0264; McKee BD, 1996, CHROMOSOMA, V104, P479, DOI 10.1007/BF00352112; McKee Bruce D, 2012, Spermatogenesis, V2, P167; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Naisbit RE, 2002, GENETICS, V161, P1517; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Petersen J. E., 2009, P1; Petersen JL, 2012, AQUACULTURE, V350, P200, DOI 10.1016/j.aquaculture.2012.03.039; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto PIS, 2006, MOL REPROD DEV, V73, P318, DOI 10.1002/mrd.20402; Racotta IS, 2008, MAR BIOL, V153, P1245, DOI 10.1007/s00227-007-0897-4; Racotta IS, 2003, AQUACULTURE, V217, P335, DOI 10.1016/S0044-8486(02)00366-6; Radovic A, 2002, BIOCHEM BIOPH RES CO, V293, P1262, DOI 10.1016/S0006-291X(02)00366-2; Redon E, 2010, REPRODUCTION, V140, P57, DOI 10.1530/REP-10-0021; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Verdugo CA, 2000, AQUACULTURE, V186, P13, DOI 10.1016/S0044-8486(99)00369-5; Rupp GS, 2011, BIOL CULTIVO MOLUSCO, P27; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; SCHUMACHER JM, 1995, BIOL REPROD, V52, P1274, DOI 10.1095/biolreprod52.6.1274; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Sloan RS, 2012, FLY, V6, P173, DOI 10.4161/fly.20247; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Strong ER, 2010, GENES-BASEL, V1, P440, DOI 10.3390/genes1030440; Su HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040075; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Sun YY, 2010, J GENET GENOMICS, V37, P137, DOI 10.1016/S1673-8527(09)60032-1; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; Thiriot-Quievreux C, 2003, J MOLLUS STUD, V69, P187, DOI 10.1093/mollus/69.3.187; THIRIOTQUIEVREUX C, 1988, AQUACULTURE, V75, P89, DOI 10.1016/0044-8486(88)90023-3; Toulza E, 2010, APPL ENVIRON MICROB, V76, P4521, DOI 10.1128/AEM.02345-09; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; Wang W, 2000, TOXICOL SCI, V56, P165, DOI 10.1093/toxsci/56.1.165; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wren JD, 2000, AM J HUM GENET, V67, P345, DOI 10.1086/303013; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xie YS, 2010, COMP BIOCHEM PHYS D, V5, P98, DOI 10.1016/j.cbd.2010.02.001; Yamashita M, 2000, ZOOL SCI, V17, P841, DOI 10.2108/zsj.17.841; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101; Yi W, 2000, DEVELOPMENT, V127, P4469; Zamudio N, 2010, HEREDITY, V105, P92, DOI 10.1038/hdy.2010.53; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang ZB, 2007, BIOL REPROD, V77, P864, DOI 10.1095/biolreprod.107.063206; Zhang ZP, 2007, COMP BIOCHEM PHYS B, V147, P466, DOI 10.1016/j.cbpb.2007.02.013; Zouros E, 1996, GENET RES, V68, P109, DOI 10.1017/S0016672300033991	129	29	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73176	10.1371/journal.pone.0073176	http://dx.doi.org/10.1371/journal.pone.0073176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066034	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000015
J	McGuire, M; Ben Farhat, J; Pedrono, G; Szumilin, E; Heinzelmann, A; Chinyumba, YN; Goossens, S; Makombe, S; Pujades-Rodriguez, M				McGuire, Megan; Ben Farhat, Jihane; Pedrono, Gaelle; Szumilin, Elisabeth; Heinzelmann, Annette; Chinyumba, Yamikani Ntakwile; Goossens, Sylvie; Makombe, Simon; Pujades-Rodriguez, Mar			Task-Sharing of HIV Care and ART Initiation: Evaluation of a Mixed-Care Non-Physician Provider Model for ART Delivery in Rural Malawi	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SCALE-UP; HUMAN-RESOURCES; SOUTH-AFRICA; LOW-INCOME; COMMUNITY; ACCESS; MORTALITY; HIV/AIDS; OUTCOMES	Background: Expanding access to antiretroviral therapy (ART) in sub-Saharan Africa requires implementation of alternative care delivery models to traditional physician-centered approaches. This longitudinal analysis compares outcomes of patients initiated on antiretroviral therapy (ART) by non-physician and physician providers. Methods: Adults (>= 15 years) initiating ART between September 2007 and March 2010, and with >1 follow-up visit were included and classified according to the proportion of clinical visits performed by nurses or by clinical officers (>= 80% of visits). Multivariable Poisson models were used to compare 2-year program attrition (mortality and lost to follow-up) and mortality by type of provider. In sensitivity analyses only patients with less severe disease were included. Results: A total of 10,112 patients contributed 14,012 person-years to the analysis: 3386 (33.5%) in the clinical officer group, 1901 (18.8%) in the nurse care group and 4825 (47.7%) in the mixed care group. Overall 2-year program retention was 81.8%. Attrition was lower in the mixed care and higher in the clinical officer group, compared to the nurse group (adjusted incidence rate ratio [aIRR]=0.54, 95% CI 0.45-0.65; and aIRR=3.03, 95% CI 2.56-3.59, respectively). While patients initiated on ART by clinical officers in the mixed care group had lower attrition (aIRR=0.36, 95% CI 0.29-0.44) than those in the overall nurse care group; no differences in attrition were found between patients initiated on ART by nurses in the mixed care group and those included in the nurse group (aIRR=1.18, 95% CI 0.95-1.47). Two-year mortality estimates were aIRR=0.72, 95% CI 0.49-1.09 and aIRR=5.04, 95% CI 3.56-7.15, respectively. Slightly higher estimates were observed when analyses were restricted to patients with less severe disease. Conclusion: The findings of this study support the use of a mixed care model with well trained and regularly supervised nurses and medical assistants to provide HIV care in countries with high HIV prevalence.	[McGuire, Megan; Ben Farhat, Jihane; Pujades-Rodriguez, Mar] Epicentre, Paris, France; [McGuire, Megan] Med Sans Frontieres, Med Unit, New York, NY USA; [Pedrono, Gaelle; Chinyumba, Yamikani Ntakwile] Med Sans Frontieres, Chiradzulu, Malawi; [Szumilin, Elisabeth; Heinzelmann, Annette; Goossens, Sylvie] Med Sans Frontieres, Paris, France; [Makombe, Simon] Minist Hlth, HIV Unit, Lilongwe, Lilongwe, Malawi; [Pujades-Rodriguez, Mar] UCL, London, England	Doctors Without Borders; University of London; University College London	Pujades-Rodriguez, M (corresponding author), Epicentre, Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018	Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez, Mar/0000-0002-1375-1028				Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Barth RE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/434375; Bartlett JA, 2009, LANCET INFECT DIS, V9, P637, DOI 10.1016/S1473-3099(09)70227-0; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ford N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001060; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fredlund VG, 2007, J INFECT DIS, V196, pS469, DOI 10.1086/521115; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Joint United Nations Programme on HIV/AIDS, 2010, UNAIDS REP GLOB AIDS; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Lynch S, 2012, SCIENCE, V337, P298, DOI 10.1126/science.1225702; McGuire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038044; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Muula AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-208; ONeil M, 2010, EVALUATION MALAWIS E; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Rasschaert F, 2011, JAIDS-J ACQ IMM DEF, V57, pS109, DOI 10.1097/QAI.0b013e31821f9b69; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; VAN DW, 2006, AIDS, V20, P653, DOI DOI 10.1097/01.AIDS.0000216364.44409.B1.PUBMED:16514294; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organisation, 2007, TASK SHIFT RAT RED T	32	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74090	10.1371/journal.pone.0074090	http://dx.doi.org/10.1371/journal.pone.0074090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066099	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000081
J	Paulsen, D; Urban, A; Knorr, A; Hirth-Dietrich, C; Siegling, A; Volk, HD; Mercer, AA; Limmer, A; Schumak, B; Knolle, P; Ruebsamen-Schaeff, H; Weber, O				Paulsen, Daniela; Urban, Andreas; Knorr, Andreas; Hirth-Dietrich, Claudia; Siegling, Angela; Volk, Hans-Dieter; Mercer, Andrew A.; Limmer, Andreas; Schumak, Beatrix; Knolle, Percy; Ruebsamen-Schaeff, Helga; Weber, Olaf			Inactivated Orf Virus Shows Antifibrotic Activity and Inhibits Human Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Replication in Preclinical Models	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; CROSS-PRESENTATION; INTERFERON-GAMMA; TGF-BETA; IN-VITRO; INDUCTION; EXPRESSION; INFECTION; FIBROSIS; ANTIGEN	Inactivated orf virus (iORFV), strain D1701, is a potent immune modulator in various animal species. We recently demonstrated that iORFV induces strong antiviral activity in animal models of acute and chronic viral infections. In addition, we found D1701-mediated antifibrotic effects in different rat models of liver fibrosis. In the present study, we compare iORFV derived from two different strains of ORFV, D1701 and NZ2, respectively, with respect to their antifibrotic potential as well as their potential to induce an antiviral response controlling infections with the hepatotropic pathogens hepatitis C virus (HCV) and hepatitis B virus (HBV). Both strains of ORFV showed anti-viral activity against HCV in vitro and against HBV in a transgenic mouse model without signs of necro-inflammation in vivo. Our experiments suggest that the absence of liver damage is potentially mediated by iORFV-induced downregulation of antigen cross-presentation in liver sinus endothelial cells. Furthermore, both strains showed significant anti-fibrotic activity in rat models of liver fibrosis. iORFV strain NZ2 appeared more potent compared to strain D1701 with respect to both its antiviral and antifibrotic activity on the basis of dosages estimated by titration of active virus. These results show a potential therapeutic approach against two important human liver pathogens HBV and HCV that independently addresses concomitant liver fibrosis. Further studies are required to characterize the details of the mechanisms involved in this novel therapeutic principle.	[Paulsen, Daniela; Urban, Andreas; Ruebsamen-Schaeff, Helga] AiCuris GmbH & Co KG, Wuppertal, Germany; [Knorr, Andreas; Hirth-Dietrich, Claudia; Siegling, Angela; Weber, Olaf] Bayer HealthCare, Leverkusen, Germany; [Volk, Hans-Dieter] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Volk, Hans-Dieter] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Mercer, Andrew A.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Limmer, Andreas; Knolle, Percy] Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Limmer, Andreas; Knolle, Percy] Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany; [Schumak, Beatrix] Univ Bonn, IMMIP, Bonn, Germany; [Knolle, Percy] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-80290 Munich, Germany; [Volk, Hans-Dieter] Heidelberg Univ, Heidelberg, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Otago; University of Bonn; University of Bonn; University of Bonn; Technical University of Munich; Ruprecht Karls University Heidelberg	Paulsen, D (corresponding author), AiCuris GmbH & Co KG, Wuppertal, Germany.	daniela.paulsen@aicuris.com	volk, hans-dieter/AAV-8053-2021; Mercer, Andrew A/G-6635-2015	volk, hans-dieter/0000-0002-7743-6668; Knolle, Percy A./0000-0003-2983-0414; Mercer, Andrew/0000-0003-3697-1071				Baroni GS, 1996, HEPATOLOGY, V23, P1189; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bauer S, 2013, IMMUNOL LETT, V149, P85, DOI 10.1016/j.imlet.2012.11.003; BHUNCHET E, 1992, HEPATOLOGY, V16, P1452, DOI 10.1002/hep.1840160623; Brody Herb, 2011, Nature, V474, pS1, DOI 10.1038/474S1a; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; BUTTNER M, 1995, VET IMMUNOL IMMUNOP, V46, P237, DOI 10.1016/0165-2427(94)05357-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cottone R, 1998, VIRUS RES, V56, P53, DOI 10.1016/S0168-1702(98)00056-2; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Friebe A, 2004, J VIROL, V78, P9400, DOI 10.1128/JVI.78.17.9400-9411.2004; Friebe A, 2011, J GEN VIROL, V92, P1571, DOI 10.1099/vir.0.028894-0; GURUJEYALAKSHMI G, 1995, EXP LUNG RES, V21, P791, DOI 10.3109/01902149509050842; Haig DM, 1998, IMMUNOLOGY, V93, P335, DOI 10.1046/j.1365-2567.1998.00438.x; Haig DM, 1989, ORF VET RES, V29, P311; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; KANE M, 1995, VACCINE, V13, pS47; Kern M, 2010, GASTROENTEROLOGY, V138, P336, DOI 10.1053/j.gastro.2009.08.057; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kruse N, 2001, J VIROL, V75, P4699, DOI 10.1128/JVI.75.10.4699-4704.2001; Lange CM, 2012, J HEPATOL, DOI [10.1016/j.jhep.2012.10.019, DOI 10.1016/J.JHEP.2012.10.019.[]; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Matsushita T, 1999, INT IMMUNOL, V11, P657, DOI 10.1093/intimm/11.5.657; McGuire MJ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-4; Mercer AA, 2006, VIRUS RES, V116, P146, DOI 10.1016/j.virusres.2005.09.011; Nowatzky J, 2012, HEPATOL RES     0913, V13, DOI [10.1111/j.1872-034X.2012.01086.x, DOI 10.1111/J.1872-034X.2012.01086.X.[]; O'Boyle DR, 2005, ANTIMICROB AGENTS CH, V49, P1346, DOI 10.1128/AAC.49.4.1346-1353.2005; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Pohscheidt M, 2008, VACCINE, V26, P1552, DOI 10.1016/j.vaccine.2008.01.032; ROBINSON AJ, 1982, ARCH VIROL, V71, P43, DOI 10.1007/BF01315174; ROCKEY DC, 1992, HEPATOLOGY, V16, P776, DOI 10.1002/hep.1840160325; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shi MN, 2006, WORLD J GASTROENTERO, V12, P2357, DOI 10.3748/wjg.v12.i15.2357; Shi MN, 2005, WORLD J GASTROENTERO, V11, P4788, DOI 10.3748/wjg.v11.i31.4788; Siegemund S, 2009, J VIROL, V83, P9411, DOI 10.1128/JVI.02362-08; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Trobonjaca Z, 2002, J IMMUNOL, V168, P3763, DOI 10.4049/jimmunol.168.8.3763; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Weber O, 2013, EUR J CLIN MICROBIOL, V32, P451, DOI 10.1007/s10096-012-1780-x; Weber O, 2003, J GEN VIROL, V84, P1843, DOI 10.1099/vir.0.19138-0; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; Wohlleber D, 2012, CELL REP, V2, P478, DOI 10.1016/j.celrep.2012.08.001	50	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74605	10.1371/journal.pone.0074605	http://dx.doi.org/10.1371/journal.pone.0074605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066148	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000130
J	Barczewska, M; Wojtkiewicz, J; Habich, A; Janowski, M; Adamiak, Z; Holak, P; Matyjasik, H; Bulte, JWM; Maksymowicz, W; Walczak, P				Barczewska, Monika; Wojtkiewicz, Joanna; Habich, Aleksandra; Janowski, Miroslaw; Adamiak, Zbigniew; Holak, Piotr; Matyjasik, Hubert; Bulte, Jeff W. M.; Maksymowicz, Wojciech; Walczak, Piotr			MR Monitoring of Minimally Invasive Delivery of Mesenchymal Stem Cells into the Porcine Intervertebral Disc	PLOS ONE			English	Article							TRANSPLANTATION; TRACKING; DEGENERATION; REGENERATION	Purpose: Bone marrow stem cell therapy is a new, attractive therapeutic approach for treatment of intervertebral disc (IVD) degeneration; however, leakage and backflow of transplanted cells into the structures surrounding the disc may lead to the formation of undesirable osteophytes. The purpose of this study was to develop a technique for minimally invasive and accurate delivery of stem cells. Methods: Porcine mesenchymal stem cells (MSCs) were labeled with superparamagnetic iron oxide nanoparticles (SPIO, Molday ION rhodamine) and first injected into the explanted swine lumbar IVD, followed by ex vivo 3T MRI. After having determined sufficient sensitivity, IVD degeneration was then induced in swine (n=3) by laser-evaporation. 3 x 10(6) SPIO-labeled cells embedded within hydrogel were injected in 2 doses using a transcutaneous cannula and an epidural anesthesia catheter. T2-weighted MR images were obtained at 3T before and immediately after cell infusion. Two weeks after injection, histological examination was performed for detection of transplanted cells. Results: MSCs were efficiently labeled with Molday ION rhodamine. Cells could be readily detected in the injected vertebral tissue explants as distinct hypointensities with sufficient sensitivity. MR monitoring indicated that the MSCs were successfully delivered into the IVD in vivo, which was confirmed by iron-positive Prussian Blue staining of the tissue within the IVD. Conclusion: We have developed a technique for non-invasive monitoring of minimally invasive stem delivery into the IVD at 3T. By using a large animal model mimicking the anatomy of IVD in humans, the present results indicate that this procedure may be clinically feasible.	[Barczewska, Monika; Wojtkiewicz, Joanna; Habich, Aleksandra; Maksymowicz, Wojciech] Univ Warmia & Mazury, Fac Med Sci, Dept Neurol & Neurosurg, Olsztyn, Poland; [Walczak, Piotr] Univ Warmia & Mazury, Fac Med Sci, Dept Radiol, Olsztyn, Poland; [Adamiak, Zbigniew; Holak, Piotr; Matyjasik, Hubert] Univ Warmia & Mazury, Fac Vet Med, Dept Surg & Radiol, Olsztyn, Poland; [Janowski, Miroslaw; Bulte, Jeff W. M.; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div MR Res, Baltimore, MD USA; [Janowski, Miroslaw; Bulte, Jeff W. M.; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Janowski, Miroslaw; Bulte, Jeff W. M.; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD 21205 USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Janowski, Miroslaw] Polish Acad Sci, Mossakowski Med Res Ctr, Dept NeuroRepair, Warsaw, Poland; [Janowski, Miroslaw] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurosurg, Warsaw, Poland	University of Warmia & Mazury; University of Warmia & Mazury; University of Warmia & Mazury; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Walczak, P (corresponding author), Univ Warmia & Mazury, Fac Med Sci, Dept Radiol, Olsztyn, Poland.	pwalczak@mri.jhu.edu	Adamiak, Zbigniew/ABG-6173-2020; adamiak, zbigniew/ABD-4580-2021; Wojtkiewicz, Joanna/AAD-8911-2019	Adamiak, Zbigniew/0000-0001-8350-0198; Wojtkiewicz, Joanna/0000-0003-0856-3644; Holak, Piotr/0000-0002-2050-1959; Barczewska, Monika/0000-0002-3152-4611; Janowski, Miroslaw/0000-0001-5261-7975; Bulte, Jeff/0000-0003-1202-1610; Walczak, Piotr/0000-0002-3733-3322	UWM [1501.801]; NCN [2012/07/B/NZ4/01427];  [MSCRFII-0193];  [MSCRFII-0052];  [MSCRFE-0178];  [RO1 NS076573];  [R01 NS045062]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076573, R01NS045062] Funding Source: NIH RePORTER	UWM; NCN; ; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by UWM 1501.801 (WM), NCN 2012/07/B/NZ4/01427 (JW), MSCRFII-0193 (PW), MSCRFII-0052 (PW), MSCRFE-0178 (MJ), RO1 NS076573 (PW) and R01 NS045062 (JWMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140; Bulte Jeff W M, 2006, Methods Mol Med, V124, P419; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Freemont AJ, 2002, J PATHOL, V196, P374, DOI 10.1002/path.1050; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Kandel R, 2008, EUR SPINE J, V17, pS480, DOI 10.1007/s00586-008-0746-2; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Maksymowicz Wojciech, 2004, Ortop Traumatol Rehabil, V6, P314; Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15; OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205; Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Saldanha KJ, 2008, EUR CELLS MATER, V16, P17, DOI 10.22203/eCM.v016a03; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Yoshikawa T, 2010, SPINE, V35, pE475, DOI 10.1097/BRS.0b013e3181cd2cf4; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	27	23	25	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74658	10.1371/journal.pone.0074658	http://dx.doi.org/10.1371/journal.pone.0074658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058619	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400093
J	Li, Q; Guo, JL; Lin, X; Yang, XS; Ma, YL; Fan, GC; Chang, J				Li, Qi; Guo, Junli; Lin, Xi; Yang, Xiangsheng; Ma, Yanlin; Fan, Guo-Chang; Chang, Jiang			An Intragenic SRF-Dependent Regulatory Motif Directs Cardiac-Specific microRNA-1-1/133a-2 Expression	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TINMAN HOMOLOG NKX-2.5; TRANSCRIPTION FACTOR; PROLIFERATION; SKELETAL; MICRORNAS; GROWTH; CARDIOGENESIS; INACTIVATION; MIR-133	Transcriptional regulation is essential for any gene expression including microRNA expression. MiR-1-1 and miR-133a-2 are essential microRNAs (miRs) involved in cardiac and skeletal muscle development and diseases. Early studies reveal two regulatory enhancers, an upstream and an intragenic, that direct the miR-1-1 and miR-133a-2 transcripts. In this study, we identify a unique serum response factor (SRF) binding motif within the enhancer through bioinformatic approaches. This motif is evolutionarily conserved and is present in a range of organisms from yeast, flies, to humans. We provide evidence to demonstrate that this regulatory motif is SRF-dependent in vitro by electrophoretic mobility shift assay, luciferase activity assay, and endogenous chromatin immunoprecipitation assay followed by DNA sequence confirmation, and in vivo by transgenic lacZ reporter mouse studies. Importantly, our transgenic mice indicate that this motif is indispensable for the expression of miR1-1/133a-2 in the heart, but not necessary in skeletal muscle, while the enhancer is sufficient for miR1-1/133a-2 gene expression in both tissues. The mutation of the motif alone completely abolishes miR-1-1/133a-2 gene expression in the animal heart, but not in the skeletal muscle. Our findings reveal an additional architecture of regulatory complex directing miR-1-1/133a-1 gene expression, and demonstrate how this intragenic enhancer differentially manages the expression of the two miRs in the heart and skeletal muscle, respectively.	[Li, Qi; Guo, Junli; Ma, Yanlin] Hainan Med Coll, Affiliated Hosp, Cardiovasc Dis & Res Inst, Hainan Prov Key Lab Human Reprod Med & Genet Res, Haikou, Hainan, Peoples R China; [Guo, Junli] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Hainan, Peoples R China; [Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Lin, Xi; Yang, Xiangsheng; Chang, Jiang] Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Hainan Medical University; Hainan Medical University; University System of Ohio; University of Cincinnati; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chang, J (corresponding author), Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.	jchang@ibt.tamhsc.edu	Lin, Xi/K-2473-2015; Fan, Guo-Chang/E-1153-2012; Ma, Yanlin/CAH-2185-2022	Lin, Xi/0000-0002-9034-7117; Fan, Guo-Chang/0000-0002-0439-8277; Ma, Yanlin/0000-0001-9668-0204; Chang, Jiang/0000-0003-3707-7557	National Natural Science Foundation of China (NSFC) [NSFC81060175]; NSFC [81000073, 81160020]; Key Project of Chinese Ministry of Education [212137]; AHA Postdoctoral Fellowship [13POST17260043]; AHA [0855030F]; National Institutes of Health-National Heart, Lung, and Blood Institute [R01HL102314, R21HL094844, K02HL098956]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL098956, R21HL094844, R01HL102314] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); AHA Postdoctoral Fellowship(American Heart Association); AHA(American Heart Association); National Institutes of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China (NSFC) grant NSFC81060175 (to Q. L.); the NSFC 81000073, 81160020 and the Key Project of Chinese Ministry of Education 212137 (to J.G.); the AHA Postdoctoral Fellowship 13POST17260043 (X.Y.); the AHA Grant-in-Aid (0855030F), the National Institutes of Health-National Heart, Lung, and Blood Institute R01HL102314, R21HL094844 and K02HL098956 (to J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang J, 2003, CIRCULATION, V108, P407, DOI 10.1161/01.CIR.0000084502.02147.83; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Diwan A, 2009, CIRC RES, V105, pE13; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Kusakabe R, 2013, GENE EXPR PATTERNS, V13, P43, DOI 10.1016/j.gep.2012.11.001; LEE TC, 1992, BIOTECHNIQUES, V12, P486; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; Xiao JN, 2007, J BIOL CHEM, V282, P12363, DOI 10.1074/jbc.C700015200; Yang XS, 2012, FASEB J, V26, P2105, DOI 10.1096/fj.11-201319; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	32	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75470	10.1371/journal.pone.0075470	http://dx.doi.org/10.1371/journal.pone.0075470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058688	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400114
J	Donthamsetty, S; Bhave, VS; Mars, WM; Bowen, WC; Orr, A; Haynes, MM; Wu, CY; Michalopoulos, GK				Donthamsetty, Shashikiran; Bhave, Vishakha S.; Mars, Wendy M.; Bowen, William C.; Orr, Anne; Haynes, Meagan M.; Wu, Chuanyue; Michalopoulos, George K.			Role of PINCH and Its Partner Tumor Suppressor Rsu-1 in Regulating Liver Size and Tumorigenesis	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; CELL-SURVIVAL; RAS TRANSFORMATION; ADAPTER PROTEIN; ONCOGENIC RAS; RHO-GTPASES; IN-VITRO; GROWTH; EXPRESSION; REGENERATION	Particularly interesting new cysteine-histidine-rich protein (PINCH) protein is part of the ternary complex known as the IPP (integrin linked kinase (ILK)-PINCH-Parvin-alpha) complex. PINCH itself binds to ILK and to another protein known as Rsu-1 (Ras suppressor 1). We generated PINCH 1 and PINCH 2 Double knockout mice (referred as PINCH DKO mice). PINCH2 elimination was systemic whereas PINCH1 elimination was targeted to hepatocytes. The genetically modified mice were born normal. The mice were sacrificed at different ages after birth. Soon after birth, they developed abnormal hepatic histology characterized by disorderly hepatic plates, increased proliferation of hepatocytes and biliary cells and increased deposition of extracellular matrix. After a sustained and prolonged proliferation of all epithelial components, proliferation subsided and final liver weight by the end of 30 weeks in livers with PINCH DKO deficient hepatocytes was 40% larger than the control mice. The livers of the PINCH DKO mice were also very stiff due to increased ECM deposition throughout the liver, with no observed nodularity. Mice developed liver cancer by one year. These mice regenerated normally when subjected to 70% partial hepatectomy and did not show any termination defect. Ras suppressor 1 (Rsu-1) protein, the binding partner of PINCH is frequently deleted in human liver cancers. Rsu-1 expression is dramatically decreased in PINCH DKO mouse livers. Increased expression of Rsu-1 suppressed cell proliferation and migration in HCC cell lines. These changes were brought about not by affecting activation of Ras (as its name suggests) but by suppression of Ras downstream signaling via RhoGTPase proteins. In conclusion, our studies suggest that removal of PINCH results in enlargement of liver and tumorigenesis. Decreased levels of Rsu-1, a partner for PINCH and a protein often deleted in human liver cancer, may play an important role in the development of the observed phenotype.	[Donthamsetty, Shashikiran; Mars, Wendy M.; Bowen, William C.; Orr, Anne; Haynes, Meagan M.; Wu, Chuanyue; Michalopoulos, George K.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Bhave, Vishakha S.] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwannee, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Michalopoulos, GK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA.	michalopoulosgk@upmc.edu		Bhave, Vishakha/0000-0003-0149-579X	National Institutes of Health [5R01CA035373, 5R01CA103958]; PPRTP (Pathology Post Doctoral Research Training Program); NATIONAL CANCER INSTITUTE [R01CA103958, R01CA035373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PPRTP (Pathology Post Doctoral Research Training Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants 5R01CA035373 & Grant 5R01CA103958 from the National Institutes of Health, and the PPRTP (Pathology Post Doctoral Research Training Program) grant awarded to Shashikiran Donthamsetty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; CUTLER ML, 1992, MOL CELL BIOL, V12, P3750, DOI 10.1128/MCB.12.9.3750; David M, 2012, CELL CYCLE, V11, P3003, DOI 10.4161/cc.21088; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dougherty GW, 2005, EXP CELL RES, V306, P168, DOI 10.1016/j.yexcr.2005.01.025; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FRANCAVILLA A, 1988, TRANSPLANT P, V20, P494; Gkretsi V, 2007, HEPATOLOGY, V45, P1025, DOI 10.1002/hep.21540; Gkretsi V, 2008, HEPATOLOGY, V48, P1932, DOI 10.1002/hep.22537; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kossman T, 1992, GROWTH FACTORS, V7, P73, DOI 10.3109/08977199209023939; Kovalevich J, 2011, J CELL PHYSIOL, V226, P940, DOI 10.1002/jcp.22437; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1999, HEPATOLOGY, V29, P90, DOI 10.1002/hep.510290149; Morgan-Fisher M, 2013, J HISTOCHEM CYTOCHEM, V61, P185, DOI 10.1369/0022155412470834; Nalesnik MA, 2012, AM J PATHOL, V180, P1495, DOI 10.1016/j.ajpath.2011.12.021; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Saito JM, 2000, GASTROENTEROLOGY, V118, P1157, DOI 10.1016/S0016-5085(00)70369-6; Solaro RJ, 2000, CIRC RES, V87, P173, DOI 10.1161/01.RES.87.3.173; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; STARZL TE, 1993, LANCET, V341, P65, DOI 10.1016/0140-6736(93)92553-6; Stolz DB, 1997, J CELL PHYSIOL, V170, P57; Street CA, 2011, ANTICANCER RES, V31, P3645; TSUDA T, 1995, ONCOGENE, V11, P397; TSUDA T, 1993, GENOMICS, V18, P461, DOI 10.1006/geno.1993.1503; Vasaturo F, 2000, BREAST CANCER RES TR, V61, P69, DOI 10.1023/A:1006462323260; Wakabayashi Y, 2008, HEPATO-GASTROENTEROL, V55, P1179; Xidakis C, 2005, DIGEST DIS SCI, V50, P935, DOI 10.1007/s10620-005-2668-8; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	38	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74625	10.1371/journal.pone.0074625	http://dx.doi.org/10.1371/journal.pone.0074625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058607	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000324695900069
J	Ham, AS; Lustig, W; Yang, L; Boczar, A; Buckheit, KW; Buckheit, RW				Ham, Anthony S.; Lustig, William; Yang, Lu; Boczar, Ashlee; Buckheit, Karen W.; Buckheit, Robert W., Jr.			In Vitro and Ex Vivo Evaluations on Transdermal Delivery of the HIV Inhibitor IQP-0410	PLOS ONE			English	Article							CONTROLLED DRUG-DELIVERY; SOCIETY-USA PANEL; PLGA NANOPARTICLES; RELEASE PROFILES; SKIN PERMEATION; AIDS; RECOMMENDATIONS; MODULATION; ZIDOVUDINE; DIFFUSION	The aim of this study was to investigate the physicochemical and in vitro/ex vivo characteristics of the pyrmidinedione IQP-0410 formulated into transdermal films. IQP-0410 is a potent therapeutic anti-HIV nonnucleoside reverse transcriptase inhibitor that would be subjected to extensive first pass metabolism, through conventional oral administration. Therefore, IQP-0410 was formulated into ethyl cellulose/HPMC-based transdermal films via solvent casting. In mano evaluations were performed to evaluate gross physical characteristics. In vitro release studies were performed in both Franz cells and USP-4 dissolution vessels. Ex vivo release and permeability assays were performed on human epidermal tissue models, and the permeated IQP-0410 was collected for in vitro HIV-1 efficacy assays in CEM-SS cells and PBMCs. Film formulation D3 resulted in pliable, strong transdermal films that were loaded with 2% (w/w) IQP-0410. Composed of 60% (w/w) ethyl cellulose and 20% (w/w) HPMC, the films contained < 1.2% (w/w) of water and were hygroscopic resulting in significant swelling under humid conditions. The water permeable nature of the film resulted in complete in vitro dissolution and drug release in 26 hours. When applied to ex vivo epidermal tissues, the films were non-toxic to the tissue and also were non-toxic to HIV target cells used in the in vitro efficacy assays. Over a 3 day application, the films delivered IQP-0410 through the skin tissue at a zero-order rate of 0.94 +/- 0.06 mu g/cm(2)/hr with 134 +/- 14.7 mu M collected in the basal media. The delivered IQP-0410 resulted in in vitro EC50 values against HIV-1 of 2.56 +/- 0.40 nM (CEM-SS) and 0.58 +/- 0.03 nM (PBMC). The film formulation demonstrated no significant deviation from target values when packaged in foil pouches under standard and accelerated environmental conditions. It was concluded that the transdermal film formulation was a potentially viable method of administering IQP-0410 that warrants further development.	[Ham, Anthony S.; Lustig, William; Yang, Lu; Boczar, Ashlee; Buckheit, Karen W.; Buckheit, Robert W., Jr.] ImQuest BioSci Inc, Frederick, MD USA		Ham, AS (corresponding author), ImQuest BioSci Inc, Frederick, MD USA.	aham@imquestbio.com			National Institutes of Health [NIH R43AI089331]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI089331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health (NIH R43AI089331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABAR A, 1992, DRUG DEV IND PHARM, V18, P1823, DOI 10.3109/03639049209040905; Buckheit KW, 2011, ANTIMICROB AGENTS CH, V55, P5243, DOI 10.1128/AAC.05237-11; BUCKHEIT RW, 1995, ANTIMICROB AGENTS CH, V39, P2718, DOI 10.1128/AAC.39.12.2718; Buckheit RW, 2001, ANTIMICROB AGENTS CH, V45, P393, DOI 10.1128/AAC.45.2.393-400.2001; Budhian A, 2008, INT J PHARMACEUT, V346, P151, DOI 10.1016/j.ijpharm.2007.06.011; CANNON CL, 1994, TOXICOL IN VITRO, V8, P889, DOI 10.1016/0887-2333(94)90095-7; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CHIEN YW, 1987, CONTROLLED DRUG DELI, P524; Cleary GW, 1984, MED APPL CONTROLLED, V1, P203; Costa P, 2003, DRUG DEV IND PHARM, V29, P89, DOI 10.1081/DDC-120016687; Feng SS, 2008, BIOMATERIALS, V29, P4146; KEITH AD, 1983, DRUG DEV IND PHARM, V9, P605, DOI 10.3109/03639048309044695; Kim DD, 1996, J PHARM SCI, V85, P214, DOI 10.1021/js950141c; Kuksal A, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070101; Kydonieus A, 1987, CONTROLLED RELEASE T; Lewi Paul, 2004, Drugs R D, V5, P245, DOI 10.2165/00126839-200405050-00001; Li YP, 2001, J CONTROL RELEASE, V71, P203, DOI 10.1016/S0168-3659(01)00218-8; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; Mirsa A, 1997, TRANSDERMAL DRUG DEL, P100; Mukherjee B, 2005, EUR J PHARM BIOPHARM, V59, P475, DOI 10.1016/j.ejpb.2004.09.009; NARA PL, 1987, AIDS RES HUM RETROV, V3, P283, DOI 10.1089/aid.1987.3.283; Oh SY, 1998, J CONTROL RELEASE, V51, P161, DOI 10.1016/S0168-3659(97)00162-4; Paudel KS, 2010, THER DELIV, V1, P109, DOI 10.4155/TDE.10.16; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Richman DD, 1996, SCIENCE, V272, P1886, DOI 10.1126/science.272.5270.1886; Sassi AB, 2004, J PHARM SCI-US, V93, P2009, DOI 10.1002/jps.20107; Scheindlin S, 2004, MOL INTERV, V4, P308, DOI 10.1124/mi.4.6.1; Siepmann J, 1999, PHARMACEUT RES, V16, P1748, DOI 10.1023/A:1018914301328; Siepmann J, 1999, J CONTROL RELEASE, V60, P379, DOI 10.1016/S0168-3659(99)00093-0; Singh I, 2006, J IRAN CHEM SOC, V3, P220, DOI 10.1007/BF03247211; Trabattoni D, 2002, CLIN DIAGN LAB IMMUN, V9, P1114, DOI 10.1128/CDLI.9.5.1114-1118.2002; UNAIDS/WHO, 2007, IDS EP; Watson KM, 2008, ANTIMICROB AGENTS CH, V52, P2787, DOI 10.1128/AAC.01657-07; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Zobrist RH, 2003, PHARMACEUT RES, V20, P103, DOI 10.1023/A:1022259011052	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75306	10.1371/journal.pone.0075306	http://dx.doi.org/10.1371/journal.pone.0075306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058672	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900105
J	Hao, XY; Li, P; Feng, YX; Han, X; Gao, J; Lin, ED; Han, YH				Hao, Xingyu; Li, Ping; Feng, Yongxiang; Han, Xue; Gao, Ji; Lin, Erda; Han, Yuanhuai			Effects of Fully Open-Air [CO2] Elevation on Leaf Photosynthesis and Ultrastructure of Isatis indigotica Fort	PLOS ONE			English	Article							SOURCE-SINK RELATIONS; CARBON-DIOXIDE; ACCLIMATION; CAPACITY; YIELD; ENRICHMENT; PLANTS; WHEAT; FACE; RESPONSES	Traditional Chinese medicine relies heavily on herbs, yet there is no information on how these herb plants would respond to climate change. In order to gain insight into such response, we studied the effect of elevated [CO2] on Isatis indigotica Fort, one of the most popular Chinese herb plants. The changes in leaf photosynthesis, chlorophyll fluorescence, leaf ultrastructure and biomass yield in response to elevated [CO2] (550 +/- 19 mu mol mol(-1)) were determined at the Free-Air Carbon dioxide Enrichment (FACE) experimental facility in North China. Photosynthetic ability of I. indigotica was improved under elevated [CO2]. Elevated [CO2] increased net photosynthetic rate (P-N), water use efficiency (WUE) and maximum rate of electron transport (J(max)) of upper most fully-expended leaves, but not stomatal conductance (g(s)), transpiration ratio (Tr) and maximum velocity of carboxylation (V-c,V-max). Elevated [CO2] significantly increased leaf intrinsic efficiency of PSII (Fv'/Fm') and quantum yield of PSII(Phi PSII), but decreased leaf non-photochemical quenching (NPQ), and did not affect leaf proportion of open PSII reaction centers (qP) and maximum quantum efficiency of PSII (Fv/Fm). The structural chloroplast membrane, grana layer and stroma thylakoid membranes were intact under elevated [CO2], though more starch grains were accumulated within the chloroplasts than that of under ambient [CO2]. While the yield of I. indigotica was higher due to the improved photosynthesis under elevated [CO2], the content of adenosine, one of the functional ingredients in indigowoad root was not affected.	[Hao, Xingyu; Li, Ping; Gao, Ji; Han, Yuanhuai] Shanxi Agr Univ, Coll Agron, Taigu, Peoples R China; [Hao, Xingyu; Feng, Yongxiang; Han, Xue; Gao, Ji; Lin, Erda] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr IEDA, Key Lab Minist Agr Agroenvironm & Climate Change, Beijing 100193, Peoples R China; [Hao, Xingyu; Han, Yuanhuai] Shanxi Acad Agr Sci, Inst Crop Genet Resources, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Taiyuan, Peoples R China; [Feng, Yongxiang] Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Peoples R China	Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Shanxi Agricultural University; Heilongjiang Bayi Agricultural University	Lin, ED (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr IEDA, Key Lab Minist Agr Agroenvironm & Climate Change, Beijing 100193, Peoples R China.	linedster@gmail.com; swgctd@163.com			National Basic Research Program of China (973 Program) [2012 CB955904]; China CDM Fund project: The impact of climate change on Chinese agriculture and eco-systems under different RCP,National Key Technology R&D Program in the 12th Five Year Plan of China [2013BAD11B03]; Shanxi 100-Talent programme; Shanxi Agricultural University Doctoral Scientific Research fund	National Basic Research Program of China (973 Program)(National Basic Research Program of China); China CDM Fund project: The impact of climate change on Chinese agriculture and eco-systems under different RCP,National Key Technology R&D Program in the 12th Five Year Plan of China; Shanxi 100-Talent programme; Shanxi Agricultural University Doctoral Scientific Research fund	This work was supported by The National Basic Research Program of China (973 Program)(No.2012 CB955904), China CDM Fund project: The impact of climate change on Chinese agriculture and eco-systems under different RCP,National Key Technology R&D Program in the 12th Five Year Plan of China (No.2013BAD11B03), the Shanxi 100-Talent programme and Shanxi Agricultural University Doctoral Scientific Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Aranjuelo I, 2011, J EXP BOT, V62, P3957, DOI 10.1093/jxb/err095; ASAKO H, 1993, GASTROENTEROLOGY, V104, P31, DOI 10.1016/0016-5085(93)90832-W; Bai ZM., 2008, GANSU MED, V27, P18; Betzelberger AM, 2010, PLANT CELL ENVIRON, V33, P1569, DOI 10.1111/j.1365-3040.2010.02165.x; BILGER W, 1995, OECOLOGIA, V102, P425, DOI 10.1007/BF00341354; Biswas DK, 2013, J EXP BOT, V64, P1485, DOI 10.1093/jxb/ert005; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Frenck G, 2011, EUR J AGRON, V35, P127, DOI 10.1016/j.eja.2011.05.004; Grayson M, 2011, NATURE, V480, pS81, DOI 10.1038/480S81a; Hao XY, 2012, PHOTOSYNTHETICA, V50, P362, DOI 10.1007/s11099-012-0043-5; Huang Jianye, 2003, Yingyong Shengtai Xuebao, V14, P253; Isopp H, 2000, PLANT CELL ENVIRON, V23, P597, DOI 10.1046/j.1365-3040.2000.00583.x; Kong WK, 2008, BIOL PHARM BULL, V31, P1301, DOI 10.1248/bpb.31.1301; Krishnan P., 2011, ADV AGRON, V111, P187; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Mohammed AR, 2010, EUR J AGRON, V33, P117, DOI 10.1016/j.eja.2009.11.006; Myers DA, 1999, PLANT CELL ENVIRON, V22, P473, DOI 10.1046/j.1365-3040.1999.00434.x; National Pharmacopoeia Council, 2005, PHARM CHIN 2005 ED; Oksanen E, 2001, ENVIRON POLLUT, V115, P437, DOI 10.1016/S0269-7491(01)00233-0; Prentice IC, 2001, CLIMATE CHANGE SCI B; Qing C., 2009, CHINESE PHARM AFFAIR, V23, P607; Rascher U, 2004, PLANT CELL ENVIRON, V27, P1239, DOI 10.1111/j.1365-3040.2004.01231.x; Rascher U, 2010, PHOTOSYNTH RES, V105, P15, DOI 10.1007/s11120-010-9548-6; Rogers A, 1998, PLANT PHYSIOL, V118, P683, DOI 10.1104/pp.118.2.683; Seneweera S, 2011, ENVIRON EXP BOT, V71, P128, DOI 10.1016/j.envexpbot.2010.11.002; Seneweera SP, 2002, FUNCT PLANT BIOL, V29, P945, DOI 10.1071/PP01250; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Shin EK, 2010, INFLAMMATION, V33, P110, DOI 10.1007/s10753-009-9164-9; Sicher RC, 1995, PHOTOSYNTH RES, V46, P409, DOI 10.1007/BF00032295; Tausz-Posch S, 2013, ENVIRON EXP BOT, V88, P81, DOI 10.1016/j.envexpbot.2011.12.002; Teng NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006035; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Vickers A, 2001, WESTERN J MED, V175, P125, DOI 10.1136/ewjm.175.2.125; VU JCV, 1989, ENVIRON EXP BOT, V29, P141, DOI 10.1016/0098-8472(89)90046-4; Wang X. L., 1994, Acta Horticulturae Sinica, V21, P245; Wang YQ, 2012, NO CHINESE HERBAL ME; Wang ZG, 2002, TRENDS PHARMACOL SCI, V23, P347, DOI 10.1016/S0165-6147(02)02051-5; Zuo BY, 2002, ACTA BOT SIN, V44, P908; 丁越, 2008, [中成药, Chinese Traditional Patent Medicine], V30, P1697; 郭力, 2006, [中成药, Chinese Traditional Patent Medicine], V28, P1064	42	27	29	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74600	10.1371/journal.pone.0074600	http://dx.doi.org/10.1371/journal.pone.0074600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058596	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324695900062
J	Hoyer, D; Tetschke, F; Jaekel, S; Nowack, S; Witte, OW; Schleussner, E; Schneider, U				Hoyer, Dirk; Tetschke, Florian; Jaekel, Susan; Nowack, Samuel; Witte, Otto W.; Schleussner, Ekkehard; Schneider, Uwe			Fetal Functional Brain Age Assessed from Universal Developmental Indices Obtained from Neuro-Vegetative Activity Patterns	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; INTRAUTERINE GROWTH-RETARDATION; TIME; COMPLEXITY; PARAMETERS; DYNAMICS; STATE	Fetal brain development involves the development of the neuro-vegetative (autonomic) control that is mediated by the autonomic nervous system (ANS). Disturbances of the fetal brain development have implications for diseases in later postnatal life. In that context, the fetal functional brain age can be altered. Universal principles of developmental biology applied to patterns of autonomic control may allow a functional age assessment. The work aims at the development of a fetal autonomic brain age score (fABAS) based on heart rate patterns. We analysed n = 113 recordings in quiet sleep, n = 286 in active sleep, and n = 29 in active awakeness from normals. We estimated fABAS from magnetocardiographic recordings (21.4-40.3 weeks of gestation) preclassified in quiet sleep (n = 113, 63 females) and active sleep (n = 286, 145 females) state by cross-validated multivariate linear regression models in a cross-sectional study. According to universal system developmental principles, we included indices that address increasing fluctuation range, increasing complexity, and pattern formation (skewness, power spectral ratio VLF/LF, pNN5). The resulting models constituted fABAS. fABAS explained 66/63% (coefficient of determination R 2 of training and validation set) of the variance by age in quiet, while 51/50% in active sleep. By means of a logistic regression model using fluctuation range and fetal age, quiet and active sleep were automatically reclassified (94.3/93.1% correct classifications). We did not find relevant gender differences. We conclude that functional brain age can be assessed based on universal developmental indices obtained from autonomic control patterns. fABAS reflect normal complex functional brain maturation. The presented normative data are supplemented by an explorative study of 19 fetuses compromised by intrauterine growth restriction. We observed a shift in the state distribution towards active awakeness. The lower WGA dependent fABAS values found in active sleep may reflect alterations in the universal developmental indices, namely fluctuation amplitude, complexity, and pattern formation that constitute fABAS.	[Hoyer, Dirk; Tetschke, Florian; Nowack, Samuel; Witte, Otto W.] Jena Univ Hosp, Biomagnet Ctr, Hans Berger Dept Neurol, Jena, Germany; [Jaekel, Susan; Schleussner, Ekkehard; Schneider, Uwe] Jena Univ Hosp, Dept Obstet, Jena, Germany; [Nowack, Samuel] Jena Univ Hosp, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Hoyer, D (corresponding author), Jena Univ Hosp, Biomagnet Ctr, Hans Berger Dept Neurol, Jena, Germany.	Dirk.Hoyer@med.uni-jena.de	Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	German Research Foundation [1634 12-2, 775/2-3]; JUH Interdisciplinary Center for Clinical Research (IZKF); Marie Curie Intra-European Fellowship [IEF-2009-237290]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1002]	German Research Foundation(German Research Foundation (DFG)); JUH Interdisciplinary Center for Clinical Research (IZKF); Marie Curie Intra-European Fellowship(European Commission); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	The work was supported by public funds: German Research Foundation (Deutsche Forschungsgemeinschaft, HO 1634 12-2, Schn 775/2-3), JUH Interdisciplinary Center for Clinical Research (IZKF), Marie Curie Intra-European Fellowship IEF-2009-237290, Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008; Baschat AA, 2000, ULTRASOUND OBST GYN, V16, P407, DOI 10.1046/j.1469-0705.2000.00284.x; Bertalanffy Lv, 1968, GEN SYSTEM THEORY FD, VXV; Camm AJ, 1996, CIRCULATION, V93, P1043; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Darwin C, 1859, ORIGN SPECIES; David M, 2007, J APPL PHYSIOL, V102, P1057, DOI 10.1152/japplphysiol.00114.2006; Ferrario M, 2007, METHOD INFORM MED, V46, P186; Ferrario M, 2009, MED BIOL ENG COMPUT, V47, P911, DOI 10.1007/s11517-009-0502-8; Frank B, 2006, MED BIOL ENG COMPUT, V44, P179, DOI 10.1007/s11517-005-0015-z; Goldstein JM, 2011, J DEV ORIG HLTH DIS, V2, P353, DOI 10.1017/S2040174411000651; Haddad N, 2011, EXP NEUROL, V228, P200, DOI 10.1016/j.expneurol.2011.01.003; Haeckel E, 1866, GEN MORPHOLOGY, VII; Haken H., 1983, SYNERGETICS INTRO NO; Hoyer D, 2005, IEEE T BIO-MED ENG, V52, P584, DOI 10.1109/TBME.2005.844023; Hoyer D, 2013, AM J PHYSIOL-REG I, V304, pR383, DOI 10.1152/ajpregu.00120.2012; Hoyer D, 2012, COMPUT BIOL MED, V42, P335, DOI 10.1016/j.compbiomed.2011.05.003; Hoyer D, 2011, IEEE ENG MED BIO, P1451, DOI 10.1109/IEMBS.2011.6090336; Hoyer D, 2007, CHAOS, V17, DOI 10.1063/1.2710448; Hoyer D, 2009, EARLY HUM DEV, V85, P379, DOI 10.1016/j.earlhumdev.2009.01.002; Kauffman S.A., 1993, ORIGINS ORDER; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lange S, 2005, MED BIOL ENG COMPUT, V43, P481, DOI 10.1007/BF02344729; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Meyberg R, 2000, Z GEBURTSH NEONATOL, V204, P218, DOI 10.1055/s-2000-9581; Nicolis G, 1977, SELF ORG NONEQUILIBR, VXII; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PILLAI M, 1990, Fetal Diagnosis and Therapy, V5, P15; PILLAI M, 1990, OBSTET GYNECOL, V76, P812, DOI 10.1097/00006250-199011000-00017; Schneider U, 2009, PHYSIOL MEAS, V30, P215, DOI 10.1088/0967-3334/30/2/008; Schneider U, 2006, BIOMED TECH, V51, P248, DOI 10.1515/BMT.2006.048; Serra V, 2009, ULTRASOUND OBST GYN, V34, P74, DOI 10.1002/uog.6365; Severi FM, 2000, FETAL DIAGN THER, V15, P8, DOI 10.1159/000020969; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Van Leeuwen P, 1999, EARLY HUM DEV, V54, P259, DOI 10.1016/S0378-3782(98)00102-9; Van Leeuwen P, 2003, PRENATAL DIAG, V23, P909, DOI 10.1002/pd.723; Van Leeuwen P, 2006, BIOMED TECH, V51, P244, DOI 10.1515/BMT.2006.047; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283; Wallwitz U, 2012, J PERINAT MED, V40, P659, DOI 10.1515/jpm-2012-0074	41	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74431	10.1371/journal.pone.0074431	http://dx.doi.org/10.1371/journal.pone.0074431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058564	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900043
J	Cerna, K; Zemenova, M; Machackova, L; Kolinova, Z; Straka, J				Cerna, Katerina; Zemenova, Monika; Machackova, Lenka; Kolinova, Zdislava; Straka, Jakub			Neighbourhood Society: Nesting Dynamics, Usurpations and Social Behaviour in Solitary Bees	PLOS ONE			English	Article							DIGGER WASP; SELFISH HERD; HYMENOPTERA; EVOLUTION; STRATEGIES; PARASITISM; SPHECIDAE; SELECTION; INSECT; MEGACHILIDAE	Intraspecific cleptoparasitism represents a facultative strategy advantageous for reducing time and energy costs. However, only a few studies about nesting dynamics have described intraspecific cleptoparasitic behaviour in obligate solitary bees. We focused on nesting dynamics with the characterisation of nest owner replacements and frequency of true usurpation in four aggregating species belonging to different phylogenetic lineages - Andrena vaga (Andrenidae), Anthophora plumipes (Apidae), Colletes cunicularius (Colletidae), and Osmia rufa (Megachilidae). Our study, based on the regular observation of individually marked females, shows that nest owner replacement affects 10-45% of nests across all of the studied species and years. However, 39-90% of these nests had been abandoned before owner change and thus true nest usurpations represent only a part of observed nest replacement cases. Females tend to abandon their nests regularly and found new ones when they live long enough, which is in accordance with risk-spreading strategy. We suggest that the original facultative strategy of observed solitary bees during nest founding is not cleptoparasitism per se but rather reuse of any pre-existing nest (similar to "entering'' strategy in apoid wasps). This is supported by gradual increase of nests founded by "entering'' during the season with an increase in the number of available nests. Although the frequent reuse of conspecific nests results in frequent contact between solitary females, and rarely, in the short-term coexistence of two females in one nest, we detected unexpectedly low level of conflict in these neighbourhood societies. We suggest that nesting dynamics with regular nest switching and reusing reduces long-term and costly intraspecific aggression, a key factor for the origin and evolution of sociality.	[Cerna, Katerina; Machackova, Lenka; Kolinova, Zdislava; Straka, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Zemenova, Monika] Czech Tech Univ, Dept Cybernet, Fac Elect Engn, CR-16635 Prague, Czech Republic	Charles University Prague; Czech Technical University Prague	Cerna, K (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	katerina.cerna@aculeataresearch.com	Straka, Jakub/A-7215-2012	Straka, Jakub/0000-0002-8987-1245	Czech Science Foundation [P506/10/0403]; SVV (Specific University Research) [SVV-2013-265206]	Czech Science Foundation(Grant Agency of the Czech Republic); SVV (Specific University Research)	This project was supported by the Czech Science Foundation (www.gacr.cz), project no. P506/10/0403. Support to KC was given by the SVV (Specific University Research) project no. SVV-2013-265206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1982, CAN J ZOOL, V60, P921, DOI 10.1139/z82-124; ALCOCK J, 1975, BEHAVIOUR, V54, P142, DOI 10.1163/156853975X00371; [Anonymous], 1971, INSECT SOC; [Anonymous], 1974, SOCIAL BEHAV BEES; BARTHELL JF, 1995, SOUTHWEST ENTOMOL, V20, P117; Ben Mordechai Y, 1978, J ENTOMOLOGY, P107; BROCKMANN HJ, 1979, BEHAVIOUR, V71, P203, DOI 10.1163/156853979X00179; Brockmann JH, 1979, J THEOR BIOL, V77, P473; Broom M, 2004, B MATH BIOL, V66, P1645, DOI 10.1016/j.bulm.2004.03.009; BULMER MG, 1984, J THEOR BIOL, V106, P529, DOI 10.1016/0022-5193(84)90005-5; EICKWORT G C, 1977, Journal of the Kansas Entomological Society, V50, P577; EICKWORT G C, 1977, Journal of the Kansas Entomological Society, V50, P1; EICKWORT GC, 1975, EVOLUTION, V29, P142, DOI [10.2307/2407147, 10.1111/j.1558-5646.1975.tb00821.x]; Fabre J. H., 1914, MASON BEES; FIELD J, 1989, BEHAVIOUR, V110, P219, DOI 10.1163/156853989X00475; FIELD J, 1992, BIOL REV, V67, P79, DOI 10.1111/j.1469-185X.1992.tb01659.x; FISHER RM, 1993, ETHOL ECOL EVOL, V5, P157, DOI 10.1080/08927014.1993.9523099; GILLESPIE JH, 1974, GENETICS, V76, P601; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HEFETZ A, 1992, J ZOOL, V226, P529, DOI 10.1111/j.1469-7998.1992.tb07496.x; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Jang YW, 1996, J INSECT BEHAV, V9, P493, DOI 10.1007/BF02214025; KAITALA V, 1990, J THEOR BIOL, V144, P445, DOI 10.1016/S0022-5193(05)80086-4; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Malyshev, 1936, EOS, V11, P201; MATHEWS RW, 1965, CONTRIBUTIONS AM ENT, V1, P1; MICHENER CD, 1958, ECOLOGY, V39, P207, DOI 10.2307/1931865; MICHENER CHARLES D., 1956, UNIV KANSAS SCI BULL, V37, P645; MILLER RC, 1973, INSECT SOC, V20, P365, DOI 10.1007/BF02226089; NEFF JL, 1982, J KANSAS ENTOMOL SOC, V55, P499; Potts SG, 1997, ECOL ENTOMOL, V22, P319, DOI 10.1046/j.1365-2311.1997.00071.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rezkova K, 2012, J INSECT BEHAV, V25, P24, DOI 10.1007/s10905-011-9274-8; ROSENHEIM JA, 1990, ANN ENTOMOL SOC AM, V83, P277, DOI 10.1093/aesa/83.3.277; Schonitzer K., 1990, Entomofauna, V11, P377; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Spessa A, 2000, ANN ENTOMOL SOC AM, V93, P684, DOI 10.1603/0013-8746(2000)093[0684:SIAMHC]2.0.CO;2; Straka J, 2013, LIFESPAN NA IN PRESS; Velthuis H, 1987, EXPERIENTIA BASEL S, P405; Vinson SB, 2000, ANN ENTOMOL SOC AM, V93, P254, DOI 10.1603/0013-8746(2000)093[0254:NSUAAF]2.0.CO;2; Ward SA, 1998, AM NAT, V152, P249, DOI 10.1086/286165; Wcislo W, 1985, SOCIOBIOLOGY, V1, P115; WCISLO WT, 1987, BIOL REV, V62, P515, DOI 10.1111/j.1469-185X.1987.tb01640.x; WCISLO WT, 1984, BEHAV ECOL SOCIOBIOL, V15, P157, DOI 10.1007/BF00299384; WILLIAMS HJ, 1986, J KANSAS ENTOMOL SOC, V59, P588; Wossler TC, 2002, APIDOLOGIE, V33, P139, DOI 10.1051/apido:2002006; Wuellner CT, 1999, J INSECT BEHAV, V12, P845, DOI 10.1023/A:1020913328589	48	9	10	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73806	10.1371/journal.pone.0073806	http://dx.doi.org/10.1371/journal.pone.0073806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066074	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000056
J	Li, XJ; He, LG; Hu, YP; Duan, H; Li, XL; Tan, SY; Zou, M; Gu, CP; Zeng, XZ; Yu, L; Xu, JK; Liu, SW				Li, Xiaojuan; He, Longgang; Hu, Yiping; Duan, Heng; Li, Xianglian; Tan, Suiyi; Zou, Min; Gu, Chunping; Zeng, Xiangzhou; Yu, Le; Xu, Jiake; Liu, Shuwen			Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; AUTOIMMUNE ARTHRITIS; MATURE OSTEOCLASTS; ADJUVANT ARTHRITIS; GENE-EXPRESSION; RAW264.7 CELLS; DIFFERENTIATION; MECHANISMS	Receptor activator of NF-kappa B ligand (RANKL) is essential for osteoclastogenesis. Targeting RANKL signaling pathways has been an encouraging strategy for treating lytic bone diseases such as osteoporosis and rheumatoid arthritis (RA). Sinomenine (SIN), derived from Chinese medicinal plant Sinomenioum acutum, is an active compound to treat RA, but its effect on osteoclasts has been hitherto unknown. In the present study, SIN was found to ameliorate M. tuberculosis H37Ra (Mt)-induced bone loss in rats with a decreased serum level of TRACP5b and RANKL, and an increased level of osteoprotegerin (OPG). In vitro study also showed that SIN could inhibit RANKL-induced osteoclast formation and bone resorption. The osteoclastic specific marker genes induced by RANKL including c-Src, MMP-9, TRACP were inhibited by SIN in a dose dependent manner. Signal transduction studies showed that SIN could obviously reduce the expression of RANK adaptor molecule TRAF6 and down-regulate RANKL-induced NF-kappa B activation. It decreased the RANKL-induced p38, JNK posphorylation but not ERK1/2 posphorylation. SIN could also reduce RANKL-mediated calcium influx which is associated with TRAF6/c-Src complex. Finally, SIN suppressed RANKL induced AP-1 and NFAT transcription, as well as the gene expression of NFATc1 and AP-1 components (Fra-1, Fra-2, c-Fos). The protein expression of c-Fos and TRAF6 were also inhibited by SIN after RANKL stimulation. Taken together, SIN could attenuate osteoclast formation and Mt-induced bone loss by mediating RANKL signaling pathways.	[Li, Xiaojuan; He, Longgang; Hu, Yiping; Duan, Heng; Li, Xianglian; Tan, Suiyi; Zou, Min; Gu, Chunping; Zeng, Xiangzhou; Yu, Le; Liu, Shuwen] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia	Southern Medical University - China; University of Western Australia	Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	liusw@smu.edu.cn	Zeng, Xiangzhou/AAK-1176-2020	Liu, Shuwen/0000-0001-6346-5006; Xu, Jiake/0000-0003-2021-8309	Natural Science Foundation of China (NSFC) [81073119, 30801413, 81228013]; Guangdong Pearl River Scholar Funded Scheme	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Pearl River Scholar Funded Scheme	This work was supported by the Natural Science Foundation of China (NSFC)(81073119, 30801413) to Xiaojuan Li and Guangdong Pearl River Scholar Funded Scheme to Shuwen Liu. This study was also supported by a grant from the Natural Science Foundation of China (NSFC) (81228013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Braun T, 2012, CURR OSTEOPOROS REP, V10, P101, DOI 10.1007/s11914-012-0104-5; Chai XY, 2012, BIOORG MED CHEM LETT, V22, P5849, DOI 10.1016/j.bmcl.2012.07.087; Deal C, 2012, CURR RHEUMATOL REP, V14, P231, DOI 10.1007/s11926-012-0253-7; Feng H, 2007, AUTOIMMUNITY, V40, P532, DOI 10.1080/08916930701615159; Geusens P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3375; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; He XB, 2005, IMMUNOL LETT, V98, P91, DOI 10.1016/j.imlet.2004.10.027; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Hu YX, 2003, CHINESE MED J-PEKING, V116, P284; Huang F, 2008, INT IMMUNOPHARMACOL, V8, P502, DOI 10.1016/j.intimp.2007.12.009; Ju XD, 2010, YAKUGAKU ZASSHI, V130, P1053, DOI 10.1248/yakushi.130.1053; Kaji H, 1997, J BONE MINER RES, V12, P734, DOI 10.1359/jbmr.1997.12.5.734; Kim MH, 2009, J CELL PHYSIOL, V221, P618, DOI 10.1002/jcp.21892; King TJ, 2012, AM J PATHOL, V181, P121, DOI 10.1016/j.ajpath.2012.03.037; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Le Li, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P129; Li XJ, 2006, LIFE SCI, V79, P665, DOI 10.1016/j.lfs.2006.02.014; LIU L, 1994, ARZNEIMITTEL-FORSCH, V44-2, P1223; Liu LA, 1996, INT J IMMUNOPHARMACO, V18, P529, DOI 10.1016/S0192-0561(96)00025-2; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Maruotti N, 2011, CLIN EXP MED, V11, P137, DOI 10.1007/s10238-010-0117-2; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Nakamura Toshitaka, 2009, Clin Calcium, V19, P381, DOI CliCa0903381386; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Ou YQ, 2011, RHEUMATOL INT, V31, P1479, DOI 10.1007/s00296-010-1506-2; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Rahman MM, 2006, J LIPID RES, V47, P1739, DOI 10.1194/jlr.M600151-JLR200; Schett G, 2005, NAT CLIN PRACT RHEUM, V1, P47, DOI 10.1038/ncprheum0036; Sinningen K, 2012, ENDOCRINE, V42, P52, DOI 10.1007/s12020-012-9696-x; Stolina M, 2005, J BONE MINER RES, V20, P1756, DOI 10.1359/JBMR.050601; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Takayanagi H, 1997, BIOCHEM BIOPH RES CO, V240, P279, DOI 10.1006/bbrc.1997.7404; Tomomura M, 2012, J BIOL CHEM, V287, P17963, DOI 10.1074/jbc.M112.358796; Tong L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2268; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wang QX, 2011, INT IMMUNOPHARMACOL, V11, P373, DOI 10.1016/j.intimp.2010.11.018; Wang Y, 2005, J ETHNOPHARMACOL, V98, P37, DOI 10.1016/j.jep.2004.12.022; Wu WN, 2011, BRIT J PHARMACOL, V164, P1445, DOI 10.1111/j.1476-5381.2011.01487.x; Wu X, 2012, J BONE MINER RES, V27, P1298, DOI 10.1002/jbmr.1576; XIE SX, 1993, ACTA PHARM SINIC, V14, pS12; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Xu M, 2008, PLANTA MED, V74, P1423, DOI 10.1055/s-2008-1081346; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Zhao Y, 2007, INT IMMUNOPHARMACOL, V7, P637, DOI 10.1016/j.intimp.2007.01.007; Zhou H, 2008, BIOCHEM BIOPH RES CO, V376, P352, DOI 10.1016/j.bbrc.2008.08.153	55	25	32	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74274	10.1371/journal.pone.0074274	http://dx.doi.org/10.1371/journal.pone.0074274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066131	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000113
J	Lone, AG; Selinger, LB; Uwiera, RRE; Xu, Y; Inglis, GD				Lone, Abdul G.; Selinger, L. Brent; Uwiera, Richard R. E.; Xu, Yong; Inglis, G. Douglas			Campylobacter jejuni Colonization Is Associated with a Dysbiosis in the Cecal Microbiota of Mice in the Absence of Prominent Inflammation	PLOS ONE			English	Article							ALLOWS ANALYSIS; GUT MICROBIOTA; SALMONELLA; HOST; INFECTION; C57BL/6; CATTLE; PCR; QUANTIFICATION; ENVIRONMENT	Background: Campylobacter jejuni causes enterocolitis in humans, but does not incite disease in asymptomatic carrier animals. To survive in the intestine, C. jejuni must successfully compete with the microbiota and overcome the host immune defense. Campylobacter jejuni colonization success varies considerably amongst individual mice, and we examined the degree to which the intestinal microbiota was affected in mice (i.e. a model carrier animal) colonized by C. jejuni at high relative to low densities. Methods: Mice were inoculated with C. jejuni or buffer, and pathogen shedding and intestinal colonization were measured. Histopathologic scoring and quantification of mRNA expression for alpha-defensins, toll-like receptors, and cytokine genes were conducted. Mucosa-associated bacterial communities were characterized by two approaches: multiplexed barcoded pyrosequencing and terminal restriction fragment length polymorphism analysis. Results: Two C. jejuni treatments were established based on the degree of cecal and colonic colonization; C. jejuni Group A animals were colonized at high cell densities, and C. jejuni Group B animals were colonized at lower cell densities. Histological examination of cecal and colonic tissues indicated that C. jejuni did not incite visible pathologic changes. Although there was no significant difference among treatments in expression of mRNA for alpha-defensins, toll-like receptors, or cytokine genes, a trend for increased expression of toll-like receptors and cytokine genes was observed for C. jejuni Group A. The results of the two methods to characterize bacterial communities indicated that the composition of the cecal microbiota of C. jejuni Group A mice differed significantly from C. jejuni Group B and Control mice. This difference was due to a reduction in load, diversity and richness of bacteria associated with the cecal mucosa of C. jejuni Group A mice. Conclusions: High density colonization by C. jejuni is associated with a dysbiosis in the cecal microbiota independent of prominent inflammation.	[Lone, Abdul G.; Inglis, G. Douglas] Agr & Agri Food Canada, Res Ctr, Lethbridge, AB, Canada; [Lone, Abdul G.; Selinger, L. Brent; Xu, Yong] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Uwiera, Richard R. E.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Agriculture & Agri Food Canada; University of Lethbridge; University of Alberta	Inglis, GD (corresponding author), Agr & Agri Food Canada, Res Ctr, Lethbridge, AB, Canada.	Douglas.Inglis@agr.gc.ca			Alberta Livestock and Meat Agency; Alberta Innovates Bio Solutions; Advanced Foods and Materials Canada Ltd; Agriculture and Agri-Food Canada (Peer Review Grant)	Alberta Livestock and Meat Agency; Alberta Innovates Bio Solutions; Advanced Foods and Materials Canada Ltd; Agriculture and Agri-Food Canada (Peer Review Grant)(Agriculture & Agri Food Canada)	This work was funded in part by grants from the Alberta Livestock and Meat Agency, Alberta Innovates Bio Solutions, Advanced Foods and Materials Canada Ltd, and Agriculture and Agri-Food Canada (Peer Review Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Andersson ML, 2012, MUCOSAL IMMUNOL, V5, P367, DOI 10.1038/mi.2012.22; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bavananthasivam J, 2012, APPL ENVIRON MICROB, V78, P6683, DOI 10.1128/AEM.01119-12; Bell JA, 2013, MICROB PATHOGENESIS, V54, P1, DOI 10.1016/j.micpath.2012.08.001; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; CALVA JJ, 1988, LANCET, V1, P503; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Cone LA, 2003, JCR-J CLIN RHEUMATOL, V9, P362, DOI 10.1097/01.rhu.0000090261.11345.87; Costa E, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-14; Costa E, 2009, J MICROBIOL METH, V78, P175, DOI 10.1016/j.mimet.2009.05.011; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Davis Lindsay, 2008, Curr Protoc Microbiol, VChapter 8, DOI 10.1002/9780471729259.mc08a03s11; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; FIGUEROA G, 1989, J CLIN MICROBIOL, V27, P1040, DOI 10.1128/JCM.27.5.1040-1044.1989; FOX JG, 1986, LAB ANIM SCI, V36, P28; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Inglis GD, 2012, J AOAC INT, V95, P5, DOI 10.5740/jaoacint.SGE_Inglis; Inglis GD, 2010, COMPARATIVE MED, V60, P469; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P5145, DOI 10.1128/AEM.71.9.5145-5153.2005; Inglis GD, 2004, APPL ENVIRON MICROB, V70, P2296, DOI 10.1128/AEM.70.4.2296-2306.2004; Inglis GD, 2003, APPL ENVIRON MICROB, V69, P3435, DOI 10.1128/AEM.69.6.3435-3447.2003; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; JESUDASON MV, 1989, INFECT IMMUN, V57, P2279, DOI 10.1128/IAI.57.8.2279-2282.1989; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Karlsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-37; Kwan PSL, 2008, APPL ENVIRON MICROB, V74, P5130, DOI 10.1128/AEM.02198-07; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011827; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mansfield LS, 2008, MICROB PATHOGENESIS, V45, P241, DOI 10.1016/j.micpath.2008.05.010; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Mcbee ME, 2008, INFECT IMMUN, V76, P4851, DOI 10.1128/IAI.00745-08; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Oksanen J., 2016, R PACKAG; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Quinn PJ, 2011, VET MICROBIOLOGY MIC, P351; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rinella ES, 2006, FEMS MICROBIOL LETT, V262, P236, DOI 10.1111/j.1574-6968.2006.00396.x; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi JS, 2007, J IMMUNOL, V179, P1245, DOI 10.4049/jimmunol.179.2.1245; Siegesmund AM, 2004, MICROBIOL-SGM, V150, P561, DOI 10.1099/mic.0.26466-0; Songer JG, 2005, GENUS BRACHYSPIRA VE, P232; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Symonds EL, 2009, CLIN EXP IMMUNOL, V157, P148, DOI 10.1111/j.1365-2249.2009.03934.x; Taboada EN, 2012, J CLIN MICROBIOL, V50, P788, DOI 10.1128/JCM.00669-11; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	81	16	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75325	10.1371/journal.pone.0075325	http://dx.doi.org/10.1371/journal.pone.0075325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066174	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000156
J	Suzuki, S; Nozawa, Y; Tsukamoto, S; Kaneko, T; Imai, H; Minami, N				Suzuki, Shinnosuke; Nozawa, Yusuke; Tsukamoto, Satoshi; Kaneko, Takehito; Imai, Hiroshi; Minami, Naojiro			ING3 Is Essential for Asymmetric Cell Division during Mouse Oocyte Maturation	PLOS ONE			English	Article							SMALL GTPASES; CYTOKINESIS; PROTEIN; FAMILY; GROWTH; PHD; ORGANIZATION; EXPRESSION; FACTOR-1; POLARITY	ING3 (inhibitor of growth family, member 3) is a subunit of the nucleosome acetyltransferase of histone 4 (NuA4) complex, which activates gene expression. ING3, which contains a plant homeodomain (PHD) motif that can bind to trimethylated lysine 4 on histone H3 (H3K4me3), is ubiquitously expressed in mammalian tissues and governs transcriptional regulation, cell cycle control, and apoptosis via p53-mediated transcription or the Fas/caspase-8 pathway. Thus, ING3 plays a number of important roles in various somatic cells. However, the role(s) of ING3 in germ cells remains unknown. Here, we show that loss of ING3 function led to the failure of asymmetric cell division and cortical reorganization in the mouse oocyte. Immunostaining showed that in fully grown germinal vesicle (GV) oocytes, ING3 localized predominantly in the GV. After germinal vesicle breakdown (GVBD), ING3 homogeneously localized in the cytoplasm. In oocytes where Ing3 was targeted by siRNA microinjection, we observed symmetric cell division during mouse oocyte maturation. In those oocytes, oocyte polarization was not established due to the failure to form an actin cap or a cortical granule-free domain (CGFD), the lack of which inhibited spindle migration. These features were among the main causes of abnormal symmetric cell division. Interestingly, an analysis of the mRNA expression levels of genes related to asymmetric cell division revealed that only mTOR was downregulated, and, furthermore, that genes downstream of mTOR (e.g., Cdc42, Rac1, and RhoA) were also downregulated in siIng3-injected oocytes. Therefore, ING3 may regulate asymmetric cell division through the mTOR pathway during mouse oocyte maturation.	[Suzuki, Shinnosuke; Nozawa, Yusuke; Imai, Hiroshi; Minami, Naojiro] Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto, Japan; [Tsukamoto, Satoshi] Natl Inst Radiol Sci, Lab Anim & Genome Sci Sect, Chiba 260, Japan; [Kaneko, Takehito] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan	Kyoto University; National Institutes for Quantum Science & Technology; Kyoto University	Minami, N (corresponding author), Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto, Japan.	oog1nao@kais.kyoto-u.ac.jp		Suzuki, Shinnosuke/0000-0003-0241-1455	Ministry of Education, Science and Culture [23380164]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Science and Culture to N.M. (grant 23380164). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguissa-Toure AH, 2011, CELL MOL LIFE SCI, V68, P45, DOI 10.1007/s00018-010-0509-1; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; ALEXANDRE H, 1988, GAMETE RES, V21, P359, DOI 10.1002/mrd.1120210405; Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Awe JP, 2013, CELL REPROGRAM; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURRENT OPINION GENE, V14; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Huang X, 2013, HISTOCHEM CELL BIOL, V139, P525, DOI 10.1007/s00418-012-1051-z; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jafarnejad SM, 2012, CANCER METAST REV, V31, P55, DOI 10.1007/s10555-011-9329-5; Jordan SN, 2012, CYTOSKELETON, V69, P919, DOI 10.1002/cm.21071; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Lee SE, 2012, MOL REPROD DEV, V79, P356, DOI 10.1002/mrd.22035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Lu M, 2012, ONCOLOGY LETT, P4; Ma PP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003377; Maro B, 2002, NATURE CELL BIOL, V4; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sun SC, 2012, FERTIL STERIL, V97, P984, DOI 10.1016/j.fertnstert.2012.01.101; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Wang SF, 2009, BIOL REPROD, V80, P555, DOI 10.1095/biolreprod.108.073197; Wang YM, 2006, J BIOL CHEM, V281, P11887, DOI 10.1074/jbc.M511309200; WEBB M, 1986, J EMBRYOL EXP MORPH, V95, P131; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang CH, 2011, CELL CYCLE, V10, P1861, DOI 10.4161/cc.10.11.15797; Zheng P, 2012, J CELL SCI; Zhong ZS, 2005, MOL REPROD DEV, V71, P256, DOI 10.1002/mrd.20253	43	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74749	10.1371/journal.pone.0074749	http://dx.doi.org/10.1371/journal.pone.0074749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066152	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000134
J	Eisen, S; Pealing, L; Aldridge, RW; Siedner, MJ; Necochea, A; Leybell, I; Valencia, T; Herrera, B; Wiles, S; Friedland, JS; Gilman, RH; Evans, CA				Eisen, Sarah; Pealing, Louise; Aldridge, Robert W.; Siedner, Mark J.; Necochea, Alejandro; Leybell, Inna; Valencia, Teresa; Herrera, Beatriz; Wiles, Siouxsie; Friedland, Jon S.; Gilman, Robert H.; Evans, Carlton A.			Effects of Ascent to High Altitude on Human Antimycobacterial Immunity	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; RESISTANT TUBERCULOSIS; HUMAN MACROPHAGES; TUBERCLE-BACILLI; GROWTH; BCG; EXPRESSION; HYPOXIA; PERU	Background: Tuberculosis infection, disease and mortality are all less common at high than low altitude and ascent to high altitude was historically recommended for treatment. The immunological and mycobacterial mechanisms underlying the association between altitude and tuberculosis are unclear. We studied the effects of altitude on mycobacteria and antimycobacterial immunity. Methods: Antimycobacterial immunity was assayed in 15 healthy adults residing at low altitude before and after they ascended to 3400 meters; and in 47 long-term high-altitude residents. Antimycobacterial immunity was assessed as the extent to which participants' whole blood supported or restricted growth of genetically modified luminescent Bacille Calmette-Guerin (BCG) mycobacteria during 96 hours incubation. We developed a simplified whole blood assay that could be used by a technician in a low-technology setting. We used this to compare mycobacterial growth in participants' whole blood versus positive-control culture broth and versus negative-control plasma. Results: Measurements of mycobacterial luminescence predicted the number of mycobacterial colonies cultured six weeks later. At low altitude, mycobacteria grew in blood at similar rates to positive-control culture broth whereas ascent to high altitude was associated with restriction (p <= 0.002) of mycobacterial growth to be 4-times less than in culture broth. At low altitude, mycobacteria grew in blood 25-times more than negative-control plasma whereas ascent to high altitude was associated with restriction (p <= 0.01) of mycobacterial growth to be only 6-times more than in plasma. There was no evidence of differences in antimycobacterial immunity at high altitude between people who had recently ascended to high altitude versus long-term high-altitude residents. Conclusions: An assay of luminescent mycobacterial growth in whole blood was adapted and found to be feasible in low-resource settings. This demonstrated that ascent to or residence at high altitude was associated with decreased mycobacterial growth in whole blood relative to controls, consistent with altitude-related augmentation of antimycobacterial cellular immunity.	[Eisen, Sarah; Pealing, Louise; Aldridge, Robert W.; Siedner, Mark J.; Leybell, Inna; Valencia, Teresa; Herrera, Beatriz; Gilman, Robert H.; Evans, Carlton A.] Univ Peruana Cayetano Heredia, IFHAD Innovat Hlth & Dev, Lab Res & Dev 218, Lima, Peru; [Eisen, Sarah; Pealing, Louise; Aldridge, Robert W.] UCL, Res Dept Infect & Populat Hlth, London, England; [Eisen, Sarah; Pealing, Louise; Aldridge, Robert W.] UCL, Sch Med, London W1N 8AA, England; [Siedner, Mark J.; Leybell, Inna; Valencia, Teresa; Herrera, Beatriz] Asociac Benef Prisma, Lima, Peru; [Necochea, Alejandro] Yale Univ, Sch Med, New Haven, CT USA; [Wiles, Siouxsie; Friedland, Jon S.; Evans, Carlton A.] Univ London Imperial Coll Sci Technol & Med, London, England; [Wiles, Siouxsie; Friedland, Jon S.; Evans, Carlton A.] Wellcome Trust Imperial Coll Ctr Global Hlth Res, London, England; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; University of London; University College London; University of London; University College London; UCL Medical School; Yale University; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Evans, CA (corresponding author), Univ Peruana Cayetano Heredia, IFHAD Innovat Hlth & Dev, Lab Res & Dev 218, Lima, Peru.	carlton.evans@ifhad.org	Wiles, Siouxsie/E-1690-2011	Wiles, Siouxsie/0000-0002-0467-0015; Aldridge, Robert/0000-0003-0542-0816; Evans, Carlton/0000-0002-6873-5447; Friedland, Jonathan S/0000-0001-7789-9649; Siedner, Mark/0000-0003-3506-842X	Wellcome Trust; charity IFHAD: Innovation For Health And Development; MRC; World Health Organization; Sir Halley Stewart Trust; Foundation for Innovative New Diagnostics; Bill & Melinda Gates Foundation; Imperial College Biomedical Research Centre; DFID; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [IPF 11-05, ACF-2009-18-028] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); charity IFHAD: Innovation For Health And Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Health Organization(World Health Organization); Sir Halley Stewart Trust; Foundation for Innovative New Diagnostics; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Imperial College Biomedical Research Centre; DFID; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded principally by the Wellcome Trust and the charity IFHAD: Innovation For Health And Development. Members of the project team and specific project activities were also funded by the Joint Global Health Trials consortium (MRC, DFID & Wellcome Trust), the World Health Organization, the Sir Halley Stewart Trust, the Foundation for Innovative New Diagnostics and the Bill & Melinda Gates Foundation. JSF acknowledges support from the Imperial College Biomedical Research Centre. SE and LP gratefully acknowledge multiple donors for supporting their medical student elective travel and subsistence for this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Pan Health Organization, 2002, AM PAN HLTH ORG SCI, V587; Burl S, 2013, J IMMUNOL METHODS, V394, P121, DOI 10.1016/j.jim.2013.05.006; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; CHOHAN IS, 1979, INT J BIOMETEOROL, V23, P21, DOI 10.1007/BF01553374; Churchyard GJ, 2009, CLIN CHEST MED, V30, P769, DOI 10.1016/j.ccm.2009.08.009; Cline JC, 1997, ANN PHARMACOTHER, V31, P775; CROWLE AJ, 1981, INFECT IMMUN, V31, P453, DOI 10.1128/IAI.31.1.453-464.1981; Eisen S, 2012, IUATLD KL PUBLISHED; Gardiner C F, 1923, Trans Am Climatol Clin Assoc, V39, P197; Harding R, 2012, LANCET INFECT DIS, V12, P643, DOI 10.1016/S1473-3099(12)70084-1; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Hoal-Van Helden EG, 2001, CELL BIOL INT, V25, P71, DOI 10.1006/cbir.2000.0679; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Ko G, 2000, TUBERCLE LUNG DIS, V80, P217, DOI 10.1054/tuld.2000.0249; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; LYON RH, 1961, AM REV RESPIR DIS, V83, P255; Mansoer JR, 1999, INT J TUBERC LUNG D, V3, P156; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; MEEHAN RT, 1987, ANN EMERG MED, V16, P974, DOI 10.1016/S0196-0644(87)80743-6; Nickel D, 2012, J IMMUNOL, V188, P4001, DOI 10.4049/jimmunol.1100976; Olender S, 2003, AM J TROP MED HYG, V68, P721, DOI 10.4269/ajtmh.2003.68.721; Perez-Padilla R, 2004, INT J TUBERC LUNG D, V8, P1315; PINTO M R M, 1972, Tubercle, V53, P182, DOI 10.1016/0041-3879(72)90015-3; RILEY RL, 1976, AM REV RESPIR DIS, V113, P413; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; ROGERS F B, 1969, Bulletin of the History of Medicine, V43, P1; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Saito M, 2006, AM J TROP MED HYG, V75, P49, DOI 10.4269/ajtmh.2006.75.49; SEVER JL, 1957, J INFECT DIS, V101, P193, DOI 10.1093/infdis/101.2.193; Sinclair D, 2011, COCHRANE DATABASE SY; Smith A, 1840, PRACTICAL OBSERVATIO, P59; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; TRAPANI IL, 1963, P SOC EXP BIOL MED, V113, P571, DOI 10.3181/00379727-113-28429; Upshur R, 2009, B WORLD HEALTH ORGAN, V87, P481, DOI 10.2471/BLT.08.051698; Vargas MH, 2004, INT J TUBERC LUNG D, V8, P1321; Vree M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-109; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization (WHO), 2012, MULT RES TB MDR TR 2; Young Douglas, 2007, Novartis Found Symp, V281, P169	41	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74220	10.1371/journal.pone.0074220	http://dx.doi.org/10.1371/journal.pone.0074220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058530	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000324408400057
J	Gong, L; Zhang, W; Zhou, JD; Lu, J; Xiong, H; Shi, XL; Chen, JQ				Gong, Liang; Zhang, Wei; Zhou, Jianding; Lu, Jie; Xiong, Hua; Shi, Xueli; Chen, Jianqiang			Prognostic Value of HIFs Expression in Head and Neck Cancer: A Systematic Review	PLOS ONE			English	Review							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SQUAMOUS-CELL-CARCINOMAS; NASOPHARYNGEAL CARCINOMA; OROPHARYNGEAL CANCER; LARYNGEAL CARCINOMA; FACTOR 1-ALPHA; OVEREXPRESSION; METAANALYSES; MARKERS; RADIOTHERAPY	Background: Tumor hypoxia plays a fundamental role in resistance to therapy and disease progression. A number of studies have assessed the prognostic role of HIFs expression in head and neck cancer (HNC), but no consistent outcomes are reported. Methodology: A systematical search was performed to search relevant literatures in PubMed, Web of Science and ISI Web of Knowledge databases. The patients' clinical characteristics and survival outcome were extracted. The correlation between HIFs expression and prognosis was analyzed. Principal Findings: A total of 28 studies assessed the association between HIFs and HNC survival, the result showed that overexpressed HIFs was significantly associated with increase of mortality risk (HR = 2.12; 95% CI: 1.52-2.94; I-2 74%). Subgroup analysis on different HIF isoforms with OS indicated that both HIF-1 alpha and HIF-2 alpha were associated with worse prognosis. The pooled HRs were 1.72(95% CI 1.34-2.20; I-2 70.7%) and 1.79(95% CI: 1.42-2.27, I-2 0%). Further subgroup analysis was performed by different geographical locations, disease subtype, stage, types of variate analysis and cut-off value. The results revealed that overexpressed HIF-1 alpha was significantly associated with poor prognosis in Asian patients (HR = 2.34; 95% CI: 1.76-3.1; I-2 48.9%), but not in European patients (HR = 1.13; 95% CI: 0.77-1.66; I-2 78.3%). Furthermore, HIF-1 alpha overexpression was significantly associated with worse OS in oral carcinoma(HR = 2.1; 95% CI: 1.11-3.97; I-2 81.7%), nasopharyngeal carcinoma(HR = 2.07; 95% CI: 1.23-3.49; I-2 22.5%) and oropharynx carcinoma(HR = 1.76; 95% CI: 1.05-2.97; I-2 61%), but not in laryngeal carcinoma(HR = 1.38; 95% CI: 0.87-2.19; I-2 62.5%). We also found that the prognostic value of HIF-1 alpha overexpression existed only when using staining and percentage as positive definition (HR = 1.82; 95% CI 1.42-2.33; I-2 9.9%). Conclusions: This study showed that overexpressed HIFs were significantly associated with increase of mortality risk. Subgroup analysis revealed that overexpressed HIF-1 alpha was significantly associated with worse prognosis of HNC in Asian countries. Additionally, HIF-1 alpha had different prognostic value in different HNC disease subtypes.	[Gong, Liang; Zhou, Jianding; Lu, Jie; Xiong, Hua; Shi, Xueli; Chen, Jianqiang] Wenzhou Med Coll, Affiliated Cixi Hosp, Dept Otorhinolaryngol, Cixi, Peoples R China; [Zhang, Wei] Zhejiang Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Chen, JQ (corresponding author), Wenzhou Med Coll, Affiliated Cixi Hosp, Dept Otorhinolaryngol, Cixi, Peoples R China.	jianqiangchencx@126.com			Nature science foundation of Zhejiang Province [LY12H13002]; project of Zhejiang Traditional Chinese Medicine Administration [2012ZZ012]; project of Zhejiang medical health science plan [2011KYA145]; project of Zhejiang traditional Chinese medicine research [2013ZB115]; Nature science foundation of Ningbo City [2012A610205, 2012A610206]	Nature science foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); project of Zhejiang Traditional Chinese Medicine Administration; project of Zhejiang medical health science plan; project of Zhejiang traditional Chinese medicine research; Nature science foundation of Ningbo City	This work was supported by the Nature science foundation of Zhejiang Province (Grant No. LY12H13002), project of Zhejiang Traditional Chinese Medicine Administration (Grant No.2012ZZ012), project of Zhejiang medical health science plan (Grant No.2011KYA145), project of Zhejiang traditional Chinese medicine research (Grant No. 2013ZB115) and Nature science foundation of Ningbo City (Grant No 2012A610205, 2012A610206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Beasley NJP, 2002, CANCER RES, V62, P2493; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fillies T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-84; Fyles AW, 1998, RADIOTHER ONCOL, V48, P149, DOI 10.1016/S0167-8140(98)00044-9; Gao Y KF, 2012, J ORAL MAXILLOFACIAL, V22, P183; [龚龙 Gong Long], 2012, [中国癌症杂志, China Oncology], V22, P269; Han MW, 2012, HEAD NECK-J SCI SPEC, V34, P1395, DOI 10.1002/hed.21945; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong A, 2013, ORAL ONCOL, V49, P354, DOI 10.1016/j.oraloncology.2012.11.006; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Huang CF, 2012, HISTOPATHOLOGY, V60, P793, DOI 10.1111/j.1365-2559.2011.04130.x; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kang FW, 2013, EXP THER MED, V5, P112, DOI 10.3892/etm.2012.779; Kappler M, 2008, STRAHLENTHER ONKOL, V184, P393, DOI 10.1007/s00066-008-1813-7; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; Koukourakis MI, 2002, INT J RADIAT ONCOL, V53, P1192, DOI 10.1016/S0360-3016(02)02848-1; Liang XH, 2011, ORAL ONCOL, V47, P92, DOI 10.1016/j.oraloncology.2010.11.014; Lin Peng, 2009, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V44, P480; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Liu SK, 2008, RADIOTHER ONCOL, V88, P258, DOI 10.1016/j.radonc.2008.04.005; Lu XG, 2008, CLIN ONCOL-UK, V20, P606, DOI 10.1016/j.clon.2008.07.001; MANTEL N, 1959, J NATL CANCER I, V22, P719; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Roh JL, 2008, J SURG ONCOL, V97, P596, DOI 10.1002/jso.21045; Schrijivers ML, 2008, INT J RADIAT ONCOL, V72, P161, DOI 10.1016/j.ijrobp.2008.05.025; Shou Z, 2012, J CANCER RES CLIN, V138, P585, DOI 10.1007/s00432-011-1125-7; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Wan XB, 2012, CANCER SCI, V103, P1586, DOI 10.1111/j.1349-7006.2012.02332.x; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Winter SC, 2006, CANCER-AM CANCER SOC, V107, P757, DOI 10.1002/cncr.21983; Wu XH, 2013, ONCOL LETT, V5, P261, DOI 10.3892/ol.2012.941; Zhang Y, 2009, MED J COMMUNICATIONS, V23, P429; Zheng Y, 2013, ONCOL LETT, V5, P1285, DOI 10.3892/ol.2013.1185; Zhu GQ, 2010, CLIN CANCER RES, V16, P4732, DOI 10.1158/1078-0432.CCR-10-1408	39	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75094	10.1371/journal.pone.0075094	http://dx.doi.org/10.1371/journal.pone.0075094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058651	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400107
J	Li, S; Hu, T; Chen, YL; Zhou, H; Li, X; Cheng, XD; Yang, R; Wang, SX; Xie, X; Ma, D				Li, Shuang; Hu, Ting; Chen, Yile; Zhou, Hang; Li, Xiong; Cheng, Xiaodong; Yang, Ru; Wang, Shixuan; Xie, Xing; Ma, Ding			Adjuvant Chemotherapy, a Valuable Alternative Option in Selected Patients with Cervical Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; SQUAMOUS-CELL CARCINOMA; EARLY-STAGE CANCER; HIGH-RISK; RADICAL HYSTERECTOMY; CONCURRENT CHEMORADIATION; PELVIC RADIATION; UTERINE CERVIX; PHASE-III; RADIOTHERAPY	Radiotherapy is the standard treatment for cervical cancer, but causes radiotherapy-induced complications. Recently, chemotherapy has been more extensively utilized. Here, we perform a large-scale comparison of chemotherapy and radiotherapy. From 2002 to 2008, 2,268 patients were grouped according to adjuvant radiotherapy or chemotherapy before and/or after surgery, and we compared the 5-year overall survival (OS) and disease-free survival (DFS) rates, recurrence rates, side effects, quality of life (QoL), and sexual activity. There were no significant differences between the treatment groups for the 5-year OS and DFS rates (OS: p = 0.053, DFS: p = 0.095), although marginally improved outcomes were observed in the chemotherapy group (OS: 86.5% vs. 82.8%; DFS: 84.5% vs. 81.4%). However, patients with early-stage disease, clinical response, and younger age had increased 5-year OS and DFS rates following chemotherapy compared to radiotherapy (p < 0.05). The chemotherapy group exhibited significantly lower 5-year recurrence and distant failure rates compared to the radiotherapy group (p < 0.001 and p = 0.007, respectively). Nausea and vomiting were the most frequent short-term complications of chemotherapy, whereas bowel and urinary complications were more frequent in the radiotherapy group. Compared to the chemotherapy group, patients who received radiotherapy reported a lower QoL, less frequent sexual activity, and more severe menopausal symptoms (p < 0.05). Cervical cancer patients treated with chemotherapy, especially those with early-stage disease, clinical responses, and younger ages, have more positive outcomes, fewer complications, better QoL and sexual activity, suggesting that chemotherapy may be a valuable alternative option for selected patients.	[Li, Shuang; Hu, Ting; Zhou, Hang; Li, Xiong; Yang, Ru; Wang, Shixuan; Ma, Ding] Huazhong Univ Sci & Technol, Dept Obstet & Gynecol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Yile] Cent S Univ, Affiliated Tumor Hosp, Hunan Prov Tumor Hosp, Dept Gynecol Neoplasms, Changsha, Hunan, Peoples R China; [Cheng, Xiaodong; Xie, Xing] Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Huazhong University of Science & Technology; Central South University	Wang, SX (corresponding author), Huazhong Univ Sci & Technol, Dept Obstet & Gynecol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	sxwang@tjh.tjmu.edu.cn; xiex@zju.edu.cn; dma@tjh.tjmu.edu.cn		Zhou, Hang/0000-0003-2719-790X	Foundation of China (973 Program) [2009CB521808]; National Natural Science Foundation of China [81230038, 81230052, 30973472, 81001151, 81071663, 30973205, 30973184, 81172464, 81101964]; National Major Science and Technology Project [2009ZX09103-739]	Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Project	This work was supported by the Foundation of China (973 Program; No. 2009CB521808) and by grants from the National Natural Science Foundation of China (NO. 81230038; 81230052; 30973472; 81001151; 81071663; 30973205; 30973184; 81172464; 81101964) and National Major Science and Technology Project (No. 2009ZX09103-739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2007, ANN ONCOL, V18, P1423, DOI 10.1093/annonc/mdm377; Banzai C, 2011, EUR J GYNAECOL ONCOL, V32, P521; Einstein MH, 2007, CANCER-AM CANCER SOC, V109, P48, DOI 10.1002/cncr.22369; Fayers PM, 2001, EORTC QLQC30 SCORING, V3rd; FIGO, FIGO GLOB GUID CERV; Frumovitz M, 2005, J CLIN ONCOL, V23, P7428, DOI 10.1200/JCO.2004.00.3996; Ganz PA, 2000, JNCI-J NATL CANCER I, V92, P1054, DOI 10.1093/jnci/92.13.1054; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Greimel ER, 2006, CANCER-AM CANCER SOC, V107, P1812, DOI 10.1002/cncr.22217; Greimel ER, 2009, PSYCHO-ONCOLOGY, V18, P476, DOI 10.1002/pon.1426; Hosaka M, 2008, J OBSTET GYNAECOL RE, V34, P552, DOI 10.1111/j.1447-0756.2008.00739.x; Hsu WC, 2009, GYNECOL ONCOL, V115, P41, DOI 10.1016/j.ygyno.2009.06.028; Hu T, 2012, EUR J CANC; Institutes NC, GUID GYN TUM CERV CA; Jensen PT, 2002, RADIOTHER ONCOL, V65, P29, DOI 10.1016/S0167-8140(02)00263-3; Kasamatsu T, 2009, BRIT J CANCER, V100, P1400, DOI 10.1038/sj.bjc.6605048; Kim JH, 2005, GYNECOL ONCOL, V96, P407, DOI 10.1016/j.ygyno.2004.10.025; Kosmas C, 2009, BRIT J CANCER, V101, P1059, DOI 10.1038/sj.bjc.6605305; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Liu J, 2010, J HUAZHONG U SCI-MED, V30, P626, DOI 10.1007/s11596-010-0554-x; Llorca J, 2006, CANCER LETT, V240, P36, DOI 10.1016/j.canlet.2005.08.021; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; May Taymaa, 2011, Chemother Res Pract, V2011, P806256, DOI 10.1155/2011/806256; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Organization WH, 1979, OFFS PUBL, V48, P16; Perez-Irizarry J, 2010, P R HEALTH SCI J, V29, P364; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Robova H, 2008, INT J GYNECOL CANCER, V18, DOI 10.1111/j.1525-1438.2007.01178.x; Ryu HS, 2005, GYNECOL ONCOL, V96, P490, DOI 10.1016/j.ygyno.2004.10.038; Shibata K, 2008, INT J CLIN ONCOL, V13, P233, DOI 10.1007/s10147-007-0744-0; Takeshima N, 2006, GYNECOL ONCOL, V103, P618, DOI 10.1016/j.ygyno.2006.04.019; THIGPEN T, 1981, CANCER, V48, P899, DOI 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6; Thirlaway K, 1996, QUAL LIFE RES, V5, P81, DOI 10.1007/BF00435972; Tsai CS, 1999, GYNECOL ONCOL, V75, P328, DOI 10.1006/gyno.1999.5527; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Vistad I, 2011, J CANCER SURVIV, V5, P208, DOI 10.1007/s11764-011-0172-z; Vizcaino AP, 2000, INT J CANCER, V86, P429, DOI 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D; Yamashita H, 2010, AM J CLIN ONCOL-CANC, V33, P583, DOI 10.1097/COC.0b013e3181cae5b7; Yoo SC, 2010, ACTA OBSTET GYN SCAN, V89, P126, DOI 10.3109/00016340903348383	40	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73837	10.1371/journal.pone.0073837	http://dx.doi.org/10.1371/journal.pone.0073837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058496	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400037
J	Lugovtsev, VY; Melnyk, D; Weir, JP				Lugovtsev, Vladimir Y.; Melnyk, Darya; Weir, Jerry P.			Heterogeneity of the MDCK Cell Line and Its Applicability for Influenza Virus Research	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; DOME FORMATION; EPITHELIAL-CELLS; CYCLIC-AMP; 2 STRAINS; DIFFERENTIATED PROPERTIES; CULTURED MONOLAYERS; OCCLUDING JUNCTIONS; ESTABLISHED LINE; EMBRYONATED EGGS	Single-cell clones have been established from the MDCK cell line, characterized for their morphology and evaluated for their suitability for influenza virus research. Three discrete cell morphotypes were identified using light microscopy. Besides morphological features, the cell types can be distinguished by the level of expression of surface glycans recognized by peanut agglutinin (PNA). All clones were susceptible to infection by influenza viruses of different subtypes of influenza A virus (H1N1, H1N1pdm09, H3N2, H5N1) and influenza B virus, and all possessed on their surface terminally sialylated glycans with both types of glycosidic linkage (alpha 2-3 and alpha 2-6). The Type-1 cell lines were able to support a multicycle replication of influenza A and B viruses without help of an exogenous trypsin. In contrast, cell lines exhibiting Type-2 morphology were unable to support multicycle replication of influenza A viruses without trypsin supplementation. Western blot analysis of the hemagglutinin of H1N1 strains demonstrated that Type-2 cells were deficient in production of proteolytically activated hemagglutinin (no cleavage between HA1/HA2 was observed). HA1/HA2 cleavage of influenza B viruses in the Type-2 cells was also significantly impaired, but not completely abrogated, producing sufficient amount of activated HA to support efficient virus replication without trypsin. In contrast, all clones of Type-1 cells were able to produce proteolytically activated hemagglutinin of influenza A and B viruses. However, the growth kinetics and plaque size of influenza A viruses varied significantly in different clones. Influenza B virus also showed different plaque size, with the biggest plaque formation in the Type-2 cells, although the growth kinetics and peak infectivity titers were similar in all clones. Taken together, the study demonstrates that the population of original MDCK cells is represented by various types of cells that differ in their capacities to support replication of influenza A and B viruses.	[Lugovtsev, Vladimir Y.; Melnyk, Darya; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Lugovtsev, VY (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	vladimir.lugovtsev@fda.hhs.gov		Lugovtsev, Vladimir/0000-0003-0573-1497	Center for Biologics Evaluation and Research, Food and Drug Administration	Center for Biologics Evaluation and Research, Food and Drug Administration	This work was supported by the Center for Biologics Evaluation and Research, Food and Drug Administration.	[Anonymous], 1965, REG AN CELL LIN SE S; Arthur JM, 2000, TISSUE CELL, V32, P446, DOI 10.1054/tice.2000.0135; Audsley JM, 2008, DRUGS, V68, P1483, DOI 10.2165/00003495-200868110-00002; Audsley JM, 2004, EXPERT OPIN BIOL TH, V4, P709, DOI 10.1517/14712598.4.5.709; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; BARKER G, 1979, J PHYSIOL-LONDON, V289, pP33; Barrett PN, 2010, CURR OPIN MOL THER, V12, P21; Buchholz B, 2011, J MOL MED-JMM, V89, P251, DOI 10.1007/s00109-010-0715-1; Cattaneo I, 2011, CELL PHYSIOL BIOCHEM, V28, P673, DOI 10.1159/000335813; Cereijido M, 1981, Ann N Y Acad Sci, V372, P422, DOI 10.1111/j.1749-6632.1981.tb15492.x; CEREIJIDO M, 1980, J MEMBRANE BIOL, V52, P147, DOI 10.1007/BF01869120; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; CHO MJ, 1989, PHARMACEUT RES, V6, P71, DOI 10.1023/A:1015807904558; Coussens PM, 2011, VACCINE, V29, P8661, DOI 10.1016/j.vaccine.2011.08.122; DEVUYST O, 1994, CELL TISSUE RES, V277, P231; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; DREHER D, 1992, AM J PHYSIOL, V262, pC358, DOI 10.1152/ajpcell.1992.262.2.C358; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Ebner S, 1998, KIDNEY INT, V54, pS139, DOI 10.1046/j.1523-1755.1998.06727.x; Fernandez R, 2000, PFLUG ARCH EUR J PHY, V441, P287, DOI 10.1007/s004240000411; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Govorkova EA, 1999, VIROLOGY, V262, P31, DOI 10.1006/viro.1999.9892; GREEN IJ, 1962, SCIENCE, V138, P42, DOI 10.1126/science.138.3536.42; Gregersen JP, 2011, FUTURE MICROBIOL, V6, P143, DOI 10.2217/FMB.10.161; Hamilton SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-66; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; HOLTHOFER H, 1988, HISTOCHEM J, V20, P471, DOI 10.1007/BF01002645; HOLTHOFER H, 1981, LAB INVEST, V45, P391; Ilyushina NA, 2012, J VIROL, V86, P11725, DOI 10.1128/JVI.01477-12; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; ISHIZUKA I, 1978, BIOCHIM BIOPHYS ACTA, V541, P467, DOI 10.1016/0304-4165(78)90156-3; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; KENNEDY BG, 1984, J CELL PHYSIOL, V121, P51, DOI 10.1002/jcp.1041210108; KERSTING U, 1993, CELL PHYSIOL BIOCHEM, V3, P42, DOI 10.1159/000154667; Klebe RJ, 1995, J CELL BIOCHEM, V59, P453, DOI 10.1002/jcb.240590406; LANG F, 1995, KIDNEY INT, V48, P1200, DOI 10.1038/ki.1995.403; LANG F, 1990, RENAL PHYSIOL BIOCH, V13, P82; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; LEHIR M, 1982, AM J PHYSIOL, V242, pC117, DOI 10.1152/ajpcell.1982.242.1.C117; LEIGHTON J, 1969, SCIENCE, V163, P472, DOI 10.1126/science.163.3866.472; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lever J E, 1981, Ann N Y Acad Sci, V372, P371, DOI 10.1111/j.1749-6632.1981.tb15489.x; LEVER JE, 1979, P NATL ACAD SCI USA, V76, P1323, DOI 10.1073/pnas.76.3.1323; LEVER JE, 1985, J CELL PHYSIOL, V122, P45, DOI 10.1002/jcp.1041220108; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; LOPEZVANCELL R, 1984, J MEMBRANE BIOL, V81, P171, DOI 10.1007/BF01868711; Lugovtsev VY, 2009, VIROLOGY, V394, P218, DOI 10.1016/j.virol.2009.08.014; MADIN SH, 1957, AM J VET RES, V18, P932; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Madin SH, 1958, UNPUB; Medema JK, 2006, DEV BIOLOGICALS, V123, P243; MEIER KE, 1983, J CELL BIOL, V97, P405, DOI 10.1083/jcb.97.2.405; MISFELDT DS, 1976, P NATL ACAD SCI USA, V73, P1212, DOI 10.1073/pnas.73.4.1212; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Murata H, 2011, VACCINE, V29, P3155, DOI 10.1016/j.vaccine.2011.02.041; NAKAZATO Y, 1989, BIOCHIM BIOPHYS ACTA, V1014, P57, DOI 10.1016/0167-4889(89)90240-1; NICHOLS GE, 1986, BIOCHIM BIOPHYS ACTA, V887, P1, DOI 10.1016/0167-4889(86)90115-1; OBERLEITHNER H, 1991, PFLUG ARCH EUR J PHY, V419, P418, DOI 10.1007/BF00371126; Omeir RL, 2011, COMPARATIVE MED, V61, P243; ONEIL RG, 1985, AM J PHYSIOL, V248, pF449, DOI 10.1152/ajprenal.1985.248.3.F449; Onions D, 2010, BIOLOGICALS, V38, P544, DOI 10.1016/j.biologicals.2010.04.003; Orellana SA, 1996, IN VITRO CELL DEV-AN, V32, P329; Palmer DF, 1975, IMMUNOLOGY SERIES US; PARTON RG, 1991, SEMIN NEPHROL, V11, P440; PFALLER W, 1989, RENAL PHYSIOL BIOCH, V12, P328; Praetorius J, 2002, EXP CELL RES, V276, P52, DOI 10.1006/excr.2002.5516; PRYDZ K, 1995, BIOCHEM SOC T, V23, P535, DOI 10.1042/bst0230535; RABITO CA, 1978, J MEMBRANE BIOL, V43, P351, DOI 10.1007/BF01871696; Reed L. J., 1988, J HYG, V27, P493; Reina J, 1997, J CLIN MICROBIOL, V35, P1900, DOI 10.1128/JCM.35.7.1900-1901.1997; RICHARDSON JCW, 1981, BIOCHIM BIOPHYS ACTA, V673, P26, DOI 10.1016/0304-4165(81)90307-X; RINDLER MJ, 1979, J CELL BIOL, V81, P635, DOI 10.1083/jcb.81.3.635; ROBERTSON JS, 1990, VIROLOGY, V179, P35, DOI 10.1016/0042-6822(90)90270-2; Rothen-Rutishauser B, 1998, PHARMACEUT RES, V15, P964, DOI 10.1023/A:1011953405272; SAIER MH, 1981, AM J PHYSIOL, V240, pC106, DOI 10.1152/ajpcell.1981.240.3.C106; Saito T, 2004, J MED VIROL, V74, P336, DOI 10.1002/jmv.20178; SCHNEEBERGER EE, 1988, AM J PHYSIOL, V254, pC432, DOI 10.1152/ajpcell.1988.254.3.C432; Seo SH, 2001, J VIROL, V75, P9517, DOI 10.1128/JVI.75.19.9517-9525.2001; Sidorenko Y, 2004, BIOTECHNOL BIOENG, V88, P1, DOI 10.1002/bit.20096; SIMMONS NL, 1982, GEN PHARMACOL, V13, P287, DOI 10.1016/0306-3623(82)90047-7; Taub M, 1979, Methods Enzymol, V58, P552; THOMAS SR, 1982, J CELL PHYSIOL, V113, P427, DOI 10.1002/jcp.1041130311; Valentich J D, 1981, Ann N Y Acad Sci, V372, P384, DOI 10.1111/j.1749-6632.1981.tb15490.x; van Wielink R, 2011, J VIROL METHODS, V171, P53, DOI 10.1016/j.jviromet.2010.09.029; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; WUNSCH S, 1995, J CELL PHYSIOL, V164, P164, DOI 10.1002/jcp.1041640121; Youil R, 2004, J VIROL METHODS, V120, P23, DOI 10.1016/j.jviromet.2004.03.011; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537	96	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75014	10.1371/journal.pone.0075014	http://dx.doi.org/10.1371/journal.pone.0075014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058646	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400105
J	Sun, X; Zhang, M; El-Zataari, M; Owyang, SY; Eaton, KA; Liu, MC; Chang, YM; Zou, WP; Kao, JY				Sun, Xia; Zhang, Min; El-Zataari, Mohamad; Owyang, Stephanie Y.; Eaton, Kathryn A.; Liu, Maochang; Chang, Yu-Ming; Zou, Weiping; Kao, John Y.			TLR2 Mediates Helicobacter pylori-Induced Tolerogenic Immune Response in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; REGULATORY T-CELLS; VACCINE-INDUCED REDUCTION; GENE-EXPRESSION; COLONIZATION; INFECTION; INDUCTION; IL-10; INTERLEUKIN-17; STIMULATION	We have shown that Helicobacter pylori induces tolerogenic programming of dendritic cells and inhibits the host immune response. Toll-like receptors (TLRs) represent a class of transmembrane pattern recognition receptors essential for microbial recognition and control of the innate immune response. In this study, we examined the role of TLRs in mediating H. pylori tolerogenic programming of dendritic cells and their impact on anti-H. pylori immunity using C57BL/6 wild-type and TLR2-knockout (TLR2KO) mice. We analyzed the response of TLR2KO bone marrow-derived dendritic cells (BMDCs) to H. pylori SS1 stimulation and the outcome of chronic H. pylori infection in TLR2KO mice. We showed that H. pylori-stimulated BMDCs upregulated the expression of TLR2, but not TLR4, TLR5, or TLR9. H. pylori-stimulated BMDCs from TLRKO mice induced lower Treg and Th17 responses, but a higher IFN-gamma response compared to H. pylori-stimulated BMDCs from wild-type mice. In vivo analyses following an H. pylori infection of 2 months duration showed a lower degree of gastric H. pylori colonization in TLR2KO mice and more severe gastric immunopathology compared to WT mice. The gastric mucosa of the infected TLR2KO mice showed a lower mRNA expression of Foxp3, IL-10, and IL-17A, but higher expression of IFN-gamma compared to the gastric mRNA expression in infected wild-type mice. Moreover, the H. pylori-specific Th1 response was higher and the Treg and Th17 responses were lower in the spleens of infected TLR2KO mice compared to infected WT mice. Our data indicate that H. pylori mediates immune tolerance through TLR2-derived signals and inhibits Th1 immunity, thus evading host defense. TLR2 may be an important target in the modulation of the host response to H. pylori.	[Sun, Xia] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250100, Shandong, Peoples R China; [Sun, Xia; Zhang, Min; El-Zataari, Mohamad; Owyang, Stephanie Y.; Liu, Maochang; Chang, Yu-Ming; Kao, John Y.] Univ Michigan Hlth Syst, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Eaton, Kathryn A.] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI USA; [Zou, Weiping] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA	Shandong University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kao, JY (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	jykao@med.umich.edu			National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01 DK087708-01]; Shandong Provincial Natural Science Foundation, China [ZR2010HQ057]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087708] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R01 DK087708-01 (J.Y.K.) and by the Shandong Provincial Natural Science Foundation, China, under the award number ZR2010HQ057 (XS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhiani AA, 2002, J IMMUNOL, V169, P6977, DOI 10.4049/jimmunol.169.12.6977; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bimczok D, 2010, MUCOSAL IMMUNOL, V3, P260, DOI 10.1038/mi.2010.10; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Eaton KA, 2007, COMPARATIVE MED, V57, P57; Gao Y, 2012, CELL IMMUNOL, V272, P242, DOI 10.1016/j.cellimm.2011.10.007; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Hitzler I, 2011, GASTROENTEROLOGY, V141, P186, DOI 10.1053/j.gastro.2011.04.009; Kabir S, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2010.00812.x; Kandulski A, 2008, HELICOBACTER, V13, P295, DOI 10.1111/j.1523-5378.2008.00612.x; Kao JY, 2006, AM J PHYSIOL-GASTR L, V291, pG73, DOI 10.1152/ajpgi.00139.2005; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; PEREZPEREZ GI, 1988, ANN INTERN MED, V109, P11, DOI 10.7326/0003-4819-109-1-11; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Raghavan S, 2004, SCAND J IMMUNOL, V60, P82, DOI 10.1111/j.0300-9475.2004.01447.x; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Wang J., 2012, INTERNAL MED, V2, P1, DOI [10.4172/2165-8048.1000113, DOI 10.4172/2165-8048.1000113]; Zhang M, 2008, HELICOBACTER, V13, P200, DOI 10.1111/j.1523-5378.2008.00606.x	38	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74595	10.1371/journal.pone.0074595	http://dx.doi.org/10.1371/journal.pone.0074595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058595	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400086
J	Asonganyi, E; Vaghasia, M; Rodrigues, C; Phadtare, A; Ford, A; Pietrobon, R; Atashili, J; Lynch, C				Asonganyi, Etienne; Vaghasia, Meenakshi; Rodrigues, Clarissa; Phadtare, Amruta; Ford, Anne; Pietrobon, Ricardo; Atashili, Julius; Lynch, Catherine			Factors Affecting Compliance with Clinical Practice Guidelines for Pap Smear Screening among Healthcare Providers in Africa: Systematic Review and Meta-Summary of 2045 Individuals	PLOS ONE			English	Review							CERVICAL-CANCER; KNOWLEDGE; AWARENESS; WOMEN; PHYSICIANS; ATTITUDES	Background: Although the importance of the Pap smear in reducing cancer incidence and mortality is known, many countries in Africa have not initiated yet widespread national cervical cancer screening programs. The World Health Organization (WHO) has published Clinical Practice Guidelines (CPGs) on cervical cancer screening in developing countries; however, there is a gap between expectations and clinical performance. Thus, the aim of this study was to conduct a systematic review and meta-summary to identify factors affecting compliance with CPGs for Pap screening among healthcare providers in Africa. Methods: And Findings: MEDLINE, Scirus, Opengate and EMBASE databases were searched in January 2012. Studies involving medical personnel practicing in Africa, whose outcome measured any factors that affect medical personnel from using a Pap smear to screen for cervical cancer, were included. Two reviewers independently evaluated titles and abstracts, then full-texts, extracted data and assessed quality of the included studies. A descriptive analysis of the included studies was conducted. We calculated Frequency effect sizes (FES) for each finding and Intensity effect sizes (IES) for each article to represent their magnitudes in the analyses. Of 1011 studies retrieved, 11 studies were included (2045 individuals). Six different themes related to the factors affecting compliance with CPGs were identified: Insufficient Knowledge/Lack of awareness (FES = 82%), Negligence/Misbeliefs (FES = 82%), Psychological Reasons (FES = 73%), Time/Cost Constraint (FES = 36%), Insufficient infrastructure/training (FES = 45%) and also no reason given (FES = 36%). IES for articles ranged between 33 and 83%. Conclusions: These results suggest that prevention initiatives should be comprehensive to include education and resources needs assessments and improvement, Pap smear test training, strategies on costing, and practitioner time studies.	[Asonganyi, Etienne] Kumba Dist Hosp, Matern Unit, Kumba, Southwest Provi, Cameroon; [Asonganyi, Etienne; Vaghasia, Meenakshi; Rodrigues, Clarissa; Phadtare, Amruta; Pietrobon, Ricardo; Atashili, Julius] Duke Univ, Dept Surg, Durham, NC USA; [Rodrigues, Clarissa] Fundacao Univ Cardiol, Inst Cardiol RS, Porto Alegre, RS, Brazil; [Ford, Anne] Duke Univ, Duke Womens Hlth Associates, Durham, NC USA; [Atashili, Julius] Univ Buea, Dept Epidemiol, Buea, Southwest Regio, Cameroon; [Lynch, Catherine] Duke Univ, Div Emergency Med, Duke Sch Med, Durham, NC USA; [Lynch, Catherine] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Duke University; Fundacao Universitaria de Cardiologia; Duke University; Duke University; Duke University	Lynch, C (corresponding author), Duke Univ, Div Emergency Med, Duke Sch Med, Durham, NC USA.	catherine.lynch@duke.edu		Staton, Catherine/0000-0002-6468-2894				Aboyeji P. A., 2004, Tropical Journal of Obstetrics and Gynaecology, V21, P114; Abrahams N, 1997, Curationis, V20, P50; Al Sairafi M, 2009, MED PRIN PRACT, V18, P35, DOI 10.1159/000163044; Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.3.CO;2-E; Anya S E, 2005, Niger J Med, V14, P283; Ayinde O A, 2003, J Obstet Gynaecol, V23, P59, DOI 10.1080/0144361021000043272; Ayinde O A, 2004, Afr J Reprod Health, V8, P68, DOI 10.2307/3583394; Bloland P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001199; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cyril CD, 2009, T R SOC TROP MED HYG, V103, P852, DOI [10.1016/j.trstmh.2009.03.020, DOI 10.1016/J.TRSTMH.2009.03.020]; Dem Ahmadou, 2008, Sante, V18, P31, DOI 10.1684/san.2008.0094; Dim CC, 2009, T ROY SOC TROP MED H, V103, P852, DOI 10.1016/j.trstmh.2009.03.020; DURANT RH, 1994, J ADOLESCENT HEALTH, V15, P4, DOI 10.1016/1054-139X(94)90381-6; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ezem BU, 2007, ANN AFR MED, V6, P94, DOI 10.4103/1596-3519.55727; Fonn S, S AFR MED J, V92, P148; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gharoro EP, 2006, INT J GYNECOL CANCER, V16, P1063, DOI 10.1111/j.1525-1438.2006.00579.x; Ghim Shin-Je, 2002, Asian Pac J Cancer Prev, V3, P207; Hyacinth HI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046583; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kawonga M, 2008, REPROD HEALTH MATTER, V16, P32, DOI 10.1016/S0968-8080(08)32403-3; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; Maaita M, 2002, J Obstet Gynaecol, V22, P421, DOI 10.1080/01443610220141416; Maalej M, 2004, EUR J OBSTET GYN R B, V113, P226, DOI 10.1016/j.ejogrb.2003.07.005; MCPHEE SJ, 1991, JAMA-J AM MED ASSOC, V266, P538, DOI 10.1001/jama.266.4.538; Moher D, 2009, PLOS MED, V6, P1, DOI DOI 10.1371/J0URNAL.PMED.0060001; Moodley J, 2006, CANCER DETECT PREV, V30, P361, DOI 10.1016/j.cdp.2006.07.005; Mutyaba T, 2006, BMC MED EDUC, V6, P1, DOI [DOI 10.1186/1472-6920-6-1, 10.1186/1472-6920-6-1]; Nwobodo E I, 2005, Niger Postgrad Med J, V12, P255; Obiechina N J A, 2009, Niger J Med, V18, P384; Olaniyan OB, 2000, TROP J OBSTET GYNAEC, V17, P18; Onajole AT, 2004, NIG MED PRACTITIONER, V45, P52; Oosthuysen J, 2010, INT DENT J, V60, P181, DOI 10.1922/IDJ_2371Oosthuysen09; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; Roy B, 2008, J CANCER EDUC, V23, P253, DOI 10.1080/08858190802189105; Sait KH, 2009, SAUDI MED J, V30, P1208; Sandelowski M, 2007, RES NURS HEALTH, V30, P99, DOI 10.1002/nur.20176; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Sherris J, 2009, INT PERSPECT SEX R H, V35, P147, DOI [10.1363/3514709, 10.1363/ifpp.35.147.09]; Tarwireyi F, 2003, J MED, V7, P83; Udigwe G O, 2006, Niger J Clin Pract, V9, P40; Urasa M, 2011, AFR HEALTH SCI, V11, P48; World Health Organization, 2002, CERV CANC SCREEN DEV, P3	45	9	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72712	10.1371/journal.pone.0072712	http://dx.doi.org/10.1371/journal.pone.0072712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069156	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100016
J	Vygodina, T; Kirichenko, A; Konstantinov, AA				Vygodina, Tatiana; Kirichenko, Anna; Konstantinov, Alexander A.			Direct Regulation of Cytochrome c Oxidase by Calcium Ions	PLOS ONE			English	Article							PROTON-PUMPING MECHANISM; RHODOBACTER-SPHAEROIDES; BINDING-SITE; CA2+ BINDING; OXIDATIVE-PHOSPHORYLATION; STRUCTURAL-CHANGES; ELECTRON-TRANSFER; O-2 REDUCTION; HEME; MITOCHONDRIA	Cytochrome c oxidase from bovine heart binds Ca2+ reversibly at a specific Cation Binding Site located near the outer face of the mitochondrial membrane. Ca2+ shifts the absorption spectrum of heme a, which allowed previously to determine the kinetics and equilibrium characteristics of the binding. However, no effect of Ca2+ on the functional characteristics of cytochrome oxidase was revealed earlier. Here we report that Ca2+ inhibits cytochrome oxidase activity of isolated bovine heart enzyme by 50-60% with K-i of similar to 1 mu M, close to K-d of calcium binding with the oxidase determined spectrophotometrically. The inhibition is observed only at low, but physiologically relevant, turnover rates of the enzyme (similar to 10 s(-1) or less). No inhibitory effect of Ca2+ is observed under conventional conditions of cytochrome c oxidase activity assays (turnover number >100 s(-1) at pH 8), which may explain why the effect was not noticed earlier. The inhibition is specific for Ca2+ and is reversed by EGTA. Na+ ions that compete with Ca2+ for binding with the Cation Binding Site, do not affect significantly activity of the enzyme but counteract the inhibitory effect of Ca2+. The Ca2+-induced inhibition of cytochrome c oxidase is observed also with the uncoupled mitochondria from several rat tissues. At the same time, calcium ions do not inhibit activity of the homologous bacterial cytochrome oxidases. Possible mechanisms of the inhibition are discussed as well as potential physiological role of Ca2+ binding with cytochrome oxidase. Ca2+-binding at the Cation Binding Site is proposed to inhibit proton-transfer through the exit part of the proton conducting pathway H in the mammalian oxidases.	[Vygodina, Tatiana; Kirichenko, Anna; Konstantinov, Alexander A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia	Lomonosov Moscow State University	Konstantinov, AA (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	konst@genebee.msu.su	Vygodina, Tatiana/D-8100-2012; Konstantinov, Alexander/J-9618-2013		Howard Hughes Medical Institute [55005615]; Russian Fund for Basic Research [11-04-01330-a]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR))	The work has been supported in part by Howard Hughes Medical Institute International Scholar Award 55005615 and Russian Fund for Basic Research grant 11-04-01330-a to AAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiele RC, 2012, TOXICOL SCI, V127, P110, DOI 10.1093/toxsci/kfs091; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Balaban RS, 2009, BIOCHIM BIOPHYS ACTA, V1787, P1384; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Capitanio N, 2012, BBA-BIOENERGETICS, V1817, P558, DOI 10.1016/j.bbabio.2011.11.003; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Cheranov SY, 2004, J PHYSIOL-LONDON, V556, P755, DOI 10.1113/jphysiol.2003.059568; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Egawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063669; EINARSDOTTIR O, 1985, BIOCHEM BIOPH RES CO, V129, P840, DOI 10.1016/0006-291X(85)91968-0; Evenas J, 1998, CURR OPIN CHEM BIOL, V2, P293, DOI 10.1016/S1367-5931(98)80072-0; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; FOWLER LR, 1962, BIOCHIM BIOPHYS ACTA, V64, P170, DOI 10.1016/0006-3002(62)90770-9; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Griffiths EJ, 2010, BBA-BIOENERGETICS, V1797, P856, DOI 10.1016/j.bbabio.2010.02.022; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kamiya K, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/36/365220; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Kirichenko A, 1998, FEBS LETT, V423, P329, DOI 10.1016/S0014-5793(98)00117-3; Kirichenko AV, 2005, BIOCHEMISTRY-US, V44, P12391, DOI 10.1021/bi050376v; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Konstantinov AA, 2010, BBA-BIOENERGETICS, V1797, P92, DOI 10.1016/j.bbabio.2010.04.278; KRAB K, 1979, BIOCHIM BIOPHYS ACTA, V547, P58, DOI 10.1016/0005-2728(79)90095-1; KRAB K, 1987, BIOCHIM BIOPHYS ACTA, V895, P25, DOI 10.1016/S0304-4173(87)80015-0; Kuznetsova SS, 2005, BIOCHEMISTRY-MOSCOW+, V70, P128, DOI 10.1007/s10541-005-0091-6; Lee A, 2002, BIOCHEMISTRY-US, V41, P8886, DOI 10.1021/bi020183x; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Lee HJ, 2013, FEBS LETT, V587, P770, DOI 10.1016/j.febslet.2013.01.069; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Marechal A, 2013, J AM CHEM SOC, V135, P5802, DOI 10.1021/ja4005706; Mills DA, 2002, J BIOL CHEM, V277, P14894, DOI 10.1074/jbc.M111922200; MITCHELL DM, 1995, FEBS LETT, V368, P148, DOI 10.1016/0014-5793(95)00626-K; MKRTCHYAN H, 1990, BIOCHEM INT, V20, P183; MUSATOV AP, 1991, BIOL MEMBRANY, V8, P229; Naraghi M, 1997, J NEUROSCI, V17, P6961; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Ouyang HL, 2012, BIOCHEMISTRY-US, V51, P7290, DOI 10.1021/bi3006847; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pfitzner U, 1999, FEBS LETT, V456, P365, DOI 10.1016/S0014-5793(99)00977-1; Rich PR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0183; Riistama S, 1999, BIOCHEMISTRY-US, V38, P10670, DOI 10.1021/bi990885v; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; SAARI H, 1980, J BIOENERG BIOMEMBR, V12, P325, DOI 10.1007/BF00744692; Salje J, 2005, BIOCHEM SOC T, V33, P829, DOI 10.1042/BST0330829; Samartsev VN, 1997, FEBS LETT, V412, P179, DOI 10.1016/S0014-5793(97)00667-4; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Sharpe MA, 2009, BIOCHEMISTRY-US, V48, P328, DOI 10.1021/bi801391r; Sharpe MA, 2005, RSC BIOMOLEC SCI, P26; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; SUGANO T, 1974, BIOCHIM BIOPHYS ACTA, V347, P340, DOI 10.1016/0005-2728(74)90074-7; Sugitani R, 2009, BBA-BIOENERGETICS, V1787, P1140, DOI 10.1016/j.bbabio.2009.04.004; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vygodina TV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P901, DOI 10.1134/S0006297912080111; Vygodina TV, 2008, BBA-BIOENERGETICS, V1777, pS110, DOI 10.1016/j.bbabio.2008.05.433; Vygodina TV, 2010, BBA-BIOENERGETICS, V1797, P102, DOI 10.1016/j.bbabio.2010.04.308; WIKSTROM M, 1975, BIOCHIM BIOPHYS ACTA, V408, P170, DOI 10.1016/0005-2728(75)90009-2; Yoshikawa S, 2003, FEBS LETT, V555, P8, DOI 10.1016/S0014-5793(03)01098-6; Yoshikawa S, 2000, J INORG BIOCHEM, V82, P1, DOI 10.1016/S0162-0134(00)00137-9; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2011, BBA-BIOENERGETICS, V1807, P1279, DOI 10.1016/j.bbabio.2011.06.008; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341	76	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74436	10.1371/journal.pone.0074436	http://dx.doi.org/10.1371/journal.pone.0074436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058566	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600093
J	Wu, JW; Chen, SY; Zhou, Y; Wang, CX; Wang, AX; Zhang, Q; Gao, X; Hu, HT; Wu, SL; Zhao, XQ				Wu, Jianwei; Chen, Shengyun; Zhou, Yong; Wang, Chunxue; Wang, Anxin; Zhang, Qian; Gao, Xiang; Hu, Haitao; Wu, Shouling; Zhao, Xingquan			Non-High-Density Lipoprotein Cholesterol on the Risks of Stroke: A Result from the Kailuan Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; SUBTYPES; POPULATION; PREDICTION; JAPANESE; PREVALENCE; MEN; HEMORRHAGE	Aims: To prospectively explore the association between non-high-density lipoprotein cholesterol (non-HDLC) and the risks of stroke and its subtypes. Methods: A total of 95,916 participants (18-98 years old; 76,354 men and 19,562 women) from a Chinese urban community who were free of myocardial infarction and stroke at baseline time point (2006-2007) were eligible and enrolled in the study. The serum non-HDLC levels of participants were determined by subtracting the high-density lipoprotein cholesterol (HDLC) from total serum cholesterol. The primary outcome was the first occurrence of stroke, which was diagnosed according to the World Health Organization criteria and classified into three subtypes: ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage. The Cox proportional hazards models were used to estimate risk of stroke and its subtypes. Results: During the four-year follow-up, we identified 1614 stroke events (1,156 ischemic, 416 intracerebral hemorrhagic and 42 subarachnoid hemorrhagic). Statistical analyses showed that hazard ratios (HR) (95% Confidence Interval: CI) of serum Non-HDLC level for total and subtypes of stroke were: 1.08 (1.03-1.12) (total), 1.10 (1.05-1.16) (ischemic), 1.03 (0.96-1.10) (intracerebral hemorrhage) and 0.83 (0.66-1.05) (subarachnoid hemorrhage). HR for non-HDLC refers to the increase per each 20 mg/dl. For total and ischemic stroke, the risks were significantly higher in the fourth and fifth quintiles of non-HDLC concentrations compared to the first quintile after adjusting the confounding factors (total stroke: 4th quintile HR=1.33 (1.12-1.59); 5th quintile HR = 1.36 (1.15-1.62); ischemic stroke: 4th quintile HR = 1.34 (1.09-1.66); 5th quintile HR = 1.53 (1.24-1.88)). Conclusions: Our data suggest that serum non-HDLC level is an independent risk factor for total and ischemic stroke, and that higher serum non-HDLC concentrations are associated with increased risks for total stroke and ischemic stroke, but not for intracerebral and subarachnoid hemorrhage.	[Wu, Jianwei; Chen, Shengyun; Zhou, Yong; Wang, Chunxue; Wang, Anxin; Zhang, Qian; Zhao, Xingquan] Capital Med Univ, Beijing TianTan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Qian] Gen Hosp Chinese Peoples Armed Police Forces, Dept Neural Stem Cell Transplantat, Beijing, Peoples R China; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Haitao] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; , Xiang/0000-0003-2617-6509; Hu, Haitao/0000-0002-6964-2314; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81202279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Natural Science Foundation of China (Grant No. 81202279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1989, STROKE, V20, P1407; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cui RZ, 2007, ATHEROSCLEROSIS, V194, P415, DOI 10.1016/j.atherosclerosis.2006.08.022; Farwell WR, 2005, AM J CARDIOL, V96, P1129, DOI 10.1016/j.amjcard.2005.06.044; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Imamura T, 2009, STROKE, V40, P382, DOI 10.1161/STROKEAHA.108.529537; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Ji JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-497; Kitamura A, 2006, STROKE, V37, P1374, DOI 10.1161/01.STR.0000221714.96986.5f; Kitamura A, 2011, J ATHEROSCLER THROMB, V18, P454, DOI 10.5551/jat.7237; Liu J, 2005, DIABETES CARE, V28, P1916, DOI 10.2337/diacare.28.8.1916; Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu XF, 2006, CEREBROVASC DIS, V22, P130, DOI 10.1159/000093241; Ohira T, 2006, STROKE, V37, P2493, DOI 10.1161/01.STR.0000239694.19359.88; Okamura T, 2009, ATHEROSCLEROSIS, V203, P587, DOI 10.1016/j.atherosclerosis.2008.07.020; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Prabhakaran S, 2008, NEUROLOGY, V70, P425, DOI 10.1212/01.wnl.0000277521.66947.e5; Ren Jie, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P934; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; Suh I, 2001, LANCET, V357, P922, DOI 10.1016/S0140-6736(00)04213-6; Tanabe N, 2010, CIRC J, V74, P1346, DOI 10.1253/circj.CJ-09-0861; Tanizaki Y, 2000, STROKE, V31, P2616, DOI 10.1161/01.STR.31.11.2616; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Wang YJ, 2012, CNS NEUROSCI THER, V18, P93, DOI 10.1111/j.1755-5949.2011.00290.x; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058923	35	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74634	10.1371/journal.pone.0074634	http://dx.doi.org/10.1371/journal.pone.0074634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058611	gold, Green Published, Green Submitted			2022-12-27	WOS:000327538600104
J	Sandal, M; Duy, TP; Cona, M; Zung, H; Carloni, P; Musiani, F; Giorgetti, A				Sandal, Massimo; Tran Phuoc Duy; Cona, Matteo; Zung, Hoang; Carloni, Paolo; Musiani, Francesco; Giorgetti, Alejandro			GOMoDo: A GPCRs Online Modeling and Docking Webserver	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; WEB SERVER; SEQUENCE; HADDOCK; OPTIMIZATION; ANTAGONIST; ALGORITHM; ALIGNMENT	G-protein coupled receptors (GPCRs) are a superfamily of cell signaling membrane proteins that include > 750 members in the human genome alone. They are the largest family of drug targets. The vast diversity and relevance of GPCRs contrasts with the paucity of structures available: only 21 unique GPCR structures have been experimentally determined as of the beginning of 2013. User-friendly modeling and small molecule docking tools are thus in great demand. While both GPCR structural predictions and docking servers exist separately, with GOMoDo (GPCR Online Modeling and Docking), we provide a web server to seamlessly model GPCR structures and dock ligands to the models in a single consistent pipeline. GOMoDo can automatically perform template choice, homology modeling and either blind or information-driven docking by combining together proven, state of the art bioinformatic tools. The web server gives the user the possibility of guiding the whole procedure. The GOMoDo server is freely accessible at http://molsim.sci.univr.it/gomodo.	[Sandal, Massimo; Cona, Matteo; Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Tran Phuoc Duy] Vietnam Natl Univ, Univ Technol, Lab Computat Phys, Ho Chi Minh City, Vietnam; [Zung, Hoang] Vietnam Natl Univ, Univ Sci, Lab Computat Phys, Ho Chi Minh City, Vietnam; [Carloni, Paolo; Giorgetti, Alejandro] German Res Sch Simulat Sci, Julich, Germany; [Carloni, Paolo] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Musiani, Francesco] Scuola Int Super Studi Avanzati Sissa ISAS, Trieste, Italy	University of Verona; Vietnam National University Hochiminh City; Vietnam National University Hochiminh City; Helmholtz Association; Research Center Julich; International School for Advanced Studies (SISSA)	Musiani, F (corresponding author), Scuola Int Super Studi Avanzati Sissa ISAS, Trieste, Italy.	musiani@sissa.it; alejandro.giorgetti@univr.it	Duy, TRAN Phuoc/N-9948-2019; Musiani, Francesco/A-7410-2016; Carloni, Paolo/H-8736-2013; Tran, Duy/A-9866-2014; Musiani, Francesco/AAA-2385-2021	Duy, TRAN Phuoc/0000-0001-8212-3706; Musiani, Francesco/0000-0003-0200-1712; Tran, Duy/0000-0001-8212-3706; Musiani, Francesco/0000-0003-0200-1712; Carloni, Paolo/0000-0002-9010-0149; Giorgetti, Alejandro/0000-0001-8738-6150	Deutsche Forschungsgemeinschaft [CA 973/6-1]; Vietnam National Foundation for Science and Technology Development [DFG.2011.01]; UniVR; Programma Operativo del Fondo Sociale Europeo of Friuli Venezia Giulia Region	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vietnam National Foundation for Science and Technology Development; UniVR; Programma Operativo del Fondo Sociale Europeo of Friuli Venezia Giulia Region	This work has been funded by a grant from the Deutsche Forschungsgemeinschaft (CA 973/6-1) and a grant from Vietnam National Foundation for Science and Technology Development (DFG.2011.01). MS benefited of a postdoctoral fellowship from UniVR. FM is funded by Programma Operativo del Fondo Sociale Europeo 2007/2013 of Friuli Venezia Giulia Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chang DTH, 2005, NUCLEIC ACIDS RES, V33, pW233, DOI 10.1093/nar/gki586; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khafizov K, 2007, J MOL MODEL, V13, P401, DOI 10.1007/s00894-006-0160-9; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Leguebe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047332; Levit Anat, 2012, Methods Mol Biol, V914, P179, DOI 10.1007/978-1-62703-023-6_11; Lupieri P, 2009, HFSP J, V3, P228, DOI 10.2976/1.3092784; Marchiori A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064675; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Modena D., 2011, ADV LIFE SCI, V1, P1; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Rayan A, 2010, J MOL MODEL, V16, P183, DOI 10.1007/s00894-009-0533-y; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rodriguez D, 2012, MOL INFORM, V31, P334, DOI 10.1002/minf.201100162; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tramontano Anna, 2008, V413, P43; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venclovas Ceslovas, 2012, Methods Mol Biol, V857, P55, DOI 10.1007/978-1-61779-588-6_3; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563	49	59	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74092	10.1371/journal.pone.0074092	http://dx.doi.org/10.1371/journal.pone.0074092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24058518	Green Submitted, Green Published, gold			2022-12-27	WOS:000324856500075
J	Duan, JC; Yu, YB; Shi, HQ; Tian, LW; Guo, CX; Huang, PL; Zhou, XQ; Peng, SQ; Sun, ZW				Duan, Junchao; Yu, Yongbo; Shi, Huiqin; Tian, Linwei; Guo, Caixia; Huang, Peili; Zhou, Xianqing; Peng, Shuangqing; Sun, Zhiwei			Toxic Effects of Silica Nanoparticles on Zebrafish Embryos and Larvae	PLOS ONE			English	Article							SINGLE SILVER NANOPARTICLES; IN-VIVO MODEL; DEVELOPMENTAL TOXICITY; LOCOMOTOR-ACTIVITY; ADULT ZEBRAFISH; TRANSPORT; CELLS; BIOCOMPATIBILITY; NANOMATERIALS; EXPOSURE	Silica nanoparticles (SiNPs) have been widely used in biomedical and biotechnological applications. Environmental exposure to nanomaterials is inevitable as they become part of our daily life. Therefore, it is necessary to investigate the possible toxic effects of SiNPs exposure. In this study, zebrafish embryos were treated with SiNPs (25, 50, 100, 200 mu g/mL) during 4-96 hours post fertilization (hpf). Mortality, hatching rate, malformation and whole-embryo cellular death were detected. We also measured the larval behavior to analyze whether SiNPs had adverse effects on larvae locomotor activity. The results showed that as the exposure dosages increasing, the hatching rate of zebrafish embryos was decreased while the mortality and cell death were increased. Exposure to SiNPs caused embryonic malformations, including pericardial edema, yolk sac edema, tail and head malformation. The larval behavior testing showed that the total swimming distance was decreased in a dose-dependent manner. The lower dose (25 and 50 mu g/mL SiNPs) produced substantial hyperactivity while the higher doses (100 and 200 mu g/mL SiNPs) elicited remarkably hypoactivity in dark periods. In summary, our data indicated that SiNPs caused embryonic developmental toxicity, resulted in persistent effects on larval behavior.	[Duan, Junchao; Yu, Yongbo; Guo, Caixia; Huang, Peili; Zhou, Xianqing; Sun, Zhiwei] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Duan, Junchao; Yu, Yongbo; Guo, Caixia; Huang, Peili; Zhou, Xianqing; Sun, Zhiwei] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing, Peoples R China; [Shi, Huiqin; Peng, Shuangqing] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Capital Medical University; Academy of Military Medical Sciences - China; Chinese University of Hong Kong	Peng, SQ (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	pengsq@hotmail.com; zwsun@hotmail.com	Tian, Linwei/A-9736-2009; Yu, Yongbo/AAE-9353-2019	Tian, Linwei/0000-0002-4739-1534; Tian, Linwei/0000-0003-2240-8886	National Natural Science Foundation of China [81230065, 81172704]; Funding Project for Academic Human Resources Development of Beijing Education Committee [PHR201006110]; Innovative Team Project of Beijing Education Committee [PHR201107116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development of Beijing Education Committee; Innovative Team Project of Beijing Education Committee	This work was supported by National Natural Science Foundation of China (no. 81230065, no. 81172704), Funding Project for Academic Human Resources Development of Beijing Education Committee (PHR201006110) and Innovative Team Project of Beijing Education Committee (PHR201107116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9; Balbus JM, 2007, ENVIRON HEALTH PERSP, V115, P1654, DOI [10.1289/ehp.10327, 10.1289/chp.10327]; Bar-Ilan O, 2012, NANOTOXICOLOGY, V6, P670, DOI 10.3109/17435390.2011.604438; Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Cheng JP, 2007, ENVIRON TOXICOL CHEM, V26, P708, DOI 10.1897/06-272R.1; Drapeau P, 2002, PROG NEUROBIOL, V68, P85, DOI 10.1016/S0301-0082(02)00075-8; Duan JC, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1700-8; Duan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062087; Duan JC, 2013, BIOMATERIALS, V34, P5853, DOI 10.1016/j.biomaterials.2013.04.032; Fako VE, 2009, ADV DRUG DELIVER REV, V61, P478, DOI 10.1016/j.addr.2009.03.008; Fent K, 2010, AQUAT TOXICOL, V100, P218, DOI 10.1016/j.aquatox.2010.02.019; Gao XY, 2011, BIOL TRACE ELEM RES, V143, P1616, DOI 10.1007/s12011-011-8990-4; Heiden TCK, 2007, TOXICOL APPL PHARM, V225, P70, DOI 10.1016/j.taap.2007.07.009; Hu YL, 2011, INT J NANOMED, V6, P3351, DOI 10.2147/IJN.S25853; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Lam KH, 2011, J CELL BIOCHEM, V112, P3313, DOI 10.1002/jcb.23257; Lee JE, 2011, ACCOUNTS CHEM RES, V44, P893, DOI 10.1021/ar2000259; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lee KJ, 2012, ANALYST, V137, P2973, DOI 10.1039/c2an35293a; Lee KJ, 2012, CHEM RES TOXICOL, V25, P1029, DOI 10.1021/tx300021u; Li Y, 2011, TOXICOL IN VITRO, V25, P1343, DOI 10.1016/j.tiv.2011.05.003; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin SJ, 2013, SMALL, V9, P1608, DOI 10.1002/smll.201202115; Lin SJ, 2011, ACS NANO, V5, P7284, DOI 10.1021/nn202116p; Linney E, 2004, NEUROTOXICOL TERATOL, V26, P709, DOI 10.1016/j.ntt.2004.06.015; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; Ostroumov SA, 2011, ECOLOGICA, V18, P3; Panessa-Warren BJ, 2009, LECT NOTES NANOSCALE, V4, P1; Park MVDZ, 2011, NANOTOXICOLOGY, V5, P168, DOI 10.3109/17435390.2010.506016; Powers CM, 2011, ENVIRON HEALTH PERSP, V119, P37, DOI 10.1289/ehp.1002337; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Ray PC, 2009, J ENVIRON SCI HEAL C, V27, P1, DOI 10.1080/10590500802708267; Riehl R, 2011, NEUROTOXICOL TERATOL, V33, P658, DOI 10.1016/j.ntt.2011.05.011; Sharif F, 2012, INT J NANOMED, V7, P1875, DOI 10.2147/IJN.S26547; Skebo JE, 2007, INT J TOXICOL, V26, P135, DOI 10.1080/10915810701226248; Thomas CR, 2011, ACS NANO, V5, P13, DOI 10.1021/nn1034857; Truong L, 2012, COMP BIOCHEM PHYS C, V155, P269, DOI 10.1016/j.cbpc.2011.09.006; Usenko CY, 2007, CARBON, V45, P1891, DOI 10.1016/j.carbon.2007.04.021; Xu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032818; Yan H, 2012, ANGEW CHEM INT EDIT, V51, P8373, DOI 10.1002/anie.201203993; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779; Zhu ZJ, 2010, SMALL, V6, P2261, DOI 10.1002/smll.201000989	47	77	80	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74606	10.1371/journal.pone.0074606	http://dx.doi.org/10.1371/journal.pone.0074606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058598	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900064
J	Poortinga, A; Van Minnen, J; Keijsers, J; Riksen, M; Goossens, D; Seeger, M				Poortinga, Ate; Van Minnen, Jan; Keijsers, Joep; Riksen, Michel; Goossens, Dirk; Seeger, Manuel			Measuring Fast-Temporal Sediment Fluxes with an Analogue Acoustic Sensor: A Wind Tunnel Study	PLOS ONE			English	Article							AEOLIAN TRANSPORT; SAND GRAINS; EROSION; VELOCITY; CLOUD; EFFICIENCY; SALTATION; PROFILE; UNITS; SOIL	In aeolian research, field measurements are important for studying complex wind-driven processes for land management evaluation and model validation. Consequently, there have been many devices developed, tested, and applied to investigate a range of aeolian-based phenomena. However, determining the most effective application and data analysis techniques is widely debated in the literature. Here we investigate the effectiveness of two different sediment traps (the BEST trap and the MWAC catcher) in measuring vertical sediment flux. The study was performed in a wind tunnel with sediment fluxes characterized using saltiphones. Contrary to most studies, we used the analogue output of five saltiphones mounted on top of each other to determine the total kinetic energy, which was then used to calculate aeolian sediment budgets. Absolute sediment losses during the experiments were determined using a balance located beneath the test tray. Test runs were conducted with different sand sizes and at different wind speeds. The efficiency of the two traps did not vary with the wind speed or sediment size but was affected by both the experimental setup (position of the lowest trap above the surface and number of traps in the saltation layer) and the technique used to calculate the sediment flux. Despite this, good agreement was found between sediment losses calculated from the saltiphone and those measured using the balance. The results of this study provide a framework for measuring sediment fluxes at small time resolution (seconds to milliseconds) in the field.	[Poortinga, Ate; Van Minnen, Jan; Keijsers, Joep; Riksen, Michel] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Goossens, Dirk] KU Leuven Dept Earth & Environm Sci, Geoinst, Geog Res Grp, Louvain, Belgium; [Goossens, Dirk] Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; [Seeger, Manuel] Univ Trier, Trier, Germany	Wageningen University & Research; KU Leuven; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Universitat Trier	Poortinga, A (corresponding author), Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands.	ate.poortinga@wur.nl	Riksen, Michel/B-3851-2014; Seeger, Manuel/V-9675-2017	Riksen, Michel/0000-0002-3695-4362; Seeger, Manuel/0000-0002-9195-156X; Poortinga, Ate/0000-0001-9647-2317				Arens SM, 1996, GEOMORPHOLOGY, V17, P3, DOI 10.1016/0169-555X(95)00089-N; Baas A, 2005, J GEOPHYS RES F, P110; Baas ACW, 2004, GEOMORPHOLOGY, V59, P99, DOI 10.1016/j.geomorph.2003.09.009; Bagnold R., 1941, PHYS BLOWN SAND DESE; Barchyn TE, 2011, EARTH SURF PROC LAND, V36, P702, DOI 10.1002/esp.2136; Basaran M, 2011, GEOMORPHOLOGY, V130, P343, DOI 10.1016/j.geomorph.2011.04.016; BAUER BO, 1992, PROF GEOGR, V44, P453, DOI 10.1111/j.0033-0124.1992.00453.x; Davidson-Arnott R, 2009, J COASTAL RES, P297; de Vries S, 2012, COAST ENG, V67, P41, DOI 10.1016/j.coastaleng.2012.04.002; Dong ZB, 2004, EARTH SURF PROC LAND, V29, P343, DOI 10.1002/esp.1030; Dong ZB, 2003, GEOMORPHOLOGY, V49, P219, DOI 10.1016/S0169-555X(02)00170-8; Ellis JT, 2009, AEOLIAN RES, V1, P19, DOI 10.1016/j.aeolia.2009.02.001; Ellis JT, 2009, GEOMORPHOLOGY, V105, P87, DOI 10.1016/j.geomorph.2008.02.017; Gabriels D, 1997, SOIL TECHNOL, V10, P1, DOI 10.1016/S0933-3630(96)00012-8; Goossens D, 2000, GEOMORPHOLOGY, V35, P233, DOI 10.1016/S0169-555X(00)00041-6; Hugenholtz CH, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001822; McCullough BD, 2008, COMPUT STAT DATA AN, V52, P4570, DOI 10.1016/j.csda.2008.03.004; Mendez MJ, 2011, GEOMORPHOLOGY, V129, P43, DOI 10.1016/j.geomorph.2011.01.011; Ogawa A, 2000, J THERM SCI, V9, P257; Panebianco JE, 2010, EARTH SURF PROC LAND, V35, P1548, DOI 10.1002/esp.1995; Poortinga A, 2013, AEOLIAN RES IN PRESS; Poortinga A, 2011, AEOLIAN RES, V3, P81, DOI 10.1016/j.aeolia.2011.05.003; Rajot JL, 2001, B SOC GEOL FR, V172, P523, DOI 10.2113/172.5.523; Ridge JT, 2011, GEOMORPHOLOGY, V134, P426, DOI 10.1016/j.geomorph.2011.07.017; Riksen M, 2008, J NAT CONSERV, V16, P26, DOI 10.1016/j.jnc.2007.07.002; Riksen MJPM, 2005, SOIL TILL RES, V83, P218, DOI 10.1016/j.still.2004.07.017; [董玉祥 DONG Yu-xiang], 2009, [地理研究, Geographical Research], V28, P1179; Schonfeldt HJ, 2012, EARTH SURF PROC LAND, V37, P1065, DOI 10.1002/esp.3228; SPAAN W P, 1991, Soil Technology, V4, P51, DOI 10.1016/0933-3630(91)90039-P; Sterk G, 1996, LAND DEGRAD DEV, V7, P325; Sterk G, 1996, SOIL SCI SOC AM J, V60, P1914, DOI 10.2136/sssaj1996.03615995006000060042x; Sterk G, 2012, CATENA, V95, P112, DOI 10.1016/j.catena.2012.02.005; Stockton P. H., 1990, Land Degradation & Rehabilitation, V2, P77, DOI 10.1002/ldr.3400020202; Temur C, 2012, J ENVIRON SCI HEAL B, V47, P842, DOI 10.1080/03601234.2012.693878; Van Pelt RS, 2009, AEOLIAN RES, V1, P55, DOI 10.1016/j.aeolia.2009.05.001; Visser, 2004, TROPICAL RESOURCE MA, P195; Visser SM, 2005, CATENA, V63, P1, DOI 10.1016/j.catena.2005.07.003; Visser SM, 2004, GEODERMA, V120, P95, DOI 10.1016/j.geoderma.2003.09.003; Yang P, 2007, GEOMORPHOLOGY, V89, P320, DOI 10.1016/j.geomorph.2006.12.012; Youssef F, 2008, ENVIRON GEOL, V55, P741, DOI 10.1007/s00254-007-1027-9; Youssef F, 2012, GEOMORPHOLOGY, V159, P178, DOI 10.1016/j.geomorph.2012.03.023; Zobeck TM, 2003, EARTH SURF PROC LAND, V28, P1163, DOI 10.1002/esp.1033; Zou XY, 2001, GEOMORPHOLOGY, V36, P155, DOI 10.1016/S0169-555X(00)00038-6	43	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74007	10.1371/journal.pone.0074007	http://dx.doi.org/10.1371/journal.pone.0074007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058512	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900029
J	Venerando, A; Franchin, C; Cant, N; Cozza, G; Pagano, MA; Tosoni, K; Al-Zahrani, A; Arrigoni, G; Ford, RC; Mehta, A; Pinna, LA				Venerando, Andrea; Franchin, Cinzia; Cant, Natasha; Cozza, Giorgio; Pagano, Mario A.; Tosoni, Kendra; Al-Zahrani, Ateeq; Arrigoni, Giorgio; Ford, Robert C.; Mehta, Anil; Pinna, Lorenzo A.			Detection of Phospho- Sites Generated by Protein Kinase CK2 in CFTR: Mechanistic Aspects of Thr1471 Phosphorylation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; TRAFFICKING; DEGRADATION; INHIBITION; ACTIVATION; PROTEASOME; CONTRIBUTE; STABILITY; SEQUENCE; BINDING	By mass spectrometry analysis of mouse Cystic Fibrosis Transmembrane-conductance Regulator (mCFTR) expressed in yeast we have detected 21 phosphopeptides accounting for 22 potential phospho-residues, 12 of which could be unambiguously assigned. Most are conserved in human CFTR (hCFTR) and the majority cluster in the Regulatory Domain, lying within consensus sequences for PKA, as identified in previous mammalian studies. This validates our yeast expression model. A number of phospho-residues were novel and human conserved, notably mouse Ser670, Ser723, Ser737, and Thr1467, that all lie in acidic sequences, compatible with their phosphorylation by protein kinase CK2. Thr1467 is localized in the C-terminal tail, embedded in a functionally important and very acidic sequence (EETEEE) which displays an optimal consensus for protein kinase CK2. Herein, we show that Thr1467, homologous to human Thr1471 is readily phosphorylated by CK2. Indeed a 42 amino acid peptide encompassing the C-terminal segment of human CFTR is readily phosphorylated at Thr1471 with favorable kinetics (Km 1.7 mu M) by CK2 holoenzyme, but neither by its isolated catalytic subunit nor by other acidophilic Ser/Thr kinases (CK1, PLK2/3, GCK/FAM20C). Our finding that by treating CFTR expressing BHK cells with the very specific CK2 inhibitor CX4945, newly synthesized wild type CFTR (and even more its Phe508del mutant) accumulates more abundantly than in the absence of CK2 inhibitor, supports the conclusion that phosphorylation of CFTR by CK2 correlates with decreased stability of the protein.	[Venerando, Andrea; Franchin, Cinzia; Cozza, Giorgio; Arrigoni, Giorgio; Pinna, Lorenzo A.] Univ Padua, Dept Biomed Sci, Padua, Italy; [Venerando, Andrea; Franchin, Cinzia; Cozza, Giorgio; Arrigoni, Giorgio; Pinna, Lorenzo A.] CNR, Inst Neurosci, Padua, Italy; [Franchin, Cinzia; Arrigoni, Giorgio] Univ Padua, Prote Ctr, VIMM, Padua, Italy; [Franchin, Cinzia; Arrigoni, Giorgio] Padova Univ Hosp, Padua, Italy; [Cant, Natasha; Al-Zahrani, Ateeq; Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Pagano, Mario A.] Univ Padua, Dept Mol Med, Padua, Italy; [Tosoni, Kendra; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Veneto Institute Molecular Medicine; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Manchester; University of Padua; University of Dundee	Pinna, LA (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	lorenzo.pinna@unipd.it	Franchin, Cinzia/AAM-1196-2021; VENERANDO, ANDREA/J-2924-2017; Franchin, Cinzia/AHE-4689-2022; Arrigoni, Giorgio/A-3535-2014	Franchin, Cinzia/0000-0001-9223-117X; VENERANDO, ANDREA/0000-0003-0379-2309; Franchin, Cinzia/0000-0001-9223-117X; Arrigoni, Giorgio/0000-0002-4103-2733; Ford, Robert/0000-0002-0958-1505; Pinna, Lorenzo A./0000-0002-8856-4956; Pagano, Mario Angelo/0000-0003-4186-7658; COZZA, GIORGIO/0000-0002-5155-4682	Fondazione per la Ricerca sulla Fibrosi Cistica [3/2011]; Wellcome Trust [088929]; Cystic Fibrosis Foundation; BBSRC PhD studentship; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione per la Ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	LAP was supported by the Fondazione per la Ricerca sulla Fibrosi Cistica (grant # 3/2011 adopted by Delegazione FFC della Valdadige and Associazione Trentina FC Fiaba"ll Villaggio di Natale'' in ricordo di Massimiliano e Sebastiano) and Associazione Italiana per la Ricerca sul Cancro. This work was funded also by Wellcome Trust (grant numbers 088929 to LAP with AM and 069150 to AM). RCF acknowledges the Cystic Fibrosis Foundation for funding under the auspices of its CFTR 3D Structure Consortium. NC was funded by a BBSRC PhD studentship. The authors are grateful to the Cassa di Risparmio di Padova e Rovigo (Cariparo) Holding for funding the acquisition of the LTQ-Orbitrap XL mass spectrometer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Carpino LA, 2001, J ORG CHEM, V66, P5245, DOI 10.1021/jo001616+; Chen EY, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-29; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Lolli G, 2012, BIOCHEMISTRY-US, V51, P6097, DOI 10.1021/bi300531c; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; McClure M, 2012, PROTEIN ENG DES SEL, V25, P7, DOI 10.1093/protein/gzr054; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Neville DCA, 1997, PROTEIN SCI, V6, P2436; O'Ryan L, 2012, JOVE-J VIS EXP, DOI 10.3791/3860; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; Pagano MA, 2008, BIOCHEMISTRY-US, V47, P7925, DOI 10.1021/bi800316z; Peters KW, 2001, PFLUG ARCH EUR J PHY, V443, pS65, DOI 10.1007/s004240100647; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Ren AX, 2013, J BIOL CHEM, V288, P12325, DOI 10.1074/jbc.M112.432724; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schultz B. D., 1999, Physiological Reviews, V79, pS109; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tosoni K, 2013, BIOCHEM J, V449, P295, DOI 10.1042/BJ20121240; Venerando A, 2011, FEBS J, V278, P387; Venerando A, 2010, CELL MOL LIFE SCI, V67, P1105, DOI 10.1007/s00018-009-0236-7; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043	45	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74232	10.1371/journal.pone.0074232	http://dx.doi.org/10.1371/journal.pone.0074232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058532	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900036
J	Alvarez, E; Castello, A; Carrasco, L; Izquierdo, JM				Alvarez, Enrique; Castello, Alfredo; Carrasco, Luis; Izquierdo, Jose M.			Poliovirus 2A Protease Triggers a Selective Nucleo-Cytoplasmic Redistribution of Splicing Factors to Regulate Alternative Pre-mRNA Splicing	PLOS ONE			English	Article							PORE COMPLEX PROTEINS; TIA-1; VIRUSES	Poliovirus protease 2A (2A(pro)) obstructs host gene expression by reprogramming transcriptional and post-transcriptional regulatory events during infection. Here we demonstrate that expression of 2A(pro) induces a selective nucleo-cytoplasm translocation of several important RNA binding proteins and splicing factors. Subcellular fractionation studies, together with immunofluorescence microscopy revealed an asymmetric distribution of HuR and TIA1/TIAR in 2A(pro) expressing cells, which modulates splicing of the human Fas exon 6. Consistent with this result, knockdown of HuR or overexpression of TIA1/TIAR, leads to Fas exon 6 inclusion in 2A(pro)-expressing cells. Therefore, poliovirus 2A(pro) can target alternative pre-mRNA splicing by regulating protein shuttling between the nucleus and the cytoplasm.	[Alvarez, Enrique; Carrasco, Luis; Izquierdo, Jose M.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Castello, Alfredo] European Mol Biol Lab, D-69012 Heidelberg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); European Molecular Biology Laboratory (EMBL)	Alvarez, E (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	ealvarez@cbm.uam.es; jmizquierdo@cbm.uam.es	Castello, Alfredo/U-6317-2018; Carrasco, Luis/H-3001-2017; Palomares, Alfredo Castello/K-8062-2019; Carrasco, Luis/E-2435-2012	Castello, Alfredo/0000-0002-1499-4662; Carrasco, Luis/0000-0003-3833-8835; Palomares, Alfredo Castello/0000-0002-1499-4662; Alvarez Vazquez, Enrique/0000-0002-4889-175X; Izquierdo, Jose M/0000-0002-7942-4046	Spanish Ministerio de Economia y Competitividad through FEDER funds [BFU2011-29653, BFU2012-31861]; Fundacion Ramon Areces	Spanish Ministerio de Economia y Competitividad through FEDER funds; Fundacion Ramon Areces	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad through FEDER funds (BFU2011-29653 (JMI) and BFU2012-31861 (LC)). The CBMSO receives an institutional grant from Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstead LL, 2007, GENE DEV, V21, P1086, DOI 10.1101/gad.1535607; Alvarez E, 2011, BIOCHEM BIOPH RES CO, V414, P142, DOI 10.1016/j.bbrc.2011.09.040; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Fitzgerald KD, 2013, J VIROL, V87, P2390, DOI 10.1128/JVI.02396-12; Fitzgerald KD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002127; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Izquierdo JM, 2010, BIOCHEM BIOPH RES CO, V402, P324, DOI 10.1016/j.bbrc.2010.10.025; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; Palmenberg A, 2010, PICORNAVIRUSES, P3; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Redondo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025699; Watters K, 2011, J VIROL, V85, P10874, DOI 10.1128/JVI.00718-11; Weidman MK, 2003, VIRUS RES, V95, P75, DOI 10.1016/S0168-1702(03)00164-3; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669	21	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73723	10.1371/journal.pone.0073723	http://dx.doi.org/10.1371/journal.pone.0073723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066065	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324494000047
J	Bhat, WW; Dhar, N; Razdan, S; Rana, S; Mehra, R; Nargotra, A; Dhar, RS; Ashraf, N; Vishwakarma, R; Lattoo, SK				Bhat, Wajid Waheed; Dhar, Niha; Razdan, Sumeer; Rana, Satiander; Mehra, Rukmankesh; Nargotra, Amit; Dhar, Rekha S.; Ashraf, Nasheeman; Vishwakarma, Ram; Lattoo, Surrinder K.			Molecular Characterization of UGT94F2 and UGT86C4, Two Glycosyltransferases from Picrorhiza kurrooa: Comparative Structural Insight and Evaluation of Substrate Recognition	PLOS ONE			English	Article							SUGAR DONOR SPECIFICITY; INDUCED LIVER TOXICITY; BETANIDIN 5-O-GLUCOSYLTRANSFERASE; CRYSTAL-STRUCTURES; UDP-GLUCOSE; METHYL JASMONATE; SALICYLIC-ACID; EXPRESSION; GLUCOSYLTRANSFERASE; CLONING	Uridine diphosphate glycosyltransferases (UGTs) are pivotal in the process of glycosylation for decorating natural products with sugars. It is one of the versatile mechanisms in determining chemical complexity and diversity for the production of suite of pharmacologically active plant natural products. Picrorhiza kurrooa is a highly reputed medicinal herb known for its hepato-protective properties which are attributed to a novel group of iridoid glycosides known as picrosides. Although the plant is well studied in terms of its pharmacological properties, very little is known about the biosynthesis of these important secondary metabolites. In this study, we identified two family-1 glucosyltransferases from P. kurrooa. The full length cDNAs of UGT94F4 and UGT86C4 contained open reading frames of 1455 and 1422 nucleotides, encoding polypeptides of 484 and 473 amino acids respectively. UGT94F2 and UGT86C4 showed differential expression pattern in leaves, rhizomes and inflorescence. To elucidate whether the differential expression pattern of the two Picrorhiza UGTs correlate with transcriptional regulation via their promoters and to identify elements that could be recognized by known iridoid-specific transcription factors, upstream regions of each gene were isolated and scanned for putative cis-regulatory elements. Interestingly, the presence of cis-regulatory elements within the promoter regions of each gene correlated positively with their expression profiles in response to different phytohormones. HPLC analysis of picrosides extracted from different tissues and elicitor-treated samples showed a significant increase in picroside levels, corroborating well with the expression profile of UGT94F2 possibly indicating its implication in picroside biosynthesis. Using homology modeling and molecular docking studies, we provide an insight into the donor and acceptor specificities of both UGTs identified in this study. UGT94F2 was predicted to be an iridoid-specific glucosyltransferase having maximum binding affinity towards 7-deoxyloganetin while as UGT86C4 was predicted to be a kaempferol-specific glucosyltransferase. These are the first UGTs being reported from P. kurrooa.	[Bhat, Wajid Waheed; Dhar, Niha; Razdan, Sumeer; Rana, Satiander; Mehra, Rukmankesh; Nargotra, Amit; Dhar, Rekha S.; Ashraf, Nasheeman; Vishwakarma, Ram; Lattoo, Surrinder K.] Indian Inst Integrat Med CSIR, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Lattoo, SK (corresponding author), Indian Inst Integrat Med CSIR, Jammu, India.	sklattoo@iiim.ac.in	Mehra, Rukmankesh/L-6525-2018; Rana, Satiander/G-3696-2012; Bhat, Wajid Waheed/E-6645-2012	Mehra, Rukmankesh/0000-0001-6010-1514; Rana, Satiander/0000-0001-9197-8378; Bhat, Wajid Waheed/0000-0002-7049-8671; DHAR, NIHA/0000-0002-3295-8016	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [NWP 0008]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi under Network Project NWP 0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Bhat WW, 2012, IN VITRO CELL DEV-PL, V48, P295, DOI 10.1007/s11627-012-9434-3; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Brazier-Hicks M, 2007, PLANT BIOTECHNOL J, V5, P627, DOI 10.1111/j.1467-7652.2007.00266.x; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; DAMTOFT S, 1995, PHYTOCHEMISTRY, V40, P773, DOI 10.1016/0031-9422(95)00211-O; Dinda B, 2007, CHEM PHARM BULL, V55, P159, DOI 10.1248/cpb.55.159; Fraissinet-Tachet L, 1998, FEBS LETT, V437, P319, DOI 10.1016/S0014-5793(98)01257-5; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Gantet P, 1998, PLANT CELL PHYSIOL, V39, P220, DOI 10.1093/oxfordjournals.pcp.a029360; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Girish C, 2012, J PHARMACOL PHARMACO, V3, P149, DOI 10.4103/0976-500X.95515; Girish C, 2009, FUND CLIN PHARMACOL, V23, P735, DOI 10.1111/j.1472-8206.2009.00722.x; Hans J, 2004, PLANT J, V39, P319, DOI 10.1111/j.1365-313X.2004.02133.x; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/PL00008158; Horvath DM, 1998, MOL PLANT MICROBE IN, V11, P895, DOI 10.1094/MPMI.1998.11.9.895; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; Imanishi S, 1998, PLANT CELL PHYSIOL, V39, P202, DOI 10.1093/oxfordjournals.pcp.a029358; Jia Q, 1999, J NAT PROD, V62, P901, DOI 10.1021/np980493+; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kawoosa T, 2010, FUNCT INTEGR GENOMIC, V10, P393, DOI 10.1007/s10142-009-0152-9; Kovinich N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-381; Kramer CM, 2003, PHYTOCHEMISTRY, V64, P1069, DOI 10.1016/S0031-9422(03)00507-7; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoud SS, 2002, TRENDS PLANT SCI, V7, P366, DOI 10.1016/S1360-1385(02)02303-8; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; Meng FJ, 2012, INT J MOL MED, V30, P263, DOI 10.3892/ijmm.2012.987; Modolo LV, 2009, J MOL BIOL, V392, P1292, DOI 10.1016/j.jmb.2009.08.017; Nagatoshi M, 2011, J BIOL CHEM, V286, P32866, DOI 10.1074/jbc.M111.242586; Noguchi A, 2009, PLANT CELL, V21, P1556, DOI 10.1105/tpc.108.063826; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Pandit S, 2013, MOL BIOL REP, V40, P1053, DOI 10.1007/s11033-012-2147-1; Rajeshkumar NV, 2003, CANCER LETT, V191, P137, DOI 10.1016/S0304-3835(02)00203-3; Rajkumar V, 2011, FOOD CHEM TOXICOL, V49, P363, DOI 10.1016/j.fct.2010.11.009; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Rastogi R, 1996, PLANTA MED, V62, P283, DOI 10.1055/s-2006-957882; Rastogi R, 2001, PHARMACOL TOXICOL, V88, P53, DOI 10.1034/j.1600-0773.2001.088002053.x; Sane SA, 2011, EXP PARASITOL, V127, P376, DOI 10.1016/j.exppara.2010.09.003; Saraswat Binduja, 1997, Indian Journal of Experimental Biology, V35, P1302; Seth P, 2000, BIOCHEM PHARMACOL, V59, P1315, DOI 10.1016/S0006-2952(00)00268-9; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Sidiq T, 2011, INT IMMUNOPHARMACOL, V11, P128, DOI 10.1016/j.intimp.2010.10.017; Singh AK, 2000, EUR J PHARMACOL, V395, P229, DOI 10.1016/S0014-2999(00)00146-1; Sood H, 2010, PLANT CELL TISS ORG, V100, P113, DOI 10.1007/s11240-009-9618-7; STUPPNER H, 1989, PLANTA MED, P559, DOI 10.1055/s-2006-962095; Taguchi G, 2001, EUR J BIOCHEM, V268, P4086, DOI 10.1046/j.1432-1327.2001.02325.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorsoe KS, 2005, PLANT PHYSIOL, V139, P664, DOI 10.1104/pp.105.063842; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; Vogt T, 2002, PLANTA, V214, P492, DOI 10.1007/s00425-001-0685-1; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040	63	32	33	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73804	10.1371/journal.pone.0073804	http://dx.doi.org/10.1371/journal.pone.0073804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066073	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000055
J	Bobrovska, N; Gozdz, W; Kralj-Iglic, V; Iglic, A				Bobrovska, Nataliya; Gozdz, Wojciech; Kralj-Iglic, Veronika; Iglic, Ales			On the Role of Anisotropy of Membrane Components in Formation and Stabilization of Tubular Structures in Multicomponent Membranes	PLOS ONE			English	Article							RED-BLOOD-CELL; SHAPE TRANSFORMATIONS; SPONTANEOUS CURVATURE; ELASTIC PROPERTIES; PHASE-TRANSITION; GIANT VESICLES; BAR PROTEINS; STABILITY; NANOTUBES; AMPHIPHYSIN	Influence of isotropic and anisotropic properties of membrane constituents (nanodomains) on formation of tubular membrane structures in two-component vesicle is numerically investigated by minimization of the free energy functional based on the deviatoric-elasticity model of the membrane. It is shown that the lateral redistribution and segregation of membrane components may induce substantial change in membrane curvature resulting in the growth of highly curved tubular structures.	[Bobrovska, Nataliya; Gozdz, Wojciech] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland; [Kralj-Iglic, Veronika] Univ Ljubljana, Fac Hlth Studies, SI-1000 Ljubljana, Slovenia; [Iglic, Ales] Univ Ljubljana, Biophys Lab, Fac Elect Engn, SI-1000 Ljubljana, Slovenia	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; University of Ljubljana; University of Ljubljana	Iglic, A (corresponding author), Univ Ljubljana, Biophys Lab, Fac Elect Engn, Trzaska 25, SI-1000 Ljubljana, Slovenia.	ales.iglic@fe.uni-lj.si	Bobrovska, Nataliya/S-5257-2016; Góźdź, Wojciech T/A-2372-2008; Gozdz, Wojciech/J-9578-2019	Góźdź, Wojciech T/0000-0003-4506-6831; Gozdz, Wojciech/0000-0003-4506-6831; Kralj-Iglic, Veronika/0000-0002-7496-2005	European Regional Development Fund within Innovative Economy Operational Programme "Grants for innovation''; Slovenian Research Agency [J1-4109, J1-4136, J3-4108, P2-0232]; NCN [2012/05/B/ST3/03302]	European Regional Development Fund within Innovative Economy Operational Programme "Grants for innovation''; Slovenian Research Agency(Slovenian Research Agency - Slovenia); NCN	The work of N.B. was realized within the International Ph.D. Projects Programme of the Foundation for Polish Science, co-financed from European Regional Development Fund within Innovative Economy Operational Programme "Grants for innovation''. A.I. and V.K.I. were supported by Slovenian Research Agency grants J1-4109, J1-4136, J3-4108 and P2-0232. W.G. would like to acknowledge support by NCN grant No. 2012/05/B/ST3/03302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; D'Onofrio TG, 2003, LANGMUIR, V19, P1618, DOI 10.1021/la026133a; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Eber N, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021702; Fosnaric M, 2008, ADV PLANAR LIP BILAY, V7, P143, DOI 10.1016/S1554-4516(08)00006-9; Fournier JB, 1996, PHYS REV LETT, V76, P4436, DOI 10.1103/PhysRevLett.76.4436; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gozdz WT, 2006, J PHYS CHEM B, V110, P21981, DOI 10.1021/jp062304z; Gozdz WT, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4731646; Gozdz WT, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3530069; Gozdz WT, 1998, PHYS REV LETT, V80, P4213, DOI 10.1103/PhysRevLett.80.4213; Gozdz WT, 2005, J PHYS CHEM B, V109, P21145, DOI 10.1021/jp052694+; Gozdz WT, 2004, LANGMUIR, V20, P7385, DOI 10.1021/la049776u; Gozdz WT, 2002, COLLOID SURFACE A, V208, P241, DOI 10.1016/S0927-7757(02)00150-4; Hagerstrand H, 2006, MOL MEMBR BIOL, V23, P277, DOI 10.1080/09687860600682536; HELFRICH W, 1988, PHYS REV A, V38, P3065, DOI 10.1103/PhysRevA.38.3065; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hiergeist C, 1996, J PHYS II, V6, P1465, DOI 10.1051/jp2:1996142; Iglic A, 2005, J PHYS A-MATH GEN, V38, P8527, DOI 10.1088/0305-4470/38/40/004; Iglic A, 2007, BLOOD CELL MOL DIS, V39, P14, DOI 10.1016/j.bcmd.2007.02.013; Iglic A, 2006, J THEOR BIOL, V240, P368, DOI 10.1016/j.jtbi.2005.09.020; Israelachvili J.N., 1991, INTERMOLECULAR SURFA; Jorgacevski J, 2010, MOL MEMBR BIOL, V27, P65, DOI 10.3109/09687681003597104; Kabaso D, 2011, MINI-REV MED CHEM, V11, P272, DOI 10.2174/138955711795305353; Kabaso D, 2012, J BIOMECH, V45, P231, DOI 10.1016/j.jbiomech.2011.10.039; Koster G, 2003, P NATL ACAD SCI USA, V100, P15583, DOI 10.1073/pnas.2531786100; Kralj-Iglic V, 2000, PHYS REV E, V61, P4230, DOI 10.1103/PhysRevE.61.4230; Kralj-Iglic V, 1999, EUR PHYS J B, V10, P5, DOI 10.1007/s100510050822; Kralj-Iglic V, 2002, J PHYS A-MATH GEN, V35, P1533, DOI 10.1088/0305-4470/35/7/305; Kralj-Iglic V, 2001, COLLOID SURFACE A, V179, P57, DOI 10.1016/S0927-7757(00)00721-4; Kralj-Iglic V, 2006, J STAT PHYS, V125, P727, DOI 10.1007/s10955-006-9051-9; Kulkarni C, 2012, NANOSCALE; Li YH, 2011, P NATL ACAD SCI USA, V108, P4731, DOI 10.1073/pnas.1015892108; Nikolov V, 2007, BIOPHYS J, V92, P4356, DOI 10.1529/biophysj.106.100032; Perutkova S, 2011, PHYS CHEM CHEM PHYS, V13, P3100, DOI 10.1039/c0cp01187h; Perutkova S, 2010, J BIOMECH, V43, P1612, DOI 10.1016/j.jbiomech.2009.12.026; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rappolt M, 2008, CHEM PHYS LIPIDS, V154, P46, DOI 10.1016/j.chemphyslip.2008.02.006; Risselada HJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.148102; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Schara K, 2009, CELL MOL BIOL LETT, V14, P636, DOI 10.2478/s11658-009-0018-0; Shlomovitz R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065008; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Thakkar FM, 2011, SOFT MATTER, V7, P3963, DOI 10.1039/c0sm00876a; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Tsafrir I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138102; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	49	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73941	10.1371/journal.pone.0073941	http://dx.doi.org/10.1371/journal.pone.0073941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066088	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000070
J	Cortes, CP; Wehbe, FH; McGowan, CC; Shepherd, BE; Duda, SN; Jenkins, CA; Gonzalez, E; Carriquiry, G; Schechter, M; Padgett, D; Cesar, C; Madero, JS; Pape, JW; Masys, DR; Sterling, TR				Cortes, Claudia P.; Wehbe, Firas H.; McGowan, Catherine C.; Shepherd, Bryan E.; Duda, Stephany N.; Jenkins, Cathy A.; Gonzalez, Elsa; Carriquiry, Gabriela; Schechter, Mauro; Padgett, Denis; Cesar, Carina; Sierra Madero, Juan; Pape, Jean W.; Masys, Daniel R.; Sterling, Timothy R.		Int Epidemiologic Databases Evalua	Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE RECONSTITUTION; INFECTED PATIENTS; RISK-FACTORS; RELAPSE; OUTCOMES; ADULTS; AIDS; ERA	Background: Antiretroviral therapy (ART) decreases mortality risk in HIV-infected tuberculosis patients, but the effect of the duration of anti-tuberculosis therapy and timing of anti-tuberculosis therapy initiation in relation to ART initiation on mortality, is unclear. Methods: We conducted a retrospective observational multi-center cohort study among HIV-infected persons concomitantly treated with Rifamycin-based anti-tuberculosis therapy and ART in Latin America. The study population included persons for whom 6 months of anti-tuberculosis therapy is recommended. Results: Of 253 patients who met inclusion criteria, median CD4+ lymphocyte count at ART initiation was 64 cells/mm(3), 171 (68%) received >180 days of anti-tuberculosis therapy, 168 (66%) initiated anti-tuberculosis therapy before ART, and 43 (17%) died. In a multivariate Cox proportional hazards model that adjusted for CD4+ lymphocytes and HIV-1 RNA, tuberculosis diagnosed after ART initiation was associated with an increased risk of death compared to tuberculosis diagnosis before ART initiation (HR 2.40; 95% CI 1.15, 5.02; P = 0.02). In a separate model among patients surviving >6 months after tuberculosis diagnosis, after adjusting for CD4+ lymphocytes, HIV-1 RNA, and timing of ART initiation relative to tuberculosis diagnosis, receipt of >6 months of anti-tuberculosis therapy was associated with a decreased risk of death (HR 0.23; 95% CI 0.08, 0.66; P = 0.007). Conclusions: The increased risk of death among persons diagnosed with tuberculosis after ART initiation highlights the importance of screening for tuberculosis before ART initiation. The decreased risk of death among persons receiving >6 months of anti-tuberculosis therapy suggests that current anti-tuberculosis treatment duration guidelines should be re-evaluated.	[Cortes, Claudia P.] Univ Chile, Santiago, Chile; [Cortes, Claudia P.] Fdn Arriaran, Santiago, Chile; [Wehbe, Firas H.; McGowan, Catherine C.; Shepherd, Bryan E.; Duda, Stephany N.; Jenkins, Cathy A.; Masys, Daniel R.; Sterling, Timothy R.] Vanderbilt Univ, Nashville, TN 37235 USA; [Gonzalez, Elsa; Carriquiry, Gabriela] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Padgett, Denis] Inst Hondureno Seguro Social, Tegucigalpa, Honduras; [Padgett, Denis] Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; [Cesar, Carina] Fdn Huesped, Buenos Aires, DF, Argentina; [Sierra Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Pape, Jean W.] Ctr GHESKIO, Port Au Prince, Haiti	Universidad de Chile; Vanderbilt University; Universidad Peruana Cayetano Heredia; Universidade Federal do Rio de Janeiro; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Sterling, TR (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.	timothy.sterling@vanderbilt.edu	Cesar, Carina/H-2831-2019; Sued, Omar/H-3325-2019; Cortes, Claudia P/AAF-7326-2020; Schechter, Mauro/AAG-7445-2020; Sierra Madero, Juan/AAW-8825-2021; Wehbe, Firas/Q-6176-2019	Sued, Omar/0000-0001-5818-770X; Cortes, Claudia P/0000-0001-9101-9783; Wehbe, Firas/0000-0002-3984-9584; Wolff, Marcelo/0000-0002-9956-8872	National Institutes of Health (NIH) [NIH 1 UO1 AI069923, NIH 1 UL1 RR024975]; National Institute of Allergy and Infectious Diseases (NIAID) [K24 AI 65298]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI065298, U01AI069923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH): grant number NIH 1 UO1 AI069923 (to CCASAnet); NIH 1 UL1 RR024975 (REDCap); and National Institute of Allergy and Infectious Diseases (NIAID) K24 AI 65298 (to TRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI K, 2011, J INT ASS PHYS AIDS; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; De D, 2011, BRAZ J INFECT DIS, V15, P553, DOI 10.1590/S1413-86702011000600009; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Hung CC, 2003, AIDS, V17, P2615, DOI 10.1097/00002030-200312050-00008; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Leonard MK, 2002, CLIN INFECT DIS, V34, P1002, DOI 10.1086/339448; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; Nettles RE, 2004, CLIN INFECT DIS, V38, P731, DOI 10.1086/381675; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; Pulido F, 1997, ARCH INTERN MED, V157, P227, DOI 10.1001/archinte.157.2.227; Sterling TR, 2011, J INFECT DIS, V204, P893, DOI 10.1093/infdis/jir421; Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	27	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74057	10.1371/journal.pone.0074057	http://dx.doi.org/10.1371/journal.pone.0074057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066096	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000078
J	Ekuni, D; Endo, Y; Tomofuji, T; Azuma, T; Irie, K; Kasuyama, K; Morita, M				Ekuni, Daisuke; Endo, Yasumasa; Tomofuji, Takaaki; Azuma, Tetsuji; Irie, Koichiro; Kasuyama, Kenta; Morita, Manabu			Effects of apoE Deficiency and Occlusal Disharmony on Amyloid-Beta Production and Spatial Memory in Rats	PLOS ONE			English	Article							APOLIPOPROTEIN-E KNOCKOUT; ALZHEIMERS-DISEASE; TOOTH LOSS; A-BETA; NEUROFIBRILLARY PATHOLOGY; TYPE-4 ALLELE; E GENOTYPE; IN-VITRO; BRAIN; ONSET	Amyloid-beta (A beta) plays a causative role in Alzheimer's disease. Apolipoprotein E (apoE) is involved in A beta accumulation, whereas occlusal disharmony increases A beta production in the rat hippocampus. The purpose of the present study was to investigate the effects of apoE deficiency and occlusal disharmony on A beta production and spatial memory. Wild-type (WT) (n = 12) and apoE-deficient [ApoE(-/-)] (n = 12) rats (Sprague-Dawley; 8 weeks old) were used. These rats were randomly divided into four groups of six rats each: two control (C) groups: WT (C-WT) and ApoE [C-ApoE(-/-)], and two occlusal disharmony (D) groups: WT (D-WT) and ApoE [D-ApoE(-/-)]. The C group received no treatment for 8 weeks. In the D group, the maxillary molar cusps were cut off for 8 weeks. The spatial memory of rats was assessed according to their behavioral performance in a radial arm maze. In both genotypes of rats, significant differences in the reference memory, A beta 42 production, beta-secretase expression and plasma corticosterone levels were observed between the C and D groups (P < 0.0125). The levels of A beta 42 and glucocorticoid receptor in the C-ApoE(-/-) group were also significantly higher than those in the C-WT group (P < 0.0125). However, no significant differences in these parameters were found between the two genotypes with occlusal disharmony. In conclusion, occlusal disharmony induces cognitive dysfunction and A beta accumulation in the rat hippocampus, and the effects of occlusal disharmony on A beta accumulation and cognitive dysfunction were larger than those of apoE deficiency.	[Ekuni, Daisuke; Endo, Yasumasa; Tomofuji, Takaaki; Azuma, Tetsuji; Irie, Koichiro; Kasuyama, Kenta; Morita, Manabu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama 7008530, Japan	Okayama University	Ekuni, D (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama 7008530, Japan.	dekuni7@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [23390480, 23792512]	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (23390480 & 23792512) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; Anderson R, 1997, PSYCHOPHARMACOLOGY, V132, P135, DOI 10.1007/s002130050329; Andoh T, 2009, J PROSTHODONT RES, V53, P155, DOI 10.1016/j.jpor.2009.06.003; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Avdesh A, 2011, J ALZHEIMERS DIS, V25, P433, DOI 10.3233/JAD-2011-101944; Belinson H, 2009, J NEURAL TRANSM, V116, P1427, DOI 10.1007/s00702-009-0218-9; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bronfman FC, 2000, NEUROSCIENCE, V97, P411, DOI 10.1016/S0306-4522(00)00016-6; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Kloet ER, 2002, NEUROBIOL LEARN MEM, V78, P570, DOI 10.1006/nlme.2002.4079; Ekuni D, 2011, NEUROMOL MED, V13, P197, DOI 10.1007/s12017-011-8151-0; Fagan AM, 1998, EXP NEUROL, V151, P314, DOI 10.1006/exnr.1998.6818; GEARING M, 1995, J NEUROPATH EXP NEUR, V54, P833, DOI 10.1097/00005072-199511000-00010; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grootendorst J, 2002, BRAIN RES, V953, P281, DOI 10.1016/S0006-8993(02)03399-1; Grootendorst J, 2001, NEUROSCIENCE, V108, P237, DOI 10.1016/S0306-4522(01)00412-2; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; HANSEN LA, 1994, NEUROSCI LETT, V182, P63, DOI 10.1016/0304-3940(94)90206-2; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Irie K, 2011, ARCH ORAL BIOL, V56, P35, DOI 10.1016/j.archoralbio.2010.09.001; Irizarry MC, 2000, ANN NY ACAD SCI, V920, P171; Ji Y, 2001, J ALZHEIMERS DIS, V3, P23, DOI 10.3233/JAD-2001-3105; Krzywkowski P, 1999, NEUROSCIENCE, V92, P1273, DOI 10.1016/S0306-4522(99)00061-5; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; NAGY Z, 1995, NEUROSCIENCE, V69, P757, DOI 10.1016/0306-4522(95)00331-C; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Narita M, 2010, NEUROSCI RES, V66, P2, DOI 10.1016/j.neures.2009.09.001; Nie J, 2010, EUR J PHARMACOL, V626, P213, DOI 10.1016/j.ejphar.2009.09.039; Ohm TG, 1999, ACTA NEUROPATHOL, V98, P273, DOI 10.1007/s004010051080; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; Okamoto N, 2010, BRAIN RES, V1349, P68, DOI 10.1016/j.brainres.2010.06.054; Peavy GM, 2007, BIOL PSYCHIAT, V62, P472, DOI 10.1016/j.biopsych.2007.03.013; Permanne B, 1997, BIOCHEM BIOPH RES CO, V240, P715, DOI 10.1006/bbrc.1997.7727; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Terada Y, 1991, NIHON HOTETSU SHIKA, V35, P931, DOI [DOI 10.2186/JJPS.35.931, 10.2186/jjps.35.931]; Xiao L, 2008, J STEROID BIOCHEM, V111, P147, DOI 10.1016/j.jsbmb.2008.03.036; Yamazaki K, 2008, HIPPOCAMPUS, V18, P542, DOI 10.1002/hipo.20440; Zhou Y, 1998, BRAIN RES, V788, P151, DOI 10.1016/S0006-8993(97)01533-3; Zlokovic BV, 1996, LIFE SCI, V59, P1483, DOI 10.1016/0024-3205(96)00310-4	54	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74966	10.1371/journal.pone.0074966	http://dx.doi.org/10.1371/journal.pone.0074966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066161	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000143
J	Garcia, MR; Pearlmutter, BA; Wellstead, PE; Middleton, RH				Garcia, Miriam R.; Pearlmutter, Barak A.; Wellstead, Peter E.; Middleton, Richard H.			A Slow Axon Antidromic Blockade Hypothesis for Tremor Reduction via Deep Brain Stimulation	PLOS ONE			English	Article							SHORT-LATENCY ACTIVATION; SUBTHALAMIC NUCLEUS; PARKINSONIAN TREMOR; CORTEX; POTENTIALS; GENERATION; MECHANISM	Parkinsonian and essential tremor can often be effectively treated by deep brain stimulation. We propose a novel explanation for the mechanism by which this technique ameliorates tremor: a reduction of the delay in the relevant motor control loops via preferential antidromic blockade of slow axons. The antidromic blockade is preferential because the pulses more rapidly clear fast axons, and the distribution of axonal diameters, and therefore velocities, in the involved tracts, is sufficiently long-tailed to make this effect quite significant. The preferential blockade of slow axons, combined with gain adaptation, results in a reduction of the mean delay in the motor control loop, which serves to stabilize the feedback system, thus ameliorating tremor. This theory, without any tuning, accounts for several previously perplexing phenomena, and makes a variety of novel predictions.	[Garcia, Miriam R.; Pearlmutter, Barak A.; Wellstead, Peter E.; Middleton, Richard H.] Natl Univ Ireland Maynooth, Hamilton Inst, Maynooth, Kildare, Ireland; [Pearlmutter, Barak A.] Natl Univ Ireland Maynooth, Dept Comp Sci, Maynooth, Kildare, Ireland; [Middleton, Richard H.] Univ Newcastle, Ctr Complex Dynam Syst & Control, Newcastle, NSW 2300, Australia	Maynooth University; Maynooth University; University of Newcastle	Pearlmutter, BA (corresponding author), Natl Univ Ireland Maynooth, Hamilton Inst, Maynooth, Kildare, Ireland.	barak@cs.nuim.ie	García, Míriam R./D-7185-2012; Pearlmutter, Barak A/M-8791-2014; Pearlmutter, Barak A./AAL-8999-2020; García, Miriam/HGD-0780-2022; Middleton, Richard/A-2950-2013	García, Míriam R./0000-0001-9538-6388; Pearlmutter, Barak A/0000-0003-0521-4553; Middleton, Richard/0000-0001-9885-8803	Science Foundation Ireland [07/IN.1/I1838, 09/IN.1/I2637]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported in part by Science Foundation Ireland grants 07/IN.1/I1838 and 09/IN.1/I2637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Baker KB, 2002, MOVEMENT DISORD, V17, P969, DOI 10.1002/mds.10206; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Bikson M, 2001, J PHYSIOL-LONDON, V531, P181, DOI 10.1111/j.1469-7793.2001.0181j.x; Blahak C, 2007, J NEUROL, V254, P169, DOI 10.1007/s00415-006-0305-x; Blahak C, 2009, MOVEMENT DISORD, V24, P1221, DOI 10.1002/mds.22536; Chomiak T, 2007, J PHYSIOL-LONDON, V579, P403, DOI 10.1113/jphysiol.2006.124057; de Paor AM, 2009, IEEE T BIO-MED ENG, V56, P2717, DOI 10.1109/TBME.2009.2019962; Deuschl G, 2000, J NEUROL, V247, P33, DOI 10.1007/PL00007781; Dimitriou M, 2013, J NEUROSCI, V33, P10898, DOI 10.1523/JNEUROSCI.5669-12.2013; Florin E, 2010, EUR J NEUROSCI, V31, P491, DOI 10.1111/j.1460-9568.2010.07083.x; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Garcia MR, 2011, IEEE DECIS CONTR P, P6481, DOI 10.1109/CDC.2011.6160710; Goodwin GC, 2001, CONTROL SYSTEM DESIGN, pXXIII; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grill Warren M., 2001, Thalamus & Related Systems, V1, P269, DOI 10.1016/S1472-9288(01)00025-5; Grimaldi G., 2008, SYNTH LECT BIOMED EN, V3, P1, DOI DOI 10.2200/S00129; Gu K., 2003, STABILITY TIME DELAY; Hammond C, 2008, MOVEMENT DISORD, V23, P2111, DOI 10.1002/mds.22120; Heida T, 2008, ADV ANAT EMBRYOL CEL, V199, P1, DOI 10.1007/978-3-540-79462-2; Holgado AJN, 2010, J NEUROSCI, V30, P12340, DOI 10.1523/JNEUROSCI.0817-10.2010; Humphries MD, 2012, EUR J NEUROSCI, V36, P2240, DOI 10.1111/j.1460-9568.2012.08085.x; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kuriakose R, 2010, CEREB CORTEX, V20, P1926, DOI 10.1093/cercor/bhp269; Lakhan Shaheen E, 2010, BMC Res Notes, V3, P60, DOI 10.1186/1756-0500-3-60; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Magill PJ, 2006, J PHYSIOL-LONDON, V574, P929, DOI 10.1113/jphysiol.2006.110379; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Raethjen J, 2002, EXP BRAIN RES, V142, P32, DOI 10.1007/s00221-001-0914-7; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Salami M, 2003, P NATL ACAD SCI USA, V100, P6174, DOI 10.1073/pnas.0937380100; Swadlow HA, 2012, SCHOLARPEDIA, V7, P1451, DOI DOI 10.4249/SCHOLARPEDIA.1451; Tass PA, 2001, EUROPHYS LETT, V55, P171, DOI 10.1209/epl/i2001-00397-8; Vaillancourt DE, 2003, NEUROLOGY, V61, P919, DOI 10.1212/01.WNL.0000086371.78447.D2; Vitek JL, 2004, MOVEMENT DISORD, V19, P907, DOI 10.1002/mds.20137; Walker HC, 2012, MOVEMENT DISORD, V27, P1404, DOI 10.1002/mds.25137; Walker HC, 2012, MOVEMENT DISORD, V27, P864, DOI 10.1002/mds.25025; WALKER RG, 2012, TLS TIMES LIT S 0713, P6, DOI DOI 10.1371/J0URNAL.P0NE.0032919; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Wilson C, 2011, FRONT SYST NEUROSCI, V5	44	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73456	10.1371/journal.pone.0073456	http://dx.doi.org/10.1371/journal.pone.0073456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066049	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324494000030
J	Richmond, SJ; Gunadasa, S; Bland, M; MacPherson, H				Richmond, Stewart J.; Gunadasa, Shalmini; Bland, Martin; MacPherson, Hugh			Copper Bracelets and Magnetic Wrist Straps for Rheumatoid Arthritis - Analgesic and Anti-Inflammatory Effects: A Randomised Double-Blind Placebo Controlled Crossover Trial	PLOS ONE			English	Article							AMERICAN-COLLEGE; DEFINITION; RELIEF; PAIN	Background: Folklore remedies for pain and inflammation in rheumatoid arthritis include the application of magnets and copper to the skin. Despite the popular use of devices containing magnets or copper for this purpose, little research has been conducted to evaluate the efficacy of such treatments. Objective: To investigate whether the practice of wearing magnetic wrists straps, or copper bracelets, offers any specific therapeutic benefit for patients with rheumatoid arthritis. Design: Randomised double-blind placebo-controlled crossover trial. Methods: 70 patients, aged 33 to 79 years and predominantly female (n = 52), with painful rheumatoid arthritis were recruited from general practices within Yorkshire. Participants were randomly allocated to wear four devices in a different order. Devices tested were: a standard (1502 to 2365 gauss) magnetic wrist strap, a demagnetised (<20 gauss) wrist strap, an attenuated (250 to 350 gauss) magnetic wrist strap, and a copper bracelet. Devices were each worn for five weeks, with treatment phases being separated by one week wash-out periods. The primary outcome measured was pain using a 100 mm visual analogue scale. Secondary pain measures were the McGill Pain Questionnaire and tender joint count. Inflammation was assessed using C-reactive protein and plasma viscosity blood tests and by swollen joint count. Physical function was assessed using the Health Assessment Questionnaire (Disability Index). Disease activity and medication use was also measured. Results: 65 participants provided complete self-report outcome data for all devices, four participants provided partial data. Analysis of treatment outcomes did not reveal any statistically significant differences (P>0.05) between the four devices in terms of their effects on pain, inflammation, physical function, disease activity, or medication use. Conclusions: Wearing a magnetic wrist strap or a copper bracelet did not appear to have any meaningful therapeutic effect, beyond that of a placebo, for alleviating symptoms and combating disease activity in rheumatoid arthritis.	[Richmond, Stewart J.; Bland, Martin; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Gunadasa, Shalmini] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland	University of York - UK; University of Aberdeen	Richmond, SJ (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	stewart.richmond@york.ac.uk		MacPherson, Hugh/0000-0003-4255-4768	National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	The CAMBRA Trial was funded as part of a doctoral training award, granted to Stewart Richmond, from the National Institute for Health Research (see: http://www.nihrtcc.nhs.uk/). Magnetic wrist straps were purchased from MagnaMax Healthcare of Ontario, Canada (no longer training) at a discount, below the usual retail price, for a bulk order (total cost 1,050) pound. Copper bracelets were purchased from a local pharmacy at trade price (total cost 175) pound. Participating haematology departments agreed to process blood tests at standard NHS rates (total cost 3,955) pound. The trial received no commercial funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett AH, 1878, BRAIN, V1, P331; Bruce B, 2003, J RHEUMATOL, V30, P167; Colbert AP, 2009, EVID-BASED COMPL ALT, V6, P133, DOI 10.1093/ecam/nem131; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Franklin B, 2002, INT J CLIN EXP HYP, V50, P332, DOI 10.1080/00207140208410109; Herr HW, 2005, UROL ONCOL-SEMIN ORI, V23, P346, DOI 10.1016/j.urolonc.2005.02.003; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mills EJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-27; Mottelay P.F., 1922, BIBLIO HIST ELECT MA; MOURINO MR, 1991, RADIOLOGY, V180, P593, DOI 10.1148/radiology.180.3.1871268; National Collaborating Centre for Chronic Conditions, 2009, RHEUM ARTHR NAT CLIN; Neogi T, 2008, J RHEUMATOL, V35, P185; Richmond SJ, 2009, COMPLEMENT THER MED, V17, P249, DOI 10.1016/j.ctim.2009.07.002; Richmond SJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-53; RUNMC, 2013, DAS CRP; Segal NA, 2001, ARCH PHYS MED REHAB, V82, P1453, DOI 10.1053/apmr.2001.24309; Senn S., 2002, CROSSOVER TRIALS CLI; Shackel NA, 1997, MED J AUSTRALIA, V167, P134, DOI 10.5694/j.1326-5377.1997.tb138811.x; STEIN MJ, 1988, J RHEUMATOL, V15, P427; Weintraub MI, 1999, AM J PAIN MANAGE, V9, P8; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong AL, 2004, SEMIN ARTHRITIS RHEU, V34, P484, DOI 10.1016/j.semarthrit.2003.12.002	25	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e71529	10.1371/journal.pone.0071529	http://dx.doi.org/10.1371/journal.pone.0071529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066023	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000003
J	Shaffer, SM; Wu, MT; Levesque, MJ; Raj, A				Shaffer, Sydney M.; Wu, Min-Tzu; Levesque, Marshall J.; Raj, Arjun			Turbo FISH: A Method for Rapid Single Molecule RNA FISH	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; TRANSCRIPTS IN-SITU; LABELED PROBES; CELL; LOCALIZATION; QPCR	Advances in RNA fluorescence in situ hybridization (RNA FISH) have allowed practitioners to detect individual RNA molecules in single cells via fluorescence microscopy, enabling highly accurate and sensitive quantification of gene expression. However, current methods typically employ hybridization times on the order of 2-16 hours, limiting its potential in applications like rapid diagnostics. We present here a set of conditions for RNA FISH (dubbed Turbo RNA FISH) that allow us to make accurate measurements with no more than 5 minutes of hybridization time and 3 minutes of washing, and show that hybridization times can go as low as 30 seconds while still producing quantifiable images. We further show that rapid hybridization is compatible with our recently developed iceFISH and SNP FISH variants of RNA FISH that enable chromosome and single base discrimination, respectively. Our method is simple and cost effective, and has the potential to dramatically increase the throughput and realm of applicability of RNA FISH.	[Shaffer, Sydney M.; Wu, Min-Tzu; Levesque, Marshall J.; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Raj, A (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	arjunraj@seas.upenn.edu		Raj, Arjun/0000-0002-2915-6960; Shaffer, Sydney/0000-0003-3539-9886	US National Institutes of Health Director's New Innovator Award [1DP2OD008514]; Burroughs-Welcome Fund Career Award at the Scientific Interface; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	US National Institutes of Health Director's New Innovator Award; Burroughs-Welcome Fund Career Award at the Scientific Interface; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge the US National Institutes of Health Director's New Innovator Award (1DP2OD008514) and a Burroughs-Welcome Fund Career Award at the Scientific Interface for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CBMM D, 1989, EMBO J, V8, P3685; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bengtsson M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-63; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chou YY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003358; Chou YY, 2012, P NATL ACAD SCI USA, V109, P9101, DOI 10.1073/pnas.1206069109; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levesque MJ, NATURE METH IN PRESS; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, METHOD ENZYMOL, V472, P365, DOI 10.1016/S0076-6879(10)72004-8; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	25	64	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75120	10.1371/journal.pone.0075120	http://dx.doi.org/10.1371/journal.pone.0075120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066168	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000150
J	Nielsen, LV; Krogager, TP; Young, C; Ferreri, C; Chatgilialoglu, C; Jensen, ON; Enghild, JJ				Nielsen, Lone Vendel; Krogager, Toke P.; Young, Clifford; Ferreri, Carla; Chatgilialoglu, Chryssostomos; Jensen, Ole Norregaard; Enghild, Jan J.			Effects of Elaidic Acid on Lipid Metabolism in HepG2 Cells, Investigated by an Integrated Approach of Lipidomics, Transcriptomics and Proteomics	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; HYDROGENATED VEGETABLE-OILS; HIGH-DENSITY; STEARIC-ACID; OLEIC-ACID; CHOLESTEROL; PROTEIN; CIS; LIPOPROTEINS; RECEPTOR	Trans fatty acid consumption in the human diet can cause adverse health effects, such as cardiovascular disease, which is associated with higher total cholesterol, a higher low density lipoprotein-cholesterol level and a decreased high density lipoprotein-cholesterol level. The aim of the study was to elucidate the hepatic response to the most abundant trans fatty acid in the human diet, elaidic acid, to help explain clinical findings on the relationship between trans fatty acids and cardiovascular disease. The human HepG2 cell line was used as a model to investigate the hepatic response to elaidic acid in a combined proteomic, transcriptomic and lipidomic approach. We found many of the proteins responsible for cholesterol synthesis up-regulated together with several proteins involved in the esterification and hepatic import/export of cholesterol. Furthermore, a profound remodeling of the cellular membrane occurred at the phospholipid level. Our findings contribute to the explanation on how trans fatty acids from the diet can cause modifications in plasma cholesterol levels by inducing abundance changes in several hepatic proteins and the hepatic membrane composition.	[Nielsen, Lone Vendel; Krogager, Toke P.; Enghild, Jan J.] Aarhus Univ, iNANO, Interdisciplinary NanoSci Ctr, Aarhus, Denmark; [Nielsen, Lone Vendel; Krogager, Toke P.; Enghild, Jan J.] Univ Aarhus, InSPIN, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Nielsen, Lone Vendel; Krogager, Toke P.; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol & Genet, Aarhus, Denmark; [Young, Clifford; Jensen, Ole Norregaard] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Ferreri, Carla; Chatgilialoglu, Chryssostomos] CNR, ISOF, I-40126 Bologna, Italy; [Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, iNANO, Interdisciplinary NanoSci Ctr, Aarhus, Denmark.	jje@mb.au.dk	Chatgilialoglu, Chryssostomos/AAG-6193-2021; FERRERI, CARLA/G-6821-2013; Jensen, Ole N/J-1763-2012; Chatgilialoglu, Chryssostomos/A-1190-2013	Chatgilialoglu, Chryssostomos/0000-0003-2626-2925; FERRERI, CARLA/0000-0002-1359-0869; Jensen, Ole N/0000-0003-1862-8528; Chatgilialoglu, Chryssostomos/0000-0003-2626-2925; Enghild, Jan Johannes/0000-0001-9292-9172; Young, Clifford/0000-0002-3945-286X				ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8; ALMENDINGEN K, 1995, J LIPID RES, V36, P1370; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CHAO FF, 1986, J LIPID RES, V27, P1174; Cohen G, 2011, DIABETES, V60, P2830, DOI 10.2337/db11-0347; Collison KS, 2009, J LIPID RES, V50, P1521, DOI 10.1194/jlr.M800418-JLR200; Couloubaly S, 2007, EUR J CLIN INVEST, V37, P692, DOI 10.1111/j.1365-2362.2007.01843.x; Dashti N, 2000, J LIPID RES, V41, P1980; de Roos B, 2005, FASEB J, V19, P813, DOI 10.1096/fj.04-2974fje; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; DUVERGER N, 1991, EUR J BIOCHEM, V201, P373, DOI 10.1111/j.1432-1033.1991.tb16294.x; ENGELHARD VH, 1976, P NATL ACAD SCI USA, V73, P4482, DOI 10.1073/pnas.73.12.4482; Ferreri C, 2006, CHEM COMMUN, P529, DOI 10.1039/b512812a; Ferreri C, 2005, FREE RADICAL BIO MED, V38, P1180, DOI 10.1016/j.freeradbiomed.2004.12.026; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HART TC, 1994, MAMM GENOME, V5, P123, DOI 10.1007/BF00292343; Harvey KA, 2010, J LIPID RES, V51, P3470, DOI 10.1194/jlr.M010371; Hodgson JM, 1996, ATHEROSCLEROSIS, V120, P147, DOI 10.1016/0021-9150(95)05696-3; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Iqbal J, 2008, J BIOL CHEM, V283, P19967, DOI 10.1074/jbc.M800398200; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Krogager TP, 2012, J PROTEOMICS, V75, P2685, DOI 10.1016/j.jprot.2012.03.023; KRONVALL G, 1979, INFECT IMMUN, V25, P1; Kumashiro N, 2013, HEPATOLOGY, V57, P1763, DOI 10.1002/hep.26170; Kummerow FA, 1999, AM J CLIN NUTR, V70, P832; LAGROST L, 1989, J LIPID RES, V30, P1525; LOPEZCASILLAS F, 1988, P NATL ACAD SCI USA, V85, P5784, DOI 10.1073/pnas.85.16.5784; LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Niu SL, 2005, BIOCHEMISTRY-US, V44, P4458, DOI 10.1021/bi048319+; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Reardon M, 2012, LIPIDS, V47, P1043, DOI 10.1007/s11745-012-3711-0; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Stender S, 2006, ATHEROSCLEROSIS SUPP, V7, P47, DOI 10.1016/j.atherosclerosissup.2006.04.011; Subbaiah PV, 1998, J LIPID RES, V39, P1438; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; Woldseth B, 1998, SCAND J CLIN LAB INV, V58, P635, DOI 10.1080/00365519850186067; WOLFF RL, 1994, BBA-LIPID LIPID MET, V1211, P198, DOI 10.1016/0005-2760(94)90269-0; Wolff RL, 2000, LIPIDS, V35, P815, DOI 10.1007/S11745-000-0590-2; Yamanashi Y, 2011, GASTROENTEROLOGY, V140, P1664, DOI 10.1053/j.gastro.2011.01.050; ZOCK PL, 1992, J LIPID RES, V33, P399	52	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74283	10.1371/journal.pone.0074283	http://dx.doi.org/10.1371/journal.pone.0074283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058537	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400060
J	Raposeiras-Roubin, S; Rodino-Janeiro, BK; Paradela-Dobarro, B; Grigorian-Shamagian, L; Garcia-Acuna, JM; Aguiar-Souto, P; Jacquet-Hervet, M; Reino-Maceiras, MV; Gonzalez-Juanatey, JR; Alvarez, E				Raposeiras-Roubin, Sergio; Rodino-Janeiro, Bruno K.; Paradela-Dobarro, Beatriz; Grigorian-Shamagian, Lilian; Garcia-Acuna, Jose M.; Aguiar-Souto, Pablo; Jacquet-Hervet, Michel; Reino-Maceiras, Maria V.; Gonzalez-Juanatey, Jose R.; Alvarez, Ezequiel			Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome	PLOS ONE			English	Article							E-NULL MICE; HEART-FAILURE; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RAGE; ELEVATION; ATHEROSCLEROSIS; ENDPRODUCTS; TRIAL; FORM	Objective: Advanced glycation end products (AGEs) have pathophysiological implications in cardiovascular diseases. The aim of our study was to evaluate the prognostic value of fluorescent AGEs and its soluble receptor (sRAGE) in the context of acute coronary syndrome (ACS), both in-hospital phase and follow-up period. Methods: A prospective clinical study was performed in patients with debut's ACS. The endpoints were the development of cardiac events (cardiac deaths, re-infarction and new-onset heart failure) during in-hospital phase and follow-up period (366 days, inter-quartile range: 273-519 days). 215 consecutive ACS patients admitted to the coronary care unit (62.7 +/- 13.0 years, 24.2% female) were included. 47.4% had a diagnosis of ST segment elevation myocardial infarction. AGEs and sRAGE were analysed by fluorescence spectroscopy and competitive ELISA, respectively. Risk scores (GRACE, TIMI, PURSUIT) were calculated retrospectively using prospective data. The complexity of coronary artery disease was evaluated by SYNTAX score. Results: The mean fluorescent AGEs and sRAGE levels were 57.7 +/- 45.1 AU and 1045.4 +/- 850.0 pg/mL, respectively. 19 patients presented cardiac events during in-hospital phase and 29 during the follow-up. In-hospital cardiac events were significantly associated with higher sRAGE levels (p=0.001), but not long-term cardiac events (p=0.365). Regarding fluorescent AGE the opposite happened. After multivariate analysis correcting by gender, left ventricular ejection fraction, glucose levels, haemoglobin, GRACE and SYNTAX scores, sRAGE was significantly associated with in-hospital prognosis, whereas fluorescent AGEs was significantly associated with long-term prognosis. Conclusions: We conclude that elevated values of sRAGE are associated with worse in-hospital prognosis, whereas high fluorescent AGE levels are associated with more follow-up events.	[Raposeiras-Roubin, Sergio; Garcia-Acuna, Jose M.; Aguiar-Souto, Pablo; Jacquet-Hervet, Michel; Reino-Maceiras, Maria V.; Gonzalez-Juanatey, Jose R.] Hosp Clin Univ Santiago de Compostela, Serv Cardiol, Santiago De Compostela, Spain; [Raposeiras-Roubin, Sergio; Rodino-Janeiro, Bruno K.; Paradela-Dobarro, Beatriz; Gonzalez-Juanatey, Jose R.; Alvarez, Ezequiel] Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Grigorian-Shamagian, Lilian] Hosp Meixoeiro, Serv Cardiol, Vigo, Spain; [Gonzalez-Juanatey, Jose R.; Alvarez, Ezequiel] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; Universidade de Santiago de Compostela	Alvarez, E (corresponding author), Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain.	ezequiel.alvarez@usc.es	Rodiño-Janeiro, Bruno Kotska/AAI-2506-2019; ROUBIN, SERGIO RAPOSEIRAS/Y-8641-2019; ACUÑA, JOSE MARIA GARCIA/Z-1972-2019; Alvarez, Ezequiel/D-8822-2011	Rodiño-Janeiro, Bruno Kotska/0000-0002-0633-6774; ACUÑA, JOSE MARIA GARCIA/0000-0003-0119-1710; Alvarez, Ezequiel/0000-0002-2381-8425; RAPOSEIRAS-ROUBIN, SERGIO/0000-0002-6462-4715; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	Plan Nacional Espanol de I+D; Instituto de Salud Carlos III - Subdireccion General de Evaluacion y Fomento de la Investigacion [PI10/01403]; ERDF; Isidro Parga Pondal program of the Xunta de Galicia (Spain); Instituto de Salud Carlos III [FI11/00325]	Plan Nacional Espanol de I+D; Instituto de Salud Carlos III - Subdireccion General de Evaluacion y Fomento de la Investigacion(Instituto de Salud Carlos III); ERDF(European Commission); Isidro Parga Pondal program of the Xunta de Galicia (Spain); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported in part by the Plan Nacional Espanol de I+D, 2008-2011 and the Instituto de Salud Carlos III - Subdireccion General de Evaluacion y Fomento de la Investigacion, PI10/01403, cofinanced by ERDF. The Isidro Parga Pondal program of the Xunta de Galicia (Spain) supported the work of E. Alvarez. Work of B. Paradela-Dobarro is supported by Instituto de Salud Carlos III, grant number FI11/00325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bansal S, 2011, MOL CELL BIOCH; Basta G, 2011, CORONARY ARTERY DIS, V22, P590, DOI 10.1097/MCA.0b013e32834c751f; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Brownlee M, 2000, METABOLISM, V49, P9, DOI 10.1016/S0026-0495(00)80078-5; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Ferrari R, 1998, EUR HEART J, V19, pB2; Geroldi D, 2006, CURR MED CHEM, V13, P1971, DOI 10.2174/092986706777585013; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Gronholdt MLM, 1998, EUR HEART J, V19, pC24; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Jabaudon M, CRIT CARE MED, V39, P480; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Munch G., 1997, CLIN CHEM LAB MED, V25, P669; Nakamura K, 2007, DIABETES-METAB RES, V23, P368, DOI 10.1002/dmrr.690; Nakamura K, 2007, MOL MED, V13, P185, DOI 10.2119/2006-00090.Nakamura; Park HJ, 2011, CIRC J, V75, P1685, DOI 10.1253/circj.CJ-10-1248; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Raposeiras-Roubin S, 2010, EUR J HEART FAIL, V12, P1092, DOI 10.1093/eurjhf/hfq117; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Selejan SR, 2012, CRIT CARE MED, V40, P1513, DOI 10.1097/CCM.0b013e318241e536; Sianos Georgios, 2005, EuroIntervention, V1, P219	27	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74302	10.1371/journal.pone.0074302	http://dx.doi.org/10.1371/journal.pone.0074302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058542	Green Submitted, gold, Green Published			2022-12-27	WOS:000324408400063
J	Sturzel, CM; Palesch, D; Khalid, M; Wissing, S; Fischer, N; Munch, J				Stuerzel, Christina Martina; Palesch, David; Khalid, Mohammad; Wissing, Silke; Fischer, Nicole; Muench, Jan			Utilization of Replication-Competent XMRV Reporter-Viruses Reveals Severe Viral Restriction in Primary Human Cells	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; RETROVIRUS XMRV; IN-VIVO; INFECTIOUS RETROVIRUS; NO ASSOCIATION; SEQUENCES; PROTEIN; GENE	The gammaretrovirus termed xenotropic murine leukemia virus-related virus (XMRV) was described to be isolated from prostate cancer tissue biopsies and from blood of patients suffering from chronic fatigue syndrome. However, many studies failed to detect XMRV and to verify these disease associations. Data suggesting the contamination of specimens in particular by PCR-based methods and recent reports demonstrating XMRV generation via recombination of two murine leukemia virus precursors raised serious doubts about XMRV being a genuine human pathogen. To elucidate cell tropism of XMRV, we generated replication competent XMRV reporter viruses encoding a green fluorescent protein or a secretable luciferase as tools to analyze virus infection of human cell lines or primary human cells. Transfection of proviral DNAs into LNCaP prostate cancer cells resulted in readily detectably reporter gene expression and production of progeny virus. Inoculation of known XMRV susceptible target cells revealed that these virions were infectious and expressed the reporter gene, allowing for a fast and highly sensitive quantification of XMRV infection. Both reporter viruses were capable of establishing a spreading infection in LNCaP and Raji B cells and could be easily passaged. However, after inoculation of primary human blood cells such as CD4 T cells, macrophages or dendritic cells, infection rates were very low, and a spreading infection was never established. In line with these results we found that supernatants derived from these XMRV infected primary cell types did not contain infectious virus. Thus, although XMRV efficiently replicated in some human cell lines, all tested primary cells were largely refractory to XMRV infection and did not support viral spread. Our results provide further evidence that XMRV is not a human pathogen.	[Stuerzel, Christina Martina; Palesch, David; Khalid, Mohammad; Muench, Jan] Univ Ulm, Med Ctr, Inst Mol Virol, D-89069 Ulm, Germany; [Wissing, Silke] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Fischer, Nicole] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany	Ulm University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Hamburg; University Medical Center Hamburg-Eppendorf	Munch, J (corresponding author), Univ Ulm, Med Ctr, Inst Mol Virol, D-89069 Ulm, Germany.	jan.muench@uni-ulm.de	Khalid, Mohammad/AAL-5990-2020	Khalid, Mohammad/0000-0003-1479-6487; Jan, Munch/0000-0001-7316-7141	Ministerium fur Wissenschaft, Forschung und Kunst, Baden-Wurttemberg	Ministerium fur Wissenschaft, Forschung und Kunst, Baden-Wurttemberg	This work was funded by a grant from the Ministerium fur Wissenschaft, Forschung und Kunst, Baden-Wurttemberg to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 2012, MBIO, V3, DOI 10.1128/mBio.00266-12; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; Blomberg J, 2012, CLIN VACCINE IMMUNOL, V19, P1399, DOI 10.1128/CVI.00391-12; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Cote M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033734; Curriu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037415; Das Gupta J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036072; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dong BH, 2010, J VIROL, V84, P1648, DOI 10.1128/JVI.01763-09; Dong BH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003144; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Hansen KA, 2003, INVEST OPHTH VIS SCI, V44, P772, DOI 10.1167/iovs.02-0091; He XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047208; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Kenyon JC, 2011, BRIT MED BULL, V98, P61, DOI 10.1093/bmb/ldr010; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Kolokithas A, 2010, J VIROL, V84, P10933, DOI 10.1128/JVI.01023-10; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044954; Lintas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016609; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Maggi F, INT J IMMUNOPATHOL P, V25, P523; Menendez-Arias L, 2011, REV MED VIROL, V21, P3, DOI 10.1002/rmv.673; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nitta T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-58; Pan JD, 2005, VET MICROBIOL, V110, P181, DOI 10.1016/j.vetmic.2005.07.015; Paolucci S, 2012, NEW MICROBIOL, V35, P341; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PARK BH, 1994, J VIROL, V68, P7516, DOI 10.1128/JVI.68.11.7516-7524.1994; Perez Jasmine T, 2013, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15g04s29; Ravichandran V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-443; Rezaei SD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-20; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakakibara S, 2011, J VIROL, V85, P3179, DOI 10.1128/JVI.02333-10; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sakuma T, 2010, HUM GENE THER, V21, P1665, DOI 10.1089/hum.2010.063; Sakuma T, 2011, J VIROL, V85, P1205, DOI 10.1128/JVI.00886-10; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-14; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Weinberg MA, 2011, CELL HOST MICROBE, V9, P260, DOI 10.1016/j.chom.2011.04.001; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yong TJ, 2004, J VIROL, V78, P12189, DOI 10.1128/JVI.78.22.12189-12197.2004; Yoshimura FK, 2001, J VIROL, V75, P6007, DOI 10.1128/JVI.75.13.6007-6015.2001	59	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74427	10.1371/journal.pone.0074427	http://dx.doi.org/10.1371/journal.pone.0074427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058563	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400076
J	Suresh, A; Subedi, K; Kyathanahalli, C; Jeyasuria, P; Condon, JC				Suresh, Arvind; Subedi, Kalpana; Kyathanahalli, Chandrashekara; Jeyasuria, Pancharatnam; Condon, Jennifer C.			Uterine Endoplasmic Reticulum Stress and Its Unfolded Protein Response May Regulate Caspase 3 Activation in the Pregnant Mouse Uterus	PLOS ONE			English	Article							APOPTOTIC CELL-DEATH; ER STRESS; INHIBITION; ISOFLAVONES; EXTRACTION; CONTRIBUTE; RESISTANCE; APOPTOSOME; PATHWAY	We have previously proposed that uterine caspase-3 may modulate uterine contractility in a gestationally regulated fashion. The objective of this study was to determine the mechanism by which uterine caspase-3 is activated and consequently controlled in the pregnant uterus across gestation. Utilizing the mouse uterus as our gestational model we examined the intrinsic and extrinsic apoptotic signaling pathways and the endoplasmic reticulum stress response as potential activators of uterine caspase-3 at the transcriptional and translational level. Our study revealed robust activation of the uterine myocyte endoplasmic reticulum stress response and its adaptive unfolded protein response during pregnancy coinciding respectively with increased uterine caspase-3 activity and its withdrawal to term. In contrast the intrinsic and extrinsic apoptotic signaling pathways remained inactive across gestation. We speculate that physiological stimuli experienced by the pregnant uterus likely potentiates the uterine myocyte endoplasmic reticulum stress response resulting in elevated caspase-3 activation, which is isolated to the pregnant mouse myometrium. However as term approaches, activation of an elevated adaptive unfolded protein response acts to limit the endoplasmic reticulum stress response inhibiting caspase-3 resulting in its decline towards term. We speculate that these events have the capacity to regulate gestational length in a caspase-3 dependent manner.	[Suresh, Arvind; Subedi, Kalpana; Kyathanahalli, Chandrashekara; Jeyasuria, Pancharatnam; Condon, Jennifer C.] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet & Gynecol, Pittsburgh, PA 15260 USA; [Suresh, Arvind; Condon, Jennifer C.] Univ Pittsburgh, Magee Womens Res Inst, Dept Cell Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Condon, JC (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet & Gynecol, Pittsburgh, PA 15260 USA.	condonj@mwri.magee.edu	Jeyasuria, Pancharatnam/B-4710-2008	Jeyasuria, Pancharatnam/0000-0002-1388-906X; Subedi, kalpana/0000-0002-1808-3268; Kyathanahalli, Chandrashekara/0000-0002-6422-6653	March of Dimes [21-FY12-152]; NICHD [1R01HD065011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065011] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the March of Dimes (#21-FY12-152) and NICHD (1R01HD065011). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Araki Kazutaka, 2012, Cold Spring Harb Perspect Biol, V4, pa015438, DOI 10.1101/cshperspect.a015438; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Binet F, 2010, BIOCHEM BIOPH RES CO, V391, P18, DOI 10.1016/j.bbrc.2009.10.141; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; BOOTH RFG, 1978, J NEUROCHEM, V30, P1003, DOI 10.1111/j.1471-4159.1978.tb12392.x; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002; Cho SY, 2009, FOOD CHEM, V117, P312, DOI 10.1016/j.foodchem.2009.04.003; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Di Sano F, 2006, J BIOL CHEM, V281, P2693, DOI 10.1074/jbc.M509110200; Gao HJ, 2012, MOL BIOL REP, V39, P9179, DOI 10.1007/s11033-012-1790-x; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Jain A, 2012, AM J PATHOL, V180, P2309, DOI 10.1016/j.ajpath.2012.03.005; Jeyasuria P, 2011, BIOL REPROD, V85, P417, DOI 10.1095/biolreprod.111.091652; Jeyasuria P, 2009, BIOL REPROD, V80, P928, DOI 10.1095/biolreprod.108.070425; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lian IA, 2011, PLACENTA, V32, P823, DOI 10.1016/j.placenta.2011.08.005; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu AX, 2011, J CLIN ENDOCR METAB, V96, pE493, DOI 10.1210/jc.2010-2192; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mendelson CR, 2005, J STEROID BIOCHEM, V93, P113, DOI 10.1016/j.jsbmb.2004.12.027; Mishra OP, 2006, NEUROSCI LETT, V401, P81, DOI 10.1016/j.neulet.2006.02.070; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Park JH, 2009, RADIAT PHYS CHEM, V78, P623, DOI 10.1016/j.radphyschem.2009.03.059; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Redman CWG, 2008, AM J PATHOL, V173, P311, DOI 10.2353/ajpath.2008.080412; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Stephenson-Famy A, 2012, MOL ENDOCRINOL, V26, P320, DOI 10.1210/me.2011-1282; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Yung HW, 2012, J PATHOL; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	49	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75152	10.1371/journal.pone.0075152	http://dx.doi.org/10.1371/journal.pone.0075152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058658	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400110
J	Migliore, J; Baumel, A; Juin, M; Fady, B; Roig, A; Duong, N; Medail, F				Migliore, Jeremy; Baumel, Alex; Juin, Marianick; Fady, Bruno; Roig, Anne; Nathalie Duong; Medail, Frederic			Surviving in Mountain Climate Refugia: New Insights from the Genetic Diversity and Structure of the Relict Shrub Myrtus nivellei (Myrtaceae) in the Sahara Desert	PLOS ONE			English	Article							EUROPAEA SUBSP-LAPERRINEI; MULTILOCUS GENOTYPE DATA; CLONAL GROWTH; PERSISTENCE; INFERENCE; OLEACEAE; PLANTS; TREE; L.; DIVERSIFICATION	The identification of past glacial refugia has become a key topic for conservation under environmental change, since they contribute importantly to shaping current patterns of biodiversity. However, little attention has been paid so far to interglacial refugia despite their key role for the survival of relict species currently occurring in climate refugia. Here, we focus on the genetic consequences of range contraction on the relict populations of the evergreen shrub Myrtus nivellei, endemic in the Saharan mountains since at least the end of the last Green Sahara period, around 5.5 ka B.P. Multilocus genotypes (nuclear microsatellites and AFLP) were obtained from 215 individuals collected from 23 wadis (temporary rivers) in the three main mountain ranges in southern Algeria (the Hoggar, Tassili n'Ajjer and Tassili n'Immidir ranges). Identical genotypes were found in several plants growing far apart within the same wadis, a pattern taken as evidence of clonality. Multivariate analyses and Bayesian clustering revealed that genetic diversity was mainly structured among the mountain ranges, while low isolation by distance was observed within each mountain range. The range contraction induced by the last episode of aridification has likely increased the genetic isolation of the populations of M. nivellei, without greatly affecting the genetic diversity of the species as a whole. The pattern of genetic diversity observed here suggests that high connectivity may have prevailed during humid periods, which is consistent with recent paleoenvironmental reconstructions.	[Migliore, Jeremy; Baumel, Alex; Juin, Marianick; Nathalie Duong; Medail, Frederic] Aix Marseille Univ, Avignon Univ, UMR CNRS IRD 7263 237, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Aix En Provence, France; [Fady, Bruno; Roig, Anne] Ecol Forets Mediterraneennes URFM, INRA, UR 629, Avignon, France	Avignon Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); INRAE	Migliore, J (corresponding author), Aix Marseille Univ, Avignon Univ, UMR CNRS IRD 7263 237, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Campus Aix Technopole Environnement Arbois Medite, Aix En Provence, France.	jeremy.migliore@imbe.fr	Baumel, Alex/AAD-4699-2021	Migliore, Jeremy/0000-0002-7534-9667	Provence-Alpes-Cote d'Azur Region; Conservatoire Botanique National de Corse (Office de l'Environnement de la Corse); Conservatoire Botanique National Mediterraneen de Porquerolles	Provence-Alpes-Cote d'Azur Region(Region Provence-Alpes-Cote d'Azur); Conservatoire Botanique National de Corse (Office de l'Environnement de la Corse)(Region Corse); Conservatoire Botanique National Mediterraneen de Porquerolles	This study was supported by the Provence-Alpes-Cote d'Azur Region, the Conservatoire Botanique National de Corse (Office de l'Environnement de la Corse) and the Conservatoire Botanique National Mediterraneen de Porquerolles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoun F, 2002, CR BIOL, V325, P617, DOI 10.1016/S1631-0691(02)01433-6; Albaladejo RG, 2009, PLANT BIOLOGY, V11, P442, DOI 10.1111/j.1438-8677.2008.00121.x; Albaladejo RG, 2010, AM J BOT, V97, pE23, DOI 10.3732/ajb.1000060; Anthelme F, 2008, J ARID ENVIRON, V72, P2232, DOI 10.1016/j.jaridenv.2008.07.003; Anthelme F, 2008, PLANT ECOL, V198, P73, DOI 10.1007/s11258-007-9386-6; Aparicio A, 2012, DIVERS DISTRIB, V18, P226, DOI 10.1111/j.1472-4642.2011.00823.x; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Baali-Cherif D, 2005, ANN BOT-LONDON, V96, P823, DOI 10.1093/aob/mci232; Bakker EG, 2001, PLANT BIOLOGY, V3, P616, DOI 10.1055/s-2001-19365; Battandier J.B., 1911, B SOC BOT FR, V58, P669, DOI [10.1080/00378941.1911.10832371, DOI 10.1080/00378941.1911.10832371]; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Besnard G, 2007, HEREDITY, V99, P649, DOI 10.1038/sj.hdy.6801051; Besnard G, 2012, ACTA BOT GALLICA, V159, P319, DOI 10.1080/12538078.2012.724281; Biebach H, 2000, IBIS, V142, P623, DOI 10.1111/j.1474-919X.2000.tb04462.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Crawford R.M.M., 2008, ECOLOGICAL LIMITS CL; Danin A, 1999, BOT REV, V65, P93, DOI 10.1007/BF02857625; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Doyle J. J., 1987, PHYTOCHEM B, P11; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Dubief J, 1959, MEMOIRE I RECHERCHES; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Garcia D, 2003, J VEG SCI, V14, P921, DOI 10.1111/j.1654-1103.2003.tb02227.x; Genner MJ, 2010, J FISH BIOL, V76, P435, DOI 10.1111/j.1095-8649.2009.02549.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Govaerts R., 2008, WORLD CHECKLIST MYRT; Habel JC, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P1, DOI 10.1007/978-3-540-92160-8; Hampe A, 2013, NEW PHYTOL, V197, P16, DOI 10.1111/nph.12059; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; Kropf M, 2012, J BIOGEOGR, V39, P799, DOI 10.1111/j.1365-2699.2011.02668.x; Leredde C, 1957, TRAVAUX I RECHERCHES, VII; Lezine AM, 2008, POLLEN OUTIL ETUDE E; Maley J, 1981, TRAVAUX DOCUMENTS OR, V129; Maley J, 2011, PALAEOECO A, V30, P227; May MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008346; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Migliore J, 2012, J BIOGEOGR, V39, P942, DOI 10.1111/j.1365-2699.2011.02646.x; Moreau R. E., 1961, Ibis, V103a, P373, DOI 10.1111/j.1474-919X.1961.tb02454.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Patiny S, 2007, INSECT SYST EVOL, V38, P19, DOI 10.1163/187631207788784012; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Petit-Maire N., 1991, PALEOENVIRONNEMENTS; Pichot C, 2001, NATURE, V412, P39, DOI 10.1038/35083687; Pritchard JK, 2000, GENETICS, V155, P945; QUEZEL P, 1978, ANN MO BOT GARD, V65, P479, DOI 10.2307/2398860; Quezel P, 1997, REV ECOLOGY DESERT C, P159; Quezel P, 1958, MISSION BOT TIBESTI, P4; Quezel P., 1965, VEGETATION SAHARA TC; Quezel P., 1960, LIBYCA, V6/7, P211; Quezel P, 1954, I RECHERCHES SAHARIE, V2; Rognon P., 1980, PALAEOECOL AFR, V27, P45; Rossetto M, 2005, J ECOL, V93, P906, DOI 10.1111/j.1365-2745.2005.01046.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salewski V, 2010, J ORNITHOL, V151, P371, DOI 10.1007/s10336-009-0464-5; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Swezey CS, 2009, J AFR EARTH SCI, V53, P89, DOI 10.1016/j.jafrearsci.2008.08.001; Trape S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004400; Vonlanthen B, 2010, AM J BOT, V97, P234, DOI 10.3732/ajb.0800329; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Watrin J, 2009, CR GEOSCI, V341, P656, DOI 10.1016/j.crte.2009.06.007; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wesche K, 2011, FLORA, V206, P91, DOI 10.1016/j.flora.2010.01.012; WICKENS G E, 1976, Kew Bulletin, V31, P105, DOI 10.2307/4108999; Wilson JS, 2012, DIVERS DISTRIB, V18, P1139, DOI 10.1111/j.1472-4642.2012.00902.x; Wright S, 1943, GENETICS, V28, P114	87	31	32	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73795	10.1371/journal.pone.0073795	http://dx.doi.org/10.1371/journal.pone.0073795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058489	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900019
J	Nachappa, P; Margolies, DC; Nechols, JR; Whitfield, AE; Rotenberg, D				Nachappa, Punya; Margolies, David C.; Nechols, James R.; Whitfield, Anna E.; Rotenberg, Dorith			Tomato Spotted Wilt Virus Benefits a Non-Vector Arthropod, Tetranychus Urticae, by Modulating Different Plant Responses in Tomato	PLOS ONE			English	Article							MEDIATED INTERACTIONS; AMINO-ACIDS; TRADE-OFFS; DEFENSE; INSECT; THRIPS; SALICYLATE; EXPRESSION; HERBIVORE; HOMOPTERA	The interaction between plant viruses and non-vector arthropod herbivores is poorly understood. However, there is accumulating evidence that plant viruses can impact fitness of non-vector herbivores. In this study, we used oligonucleotide microarrays, phytohormone, and total free amino acid analyses to characterize the molecular mechanisms underlying the interaction between Tomato spotted wilt virus (TSWV) and a non-vector arthropod, twospotted spider mite (Tetranychus urticae), on tomato plants, Solanum lycopersicum. Twospotted spider mites showed increased preference for and fecundity on TSWV-infected plants compared to mock-inoculated plants. Transcriptome profiles of TSWV-infected plants indicated significant up-regulation of salicylic acid (SA)-related genes, but no apparent down-regulation of jasmonic acid (JA)-related genes which could potentially confer induced resistance against TSM. This suggests that there was no antagonistic crosstalk between the signaling pathways to influence the interaction between TSWV and spider mites. In fact, SA- and JA-related genes were up-regulated when plants were challenged with both TSWV and the herbivore. TSWV infection resulted in down-regulation of cell wall-related genes and photosynthesis-associated genes, which may contribute to host plant susceptibility. There was a three-fold increase in total free amino acid content in virus-infected plants compared to mock-inoculated plants. Total free amino acid content is critical for arthropod nutrition and may, in part, explain the apparent positive indirect effect of TSWV on spider mites. Taken together, these data suggest that the mechanism(s) of increased host suitability of TSWV-infected plants to non-vector herbivores is complex and likely involves several plant biochemical processes.	[Nachappa, Punya] Indiana Univ Purdue Univ, Ft Wayne, IN 46805 USA; [Margolies, David C.; Nechols, James R.] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Whitfield, Anna E.; Rotenberg, Dorith] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	Purdue University System; Indiana University Purdue University Fort Wayne; Kansas State University; Kansas State University	Nachappa, P (corresponding author), Indiana Univ Purdue Univ, Ft Wayne, IN 46805 USA.	nachappa@ipfw.edu	Nachappa, Punya/AAO-4198-2020	Nachappa, Punya/0000-0002-9673-9939; Rotenberg, Dorith/0000-0002-9018-8822	Ecological Genomics Institute at Kansas 565 State University; Kansas State University Open Access Publishing Fund	Ecological Genomics Institute at Kansas 565 State University; Kansas State University Open Access Publishing Fund	This work was supported by a seed grant from The Ecological Genomics Institute at Kansas 565 State University. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Belliure B, 2010, BASIC APPL ECOL, V11, P162, DOI 10.1016/j.baae.2009.09.004; BLUA MJ, 1994, J CHEM ECOL, V20, P691, DOI 10.1007/BF02059607; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Carter W, 1939, J ANIM ECOL, V8, P261, DOI 10.2307/1234; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; El Fahaam Y. M., 1990, AGR SCI, V2, P271; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/annurev.py.30.090192.001531; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Hammond AM, 1988, PLANT STRESS INSECT, P657; HARE JD, 1987, ENTOMOL EXP APPL, V44, P31, DOI 10.1007/BF00361306; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; MARKKULA M., 1964, Annales Agriculturae Fenniae, V3, P265; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nault BA, 2002, CROP PROT, V21, P359, DOI 10.1016/S0261-2194(01)00103-X; Pan HP, 2013, J ECON ENTOMOL, V106, P924, DOI 10.1603/EC12365; Pan XQ, 2008, PHYTOCHEMISTRY, V69, P1773, DOI 10.1016/j.phytochem.2008.02.008; PENACORTES H, 1993, PLANTA, V191, P123, DOI 10.1007/BF00240903; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; SELMAN IW, 1961, ANN APPL BIOL, V49, P601, DOI 10.1111/j.1744-7348.1961.tb03657.x; Sherwood J. L., 2001, ENCY PLANT PATHOLOGY, P1034; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Tabachnick B, 2001, USING MULTIVARIATE A; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; VANDEVRIE M, 1972, HILGARDIA, V41, P343, DOI 10.3733/hilg.v41n13p343; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Whitfield AE, 2008, PHYTOPATHOLOGY, V98, P45, DOI 10.1094/PHYTO-98-1-0045; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; YUDIN LS, 1987, J ECON ENTOMOL, V80, P51, DOI 10.1093/jee/80.1.51; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x	52	31	34	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75909	10.1371/journal.pone.0075909	http://dx.doi.org/10.1371/journal.pone.0075909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058708	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900131
J	Yang, XP; La Rosa, FG; Genova, EE; Huber, K; Schaack, J; DeGregori, J; Serkova, NJ; Li, Y; Su, LJ; Kessler, E; Flaig, TW				Yang, Xiaoping; La Rosa, Francisco G.; Genova, Elizabeth Erin; Huber, Kendra; Schaack, Jerome; DeGregori, James; Serkova, Natalie J.; Li, Yuan; Su, Lih-Jen; Kessler, Elizabeth; Flaig, Thomas W.			Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia	PLOS ONE			English	Article							CONDITIONAL MOUSE MODEL; BETA-CATENIN ACTIVATION; K-RAS; LUNG-CANCER; HA-RAS; CRE RECOMBINASE; CELL CARCINOMA; ONCOGENIC KRAS; EARLY-ONSET; MICE	The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate the effect of intravesical delivery on Cre recombination (Adeno-Cre), we examined activity and expression of beta-galactosidase in the bladder of control ROSA transgenic mice. The results confirmed specific recombination as evidenced by beta-galactosidase activity in the bladder urothelium of these mice. Then, we administered the same adenovirus into the bladder of double transgenic Kras(LSLG12D/+). p53(fl/fl) mice. The virus solution was held in place by a distal urethral retention suture for 2 hours. To our surprise, there was a rapid development of a spindle-cell tumor with sarcoma characteristics near the suture site, within the pelvic area but outside the urinary track. Since we did not see any detectable beta-galactosidase in the area outside of the bladder in the validating (control) experiment, we interpreted that this sarcoma formation was likely due to transduction by Adeno-Cre in the soft tissue of the suture site. To avoid the loss of skin integrity associated with the retention suture, we transitioned to an alternative technique without suture to retain the Adeno-Cre into the bladder cavity. Interestingly, although multiple Adeno-Cre treatments were applied, only urothelial hyperplasia but not carcinogenesis was observed in the subsequent experiments of up to 6 months. In conclusion, we observed that the simultaneous inactivation of p53 and activation of Kras induces quick formation of spindle-cell sarcoma in the soft tissues adjacent to the bladder but slow formation of urothelial hyperplasia inside the bladder. These results strongly suggest that the effect of oncogene regulation to produce either hyperplasia or carcinogenesis greatly depends on the tissue type.	[Yang, Xiaoping; Li, Yuan; Su, Lih-Jen; Kessler, Elizabeth; Flaig, Thomas W.] Univ Colorado, Sch Med, Dept Med, Div Med Oncol, Aurora, CO 80045 USA; [La Rosa, Francisco G.; Genova, Elizabeth Erin] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Huber, Kendra; Serkova, Natalie J.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO USA; [Schaack, Jerome] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [DeGregori, James] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Yang, Xiaoping; La Rosa, Francisco G.; DeGregori, James; Serkova, Natalie J.; Flaig, Thomas W.] Univ Colorado, Ctr Canc, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Yang, XP (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.	Xiaoping.Yang@ucdenver.edu; Thomas.Flaig@ucdenver.edu	La Rosa, Francisco G./AAE-9174-2020	DeGregori, James/0000-0002-1287-1976	ACS IRG grant; Herbert Crane Endowment; National Institutes of Health/National Center for Research Resources Colorado CTSI grant [UL1 RR025780]; Cancer Center Core grant [P30 CA046934-25]; NATIONAL CANCER INSTITUTE [P50CA058187, P30CA046934, R01CA157850] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	ACS IRG grant; Herbert Crane Endowment; National Institutes of Health/National Center for Research Resources Colorado CTSI grant; Cancer Center Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work is in part supported by an ACS IRG grant to X. Yang. The authors also acknowledge the generous support of the Herbert Crane Endowment. The authors appreciate the contribution to this research made by the University of Colorado Anschutz Medical Campus Cancer Center Research Histology Core, supported in part by National Institutes of Health/National Center for Research Resources Colorado CTSI grant number UL1 RR025780 and Cancer Center Core grant P30 CA046934-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Ahmad I, 2011, DIS MODEL MECH, V4, P548, DOI 10.1242/dmm.006874; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Avritscher EBC, 2006, UROLOGY, V68, P549, DOI 10.1016/j.urology.2006.03.062; Ayan S., 2001, International Urology and Nephrology, V33, P363, DOI 10.1023/A:1015213713048; Bex A, 2002, J UROLOGY, V168, P2641, DOI 10.1016/S0022-5347(05)64235-8; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Bindels EMJ, 2005, ADV OTO-RHINO-LARYNG, V62, P1; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Deng Chu-Xia, 2004, Methods Mol Biol, V280, P185; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Iatropoulos MJ, 1996, EXP TOXICOL PATHOL, V48, P175, DOI 10.1016/S0940-2993(96)80039-X; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; KNOWLES MA, 1995, BRIT J UROL, V75, P57; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Malmstrom PU, 2011, BJU INT, V107, P1543, DOI 10.1111/j.1464-410X.2011.10235.x; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olderoy G, 1998, ANTICANCER RES, V18, P2675; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Orntoft TF, 1998, UROL RES, V26, P223, DOI 10.1007/s002400050050; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Raimondi AR, 2009, CANCER RES, V69, P4159, DOI 10.1158/0008-5472.CAN-08-4645; Schaack J, 2004, P NATL ACAD SCI USA, V101, P3124, DOI 10.1073/pnas.0303709101; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thanan R, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/165879; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; UCHIDA T, 1995, J UROLOGY, V153, P1097, DOI 10.1016/S0022-5347(01)67517-7; UCHIDA T, 1995, UROL INT, V55, P63, DOI 10.1159/000282753; WILLIAMSON MP, 1994, GENE CHROMOSOME CANC, V9, P108, DOI 10.1002/gcc.2870090206; Yang XP, 2013, CLIN CANCER RES, V19, P148, DOI 10.1158/1078-0432.CCR-12-1258; Yang XP, 2010, INT BRAZ J UROL, V36, P273, DOI 10.1590/S1677-55382010000300003; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	54	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74809	10.1371/journal.pone.0074809	http://dx.doi.org/10.1371/journal.pone.0074809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058630	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900082
J	Adams, Y; Rowe, JA				Adams, Yvonne; Rowe, J. Alexandra			The Effect of Anti-Rosetting Agents against Malaria Parasites under Physiological Flow Conditions	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; RED-BLOOD-CELLS; HUMAN CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; IN-VITRO; ENDOTHELIAL-CELLS; HEPARAN-SULFATE; ADHESION; INHIBITION; BINDING	Rosetting remains the dominant malaria parasite adhesion phenotype associated with severe disease and pathogenicity in Africa. The formation of rosettes, whereby a Plasmodium falciparum infected erythrocyte (IE) adheres to two or more non-IEs, is thought to facilitate the occlusion of microvascular blood vessels by adhering to host endothelial cells and other bound IEs. Current methods of determining the rosette-disrupting capabilities of antibodies/drugs have focused on static assays. As IEs in vivo are exposed to shear stresses within the microvasculature, the effect of flow conditions on rosetting requires further examination. This study establishes a new rosetting flow assay using a closed perfusion system together with inverted fluorescence microscopy and image analysis, and confirms previous reports that rosettes exist under shear stresses equivalent to those present in the microvasculature (0.5-1.0 dyn/cm(2)). Furthermore, we tested the effectiveness of rosette-disrupting PfEMP1 antibodies, heparin and fucoidan over a range of concentrations on two P. falciparum strains, and found no statistically significant differences between the results of static and flow assays. The new flow assay is a valuable addition to the tools available to study rosetting. However, the static assay has good predictive value and remains useful as the standard screening test for rosette-disrupting interventions.	[Adams, Yvonne; Rowe, J. Alexandra] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Rowe, JA (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Alex.Rowe@ed.ac.uk	Adams, Yvonne/AAX-8901-2021; Adams, Yvonne/GRX-3572-2022	Adams, Yvonne/0000-0001-8041-6580; Rowe, Alexandra/0000-0002-7702-1892	Wellcome Trust (Senior Research Fellowship) [084226]	Wellcome Trust (Senior Research Fellowship)(Wellcome Trust)	This work was funded by the Wellcome Trust (Senior Research Fellowship to JAR, grant no. 084226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, INFECT IMMUN, V68, P264, DOI 10.1128/IAI.68.1.264-269.2000; Adams Y, 2005, PARASITOL RES, V97, P290, DOI 10.1007/s00436-005-1426-3; Adams Y, 2006, ANTIMICROB AGENTS CH, V50, P2850, DOI 10.1128/AAC.00313-06; Andrews KT, 2005, INFECT IMMUN, V73, P4288, DOI 10.1128/IAI.73.7.4288-4294.2005; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; CARLSON J, 1992, AM J TROP MED HYG, V46, P595, DOI 10.4269/ajtmh.1992.46.595; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chotivanich KT, 2000, ANN TROP MED PARASIT, V94, P219, DOI 10.1080/00034980050006384; Chu Y, 1997, BRIT J HAEMATOL, V99, P777; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Cooke BM, 1998, MOL MICROBIOL, V30, P83, DOI 10.1046/j.1365-2958.1998.01040.x; COOKE BM, 1993, PARASITOLOGY, V107, P359, DOI 10.1017/S0031182000067706; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; KAUL DK, 1991, BLOOD, V78, P812; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; Lipowsky H, 1985, SHEAR STRESS CICULAT; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; NASH GB, 1992, BRIT J HAEMATOL, V82, P757, DOI 10.1111/j.1365-2141.1992.tb06955.x; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Paton D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-91; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; ROGERSON SJ, 1994, AM J TROP MED HYG, V51, P198, DOI 10.4269/ajtmh.1994.51.198; ROWE A, 1994, EXP PARASITOL, V79, P506, DOI 10.1006/expr.1994.1111; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 1998, MOL BIOCHEM PARASIT, V92, P177, DOI 10.1016/S0166-6851(97)00237-5; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; Xiao LH, 1996, EXP PARASITOL, V84, P42, DOI 10.1006/expr.1996.0088	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73999	10.1371/journal.pone.0073999	http://dx.doi.org/10.1371/journal.pone.0073999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066091	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000073
J	Ando, D; Colvin, M; Rexach, M; Gopinathan, A				Ando, David; Colvin, Michael; Rexach, Michael; Gopinathan, Ajay			Physical Motif Clustering within Intrinsically Disordered Nucleoporin Sequences Reveals Universal Functional Features	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; TRANSPORT; ARCHITECTURE; VISUALIZATION; TRANSLOCATION; EVOLUTION; DYNAMICS; REGIONS; CHARGE	Bioinformatics of disordered proteins is especially challenging given high mutation rates for homologous proteins and that functionality may not be strongly related to sequence. Here we have performed a novel bioinformatic analysis, based on the spatial clustering of physically relevant features such as binding motifs and charges within disordered proteins, on thousands of Nuclear Pore Complex (NPC) FG motif containing proteins (FG nups). The biophysical mechanism by which FG nups regulate nucleocytoplasmic transport has remained elusive. Our analysis revealed a set of highly conserved spatial features in the sequence structure of individual FG nups, such as the separation, localization, and ordering of FG motifs and charged residues along the protein chain. These functionally conserved features provide insight into the particular biophysical mechanisms responsible for regulation of nucleocytoplasmic traffic in the NPC, strongly constraining current models. Additionally this method allows us to identify potentially functionally analogous disordered proteins across distantly related species.	[Ando, David; Gopinathan, Ajay] Univ Calif Merced, Dept Phys, Merced, CA USA; [Colvin, Michael] Univ Calif Merced, Merced, CA USA; [Rexach, Michael] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Santa Cruz	Gopinathan, A (corresponding author), Univ Calif Merced, Dept Phys, Merced, CA USA.	agopinathan@ucmerced.edu		Gopinathan, Ajay/0000-0002-9369-8780	National Institutes of Health Grant [GM077520]; National Science Foundation [EF-1038697, NSF-DBI-0960480]; James S. McDonnell Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077520] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institutes of Health Grant GM077520 (to MR), National Science Foundation grants EF-1038697 (to AG), NSF-DBI-0960480 (to AG and MC), and a James S. McDonnell Foundation Award (to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtert E, 2008, LECT NOTES COMPUT SC, V5069, P580; AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Atkinson CE, 2013, BIOPHYS J, V104, P37, DOI 10.1016/j.bpj.2012.11.3823; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bohm C, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P27, DOI 10.1109/ICDM.2004.10087; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Cardarelli F, 2012, P NATL ACAD SCI USA, V109, P9863, DOI 10.1073/pnas.1200486109; Colwell LJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000747; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Grunwald D, 2012, CURR OPIN CELL BIOL, V24, P100, DOI 10.1016/j.ceb.2011.11.011; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Liashkovich I, 2012, J CONTROLLED RELEASE; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mincer JS, 2011, P NATL ACAD SCI USA, V108, pE351, DOI 10.1073/pnas.1104521108; Moesa HA, 2012, MOL BIOSYST, V8, P3262, DOI 10.1039/c2mb25202c; Murphy LR, 2000, PROTEIN ENG, V13, P149, DOI 10.1093/protein/13.3.149; Nguyen Ba Alex N, 2012, Sci Signal, V5, prs1, DOI 10.1126/scisignal.2002515; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Shaulov L, 2012, STRUCTURE, V20, P407, DOI 10.1016/j.str.2012.01.022; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Tasoulis D. K., 2004, EUR S INT TECHN HYBR, P47; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201	46	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73831	10.1371/journal.pone.0073831	http://dx.doi.org/10.1371/journal.pone.0073831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066078	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000060
J	Cokic, I; Kali, A; Wang, XZ; Yang, HJ; Tang, RLQ; Thajudeen, A; Shehata, M; Amorn, AM; Liu, EZ; Stewart, B; Bennett, N; Harlev, D; Tsaftaris, SA; Jackman, WM; Chugh, SS; Dharmakumar, R				Cokic, Ivan; Kali, Avinash; Wang, Xunzhang; Yang, Hsin-Jung; Tang, Richard L. Q.; Thajudeen, Anees; Shehata, Michael; Amorn, Allen M.; Liu, Enzhao; Stewart, Brian; Bennett, Nathan; Harlev, Doron; Tsaftaris, Sotirios A.; Jackman, Warren M.; Chugh, Sumeet S.; Dharmakumar, Rohan			Iron Deposition following Chronic Myocardial Infarction as a Substrate for Cardiac Electrical Anomalies: Initial Findings in a Canine Model	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR SCAR; MAGNETIC-RESONANCE; SUBENDOCARDIAL RESECTION; DIASTOLIC POTENTIALS; PASSIVE TRANSMISSION; QT INTERVAL; TACHYCARDIA; HEART; THALASSEMIA	Purpose: Iron deposition has been shown to occur following myocardial infarction (MI). We investigated whether such focal iron deposition within chronic MI lead to electrical anomalies. Methods: Two groups of dogs (ex-vivo (n = 12) and in-vivo (n = 10)) were studied at 16 weeks post MI. Hearts of animals from ex-vivo group were explanted and sectioned into infarcted and non-infarcted segments. Impedance spectroscopy was used to derive electrical permittivity ((epsilon) over bar) and conductivity ((sigma) over bar). Mass spectrometry was used to classify and characterize tissue sections with (IRON+) and without (IRON-) iron. Animals from in-vivo group underwent cardiac magnetic resonance imaging (CMR) for estimation of scar volume (late-gadolinium enhancement, LGE) and iron deposition (T2*) relative to left-ventricular volume. 24-hour electrocardiogram recordings were obtained and used to examine Heart Rate (HR), QT interval (QT), QT corrected for HR (QTc) and QTc dispersion (QTcd). In a fraction of these animals (n = 5), ultra-high resolution electroanatomical mapping (EAM) was performed, co-registered with LGE and T2* CMR and were used to characterize the spatial locations of isolated late potentials (ILPs). Results: Compared to IRON- sections, IRON+ sections had higher (epsilon) over bar, but no difference in (sigma) over bar. A linear relationship was found between iron content and (epsilon) over bar (p<0.001), but not <(sigma)over bar> (p = 0.34). Among two groups of animals (Iron (<1.5%) and Iron (>1.5%)) with similar scar volumes (7.28%+/- 1.02% (Iron (<1.5%)) vs 8.35%+/- 2.98% (Iron (>1.5%)), p = 0.51) but markedly different iron volumes (1.12%+/- 0.64% (Iron (<1.5%)) vs 2.47%+/- 0.64% (Iron (>1.5%)), p = 0.02), QT and QTc were elevated and QTcd was decreased in the group with the higher iron volume during the day, night and 24-hour period (p<0.05). EAMs co-registered with CMR images showed a greater tendency for ILPs to emerge from scar regions with iron versus without iron. Conclusion: The electrical behavior of infarcted hearts with iron appears to be different from those without iron. Iron within infarcted zones may evolve as an arrhythmogenic substrate in the post MI period.	[Cokic, Ivan; Kali, Avinash; Yang, Hsin-Jung; Tang, Richard L. Q.; Dharmakumar, Rohan] Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA; [Kali, Avinash; Dharmakumar, Rohan] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Kali, Avinash; Yang, Hsin-Jung] Univ Calif Los Angeles, Dept Biomed Engn, Los Angeles, CA USA; [Wang, Xunzhang; Thajudeen, Anees; Shehata, Michael; Amorn, Allen M.; Liu, Enzhao; Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Stewart, Brian; Bennett, Nathan; Harlev, Doron] Rhythmia Med, Burlington, MA USA; [Tsaftaris, Sotirios A.] Inst Adv Studies Lucca, Inst Markets Technol, Lucca, Italy; [Tsaftaris, Sotirios A.] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL USA; [Tang, Richard L. Q.; Tsaftaris, Sotirios A.; Dharmakumar, Rohan] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Jackman, Warren M.] Univ Oklahoma, Hlth Sci Ctr, Heart Rhythm Inst, Oklahoma City, OK USA; [Chugh, Sumeet S.; Dharmakumar, Rohan] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; Northwestern University; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; IMT School for Advanced Studies Lucca; Northwestern University; Northwestern University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Los Angeles	Dharmakumar, R (corresponding author), Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA.	rohandkumar@csmc.edu		Tsaftaris, Sotirios/0000-0002-8795-9294	National Heart, Lung, and Blood Institute [HL091989]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091989] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant from the National Heart, Lung, and Blood Institute (HL091989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AHNVE S, 1985, AM HEART J, V109, P568, DOI 10.1016/0002-8703(85)90564-2; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; Boye P, 2011, JACC-CARDIOVASC IMAG, V4, P871, DOI 10.1016/j.jcmg.2011.04.014; BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3; Cabo C, 1998, CIRCULATION, V98, P2598, DOI 10.1161/01.CIR.98.23.2598; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; Cinca J, 1998, CARDIOVASC RES, V40, P103, DOI 10.1016/S0008-6363(98)00145-X; CINCA J, 1995, CIRCULATION, V91, P1552, DOI 10.1161/01.CIR.91.5.1552; Dawson DK, 2013, JACC-CARDIOVASC IMAG, V6, P335, DOI 10.1016/j.jcmg.2012.09.012; DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589; DEBAKKER JMT, 1990, J AM COLL CARDIOL, V15, P1594, DOI 10.1016/0735-1097(90)92832-M; ELSHERIF N, 1985, PACE, V8, P440, DOI 10.1111/j.1540-8159.1985.tb05784.x; ENGLE MA, 1964, ANN NY ACAD SCI, V119, P694; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Grimnes S, 2008, BIOIMPEDANCE BIOELEC, Vxi; Gupta S, 2012, JACC-CARDIOVASC IMAG, V5, P207, DOI 10.1016/j.jcmg.2011.08.021; Hildebrand AM, 2009, CAN J CARDIOL, V25, pE424, DOI 10.1016/S0828-282X(09)70538-0; Isma'eel H, 2009, INT J CARDIOL, V132, P453, DOI 10.1016/j.ijcard.2007.08.103; Issa ZF, 2019, CLIN ARRHYTHMOLOGY E, V3rd, DOI [10.1016/B978-1-4557-1274-8.00006-3, DOI 10.1016/B978-1-4557-1274-8.00006-3]; Jackowski C, 2013, J AM COLL CARDIOL; Jackowski C, 2006, EUR HEART J, V27, P2459, DOI 10.1093/eurheartj/ehl255; Jackson JD, 1999, CLASSICAL ELECTRODYN, Vxxi; JOSEPHSON ME, 1978, CIRCULATION, V57, P659, DOI 10.1161/01.CIR.57.4.659; Kali A, 2013, CIRC-CARDIOVASC IMAG, V6, P218, DOI 10.1161/CIRCIMAGING.112.000133; KAYE SB, 1978, BRIT MED J, V1, P342, DOI 10.1136/bmj.1.6109.342; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, P101, DOI 10.1002/bem.2250130710; Klem I, 2012, J AM COLL CARDIOL, V60, P408, DOI 10.1016/j.jacc.2012.02.070; Kocovic DZ, 1999, J AM COLL CARDIOL, V34, P381, DOI 10.1016/S0735-1097(99)00205-3; Kofod G, 2011, ACS NANO, V5, P1623, DOI 10.1021/nn103097q; Kulbertus H, 1977, REENTRANT ARRHYTHMIA, Vx; Kumar A, 2011, JACC-CARDIOVASC IMAG, V4, P1274, DOI 10.1016/j.jcmg.2011.08.016; MILLER JM, 1995, CIRCULATION, V91, P2385, DOI 10.1161/01.CIR.91.9.2385; MILLER JM, 1984, CIRCULATION, V70, P624, DOI 10.1161/01.CIR.70.4.624; Nakahara S, 2011, HEART RHYTHM, V8, P1060, DOI 10.1016/j.hrthm.2011.02.029; O'Regan DP, 2010, HEART, V96, P1885, DOI 10.1136/hrt.2010.200634; Saito J, 1998, J INTERV CARD ELECTR, V2, P235, DOI 10.1023/A:1009776618809; Schwan H. P., 1963, PHYS TECHNIQUES BIOL, P323, DOI DOI 10.1002/JCP.1030660505; SCHWAN HP, 1957, ANN NY ACAD SCI, V65, P1007, DOI 10.1111/j.1749-6632.1957.tb36701.x; Schwartz KA, 2002, J APPL PHYSIOL, V93, P746, DOI 10.1152/japplphysiol.01144.2001; Schwartzman D, 1999, J INTERV CARD ELECTR, V3, P213, DOI 10.1023/A:1009887306055; Scott PA, 2013, EUROPACE, V15, P899, DOI 10.1093/europace/eus362; Scott PA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P324, DOI 10.1161/CIRCEP.110.959544; Shenasa M, 2013, CARDIAC MAPPING, Vxx; SIMSON MB, 1981, AM J PHYSIOL, V241, pH363, DOI 10.1152/ajpheart.1981.241.3.H363; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Tsuda N, 1991, ELECT CONDUCTION OXI, Vx; TUCKER HS, 1948, AM HEART J, V35, P993, DOI 10.1016/0002-8703(48)90599-7; Wang JB, 2006, ANAL CHEM, V78, P1769, DOI 10.1021/ac051113+; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Yi G, 1998, AM J CARDIOL, V81, P950, DOI 10.1016/S0002-9149(98)00071-X	52	19	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73193	10.1371/journal.pone.0073193	http://dx.doi.org/10.1371/journal.pone.0073193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066038	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000324494000019
J	Hanna, MC; Go, C; Roden, C; Jones, RT; Pochanard, P; Javed, AY; Javed, A; Mondal, C; Palescandolo, E; Van Hummelen, P; Hatton, C; Bass, AJ; Chun, SM; Na, DC; Kim, TI; Jang, SJ; Osarogiagbon, RU; Hahn, WC; Meyerson, M; Garraway, LA; MacConaill, LE				Hanna, Megan C.; Go, Christina; Roden, Christine; Jones, Robert T.; Pochanard, Panisa; Javed, Ahmed Yasir; Javed, Awais; Mondal, Chandrani; Palescandolo, Emanuele; Van Hummelen, Paul; Hatton, Charles; Bass, Adam J.; Chun, Sung Min; Na, Deuk Chae; Kim, Tae-Im; Jang, Se Jin; Osarogiagbon, Raymond U.; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.; MacConaill, Laura E.			Colorectal Cancers from Distinct Ancestral Populations Show Variations in BRAF Mutation Frequency	PLOS ONE			English	Article							MOLECULAR ANALYSIS; KOREA INCIDENCE; KRAS MUTATIONS; GENE-MUTATIONS; RAS MUTATIONS; HUMAN-BREAST; LUNG-CANCER; SURVIVAL; MORTALITY; ONCOGENE	It has been demonstrated for some cancers that the frequency of somatic oncogenic mutations may vary in ancestral populations. To determine whether key driver alterations might occur at different frequencies in colorectal cancer, we applied a high-throughput genotyping platform (OncoMap) to query 385 mutations across 33 known cancer genes in colorectal cancer DNA from 83 Asian, 149 Black and 195 White patients. We found that Asian patients had fewer canonical oncogenic mutations in the genes tested (60% vs Black 79% (P = 0.011) and White 77% (P = 0.015)), and that BRAF mutations occurred at a higher frequency in White patients (17% vs Asian 4% (P = 0.004) and Black 7% (P = 0.014)). These results suggest that the use of genomic approaches to elucidate the different ancestral determinants harbored by patient populations may help to more precisely and effectively treat colorectal cancer.	[Hanna, Megan C.; Go, Christina; Roden, Christine; Jones, Robert T.; Pochanard, Panisa; Mondal, Chandrani; Palescandolo, Emanuele; Van Hummelen, Paul; Hatton, Charles; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.; MacConaill, Laura E.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Hanna, Megan C.; Go, Christina; Roden, Christine; Jones, Robert T.; Pochanard, Panisa; Mondal, Chandrani; Palescandolo, Emanuele; Van Hummelen, Paul; Hatton, Charles; Bass, Adam J.; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.; MacConaill, Laura E.] Harvard Univ, Sch Med, Boston, MA USA; [Hanna, Megan C.; Go, Christina; Roden, Christine; Jones, Robert T.; Pochanard, Panisa; Mondal, Chandrani; Palescandolo, Emanuele; Van Hummelen, Paul; Hatton, Charles; Bass, Adam J.; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.; MacConaill, Laura E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hanna, Megan C.; Bass, Adam J.; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.; MacConaill, Laura E.] Broad Inst, Cambridge, MA USA; [Javed, Ahmed Yasir; Javed, Awais; Osarogiagbon, Raymond U.] Boston Baskin Canc Fdn, Baptist Canc Ctr, Memphis, TN USA; [Chun, Sung Min; Na, Deuk Chae; Kim, Tae-Im; Jang, Se Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Ulsan; Asan Medical Center	MacConaill, LE (corresponding author), Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA.	Laura_Macconaill@dfci.harvard.edu	Go, Christina/I-6475-2018	Go, Christina/0000-0002-7716-8720; Chun, Sung-Min/0000-0002-3357-1382; Meyerson, Matthew/0000-0002-9133-8108; van hummelen, paul/0000-0002-4801-8600; Hatton, Charlie/0000-0001-9903-4291; Jones, Robert/0000-0001-8007-4023	Dana-Farber Cancer Institute; DF/HCC Pilot Program; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF); Korean Ministry of Education, Science and Technology (MEST) [2011-0030105]	Dana-Farber Cancer Institute; DF/HCC Pilot Program; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Dana-Farber Cancer Institute, the DF/HCC Pilot Program, and the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science and Technology (MEST) (2011-0030105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2004, CANCER-AM CANCER SOC, V101, P66, DOI 10.1002/cncr.20337; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Chan TL, 2003, CANCER RES, V63, P4878; Cheung DY, 2008, INTERNAL MED, V47, P1649, DOI 10.2169/internalmedicine.47.1269; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; El-Osta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025806; English DR, 2008, CANCER EPIDEM BIOMAR, V17, P1774, DOI 10.1158/1055-9965.EPI-08-0091; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Immervoll H, 2006, VIRCHOWS ARCH, V448, P788, DOI 10.1007/s00428-006-0191-8; Jacob BJ, 2012, GASTROINTEST ENDOSC, V76, P355, DOI 10.1016/j.gie.2012.03.247; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Jung KW, 2011, CANCER RES TREAT, V43, P1, DOI 10.4143/crt.2011.43.1.1; Kawesha A, 2000, INT J CANCER, V89, P469, DOI 10.1002/1097-0215(20001120)89:6<469::AID-IJC1>3.0.CO;2-L; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Moghimi-Dehkordi B, 2012, WORLD J GASTRO ONCOL, V4, P71, DOI 10.4251/wjgo.v4.i4.71; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rozek LS, 2010, CANCER EPIDEM BIOMAR, V19, P838, DOI 10.1158/1055-9965.EPI-09-1112; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sylvester BE, 2012, CLIN CANCER RES, V18, P350, DOI 10.1158/1078-0432.CCR-11-1397; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31; Yee YK, 2009, J GASTROEN HEPATOL, V24, P1810, DOI 10.1111/j.1440-1746.2009.06138.x	34	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74950	10.1371/journal.pone.0074950	http://dx.doi.org/10.1371/journal.pone.0074950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066160	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000142
J	Nakagomi, M; Fujimaki, N; Ito, A; Toda, T; Fukasawa, H; Shudo, K; Tomita, R				Nakagomi, Madoka; Fujimaki, Nobuko; Ito, Ai; Toda, Takahiro; Fukasawa, Hiroshi; Shudo, Koichi; Tomita, Ryoichi			A Novel Aromatic Carboxylic Acid Inactivates Luciferase by Acylation of an Enzymatically Active Regulatory Lysine Residue	PLOS ONE			English	Article							FIREFLY LUCIFERASE; COA SYNTHETASE; PTC124; ENZYME; DEACETYLATION; ACTIVATION; EXPRESSION; MECHANISM; ASSAYS	Firefly luciferase (Luc) is widely used as a reporter enzyme in cell-based assays for gene expression. A novel aromatic carboxylic acid, F-53, reported here for the first time, substantially inhibited the enzymatic activity of Luc in a Luc reporter screening. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and tandem mass spectrometry (MS/MS) analyses showed that F-53 modifies Luc at lysine-529 via amidation of the F-53 carboxyl group. The lysine-529 residue of Luc, which plays a regulatory catalytic role, can be acetylated. Luc also has a long-chain fatty acyl-CoA synthase activity. An in vitro assay that involved both recombinant Luc and mouse liver microsomes identified F-53-CoA as the reactive form produced from F-53. However, whereas the inhibitory effect of F-53 is observed in Hela cells that transiently expressed Luc, it is not observed in an in vitro assay that involves recombinant Luc alone. Therefore, insights into the activities of certain mammalian transferases can be translated to better understand the acylation by F-53. The insights from this study about the novel inhibitory modification mechanism might help not only to avoid misinterpretation of the results of Luc-based reporter screening assays but also to explain the pharmacological and toxicological effects of carboxylic acid-containing drugs.	[Nakagomi, Madoka; Toda, Takahiro; Fukasawa, Hiroshi; Shudo, Koichi] Res Fdn Itsuu Lab, Dept Biol, Tokyo, Japan; [Fujimaki, Nobuko; Ito, Ai; Shudo, Koichi] Res Fdn Itsuu Lab, Dept Chem, Tokyo, Japan; [Tomita, Ryoichi] Inst Med Mol Design Inc, Mol Funct Dept, Tokyo, Japan		Nakagomi, M (corresponding author), Res Fdn Itsuu Lab, Dept Biol, Tokyo, Japan.	mnakagomi@itsuu.or.jp		Ito, Ai/0000-0003-0797-1478	Research Foundation ITSUU Laboratory	Research Foundation ITSUU Laboratory	This work was supported by Research Foundation ITSUU Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Boelsterli Urs A, 2002, Curr Drug Metab, V3, P439, DOI 10.2174/1389200023337315; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Delacroix T, 2000, J ORG CHEM, V65, P8108, DOI 10.1021/jo000971x; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Grigg R, 2003, TETRAHEDRON LETT, V44, P6979, DOI 10.1016/S0040-4039(03)01805-7; Grillo MP, 2011, CURR DRUG METAB, V12, P229; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hashimoto Y, 2002, BIOORGAN MED CHEM, V10, P461, DOI 10.1016/S0968-0896(01)00308-X; Hashimoto Y, 1998, CURR MED CHEM, V5, P163; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Inouye S, 2010, CELL MOL LIFE SCI, V67, P387, DOI 10.1007/s00018-009-0170-8; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; MCELROY WD, 1969, PHOTOCHEM PHOTOBIOL, V10, P153, DOI 10.1111/j.1751-1097.1969.tb05676.x; Ning ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058854; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Palermo R, 2012, ONCOGENE, V31, P3807, DOI 10.1038/onc.2011.533; Shimshoni JA, 2011, BBA-MOL CELL BIOL L, V1811, P163, DOI 10.1016/j.bbalip.2010.12.006; Skonberg C, 2008, EXPERT OPIN DRUG MET, V4, P425, DOI 10.1517/17425255.4.4.425 ; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Toda T, 2009, XENOBIOTICA, V39, P323, DOI 10.1080/00498250802651984; Wan J, 2007, TETRAHEDRON, V63, P9338, DOI 10.1016/j.tet.2007.07.009; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	35	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75445	10.1371/journal.pone.0075445	http://dx.doi.org/10.1371/journal.pone.0075445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066181	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000163
J	Qiu, LX; Lin, JH; Ying, M; Chen, WQ; Yang, JM; Deng, TT; Chen, JF; Shi, DY; Yang, JY				Qiu, Longxin; Lin, Jianhui; Ying, Miao; Chen, Weiqiang; Yang, Jinmei; Deng, Tiantian; Chen, Jinfeng; Shi, Duanyu; Yang, James Y.			Aldose Reductase Is Involved in the Development of Murine Diet-Induced Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; ACTIVATED-RECEPTOR-ALPHA; NECROSIS-FACTOR-ALPHA; FATTY LIVER-DISEASE; GENE-EXPRESSION; MICE; INHIBITION; INDUCTION; FIBROSIS; INJURY	Hepatic aldose reductase (AR) expression is known to be induced in liver diseases, including hepatitis and hepatocellular carcinoma. However, the role of AR in the development of these diseases remains unclear. We performed this current study to determine whether and how AR might be involved in the development of diet-induced nonalcoholic steatohepatitis. Our results showed that the level of AR protein expression was significantly higher in db/db mice fed the methionine-cholinedeficient (MCD) diet than in mice fed the control diet. In parallel with the elevation in AR, steatohepatitis was observed in MCD diet-fed mice, and this diet-induced steatohepatitis was significantly attenuated by lentiviral-mediated knock-down of the AR gene. This suppressive effect of AR knock-down was associated with repressed levels of serum alanine aminotransferase and hepatic lipoperoxides, reduced mRNA and protein expression of hepatic cytochrome P450 2E1 (CYP2E1), and decreased mRNA expression of pro-inflammatory tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). Moreover, AR-induced elevations on the level of CYP2E1 expression, reactive oxygen species, mRNA expression of TNF-alpha and IL-6 were confirmed in AML12 hepatocytes. Further, lentiviral-mediated knock-down of AR ameliorated MCD diet-induced collagen deposition in the livers of db/db mice. With the improvement in liver fibrosis, the mRNA levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and matrix metalloproteinase-2 (MMP-2), two genes involved in hepatic fibrogenesis, were found to be significantly suppressed, while TIMP-2 and MMP-13 were unaffected. Together these data indicate that inhibition of AR alleviates the MCD diet-induced liver inflammation and fibrosis in db/db mice, probably through dampening CYP2E1 mediated-oxidative stress and ameliorating the expression of pro-inflammatory cytokines.	[Qiu, Longxin; Lin, Jianhui; Ying, Miao; Chen, Weiqiang; Yang, Jinmei; Deng, Tiantian; Chen, Jinfeng; Shi, Duanyu] Longyan Univ, Sch Life Sci, Longyan, Peoples R China; [Qiu, Longxin] Longyan Univ, Fujian Key Lab Prevent Vet Med & Biotechnol, Longyan, Peoples R China; [Yang, James Y.] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Yang, James Y.] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China	Longyan University; Longyan University; Xiamen University; Xiamen University	Qiu, LX (corresponding author), Longyan Univ, Sch Life Sci, Longyan, Peoples R China.	qlongxin@tom.com; jyqy2008@gmail.com			Natural Science Foundation of Fujian Province, China [2009J01180]; Science Planning Program of Fujian Province, China [2010N0023]	Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Science Planning Program of Fujian Province, China	This work was supported in part by grants from the Natural Science Foundation of Fujian Province, China (#2009J01180) and the Science Planning Program of Fujian Province, China (#2010N0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KE, 2005, HISTOL HISTOPATHOL, V20, P429, DOI 10.14670/HH-20.429; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; CLEMENTS RS, 1986, DRUGS, V32, P3, DOI 10.2165/00003495-198600322-00003; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Larter CZ, 2006, J HEPATOL, V44, P253, DOI 10.1016/j.jhep.2005.11.030; Leclercq GRI, 2001, AM J PHYSIOL-GASTR L, V281, pG1135; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Memon RA, 2001, NAT MED, V7, P2, DOI 10.1038/83316; Nieto N, 2002, J BIOL CHEM, V277, P9853, DOI 10.1074/jbc.M110506200; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Parola M, 1996, BIOCHEM BIOPH RES CO, V222, P261, DOI 10.1006/bbrc.1996.0732; Poulos JE, 1997, AM J PHYSIOL-GASTR L, V273, pG804, DOI 10.1152/ajpgi.1997.273.4.G804; Qiu LX, 2008, J BIOL CHEM, V283, P17175, DOI 10.1074/jbc.M801791200; Qiu LX, 2012, EXP DIABETES RES, DOI 10.1155/2012/789730; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Ruef J, 2000, ARTERIOSCL THROM VAS, V20, P1745, DOI 10.1161/01.ATV.20.7.1745; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Shen B, 2008, HEPATOLOGY, V47, P473, DOI 10.1002/hep.22039; Spycher S, 1996, BIOCHEM BIOPH RES CO, V226, P512, DOI 10.1006/bbrc.1996.1386; Takahashi M, 1996, JPN J CANCER RES, V87, P337, DOI 10.1111/j.1349-7006.1996.tb00227.x; Tamasi V, 2008, MOL PHARMACOL, V73, P968, DOI 10.1124/mol.107.036780; Toda K, 2000, J GASTROENTEROL, V35, P214, DOI 10.1007/s005350050333; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Tracey WR, 2000, AM J PHYSIOL-HEART C, V279, pH1447, DOI 10.1152/ajpheart.2000.279.4.H1447; Voican CS, 2011, J HEPATOL, V54, P388, DOI 10.1016/j.jhep.2010.07.054; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535	38	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73591	10.1371/journal.pone.0073591	http://dx.doi.org/10.1371/journal.pone.0073591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066058	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000039
J	Spahn, P; Reuter, R				Spahn, Philipp; Reuter, Rolf			A Vertex Model of Drosophila Ventral Furrow Formation	PLOS ONE			English	Article							CELL-SHAPE CHANGES; ADHERENS JUNCTIONS; APICAL CONSTRICTION; MESODERM INVAGINATION; FOLDED-GASTRULATION; MECHANICS; MYOSIN; MORPHOGENESIS; FORCES; LOCALIZATION	Ventral furrow formation in Drosophila is an outstanding model system to study the mechanisms involved in large-scale tissue rearrangements. Ventral cells accumulate myosin at their apical sides and, while being tightly coupled to each other via apical adherens junctions, execute actomyosin contractions that lead to reduction of their apical cell surface. Thereby, a band of constricted cells along the ventral epithelium emerges which will form a tissue indentation along the ventral midline (the ventral furrow). Here we adopt a 2D vertex model to simulate ventral furrow formation in a surface view allowing easy comparison with confocal live-recordings. We show that in order to reproduce furrow morphology seen in vivo, a gradient of contractility must be assumed in the ventral epithelium which renders cells more contractile the closer they lie to the ventral midline. The model predicts previous experimental findings, such as the gain of eccentric morphology of constricting cells and an incremental fashion of apical cell area reduction. Analysis of the model suggests that this incremental area reduction is caused by the dynamical interplay of cell elasticity and stochastic contractility as well as by the opposing forces from contracting neighbour cells. We underpin results from the model through in vivo analysis of ventral furrow formation in wildtype and twi mutant embryos. Our results show that ventral furrow formation can be accomplished as a "tug-of-war" between stochastically contracting, mechanically coupled cells and may require less rigorous regulation than previously thought. Summary: For the developmental biologist it is a fascinating question how cells can coordinate major tissue movements during embryonic development. The so-called ventral furrow of the Drosophila embryo is a well-studied example of such a process when cells from a ventral band, spanning nearly the entire length of the embryo, undergo dramatic shape change by contracting their tips and then fold inwards into the interior of the embryo. Although numerous genes have been identified that are critical for ventral furrow formation, it is an open question how cells work together to elicit this tissue rearrangement. We use a computational model to mimic the physical properties of cells in the ventral epithelium and simulate the formation of the furrow. We find that the ventral furrow can form through stochastic self-organisation and that previous experimental observations can be readily explained in our model by considering forces that arise when cells execute contractions while being coupled to each other in a mechanically coherent epithelium. The model highlights the importance of a physical perspective when studying tissue morphogenesis and shows that only a minimal genetic regulation may be required to drive complex processes in embryonic development.	[Spahn, Philipp; Reuter, Rolf] Univ Tubingen, Fachbereich Biol, Abt Genet Tiere, Interfak Inst Zellbiol, Tubingen, Germany	Eberhard Karls University of Tubingen	Reuter, R (corresponding author), Univ Tubingen, Fachbereich Biol, Abt Genet Tiere, Interfak Inst Zellbiol, Tubingen, Germany.	rolf.reuter@uni-tuebingen.de						Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; Brezavscek AH, 2012, BIOPHYS J, V103, P1069, DOI 10.1016/j.bpj.2012.07.018; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Conte V, 2008, J MECH BEHAV BIOMED, V1, P188, DOI 10.1016/j.jmbbm.2007.10.002; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Driquez B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066007; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Hocevar A, 2011, ARXIV11084795V1QBIOC; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; Ip YT, 2002, CURR OPIN GENET DEV, V12, P423, DOI 10.1016/S0959-437X(02)00320-9; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Munoz JJ, 2007, J BIOMECH, V40, P1372, DOI 10.1016/j.jbiomech.2006.05.006; Nagai T, 2001, PHILOS MAG B, V81, P699, DOI 10.1080/13642810110055328; Nagai T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061903; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Oda H, 2001, J CELL SCI, V114, P493; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; SIMPSON P, 1983, GENETICS, V105, P615; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Spahn P, 2012, J CELL SCI, V125, P3801, DOI 10.1242/jcs.101196; STAVANS J, 1993, REP PROG PHYS, V56, P733, DOI 10.1088/0034-4885/56/6/002; SWEETON D, 1991, DEVELOPMENT, V112, P775	42	39	39	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75051	10.1371/journal.pone.0075051	http://dx.doi.org/10.1371/journal.pone.0075051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066163	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000145
J	Wade, D; Diaw, PA; Daneau, G; Camara, M; Dieye, TN; Mboup, S; Kestens, L				Wade, Djibril; Diaw, Papa Alassane; Daneau, Geraldine; Camara, Makhtar; Dieye, Tandakha Ndiaye; Mboup, Souleymane; Kestens, Luc			CD4 T-Cell Enumeration in a Field Setting: Evaluation of CyFlow Counter Using the CD4 Easy Count Kit-Dry and Pima CD4 Systems	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; HIV-INFECTED INDIVIDUALS; FLOW-CYTOMETRY; ANTIRETROVIRAL THERAPY; PERFORMANCE EVALUATION; HIV-1-INFECTED PATIENTS; ALTERNATIVE METHODS; FACSCOUNT SYSTEM; POOR SETTINGS; POINT	Background: Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enumeration. However, the use of FCM in developing countries is problematic due to their cost and complexity. Lower-cost technologies have been introduced. We evaluated CyFlow Counter together with its lyophilized reagents, and Pima CD4 in high-temperature area, using FACSCount as reference. Materials and Methods: Whole blood samples were consecutively collected by venipuncture from 111 HIV+ patients and 17 HIV-negative donors. CD4 T-cell enumeration was performed on CyFlow Counter, Pima CD4 and FACSCount. Results: CyFlow Counter and Pima CD4 systems showed good correlation with FACSCount (slope of 0.82 and 0.90, and concordance rho(c) of 0.94 and 0.98, respectively). CyFlow Counter showed absolute or relative biases (LOA) of 263 cells/mm(3) (-245 to 120) or -9.8% (-38.1 to 18.4) respectively, and Pima CD4 showed biases (LOA) of -30 cells/mm(3) (-160 to 101) or -3.5% (-41.0 to 33.9%). CyFlow Counter and Pima CD4 showed respectively 106.7% and 105.9% of similarity with FACSCount. According to WHO-2010 ART initiation threshold of 350 cells/mm(3), CyFlow Counter and Pima CD4 showed respectively sensibility of 100% and 97%, and specificity of 91% and 93%. CyFlow Counter and Pima CD4 were strongly correlated (slope of 1.09 and rho(c) of 0.95). These alternative systems showed good agreement with bias of 33 cells/mm(3) (-132 to 203) or 6.3% (-31.2 to 43.8), and similarity of 104.3%. Conclusion: CyFlow Counter using CD4 easy count kit-dry and Pima CD4 systems can accurately provide CD4 T-cell counts with acceptable agreement to those of FACSCount.	[Wade, Djibril; Diaw, Papa Alassane; Camara, Makhtar; Dieye, Tandakha Ndiaye; Mboup, Souleymane] Le Dantec Univ Teaching Hosp, Immunol Unit, Bacteriol Lab, Dakar, Senegal; [Wade, Djibril; Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Immunol Lab, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Wade, Djibril; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp	Wade, D (corresponding author), Le Dantec Univ Teaching Hosp, Immunol Unit, Bacteriol Lab, Dakar, Senegal.	wadedjibril@yahoo.fr	Wade, Djibril/AAK-1418-2021	Wade, Djibril/0000-0002-1321-365X; Daneau, Geraldine/0000-0002-2570-0893	Belgian Directorate General for Development Cooperation	Belgian Directorate General for Development Cooperation	Financial support was provided by the Belgian Directorate General for Development Cooperation. PIMA Analyser and disposable cartridges were kindly provided by Alere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson David A, 2011, Curr HIV/AIDS Rep, V8, P31, DOI 10.1007/s11904-010-0067-z; Balakrishnan P, 2006, JAIDS-J ACQ IMM DEF, V43, P23, DOI 10.1097/01.qai.0000227791.92203.d5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cassens U, 2004, ANTIVIR THER, V9, P395; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Didier JM, 2001, J ACQ IMMUN DEF SYND, V26, P193, DOI 10.1097/00126334-200102010-00017; Dieye TN, 2011, J IMMUNOL METHODS, V372, P7, DOI 10.1016/j.jim.2011.07.012; Dieye TN, 2005, JAIDS-J ACQ IMM DEF, V39, P32, DOI 10.1097/01.qai.0000160515.20581.ad; Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kandathil AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1006, DOI 10.1128/CDLI.12.8.1006-1009.2005; Karcher H, 2006, CYTOM PART B-CLIN CY, V70B, P163, DOI 10.1002/cyto.b.20093; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Lynen L, 2006, JAIDS-J ACQ IMM DEF, V43, P179, DOI 10.1097/01.qai.0000242447.82403.c2; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Pattanapanyasat K, 2005, CLIN DIAGN LAB IMMUN, V12, P1416, DOI 10.1128/CDLI.12.12.1416-1424.2005; Pattanapanyasat K, 2008, JAIDS-J ACQ IMM DEF, V49, P339, DOI 10.1097/QAI.0b013e31818c1721; Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Strauss K, 1996, CYTOMETRY, V26, P52; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; WHO, 2010, ANT THER HIV INF AD; WHO, 2010, TECHN BRIEF CD4 TECH; World Health Organisation (WHO) regional office for Africa, 2011, HIV WHO AFR REG PROG; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x; Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33	42	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75484	10.1371/journal.pone.0075484	http://dx.doi.org/10.1371/journal.pone.0075484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066184	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000166
J	Wang, T; Ji, XM; Luo, C; Fan, JJ; Hou, ZG; Chen, MJ; Han, RH; Ni, CH				Wang, Ting; Ji, Xiaoming; Luo, Chen; Fan, Jingjing; Hou, Zhiguo; Chen, Minjuan; Han, Ruhui; Ni, Chunhui			Polymorphisms in SELE Gene and Risk of Coal Workers' Pneumoconiosis in Chinese: A Case-Control Study	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INDUCED PULMONARY-FIBROSIS; BLEOMYCIN-INDUCED SCLERODERMA; EXONIC SPLICING ENHANCERS; IMMUNE-COMPLEX DEPOSITION; HIGH-ORDER INTERACTIONS; P-SELECTIN; LUNG FIBROSIS; DISEASE; ICAM-1	Background: Coal workers' pneumoconiosis (CWP) is characterized by chronic pulmonary inflammation and fibrotic nodular lesions that usually lead to progressive fibrosis. Inflammation is the first step in the development of CWP. E-selectin, an adhesion molecule, is involved in the development of various inflammatory diseases. Methods: We investigated the association between the functional polymorphisms in SELE and the risk of CWP in Han Chinese population. Three polymorphisms (T1880C/rs5355, T1559C/rs5368, A16089G/rs4786) in SELE were genotyped and analyzed in a case-control study with 697 CWP cases and 694 controls. The genotyping was based on the TaqMan method with the ABI 7900HT Real Time PCR system. Results: The SELE rs5368 CT genotype was associated with a significantly increased risk of CWP (OR = 1.28, 95% CI = 1.02-1.60, P = 0.03) relative to the CC genotype. The statistical analysis of classification and regression tree (CART) and multifactor dimensionality reduction (MDR) were used to predict the interactions among risk factors of CWP. The MDR analysis found that the best interaction model was the two-factor model that contains pack-years smoked and SELE rs5368 genotypes. For non-smokers, the CART analysis showed an increased risk of CWP for carriers of the SELE rs_5368 variant genotype compared with the common genotype (OR = 1.51; 95% CI = 1.11-2.05, P = 0.0069). Conclusion: The results suggest that the T1559C/rs5368 polymorphism and smoking are involved in the susceptibility to CWP. Further studies are warranted to validate these findings.	[Wang, Ting; Ji, Xiaoming; Luo, Chen; Fan, Jingjing; Hou, Zhiguo; Chen, Minjuan; Han, Ruhui; Ni, Chunhui] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ni, CH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China.	chni@njmu.edu.cn	wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [81072282, 81273044]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81072282, 81273044) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://jsycw.ec.js.edu.cn/default.aspx). These two funders joined in study design and preparation of the manuscript.	Abu-Amero KK, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-52; Ban HJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-26; Binns RM, 1996, AM J PHYSIOL-HEART C, V270, pH183, DOI 10.1152/ajpheart.1996.270.1.H183; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen H, 2008, GENES IMMUN, V9, P182, DOI 10.1038/sj.gene.6364452; Chen M, 2007, CARCINOGENESIS, V28, P2160, DOI 10.1093/carcin/bgm167; Fenoglio C, 2009, J NEUROL, V256, P832, DOI 10.1007/s00415-009-5016-7; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hamaguchi Y, 2002, AM J PATHOL, V161, P1607, DOI 10.1016/S0002-9440(10)64439-2; Horikawa M, 2006, AM J PATHOL, V169, P740, DOI 10.2353/ajpath.2006.060086; Issekutz AC, 2002, J IMMUNOL, V168, P1934, DOI 10.4049/jimmunol.168.4.1934; Khazen D, 2009, EUR J GASTROEN HEPAT, V21, P167, DOI 10.1097/MEG.0b013e32830e6fc8; Kimura T, 2004, J IMMUNOL, V172, P5782, DOI 10.4049/jimmunol.172.9.5782; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lebensburger JD, 2012, BLOOD, V119, P1915, DOI 10.1182/blood-2011-08-374447; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Matsushita Y, 2007, J IMMUNOL, V179, P698, DOI 10.4049/jimmunol.179.1.698; McCunney RJ, 2009, J OCCUP ENVIRON MED, V51, P462, DOI 10.1097/JOM.0b013e3181a01ada; Miller MA, 2005, NUTR METAB CARDIOVAS, V15, P65, DOI 10.1016/j.numecd.2004.05.002; Nawrot TS, 2008, AM J RESP CRIT CARE, V177, P696, DOI 10.1164/rccm.200801-116UP; Osaka D, 2011, INT J MED SCI, V8, P302, DOI 10.7150/ijms.8.302; Podgoreanu MV, 2006, CIRCULATION, V114, pI275, DOI 10.1161/CIRCULATIONAHA.105.001032; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sakkas LI, 2006, NAT CLIN PRACT RHEUM, V2, P679, DOI 10.1038/ncprheum0346; Shimada Y, 2003, J IMMUNOL, V170, P4325, DOI 10.4049/jimmunol.170.8.4325; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srivastava M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-54; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Wang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022624; Wang ML, 2010, J HUM GENET, V55, P13, DOI 10.1038/jhg.2009.112; Wu SM, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-115; Yanaba K, 2004, J LEUKOCYTE BIOL, V76, P374, DOI 10.1189/jlb.1203650; Yanaba K, 2003, AM J PATHOL, V162, P1463, DOI 10.1016/S0002-9440(10)64279-4; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778; Zhai RH, 2010, J CLIN ONCOL, V28, P2445, DOI 10.1200/JCO.2009.26.2790; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5; ZYLKA-WLOSZCZYK M, 1991, Medycyna Pracy, V42, P327	40	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73254	10.1371/journal.pone.0073254	http://dx.doi.org/10.1371/journal.pone.0073254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066042	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000023
J	Bystrom, J; Thomson, SJ; Johansson, J; Edin, ML; Zeldin, DC; Gilroy, DW; Smith, AM; Bishop-Bailey, D				Bystrom, Jonas; Thomson, Scott J.; Johansson, Jorgen; Edin, Matthew L.; Zeldin, Darryl C.; Gilroy, Derek W.; Smith, Andrew M.; Bishop-Bailey, David			Inducible CYP2J2 and Its Product 11,12-EET Promotes Bacterial Phagocytosis: A Role for CYP2J2 Deficiency in the Pathogenesis of Crohn's Disease?	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; ULCERATIVE-COLITIS; ACUTE-INFLAMMATION; SMOOTH-MUSCLE; IN-VITRO; CYTOCHROME-P450; EXPRESSION; RECEPTOR; METABOLITES; INHIBITORS	The epoxygenase CYP2J2 has an emerging role in inflammation and vascular biology. The role of CYP2J2 in phagocytosis is not known and its regulation in human inflammatory diseases is poorly understood. Here we investigated the role of CYP2J2 in bacterial phagocytosis and its expression in monocytes from healthy controls and Crohns disease patients. CYP2J2 is anti-inflammatory in human peripheral blood monocytes. Bacterial LPS induced CYP2J2 mRNA and protein. The CYP2J2 arachidonic acid products 11,12-EET and 14,15-EET inhibited LPS induced TNF alpha release. THP-1 monocytes were transformed into macrophages by 48h incubation with phorbol 12-myristate 13-acetate. Epoxygenase inhibition using a non-selective inhibitor SKF525A or a selective CYP2J2 inhibitor Compound 4, inhibited E. coli particle phagocytosis, which could be specifically reversed by 11,12-EET. Moreover, epoxygenase inhibition reduced the expression of phagocytosis receptors CD11b and CD68. CD11b also mediates L. monocytogenes phagocytosis. Similar, to E. coli bioparticle phagocytosis, epoxygenase inhibition also reduced intracellular levels of L. monocytogenes, which could be reversed by co-incubation with 11,12-EET. Disrupted bacterial clearance is a hallmark of Crohn's disease. Unlike macrophages from control donors, macrophages from Crohn's disease patients showed no induction of CYP2J2 in response to E. coli. These results demonstrate that CYP2J2 mediates bacterial phagocytosis in macrophages, and implicates a defect in the CYP2J2 pathway may regulate bacterial clearance in Crohn's disease.	[Bystrom, Jonas] Queen Mary Univ, William Harvey Res Inst, London, England; [Thomson, Scott J.; Bishop-Bailey, David] Univ London Royal Vet Coll, London, England; [Johansson, Jorgen] Umea Univ, Dept Mol Biol, Umea, Sweden; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Gilroy, Derek W.; Smith, Andrew M.] UCL, Dept Med, London, England	University of London; Queen Mary University London; University of London; University of London Royal Veterinary College; Umea University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; University College London	Bishop-Bailey, D (corresponding author), Univ London Royal Vet Coll, London, England.	dbishopbailey@rvc.ac.uk	Edin, Matthew/AAI-1934-2019; Zeldin, Darryl C/Y-7091-2018; Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020	Zeldin, Darryl C/0000-0002-2087-7307; Gilroy, Derek/0000-0003-3476-0844; Johansson, Jorgen/0000-0002-0904-497X; Edin, Matthew/0000-0002-7042-500X; Bishop-Bailey, David/0000-0003-2455-596X; Smith, Andrew/0000-0002-4691-5973	British Heart Foundation [PG/08/070/25464, PG/11/39/28890]; Intramural Research Programs of the National Institutes of Health, NIEHS; ERC [260764-RNAntibiotics]	British Heart Foundation(British Heart Foundation); Intramural Research Programs of the National Institutes of Health, NIEHS; ERC(European Research Council (ERC)European Commission)	This work was funded by grants from the British Heart Foundation (PG/08/070/25464; PG/11/39/28890), and the Intramural Research Programs of the National Institutes of Health, NIEHS (D.C.Z.). JJ was funded by ERC Starting Grant 260764-RNAntibiotics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari A, 2013, PROSTAGLAND IN PRESS; BAIN B, 1972, TRANSPLANT P, V4, P163; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Bishop-Bailey D, 2002, CIRC RES, V91, P210, DOI 10.1161/01.RES.0000029080.15742.85; Bishop-Bailey D, 1998, ARTERIOSCL THROM VAS, V18, P1655, DOI 10.1161/01.ATV.18.10.1655; Bystrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026591; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Capdevila JH, 2000, J LIPID RES, V41, P163; daSilva RP, 1996, BIOCHEM SOC T, V24, P220, DOI 10.1042/bst0240220; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; DREVETS DA, 1993, J IMMUNOL, V151, P5431; Ehlers MR, 2000, INFLAMM BOWEL DIS, V2, P289; Glaser P, 2001, SCIENCE, V294, P849; HARVEY RF, 1980, LANCET, V1, P514; Herse F, 2012, CIRCULATION, V126, P2990, DOI 10.1161/CIRCULATIONAHA.112.127340; Kundu S, 2013, J LIPID RES, V54, P436, DOI 10.1194/jlr.M031914; Lafite P, 2006, BIOORG MED CHEM LETT, V16, P2777, DOI 10.1016/j.bmcl.2006.02.004; Lafite P, 2007, ARCH BIOCHEM BIOPHYS, V464, P155, DOI 10.1016/j.abb.2007.03.028; LIU Y, 1995, GASTROENTEROLOGY, V108, P1396, DOI 10.1016/0016-5085(95)90687-8; Ma JX, 1998, GENOMICS, V49, P152, DOI 10.1006/geno.1998.5235; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Nakayama K, 2008, LIFE SCI, V83, P339, DOI 10.1016/j.lfs.2008.06.026; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Vainer B, 2000, AM J SURG PATHOL, V24, P1115, DOI 10.1097/00000478-200008000-00009; Werner K, 2002, PROSTAG LEUKOTR ESS, V67, P397, DOI 10.1054/plef.2002.0449; Williams Geoffrey, 2005, Can J Infect Dis Med Microbiol, V16, P289; Willson KJ, 2012, MED J AUSTRALIA, V197, P466, DOI 10.5694/mja11.10521; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Wu S, 1996, J BIOL CHEM, V271, P3460; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang WY, 2013, MOL CARCINOGEN, V52, P726, DOI 10.1002/mc.21918; Zhang WY, 2012, DIGEST DIS SCI, V57, P2580, DOI 10.1007/s10620-012-2217-1	39	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75107	10.1371/journal.pone.0075107	http://dx.doi.org/10.1371/journal.pone.0075107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058654	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400109
J	Gehrt, SD; Wilson, EC; Brown, JL; Anchor, C				Gehrt, Stanley D.; Wilson, Evan C.; Brown, Justin L.; Anchor, Chris			Population Ecology of Free-Roaming Cats and Interference Competition by Coyotes in Urban Parks	PLOS ONE			English	Article							FERAL CATS; HABITAT USE; HOME-RANGE; STRIPED SKUNKS; HOUSE CATS; SURVIVAL; PATTERNS; ENVIRONMENT; DENSITIES; SUBURBAN	Free-roaming cats are a common element of urban landscapes worldwide, often causing controversy regarding their impacts on ecological systems and public health. We monitored cats within natural habitat fragments in the Chicago metropolitan area to characterize population demographics, disease prevalence, movement patterns and habitat selection, in addition to assessing the possible influence of coyotes on cats. The population was dominated by adults of both sexes, and 24% of adults were in reproductive condition. Annual survival rate was relatively high (S=0.70, SE=0.10), with vehicles and predation the primary causes of death. Size of annual home range varied by sex, but not reproductive status or body weight. We observed partitioning of the landscape by cats and coyotes, with little interspecific overlap between core areas of activity. Coyotes selected for natural habitats whereas cats selected for developed areas such as residences. Free-roaming cats were in better condition than we predicted, but their use of natural habitat fragments, and presumably their ecological impact, appeared to be limited by coyotes through intraguild competition.	[Gehrt, Stanley D.; Wilson, Evan C.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Gehrt, Stanley D.; Brown, Justin L.] Max McGraw Wildlife Fdn, Dundee, IL USA; [Anchor, Chris] Forest Preserve Dist Cook, Elgin, IL USA	University System of Ohio; Ohio State University	Gehrt, SD (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	gehrt.1@osu.edu		Wilson, Evan/0000-0002-7294-6300	Cook County Animal and Rabies Control	Cook County Animal and Rabies Control	Funding was provided by Cook County Animal and Rabies Control (www.cookcountygov.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P.J., 2010, URBAN CARNIVORES ECO, P157; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Bekoff M., 2003, WILD MAMMALS N AM BI; Bevins SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031403; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calver MC, 2011, BIOL CONSERV, V144, P1895, DOI 10.1016/j.biocon.2011.04.015; Conner L. Mike, 2001, P275, DOI 10.1016/B978-012497781-5/50011-6; Crooks Kevin R., 2010, P185; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Edwards GP, 2002, AUSTRAL ECOL, V27, P26, DOI 10.1046/j.1442-9993.2002.01156.x; Ferreira JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025970; Gehrt S.D., 2011, CITIES ENV, V4, P1, DOI DOI 10.15365/CATE.4132011; Gehrt SD, 2005, J MAMMAL, V86, P1164, DOI 10.1644/04-MAMM-A-173R2.1; Gehrt Stanley D., 2010, P79; Gehrt SD, 2010, J WILDLIFE DIS, V46, P335, DOI 10.7589/0090-3558-46.2.335; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Graser WH, 2012, J WILDLIFE MANAGE, V76, P976, DOI 10.1002/jwmg.344; Grubbs SE, 2009, J WILDLIFE MANAGE, V73, P683, DOI 10.2193/2008-033; Hall LS, 2000, MAMMALIA, V64, P19, DOI 10.1515/mamm.2000.64.1.19; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Horn JA, 2011, J WILDLIFE MANAGE, V75, P1177, DOI 10.1002/jwmg.145; Hunter J, 2008, ETHOL ECOL EVOL, V20, P295, DOI 10.1080/08927014.2008.9522514; Jessup DA, 2004, JAVMA-J AM VET MED A, V225, P1377, DOI 10.2460/javma.2004.225.1377; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kays RW, 2004, ANIM CONSERV, V7, P273, DOI 10.1017/S1367943004001489; Lappin M, 1999, IN PRACTICE, V21, P578, DOI 10.1136/inpract.21.10.578; Longcore T, 2009, CONSERV BIOL, V23, P887, DOI 10.1111/j.1523-1739.2009.01174.x; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Schmidt PM, 2007, J WILDLIFE MANAGE, V71, P915, DOI 10.2193/2006-066; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; United States Census, 2010, STAT COUNT QUICK FAC; Wang YQ, 2001, CONSERV BIOL, V15, P835, DOI 10.1046/j.1523-1739.2001.015004835.x; Willingham A.N., 2008, THESIS OHIO STATE U	41	60	64	1	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75718	10.1371/journal.pone.0075718	http://dx.doi.org/10.1371/journal.pone.0075718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058699	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400119
J	Picca, A; Pesce, V; Fracasso, F; Joseph, AM; Leeuwenburgh, C; Lezza, AMS				Picca, Anna; Pesce, Vito; Fracasso, Flavio; Joseph, Anna-Maria; Leeuwenburgh, Christiaan; Lezza, Angela M. S.			Aging and Calorie Restriction Oppositely Affect Mitochondrial Biogenesis through TFAM Binding at Both Origins of Mitochondrial DNA Replication in Rat Liver	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-A; HEAVY-STRAND PROMOTER; PEROXIREDOXIN-III; PHENOTYPIC ALTERATIONS; OXIDATIVE STRESS; SKELETAL-MUSCLE; AGE; EXPRESSION; BRAIN; NEURODEGENERATION	Aging affects mitochondria in a tissue-specific manner. Calorie restriction (CR) is, so far, the only intervention able to delay or prevent the onset of several age-related changes also in mitochondria. Using livers from middle age (18-month-old), 28-month-old and 32-month-old ad libitum-fed and 28-month-old calorie-restricted rats we found an age-related decrease in mitochondrial DNA (mtDNA) content and mitochondrial transcription factor A (TFAM) amount, fully prevented by CR. We revealed also an age-related decrease, completely prevented by CR, for the proteins PGC-1 alpha NRF-1 and cytochrome c oxidase subunit IV, supporting the efficiency of CR to forestall the age-related decrease in mitochondrial biogenesis. Furthermore, CR counteracted the age-related increase in oxidative damage to proteins, represented by the increased amount of oxidized peroxiredoxins (PRX-SO3) in the ad libitum-fed animals. An unexpected age-related decrease in the mitochondrial proteins peroxiredoxin III (Prx III) and superoxide dismutase 2 (SOD2), usually induced by increased ROS and involved in mitochondrial biogenesis, suggested a prevailing relevance of the age-reduced mitochondrial biogenesis above the induction by ROS in the regulation of expression of these genes with aging. The partial prevention of the decrease in Prx III and SOD2 proteins by CR also supported the preservation of mitochondrial biogenesis in the anti-aging action of CR. To investigate further the age- and CR-related effects on mitochondrial biogenesis we analyzed the in vivo binding of TFAM to specific mtDNA regions and demonstrated a marked increase in the TFAM-bound amounts of mtDNA at both origins of replication with aging, fully prevented by CR. A novel, positive correlation between the paired amounts of TFAM-bound mtDNA at these sub-regions was found in the joined middle age ad libitum-fed and 28-month-old calorie-restricted groups, but not in the 28-month-old ad libitum-fed counterpart suggesting a quite different modulation of TFAM binding at both origins of replication in aging and CR.	[Picca, Anna; Joseph, Anna-Maria; Leeuwenburgh, Christiaan] Univ Florida, Div Biol Aging, Inst Aging, Dept Aging & Geriatr Res, Gainesville, FL USA; [Pesce, Vito; Fracasso, Flavio; Lezza, Angela M. S.] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy	State University System of Florida; University of Florida; Universita degli Studi di Bari Aldo Moro	Lezza, AMS (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	angelamariaserena.lezza@uniba.it	Picca, Anna/K-2305-2018	Picca, Anna/0000-0001-7032-3487; Leeuwenburgh, Christiaan/0000-0003-0826-4257; PESCE, VITO/0000-0002-9148-3129	University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center [1 P30 AG028740];  [NIA R01 AG17994]; NATIONAL INSTITUTE ON AGING [P30AG028740, R01AG017994] Funding Source: NIH RePORTER	University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to CL (NIA R01 AG17994), the University of Florida Institute on Aging and the Claude D. Pepper Older Americans Independence Center (1 P30 AG028740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje; Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009; Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211; Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5; Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x; Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164; Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2010.3766, 10.1089/ars.2011.3952]; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lezza Angela M S, 2012, [Frontiers in Biology, 生物学前沿], V7, P30; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008; MIGUEL J, 1986, ALAN REV LISS, P51; Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Navarro A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00034; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2; Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715; Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICCA A, 2012, DORDR AGE       0904, DOI DOI 10.1007/S11357-012-9465-Z; Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X; Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109	57	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74644	10.1371/journal.pone.0074644	http://dx.doi.org/10.1371/journal.pone.0074644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058615	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400092
J	Schirmer, S; Ritter, RG; Fansa, H				Schirmer, Steffen; Ritter, Ralf-Gerhard; Fansa, Hisham			Vascular Surgery, Microsurgery and Supramicrosurgery for Treatment of Chronic Diabetic Foot Ulcers to Prevent Amputations	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATIONS; BREVIS MUSCLE FLAP; PERIPHERAL NEUROPATHY; CHRONIC OSTEOMYELITIS; PERFORATOR FLAP; LOWER LEG; RECONSTRUCTION; REVASCULARIZATION; DECOMPRESSION; INFECTIONS	Introduction: Diabetic foot ulcers occur in approximately 2,5% of patients suffering from diabetes and may lead to major infections and amputation. Such ulcers are responsible for a prolonged period of hospitalization and comorbidities caused by infected diabetic foot ulcers. Small, superficial ulcers can be treated by special conservative means. However, exposed bones or tendons require surgical intervention in order to prevent osteomyelitis. In many cases reconstructive surgery is necessary, sometimes in combination with revascularization of the foot. There are studies on non surgical treatment of the diabetic foot ulcer. Most of them include patients, classified Wagner 1-2 without infection. Patients presenting Wagner 3D and 4D however are at a higher risk of amputation. The evolution of microsurgery has extended the possibilities of limb salvage. Perforator based flaps can minimize the donorsite morbidity. Patients and Methods: 41 patients were treated with free tissue transfer for diabetic foot syndrome and chronic defects. 44 microvascular flaps were needed. The average age of patients was 64.3 years. 18 patients needed revascularization. 3 patients needed 2 microvascular flaps. In 6 cases supramicrosurgical technique was used. Results: There were 2 flap losses leading to amputation. 4 other patients required amputation within 6 months postoperatively due to severe infection or bypass failure. Another 4 patients died within one year after reconstruction. The remaining patients were ambulated. Discussion: Large defects of the foot can be treated by free microvascular myocutaneous or fasciocutaneous tissue transfer. If however, small defects, exposing bones or tendons, are not eligible for local flaps, small free microvascular flaps can be applied. These flaps cause a very low donor site morbidity. Arterialized venous flaps are another option for defect closure. Amputation means reduction of quality of life and can lead to an increased mortality postoperatively.	[Schirmer, Steffen; Fansa, Hisham] Klinikum Bielefeld, Dept Plast Reconstruct & Aesthet Surg, Bielefeld, North Rhine Wes, Germany; [Ritter, Ralf-Gerhard] Klinikum Bielefeld, Dept Vasc & Endovasc Surg, Bielefeld, North Rhine Wes, Germany		Schirmer, S (corresponding author), Klinikum Bielefeld, Dept Plast Reconstruct & Aesthet Surg, Bielefeld, North Rhine Wes, Germany.	steffenschirmer@web.de		Fansa, Hisham/0000-0003-4532-8408				Aksoy DY, 2004, EXP CLIN ENDOCR DIAB, V112, P526, DOI 10.1055/s-2004-821310; [Anonymous], 1990, Diabet Med, V7, P360; Armstrong David G, 2004, Int Wound J, V1, P123, DOI 10.1111/j.1742-4801.2004.00035.x; Bach AD, 2007, ANN PLAS SURG, V58, P397, DOI 10.1097/01.sap.0000239842.24021.e4; Chien SH, 2011, PLAST RECONSTR SURG, V127, P1222, DOI 10.1097/PRS.0b013e318205f461; Cruz CP, 2003, AM J SURG, V186, P449, DOI 10.1016/j.amjsurg.2003.07.027; Dellon AL, 2012, J RECONSTR MICROSURG, V28, P241, DOI 10.1055/s-0032-1306372; DELLON AL, 1992, PLAST RECONSTR SURG, V89, P689, DOI 10.1097/00006534-199204000-00018; Descamps-Latscha B, 1993, Curr Opin Nephrol Hypertens, V2, P883, DOI 10.1097/00041552-199311000-00005; Fansa H, 2006, UNFALLCHIRURG, V109, P453, DOI 10.1007/s00113-006-1077-6; Ghali S, 2009, PLAST RECONSTR SURG, V123, P1157, DOI 10.1097/PRS.0b013e31819f25a4; Hong JP, 2009, PLAST RECONSTR SURG, V123, P230, DOI 10.1097/PRS.0b013e3181904dc4; Hong JP, 2006, PLAST RECONSTR SURG, V117, P1599, DOI 10.1097/01.prs.0000207057.16292.8f; Hong JP, 2005, PLAST RECONSTR SURG, V115, P142, DOI 10.1097/01.PRS.0000138750.54859.AC; Hunt NA, 2011, PLAST RECONSTR SURG, V127, p289S, DOI 10.1097/PRS.0b013e3181fbe2a6; Illig KA, 2001, J VASC SURG, V33, P17, DOI 10.1067/mva.2001.112301; Kim JY, 2007, J RECONSTR MICROSURG, V23, P373, DOI 10.1055/s-2007-992345; Koshima I, 1998, PLAST RECONSTR SURG, V102, P1052, DOI 10.1097/00006534-199809040-00020; Kuo YR, 2001, PLAST RECONSTR SURG, V107, P1766, DOI 10.1097/00006534-200106000-00019; Lipsky BA, 2006, PLAST RECONSTR SURG, V117, p212S, DOI 10.1097/01.prs.0000222737.09322.77; Lorenzetti F, 2001, EUR J VASC ENDOVASC, V22, P161, DOI 10.1053/ejvs.2001.1419; Mahmoodi BK, 2008, CIRCULATION, V117, P224, DOI 10.1161/CIRCULATIONAHA.107.716951; Malikov S, 2009, ANN VASC SURG, V23, P745, DOI 10.1016/j.avsg.2009.09.002; Musharrafieh R, 2003, MICROSURG, V23, P257, DOI 10.1002/micr.10118; NAKAYAMA Y, 1981, PLAST RECONSTR SURG, V67, P328, DOI 10.1097/00006534-198103000-00009; Nehler MR, 2003, J VASC SURG, V38, P7, DOI 10.1016/S0741-5214(03)00092-2; Neville RF, 2011, PLAST RECONSTR SURG, V127, p154S, DOI 10.1097/PRS.0b013e3182006ea3; O'Loughlin A, 2010, INT J LOW EXTR WOUND, V9, P90, DOI 10.1177/1534734610371600; Rao NL, 2011, PLAST RECONSTR SURG, V127, p177S, DOI 10.1097/PRS.0b013e3182001f0f; Rozina SA, 2005, PLAST RECONSTR SURG, V115, P464, DOI [10.1097/01.PRS.0000149481.73952.F3, DOI 10.1097/01.PRS.0000149481.73952.F3.PUBMED:15692351]; Santanelli F, 2002, Minerva Chir, V57, P289; Santanelli F, 2002, PLAST RECONSTR SURG, V109, P2314, DOI 10.1097/00006534-200206000-00023; Scherer SS, 2012, PLAST RECONSTR SURG, V129, p46E, DOI 10.1097/PRS.0b013e3182362010; Schirmer S, 2011, HANDCHIR MIKROCHIR P, V43, P338, DOI 10.1055/s-0031-1273685; Schmidt AB, 2010, PLAST RECONSTR SURG, V126, P924, DOI 10.1097/PRS.0b013e3181e3b74d; Smith IM, 2006, J PLAST RECONSTR AES, V59, P11, DOI 10.1016/j.bjps.2005.07.002; Stone Patrick A, 2007, W V Med J, V103, P14; Valdivia JMV, 2005, J AM PODIAT MED ASSN, V95, P451, DOI 10.7547/0950451; Vuorisalo S, 2009, J CARDIOVASC SURG, V50, P275; Woo SH, 2007, PLAST RECONSTR SURG, V119, P1823, DOI 10.1097/01.prs.0000259094.68803.3d; Zhang WC, 2013, J NEUROL SURG PART A, V74, P96, DOI 10.1055/s-0032-1320029	41	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74704	10.1371/journal.pone.0074704	http://dx.doi.org/10.1371/journal.pone.0074704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058622	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400094
J	Bjarnarson, SP; Benonisson, H; Del Giudice, G; Jonsdottir, I				Bjarnarson, Stefania P.; Benonisson, Hreinn; Del Giudice, Giuseppe; Jonsdottir, Ingileif			Pneumococcal Polysaccharide Abrogates Conjugate-Induced Germinal Center Reaction and Depletes Antibody Secreting Cell Pool, Causing Hyporesponsiveness	PLOS ONE			English	Article							SEROTYPE-SPECIFIC HYPORESPONSIVENESS; HEAT-LABILE ENTEROTOXIN; SPLENIC MARGINAL ZONE; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; IMMUNOLOGICAL PARALYSIS; IMMUNE-RESPONSES; DENDRITIC CELLS; VACCINE; IMMUNOGENICITY	Background: Plain pneumococcal polysaccharide (PPS) booster administered during second year of life has been shown to cause hyporesponsiveness. We assessed the effects of PPS booster on splenic memory B cell responses and persistence of PPS-specific long-lived plasma cells in the bone marrow (BM). Methods: Neonatal mice were primed subcutanously (s.c.) or intranasally (i.n.) with pneumococcal conjugate (Pnc1-TT) and the adjuvant LT-K63, and boosted with PPS+LT-K63 or saline 1, 2 or 3 times with 16 day intervals. Seven days after each booster, spleens were removed, germinal centers (GC), IgM(+), IgG(+) follicles and PPS-specific antibody secreting cells (AbSC) in spleen and BM enumerated. Results: PPS booster s.c., but not i.n., compromised the Pnc1-TT-induced PPS-specific Abs by abrogating the Pnc1-TT-induced GC reaction and depleting PPS-specific AbSCs in spleen and limiting their homing to the BM. There was no difference in the frequency of PPS-specific AbSCs in spleen and BM between mice that received 1, 2 or 3 PPS boosters s. c.. Repeated PPS+LT-K63 booster i.n. reduced the frequency of PPS-specific IgG(+) AbSCs in BM. Conclusions: PPS booster-induced hyporesponsiveness is caused by abrogation of conjugate-induced GC reaction and depletion of PPS-specific IgG(+) AbSCs resulting in no homing of new PPS-specific long-lived plasma cells to the BM or survival. These results should be taken into account in design of vaccination schedules where polysaccharides are being considered.	[Bjarnarson, Stefania P.; Benonisson, Hreinn; Jonsdottir, Ingileif] Natl Univ Hosp Iceland, Landspitali, Dept Immunol, Reykjavik, Iceland; [Bjarnarson, Stefania P.; Benonisson, Hreinn; Jonsdottir, Ingileif] Univ Iceland, Fac Med, Reykjavik, Iceland; [Del Giudice, Giuseppe] Novartis Vaccines & Diagnost, Siena, Italy; [Jonsdottir, Ingileif] DeCODE Genet, Reykjavik, Iceland	Landspitali National University Hospital; University of Iceland; Novartis	Jonsdottir, I (corresponding author), Natl Univ Hosp Iceland, Landspitali, Dept Immunol, Reykjavik, Iceland.	ingileif@landspitali.is		Bjarnarson, Stefania P/0000-0003-3823-6329	Icelandic Research Fund for Graduate Students [50940005]; Icelandic Research Fund [40438021-23]; Eimskip University Fund; University of Iceland Research Fund; Landspitali University Hospital Research Fund	Icelandic Research Fund for Graduate Students; Icelandic Research Fund; Eimskip University Fund; University of Iceland Research Fund; Landspitali University Hospital Research Fund	This work was supported by The Icelandic Research Fund for Graduate Students (nr. 50940005), The Icelandic Research Fund (40438021-23), Eimskip University Fund, University of Iceland Research Fund and Landspitali University Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman H, 1998, PEDIATR INFECT DIS J, V17, P211, DOI 10.1097/00006454-199803000-00008; Andreo F, 2009, EUR J CLIN MICROBIOL, V28, P197, DOI 10.1007/s10096-008-0606-3; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; [Anonymous], 2012, WKLY EPIDEMIOL REC; Anttila M, 1999, VACCINE, V17, P1970, DOI 10.1016/S0264-410X(98)00458-7; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Benonisson H, 2012, POLYSACCHARIDE INDUC; Bjarnarson SP, 2005, EUR J IMMUNOL, V35, P1037, DOI 10.1002/eji.200425850; Bjarnarson SP, 2012, J IMMUNOL, V189, P1265, DOI 10.4049/jimmunol.1200761; Blum MD, 2000, VACCINE, V18, P2359, DOI 10.1016/S0264-410X(00)00021-9; Borrow R, 2008, INFECT IMMUN, V76, P5305, DOI 10.1128/IAI.00796-08; Breukels MA, 2005, SCAND J IMMUNOL, V61, P322, DOI 10.1111/j.1365-3083.2005.01584.x; BRODEUR PH, 1980, J IMMUNOL, V125, P1499; Brynjolfsson SF, 2012, J INFECT DIS, V205, P422, DOI 10.1093/infdis/jir750; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1053, DOI 10.1097/00006454-199711000-00010; Dagan R, 2010, J INFECT DIS, V201, P1570, DOI 10.1086/652006; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Ekstrom N, 2007, INFECT IMMUN, V75, P1794, DOI 10.1128/IAI.01673-06; FELTON LD, 1955, J IMMUNOL, V74, P17; Francis JP, 2009, CLIN VACCINE IMMUNOL, V16, P1633, DOI 10.1128/CVI.00247-09; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11; Granoff DM, 2007, PEDIATR INFECT DIS J, V26, P716, DOI 10.1097/INF.0b013e3180cc2c25; GRIFFIOEN AW, 1991, INFECT IMMUN, V59, P1839, DOI 10.1128/IAI.59.5.1839-1845.1991; Guttormsen HK, 1998, INFECT IMMUN, V66, P2026, DOI 10.1128/IAI.66.5.2026-2032.1998; Hamer DH, 2002, CLIN INFECT DIS, V34, P1025, DOI 10.1086/339446; Jakobsen H, 2002, INFECT IMMUN, V70, P1443, DOI 10.1128/IAI.70.3.1443-1452.2002; JOHNSTON RB, 1979, PEDIATRICS, V64, P781; Jonsdottir I, 2007, J COMP PATHOL, V137, pS20, DOI 10.1016/j.jcpa.2007.04.007; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; KOSKELA M, 1986, PEDIATR INFECT DIS J, V5, P45, DOI 10.1097/00006454-198601000-00009; Licciardi PV, 2012, J ALLERGY CLIN IMMUN, V129, P794, DOI 10.1016/j.jaci.2011.11.043; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MOSIER DE, 1975, J EXP MED, V141, P216, DOI 10.1084/jem.141.1.216; MUSHER DM, 1993, CLIN INFECT DIS, V17, P66, DOI 10.1093/clinids/17.1.66; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; O'Grady KAF, 2010, CLIN INFECT DIS, V50, P970, DOI 10.1086/651079; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; PICHICHERO ME, 1985, LANCET, V2, P468; Pihlgren M, 2003, J IMMUNOL, V170, P2824, DOI 10.4049/jimmunol.170.6.2824; Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586/ERV.11.8, 10.1586/erv.11.8]; Robbins J B, 1996, Adv Exp Med Biol, V397, P169; Rodenburg GD, 2011, J PEDIATR-US, V159, P965, DOI 10.1016/j.jpeds.2011.06.011; Russell FM, 2011, VACCINE, V29, P535, DOI 10.1016/j.vaccine.2010.10.046; Russell FM, 2010, VACCINE, V28, P3341, DOI 10.1016/j.vaccine.2010.02.087; Russell FM, 2010, VACCINE, V28, P3086, DOI 10.1016/j.vaccine.2010.02.065; Sigurdardottir ST, 2002, PEDIATR INFECT DIS J, V21, P548, DOI 10.1097/00006454-200206000-00013; Sigurdardottir ST, 2003, EFFECT PNEUMOCOCCAL; Sigurdardottir ST, 2012, NUMBER INFANT PCV DO; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; SZU SC, 1994, INFECT IMMUN, V62, P4440, DOI 10.1128/IAI.62.10.4440-4444.1994; Truck J, 2012, IMMUNOBIOLOGY; Vakevainen M, 2010, J PEDIATR-US, V157, P778, DOI 10.1016/j.jpeds.2010.04.071; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; You Y, 2011, J IMMUNOL, V186, P2172, DOI 10.4049/jimmunol.1002106; Zandvoort A, 2001, TISSUE ANTIGENS, V58, P234, DOI 10.1034/j.1399-0039.2001.580403.x	64	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72588	10.1371/journal.pone.0072588	http://dx.doi.org/10.1371/journal.pone.0072588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069152	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100012
J	Dutriaux, A; Godart, A; Brachet, A; Silber, J				Dutriaux, Annie; Godart, Aurelie; Brachet, Anna; Silber, Joel			The Insulin Receptor Is Required for the Development of the Drosophila Peripheral Nervous System	PLOS ONE			English	Article							FINGER TRANSCRIPTION FACTOR; TUBEROUS SCLEROSIS COMPLEX; GROWTH-FACTOR RECEPTOR; EGF-RECEPTOR; CELL-GROWTH; ORGAN DEVELOPMENT; GENE-EXPRESSION; NOTCH; ENHANCER; SPLIT	The Insulin Receptor (InR) in Drosophila presents features conserved in its mammalian counterparts. InR is required for growth; it is expressed in the central and embryonic nervous system and modulates the time of differentiation of the eye photoreceptor without altering cell fate. We show that the InR is required for the formation of the peripheral nervous system during larval development and more particularly for the formation of sensory organ precursors (SOPs) on the fly notum and scutellum. SOPs arise in the proneural cluster that expresses high levels of the proneural proteins Achaete (Ac) and Scute (Sc). The other cells will become epidermis due to lateral inhibition induced by the Notch (N) receptor signal that prevents its neighbors from adopting a neural fate. In addition, misexpression of the InR or of other components of the pathway (PTEN, Akt, FOXO) induces the development of an abnormal number of macrochaetes that are Drosophila mechanoreceptors. Our data suggest that InR regulates the neural genes ac, sc and sens. The FOXO transcription factor which is localized in the cytoplasm upon insulin uptake, displays strong genetic interaction with the InR and is involved in Ac regulation. The genetic interactions between the epidermal growth factor receptor (EGFR), Ras and InR/FOXO suggest that these proteins cooperate to induce neural gene expression. Moreover, InR/FOXO is probably involved in the lateral inhibition process, since genetic interactions with N are highly significant. These results show that the InR can alter cell fate, independently of its function in cell growth and proliferation.	[Dutriaux, Annie; Godart, Aurelie; Brachet, Anna; Silber, Joel] Univ Paris Diderot, IJM, UMR CNRS 7592, Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Silber, J (corresponding author), Univ Paris Diderot, IJM, UMR CNRS 7592, Sorbonne Paris Cite, Paris, France.	joel.silber@univ-paris-diderot.fr		Brachet, Anna/0000-0001-5672-4153; Dutriaux, Annie/0000-0002-4398-4850				Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; ARTAVANISTSAKONAS S, 1991, ANNU REV CELL BIOL, V7, P427; Asha H, 2003, GENETICS, V163, P203; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bateman JM, 2006, CELL MOL LIFE SCI, V63, P1701, DOI 10.1007/s00018-006-6036-4; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; BONDY CA, 1990, MOL ENDOCRINOL, V4, P1386, DOI 10.1210/mend-4-9-1386; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Buff E, 1998, DEVELOPMENT, V125, P2075; CLIFFORD RJ, 1989, GENETICS, V123, P771; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Culi J, 2001, DEVELOPMENT, V128, P299; Delanoue R, 2004, CELL DEATH DIFFER, V11, P110, DOI 10.1038/sj.cdd.4401321; DIAZBENJUMEA FJ, 1990, P ROY SOC B-BIOL SCI, V242, P36, DOI 10.1098/rspb.1990.0100; Escudero LM, 2005, DEVELOPMENT, V132, P1211, DOI 10.1242/dev.01691; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Heitzler P, 1996, DEVELOPMENT, V122, P161; Heitzler P, 1996, GENETICS, V143, P1271; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Huang H, 1999, DEVELOPMENT, V126, P5365; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; Mattila J, 2008, P NATL ACAD SCI USA, V105, P14873, DOI 10.1073/pnas.0803022105; McNeill H, 2008, GENETICS, V179, P843, DOI 10.1534/genetics.107.083097; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Oldham S, 2002, DEVELOPMENT, V129, P4103; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Simon F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000594; SIMPSON P, 1990, TRENDS GENET, V6, P343, DOI 10.1016/0168-9525(90)90260-D; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; USUI K, 1992, DEVELOPMENT, V116, P601; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; XU T, 1993, DEVELOPMENT, V117, P1223	55	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e71857	10.1371/journal.pone.0071857	http://dx.doi.org/10.1371/journal.pone.0071857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069139	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100004
J	Ghosh, BCP; Carpenter, RHS; Rowe, JB				Ghosh, Boyd C. P.; Carpenter, Roger H. S.; Rowe, James B.			A Longitudinal Study of Motor, Oculomotor and Cognitive Function in Progressive Supranuclear Palsy	PLOS ONE			English	Article							RICHARDSON-OLSZEWSKI SYNDROME; DETERMINING SAMPLE-SIZE; NATURAL-HISTORY; CLINICAL-FEATURES; SUBCORTICAL DEMENTIA; DIAGNOSTIC-CRITERIA; BRAIN ATROPHY; BASAL GANGLIA; SURVIVAL; DEGENERATION	Objective: We studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials and to illuminate the progression of pathophysiology. Methods: Twenty three patients with progressive supranuclear palsy (Richardson's syndrome) were compared to 22 matched controls at baseline and 16 of these patients compared at baseline and one year using: the progressive supranuclear palsy rating scale; the unified Parkinson's disease rating scale; the revised Addenbrooke's cognitive examination; the frontal assessment battery; the cubes section of the visual object and space perception battery; the Hayling and Brixton executive tests; and saccadic latencies. Results: Patients were significantly impaired in all domains at baseline. However, cognitive performance was maintained over a year on the majority of tests. The unified Parkinson's disease rating scale, saccadic latency and progressive supranuclear palsy rating scale deteriorated over a year, with the latter showing the largest change. Power estimates indicate that using the progressive supranuclear palsy rating scale as an outcome measure in a clinical trial would require 45 patients per arm, to identify a 50% reduction in rate of decline with 80% power. Conclusions: Motor, oculomotor and cognitive domains deteriorate at different rates in progressive supranuclear palsy. This may be due to differential degeneration of their respective cortical-subcortical circuits, and has major implications for the selection of outcome measures in clinical trials due to wide variation in sensitivity to annual rates of decline.	[Ghosh, Boyd C. P.] Southampton Univ Hosp NHS Trust, Wessex Neurosci Ctr, Southampton, Hants, England; [Ghosh, Boyd C. P.; Rowe, James B.] Univ Cambridge, Dept Clin Neurosci, Cambridge, Cambs, England; [Carpenter, Roger H. S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, Cambs, England; [Rowe, James B.] MRC, Cognit & Brain Sci Unit, Cambridge, Cambs, England; [Rowe, James B.] Behav & Clin Neurosci Inst, Cambridge, Cambs, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Cambridge; University of Cambridge; University of Cambridge	Ghosh, BCP (corresponding author), Southampton Univ Hosp NHS Trust, Wessex Neurosci Ctr, Southampton, Hants, England.	boydghosh@doctors.org.uk	Tick, Beata/ABA-1728-2020; Rowe, James/C-3661-2013	Rowe, James/0000-0001-7216-8679; Carpenter, Roger/0000-0003-2572-1448; Ghosh, Boyd/0000-0001-5887-9220	Medical Research Council [G0700503]; Guarantors of Brain; Raymond and Beverley Sackler Trust; Wellcome Trust [088324]; Cambridge NIHR Comprehensive Biomedical Research Centre including the Cambridge Brain Bank; Medical Research Council [G0001354, G0001354B, G1000183B, MC_U105597119] Funding Source: researchfish; MRC [G0700503, MC_U105597119] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Guarantors of Brain; Raymond and Beverley Sackler Trust; Wellcome Trust(Wellcome Trust); Cambridge NIHR Comprehensive Biomedical Research Centre including the Cambridge Brain Bank; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council [G0700503 to BG]; the Guarantors of Brain (BG); the Raymond and Beverley Sackler Trust (BG). JR is supported by the Wellcome Trust [088324] and the Cambridge NIHR Comprehensive Biomedical Research Centre including the Cambridge Brain Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ali FR, 2006, EXP BRAIN RES, V169, P237, DOI 10.1007/s00221-005-0143-6; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Brown RG, 2010, BRAIN, V133, P2382, DOI 10.1093/brain/awq158; BRUSA A, 1980, ITAL J NEUROL SCI, V1, P205; Burgess P.W., 1997, HAYLING BRIXTON TEST; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; CARPENTER RHS, 1994, J PHYSIOL-LONDON, V480P, pP4; Carrilho PEM, 2002, ARQ NEURO-PSIQUIAT, V60, P917, DOI 10.1590/S0004-282X2002000600006; Chiu WZ, 2010, J NEUROL NEUROSUR PS, V81, P441, DOI 10.1136/jnnp.2009.195719; COLLINS SJ, 1995, J NEUROL NEUROSUR PS, V58, P167, DOI 10.1136/jnnp.58.2.167; DANTONA R, 1985, BRAIN, V108, P785, DOI 10.1093/brain/108.3.785; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fahn S, 1986, RECENT DEV PARKINSON; Faul F., 1992, GPOWER PRIORI POSTHO; Ghosh BCP, 2009, J NEUROL NEUROSUR PS, V80, P1143, DOI 10.1136/jnnp.2008.155846; Goetz CG, 2003, NEUROLOGY, V60, P917, DOI 10.1212/01.WNL.0000052686.97625.27; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; GOLBE LI, 1988, NEUROLOGY, V38, P1031, DOI 10.1212/WNL.38.7.1031; Gold M, 2012, NEUROPSYCH DIS TREAT, V8, P85, DOI 10.2147/NDT.S12518; Kaat LD, 2007, NEUROLOGY, V69, P723, DOI 10.1212/01.wnl.0000267643.24870.26; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Macia F, 2003, REV NEUROL-FRANCE, V159, P31; MAHER ER, 1986, NEUROLOGY, V36, P1005, DOI 10.1212/WNL.36.7.1005; Michell AW, 2006, EXP BRAIN RES, V174, P7, DOI 10.1007/s00221-006-0412-z; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; Nath U, 2003, NEUROLOGY, V60, P910, DOI 10.1212/01.WNL.0000052991.70149.68; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; OBER JK, 2003, HAND HELD SYSTEM AMB, P187; Papapetropoulos S, 2005, PARKINSONISM RELAT D, V11, P459, DOI 10.1016/j.parkreldis.2005.06.003; Paviour DC, 2007, J NEUROL, V254, P478, DOI 10.1007/s00415-006-0396-4; Payan CAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022293; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; PIERROTDESEILLIGNY C, 1989, BRAIN, V112, P471, DOI 10.1093/brain/112.2.471; PILLON B, 1992, PROGR SUPRANUCLEAR P; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Rivaud-Pechoux S, 2000, NEUROLOGY, V54, P1029, DOI 10.1212/WNL.54.5.1029; Santacruz P, 1998, NEUROLOGY, V50, P1637, DOI 10.1212/WNL.50.6.1637; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Warrington EK., 1991, VISUAL OBJECT SPACE; Whitwell JL, 2012, PARKINSONISM RELAT D, V18, P252, DOI 10.1016/j.parkreldis.2011.10.013	45	18	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74486	10.1371/journal.pone.0074486	http://dx.doi.org/10.1371/journal.pone.0074486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058574	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000327538600095
J	Gonzales, L; Ali, ZB; Nygren, E; Wang, ZY; Karlsson, S; Zhu, BL; Quiding-Jarbrink, M; Sjoling, A				Gonzales, Lucia; Ali, Zahra Bagher; Nygren, Erik; Wang, Zhiyun; Karlsson, Stefan; Zhu, Baoli; Quiding-Jarbrink, Marianne; Sjoling, Asa			Alkaline pH Is a Signal for Optimal Production and Secretion of the Heat Labile Toxin, LT in Enterotoxigenic Escherichia Coli (ETEC)	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; CAMP RECEPTOR PROTEIN; CYCLIC-AMP LEVELS; VIBRIO-CHOLERAE; ENTERO-TOXIN; DEPENDENT REPRESSION; STABLE ENTEROTOXIN; ADENYLATE-CYCLASE; EXPRESSION; GENES	Enterotoxigenic Escherichia coli (ETEC) cause secretory diarrhea in children and travelers to endemic areas. ETEC spreads through the fecal-oral route. After ingestion, ETEC passes through the stomach and duodenum before it colonizes the lower part of the small intestine, exposing bacteria to a wide range of pH and environmental conditions. This study aimed to determine the impact of external pH and activity of the Cyclic AMP receptor protein (CRP) on the regulation of production and secretion of heat labile (LT) enterotoxin. ETEC strain E2863wt and its isogenic mutant E2863 Delta CRP were grown in LBK media buffered to pH 5, 7 and 9. GM1 ELISA, cDNA and cAMP analyses were carried out on bacterial pellet and supernatant samples derived from 3 and 5 hours growth and from overnight cultures. We confirm that CRP is a repressor of LT transcription and production as has been shown before but we show for the first time that CRP is a positive regulator of LT secretion both in vitro and in vivo. LT secretion increased at neutral to alkaline pH compared to acidic pH 5 where secretion was completely inhibited. At pH 9 secretion of LT was optimal resulting in 600 percent increase of secreted LT compared to unbuffered LBK media. This effect was not due to membrane leakage since the bacteria were viable at pH 9. The results indicate that the transition to the alkaline duodenum and/or exposure to high pH close to the epithelium as well as activation of the global transcription factor CRP are signals that induce secretion of the LT toxin in ETEC.	[Gonzales, Lucia; Ali, Zahra Bagher; Nygren, Erik; Karlsson, Stefan; Quiding-Jarbrink, Marianne; Sjoling, Asa] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Gonzales, Lucia] Univ Mayor San Andres, Inst Biol Mol & Biotecnol, La Paz, Bolivia; [Wang, Zhiyun; Zhu, Baoli] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	University of Gothenburg; Universidad Mayor de San Andres; Chinese Academy of Sciences; Institute of Microbiology, CAS	Sjoling, A (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden.	asa.sjoling@microbio.gu.se	Quiding-JÃrbrink, Marianne/AAU-5746-2021; Gonzales Strömberg, Lucia/GYQ-8934-2022	Quiding-JÃrbrink, Marianne/0000-0002-1978-8091; Gonzales Strömberg, Lucia/0000-0001-7441-8483; Nygren, Erik/0000-0001-6783-4622; Sjoling, Asa/0000-0003-1529-1720; Nordqvist, Stefan/0000-0003-4238-6004	Swedish Research Council [521-2011-3435]; Swedish Research Links [348-2011-7292]; VINNOVA [2011-03491]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Links; VINNOVA(Vinnova)	The study was funded by the Swedish Research Council (521-2011-3435), the Swedish Research Links (348-2011-7292) and VINNOVA (2011-03491) to Asa Sjoling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1985, J BIOL CHEM, V260, P3063; Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; Aoki H, 2009, MED MOL MORPHOL, V42, P40, DOI 10.1007/s00795-008-0431-x; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Bodero MD, 2009, INFECT IMMUN, V77, P791, DOI 10.1128/IAI.00928-08; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CLEMENTS JD, 1985, INFECT IMMUN, V50, P317, DOI 10.1128/IAI.50.1.317-319.1985; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jonge R, 2003, J APPL MICROBIOL, V94, P555; Findlay G, 1994, BIOCH SOC T, V22; FOREMAN DT, 1995, MOL MICROBIOL, V18, P237, DOI 10.1111/j.1365-2958.1995.mmi_18020237.x; GIBERT I, 1990, CURR MICROBIOL, V20, P83, DOI 10.1007/BF02092878; GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979; GOLDENBAUM PE, 1979, J BACTERIOL, V140, P459, DOI 10.1128/JB.140.2.459-467.1979; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Hantke K, 2011, J BACTERIOL, V193, P1086, DOI 10.1128/JB.01399-10; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HIRST TR, 1994, BIOCHEM SOC T, V22, P306, DOI 10.1042/bst0220306; HOFSTRA H, 1985, J BIOL CHEM, V260, P6037; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Kansal R, 2013, INFECT IMMUN, V81, P259, DOI 10.1128/IAI.00919-12; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Kimata K, 1997, P NATL ACAD SCI USA, V94, P12914, DOI 10.1073/pnas.94.24.12914; KUNKEL SL, 1979, INFECT IMMUN, V23, P652, DOI 10.1128/IAI.23.3.652-659.1979; Lothigius A, 2008, J APPL MICROBIOL, V104, P1128, DOI 10.1111/j.1365-2672.2007.03628.x; Ma Z, 2003, J BACTERIOL, V185, P6852, DOI 10.1128/JB.185.23.6852-6859.2003; Malhotra S, 2000, J BACTERIOL, V182, P6999, DOI 10.1128/JB.182.24.6999-7006.2000; MINAMI J, 1984, ACTA MED OKAYAMA, V38, P461; Mizumori M, 2009, J PHYSIOL-LONDON, V587, P3651, DOI 10.1113/jphysiol.2009.172270; MOSS J, 1978, J CLIN INVEST, V62, P281, DOI 10.1172/JCI109127; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; NILSSON G, 1984, NATURE, V312, P75, DOI 10.1038/312075a0; Nygren E, 2009, INFECT IMMUN, V77, P3475, DOI 10.1128/IAI.01197-08; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Lasaro MAS, 2006, FEMS IMMUNOL MED MIC, V48, P123, DOI 10.1111/j.1574-695X.2006.00134.x; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Sjoling A, 2006, MICROBES INFECT, V8, P2797, DOI 10.1016/j.micinf.2006.08.011; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Thede GL, 2011, J BACTERIOL, V193, P2149, DOI 10.1128/JB.01296-10; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; WENSINK J, 1978, BIOCHIM BIOPHYS ACTA, V514, P128, DOI 10.1016/0005-2736(78)90082-2; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wulfing C, 1997, ARCH MICROBIOL, V167, P280, DOI 10.1007/s002030050444; Yamanaka H, 1998, MICROB PATHOGENESIS, V25, P111, DOI 10.1006/mpat.1998.0211; YU J, 1992, MOL MICROBIOL, V6, P1949, DOI 10.1111/j.1365-2958.1992.tb01368.x; Zhao G, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-30; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984; Zrimi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015347	57	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74069	10.1371/journal.pone.0074069	http://dx.doi.org/10.1371/journal.pone.0074069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058516	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900030
J	Kroeger, D; Florea, B; Amzica, F				Kroeger, Daniel; Florea, Bogdan; Amzica, Florin			Human Brain Activity Patterns beyond the Isoelectric Line of Extreme Deep Coma	PLOS ONE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; BURST-SUPPRESSION; DENTATE GYRUS; ISOFLURANE ANESTHESIA; ELECTRICAL-ACTIVITY; SHARP WAVES; IN-VIVO; RAT; INHIBITION; EEG	The electroencephalogram (EEG) reflects brain electrical activity. A flat (isoelectric) EEG, which is usually recorded during very deep coma, is considered to be a turning point between a living brain and a deceased brain. Therefore the isoelectric EEG constitutes, together with evidence of irreversible structural brain damage, one of the criteria for the assessment of brain death. In this study we use EEG recordings for humans on the one hand, and on the other hand double simultaneous intracellular recordings in the cortex and hippocampus, combined with EEG, in cats. They serve to demonstrate that a novel brain phenomenon is observable in both humans and animals during coma that is deeper than the one reflected by the isoelectric EEG, and that this state is characterized by brain activity generated within the hippocampal formation. This new state was induced either by medication applied to postanoxic coma (in human) or by application of high doses of anesthesia (isoflurane in animals) leading to an EEG activity of quasi-rhythmic sharp waves which henceforth we propose to call n-complexes (Nu-complexes). Using simultaneous intracellular recordings in vivo in the cortex and hippocampus (especially in the CA3 region) we demonstrate that n-complexes arise in the hippocampus and are subsequently transmitted to the cortex. The genesis of a hippocampal n-complex depends upon another hippocampal activity, known as ripple activity, which is not overtly detectable at the cortical level. Based on our observations, we propose a scenario of how self-oscillations in hippocampal neurons can lead to a whole brain phenomenon during coma.	[Kroeger, Daniel; Amzica, Florin] Univ Montreal, Sch Dent, Dept Stomatol, Montreal, PQ, Canada; [Florea, Bogdan] Med Ctr Regina Maria, Cluj Napoca, Romania	Universite de Montreal	Amzica, F (corresponding author), Univ Montreal, Sch Dent, Dept Stomatol, Montreal, PQ, Canada.	florin.amzica@umontreal.ca		Kroeger, Daniel/0000-0002-8020-4972	Canadian Institutes for Health Research [MOP-67175]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes for Health Research, grant no. MOP-67175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1966, ACTA PHYSIOL SCAND, V66, P448, DOI 10.1111/j.1748-1716.1966.tb03223.x; AYALA GF, 1973, BRAIN RES, V52, P1, DOI 10.1016/0006-8993(73)90647-1; BISCOE TJ, 1985, Q J EXP PHYSIOL CMS, V70, P189, DOI 10.1113/expphysiol.1985.sp002902; Brenner RP, 2005, NEUROLOGIST, V11, P271, DOI 10.1097/01.nrl.0000178756.44055.f6; BRENNER RP, 1985, NEUROL CLIN, V3, P615, DOI 10.1016/S0733-8619(18)31025-9; BUZSAKI G, 1987, BRAIN RES, V400, P321, DOI 10.1016/0006-8993(87)90631-7; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHATRIAN GE, 1990, CURRENT PRACTICE CLI, P425; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Davis H, 1938, RES PUBL ASSOC RES N, V19, P50; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Dudek F E, 1986, Adv Neurol, V44, P593; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; EGER EI, 1984, BRIT J ANAESTH, V56, pS71; Fernandez de Sevilla D, 2003, EUR J NEUROSCI, V17, P555, DOI 10.1046/j.1460-9568.2003.02490.x; Ferron JF, 2009, J NEUROSCI, V29, P9850, DOI 10.1523/JNEUROSCI.5176-08.2009; Fischgold H, 1959, ELECTROEN CLIN NEURO, V11, P1; HABLITZ JJ, 1981, CELL MOL NEUROBIOL, V1, P325, DOI 10.1007/BF00716267; HEINEMANN U, 1992, EPILEPSY RES, P273; JAMA, 1981, JAMA-J AM MED ASSOC, V246, P2186; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; LERMAN J, 1986, ANESTHESIOLOGY, V65, P307; NEWBERG LA, 1983, ANESTHESIOLOGY, V59, P23, DOI 10.1097/00000542-198307000-00005; Niedermeyer E, 1999, CLIN ELECTROENCEPHAL, V30, P99, DOI 10.1177/155005949903000305; NUNEZ A, 1990, EXP NEUROL, V109, P294, DOI 10.1016/S0014-4886(05)80020-2; Pagni CA, 1964, ACTA NEUROCHIR, V13, P35; SILVERMAN D, 1975, HDB ELECTROENCEPHALO, P81; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; SWANK RL, 1949, J NEUROPHYSIOL, V12, P137, DOI 10.1152/jn.1949.12.2.137; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TEASDALE G, 1974, LANCET, V2, P81; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Walker AE, 1977, CEREBRAL DEATH; WEISSENBORN K, 1991, CLIN NEUROL NEUROSUR, V93, P77, DOI 10.1016/0303-8467(91)90015-H; ZARET BS, 1985, ELECTROEN CLIN NEURO, V61, P199, DOI 10.1016/0013-4694(85)91085-5; Zhang H, 2010, J NEUROSCI, V30, P13431, DOI 10.1523/JNEUROSCI.1144-10.2010	45	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75257	10.1371/journal.pone.0075257	http://dx.doi.org/10.1371/journal.pone.0075257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058669	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900104
J	Luo, ZC; Zhao, YJ; Ouyang, FX; Yang, ZJ; Guo, YN; Zhang, J				Luo, Zhong-Cheng; Zhao, Yan-Jun; Ouyang, Fengxiu; Yang, Zu-Jing; Guo, Yu-Na; Zhang, Jun			Diabetes and Perinatal Mortality in Twin Pregnancies	PLOS ONE			English	Article							NEONATAL OUTCOMES; WOMEN; MELLITUS; TYPE-1; FETAL	Background: Diabetes in pregnancy has been associated with a paradoxically reduced risk of neonatal death in twin pregnancies. Risk "shift" may be a concern in that the reduction in neonatal deaths may be due to an increase in fetal deaths (stillbirths). This study aimed to clarify the impact of diabetes on the risk of perinatal death (neonatal death plus stillbirth) in twin pregnancies. Methods: This was a retrospective cohort study of twin births using the largest available dataset on twin births (the U.S. matched multiple birth data 1995-2000; 19,676 neonates from diabetic pregnancies, 541,481 from non-diabetic pregnancies). Cox proportional hazard models were applied to estimate the adjusted hazard ratios (aHR) of perinatal death accounting for twin cluster-level dependence. Results: Comparing diabetic versus non-diabetic twin pregnancies, overall perinatal mortality rate was counterintuitively lower [2.1% versus 3.3%, aHR 0.70 (95% confidence intervals 0.63-0.78)]. Individually, both stillbirth and neonatal mortality rates were lower in diabetic pregnancies, but we identified significant differences by gestational age and birth weight. Diabetes was associated with a survival benefit in pregnancies completed before 32 weeks [aHR 0.55 (0.48-0.63)] or with birth weight <1500 g [aHR 0.61 (0.53-0.69)]. In contrast, diabetes was associated with an elevated risk of perinatal death in pregnancies delivered between 32 and 36 weeks [aHR 1.38 (1.10-1.72)] or with birth weight >=2500 g [aHR 2.20 (1.55-3.13)]. Conclusions: Diabetes in pregnancy appears to be "protective" against perinatal death in twin pregnancies ending in very preterm or very low birth weight births. Prospective studies are required to clarify whether these patterns of risk are real, or they are artifacts of unmeasured confounders. Additional data correlating these outcomes with the types of diabetes in pregnancy are also needed to distinguish the effects of pre-gestational vs. gestational diabetes.	[Luo, Zhong-Cheng; Zhao, Yan-Jun; Ouyang, Fengxiu; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Minist Educ,Shanghai Key Lab Childrens Environm H, Shanghai 200030, Peoples R China; [Yang, Zu-Jing] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Guo, Yu-Na] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Luo, Zhong-Cheng] Univ Montreal, St Justine Hosp, Dept Obstet & Gynecol, Montreal, PQ, Canada	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Luo, ZC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Minist Educ,Shanghai Key Lab Childrens Environm H, Shanghai 200030, Peoples R China.	zc_luo@yahoo.com	Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Shanghai Xinhua Hospital, National 211 Program; National Natural Science Foundation of China [81273091, 81102139]; Shanghai Pujiang Program [12PJD026]	Shanghai Xinhua Hospital, National 211 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by Shanghai Xinhua Hospital, National 211 Program. JZ and FO were supported by the National Natural Science Foundation of China (grant # 81273091 and # 81102139). FO was supported by the Shanghai Pujiang Program (grant # 12PJD026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; Bell R, 2008, BJOG-INT J OBSTET GY, V115, P445, DOI 10.1111/j.1471-0528.2007.01644.x; Black MH, 2010, DIABETES CARE, V33, P2524, DOI 10.2337/dc10-1445; Boulot P, 2003, DIABETES CARE, V26, P2990; Buhling Kai J., 2003, Archives of Gynecology and Obstetrics, V269, P33, DOI 10.1007/s00404-003-0483-z; Centers for Disease Control and Prevention (CDC) National Center for Heath Statistics (NCHS), NCHS CDROM SER, P20; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; DiGiuseppe David L, 2002, Matern Child Health J, V6, P169, DOI 10.1023/A:1019726112597; Hod M, 2007, DIABETES CARE, V30, pS180, DOI 10.2337/dc07-s213; Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59; Lu SE, 2005, LIFETIME DATA ANAL, V11, P61, DOI 10.1007/s10985-004-5640-6; Luo ZC, 2011, DIABETIC MED, V28, P1068, DOI 10.1111/j.1464-5491.2011.03366.x; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; Middleton P, 2012, COCHRANE DB SYST REV, V8, DOI [10.1002/14651858.1, DOI 10.1002/14651858.1.PUBMED:2289597620824880]; Moreno-Castilla C, 2013, DIABETES CARE, V36, P2233, DOI 10.2337/dc12-2714; Murphy HR, 2011, DIABETIC MED, V28, P1060, DOI 10.1111/j.1464-5491.2011.03333.x; OWEN J, 1995, AM J OBSTET GYNECOL, V172, P615, DOI 10.1016/0002-9378(95)90581-2; Schwartz DB, 1999, AM J OBSTET GYNECOL, V181, P912, DOI 10.1016/S0002-9378(99)70324-8; Sivan E, 2002, OBSTET GYNECOL, V99, P91, DOI 10.1016/S0029-7844(01)01661-1; Verheijen ECJ, 2005, BJOG-INT J OBSTET GY, V112, P1500, DOI 10.1111/j.1471-0528.2005.00747.x; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Yamashita H, 2000, CLIN OBSTET GYNECOL, V43, P87, DOI 10.1097/00003081-200003000-00009; Yang J, 2006, OBSTET GYNECOL, V108, P644, DOI 10.1097/01.AOG.0000231688.08263.47	25	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75354	10.1371/journal.pone.0075354	http://dx.doi.org/10.1371/journal.pone.0075354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058678	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900110
J	Tian, JS; Shi, BY; Xiang, H; Gao, S; Qin, XM; Du, GH				Tian, Jun-Sheng; Shi, Bi-Yun; Xiang, Huan; Gao, Shan; Qin, Xue-Mei; Du, Guan-Hua			H-1-NMR-Based Metabonomic Studies on the Anti-Depressant Effect of Genipin in the Chronic Unpredictable Mild Stress Rat Model	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; GENIPOSIDE; METABOLISM; ACTIVATION; XIAOYAOSAN; CULTIVARS; VALIDITY; BEHAVIOR; REVEALS; URINE	The purpose of this work was to investigate the anti-depressant effect of genipin and its mechanisms using H-1-NMR spectroscopy and multivariate data analysis on a chronic unpredictable mild stress (CUMS) rat model. Rat serum and urine were analyzed by nuclear magnetic resonance (NMR)-based metabonomics after oral administration of either genipin or saline for 2 weeks. Significant differences in the metabolic profile of the CUMS-treated group and the control group were observed, which were consistent with the results of behavioral tests. Metabolic effects of CUMS included decreases in serum trimetlylamine oxide (TMAO) and beta-hydroxybutyric acid (beta-HB), and increases in lipid, lactate, alanine and N-acetylglycoproteins. In urine, decreases in creatinine and betaine were observed, while citrate, trimethylamine (TMA) and dimethylamine were increased. These changes suggest that depression may be associated with gut microbes, energy metabolism and glycometabolism. Genipin showed the best anti-depressive effects at a dose of 100 mg/kg in rats. These results indicate that metabonomic approaches could be powerful tools for the investigation of the biochemical changes in pathological conditions or drug treatment.	[Tian, Jun-Sheng; Shi, Bi-Yun; Qin, Xue-Mei; Du, Guan-Hua] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Peoples R China; [Xiang, Huan] Shanxi Univ, Dept Phys Educ, Taiyuan, Peoples R China; [Gao, Shan] Tianjin Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med, Taiyuan, Peoples R China; [Du, Guan-Hua] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Du, Guan-Hua] Peking Union Med Coll, Beijing 100021, Peoples R China	Shanxi University; Shanxi University; Tianjin University of Traditional Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qin, XM (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Peoples R China.	qinxm@sxu.edu.cn			National Natural Science Foundation of China [81102833, 81173366, 81173469]; Program of International S&T Cooperation of China [2011DFA32630]; National S&T Major Projects for "Major New Drugs Innovation and Development" [2012ZX09103201-035]; Programs of S&T of Shanxi Province [2012021031-2, 20130313015-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International S&T Cooperation of China; National S&T Major Projects for "Major New Drugs Innovation and Development"; Programs of S&T of Shanxi Province	This study was financially supported by the National Natural Science Foundation of China (No. 81102833, No. 81173366, and No. 81173469), the Program of International S&T Cooperation of China (No. 2011DFA32630), National S&T Major Projects for "Major New Drugs Innovation and Development" (2012ZX09103201-035), and the Programs of S&T of Shanxi Province (No. 2012021031-2 and No. 20130313015-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO T, 1994, BIOL PHARM BULL, V17, P1573; BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0; Bertram HC, 2011, J AGR FOOD CHEM, V59, P12499, DOI 10.1021/jf204201f; Bertram HC, 2010, J AGR FOOD CHEM, V58, P4336, DOI 10.1021/jf904321p; Bertram HC, 2009, METABOLISM, V58, P1039, DOI 10.1016/j.metabol.2009.03.011; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Brown PN, 2012, J AGR FOOD CHEM, V60, P261, DOI 10.1021/jf2033335; Harro J, 1999, EUR NEUROPSYCHOPHARM, V10, P5, DOI 10.1016/S0924-977X(99)00043-7; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Hedman E, 2011, BEHAV RES THER, V49, P729, DOI 10.1016/j.brat.2011.07.009; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Lelono R A A, 2009, Pak J Biol Sci, V12, P949, DOI 10.3923/pjbs.2009.949.956; Li ZY, 2010, RAPID COMMUN MASS SP, V24, P3539, DOI 10.1002/rcm.4809; Liao PQ, 2009, J RARE EARTH, V27, P280, DOI 10.1016/S1002-0721(08)60234-3; Liu XJ, 2012, J PHARM PHARMACOL, V64, P578, DOI 10.1111/j.2042-7158.2011.01412.x; Maes M, 1997, PSYCHIAT RES, V66, P1, DOI 10.1016/S0165-1781(96)02915-0; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Paik YS, 2001, J AGR FOOD CHEM, V49, P430, DOI 10.1021/jf000978f; Park JE, 2002, J AGR FOOD CHEM, V50, P6511, DOI 10.1021/jf020499b; Rodrigues JA, 2011, ANAL CHIM ACTA, V702, P178, DOI 10.1016/j.aca.2011.06.042; Shi BY, 2013, BEHAV BRAIN RES, V241, P86, DOI 10.1016/j.bbr.2012.11.036; Sluzewska A, 1999, ADV EXP MED BIOL, V461, P59; Straadt IK, 2010, J AGR FOOD CHEM, V58, P6376, DOI 10.1021/jf904197u; Teague CR, 2007, J PROTEOME RES, V6, P2080, DOI 10.1021/pr060412s; Tian JS, 2010, NEUROSCI LETT, V479, P236, DOI 10.1016/j.neulet.2010.05.069; Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu WX, 2012, J PROTEOME RES, V11, P3423, DOI 10.1021/pr300280t; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Zhang LM, 2011, J PROTEOME RES, V10, P614, DOI 10.1021/pr100792q; Zhao XJ, 2011, J PROTEOME RES, V10, P5183, DOI 10.1021/pr2006457; Zheng HZ, 2000, MODERN RES APPL CHIN, V4; Zheng SN, 2011, METABOLOMICS, V7, P413, DOI 10.1007/s11306-010-0261-4; Zhou YZ, 2012, CHROMATOGRAPHIA, V75, P157, DOI 10.1007/s10337-011-2167-3; Zhou YZ, 2011, J ETHNOPHARMACOL, V137, P236, DOI 10.1016/j.jep.2011.05.016	39	39	56	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75721	10.1371/journal.pone.0075721	http://dx.doi.org/10.1371/journal.pone.0075721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058700	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900125
J	Gysi, S; Rhiner, C; Flibotte, S; Moerman, DG; Hengartner, MO				Gysi, Stephan; Rhiner, Christa; Flibotte, Stephane; Moerman, Donald G.; Hengartner, Michael O.			A Network of HSPG Core Proteins and HS Modifying Enzymes Regulates Netrin-Dependent Guidance of D-Type Motor Neurons in Caenorhabditis elegans	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AXON GUIDANCE; RNA INTERFERENCE; CELL-MIGRATION; NERVOUS-SYSTEM; GROWTH CONE; GENES; SYNDECAN; LAR; GLYPICAN	Heparan sulfate proteoglycans (HSPGs) are proteins with long covalently attached sugar side chains of the heparan sulfate (HS) type. Depending on the cellular context HS chains carry multiple structural modifications such as sulfate residues or epimerized sugars allowing them to bind to a wide range of molecules. HSPGs have been found to play extremely diverse roles in animal development and were shown to interact with certain axon guidance molecules. In this study we describe the role of the Caenorhabditis elegans HSPG core proteins Syndecan (SDN-1) and Glypican (LON-2) and the HS modifying enzymes in the dorsal guidance of D-type motor axons, a process controlled mainly by the conserved axon guidance molecule UNC-6/Netrin. Our genetic analysis established the specific HS code relevant for this axon guidance event. Using two sensitized genetic backgrounds, we isolated novel components influencing D-type motor axon guidance with a link to HSPGs, as well as new alleles of several previously characterized axon guidance genes. Interestingly, the dorsal axon guidance defects induced by mutations in zfp-1 or lin-35 depended on the transgene oxIs12 used to visualize the D-type motor neurons. oxIs12 is a large multi-copy transgene that enlarges the X chromosome by approximately 20%. In a search for genes with a comparable phenotype we found that a mutation in the known dosage compensation gene dpy-21 showed similar axon guidance defects as zfp-1 or lin-35 mutants. Thus, derepression of genes on X, where many genes relevant for HS dependent axon guidance are located, might also influence axon guidance of D-type motor neurons.	[Gysi, Stephan; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Gysi, Stephan; Hengartner, Michael O.] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Rhiner, Christa] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Flibotte, Stephane; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of Zurich; University of Zurich; University of Bern; University of British Columbia	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@imls.uzh.ch		Hengartner, Michael/0000-0002-7584-596X; Flibotte, Stephane/0000-0001-9613-7666; Rhiner, Christa/0000-0001-7577-8042	Neuroscience Center Zurich; Kanton of Zurich; Swiss National Science Foundation; Ernst Hadorn Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Neuroscience Center Zurich; Kanton of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst Hadorn Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Neuroscience Center Zurich (www.neuroscience.ethz.ch), the Kanton of Zurich, the Swiss National Science Foundation (www.snf.ch), and the Ernst Hadorn Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2003, J NEUROSCI, V23, P3577; Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BRENNER S, 1974, GENETICS, V77, P71; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; CHAPLIN T, 1995, BLOOD, V85, P1435, DOI 10.1182/blood.V85.6.1435.bloodjournal8561435; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dudley NR, 2002, P NATL ACAD SCI USA, V99, P4191, DOI 10.1073/pnas.062605199; Durbin R., 1987, THESIS; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fay DS, 2007, DEV BIOL, V306, P1, DOI 10.1016/j.ydbio.2007.03.016; Flibotte S, 2009, GENETICS, V181, P33, DOI 10.1534/genetics.108.096487; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Grishok A, 2008, P NATL ACAD SCI USA, V105, P20386, DOI 10.1073/pnas.0810589105; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Harrington RJ, 2002, DEVELOPMENT, V129, P2141; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Hudson ML, 2006, DEV BIOL, V294, P352, DOI 10.1016/j.ydbio.2006.02.036; Irie A, 2002, DEVELOPMENT, V129, P61; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Korswagen HC, 1997, GENE DEV, V11, P1493, DOI 10.1101/gad.11.12.1493; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Merz DC, 2003, DEV BIOL, V256, P173, DOI 10.1016/S0012-1606(03)00014-9; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; Mizuguchi S, 2009, TRENDS GLYCOSCI GLYC, V21, P179, DOI 10.4052/tigg.21.179; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Rhiner C, 2006, THESCIENTIFICWORLDJO, V6, P1024, DOI 10.1100/tsw.2006.202; ROGALSKI TM, 1995, GENETICS, V139, P159; Sarafi-Reinach TR, 2000, GENE DEV, V14, P2472, DOI 10.1101/gad.832300; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Smart AD, 2011, DEV NEUROBIOL, V71, P608, DOI 10.1002/dneu.20854; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Stringham E, 2002, DEVELOPMENT, V129, P3367; Stringham EG, 2009, CELL ADHES MIGR, V3, P342, DOI 10.4161/cam.3.4.9451; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Tecle E, 2013, G3-GENES GENOM GENET, V3, P541, DOI 10.1534/g3.112.005199; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wacker I, 2003, DEVELOPMENT, V130, P3795, DOI 10.1242/dev.00570; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; Yonker SA, 2003, DEVELOPMENT, V130, P6519, DOI 10.1242/dev.00886; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zipperlen P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r19	68	19	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74908	10.1371/journal.pone.0074908	http://dx.doi.org/10.1371/journal.pone.0074908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066155	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000137
J	Kirac, I; Matosevic, P; Augustin, G; Simunovic, I; Hostic, V; Zupancic, S; Hayward, C; Antoljak, N; Rudan, I; Campbell, H; Dunlop, MG; Vrdoljak, DV; Kovacevic, D; Zgaga, L				Kirac, Iva; Matosevic, Petar; Augustin, Goran; Simunovic, Iva; Hostic, Vedran; Zupancic, Sven; Hayward, Caroline; Antoljak, Natasa; Rudan, Igor; Campbell, Harry; Dunlop, Malcolm G.; Vrdoljak, Danko Velimir; Kovacevic, Dujo; Zgaga, Lina			SMAD7 Variant rs4939827 Is Associated with Colorectal Cancer Risk in Croatian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; TGF-BETA; SCAN; METAANALYSIS; MORTALITY; TRENDS; 8Q24	Background: Twenty common genetic variants have been associated with risk of developing colorectal cancer (CRC) in genome wide association studies to date. Since large differences between populations exist, generalisability of findings to any specific population needs to be confirmed. Aim: The aim of this study was to perform an association study between risk variants: rs10795668, rs16892766, rs3802842 and rs4939827 and CRC risk in Croatian population. Methods: An association study was performed on 320 colorectal cancer cases and 594 controls recruited in Croatia. We genotyped four variants previously associated with CRC: rs10795668, rs16892766, rs3802842 and rs4939827. Results: SMAD7 variant rs4939827 (18q21.1) was significantly associated with CRC risk in Croatian population. C allele was associated with a decreased risk, odds ratio (OR): 0.70 (95% CI: 0.57-0.85, P=3.5E-04). Compared to TT homozygotes, risk was reduced by 34% in heterozygotes (OR=0.66, 95% CI: 0.47-0.92) and by 52% in CC homozygotes (OR=0.48, 95% CI: 0.33-0.72). Conclusion: Our results show association of rs4939827 with colorectal cancer risk in Croatian population. The higher strength of the association in comparison to other studies suggests population-specific environmental or genetic factors may be modifying the association. More studies are needed to further describe role of rs4939827 in CRC. Likely reason for failure of replication for other 3 loci is inadequate study power.	[Kirac, Iva; Vrdoljak, Danko Velimir] Sestre Milosrdnice Univ Hosp Ctr, Univ Hosp Tumours, Dept Surg Oncol, Zagreb, Croatia; [Matosevic, Petar; Augustin, Goran] Univ Hosp Ctr, Dept Surg, Zagreb, Croatia; [Simunovic, Iva] Tech Univ Munich, German Heart Ctr, D-80290 Munich, Germany; [Hostic, Vedran] Sestre Milosrdnice Univ Hosp Ctr, Dept Anaesthesiol, Zagreb, Croatia; [Zupancic, Sven; Kovacevic, Dujo] Sestre Milosrdnice Univ Hosp Ctr, Dept Surg, Zagreb, Croatia; [Hayward, Caroline; Dunlop, Malcolm G.] Univ Edinburgh, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Antoljak, Natasa] Croatian Natl Inst Publ Hlth, Zagreb, Croatia; [Antoljak, Natasa; Zgaga, Lina] Univ Zagreb, Sch Med, Dept Med Stat Epidemiol & Med Informat, Zagreb 41001, Croatia; [Rudan, Igor; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Zgaga, Lina] Trinity Coll Dublin, Dept Publ Hlth & Primary Care, Dublin, Ireland	University of Zagreb; University of Zagreb; German Heart Centre Munich; Technical University of Munich; University of Zagreb; University of Zagreb; University of Edinburgh; University of Zagreb; University of Edinburgh; Trinity College Dublin	Kirac, I (corresponding author), Sestre Milosrdnice Univ Hosp Ctr, Univ Hosp Tumours, Dept Surg Oncol, Zagreb, Croatia.	iva.kirac@kbcsm.hr	Campbell, Harry/E-2959-2010; Hayward, Caroline/M-8818-2016; Dunlop, Malcolm G/F-1973-2011; Augustin, Goran/N-1912-2013; Rudan, Igor/I-1467-2012; Zgaga, Lina/Q-9415-2018; Matosevic, Petar/C-8204-2013	Campbell, Harry/0000-0002-6169-6262; Hayward, Caroline/0000-0002-9405-9550; Dunlop, Malcolm G/0000-0002-3033-5851; Augustin, Goran/0000-0002-0202-3324; Rudan, Igor/0000-0001-6993-6884; Zgaga, Lina/0000-0003-4089-9703; Matosevic, Petar/0000-0001-6295-6161; , Sven/0000-0002-7053-5460	Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_PC_U127527198, MC_U127527198] Funding Source: researchfish; MRC [MC_PC_U127527198, MC_U127527198] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, DECEASED PERSONS CRO; Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Edge SB, 2009, AJCC CANC STAGING MA, V7; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Halder SK, 2005, EXP CELL RES, V307, P231, DOI 10.1016/j.yexcr.2005.03.009; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katicic M, 2012, WORLD J GASTROENTERO, V18, P4300, DOI 10.3748/wjg.v18.i32.4300; Kirac I, 2012, CROAT MED J, V53, P124, DOI 10.3325/cmj.2012.53.124; Kruglyak L, 1999, P NATL ACAD SCI USA, V96, P1170, DOI 10.1073/pnas.96.4.1170; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Loh YH, 2011, CANCER EPIDEMIOL, V35, P369, DOI 10.1016/j.canep.2010.09.011; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033318; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Theodoratou E, 2012, JNCI-J NATL CANCER I, V104, P1433, DOI 10.1093/jnci/djs369; Thompson CL, 2009, CARCINOGENESIS, V30, P982, DOI 10.1093/carcin/bgp086; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	29	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74042	10.1371/journal.pone.0074042	http://dx.doi.org/10.1371/journal.pone.0074042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066093	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000324494000075
J	Li, J; Wang, R; Luo, D; Li, S; Xiao, C				Li, Jiang; Wang, Rui; Luo, Dan; Li, Shuang; Xiao, Cheng			Association between Serum Ferritin Levels and Risk of the Metabolic Syndrome in Chinese Adults: A Population Study	PLOS ONE			English	Article							BODY IRON STORES; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; THALASSEMIA MAJOR; PHYSICAL-ACTIVITY; MEN; HEALTH; HYPERINSULINEMIA; HEMOCHROMATOSIS	Ferritin is a ubiquitous intracellular protein that can store and release iron and act as a buffer against iron deficiency and iron overload. Ferritin is widely used as a clinical biomarker to evaluate iron status. Increased serum ferritin concentrations have been reported to be associated with metabolic syndrome (MetS) features. However, serum ferritin concentrations differ significantly according to sex and ethnicity, and the data concerning the relationship between serum ferritin concentrations and MetS in Asian men and women are conflicting. This study aimed to explore the relationship between serum ferritin and MetS in Chinese population. Fasting blood samples and anthropometric data collected on 8,441 adults aged 18 and older in 2009 as part of the China Health and Nutrition Survey, a large-scale longitudinal, household-based survey in China. Data was collected by trained physicians and biomarkers were measured with Hitachi Clinical Autoanalyzer 7600 D model and P model. Median levels of serum ferritin were significantly higher in men compared with women (121.9 vs. 51.0 ng/ml, P < 0.001), and significantly lower in non metabolic syndrome population with MetS population (73.2 vs. 106.0 ng/ml, P < 0.001). The difference remained significant after further adjusted for age, nationality, Body mass index (BMI), smoking status, and alcohol consumption. For both men and women, the highest prevalence of MetS occurred in the highest quartile of serum ferritin. The odds ratios increased progressively across the ferritin quartiles (P < 0.001 for trend). Increased serum ferritin concentrations are associated with the metabolic syndrome among men and women in China.	[Li, Jiang; Li, Shuang] Minist Hlth, China Japan Friendship Hosp, Dept Lab Med, Beijing, Peoples R China; [Luo, Dan; Xiao, Cheng] Minist Hlth, China Japan Friendship Hosp, Inst Clin Med, Beijing, Peoples R China; [Wang, Rui] Beijing Red Cross Blood Ctr, Blood Screening Lab, Beijing, Peoples R China; [Xiao, Cheng] Peoples Hosp Yichun City, Dept Rheumatol, Yichun, Jiangxi, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital	Xiao, C (corresponding author), Minist Hlth, China Japan Friendship Hosp, Inst Clin Med, Beijing, Peoples R China.	xc2002812@126.com	Xiao, Cheng/AAM-7764-2020		National Institutes of Health [R01-HD30880, DK056350, R24 HD050924, R01-HD38700, R21DK089306]; Fogarty International Center; Chinese Center for Disease Control and Prevention National Institute of Nutrition and Food Safety; China-Japan Friendship Hospital, Ministry of Health of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R01HD030880] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R21DK089306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Chinese Center for Disease Control and Prevention National Institute of Nutrition and Food Safety; China-Japan Friendship Hospital, Ministry of Health of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health (R01-HD30880, DK056350, R24 HD050924, R01-HD38700 and R21DK089306) and Fogarty International Center, with added financial support from the Chinese Center for Disease Control and Prevention National Institute of Nutrition and Food Safety and the China-Japan Friendship Hospital, Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, EC PREV CONTR IR DEF; Bozzini C, 2005, DIABETES CARE, V28, P2061, DOI 10.2337/diacare.28.8.2061; Cario H, 2003, EUR J PEDIATR, V162, P139, DOI 10.1007/s00431-002-1121-7; Choi KM, 2005, METABOLISM, V54, P1510, DOI 10.1016/j.metabol.2005.05.018; De Benoist B, 2008, ORLDWIDE PREVALENCE; de Haan B B, 1973, Eur J Clin Invest, V3, P179; DMOCHOWSKI K, 1993, J CLIN ENDOCR METAB, V77, P478, DOI 10.1210/jc.77.2.478; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Gonzalez AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Halle M, 1997, ATHEROSCLEROSIS, V128, P235, DOI 10.1016/S0021-9150(96)05994-1; Harris EL, 2007, ARCH INTERN MED, V167, P722, DOI 10.1001/archinte.167.7.722; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kasapoglu B, 2010, INDIAN J MED RES, V132, P56; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Liao MZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034085, 10.1371/journal.pone.0039234]; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Luan DC, 2008, DIABETES CARE, V31, P285, DOI 10.2337/dc07-0921; Martinelli N, 2012, PLOS ONE, V7, P29; MERKEL PA, 1988, NEW ENGL J MED, V318, P809, DOI 10.1056/NEJM198803313181303; Milman N, 2001, EUR J HAEMATOL, V66, P115, DOI 10.1034/j.1600-0609.2001.00312.x; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; NIEDERAU C, 1984, DIABETOLOGIA, V26, P441; Oda E, 2010, INTERNAL MED, V49, P117, DOI 10.2169/internalmedicine.49.2670; Park SK, 2012, DIABETES CARE, V35, P2521, DOI 10.2337/dc12-0543; Parvanta SA, 2010, J ADOLESCENT HEALTH, V46, P339, DOI 10.1016/j.jadohealth.2009.08.002; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; Powell LW, 1998, ANN INTERN MED, V129, P925, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00002; Ren Y, 2004, DIABETES CARE, V27, P622, DOI 10.2337/diacare.27.2.622; Sheu WHH, 2003, CLIN ENDOCRINOL, V58, P380, DOI 10.1046/j.1365-2265.2003.01729.x; Shi ZM, 2006, DIABETES CARE, V29, P1878, DOI 10.2337/dc06-0327; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Tuomainen TP, 1997, DIABETES CARE, V20, P426, DOI 10.2337/diacare.20.3.426; Williams MJA, 2002, ATHEROSCLEROSIS, V165, P179, DOI 10.1016/S0021-9150(02)00233-2; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646	40	28	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74168	10.1371/journal.pone.0074168	http://dx.doi.org/10.1371/journal.pone.0074168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066115	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000097
J	Tomura, M; Sakaue-Sawano, A; Mori, Y; Takase-Utsugi, M; Hata, A; Ohtawa, K; Kanagawa, O; Miyawaki, A				Tomura, Michio; Sakaue-Sawano, Asako; Mori, Yoshiko; Takase-Utsugi, Mitsuyo; Hata, Akihiro; Ohtawa, Kenji; Kanagawa, Osami; Miyawaki, Atsushi			Contrasting Quiescent G(0) Phase with Mitotic Cell Cycling in the Mouse Immune System	PLOS ONE			English	Article							PROLIFERATION; SELECTION	A transgenic mouse line expressing Fucci (fluorescent ubiquitination-based cell-cycle indicator) probes allows us to monitor the cell cycle in the hematopoietic system. Two populations with high and low intensities of Fucci signals for Cdt1(30/120) accumulation were identified by FACS analysis, and these correspond to quiescent G(0) and cycling G(1) cells, respectively. We observed the transition of immune cells between quiescent and proliferative phases in lymphoid organs during differentiation and immune responses.	[Tomura, Michio; Mori, Yoshiko; Takase-Utsugi, Mitsuyo; Kanagawa, Osami] RIKEN, Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Yokohama, Kanagawa, Japan; [Tomura, Michio; Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Lab Cell Funct & Dynam, Brain Sci Inst, Wako, Saitama, Japan; [Tomura, Michio; Hata, Akihiro] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] JST, ERATO, Wako, Saitama, Japan; [Ohtawa, Kenji] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan	RIKEN; RIKEN; Kyoto University; Japan Science & Technology Agency (JST); RIKEN	Kanagawa, O (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Yokohama, Kanagawa, Japan.	kanagawa7@gmail.com; matsushi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390; Utsugi, Mitsuyo/0000-0002-6810-9630	Japan MEXT; HFSP (the Human Frontier Science Program)	Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); HFSP (the Human Frontier Science Program)	This work was partly supported by grants from Japan MEXT Grant-in-Aid for Scientific Research on priority areas and HFSP (the Human Frontier Science Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; GERDES J, 1984, J IMMUNOL, V133, P1710; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; NIKOLICZUGIC J, 1988, P NATL ACAD SCI USA, V85, P8633, DOI 10.1073/pnas.85.22.8633; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PlanasSilva MD, 1997, CURR OPIN CELL BIOL, V9, P768, DOI 10.1016/S0955-0674(97)80076-2; Sakaue-Sawano A, 2011, IMAGING DEV BIOL, P331; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	14	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73801	10.1371/journal.pone.0073801	http://dx.doi.org/10.1371/journal.pone.0073801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066072	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000054
J	Arshad, MI; Patrat-Delon, S; Piquet-Pellorce, C; L'Helgoualc'h, A; Rauch, M; Genet, V; Lucas-Clerc, C; Bleau, C; Lamontagne, L; Samson, M				Arshad, Muhammad Imran; Patrat-Delon, Solene; Piquet-Pellorce, Claire; L'Helgoualc'h, Annie; Rauch, Michel; Genet, Valentine; Lucas-Clerc, Catherine; Bleau, Christian; Lamontagne, Lucie; Samson, Michel			Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; DOUBLE-STRANDED-RNA; KUPFFER CELLS; RECEPTOR; LIVER; INTERLEUKIN-33; ACTIVATION; EXPRESSION; DISEASE	The IL-33/ST2 axis is known to be involved in liver pathologies. Although, the IL-33 levels increased in sera of viral hepatitis patients in human, the cellular sources of IL-33 in viral hepatitis remained obscure. Therefore, we aimed to investigate the expression of IL-33 in murine fulminant hepatitis induced by a Toll like receptor (TLR3) viral mimetic, poly(I:C) or by pathogenic mouse hepatitis virus (L2-MHV3). The administration of poly(I:C) plus D-galactosamine (D-GalN) in mice led to acute liver injury associated with the induction of IL-33 expression in liver sinusoidal endothelial cells (LSEC) and vascular endothelial cells (VEC), while the administration of poly(I:C) alone led to hepatocyte specific IL-33 expression in addition to vascular IL-33 expression. The hepatocyte-specific IL-33 expression was down-regulated in NK-depleted poly(I:C) treated mice suggesting a partial regulation of IL-33 by NK cells. The CD1d KO (NKT deficient) mice showed hepatoprotection against poly(I:C)-induced hepatitis in association with increased number of IL-33 expressing hepatocytes in CD1d KO mice than WT controls. These results suggest that hepatocyte-specific IL-33 expression in poly(I:C) induced liver injury was partially dependent of NK cells and with limited role of NKT cells. In parallel, the L2-MHV3 infection in mice induced fulminant hepatitis associated with up-regulated IL-33 expression as well as pro-inflammatory cytokine microenvironment in liver. The LSEC and VEC expressed inducible expression of IL-33 following L2-MHV3 infection but the hepatocyte-specific IL-33 expression was only evident between 24 to 32h of post infection. In conclusion, the alarmin cytokine IL-33 was over-expressed during fulminant hepatitis in mice with LSEC, VEC and hepatocytes as potential sources of IL-33.	[Arshad, Muhammad Imran; Patrat-Delon, Solene; Piquet-Pellorce, Claire; L'Helgoualc'h, Annie; Rauch, Michel; Genet, Valentine; Samson, Michel] INSERM, U1085, IRSET, Rennes, Bretagne, France; [Arshad, Muhammad Imran; Patrat-Delon, Solene; Piquet-Pellorce, Claire; L'Helgoualc'h, Annie; Rauch, Michel; Genet, Valentine; Lucas-Clerc, Catherine; Samson, Michel] Univ Rennes 1, Rennes, Bretagne, France; [Arshad, Muhammad Imran; Patrat-Delon, Solene; Piquet-Pellorce, Claire; L'Helgoualc'h, Annie; Rauch, Michel; Genet, Valentine; Samson, Michel] INSERM, US18, CNRS, Struct Federat BioSit UMS 3480, Rennes, Bretagne, France; [Lucas-Clerc, Catherine] Univ Rennes 1, CHU Rennes, Serv Biochim, Rennes, Bretagne, France; [Bleau, Christian; Lamontagne, Lucie] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Arshad, Muhammad Imran] Univ Agr Faisalabad, Inst Microbiol, Faisalabad, Pakistan	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; University of Quebec; University of Quebec Montreal; University of Agriculture Faisalabad	Samson, M (corresponding author), INSERM, U1085, IRSET, Rennes, Bretagne, France.	michel.samson@univ-rennes1.fr	PIQUET-PELLORCE, Claire SL/I-4195-2015; Arshad, Muhammad Imran/P-5550-2018; Samson, Michel/F-8356-2013; Arshad, Muhammad/E-2292-2016	PIQUET-PELLORCE, Claire SL/0000-0003-3198-1975; Arshad, Muhammad Imran/0000-0003-2218-9054; Arshad, Muhammad/0000-0001-7199-0118	Institut National de la Sante et de la Recherche Medicale; Ministere de l'Education Nationale de la Recherche et de la Technologie; University of Rennes 1; Region Bretagne; Ligue contre le cancer, comites du Grand Ouest; NSERC from Government of Canada; Government of Pakistan (Higher Education Commission, University of Agriculture, Faisalabad); Natural Sciences and Engineering Research Council (Canada)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Education Nationale de la Recherche et de la Technologie; University of Rennes 1; Region Bretagne(Region Bretagne); Ligue contre le cancer, comites du Grand Ouest; NSERC from Government of Canada; Government of Pakistan (Higher Education Commission, University of Agriculture, Faisalabad); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Institut National de la Sante et de la Recherche Medicale, the Ministere de l'Education Nationale de la Recherche et de la Technologie, the University of Rennes 1, the Region Bretagne, the "Ligue contre le cancer, comites du Grand Ouest" and by NSERC from Government of Canada. MIA was supported by a Ph.D fellowship from the Government of Pakistan (Higher Education Commission, University of Agriculture, Faisalabad). CB was supported by a Ph.D. fellowship from Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Aparicio JL, 2011, INT IMMUNOPHARMACOL, V11, P1591, DOI 10.1016/j.intimp.2011.05.020; Arshad MI, 2012, LIVER INT, V32, P1200, DOI 10.1111/j.1478-3231.2012.02802.x; Arshad MI, 2011, EUR J IMMUNOL, V41, P2341, DOI 10.1002/eji.201041332; Arshad MI, 2012, HEPATOLOGY, V56, P2353, DOI 10.1002/hep.25893; Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Cavanaugh PF, 1996, RES COMMUN MOL PATH, V91, P131; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Dejager L, 2008, CYTOKINE, V42, P55, DOI 10.1016/j.cyto.2008.01.014; GODFRAIND C, 1995, LAB INVEST, V73, P615; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; Jacques A, 2008, CLIN EXP IMMUNOL, V152, P298, DOI 10.1111/j.1365-2249.2008.03628.x; Jacques A, 2009, IMMUNOLOGY, V128, pe181, DOI 10.1111/j.1365-2567.2008.02946.x; LAMONTAGNE L, 1989, J IMMUNOL, V142, P4458; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Lehoux M, 2004, CLIN EXP IMMUNOL, V137, P41, DOI 10.1111/j.1365-2249.2004.02501.x; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lisbonne M, 2011, EUR J IMMUNOL, V41, P1720, DOI 10.1002/eji.201041006; Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x; Miyagaki T, 2011, J INVEST DERMATOL, V131, P794, DOI 10.1038/jid.2010.366; Patrick AL, 2007, AM J PHYSIOL-GASTR L, V293, pG663, DOI 10.1152/ajpgi.00070.2007; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Roth GA, 2010, J SURG RES, V163, pE79, DOI 10.1016/j.jss.2010.04.004; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Sponheim J, 2010, AM J PATHOL, V177, P2804, DOI 10.2353/ajpath.2010.100378; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wang J, 2012, J INTERF CYTOK RES, V32, P248, DOI 10.1089/jir.2011.0109; Wang J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/819636; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003	34	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74278	10.1371/journal.pone.0074278	http://dx.doi.org/10.1371/journal.pone.0074278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058536	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400059
J	McFarland, DJ				McFarland, Dennis J.			Modeling Individual Subtests of the WAIS IV with Multiple Latent Factors	PLOS ONE			English	Article							CROSS-VALIDATION; MEMORY; BRAIN	Performance on a cognitive test can be viewed either as measuring a unitary function or as reflecting the operation of multiple factors. Individual subtests in batteries designed to measure human abilities are commonly modeled as a single latent factor. Several latent factors are then used to model groups of subtests. However these latent factors are not independent as they are related through hierarchical or oblique structures. As a result, the simple structure of subtest performance results in complex latent factors. The present study used structural equation modeling to evaluate several multidimensional models of the Wechsler Adult Intelligence Scales-fourth edition (WAIS-IV) subtests. Multidimensional models of subtest performance provided better model fit as compared to several previously proposed one dimensional models. These multidimensional models also generalized well to new samples of populations differing in age from that used to estimate the model parameters. Overall these results show that models that describe subtests as multidimensional functions of uncorrelated factors provided a better fit to the WAIS-IV correlations than models that describe subtests as one dimensional functions of correlated factors. There appears to be a trade-off in modeling subtests as one dimensional and modeling with homogeneous latent traits. More consideration should be given to models that include multiple uncorrelated latent factors as determinants of the performance on a given subtest. These results support the view that performance on any given cognitive test is potentially the result of multiple factors. Simple structure may be too simple.	New York State Dept Hlth, Lab Neural Injury & Repair, Wadsworth Ctr, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center	McFarland, DJ (corresponding author), New York State Dept Hlth, Lab Neural Injury & Repair, Wadsworth Ctr, Albany, NY USA.	mcfarlan@wadsworth.org						Anderson EJ, 2010, EXP BRAIN RES, V200, P91, DOI 10.1007/s00221-009-2000-5; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Bartholomew DJ, 2009, BRIT J MATH STAT PSY, V62, P569, DOI 10.1348/000711008X365676; Benson N, 2010, PSYCHOL ASSESSMENT, V22, P121, DOI 10.1037/a0017767; BROOKS JO, 1990, J EXP PSYCHOL LEARN, V16, P1134, DOI 10.1037/0278-7393.16.6.1134; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; CACACE AT, 1992, J NEUROSCI METH, V44, P145, DOI 10.1016/0165-0270(92)90007-Z; Canivez GL, 2010, PSYCHOL ASSESSMENT, V22, P827, DOI 10.1037/a0020429; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; CATTELL RB, 1962, PSYCHOL BULL, V59, P389, DOI 10.1037/h0048441; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; Franzen M., 2000, RELIABILITY VALIDITY; Franzen M. D., 1989, RELIABILITY VALIDITY; Gignac G. E., 2006, J INDIVID DIFFER, V27, P73, DOI [10.1027/1614-0001.27.2.73, DOI 10.1027/1614-0001.27.2.73]; Grossberg S, 2000, TRENDS COGN SCI, V4, P233, DOI 10.1016/S1364-6613(00)01464-9; GUILFORD JP, 1963, PSYCHOL BULL, V60, P289; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hart B, 1912, BRIT J PSYCHOL, V5, P51, DOI 10.1111/j.2044-8295.1912.tb00055.x; KAPLAN E, 1988, APHASIOLOGY, V2, P309, DOI 10.1080/02687038808248930; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; MACCALLUM RC, 1992, PSYCHOL BULL, V111, P490, DOI 10.1037/0033-2909.111.3.490; McFarland DJ, 2012, J CLIN EXP NEUROPSYC, V34, P378, DOI 10.1080/13803395.2011.645018; McFarland DJ., 1995, AM J AUDIOL, V4, P32, DOI DOI 10.1044/1059-0889.0403.36; Messaoud-Galusi S, 2011, J SPEECH LANG HEAR R, V54, P1682, DOI 10.1044/1092-4388(2011/09-0261); Milberg W. P., 2009, NEUROPSYCHOLOGICAL A; Mosier CI, 1951, EDUC PSYCHOL MEAS, V11, P5, DOI 10.1177/001316445101100101; Quine W. V. O., 1966, WAYS PARADOX; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; SAS Institute Inc, 2010, SAS STAT 9 22 US GUI; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; Smith GT, 2009, PSYCHOL ASSESSMENT, V21, P272, DOI 10.1037/a0016699; STEIGER JH, 1979, PSYCHOMETRIKA, V44, P157, DOI 10.1007/BF02293967; Thurstone LL, 1940, PSYCHOL BULL, V37, P189, DOI 10.1037/h0059402; Toga AW, 2005, ANNU REV NEUROSCI, V28, P1, DOI 10.1146/annurev.neuro.28.061604.135655; Tulsky DS, 2003, PSYCHOL ASSESSMENT, V15, P149, DOI 10.1037/1040-3590.15.2.149; Ward LC, 2012, PSYCHOL ASSESSMENT, V24, P328, DOI 10.1037/a0025614; Wechsler D., 2012, WAIS 4 KASIKIRJA	40	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74980	10.1371/journal.pone.0074980	http://dx.doi.org/10.1371/journal.pone.0074980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058643	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400103
J	Park, CM; March, K; Williams, S; Kukadia, S; Ghosh, AK; Jones, S; Tillin, T; Chaturvedi, N; Hughes, AD				Park, Chloe M.; March, Katherine; Williams, Suzanne; Kukadia, Suraj; Ghosh, Arjun K.; Jones, Siana; Tillin, Therese; Chaturvedi, Nish; Hughes, Alun D.			Feasibility and Reproducibility of Left Ventricular Rotation by Speckle Tracking Echocardiography in Elderly Individuals and the Impact of Different Software	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CORONARY-HEART-DISEASE; MAGNETIC-RESONANCE; DIASTOLIC DYSFUNCTION; TWIST MECHANICS; TORSION; DEFORMATION; PRINCIPLES; PARAMETERS; FRACTION	Background: Changes in ventricular rotation measured by two-dimensional speckle tracking echocardiography (2DSTE) are early indicators of cardiac disease. Data on the clinical feasibility of this important measure are scarce and there is no information on the comparability of different software versions. We assessed the feasibility, reproducibility and within patient temporal variability of 2DSTE in a large community based sample of older adults. We additionally compared 2DSTE results to those generated by 3DSTE. Methods and results: 1408 participants underwent transthoracic echocardiography. Using Philips Qlab 8.1 peak LV rotation at either the base or the apex was analysable in 432 (31%) participants. Peak twist measurements were achieved in 274 (20%) participants. 66 participants were randomly selected for the reproducibility study. 20 additional participants had scans 4-6 weeks apart for temporal variability and 3D echocardiography to assess the agreement between 2DSTE and 3DSTE. Reproducibility was evaluated using the intraclass coefficient of correlation (ICC). Better reproducibility for rotation and twist were obtained when measured at the endocardium, and when using more recent software versions, Peak twist and rotation were significantly different using two versions of the same software. Agreement with 3DSTE was better using newer software. Conclusion: Feasibility of 2DSTE is low in this cohort of elderly individuals severely limiting its utility in clinical settings. However if high quality images can be acquired assessment of ventricular rotation by 2DSTE is reproducible. Caution should be taken when comparing measurements of ventricular rotation by software from different vendors or different versions of software from the same vendor.	[Park, Chloe M.; March, Katherine; Williams, Suzanne; Kukadia, Suraj; Ghosh, Arjun K.; Jones, Siana; Tillin, Therese; Chaturvedi, Nish; Hughes, Alun D.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England	Imperial College London	Park, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England.	chloe.park@imperial.ac.uk	Hughes, Alun David/N-3781-2013; Ghosh, Arjun/ABC-9543-2020	Hughes, Alun David/0000-0001-5432-5271; Ghosh, Arjun/0000-0003-4992-2412; Park, Chloe/0000-0001-8302-7484; Tillin, Therese/0000-0003-1590-9826	Wellcome Trust [082464/2/07/2]; British Heart Foundation [SP/07001/23603, PG 08 103]; British Heart Foundation [PG/08/103/26133] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The work was supported by the Wellcome Trust [082464/2/07/2] and the British Heart Foundation [SP/07001/23603, PG 08 103]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu U, 2009, EUR J ECHOCARDIOGR, V10, P303, DOI 10.1093/ejechocard/jen238; Blackburn H, 1969, J Electrocardiol, V2, P305; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Chang SA, 2010, HEART, V96, P49, DOI 10.1136/hrt.2009.166629; Chung J, 2006, J AM COLL CARDIOL, V47, P384, DOI 10.1016/j.jacc.2005.08.061; FLAMENG W, 1984, CIRCULATION, V70, P7, DOI 10.1161/01.CIR.70.1.7; Fonseca CG, 2004, AM J CARDIOL, V94, P1391, DOI 10.1016/j.amjcard.2004.07.143; Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511; Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048; Han W, 2008, CHINESE MED J-PEKING, V121, P1543, DOI 10.1097/00029330-200808020-00008; Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558; INGELS NB, 1989, CIRC RES, V64, P915, DOI 10.1161/01.RES.64.5.915; Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Murdoch DR, 1998, EUR HEART J, V19, P1829, DOI 10.1053/euhj.1998.1269; Narula J, 2007, J AM COLL CARDIOL, V49, P917, DOI 10.1016/j.jacc.2006.12.006; Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082; Oxenham HC, 2003, J CARDIOV MAGN RESON, V5, P421, DOI 10.1081/JCMR-120022258; Park SJ, 2008, J AM SOC ECHOCARDIOG, V21, P1129, DOI 10.1016/j.echo.2008.04.002; PICANO E, 1990, CIRCULATION, V81, P58, DOI 10.1161/01.CIR.81.1.58; PRINZEN FW, 1986, AM J PHYSIOL, V250, pH255, DOI 10.1152/ajpheart.1986.250.2.H255; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Russel IK, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-26; Saito M, 2009, HEART, V95, P290, DOI 10.1136/hrt.2008.145979; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006; Taber LA, 1996, J BIOMECH, V29, P745, DOI 10.1016/0021-9290(95)00129-8; Takeuchi M, 2006, J AM SOC ECHOCARDIOG, V19, P1077, DOI 10.1016/j.echo.2006.04.011; Tillin T, 2010, INT J EPIDEMIOL; Torrent-Guasp F, 2005, EUR J CARDIO-THORAC, V27, P191, DOI 10.1016/j.ejcts.2004.11.026; van Dalen BM, 2008, AM J PHYSIOL-HEART C, V295, pH1705, DOI 10.1152/ajpheart.00513.2008; van Dalen BM, 2009, EUR J ECHOCARDIOGR, V10, P669, DOI 10.1093/ejechocard/jep036; Wang JW, 2009, J AM SOC ECHOCARDIOG, V22, P95, DOI 10.1016/j.echo.2008.10.015	34	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75098	10.1371/journal.pone.0075098	http://dx.doi.org/10.1371/journal.pone.0075098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058652	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400108
J	Yu, LN; Zhang, QL; Li, X; Hua, X; Cui, YM; Zhang, NJ; Liao, WT; Ding, YQ				Yu, Li-Na; Zhang, Qing-Ling; Li, Xin; Hua, Xing; Cui, Yan-Mei; Zhang, Nian-Jie; Liao, Wen-Ting; Ding, Yan-Qing			Tiam1 Transgenic Mice Display Increased Tumor Invasive and Metastatic Potential of Colorectal Cancer after 1,2-Dimethylhydrazine Treatment	PLOS ONE			English	Article							EXCHANGE FACTOR TIAM1; RAC ACTIVATOR TIAM1; COLON-CARCINOMA; CELL-MIGRATION; EXPRESSION; GTPASES; OVEREXPRESSION; ADHESION; PROTEIN; GROWTH	Background: T lymphoma invasion and metastasis 1 (Tiam1) is a potential modifier of tumor development and progression. Our previous study in vitro and in nude mice suggested a promotion role of Tiam1 on invasion and metastasis of colorectal cancer (CRC). In the present study, we generated Tiam1/C1199-CopGFP transgenic mice to investigate the tumorigenetic, invasive and metastatic alterations in the colon and rectum of wild-type and Tiam1 transgenic mice under 1,2-dimethylhydrazine (DMH) treatment. Methods: Transgenic mice were produced by the method of pronuclear microinlectlon. Whole-body fluorescence imaging (Lighttools, Edmonton, Alberta, Canada), PCR, and immunohistochemical techniques (IHC) were applied sequentially to identify the transgenic mice. The carcinogen DMH (20 mg/kg) was used to induce colorectal tumors though intraperitoneal (i.p.) injections once a week for 24 weeks from the age of 4 weeks on Tiam1 transgenic or non-transgenic mice. Results: We successfully generated Tiam1/C1199-CopGFP transgenic mice and induced primary tumors in the intestine of both wild type and Tiam1 transgenic mice by DMH treatment. In addition, Tiam1 transgenic mice developed larger and more aggressive neoplasm than wild-type mice. Moreover, immunohistochemical staining revealed that upregulation of Tiam1 was correlated with increased expression of beta-Catenin and Vimentin, and downregulation of E-Cadherin in these mice. Conclusions: Our study has provided in vivo evidence supporting that Tiam1 promotes invasion and metastasis of CRC, most probably through activation of Wnt/beta-catenin signaling pathway, in a Tiam1 transgenic mouse model.	[Yu, Li-Na; Zhang, Qing-Ling; Li, Xin; Cui, Yan-Mei; Zhang, Nian-Jie; Liao, Wen-Ting; Ding, Yan-Qing] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yu, Li-Na; Zhang, Qing-Ling; Li, Xin; Cui, Yan-Mei; Zhang, Nian-Jie; Liao, Wen-Ting; Ding, Yan-Qing] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yu, Li-Na; Zhang, Qing-Ling; Li, Xin; Cui, Yan-Mei; Zhang, Nian-Jie; Liao, Wen-Ting; Ding, Yan-Qing] Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou, Guangdong, Peoples R China; [Hua, Xing] Jinan Univ, Affiliated Hosp 4, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Hua, Xing] Guangzhou Red Cross Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Jinan University	Liao, WT (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	liaowt2002@gmail.com; dyq@fimmu.com			Natural Science Foundation of China [81001111, 81071735, 30901791]; Natural Science Foundation of Guangdong [S2011040003696]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by the Natural Science Foundation of China (nos: 81001111, 81071735, 30901791) and the Natural Science Foundation of Guangdong (S2011040003696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Bao YY, 2013, APOPTOSIS, V18, P260, DOI 10.1007/s10495-013-0802-1; Baraniskin A, 2012, CARCINOGENESIS, V33, P732, DOI 10.1093/carcin/bgs020; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cruz-Monserrate Z, 2008, NEOPLASIA, V10, P408, DOI 10.1593/neo.07868; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Qi Y, 2009, ORL-J OTO-RHIN-LARYN, V71, P163, DOI 10.1159/000223440; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Walch A, 2008, MODERN PATHOL, V21, P544, DOI 10.1038/modpathol.2008.3; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Xu K, 2010, ONCOGENE, V29, P6533, DOI 10.1038/onc.2010.385; Zhong M, 2013, CELL PHYSIOL BIOCHEM, V31, P209, DOI 10.1159/000343362	28	45	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73077	10.1371/journal.pone.0073077	http://dx.doi.org/10.1371/journal.pone.0073077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069171	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100028
J	Zerillo, MM; Adhikari, BN; Hamilton, JP; Buell, CR; Levesque, CA; Tisserat, N				Zerillo, Marcelo M.; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Levesque, C. Andre; Tisserat, Ned			Carbohydrate-Active Enzymes in Pythium and Their Role in Plant Cell Wall and Storage Polysaccharide Degradation	PLOS ONE			English	Article							ASPERGILLUS-NIGER; GENE FAMILY; PHYTOPATHOGENIC OOMYCETE; CELLULOSE DECOMPOSITION; PHYTOPHTHORA-INFESTANS; L-ARABINOFURANOSIDASE; GLYCOSYL HYDROLASE; BETA-GLUCOSIDASE; ALPHA-XYLOSIDASE; GENOME SEQUENCE	Carbohydrate-active enzymes (CAZymes) are involved in the metabolism of glycoconjugates, oligosaccharides, and polysaccharides and, in the case of plant pathogens, in the degradation of the host cell wall and storage compounds. We performed an in silico analysis of CAZymes predicted from the genomes of seven Pythium species (Py. aphanidermatum, Py. arrhenomanes, Py. irregulare, Py. iwayamai, Py. ultimum var. ultimum, Py. ultimum var. sporangiiferum and Py. vexans) using the "CAZymes Analysis Toolkit'' and "Database for Automated Carbohydrate-active Enzyme Annotation'' and compared them to previously published oomycete genomes. Growth of Pythium spp. was assessed in a minimal medium containing selected carbon sources that are usually present in plants. The in silico analyses, coupled with our in vitro growth assays, suggest that most of the predicted CAZymes are involved in the metabolism of the oomycete cell wall with starch and sucrose serving as the main carbohydrate sources for growth of these plant pathogens. The genomes of Pythium spp. also encode pectinases and cellulases that facilitate degradation of the plant cell wall and are important in hyphal penetration; however, the species examined in this study lack the requisite genes for the complete saccharification of these carbohydrates for use as a carbon source. Genes encoding for xylan, xyloglucan, (galacto)(gluco) mannan and cutin degradation were absent or infrequent in Pythium spp.. Comparative analyses of predicted CAZymes in oomycetes indicated distinct evolutionary histories. Furthermore, CAZyme gene families among Pythium spp. were not uniformly distributed in the genomes, suggesting independent gene loss events, reflective of the polyphyletic relationships among some of the species.	[Zerillo, Marcelo M.; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI USA; [Levesque, C. Andre] Agr & Agri Food Canada, Ottawa, ON, Canada; [Levesque, C. Andre] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Colorado State University; Michigan State University; Agriculture & Agri Food Canada; Carleton University	Zerillo, MM (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	mzerillo@colostate.edu	Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; zerillo, marcelo M/AAE-1735-2022	Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Adhikari, Bishwo/0000-0003-4840-9609; Buell, C Robin/0000-0002-6727-4677	USDA National Research Initiative Cooperative State Research Extension Education Service [2006-55605-16645]; USDA National Institute of Food and Agriculture Microbial Genome Sequencing Program [2007-35600-17774, 2007-35600-18886]	USDA National Research Initiative Cooperative State Research Extension Education Service; USDA National Institute of Food and Agriculture Microbial Genome Sequencing Program	Funding for the work was provided by a grant to CRB and NT by the USDA National Research Initiative Cooperative State Research Extension Education Service (grant 2006-55605-16645), USDA National Institute of Food and Agriculture Microbial Genome Sequencing Program (2007-35600-17774 and 2007-35600-18886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad ZG dCA, 2010, PERSOONIA, V24; Ademark P, 2001, EUR J BIOCHEM, V268, P2982, DOI 10.1046/j.1432-1327.2001.02188.x; Agrios GN, 2005, PLANT PATHOLOGY, Vxxiii; Alexopoulos C. J., 1996; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; ARONSON JM, 1978, MYCOLOGIA, V70, P363, DOI 10.2307/3759034; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; BAKER CJ, 1978, PHYTOPATHOLOGY, V68, P1577, DOI 10.1094/Phyto-68-1577; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bedard JEJ, 2006, MYCOL RES, V110, P86, DOI 10.1016/j.mycres.2005.08.001; Boudjeko T, 2006, PLANTA, V223, P271, DOI 10.1007/s00425-005-0090-2; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brunner F, 2002, PHYTOCHEMISTRY, V59, P689, DOI 10.1016/S0031-9422(02)00045-6; BULONE V, 1992, EXP MYCOL, V16, P8, DOI 10.1016/0147-5975(92)90037-R; Burges A, 1958, MICROORGANISMS SOIL; Campion C, 1998, CAN J MICROBIOL, V44, P221, DOI 10.1139/cjm-44-3-221; Campion C, 1997, EUR J PLANT PATHOL, V103, P725, DOI 10.1023/A:1008657319518; CAMPOSTAKAKI GM, 1982, J GEN MICROBIOL, V128, P207; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Chen W., 2011, COMPENDIUM CHICKPEA; CHERIF M, 1993, CAN J MICROBIOL, V39, P213, DOI 10.1139/m93-030; CHERIF M, 1991, PHYSIOL MOL PLANT P, V39, P353, DOI 10.1016/0885-5765(91)90017-C; COPAPATINO JL, 1994, CARBOHYD RES, V253, P265, DOI 10.1016/0008-6215(94)80071-5; Costanzo S, 2006, FUNGAL GENET BIOL, V43, P707, DOI 10.1016/j.fgb.2006.04.006; Coutinho PM, 2009, FUNGAL GENET BIOL, V46, pS161, DOI 10.1016/j.fgb.2008.07.020; de Vries RP, 2004, APPL ENVIRON MICROB, V70, P3954, DOI 10.1128/AEM.70.7.3954-3959.2004; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; DEACON JW, 1979, T BRIT MYCOL SOC, V72, P469, DOI 10.1016/S0007-1536(79)80156-4; Dick M, 1990, HDB PROTOCTISTA STRU, Vxli; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; Erwin D. C., 1983, PHYTOPHTHORA ITS BIO; Erwin DC, 1996, PHYTOPHTHORA DIS WOR, Vxii; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; GOLD SE, 1985, PHYTOPATHOLOGY, V75, P333, DOI 10.1094/Phyto-75-333; Gotesson A, 2002, MOL PLANT MICROBE IN, V15, P907, DOI 10.1094/MPMI.2002.15.9.907; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; Gupta AK, 2000, CARBOHYDRATE RESERVE; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hall R, 1991, COMPENDIUM BEAN DIS; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hartman GL., 1999, COMPENDIUM SOYBEAN D, V4th ed.; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; HERR D, 1978, EUR J APPL MICROBIOL, V5, P29, DOI 10.1007/BF00515684; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ihaka R, 1996, J COMPUT GRAPH STAT, V5, P16; JANARDHANAN KK, 1974, MYCOPATH MYCOL APPL, V52, P325, DOI 10.1007/BF02198762; Jiang RHY, 2006, MOL PLANT MICROBE IN, V19, P1311, DOI 10.1094/MPMI-19-1311; Jordan DB, 2007, BBA-PROTEINS PROTEOM, V1774, P1192, DOI 10.1016/j.bbapap.2007.06.010; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Leath KT, 1990, COMPENDIUM ALFALFA D, P16; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levesque CA, 2011, FUNGAL DIVERS, V50, P35, DOI 10.1007/s13225-011-0128-7; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; LEVESQUE CA, 1993, MYCOL RES, V97, P299, DOI 10.1016/S0953-7562(09)81124-6; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; MENA GL, 1994, PHYTOPATHOLOGY, V84, P502, DOI 10.1094/Phyto-84-502; Mendoza L, 1996, J MYCOL MED, V6, P151; MOORE LD, 1968, PHYTOPATHOLOGY, V58, P833; Munoz CI, 1998, CURR GENET, V33, P225, DOI 10.1007/s002940050330; NEMEC S, 1974, MYCOPATH MYCOL APPL, V52, P283, DOI 10.1007/BF02198756; Nijikken Y, 2007, FEBS LETT, V581, P1514, DOI 10.1016/j.febslet.2007.03.009; Okuyama M, 2006, FEBS LETT, V580, P2707, DOI 10.1016/j.febslet.2006.04.025; Ospina-Giraldo MD, 2010, CURR GENET, V56, P495, DOI 10.1007/s00294-010-0317-z; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picard K, 2000, APPL ENVIRON MICROB, V66, P4305, DOI 10.1128/AEM.66.10.4305-4314.2000; PORTER DM, 1984, COMPENDIUM PEANUT DI; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Riederer M., 2006, BIOL PLANT CUTICLE; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Rose J.K.C., 2003, PLANT CELL WALL; Schroeder KL, 2012, PLANT DIS IN PRESS; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-444; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR EE, 1963, CAN J MICROBIOL, V9, P353, DOI 10.1139/m63-043; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Torto TA, 2002, CURR GENET, V40, P385, DOI 10.1007/s00294-002-0272-4; Tripathy S, 2006, NUCLEIC ACIDS RES, V34, pD379, DOI 10.1093/nar/gkj042; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Valaskova V, 2006, MICROBIOL-SGM, V152, P3613, DOI 10.1099/mic.0.29149-0; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Willfor S, 2008, CARBOHYD POLYM, V72, P197, DOI 10.1016/j.carbpol.2007.08.006; WINSTEAD NN, 1961, PHYTOPATHOLOGY, V51, P270; Wu CH, 2008, MOL PLANT MICROBE IN, V21, P480, DOI 10.1094/MPMI-21-4-0480; Yakovlev I, 2012, APPL MICROBIOL BIOT, V95, P979, DOI 10.1007/s00253-012-4206-x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zavaliev R, 2011, PROTOPLASMA, V248, P117, DOI 10.1007/s00709-010-0247-0	106	60	61	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72572	10.1371/journal.pone.0072572	http://dx.doi.org/10.1371/journal.pone.0072572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069150	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100011
J	Zi, WJ; Shuai, J				Zi, Wen-Jie; Shuai, Jie			RETRACTED: Cortisol as a Prognostic Marker of Short-Term Outcome in Chinese Patients with Acute Ischemic Stroke (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							PITUITARY-ADRENAL AXIS; SERUM-CORTISOL; ACUTE-PHASE; STRESS; MORTALITY; GLUCOCORTICOIDS; CLASSIFICATION; ACTIVATION; HORMONE; BURDEN	Background: Early prediction of outcome is important for allocation of therapeutic strategies. Endocrine alterations of the hypothalamus-pituitary-axis are one of the first stress-induced alterations after cerebral ischemia. We therefore evaluated the prognostic value of serum cortisol in Chinese patients with an acute ischemic stroke. Methods: In a prospective observational study, serum cortisol was measured using a solid-phase, competitive chemiluminescent enzyme immunoassay on admission in serum of 226 consecutive Chinese patients with an acute ischemic stroke. The prognostic value of serum cortisol to predict the functional outcome, mortality within 90 days, was compared with clinical variables (e. g., advanced age and the National Institutes of Health Stroke Scale [NHISS] score) and with other known predictors. Results: Patients with a poor outcome and nonsurvivors had significantly increased serum cortisol levels on admission (P<0.0001, P<0.0001). There was a positive correlation between levels of cortisol and the NIHSS (r = 0.298, P<0.0001), glucose levels (r = 0.324, P<0.0001) and infarct volume (r = 0.328, P<0.0001). Cortisol was an independent prognostic marker of functional outcome and death [odds ratio 3.44 (2.58-6.23) and 4.21 (1.89-9.24), respectively, P<0.0001 for both, adjusted for age, the NIHSS and other predictors] in patients with ischemic stroke. In receiver operating characteristic curve analysis, cortisol could improve the NIHSS score in predicting short-term functional outcome (Area under the curve [AUC] of the combined model, 0.87; 95% CI, 0.82-0.92; P = 0.01) and mortality (AUC of the combined model, 0.90; 95% CI, 0.84-0.95; P = 0.01). Conclusion: Cortisol can be seen as an independent short-term prognostic marker of functional outcome and death in Chinese patients with acute ischemic stroke even after correcting confounding factors. Combined model can add significant additional predictive information to the clinical score of the NIHSS.	[Zi, Wen-Jie; Shuai, Jie] Third Mil Med Univ, Xin Qiao Hosp, Dept Neurol, Chongqing, Peoples R China	Army Medical University	Shuai, J (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Neurol, Chongqing, Peoples R China.	zhangbytianjin@163.com						ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Anne M, 2007, CURR NEUROVASC RES, V4, P170, DOI 10.2174/156720207781387169; ASTROM M, 1993, STROKE, V24, P52, DOI 10.1161/01.STR.24.1.52; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Christensen H, 2004, J NEUROL SCI, V217, P175, DOI 10.1016/j.jns.2003.09.013; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; FASSBENDER K, 1994, STROKE, V25, P1105, DOI 10.1161/01.STR.25.6.1105; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Fiorentino L, 2012, J GERONTOL A-BIOL, V67, P677, DOI 10.1093/gerona/glr230; Fuchs E, 1998, NEUROSCI BIOBEHAV R, V23, P295, DOI 10.1016/S0149-7634(98)00031-1; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Ibrahimagic Omer C, 2005, Med Arh, V59, P79; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Katan M, 2011, EXPERT REV NEUROTHER, V11, P225, DOI 10.1586/ERN.10.200; Krugers HJ, 2000, STROKE, V31, P1162, DOI 10.1161/01.STR.31.5.1162; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mu DL, 2010, CRIT CARE, V14, DOI 10.1186/cc9393; MURROS K, 1993, J NEUROL SCI, V116, P12, DOI 10.1016/0022-510X(93)90083-B; Neidert S, 2011, J INTERN MED, V269, P420, DOI 10.1111/j.1365-2796.2010.02327.x; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; Parker CR, 2000, J CLIN ENDOCR METAB, V85, P48, DOI 10.1210/jc.85.1.48; Potocki M, 2010, CRIT CARE, V14, DOI 10.1186/cc9336; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schoorlemmer RMM, 2009, CLIN ENDOCRINOL, V71, P779, DOI 10.1111/j.1365-2265.2009.03552.x; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Slowik A, 2002, J NEUROL SCI, V196, P27, DOI 10.1016/S0022-510X(02)00018-7; Wilkinson CW, 2001, J CLIN ENDOCR METAB, V86, P545, DOI 10.1210/jc.86.2.545; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	35	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72758	10.1371/journal.pone.0072758	http://dx.doi.org/10.1371/journal.pone.0072758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069157	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100017
J	Asante, CO; Martin, JH				Asante, Curtis O.; Martin, John H.			Differential Joint-Specific Corticospinal Tract Projections within the Cervical Enlargement	PLOS ONE			English	Article							MOUSE MOTOR CORTEX; SPINAL-CORD; INTRACORTICAL MICROSTIMULATION; CHOLINERGIC INTERNEURONS; PRECENTRAL CORTEX; PARTITION CELLS; NEURONS; CIRCUITS; ORGANIZATION; PREMOTOR	The motor cortex represents muscle and joint control and projects to spinal cord interneurons and-in many primates, including humans-motoneurons, via the corticospinal tract (CST). To examine these spinal CST anatomical mechanisms, we determined if motor cortex sites controlling individual forelimb joints project differentially to distinct cervical spinal cord territories, defined regionally and by the locations of putative last-order interneurons that were transneuronally labeled by intramuscular injection of pseudorabies virus. Motor cortex joint-specific sites were identified using intracortical-microstimulation. CST segmental termination fields from joint-specific sites, determined using anterograde tracers, comprised a high density core of terminations that was consistent between animals and a surrounding lower density projection that was more variable. Core terminations from shoulder, elbow, and wrist control sites overlapped in the medial dorsal horn and intermediate zone at C5/C6 but were separated at C7/C8. Shoulder sites preferentially terminated dorsally, in the dorsal horn; wrist/digit sites, more ventrally in the intermediate zone; and elbow sites, medially in the dorsal horn and intermediate zone. Pseudorabies virus injected in shoulder, elbow, or wrist muscles labeled overlapping populations of predominantly muscle-specific putative premotor interneurons, at a survival time for disynaptic transfer from muscle. At C5/C6, CST core projections from all joint zones were located medial to regions of densely labeled last-order interneurons, irrespective of injected muscle. At C7/C8 wrist CST core projections overlapped the densest interneuron territory, which was located in the lateral intermediate zone. In contrast, elbow CST core projections were located medial to the densest interneuron territories, and shoulder CST core projections were located dorsally and only partially overlapped the densest interneuron territory. Our findings show a surprising fractionation of CST terminations in the caudal cervical enlargement that may be organized to engage different spinal premotor circuits for distal and proximal joint control.	[Asante, Curtis O.; Martin, John H.] CUNY City Coll, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA; [Martin, John H.] Columbia Univ, Dept Neurosci, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); Columbia University	Martin, JH (corresponding author), CUNY City Coll, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.	jmartin@ccny.cuny.edu			National Institutes of Health (NIH) [NS064004, NS 079569]; March of Dimes Research Foundation; Motor Neuron Center of Columbia University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064004, R01NS079569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Foundation(March of Dimes); Motor Neuron Center of Columbia University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) NS064004, NS 079569, March of Dimes Research Foundation, and Motor Neuron Center of Columbia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Anelli R, 2005, J NEUROCYTOL, V34, P369, DOI 10.1007/s11068-006-8724-2; ASANUMA H, 1976, EXP BRAIN RES, V26, P443; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brown, 1981, ORG SPINAL CORD ANAT; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; Cederquist GY, 2013, J NEUROSCI, V33, P6321, DOI 10.1523/JNEUROSCI.5140-12.2013; Chakrabarty S, 2011, EUR J NEUROSCI, V34, P682, DOI 10.1111/j.1460-9568.2011.07798.x; Chakrabarty S, 2010, J NEUROSCI, V30, P2277, DOI 10.1523/JNEUROSCI.5286-09.2010; Chakrabarty S, 2009, J NEUROSCI, V29, P8816, DOI 10.1523/JNEUROSCI.0735-09.2009; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Enjin A, 2010, J COMP NEUROL, V518, P2284, DOI 10.1002/cne.22332; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Granmo M, 2008, J NEUROSCI, V28, P5494, DOI 10.1523/JNEUROSCI.0651-08.2008; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; Jovanovic K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011743; Kuypers HGJM., HDB PHYSL NERVOUS SY, P56; Lemon RN, 1998, NOVART FDN SYMP, V218, P202; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Mentis GZ, 2006, J NEUROSCI, V26, P13297, DOI 10.1523/JNEUROSCI.2945-06.2006; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Olave MJ, 2002, EXP BRAIN RES, V145, P448, DOI 10.1007/s00221-002-1142-5; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Porter R, 1993, CORTICOSPINAL FUNCTI; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; SCHMIDT EM, 1990, J NEUROPHYSIOL, V64, P1668, DOI 10.1152/jn.1990.64.6.1668; SCHOEN J H, 1964, Prog Brain Res, V11, P203; Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009; Shehab SAS, 2003, BRAIN RES, V964, P218, DOI 10.1016/S0006-8993(02)04001-5; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stout EE, 2012, J NEUROPHYS IN PRESS, DOI [10.1152/jn.00650.2011, DOI 10.1152/JN.00650.2011)]; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Tosolini AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00058; VERBURGH CA, 1989, EXP BRAIN RES, V75, P73; Yang HW, 2003, EXP BRAIN RES, V149, P458, DOI 10.1007/s00221-003-1393-9; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	48	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74454	10.1371/journal.pone.0074454	http://dx.doi.org/10.1371/journal.pone.0074454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058570	Green Published, gold			2022-12-27	WOS:000324695900045
J	Elliott, R; Li, F; Dragomir, I; Chua, MMW; Gregory, BD; Weiss, SR				Elliott, Ruth; Li, Fan; Dragomir, Isabelle; Chua, Ming Ming W.; Gregory, Brian D.; Weiss, Susan R.			Analysis of the Host Transcriptome from Demyelinating Spinal Cord of Murine Coronavirus-Infected Mice	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ANTIGEN-PRESENTING CELLS; MYELIN BASIC-PROTEIN; CLASS-I MOLECULES; MULTIPLE-SCLEROSIS; VIRAL PERSISTENCE; DIFFERENTIAL EXPRESSION	Persistent infection of the mouse central nervous system (CNS) with mouse hepatitis virus (MHV) induces a demyelinating disease pathologically similar to multiple sclerosis and is therefore used as a model system. There is little information regarding the host factors that correlate with and contribute to MHV-induced demyelination. Here, we detail the genes and pathways associated with MHV-induced demyelinating disease in the spinal cord. High-throughput sequencing of the host transcriptome revealed that demyelination is accompanied by numerous transcriptional changes indicative of immune infiltration as well as changes in the cytokine milieu and lipid metabolism. We found evidence that a Th1-biased cytokine/chemokine response and eicosanoid-derived inflammation accompany persistent MHV infection and that antigen presentation is ongoing. Interestingly, increased expression of genes involved in lipid transport, processing, and catabolism, including some with known roles in neurodegenerative diseases, coincided with demyelination. Lastly, expression of several genes involved in osteoclast or bone-resident macrophage function, most notably TREM2 and DAP12, was upregulated in persistently infected mouse spinal cord. This study highlights the complexity of the host antiviral response, which accompany MHV-induced demyelination, and further supports previous findings that MHV-induced demyelination is immune-mediated. Interestingly, these data suggest a parallel between bone reabsorption by osteoclasts and myelin debris clearance by microglia in the bone and the CNS, respectively. To our knowledge, this is the first report of using an RNA-seq approach to study the host CNS response to persistent viral infection.	[Elliott, Ruth; Chua, Ming Ming W.; Weiss, Susan R.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Fan; Dragomir, Isabelle; Gregory, Brian D.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Weiss, SR (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	weisssr@upenn.edu	Gregory, Brian D/G-2890-2010	Li, Fan/0000-0002-2400-9021	National Multiple Sclerosis Society [RG 3843A6/1]; National Institutes of Health (NIH) [RO1-NS-054695]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054695] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant RG 3843A6/1 from the National Multiple Sclerosis Society and National Institutes of Health (NIH) grant RO1-NS-054695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aoki N, 2000, J IMMUNOL, V165, P3790, DOI 10.4049/jimmunol.165.7.3790; ARM JP, 1991, J BIOL CHEM, V266, P15966; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bender SJ, 2010, J VIROL, V84, P11030, DOI 10.1128/JVI.02688-09; Bender SJ, 2010, J NEUROIMMUNE PHARM, V5, P336, DOI 10.1007/s11481-010-9202-2; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bergmann CC, 1998, ADV EXP MED BIOL, V440, P751; Bergmann CC, 1999, J IMMUNOL, V163, P3379; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bornsen L, 2011, MULT SCLER J, V17, P32, DOI 10.1177/1352458510382247; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Caamano J, 1999, J IMMUNOL, V163, P4453; CANTZ M, 1974, EUR J BIOCHEM, V47, P581, DOI 10.1111/j.1432-1033.1974.tb03729.x; CASTRO RF, 1994, VIROLOGY, V200, P733, DOI 10.1006/viro.1994.1237; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dandekar AA, 2005, J VIROL, V79, P9388, DOI 10.1128/JVI.79.15.9388-9396.2005; Dandekar AA, 2001, J VIROL, V75, P6115, DOI 10.1128/JVI.75.13.6115-6120.2001; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; DUBOISDALCQ ME, 1982, VIROLOGY, V119, P317, DOI 10.1016/0042-6822(82)90092-7; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Eto M, 2008, J PERIPHER NERV SYST, V13, P242, DOI 10.1111/j.1529-8027.2008.00183.x; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Ferrandi C, 2011, MULT SCLER, V17, P43, DOI 10.1177/1352458510381258; FLEURY HJA, 1980, NEUROPATH APPL NEURO, V6, P165, DOI 10.1111/j.1365-2990.1980.tb00288.x; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Gingras MC, 2001, IMMUNOGENETICS, V53, P468, DOI 10.1007/s002510100345; Glezer I, 2010, BRAIN BEHAV IMMUN, V24, P695, DOI 10.1016/j.bbi.2010.01.005; GOMBOLD JL, 1993, J VIROL, V67, P4504, DOI 10.1128/JVI.67.8.4504-4512.1993; Gonzalez JM, 2006, AM J PATHOL, V168, P796, DOI 10.2353/ajpath.2006.050496; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hosking MP, 2010, CRIT REV IMMUNOL, V30, P119, DOI 10.1615/CritRevImmunol.v30.i2.20; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Ireland DDC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000602; JOHNSON AB, 1971, P NATL ACAD SCI USA, V68, P2694, DOI 10.1073/pnas.68.11.2694; Knobler R L, 1983, Acta Neuropathol Suppl, V9, P31; KNOBLER RL, 1982, NATURE, V298, P279, DOI 10.1038/298279a0; KNOBLER RL, 1981, J NEUROIMMUNOL, V1, P81, DOI 10.1016/0165-5728(81)90010-2; KRISTENSSON K, 1986, NATURE, V322, P544, DOI 10.1038/322544a0; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LAMPERT PW, 1973, ACTA NEUROPATHOL, V24, P76, DOI 10.1007/BF00691421; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; LAVI E, 1984, J VIROL, V51, P563, DOI 10.1128/JVI.51.2.563-566.1984; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; Lavi E, 1984, Adv Exp Med Biol, V173, P237; LEDEEN RW, 1984, J LIPID RES, V25, P1548; Lee SK, 2006, CURR OPIN RHEUMATOL, V18, P411, DOI 10.1097/01.bor.0000231911.42666.78; Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026; Liu MT, 2001, J IMMUNOL, V167, P4091, DOI 10.4049/jimmunol.167.7.4091; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; MacNamara KC, 2005, J VIROL, V79, P3370, DOI 10.1128/JVI.79.6.3370-3381.2005; MARKS SC, 1989, AM J MED GENET, V34, P43, DOI 10.1002/ajmg.1320340110; Marten NW, 1999, J IMMUNOL, V162, P3905; Marten NW, 2000, J VIROL, V74, P7903, DOI 10.1128/JVI.74.17.7903-7910.2000; MARTENSON RE, 1972, J IMMUNOL, V109, P262; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Matthews AE, 2002, J NEUROVIROL, V8, P257, DOI 10.1080/13550280290049697; Matthews AE, 2002, J NEUROVIROL, V8, P76, DOI 10.1080/13550280290049534; Mirshafiey A, 2010, IMMUNOPHARM IMMUNOT, V32, P543, DOI 10.3109/08923971003667627; Mitew S, 2010, ACTA NEUROPATHOL, V119, P567, DOI 10.1007/s00401-010-0657-2; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Parra B, 2001, ADV EXP MED BIOL, V494, P335; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Pewe L, 1996, IMMUNITY, V5, P253, DOI 10.1016/S1074-7613(00)80320-9; Phares TW, 2009, J IMMUNOL, V182, P5430, DOI 10.4049/jimmunol.0803557; POWELL HC, 1975, LAB INVEST, V33, P440; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Rose KM, 2010, J VIROL, V84, P5656, DOI 10.1128/JVI.00211-10; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Roth-Cross JK, 2007, J VIROL, V81, P7189, DOI 10.1128/JVI.00013-07; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sagar D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-245; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SANDBERGWOLLHEIM M, 1975, SCAND J IMMUNOL, V4, P831, DOI 10.1111/j.1365-3083.1975.tb03724.x; Santamaria I, 1998, J BIOL CHEM, V273, P16816, DOI 10.1074/jbc.273.27.16816; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Schmitz G, 1999, PATHOBIOLOGY, V67, P236, DOI 10.1159/000028100; Scott EP, 2008, J NEUROVIROL, V14, P5, DOI 10.1080/13550280701750635; SEDGWICK JD, 1986, J NEUROIMMUNOL, V13, P217, DOI 10.1016/0165-5728(86)90066-4; Shi J, 2011, COGN BEHAV NEUROL, V24, P128, DOI 10.1097/WNN.0b013e31823380b5; Spach KM, 2004, PHYSIOL GENOMICS, V18, P141, DOI 10.1152/physiolgenomics.00003.2004; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPILSBURY K, 1995, BLOOD, V85, P1620, DOI 10.1182/blood.V85.6.1620.bloodjournal8561620; Stark Z, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-5; Stohlman S A, 1995, Adv Exp Med Biol, V380, P173; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sutherland RM, 1997, J NEUROVIROL, V3, P225, DOI 10.3109/13550289709018297; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; SWANBORG RH, 1971, J IMMUNOL, V107, P281; Takebayashi H, 2002, MECH DEVELOP, V113, P169, DOI 10.1016/S0925-4773(02)00021-7; Tamam Y, 2011, EUR REV MED PHARMACO, V15, P1122; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Templeton SP, 2008, BRAIN PATHOL, V18, P40, DOI 10.1111/j.1750-3639.2007.00098.x; Tsunoda I, 2004, MULT SCLER J, V10, P26, DOI 10.1191/1352458504ms982oa; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; WANG FI, 1992, LAB INVEST, V66, P744; Wilson HL, 2012, BIOL-TARGETS THER, V6, P117, DOI 10.2147/BTT.S24734; WOYCIECHOWSKA J L, 1984, Journal of Experimental Pathology (New York), V1, P295; Wu GF, 2001, ADV EXP MED BIOL, V494, P341; Wu GF, 1999, J VIROL, V73, P8771, DOI 10.1128/JVI.73.10.8771-8780.1999; Wu GF, 2000, J IMMUNOL, V165, P2278, DOI 10.4049/jimmunol.165.4.2278; WUCHERPFENNIG KW, 1994, CLIN IMMUNOL IMMUNOP, V72, P293, DOI 10.1006/clin.1994.1145; Xue SR, 1999, J VIROL, V73, P6327, DOI 10.1128/JVI.73.8.6327-6334.1999; Zhao JX, 2009, J IMMUNOL, V183, P5163, DOI 10.4049/jimmunol.0902164; ZHAO L, 2011, J VIROL; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; ZIMPRICH F, 1991, J VIROL, V65, P1789	147	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75346	10.1371/journal.pone.0075346	http://dx.doi.org/10.1371/journal.pone.0075346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058676	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900108
J	Kuebler, M; Yom-Tov, E; Pelleg, D; Puhl, RM; Muennig, P				Kuebler, Meghan; Yom-Tov, Elad; Pelleg, Dan; Puhl, Rebecca M.; Muennig, Peter			When Overweight Is the Normal Weight: An Examination of Obesity Using a Social Media Internet Database	PLOS ONE			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; UNITED-STATES; METABOLICALLY HEALTHY; STIGMA; PREVALENCE; CHILDREN; STRESS; DISCRIMINATION; MISPERCEPTION	Using a large social media database, Yahoo Answers, we explored postings to an online forum in which posters asked whether their height and weight qualify themselves as "skinny,'' "thin,'' "fat,'' or "obese'' over time and across forum topics. We used these data to better understand whether a higher-than-average body mass index (BMI) in one's county might, in some ways, be protective for one's mental and physical health. For instance, we explored whether higher proportions of obese people in one's county predicts lower levels of bullying or "am I fat?'' questions from those with a normal BMI relative to his/her actual BMI. Most women asking whether they were themselves fat/obese were not actually fat/obese. Both men and women who were actually overweight/obese were significantly more likely in the future to ask for advice about bullying than thinner individuals. Moreover, as mean county-level BMI increased, bullying decreased and then increased again (in a U-shape curve). Regardless of where they lived, posters who asked "am I fat?'' who had a BMI in the healthy range were more likely than other posters to subsequently post on health problems, but the proportions of such posters also declined greatly as county-level BMI increased. Our findings suggest that obese people residing in counties with higher levels of BMI may have better physical and mental health than obese people living in counties with lower levels of BMI by some measures, but these improvements are modest.	[Kuebler, Meghan; Muennig, Peter] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Yom-Tov, Elad] Microsoft Res Israel, Herzliyya, Israel; [Pelleg, Dan] Yahoo Labs, Haifa, Matam Park, Israel; [Puhl, Rebecca M.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT USA	Columbia University; Yale University	Kuebler, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.	meghankuebler@gmail.com; pm124@columbia.edu	Puhl, Rebecca/ABE-9260-2021	Muennig, Peter/0000-0002-4234-0498; Yom-Tov, Elad/0000-0002-2380-4584				Ali MM, 2011, SOUTH ECON J, V77, P827, DOI 10.4284/0038-4038-77.4.827; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Boyes AD, 2009, J SEX MARITAL THER, V35, P282, DOI 10.1080/00926230902851280; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Center for Disease Control, 2012, DEF OV OB; Centers for Disease Control and Prevention, 2008, COUNT LEV EST OB US; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Falkner NH, 1999, OBES RES, V7, P572, DOI 10.1002/j.1550-8528.1999.tb00716.x; Friedman KE, 2005, OBES RES, V13, P907, DOI 10.1038/oby.2005.105; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Guo S S, 1999, Am J Clin Nutr, V70, p145S, DOI 10.1093/ajcn/70.1.145s; Homan G, 2012, HUM REPROD, V27, P2396, DOI 10.1093/humrep/des176; Jaworowska A, 2009, BIOMED PHARMACOTHER, V63, P679, DOI 10.1016/j.biopha.2008.08.005; Johnson F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a494; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LEMARCHAND L, 1988, AM J EPIDEMIOL, V128, P874, DOI 10.1093/oxfordjournals.aje.a115040; Mackey ER, 2008, J YOUTH ADOLESCENCE, V37, P1097, DOI 10.1007/s10964-008-9299-2; Matthiasdottir E, 2012, EUR J PUBLIC HEALTH, V22, P116, DOI 10.1093/eurpub/ckq178; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; McDowell Margaret A, 2008, Natl Health Stat Report, P1; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Muennig P, 2008, AM J PUBLIC HEALTH, V98, P501, DOI 10.2105/AJPH.2007.114769; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019; Muennig P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-128; Muennig P, 2009, STRESS HEALTH, V25, P241, DOI 10.1002/smi.1243; Neuman WL, 2011, SOCIAL RES METHODS Q, V7th; Nieto-Garcia F J, 1990, Epidemiology, V1, P146, DOI 10.1097/00001648-199003000-00011; Nihiser AJ, 2007, J SCHOOL HEALTH, V77, P651, DOI 10.1111/j.1746-1561.2007.00249.x; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pelleg D, 2013, TOUCH SCREENS TOUCHY; Phillips Katharine A, 2004, World Psychiatry, V3, P12; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rosenberger PH, 2007, OBES SURG, V17, P470, DOI 10.1007/s11695-007-9082-6; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Roy JP, 2004, MED HYPOTHESES, V62, P222, DOI 10.1016/S0306-9877(03)00315-3; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singleton R.A., 2005, APPROACHES SOCIAL RE; US Bureau of Census, 2001, US CENS POP HOUS 200; Wang J, 2010, J ADOLESCENT HEALTH, V47, P99, DOI 10.1016/j.jadohealth.2009.12.007; Webster M, 2012, SOCIAL MEDIA	57	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73479	10.1371/journal.pone.0073479	http://dx.doi.org/10.1371/journal.pone.0073479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058478	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900015
J	Lim, SM; Koraka, P; van Boheemen, S; Roose, JM; Jaarsma, D; van de Vijver, DAMC; Osterhaus, ADME; Martina, BEE				Lim, Stephanie M.; Koraka, Penelope; van Boheemen, Sander; Roose, Jouke M.; Jaarsma, Dick; van de Vijver, David A. M. C.; Osterhaus, Albert D. M. E.; Martina, Byron E. E.			Characterization of the Mouse Neuroinvasiveness of Selected European Strains of West Nile Virus	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; COOPERATIVE INTERACTIONS; PHYLOGENETIC ANALYSIS; UNITED-STATES; LINEAGE 2; INFECTION; ENCEPHALITIS; VIRULENCE; EXPRESSION; PATHOLOGY	West Nile virus (WNV) has caused outbreaks and sporadic infections in Central, Eastern and Mediterranean Europe for over 45 years. Most strains responsible for the European and Mediterranean basin outbreaks are classified as lineage 1. In recent years, WNV strains belonging to lineage 1 and 2 have been causing outbreaks of neuroinvasive disease in humans in countries such as Italy, Hungary and Greece, while mass mortality among birds was not reported. This study characterizes three European strains of WNV isolated in Italy (FIN and Ita09) and Hungary (578/10) in terms of in vitro replication kinetics on neuroblastoma cells, LD50 values in C57BL/6 mice, median day mortality, cumulative mortality, concentration of virus in the brain and spinal cord, and the response to infection in the brain. Overall, the results indicate that strains circulating in Europe belonging to both lineage 1 and 2 are highly virulent and that Ita09 and 578/10 are more neurovirulent compared to the FIN strain.	[Lim, Stephanie M.; Koraka, Penelope; van Boheemen, Sander; Roose, Jouke M.; van de Vijver, David A. M. C.; Osterhaus, Albert D. M. E.; Martina, Byron E. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Jaarsma, Dick] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Martina, BEE (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	b.martina@erasmusmc.nl		van de Vijver, David/0000-0001-5877-8526; Martina, Byron/0000-0003-4980-4619; Osterhaus, Albert/0000-0002-6074-1172	European Community's Seventh Framework Programme; EC [261466]	European Community's Seventh Framework Programme(European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results has received complete funding from the European Community's Seventh Framework Programme (FP7/2007 - 2013) under the project "VECTORIE", EC grant agreement number 261466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Barzon L, 2009, EUROSURVEILLANCE, V14; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Burt FJ, 2002, EMERG INFECT DIS, V8, P820, DOI 10.3201/eid0808.020027; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Centers for Disease Control and Prevention, 1999, MMWR-MORBID MORTAL W, P890; Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58; Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0; Cushing MM, 2004, AM J CLIN PATHOL, V121, P26, DOI 10.1309/G23CP54DAR1BCY8L; Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Deubel V, 2001, ANN NY ACAD SCI, V951, P195; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2007, EVOLUTION HLTH DIS; Ellis AE, 2007, J WILDLIFE DIS, V43, P214, DOI 10.7589/0090-3558-43.2.214; Finny D., 1947, PROBIT ANAL STAT TRE, P256; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; KARBER G, 1931, ARCH EXP PATHOL PH, P162; Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006; Komar N, 2000, REV SCI TECH OIE, V19, P166, DOI 10.20506/rst.19.1.1201; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; MANUELIDIS EE, 1956, J NEUROPATH EXP NEUR, V15, P448, DOI 10.1097/00005072-195610000-00007; Mateo R, 2006, AM J TROP MED HYG, V75, P356, DOI 10.4269/ajtmh.2006.75.356; Mori I, 2000, MICROBIOL IMMUNOL, V44, P729, DOI 10.1111/j.1348-0421.2000.tb02556.x; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Ng ML, 2001, J MED VIROL, V65, P758, DOI 10.1002/jmv.2101; Olberg RA, 2004, EMERG INFECT DIS, V10, P712, DOI 10.3201/eid1004.030675; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Papadogiannakis A., 2010, EUROSEC 10, P15; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rizzo C, 2009, EUROSURVEILLANCE, P14; Rossini G, 2008, EUROSURVEILLANCE, V13; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Tran CT, 1998, NEUROPATH APPL NEURO, V24, P293, DOI 10.1046/j.1365-2990.1998.00120.x; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Weiss RA, 2002, TRENDS MICROBIOL, V10, P314, DOI 10.1016/S0966-842X(02)02391-0; Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036; Xiao SY, 2001, EMERG INFECT DIS, V7, P714	57	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74575	10.1371/journal.pone.0074575	http://dx.doi.org/10.1371/journal.pone.0074575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058590	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900058
J	Sheets, AL; Lai, PL; Fisher, LC; Basso, DM				Sheets, Alison L.; Lai, Po-Lun; Fisher, Lesley C.; Basso, D. Michele			Quantitative Evaluation of 3D Mouse Behaviors and Motor Function in the Open- Field after Spinal Cord Injury Using Markerless Motion Tracking	PLOS ONE			English	Article							CENTER-OF-MASS; SHAPE-FROM-SILHOUETTE; OVERGROUND LOCOMOTION; GAIT ANALYSIS; VISUAL HULL; RECOVERY; SCALE; MICE; CONTUSION; TREADMILL	Thousands of scientists strive to identify cellular mechanisms that could lead to breakthroughs in developing ameliorative treatments for debilitating neural and muscular conditions such as spinal cord injury (SCI). Most studies use rodent models to test hypotheses, and these are all limited by the methods available to evaluate animal motor function. This study's goal was to develop a behavioral and locomotor assessment system in a murine model of SCI that enables quantitative kinematic measurements to be made automatically in the open-field by applying markerless motion tracking approaches. Threedimensional movements of eight naive, five mild, five moderate, and four severe SCI mice were recorded using 10 cameras (100 Hz). Background subtraction was used in each video frame to identify the animal's silhouette, and the 3D shape at each time was reconstructed using shape-from-silhouette. The reconstructed volume was divided into front and back halves using k-means clustering. The animal's front Center of Volume (CoV) height and whole-body CoV speed were calculated and used to automatically classify animal behaviors including directed locomotion, exploratory locomotion, meandering, standing, and rearing. More detailed analyses of CoV height, speed, and lateral deviation during directed locomotion revealed behavioral differences and functional impairments in animals with mild, moderate, and severe SCI when compared with naive animals. Naive animals displayed the widest variety of behaviors including rearing and crossing the center of the open-field, the fastest speeds, and tallest rear CoV heights. SCI reduced the range of behaviors, and decreased speed (r =.70 p<005) and rear CoV height (r =.65 p,. 01) were significantly correlated with greater lesion size. This markerless tracking approach is a first step toward fundamentally changing how rodent movement studies are conducted. By providing scientists with sensitive, quantitative measurement methods, subjectivity and human error is reduced, potentially providing insights leading to breakthroughs in treating human disease.	[Sheets, Alison L.] Ohio State Univ, Dept Mech & Aeronaut Engn, Columbus, OH 43210 USA; [Lai, Po-Lun] Ohio State Univ, Columbus, OH 43210 USA; [Fisher, Lesley C.; Basso, D. Michele] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sheets, AL (corresponding author), Ohio State Univ, Dept Mech & Aeronaut Engn, Columbus, OH 43210 USA.	Alison.sheets@gmail.com			National Institute of Health [R21 NS-077446-01, NINDS P30-NS045758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R21NS077446] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this research was provided by the National Institute of Health (R21 NS-077446-01 and NINDS P30-NS045758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2009, J EXP BIOL, V212, P2668, DOI 10.1242/jeb.027581; Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BASSO DM, 1994, RESTOR NEUROL NEUROS, V7, P95, DOI 10.3233/RNN-1994-7205; Bauman JM, 2010, J NEUROSCI METH, V186, P18, DOI 10.1016/j.jneumeth.2009.10.017; Bouguet J-Y, 2010, CAMERA CALIBRATION T; Cheung GKM, 2003, PROC CVPR IEEE, P77; Cheung KM, 2005, INT J COMPUT VISION, V63, P225, DOI 10.1007/s11263-005-6879-4; Corazza S, 2006, ANN BIOMED ENG, V34, P1019, DOI 10.1007/s10439-006-9122-8; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hansen CN, 2013, J NEUROSCI IN PRESS; Herbin M, 2007, BEHAV BRAIN RES, V181, P173, DOI 10.1016/j.bbr.2007.04.001; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Kafkafi N, 2001, J NEUROSCI METH, V109, P111, DOI 10.1016/S0165-0270(01)00392-2; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; LAURENTINI A, 1994, IEEE T PATTERN ANAL, V16, P150, DOI 10.1109/34.273735; Leblond H, 2003, J NEUROSCI, V23, P11411; Leroy T, 2009, BEHAV RES METHODS, V41, P787, DOI 10.3758/BRM.41.3.787; Leroy T, 2009, BEHAV RES METHODS, V41, P148, DOI [10.3758/BRM.41.1.148, 10.3758/BRM.41.1.48]; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Magnuson DSK, 2009, NEUROREHAB NEURAL RE, V23, P535, DOI 10.1177/1545968308331147; Mundermann L, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Po-Lun Lai, 2011, Proceedings of the 2011 International Conference on Image Processing, Computer Vision, & Pattern Recognition (IPCV 2011), P440; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Smith RR, 2006, J NEUROTRAUM, V23, P1654, DOI 10.1089/neu.2006.23.1654; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Thota A, 2001, Biomed Sci Instrum, V37, P63	34	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74536	10.1371/journal.pone.0074536	http://dx.doi.org/10.1371/journal.pone.0074536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058586	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900055
J	Sitta, E; Nagao, R; Varela, H				Sitta, Elton; Nagao, Raphael; Varela, Hamilton			The Electro-Oxidation of Ethylene Glycol on Platinum over a Wide pH Range: Oscillations and Temperature Effects	PLOS ONE			English	Article							FORMIC-ACID OXIDATION; POTENTIAL OSCILLATIONS; ELECTROCHEMICAL OXIDATION; MECHANISTIC ASPECTS; GALVANOSTATIC ELECTROOXIDATION; ELECTRODE; SURFACE; FORMALDEHYDE; PT(100); SPECTROSCOPY	We report a comprehensive study of the electro-oxidation of ethylene glycol (EG) on platinum with emphasis on the effects exerted by the electrolyte pH, the EG concentration, and temperature, under both regular and oscillatory conditions. We extracted and discussed parameters such as voltammetric activity, reaction orders (with respect to [EG]), oscillation's amplitude, frequency and waveform, and the evolution of the mean electrode potential at six pH values from 0 to 14. In addition, we obtained the apparent activation energies under several different conditions. Overall, we observed that increasing the electrolyte pH results in a discontinuous transition in most properties studied under both voltammetric and oscillatory regimes. As a relevant result in this direction, we found that the increase in the reaction order with pH is mediated by a minimum (similar to 0) at pH = 12. Furthermore, the solution pH strongly affects all features investigated, c.f. the considerable increase in the oscillatory frequency and the decrease in the, oscillatory, activation energy as the pH increase. We suggest that adsorbed CO is probably the main surface-blocking species at low pH, and its absence at high pH is likely to be the main reason behind the differences observed. The size of the parameter region investigated and the amount of comparable parameters and properties presented in this study, as well as the discussion that followed illustrate the strategy of combining investigations under conventional and oscillatory regimes of electrocatalytic systems.	[Sitta, Elton; Nagao, Raphael; Varela, Hamilton] Univ Sao Paulo, Inst Chem Sao Carlos, BR-13560 Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Varela, H (corresponding author), Univ Sao Paulo, Inst Chem Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.	varela@iqsc.usp.br	Nagao, Raphael/J-9148-2013; Varela, Hamilton/C-3901-2012; Sitta, Elton/I-3228-2013; Nagao, Raphael/Y-5114-2019; Varela, Hamilton/AAJ-2735-2021	Nagao, Raphael/0000-0001-8400-9093; Varela, Hamilton/0000-0002-6237-6068; Sitta, Elton/0000-0003-3181-0076; Nagao, Raphael/0000-0001-8400-9093; Varela, Hamilton/0000-0002-6237-6068	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [160499/2011-9, 200939/2012-2, 306151/2010-3]; FAPESP [09/07629-6, 09/00153-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	ES (Grant No. 160499/2011-9 and 200939/2012-2) and HV (Grant No. 306151/2010-3) thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for financial support. HV (Grant No. 09/07629-6) and RN (Grant No. 09/00153-6) acknowledge FAPESP for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAHADILY FN, 1991, J ELECTROANAL CHEM, V308, P151, DOI 10.1016/0022-0728(91)85064-V; Batista EA, 2004, J ELECTROANAL CHEM, V571, P273, DOI 10.1016/j.jelechem.2004.05.016; Boscheto E, 2010, J ELECTROANAL CHEM, V642, P17, DOI 10.1016/j.jelechem.2010.01.026; Cabral MF, 2013, PHYS CHEM CHEM PHYS, V15, P1437, DOI 10.1039/c2cp42890c; Carbonio EA, 2009, PHYS CHEM CHEM PHYS, V11, P665, DOI 10.1039/b811636a; CHANG SC, 1991, J AM CHEM SOC, V113, P9506, DOI 10.1021/ja00025a014; CHRISTENSEN PA, 1989, J ELECTROANAL CHEM, V260, P347, DOI 10.1016/0022-0728(89)87149-9; CONWAY BE, 1978, J CHEM SOC FARAD T 1, V74, P1373, DOI 10.1039/f19787401373; Fan YJ, 2004, ELECTROCHIM ACTA, V49, P4659, DOI 10.1016/j.electacta.2004.05.020; Ferreira GCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050145; Gisbert R, 2011, ELECTROCHIM ACTA, V56, P2443, DOI 10.1016/j.electacta.2010.11.032; HACHKAR M, 1990, J ELECTROANAL CHEM, V287, P81, DOI 10.1016/0022-0728(90)87161-C; HAUFFE W, 1978, ELECTROCHIM ACTA, V23, P299, DOI 10.1016/0013-4686(78)80065-6; Herrero E, 2004, J ELECTROANAL CHEM, V567, P139, DOI 10.1016/j.jelechem.2003.12.019; Honda Y, 1997, CHEM PHYS LETT, V273, P141, DOI 10.1016/S0009-2614(97)00601-5; Kiss IZ, 2012, J PHYS CHEM C, V116, P9561, DOI 10.1021/jp300714w; Kiss IZ, 2009, PHYS CHEM CHEM PHYS, V11, P5720, DOI 10.1039/b904650j; Kiss IZ, 2009, PHYS CHEM CHEM PHYS, V11, P7669, DOI 10.1039/b905295j; Koper M. T. M., 2009, FUEL CELL CATALYSIS, P159; Koper MTM, 1996, J CHEM SOC FARADAY T, V92, P3975, DOI 10.1039/ft9969203975; KOROS E, 1974, NATURE, V251, P703, DOI 10.1038/251703a0; Krewer U, 2011, CHEMPHYSCHEM, V12, P2518, DOI 10.1002/cphc.201100095; Kwon Y, 2011, CHEMCATCHEM, V3, P1176, DOI 10.1002/cctc.201100023; Lai SCS, 2010, CATAL TODAY, V154, P92, DOI 10.1016/j.cattod.2010.01.060; Lai SCS, 2010, J PHYS CHEM LETT, V1, P1122, DOI 10.1021/jz100272f; Lamm A., 2003, HDB FUEL CELLS FUNDA, V2, P679; Lee J, 2002, ELECTROCHIM ACTA, V47, P2297, DOI 10.1016/S0013-4686(02)00075-0; Lin JL, 2013, J ELECTROANAL CHEM, V688, P165, DOI 10.1016/j.jelechem.2012.08.027; Mukouyama Y, 2006, J PHYS CHEM B, V110, P11912, DOI 10.1021/jp061129j; Nagao R, 2008, J PHYS CHEM A, V112, P4617, DOI 10.1021/jp801361j; Nagao R, 2013, J PHYS CHEM C, V117, P15098, DOI 10.1021/jp4028047; Nagao R, 2012, PHYS CHEM CHEM PHYS, V14, P8294, DOI 10.1039/c2cp00037g; Nagao R, 2010, J PHYS CHEM C, V114, P22262, DOI 10.1021/jp109554r; Naito M, 2000, PHYS CHEM CHEM PHYS, V2, P1193, DOI 10.1039/a908490h; Okamoto H, 1997, J PHYS CHEM A, V101, P8480, DOI 10.1021/jp971858m; Oliveira CP, 2012, ELECTROCHIM ACTA, V85, P674, DOI 10.1016/j.electacta.2012.08.087; Perini N, 2013, CATAL COMMUN, V30, P23, DOI 10.1016/j.catcom.2012.10.019; Rincon A, 2005, ELECTROCHEM COMMUN, V7, P1027, DOI 10.1016/j.elecom.2005.06.017; RUOFF P, 1994, NATURWISSENSCHAFTEN, V81, P456; RUOFF P, 1992, J INTERDISCIPL CYCLE, V23, P92, DOI 10.1080/09291019209360133; Samjeske G, 2005, J PHYS CHEM B, V109, P23509, DOI 10.1021/jp055220j; Samjeske G, 2005, ANGEW CHEM INT EDIT, V44, P5694, DOI 10.1002/anie.200501009; SCHELL M, 1989, J PHYS CHEM-US, V93, P4806, DOI 10.1021/j100349a025; Schnaidt J, 2013, CATAL TODAY, V202, P154, DOI 10.1016/j.cattod.2012.05.019; Schnaidt J, 2012, J PHYS CHEM C, V116, P2872, DOI 10.1021/jp208162q; Sitta E, 2011, CHEM COMMUN, V47, P3775, DOI 10.1039/c0cc05353h; Sitta E, 2010, PHYS CHEM CHEM PHYS, V12, P15195, DOI 10.1039/c002574g; Sitta E, 2010, ELECTROCATALYSIS-US, V1, P19, DOI 10.1007/s12678-010-0005-2; Strasser P, 1997, J CHEM PHYS, V107, P979, DOI 10.1063/1.474450; Strmcnik D, 2009, NAT CHEM, V1, P466, DOI [10.1038/nchem.330, 10.1038/NCHEM.330]; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Swamy BEK, 2009, J ELECTROANAL CHEM, V625, P69, DOI 10.1016/j.jelechem.2008.10.001; Urvolgyi M, 2012, CHEM ENG SCI, V83, P56, DOI 10.1016/j.ces.2011.10.073; Vielstich W, 2003, HDB FUEL CELLS FUNDA, P601; Zhang LJ, 2005, ACTA PHYS-CHIM SIN, V21, P977, DOI 10.3866/PKU.WHXB20050907	55	20	20	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75086	10.1371/journal.pone.0075086	http://dx.doi.org/10.1371/journal.pone.0075086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058650	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900093
J	Thompson, JJ; Blair, MR; Chen, LH; Henrey, AJ				Thompson, Joseph J.; Blair, Mark R.; Chen, Lihan; Henrey, Andrew J.			Video Game Telemetry as a Critical Tool in the Study of Complex Skill Learning	PLOS ONE			English	Article							EXPERT; PERFORMANCE; PERCEPTION	Cognitive science has long shown interest in expertise, in part because prediction and control of expert development would have immense practical value. Most studies in this area investigate expertise by comparing experts with novices. The reliance on contrastive samples in studies of human expertise only yields deep insight into development where differences are important throughout skill acquisition. This reliance may be pernicious where the predictive importance of variables is not constant across levels of expertise. Before the development of sophisticated machine learning tools for data mining larger samples, and indeed, before such samples were available, it was difficult to test the implicit assumption of static variable importance in expertise development. To investigate if this reliance may have imposed critical restrictions on the understanding of complex skill development, we adopted an alternative method, the online acquisition of telemetry data from a common daily activity for many: video gaming. Using measures of cognitive-motor, attentional, and perceptual processing extracted from game data from 3360 Real-Time Strategy players at 7 different levels of expertise, we identified 12 variables relevant to expertise. We show that the static variable importance assumption is false - the predictive importance of these variables shifted as the levels of expertise increased - and, at least in our dataset, that a contrastive approach would have been misleading. The finding that variable importance is not static across levels of expertise suggests that large, diverse datasets of sustained cognitive-motor performance are crucial for an understanding of expertise in real-world contexts. We also identify plausible cognitive markers of expertise.	[Thompson, Joseph J.; Blair, Mark R.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Chen, Lihan] Simon Fraser Univ, Cognit Sci Program, Burnaby, BC V5A 1S6, Canada; [Henrey, Andrew J.] Simon Fraser Univ, Dept Stat, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University; Simon Fraser University	Thompson, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	jjthomps@sfu.ca			Social Sciences and Humanities Research Council of Canada; Simon Fraser University	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Simon Fraser University	This research was made possible by funding from the Social Sciences and Humanities Research Council of Canada and from Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Blizzard Entertainment, 2011, MAST LEAG; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Charness N, 2005, APPL COGNITIVE PSYCH, V19, P151, DOI 10.1002/acp.1106; CHARNESS N, 1983, J VERB LEARN VERB BE, V22, P406, DOI 10.1016/S0022-5371(83)90264-5; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; de Groot AD, 2008, THOUGHT CHOICE CHESS; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P3; Ericsson KA, 2007, J EXP PSYCHOL-APPL, V13, P115, DOI 10.1037/1076-898X.13.3.115; Ericsson KA, 2010, WIRES COGN SCI, V1, P404, DOI 10.1002/wcs.47; ERICSSON KA, 1994, AM PSYCHOL, V49, P725, DOI 10.1037/0003-066X.49.8.725; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lewis JM, 2011, P 33 ANN C COGN SCI, P687; Linkletter C, 2006, TECHNOMETRICS, V48, P478, DOI 10.1198/004017006000000228; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; MANE A, 1989, ACTA PSYCHOL, V71, P17, DOI 10.1016/0001-6918(89)90003-6; Palmeri TJ, 1997, J EXP PSYCHOL LEARN, V23, P324, DOI 10.1037/0278-7393.23.2.324; PARKER JF, 1960, PSYCHOL MONOGR, V74, P1; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Proctor RW, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P265; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; REITMAN JS, 1976, COGNITIVE PSYCHOL, V8, P336, DOI 10.1016/0010-0285(76)90011-6; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; SCHMIDT HG, 1993, MEM COGNITION, V21, P338, DOI 10.3758/BF03208266; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Sellers BC, 2012, P HUM FACT ERG SOC 5, V56, P1039; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SIMON HA, 1973, AM SCI, V61, P394; Stern Y, 2011, AGING NEUROPSYCHOL C, V18, P653, DOI 10.1080/13825585.2011.613450; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Sutter JD, 2012, WIRED SUCCESS DESTRU	34	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75129	10.1371/journal.pone.0075129	http://dx.doi.org/10.1371/journal.pone.0075129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058656	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900095
J	VanBuren, CS; Bonnan, M				VanBuren, Collin S.; Bonnan, Matthew			Forearm Posture and Mobility in Quadrupedal Dinosaurs	PLOS ONE			English	Article							NUCLEAR-DNA; SAUROPODOMORPH DINOSAUR; FUNCTIONAL-MORPHOLOGY; MORPHOMETRIC-ANALYSIS; FORELIMB MUSCULATURE; MANUS SHAPE; LONG BONES; EVOLUTION; LOCOMOTION; MITOCHONDRIAL	Quadrupedality evolved four independent times in dinosaurs; however, the constraints associated with these transitions in limb anatomy and function remain poorly understood, in particular the evolution of forearm posture and rotational ability (i.e., active pronation and supination). Results of previous qualitative studies are inconsistent, likely due to an inability to quantitatively assess the likelihood of their conclusions. We attempt to quantify antebrachial posture and mobility using the radius bone because its morphology is distinct between extant sprawled taxa with a limited active pronation ability and parasagittal taxa that have an enhanced ability to actively pronate the manus. We used a sliding semi-landmark, outline-based geometric morphometric approach of the proximal radial head and a measurement of the angle of curvature of the radius in a sample of 189 mammals, 49 dinosaurs, 35 squamates, 16 birds, and 5 crocodilians. Our results of radial head morphology showed that quadrupedal ceratopsians, bipedal non-hadrosaurid ornithopods, and theropods had limited pronation/supination ability, and sauropodomorphs have unique radial head morphology that likely allowed limited rotational ability. However, the curvature of the radius showed that no dinosaurian clade had the ability to cross the radius about the ulna, suggesting parallel antebrachial elements for all quadrupedal dinosaurs. We conclude that the bipedal origins of all quadrupedal dinosaur clades could have allowed for greater disparity in forelimb posture than previously appreciated, and future studies on dinosaur posture should not limit their classifications to the overly simplistic extant dichotomy.	[VanBuren, Collin S.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Bonnan, Matthew] Richard Stockton Coll New Jersey, Biol Program, Galloway, NJ USA	University of Toronto	VanBuren, CS (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	collin.vanburen@mail.utoronto.ca			Western Illinois University Centennial Honors College; College of Arts and Sciences	Western Illinois University Centennial Honors College; College of Arts and Sciences	CSV was funded by the Western Illinois University Centennial Honors College and College of Arts and Sciences during the course of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexander R.M., 1982, LOCOMOTION ANIMALS; Amer SAM, 2005, GENE, V346, P249, DOI 10.1016/j.gene.2004.11.014; Andersson K, 2004, ZOOL J LINN SOC-LOND, V142, P91, DOI 10.1111/j.1096-3642.2004.00129.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; [Anonymous], 1885, INTRO OSTEOLOGY MAMM; Argot C, 2004, ZOOL J LINN SOC-LOND, V140, P487, DOI 10.1111/j.1096-3642.2004.00110.x; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; Beer F.P., 1981, MECH MATER; Benton M.J., 2005, VERTEBRATE PALAEONTO; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Biewener AA, 1989, SCIENCE, P245; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bonnan MF, 2007, ANAT REC, V290, P1089, DOI 10.1002/ar.20578; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P139; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; Brett-Surman M.K., 2006, HORNS BEAKS CERATOPS, P135; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Brown JW, 2007, BIOL LETTERS, V3, P257, DOI 10.1098/rsbl.2006.0611; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Cione AL, 2000, NEOGENO ARGENTINA, P14; Clemente CJ, 2011, J EXP BIOL, V214, P3013, DOI 10.1242/jeb.059345; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; Dodson Peter, 1997, P393; ENGLISH AW, 1977, J MORPHOL, V151, P325, DOI 10.1002/jmor.1051510303; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Frostick L.E., 1986, SEDIMENTATION AFRICA, V25, P113; Fujiwara S, 2012, P ROY SOC B-BIOL SCI, V279, P2561, DOI 10.1098/rspb.2012.0190; Fujiwara S, 2010, J MORPHOL, V271, P883, DOI 10.1002/jmor.10846; Fujiwara S, 2009, J VERTEBR PALEONTOL, V29, P1136, DOI 10.1671/039.029.0406; Fujiwara S, 2009, J MORPHOL, V270, P1084, DOI 10.1002/jmor.10744; Fyler CA, 2005, J BIOGEOGR, V32, P1267, DOI 10.1111/j.1365-2699.2005.01281.x; Gambaryan PP, 1997, ACTA PALAEONTOL POL, V42, P13; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Gatton P. M., 1970, J. Paleont., V44, P464; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; HAINES RW, 1958, Q REV BIOL, V33, P1, DOI 10.1086/402206; Harvey Kathryn J., 2010, Australian Mammalogy, V32, P1, DOI 10.1071/AM08022; Higham TE, 2001, J EXP BIOL, V204, P4141; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Huxley TH, 1880, P ZOOL SOC LOND, P655; Iwaniuk AN, 1999, BEHAV BRAIN RES, V99, P35, DOI 10.1016/S0166-4328(98)00067-9; Iwaniuk AN, 1999, CAN J ZOOL, V77, P1064, DOI 10.1139/cjz-77-7-1064; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; LANDSMEER JMF, 1983, J MORPHOL, V175, P119, DOI 10.1002/jmor.1051750202; Lockley M.G., 1999, DINOSAUR TRACKS OTHE; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Maidment SCR, ACTA PALAEO IN PRESS; Maidment SCR, 2012, P ROY SOC B-BIOL SCI, V279, P3765, DOI 10.1098/rspb.2012.1040; Maidment SCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036904; Marshall L., 1991, FOSILES FACIES BOLIV, V12, P631; Matthew WD, 1904, AM NAT, V38, P811, DOI 10.1086/278461; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Middleton KM, 2000, ZOOL J LINN SOC-LOND, V128, P149; Middleton KM, 2008, ZOOLOGICAL J LINNEAN, V128, P149; MOLNAR R E, 1977, Evolutionary Theory, V3, P165; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Parchman AJ, 2003, J EXP BIOL, V206, P1379, DOI 10.1242/jeb.00267; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Pereira SL, 2006, MOL PHYLOGENET EVOL, V38, P499, DOI 10.1016/j.ympev.2005.07.007; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; PETERSON JA, 1984, J ZOOL, V202, P1; Polly P. David, 2007, P245; Pyron RA, 2010, SYST BIOL, V59, P185, DOI 10.1093/sysbio/syp090; Rasmussen Mette Elstrup, 1998, Oryctos, V1, P127; Reilly SM, 1998, J EXP BIOL, V201, P2559; Reisz RR, 2010, J VERTEBR PALEONTOL, V30, P1653, DOI 10.1080/02724634.2010.521604; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ., 2013, TPS SOFTWARE SERIES; Roos J, 2007, MOL PHYLOGENET EVOL, V45, P663, DOI 10.1016/j.ympev.2007.06.018; RUSSELL LORIS S., 1935, BULL NAT MUS CANADA, V77, P39; Schulte JA, 2003, P ROY SOC B-BIOL SCI, V270, P597, DOI 10.1098/rspb.2002.2272; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Senter P, 2012, PALEONTOLOGICA ELECT, V15; Sereno Paul C., 2006, P315; Sheets HD, 2004, IMP INTERGRATE MORPH; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Slice DE, 2001, SYST BIOL, V50, P141, DOI 10.1080/10635150119110; Tallman M, 2012, ANAT REC, V295, P454, DOI 10.1002/ar.22405; TAYLOR ME, 1974, J MORPHOL, V143, P307, DOI 10.1002/jmor.1051430305; Thewissen JGM, 2007, ANATOMIA HISTOLOGIA, V19, P37; Thompson S, 2007, P INT WORKSH PERV LE, P10; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Warren RD, 1997, AM J PHYS ANTHROPOL, V104, P471, DOI 10.1002/(SICI)1096-8644(199712)104:4<471::AID-AJPA4>3.0.CO;2-V; Webster M, 2010, PALEONTOLOGICAL SOC, V,, P163, DOI DOI 10.1017/S1089332600001868; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wright JL, 1999, SP PALAEONT, P209; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Zarza E, 2008, MOL ECOL, V17, P3259, DOI 10.1111/j.1365-294X.2008.03826.x; Zrzavy J, 2004, ZOOL SCR, V33, P311, DOI 10.1111/j.0300-3256.2004.00152.x	119	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74842	10.1371/journal.pone.0074842	http://dx.doi.org/10.1371/journal.pone.0074842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058633	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900084
J	Whitehouse, MJ; Harrison, NM; Mackenzie, J; Hinsley, SA				Whitehouse, Michael J.; Harrison, Nancy M.; Mackenzie, Julia; Hinsley, Shelley A.			Preferred Habitat of Breeding Birds May Be Compromised by Climate Change: Unexpected Effects of an Exceptionally Cold, Wet Spring	PLOS ONE			English	Article							GREAT TITS; PHENOTYPIC PLASTICITY; CLUTCH SIZE; WINTER MOTH; BLUE TITS; TEMPERATURE; SUCCESS; DATE; PHENOLOGY; SELECTION	Previous studies of the consequences for breeding birds of climate change have explored how their populations may respond to increasing temperatures. However, few have considered the likely outcome of predicted extreme conditions and the relative vulnerability of populations in different habitats. Here, we compare phenology and breeding success in great tits and blue tits over a 10 year period, including the extremely harsh conditions during spring 2012, at three sites in eastern England - mixed deciduous woodland, riparian and urban habitat. Production, measured as brood biomass, was significantly lower in 2012 compared with the previous 9 years, with the decrease in productivity relatively greatest in woodland habitat. Production was related to hatch delay, i.e. birds not initiating incubation immediately after clutch completion, which was more common in 2012 than in previous years. The best predictor of hatch delay was daytime temperature (not nighttime minimum temperature) and rainfall, which convincingly reflected low growth and activity of caterpillar prey. We found that birds breeding in riparian and urban habitats were less vulnerable to the extremes of weather than those breeding in mixed deciduous woodland.	[Whitehouse, Michael J.; Harrison, Nancy M.; Mackenzie, Julia] Anglia Ruskin Univ, Dept Life Sci, Cambridge, Cambs, England; [Hinsley, Shelley A.] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England	Anglia Ruskin University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Harrison, NM (corresponding author), Anglia Ruskin Univ, Dept Life Sci, Cambridge, Cambs, England.	Nancy.harrison@anglia.ac.uk			Anglia Ruskin University and Centre for Ecology and Hydrology; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Anglia Ruskin University and Centre for Ecology and Hydrology; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Research reported here was supported by Anglia Ruskin University and Centre for Ecology and Hydrology. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 1988, SCIENCE, V240, P798, DOI [10.1126/science.3363360, DOI 10.1126/SCIENCE.3363360.PUBMED:3363360]; BOYCE MS, 1987, ECOLOGY, V68, P142, DOI 10.2307/1938814; Burghardt KT, 2009, CONSERV BIOL, V23, P219, DOI 10.1111/j.1523-1739.2008.01076.x; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; COWIE RJ, 1987, ARDEA, V75, P81; Cresswell W, 2003, J ANIM ECOL, V72, P356, DOI 10.1046/j.1365-2656.2003.00701.x; Dennis R. L., 1993, BUTTERFLIES CLIMATE; Dennis RLH, 2007, EUR J ENTOMOL, V104, P763, DOI 10.14411/eje.2007.097; DHONDT AA, 1979, IBIS, V121, P329, DOI 10.1111/j.1474-919X.1979.tb06851.x; Gienapp P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0289; Gosler A, 1993, GREAT TIT; Heij ME, 2006, P ROY SOC LOND B BIO, V273, P2353, DOI [10.1098/rspb.2006.3584, DOI 10.1098/RSPB.2006.3584]; Hinsley SA, 1999, J AVIAN BIOL, V30, P271, DOI 10.2307/3677353; Hinsley SA, 2008, LANDSCAPE ECOL, V23, P615, DOI 10.1007/s10980-008-9225-8; Hinsley SA, 2009, LANDSCAPE RES, V34, P509, DOI 10.1080/01426390903177276; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Husby A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000585; Lack D., 1966, POPULATION STUDIES B; Laland KN, 2011, SCIENCE, V334, P1512, DOI 10.1126/science.1210879; Mackenzie J, 2010, IMPACT FLORAL ORIGIN; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perrins, 1993, BIRDS W PALAEARCTIC, VVII; Perrins C.M., 1979, BRIT TITS; PERRINS CM, 1991, IBIS, V133, P49, DOI 10.1111/j.1474-919X.1991.tb07668.x; PERRINS CM, 1989, WILSON BULL, V101, P236; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Porlier M, 2012, J ANIM ECOL, V81, P1041, DOI 10.1111/j.1365-2656.2012.01996.x; Rackham O., 1990, TREES WOODLAND BRIT, V2; Ramsay Scott M., 2007, P55; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; RIDDINGTON R, 1995, IBIS, V137, P371, DOI 10.1111/j.1474-919X.1995.tb08035.x; Robinson R.A., 2005, 407 BTO; Singer MS, 2012, AM NAT, V179, P363, DOI 10.1086/664080; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; UK Met Office, 2011, CLIM OBS PROJ IMP; UK Met Office, 2012, 2012 WEATH SUMM; van Asch M, 2013, NAT CLIM CHANGE, V3, P244, DOI [10.1038/nclimate1717, 10.1038/NCLIMATE1717]; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Visser ME, 2012, J ORNITHOL, V153, pS75, DOI 10.1007/s10336-011-0770-6; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	49	22	22	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75536	10.1371/journal.pone.0075536	http://dx.doi.org/10.1371/journal.pone.0075536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058694	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000324695900121
J	Hu, PZ; Chung, LWK; Berel, D; Frierson, HF; Yang, H; Liu, CY; Wang, RX; Li, QL; Rogatko, A; Zhau, HYE				Hu, Peizhen; Chung, Leland W. K.; Berel, Dror; Frierson, Henry F.; Yang, Hua; Liu, Chunyan; Wang, Ruoxiang; Li, Qinlong; Rogatko, Andre; Zhau, Haiyen E.			Convergent RANK- and c-Met-Mediated Signaling Components Predict Survival of Patients with Prostate Cancer: An Interracial Comparative Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE BIOMARKERS; RACIAL DISPARITY; CELLS; METASTASIS; EXPRESSION; RECEPTOR; DIFFERENTIATION; ANGIOGENESIS	We reported (PLoS One 6 (12):e28670, 2011) that the activation of c-Met signaling in RANKL-overexpressing bone metastatic LNCaP cell and xenograft models increased expression of RANK, RANKL, c-Met, and phosphorylated c-Met, and mediated downstream signaling. We confirmed the significance of the RANK-mediated signaling network in castration resistant clinical human prostate cancer (PC) tissues. In this report, we used a multispectral quantum dot labeling technique to label six RANK and c-Met convergent signaling pathway mediators simultaneously in formalin fixed paraffin embedded (FFPE) tissue specimens, quantify the intensity of each expression at the sub-cellular level, and investigated their potential utility as predictors of patient survival in Caucasian-American, African-American and Chinese men. We found that RANKL and neuropilin-1 (NRP-1) expression predicts survival of Caucasian-Americans with PC. A Gleason score >= 8 combined with nuclear p-c-Met expression predicts survival in African-American PC patients. Neuropilin-1, p-NF-kappa B p65 and VEGF are predictors for the overall survival of Chinese men with PC. These results collectively support interracial differences in cell signaling networks that can predict the survival of PC patients.	[Hu, Peizhen; Chung, Leland W. K.; Liu, Chunyan; Wang, Ruoxiang; Li, Qinlong; Zhau, Haiyen E.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Berel, Dror; Rogatko, Andre] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Frierson, Henry F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Yang, Hua] Jilin Univ, Dept Pathol, Changchun 130023, Jilin, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Virginia; Jilin University	Zhau, HYE (corresponding author), Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA.	Haiyen.zhau@cshs.org			PCF Challenge Award; BOG Endowed Cancer Research Chair;  [NIH2 P01CA 98912];  [NIH1 R01 CA122602]; NATIONAL CANCER INSTITUTE [R01CA122602, P01CA098912] Funding Source: NIH RePORTER	PCF Challenge Award; BOG Endowed Cancer Research Chair; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH2 P01CA 98912, NIH1 R01 CA122602 and PCF Challenge Award and BOG Endowed Cancer Research Chair to LWKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu GCY, 2013, AM ASS CANC RES 2013; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grivas PD, 2013, CRIT REV ONCOL HEMAT, V85, P82, DOI 10.1016/j.critrevonc.2012.05.003; Hatcher D, 2009, AM J TRANSL RES, V1, P235; Hu PZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028670; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Kachroo N, 2013, J CANCER RES CLIN, V139, P1, DOI 10.1007/s00432-012-1351-7; Koeneman KS, 1999, PROSTATE, V39, P246; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Kyrgidis A, 2012, LANCET, V379, pE50, DOI 10.1016/S0140-6736(12)60764-8; Lee HJ, 2013, DEVELOPMENT, V140, P1397, DOI 10.1242/dev.088948; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; Odero-Marah VA, 2008, CELL RES, V18, P858, DOI 10.1038/cr.2008.84; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Talagas M, 2013, ANTICANCER RES, V33, P2065; Thatai LC, 2004, UROLOGY, V64, P738, DOI 10.1016/j.urology.2004.05.024; Tran PT, 2012, CURR MOL MED, V12, P772; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Zhang S, 2011, ONCOGENE, V30, P4941, DOI 10.1038/onc.2011.199; Zhang SM, 2013, J BIOL CHEM, V288, P1469, DOI 10.1074/jbc.M112.438341; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9; Zhau H E, 1995, Urol Oncol, V1, P51, DOI 10.1016/1078-1439(95)00009-7; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1997, J CELL BIOCHEM, P182	28	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73081	10.1371/journal.pone.0073081	http://dx.doi.org/10.1371/journal.pone.0073081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066029	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000010
J	Koshimizu, E; Miyatake, S; Okamoto, N; Nakashima, M; Tsurusaki, Y; Miyake, N; Saitsu, H; Matsumoto, N				Koshimizu, Eriko; Miyatake, Satoko; Okamoto, Nobuhiko; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi			Performance Comparison of Bench-Top Next Generation Sequencers Using Microdroplet PCR-Based Enrichment for Targeted Sequencing in Patients with Autism Spectrum Disorder	PLOS ONE			English	Article							DE-NOVO MUTATIONS; VARIANTS; SEIZURES; STRAND; RISK	Next-generation sequencing (NGS) combined with enrichment of target genes enables highly efficient and low-cost sequencing of multiple genes for genetic diseases. The aim of this study was to validate the accuracy and sensitivity of our method for comprehensive mutation detection in autism spectrum disorder (ASD). We assessed the performance of the bench-top Ion Torrent PGM and Illumina MiSeq platforms as optimized solutions for mutation detection, using microdroplet PCR-based enrichment of 62 ASD associated genes. Ten patients with known mutations were sequenced using NGS to validate the sensitivity of our method. The overall read quality was better with MiSeq, largely because of the increased indel-related error associated with PGM. The sensitivity of SNV detection was similar between the two platforms, suggesting they are both suitable for SNV detection in the human genome. Next, we used these methods to analyze 28 patients with ASD, and identified 22 novel variants in genes associated with ASD, with one mutation detected by MiSeq only. Thus, our results support the combination of target gene enrichment and NGS as a valuable molecular method for investigating rare variants in ASD.	[Koshimizu, Eriko; Miyatake, Satoko; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka, Japan	Yokohama City University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Matsumoto, N (corresponding author), Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021	Tsurusaki, Yoshinori/0000-0002-7240-6355; Saitsu, Hirotomo/0000-0003-0723-0960	Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	Research grants from the Ministry of Health, Labour and Welfare: the Japan Science and Technology Agency: and the Strategic Research Program for Brain Sciences, Grant-in-Aid for Scientific Research on Innovative Areas (Transcription cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientist from Japan Society for the Promotion of Science, and Grant from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Reynolds JJ, 2013, BRAIN, V136, P14, DOI 10.1093/brain/aws310; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Stein JL, 2013, NEURON, V77, P209, DOI 10.1016/j.neuron.2013.01.010; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	31	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74167	10.1371/journal.pone.0074167	http://dx.doi.org/10.1371/journal.pone.0074167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066114	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000096
J	Assi, J; Srivastava, G; Matta, A; Chang, MC; Walfish, PG; Ralhan, R				Assi, Jasmeet; Srivastava, Gunjan; Matta, Ajay; Chang, Martin C.; Walfish, Paul G.; Ralhan, Ranju			Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence	PLOS ONE			English	Article							FACTOR-KAPPA-B; TISSUE TRANSGLUTAMINASE; CANCER-CELLS; BIOLOGICAL SIGNIFICANCE; MESENCHYMAL TRANSITION; DRUG-RESISTANCE; OVARIAN-CANCER; GTP-BINDING; EXPRESSION; FIBROBLASTS	Introduction: Molecular markers for predicting breast cancer patients at high risk of recurrence are urgently needed for more effective disease management. The impact of alterations in extracellular matrix components on tumor aggressiveness is under intense investigation. Overexpression of Transglutaminase 2 (TG2), a multifunctional enzyme, in cancer cells impacts epithelial mesenchymal transition, growth, invasion and interactions with tumor microenvironment. The objective of our study is to determine the clinical relevance of stromal TG2 overexpression and explore its potential to identify breast cancers at high risk of recurrence. Methods: This retrospective study is based on immunohistochemical analysis of TG2 expression in normal breast tissues (n = 40) and breast cancers (n = 253) with clinical, pathological and follow-up data available for up to 12 years. TG2 expression was correlated with clinical and pathological parameters as well as disease free survival (DFS) of breast cancer patients. Results: Stromal TG2 overexpression was observed in 114/253 (45.0%) breast cancer tissues as compared to breast normal tissues. Among invasive ductal carcinomas (IDC) of the breast, 97/168 (57.7%) showed strong TG2 expression in tumor stroma. Importantly, IDC patients showing stromal TG2 accumulation had significantly reduced DFS (mean DFS = 110 months) in comparison with patients showing low expression (mean DFS = 130 months) in Kaplan-Meier survival analysis (p < 0.001). In Cox multivariate regression analysis, stromal TG2 accumulation was an independent risk factor for recurrence (p = 0.006, Hazard's ratio, H. R. = 3.79). Notably, these breast cancer patients also showed immunostaining of N-epsilon gamma-glutamyl lysine amino residues in tumor stroma demonstrating the transamidating activity of TG2. Conclusions: Accumulation of TG2 in tumor stroma is an independent risk factor for identifying breast cancer patients at high risk of recurrence. TG2 overexpression in tumor stroma may serve as a predictor of poor prognosis for IDC of the breast.	[Assi, Jasmeet; Srivastava, Gunjan; Matta, Ajay; Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Chang, Martin C.; Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Chang, Martin C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Univ Toronto, Toronto, ON, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Walfish, PG (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Alex & Simona Shnaider Lab Mol Oncol, Joseph & Wolf Lebovic Hlth Complex, Toronto, ON M5G 1X5, Canada.	pwalfish@mtsinai.on.ca; rralhan@mtsinai.on.ca	MATTA, AJAY/AFT-2977-2022; Chang, Martin/J-2329-2016		Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics; Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Oncology; George Knudson Oakdale Golf Tournament Annual Fundraiser; Mount Sinai Hospital Department of Medicine Research Fund	Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics(Canadian Institutes of Health Research (CIHR)); Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Oncology; George Knudson Oakdale Golf Tournament Annual Fundraiser; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR), Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Oncology, George Knudson Oakdale Golf Tournament Annual Fundraiser, and Mount Sinai Hospital Department of Medicine Research Fund (PGW) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Almendro V, 2011, CLIN TRANSL ONCOL, V13, P767, DOI 10.1007/s12094-011-0731-9; Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Fordyce CA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3368; Grigoriev MY, 2001, J EXP CLIN CANC RES, V20, P265; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Jeon JH, 2003, EMBO J, V22, P5273, DOI 10.1093/emboj/cdg495; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang SK, 2004, J BIOL CHEM, V279, P36593, DOI 10.1074/jbc.M402084200; Khanna M, 2011, MOL CANCER THER, V10, P626, DOI 10.1158/1535-7163.MCT-10-0912; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; Kumar A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3085; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kuo TF, 2011, FEBS J, V278, P4756, DOI 10.1111/j.1742-4658.2011.08409.x; Lin CY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-87; Lisanti MP, 2010, CANCER BIOL THER, V10, P537, DOI 10.4161/cbt.10.6.13370; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mangala LS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-33; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; Oh K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3034; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park Kang-Seo, 2011, Front Biosci (Elite Ed), V3, P341, DOI 10.2741/e249; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tripathi SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019213; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004	47	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74437	10.1371/journal.pone.0074437	http://dx.doi.org/10.1371/journal.pone.0074437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058567	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400078
J	Fan, Q; Huang, ZM; Boucher, M; Shang, XY; Zuo, L; Brinks, H; Lau, WB; Zhang, JK; Chuprun, JK; Gao, EH				Fan, Qian; Huang, Zheng M.; Boucher, Matthieu; Shang, Xiying; Zuo, Lin; Brinks, Henriette; Lau, Wayne Bond; Zhang, Jianke; Chuprun, J. Kurt; Gao, Erhe			Inhibition of Fas-Associated Death Domain-Containing Protein (FADD) Protects against Myocardial Ischemia/Reperfusion Injury in a Heart Failure Mouse Model	PLOS ONE			English	Article							RHEUMATOID SYNOVIOCYTES; SIGNALING COMPLEX; MYOCYTE APOPTOSIS; GENE-THERAPY; CELL-DEATH; RECEPTOR; INFARCTION; CARDIOMYOCYTES; DISEASE; TNF	Aim: As technological interventions treating acute myocardial infarction (MI) improve, post-ischemic heart failure increasingly threatens patient health. The aim of the current study was to test whether FADD could be a potential target of gene therapy in the treatment of heart failure. Methods: Cardiomyocyte-specific FADD knockout mice along with non-transgenic littermates (NLC) were subjected to 30 minutes myocardial ischemia followed by 7 days of reperfusion or 6 weeks of permanent myocardial ischemia via the ligation of left main descending coronary artery. Cardiac function were evaluated by echocardiography and left ventricular (LV) catheterization and cardiomyocyte death was measured by Evans blue-TTC staining, TUNEL staining, and caspase-3, -8, and -9 activities. In vitro, H9C2 cells transfected with ether scramble siRNA or FADD siRNA were stressed with chelerythrin for 30 min and cleaved caspase-3 was assessed. Results: FADD expression was significantly decreased in FADD knockout mice compared to NLC. Ischemia/reperfusion (I/R) upregulated FADD expression in NLC mice, but not in FADD knockout mice at the early time. FADD deletion significantly attenuated I/R-induced cardiac dysfunction, decreased myocardial necrosis, and inhibited cardiomyocyte apoptosis. Furthermore, in 6 weeks long term permanent ischemia model, FADD deletion significantly reduced the infarct size (from 41.20 +/- 3.90% in NLC to 26.83 +/- 4.17% in FADD deletion), attenuated myocardial remodeling, improved cardiac function and improved survival. In vitro, FADD knockdown significantly reduced chelerythrin-induced the level of cleaved caspase-3. Conclusion: Taken together, our results suggest FADD plays a critical role in post-ischemic heart failure. Inhibition of FADD retards heart failure progression. Our data supports the further investigation of FADD as a potential target for genetic manipulation in the treatment of heart failure.	[Fan, Qian; Huang, Zheng M.; Boucher, Matthieu; Shang, Xiying; Zuo, Lin; Brinks, Henriette; Chuprun, J. Kurt; Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Fan, Qian] Beijing Capital Med Univ, Beijing Chaoyang Hosp, Dept Gerontol, Beijing, Peoples R China; [Lau, Wayne Bond] Thomas Jefferson Univ Hosp, Dept Emergency Med, Philadelphia, PA 19107 USA; [Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Capital Medical University; Jefferson University; Jefferson University	Gao, EH (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA.	erhe.gao@temple.edu	Boucher, Matthieu/AAV-2538-2021	Fan, Qian/0000-0002-8269-3060; Lau, Wayne Bond/0000-0002-8064-8290	National Institutes of Health (NIH) [P01 HL075443]; American Heart Association post-doctoral fellowship; Fonds de la Recherche en Sante du Quebec postdoctoral scholarship (Quebec, Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association post-doctoral fellowship(American Heart Association); Fonds de la Recherche en Sante du Quebec postdoctoral scholarship (Quebec, Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a National Institutes of Health (NIH) grants P01 HL075443 (Project 1 and Core B) (to Walter J. Koch). Matthieu Boucher was supported by an American Heart Association post-doctoral fellowship (Great Rivers Affiliate) and a Fonds de la Recherche en Sante du Quebec postdoctoral scholarship (Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Binah O, 2004, ANN NY ACAD SCI, V1015, P338, DOI 10.1196/annals.1302.030; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Date T, 2003, J MOL CELL CARDIOL, V35, P811, DOI 10.1016/S0022-2828(03)00139-1; Davidson SM, 2003, J MOL CELL CARDIOL, V35, P1359, DOI 10.1016/J.yjmcc.2003.08.001; Fan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066234; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Ferrari R, 1999, PHARMACOL RES, V40, P97, DOI 10.1006/phrs.1998.0463; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Giampietri C, 2008, J HYPERTENS, V26, P1008, DOI 10.1097/HJH.0b013e3282f6a179; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kobayashi T, 2000, GENE THER, V7, P527, DOI 10.1038/sj.gt.3301127; Kobayashi T, 2000, ARTHRITIS RHEUM, V43, P1106, DOI 10.1002/1529-0131(200005)43:5<1106::AID-ANR21>3.0.CO;2-F; Kondo S, 1998, HUM GENE THER, V9, P1599, DOI 10.1089/hum.1998.9.11-1599; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Liang CS, 2009, J AM COLL CARDIOL, V53, P21, DOI 10.1016/j.jacc.2008.09.026; Mani K, 2003, J AM COLL CARDIOL, V41, P761, DOI 10.1016/S0735-1097(02)02958-3; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Shilkrut M, 2003, J MOL CELL CARDIOL, V35, P1229, DOI 10.1016/S0022-2828(03)00232-3; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; Xiao JF, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0239-z; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	38	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73537	10.1371/journal.pone.0073537	http://dx.doi.org/10.1371/journal.pone.0073537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058479	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400028
J	Hiller, KM; Stoneking, L; Min, A; Rhodes, SM				Hiller, Katherine M.; Stoneking, Lisa; Min, Alice; Rhodes, Suzanne Michelle			Syndromic Surveillance for Influenza in the Emergency Department-A Systematic Review	PLOS ONE			English	Review							PUBLIC-HEALTH SURVEILLANCE; RESPIRATORY SYNCYTIAL VIRUS; NEW-YORK; CHIEF COMPLAINTS; ILLNESS; OUTBREAK; FEVER; AUSTRALIA; EPIDEMICS; DIAGNOSES	The science of surveillance is rapidly evolving due to changes in public health information and preparedness as national security issues, new information technologies and health reform. As the Emergency Department has become a much more utilized venue for acute care, it has also become a more attractive data source for disease surveillance. In recent years, influenza surveillance from the Emergency Department has increased in scope and breadth and has resulted in innovative and increasingly accepted methods of surveillance for influenza and influenza-like-illness (ILI). We undertook a systematic review of published Emergency Department-based influenza and ILI syndromic surveillance systems. A PubMed search using the keywords "syndromic'', "surveillance'', "influenza'' and "emergency'' was performed. Manuscripts were included in the analysis if they described (1) data from an Emergency Department (2) surveillance of influenza or ILI and (3) syndromic or clinical data. Meeting abstracts were excluded. The references of included manuscripts were examined for additional studies. A total of 38 manuscripts met the inclusion criteria, describing 24 discrete syndromic surveillance systems. Emergency Department-based influenza syndromic surveillance has been described worldwide. A wide variety of clinical data was used for surveillance, including chief complaint/presentation, preliminary or discharge diagnosis, free text analysis of the entire medical record, Google flu trends, calls to teletriage and help lines, ambulance dispatch calls, case reports of H1N1 in the media, markers of ED crowding, admission and Left Without Being Seen rates. Syndromes used to capture influenza rates were nearly always related to ILI (i.e. fever +/- a respiratory or constitutional complaint), however, other syndromes used for surveillance included fever alone, "respiratory complaint'' and seizure. Two very large surveillance networks, the North American DiSTRIBuTE network and the European Triple S system have collected large-scale Emergency Department-based influenza and ILI syndromic surveillance data. Syndromic surveillance for influenza and ILI from the Emergency Department is becoming more prevalent as a measure of yearly influenza outbreaks.	[Hiller, Katherine M.; Stoneking, Lisa; Min, Alice; Rhodes, Suzanne Michelle] Univ Arizona, Dept Emergency Med, Tucson, AZ 85721 USA	University of Arizona	Hiller, KM (corresponding author), Univ Arizona, Dept Emergency Med, Tucson, AZ 85721 USA.	khiller@aemrc.arizona.edu						[Anonymous], 2008, ADV DIS SURVEILL; Ansaldi F, 2008, J Prev Med Hyg, V49, P131; Bellazzini MA, 2011, AM J EMERG MED, V29, P70, DOI 10.1016/j.ajem.2009.09.009; Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022; Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Brillman Judith C, 2005, BMC Med Inform Decis Mak, V5, P4, DOI 10.1186/1472-6947-5-4; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Burkom HO, 2011, ANAL EVALUATION STAN, P1450; De Florentiis D, 2011, J Prev Med Hyg, V52, P134; Elliot AJ, 2012, EMERG MED J, V29, P954, DOI 10.1136/emermed-2011-200684; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Espino JU, 2001, J AM MED INFORM ASSN, P164; Gangnon Ronald, 2009, WMJ, V108, P256; Greenko J, 2003, J URBAN HEALTH, V80, pI50; Haddock Robert L, 2010, Hawaii Med J, V69, P50; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Kass-Hout TA, 2012, J AM MED INFORM ASSN, V19, P1075, DOI 10.1136/amiajnl-2011-000793; Kass-Hout TA, 2012, J AM MED INFORM ASSN, V19, P775, DOI 10.1136/amiajnl-2012-000847; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lemay R, 2008, BIOSECUR BIOTERROR, V6, P161, DOI 10.1089/bsp.2007.0056; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Malik MT, 2011, CAN J PUBLIC HEALTH, V102, P294, DOI 10.1007/BF03404053; May LS, 2010, WEST J EMERG MED, V11, P1; McLeod M, 2009, AUST NZ J PUBL HEAL, V33, P289, DOI 10.1111/j.1753-6405.2009.00391.x; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Moore K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-338; Muscatello DJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-141; Newell MB, 2006, VICTORIAN INFECT DIS, P1; Olson D, 2011, GENERATION PREDICTIO, P5172; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Olson Donald R, 2011, PLoS Curr, V3, pRRN1251, DOI 10.1371/currents.RRN1251; Painter I., 2013, ONLINE J PUBLIC HLTH, V5, pe186; Plagianos MG, 2011, EMERG INFECT DIS, V17, P1724, DOI 10.3201/eid1709.101357; Polkinghorne BG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-291; Qian YH, 2011, INFLUENZA OTHER RESP, V5, pR479, DOI 10.1111/j.1750-2659.2011.00248.x; Reeder Blaine, 2011, BMC Res Notes, V4, P187, DOI 10.1186/1756-0500-4-187; Schindeler SK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-190; Shimoni Z, 2008, EUR J INTERN MED, V19, P494, DOI 10.1016/j.ejim.2007.04.028; Shimoni Zvi, 2012, Environmental Health and Preventive Medicine, V17, P69, DOI 10.1007/s12199-011-0213-2; Silka PA, 2003, AM J EMERG MED, V21, P534, DOI 10.1016/j.ajem.2003.08.011; Smith PF, 2013, J PUBLIC HEALTH MAN, V19, P231, DOI 10.1097/PHH.0b013e318262906e; Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9; Sosin Daniel M, 2004, MMWR Suppl, V53, P125; Sosin Daniel M, 2003, Biosecur Bioterror, V1, P247, DOI 10.1089/153871303771861441; South Brett R, 2008, AMIA Annu Symp Proc, P692; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; van Dijk A, 2009, EMERG INFECT DIS, V15, P799, DOI 10.3201/eid1505.081174; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Yuan Christine M, 2004, MMWR Suppl, V53, P56; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	56	53	53	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73832	10.1371/journal.pone.0073832	http://dx.doi.org/10.1371/journal.pone.0073832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058494	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400035
J	Li, LT; Zhu, YB; Ma, JF; Li, ZY; Dong, ZP				Li, Li-Tao; Zhu, Yan-Bin; Ma, Ji-Fang; Li, Zhi-Yong; Dong, Zhi-Ping			An Analysis of the Athetis lepigone Transcriptome from Four Developmental Stages	PLOS ONE			English	Article							PROTEINS	Athetis lepigone Moschler (Lepidoptera: Noctuidae) has recently become an important insect pest of maize (Zea mays) crops in China. In order to understand the characteristics of the different developmental stages of this pest, we used Illumina short-read sequences to perform de novo transcriptome assembly and gene expression analysis for egg, larva, pupa and adult developmental stages. We obtained 10.08 Gb of raw data from Illumina sequencing and recovered 81,356 unigenes longer than 100 bp through a de novo assembly. The total sequence length reached 49.75 Mb with 858 bp of N50 and an average unigene length of 612 bp. Annotation analysis of predicted proteins indicate that 33,736 unigenes (41.47% of total unigenes) are matches to genes in the Genbank Nr database. The unigene sequences were subjected to GO, COG and KEGG functional classification. A large number of differentially expressed genes were recovered by pairwise comparison of the four developmental stages. The most dramatic differences in gene expression were found in the transitions from one stage to another stage. Some of these differentially expressed genes are related to cuticle and wing formation as well as the growth and development. We identified more than 2,500 microsatellite markers that may be used for population studies of A. lepigone. This study lays the foundation for further research on population genetics and gene function analysis in A. lepigone.	[Li, Li-Tao; Zhu, Yan-Bin; Ma, Ji-Fang; Li, Zhi-Yong; Dong, Zhi-Ping] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Peoples R China; [Zhu, Yan-Bin] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Hebei Agricultural University	Dong, ZP (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Peoples R China.	dzping001@163.com			Project of Hebei Department of Science and Technology [11220301D]	Project of Hebei Department of Science and Technology	This study was supported by the Project of Hebei Department of Science and Technology (11220301D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Berger N, 2012, BBA-GENE REGUL MECH, V1819, P863, DOI 10.1016/j.bbagrm.2012.02.022; Chen X, 2012, INSECT BIOCHEM MOLEC, V42, P665, DOI 10.1016/j.ibmb.2012.05.004; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; [姜京宇 Jiang Jingyu], 2008, [植物保护, Plant Protection], V34, P123; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Lindeborg Mats, 2008, Entomologisk Tidskrift, V129, P43; Ma J.F., 2012, CHINA PLANT PROTECTI, V32, P37; Ma JF, 2011, J HEBEI AGR SCI, V9, P1; Ma JF, 2012, CHINA PLANT PROTECTI, V32, P16; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nowacki Janusz, 2001, Polskie Pismo Entomologiczne, V70, P271; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Poltavsky A., 2009, ENTOMOL REV, V89, P1072, DOI [10.1134/S0013873809090085, DOI 10.1134/S0013873809090085]; Poltavsky Alexander Nikolaevitch, 2003, Phegea, V31, P167; Sangwan I, 2002, PLANT PHYSIOL, V129, P1788, DOI 10.1104/pp.002618; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Wang YQ, 2011, J HEBEI AGR SCI, V15, P4; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhang ZL, 2009, SHENYANG INSECT ILLU; Zhu Yan-Bin, 2012, Acta Entomologica Sinica, V55, P457	29	26	37	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73911	10.1371/journal.pone.0073911	http://dx.doi.org/10.1371/journal.pone.0073911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058501	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400041
J	Liu, Y; Yu, FL; Huang, HY; Han, JX				Liu, Yi; Yu, Fengling; Huang, Haiyan; Han, Jinxiang			Development of Recombinant Antigen Array for Simultaneous Detection of Viral Antibodies	PLOS ONE			English	Article							PROTEIN MICROARRAY; INFECTION; ASSAY; ENCEPHALITIS; IMMUNOASSAY; VIRUSES; TYPE-1; HSV-1	Protein microarrays have been developed to study antibody reactivity against a large number of antigens, demonstrating extensive perspective for clinical application. We developed a viral antigen array by spotting four recombinant antigens and synthetic peptide, including glycoprotein G of herpes simplex virus (HSV) type 1 and 2, phosphoprotein 150 of cytomegalovirus (CMV), Rubella virus (RV) core plus glycoprotein E1 and E2 as well as a E1 peptide with the optimal concentrations on activated glass slides to simultaneously detect IgG and IgM against HSV1, HSV2, CMV and RV in clinical specimens of sera and cerebrospinal fluids (CSFs). The positive reference sera were initially used to measure the sensitivity and specificity of the array with the optimal conditions. Then clinical specimens of 144 sera and 93 CSFs were tested for IgG and IgM antibodies directed against HSV1, HSV2, CMV and RV by the antigen array. Specificity of the antigen array for viral antibodies detection was satisfying compared to commercial ELISA kits but sensitivity of the array varied relying on quality and antigenic epitopes of the spotting antigens. In short, the recombinant antigen array has potential to simultaneous detect multiple viral antibodies using minute amount (3 mu l) of samples, which holds the particularly advantage to detect viral antibodies in clinical CSFs being suspicious of neonatal meningitis and encephalitis.	[Liu, Yi] Shandong Univ, Pediat Res Inst, Qilu Childrens Hosp, Jinan 250100, Peoples R China; [Yu, Fengling] Shandong Univ, Clin Lab, Qilu Childrens Hosp, Jinan 250100, Peoples R China; [Huang, Haiyan; Han, Jinxiang] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Minist Hlth, Key Lab Biotech Drugs, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Han, JX (corresponding author), Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Minist Hlth, Key Lab Biotech Drugs, Jinan, Peoples R China.	jinxiang.han@yahoo.com			Key Project Foundation of Shandong Province [2004GG2202150]; Natural Science Foundation of Shandong Province [Y2007C072]	Key Project Foundation of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was funded by Key Project Foundation of Shandong Province (2004GG2202150) and Natural Science Foundation of Shandong Province (Y2007C072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzoni A, 2009, EUR J CLIN MICROBIOL, V28, P1067, DOI 10.1007/s10096-009-0748-y; Chen JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001899; Feron D, 2013, ANAL BIOCHEM, V433, P202, DOI 10.1016/j.ab.2012.10.012; Guo DD, 2006, SHANDONG MED, V46, P13; Hanson KE, 2007, J CLIN MICROBIOL, V45, P721, DOI 10.1128/JCM.01950-06; Jaaskelainen AJ, 2009, J VIROL METHODS, V160, P167, DOI 10.1016/j.jviromet.2009.05.013; James SH, 2009, ANTIVIR RES, V83, P207, DOI 10.1016/j.antiviral.2009.04.010; Kalantari-Dehaghi M, 2012, J VIROL, V86, P4328, DOI 10.1128/JVI.05194-11; Liu Brian C-S, 2012, Expert Opin Med Diagn, V6, P187, DOI 10.1517/17530059.2012.672969; [刘毅 Liu Yi], 2005, [山东大学学报. 医学版, Journal of Shandong University], V43, P473; MacBeath G, 2000, SCIENCE, V289, P1760; Maecker HT, 2012, NAT REV RHEUMATOL, V8, P317, DOI 10.1038/nrrheum.2012.66; Maters AW, 2012, DIAGN MICR INFEC DIS, V73, P273, DOI 10.1016/j.diagmicrobio.2012.03.023; Perkins D, 2007, J CELL MOL MED, V11, P581, DOI 10.1111/j.1582-4934.2007.00045.x; Scheper T, 2010, J VIROL METHODS, V166, P42, DOI 10.1016/j.jviromet.2010.02.015; Singh DD, 2012, CURR MICROBIOL, V65, P290, DOI 10.1007/s00284-012-0154-z; Steiner I, 2011, CURR OPIN NEUROL, V24, P268, DOI 10.1097/WCO.0b013e328346be6f; Tom I, 2013, CURR PROTOC PROTEIN; van der Weiden S, 2011, EARLY HUM DEV, V87, P103, DOI 10.1016/j.earlhumdev.2010.11.005; VORNHAGEN R, 1995, J CLIN MICROBIOL, V33, P1927, DOI 10.1128/JCM.33.7.1927-1930.1995; Wadia PP, 2011, METHODS MOL BIOL, V723, P81, DOI 10.1007/978-1-61779-043-0_7; Wandinger KP, 2011, J VIROL METHODS, V174, P85, DOI 10.1016/j.jviromet.2011.04.001; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006; Yan H, 2010, J VIROL METHODS, V169, P351, DOI 10.1016/j.jviromet.2010.08.003; Yang J, 2008, PRAC J MED PHARM, V25, P216; Zandi K, 2007, FEMS IMMUNOL MED MIC, V50, P319, DOI 10.1111/j.1574-695X.2007.00247.x; Zhang YF, 2012, ANAL BIOCHEM, V430, P185, DOI 10.1016/j.ab.2012.08.021	27	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73842	10.1371/journal.pone.0073842	http://dx.doi.org/10.1371/journal.pone.0073842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058498	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400038
J	Shi, Z; Hayes, G; Ruvkun, G				Shi, Zhen; Hayes, Gabriel; Ruvkun, Gary			Dual Regulation of the lin-14 Target mRNA by the lin-4 miRNA	PLOS ONE			English	Article							HETEROCHRONIC GENE LIN-14; POSTEMBRYONIC DEVELOPMENTAL EVENTS; CAENORHABDITIS-ELEGANS; TRANSLATIONAL REPRESSION; C-ELEGANS; PROTEIN-SYNTHESIS; MICRORNA TARGETS; INITIATION; DECAY; EXPRESSION	microRNAs (miRNAs) are similar to 22 nt regulatory RNAs that in animals typically bind with partial complementarity to sequences in the 39 untranslated (UTR) regions of target mRNAs, to induce a decrease in the production of the encoded protein. The relative contributions of translational inhibition of intact mRNAs and degradation of mRNAs caused by binding of the miRNA vary; for many genetically validated miRNA targets, translational repression has been implicated, whereas some analyses of other miRNA targets have revealed only modest translational repression and more significant mRNA destabilization. In Caenorhabditis elegans, the lin-4 miRNA accumulates during early larval development, binds to target elements in the lin-14 mRNA, and causes a sharp decrease in the abundance of LIN-14 protein. Here, we monitor the dynamics of lin-14 mRNA and protein as well as lin-4 miRNA levels in finely staged animals during early larval development. We find complex regulation of lin-14, with the abundance of lin-14 mRNA initially modestly declining followed by fluctuation but little further decline of lin-14 mRNA levels accompanied by continuing and more dramatic decline in LIN-14 protein abundance. We show that the translational inhibition of lin-14 is dependent on binding of the lin-4 miRNA to multiple lin-4 complementary sites in the lin-14 3'UTR. Our results point to the importance of translational inhibition in silencing of lin-14 by the lin-4 miRNA.	[Shi, Zhen; Hayes, Gabriel; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Shi, Zhen] Harvard Univ, Sch Med, Biol Sci Dent Med Program, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu			NIH [R01-GM44619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619, R01GM098647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH to G. R. (R01-GM44619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Holtz J, 2009, RNA, V15, P400, DOI 10.1261/rna.1258309; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Reinhart BJ, 2001, GENETICS, V157, P199; RUVKUN G, 1989, GENETICS, V121, P501; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stadler M, 2012, GENOME RES; Stoeckius M, 2009, NAT METHODS, V6, P745, DOI [10.1038/nmeth.1370, 10.1038/NMETH.1370]; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	26	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75475	10.1371/journal.pone.0075475	http://dx.doi.org/10.1371/journal.pone.0075475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058689	gold, Green Submitted, Green Published			2022-12-27	WOS:000324408400115
J	Averaimo, S; Abeti, R; Savalli, N; Brown, LJ; Curmi, PMG; Breit, SN; Mazzanti, M				Averaimo, Stefania; Abeti, Rosella; Savalli, Nicoletta; Brown, Louise J.; Curmi, Paul M. G.; Breit, Samuel N.; Mazzanti, Michele			Point Mutations in the Transmembrane Region of the Clic1 Ion Channel Selectively Modify Its Biophysical Properties	PLOS ONE			English	Article							CHLORIDE CHANNEL; MOLECULAR-CLONING; PROTEIN; NCC27; FORM; PORE; BLOCK	Chloride intracellular Channel 1 (CLIC1) is a metamorphic protein that changes from a soluble cytoplasmic protein into a transmembrane protein. Once inserted into membranes, CLIC1 multimerises and is able to form chloride selective ion channels. Whilst CLIC1 behaves as an ion channel both in cells and in artificial lipid bilayers, its structure in the soluble form has led to some uncertainty as to whether it really is an ion channel protein. CLIC1 has a single putative transmembrane region that contains only two charged residues: arginine 29 (Arg29) and lysine 37 (Lys37). As charged residues are likely to have a key role in ion channel function, we hypothesized that mutating them to neutral alanine to generate K37A and R29A CLIC1 would alter the electrophysiological characteristics of CLIC1. By using three different electrophysiological approaches: i) single channel Tip-Dip in artificial bilayers using soluble recombinant CLIC1, ii) cell-attached and iii) whole-cell patch clamp recordings in transiently transfected HEK cells, we determined that the K37A mutation altered the single-channel conductance while the R29A mutation affected the single-channel open probability in response to variation in membrane potential. Our results show that mutation of the two charged amino acids (K37 and R29) in the putative transmembrane region of CLIC1 alters the biophysical properties of the ion channel in both artificial bilayers and cells. Hence these charged residues are directly involved in regulating its ion channel activity. This strongly suggests that, despite its unusual structure, CLIC1 itself is able to form a chloride ion channel.	[Averaimo, Stefania; Savalli, Nicoletta; Mazzanti, Michele] Univ Milan, Dipartimento Biosci, Milan, Italy; [Abeti, Rosella] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Brown, Louise J.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Curmi, Paul M. G.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia	University of Milan; University of London; University College London; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney	Averaimo, S (corresponding author), Univ Paris 06, Inst Vis, Paris, France.	stefania.averaimo@inserm.fr	Curmi, Paul/G-7185-2011	Curmi, Paul/0000-0001-5762-7638; Brown, Louise/0000-0001-8592-2431; Abeti, Rosella/0000-0001-9817-8779; Mazzanti, Michele/0000-0002-1819-3811	Italian Ministry of Education and Scientific Research	Italian Ministry of Education and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This research was funded by PRIN 2009-2011 n. 2009R4L8L4, Italian Ministry of Education and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Averaimo S, 2010, FEBS LETT, V584, P2076, DOI 10.1016/j.febslet.2010.02.073; BROWN AM, 1993, ANN NY ACAD SCI, V707, P74, DOI 10.1111/j.1749-6632.1993.tb38043.x; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Edwards JC, 2010, FEBS LETT, V584, P2102, DOI 10.1016/j.febslet.2010.01.037; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; HILLE B, 2001, ION CHANNELS EXCITAB, V18; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LANDRY D, 1993, J BIOL CHEM, V268, P14948; Legg-E'Silva D, 2012, BIOCHEMISTRY-US, V51, P7854, DOI 10.1021/bi300874b; Linsdell P, 1997, J GEN PHYSIOL, V110, P365, DOI 10.1085/jgp.110.4.365; Linsdell P, 1997, J GEN PHYSIOL, V110, P355, DOI 10.1085/jgp.110.4.355; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; MAZZANTI M, 1989, PFLUG ARCH EUR J PHY, V413, P322, DOI 10.1007/BF00583549; Milton RH, 2008, J NEUROSCI, V28, P11488, DOI 10.1523/JNEUROSCI.2431-08.2008; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Novarino G, 2004, J NEUROSCI, V24, P5322, DOI 10.1523/JNEUROSCI.1170-04.2004; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; REDHEAD CR, 1992, P NATL ACAD SCI USA, V89, P3716, DOI 10.1073/pnas.89.9.3716; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Singh H, 2010, FEBS LETT, V584, P2112, DOI 10.1016/j.febslet.2010.03.013; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; TAGLIALATELA M, 1993, PFLUG ARCH EUR J PHY, V423, P104, DOI 10.1007/BF00374967; Tonini R, 2000, FASEB J, V14, P1171, DOI 10.1096/fasebj.14.9.1171; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; Yang SG, 2010, NEUROCHEM INT, V57, P914, DOI 10.1016/j.neuint.2010.09.011	39	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74523	10.1371/journal.pone.0074523	http://dx.doi.org/10.1371/journal.pone.0074523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058583	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900053
J	Ekstrom, K; Omar, O; Graneli, C; Wang, XQ; Vazirisani, F; Thomsen, P				Ekstrom, Karin; Omar, Omar; Graneli, Cecilia; Wang, Xiaoqin; Vazirisani, Forugh; Thomsen, Peter			Monocyte Exosomes Stimulate the Osteogenic Gene Expression of Mesenchymal Stem Cells	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; IN-VITRO; DIFFERENTIATION; MACROPHAGES; ACCUMULATION; MECHANISM; VESICLES; PROTEIN; GROWTH; RNA	Inflammation and regeneration at the implant-bone interface are intimately coupled via cell-cell communication. In contrast to the prevailing view that monocytes/macrophages orchestrate mesenchymal stem cells (MSCs) and progenitor cells via the secretion of soluble factors, we examined whether communication between these different cell types also occurs via exosomes. LPS-stimulated human monocytes released exosomes, positive for CD9, CD63, CD81, Tsg101 and Hsp70, as determined by flow cytometry and Western blot. These exosomes also contained wide size distribution of RNA, including RNA in the size of microRNAs. The exosomes were shown to interact with human mesenchymal stem cells. After 24 h of culture, a considerable portion of the MSCs had internalised PKH67-labelled exosomes. Furthermore, after 72 h, the gene expression of the osteogenic markers runt-related transcription factor 2 (RUNX2) and bone morphogenetic protein-2 (BMP-2) had increased in comparison with control medium, whereas no significant difference in osteocalcin (OC) expression was demonstrated. The present results show that, under given experimental conditions, monocytes communicate with MSCs via exosomes, resulting in the uptake of exosomes in MSCs and the stimulation of osteogenic differentiation. The present observations suggest that exosomes constitute an additional mode of cell-cell signalling with an effect on MSC differentiation during the transition from injury and inflammation to bone regeneration.	[Ekstrom, Karin; Omar, Omar; Graneli, Cecilia; Wang, Xiaoqin; Vazirisani, Forugh; Thomsen, Peter] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden; [Ekstrom, Karin; Omar, Omar; Graneli, Cecilia; Wang, Xiaoqin; Vazirisani, Forugh; Thomsen, Peter] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden	University of Gothenburg	Ekstrom, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.	karin.ekstrom@biomaterials.gu.se	Ekström, Karin/M-7501-2013; Omar, Omar/C-9264-2019; Omar, Omar/I-2126-2017	Ekström, Karin/0000-0001-7808-4572; Omar, Omar/0000-0002-2610-1294; Omar, Omar/0000-0002-2610-1294; Wang, Xiaoqin/0000-0001-9779-5089; Thomsen, Peter/0000-0003-3910-6665; Graneli, Cecilia/0000-0003-1133-8755	Swedish Research Council [K2012-52X-09495-25-3]; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gataland Region; Hjalmar Svensson Fund; Lundberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gataland Region; Hjalmar Svensson Fund; Lundberg Foundation(European Commission)	The support of the Swedish Research Council (grant K2012-52X-09495-25-3), the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, the Vastra Gataland Region, the Hjalmar Svensson Fund and the Lundberg Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; Gross JC, 2012, NAT CELL BIOL; Hu R, 2010, EXPERT OPIN THER TAR, V14, P1109, DOI 10.1517/14728222.2010.512916; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Jason Webber RS, 2010, CANCER RES, P70; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lasser C, 2011, AM J RHINOL ALLERGY, V25, P89, DOI 10.2500/ajra.2011.25.3573; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055; Omar O, 2010, J MATER SCI-MATER M, V21, P969, DOI 10.1007/s10856-009-3915-x; Omar OM, 2011, BIOMATERIALS, V32, P374, DOI 10.1016/j.biomaterials.2010.09.011; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Singh PP, 2012, J IMMUNOL, V189, P777, DOI 10.4049/jimmunol.1103638; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	38	141	152	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75227	10.1371/journal.pone.0075227	http://dx.doi.org/10.1371/journal.pone.0075227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058665	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900101
J	Karki, R; Igwe, OJ				Karki, Rajendra; Igwe, Orisa J.			Toll-Like Receptor 4-Mediated Nuclear Factor Kappa B Activation Is Essential for Sensing Exogenous Oxidants to Propagate and Maintain Oxidative/Nitrosative Cellular Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; ADAPTER MOLECULE; FREE-RADICALS; PEROXYNITRITE; SUPEROXIDE; TLR4; INFLAMMATION; ANTIOXIDANT; IMMUNE	The mechanism(s) by which cells can sense exogenous oxidants that may contribute to intracellular oxidative/nitrosative stress is not clear. The objective of this study was to determine how cells might respond to exogenous oxidants to potentially initiate, propagate and/or maintain inflammation associated with many human diseases through NF-kappa B activation. First, we used HEK-Blue cells that are stably transfected with mouse toll-like receptor 4 (mTLR4) or mouse TLR2. These cells also express optimized secreted embryonic alkaline phosphatase (SEAP) reporter gene under the control of a promoter inducible by NF-kappa B transcription factor. These cells were challenged with their respective receptor-specific ligands, different pro-oxidants and/or inhibitors that act at different levels of the receptor signaling pathways. A neutralizing antibody directed against TLR4 inhibited responses to both TLR4-specific agonist and a prooxidant, which confirmed that both agents act through TLR4. We used the level of SEAP released into the culture media due to NF-kappa B activation as a measure of TLR4 or TLR2 stimulation. Pro-oxidants evoked increased release of SEAP from HEK-Blue mTLR4 cells at a much lower concentration compared with release from the HEK-Blue mTLR2 cells. Specific TLR4 signaling pathway inhibitors and oxidant scavengers (anti-oxidants) significantly attenuated oxidant-induced SEAP release by TLR4 stimulation. Furthermore, a novel pro-oxidant that decays to produce the same reactants as activated phagocytes induced inflammatory pain responses in the mouse orofacial region with increased TLR4 expression, and IL-1 beta and TNF alpha tissue levels. EUK-134, a synthetic serum-stable scavenger of oxidative species decreased these effects. Our data provide in vitro and related in vivo evidence that exogenous oxidants can induce and maintain inflammation by acting mainly through a TLR4-dependent pathway, with implications in many chronic human ailments.	[Karki, Rajendra; Igwe, Orisa J.] Univ Missouri Kansas City, Div Pharmacol & Toxicol, Kansas City, MO USA	University of Missouri System; University of Missouri Kansas City	Igwe, OJ (corresponding author), Univ Missouri Kansas City, Div Pharmacol & Toxicol, Kansas City, MO USA.	igweo@umkc.edu	Karki, Rajendra/H-6647-2019	Karki, Rajendra/0000-0003-4436-9128	National Institutes of Health Grant [NIDCR DE021888]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R15DE021888] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grant - NIDCR DE021888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Afanas'ev IB, 2007, MOL BIOTECHNOL, V37, P2, DOI 10.1007/s12033-007-0056-7; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altug S, 2006, CHRONOBIOL INT, V23, P583, DOI 10.1080/07420520600650703; Ambalavanar R, 2006, NEUROSCI LETT, V399, P249, DOI 10.1016/j.neulet.2006.02.003; Atsu SS, 2006, RHEUMATOL INT, V26, P781, DOI 10.1007/s00296-006-0110-y; BAIRD MB, 1977, CHEM-BIOL INTERACT, V16, P145, DOI 10.1016/0009-2797(77)90124-7; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benoliel R, 2010, CURR PAIN HEADACHE R, V14, P33, DOI 10.1007/s11916-009-0085-y; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Cuddy LK, 2012, J NEUROSCI, V32, P5573, DOI 10.1523/JNEUROSCI.5235-11.2012; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; EDWARDS JC, 1982, J LIPID RES, V23, P994; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Graff-Radford SB, 2009, NEUROLOGIST, V15, P171, DOI 10.1097/NRL.0b013e31819827d8; Hakim AW, 2009, J NEUROPHYSIOL, V102, P1551, DOI 10.1152/jn.00326.2009; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; Hamada Y, 2006, ORAL SURG ORAL MED O, V102, P596, DOI 10.1016/j.tripleo.2005.11.010; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; HODGSON EK, 1974, BIOCHEMISTRY-US, V13, P3811, DOI 10.1021/bi00715a030; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Jia Ze-jun, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P168, DOI 10.3881/j.issn.1000-503X.2012.02.013; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kopp S, 2001, J OROFAC PAIN, V15, P9; Lass A, 1996, BBA-LIPID LIPID MET, V1303, P111, DOI 10.1016/0005-2760(96)00088-4; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Little JW, 2012, AMINO ACIDS, V42, P75, DOI 10.1007/s00726-010-0633-0; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; MEYER M, 1994, CHEM-BIOL INTERACT, V91, P91, DOI 10.1016/0009-2797(94)90029-9; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MIESEL R, 1989, INORG CHIM ACTA, V160, P119, DOI 10.1016/S0020-1693(00)85411-0; MIESEL R, 1995, FREE RADICAL RES, V23, P213, DOI 10.3109/10715769509064035; MIESEL R, 1993, INFLAMMATION, V17, P595, DOI 10.1007/BF00914197; MIESEL R, 1995, CLIN EXP RHEUMATOL, V13, P595; Milam SB, 1998, J ORAL MAXIL SURG, V56, P214, DOI 10.1016/S0278-2391(98)90872-2; Minard KI, 2010, BIOCHEMISTRY-US, V49, P6299, DOI 10.1021/bi100825z; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Miyamoto M, 2011, NEUROSCI LETT, V491, P8, DOI 10.1016/j.neulet.2010.12.060; Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PARNHAM MJ, 1991, AGENTS ACTIONS, V32, P4, DOI 10.1007/BF01983300; Paul-Clark MJ, 2008, MOL MED, V14, P238, DOI 10.2119/2007-00098.Paul-Clark; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Qureshi N, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P687; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Salvemini D, 2006, BIOCHEM SOC T, V34, P965, DOI 10.1042/BST0340965; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; SCHALKWIJK J, 1987, INT J TISSUE REACT, V9, P39; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tzortzaki EG, 2012, CHEST, V141, P1243, DOI 10.1378/chest.11-1653; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wegner H. E. H., 1995, International Urology and Nephrology, V27, P621, DOI 10.1007/BF02564750; Wu FX, 2010, INT J MED SCI, V7, P251; Xiang M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/916425	86	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73840	10.1371/journal.pone.0073840	http://dx.doi.org/10.1371/journal.pone.0073840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058497	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900024
J	Lin, KW; Tharp, M; Conway, M; Hsieh, A; Ross, M; Kim, J; Kim, HE				Lin, Ko-Wei; Tharp, Melissa; Conway, Mike; Hsieh, Alexander; Ross, Mindy; Kim, Jihoon; Kim, Hyeon-Eui			Feasibility of Using Clinical Element Models (CEM) to Standardize Phenotype Variables in the Database of Genotypes and Phenotypes (dbGaP)	PLOS ONE			English	Article							POST-COORDINATION; TERMINOLOGIES; QUALITY; COVERAGE	The database of Genotypes and Phenotypes (dbGaP) contains various types of data generated from genome-wide association studies (GWAS). These data can be used to facilitate novel scientific discoveries and to reduce cost and time for exploratory research. However, idiosyncrasies and inconsistencies in phenotype variable names are a major barrier to reusing these data. We addressed these challenges in standardizing phenotype variables by formalizing their descriptions using Clinical Element Models (CEM). Designed to represent clinical data, CEMs were highly expressive and thus were able to represent a majority (77.5%) of the 215 phenotype variable descriptions. However, their high expressivity also made it difficult to directly apply them to research data such as phenotype variables in dbGaP. Our study suggested that simplification of the template models makes it more straightforward to formally represent the key semantics of phenotype variables.	[Lin, Ko-Wei; Tharp, Melissa; Conway, Mike; Hsieh, Alexander; Ross, Mindy; Kim, Jihoon; Kim, Hyeon-Eui] Univ Calif San Diego, Sch Med, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kim, HE (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA.	hyk038@ucsd.edu		Kim, Hyeoneui/0000-0002-5931-7286; Lin, Ko-Wei/0000-0001-6645-2091	NIH/NHLBI [UH2HL108785]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH3HL108785, UH2HL108785] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM011271] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the NIH/NHLBI grant UH2HL108785 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson D, 2010, STUD HEALTH TECHNOL, V160, P1164, DOI 10.3233/978-1-60750-588-4-1164; Chute CG, 1996, J AM MED INFORM ASSN, V3, P224, DOI 10.1136/jamia.1996.96310636; Chute Christopher G, 2011, AMIA Annu Symp Proc, V2011, P248; Clinical Data Interchange Standards Consortium, STUD DAT TAB MOD; Coyle J., 2008, CLIN ELEMENT MODEL; Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74; Green JM, 2006, J AM MED INFORM ASSN, V13, P321, DOI 10.1197/jamia.M1973; Harkema H, 2011, J AM MED INFORM ASSN, V18, pI150, DOI 10.1136/amiajnl-2011-000431; Heymans S, 2011, J BIOMED SEMANT, V2, DOI 10.1186/2041-1480-2-2; *HLTH LEV 7 INT HL, HLTH LEV 7 HL7 REF I; HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007; HSIEH A, 2012, DEMOGRAPHICS IDENTIF, P40; Humphreys BL, 1997, J AM MED INFORM ASSN, V4, P484, DOI 10.1136/jamia.1997.0040484; *INT HEALTHC GE HE, CLIN EL MOD BROWS; *INT HLTH TERM STA, SNOMED CT US GUID; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; LIN KW, 2012, AM J RESP CRIT CARE, V185, pA5778; LIN KW, 2012, FEASIBILITY USING CL, P123; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; *NAT HUM GEN RES I, EL MED REC GEN; Navas H, 2010, STUD HEALTH TECHNOL, V160, P1045, DOI 10.3233/978-1-60750-588-4-1045; Navigli R, 2008, FRONT ARTIF INTEL AP, V167, P71; Pan HQ, 2012, HUM MUTAT, V33, P849, DOI 10.1002/humu.22074; Pathak Jyotishman, 2011, AMIA Jt Summits Transl Sci Proc, V2011, P41; Pathak J, 2011, J AM MED INFORM ASSN, V18, P376, DOI 10.1136/amiajnl-2010-000061; Percha B, 2012, J AM MED INFORM ASSN, V19, P913, DOI 10.1136/amiajnl-2011-000607; Rea S, 2012, J BIOMED INFORM, V45, P763, DOI 10.1016/j.jbi.2012.01.009; Rector A, 2012, J BIOMED INFORM, V45, P199, DOI 10.1016/j.jbi.2011.10.002; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Schulz S, 2010, STUD HEALTH TECHNOL, V160, P1000, DOI 10.3233/978-1-60750-588-4-1000; Tao C., 2012, J AM MED INFORM ASS; *THE INT HLTH TERM, SNOWMED CLIN TERMS S; *THE OFF NAT COORD, AR 4 SEC US EHR DAT; Tobias Jonathan, 2006, BMC Med Inform Decis Mak, V6, P25, DOI 10.1186/1472-6947-6-25; Wu ST, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-1	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e76384	10.1371/journal.pone.0076384	http://dx.doi.org/10.1371/journal.pone.0076384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058713	Green Published, gold			2022-12-27	WOS:000324695900136
J	Stoner, AM; Anderson, SE; Buckley, TJ				Stoner, Alexis M.; Anderson, Sarah E.; Buckley, Timothy J.			Ambient Air Toxics and Asthma Prevalence among a Representative Sample of US Kindergarten-Age Children	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; AUTISM SPECTRUM DISORDERS; ENVIRONMENTAL JUSTICE; PUBLIC-HEALTH; CANCER-RISK; POLLUTION; EXPOSURE; POLLUTANTS; DISPARITIES; ALLERGY	Background: Criteria pollutants have been associated with exacerbation of children's asthma, but the role of air toxics in relation to asthma is less clear. Our objective was to evaluate whether exposure to outdoor air toxics in early childhood increased asthma risk or severity. Methods: Air toxics exposure was estimated using the 2002 National Air toxics Assessment (NATA) and linked to longitudinal data (n=6950) from a representative sample of US children born in 2001 and followed through kindergarten-age in the Early Child Longitudinal Study - Birth Cohort (ECLS-B). Results: Overall, 17.7% of 5.5 year-olds had ever been told by a healthcare professional they had asthma, and 6.8% had been hospitalized or visited an emergency room for an asthma attack. Higher rates of asthma were observed among boys (20.1%), low-income (24.8%), and non-Hispanic black children (30.0%) (p <= 0.05). Air toxics exposure was greater for minority race/ethnicity (p<0.0001), low income (p<0.0001), non-rural area (p<0.001). Across all analyses, greater air toxics exposure, as represented by total NATA respiratory hazard index, or when limited to respiratory hazard index from onroad mobile sources or diesel PM, was not associated with a greater prevalence of asthma or hospitalizations (p trend >0.05). In adjusted logistic regression models, children exposed to the highest respiratory hazard index were not more likely to have asthma compared to those exposed to the lowest respiratory hazard index of total, onroad sources, or diesel PM. Conclusions: Early childhood exposure to outdoor air toxics in a national sample has not previously been studied relative to children's asthma. Within the constraints of the study, we found no evidence that early childhood exposure to outdoor air toxics increased risk for asthma. As has been previously reported, it is evident that there are environmental justice and disparity concerns for exposure to air toxics and asthma prevalence in US children.	[Stoner, Alexis M.; Buckley, Timothy J.] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Anderson, Sarah E.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Buckley, TJ (corresponding author), US EPA, Durham, NC USA.	Buckley.Timothy@epa.gov	Buckley, Timothy/AAS-7516-2021	Stoner, Alexis/0000-0001-7022-4059				Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; American Lung Association, 2012, ASTHM CHILDR FACT SH; American Lung Association, 2012, CUTT TOB RUR ROOTS T; Anderson MJ, 2001, J EXPO ANAL ENV EPID, V11, P295, DOI 10.1038/sj.jea.7500168; Apelberg BJ, 2005, ENVIRON HEALTH PERSP, V113, P693, DOI 10.1289/ehp.7609; Bethel J., 2005, 2005147 NCES US DEP; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brulle RJ, 2006, ANNU REV PUBL HEALTH, V27, P103, DOI 10.1146/annurev.publhealth.27.021405.102124; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; Corburn J, 2006, HEALTH PLACE, V12, P167, DOI 10.1016/j.healthplace.2004.11.002; Delfino RJ, 2006, ENVIRON HEALTH PERSP, V114, P1736, DOI 10.1289/ehp.9141; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, P573, DOI 10.1289/ehp.02110s4573; Diette GB, 2007, ENVIRON HEALTH PERSP, V115, P1665, DOI 10.1289/ehp.10088; Gale SL, 2012, J EXPO SCI ENV EPID, V22, P386, DOI 10.1038/jes.2012.29; Goldman LR, 2000, ENVIRON HEALTH PERSP, V108, P443, DOI 10.2307/3454535; *I SAS I, 2009, SAS STAT SOFTW VERS; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Lee YL, 2011, INT J HYG ENVIR HEAL, V214, P369, DOI 10.1016/j.ijheh.2011.05.004; LEIKAUF GD, 1995, ENVIRON HEALTH PERSP, V103, P253, DOI 10.2307/3432382; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; Linder SH, 2008, ENVIRON SCI TECHNOL, V42, P4312, DOI 10.1021/es072042u; Maantay J, 2007, HEALTH PLACE, V13, P32, DOI 10.1016/j.healthplace.2005.09.009; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miller RL, 2010, PEDIATR ALLERGY IMMU, V21, P260, DOI 10.1111/j.1399-3038.2009.00980.x; Morello-Frosch R, 2002, ENVIRON HEALTH PERSP, V110, P149, DOI 10.1289/ehp.02110s2149; Nazaroff WW, 2004, J EXPO ANAL ENV EPID, V14, pS71, DOI 10.1038/sj.jea.7500361; Payne-Sturges DC, 2004, ENVIRON HEALTH PERSP, V112, P589, DOI 10.1289/ehp.6496; Rosenbaum AS, 1999, J AIR WASTE MANAGE, V49, P1138, DOI 10.1080/10473289.1999.10463919; Snow K., 2009, EARLY CHILDHOOD LONG; Snow K., 2007, 2008024 NCES US DEP; Suwanwaiphatthana Wiparat, 2010, Pediatr Nurs, V36, P25; Tzivian L, 2011, J ASTHMA, V48, P470, DOI 10.3109/02770903.2011.570407; *US EPA, 2002, NAT AIR TOX ASS; WALLACE LA, 1992, ANN NY ACAD SCI, V641, P7, DOI 10.1111/j.1749-6632.1992.tb16527.x; WARE JH, 1993, AM J EPIDEMIOL, V137, P1287, DOI 10.1093/oxfordjournals.aje.a116639; WARE JH, 1986, AM REV RESPIR DIS, V133, P834; Weisel CP, 2002, ENVIRON HEALTH PERSP, V110, P527, DOI 10.1289/ehp.02110s4527; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; WinklerPrins V, 2011, J FAM PRACTICE, V60, P152; Woodruff TJ, 1998, ENVIRON HEALTH PERSP, V106, P245, DOI 10.2307/3434011; 2005, NAT HLTH INT SURV LI	41	21	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75176	10.1371/journal.pone.0075176	http://dx.doi.org/10.1371/journal.pone.0075176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058662	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900099
J	Tsukamoto, T; Li, XL; Morita, H; Minowa, T; Aizawa, T; Hanagata, N; Demura, M				Tsukamoto, Takashi; Li, Xianglan; Morita, Hiromi; Minowa, Takashi; Aizawa, Tomoyasu; Hanagata, Nobutaka; Demura, Makoto			Role of S-Palmitoylation on IFITM5 for the Interaction with FKBP11 in Osteoblast Cells	PLOS ONE			English	Article							WEST NILE VIRUS; PROTEIN PALMITOYLATION; EXPRESSION; 2-BROMOPALMITATE; LOCALIZATION; RESISTANCE; BRIL	Recently, one of the interferon-induced transmembrane (IFITM) family proteins, IFITM3, has become an important target for the activity against influenza A (H1N1) virus infection. In this protein, a post-translational modification by fatty acids covalently attached to cysteine, termed S-palmitoylation, plays a crucial role for the antiviral activity. IFITM3 possesses three cysteine residues for the S-palmitoylation in the first transmembrane (TM1) domain and in the cytoplasmic (CP) loop. Because these cysteines are well conserved in the mammalian IFITM family proteins, the S-palmitoylation on these cysteines is significant for their functions. IFITM5 is another IFITM family protein and interacts with the FK506-binding protein 11 (FKBP11) to form a higher-order complex in osteoblast cells, which induces the expression of immunologically relevant genes. In this study, we investigated the role played by S-palmitoylation of IFITM5 in its interaction with FKBP11 in the cells, because this interaction is a key process for the gene expression. Our investigations using an established reporter, 17-octadecynoic acid (17-ODYA), and an inhibitor for the S-palmitoylation, 2-bromopalmitic acid (2BP), revealed that IFITM5 was S-palmitoylated in addition to IFITM3. Specifically, we found that cysteine residues in the TM1 domain and in the CP loop were S-palmitoylated in IFITM5. Then, we revealed by immunoprecipitation and western blot analyses that the interaction of IFITM5 with FKBP11 was inhibited in the presence of 2BP. The mutant lacking the S-palmitoylation site in the TM1 domain lost the interaction with FKBP11. These results indicate that the S-palmitoylation on IFITM5 promotes the interaction with FKBP11. Finally, we investigated bone nodule formation in osteoblast cells in the presence of 2BP, because IFITM5 was originally identified as a bone formation factor. The experiment resulted in a morphological aberration of the bone nodule. This also indicated that the S-palmitoylation contributes to bone formation.	[Tsukamoto, Takashi; Aizawa, Tomoyasu; Hanagata, Nobutaka; Demura, Makoto] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Tsukamoto, Takashi; Aizawa, Tomoyasu; Demura, Makoto] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Li, Xianglan; Morita, Hiromi; Minowa, Takashi; Hanagata, Nobutaka] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki, Japan	Hokkaido University; Hokkaido University; National Institute for Materials Science	Tsukamoto, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan.	tsukamoto.takashi@g.mbox.nagoya-u.ac.jp; demura@sci.hokudai.ac.jp	Tsukamoto, Takashi/F-3993-2017; Aizawa, Tomoyasu/F-5278-2011; Demura, Makoto/F-5272-2011	Tsukamoto, Takashi/0000-0002-6348-6664; Aizawa, Tomoyasu/0000-0001-9134-7576; Demura, Makoto/0000-0003-0912-9284; Hanagata, Nobutaka/0000-0001-6079-3426; Minowa, Takashi/0000-0003-0046-5230				Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Davda D, 2013, ACS CHEM BIOL, DOI [10.1021/cb400380s, DOI 10.1021/CB400380S.PUBMED:23844586]; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; EVANS SS, 1993, J IMMUNOL, V150, P736; EVANS SS, 1990, BLOOD, V76, P2583; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Kasaai B, 2013, J BIOL CHEM, V288, P13278, DOI 10.1074/jbc.M113.457010; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu YS, 2012, BONE, V51, P933, DOI 10.1016/j.bone.2012.07.024; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2012, BIOORGAN MED CHEM, V20, P650, DOI 10.1016/j.bmc.2011.03.062; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zheng BH, 2013, J AM CHEM SOC, V135, P7082, DOI 10.1021/ja311416v	36	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75831	10.1371/journal.pone.0075831	http://dx.doi.org/10.1371/journal.pone.0075831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058703	Green Published, gold			2022-12-27	WOS:000324695900127
J	Wattiez, AS; Pichon, X; Dupuis, A; Hernandez, A; Privat, AM; Aissouni, Y; Chalus, M; Pelissier, T; Eschalier, A; Marin, P; Courteix, C				Wattiez, Anne-Sophie; Pichon, Xavier; Dupuis, Amandine; Hernandez, Alejandro; Privat, Anne-Marie; Aissouni, Youssef; Chalus, Maryse; Pelissier, Teresa; Eschalier, Alain; Marin, Philippe; Courteix, Christine			Disruption of 5-HT2A Receptor-PDZ Protein Interactions Alleviates Mechanical Hypersensitivity in Carrageenan-Induced Inflammation in Rats	PLOS ONE			English	Article							SPINAL DORSAL-HORN; SEROTONIN RECEPTORS; NEUROPATHIC PAIN; CORD; FLUOXETINE; NEURONS; ANTIDEPRESSANTS; PATHOPHYSIOLOGY; TRANSMISSION; HYPERALGESIA	Despite common pathophysiological mechanisms, inflammatory and neuropathic pain do not respond equally to the analgesic effect of antidepressants, except for selective serotonin reuptake inhibitors (SSRIs), which show a limited efficacy in both conditions. We previously demonstrated that an interfering peptide (TAT-2ASCV) disrupting the interaction between 5-HT2A receptors and its associated PDZ proteins (e. g. PSD-95) reveals a 5-HT2A receptor-mediated anti-hyperalgesic effect and enhances the efficacy of fluoxetine (a SSRI) in diabetic neuropathic pain conditions in rats. Here, we have examined whether the same strategy would be useful to treat inflammatory pain. Sub-chronic inflammatory pain was induced by injecting lambda-carrageenan (100 mu l, 2%) into the left hind paw of the rat. Mechanical hyperalgesia was assessed after acute treatment with TAT-2ASCV or/and fluoxetine (SSRI) 2.5 h after lambda-carrageenan injection. Possible changes in the level of 5-HT2A receptors and its associated PDZ protein PSD-95 upon inflammation induction were quantified by Western blotting in dorsal horn spinal cord. Administration of TAT-2ASCV peptide (100 ng/rat, intrathecally) but not fluoxetine (10 mg/kg, intraperitoneally) relieves mechanical hyperalgesia (paw pressure test) in inflamed rats. This anti-hyperalgesic effect involves spinal 5-HT2A receptors and GABAergic interneurons as it is abolished by a 5-HT2A antagonist (M100907, 150 ng/rat, intrathecally) and a GABA(A) antagonist, (bicuculline, 3 mu g/rat, intrathecally). We also found a decreased expression of 5-HT2A receptors in the dorsal spinal cord of inflamed animals which could not be rescued by TAT-2ASCV injection, while the amount of PSD-95 was not affected by inflammatory pain. Finally, the coadministration of fluoxetine does not further enhance the anti-hyperalgesic effect of TAT-2ASCV peptide. This study reveals a role of the interactions between 5-HT2A receptors and PDZ proteins in the pathophysiological pathways of inflammatory pain and opens new perspectives in its control thanks to molecules disrupting 5-HT2A receptor/PDZ protein interactions.	[Wattiez, Anne-Sophie; Pichon, Xavier; Dupuis, Amandine; Privat, Anne-Marie; Aissouni, Youssef; Chalus, Maryse; Eschalier, Alain; Courteix, Christine] Univ Clermont Ferrand 2, Univ Auvergne, Clermont Ferrand, France; [Wattiez, Anne-Sophie; Pichon, Xavier; Dupuis, Amandine; Privat, Anne-Marie; Aissouni, Youssef; Chalus, Maryse; Eschalier, Alain; Courteix, Christine] INSERM, U1107, NEURO DOL, Clermont Ferrand, France; [Hernandez, Alejandro] Univ Santiago Chile, Fac Chem & Biol, Dept Biol, Neurobiol Lab, Santiago, Chile; [Pelissier, Teresa] Univ Chile, Fac Med, Program Mol & Clin Pharmacol, Santiago, Chile; [Eschalier, Alain] Ctr Hosp Univ Clermont Ferrand, Serv Pharmacol, Clermont Ferrand, France; [Marin, Philippe] Univ Montpellier I, CNRS, Inst Genom Fonct, Unite Mixte Rech 5203, Montpellier, France; [Marin, Philippe] Univ Montpellier 2, Montpellier, France; [Marin, Philippe] INSERM, U661, Montpellier, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad de Santiago de Chile; Universidad de Chile; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Courteix, C (corresponding author), Univ Clermont Ferrand 2, Univ Auvergne, Clermont Ferrand, France.	christine.courteix@udamail.fr	ESCHALIER, Alain/L-9957-2015; Wattiez, Anne-Sophie/V-3754-2019; Pichon, Xavier/AAG-9144-2020; Hernandez, Alejandro/M-4796-2019; aissouni, youssef/K-2254-2015	Pichon, Xavier/0000-0002-0755-2305; aissouni, youssef/0000-0002-9264-7690; Hernandez, Alejandro/0000-0001-9222-6522; Wattiez, Anne-Sophie/0000-0002-4392-2211	French National Agency for Research [ANR-08-MNP-026]; Dicyt AHK, Chile; French Ministere de l'Enseignement Superieur et de la Recherche; Universite d'Auvergne; INSERM; Region Auvergne-FEDER; Inserm-Region Auvergne; la Fondation pour la Recherche Medicale (Contracts Equipe FRM)	French National Agency for Research(French National Research Agency (ANR)); Dicyt AHK, Chile; French Ministere de l'Enseignement Superieur et de la Recherche; Universite d'Auvergne; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Auvergne-FEDER(Region Auvergne-Rhone-Alpes); Inserm-Region Auvergne(Region Auvergne-Rhone-Alpes); la Fondation pour la Recherche Medicale (Contracts Equipe FRM)	This work was supported by the French National Agency for Research (noANR-08-MNP-026) and Dicyt 2012-AHK, Chile. A. E. and C. C. were supported by the French Ministere de l'Enseignement Superieur et de la Recherche, the Universite d'Auvergne and INSERM. A. S. W. was supported by grant from the Region Auvergne-FEDER. X. P. was a recipient of a doctoral fellowship from Inserm-Region Auvergne. P. M. was also supported by grants from la Fondation pour la Recherche Medicale (Contracts Equipe FRM 2005, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2004, PHARMACOL RES, V49, P119, DOI 10.1016/j.phrs.2003.07.016; Allen JA, 2008, NEUROPHARMACOLOGY, V55, P961, DOI 10.1016/j.neuropharm.2008.06.048; Andreasen JT, 2013, NEUROPHARMACOLOGY, V67, P193, DOI 10.1016/j.neuropharm.2012.11.006; Anjaneyulu M, 2004, EUR J PHARMACOL, V497, P285, DOI 10.1016/j.ejphar.2004.06.063; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Bouzidi N, 2013, BIOORG MED CHEM LETT, V23, P2624, DOI 10.1016/j.bmcl.2013.02.100; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; Eschalier Alain, 2007, Rev Med Suisse, V3, P1581; Finnerup Nanna Brix, 2010, F1000 Med Rep, V2, P52, DOI 10.3410/M2-52; Fishbain DA, 2000, PAIN MED, V1, P310, DOI 10.1046/j.1526-4637.2000.00042.x; Honda M, 2006, NEUROPHARMACOLOGY, V51, P866, DOI 10.1016/j.neuropharm.2006.05.031; Iwasaki T, 2013, EUR J PHARMACOL, V702, P149, DOI 10.1016/j.ejphar.2013.01.058; Jones CK, 2006, NEUROPHARMACOLOGY, V51, P1172, DOI 10.1016/j.neuropharm.2006.08.005; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; KAYSER V, 1987, PAIN, V28, P99, DOI 10.1016/0304-3959(87)91064-5; Liu FY, 2007, J PHARMACOL EXP THER, V321, P1046, DOI 10.1124/jpet.106.115204; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Obata H, 2003, BRAIN RES, V965, P114, DOI 10.1016/S0006-8993(02)04145-8; Obata H, 2001, PAIN, V90, P173, DOI 10.1016/S0304-3959(00)00401-2; Okamoto K, 2007, NEUROSCIENCE, V147, P1090, DOI 10.1016/j.neuroscience.2007.05.012; Perrot S, 2006, EUR J PAIN, V10, P185, DOI 10.1016/j.ejpain.2005.03.004; Pichon X, 2010, MOL THER, V18, P1462, DOI 10.1038/mt.2010.101; Raote I, 2013, MOL PHARMACOL, V83, P42, DOI 10.1124/mol.112.078626; Sasaki M, 2003, ANESTH ANALG, V96, P1072, DOI 10.1213/01.ANE.0000050560.15341.A8; Sasaki M, 2001, EUR J PHARMACOL, V424, P45, DOI 10.1016/S0014-2999(01)01117-7; Sawynok J, 1999, PAIN, V82, P149, DOI 10.1016/S0304-3959(99)00043-3; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; van Laar Mart, 2012, Open Rheumatol J, V6, P320, DOI 10.2174/1874312901206010320; Wang YY, 2009, J CHEM NEUROANAT, V38, P75, DOI 10.1016/j.jchemneu.2009.04.003; WINTER CA, 1965, J PHARMACOL EXP THER, V150, P165; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xu QH, 2011, CURR OPIN ANESTHESIO, V24, P400, DOI 10.1097/ACO.0b013e32834871df; Yokogawa F, 2002, ANESTH ANALG, V95, P163, DOI 10.1097/00000539-200207000-00029; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zhang YQ, 2000, NEUROREPORT, V11, P3539, DOI 10.1097/00001756-200011090-00027; Zhang YQ, 2001, BRAIN RES, V900, P146, DOI 10.1016/S0006-8993(01)02283-1; Zhao ZQ, 2007, J NEUROSCI, V27, P6045, DOI 10.1523/JNEUROSCI.1623-07.2007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	40	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74661	10.1371/journal.pone.0074661	http://dx.doi.org/10.1371/journal.pone.0074661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058620	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900075
J	Boon, MR; van den Berg, SAA; Wang, YN; van den Bossche, J; Karkampouna, S; Bauwens, M; De Saint-Hubert, M; van der Horst, G; Vukicevic, S; de Winther, MPJ; Havekes, LM; Jukema, JW; Tamsma, JT; van der Pluijm, G; van Dijk, KW; Rensen, PCN				Boon, Mariette R.; van den Berg, Sjoerd A. A.; Wang, Yanan; van den Bossche, Jan; Karkampouna, Sofia; Bauwens, Matthias; De Saint-Hubert, Marijke; van der Horst, Geertje; Vukicevic, Slobodan; de Winther, Menno P. J.; Havekes, Louis M.; Jukema, J. Wouter; Tamsma, Jouke T.; van der Pluijm, Gabri; van Dijk, Ko Willems; Rensen, Patrick C. N.			BMP7 Activates Brown Adipose Tissue and Reduces Diet-Induced Obesity Only at Subthermoneutrality	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; WHITE FAT; ADIPOCYTES; THERMOGENESIS; MUSCLE; ATHEROSCLEROSIS; IDENTIFICATION; MOUSE; CELL	Background/Aims: Brown adipose tissue (BAT) dissipates energy stored in triglycerides as heat via the uncoupling protein UCP-1 and is a promising target to combat hyperlipidemia and obesity. BAT is densely innervated by the sympathetic nervous system, which increases BAT differentiation and activity upon cold exposure. Recently, Bone Morphogenetic Protein 7 (BMP7) was identified as an inducer of BAT differentiation. We aimed to elucidate the role of sympathetic activation in the effect of BMP7 on BAT by treating mice with BMP7 at varying ambient temperature, and assessed the therapeutic potential of BMP7 in combating obesity. Methods and Results: High-fat diet fed lean C57Bl6/J mice were treated with BMP7 via subcutaneous osmotic minipumps for 4 weeks at 21 degrees C or 28 degrees C, the latter being a thermoneutral temperature in which sympathetic activation of BAT is largely diminished. At 21 degrees C, BMP7 increased BAT weight, increased the expression of Ucp1, Cd36 and hormone-sensitive lipase in BAT, and increased total energy expenditure. BMP7 treatment markedly increased food intake without affecting physical activity. Despite that, BMP7 diminished white adipose tissue (WAT) mass, accompanied by increased expression of genes related to intracellular lipolysis in WAT. All these effects were blunted at 28 degrees C. Additionally, BMP7 resulted in extensive 'browning' of WAT, as evidenced by increased expression of BAT markers and the appearance of whole clusters of brown adipocytes via immunohistochemistry, independent of environmental temperature. Treatment of diet-induced obese C57Bl6/J mice with BMP7 led to an improved metabolic phenotype, consisting of a decreased fat mass and liver lipids as well as attenuated dyslipidemia and hyperglycemia. Conclusion: Together, these data show that BMP7-mediated recruitment and activation of BAT only occurs at subthermoneutral temperature, and is thus likely dependent on sympathetic activation of BAT, and that BMP7 may be a promising tool to combat obesity and associated disorders.	[Boon, Mariette R.; Wang, Yanan; Havekes, Louis M.; Tamsma, Jouke T.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Boon, Mariette R.; van den Berg, Sjoerd A. A.; Wang, Yanan; Havekes, Louis M.; Jukema, J. Wouter; van Dijk, Ko Willems; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [van den Berg, Sjoerd A. A.; van Dijk, Ko Willems] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [van den Bossche, Jan; de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Karkampouna, Sofia] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Bauwens, Matthias; De Saint-Hubert, Marijke] Maastricht Univ, Dept Nucl Med, Maastricht, Netherlands; [van der Horst, Geertje; van der Pluijm, Gabri] Leiden Univ, Dept Urol, Med Ctr, Leiden, Netherlands; [Vukicevic, Slobodan] Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Zagreb 41001, Croatia; [Havekes, Louis M.; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Havekes, Louis M.] TNO Biosci, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zagreb; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Boon, MR (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands.	m.r.boon@lumc.nl	van den Berg, Sjoerd A/R-9541-2018; Rensen, Patrick C.N./D-7176-2018; Vukicevic, Slobodan/AEG-2646-2022; van Dijk, Ko Willems/A-1798-2008; Boon, Mariëtte/O-3660-2016; Jukema, J. Wouter/ABD-6503-2021; Wang, Yanan/C-4143-2019; van Dijk, Ko Willems/AAT-4681-2021	Rensen, Patrick C.N./0000-0002-8455-4988; Vukicevic, Slobodan/0000-0003-4076-0285; van Dijk, Ko Willems/0000-0002-2172-7394; Jukema, J. Wouter/0000-0002-3246-8359; Wang, Yanan/0000-0002-0327-0458; van Dijk, Ko Willems/0000-0002-2172-7394; de Winther, Menno/0000-0002-4038-6636; van der Horst, Geertje/0000-0003-1696-160X; van den Berg, Sjoerd/0000-0001-5937-7505; van der Pluijm, Gabri/0000-0002-1351-1884; De Saint-Hubert, Marijke/0000-0003-2374-3280; van den Berg, Sjoerd/0000-0001-8967-376X; Van den Bossche, Jan/0000-0002-7852-2891	Board of Directors of the Leiden University Medical Center (LUMC); Netherlands Heart Foundation [2009T038, 2007T067]	Board of Directors of the Leiden University Medical Center (LUMC); Netherlands Heart Foundation(Netherlands Heart Foundation)	MRB is supported by the Board of Directors of the Leiden University Medical Center (LUMC). PCNR and MPJdW are Established Investigators of the Netherlands Heart Foundation (2009T038 and 2007T067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lockie SH, 2012, DIABETES, V61, P2753, DOI 10.2337/db11-1556; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Van Klinken JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036162; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	34	69	76	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74083	10.1371/journal.pone.0074083	http://dx.doi.org/10.1371/journal.pone.0074083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066098	Green Published, Green Accepted, gold			2022-12-27	WOS:000324494000080
J	Dominguez, JF; Egan, GF; Gray, MA; Poudel, GR; Churchyard, A; Chua, P; Stout, JC; Georgiou-Karistianis, N				Dominguez D, Juan F.; Egan, Gary F.; Gray, Marcus A.; Poudel, Govinda R.; Churchyard, Andrew; Chua, Phyllis; Stout, Julie C.; Georgiou-Karistianis, Nellie			Multi-Modal Neuroimaging in Premanifest and Early Huntington's Disease: 18 Month Longitudinal Data from the IMAGE-HD Study	PLOS ONE			English	Article							WHOLE-BRAIN ATROPHY; BASAL GANGLIA; CAUDATE ATROPHY; CLINICAL-TRIALS; PROGRESSION; ONSET; IRON; MRI; AGE; NEUROPATHOLOGY	IMAGE-HD is an Australian based multi-modal longitudinal magnetic resonance imaging (MRI) study in premanifest and early symptomatic Huntington's disease (pre-HD and symp-HD, respectively). In this investigation we sought to determine the sensitivity of imaging methods to detect macrostructural (volume) and microstructural (diffusivity) longitudinal change in HD. We used a 3T MRI scanner to acquire T-1 and diffusion weighted images at baseline and 18 months in 31 pre-HD, 31 symp-HD and 29 controls. Volume was measured across the whole brain, and volume and diffusion measures were ascertained for caudate and putamen. We observed a range of significant volumetric and, for the first time, diffusion changes over 18 months in both pre-HD and symp-HD, relative to controls, detectable at the brain-wide level (volume change in grey and white matter) and in caudate and putamen (volume and diffusivity change). Importantly, longitudinal volume change in the caudate was the only measure that discriminated between groups across all stages of disease: far from diagnosis (>15 years), close to diagnosis (<15 years) and after diagnosis. Of the two diffusion metrics (mean diffusivity, MD; fractional anisotropy, FA), only longitudinal FA change was sensitive to group differences, but only after diagnosis. These findings further confirm caudate atrophy as one of the most sensitive and early biomarkers of neurodegeneration in HD. They also highlight that different tissue properties have varying schedules in their ability to discriminate between groups along disease progression and may therefore inform biomarker selection for future therapeutic interventions.	[Dominguez D, Juan F.; Egan, Gary F.; Gray, Marcus A.; Poudel, Govinda R.; Chua, Phyllis; Stout, Julie C.; Georgiou-Karistianis, Nellie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Egan, Gary F.; Gray, Marcus A.; Poudel, Govinda R.] Monash Univ, MBI, Melbourne, Vic 3004, Australia; [Egan, Gary F.; Poudel, Govinda R.] VLSCI, Life Sci Computat Ctr, Melbourne, Vic, Australia; [Egan, Gary F.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Gray, Marcus A.] Univ Queensland, Gehrmann Lab, Ctr Adv Imaging, St Lucia, Qld, Australia; [Churchyard, Andrew] Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia	Monash University; Monash University; University of Melbourne; University of Queensland; Monash University	Georgiou-Karistianis, N (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia.	nellie.georgiou-karistianis@monash.edu	Egan, Gary F./A-1381-2013; Georgiou-Karistianis, Nellie/ABC-5623-2020; Poudel, Govinda/AAR-8078-2020; Georgiou-Karistianis, Nellie/H-9727-2014; Gray, Marcus/F-6521-2013; Chua, Phyllis ML/I-2109-2014	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Poudel, Govinda/0000-0002-0043-7531; Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Gray, Marcus/0000-0001-8671-6939; Chua, Phyllis ML/0000-0001-6503-6678; Dominguez Duque, Juan Fernando/0000-0002-6715-1060; Stout, Julie/0000-0001-9637-8590; Dominguez, Juan/0000-0001-9643-1849; Egan, Gary/0000-0002-3186-4026	CHDI Foundation Inc. New York, USA [A - 3433]; National Health and Medical Research Council (NHMRC), Australia [606650]	CHDI Foundation Inc. New York, USA; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the CHDI Foundation Inc. New York, USA [A - 3433] http://chdifoundation.org/; and the National Health and Medical Research Council (NHMRC), Australia [606650] http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aylward EH, 2000, MOVEMENT DISORD, V15, P552, DOI 10.1002/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P; Aylward EH, 1997, NEUROLOGY, V48, P394, DOI 10.1212/WNL.48.2.394; Aylward EH, 2011, J NEUROL NEUROSUR PS, V82, P405, DOI 10.1136/jnnp.2010.208264; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bohanna I, 2008, BRAIN RES REV, V58, P209, DOI 10.1016/j.brainresrev.2008.04.001; Bohanna I, 2011, BRAIN IMAGING BEHAV, V5, P171, DOI 10.1007/s11682-011-9121-8; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; Georgiou-Karistianis N, 2013, NEUROBIOL DIS, V51, P82, DOI 10.1016/j.nbd.2012.10.001; Georgiou-Karistianis N, 2013, NEUROSCI BIOBEHAV R, V37, P480, DOI 10.1016/j.neubiorev.2013.01.022; Georgiou-Karistianis N, 2009, EXP NEUROL, V220, P5, DOI 10.1016/j.expneurol.2009.08.001; Gomez-Tortosa E, 2001, ANN NEUROL, V49, P29, DOI 10.1002/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B; Grace J.M.P., 2001, FRSBE SELF RATING FO; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Henley SMD, 2009, MOVEMENT DISORD, V24, P932, DOI 10.1002/mds.22485; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Hobbs NZ, 2010, AM J NEURORADIOL, V31, P1036, DOI 10.3174/ajnr.A2018; Hobbs NZ, 2010, J NEUROL NEUROSUR PS, V81, P756, DOI 10.1136/jnnp.2009.190702; Hobbs NZ, 2009, NEUROIMAGE, V47, P1659, DOI 10.1016/j.neuroimage.2009.06.003; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Majid DSA, 2011, MOVEMENT DISORD, V26, P2544, DOI 10.1002/mds.23912; Mandelli ML, 2010, AM J NEURORADIOL, V31, P706, DOI 10.3174/ajnr.A1891; Mascalchi M, 2004, RADIOLOGY, V232, P867, DOI 10.1148/radiol.2322030820; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Nelson H., 1991, NATL ADULT READING T; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Paulsen JS, 2006, ARCH NEUROL-CHICAGO, V63, P883, DOI 10.1001/archneur.63.6.883; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; Reading SAJ, 2005, PSYCHIAT RES-NEUROIM, V140, P55, DOI 10.1016/j.pscychresns.2005.05.011; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Rosas HD, 2012, ALTERATIONS BRAIN TR; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sanchez-Castaneda C, 2013, HUM BRAIN MAPP, V34, P1625, DOI 10.1002/hbm.22019; Seppi K, 2006, MOVEMENT DISORD, V21, P1043, DOI 10.1002/mds.20868; Smith A., 1982, SYMBOL DIGIT MODALIT; Sritharan A, 2010, J NEUROL NEUROSUR PS, V81, P257, DOI 10.1136/jnnp.2007.142786; StataCorp, 2021, STATA STAT SOFTWARE; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Vandenberghe W, 2009, J NEUROL, V256, P109, DOI 10.1007/s00415-009-0086-0; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Watson D, 2005, ASSESSMENT, V12, P50, DOI 10.1177/1073191104271483; Weaver KE, 2009, EXP NEUROL, V216, P525, DOI 10.1016/j.expneurol.2008.12.026; Wild EJ, 2010, MOVEMENT DISORD, V25, P888, DOI 10.1002/mds.22969; Wolf RC, 2012, EXP NEUROL, V237, P191, DOI 10.1016/j.expneurol.2012.06.014; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74131	10.1371/journal.pone.0074131	http://dx.doi.org/10.1371/journal.pone.0074131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066104	Green Published, gold			2022-12-27	WOS:000324494000086
J	Han, D; Sadowsky, MJ; Chong, Y; Hur, HG				Han, Dongfei; Sadowsky, Michael J.; Chong, Youhoon; Hur, Hor-Gil			Characterization of a Self-sufficient Trans-Anethole Oxygenase from Pseudomonas putida JYR-1	PLOS ONE			English	Article							BAEYER-VILLIGER MONOOXYGENASES; RHODOCOCCUS-OPACUS 1CP; STYRENE MONOOXYGENASE; ESCHERICHIA-COLI; FLAVOPROTEIN MONOOXYGENASE; CYTOCHROME-P450 SYSTEMS; REDUCTASE DOMAIN; IDENTIFICATION; COMPONENT; GENES	A novel flavoprotein monooxygenase, trans-anethole oxygenase (TAO), from Pseudomonas putida JYR-1, which is capable of catalyzing the oxidation of trans-anethole to p-anisaldehyde, was heterologously expressed in E. coli and purified. Enzymatic kinetics of diverse substrates and cofactors revealed that TAO is likely to be a novel self-sufficient flavoprotein monooxygenase. Enzyme assays of GST-TAO demonstrated that TAO catalyzed a trans-anethole oxidation reaction without auxiliary component enzyme-like electron-transfer flavin reductases. The single component TAO had the ability to reduce flavin cofactors and simultaneously oxidize trans-anthole to p-anisaldehyde. In the processes of reduction of flavin and oxidation of trans-anethole, TAO accepted various flavin and NAD(P)H cofactors. TAO also catalyzed oxidation of isoeugenol, O-methyl isoeugenol, and isosafrole, all of which contain the 2-propenyl functional group on the aromatic ring structure with different catalytic efficiency. TAO had the greatest catalytic efficiency (k(cat)/K-m) with the original substrate, trans-anethole. Investigation about partially deleted mutants of TAO indicated that reductase active sites appeared to be located near the N terminal. Site directed mutagenesis studies also proved that the proposed flavin binding sites, Trp-38, Thr-43, Tyr-55, were critical for flavin reduction. However, disruption of any portion of TAO eliminated the oxygenase activity.	[Han, Dongfei; Hur, Hor-Gil] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Chong, Youhoon] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Konkuk University	Hur, HG (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea.	hghur@gist.ac.kr	Sadowsky, Michael/J-2507-2016; Han, Dongfei/ABB-3352-2020	Sadowsky, Michael/0000-0001-8779-2781; Han, Dongfei/0000-0003-4007-8454	National Research Foundation of Korea [NRF: 2010-0029224]; Korea government (MEST)	National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF: 2010-0029224) grant funded by the Korea government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BLAKESLEY RW, 1977, ANAL BIOCHEM, V82, P580, DOI 10.1016/0003-2697(77)90197-X; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Gonzalo G, 2010, CHEMBIOCHEM, V11, P2208, DOI 10.1002/cbic.201000395; De Mot R, 2002, TRENDS MICROBIOL, V10, P502, DOI 10.1016/S0966-842X(02)02458-7; Han D, 2012, J AGR FOOD CHEM, V60, P11972, DOI 10.1021/jf303531u; Han D, 2012, APPL ENVIRON MICROB, V78, P5238, DOI 10.1128/AEM.00781-12; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Jensen CN, 2012, CHEMBIOCHEM, V13, P872, DOI 10.1002/cbic.201200006; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; Kubota M, 2005, BIOSCI BIOTECH BIOCH, V69, P2421, DOI 10.1271/bbb.69.2421; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Lewis DFV, 2000, BBA-BIOENERGETICS, V1460, P353, DOI 10.1016/S0005-2728(00)00202-4; Li SY, 2007, J AM CHEM SOC, V129, P12940, DOI 10.1021/ja075842d; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Newberne P, 1999, FOOD CHEM TOXICOL, V37, P789, DOI 10.1016/S0278-6915(99)00037-X; Nodate M, 2006, APPL MICROBIOL BIOT, V71, P455, DOI 10.1007/s00253-005-0147-y; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Roberts GA, 2002, J BACTERIOL, V184, P3898, DOI 10.1128/JB.184.14.3898-3908.2002; Ryu J, 2005, J AGR FOOD CHEM, V53, P5954, DOI 10.1021/jf040445x; Ryu JY, 2010, ARCH MICROBIOL, V192, P201, DOI 10.1007/s00203-010-0547-y; Sambook J, 1989, MOL CLONING LAB MANU; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; ten Brink GJ, 2004, CHEM REV, V104, P4105, DOI 10.1021/cr030011l; Tischler D, 2010, J BACTERIOL, V192, P5220, DOI 10.1128/JB.00723-10; Tischler D, 2009, J BACTERIOL, V191, P4996, DOI 10.1128/JB.00307-09; Ukaegbu UE, 2010, BIOCHEMISTRY-US, V49, P1678, DOI 10.1021/bi901693u; Urlacher VB, 2006, CURR OPIN CHEM BIOL, V10, P156, DOI 10.1016/j.cbpa.2006.02.001; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Yamada M, 2007, ARCH MICROBIOL, V187, P511, DOI 10.1007/s00203-007-0218-9	33	4	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73350	10.1371/journal.pone.0073350	http://dx.doi.org/10.1371/journal.pone.0073350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066043	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000024
J	Hu, SL; Qu, YY; Xu, XY; Xu, QY; Geng, JS; Xu, JY				Hu, Songliu; Qu, Yuanyuan; Xu, Xiangying; Xu, Qingyong; Geng, Jingshu; Xu, Jianyu			Nuclear Survivin and Its Relationship to DNA Damage Repair Genes in Non-Small Cell Lung Cancer Investigated Using Tissue Array	PLOS ONE			English	Article							MOLECULAR-MECHANISM; EXPRESSION; RADIORESISTANCE; LOCALIZATION; PREDICTOR; PROGNOSIS; APOPTOSIS; PKCS	Purpose: To investigate the predictive role and association of nuclear survivin and the DNA double-strand breaks repair genes in non-small cell lung cancer (NSCLC): DNA-dependent protein kinase catalytic subunit (DNA-PKcs), Ku heterodimeric regulatory complex 70-KD subunit (Ku70) and ataxia-telangiectasia mutated (ATM). Methods: The protein expression of nuclear survivin, DNA-PKcs, Ku70 and ATM were investigated using immunohistochemistry in tumors from 256 patients with surgically resected NSCLC. Furthermore, we analyzed the correlation between the expression of nuclear survivin, DNA-PKcs, Ku70 and ATM. Univariate and multivariate analyses were performed to determine the prognostic factors that inuenced the overall survival and disease-free survival of NSCLC. Results: The expression of nuclear survivin, DNA-PKcs, Ku70 and ATM was significantly higher in tumor tissues than in normal tissues. By dichotomizing the specimens as expressing low or high levels of nuclear survivin, nuclear survivin correlated significantly with the pathologic stage (P = 0.009) and lymph node status (P = 0.004). The nuclear survivin levels were an independent prognostic factor for both the overall survival and the disease-free survival in univariate and multivariate analyses. Patients with low Ku70 and DNA-PKcs expression had a greater benefit from radiotherapy than patients with high expression of Ku70 (P = 0.012) and DNA-PKcs (P = 0.02). Nuclear survivin expression positively correlated with DNA-PKcs (P < 0.001) and Ku70 expression (P < 0.001). Conclusions: Nuclear survivin may be a prognostic factor for overall survival in patients with resected stage I-IIIA NSCLC. DNA-PKcs and Ku70 could predict the effect of radiotherapy in patients with NSCLC. Nuclear survivin may also stimulates DNA double-strand breaks repair by its interaction with DNA-PKcs and Ku70.	[Hu, Songliu; Qu, Yuanyuan; Xu, Xiangying; Xu, Qingyong; Geng, Jingshu; Xu, Jianyu] Harbin Med Univ, Affiliated Hosp 3, Dept Radiat Oncol, Harbin, Peoples R China; [Geng, Jingshu] Harbin Med Univ, Affiliated Hosp 3, Dept Pathol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Xu, JY (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Radiat Oncol, Harbin, Peoples R China.	husongliu@126.com			hospital research startup fund of the Third Affiliated Hospital of Harbin Medical University [JJ2010-08]; Heilongjiang Provincial Science and Technology projects [WB12C101]	hospital research startup fund of the Third Affiliated Hospital of Harbin Medical University; Heilongjiang Provincial Science and Technology projects	Songliu Hu was supported by a hospital research startup fund of the Third Affiliated Hospital of Harbin Medical University (JJ2010-08), and Xiangying Xu was supported by Heilongjiang Provincial Science and Technology projects (WB12C101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Atikcan S, 2006, RESP MED, V100, P2220, DOI 10.1016/j.rmed.2006.02.031; Beskow C, 2009, BRIT J CANCER, V101, P816, DOI 10.1038/sj.bjc.6605201; Bouchaert P, 2012, INT J RAD ONCOL BIOL; Bria E, 2008, EJSO-EUR J SURG ONC, V34, P593, DOI 10.1016/j.ejso.2007.06.002; Capalbo G, 2010, INT J RADIAT ONCOL, V77, P226, DOI 10.1016/j.ijrobp.2009.12.001; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Dai CH, 2010, JPN J CLIN ONCOL, V40, P327, DOI 10.1093/jjco/hyp165; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Fan J, 2008, LUNG CANCER, V61, P91, DOI 10.1016/j.lungcan.2007.11.011; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fortugno P, 2002, J CELL SCI, V115, P575; Friesland S, 2003, HEAD NECK-J SCI SPEC, V25, P313, DOI 10.1002/hed.10199; Ghosh JC, 2006, CANCER RES, V66, P11576, DOI 10.1158/0008-5472.CAN-06-3095; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Leifler KS, 2010, INT J ONCOL, V37, P1547, DOI 10.3892/ijo_00000808; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lu B, 2004, BRIT J CANCER, V91, P537, DOI 10.1038/sj.bjc.6602027; Mohamed S, 2009, EUR RESPIR J, V33, P127, DOI 10.1183/09031936.00068708; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Noguchi T, 2002, ANN SURG ONCOL, V9, P1017, DOI 10.1245/ASO.2002.04.030; Reichert S, 2011, RADIOTHER ONCOL, V101, P51, DOI 10.1016/j.radonc.2011.06.037; Rodel F, 2005, CANCER RES, V65, P4881, DOI 10.1158/0008-5472.CAN-04-3028; Roos WP, 2012, CANC LETT; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shinohara ET, 2005, CANCER-AM CANCER SOC, V103, P1685, DOI 10.1002/cncr.20951; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Vischioni B, 2004, ANN ONCOL, V15, P1654, DOI 10.1093/annonc/mdh436; Xing JL, 2008, CANCER-AM CANCER SOC, V112, P2756, DOI 10.1002/cncr.23533; Xu P, 2012, MED ONCOL, V29, P1643, DOI 10.1007/s12032-011-0053-3	35	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74161	10.1371/journal.pone.0074161	http://dx.doi.org/10.1371/journal.pone.0074161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066112	gold, Green Published			2022-12-27	WOS:000324494000094
J	Rahman, SM; Akesson, A; Kippler, M; Grander, M; Hamadani, JD; Streatfield, PK; Persson, LA; El Arifeen, S; Vahter, M				Rahman, Syed Moshfiqur; Akesson, Agneta; Kippler, Maria; Grander, Margaretha; Hamadani, Jena Derakhshani; Streatfield, Peter Kim; Persson, Lars-Ake; El Arifeen, Shams; Vahter, Marie			Elevated Manganese Concentrations in Drinking Water May Be Beneficial for Fetal Survival	PLOS ONE			English	Article							INFANT-MORTALITY; ARSENIC EXPOSURE; PREGNANCY; BANGLADESH; MATLAB; BIRTH; GROUNDWATER; ASSOCIATION; CHILDREN; QUALITY	Background: Elevated exposure to the essential element manganese (Mn) can be toxic. Manganese concentrations in ground water vary considerably, and reported associations between Mn and early-life mortality and impaired development have raised concern. We assessed the effects of drinking water Mn exposure during pregnancy upon fetal and infant survival. Methods: In this population-based cohort study, we identified the outcomes of pregnancies registered between February 2002 and April 2003 in Matlab, Bangladesh. Using inductively coupled plasma mass spectrometry, we measured the concentrations of Mn and other elements in the pregnant women's drinking water. Results: A total of 1,875 women were included in the analysis of spontaneous abortions (n=158) and 1,887 women in the perinatal mortality analysis (n=70). Water Mn ranged from 3.0-6,550 mu g/L (median=217 mu g/L). The adjusted odds ratio (OR) for spontaneous abortion was 0.65 (95% CI 0.43-0.99) in the highest water Mn tertile (median=1,292 mu g/L) as compared to the lowest tertile (median=56 mu g/L). The corresponding OR for perinatal mortality was 0.69 (95% CI 0.28-1.71), which increased to 0.78 (95% CI 0.29-2.08) after adjustment for BMI and place of delivery (home/health facility; n=1,648). Conclusions: Elevated water Mn concentrations during pregnancy appear protective for the fetus, particularly in undernourished women. This effect may be due to the element's role in antioxidant defense.	[Rahman, Syed Moshfiqur; Akesson, Agneta; Kippler, Maria; Grander, Margaretha; Vahter, Marie] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Rahman, Syed Moshfiqur; Hamadani, Jena Derakhshani; Streatfield, Peter Kim; El Arifeen, Shams] Icddr B, Dhaka, Bangladesh; [Persson, Lars-Ake] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Karolinska Institutet; International Centre for Diarrhoeal Disease Research (ICDDR); Uppsala University	Vahter, M (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	marie.vahter@ki.se	Akesson, Agneta/AAW-4794-2021; Rahman, Syed Moshfiqur/AAH-9000-2019; Vahter, Marie/HGB-1674-2022; Akesson, Agneta/GVT-6758-2022	Akesson, Agneta/0000-0001-9594-4140; Rahman, Syed Moshfiqur/0000-0002-9441-0590; Akesson, Agneta/0000-0001-9594-4140; Arifeen, Shams/0000-0002-5372-5932; Persson, Lars Ake/0000-0003-0710-7954; Kippler, Maria/0000-0002-9010-9821	Swedish Research Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS); Swedish International Development Cooperation Agency (Sida); Karolinska Institutet	Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish International Development Cooperation Agency (Sida); Karolinska Institutet(Karolinska Institutet)	The research protocol was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Swedish International Development Cooperation Agency (Sida), and Karolinska Institutet. icddr, b acknowledges the donors that provided unrestricted support, including the Australian International Development Agency (AusAID), the Government of Bangladesh (GoB), the Canadian International Development Agency (CIDA), Sida, and the Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 2012, TOX PROF MANG; ASCHENGRAU A, 1989, ARCH ENVIRON HEALTH, V44, P283, DOI 10.1080/00039896.1989.9935895; ASCHENGRAU A, 1993, ARCH ENVIRON HEALTH, V48, P105, DOI 10.1080/00039896.1993.9938403; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Becker S, 1998, INT J EPIDEMIOL, V27, P814, DOI 10.1093/ije/27.5.814; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Cherry N, 2012, INT J ENV RES PUB HE, V9, P171, DOI 10.3390/ijerph9010171; Cherry N, 2010, ARCH ENVIRON OCCUP H, V65, P148, DOI 10.1080/19338240903390362; Chowdhury HR, 2010, J HEALTH POPUL NUTR, V28, P375; DAVIDSSON L, 1995, AM J CLIN NUTR, V62, P984, DOI 10.1093/ajcn/62.5.984; Erikson KM, 2007, PHARMACOL THERAPEUT, V113, P369, DOI 10.1016/j.pharmthera.2006.09.002; Food and Nutrition Board Institute of Medicine, 2001, DIET REF INT VIT A V; Frisbie SH, 2012, ENVIRON HEALTH PERSP, V120, P775, DOI 10.1289/ehp.1104693; Gerber GB, 2002, CRIT REV ONCOL HEMAT, V42, P25, DOI 10.1016/S1040-8428(01)00178-0; Hafeman D, 2007, ENVIRON HEALTH PERSP, V115, P1107, DOI 10.1289/ehp.10051; Hovdenak N, 2012, EUR J OBSTET GYN R B, V164, P127, DOI 10.1016/j.ejogrb.2012.06.020; International Centre for Diarrhoeal Disease Research Bangladesh, 2006, HLTH DEM SURV SYST M, V35; Jakariya M, 2005, NATURAL ARSENIC IN GROUNDWATER: OCCURRENCE, REMEDIATION AND MANAGEMENT, P319; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kippler M, 2009, ENVIRON RES, V109, P914, DOI 10.1016/j.envres.2009.07.006; Kippler M, 2010, TOXICOL LETT, V198, P20, DOI 10.1016/j.toxlet.2010.04.029; Li L, 2008, ENVIRON HEALTH PERSP, V116, P315, DOI 10.1289/ehp.10639; Ljung KS, 2009, ENVIRON SCI TECHNOL, V43, P2595, DOI 10.1021/es803143z; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Mistry HD, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/841749; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Roels HA, 2012, NEUROTOXICOLOGY, V33, P872, DOI 10.1016/j.neuro.2012.03.009; Saha KK, 2008, AM J CLIN NUTR, V87, P1852, DOI 10.1093/ajcn/87.6.1852; Spangler AH, 2009, ECOHEALTH, V6, P596, DOI 10.1007/s10393-010-0291-4; Spencer A, 1999, NUTRITION, V15, P731, DOI 10.1016/S0899-9007(99)00144-6; Takser L, 2004, ENVIRON RES, V95, P119, DOI 10.1016/j.envres.2003.11.002; Vahter ME, 2006, J HEALTH POPUL NUTR, V24, P236; Watanabe C, 2004, TOXICOL APPL PHARM, V198, P272, DOI 10.1016/j.taap.2003.10.024; Wood RJ, 2009, NUTR REV, V67, P416, DOI 10.1111/j.1753-4887.2009.00214.x; Yazbeck C, 2006, SCI TOTAL ENVIRON, V354, P28, DOI 10.1016/j.scitotenv.2004.12.012	38	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74119	10.1371/journal.pone.0074119	http://dx.doi.org/10.1371/journal.pone.0074119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066101	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000324494000083
J	Shi, XH; Larkin, JC; Chen, BS; Sadovsky, Y				Shi, Xiao-Hua; Larkin, Jacob C.; Chen, Baosheng; Sadovsky, Yoel			The Expression and Localization of N-Myc Downstream-Regulated Gene 1 in Human Trophoblasts	PLOS ONE			English	Article							METASTASIS-SUPPRESSOR GENE; TERM HUMAN TROPHOBLASTS; CELL-DIFFERENTIATION; IRON CHELATORS; UP-REGULATION; NDRG1; BINDING; PROTEIN; GROWTH; IDENTIFICATION	The protein N-Myc downstream-regulated gene 1 (NDRG1) is implicated in the regulation of cell proliferation, differentiation, and cellular stress response. NDRG1 is expressed in primary human trophoblasts, where it promotes cell viability and resistance to hypoxic injury. The mechanism of action of NDRG1 remains unknown. To gain further insight into the intracellular action of NDRG1, we analyzed the expression pattern and cellular localization of endogenous NDRG1 and transfected Myc-tagged NDRG1 in human trophoblasts exposed to diverse injuries. In standard conditions, NDRG1 was diffusely expressed in the cytoplasm at a low level. Hypoxia or the hypoxia mimetic cobalt chloride, but not serum deprivation, ultraviolet (UV) light, or ionizing radiation, induced the expression of NDRG1 in human trophoblasts and the redistribution of NDRG1 into the nucleus and cytoplasmic membranes associated with the endoplasmic reticulum (ER) and microtubules. Mutation of the phosphopantetheine attachment site (PPAS) within NDRG1 abrogated this pattern of redistribution. Our results shed new light on the impact of cell injury on NDRG1 expression patterns, and suggest that the PPAS domain plays a key role in NDRG1's subcellular distribution.	[Shi, Xiao-Hua; Larkin, Jacob C.; Sadovsky, Yoel] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Chen, Baosheng] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sadovsky, Y (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	ysadovsky@mwri.magee.edu	Larkin, Jacob/AAF-9192-2020		NIH [R01 HD045675, R01 ES11597]; American Association of OBGYN Foundation/Society for Maternal-Fetal Medicine; Pennsylvania Department of Health Research Formula Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011597] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of OBGYN Foundation/Society for Maternal-Fetal Medicine; Pennsylvania Department of Health Research Formula Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project is supported by NIH grants R01 HD045675, R01 ES11597 (both to YS), a grant from the American Association of OBGYN Foundation/Society for Maternal-Fetal Medicine (JL), and Pennsylvania Department of Health Research Formula Funds (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Banz VM, 2009, BBA-MOL CELL RES, V1793, P1597, DOI 10.1016/j.bbamcr.2009.08.002; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Caruso RP, 2004, CLIN CANCER RES, V10, P222, DOI 10.1158/1078-0432.CCR-0604-3; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chen S, 2009, LEUKEMIA RES, V33, P1108, DOI 10.1016/j.leukres.2008.10.016; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Choi SJ, 2007, AM J OBSTET GYNECOL, V196, P45, DOI 10.1016/j.ajog.2006.08.029; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Fotovati A, 2006, CLIN CANCER RES, V12, P3010, DOI 10.1158/1078-0432.CCR-05-1962; Fujii T, 2008, CURR MED CHEM, V15, P528, DOI 10.2174/092986708783769759; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Hirata K, 2004, GLIA, V47, P325, DOI 10.1002/glia.20037; Hunter M, 2005, BIOCHEM BIOPH RES CO, V332, P982, DOI 10.1016/j.bbrc.2005.05.050; Hunter M, 2003, HUM MUTAT, V22, P129, DOI 10.1002/humu.10240; Hwang J, 2011, J BIOL CHEM, V286, P12450, DOI 10.1074/jbc.M110.170803; Jung EU, 2010, CANCER LETT, V298, P9, DOI 10.1016/j.canlet.2010.05.020; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Karaczyn A, 2006, J CELL BIOCHEM, V97, P1025, DOI 10.1002/jcb.20705; Kim KT, 2004, J BIOL CHEM, V279, P38597, DOI 10.1074/jbc.M400781200; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lin TM, 1997, P NATL ACAD SCI USA, V94, P4988, DOI 10.1073/pnas.94.10.4988; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsugaki T, 2010, ONCOL REP, V24, P721, DOI 10.3892/or_00000913; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Mishima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025865; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Nelson DM, 1999, AM J OBSTET GYNECOL, V180, P896, DOI 10.1016/S0002-9378(99)70661-7; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; RIEMER RK, 1993, IN VITRO CELL DEV-AN, V29A, P478, DOI 10.1007/BF02639382; Roh CR, 2005, PLACENTA, V26, P319, DOI 10.1016/j.placenta.2004.06.013; SADOVSKY Y, 1995, MOL CELL BIOL, V15, P1554; SADOVSKY Y, 1993, ENDOCRINOLOGY, V132, P1609, DOI 10.1210/en.132.4.1609; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Sibold S, 2007, FEBS LETT, V581, P989, DOI 10.1016/j.febslet.2007.01.080; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Song Y, 2010, HUM PATHOL, V41, P214, DOI 10.1016/j.humpath.2009.07.011; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Sugiki T, 2004, BIOL PHARM BULL, V27, P628, DOI 10.1248/bpb.27.628; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Ulrix W, 1999, FEBS LETT, V455, P23, DOI 10.1016/S0014-5793(99)00845-5; vanBelzen N, 1997, LAB INVEST, V77, P85; Xu B, 1999, BIOL REPROD, V61, P681, DOI 10.1095/biolreprod61.3.681; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Zhou YR, 2011, BIOCHEMISTRY-US, V50, P2850, DOI 10.1021/bi101829r; Zoroddu MA, 2001, J INORG BIOCHEM, V84, P47, DOI 10.1016/S0162-0134(00)00204-X	63	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75473	10.1371/journal.pone.0075473	http://dx.doi.org/10.1371/journal.pone.0075473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066183	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324494000165
J	Zhang, R; Xu, P; Guo, LJ; Zhang, YS; Li, PY; Yao, DZ				Zhang, Rui; Xu, Peng; Guo, Lanjin; Zhang, Yangsong; Li, Peiyang; Yao, Dezhong			Z-Score Linear Discriminant Analysis for EEG Based Brain-Computer Interfaces	PLOS ONE			English	Article							SPATIAL-PATTERNS; BCI; SYSTEM; CLASSIFICATION; POTENTIALS; ALGORITHMS; SIGNAL	Linear discriminant analysis (LDA) is one of the most popular classification algorithms for brain-computer interfaces (BCI). LDA assumes Gaussian distribution of the data, with equal covariance matrices for the concerned classes, however, the assumption is not usually held in actual BCI applications, where the heteroscedastic class distributions are usually observed. This paper proposes an enhanced version of LDA, namely z-score linear discriminant analysis (Z-LDA), which introduces a new decision boundary definition strategy to handle with the heteroscedastic class distributions. Z-LDA defines decision boundary through z-score utilizing both mean and standard deviation information of the projected data, which can adaptively adjust the decision boundary to fit for heteroscedastic distribution situation. Results derived from both simulation dataset and two actual BCI datasets consistently show that Z-LDA achieves significantly higher average classification accuracies than conventional LDA, indicating the superiority of the new proposed decision boundary definition strategy.	[Zhang, Rui; Xu, Peng; Guo, Lanjin; Zhang, Yangsong; Li, Peiyang; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Xu, P (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	xupeng@uestc.edu.cn; dyao@uestc.edu.cn	Zhang, Rui/AAB-4675-2020	Zhang, Rui/0000-0002-9815-5101; Zhang, Yangsong/0000-0002-6764-3567; Yao, Dezhong/0000-0002-8042-879X	973 program [2011CB707803]; National Nature Science Foundation of China [61175117, 31070881, 31100745]; 863 project [2012AA011601]; program for New Century Excellent Talents in University [NCET-12-0089]; National Science & Technology Pillar Program [2012BAI16B02]; '111' project	973 program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 project(National High Technology Research and Development Program of China); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science & Technology Pillar Program; '111' project(Ministry of Education, China - 111 Project)	This work was supported by grants from 973 program 2011CB707803, the National Nature Science Foundation of China (#61175117, #31070881 and #31100745), the 863 project 2012AA011601, the program for New Century Excellent Talents in University (#NCET-12-0089), the National Science & Technology Pillar Program 2012BAI16B02 and '111' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Badia SBI, 2013, IEEE T NEUR SYS REH, V21, P174, DOI 10.1109/TNSRE.2012.2229295; Bishop Christopher M., 2006, PATTERN RECOGNITION; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Bostanov V, 2004, IEEE T BIO-MED ENG, V51, P1057, DOI 10.1109/TBME.2004.826702; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cincotti F, 2008, BRAIN RES BULL, V75, P796, DOI 10.1016/j.brainresbull.2008.01.007; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Fukunaga K., 2013, INTRO STAT PATTERN R; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hastie T, 1996, IEEE T PATTERN ANAL, V18, P607, DOI 10.1109/34.506411; Jin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049688; Lei X, 2009, IEEE T NEUR SYS REH, V17, P521, DOI 10.1109/TNSRE.2009.2027705; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Li ZF, 2009, IEEE T PATTERN ANAL, V31, P755, DOI 10.1109/TPAMI.2008.174; Loog M, 2004, IEEE T PATTERN ANAL, V26, P732, DOI 10.1109/TPAMI.2004.13; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; McFarland DJ, 2008, J NEURAL ENG, V5, P155, DOI 10.1088/1741-2560/5/2/006; McFarland DJ, 2003, BIOL PSYCHOL, V63, P237, DOI 10.1016/S0301-0511(03)00073-5; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Nazarpour K, 2009, IEEE T BIO-MED ENG, V56, P2104, DOI 10.1109/TBME.2009.2021529; Qian K, 2010, CLIN NEUROPHYSIOL, V121, P1304, DOI 10.1016/j.clinph.2010.03.001; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Royer AS, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016005; Scherer R, 2004, IEEE T BIO-MED ENG, V51, P979, DOI 10.1109/TBME.2004.827062; Shahid S, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025014; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Webb A. R., 2003, STAT PATTERN RECOGNI; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu Peng, 2011, PLoS One, V6, pe14634, DOI 10.1371/journal.pone.0014634; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	38	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74433	10.1371/journal.pone.0074433	http://dx.doi.org/10.1371/journal.pone.0074433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058565	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400077
J	Dawson, JE; Farber, PJ; Forman-Kay, JD				Dawson, Jennifer E.; Farber, Patrick J.; Forman-Kay, Julie D.			Allosteric Coupling between the Intracellular Coupling Helix 4 and Regulatory Sites of the First Nucleotide-binding Domain of CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; NMR CHEMICAL-SHIFTS; CYSTIC-FIBROSIS; ATP-BINDING; ABC TRANSPORTER; MOLECULAR-DYNAMICS; DEPENDENT INTERACTIONS; CONFORMATIONAL-CHANGES; CYTOPLASMIC LOOP	Cystic fibrosis is caused by mutations in CFTR (cystic fibrosis transmembrane conductance regulator), leading to folding and processing defects and to chloride channel gating misfunction. CFTR is regulated by ATP binding to its cytoplasmic nucleotide-binding domains, NBD1 and NBD2, and by phosphorylation of the NBD1 regulatory insert (RI) and the regulatory extension (RE)/R region. These regulatory effects are transmitted to the rest of the channel via NBD interactions with intracellular domain coupling helices (CL), particularly CL4. Using a sensitive method for detecting inter-residue correlations between chemical shift changes in NMR spectra, an allosteric network was revealed within NBD1, with a construct lacking RI. The CL4-binding site couples to the RI-deletion site and the C-terminal residues of NBD1 that precede the R region in full-length CFTR. Titration of CL4 peptide into NBD1 perturbs the conformational ensemble in these sites with similar titration patterns observed in F508del, the major CF-causing mutant, and in suppressor mutants F494N, V510D and Q637R NBD1, as well as in a CL4-NBD1 fusion construct. Reciprocally, the C-terminal mutation, Q637R, perturbs dynamics in these three sites. This allosteric network suggests a mechanism synthesizing diverse regulatory NBD1 interactions and provides biophysical evidence for the allosteric coupling required for CFTR function.	[Dawson, Jennifer E.; Farber, Patrick J.; Forman-Kay, Julie D.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Dawson, Jennifer E.; Farber, Patrick J.; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Forman-Kay, JD (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	forman@sickkids.ca		Forman-Kay, Julie/0000-0001-8265-972X; Dawson, Jennifer Erin/0000-0002-8387-6109	Cystic Fibrosis Foundation [Forman05XXO]; CF Canada Post-doctoral fellowship; CF Canada [2583]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CF Canada Post-doctoral fellowship; CF Canada	Funding came from the Cystic Fibrosis Foundation Therapeutics Grant Forman05XXO, www.cff.org/research/CFFT, CF Canada Post-doctoral fellowship, www.cysticfibrosis.ca, and CF Canada Grant 2583 www.cysticfibrosis.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BIJMAN J, 1993, AM J PHYSIOL, V264, pL229, DOI 10.1152/ajplung.1993.264.3.L229; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bozoky Z, 2012, PEDIATR PULM, V47, P226; Campbell JD, 2004, BIOPHYS J, V87, P3703, DOI 10.1529/biophysj.104.046870; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chong P, 2010, PEDIATR PULM, P240; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Damas JM, 2011, PROTEIN SCI, V20, P1220, DOI 10.1002/pro.650; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer RA, 1932, STAT METHODS RESEACH; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Goddard TD, SPARKY; Hansen DF, 2007, J AM CHEM SOC, V129, P11468, DOI 10.1021/ja072717t; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kern A, 2004, BIOCHEM J, V380, P549, DOI 10.1042/BJ20031607; MANAVALAN P, 1993, J PROTEIN CHEM, V12, P279, DOI 10.1007/BF01028190; Masterson LR, 2012, ADV PROTEIN CHEM STR, V87, P363, DOI 10.1016/B978-0-12-398312-1.00012-3; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Salvatore F, 2002, AM J MED GENET, V111, P88, DOI 10.1002/ajmg.10461; Schrodinger L., PYMOL MOL GRAPHICS S; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stollar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051282; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Tsai MF, 2009, J GEN PHYSIOL, V133, P405, DOI 10.1085/jgp.200810186; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Walker JM, 2012, ALLOSTERY METHODS PR; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Weng J-W, 2010, J BIOL CHEM, P285; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	81	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74347	10.1371/journal.pone.0074347	http://dx.doi.org/10.1371/journal.pone.0074347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058550	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900041
J	Latorre, L; Larrinaga, AR; Santamaria, L				Latorre, Lucia; Larrinaga, Asier R.; Santamaria, Luis			Rats and Seabirds: Effects of Egg Size on Predation Risk and the Potential of Conditioned Taste Aversion as a Mitigation Method	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; RODENT ERADICATION; LITHIUM-CHLORIDE; INTRODUCED RATS; ISLANDS; CONSEQUENCES; EXTINCTION; IMPACT; BIRDS; FOREST	Seabirds nesting on islands are threatened by invasive rodents, such as mice and rats, which may attack eggs, chicks and even adults. The low feasibility of rat eradications on many islands makes the development of alternate control plans necessary. We used a combination of field experiments on a Mediterranean island invaded by black rats (Rattus rattus) to evaluate (1) the predation risk posed to different-sized seabird eggs and (2), the potential of two deterrent methods (electronic and chemical) to reduce its impact. Rats were able to consume eggs of all sizes (12 to 68 g), but survival increased 13 times from the smallest to the largest eggs (which also had more resistant eggshells). Extrapolation to seabird eggs suggests that the smallest species (Hydrobates pelagicus) suffer the most severe predation risk, but even the largest (Larus michahellis) could suffer >60% mortality. Nest attack was not reduced by the deterrents. However, chemical deterrence (conditioned taste aversion by lithium chloride) slowed the increase in predation rate over time, which resulted in a three-fold increase in egg survival to predation as compared to both control and electronic deterrence. At the end of the experimental period, this effect was confirmed by a treatment swap, which showed that conferred protection remains at least 15 days after cessation of the treatment. Results indicate that small seabird species are likely to suffer severe rates of nest predation by rats and that conditioned taste aversion, but not electronic repellents, may represent a suitable method to protect colonies when eradication or control is not feasible or cost-effective.	[Latorre, Lucia; Larrinaga, Asier R.; Santamaria, Luis] Mediterranean Inst Adv Studies CSIC UIB, Lab Spatial Ecol, Mallorca, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Latorre, L (corresponding author), Mediterranean Inst Adv Studies CSIC UIB, Lab Spatial Ecol, Mallorca, Balearic Island, Spain.	lulatorre81@hotmail.com	Santamaria, Luis/C-1438-2012; Latorre, Lucía/AAC-9651-2021; Larrinaga, Asier/B-3826-2013	Santamaria, Luis/0000-0002-5072-2912; Larrinaga, Asier/0000-0001-6813-8784	Environment and Nature Council of the Balearic Government; Spanish Scientific Research Council (JAEDoc program); European Social Fund; Spanish Ministry of Science and Innovation [CGL2011-30249]	Environment and Nature Council of the Balearic Government; Spanish Scientific Research Council (JAEDoc program); European Social Fund(European Social Fund (ESF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funds were provided by the Environment and Nature Council of the Balearic Government (project DRAGORAT; Sa Dragonera Natural Park's research grants, IX Edition, 2007). ARL received funding support from the Spanish Scientific Research Council (JAEDoc program, co-funded by the European Social Fund). The Spanish Ministry of Science and Innovation also supported this work by the awarded project SEAGRAPE, ref. CGL2011-30249. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral Joao, 2010, Conservation Evidence, V7, P16; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Barber AG, 1915, ANIM BEHAV, V5, P292, DOI [10.1037/h0073252, DOI 10.1037/H0073252]; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; BERTRAM DF, 1995, CAN FIELD NAT, V109, P6; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Bowen L, 1997, CONSERV BIOL, V11, P1249, DOI 10.1046/j.1523-1739.1997.96368.x; Brosset A, 1963, MAMMALIA, V27, P323; Brown KP, 1998, IBIS, V140, P274, DOI 10.1111/j.1474-919X.1998.tb04389.x; Capizzi D, 2010, BIOL CONSERV, V143, P1716, DOI 10.1016/j.biocon.2010.04.020; Carlin B, 1969, ULTRASONICA; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; de Brugada I, 2005, LEARN BEHAV, V33, P363, DOI 10.3758/BF03192864; DeGraaf RM, 1996, WILSON BULL, V108, P535; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Ebenhard T., 1988, Viltrevy (Stockholm), V13, P1; Foynes MM, 2004, PHARMACOL BIOCHEM BE, V79, P303, DOI 10.1016/j.pbb.2004.08.002; GARCIA J, 1955, SCIENCE, V122, P157; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Genovesi P., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P56; Gentle M, 2006, APPL ANIM BEHAV SCI, V97, P303, DOI 10.1016/j.applanim.2005.08.005; Gonzalez JM, 2003, ATLES DELS AUCELLS N; Goodner Brad W., 1998, Virginia Journal of Science, V49, P221; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Harrison C, 1991, GUIA CAMPO NIDOS HUE; Haskell DG, 1995, AUK, V112, P767; Hedeker D, 2010, LONGITUDINAL DATA AN; Hilton GM, 2010, IBIS, V152, P443, DOI 10.1111/j.1474-919X.2010.01031.x; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Howard WE, 1982, SEM WORKSH PEST PEST, P35; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; Imber M, 2000, NEW ZEAL J ECOL, V24, P153; IMBER MJ, 1976, IBIS, V118, P51, DOI 10.1111/j.1474-919X.1976.tb02010.x; Jones H, 2008, POETRY WALES, V43, P22; Lack D., 1968, pvii; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Loope LL, 1989, BIOL INVASIONS GLOBA, P257; Loy I, 2002, Q J EXP PSYCHOL-B, V55, P365, DOI 10.1080/02724990244000070; Igual JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004826; MARTIN GM, 1976, LEARN MOTIV, V7, P274, DOI 10.1016/0023-9690(76)90034-5; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; Mason JR, 1998, P VERTEBRATE PEST C, V18, DOI [10.5070/V418110271, DOI 10.5070/V418110271]; Mayol J., 2012, Aliens: The Invasive Species Bulletin, P29; MAYR E, 1965, SCIENCE, V150, P1587, DOI 10.1126/science.150.3703.1587; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Nicholls H, 2013, NATURE, V497, P306, DOI 10.1038/497306a; NICOLAUS L K, 1982, Northwest Science, V56, P165; Paradis S, 2004, BEHAV PROCESS, V67, P11, DOI 10.1016/j.beproc.2004.01.014; PORTAVELLA M, 1993, PSYCHOPHARMACOLOGY, V111, P190, DOI 10.1007/BF02245522; Prieto J, 2003, BIODIVERS CONSERV, V12, P2477, DOI 10.1023/A:1025825924678; Redstone Strategy Group LLC, 2008, REST GLOB THREAT SEA; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Robinet O, 1998, BIOL CONSERV, V86, P223, DOI 10.1016/S0006-3207(97)00181-X; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; Russell J.C., 2008, Science for Conservation (Wellington), V286, P1; SALES GD, 1991, BEHAV PROCESS, V24, P83, DOI 10.1016/0376-6357(91)90001-G; Salvande M, 2006, PLANT ECOL, V187, P143, DOI 10.1007/s11258-006-9139-y; Schumake SA, 1998, REPELLENTS WILDLIFE, P253; Simberloff D, 2000, RAFFLES B ZOOL, V48, P1; St Clair JJH, 2011, BIOL CONSERV, V144, P68, DOI 10.1016/j.biocon.2010.10.006; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Tesoro Cruz Emiliano, 2000, Veterinaria - Mexico, V31, P185; Thorsen M, 2000, BIOL CONSERV, V96, P133, DOI 10.1016/S0006-3207(00)00059-8; TINBERGEN N., 1967, P 14 INT ORNITHOLOGI, P43; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Towns DR, 2009, OIKOS, V118, P420, DOI 10.1111/j.1600-0706.2008.17186.x; Towns David R., 1996, Pacific Conservation Biology, V2, P286; Towns DR, 2003, NEW ZEAL J ZOOL, V30, P377, DOI 10.1080/03014223.2003.9518348; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wesolowski T, 2005, J AVIAN BIOL, V36, P361, DOI 10.1111/j.0908-8857.2005.03570.x	72	9	9	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e76138	10.1371/journal.pone.0076138	http://dx.doi.org/10.1371/journal.pone.0076138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058712	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900135
J	Leung, Y; Kandyba, E; Chen, YB; Ruffins, S; Kobielak, K				Leung, Yvonne; Kandyba, Eve; Chen, Yi-Bu; Ruffins, Seth; Kobielak, Krzysztof			Label Retaining Cells (LRCs) with Myoepithelial Characteristic from the Proximal Acinar Region Define Stem Cells in the Sweat Gland	PLOS ONE			English	Article							HAIR FOLLICLE; MAMMARY-GLAND; WOUND REPAIR; NICHE; P63; MICE; IDENTIFICATION; HOMEOSTASIS; EXPRESSION; CONTRIBUTE	Slow cycling is a common feature shared among several stem cells (SCs) identified in adult tissues including hair follicle and cornea. Recently, existence of unipotent SCs in basal and lumenal layers of sweat gland (SG) has been described and label retaining cells (LRCs) have also been localized in SGs; however, whether these LRCs possess SCs characteristic has not been investigated further. Here, we used a H2BGFP LRCs system for in vivo detection of infrequently dividing cells. This system allowed us to specifically localize and isolate SCs with label-retention and myoepithelial characteristics restricted to the SG proximal acinar region. Using an alternative genetic approach, we demonstrated that SG LRCs expressed keratin 15 (K15) in the acinar region and lineage tracing determined that K15 labeled cells contributed long term to the SG structure but not to epidermal homeostasis. Surprisingly, wound healing experiments did not activate proximal acinar SG cells to participate in epidermal healing. Instead, predominantly non-LRCs in the SG duct actively divided, whereas the majority of SG LRCs remained quiescent. However, when we further challenged the system under more favorable isolated wound healing conditions, we were able to trigger normally quiescent acinar LRCs to trans-differentiate into the epidermis and adopt its long term fate. In addition, dissociated SG cells were able to regenerate SGs and, surprisingly, hair follicles demonstrating their in vivo plasticity. By determining the gene expression profile of isolated SG LRCs and non-LRCs in vivo, we identified several Bone Morphogenetic Protein (BMP) pathway genes to be up-regulated and confirmed a functional requirement for BMP receptor 1A (BMPR1A)-mediated signaling in SG formation. Our data highlight the existence of SG stem cells (SGSCs) and their primary importance in SG homeostasis. It also emphasizes SGSCs as an alternative source of cells in wound healing and their plasticity for regenerating different skin appendages.	[Leung, Yvonne; Kandyba, Eve; Ruffins, Seth; Kobielak, Krzysztof] Univ So Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90089 USA; [Chen, Yi-Bu] Univ So Calif, Norris Med Lib, Los Angeles, CA USA; [Leung, Yvonne; Kandyba, Eve; Kobielak, Krzysztof] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Kobielak, K (corresponding author), Univ So Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90089 USA.	kkobiela@med.usc.edu	Kobielak, Krzysztof/ABI-7874-2020	Kobielak, Krzysztof/0000-0002-6319-8849	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R03-AR061028, R01-AR061552]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061552, R03AR061028] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Grants R03-AR061028 (to KK) and R01-AR061552 (to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Biedermann T, 2010, J INVEST DERMATOL, V130, P1996, DOI 10.1038/jid.2010.83; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kandyba E, 2013, P NATL ACAD SCI US; Kobielak K, 2001, AM J MED GENET, V100, P191, DOI 10.1002/ajmg.1225.abs; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; LEE MMC, 1960, ANAT REC, V136, P97, DOI 10.1002/ar.1091360204; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; LOBITZ WC, 1956, J INVEST DERMATOL, V26, P247, DOI 10.1038/jid.1956.37; LOBITZ WC, 1954, J INVEST DERMATOL, V22, P189, DOI 10.1038/jid.1954.24; LOBITZ WC, 1954, J INVEST DERMATOL, V23, P329, DOI 10.1038/jid.1954.116; LOBITZ WC, 1961, ANNU REV MED, V12, P289, DOI 10.1146/annurev.me.12.020161.001445; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mikkola ML, 2009, AM J MED GENET A, V149A, P2031, DOI 10.1002/ajmg.a.32855; Miller SJ, 1998, J INVEST DERMATOL, V110, P13, DOI 10.1046/j.1523-1747.1998.00087.x; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nakamura M, 2009, J INVEST DERMATOL, V129, P2077, DOI 10.1038/jid.2008.443; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rittie L, 2013, AM J PATHOL, V182, P163, DOI 10.1016/j.ajpath.2012.09.019; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schon M, 1999, J CELL SCI, V112, P1925; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Wisniewski Slawomir A., 2002, Journal of Applied Genetics, V43, P97; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	52	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74174	10.1371/journal.pone.0074174	http://dx.doi.org/10.1371/journal.pone.0074174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058524	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900033
J	Momohara, Y; Kanai, A; Nagayama, T				Momohara, Yuto; Kanai, Akihiro; Nagayama, Toshiki			Aminergic Control of Social Status in Crayfish Agonistic Encounters	PLOS ONE			English	Article							DOMINANCE HIERARCHY FORMATION; INDUCED SYNAPTIC ENHANCEMENT; PRIOR CONTEST EXPERIENCE; AGGRESSIVE-BEHAVIOR; BIOGENIC-AMINES; DEPENDENT MODULATION; SEROTONIN; OCTOPAMINE; WINNER; PHARMACOLOGY	Using pairings of male crayfish Procambarus clarkii with a 3-7% difference in size, we confirmed that physically larger crayfish were more likely to win encounters (winning probability of over 80%). Despite a physical disadvantage, small winners of the first pairings were more likely to win their subsequent conflicts with larger naive animals (winning probability was about 70%). By contrast, the losers of the first pairings rarely won their subsequent conflicts with smaller naive animals (winning probability of 6%). These winner and loser effects were mimicked by injection of serotonin and octopamine. Serotonin-injected naive small crayfish were more likely to win in pairings with untreated larger naive crayfish (winning probability of over 60%), while octopamine-injected naive large animals were beaten by untreated smaller naive animals (winning probability of 20%). Furthermore, the winner effects of dominant crayfish were cancelled by the injection of mianserin, an antagonist of serotonin receptors and were reinforced by the injection of fluoxetin, serotonin reuptake inhibitor, just after the establishment of social order of the first pairings. Injection of octopamine channel blockers, phentolamine and epinastine, by contrast, cancelled the loser effects. These results strongly suggested that serotonin and octopamine were responsible for winner and loser effects, respectively.	[Momohara, Yuto; Kanai, Akihiro] Yamagata Univ, Grad Sch Sci & Engn, Div Biol, Yamagata 990, Japan; [Nagayama, Toshiki] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan	Yamagata University; Yamagata University	Nagayama, T (corresponding author), Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan.	nagayama@sci.kj.yamagata-u.ac.jp		Momohara, Yuto/0000-0001-8155-9997	Ministry of Education, Science, Sport and Culture	Ministry of Education, Science, Sport and Culture	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sport and Culture to T.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro A, 2011, PHARMACOL BIOCHEM BE, V99, P75, DOI 10.1016/j.pbb.2011.04.004; Antonsen BL, 1997, J COMP PHYSIOL A, V181, P501, DOI 10.1007/s003590050134; Aquiloni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050047; Araki M, 2005, J NEUROPHYSIOL, V94, P2644, DOI 10.1152/jn.00502.2005; Araki M, 2013, J EXP BIOL, V216, P681, DOI 10.1242/jeb.075689; Araki M, 2012, J COMP PHYSIOL A, V198, P607, DOI 10.1007/s00359-012-0733-2; Badino P, 2004, COMP BIOCHEM PHYS A, V139, P343, DOI 10.1016/j.cbpb.2004.09.019; Begg DP, 2005, BEHAV BRAIN RES, V161, P286, DOI 10.1016/j.bbr.2005.02.027; Beggs KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026809; BERRILL M, 1984, ANIM BEHAV, V32, P333, DOI 10.1016/S0003-3472(84)80265-1; BOVBJERG RICHARD V., 1956, PHYSIOL ZOOL, V29, P127; BOVBJERG RV, 1953, PHYSIOL ZOOL, V26, P173, DOI 10.1086/physzool.26.2.30154514; Cattaert D, 2010, J NEUROSCI, V30, P5603, DOI 10.1523/JNEUROSCI.0367-10.2010; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; Daws AG, 2002, MAR FRESHW BEHAV PHY, V35, P139, DOI 10.1080/1023624021000014725; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; Drummond H, 1998, ANIM BEHAV, V55, P1669, DOI 10.1006/anbe.1997.0714; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; Ferris CF, 1999, BEHAV NEUROSCI, V113, P804, DOI 10.1037/0735-7044.113.4.804; Fujimoto S, 2011, J EXP BIOL, V214, P2718, DOI 10.1242/jeb.057752; Fuxjager MJ, 2010, P NATL ACAD SCI USA, V107, P12393, DOI 10.1073/pnas.1001394107; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293, DOI 10.1124/mol.51.2.293; Gill MD, 1999, J NEUROPHYSIOL, V82, P3586, DOI 10.1152/jn.1999.82.6.3586; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Goubault M, 2012, AM NAT, V180, P364, DOI 10.1086/667192; Haller J, 1998, NEUROSCI BIOBEHAV R, V22, P85; Hemsworth R, 2007, BIOL BULL-US, V213, P187, DOI 10.2307/25066634; Herberholz J, 2007, BIOL BULL-US, V213, P21, DOI 10.2307/25066615; HOYER D, 1994, PHARMACOL REV, V46, P157; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Hsu YY, 1999, ANIM BEHAV, V57, P903, DOI 10.1006/anbe.1998.1049; Huber R, 1998, J COMP PHYSIOL A, V182, P573, DOI 10.1007/s003590050204; Huber R, 2005, J COMP PHYSIOL A, V191, P231, DOI 10.1007/s00359-004-0585-5; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P60, DOI 10.1159/000113355; Huber R, 2001, BRAIN BEHAV EVOLUT, V57, P271, DOI 10.1159/000047245; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Il-Han J, 2010, J EXP BIOL, V213, P3603, DOI 10.1242/jeb.048256; Issa FA, 1999, J EXP BIOL, V202, P3497; Kaczer L, 2007, NEUROBIOL LEARN MEM, V87, P140, DOI 10.1016/j.nlm.2006.08.002; Kaczer L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006223; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kasumovic MM, 2010, BEHAV ECOL, V21, P404, DOI 10.1093/beheco/arp204; Khazraie K, 1999, BEHAV PROCESS, V44, P341, DOI 10.1016/S0376-6357(98)00058-8; Kravitz EA, 2000, J COMP PHYSIOL A, V186, P221, DOI 10.1007/s003590050423; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Lan YT, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-28; Larson ET, 2001, BEHAV BRAIN RES, V121, P95, DOI 10.1016/S0166-4328(00)00393-4; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Lowe M. E., 1956, TULANE STUD ZOOL, V4, P139; Molaei G, 2003, J INSECT PHYSIOL, V49, P1073, DOI 10.1016/j.jinsphys.2003.08.004; Oliveira RF, 2009, P ROY SOC B-BIOL SCI, V276, P2249, DOI 10.1098/rspb.2009.0132; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; Pavey CR, 1996, J ZOOL, V238, P445, DOI 10.1111/j.1469-7998.1996.tb05405.x; Pedetta S, 2010, PHYSIOL BEHAV, V101, P438, DOI 10.1016/j.physbeh.2010.07.008; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; RANTA E, 1992, ETHOLOGY, V92, P217; REAL D, 1990, BRAIN RES, V521, P203, DOI 10.1016/0006-8993(90)91544-Q; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Sato D, 2012, J EXP BIOL, V215, P1210, DOI 10.1242/jeb.066191; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Schneider H, 1996, J COMP NEUROL, V371, P3; SCHNEIDER H, 1993, J COMP NEUROL, V329, P129, DOI 10.1002/cne.903290109; Seebacher F, 2006, FUNCT ECOL, V20, P1045, DOI 10.1111/j.1365-2435.2006.01194.x; Sneddon LU, 2000, J EXP BIOL, V203, P537; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Takahashi A, 2010, J NEUROSCI, V30, P11771, DOI 10.1523/JNEUROSCI.1814-10.2010; Tricarico E, 2007, ANIM BEHAV, V74, P1715, DOI 10.1016/j.anbehav.2007.04.015; Troppmann B, 2007, J INSECT PHYSIOL, V53, P774, DOI 10.1016/j.jinsphys.2007.02.020; Ueno R, 2012, J EXP BIOL, V215, P2841, DOI 10.1242/jeb.072520; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Walker EA, 2005, NEUROPHARMACOLOGY, V49, P1210, DOI 10.1016/j.neuropharm.2005.07.015; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; WINBERG S, 1992, J COMP PHYSIOL A, V170, P93; Yeh SR, 1997, J NEUROSCI, V17, P697; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zulandt T, 2008, ANIM BEHAV, V75, P13, DOI 10.1016/j.anbehav.2007.04.017	82	37	39	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74489	10.1371/journal.pone.0074489	http://dx.doi.org/10.1371/journal.pone.0074489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058575	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900047
J	Faresjo, A; Theodorsson, E; Chatziarzenis, M; Sapouna, V; Claesson, HP; Koppner, J; Faresjo, T				Faresjo, Ashild; Theodorsson, Elvar; Chatziarzenis, Marios; Sapouna, Vasiliki; Claesson, Hans-Peter; Koppner, Jenny; Faresjo, Tomas			Higher Perceived Stress but Lower Cortisol Levels Found among Young Greek Adults Living in a Stressful Social Environment in Comparison with Swedish Young Adults	PLOS ONE			English	Article							SALIVARY CORTISOL; ECONOMIC CRISES; HAIR; HEALTH; BIOMARKER; FIBROMYALGIA; RESPONSES; AXIS; LIFE	The worldwide financial crisis during recent years has raised concerns of negative public health effects. This is notably evident in southern Europe. In Greece, where the financial austerity has been especially pronounced, the prevalence of mental health problems including depression and suicide has increased, and outbreaks of infectious diseases have risen. The main objective in this study was to investigate whether different indicators of health and stress levels measured by a new biomarker based on cortisol in human hair were different amongst comparable Greek and Swedish young adults, considering that Sweden has been much less affected by the recent economic crises. In this cross-sectional comparative study, young adults from the city of Athens in Greece (n = 124) and from the city of Linkoping in Sweden (n = 112) participated. The data collection comprised answering a questionnaire with different health indicators and hair samples being analyzed for the stress hormone cortisol, a biomarker with the ability to retrospectively measure long-term cortisol exposure. The Greek young adults reported significantly higher perceived stress (p < 0.0001), had experienced more serious life events (p = 0.002), had lower hope for the future (p < 0.0001), and had significantly more widespread symptoms of depression (p < 0.0001) and anxiety (p < 0.0001) than the Swedes. But, the Greeks were found to have significantly lower cortisol levels (p < 0.0001) than the Swedes, and this difference was still significant in a multivariate regression (p < 0.0001), after adjustments for potential intervening variables. A variety of factors related to differences in the physical or sociocultural environment between the two sites, might possibly explain this finding. However, a potential biological mechanism is that long-term stress exposure could lead to a lowering of the cortisol levels. This study points out a possible hypothesis that the cortisol levels of the Greek young adults might have been suppressed and their HPA-axis down-regulated after living in a stressful environment with economic and social pressure.	[Faresjo, Ashild; Claesson, Hans-Peter; Koppner, Jenny; Faresjo, Tomas] Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, Div Community Med, Linkoping, Sweden; [Theodorsson, Elvar] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Clin Chem, Linkoping, Sweden; [Chatziarzenis, Marios] Thriasson Gen Hosp Elefsina, Elefsina Hlth Ctr, Athens, Greece; [Sapouna, Vasiliki] Univ Athens, Sch Philosophy, Dept Psychol, Athens, Greece	Linkoping University; Linkoping University; National & Kapodistrian University of Athens	Faresjo, A (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, Div Community Med, Linkoping, Sweden.	ashild.olsen.faresjo@liu.se	Theodorsson, Elvar/H-2096-2011; Faresjo, Tomas/B-3598-2015	Theodorsson, Elvar/0000-0003-0756-7723; Olsen Faresjo, Ashild/0000-0003-0723-139X; Faresjo, Tomas/0000-0003-4224-1032				Berk M, 2006, PSYCHOL MED, V36, P181, DOI 10.1017/S0033291705006665; Binder EB, 2012, BIOL PSYCHIAT, V71, P282, DOI 10.1016/j.biopsych.2011.12.008; Bremmer MA, 2007, BIOL PSYCHIAT, V62, P479, DOI 10.1016/j.biopsych.2006.11.033; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Davenport MD, 2008, BIOL PSYCHIAT, V63, P990, DOI 10.1016/j.biopsych.2007.10.025; Dettenborn L, 2010, PSYCHONEUROENDOCRINO, V35, P1404, DOI 10.1016/j.psyneuen.2010.04.006; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Ebrecht M, 2004, PSYCHONEUROENDOCRINO, V29, P798, DOI 10.1016/S0306-4530(03)00144-6; Economou M, 2012, LANCET, V380, P337, DOI 10.1016/S0140-6736(12)61244-6; Falagas ME, 2009, INT J CLIN PRACT, V63, P1128, DOI 10.1111/j.1742-1241.2009.02124.x; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; GALBO H, 1981, INT J SPORTS MED, V2, P203, DOI 10.1055/s-2008-1034610; Gibson EL, 1999, PSYCHOSOM MED, V61, P214, DOI 10.1097/00006842-199903000-00014; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Griep EN, 1998, J RHEUMATOL, V25, P1374; Groschl M, 2003, CLIN CHEM, V49, P1688, DOI 10.1373/49.10.1688; Gur A, 2004, ARTHRITIS RES THER, V6, pR232, DOI 10.1186/ar1163; Hamar M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031356, DOI 10.1371/J0URNAL.P0NE.0031356.EPUB]; Hammerfald K, 2006, PSYCHONEUROENDOCRINO, V31, P333, DOI 10.1016/j.psyneuen.2005.08.007; Heim CM, 2007, ENCY STRESS, P400; Hinkelmann K, 2013, BIOL PSYCHIAT   0529, V29; Jessop DS, 2008, STRESS, V11, P1, DOI 10.1080/10253890701365527; Karanikolos M, 2013, LANCET EARLY ON 0327, DOI [10.1016/S0140-6736(13):60102-60106, DOI 10.1016/S0140-6736(13):60102-60106]; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Loussouarn G, 2005, INT J DERMATOL, V44, P6, DOI 10.1111/j.1365-4632.2005.02800.x; Madianos M, 2011, SOC PSYCH PSYCH EPID, V46, P943, DOI 10.1007/s00127-010-0265-4; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Morelius E, 2004, SCAND J CLIN LAB INV, V64, P113, DOI 10.1080/00365510410004452; Nijm J, 2009, ANN MED, V41, P224, DOI 10.1080/07853890802508934; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Raul JS, 2004, CLIN BIOCHEM, V37, P1105, DOI 10.1016/j.clinbiochem.2004.02.010; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; SAPOLSKY RM, 1987, ENDOCRINOLOGY, V121, P1605, DOI 10.1210/endo-121-5-1605; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Whitworth Judith A, 2005, Vasc Health Risk Manag, V1, P291, DOI 10.2147/vhrm.2005.1.4.291; Wietzman ED, 1971, J CLIN ENDOCRINOL, V33, P14; World Health Organization, 2011, MENT HLTH EUR	45	48	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73828	10.1371/journal.pone.0073828	http://dx.doi.org/10.1371/journal.pone.0073828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066077	Green Published, gold			2022-12-27	WOS:000324494000059
J	Hu, B; Chen, Y; Usmani, SZ; Ye, SQ; Qiang, W; Papanikolaou, X; Heuck, CJ; Yaccoby, S; Williams, BO; Van Rhee, F; Barlogie, B; Epstein, J; Qiang, YW				Hu, Bo; Chen, Yu; Usmani, Saad Z.; Ye, Shiqiao; Qiang, Wei; Papanikolaou, Xenofon; Heuck, Christoph J.; Yaccoby, Shmuel; Williams, Bart O.; Van Rhee, Frits; Barlogie, Bart; Epstein, Joshua; Qiang, Ya-Wei			Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; IN-VIVO; PROTEASOME INHIBITORS; SERUM CONCENTRATIONS; BORTEZOMIB; DICKKOPF-1; DISEASE; DKK1; EXPRESSION; CATENIN	Carfilzomib, the next generation of proteasome inhibitor, may increase osteoblast-related markers in patients with multiple myeloma, but the molecular mechanism of its effect on mesenchymal stem cell differentiation to osteoblasts remains unknown. Herein, we demonstrated that carfilzomib significantly promoted mesenchymal stem cell differentiation into osteoblasts. In osteoprogenitor cells and primary mesenchymal stem cells from patients with myeloma, carfilzomib induced increases in alkaline phosphatase activity, matrix mineralization, and calcium deposition via Wnt-independent activation of beta-catenin/TCF signaling. Using affinity pull-down assays with immunoblotting analysis and immunofluorescence, we found that carfilzomib induced stabilization of both free and active forms of beta-catenin in a time- and dose-dependent manner that was not associated with beta-catenin transcriptional regulation. Nuclear translocation of beta-catenin protein was associated with TCF transcriptional activity that was independent of the effects of GSK3 beta-activation and of signaling induced by 19 Wnt ligands, 10 Frizzled receptors, and LRP5/6 co-receptors. Blocking activation of beta-catenin/TCF signaling by dominant negative TCF1 or TCF4 attenuated carfilzomib-induced matrix mineralization. Thus, carfilzomib induced osteoblast differentiation via Wnt-independent activation of the beta-catenin/TCF pathway. These results provide a novel molecular mechanism critical to understanding the anabolic role of carfilzomib on myeloma-induced bone disease.	[Hu, Bo; Chen, Yu; Usmani, Saad Z.; Ye, Shiqiao; Qiang, Wei; Papanikolaou, Xenofon; Heuck, Christoph J.; Yaccoby, Shmuel; Van Rhee, Frits; Barlogie, Bart; Epstein, Joshua; Qiang, Ya-Wei] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI USA	University of Arkansas System; University of Arkansas Medical Sciences; Van Andel Institute	Qiang, YW (corresponding author), Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA.	yqiang@uams.edu	Williams, Bart/A-3539-2013; Qiang, Ya-Wei/Q-2206-2019; Usmani, Saad Z/H-2705-2012; Ye, Shiqiao/N-2873-2015; Usmani, Saad Z/HCI-4676-2022	Williams, Bart/0000-0002-5261-5301; Qiang, Ya-Wei/0000-0002-2479-1412; Ye, Shiqiao/0000-0003-1529-7102; Usmani, Saad Z/0000-0002-5484-8731	Multiple Myeloma Research Foundation; National Institutes of Health [CA055819]; NATIONAL CANCER INSTITUTE [P01CA055819] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Multiple Myeloma Research Foundation (2006 MMRF Seniors Award and 2010 MMRF Microenvironment Award grants to YWQ). The URL of any funder's website is http://www.themmrf.org and by the National Institutes of Health (grant to YWQ, JE, and BB) (CA055819). The URL of any funder's website is http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colla S, 2007, BLOOD, V109, P4470, DOI 10.1182/blood-2006-11-056747; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Heider U, 2006, EUR J HAEMATOL, V77, P233, DOI 10.1111/j.1600-0609.2006.00692.x; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Kaiser M, 2008, EUR J HAEMATOL, V80, P490, DOI 10.1111/j.1600-0609.2008.01065.x; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Oyajobi BO, 2007, BRIT J HAEMATOL, V139, P434, DOI 10.1111/j.1365-2141.2007.06829.x; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Politou MC, 2006, INT J CANCER, V119, P1728, DOI 10.1002/ijc.22033; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Qiang YW, 2012, SEMIN HEMATOL, V49, P243, DOI 10.1053/j.seminhematol.2012.04.011; Qiang YW, 2009, CANCER ETIOL DIAGN T, P51; Qiang YW, 2010, BRIT J HAEMATOL, V148, P726, DOI 10.1111/j.1365-2141.2009.08009.x; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Roodman GD, 2004, BLOOD CELL MOL DIS, V32, P290, DOI 10.1016/j.bcmd.2004.01.001; Shaughnessy JD, 2003, IMMUNOL REV, V194, P140, DOI 10.1034/j.1600-065X.2003.00054.x; Siegel DS, 2012, BLOOD; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Terpos E, 2008, LEUKEMIA, V22, P2247, DOI 10.1038/leu.2008.235; Terpos E, 2007, BLOOD, V110, P1098, DOI 10.1182/blood-2007-03-067710; Terpos E, 2006, BRIT J HAEMATOL, V135, P688, DOI 10.1111/j.1365-2141.2006.06356.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Vij R, 2012, BLOOD, V119, P5661, DOI 10.1182/blood-2012-03-414359; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Zangari M, 2012, CANCER TREAT REV, V38, P968, DOI 10.1016/j.ctrv.2011.12.007; Zangari M, 2011, EUR J HAEMATOL, V86, P484, DOI 10.1111/j.1600-0609.2011.01602.x	45	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74191	10.1371/journal.pone.0074191	http://dx.doi.org/10.1371/journal.pone.0074191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066119	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000101
J	Towers, RJ; Carapetis, JR; Currie, BJ; Davies, MR; Walker, MJ; Dougan, G; Giffard, PM				Towers, Rebecca J.; Carapetis, Jonathan R.; Currie, Bart J.; Davies, Mark R.; Walker, Mark J.; Dougan, Gordon; Giffard, Philip M.			Extensive Diversity of Streptococcus pyogenes in a Remote Human Population Reflects Global-Scale Transmission Rather than Localised Diversification	PLOS ONE			English	Article							ACUTE RHEUMATIC-FEVER; GROUP-A STREPTOCOCCI; POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; ABORIGINAL COMMUNITIES; VACCINE DEVELOPMENT; NORTHERN-TERRITORY; HIGH-RATES; EPIDEMIOLOGY; AUSTRALIA; INFECTION	The Indigenous population of the Northern Territory of Australia (NT) suffers from a very high burden of Streptococcus pyogenes disease, including cardiac and renal sequelae. The aim of this study was to determine if S. pyogenes isolated from this population represent NT endemic strains, or conversely reflect strains with global distribution. emm sequence typing data were used to select 460 S. pyogenes isolates representing NT S. pyogenes diversity from 1987-2008. These isolates were genotyped using either multilocus sequence typing (MLST) or a high resolution melting-based MLST surrogate (Minim typing). These data were combined with MLST data from other studies on NT S. pyogenes to yield a set of 731 MLST or Minim typed isolates for analysis. goeBURST analysis of MLST allelic profiles and neighbour-joining trees of the MLST allele sequences revealed that a large proportion of the known global S. pyogenes MLST-defined diversity has now been found in the NT. Specifically, fully sequence typed NT isolates encompass 19% of known S. pyogenes STs and 43% of known S. pyogenes MLST alleles. These analyses provided no evidence for major NT-endemic strains, with many STs and MLST alleles shared between the NT and the rest of the world. The relationship between the number of known Minim types, and the probability that a Minim type identified in a calendar year would be novel was determined. This revealed that Minim types typically persist in the NT for > 1 year, and indicate that the majority of NT Minim types have been identified. This study revealed that many diverse S. pyogenes strains exhibit global scale mobility that extends to isolated populations. The burden of S. pyogenes disease in the NT is unlikely to be due to the nature of NT S. pyogenes strains, but is rather a function of social and living conditions.	[Towers, Rebecca J.; Carapetis, Jonathan R.; Currie, Bart J.; Giffard, Philip M.] Menzies Sch Hlth Res, Div Global & Trop Hlth, Casuarina, NT, Australia; [Carapetis, Jonathan R.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA, Australia; [Davies, Mark R.; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England	Charles Darwin University; Menzies School of Health Research; Telethon Kids Institute; University of Western Australia; University of Queensland; Wellcome Trust Sanger Institute	Giffard, PM (corresponding author), Menzies Sch Hlth Res, Div Global & Trop Hlth, Casuarina, NT, Australia.	phil.giffard@menzies.edu.au	Davies, Mark R/J-2128-2014; Giffard, Philip/N-2293-2013; Walker, Mark J./F-6940-2011; Carapetis, Jonathan R/H-8933-2014	Davies, Mark R/0000-0001-6141-5179; Carapetis, Jonathan R/0000-0002-1182-9792; Giffard, Phil/0000-0002-3030-9127; Walker, Mark/0000-0001-7423-2769	National Health and Medical Research Council (Australia) [436034]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded in part by the by a National Health and Medical Research Council (Australia) Post-doctoral training fellowship awarded to RT (Grant number 436034; http://www.nhmrc.gov.au/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033530; Andrews Ross M, 2009, Pediatr Clin North Am, V56, P1421, DOI 10.1016/j.pcl.2009.09.002; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; BISNO AL, 1990, ANNU REV MED, V41, P319, DOI 10.1146/annurev.me.41.020190.001535; Bryant PA, 2009, CIRCULATION, V119, P742, DOI 10.1161/CIRCULATIONAHA.108.792135; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; CURRIE B, 1993, MED J AUSTRALIA, V158, P609, DOI 10.5694/j.1326-5377.1993.tb137630.x; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Guilherme L, 2010, J CLIN IMMUNOL, V30, P17, DOI 10.1007/s10875-009-9332-6; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Marshall CS, 2011, AM J TROP MED HYG, V85, P703, DOI 10.4269/ajtmh.2011.11-0185; McDonald MI, 2008, EPIDEMIOL INFECT, V136, P529, DOI 10.1017/S0950268807008655; McDonald MI, 2007, EPIDEMIOL INFECT, V135, P1398, DOI 10.1017/S0950268807008023; McDonald Malcolm, 2007, Heart Lung Circ, V16, P254, DOI 10.1016/j.hlc.2007.02.087; McDonald MI, 2006, CLIN INFECT DIS, V43, P683, DOI 10.1086/506938; McGregor KF, 2004, J INFECT DIS, V189, P717, DOI 10.1086/381452; Pandey M, 2013, J IMMUNOL, V190, P2692, DOI 10.4049/jimmunol.1202333; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Richardson LJ, 2010, VACCINE, V28, P5301, DOI 10.1016/j.vaccine.2010.05.046; Rodriguez-Iturbe B, 2007, KIDNEY INT, V71, P1094, DOI 10.1038/sj.ki.5002169; Rodriguez-Iturbe B, 2008, J AM SOC NEPHROL, V19, P1855, DOI 10.1681/ASN.2008010092; Sakota V, 2006, J CLIN MICROBIOL, V44, P2160, DOI 10.1128/JCM.02456-05; Smoot JC, 2002, J CLIN MICROBIOL, V40, P1805, DOI 10.1128/JCM.40.5.1805-1810.2002; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; White AV, 2001, MED J AUSTRALIA, V174, P492, DOI 10.5694/j.1326-5377.2001.tb143394.x	30	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73851	10.1371/journal.pone.0073851	http://dx.doi.org/10.1371/journal.pone.0073851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066079	gold, Green Published			2022-12-27	WOS:000324494000061
J	Xiao, GZ; Tang, LQ; Yuan, FF; Zhu, W; Zhang, SH; Liu, ZF; Geng, Y; Qiu, XW; Zhang, YL; Su, L				Xiao, Guizhen; Tang, Liqun; Yuan, Fangfang; Zhu, Wei; Zhang, Shaoheng; Liu, Zhifeng; Geng, Yan; Qiu, Xiaowen; Zhang, Yali; Su, Lei			Eicosapentaenoic Acid Enhances Heat Stress-Impaired Intestinal Epithelial Barrier Function in Caco-2 Cells	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TIGHT JUNCTION PERMEABILITY; GAMMA-LINOLENIC ACID; NF-KAPPA-B; EXPRESSION; OCCLUDIN; PROTEINS; EPA; TRANSCRIPTION; HYPERTHERMIA	Objective: Dysfunction of the intestinal epithelial tight junction (TJ) barrier is known to have an important etiologic role in the pathophysiology of heat stroke. N-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), play a role in maintaining and protecting the TJ structure and function. This study is aimed at investigating whether n-3 PUFAs could alleviate heat stress-induced dysfunction of intestinal tight junction. Methods: Human intestinal epithelial Caco-2 cells were pre-incubated with EPA, DHA or arachidonic acid (AA) and then exposed to heat stress. Transepithelial electrical resistance (TEER) and Horseradish Peroxidase (HRP) permeability were measured to analyze barrier integrity. Levels of TJ proteins, including occludin, ZO-1 and claudin-2, were analyzed by Western blot and localized by immunofluorescence microscopy. Messenger RNA levels were determined by quantitative real time polymerase chain reaction (Q-PCR). TJ morphology was observed by transmission electron microscopy. Results: EPA effectively attenuated the decrease in TEER and impairment of intestinal permeability in HRP flux induced by heat exposure. EPA significantly elevated the expression of occludin and ZO-1, while DHA was less effective and AA was not at all effective. The distortion and redistribution of TJ proteins, and disruption of morphology were also effectively prevented by pretreatment with EPA. Conclusion: This study indicates for the first time that EPA is more potent than DHA in protecting against heat-induced permeability dysfunction and epithelial barrier damage of tight junction.	[Xiao, Guizhen; Zhu, Wei; Zhang, Shaoheng; Zhang, Yali] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Tang, Liqun; Yuan, Fangfang; Liu, Zhifeng; Geng, Yan; Su, Lei] Gen Hosp Guangzhou Mil Command, Dept Intens Care Unit, Key Lab Hot Zone Trauma Care & Tissue Repair PLA, Guangzhou, Guangdong, Peoples R China; [Qiu, Xiaowen] Gen Hosp Guangzhou Mil Command, Dept Nutr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Theater Command General Hospital; Southern Theater Command General Hospital	Zhang, YL (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China.	zyl41531@163.com; slei_icu@163.com			National Natural Science Foundation of China [81071529, 81101467]; Guangdong Province Natural Science Foundation of China [10151001002000001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	This work was supported by grant from National Natural Science Foundation of China (numbers 81071529 and 81101467) and Guangdong Province Natural Science Foundation of China (number 10151001002000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock Tricia A, 2002, Surg Infect (Larchmt), V3, P145, DOI 10.1089/109629602760105817; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24; Blatteis CM, 2000, J PHYSIOL-LONDON, V526, P470; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Calder PC, 2009, BRIT J NUTR, V101, pS1, DOI 10.1017/S0007114509377867; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Caplan MS, 2001, PEDIATR RES, V49, P647, DOI 10.1203/00006450-200105000-00007; Chen M, 2008, ENDOCRINOLOGY, V149, P4871, DOI 10.1210/en.2007-1093; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dokladny K, 2008, AM J PATHOL, V172, P659, DOI 10.2353/ajpath.2008.070522; Ferrer R, 2010, BIOCHEM PHARMACOL, V80, P431, DOI 10.1016/j.bcp.2010.04.033; GATHIRAM P, 1988, CIRC SHOCK, V25, P223; GATHIRAM P, 1987, CIRC SHOCK, V23, P157; Grau-Carmona T, 2011, CLIN NUTR, V30, P578, DOI 10.1016/j.clnu.2011.03.004; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Johnson LG, 2005, ADV DRUG DELIVER REV, V57, P111, DOI 10.1016/j.addr.2004.08.004; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Kimura Y, 1997, AM J PATHOL, V151, P45; Koller M, 2003, CLIN NUTR, V22, P59, DOI 10.1054/clnu.2002.0592; Lambert GP, 2002, J APPL PHYSIOL, V92, P1750, DOI 10.1152/japplphysiol.00787.2001; Lambert GP, 2001, J APPL PHYSIOL, V90, P2075, DOI 10.1152/jappl.2001.90.6.2075; Li QR, 2008, MOL IMMUNOL, V45, P1356, DOI 10.1016/j.molimm.2007.09.003; Li QR, 2008, FEBS J, V275, P411, DOI 10.1111/j.1742-4658.2007.06210.x; Mickleborough TD, 2009, CLIN NUTR, V28, P71, DOI 10.1016/j.clnu.2008.10.012; Moorthy G, 2009, NUTRITION, V25, P350, DOI 10.1016/j.nut.2008.09.004; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Nano JL, 2003, PROSTAG LEUKOTR ESS, V69, P207, DOI 10.1016/S0952-3278(03)00083-8; Novak TE, 2003, AM J PHYSIOL-LUNG C, V284, pL84, DOI 10.1152/ajplung.00077.2002; OH IS, 2005, CELL METAB, V1, P331; PEPPELENBOSCH MP, 1993, CELL, V74, P565, DOI 10.1016/0092-8674(93)80057-L; Roig-Perez S, 2009, J MEMBRANE BIOL, V228, P141, DOI 10.1007/s00232-009-9166-4; Saito Y, 2008, ATHEROSCLEROSIS, V200, P135, DOI 10.1016/j.atherosclerosis.2008.06.003; Sakaguchi T, 2002, CELL MICROBIOL, V4, P367, DOI 10.1046/j.1462-5822.2002.00197.x; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SHAPIRO Y, 1986, EUR J APPL PHYSIOL O, V55, P410, DOI 10.1007/BF00422742; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Soeters PB, 2007, CURR OPIN CLIN NUTR, V10, P632, DOI 10.1097/MCO.0b013e3282a0780e; Strauss JG, 2003, BIOCHEM J, V371, P981, DOI 10.1042/BJ20021437; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Usami M, 2003, NUTRITION, V19, P150, DOI 10.1016/S0899-9007(02)00927-9; Usami M, 2001, CLIN NUTR, V20, P351, DOI 10.1054/clnu.2001.0430; Willemsen LEM, 2008, EUR J NUTR, V47, P183, DOI 10.1007/s00394-008-0712-0; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Youmba SB, 2012, J PEDIATR GASTR NUTR, V54, P463, DOI 10.1097/MPG.0b013e318247240d	51	45	51	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73571	10.1371/journal.pone.0073571	http://dx.doi.org/10.1371/journal.pone.0073571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066055	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000036
J	Xing, XW; Liu, YL; Vargas, M; Wang, YS; Feng, YQ; Zhou, X; Yuan, BF				Xing, Xi-Wen; Liu, Yu-Li; Vargas, Mario; Wang, Yinsheng; Feng, Yu-Qi; Zhou, Xiang; Yuan, Bi-Feng			Mutagenic and Cytotoxic Properties of Oxidation Products of 5-Methylcytosine Revealed by Next-Generation Sequencing	PLOS ONE			English	Article							DNA METHYLATION; TET PROTEINS; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; LESIONS; BYPASS; 5-CARBOXYLCYTOSINE; CONVERSION; EFFICIENT; CANCERS	5-methylcytosine (5-mC) can be sequentially oxidized to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-foC), and finally to 5-carboxylcytosine (5-caC), which is thought to function in active DNA cytosine demethylation in mammals. Although the roles of 5-mC in epigenetic regulation of gene expression are well established, the effects of 5-hmC, 5-foC and 5-caC on DNA replication remain unclear. Here we report a systematic study on how these cytosine derivatives (5-hmC, 5-foC and 5-caC) perturb the efficiency and accuracy of DNA replication using shuttle vector technology in conjugation with next-generation sequencing. Our results demonstrated that, in Escherichia coli cells, all the cytosine derivatives could induce CT transition mutation at frequencies of 0.17%-1.12%, though no effect on replication efficiency was observed. These findings provide an important new insight on the potential mutagenic properties of cytosine derivatives occurring as the intermediates of DNA demethylation.	[Xing, Xi-Wen; Liu, Yu-Li; Feng, Yu-Qi; Zhou, Xiang; Yuan, Bi-Feng] Wuhan Univ, Dept Chem, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China; [Vargas, Mario; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	Wuhan University; University of California System; University of California Riverside	Zhou, X (corresponding author), Wuhan Univ, Dept Chem, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.	xzhou@whu.edu.cn; bfyuan@whu.edu.cn	Yuan, Bi-Feng/K-5803-2013; Feng, Yu-Qi/H-1479-2011	Yuan, Bi-Feng/0000-0001-5223-4659; Feng, Yu-Qi/0000-0003-1107-5385	National Basic Research Program of China (973 Program) [2013CB910702, 2012CB720601]; National Natural Science Foundation of China [91217309, 91017013, 31070327, 21205091, 21228501]; Ph.D. Programs Foundation of Ministry of Education of China [20120141120037]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are thankful for the financial support from the National Basic Research Program of China (973 Program) (2013CB910702, 2012CB720601); the National Natural Science Foundation of China (91217309,91017013, 31070327, 21205091, 21228501); Ph.D. Programs Foundation of Ministry of Education of China (20120141120037), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kriukiene E, 2012, CHEM SOC REV, V41, P6916, DOI 10.1039/c2cs35104h; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Munzel M, 2011, CHEM-EUR J, V17, P13782, DOI 10.1002/chem.201102782; Nachman MW, 2000, GENETICS, V156, P297; Ndlovu MN, 2011, TRENDS BIOCHEM SCI, V36, P381, DOI 10.1016/j.tibs.2011.03.002; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rottach A, 2009, J CELL BIOCHEM, V108, P43, DOI 10.1002/jcb.22253; Shen L, 2013, CURR OPIN CELL BIOL, V25, P289, DOI 10.1016/j.ceb.2013.02.017; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159; Yuan BF, 2010, CHEM RES TOXICOL, V23, P11, DOI 10.1021/tx9004264	34	19	20	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e72993	10.1371/journal.pone.0072993	http://dx.doi.org/10.1371/journal.pone.0072993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066027	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000008
J	Zha, WJ; Cao, L; Shen, Y; Huang, M				Zha, Wangjian; Cao, Liu; Shen, Ying; Huang, Mao			Roles of Mir-144-ZFX Pathway in Growth Regulation of Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							SELF-RENEWAL; TUMOR-SUPPRESSOR; GASTRIC-CANCER; STEM-CELLS; ZFX GENE; EXPRESSION; APOPTOSIS; PROLIFERATION; MICRORNA-144; PROMOTES	Background: Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung carcinoma (NSCLC) accounts for most of the lung cancer cases and the prognosis of this disease remains poor despite decades of intensive investigation. Thus new insights into underlying mechanisms by which NSCLC develops are avidly needed as the basis for development of new lines of therapeutic strategies. The past decade has witnessed a growing interest on the regulatory roles of micro RNAs on various categories of malignancies. Related data has been well documented in carcinogenesis and pathophysiology of a variety of malignancies. Even so, there is a relative lack of data on roles of mir-144 in tumor biology and there has been no report showing the involvement of mir-144 in NSCLC development. Methods/Principal Finding: From human NSCLC tumor tissue samples and cell culture samples, we found that the expression of mir-144 is associated with malignant phenotype of NSCLC. Further investigations showed that ectopic mir-144 expression dramatically inhibits NSCLC tumor cell growth and induces apoptosis as manifested by elevated apoptotic protein markers and flowcytometry change. Moreover, we also found that ZFX protein expression is also associated with malignant phenotype of NSCLC and knockdown of ZFX protein results in a similar effect as of ectopic mir-144 expression. Finally, we found that ZFX expression is highly adjustable upon presence of mir-144 and ectopic expression of ZFX dramatically dampens mir-144 action of tumor inhibition. Conclusions: Our results for the first time showed mir-144-ZFX pathway is involved in the development of NSCLC, which sheds a light for further investigations on underlying mechanisms toward better understanding and management of NSCLC.	[Zha, Wangjian; Huang, Mao] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Cao, Liu] Nanjing Med Univ, Nanjing Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Shen, Ying] Univ Calif San Diego, Moores Canc Ctr, Div Neurosurg, La Jolla, CA 92093 USA	Nanjing Medical University; Nanjing Medical University; University of California System; University of California San Diego	Huang, M (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	huangmao6114@126.com	Shen, Ying/AAE-3005-2022		National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2011ZX09302-003-02]	National Major Scientific and Technological Special Project for "Significant New Drugs Development"	This work was supported by the National Major Scientific and Technological Special Project for "Significant New Drugs Development" (2011ZX09302-003-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi S, 2012, BRIT J CANCER, V107, P1345, DOI 10.1038/bjc.2012.326; An J, 2013, J CELL BIOCH; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Chien WW, 2011, ONCOGENE, V30, P1880, DOI 10.1038/onc.2010.570; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058929; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Grosso S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.71; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kalimutho M, 2011, J GASTROENTEROL, V46, P1391, DOI 10.1007/s00535-011-0456-0; Kang SM, 2013, CANCER LETT, V335, P487, DOI 10.1016/j.canlet.2013.03.006; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li YX, 2012, BIOCHEM BIOPH RES CO, V426, P615, DOI 10.1016/j.bbrc.2012.08.139; Liu T, 2013, INT J MOL MED, V31, P188, DOI 10.3892/ijmm.2012.1182; Miao LJ, 2013, FEBS LETT, V587, P1359, DOI 10.1016/j.febslet.2013.03.006; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Nikpour P, 2012, J BIOSCIENCES, V37, P85, DOI 10.1007/s12038-011-9174-2; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Solomides CC, 2012, ACTA CYTOL, V56, P645, DOI 10.1159/000343473; Soriano A, 2013, PHARM RES; Sureban SM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-40; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang XC, 2011, CANCER LETT, V311, P203, DOI 10.1016/j.canlet.2011.07.026; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Yu YJ, 2013, TRANSL ONCOL, V6, P180, DOI 10.1593/tlo.12397; Zhang LY, 2013, CARCINOGENESIS, V34, P454, DOI 10.1093/carcin/bgs346; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhou YX, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-114	44	62	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74175	10.1371/journal.pone.0074175	http://dx.doi.org/10.1371/journal.pone.0074175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066116	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000098
J	Jiang, HT; Qu, LL; Dou, RR; Lu, LF; Bian, SS; Zhu, WM				Jiang, Haitao; Qu, Linlin; Dou, Rongrong; Lu, Lianfang; Bian, Sishan; Zhu, Weiming			Potential Role of Mesenchymal Stem Cells in Alleviating Intestinal Ischemia/Reperfusion Impairment	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MARROW STROMAL CELLS; NF-KAPPA-B; BONE-MARROW; ADIPOSE-TISSUE; LUNG INJURY; MOUSE MODEL; DIFFERENTIATION; ACTIVATION; TRANSPLANTATION	Background: Transplantation of bone marrow mesenchymal stem cells (MSCs) provides a promising therapeutic efficiency for a variety of disorders caused by ischemia or reperfusion impairment. We have previously demonstrated the efficacy of MSCs in mitigating intestinal ischemia/reperfusion (I/R) injuries in rats, but the mechanism by which MSCs engraft ameliorates I/R injuries has largely been unknown. The present study aimed at investigating probable mechanisms by which MSCs exert their function. Methods: Male donor derived rat MSCs were implanted into intestine of female recipient rat by direct submucosal injection after superior mesenteric artery clamping and unclamping. The homed MSCs were detected by Y chromosome in situ hybridization probe, and the tumor necrosis factor-alpha (TNF-alpha) content in intestinal mucosa was determined by ELISA. Expression of proliferative cell nuclear antigen (PCNA) in bowel mucosa was assayed by real-time PCR and intestinal mucosa expression of phosphorylation extracellular signal-regulated kinase (pERK1/2) and nuclear factor-kappa B (NF-kappa B) were evaluated by western blot. Results: Four and seven days after MSCs transplantation, the TNF-alpha content of bowel mucosa in MSCs group was significantly lower than that in saline group. The PCNA in bowel mucosa showed higher expression in MSCs treated group than the saline group, both at 4 and 7 days after cell transplantation. The expression of intestinal mucosal pERK1/2 in MSCs treated group was markedly higher than that in saline group, and the expression of NF-kappa B in MSCs treated group was noticeably decreased than that in saline group at 4 and 7 days post MSCs transplantation. Conclusion: The present investigation provides novel evidence that MSCs have the potential to reduce intestinal I/R injuries probably due to their ability to accelerate cell proliferation and decrease the inflammatory response within intestinal mucosa after ischemia and reperfusion.	[Jiang, Haitao; Qu, Linlin; Dou, Rongrong; Lu, Lianfang] Qingdao Univ, Coll Med, Affiliated Hosp 2, Dept Gen Surg, Qingdao 266071, Peoples R China; [Bian, Sishan] Shandong Prov Hosp Tradit Chinese Med, Dept Gen Surg, Jinan, Peoples R China; [Zhu, Weiming] Nanjing Univ, Res Inst Gen Surg, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Qingdao University; Nanjing University	Jiang, HT (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp 2, Dept Gen Surg, Qingdao 266071, Peoples R China.	jianght6717@gmail.com			Natural Science Foundation of Jiangsu Province [BK2007154]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS20110004]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province	This study was supported by the Natural Science Foundation of Jiangsu Province (No. BK2007154) and Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS20110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Campolo M, 2013, J LEUKOCYTE BIOL, V93, P277, DOI 10.1189/jlb.0712317; CATY MG, 1990, ANN SURG, V212, P694, DOI 10.1097/00000658-199012000-00007; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; El-Assal ON, 2005, GASTROENTEROLOGY, V129, P609, DOI 10.1053/j.gastro.2005.05.054; Fisher-Shoval Y, 2012, J MOL NEUROSCI, V48, P176, DOI 10.1007/s12031-012-9805-6; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hisanaga E, 2008, ENDOCR J, V55, P535, DOI 10.1507/endocrj.K07E-173; Ikeda M, 1998, BIOCHEM BIOPH RES CO, V247, P462, DOI 10.1006/bbrc.1998.8811; Itoh H, 2000, TRANSPLANTATION, V69, P598, DOI 10.1097/00007890-200002270-00022; Jiang HT, 2011, J SURG RES, V168, P127, DOI 10.1016/j.jss.2009.07.035; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; KOIKE K, 1993, J SURG RES, V54, P469, DOI 10.1006/jsre.1993.1072; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li W, 2001, AM J PHYSIOL-GASTR L, V280, pG75, DOI 10.1152/ajpgi.2001.280.1.G75; Lovell MJ, 2010, ATHEROSCLEROSIS, V213, P67, DOI 10.1016/j.atherosclerosis.2010.07.045; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nichols TC, 2004, DRUG NEWS PERSPECT, V17, P99, DOI 10.1358/dnp.2004.17.2.829042; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; Souza AL, 2000, J TRAUMA, V49, P232, DOI 10.1097/00005373-200008000-00008; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345	42	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74468	10.1371/journal.pone.0074468	http://dx.doi.org/10.1371/journal.pone.0074468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058571	Green Submitted, gold, Green Published			2022-12-27	WOS:000324408400079
J	Kaya, HB; Cetin, O; Kaya, H; Sahin, M; Sefer, F; Kahraman, A; Tanyolac, B				Kaya, Hilal Betul; Cetin, Oznur; Kaya, Hulya; Sahin, Mustafa; Sefer, Filiz; Kahraman, Abdullah; Tanyolac, Bahattin			SNP Discovery by Illumina-Based Transcriptome Sequencing of the Olive and the Genetic Characterization of Turkish Olive Genotypes Revealed by AFLP, SSR and SNP Markers	PLOS ONE			English	Article							OLEA-EUROPAEA L.; MICROSATELLITE MARKERS; MOLECULAR CHARACTERIZATION; POPULATION-STRUCTURE; MOROCCAN OLIVE; LINKAGE MAP; DIVERSITY; CULTIVARS; POLYMORPHISM; VARIETIES	Background: The olive tree (Olea europaea L.) is a diploid (2n = 2x = 46) outcrossing species mainly grown in the Mediterranean area, where it is the most important oil-producing crop. Because of its economic, cultural and ecological importance, various DNA markers have been used in the olive to characterize and elucidate homonyms, synonyms and unknown accessions. However, a comprehensive characterization and a full sequence of its transcriptome are unavailable, leading to the importance of an efficient large-scale single nucleotide polymorphism (SNP) discovery in olive. The objectives of this study were (1) to discover olive SNPs using next-generation sequencing and to identify SNP primers for cultivar identification and (2) to characterize 96 olive genotypes originating from different regions of Turkey. Methodology/Principal Findings: Next-generation sequencing technology was used with five distinct olive genotypes and generated cDNA, producing 126,542,413 reads using an Illumina Genome Analyzer IIx. Following quality and size trimming, the high-quality reads were assembled into 22,052 contigs with an average length of 1,321 bases and 45 singletons. The SNPs were filtered and 2,987 high-quality putative SNP primers were identified. The assembled sequences and singletons were subjected to BLAST similarity searches and annotated with a Gene Ontology identifier. To identify the 96 olive genotypes, these SNP primers were applied to the genotypes in combination with amplified fragment length polymorphism (AFLP) and simple sequence repeats (SSR) markers. Conclusions/Significance: This study marks the highest number of SNP markers discovered to date from olive genotypes using transcriptome sequencing. The developed SNP markers will provide a useful source for molecular genetic studies, such as genetic diversity and characterization, high density quantitative trait locus (QTL) analysis, association mapping and map-based gene cloning in the olive. High levels of genetic variation among Turkish olive genotypes revealed by SNPs, AFLPs and SSRs allowed us to characterize the Turkish olive genotype.	[Kaya, Hilal Betul; Tanyolac, Bahattin] Ege Univ, Dept Bioengn, Izmir, Turkey; [Cetin, Oznur; Kaya, Hulya; Sahin, Mustafa; Sefer, Filiz] Olive Res Stn, Izmir, Turkey; [Kahraman, Abdullah] Harran Univ, Dept Field Crops, S Urfa, Turkey	Ege University; Harran University	Tanyolac, B (corresponding author), Ege Univ, Dept Bioengn, Izmir, Turkey.	bahattin.tanyolac@ege.edu.tr	Kahraman, Abdullah/AAB-1400-2020; Tanyolac, Bahattin/AAD-3762-2019; Kahraman, Abdullah/W-1029-2017	Kaya, Hilal Betul/0000-0002-2543-7212; Kahraman, Abdullah/0000-0002-8829-3797	Turkish Technical and Research Council [108G096]	Turkish Technical and Research Council(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This manuscript was funded by Turkish Technical and Research Council with the project number of 108G096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2011, AFRICAN J AGR RES, V6; Achtak H, 2009, J AM SOC HORTIC SCI, V134, P624, DOI 10.21273/JASHS.134.6.624; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Alba V, 2009, SCI HORTIC-AMSTERDAM, V123, P11, DOI 10.1016/j.scienta.2009.07.007; Albertini E, 2011, MOL BREEDING, V27, P533, DOI 10.1007/s11032-010-9452-y; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Angiolillo A, 1999, THEOR APPL GENET, V98, P411, DOI 10.1007/s001220051087; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; [Anonymous], 1997, IPGRI TECHNICAL B IPGRI TECHNICAL B; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Bandelj D, 2004, EUPHYTICA, V136, P93, DOI 10.1023/B:EUPH.0000019552.42066.10; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Belaj A, 2001, J AM SOC HORTIC SCI, V126, P64, DOI 10.21273/JASHS.126.1.64; Belaj A, 2004, HORTSCIENCE, V39, P1557, DOI 10.21273/HORTSCI.39.7.1557; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Belaj A, 2010, SCI HORTIC-AMSTERDAM, V124, P323, DOI 10.1016/j.scienta.2010.01.010; Boskou G, 2006, FOOD CHEM, V94, P558, DOI 10.1016/j.foodchem.2004.12.005; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bracci T, 2011, PLANT CELL REP, V30, P449, DOI 10.1007/s00299-010-0991-9; Carriero F, 2002, THEOR APPL GENET, V104, P301, DOI 10.1007/s001220100691; Charafi J, 2008, GENET RESOUR CROP EV, V55, P893, DOI 10.1007/s10722-007-9294-6; Cipriani G, 2002, THEOR APPL GENET, V104, P223, DOI 10.1007/s001220100685; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Consolandi C, 2007, J BIOTECHNOL, V129, P565, DOI 10.1016/j.jbiotec.2007.01.025; Corrado G, 2011, J HORTIC SCI BIOTECH, V86, P461, DOI 10.1080/14620316.2011.11512789; Daoud D, 2007, J HORTIC SCI, V82; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; de la Rosa R, 2003, THEOR APPL GENET, V106, P1273, DOI 10.1007/s00122-002-1189-5; De La Rosa R, 2002, MOL ECOL NOTES, V2, P265, DOI 10.1046/j.1471-8286.2002.00217.x; Diaz A, 2006, J AM SOC HORTIC SCI, V131, P250, DOI 10.21273/JASHS.131.2.250; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Diez CM, 2011, ANN BOT-LONDON, V108, P797, DOI 10.1093/aob/mcr194; do Val ADB, 2012, GENET MOL RES, V11, P556, DOI 10.4238/2012.March.8.4; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Ercisli S, 2009, GENET MOL RES, V8, P414, DOI 10.4238/vol8-2gmr576; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; FAOSTAT, 2010, STAT DAT FAOSTAT; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gemas VJV, 2004, GENET RESOUR CROP EV, V51, P501, DOI 10.1023/B:GRES.0000024152.16021.40; Giraldo E, 2008, J AM SOC HORTIC SCI, V133, P69, DOI 10.21273/JASHS.133.1.69; Gouta H, 2010, HEREDITAS, V147, P283, DOI 10.1111/j.1601-5223.2009.02147.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grati-Kamoun N, 2006, GENET RESOUR CROP EV, V53, P265, DOI 10.1007/s10722-004-6130-0; Green P. S., 2002, Kew Bulletin, V57, P91, DOI 10.2307/4110824; Gupta P, 2012, MOL BREEDING, V30, P1325, DOI 10.1007/s11032-012-9719-6; Hakim I. R., 2010, Diversity, V2, P17; Haouane H, 2011, GENETICA, V139, P1083, DOI 10.1007/s10709-011-9608-7; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Henry RJ, 2012, J BIOSCIENCES, V37, P829, DOI 10.1007/s12038-012-9253-z; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Ipek A, 2012, SCI AGR, V69, P327, DOI 10.1590/S0103-90162012000500007; Isik N, 2011, CROP SCI, V51, P1646, DOI 10.2135/cropsci2010.11.0625; Jackson Scott, 2006, Plant Cell, V18, P1100; Khadari B, 2008, TREE GENET GENOMES, V4, P213, DOI 10.1007/s11295-007-0102-4; Khadari B, 2005, HORTSCIENCE, V40, P29, DOI 10.21273/HORTSCI.40.1.29; Khadari B, 2003, THEOR APPL GENET, V106, P521, DOI 10.1007/s00122-002-1079-x; Kim S, 2011, INT J DATA MIN BIOIN, V5, P231; Koehmstedt AM, 2011, GENET RESOUR CROP EV, V58, P519, DOI 10.1007/s10722-010-9595-z; Lopes MS, 2004, HORTSCIENCE, V39, P1562, DOI 10.21273/HORTSCI.39.7.1562; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martins-Lopes P, 2008, J AGR FOOD CHEM, V56, P11786, DOI 10.1021/jf801146z; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mekuria GT, 2002, SCI HORTIC-AMSTERDAM, V94, P91, DOI 10.1016/S0304-4238(01)00375-2; Menini U, 1998, OLIVE GERMPLASM CULT; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Omrani-Sabbaghi A, 2007, SCI HORTIC-AMSTERDAM, V112, P439, DOI 10.1016/j.scienta.2006.12.051; Ozkaya MT, 2006, SCI HORTIC-AMSTERDAM, V108, P205, DOI 10.1016/j.scienta.2006.01.016; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paszkiewicz K, 2012, BIOINFORMATICS FOR HIGH THROUGHPUT SEQUENCING, P231, DOI 10.1007/978-1-4614-0782-9_14; Poljuha D, 2008, SCI HORTIC-AMSTERDAM, V115, P223, DOI 10.1016/j.scienta.2007.08.018; Pritchard JK, 2000, GENETICS, V155, P945; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Saddoud O, 2007, HEREDITAS, V144, P149, DOI 10.1111/j.2007.0018-0661.01967.x; Sanz-Cortes F, 2001, J AM SOC HORTIC SCI, V126, P7, DOI 10.21273/JASHS.126.1.07; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; Sefc KM, 2000, MOL ECOL, V9, P1171, DOI 10.1046/j.1365-294x.2000.00954.x; Sexton T, 2011, BMC P, V5, pO9; Sexton TR, 2010, AUST FORESTRY, V73, P254, DOI 10.1080/00049158.2010.10676336; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Visioli F, 2002, CRITICAL REV FOOD SC, V42, P3; Vizoso P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-423; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wiesman Z, 1998, J AM SOC HORTIC SCI, V123, P837, DOI 10.21273/JASHS.123.5.837; Wong MML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-726; You FM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-354; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley	111	46	50	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73674	10.1371/journal.pone.0073674	http://dx.doi.org/10.1371/journal.pone.0073674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058483	gold, Green Submitted, Green Published			2022-12-27	WOS:000324408400032
J	Qin, LH; Gao, SH; Wang, J; Zheng, RJ; Lu, JM; Hu, ZY				Qin, Lianhua; Gao, Shihui; Wang, Jie; Zheng, Ruijuan; Lu, Junmei; Hu, Zhongyi			The Conservation and Application of Three Hypothetical Protein Coding Gene for Direct Detection of Mycobacterium tuberculosis in Sputum Specimens	PLOS ONE			English	Article							ACID-AMPLIFICATION TESTS; REAL-TIME PCR; DIAGNOSIS; IS6110; IDENTIFICATION; METAANALYSIS; COMPLEX; ASSAY; DNA	Background: Accurate and early diagnosis of tuberculosis (TB) is of major importance in the control of TB. One of the most important technical advances in diagnosis of tuberculosis is the development of nucleic acid amplification (NAA) tests. However, the choice of the target sequence remains controversial in NAA tests. Recently, interesting alternatives have been found in hypothetical protein coding sequences from mycobacterial genome. Methodology/Principal Findings: To obtain rational biomarker for TB diagnosis, the conservation of three hypothetical genes was firstly evaluated in 714 mycobacterial strains. The results showed that SCAR1 (Sequenced Characterized Amplified Region) based on Rv0264c coding gene showed the highest conservation (99.8%) and SCAR2 based on Rv1508c gene showed the secondary high conservation (99.7%) in M. tuberculosis (MTB) strains. SCAR3 based on Rv2135c gene (3.2%) and IS6110 (8%) showed relatively high deletion rate in MTB strains. Secondly, three SCAR markers were evaluated in 307 clinical sputum from patients in whom TB was suspected or patients with diseases other than TB. The amplification of IS6110 and 16SrRNA sequences together with both clinical and bacteriological identification was as a protocol to evaluate the efficacy of SCAR markers. The sensitivities and specificities, positive predictive value (PPV) and negative predictive value (NPV) of all NAA tests were higher than those of bacteriological detection. In four NAA tests, IS6110 and SCAR3 showed the highest PPV (100%) and low NPV (70% and 68.8%, respectively), and SCAR1 and SCAR2 showed the relatively high PPV and NPV (97% and 82.6%, 95.6% and 88.8%, respectively). Conclusions/Significance: Our result indicated that SCAR1 and SCAR2 with a high degree of sequence conservation represent efficient and promising alternatives as NAA test targets in identification of MTB. Moreover, the targets developed from this study may provide more alternative targets for the development of a multisite system to effectively detect MTB in samples.	[Qin, Lianhua; Gao, Shihui; Wang, Jie; Zheng, Ruijuan; Lu, Junmei; Hu, Zhongyi] Tongji Univ, Shanghai Key Lab TB, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China	Tongji University	Hu, ZY (corresponding author), Tongji Univ, Shanghai Key Lab TB, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China.	shhuzy@163.com			Ministry of Science and Technology of the People's Republic of China [2012ZX10003002-008, 2009CB522605]; National Natural Science Foundation of China [81201254]; Science and Technology Commission of Shanghai Municipality, Shanghai, P. R. China [11ZR1430200]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, Shanghai, P. R. China(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of the People's Republic of China (No. 2012ZX10003002-008, and No. 2009CB522605), National Natural Science Foundation of China (No. 81201254), Science and Technology Commission of Shanghai Municipality, Shanghai, P. R. China (No. 11ZR1430200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodari NY, 2011, CLIN VACCINE IMMUNOL, V18, P477, DOI 10.1128/CVI.00405-10; Beqaj SH, 2007, DIAGN MOL PATHOL, V16, P169, DOI 10.1097/PDM.0b013e318037552e; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; BRISSONNOEL A, 1991, LANCET, V338, P364, DOI 10.1016/0140-6736(91)90492-8; Cuccu B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-167; Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; GLENNON M, 1994, TUBERCLE LUNG DIS, V75, P353, DOI 10.1016/0962-8479(94)90081-7; Hemal AK, 2000, UROLOGY, V56, P570, DOI 10.1016/S0090-4295(00)00668-3; Herrera EA, 1996, J CLIN MICROBIOL, V34, P1108, DOI 10.1128/JCM.34.5.1108-1113.1996; Kent PT, 1985, GUIDE LEVEL 3 LAB; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Patel S, 1997, J CLIN MICROBIOL, V35, P2375, DOI 10.1128/JCM.35.9.2375-2380.1997; Richardson ET, 2009, J CLIN MICROBIOL, V47, P1497, DOI 10.1128/JCM.01868-08; Ritis K, 2000, J INTERN MED, V248, P415, DOI 10.1046/j.1365-2796.2000.00750.x; Saves I, 2002, J CLIN MICROBIOL, V40, P943, DOI 10.1128/JCM.40.3.943-950.2002; THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188; Watt B, 2000, SCOT MED J, V45, P38, DOI 10.1177/00369330000450S118; Weil A, 1996, J CLIN MICROBIOL, V34, P2309, DOI 10.1128/JCM.34.9.2309-2311.1996; Woods GL, 2001, ARCH PATHOL LAB MED, V125, P122	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73955	10.1371/journal.pone.0073955	http://dx.doi.org/10.1371/journal.pone.0073955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058507	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400046
J	Stark, K; Burger, A; Wu, JM; Shelton, P; Polin, L; Li, J				Stark, Karri; Burger, Angelika; Wu, Jianmei; Shelton, Phillip; Polin, Lisa; Li, Jing			Reactivation of Estrogen Receptor a by Vorinostat Sensitizes Mesenchymal-Like Triple-Negative Breast Cancer to Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; CARCINOMA-CELL-LINES; ANTICANCER AGENT; GENE-EXPRESSION; ER-ALPHA; TRANSCRIPTIONAL ACTIVATION; DEPENDENT TRANSCRIPTION; NEOADJUVANT PACLITAXEL; TRANSIENT EXPRESSION; AH RESPONSIVENESS	Objective: Aminoflavone (AF) acts as a ligand of the aryl hydrocarbon receptor (AhR). Expression of estrogen receptor a (ERa) and AhR-mediated transcriptional induction of CYP1A1 can sensitize breast cancer cells to AF. The objective of this study was to investigate the combined antitumor effect of AF and the histone deacetylase inhibitor vorinostat for treating mesenchymal-like triple-negative breast cancer (TNBC) as well as the underlying mechanisms of such treatment. Methods: In vitro antiproliferative activity of AFP464 (AF prodrug) in breast cancer cell lines was evaluated by MTS assay. In vitro, the combined effect of AFP464 and vorinostat on cell proliferation was assessed by the Chou-Talalay method. In vivo, antitumor activity of AFP464, given alone and in combination with vorinostat, was studied using TNBC xenograft models. Knockdown of ERa was performed using specific, small-interfering RNA. Western blot, quantitative RT-PCR, immunofluorescence, and immunohistochemical staining were performed to study the mechanisms underlying the combined antitumor effect. Results: Luminal and basal A subtype breast cancer cell lines were sensitive to AFP464, whereas basal B subtype or mesenchymal-like TNBC cells were resistant. Vorinostat sensitized mesenchymal-like TNBC MDA-MB-231 and Hs578T cells to AFP464. It also potentiated the antitumor activity of AFP464 in a xenograft model using MDA-MB-231 cells. In vitro and in vivo mechanistic studies suggested that vorinostat reactivated ERa expression and restored AhR-mediated transcriptional induction of CYP1A1. Conclusion: The response of breast cancer cells to AF or AFP464 was associated with their gene expression profile. Vorinostat sensitized mesenchymal-like TNBC to AF, at least in part, by reactivating ERa expression and restoring the responsiveness of AhR to AF.	[Stark, Karri; Burger, Angelika; Wu, Jianmei; Polin, Lisa; Li, Jing] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Shelton, Phillip] Univ Maryland, Dept Pharmacol, Baltimore, MD 21201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; University System of Maryland; University of Maryland Baltimore	Li, J (corresponding author), Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA.	lijin@karmanos.org			Tigris Pharmaceuticals and Translational Research Initiative Funds from the National Cancer Institute; United States Public Health Service Cancer Center [P30 CA022453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Tigris Pharmaceuticals and Translational Research Initiative Funds from the National Cancer Institute; United States Public Health Service Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Tigris Pharmaceuticals and Translational Research Initiative Funds from the National Cancer Institute (Angelika Burger) and the United States Public Health Service Cancer Center Support Grant P30 CA022453 (Jing Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer JA, 2010, CLIN CANCER RES, V16, P681, DOI 10.1158/1078-0432.CCR-09-1091; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Glaser KB, 2003, MOL CANCER THER, V2, P151; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Jang ER, 2004, ONCOGENE, V23, P1724, DOI 10.1038/sj.onc.1207315; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kuffel MJ, 2002, MOL PHARMACOL, V62, P143, DOI 10.1124/mol.62.1.143; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Loaiza-Perez AI, 2004, MOL CANCER THER, V3, P715; Loaiza-Perez AI, 2004, J UROLOGY, V171, P1688, DOI 10.1097/01.ju.0000108860.03389.1b; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; Meng LH, 2007, ONCOGENE, V26, P4806, DOI 10.1038/sj.onc.1210283; Meng LH, 2005, CANCER RES, V65, P5337, DOI 10.1158/0008-5472.CAN-05-0003; Meng LH, 2006, CANCER RES, V66, P9656, DOI 10.1158/0008-5472.CAN-06-0796; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Safe S, 2003, CHEM RES TOXICOL, V16, P807, DOI 10.1021/tx034036r; Sasakawa Y, 2005, BIOCHEM PHARMACOL, V69, P603, DOI 10.1016/j.bcp.2004.11.008; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Shelton P. M., 2009, CANC RES S2, V69, P2153; Spink DC, 2003, CARCINOGENESIS, V24, P1941, DOI 10.1093/carcin/bgg162; Stark K, 2010, CYTOPLASMIC EXPRESSI; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; THOMSEN JS, 1991, EUR J BIOCHEM, V197, P577, DOI 10.1111/j.1432-1033.1991.tb15946.x; THOMSEN JS, 1994, CARCINOGENESIS, V15, P933, DOI 10.1093/carcin/15.5.933; Vassal G, 2003, CANCER CHEMOTH PHARM, V51, P385, DOI 10.1007/s00280-003-0584-1; VICKERS PJ, 1989, MOL ENDOCRINOL, V3, P157, DOI 10.1210/mend-3-1-157; Wang WL, 1996, BRIT J CANCER, V73, P316, DOI 10.1038/bjc.1996.55; Wihlen B, 2009, MOL CANCER RES, V7, P977, DOI 10.1158/1541-7786.MCR-08-0396; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Wilson MK, 2006, RESPONSE BREAST CANC; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XW, 2001, CANCER RES, V61, P7025; Yang XW, 2000, CANCER RES, V60, P6890; Zhou Q, 2007, CANCER BIOL THER, V6, P64, DOI 10.4161/cbt.6.1.3549	58	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74525	10.1371/journal.pone.0074525	http://dx.doi.org/10.1371/journal.pone.0074525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058584	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400083
J	Gregory, LS; Choi, W; Burke, L; Clements, JA				Gregory, Laura S.; Choi, Wilson; Burke, Leslie; Clements, Judith A.			Breast Cancer Cells Induce Osteolytic Bone Lesions In vivo through a Reduction in Osteoblast Activity in Mice	PLOS ONE			English	Article							TRABECULAR BONE; KAPPA-B; ZOLEDRONIC ACID; TUMOR BURDEN; CAUSAL ROLE; NUDE-MICE; METASTASIS; EXPRESSION; OSTEOPROTEGERIN; PATHOGENESIS	Bone metastases are severely debilitating and have a significant impact on the quality of life of women with metastatic breast cancer. Treatment options are limited and in order to develop more targeted therapies, improved understanding of the complex mechanisms that lead to bone lesion development are warranted. Interestingly, whilst prostate-derived bone metastases are characterised by mixed or osteoblastic lesions, breast-derived bone metastases are characterised by osteolytic lesions, suggesting unique regulatory patterns. This study aimed to measure the changes in bone formation and bone resorption activity at two time-points (18 and 36 days) during development of the bone lesion following intratibial injection of MDA-MB-231 human breast cancer cells into the left tibiae of Severely Combined Immuno-Deficient (SCID) mice. The contralateral tibia was used as a control. Tibiae were extracted and processed for undecalcified histomorphometric analysis. We provide evidence that the early bone loss observed following exposure to MDA-MB-231 cells was due to a significant reduction in mineral apposition rate, rather than increased levels of bone resorption. This suggests that osteoblast activity was impaired in the presence of breast cancer cells, contrary to previous reports of osteoclast-dependent bone loss. Furthermore mRNA expression of Dickkopf Homolog 1 (DKK-1) and Noggin were confirmed in the MDA-MB-231 cell line, both of which antagonise osteoblast regulatory pathways. The observed bone loss following injection of cancer cells was due to an overall thinning of the trabecular bone struts rather than perforation of the bone tissue matrix (as measured by trabecular width and trabecular separation, respectively), suggesting an opportunity to reverse the cancer-induced bone changes. These novel insights into the mechanisms through which osteolytic bone lesions develop may be important in the development of new treatment strategies for metastatic breast cancer patients.	[Gregory, Laura S.; Choi, Wilson; Burke, Leslie; Clements, Judith A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Gregory, Laura S.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Skeletal Biol & Forens Anat Res Program, Brisbane, Qld 4001, Australia; [Choi, Wilson; Clements, Judith A.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Gregory, LS (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	l.gregory@qut.edu.au		Burke, Lez/0000-0002-2932-6843; Clements, Judith/0000-0001-6026-1964	Queensland University of Technology	Queensland University of Technology	Internal Queensland University of Technology funding was used to fund the entirety of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare & Cancer Australia, 2012, BREAST CANC AUSTR OV; BARON R, 1984, ANAT REC, V208, P137, DOI 10.1002/ar.1092080114; Bendre MS, 2005, CANCER RES, V65, P11001, DOI 10.1158/0008-5472.CAN-05-2630; Bone HG, 2008, J CLIN ENDOCR METAB, V93, P2149, DOI 10.1210/jc.2007-2814; Brown HK, 2012, CLIN EXP METASTAS, V29, P927, DOI 10.1007/s10585-012-9481-5; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Bussard KM, 2009, J MAMMARY GLAND BIOL, V14, P387, DOI 10.1007/s10911-009-9159-z; Canon J, 2012, BREAST CANCER RES TR, V135, P771, DOI 10.1007/s10549-012-2222-2; Coombs WT, 1996, REV EDUC RES, V66, P137, DOI 10.3102/00346543066002137; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Duivenvoorden WCM, 2007, BRIT J CANCER, V96, P1526, DOI 10.1038/sj.bjc.6603740; Eriksen EF., 1994, BONE HISTOMORPHOMETR; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Gallet M, 2004, BIOCHEM BIOPH RES CO, V319, P690, DOI 10.1016/j.bbrc.2004.05.033; Gordon AH, 2005, CANCER RES, V65, P3209, DOI 10.1158/0008-5472.CAN-04-4017; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hall CL, 2008, PROSTATE, V68, P1396, DOI 10.1002/pros.20805; Hall CL, 2006, CANCER METAST REV, V25, P551, DOI 10.1007/s10555-006-9022-2; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Hussein O, 2011, J CELL COMMUN SIGNAL, V5, P85, DOI 10.1007/s12079-011-0117-3; Hussein O, 2011, BONE, V48, P202, DOI 10.1016/j.bone.2010.09.006; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; LI XJ, 1990, ANAT RECORD, V227, P12, DOI 10.1002/ar.1092270103; Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Morgan H, 2004, INT J CANCER, V109, P653, DOI 10.1002/ijc.20056; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Parfitt AM, 2000, BONE, V26, P319, DOI 10.1016/S8756-3282(00)80937-0; PARFITT AM, 1987, AM J MED, V82, P68, DOI 10.1016/0002-9343(87)90274-9; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Quinn GP, 2003, EXPT DESIGN DATA ANA; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rose AAN, 2010, FUTURE ONCOL, V6, P55, DOI 10.2217/FON.09.138; Sasaki A, 1998, CANCER RES, V58, P462; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; Thai L, 2006, CANCER RES, V66, P5363, DOI 10.1158/0008-5472.CAN-05-4386; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Voorzanger-Rousselot N, 2009, CALCIFIED TISSUE INT, V84, P348, DOI 10.1007/s00223-009-9225-y; Vukmirovic-Popovic S, 2002, BONE, V31, P529, DOI 10.1016/S8756-3282(02)00847-5; Walsh William R., 2003, HDB HISTOLOGY METHOD, P35, DOI DOI 10.1007/978-1-59259-417-7_2; Wardley A, 2005, BRIT J CANCER, V92, P1869, DOI 10.1038/sj.bjc.6602551; Wedin R, 2001, CANCER, V92, P257, DOI 10.1002/1097-0142(20010715)92:2<257::AID-CNCR1317>3.0.CO;2-R; Yin JJ, 2003, P NATL ACAD SCI USA, V100, P10954, DOI 10.1073/pnas.1830978100; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zheng Y, 2007, BONE, V40, P471, DOI 10.1016/j.bone.2006.09.016; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	57	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e68103	10.1371/journal.pone.0068103	http://dx.doi.org/10.1371/journal.pone.0068103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069136	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100003
J	Zhou, Y; Gong, ZY; Yang, ZF; Yuan, Y; Zhu, JY; Wang, M; Yuan, FH; Wu, SJ; Wang, ZQ; Yi, CD; Xu, TH; Ryom, M; Gu, MH; Liang, GH				Zhou, Yong; Gong, Zhiyun; Yang, Zefeng; Yuan, Yuan; Zhu, Jinyan; Wang, Man; Yuan, Fuhai; Wu, Shujun; Wang, Zhiqin; Yi, Chuandeng; Xu, Tinghua; Ryom, MyongChol; Gu, Minghong; Liang, Guohua			Mutation of the Light-Induced Yellow Leaf 1 Gene, Which Encodes a Geranylgeranyl Reductase, Affects Chlorophyll Biosynthesis and Light Sensitivity in Rice	PLOS ONE			English	Article							FUNCTIONAL ASSIGNMENT; ALPHA-TOCOPHEROL; TOBACCO PLANTS; MG-CHELATASE; BCHP GENE; VITAMIN-E; BACTERIOCHLOROPHYLL; ENZYME; STRESS; IDENTIFICATION	Chlorophylls (Chls) are crucial for capturing light energy for photosynthesis. Although several genes responsible for Chl biosynthesis were characterized in rice (Oryza sativa), the genetic properties of the hydrogenating enzyme involved in the final step of Chl synthesis remain unknown. In this study, we characterized a rice light-induced yellow leaf 1-1 (lyl1-1) mutant that is hypersensitive to high-light and defective in the Chl synthesis. Light-shading experiment suggested that the yellowing of lyl1-1 is light-induced. Map-based cloning of LYL1 revealed that it encodes a geranylgeranyl reductase. The mutation of LYL1 led to the majority of Chl molecules are conjugated with an unsaturated geranylgeraniol side chain. LYL1 is the firstly defined gene involved in the reduction step from Chl-geranylgeranylated (Chl(GG)) and geranylgeranyl pyrophosphate (GGPP) to Chl-phytol (Chl(Phy)) and phytyl pyrophosphate (PPP) in rice. LYL1 can be induced by light and suppressed by darkness which is consistent with its potential biological functions. Additionally, the lyl1-1 mutant suffered from severe photooxidative damage and displayed a drastic reduction in the levels of alpha-tocopherol and photosynthetic proteins. We concluded that LYL1 also plays an important role in response to high-light in rice.	[Zhou, Yong; Gong, Zhiyun; Yang, Zefeng; Yuan, Yuan; Wang, Man; Yuan, Fuhai; Wang, Zhiqin; Yi, Chuandeng; Xu, Tinghua; Ryom, MyongChol; Gu, Minghong; Liang, Guohua] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Key Lab, Minist Educ Plant Funct Genom, Yangzhou, Jiangsu, Peoples R China; [Zhu, Jinyan] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China; [Wu, Shujun] Shanghai Acad Agr Sci, Shanghai, Peoples R China	Yangzhou University; Jiangsu Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences	Liang, GH (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Key Lab, Minist Educ Plant Funct Genom, Yangzhou, Jiangsu, Peoples R China.	ricegb@yzu.edu.cn		Yang, Zefeng/0000-0002-3465-8594	State Key Program of Basic Research of China [2013CBA01405, 2010CB125904]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [10KJA210059]; Key Science and Technology Support Program of Jiangsu Province [BE2012309]; Research Fund for the Doctoral Program of Higher Education of China [20103250110004]; Priority Academic Program Development of Jiangsu Higher Education Institutions	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Key Science and Technology Support Program of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by grants from the State Key Program of Basic Research of China (No. 2013CBA01405 and 2010CB125904, http://www.973.gov.cn/), the Natural Science Foundation of Jiangsu Higher Education Institutions of China (10KJA210059, http://www.ec.js.edu.cn/), the Key Science and Technology Support Program of Jiangsu Province (BE2012309, http://www.jstd.gov.cn/), the Research Fund for the Doctoral Program of Higher Education of China (20103250110004, http://www.moe.gov.cn/) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2007, PLANT PHYSIOL, V143, P1720, DOI 10.1104/pp.106.094771; Addlesee HA, 1999, J BACTERIOL, V181, P7248, DOI 10.1128/JB.181.23.7248-7255.1999; Addlesee HA, 1996, FEBS LETT, V389, P126, DOI 10.1016/0014-5793(96)00549-2; Addlesee HA, 2002, J BACTERIOL, V184, P1578, DOI 10.1128/JB.184.6.1578-1586.2002; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; BLOCK MA, 1980, BIOCHIM BIOPHYS ACTA, V631, P210, DOI 10.1016/0304-4165(80)90069-0; BOLLIVAR DW, 1994, BIOCHEMISTRY-US, V33, P12763, DOI 10.1021/bi00209a006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Chew AGM, 2008, J BACTERIOL, V190, P747, DOI 10.1128/JB.01430-07; ELLSWORTH RK, 1974, ANAL BIOCHEM, V57, P534, DOI 10.1016/0003-2697(74)90108-0; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; FRYER MJ, 1992, PLANT CELL ENVIRON, V15, P381, DOI 10.1111/j.1365-3040.1992.tb00988.x; GAUBIER P, 1995, MOL GEN GENET, V249, P58, DOI 10.1007/BF00290236; Giannino D, 2004, J EXP BOT, V55, P2063, DOI 10.1093/jxb/erh217; Grasses T, 2001, PLANTA, V213, P620, DOI 10.1007/s004250100532; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Jensen PE, 1996, MOL GEN GENET, V250, P383; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Maeda H, 2005, PLANT PHYSIOL, V138, P1422, DOI 10.1104/pp.105.061135; Maeda H, 2006, PLANT CELL, V18, P2710, DOI 10.1105/tpc.105.039404; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Morita R, 2005, BREEDING SCI, V55, P361, DOI 10.1270/jsbbs.55.361; Munne-Bosch S, 2002, CRIT REV PLANT SCI, V21, P31, DOI 10.1016/S0735-2689(02)80037-5; Muzzalupo I, 2011, PLANT FOOD HUM NUTR, V66, P1, DOI 10.1007/s11130-011-0208-6; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; NAKAYASHIKI T, 1995, GENE, V153, P67, DOI 10.1016/0378-1119(94)00805-3; Oster U, 1997, J BIOL CHEM, V272, P9671; Panfili G, 2003, J AGR FOOD CHEM, V51, P3940, DOI 10.1021/jf030009v; PONTOPPIDAN B, 1994, EUR J BIOCHEM, V225, P529, DOI 10.1111/j.1432-1033.1994.00529.x; Porra RJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P492, DOI 10.1111/j.1751-1097.1997.tb08596.x; Qin AJ, 2001, AVIAN DIS, V45, P938, DOI 10.2307/1592872; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Schoefs B, 2000, FEBS LETT, V486, P243, DOI 10.1016/S0014-5793(00)02309-7; Shibata M, 2004, PLANT SCI, V166, P593, DOI 10.1016/j.plantsci.2003.10.014; Shpilyov AV, 2013, PLANT J, V73, P336, DOI 10.1111/tpj.12044; Shpilyov AV, 2005, BBA-BIOENERGETICS, V1706, P195, DOI 10.1016/j.bbabio.2004.11.001; Simons B, 2006, J IMMUNOL METHODS, V315, P88, DOI 10.1016/j.jim.2006.07.004; SOLL J, 1981, BIOCHEM BIOPH RES CO, V99, P907, DOI 10.1016/0006-291X(81)91249-3; SOLL J, 1983, PLANT PHYSIOL, V71, P849, DOI 10.1104/pp.71.4.849; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Yang ZP, 2012, BIOCHEM BIOPH RES CO, V418, P565, DOI 10.1016/j.bbrc.2012.01.073; Zhang GY, 2012, TRANSGENIC RES; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	57	15	23	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75299	10.1371/journal.pone.0075299	http://dx.doi.org/10.1371/journal.pone.0075299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058671	Green Submitted, Green Published, gold			2022-12-27	WOS:000327538600134
J	Dhalwani, NN; Tata, LJ; Coleman, T; Fleming, KM; Szatkowski, L				Dhalwani, Nafeesa N.; Tata, Laila J.; Coleman, Tim; Fleming, Kate M.; Szatkowski, Lisa			Completeness of Maternal Smoking Status Recording during Pregnancy in United Kingdom Primary Care Data	PLOS ONE			English	Article							ASTHMA; IMPACT	Background: Given the health impacts of smoking during pregnancy and the opportunity for primary healthcare teams to encourage pregnant smokers to quit, our primary aim was to assess the completeness of gestational smoking status recording in primary care data and investigate whether completeness varied with women's characteristics. As a secondary aim we assessed whether completeness of recording varied before and after the introduction of the Quality and Outcomes Framework (QOF). Methods: In The Health Improvement Network (THIN) database we calculated the proportion of pregnancies ending in live births or stillbirths where there was a recording of maternal smoking status for each year from 2000 to 2009. Logistic regression was used to assess variation in the completeness of maternal smoking recording by maternal characteristics, before and after the introduction of QOF. Results: Women had a record of smoking status during the gestational period in 28% of the 277,552 pregnancies identified. In 2000, smoking status was recorded in 9% of pregnancies, rising to 43% in 2009. Pregnant women from the most deprived group were 17% more likely to have their smoking status recorded than pregnant women from the least deprived group before QOF implementation (OR 1.17, 95% CI 1.10-1.25) and 42% more likely afterwards (OR 1.42, 95% CI 1.37-1.47). A diagnosis of asthma was related to recording of smoking status during pregnancy in both the pre-QOF (OR 1.63, 95% CI 1.53-1.74) and post-QOF periods (OR 2.08, 95% CI 2.02-2.15). There was no association between having a diagnosis of diabetes and recording of smoking status during pregnancy pre-QOF however, post-QOF diagnosis of diabetes was associated with a 12% increase in recording of smoking status (OR 1.12, 95% CI 1.05-1.19). Conclusion: Recording of smoking status during pregnancy in primary care data is incomplete though has improved over time, especially after the implementation of the QOF, and varies by maternal characteristics and QOF-incentivised morbidities.	[Dhalwani, Nafeesa N.; Tata, Laila J.; Fleming, Kate M.; Szatkowski, Lisa] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Dhalwani, Nafeesa N.; Coleman, Tim] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Dhalwani, NN (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	nafeesa.dhalwani@nottingham.ac.uk	Fleming, Kate M/A-6475-2010; Dhalwani, Nafeesa/F-3443-2015; Greiver, Michelle/N-8764-2015; Tata, Laila/J-5227-2012	Fleming, Kate M/0000-0002-6572-5016; Dhalwani, Nafeesa/0000-0003-3204-1328; Greiver, Michelle/0000-0001-8957-0285; Szatkowski, Lisa/0000-0003-3295-5891; Tata, Laila/0000-0002-6404-8658; Coleman, Tim/0000-0002-7303-4805	University of Nottingham International Research Excellence Scholarship; National Institute for Health Research (NIHR) [RP-PG 0109-10020]; British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council; UK Clinical Research Collaboration; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish; National Institute for Health Research [RP-PG-0109-10020] Funding Source: researchfish	University of Nottingham International Research Excellence Scholarship; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council; UK Clinical Research Collaboration; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	NND is supported by a University of Nottingham International Research Excellence Scholarship and the National Institute for Health Research (NIHR). This article presents independent research funded by the NIHR under its Programme Grants for Applied Research Programme (reference RP-PG 0109-10020). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. NND, TC and LS are members of the UK Centre for Tobacco Control Studies (UKCTCS), a UKCRC Public Health Research Centre of Excellence. The UKCTCS receives core funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council and the Department of Health under auspices of the UK Clinical Research Collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauld L, 2007, EXPLORING REDUCTIONS; Coleman T, 2007, ADDICTION, V102, P803, DOI 10.1111/j.1360-0443.2007.01766.x; CSD Medical Research UK, 2011, THIN DAT GUID RES; Department of Health, 1998, SMOK KILLS; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Gillam S, 2011, QUALITY OUTCOMES FRA; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Langley TE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-773; Langley TE, 2011, ADDICTION, V106, P1319, DOI 10.1111/j.1360-0443.2011.03426.x; Lindley AA, 2000, AM J EPIDEMIOL, V152, P219, DOI 10.1093/aje/152.3.219; MANT D, 1986, BRIT MED J, V292, P102, DOI 10.1136/bmj.292.6513.102; Mant J, 2000, J PUBLIC HEALTH MED, V22, P198, DOI 10.1093/pubmed/22.2.198; McCowan LME, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1081; National Collaborating Centre for Women's and Children's Health, 2010, HYP PREGN MAN HYP DI; National Collaborating Centre for Women's and Children's Health (UK), 2008, DIAB PREGN MAN DIAB; National Health Service Information Centre - QOF Business Rules team, 2011, NEW GMS CONTR QOF IM; National Institute for Health and Clinical Excellence, 2012, QUAL STAND ANT CAR Q; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; National Institute for Health and Clinical Excellence, 2012, REFERRAL PATHWAY PRE; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN DUR PREGN; National Institute for Health and Clinical Excellence, 2010, ANT CAR; National Institute for Health and Clinical Excellence, 2010, PH26 QUITT SMOK PREG; Nelson-Piercy C, 2001, THORAX, V56, P325, DOI 10.1136/thorax.56.4.325; Pickett KE, 2003, OBSTET GYNECOL, V101, P140, DOI 10.1016/S0029-7844(02)02370-0; Redshaw M., 2010, DELIVERED CARE NATL; Royal College of Obstetricians and Gynaecologists, 2008, STAND MAT CAR REP WO; Simon C, 2008, INNOVAIT, V1, P206; Smith A., 2010, ROLE GPS MATERNITY C; StataCorp, 2009, STAT REL 11 STAT SOF; Szatkowski L, 2012, J EPIDEMIOL COMMUN H, V66, P791, DOI 10.1136/jech.2010.120154; Taggar JS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-329; Tata LJ, 2007, AM J EPIDEMIOL, V165, P1023, DOI 10.1093/aje/kwk092; The Information Centre, 2006, STAT NHS STOP SMOK S; The NHS Information Centre IFF Research, 2011, INF FEED SURV 2010 E; Townsend PP., 1988, HLTH DEPRIVATION INE; Ward P, 2007, BR J PRIM CARE NURS, V1, P129; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wilson A, 2000, BRIT J GEN PRACT, V50, P465	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e72218	10.1371/journal.pone.0072218	http://dx.doi.org/10.1371/journal.pone.0072218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069143	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000324777300005
J	Hebden, L; Kostan, E; O'Leary, F; Hodge, A; Allman-Farinelli, M				Hebden, Lana; Kostan, Engracia; O'Leary, Fiona; Hodge, Allison; Allman-Farinelli, Margaret			Validity and Reproducibility of a Food Frequency Questionnaire as a Measure of Recent Dietary Intake in Young Adults	PLOS ONE			English	Article							VALIDATION; AGREEMENT; HABITS; AGE	This research assessed the relative validity and reproducibility of the Dietary Questionnaire for Epidemiological Studies (DQESV2) over one month in young adults, given the lack of concise and convenient instruments for assessing recent dietary intake in this population. Participants were recruited from a large Australian university (N = 102; 35% male; age 18-34 years; body mass index 16-37 kg/m(2)). Five one-day weighed food records (WFR) were administered over one month followed by the DQESV2. Estimates for nutrients (energy, protein, total fat, saturated fat, carbohydrate, sugars, dietary fibre, and alcohol) and fruit and vegetable servings were compared between methods using correlation coefficients, 95% limits of agreement, and quintile classifications. One week later, a second DQESV2 was completed by n = 77 of the participants to assess reproducibility using intra-class correlations (ICC) and weighted kappa. Comparing methods, all nutrients and fruit and vegetable servings showed significant positive correlations (P<0.05) except protein intake in males; over 60% of participants were within one quintile classification except total fat and dietary fibre intakes in males (55% and 56%, respectively); and differences in nutrient and food intakes between methods were all within +/-20% of the mean WFR values except alcohol intake in females. Between first and second administrations of the DQESV2 all ICC coefficients were positive (P<0.01) and weighted kappa coefficients ranged from 0.54 for fruit servings (including fruit juice) in males to 0.91 for protein intake in females. Over a one month period, the DQESV2 demonstrated good reproducibility for the studied nutrients and for fruit and vegetable servings and provided a valid measure of the studied nutrients, except alcohol in females, and of fruit servings (including fruit juice) in both genders, at the group level in this young adult population.	[Hebden, Lana; Kostan, Engracia; O'Leary, Fiona; Allman-Farinelli, Margaret] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Hodge, Allison] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia	University of Sydney; Cancer Council Victoria	Hebden, L (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	lana.hebden@sydney.edu.au	O'Leary, Fiona/ABG-9370-2020	O'Leary, Fiona/0000-0002-4024-0055; Hodge, Allison/0000-0001-5464-2197				Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Cashel K, 1994, CORE FOOD GROUPS SCI; Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478; Food Standards Australia New Zealand, 2008, AUSNUT 2007 MEAS DAT; Food Standards Australia New Zealand,, 2011, NUTTAB 2010AUSTRALIA; Giles GG, 1996, DIETARY QUESTIONNAIR; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P567; Ibiebele TI, 2009, PUBLIC HEALTH NUTR, V12, P2359, DOI 10.1017/S1368980009005023; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Kimmons Joel, 2009, Medscape J Med, V11, P26; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marks GC, 2006, J NUTR, V136, P459, DOI 10.1093/jn/136.2.459; McLennan W, 1999, NATL NUTR SURVEY SEL; National Health and Medical Research Council, 2013, ED GUID; Pedisic Z, 2008, COLLEGIUM ANTROPOL, V32, P1069; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Rosalind SG, 2005, PRINCIPLES NUTR ASSE, P149; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Woods RK, 2002, ASIA PAC J CLIN NUTR, V11, P56, DOI 10.1046/j.1440-6047.2002.00273.x; Xinying PX, 2004, ASIA PAC J CLIN NUTR, V13, P318	27	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75156	10.1371/journal.pone.0075156	http://dx.doi.org/10.1371/journal.pone.0075156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058660	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900097
J	Ingram, WM; Goodrich, LM; Robey, EA; Eisen, MB				Ingram, Wendy Marie; Goodrich, Leeanne M.; Robey, Ellen A.; Eisen, Michael B.			Mice Infected with Low-Virulence Strains of Toxoplasma gondii Lose Their Innate Aversion to Cat Urine, Even after Extensive Parasite Clearance	PLOS ONE			English	Article							BEHAVIOR; RECOMBINATION; MIGRATION; LINEAGES; IMMUNITY	Toxoplasma gondii chronic infection in rodent secondary hosts has been reported to lead to a loss of innate, hard-wired fear toward cats, its primary host. However the generality of this response across T. gondii strains and the underlying mechanism for this pathogen-mediated behavioral change remain unknown. To begin exploring these questions, we evaluated the effects of infection with two previously uninvestigated isolates from the three major North American clonal lineages of T. gondii, Type III and an attenuated strain of Type I. Using an hour-long open field activity assay optimized for this purpose, we measured mouse aversion toward predator and non-predator urines. We show that loss of innate aversion of cat urine is a general trait caused by infection with any of the three major clonal lineages of parasite. Surprisingly, we found that infection with the attenuated Type I parasite results in sustained loss of aversion at times post infection when neither parasite nor ongoing brain inflammation were detectable. This suggests that T. gondii-mediated interruption of mouse innate aversion toward cat urine may occur during early acute infection in a permanent manner, not requiring persistence of parasite cysts or continuing brain inflammation.	[Ingram, Wendy Marie; Goodrich, Leeanne M.; Robey, Ellen A.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	erobey@berkeley.edu; mbeisen@lbl.gov		Eisen, Michael/0000-0002-7528-738X; Ingram, Wendy/0000-0002-1643-3367	NIH [R01AI065537, R01AI093132]; HHMI; NSF; Genentech Scholars Program award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093132, R01AI065537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); Genentech Scholars Program award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01AI065537 and R01AI093132 awarded to E. A. R., an HHMI investigator award to M. B. E, an NSF graduate research fellowship to W. M. I., and a Genentech Scholars Program award to L. M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; DUBEY JP, 1976, J PROTOZOOL, V23, P537, DOI 10.1111/j.1550-7408.1976.tb03836.x; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gatkowska J, 2012, PARASITOL RES, V111, P53, DOI 10.1007/s00436-011-2800-y; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Gulinello M, 2010, MICROBES INFECT, V12, P528, DOI 10.1016/j.micinf.2010.03.009; Haroon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035516; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hoarau JJ, 2011, CNS NEUROL DISORD-DR, V10, P25, DOI 10.2174/187152711794488601; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; HUTCHISON WM, 1965, NATURE, V206, P961, DOI 10.1038/206961a0; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Kirisits MJ, 2000, INT J PARASITOL, V30, P149, DOI 10.1016/S0020-7519(00)00009-6; Koshy AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002825; Koshy AA, 2010, NAT METHODS, V7, P307, DOI [10.1038/nmeth.1438, 10.1038/NMETH.1438]; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; Mitra R, 2013, DIS MODEL MECH, V6, P516, DOI 10.1242/dmm.009928; PARKER SJ, 1991, CLIN EXP IMMUNOL, V84, P207, DOI 10.1111/j.1365-2249.1991.tb08150.x; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Reese ML, 2011, J BIOL CHEM, V286, P29366, DOI 10.1074/jbc.M111.253435; ROBERTS CW, 1995, INFECT IMMUN, V63, P2549, DOI 10.1128/IAI.63.7.2549-2555.1995; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Schneider AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060215; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; SUZUKI Y, 1994, PARASITOL RES, V80, P125, DOI 10.1007/BF00933779; SUZUKI Y, 1993, INFECT IMMUN, V61, P2284, DOI 10.1128/IAI.61.6.2284-2288.1993; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Truppel JH, 2010, PARASITOL RES, V107, P141, DOI 10.1007/s00436-010-1848-4; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104	39	92	95	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75246	10.1371/journal.pone.0075246	http://dx.doi.org/10.1371/journal.pone.0075246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058668	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900103
J	Miyajima, M; Nakajima, M; Motoi, Y; Moriya, M; Sugano, H; Ogino, I; Nakamura, E; Tada, N; Kunichika, M; Arai, H				Miyajima, Masakazu; Nakajima, Madoka; Motoi, Yumiko; Moriya, Masao; Sugano, Hidenori; Ogino, Ikuko; Nakamura, Eri; Tada, Norihiro; Kunichika, Miyuki; Arai, Hajime			Leucine-Rich alpha 2-Glycoprotein Is a Novel Biomarker of Neurodegenerative Disease in Human Cerebrospinal Fluid and Causes Neurodegeneration in Mouse Cerebral Cortex	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; COMMON LRRK2 MUTATION; ALPHA-2 GLYCOPROTEIN; ALZHEIMERS-DISEASE; ANIMAL-MODEL; EXPRESSION; INFLAMMATION; GENE; IDENTIFICATION; DIAGNOSIS	Leucine-rich alpha 2-glycoprotein (LRG) is a protein induced by inflammation. It contains a leucine-rich repeat (LRR) structure and easily binds with other molecules. However, the function of LRG in the brain during aging and neurodegenerative diseases has not been investigated. Here, we measured human LRG (hLRG) concentration in the cerebrospinal fluid (CSF) and observed hLRG expression in post-mortem human cerebral cortex. We then generated transgenic (Tg) mice that over-expressed mouse LRG (mLRG) in the brain to examine the effects of mLRG accumulation. Finally, we examined protein-protein interactions using a protein microarray method to screen proteins with a high affinity for hLRG. The CSF concentration of hLRG increases with age and is significantly higher in patients with Parkinson's disease with dementia (PDD) and progressive supranuclear palsy (PSP) than in healthy elderly people, idiopathic normal pressure hydrocephalus (iNPH) patients, and individuals with Alzheimer's disease (AD). Tg mice exhibited neuronal degeneration and neuronal decline. Accumulation of LRG in the brains of PDD and PSP patients is not a primary etiological factor, but it is thought to be one of the causes of neurodegeneration. It is anticipated that hLRG CSF levels will be a useful biomarker for the early diagnosis of PDD and PSP.	[Miyajima, Masakazu; Nakajima, Madoka; Moriya, Masao; Sugano, Hidenori; Ogino, Ikuko; Arai, Hajime] Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Motoi, Yumiko] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Nakamura, Eri; Tada, Norihiro] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Lab Genome Res, Tokyo, Japan; [Kunichika, Miyuki] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Miyajima, M (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan.	mmasaka@juntendo.ac.jp	Nakajima, Madoka/AAU-6505-2021	Sugano, Hidenori/0000-0002-7836-6585	Ministry of Health, Labour [23592106, 23592142]; Welfare of Japan	Ministry of Health, Labour; Welfare of Japan	This work was partly supported by Grants-in-Aid for Scientific Research (KAKENHI 23592106, 23592142). MN is funded by a Grant-in-Aid for Scientific Research (KAKENHI 23592106). M. Miyajima is funded by a Grant-in-Aid for Scientific Research (KAKENHI 23592142). HA is funded by a Research Grant from the Ministry of Health, Labour, and Welfare of Japan (2012-Nanchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Di Fonzo A, 2005, LANCET, V365, P412; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kang JH, 2013, CLIN CHEM, V59, P903, DOI 10.1373/clinchem.2013.202937; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koivisto AM, 2013, NEUROSURGERY, V72, P1, DOI 10.1227/NEU.0b013e31827414b3; Lantos PL, 2000, J NEUROL NEUROSUR PS, V69, P705; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Li X, 2006, ACTA NEUROCHIR, V148, P859, DOI 10.1007/s00701-006-0787-4; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Mutez E, 2011, NEUROBIOL AGING, V32, P1839, DOI 10.1016/j.neurobiolaging.2009.10.016; Nakajima M, 2012, ACTA NEUROCHIR SUPPL, V113, P97, DOI 10.1007/978-3-7091-0923-6_20; Nakajima M, 2011, ACTA NEUROCHIR, V153, P1339, DOI 10.1007/s00701-011-0963-z; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Toft M, 2005, LANCET, V365, P1229, DOI 10.1016/S0140-6736(05)74809-1; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Yan Q, 2003, J NEUROSCI, V23, P7504; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74453	10.1371/journal.pone.0074453	http://dx.doi.org/10.1371/journal.pone.0074453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058569	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900044
J	Zhang, XJ; Zhu, HX; Wu, XM; Wang, ML; Gu, DY; Gong, WD; Xu, Z; Tan, YF; Gong, YL; Zhou, JW; Tang, CJ; Tong, N; Chen, JF; Zhang, ZD				Zhang, Xiaojing; Zhu, Haixia; Wu, Xiaomin; Wang, Meilin; Gu, Dongying; Gong, Weida; Xu, Zhi; Tan, Yongfei; Gong, Yongling; Zhou, Jianwei; Tang, Cuiju; Tong, Na; Chen, Jinfei; Zhang, Zhengdong			A Genetic Polymorphism in TOX3 Is Associated with Survival of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							BREAST-CANCER; ESTROGEN-RECEPTOR; RISK; SUSCEPTIBILITY; TRANSCRIPTION; CHEMOTHERAPY; VARIANTS	Purpose: Recently, genetic polymorphism (rs3803662C>T) in TOX3 was reported to induce the risk of breast cancer. In this study, we hypothesized that rs3803662 could influence gastric cancer survival outcomes. Methods: With multiplex SNaPshot method, we genotyped TOX3 rs3803662 in 880 gastric patients with surgical resection. The association between genotype and survival outcomes was performed by the Kaplan-Meier method, Cox regression analysis models and the log-rank test. Results: There was no association in the analyses of rs3803662 and survival of gastric cancer. However, the stratified analysis by histology showed that rs3803662 CT/TT genotype was associated with a significantly better survival for diffuse-type gastric cancer (log-rank p = 0.030, hazard ratio [HR] = 0.67, 95% confidence interval [CI] = 0.46-0.96), than the CC genotype. In addition, this favorable effect was especially obvious among gastric cancer patients with tumor size >5 cm, T3 and T4 depth of invasion, lymph node metastasis, no drinking, no distant metastasis, no chemotherapy and gastric cardia cancer. Conclusions: TOX3 rs3803662 might play an important role in the prognostic outcome and treatment of gastric cancer, especially perhaps further help in explaining the reduced risk of death associated with diffuse-type gastric cancer.	[Zhang, Xiaojing; Wu, Xiaomin; Gu, Dongying; Xu, Zhi; Gong, Yongling; Tang, Cuiju; Chen, Jinfei] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Haixia] Nantong Canc Hosp, Core Lab, Nantong, Peoples R China; [Wang, Meilin; Tong, Na; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China; [Gong, Weida; Tan, Yongfei] Yixing Canc Hosp, Dept Surg, Yixing, Peoples R China; [Zhou, Jianwei] Nanjing Med Univ, Dept Mol Cell Biol & Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaojing; Zhang, Zhengdong] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China; [Wu, Xiaomin] Yancheng 1 Peoples Hosp, Dept Oncol, Yancheng, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Zhejiang Cancer Hospital	Chen, JF (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	jinfeichen@sohu.com; drzdzhang@gmail.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81071641, 81000880]; National Basic Science Research Program [2013CB911300]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project [81001274, 30972444, 81230068, BK2010080, 81102089, BK2011773]; Qin Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Research Program(National Basic Research Program of China); Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Qin Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	The work was supported by grants from National Natural Science Foundation of China to Dr. J Chen (Grant No. 81071641), Dr. Z Xu (Grant No. 81000880); a grant from National Basic Science Research Program to Dr. J Chen (2013CB911300); a grant from Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project to Dr. J Chen, Dr. H. Zhu (Grant No. 81001274), Dr. Z Zhang (30972444, 81230068 and BK2010080), Dr. M. Wang (81102089 and BK2011773), the Qin Lan Project of Jiangsu Provincial Department of Education, and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Chen XZ, 2008, WORLD J GASTROENTERO, V14, P2715, DOI 10.3748/wjg.14.2715; Choi IK, 2012, CANCER CHEMOTH PHARM, V70, P555, DOI 10.1007/s00280-012-1944-5; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Fasching PA, 2012, HUM MOL GENET, V21, P3926, DOI 10.1093/hmg/dds159; Gudmundsdottir ET, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-621; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Kushi LH, 2006, CA-CANCER J CLIN, V56, P254, DOI 10.3322/canjclin.56.5.254; Liu L, 2011, J THORAC ONCOL, V6, P1793, DOI 10.1097/JTO.0b013e3182272273; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Meyer HJ, 2011, DTSCH ARZTEBL INT, V108, P698, DOI 10.3238/arztebl.2011.0698; Riaz M, 2011, BREAST CANC RES TREA; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016; Wang ML, 2011, INT J CANCER, V129, P1207, DOI 10.1002/ijc.25740; Wang W, 2012, ONCOL REP, V27, P1953, DOI 10.3892/or.2012.1727; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Xiao HW, 2011, BONE MARROW TRANSPL, V46, P400, DOI 10.1038/bmt.2010.135; Xu CY, 2010, ANN SURG ONCOL, V17, P2503, DOI 10.1245/s10434-010-1031-2; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zhao QH, 2011, CANCER SCI, V102, P1293, DOI 10.1111/j.1349-7006.2011.01959.x	22	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e72186	10.1371/journal.pone.0072186	http://dx.doi.org/10.1371/journal.pone.0072186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069142	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300002
J	Aguirre-Gamboa, R; Gomez-Rueda, H; Martinez-Ledesma, E; Martinez-Torteya, A; Chacolla-Huaringa, R; Rodriguez-Barrientos, A; Tamez-Pena, JG; Trevino, V				Aguirre-Gamboa, Raul; Gomez-Rueda, Hugo; Martinez-Ledesma, Emmanuel; Martinez-Torteya, Antonio; Chacolla-Huaringa, Rafael; Rodriguez-Barrientos, Alberto; Tamez-Pena, Jose G.; Trevino, Victor			SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis	PLOS ONE			English	Article							SIGNATURES; CELL; RECURRENCE; SUBTYPES	Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for cancer prognosis. An important source of information for virtual validation is the high number of available cancer datasets. Nevertheless, assessing the prognostic performance of a gene expression signature along datasets is a difficult task for Biologists and Physicians and also time-consuming for Statisticians and Bioinformaticians. Therefore, to facilitate performance comparisons and validations of survival biomarkers for cancer outcomes, we developed SurvExpress, a cancer-wide gene expression database with clinical outcomes and a web-based tool that provides survival analysis and risk assessment of cancer datasets. The main input of SurvExpress is only the biomarker gene list. We generated a cancer database collecting more than 20,000 samples and 130 datasets with censored clinical information covering tumors over 20 tissues. We implemented a web interface to perform biomarker validation and comparisons in this database, where a multivariate survival analysis can be accomplished in about one minute. We show the utility and simplicity of SurvExpress in two biomarker applications for breast and lung cancer. Compared to other tools, SurvExpress is the largest, most versatile, and quickest free tool available. SurvExpress web can be accessed in http://bioinformatica.mty.itesm.mx/SurvExpress (a tutorial is included). The website was implemented in JSP, JavaScript, MySQL, and R.	[Aguirre-Gamboa, Raul; Gomez-Rueda, Hugo; Martinez-Ledesma, Emmanuel; Martinez-Torteya, Antonio; Chacolla-Huaringa, Rafael; Rodriguez-Barrientos, Alberto; Tamez-Pena, Jose G.; Trevino, Victor] Tecnol Monterrey, Catedra Bioinformat, Monterrey, Nuevo Leon, Mexico	Tecnologico de Monterrey	Trevino, V (corresponding author), Tecnol Monterrey, Catedra Bioinformat, Monterrey, Nuevo Leon, Mexico.	vtrevino@itesm.mx	Tamez-Pena, Jose/B-1845-2009; Martinez Ledesma, Juan Emmanuel/A-5061-2015; Trevino, Victor/C-9219-2009	Tamez-Pena, Jose/0000-0003-1361-5162; Trevino, Victor/0000-0002-7472-9844; Martinez Ledesma, Juan Emmanuel/0000-0003-1191-7917; Chacolla, Rafael Julian/0000-0002-6730-7643	Catedra de Bioinformatica at ITESM (Tecnologico de Monterrey) [CAT220]; CONACyT [83929, 140601]	Catedra de Bioinformatica at ITESM (Tecnologico de Monterrey); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors are thankful for the financial support from Catedra de Bioinformatica CAT220 at ITESM (Tecnologico de Monterrey) and CONACyT grants 83929 and 140601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boutros PC, 2009, PROGNOSTIC GENE SIGN; Bovelstad HM, 2011, BIOMETRICAL J, V53, P202, DOI 10.1002/bimj.201000048; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Collett, 1993, MODELLING SURVIVAL D; Corradi L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S10; Elfilali A, 2006, NUCLEIC ACIDS RES, V34, pD613, DOI 10.1093/nar/gkj022; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jezequel P, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas060; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	27	524	529	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74250	10.1371/journal.pone.0074250	http://dx.doi.org/10.1371/journal.pone.0074250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066126	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000108
J	Facchini, A; Mocenni, C				Facchini, Angelo; Mocenni, Chiara			Recurrence Methods for the Identification of Morphogenetic Patterns	PLOS ONE			English	Article							SYSTEMS; QUANTIFICATION; PLOTS	This paper addresses the problem of identifying the parameters involved in the formation of spatial patterns in nonlinear two dimensional systems. To this aim, we perform numerical experiments on a prototypical model generating morphogenetic Turing patterns, by changing both the spatial frequency and shape of the patterns. The features of the patterns and their relationship with the model parameters are characterized by means of the Generalized Recurrence Quantification measures. We show that the recurrence measures Determinism and Recurrence Entropy, as well as the distribution of the line lengths, allow for a full characterization of the patterns in terms of power law decay with respect to the parameters involved in the determination of their spatial frequency and shape. A comparison with the standard two dimensional Fourier transform is performed and the results show a better performance of the recurrence indicators in identifying a reliable connection with the spatial frequency of the patterns. Finally, in order to evaluate the robustness of the estimation of the power low decay, extensive simulations have been performed by adding different levels of noise to the patterns.	[Facchini, Angelo] Enel Fdn, Rome, Italy; [Mocenni, Chiara] Univ Siena, Dept Informat Engn & Math Sci, I-53100 Siena, Italy	ENEL SpA; University of Siena	Mocenni, C (corresponding author), Univ Siena, Dept Informat Engn & Math Sci, Via Laterina 8, I-53100 Siena, Italy.	mocenni@dii.unisi.it	Mocenni, Chiara/X-4424-2019; Mocenni, Chiara/AAU-5018-2021	Mocenni, Chiara/0000-0002-1259-6003; FACCHINI, Angelo/0000-0003-2652-5238	European Project AWARE, Seventh Framework Programme [226456]	European Project AWARE, Seventh Framework Programme	The study is supported by the European Project AWARE, Project N. 226456, Seventh Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard J, 1981, PHYS LETT A, V93, P363; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Epstein S, 2006, PNAS, V103, P15727; Facchini A, 2009, PHYS LETT A, V373, P4266, DOI 10.1016/j.physleta.2009.09.049; Facchini A, 2009, PHYSICA D, V238, P162, DOI 10.1016/j.physd.2008.09.013; Guo LZ, 2007, IEEE T AUTOMAT CONTR, V52, P622, DOI 10.1109/TAC.2007.894513; KAC M, 1947, B AM MATH SOC, V53, P1002, DOI 10.1090/S0002-9904-1947-08927-8; Marcos-Nikolaus P, 2002, INT J BIFURCAT CHAOS, V12, P369, DOI 10.1142/S0218127402004371; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2007, PHYS LETT A, V360, P545, DOI 10.1016/j.physleta.2006.08.058; Mocenni C, 2011, MATH COMPUT MODEL, V53, P1535, DOI 10.1016/j.mcm.2010.04.008; Mocenni C, 2010, P NATL ACAD SCI USA, V107, P8097, DOI 10.1073/pnas.0910414107; Murray, 2002, MATH BIOL I INTRO IN; Poincare JH, 1890, ACTA MATH-DJURSHOLM, V13, P1; Trulla LL, 1996, PHYS LETT A, V223, P255, DOI 10.1016/S0375-9601(96)00741-4; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5	18	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73686	10.1371/journal.pone.0073686	http://dx.doi.org/10.1371/journal.pone.0073686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066062	gold, Green Published			2022-12-27	WOS:000324494000044
J	Higginbotham, SJ; Arnold, AE; Ibanez, A; Spadafora, C; Coley, PD; Kursar, TA				Higginbotham, Sarah J.; Arnold, A. Elizabeth; Ibanez, Alicia; Spadafora, Carmenza; Coley, Phyllis D.; Kursar, Thomas A.			Bioactivity of Fungal Endophytes as a Function of Endophyte Taxonomy and the Taxonomy and Distribution of Their Host Plants	PLOS ONE			English	Article							NATURAL-PRODUCTS; TRYPANOSOMA-CRUZI; TROPICAL FOREST; DRUG DISCOVERY; DIVERSITY; COLONIZATION; METABOLITES; HERBIVORY; LEAVES; SP.	Fungal endophytes - fungi that grow within plant tissues without causing immediate signs of disease - are abundant and diverse producers of bioactive secondary metabolites. Endophytes associated with leaves of tropical plants are an especially exciting and relatively untapped source of novel compounds. However, one major challenge in drug discovery lies in developing strategies to efficiently recover highly bioactive strains. As part of a 15-year drug discovery project, foliar endophytes were isolated from 3198 plant samples (51 orders, 105 families and at least 232 genera of angiosperms and ferns) collected in nine geographically distinct regions of Panama. Extracts from culture supernatants of >2700 isolates were tested for bioactivity (in vitro percent inhibition of growth, % IG) against a human breast cancer cell line (MCF-7) and the causative agents of malaria, leishmaniasis, and Chagas' disease. Overall, 32.7% of endophyte isolates were highly active in at least one bioassay, including representatives of diverse fungal lineages, host lineages, and collection sites. Up to 17% of isolates tested per assay were highly active. Most bioactive strains were active in only one assay. Fungal lineages differed in the incidence and degree of bioactivity, as did fungi from particular plant taxa, and greater bioactivity was observed in endophytes isolated from plants in cloud forests vs. lowland forests. Our results suggest that using host taxonomy and forest type to tailor plant collections, and selecting endophytes from specific orders or families for cultivation, will markedly increase the efficiency and efficacy of discovering bioactive metabolites for particular pharmaceutical targets.	[Higginbotham, Sarah J.; Ibanez, Alicia; Coley, Phyllis D.; Kursar, Thomas A.] Smithsonian Trop Res Inst, Panama City, Panama; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Coley, Phyllis D.; Kursar, Thomas A.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Spadafora, Carmenza] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Arizona; Utah System of Higher Education; University of Utah; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP)	Higginbotham, SJ (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	higginbothams@si.edu	Trilety, Roman/I-8225-2014; Spadafora, Carmenza/ABE-8973-2020	Trilety, Roman/0000-0002-3778-0368; Spadafora, Carmenza/0000-0002-3002-9467	International Cooperative Biodiversity Groups program [2 U01 TW006634-06]; College of Agriculture and Life Sciences at the University of Arizona; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	International Cooperative Biodiversity Groups program; College of Agriculture and Life Sciences at the University of Arizona; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the International Cooperative Biodiversity Groups program (ICBG-Panama http://www.icbg.org/, grant number 2 U01 TW006634-06) and the College of Agriculture and Life Sciences at the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanza A., 2011, Current Trends in Biotechnology and Pharmacy, V5, P1130; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2002, BIODIVERS CONSERV, V11, P1663, DOI 10.1023/A:1016888000369; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Bennani YL, 2012, DRUG DISCOV TODAY, V17, pS31, DOI 10.1016/j.drudis.2011.12.007; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Calderon AI, 2012, PHARM BIOL, V50, P61, DOI 10.3109/13880209.2011.602417; Campos FF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000348; Carter GT, 2011, NAT PROD REP, V28, P1783, DOI 10.1039/c1np00033k; Chirac P, 2004, NATURE, V431, P629, DOI 10.1038/431629a; COLEY PD, 1993, ECOLOGY, V74, P619, DOI 10.2307/1939322; Coley PD, 2008, DAEDALUS-US, V137, P92, DOI 10.1162/daed.2008.137.1.92; Cota BB, 2008, FEMS MICROBIOL LETT, V285, P177, DOI 10.1111/j.1574-6968.2008.01221.x; Cubilla-Rios L, 2008, PLANTA MED, V74, P963; Cui JL, 2011, PHYTOTHER RES, V25, P1189, DOI 10.1002/ptr.3361; Demain AL, 2011, MICROB BIOTECHNOL, V4, P687, DOI 10.1111/j.1751-7915.2010.00221.x; Donadio S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/ja.2010.62; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fenwick A, 2012, PUBLIC HEALTH, V126, P233, DOI 10.1016/j.puhe.2011.11.015; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; Gallup JL, 2000, AM J AGR ECON, V82, P731, DOI 10.1111/0002-9092.00071; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; Higgins KL, 2011, MYCOLOGIA, V103, P247, DOI 10.3852/09-158; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; Hubbard M, 2012, BOTANY, V90, P137, DOI [10.1139/b11-091, 10.1139/B11-091]; Kaczorowski GJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00078; Kingston DGI, 2011, J NAT PROD, V74, P496, DOI 10.1021/np100550t; Knight V, 2003, APPL MICROBIOL BIOT, V62, P446, DOI 10.1007/s00253-003-1381-9; Kursar TA, 2006, BIOSCIENCE, V56, P1005, DOI 10.1641/0006-3568(2006)56[1005:SEBAPC]2.0.CO;2; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Maddison WP, 2011, MESQUITE MODULAR SYS; Martinez-Luis S, 2008, PLANTA MED, V74, P1047; Molinar E, 2012, TETRAHEDRON LETT, V53, P919, DOI 10.1016/j.tetlet.2011.12.021; Molinar-Toribio E, 2006, PHARM BIOL, V44, P550, DOI 10.1080/13880200600885234; Moreno C, 2011, NAT PROD COMMUN, V6, P835; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Ren AZ, 2011, INT J PHYTOREMEDIAT, V13, P233, DOI 10.1080/15226511003671387; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; Shute P. G., 1963, Archives Roumaines de Pathologie Experimentale et de Microbiologie, V22, P887; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2002, CRIT REV BIOTECHNOL, V22, P315, DOI 10.1080/07388550290789531; Sullivan TJ, 2007, NEW PHYTOL, V176, P673, DOI 10.1111/j.1469-8137.2007.02201.x; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Varughese T, 2012, TETRAHEDRON LETT, V53, P1624, DOI 10.1016/j.tetlet.2012.01.076; Wang XN, 2011, J NAT PROD, V74, P2052, DOI 10.1021/np2000864; Wiyakrutta S, 2004, WORLD J MICROB BIOT, V20, P265, DOI 10.1023/B:WIBI.0000023832.27679.a8; World Health Organization, GLOB HLTH OBS GHO CA; Xu J, 2010, FUNGAL DIVERS, V44, P15, DOI 10.1007/s13225-010-0055-z; Yan X, 2011, AFR J BIOTECHNOL, V10, P15117, DOI 10.5897/AJB11.228; Zhang DX, 2009, PLANT PHYSIOL, V150, P1072, DOI 10.1104/pp.109.138222; Zheng CJ, 2012, PHARM BIOL, V50, P129, DOI 10.3109/13880209.2011.569726	60	78	82	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73192	10.1371/journal.pone.0073192	http://dx.doi.org/10.1371/journal.pone.0073192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066037	Green Published, gold			2022-12-27	WOS:000324494000018
J	Stelitano, V; Giardina, G; Paiardini, A; Castiglione, N; Cutruzzola, F; Rinaldo, S				Stelitano, Valentina; Giardina, Giorgio; Paiardini, Alessandro; Castiglione, Nicoletta; Cutruzzola, Francesca; Rinaldo, Serena			C-di-GMP Hydrolysis by Pseudomonas aeruginosa HD-GYP Phosphodiesterases: Analysis of the Reaction Mechanism and Novel Roles for pGpG	PLOS ONE			English	Article							DEPENDENT DYNAMIC INTERACTIONS; PROTEINS MEDIATE VIRULENCE; ALLOSTERIC ACTIVATION; STRUCTURAL INSIGHT; SEQUENCE ALIGNMENT; BIOFILM FORMATION; DOMAIN PROTEIN; CELL-CYCLE; PHOSPHORYLATION; GGDEF	In biofilms, the bacterial community optimizes the strategies to sense the environment and to communicate from cell to cell. A key player in the development of a bacterial biofilm is the second messenger c-di-GMP, whose intracellular levels are modulated by the opposite activity of diguanylate cyclases and phosphodiesterases. Given the huge impact of bacterial biofilms on human health, understanding the molecular details of c-di-GMP metabolism represents a critical step in the development of novel therapeutic approaches against biofilms. In this study, we present a detailed biochemical characterization of two c-di-GMP phosphodiesterases of the HD-GYP subtype from the human pathogen Pseudomonas aeruginosa, namely PA4781 and PA4108. Upstream of the catalytic HD-GYP domain, PA4781 contains a REC domain typical of two-component systems, while PA4108 contains an uncharacterized domain of unknown function. Our findings shed light on the activity and catalytic mechanism of these phosphodiesterases. We show that both enzymes hydrolyse c-di-GMP in a two-step reaction via the linear intermediate pGpG and that they produce GMP in vitro at a surprisingly low rate. In addition, our data indicate that the non-phosphorylated REC domain of PA4781 prevents accessibility of c-di-GMP to the active site. Both PA4108 and phosphorylated PA4781 are also capable to use pGpG as an alternative substrate and to hydrolyse it into GMP; the affinity of PA4781 for pGpG is one order of magnitude higher than that for c-di-GMP. These results suggest that these enzymes may not work (primarily) as genuine phosphodiesterases. Moreover, the unexpected affinity of PA4781 for pGpG may indicate that pGpG could also act as a signal molecule in its own right, thus further widening the c-di-GMP-related signalling scenario.	[Stelitano, Valentina; Giardina, Giorgio; Castiglione, Nicoletta; Cutruzzola, Francesca; Rinaldo, Serena] Univ Roma La Sapienza, Dept Biochem Sci, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Stelitano, Valentina; Giardina, Giorgio; Paiardini, Alessandro; Castiglione, Nicoletta; Cutruzzola, Francesca; Rinaldo, Serena] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Cutruzzola, F (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy.	francesca.cutruzzola@uniroma1.it	Giardina, Giorgio/M-8882-2019; Cutruzzola', Francesca/G-4052-2011; Giardina, Giorgio/C-7529-2009; rinaldo, serena/O-6989-2014	Giardina, Giorgio/0000-0002-0802-1370; Cutruzzola', Francesca/0000-0002-4621-2135; Giardina, Giorgio/0000-0002-0802-1370; rinaldo, serena/0000-0003-0682-023X; Paiardini, Alessandro/0000-0001-9078-7545	Ministero della Universita e Ricerca of Italy [RBRN07BMCT, 20094BJ9R7, RBFR10LHD1]; Sapienza University of Rome; Fondazione Italiana Fibrosi Cistica [13/2009]; Sapienza University of Rome [C26A10NXKK]	Ministero della Universita e Ricerca of Italy; Sapienza University of Rome; Fondazione Italiana Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Sapienza University of Rome	This work was supported by Ministero della Universita e Ricerca of Italy [RBRN07BMCT and 20094BJ9R7 to FC, RBFR10LHD1 to SR]; Sapienza University of Rome to FC and AP; Fondazione Italiana Fibrosi Cistica [13/2009- with the contribution of Delegazione Novara and Delegazione Cosenza2 to FC]. VS acknowledges a Post-doctoral fellowship on the project C26A10NXKK funded by Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Antoniani D, 2013, APPL MICROBIOL BIOT, V97, P7325, DOI 10.1007/s00253-013-4875-0; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Burke DF, 1999, PROTEINS, P55; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; EDMUNDS AC, 2013, J BACTERIOL, P75975; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lovering AL, 2011, MBIO, V2, DOI 10.1128/mBio.00163-11; Malone JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002760; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Milani M, 2005, STRUCTURE, V13, P1289, DOI 10.1016/j.str.2005.05.014; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Nickels BE, 2012, TRANSCR-AUSTIN, V3, P300, DOI 10.4161/trns.21903; Paiardini A, 2005, NUCLEIC ACIDS RES, V33, pW50, DOI 10.1093/nar/gki416; Palardini A, 2008, NEUROPEPTIDES, V42, P205, DOI 10.1016/j.npep.2007.11.004; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Povolotsky TL, 2012, J BIOTECHNOL, V160, P10, DOI 10.1016/j.jbiotec.2011.12.024; Pulliainen AT, 2012, P NATL ACAD SCI USA, V109, P9581, DOI 10.1073/pnas.1117651109; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2012, MOL MICROBIOL, V86, P557, DOI 10.1111/mmi.12000; Ryan RP, 2010, VIRULENCE, V1, P404, DOI 10.4161/viru.1.5.12704; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Salter EA, 2007, J PHYS CHEM B, V111, P4547, DOI 10.1021/jp066582+; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Stelitano V, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt028; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	59	41	46	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74920	10.1371/journal.pone.0074920	http://dx.doi.org/10.1371/journal.pone.0074920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066157	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000139
J	Zarate, JM; Ritson, CR; Poeppel, D				Zarate, Jean Mary; Ritson, Caroline R.; Poeppel, David			The Effect of Instrumental Timbre on Interval Discrimination	PLOS ONE			English	Article							MUSICAL INTERVALS; FREQUENCY-DISCRIMINATION; SIGNAL-DETECTION; COMPLEX TONES; PITCH; PERCEPTION; BOUNDARY; SIZE	We tested non-musicians and musicians in an auditory psychophysical experiment to assess the effects of timbre manipulation on pitch-interval discrimination. Both groups were asked to indicate the larger of two presented intervals, comprised of four sequentially presented pitches; the second or fourth stimulus within a trial was either a sinusoidal (or "pure"), flute, piano, or synthetic voice tone, while the remaining three stimuli were all pure tones. The interval-discrimination tasks were administered parametrically to assess performance across varying pitch distances between intervals ("interval-differences"). Irrespective of timbre, musicians displayed a steady improvement across interval-differences, while non-musicians only demonstrated enhanced interval discrimination at an interval-difference of 100 cents (one semitone in Western music). Surprisingly, the best discrimination performance across both groups was observed with pure-tone intervals, followed by intervals containing a piano tone. More specifically, we observed that: 1) timbre changes within a trial affect interval discrimination; and 2) the broad spectral characteristics of an instrumental timbre may influence perceived pitch or interval magnitude and make interval discrimination more difficult.	[Zarate, Jean Mary; Ritson, Caroline R.; Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	New York University	Zarate, JM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	jean.m.zarate@nyu.edu	Zarate, Jean Mary/B-1450-2008; Zarate, Jean Mary/Q-1702-2019	Zarate, Jean Mary/0000-0002-7418-2199; Zarate, Jean Mary/0000-0002-7418-2199	GRAMMY Foundation(R); National Institutes of Health [NIH R01 05660]	GRAMMY Foundation(R); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was funded in part by a grant from the GRAMMY Foundation (R) to J.M.Z. and by a grant from the National Institutes of Health (NIH R01 05660 to D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchert EMO, 2011, J EXP PSYCHOL HUMAN, V37, P257, DOI 10.1037/a0020670; Bregman A.S., 1990, AUDITORY SCENE ANAL; Burns EdwardM., 1999, PSYCHOL MUSIC, V2nd, P215, DOI DOI 10.1016/B978-012213564-4/50008-1; BURNS EM, 1978, J ACOUST SOC AM, V63, P456, DOI 10.1121/1.381737; de Cheveigne A, 2002, J ACOUST SOC AM, V111, P1917, DOI 10.1121/1.1458024; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; DORFMAN DD, 1968, PSYCHOMETRIKA, V33, P117, DOI 10.1007/BF02289677; DOWLING WJ, 1978, PSYCHOL REV, V85, P341, DOI 10.1037/0033-295X.85.4.341; DOWLING WJ, 1986, MUSIC COGNITION, P1; Grassi M, 2009, BEHAV RES METHODS, V41, P20, DOI 10.3758/BRM.41.1.20; Han SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020160; Hill TJW, 2007, J ACOUST SOC AM, V121, P2376, DOI 10.1121/1.2697059; HOUTSMA AJM, 1968, J ACOUST SOC AM, V44, P383, DOI 10.1121/1.1970636; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; McDermott JH, 2010, J ACOUST SOC AM, V128, P1943, DOI 10.1121/1.3478785; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; MOORE BCJ, 1990, J ACOUST SOC AM, V87, P2163, DOI 10.1121/1.399184; RAKOWSKI A, 1976, J ACOUST SOC AM, V59, pS50, DOI 10.1121/1.2002737; Rakowski A., 1990, PSYCHOL MUSIC, V18, P60, DOI [10.1177/0305735690181005, DOI 10.1177/0305735690181005]; ROSENBLITH WA, 1953, J ACOUST SOC AM, V25, P980, DOI 10.1121/1.1907230; Russo FA, 2005, PERCEPT PSYCHOPHYS, V67, P559, DOI 10.3758/BF03193514; SINGH PG, 1992, J ACOUST SOC AM, V92, P2650, DOI 10.1121/1.404381; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; SWETS J, 1982, PSYCHOPHYSIOLOGY, V19, P300; WARD WD, 1954, J ACOUST SOC AM, V26, P369, DOI 10.1121/1.1907344; Ward WD, 1970, FDN MODERN AUDITORY, P405; Warrier CM, 2002, PERCEPT PSYCHOPHYS, V64, P198, DOI 10.3758/BF03195786; Zarate JM, 2012, J ACOUST SOC AM, V132, P984, DOI 10.1121/1.4733535; ZATORRE RJ, 1983, J EXP PSYCHOL HUMAN, V9, P739, DOI 10.1037/0096-1523.9.5.739; ZATORRE RJ, 1979, PERCEPT PSYCHOPHYS, V26, P384, DOI 10.3758/BF03204164	31	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75410	10.1371/journal.pone.0075410	http://dx.doi.org/10.1371/journal.pone.0075410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066179	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000161
J	Chen, SY; Chen, YM; Liu, XY; Li, M; Wu, BD; Li, YQ; Liang, Y; Shao, XF; Holthofer, H; Zou, HQ				Chen, Shanying; Chen, Youming; Liu, Xinyu; Li, Mi; Wu, Bide; Li, Yongqiang; Liang, Yan; Shao, Xiaofei; Holthoefer, Harry; Zou, Hequn			Association of Insulin Resistance with Chronic Kidney Disease in Non-Diabetic Subjects with Normal Weight	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BODY-MASS INDEX; METABOLICALLY-OBESE; RISK-FACTORS; MICROALBUMINURIA; AMERICANS; WAIST	Objective: To the best of our knowledge, the association of insulin resistance (IR) with chronic kidney disease (CKD) has not been well studied in normal-weight individuals. The aim of this study is to examine whether IR is associated with CKD in non-diabetic subjects with normal weight. We also examine whether the presence of obesity modifies the association of IR with CKD. Methods: Data were drawn from a cross-sectional survey in China. Both estimated glomerular filtration rate and urinary albumin to creatinine ratio were used as markers of CKD. Logistic regression models and the quartiles of homeostatic model assessment of insulin resistance were used to explore the associations of IR with CKD in entire cohort, normal-weight and overweight/obese subpopulations. Results: In normal-weight subpopulation, the prevalence of IR and metabolic syndrome were 11.11% and 8.99%, respectively. In the entire cohort, the highest quartile HOMA-insulin resistance had a 70% increased risk for CKD (RR 1.70, 95% CI 1.07, 2.71, P=0.03, comparing the highest to the lowest quartile). However, when adding obesity to the model, the association was abolished. IR was associated with CKD in overweight/obese subpopulation but not in normal-weight subpopulation. Conclusion: IR and MetS in normal-weight individuals is common in the Chinese population. IR is associated with CKD in overweight/obese subpopulation but not in normal-weight subpopulation and the presence of obesity modifies the association of IR with CKD.	[Chen, Shanying; Liu, Xinyu; Li, Yongqiang; Liang, Yan; Shao, Xiaofei; Zou, Hequn] Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Chen, Shanying; Wu, Bide] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Nephrol, Zhangzhou, Fujian, Peoples R China; [Chen, Youming] Southern Med Univ, Affiliated Hosp 3, Clin Lab, Guangzhou, Guangdong, Peoples R China; [Li, Mi] Sun Yat Sen Univ, Affiliated Hosp 5, Blood Purificat Ctr, Zhuhai, Guangdong, Peoples R China; [Holthoefer, Harry] Dublin City Univ, Natl Ctr Sensor Res BioAnalyt Sci, Dublin 9, Ireland	Southern Medical University - China; Fujian Medical University; Southern Medical University - China; Sun Yat Sen University; Dublin City University	Zou, HQ (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	hequnzou@hotmail.com	Zou, He/GXH-0280-2022		EU FP7 Program, UroSense; ISN Research Committee grant; Guangdong Provincial Science and Technique Program [2011B031800386]	EU FP7 Program, UroSense; ISN Research Committee grant; Guangdong Provincial Science and Technique Program	This study was supported by the following science foundation: 1. EU FP7 Program, UroSense, 2011; 2. ISN Research Committee grant, 2007; 3. ISN Research Committee grant, 2004; 4. Guangdong Provincial Science and Technique Program (No. 2011B031800386), 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEWALL S, 1995, J INTERN MED, V237, P195, DOI 10.1111/j.1365-2796.1995.tb01161.x; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Cheng HT, 2012, J CLIN ENDOCR METAB, V97, P1268, DOI 10.1210/jc.2011-2658; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; De Cosmo S, 2006, DIABETES CARE, V29, P432, DOI 10.2337/diacare.29.02.06.dc05-1841; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halimi JM, 2001, J CARDIOVASC RISK, V8, P139, DOI 10.1097/00043798-200106000-00004; Hanley AJG, 2003, DIABETES, V52, P463, DOI 10.2337/diabetes.52.2.463; Hoehner CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015762.92814.85; Kim YI, 2001, DIABETES RES CLIN PR, V52, P145, DOI 10.1016/S0168-8227(01)00228-5; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Liao MT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691369; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Masharani UB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019878; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Mykkanen L, 1998, DIABETES, V47, P793, DOI 10.2337/diabetes.47.5.793; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Parvanova AI, 2006, DIABETES, V55, P1456, DOI 10.2337/db05-1484; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Xing XY, 2004, CHINESE J DIABET, V12, P182	29	25	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74058	10.1371/journal.pone.0074058	http://dx.doi.org/10.1371/journal.pone.0074058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058515	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400050
J	Fujita, M; Mahanty, S; Zoghbi, SS; Araneta, MDF; Hong, J; Pike, VW; Innis, RB; Nash, TE				Fujita, Masahiro; Mahanty, Siddhartha; Zoghbi, Sami S.; Araneta, Maria Desiree Ferraris; Hong, Jinsoo; Pike, Victor W.; Innis, Robert B.; Nash, Theodore E.			PET Reveals Inflammation around Calcified Taenia solium Granulomas with Perilesional Edema	PLOS ONE			English	Article							BENZODIAZEPINE-RECEPTOR; TRANSLOCATOR PROTEIN; 18 KDA; NEUROCYSTICERCOSIS; METHOTREXATE; RADIOLIGAND; EXPRESSION; MONKEY	Objective: Neurocysticercosis, an infection with the larval form of the tapeworm, Taenia solium, is the cause of 29% of epilepsy in endemic regions. Epilepsy in this population is mostly associated with calcified granulomas; at the time of seizure recurrence 50% of those with calcifications demonstrate transient surrounding perilesional edema. Whether edema is consequence of the seizure, or a result of host inflammation directed against parasite antigens or other processes is unknown. To investigate whether perilesional edema is due to inflammation, we imaged a marker of neuroinflammation, translocater protein (TSPO), using positron emission tomography (PET) and the selective ligand C-11-PBR28. Methods: In nine patients with perilesional edema, degenerating cyst or both, PET findings were compared to the corresponding magnetic resonance images. Degenerating cysts were also studied because unlike perilesional edema, degenerating cysts are known to have inflammation. In three of the nine patients, changes in C-11-PBR28 binding were also studied over time. C-11-PBR28 binding was compared to the contralateral un-affected region. Results: C-11-PBR28 binding increased by a mean of 13% in perilesional edema or degenerating cysts (P = 0.0005, n = 13 in nine patients). Among these 13 lesions, perilesional edema (n = 10) showed a slightly smaller increase of 10% compared to the contralateral side (P = 0.005) than the three degenerating cysts. In five lesions with perilesional edema in which repeated measurements of C-11-PBR28 binding were done, increased binding lasted for 2-9 months. Conclusions: Increased TSPO in perilesional edema indicates an inflammatory etiology. The long duration of increased TSPO binding after resolution of the original perilesional edema and the pattern of periodic episodes is consistent with intermittent exacerbation from a continued baseline presence of low level inflammation. Novel anti-inflammatory measures may be useful in the prevention or treatment of seizures in this population.	[Fujita, Masahiro; Zoghbi, Sami S.; Araneta, Maria Desiree Ferraris; Hong, Jinsoo; Pike, Victor W.; Innis, Robert B.] NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA; [Mahanty, Siddhartha; Nash, Theodore E.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fujita, M (corresponding author), NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA.	FujitaM@intra.nimh.nih.gov	Pike, Victor/AAJ-4139-2020	Mahanty, Siddhartha/0000-0003-1068-0524; Fujita, Masahiro/0000-0001-7078-6844	Intramural Research Programs of the National Institute of Mental Health; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, United States of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002793] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Mental Health; National Institutes of Allergy and Infectious Diseases, National Institutes of Health, United States of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Programs of the National Institute of Mental Health and the National Institutes of Allergy and Infectious Diseases, National Institutes of Health, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; Carson R.E., 2003, POSITRON EMISSION TO; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Fujita M, 2008, NEUROIMAGE, V40, P43, DOI 10.1016/j.neuroimage.2007.11.011; Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694; Kreisl WC, 2010, NEUROIMAGE, V49, P2924, DOI 10.1016/j.neuroimage.2009.11.056; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Mitre E, 2007, CLIN INFECT DIS, V44, P549, DOI 10.1086/511040; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Nash TE, 2001, CLIN INFECT DIS, V33, P1649, DOI 10.1086/323670; Nash T, 2012, PATHOG GLOB HEALTH, V106, P275, DOI 10.1179/2047773212Y.0000000026; Nash TE, 2011, NAT REV NEUROL, V7, P584, DOI 10.1038/nrneurol.2011.135; Nash TE, 2008, LANCET NEUROL, V7, P1099, DOI 10.1016/S1474-4422(08)70243-6; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ooi WW, 2011, AM J TROP MED HYG, V85, P460, DOI 10.4269/ajtmh.2011.11-0221; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063	21	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74052	10.1371/journal.pone.0074052	http://dx.doi.org/10.1371/journal.pone.0074052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058514	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400049
J	Gao, F; Lin, E; Feng, YP; Mack, WJ; Shen, YF; Wang, K				Gao, Fan; Lin, Edwin; Feng, Yaping; Mack, William J.; Shen, Yufeng; Wang, Kai			Characterizing Immunoglobulin Repertoire from Whole Blood by a Personal Genome Sequencer	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; IMMUNE-RESPONSE; READ ALIGNMENT; MENINGIOMAS; GENERATION; PLATFORMS; BIOBANK; DNA	In human immune system, V(D)J recombination produces an enormously large repertoire of immunoglobulins (Ig) so that they can tackle different antigens from bacteria, viruses and tumor cells. Several studies have demonstrated the utility of next-generation sequencers such as Roche 454 and Illumina Genome Analyzer to characterize the repertoire of immunoglobulins. However, these techniques typically require separation of B cell population from whole blood and require a few weeks for running the sequencers, so it may not be practical to implement them in clinical settings. Recently, the Ion Torrent personal genome sequencer has emerged as a tabletop personal genome sequencer that can be operated in a time-efficient and cost-effective manner. In this study, we explored the technical feasibility to use multiplex PCR for amplifying V(D)J recombination for IgH, directly from whole blood, then sequence the amplicons by the Ion Torrent sequencer. The whole process including data generation and analysis can be completed in one day. We tested the method in a pilot study on patients with benign, atypical and malignant meningiomas. Despite the noisy data, we were able to compare the samples by their usage frequencies of the V segment, as well as their somatic hypermutation rates. In summary, our study suggested that it is technically feasible to perform clinical monitoring of V(D)J recombination within a day by personal genome sequencers.	[Gao, Fan; Mack, William J.; Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Lin, Edwin; Feng, Yaping; Shen, Yufeng] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Shen, Yufeng] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Shen, Yufeng] Columbia Univ, JP Sulzberger Columbia Genome Ctr, New York, NY USA; [Wang, Kai] Univ So Calif, Dept Psychiat, Los Angeles, CA USA	University of Southern California; Columbia University; Columbia University; Columbia University; University of Southern California	Shen, YF (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.	ys2411@columbia.edu; kaiwang@usc.edu		Lin, Edwin/0000-0002-3951-3976	Department of Systems Biology at Columbia University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER	Department of Systems Biology at Columbia University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We are grateful for the patients with meningiomas for donating blood samples for research purposes. We thank the USC Brain Tumor Bank for providing whole blood samples and paired phenotype data. We thank members of the Wang lab, Shen lab, and Columbia Genome Center for helpful discussions and comments. Y.S. is supported by Department of Systems Biology at Columbia University.	Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Fan CT, 2008, PHARMACOGENOMICS, V9, P235, DOI 10.2217/14622416.9.2.235; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Heckel D, 1997, HUM MOL GENET, V6, P2031, DOI 10.1093/hmg/6.12.2031; Kaiser J, 2006, SCIENCE, V312, P1584; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; PEES HW, 1976, CLIN EXP IMMUNOL, V24, P310; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; ROSSI ML, 1988, J CLIN PATHOL, V41, P314, DOI 10.1136/jcp.41.3.314; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Thornton H, 2009, INT J SURG, V7, P501, DOI 10.1016/j.ijsu.2009.09.001; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75294	10.1371/journal.pone.0075294	http://dx.doi.org/10.1371/journal.pone.0075294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058670	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400112
J	Moriguchi, K; Yamamoto, S; Tanaka, K; Kurata, N; Suzuki, K				Moriguchi, Kazuki; Yamamoto, Shinji; Tanaka, Katsuyuki; Kurata, Nori; Suzuki, Katsunori			Trans-Kingdom Horizontal DNA Transfer from Bacteria to Yeast Is Highly Plastic Due to Natural Polymorphisms in Auxiliary Nonessential Recipient Genes	PLOS ONE			English	Article							IV SECRETION SYSTEMS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PROTEIN OSMOTIN; CONJUGATION; EVOLUTION; RESISTANCE; PLASMIDS; CELLS; RNA	With the rapid accumulation of genomic information from various eukaryotes in the last decade, genes proposed to have been derived from recent horizontal gene transfer (HGT) events have been reported even in non-phagotrophic unicellular and multicellular organisms, but the molecular pathways underlying HGT remain to be explained. The development of in vitro HGT detection systems, which permit the molecular and genetic analyses of donor and recipient organisms and quantify HGT, are helpful in order to gain insight into mechanisms that may contribute to contemporary HGT events or may have contributed to past HGT events. We applied a horizontal DNA transfer system model based on conjugal gene transfer called trans-kingdom conjugation (TKC) from the prokaryote Escherichia coli to the eukaryote Saccharomyces cerevisiae, and assessed whether and to what extent genetic variations in the eukaryotic recipient affect its receptivity to TKC. Strains from a collection of 4,823 knock-out mutants of S. cerevisiae MAT-alpha haploids were tested for their individual TKC receptivity. Two types of mutants, an ssd1 mutant and respiratory mutants, which are also found in experimental strains and in nature widely, were identified as highly receptive mutants. The TKC efficiency for spontaneously accrued petite (rho(-/0)) mutants of the functional allele (SSD1-V) strain showed increased receptivity. The TKC efficiency of the ssd1 Delta mutant was 36% for bacterial conjugation, while that of the petite/ssd1 Delta double mutants was even higher (220% in average) compared to bacterial conjugation. This increased TKC receptivity was also observed when other conjugal transfer systems were applied and the donor bacterium was changed to Agrobacterium tumefaciens. These results support the idea that the genomes of certain eukaryotes have been exposed to exogenous DNA more frequently and continuously than previously thought.	[Moriguchi, Kazuki; Yamamoto, Shinji; Tanaka, Katsuyuki; Suzuki, Katsunori] Hiroshima Univ, Dept Biol Sci, Hiroshima, Japan; [Kurata, Nori] Natl Inst Genet, Mishima, Shizuoka 411, Japan	Hiroshima University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Moriguchi, K (corresponding author), Hiroshima Univ, Dept Biol Sci, Hiroshima, Japan.	kmoriguc@hiroshima-u.ac.jp			NIG Cooperative Research Program [2006-A48]; JSPS KAKENHI [20570221, 21510209]	NIG Cooperative Research Program; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by the NIG Cooperative Research Program (2006-A48) and JSPS KAKENHI (20570221 and 21510209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293; BERNARDI G, 1979, TRENDS BIOCHEM SCI, V4, P197, DOI 10.1016/0968-0004(79)90079-3; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Gank KD, 2008, EUKARYOT CELL, V7, P1318, DOI 10.1128/EC.00402-07; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Ibeas JI, 2001, PLANT J, V25, P271, DOI 10.1046/j.1365-313x.2001.00967.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kawai S, 2004, BIOCHEM BIOPH RES CO, V317, P100, DOI 10.1016/j.bbrc.2004.03.011; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lee H, 2010, EUKARYOT CELL, V9, P558, DOI 10.1128/EC.00316-09; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; McDonald HB, 2002, GENETICS, V162, P705; Mizuta M, 2012, MICROBIOL RES, V167, P311, DOI 10.1016/j.micres.2011.10.001; Moriguchi K, 2013, APPL ENVIRON MICROB, V79, P4393, DOI 10.1128/AEM.00770-13; NISHIKAWA M, 1992, CURR GENET, V21, P101, DOI 10.1007/BF00318467; NISHIKAWA M, 1990, JPN J GENET, V65, P323, DOI 10.1266/jjg.65.323; Nishikawa M, 1998, GENET ANAL-BIOMOL E, V14, P65, DOI 10.1016/S1050-3862(97)10003-1; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohyama Y, 2010, GENES CELLS, V15, P1169, DOI 10.1111/j.1365-2443.2010.01452.x; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; SCHMIDHAUSER TJ, 1985, J BACTERIOL, V164, P446, DOI 10.1128/JB.164.1.446-455.1985; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Suzuki K, 2002, PLANT J, V32, P775, DOI 10.1046/j.1365-313X.2002.01468.x; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Uesono Y, 1997, J BIOL CHEM, V272, P16103, DOI 10.1074/jbc.272.26.16103; Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779; Wheeler RT, 2003, P NATL ACAD SCI USA, V100, P2766, DOI 10.1073/pnas.0437995100; Yamamoto S, 2007, GENES GENET SYST, V82, P197, DOI 10.1266/ggs.82.197	39	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74590	10.1371/journal.pone.0074590	http://dx.doi.org/10.1371/journal.pone.0074590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058593	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400085
J	Ricard, C; Stanchi, F; Rodriguez, T; Amoureux, MC; Rougon, G; Debarbieux, F				Ricard, Clement; Stanchi, Fabio; Rodriguez, Thieric; Amoureux, Marie-Claude; Rougon, Genevieve; Debarbieux, Franck			Dynamic Quantitative Intravital Imaging of Glioblastoma Progression Reveals a Lack of Correlation between Tumor Growth and Blood Vessel Density	PLOS ONE			English	Article							CELL INVASION; ANGIOGENESIS; VEGF; BEVACIZUMAB; MACROPHAGES; THERAPY; MICROENVIRONMENT; ACCUMULATION; RECRUITMENT; MECHANISMS	The spatiotemporal and longitudinal monitoring of cellular processes occurring in tumors is critical for oncological research. We focused on glioblastoma multiforme (GBM), an untreatable highly vascularized brain tumor whose progression is thought to critically depend on the oxygen and metabolites supplied by blood vessels. We optimized protocols for orthotopic GBM grafting in mice that were able to recapitulate the biophysical constraints normally governing tumor progression and were suitable for intravital multiphoton microscopy. We repeatedly imaged tumor cells and blood vessels during GBM development. We established methods for quantitative correlative analyses of dynamic imaging data over wide fields in order to cover the entire tumor. We searched whether correlations existed between blood vessel density, tumor cell density and proliferation in control tumors. Extensive vascular remodeling and the formation of new vessels accompanied U87 tumor cell growth, but no strong correlation was found between local cell density and the extent of local blood vessel density irrespective of the tumor area or time points. The technique moreover proves useful for comparative analysis of mice subjected either to Bevacizumab anti-angiogenic treatment that targets VEGF or to AMD3100, an antagonist of CXCR4 receptor. Bevacizumab treatment massively reduced tumoral vessel densities but only transiently reduced U87 tumor growth rate. Again, there was no correlation between local blood vessel density and local cell density. Moreover, Bev applied only prior to tumor implantation inhibited tumor growth to the same extent as post-grafting treatment. AMD3100 achieved a potent inhibition of tumor growth without significant reduction in blood vessel density. These results indicate that in the brain, in this model, tumor growth can be sustained without an increase in blood vessel density and suggest that GBM growth is rather governed by stromal properties.	[Ricard, Clement; Stanchi, Fabio; Rodriguez, Thieric; Amoureux, Marie-Claude; Rougon, Genevieve; Debarbieux, Franck] Aix Marseille Univ, CNRS 7288, Dev Biol Inst Marseille Luminy IBDML, Marseille, France; [Ricard, Clement; Amoureux, Marie-Claude; Rougon, Genevieve; Debarbieux, Franck] European Ctr Med Imaging CERIMED, Marseille, France; [Stanchi, Fabio] KU, Vesalius Onderzoeksctr VIB3, Louvain, Belgium	UDICE-French Research Universities; Aix-Marseille Universite; KU Leuven	Rougon, G (corresponding author), Aix Marseille Univ, CNRS 7288, Dev Biol Inst Marseille Luminy IBDML, Marseille, France.	genevieve.rougon@univ-amu.fr; franck.debarbieux@univ-amu.fr		Stanchi, Fabio/0000-0003-3393-2472; ROUGON, Genevieve/0000-0003-1316-8200	Association de Recherche sur le Cancer, Institut National du Cancer [INCa-DGOS-Inserm 6038]; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR JCJC PathoVisu3Dyn); Federation de Recherche sur le Cerveau (FRC); Federation de la Recherche Medicale (FRM); Canceropole PACA	Association de Recherche sur le Cancer, Institut National du Cancer; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR JCJC PathoVisu3Dyn)(French National Research Agency (ANR)); Federation de Recherche sur le Cerveau (FRC); Federation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Canceropole PACA(Region Grand-Est)	This work was supported by grants from Association de Recherche sur le Cancer, Institut National du Cancer (INCa-DGOS-Inserm 6038) to GR, from Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR JCJC PathoVisu3Dyn), Federation de Recherche sur le Cerveau (FRC) to FD; and by fellowships from the Federation de la Recherche Medicale (FRM) to FS, TR, CR and from Canceropole PACA to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Benayoun L, 2012, STEM CELLS, V30, P1831, DOI 10.1002/stem.1170; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brodbelt A, 2007, BRIT J NEUROSURG, V21, P510, DOI 10.1080/02688690701447420; Chamberlain MC, 2011, CLIN MED INSIGHTS-ON, V5, P117, DOI 10.4137/CMO.S7232; Chi AS, 2009, NEUROTHERAPEUTICS, V6, P513, DOI 10.1016/j.nurt.2009.04.010; Crawford Y, 2009, TRENDS PHARMACOL SCI, V30, P624, DOI 10.1016/j.tips.2009.09.004; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Fink J, 2011, CURR TREAT OPTION ON, V12, P240, DOI 10.1007/s11864-011-0157-1; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gerstner ER, 2010, NEURO-ONCOLOGY, V12, P466, DOI 10.1093/neuonc/nop051; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; HOCHWALD GM, 1985, J NEUROCHEM, V44, P1832, DOI 10.1111/j.1471-4159.1985.tb07176.x; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Liu BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008611; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Norden AD, 2008, CURR OPIN ONCOL, V20, P652, DOI 10.1097/CCO.0b013e32831186ba; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Ribatti D, 2012, CURR MED CHEM, V19, P955, DOI 10.2174/092986712799320655; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Schuss P, 2011, J NEURO-ONCOL, V103, P765, DOI 10.1007/s11060-010-0437-9; Shojaei F, 2008, DRUG RESIST UPDATE, V11, P219, DOI 10.1016/j.drup.2008.09.001; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Winkler F, 2009, GLIA, V57, P1306, DOI 10.1002/glia.20850; Zhang L, 2012, J VIS EXP; Zhang LF, 2012, JOVE-J VIS EXP, DOI 10.3791/4201	48	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72655	10.1371/journal.pone.0072655	http://dx.doi.org/10.1371/journal.pone.0072655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069154	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100014
J	Ruppert, JLW; Travers, MJ; Smith, LL; Fortin, MJ; Meekan, MG				Ruppert, Jonathan L. W.; Travers, Michael J.; Smith, Luke L.; Fortin, Marie-Josee; Meekan, Mark G.			Caught in the Middle: Combined Impacts of Shark Removal and Coral Loss on the Fish Communities of Coral Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BASE-LINES; PELAGIC SHARKS; MARINE; DEGRADATION; ECOSYSTEM; PATTERNS; PREDATOR; DECLINE; CONSEQUENCES	Due to human activities, marine and terrestrial ecosystems face a future where disturbances are predicted to occur at a frequency and severity unprecedented in the recent past. Of particular concern is the ability of systems to recover where multiple stressors act simultaneously. We examine this issue in the context of a coral reef ecosystem where increases in stressors, such as fisheries, benthic degradation, cyclones and coral bleaching, are occurring at global scales. By utilizing long-term (decadal) monitoring programs, we examined the combined effects of chronic (removal of sharks) and pulse (cyclones, bleaching) disturbances on the trophic structure of coral reef fishes at two isolated atoll systems off the coast of northwest Australia. We provide evidence consistent with the hypothesis that the loss of sharks can have an impact that propagates down the food chain, potentially contributing to mesopredator release and altering the numbers of primary consumers. Simultaneously, we show how the effects of bottom-up processes of bleaching and cyclones appear to propagate up the food chain through herbivores, planktivores and corallivores, but do not affect carnivores. Because their presence may promote the abundance of herbivores, the removal of sharks by fishing has implications for both natural and anthropogenic disturbances involving the loss of corals, as herbivores are critical to the progress and outcome of coral recovery.	[Ruppert, Jonathan L. W.; Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Ruppert, Jonathan L. W.; Travers, Michael J.; Meekan, Mark G.] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia; [Smith, Luke L.] Woodside Energy, Perth, WA, Australia	University of Toronto; Australian Institute of Marine Science; University of Western Australia; Woodside Petroleum Limited	Ruppert, JLW (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	jonathan.ruppert@utoronto.ca		Meekan, Mark/0000-0002-3067-9427	AIMS; Woodside Energy; NSERC	AIMS; Woodside Energy; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by AIMS, Woodside Energy, and NSERC scholarship to Jonathan L.W. Ruppert and grant to Marie-Josee Fortin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brashares Justin S., 2010, P221; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; De'ath G, 2012, P NATL ACAD SCI; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Emslie MJ, 2011, CORAL REEFS, V30, P461, DOI 10.1007/s00338-011-0730-x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Field IC, 2009, FISH FISH, V10, P323, DOI 10.1111/j.1467-2979.2009.00325.x; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gilmour JG, 2011, LONG TERM MONITORING; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2010, CRC MAR BIOL SER, P611; Heyward A., 2011, MONITORING STUDY S5; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; IPCC, 2007, CONTRIBUTION WORKING; JACKSON DA, 1989, ECOLOGY, V70, P1472, DOI 10.2307/1938206; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jonker M., 2008, LONG TERM MONITORING; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LETOURNEUR Y, 1993, ENVIRON BIOL FISH, V37, P109, DOI 10.1007/BF00000586; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MORAN PJ, 1988, CORAL REEFS, V7, P125, DOI 10.1007/BF00300972; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Mumby PJ, 2011, P NATL ACAD SCI USA, V108, P17626, DOI 10.1073/pnas.1100436108; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Ninio R, 2002, CORAL REEFS, V21, P95, DOI 10.1007/s00338-001-0202-9; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; Okey TA, 2004, ECOL MODEL, V172, P383, DOI 10.1016/j.ecolmodel.2003.09.019; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pierre Legendre, AN T TESTS T TEST IN; Pierre Legendre, BONF SID CORR MULT T; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Rees P.B., 2003, NEED KNOW REPORT DIS; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Salomon AK, 2010, CONSERV BIOL, V24, P382, DOI 10.1111/j.1523-1739.2009.01436.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Skewes T., 1999, SURVEY STOCK SIZE ES; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Team RDC, 2012, R LANG ENV STAT COMP; Thibaut LM, 2012, ECOLOGY, V93, P891, DOI 10.1890/11-1753.1; Thompson A.A., 1996, VISUAL CENSUS SURVEY, V3; Underwood JN, 2012, ECOL EVOL, V2, P666, DOI 10.1002/ece3.80; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Williams ID, 2011, J MAR BIOL, DOI DOI 10.1155/2011/826234; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	71	115	115	4	263	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74648	10.1371/journal.pone.0074648	http://dx.doi.org/10.1371/journal.pone.0074648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058618	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900074
J	Wang, YC; Chao, TK; Chang, CC; Yo, YT; Yu, MH; Lai, HC				Wang, Yu-Chi; Chao, Tai-Kuang; Chang, Cheng-Chang; Yo, Yi-Te; Yu, Mu-Hsien; Lai, Hung-Cheng			Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells	PLOS ONE			English	Article							IN-VITRO PROPAGATION; RESISTANCE; REVEALS; EXPRESSION; LEUKEMIA; TUMORS	The primary cause of death from breast cancer is the progressive growth of tumors and resistance to conventional therapies. It is currently believed that recurrent cancer is repopulated according to a recently proposed cancer stem cell hypothesis. New therapeutic strategies that specifically target cancer stem-like cells may represent a new avenue of cancer therapy. We aimed to discover novel compounds that target breast cancer stem-like cells. We used a dye-exclusion method to isolate side population (SP) cancer cells and, subsequently, subjected these SP cells to a sphere formation assay to generate SP spheres (SPS) from breast cancer cell lines. Surface markers, stemness genes, and tumorigenicity were used to test stem properties. We performed a high-throughput drug screening using these SPS. The effects of candidate compounds were assessed in vitro and in vivo. We successfully generated breast cancer SPS with stem-like properties. These SPS were enriched for CD44(high) (2.8-fold) and CD24(low) (4-fold) cells. OCT4 and ABCG2 were overexpressed in SPS. Moreover, SPS grew tumors at a density of 10 3, whereas an equivalent number of parental cells did not initiate tumor formation. A clinically approved drug, niclosamide, was identified from the LOPAC chemical library of 1,258 compounds. Niclosamide downregulated stem pathways, inhibited the formation of spheroids, and induced apoptosis in breast cancer SPS. Animal studies also confirmed this therapeutic effect. The results of this proof-of-principle study may facilitate the development of new breast cancer therapies in the near future. The extension of niclosamide clinical trials is warranted.	[Wang, Yu-Chi; Chang, Cheng-Chang; Yu, Mu-Hsien; Lai, Hung-Cheng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Yu-Chi; Chang, Cheng-Chang; Yu, Mu-Hsien; Lai, Hung-Cheng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wang, Yu-Chi; Chang, Cheng-Chang; Yo, Yi-Te; Yu, Mu-Hsien; Lai, Hung-Cheng] Natl Def Med Ctr, Lab Epigenet & Canc Stem Cells, Taipei, Taiwan; [Chao, Tai-Kuang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Lai, HC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	hclai@ndmctsgh.edu.tw		Chang, Cheng-Chang/0000-0002-7356-446X	National Science Council, Taiwan, Republic of China (ROC) [NSC101-2314-B-016-019]; Tri-Service General Hospital, Taiwan, Republic of China (ROC) [TSGH-26 C102-008-S01, TSGH-C102-008-S02, TSGH-C102-008-S03]	National Science Council, Taiwan, Republic of China (ROC)(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Taiwan, Republic of China (ROC)	This work was supported by: National Science Council, Taiwan, Republic of China (ROC); grant number: NSC101-2314-B-016-019; Tri-Service General Hospital, Taiwan, Republic of China (ROC); grant numbers: TSGH-26 C102-008-S01; TSGH-C102-008-S02; TSGH-C102-008-S03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bialkowska AB, 2009, MOL CANCER THER, V8, P563, DOI 10.1158/1535-7163.MCT-08-0767; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hambardzumyan D, 2006, CANCER CELL, V10, P454, DOI 10.1016/j.ccr.2006.11.008; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; KATZ M, 1977, DRUGS, V13, P124, DOI 10.2165/00003495-197713020-00002; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Singh SK, 2003, CANCER RES, V63, P5821; Storms RW, 2000, BLOOD, V96, P2125; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015	33	78	81	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74538	10.1371/journal.pone.0074538	http://dx.doi.org/10.1371/journal.pone.0074538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058587	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900056
J	Xie, HB; Wang, YS; Zhang, H; Qi, H; Zhou, HX; Li, FR				Xie, Hongbin; Wang, Yunshuai; Zhang, Hui; Qi, Hui; Zhou, Hanxin; Li, Fu-Rong			Role of Injured Pancreatic Extract Promotes Bone Marrow-Derived Mesenchymal Stem Cells Efficiently Differentiate into Insulin-Producing Cells	PLOS ONE			English	Article							MANIPULATION IN-VITRO; REGENERATING PANCREAS; STROMAL CELLS; DIABETIC-RATS; TRANSPLANTATION; PROLIFERATION; GENERATION; THERAPY; LIVER; MICE	Mesenchymal stem cells (MSCs) can be successfully induced to differentiate into insulin-producing cells IPCs) by a variety of small molecules and cytokines in vitro. However, problems remain, such as low transdifferentiation efficiency and poor maturity of trans-differentiated cells. The damaged pancreatic cells secreted a large amount of soluble proteins, which were able to promote pancreative islet regeneration and MSCs differentiation. In this study, we utilized the rat injured pancreatic tissue extract to modulate rat bone marrow-derived MSCs differentiation into IPCs by the traditional two-step induction. Our results showed that injured pancreatic tissue extract could effectively promote the trans-differentiation efficiency and maturity of IPCs by the traditional induction. Moreover, IPCs were able to release more insulin in a glucose-dependent manner and ameliorate better the diabetic conditions of streptozotocin (STZ)-treated rats. Our study provides a new strategy to induce an efficient and directional differentiation of MSCs into IPCs.	[Xie, Hongbin; Wang, Yunshuai; Qi, Hui; Li, Fu-Rong] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China; [Zhang, Hui] Nevada Canc Inst, Lab Canc Cell Prote, Las Vegas, NV USA; [Zhou, Hanxin] Shenzhen Univ, Shenzhen Peoples Hosp 2, Hosp 1, Dept Gen Surg, Shenzhen, Peoples R China; [Li, Fu-Rong] Shenzhen Inst Gerontol, Shenzhen, Peoples R China	Jinan University; University of California System; University of California San Diego; Shenzhen University	Li, FR (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China.	frli62@163.comf			national 973 special plan of China [2007CB516811, 2004CCA01500]; National Natural Science Foundation of China [81270857]; Natural Science Foundation of Guangdong [37415, 6027540]; Science and Technology Project of Shenzhen [201001005?201001002]	national 973 special plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Science and Technology Project of Shenzhen	This research was supported by the national 973 special plan of China (No. 2007CB516811 and 2004CCA01500), The National Natural Science Foundation of China (No. 81270857), the Natural Science Foundation of Guangdong (No. 37415 and No. 6027540) and The Science and Technology Project of Shenzhen (No. 201001005?201001002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidibbiat A, 2008, J ENDOCRINOL, V196, P33, DOI 10.1677/JOE-07-0397; Basta G, 2004, TRANSPL P, V36, P2857, DOI 10.1016/j.transproceed.2004.10.026; Bernal-Mizrachi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011969; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Chang C, 2007, TRANSPL P, V39, P3363, DOI 10.1016/j.transproceed.2007.09.026; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chen W, 2009, ENDOCRINOLOGY, V150, P570, DOI 10.1210/en.2008-1009; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Hardikar AA, 1999, J ENDOCRINOL, V162, P189, DOI 10.1677/joe.0.1620189; Hardikar AA, 1999, DIABETES RES CLIN PR, V46, P203, DOI 10.1016/S0168-8227(99)00098-4; Heinis M, 2010, HORM RES PAEDIAT, V74, P77, DOI 10.1159/000314894; Kabelitz D, 2008, TRENDS IMMUNOL, V29, P68, DOI 10.1016/j.it.2007.11.001; Kanitkar Meghana, 2004, Rev Diabet Stud, V1, P185, DOI 10.1900/RDS.2004.1.185; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kim JH, 2007, YONSEI MED J, V48, P109, DOI 10.3349/ymj.2007.48.1.109; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Li FR, 2009, PANCREAS, V38, P227, DOI 10.1097/MPA.0b013e3181788e3d; Li L, 2008, TISSUE CELL, V40, P437, DOI 10.1016/j.tice.2008.04.006; Li LS, 2008, STEM CELLS DEV, V17, P815, DOI 10.1089/scd.2008.0060; Li YH, 2003, NAT SCI DEV, V13, P593; Liu M, 2008, J CELL MOL MED, V12, P1155, DOI 10.1111/j.1582-4934.2008.00288.x; Liu XN, 2008, BIOMED ENVIRON SCI, V21, P110, DOI 10.1016/S0895-3988(08)60015-X; Liu YX, 2009, CLONING STEM CELLS, V11, P51, DOI 10.1089/clo.2008.0049; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Marandi M, 2007, NEUROSCI LETT, V420, P198, DOI 10.1016/j.neulet.2007.04.041; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P149, DOI 10.1007/s00005-012-0213-y; QUINN D, 1991, J CELL BIOL, V113, P987, DOI 10.1083/jcb.113.5.987; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342; Xu YX, 2009, TRANSPL P, V41, P1878, DOI 10.1016/j.transproceed.2009.01.087	37	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e76056	10.1371/journal.pone.0076056	http://dx.doi.org/10.1371/journal.pone.0076056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058711	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900134
J	Zeng, RP; Zhang, XZ; Su, Y; Li, M; Wu, KF; Wen, F				Zeng, Renpan; Zhang, Xiongze; Su, Yu; Li, Meng; Wu, Kunfang; Wen, Feng			The Noninvasive Retro-Mode Imaging Modality of Confocal Scanning Laser Ophthalmoscopy in Polypoidal Choroidal Vasculopathy: A Preliminary Application	PLOS ONE			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; FUNDUS AUTOFLUORESCENCE; CHINESE PATIENTS; VISUALIZATION; FEATURES; LESIONS; EYES	Purpose: To evaluate the validity of the novel and noninvasive retro-mode imaging modality of confocal scanning laser ophthalmoscopy (cSLO) for detecting the morphological features of polypoidal choroidal vasculopathy (PCV). Design: Prospective, observational, consecutive case series. Methods: Twenty-six patients (29 eyes) with PCV were enrolled in this study. All patients underwent comprehensive ophthalmologic examinations and imaging studies, including retro-mode imaging, fundus autofluorescence (FAF), fundus photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA) and spectral-domain optical coherence tomography (SD-OCT). We investigated the retro-mode images and compared the results with those of SD-OCT, FFA and ICGA. Results: In the 29 PCV eyes, the retro-mode images clearly revealed polypoidal lesions in 27 (93.1%) eyes as well as branching vascular networks in 16 (55.2%) eyes. Others findings, including pigment epithelial detachment (PED) in 20 (69.0%) eyes, neuroretinal detachment (NRD) in 3 (10.3%) eyes, cystoid macular edema (CME) in 3 (10.3%) eyes, drusen in 4 (13.8%) eyes and minute granular changes of the retinal pigment epithelium (RPE) in 12 (41.3%) eyes, were also clearly visualized. When we compared the results with those of SD-OCT, FFA and ICGA, there was no significant difference between ICGA and retro-mode imaging for finding polypoidal lesions and (or) branching choroidal vascular networks (P>0.05). However, the rate of PED detection was significantly better with retro-mode imaging than with the ICGA (P<0.05). The differences were not statistically significant between SD-OCT and retro-mode imaging for detecting PED, NRD, CME, drusen and minute granular RPE changes (P>0.05). The differences were not statistically significant between FFA and retro-mode imaging for detecting PED, NRD, CME (P>0.05). Conclusions: The novel and noninvasive retro-mode imaging by cSLO is able to clearly visualize the morphological features of PCV.	[Zeng, Renpan; Zhang, Xiongze; Su, Yu; Li, Meng; Wu, Kunfang; Wen, Feng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wen, F (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	wenfeng208@yahoo.com.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [81271011, 81200705]; Fundamental Research Funds of State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This study was supported by the National Natural Science Foundation of China (grant number: 81271011 and 81200705) and the Fundamental Research Funds of State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Sachi, 2010, Ophthalmic Surg Lasers Imaging, P1, DOI 10.3928/15428877-20100215-76; Acton JH, 2011, ACTA OPHTHALMOL, V89, pE404, DOI 10.1111/j.1755-3768.2011.02123.x; Anastasakis A, 2011, RETINA-J RET VIT DIS, V31, P949, DOI 10.1097/IAE.0b013e3181f441f6; Ciardella AP, 2004, SURV OPHTHALMOL, V49, P25, DOI 10.1016/j.survophthal.2003.10.007; Elsner AE, 1996, VISION RES, V36, P191, DOI 10.1016/0042-6989(95)00100-E; Iijima H, 2000, AM J OPHTHALMOL, V129, P21, DOI 10.1016/S0002-9394(99)00253-6; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Jorzik JJ, 2005, RETINA-J RET VIT DIS, V25, P405, DOI 10.1097/00006982-200506000-00003; Katome T, 2012, RETINA-J RET VIT DIS, V32, P1892, DOI 10.1097/IAE.0b013e3182497141; Katome T, 2012, CLIN EXP OPHTHALMOL, V40, pE120, DOI 10.1111/j.1442-9071.2011.02699.x; Khan S, 2012, RETINA-J RET VIT DIS, V32, P1057, DOI 10.1097/IAE.0b013e31823beb14; Li XX, 2012, OPHTHALMOLOGY, V119, P2087, DOI 10.1016/j.ophtha.2012.05.016; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maurizio BP, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-8; Nagase S, 2012, OPHTHAL SURG LASERS, V43, P5; Ohkoshi K, 2010, AM J OPHTHALMOL, V150, P856, DOI 10.1016/j.ajo.2010.06.022; Pilotto E, 2013, GRAEF ARCH CLIN EXP, V251, P27, DOI 10.1007/s00417-012-2031-7; Saito M, 2008, RETINA-J RET VIT DIS, V28, P459, DOI 10.1097/IAE.0b013e318156db60; Sato T, 2007, RETINA-J RET VIT DIS, V27, P589, DOI 10.1097/01.iae.0000249386.63482.05; Shin YU, 2012, AM J OPHTHALMOL, V154, P155, DOI 10.1016/j.ajo.2012.01.023; Takeda Muneyasu, 2013, Nippon Ganka Gakkai Zasshi, V117, P44; Tanaka Y, 2010, AM J OPHTHALMOL, V149, P635, DOI 10.1016/j.ajo.2009.10.024; Ueno C, 2012, RETINA-J RET VIT DIS, V32, P2006, DOI 10.1097/IAE.0b013e31825c1c31; Vujosevic S, 2012, ACTA OPHTHALMOL, V90, pe374, DOI 10.1111/j.1755-3768.2012.02410.x; Wen F, 2004, GRAEF ARCH CLIN EXP, V242, P625, DOI 10.1007/s00417-003-0667-z; Yamagishi T, 2012, OPHTHALMOLOGY, V119, P1650, DOI 10.1016/j.ophtha.2012.02.016; Yamamoto M, 2010, CLIN EXP OPHTHALMOL, V38, P27, DOI 10.1111/j.1442-9071.2010.02193.x; Yamamoto Motoshi, 2009, International Ophthalmology, V29, P503, DOI 10.1007/s10792-008-9274-7; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296	30	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75711	10.1371/journal.pone.0075711	http://dx.doi.org/10.1371/journal.pone.0075711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058698	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900124
J	Chao, TF; Hung, CL; Tsao, HM; Lin, YJ; Yun, CH; Lai, YH; Chang, SL; Lo, LW; Hu, YF; Tuan, TC; Chang, HY; Kuo, JY; Yeh, HI; Wu, TJ; Hsieh, MH; Yu, WC; Chen, SA				Chao, Tze-Fan; Hung, Chung-Lieh; Tsao, Hsuan-Ming; Lin, Yenn-Jiang; Yun, Chun-Ho; Lai, Yau-Huei; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chang, Hung-Yu; Kuo, Jen-Yuan; Yeh, Hung-I; Wu, Tsu-Juey; Hsieh, Ming-Hsiung; Yu, Wen-Chung; Chen, Shih-Ann			Epicardial Adipose Tissue Thickness and Ablation Outcome of Atrial Fibrillation	PLOS ONE			English	Article							BODY-FAT COMPOSITION; CATHETER ABLATION; PERICARDIAL FAT; RISK; EFFICACY; ELECTROGRAMS; RECURRENCE; IMPACT	Objectives: Epicardial fat was closely related to atrial fibrillation (AF). Transthoracic echocardiography (TTE) has been proposed to be a convenient imaging tool in assessing epicardial adipose tissue (EAT). The goal of the present study was to investigate whether the EAT thickness measured on TTE was a useful parameter in predicting procedural outcomes of AF ablations. Methods and Results: A total of 227 paroxysmal AF (PAF) and 56 non-paroxysmal AF (non-PAF) patients receiving catheter ablations from 2008-2010 were enrolled. Echocardiography-derived regional EAT thickness from parasternal long-axis view was quantified for each patient. Free of recurrence was defined as the absence of atrial arrhythmias without using antiarrhythmic agents after ablations. The mean EAT thickness of the study population was 6.1 +/- 0.8 mm. Non-PAF patients had a thicker EAT than that of PAF patients (7.0 +/- 0.7 mm versus 5.9 +/- 0.7 mm, p value <0.001). During the follow-up of 16 +/- 9 months, there were 95 patients (33.6%) suffering from recurrences of atrial arrhythmias. Non-PAF, chads(2) score, left atrial diameter and EAT thickness were independent predictors of recurrence after catheter ablations. At a cutoff value of 6 mm for PAF and 6.9 mm for non-PAF, the measurement of EAT thickness could help us to identify patients at risk of recurrences. Conclusions: EAT thickness may serve as a useful parameter in predicting recurrences after AF ablations. Compared to other imaging modalities, TTE can be an alternative choice with less cost and time in assessing the effects of EAT on ablation outcomes.	[Chao, Tze-Fan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Yu, Wen-Chung; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chao, Tze-Fan; Tsao, Hsuan-Ming; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Wu, Tsu-Juey; Yu, Wen-Chung; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chao, Tze-Fan; Tsao, Hsuan-Ming; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Wu, Tsu-Juey; Yu, Wen-Chung; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Hung, Chung-Lieh; Lai, Yau-Huei; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Hung, Chung-Lieh; Lai, Yau-Huei; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Hung, Chung-Lieh; Lai, Yau-Huei; Kuo, Jen-Yuan; Yeh, Hung-I] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Hung, Chung-Lieh] Kainan Univ, Dept Hlth Ind Management, Taoyuan, Taiwan; [Tsao, Hsuan-Ming] Natl Yang Ming Univ Hosp, Div Cardiol, Ilan, Taiwan; [Yun, Chun-Ho] Mackay Mem Hosp, Dept Internal Med, Div Radiol, Taipei, Taiwan; [Chang, Hung-Yu] Cheng Hsin Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Wu, Tsu-Juey] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsieh, Ming-Hsiung] Taipei Med Univ, Wan Fang Hosp, Dept Med, Div Cardiol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Nan Kai University Technology; Mackay Memorial Hospital; Cheng Hsin General Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Yu, WC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	wcyu@vghtpe.gov.tw	Chang, Shih-Lin/AGT-1191-2022; Kuo, Jen-Yuan/AAX-5448-2021		Taipei Veterans General Hospital, Taiwan [V99C1-120, V100C-109, V101C-060]; National Science Council, Taiwan [NSC98-2314-B-010-031- MY3, NSC 99-2911-I-008-100, NSC99-2628-B-075-007-MY3, NSC100-2314-B-010-033- MY3]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural grants (V99C1-120, V100C-109 and V101C-060) from Taipei Veterans General Hospital, Taiwan, and grants (NSC98-2314-B-010-031- MY3, NSC 99-2911-I-008-100, NSC99-2628-B-075-007-MY3, NSC100-2314-B-010-033- MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Batal O, 2010, CIRC-ARRHYTHMIA ELEC, V3, P230, DOI 10.1161/CIRCEP.110.957241; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Chang HY, 2012, J CARDIOVASC ELECTR, V23, P955, DOI 10.1111/j.1540-8167.2012.02337.x; Chang SL, 2007, J CARDIOVASC ELECTR, V18, P607, DOI 10.1111/j.1540-8167.2007.00823.x; Chao TF, 2012, HEART RHYTHM, V9, P1185, DOI 10.1016/j.hrthm.2012.03.007; Chao TF, 2012, CIRC-ARRHYTHMIA ELEC, V5, P514, DOI 10.1161/CIRCEP.111.968032; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; Hartono B, 2012, J CARDIOVASC ELECTR, V23, P239, DOI 10.1111/j.1540-8167.2011.02170.x; Iacobellis G, 2004, AM J CARDIOL, V94, P1084, DOI 10.1016/j.amjcard.2004.06.075; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2008, OBESITY, V16, P887, DOI 10.1038/oby.2008.6; Jeong JW, 2007, CIRC J, V71, P536, DOI 10.1253/circj.71.536; Lai YH, 2012, J AM SOC ECHOCARDIOG, V25, P234, DOI 10.1016/j.echo.2011.09.018; Lin YJ, 2008, HEART RHYTHM, V5, P406, DOI 10.1016/j.hrthm.2007.12.009; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Lin YJ, 2009, J CARDIOVASC ELECTR, V20, P607, DOI 10.1111/j.1540-8167.2008.01393.x; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Nagashima K, 2011, CIRC J, V75, P2559, DOI 10.1253/circj.CJ-11-0554; Nelson MR, 2011, J AM SOC ECHOCARDIOG, V24, P339, DOI 10.1016/j.echo.2010.11.008; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sade LE, 2009, ATHEROSCLEROSIS, V204, P580, DOI 10.1016/j.atherosclerosis.2008.09.038; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Tsao HM, 2011, AM J CARDIOL, V107, P1498, DOI 10.1016/j.amjcard.2011.01.027; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Yun CH, 2012, EUR J RADIOL, V81, P749, DOI 10.1016/j.ejrad.2011.01.035	32	47	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74926	10.1371/journal.pone.0074926	http://dx.doi.org/10.1371/journal.pone.0074926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066158	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000140
J	Kim, SR; Jung, YR; An, HJ; Kim, DH; Jang, EJ; Choi, YJ; Moon, KM; Park, MH; Park, CH; Chung, KW; Bae, HR; Choi, YW; Kim, ND; Chung, HY				Kim, So Ra; Jung, Yu Ri; An, Hye Jin; Kim, Dae Hyun; Jang, Eun Ji; Choi, Yeon Ja; Moon, Kyoung Mi; Park, Min Hi; Park, Chan Hum; Chung, Ki Wung; Bae, Ha Ram; Choi, Yung Whan; Kim, Nam Deuk; Chung, Hae Young			Anti-Wrinkle and Anti-Inflammatory Effects of Active Garlic Components and the Inhibition of MMPs via NF-kB Signaling	PLOS ONE			English	Article							FACTOR-KAPPA-B; MATRIX METALLOPROTEINASE-1; ULTRAVIOLET-IRRADIATION; SKIN; CYCLOOXYGENASE; MODULATION; DEPENDENCE; PROTEINS; CELLS; AP-1	Skin aging is a multisystem degenerative process caused by several factors, such as, UV irradiation, stress, and smoke. Furthermore, wrinkle formation is a striking feature of photoaging and is associated with oxidative stress and inflammatory response. In the present study, we investigated whether caffeic acid, S-allyl cysteine, and uracil, which were isolated from garlic, modulate UVB-induced wrinkle formation and effect the expression of matrix-metalloproteinase (MMP) and NF-kB signaling. The results obtained showed that all three compounds significantly inhibited the degradation of type. procollagen and the expressions of MMPs in vivo and attenuated the histological collagen fiber disorder and oxidative stress in vivo. Furthermore, caffeic acid and S-allyl cysteine were found to decrease oxidative stress and inflammation by modulating the activities of NF-kB and AP-1, and uracil exhibited an indirect anti-oxidant effect by suppressing cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expressions levels and downregulating transcriptional factors. These results suggest that the anti-wrinkle effects of caffeic acid, S-allyl cysteine, and uracil are due to anti-oxidant and/or anti-inflammatory effects. Summarizing, caffeic acid, S-allyl cysteine, and uracil inhibited UVB-induced wrinkle formation by modulating MMP via NF-kB signaling.	[Kim, So Ra; Jung, Yu Ri; An, Hye Jin; Kim, Dae Hyun; Jang, Eun Ji; Choi, Yeon Ja; Moon, Kyoung Mi; Park, Min Hi; Park, Chan Hum; Chung, Ki Wung; Bae, Ha Ram; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan, South Korea; [Choi, Yung Whan] Pusan Natl Univ, Dept Hort Biosci, Miryang, South Korea	Pusan National University; Pusan National University	Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan, South Korea.	hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020		"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ00652213]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ00652213)" Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzi A, 2004, ANN NY ACAD SCI, V1031, P86, DOI 10.1196/annals.1331.009; Beak SM, 2004, BIOCHIMIE, V86, P425, DOI 10.1016/j.biochi.2004.06.010; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Breidenbach M, 2006, CANCER LETT, V240, P114, DOI 10.1016/j.canlet.2005.09.007; Chen Z, 2005, J INVEST DERMATOL, V124, P70, DOI 10.1111/j.0022-202X.2004.23550.x; Chiang HM, 2011, FOOD CHEM TOXICOL, V49, P309, DOI 10.1016/j.fct.2010.10.034; Colin-Gonzalez AL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/907162; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Fineschi S, 2007, RHEUMATOLOGY, V46, P1779, DOI 10.1093/rheumatology/kem241; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 2001, J INVEST DERMATOL, V117, P219, DOI 10.1046/j.0022-202x.2001.01432.x; HABIB A, 1993, J BIOL CHEM, V268, P23448; Ishitsuka Y, 2012, CLIN EXP DERMATOL, V37, P252, DOI 10.1111/j.1365-2230.2011.04215.x; Ishitsuka Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P698, DOI 10.1562/2006-07-24-RA-978; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Kim JM, 2006, FREE RADICAL RES, V40, P827, DOI 10.1080/10715760600719540; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; Leo L, 2008, J AGR FOOD CHEM, V56, P4154, DOI 10.1021/jf073322w; LIU M, 1994, CARCINOGENESIS, V15, P1089, DOI 10.1093/carcin/15.6.1089; Masnec IS, 2008, COLLEGIUM ANTROPOL, V32, P177; OKADA Y, 1995, LAB INVEST, V72, P311; Pfau JC, 2011, J IMMUNOTOXICOL, V8, P159, DOI 10.3109/1547691X.2011.562257; Pillai S., 2005, International Journal of Cosmetic Science, V27, P17, DOI 10.1111/j.1467-2494.2004.00241.x; Pluemsamran T, 2012, PHOTOCHEM PHOTOBIOL, V88, P961, DOI 10.1111/j.1751-1097.2012.01118.x; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Schwartz GK, 2005, J CLIN ONCOL, V23, P4499, DOI 10.1200/JCO.2005.18.341; Studzinski GP, 1996, CANCER RES, V56, P5513; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024; Yamamoto Y, 2001, J DERMATOL SCI, V27, pS1	36	98	103	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73877	10.1371/journal.pone.0073877	http://dx.doi.org/10.1371/journal.pone.0073877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066081	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000063
J	Maiorano, L; Amori, G; Capula, M; Falcucci, A; Masi, M; Montemaggiori, A; Pottier, J; Psomas, A; Rondinini, C; Russo, D; Zimmermann, NE; Boitani, L; Guisan, A				Maiorano, Luigi; Amori, Giovanni; Capula, Massimo; Falcucci, Alessandra; Masi, Monica; Montemaggiori, Alessandro; Pottier, Julien; Psomas, Achilleas; Rondinini, Carlo; Russo, Danilo; Zimmermann, Niklaus E.; Boitani, Luigi; Guisan, Antoine			Threats from Climate Change to Terrestrial Vertebrate Hotspots in Europe	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; POTENTIAL IMPACTS; PROTECTED AREAS; FUTURE; DISTRIBUTIONS; COINCIDENCE; DIVERSITY; RESPONSES; PATTERNS; SURFACES	We identified hotspots of terrestrial vertebrate species diversity in Europe and adjacent islands. Moreover, we assessed the extent to which by the end of the 21st century such hotspots will be exposed to average monthly temperature and precipitation patterns which can be regarded as extreme if compared to the climate experienced during 1950-2000. In particular, we considered the entire European sub-continent plus Turkey and a total of 1149 species of terrestrial vertebrates. For each species, we developed species-specific expert-based distribution models (validated against field data) which we used to calculate species richness maps for mammals, breeding birds, amphibians, and reptiles. Considering four global circulation model outputs and three emission scenarios, we generated an index of risk of exposure to extreme climates, and we used a bivariate local Moran's I to identify the areas with a significant association between hotspots of diversity and high risk of exposure to extreme climates. Our results outline that the Mediterranean basin represents both an important hotspot for biodiversity and especially for threatened species for all taxa. In particular, the Iberian and Italian peninsulas host particularly high species richness as measured over all groups, while the eastern Mediterranean basin is particularly rich in amphibians and reptiles; the islands (both Macaronesian and Mediterranean) host the highest richness of threatened species for all taxa occurs. Our results suggest that the main hotspots of biodiversity for terrestrial vertebrates may be extensively influenced by the climate change projected to occur over the coming decades, especially in the Mediterranean bioregion, posing serious concerns for biodiversity conservation.	[Maiorano, Luigi; Pottier, Julien; Guisan, Antoine] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Maiorano, Luigi; Falcucci, Alessandra; Masi, Monica; Montemaggiori, Alessandro; Rondinini, Carlo; Boitani, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Amori, Giovanni] CNR, Inst Ecosyst Studies, Rome, Italy; [Capula, Massimo] Museo Civ Zool, Rome, Italy; [Psomas, Achilleas; Zimmermann, Niklaus E.] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Russo, Danilo] Univ Naples Federico II, Dipartimento Agr, Portici, Italy; [Guisan, Antoine] Univ Lausanne, Inst Earth Sci, Lausanne, Switzerland	University of Lausanne; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Naples Federico II; University of Lausanne	Maiorano, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	luigi.maiorano@uniroma1.it	Zimmermann, Niklaus E./A-4276-2008; Rondinini, Carlo/E-9027-2011; Psomas, Achilleas/M-1141-2013; Guisan, Antoine/A-1057-2011; Maiorano, Luigi/A-8637-2008	Zimmermann, Niklaus E./0000-0003-3099-9604; Guisan, Antoine/0000-0002-3998-4815; Maiorano, Luigi/0000-0002-2957-8979; Russo, Danilo/0000-0002-1934-7130; Rondinini, Carlo/0000-0002-6617-018X				Anandhi A, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009104; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bartolino V, 2011, POPUL ECOL, V53, P351, DOI 10.1007/s10144-010-0229-2; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Catullo G, 2008, BIOL CONSERV, V141, P2730, DOI 10.1016/j.biocon.2008.08.019; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chen J, 2011, J HYDROL, V401, P190, DOI 10.1016/j.jhydrol.2011.02.020; Civantos E, 2012, BIOSCIENCE, V62, P658, DOI 10.1525/bio.2012.62.7.8; COX N, 2006, STATUS DISTRIBUTION; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Davis S.D., 1994, CTR PLANT DIVERSITY, V1; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Diaz-Nieto J, 2005, CLIMATIC CHANGE, V69, P245, DOI 10.1007/s10584-005-1157-6; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Falcucci A, 2008, J MAMMAL, V89, P1502, DOI 10.1644/07-MAMM-A-229.1; Flojgaard C, 2011, GLOBAL ECOL BIOGEOGR, V20, P218, DOI 10.1111/j.1466-8238.2010.00604.x; Fronzek S, 2012, GLOBAL ECOL BIOGEOGR, V21, P19, DOI 10.1111/j.1466-8238.2011.00695.x; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; Gaston Kevin J., 1994, Biodiversity Letters, V2, P108, DOI 10.2307/2999714; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Mackey BG, 2001, J BIOGEOGR, V28, P1147, DOI 10.1046/j.1365-2699.2001.00626.x; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MUdail F., 2006, ANN GEOGR, V651, P618, DOI DOI 10.3406/GE0.2006.21290; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Ohlemuller R, 2006, GLOBAL ECOL BIOGEOGR, V15, P395, DOI 10.1111/j.1466-822X.2006.00245.x; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pascual LL, 2011, ACTA OECOL, V37, P399, DOI 10.1016/j.actao.2011.05.004; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Sindaco Roberto, 2008, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wintle BA, 2011, NAT CLIM CHANGE, V1, P355, DOI 10.1038/NCLIMATE1227; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	60	61	63	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74989	10.1371/journal.pone.0074989	http://dx.doi.org/10.1371/journal.pone.0074989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066162	Green Published, gold			2022-12-27	WOS:000324494000144
J	Ohta, S; Misawa, A; Lefebvre, V; Okano, H; Kawakami, Y; Toda, M				Ohta, Shigeki; Misawa, Aya; Lefebvre, Veronique; Okano, Hideyuki; Kawakami, Yutaka; Toda, Masahiro			Sox6 Up-Regulation by Macrophage Migration Inhibitory Factor Promotes Survival and Maintenance of Mouse Neural Stem/Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; EXPRESSION; GENE; IDENTIFICATION; PROTEINS; L-SOX5; FAMILY	Macrophage migration inhibitory factor (MIF) has important roles in supporting the proliferation and/or survival of murine neural stem/progenitor cells (NSPCs), but downstream effectors remain unknown. We show here that MIF robustly increases the expression of Sox6 in NSPCs in vitro. During neural development, Sox6 is expressed in the ventricular zone of the ganglionic eminence (GE) of mouse brains at embryonic day 14.5 (E14.5), cultured NSPCs from E14.5 GE, and NSPCs in the subventricular zone (SVZ) around the lateral ventricle (LV) of the adult mouse forebrain. Retroviral overexpression of Sox6 in NSPCs increases the number of primary and secondary neurospheres and inhibits cell differentiation. This effect is accompanied with increased expression of Hes1 and Bcl-2 and Akt phosphorylation, thus suggesting a role for Sox6 in promoting cell survival and/or self-renewal ability. Constitutive activation of the transcription factor Stat3 results in up-regulation of Sox6 expression and chromatin immunoprecipitation analysis showed that MIF increases Stat3 binding to the Sox6 promoter in NSPCs, indicating that Stat3 stimulates Sox6 expression downstream of MIF. Finally, the ability of MIF to increase the number of primary and secondary neurospheres is inhibited by Sox6 gene silencing. Collectively, our data identify Sox6 as an important downstream effector of MIF signaling in stemness maintenance of NSPCs.	[Ohta, Shigeki; Misawa, Aya; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling,Shinjuku Ku, Tokyo, Japan; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med NC10, Cleveland, OH 44106 USA; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Toda, Masahiro] Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Tokyo 160, Japan	Keio University; Cleveland Clinic Foundation; Keio University; Keio University	Kawakami, Y (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling,Shinjuku Ku, Tokyo, Japan.	yutakawa@z5.keio.jp; todam@z2.keio.jp	Kawakami, Yutaka/E-7429-2013; Ohta, shigeki/L-1677-2013; Okano, Hideyuki/I-7584-2019; Ohta, Shigeki/Y-4455-2019; nakamura, asuka/S-7235-2016	Kawakami, Yutaka/0000-0003-4836-2855; Ohta, Shigeki/0000-0003-2994-4278; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, a Grant-in-Aid for the Global COE program to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Hamada-Kanazawa M, 2004, FEBS LETT, V560, P192, DOI 10.1016/S0014-5793(04)00086-9; Hattori Y, 2007, BIOCHEM BIOPH RES CO, V364, P737, DOI 10.1016/j.bbrc.2007.10.041; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Ikeda T, 2007, BIOCHEM BIOPH RES CO, V357, P383, DOI 10.1016/j.bbrc.2007.03.133; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kitamura T, 1998, INT J HEMATOL, V67, P351; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Scheel JR, 2005, NAT METHODS, V2, P363, DOI 10.1038/nmeth755; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Ueda R, 2004, ONCOGENE, V23, P1420, DOI 10.1038/sj.onc.1207252; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	31	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74315	10.1371/journal.pone.0074315	http://dx.doi.org/10.1371/journal.pone.0074315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066135	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000117
J	Owen, JA; Barreto, E; Cressman, JR				Owen, Jeremy A.; Barreto, Ernest; Cressman, John R.			Controlling Seizure-Like Events by Perturbing Ion Concentration Dynamics with Periodic Stimulation	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; LOW-FREQUENCY STIMULATION; ELECTRICAL-STIMULATION; ANTERIOR NUCLEUS; MODEL; THALAMUS; EPILEPSY	We investigate the effects of adding periodic stimulation to a generic, conductance-based neuron model that includes ion concentration dynamics of sodium and potassium. Under conditions of high extracellular potassium, the model exhibits repeating, spontaneous, seizure-like bursting events associated with slow modulation of the ion concentrations local to the neuron. We show that for a range of parameter values, depolarizing and hyperpolarizing periodic stimulation pulses (including frequencies lower than 4 Hz) can stop the spontaneous bursting by interacting with the ion concentration dynamics. Stimulation can also control the magnitude of evoked responses to modeled physiological inputs. We develop an understanding of the nonlinear dynamics of this system by a timescale separation procedure that identifies effective nullclines in the ion concentration parameter space. Our results suggest that the manipulation of ion concentration dynamics via external or endogenous stimulation may play an important role in neuronal excitability, seizure dynamics, and control.	[Owen, Jeremy A.] Univ Cambridge, Kings Coll, Cambridge, England; [Barreto, Ernest; Cressman, John R.] George Mason Univ, Sch Phys Astron & Computat Sci, Fairfax, VA 22030 USA; [Barreto, Ernest; Cressman, John R.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	University of Cambridge; George Mason University; George Mason University	Cressman, JR (corresponding author), George Mason Univ, Sch Phys Astron & Computat Sci, Fairfax, VA 22030 USA.	jcressma@gmu.edu	Barreto, Ernest/AAM-6677-2021	Barreto, Ernest/0000-0003-3781-7797	George Mason University Libraries Open Access Publishing Fund; JRC Start up funds; National Institutes of Health Collaborative Research in Computational Neuroscience [EB NIH CRCNS R01-MH079502]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079502] Funding Source: NIH RePORTER	George Mason University Libraries Open Access Publishing Fund; JRC Start up funds; National Institutes of Health Collaborative Research in Computational Neuroscience(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund, JRC Start up funds, and EB NIH CRCNS R01-MH079502 (National Institutes of Health Collaborative Research in Computational Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avoli M, 2001, EPILEPSIA, V42, P2, DOI 10.1046/j.1528-1157.2001.042suppl.3002.x; Barbarosie M, 2000, J NEUROPHYSIOL, V83, P1115, DOI 10.1152/jn.2000.83.3.1115; Barbarosie M, 1997, J NEUROSCI, V17, P9308; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Chkhenkeli SA, 2004, CLIN NEUROL NEUROSUR, V106, P318, DOI 10.1016/j.clineuro.2004.01.009; Cressman J, 2011, CLIN GENETIC ASPECTS; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; Dayan P, 2001, COMPUTATIONAL NEUROS; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Fridley J, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11334; Gluckman BJ, 2001, J NEUROSCI, V21, P590, DOI 10.1523/JNEUROSCI.21-02-00590.2001; GROSSMAN Y, 1979, J PHYSIOL-LONDON, V295, P283, DOI 10.1113/jphysiol.1979.sp012969; Halpern CH, 2008, NEUROTHERAPEUTICS, V5, P59, DOI 10.1016/j.nurt.2007.10.065; Hamani C, 2008, EPILEPSY RES, V78, P117, DOI 10.1016/j.eplepsyres.2007.09.010; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; HOTSON JR, 1973, EXP NEUROL, V38, P20, DOI 10.1016/0014-4886(73)90004-6; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; JERGER K, 1995, J NEUROPHYSIOL, V73, P876, DOI 10.1152/jn.1995.73.2.876; Jiruska P, 2010, EPILEPSIA, V51, P93, DOI 10.1111/j.1528-1167.2010.02619.x; Khosravani H, 2003, BIOPHYS J, V84, P687, DOI 10.1016/S0006-3495(03)74888-7; Kile KB, 2010, EPILEPSIA, V51, P1745, DOI 10.1111/j.1528-1167.2010.02679.x; Kinoshita M, 2005, CLIN NEUROPHYSIOL, V116, P1291, DOI 10.1016/j.clinph.2005.02.010; Kinoshita M, 2004, EPILEPSIA, V45, P787, DOI 10.1111/j.0013-9580.2004.60203.x; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Nagel SJ, 2009, NEUROMODULATION, V12, P270, DOI 10.1111/j.1525-1403.2009.00239.x; RAFIQ A, 1995, J NEUROPHYSIOL, V74, P2028, DOI 10.1152/jn.1995.74.5.2028; Rashid S, 2012, EPILEPSIA, V53, P147, DOI 10.1111/j.1528-1167.2011.03348.x; Rolston JD, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11335; Schulze-Bonhage A, 2009, DTSCH ARZTEBL INT, V106, P407, DOI 10.3238/arztebl.2009.0407; Sunderam S, 2010, EPILEPSY BEHAV, V17, P6, DOI 10.1016/j.yebeh.2009.10.017; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Zandt BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022127; Zhong XL, 2011, BRAIN RES BULL, V85, P81, DOI 10.1016/j.brainresbull.2011.03.020; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73820	10.1371/journal.pone.0073820	http://dx.doi.org/10.1371/journal.pone.0073820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066075	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000057
J	Volk, M; Maver, A; Lovrecic, L; Juvan, P; Peterlin, B				Volk, Marija; Maver, Ales; Lovrecic, Luca; Juvan, Peter; Peterlin, Borut			Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21	PLOS ONE			English	Article							DOWN-SYNDROME BRAIN; GENE-EXPRESSION; HUMAN FETUSES; CLASSIFICATION; HEART	A universal biomarker panel with the potential to predict high-risk pregnancies or adverse pregnancy outcome does not exist. Transcriptome analysis is a powerful tool to capture differentially expressed genes (DEG), which can be used as biomarker-diagnostic-predictive tool for various conditions in prenatal setting. In search of biomarker set for predicting high-risk pregnancies, we performed global expression profiling to find DEG in Ts21. Subsequently, we performed targeted validation and diagnostic performance evaluation on a larger group of case and control samples. Initially, transcriptomic profiles of 10 cultivated amniocyte samples with Ts21 and 9 with normal euploid constitution were determined using expression microarrays. Datasets from Ts21 transcriptomic studies from GEO repository were incorporated. DEG were discovered using linear regression modelling and validated using RT-PCR quantification on an independent sample of 16 cases with Ts21 and 32 controls. The classification performance of Ts21 status based on expression profiling was performed using supervised machine learning algorithm and evaluated using a leaveone- out cross validation approach. Global gene expression profiling has revealed significant expression changes between normal and Ts21 samples, which in combination with data from previously performed Ts21 transcriptomic studies, were used to generate a multi-gene biomarker for Ts21, comprising of 9 gene expression profiles. In addition to biomarker's high performance in discriminating samples from global expression profiling, we were also able to show its discriminatory performance on a larger sample set 2, validated using RT-PCR experiment (AUC = 0.97), while its performance on data from previously published studies reached discriminatory AUC values of 1.00. Our results show that transcriptomic changes might potentially be used to discriminate trisomy of chromosome 21 in the prenatal setting. As expressional alterations reflect both, causal and reactive cellular mechanisms, transcriptomic changes may thus have future potential in the diagnosis of a wide array of heterogeneous diseases that result from genetic disturbances.	[Volk, Marija; Maver, Ales; Lovrecic, Luca; Peterlin, Borut] Univ Med Ctr, Dept Obstet & Gynecol, Clin Inst Med Genet, Ljubljana, Slovenia; [Juvan, Peter] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Genom & Biochips, Ljubljana 61000, Slovenia	University Medical Centre Ljubljana; University of Ljubljana	Peterlin, B (corresponding author), Univ Med Ctr, Dept Obstet & Gynecol, Clin Inst Med Genet, Ljubljana, Slovenia.	medicalgenetics.umcl@gmail.com	Peterlin, Borut/C-6086-2011; Lovrecic, Luca/S-8196-2018	Peterlin, Borut/0000-0001-7824-4978; Lovrecic, Luca/0000-0003-4119-9530; Juvan, Peter/0000-0003-2873-5247	Slovenian Research Agency [P3-03269]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work has been supported by Slovenian Research Agency grant number P3-03269 (http://www.arrs.gov.si). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altug-Teber O, 2007, CYTOGENET GENOME RES, V119, P171, DOI 10.1159/000112058; Chou CY, 2008, MAMM GENOME, V19, P398, DOI 10.1007/s00335-008-9121-1; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Giannone S, 2004, ANN HUM GENET, V68, P546, DOI 10.1046/j.1529-8817.2003.00123.x; Gudgeon JM, 2007, GENET MED, V9, P473, DOI 10.1097/GIM.0b013e3180a6e9ef; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Rozovski U, 2007, HUM REPROD, V22, P2538, DOI 10.1093/humrep/dem214; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000	20	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74184	10.1371/journal.pone.0074184	http://dx.doi.org/10.1371/journal.pone.0074184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066117	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000099
J	Geng, B; Cai, B; Liao, F; Zheng, Y; Zeng, Q; Fan, XF; Gong, YS; Yang, JC; Cui, QH; Tang, CS; Xu, GH				Geng, Bin; Cai, Bo; Liao, Feng; Zheng, Yang; Zeng, Qiang; Fan, Xiaofang; Gong, Yongsheng; Yang, Jichun; Cui, Qing Hua; Tang, Chaoshu; Xu, Guo Heng			Increase or Decrease Hydrogen Sulfide Exert Opposite Lipolysis, but Reduce Global Insulin Resistance in High Fatty Diet Induced Obese Mice	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; GAMMA-GLUTAMYL-TRANSFERASE; PROTEIN-KINASE; GLUCOSE-UTILIZATION; 3T3L1 ADIPOCYTES; PLASMA CYSTEINE; METABOLISM; PHOSPHORYLATION; ACTIVATION	Objective: Adipose tissue expressed endogenous cystathionine gamma lyase (CSE)/hydrogen sulfide (H2S) system. H2S precursor inhibited catecholamine stimulated lipolysis. Thus, we hypothesized that CSE/H2S system regulates lipolysis which contributed to the pathogenesis of insulin resistance. Methods: We treated rat adipocyte with DL-propargylglycine (PAG, a CSE inhibitor), L-cysteine (an H2S precursor) plus pyridoxial phosphate (co-enzyme) or the H2S chronic release donor GYY4137, then the glycerol level was assayed for assessing the lipolysis. Then, the effects of PAG and GYY4137 on insulin resistance in high fatty diet (HFD) induced obese mice were investigated. Results: Here, we found that PAG time-dependently increased basal or isoproterenol stimulated lipolysis. However, L-cysteine plus pyridoxial phosphate or GYY4137 significantly reduced it. PAG increased phosphorylated protein kinase A substrate, perilipin 1 and hormone sensitive lipase, but L-cysteine and GYY4137 decreased the parameters. In HFD induced obese mice, PAG increased adipose basal lipolysis, thus blunted fat mass increase, resulting in lowering insulin resistance evidenced by reduction of fasting glucose, insulin level, HOMA index, oral glucose tolerance test (OGTT) curve area and elevating the insulin tolerance test (ITT) response. GYY4137 inhibited lipolysis in vivo without increasing fat mass, but also ameliorated the insulin resistance in HFD mice. Conclusion: These results implicated that inhibition endogenous CSE/H2S system in adipocytes increased lipolysis by a protein kinase A-perilipin/hormone-sensitive lipase pathway, thus blunted fat mass increase and reduced insulin resistance in obese mice; giving H2S donor decreased lipolysis, also reduced insulin resistance induced by HFD. Our data showed that increase or decrease H2S induced opposite lipolysis, but had the same effect on insulin resistance. The paradoxical regulation may be resulted from different action of H2S on metabolic and endocrine function in adipocyte.	[Geng, Bin; Cai, Bo; Liao, Feng; Zheng, Yang; Yang, Jichun; Cui, Qing Hua; Tang, Chaoshu; Xu, Guo Heng] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Cai, Bo] Guangdong Med Collage, Dept Physiol, Zhan Jiang, Guangdong, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng; Tang, Chaoshu] Wenzhou Med Univ, Inst Hypoxia Med, Wen Zhou, Zhejiang, Peoples R China	Peking University; Guangdong Medical University; Chinese People's Liberation Army General Hospital; Wenzhou Medical University	Geng, B (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	bingeng@hsc.pku.edu.cn; xug@hsc.pku.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	Major State Basic Research Development Program of the People's Republic of China [2012CB517806, 2009CB941603]; National Natural Science Foundation of the People's Republic China [81170235, 81070114]	Major State Basic Research Development Program of the People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of the People's Republic China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of the People's Republic of China (nos. 2012CB517806 and 2009CB941603) and the National Natural Science Foundation of the People's Republic China (nos. 81170235 and 81070114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Chang L, 2008, AMINO ACIDS, V34, P573, DOI 10.1007/s00726-007-0011-8; Commerford SR, 2000, AM J PHYSIOL-ENDOC M, V279, pE875, DOI 10.1152/ajpendo.2000.279.4.E875; CZECH MP, 1972, J BIOL CHEM, V247, P6218; CZECH MP, 1974, J BIOL CHEM, V249, P1001; Dhawan SS, 2011, ATHEROSCLEROSIS, V219, P266, DOI 10.1016/j.atherosclerosis.2011.05.020; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; Elshorbagy AK, 2011, NUTR METAB CARDIOVAS; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Giral P, 2008, ARTERIOSCL THROM VAS, V28, P587, DOI 10.1161/ATVBAHA.107.157891; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Huang CY, 2012, CELL BIOCH FUNCT; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kawasaki M, 2010, CYTOTECHNOLOGY, V62, P225, DOI 10.1007/s10616-010-9282-0; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Londos C, 1996, INT J OBESITY, V20, pS97; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; OLEFSKY JM, 1979, HORM METAB RES, V11, P209, DOI 10.1055/s-0028-1092709; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; van den Brandhof WE, 2001, ATHEROSCLEROSIS, V157, P403, DOI 10.1016/S0021-9150(00)00724-3; Wueest S, 2009, DIABETOLOGIA, V52, P541, DOI 10.1007/s00125-008-1223-5; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yong QC, 2008, J MOL CELL CARDIOL, V44, P701, DOI 10.1016/j.yjmcc.2008.01.007; Yu Fang, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P493; de Pina MZ, 2008, J BIOL CHEM, V283, P12373, DOI 10.1074/jbc.M706832200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	42	53	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73892	10.1371/journal.pone.0073892	http://dx.doi.org/10.1371/journal.pone.0073892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058499	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400039
J	Helminen, A; Vakevainen, S; Salaspuro, M				Helminen, Andreas; Vakevainen, Satu; Salaspuro, Mikko			ALDH2 Genotype Has No Effect on Salivary Acetaldehyde without the Presence of Ethanol in the Systemic Circulation	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER-RISK; ALDEHYDE DEHYDROGENASE-2; GENETIC POLYMORPHISMS; ALDH2-DEFICIENT SUBJECTS; GASTRIC-CANCER; ALCOHOL; TOBACCO; ADH1B; CONSUMPTION	Background: Acetaldehyde associated with alcoholic beverages was recently classified as carcinogenic (Group 1) to humans based on uniform epidemiological and biochemical evidence. ALDH2 (aldehyde dehydrogenase 2) deficient alcohol consumers are exposed to high concentrations of salivary acetaldehyde and have an increased risk of upper digestive tract cancer. However, this interaction is not seen among ALDH2 deficient non-drinkers or rare drinkers, regardless of their smoking status or consumption of edibles containing ethanol or acetaldehyde. Therefore, the aim of this study was to examine the effect of the ALDH2 genotype on the exposure to locally formed acetaldehyde via the saliva without ethanol ingestion. Methods: The ALDH2 genotypes of 17 subjects were determined by PCR-RFLP. The subjects rinsed out their mouths with 5 ml of 40 vol% alcohol for 5 seconds. Salivary ethanol and acetaldehyde levels were measured by gas chromatography. Results: Acetaldehyde reached mutagenic levels rapidly and the exposure continued for up to 20 minutes. The mean salivary acetaldehyde concentrations did not differ between ALDH2 genotypes. Conclusions: For ALDH2 deficient subjects, an elevated exposure to endogenously formed acetaldehyde requires the presence of ethanol in the systemic circulation. Impact: Our findings provide a logical explanation for how there is an increased incidence of upper digestive tract cancers among ALDH2 deficient alcohol drinkers, but not among those ALDH2 deficient subjects who are locally exposed to acetaldehyde without bloodborne ethanol being delivered to the saliva. Thus, ALDH2 deficient alcohol drinkers provide a human model for increased local exposure to acetaldehyde derived from the salivary glands.	[Helminen, Andreas; Vakevainen, Satu; Salaspuro, Mikko] Univ Helsinki, Fac Med, Res Unit Acetaldehyde & Canc, Helsinki, Finland	University of Helsinki	Helminen, A (corresponding author), Univ Helsinki, Fac Med, Res Unit Acetaldehyde & Canc, Helsinki, Finland.	andreas.helminen@helsinki.fi	Salaspuro, Mikko/AAW-5575-2021	Netti, Andreas/0000-0003-1226-521X; Salaspuro, Mikko/0000-0002-7562-5414	Yrjo Jahnsson Foundation [6234, 6071]; Sigrid Juselius Foundation [642]	Yrjo Jahnsson Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Funding provided by Yrjo Jahnsson Foundation grant number 6234 (AH), Yrjo Jahnsson Foundation grant number 6071 (SV), Sigrid Juselius Foundation grant number 642 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, EVAL MONOGR CARCIN 1, V71, P1; Balbo S, 2012, CANCER EPIDEM BIOMAR, V21, P601, DOI 10.1158/1055-9965.EPI-11-1175; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Dong YJ, 1996, ALCOHOL, V13, P257, DOI 10.1016/0741-8329(95)02052-7; FERON VJ, 1991, MUTAT RES, V259, P363, DOI 10.1016/0165-1218(91)90128-9; GOEDDE HW, 1992, HUM GENET, V88, P344; Hayashida M, 2010, ANAL SCI, V26, P503, DOI 10.2116/analsci.26.503; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Hui, 2004, HDB FOOD BEVERAGE FE; Islami F, 2009, BRIT J CANCER, V101, P1641, DOI 10.1038/sj.bjc.6605372; Kurkivuori J, 2007, ORAL ONCOL, V43, P181, DOI 10.1016/j.oraloncology.2006.02.005; Lachenmeier DW, 2009, ADDICTION, V104, P533, DOI 10.1111/j.1360-0443.2009.02516.x; Lee CH, 2008, INT J CANCER, V122, P1347, DOI 10.1002/ijc.23264; Linderborg K, 2011, FOOD CHEM TOXICOL, V49, P2103, DOI 10.1016/j.fct.2011.05.024; Muto M, 2000, INT J CANCER, V88, P342, DOI 10.1002/1097-0215(20001101)88:3&lt;342::AID-IJC4&gt;3.0.CO;2-I; Nieminen MT, 2013, CANCER EPIDEM BIOMAR, V22, P69, DOI 10.1158/1055-9965.EPI-12-0908; Nieminen MT, 2009, ORAL ONCOL, V45, pE245, DOI 10.1016/j.oraloncology.2009.08.002; Pelucchi C, 2008, EUR J CANCER PREV, V17, P340, DOI 10.1097/CEJ.0b013e3282f75e91; Ren JS, 2012, CANCER EPIDEM BIOMAR, V21, P905, DOI 10.1158/1055-9965.EPI-12-0202; Salaspuro M, 2011, J DIGEST DIS, V12, P51, DOI 10.1111/j.1751-2980.2011.00480.x; Salaspuro M, 2009, SCAND J GASTROENTERO, V44, P912, DOI 10.1080/00365520902912563; Salaspuro V, 2004, INT J CANCER, V111, P480, DOI 10.1002/ijc.20293; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; TUYNS AJ, 1977, B CANCER, V64, P45; Uebelacker M, 2011, J AUTOM METHOD MANAG, DOI 10.1155/2011/907317; Vakevainen S, 2001, ALCOHOL CLIN EXP RES, V25, P829, DOI 10.1111/j.1530-0277.2001.tb02286.x; Vakevainen S, 2000, ALCOHOL CLIN EXP RES, V24, P873, DOI 10.1111/j.1530-0277.2000.tb02068.x; Wang XQ, 2012, J AM COLL NUTR, V31, P375, DOI 10.1080/07315724.2012.10720447; Wu M, 2013, INT J CANCER, V132, P1868, DOI 10.1002/ijc.27803; Yang SJ, 2007, WORLD J GASTROENTERO, V13, P5760, DOI 10.3748/wjg.v13.i43.5760; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 1996, CANCER EPIDEM BIOMAR, V5, P99; Yokoyama A, 1997, CANCER EPIDEM BIOMAR, V6, P1105; Yokoyama A, 2008, ALCOHOL CLIN EXP RES, V32, P1607, DOI 10.1111/j.1530-0277.2008.00739.x; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115; Zeka A, 2003, CANCER CAUSE CONTROL, V14, P897, DOI 10.1023/B:CACO.0000003854.34221.a8; Zhang GH, 2010, WORLD J GASTROENTERO, V16, P6020, DOI 10.3748/wjg.v16.i47.6020	42	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74418	10.1371/journal.pone.0074418	http://dx.doi.org/10.1371/journal.pone.0074418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058561	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400074
J	Tait, LW; Schiel, DR				Tait, Leigh W.; Schiel, David R.			Impacts of Temperature on Primary Productivity and Respiration in Naturally Structured Macroalgal Assemblages	PLOS ONE			English	Article							MACROCYSTIS-PYRIFERA; BENTHIC METABOLISM; SEASONAL-VARIATION; PHOTOSYNTHESIS; LIGHT; CANOPY; PHYTOPLANKTON; IRRADIANCE; NUTRIENTS; RESPONSES	Rising global temperatures caused by human-mediated change has already triggered significant responses in organismal physiology, distribution and ecosystem functioning. Although the effects of rising temperature on the physiology of individual organisms are well understood, the effect on community-wide processes has remained elusive. The fixation of carbon via primary productivity is an essential ecosystem function and any shifts in the balance of primary productivity and respiration could alter the carbon balance of ecosystems. Here we show through a series of tests that respiration of naturally structured algal assemblages in southern New Zealand greatly increases with rising temperature, with implications for net primary productivity (NPP). The NPP of in situ macroalgal assemblages was minimally affected by natural temperature variation, possibly through photo-acclimation or temperature acclimation responses, but respiration rates and compensating irradiance were negatively affected. However, laboratory experiments testing the impacts of rising temperature on several photosynthetic parameters showed a decline in NPP, increasing respiration rates and increasing compensating irradiance. The respiration Q(10) of laboratory assemblages (the difference in metabolic rates over 10 degrees C) averaged 2.9 compared to a Q(10) of 2 often seen in other autotrophs. However, gross primary productivity (GPP) Q(10) averaged 2, indicating that respiration was more severely affected by rising temperature. Furthermore, combined high irradiance and high temperature caused photoinhibition in the laboratory, and resulted in 50% lower NPP at high irradiance. Our study shows that communities may be more severely affected by rising global temperatures than would be expected by responses of individual species. In particular, enhanced respiration rates and rising compensation points have the potential to greatly affect the carbon balance of macroalgal assemblages through declines in sub-canopy NPP, the impacts of which may be exacerbated over longer time-scales and could result in declines in sub-canopy species richness and abundance.	[Tait, Leigh W.; Schiel, David R.] Univ Canterbury, Sch Biol Sci, MERG, Christchurch 1, New Zealand		Tait, LW (corresponding author), Univ Canterbury, Sch Biol Sci, MERG, Christchurch 1, New Zealand.	lwt13@uclive.ac.nz		Tait, Leigh/0000-0001-9153-139X	University of Canterbury scholarship; Andrew W Mellon Foundation of New York; New Zealand Foundation for Research, Science and Technology (Coasts and Oceans OBI) [C01X0307, C01X0501]	University of Canterbury scholarship; Andrew W Mellon Foundation of New York; New Zealand Foundation for Research, Science and Technology (Coasts and Oceans OBI)(New Zealand Foundation for Research, Science and Technology)	This work was funded by a University of Canterbury scholarship, the Andrew W Mellon Foundation of New York, and the New Zealand Foundation for Research, Science and Technology (Coasts and Oceans OBI, grants C01X0307 and C01X0501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera J, 2002, MAR BIOL, V140, P1087, DOI 10.1007/s00227-002-0792-y; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722, DOI 10.4319/lo.2006.51.6.2722; Bruhn J, 1996, MAR BIOL, V125, P639, DOI 10.1007/BF00349245; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Chiswell SM, 2001, NEW ZEAL J MAR FRESH, V35, P307, DOI 10.1080/00288330.2001.9517000; DAVEY MC, 1989, POLAR BIOL, V10, P29, DOI 10.1007/BF00238287; Davies TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028362; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; GERARD VA, 1984, MAR BIOL, V84, P189, DOI 10.1007/BF00393004; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Griffin KL, 2002, NEW PHYTOL, V154, P609, DOI 10.1046/j.1469-8137.2002.00410.x; Hancke K, 2004, AQUAT MICROB ECOL, V37, P265, DOI 10.3354/ame037265; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; HENLEY WJ, 1992, OECOLOGIA, V89, P516, DOI 10.1007/BF00317158; Herzka SZ, 1997, MAR ECOL PROG SER, V152, P103, DOI 10.3354/meps152103; HOLBROOK NM, 1991, J EXP MAR BIOL ECOL, V146, P39; Hubas C, 2006, MAR ECOL PROG SER, V316, P53, DOI 10.3354/meps316053; IPCC, 2007, CLIM CHANG 2007 PHYS; KELLER AA, 1989, LIMNOL OCEANOGR, V34, P82, DOI 10.4319/lo.1989.34.1.0082; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Martinez B, 2012, OECOLOGIA, V170, P341, DOI 10.1007/s00442-012-2324-x; Masini RJ, 1997, AQUAT BOT, V58, P21, DOI 10.1016/S0304-3770(97)00008-9; Migne A, 2004, CONT SHELF RES, V24, P1437, DOI 10.1016/j.csr.2004.06.002; Miller RJ, 2011, LIMNOL OCEANOGR, V56, P119, DOI 10.4319/lo.2011.56.1.0119; MORRIS S, 1983, ESTUAR COAST SHELF S, V17, P339, DOI 10.1016/0272-7714(83)90026-4; Olabarria C, 2013, OIKOS, V122, P1065, DOI 10.1111/j.1600-0706.2012.20825.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tait LW, 2010, MAR ECOL PROG SER, V416, P115, DOI 10.3354/meps08781; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Walsby AE, 1997, NEW PHYTOL, V136, P189, DOI 10.1046/j.1469-8137.1997.00736.x; Yellowlees D, 2003, ADV PHOTO RESPIRAT, V14, P437	48	52	52	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74413	10.1371/journal.pone.0074413	http://dx.doi.org/10.1371/journal.pone.0074413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058560	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400073
J	Uchida, S; Uchida, H; Maruyama, T; Kajitani, T; Oda, H; Miyazaki, K; Kagami, M; Yoshimura, Y				Uchida, Sayaka; Uchida, Hiroshi; Maruyama, Tetsuo; Kajitani, Takashi; Oda, Hideyuki; Miyazaki, Kaoru; Kagami, Maki; Yoshimura, Yasunori			Molecular Analysis of a Mutated FSH Receptor Detected in a Patient with Spontaneous Ovarian Hyperstimulation Syndrome	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; SECRETING PITUITARY MICROADENOMA; GONADOTROPH ADENOMA; SUCCESSFUL PREGNANCY; WOMAN; GENE; BIOACTIVITY; MUTATIONS; INSIGHTS; DATABASE	Spontaneous ovarian hyperstimulation syndrome (sOHSS) is a rare event that may result from a FSH-producing pituitary adenoma (FSHoma), activating mutations of the FSH receptor (FSHR), and cross-reactivity of the FSHR to elevated hCG and TSH in the setting of pregnancy or hypothyroidism. The objective of this study was to investigate whether an aberrant FSHR was present in a woman with sOHSS and a non-surgically diagnosed FSHoma whose serum FSH levels and FSH bioactivity were nearly normal. Sequencing of the patient's FSHR gene revealed a heterozygous novel missense mutation c. 1536G>A resulting in an amino acid substitution M512I. We asked whether this mutant FSHR affected FSHR-mediated signaling pathways involving cAMP/protein kinase A (PKA), phosphatidylinositol-3 kinase (PI3K)/protein kinase B (AKT) and v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog kinase (SRC)/p42/p44 extracellular signal-regulated protein kinases (ERK1/2). Thus, 293T cells expressing wild-type (FSHRwt), the mutant FSHR (FSHRmt), or both (FSHRwt/mt) were treated with FSH and subjected to measurements of intracellular cAMP, cAMP-induced CRE (cAMP response element)-mediated luciferase assays and immunoblot analyses of phosphorylated PI3K and ERK1/2. There were no differences in luciferase activities or phosphorylation levels of ERK1/2 among FSHRwt, FSHRmt cells and FSHwt/mt cells. However, FSHRmt cells showed a significant reduction in both cAMP production and PI3K phosphorylation levels with unchanged phosphorylation of ERK1/2 upon FSH stimulation in comparison to FSHwt cells. Also, FSH treatment did not provoke PI3K phosphorylation in FSHwt/mt cells. These results indicate that the novel missense M512I FSHR mutation identified herein did not participate in hyperactivation of FSHR-mediated signaling pathways but rather in hypoactivation of the FSH-mediated PI3K/AKT pathway. Thus, this study demonstrates a new functional property of this novel mutatnt FSHR, which, however, might not be involved in the pathogenesis of sOHSS in this FSHoma patient.	[Uchida, Sayaka; Uchida, Hiroshi; Maruyama, Tetsuo; Kajitani, Takashi; Oda, Hideyuki; Miyazaki, Kaoru; Kagami, Maki; Yoshimura, Yasunori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan	Keio University	Maruyama, T (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan.	tetsuo@a5.keio.jp	UCHIDA, HIROSHI/AAB-2296-2019	UCHIDA, HIROSHI/0000-0001-6148-7658	Ministry of Health, Labor, and Welfare [17C-2]	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants for Child Health and Development (17C-2) and for Research on Children and Families from the Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.02.071; Beshay VE, 2007, SEMIN REPROD MED, V25, P388, DOI 10.1055/s-2007-984745; Binder H, 2007, INT J FERTIL WOMEN M, V52, P11; Borgato S, 1998, J ENDOCRINOL INVEST, V21, P372, DOI 10.1007/BF03350773; Castelbaum AJ, 2002, FERTIL STERIL, V78, P1311, DOI 10.1016/S0015-0282(02)04342-X; Castelo-Branco C, 2009, REPROD BIOMED ONLINE, V19, P153, DOI 10.1016/S1472-6483(10)60065-X; Catargi B, 1999, J CLIN ENDOCR METAB, V84, P3404, DOI 10.1210/jc.84.9.3404; Christin-Maitre S, 1998, J CLIN ENDOCR METAB, V83, P3450, DOI 10.1210/jc.83.10.3450; Cooper O, 2008, NAT CLIN PRACT ENDOC, V4, P234, DOI 10.1038/ncpendmet0758; Costagliola S, 2005, REPRODUCTION, V130, P275, DOI 10.1530/rep.1.00662; De Leener A, 2006, J CLIN ENDOCR METAB, V91, P555, DOI 10.1210/jc.2005-1580; DJERASSI A, 1995, J CLIN ENDOCR METAB, V80, P591, DOI 10.1210/jc.80.2.591; GALWAY AB, 1990, J CLIN ENDOCR METAB, V71, P907, DOI 10.1210/jcem-71-4-907; Genua M, 2009, CANCER RES, V69, P7270, DOI 10.1158/0008-5472.CAN-09-0088; Ghayuri M, 2007, OBSTET GYNECOL, V109, P547, DOI 10.1097/01.AOG.0000247316.60573.4a; Gryngarten MG, 2010, HORM RES PAEDIAT, V73, P293, DOI 10.1159/000284395; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; Kajitani T, 2008, HUM REPROD, V23, P435, DOI 10.1093/humrep/dem374; Kihara M, 2006, GYNECOL ENDOCRINOL, V22, P110, DOI 10.1080/09513590600581665; Lussiana C, 2009, GYNECOL ENDOCRINOL, V25, P455, DOI 10.1080/09513590902898213; Lussiana C, 2008, OBSTET GYNECOL SURV, V63, P785, DOI 10.1097/OGX.0b013e31818957eb; Maruyama T, 2005, OBSTET GYNECOL, V105, P1215, DOI 10.1097/01.AOG.0000141554.50747.16; Meduri G, 2008, MOL CELL ENDOCRINOL, V282, P130, DOI 10.1016/j.mce.2007.11.027; Mor Eliran, 2005, Fertil Steril, V84, P757; Murata Y, 2003, J CLIN ENDOCR METAB, V88, P1988, DOI 10.1210/jc.2002-021820; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Papanikolaou EG, 2006, FERTIL STERIL, V85, P112, DOI 10.1016/j.fertnstert.2005.07.1292; Pentz-Vidovic I, 2000, EUR J ENDOCRINOL, V143, P607, DOI 10.1530/eje.0.1430607; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Roberts JE, 2005, FERTIL STERIL, V83, P208, DOI 10.1016/j.fertnstert.2004.06.061; ROTMENSCH S, 1989, AM J OBSTET GYNECOL, V160, P1220, DOI 10.1016/0002-9378(89)90196-8; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimon I, 2001, J CLIN ENDOCR METAB, V86, P3635, DOI 10.1210/jc.86.8.3635; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Smits G, 2003, NEW ENGL J MED, V349, P760, DOI 10.1056/NEJMoa030064; Sugita T, 2005, GYNECOL OBSTET INVES, V59, P138, DOI 10.1159/000083087; Tashiro H, 1999, FERTIL STERIL, V72, P158, DOI 10.1016/S0015-0282(99)00197-1; Valimaki MJ, 1999, J CLIN ENDOCR METAB, V84, P4204, DOI 10.1210/jc.84.11.4204; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; ZALEL Y, 1992, AM J OBSTET GYNECOL, V167, P122, DOI 10.1016/S0002-9378(11)91642-1	42	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75478	10.1371/journal.pone.0075478	http://dx.doi.org/10.1371/journal.pone.0075478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058690	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400116
J	Wu, HL; Duan, ZT; Jiang, ZD; Cao, WJ; Wang, ZB; Hu, KW; Gao, X; Wang, SK; He, BS; Zhang, ZY; Xie, HG				Wu, Hai-Lu; Duan, Zhao-Tao; Jiang, Zong-Dan; Cao, Wei-Jun; Wang, Zhi-Bing; Hu, Ke-Wei; Gao, Xin; Wang, Shu-Kui; He, Bang-Shun; Zhang, Zhen-Yu; Xie, Hong-Guang			Increased Endoplasmic Reticulum Stress Response Is Involved in Clopidogrel-Induced Apoptosis of Gastric Epithelial Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; ER STRESS; OXIDATIVE STRESS; CHOP GADD153; DEATH; P38; ULCER; TRB3; ASPIRIN	Background: The widespread use of clopidogrel alone or in combination with aspirin may result in gastrointestinal mucosal injury, clinically represented as recurrent ulceration and bleeding complications. Our recent work suggested that clopidogrel significantly induced human gastric epithelial cell (GES-1) apoptosis and disrupted gastric mucosal barrier, and that a p38 MAPK inhibitor could attenuate such injury. However, their exact mechanisms are largely unknown. Methods: The GES-1 cells were used as a model system, the effects of clopidogrel on the whole gene expression profile were evaluated by human gene expression microarray and gene ontology analysis, changes of the mRNA and protein expression were determined by real-time PCR and Western blot analysis, and cell viability and apoptosis were measured by MTT assay and flow cytometry analysis, respectively. Results: Gene microarray analysis identified 79 genes that were differentially expressed (P<0.05 and fold-change>3) when cells were treated with or without clopidogrel. Gene ontology analysis revealed that response to stress and cell apoptosis dysfunction were ranked in the top 10 cellular events being affected, and that the major components of endoplasmic reticulum stress-mediated apoptosis pathway - CHOP and TRIB3- were up-regulated in a concentration-and time-dependent manner when cells were treated with clopidogrel. Pathway analysis demonstrated that multiple MAPK kinases were phosphorylated in clopidogrel-treated GES-1 cells, but that only SB-203580 (a p38-specific MAPK inhibitor) attenuated cell apoptosis and CHOP over-expression, both of which were induced by clopidogrel. Conclusions: Increased endoplasmic reticulum stress response is involved in clopidogrel-induced gastric mucosal injury, acting through p38 MAPK activation.	[Wu, Hai-Lu; Duan, Zhao-Tao; Jiang, Zong-Dan; Cao, Wei-Jun; Wang, Zhi-Bing; Hu, Ke-Wei; Gao, Xin; Zhang, Zhen-Yu] Nanjing Med Univ, Nanjing Hosp 1, Dept Med, Div Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Wang, Shu-Kui; He, Bang-Shun; Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Gen Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Div Clin Pharmacol, Gen Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, ZY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Med, Div Gastroenterol, Nanjing, Jiangsu, Peoples R China.	zhangzhenyu808@126.com; hongg.xie@gmail.com			Nanjing Department of Health, Jiangsu, China [YKK10107]; Ministry of Human Resource and Social Security, China [2012-258]; Natural Science Foundation of Jiangsu Province, China [BK2012525]; Nanjing First Hospital, China	Nanjing Department of Health, Jiangsu, China; Ministry of Human Resource and Social Security, China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Nanjing First Hospital, China	This study was supported, in part, by a grant from the Nanjing Department of Health, Jiangsu, China (YKK10107, to Z-YZ); a start grant from the Ministry of Human Resource and Social Security, China (2012-258), a grant from the Natural Science Foundation of Jiangsu Province, China (BK2012525), and a start grant from Nanjing First Hospital, China (all to H-GX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WB, 2012, ANIM GENET, V43, P525, DOI 10.1111/j.1365-2052.2011.02287.x; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chhabra R, 2011, RNA BIOL, V8, P648, DOI 10.4161/rna.8.4.15583; Chiou SK, 2010, J PHARMACOL EXP THER, V334, P693, DOI 10.1124/jpet.110.168153; Choi CH, 2010, MOL PHARMACOL, V78, P114, DOI 10.1124/mol.110.063495; Choi SR, 2009, J PHYSIOL PHARMACOL, V60, P5; Corazzari M, 2005, BIOCHEM BIOPH RES CO, V331, P810, DOI 10.1016/j.bbrc.2005.03.184; Dogra N, 2012, J BIOL CHEM, V287, P30625, DOI 10.1074/jbc.M111.324228; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Feng R, 2011, BIOCHEM BIOPH RES CO, V406, P299, DOI 10.1016/j.bbrc.2011.02.036; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Gomi A, 2013, J DAIRY SCI, V96, P832, DOI 10.3168/jds.2012-5950; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Jainu M, 2006, CHEM-BIOL INTERACT, V161, P262, DOI 10.1016/j.cbi.2006.04.011; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Lim MS, 2006, TOXICOL APPL PHARM, V217, P322, DOI 10.1016/j.taap.2006.09.012; Lou LX, 2006, LIFE SCI, V79, P1856, DOI 10.1016/j.lfs.2006.06.022; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marx J, 2006, SCIENCE, V313, P1564, DOI 10.1126/science.313.5793.1564; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Mauro M, 2004, BRIT J HAEMATOL, V124, P200, DOI 10.1046/j.1365-2141.2003.04743.x; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Meir O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009516; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Omatsu T, 2009, J GASTROENTEROL, V44, P30, DOI 10.1007/s00535-008-2293-3; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pabst MA, 1996, LAB INVEST, V74, P78; Park S, 2004, DIGEST DIS SCI, V49, P384, DOI 10.1023/B:DDAS.0000020490.34220.6d; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Raghubir R, 2011, METHOD ENZYMOL, V489, P259, DOI 10.1016/B978-0-12-385116-1.00015-7; Ramirez-Alcantara V, 2009, AM J PHYSIOL-GASTR L, V297, pG990, DOI 10.1152/ajpgi.00219.2009; Saberi S, 2012, HELICOBACTER, V17, P350, DOI 10.1111/j.1523-5378.2012.00954.x; Schroeder M, 2010, METHODS MOL BIOL, V648, P43, DOI 10.1007/978-1-60761-756-3_3; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Shin JS, 2012, INTERACT CARDIOV TH, V14, P622, DOI 10.1093/icvts/ivs019; Shmulevich Emilia, 2011, Can J Cardiovasc Nurs, V21, P27; Taha AS, 2006, ALIMENT PHARM THER, V23, P489, DOI 10.1111/j.1365-2036.2006.02784.x; Takayama S, 2012, J PHYSIOL PHARMACOL, V63, P41; Tang JR, 2002, BIOCHEM BIOPH RES CO, V290, P1255, DOI 10.1006/bbrc.2002.6336; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Wang KW, 2011, CELL SIGNAL, V23, P1677, DOI 10.1016/j.cellsig.2011.06.003; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wu HL, 2013, TOXICOLOGY, V304, P41, DOI 10.1016/j.tox.2012.11.020; Xie HG, 2011, PHARMACOL THERAPEUT, V129, P267, DOI 10.1016/j.pharmthera.2010.10.001; Xu LY, 2012, MOL CANCER THER, V11, P2174, DOI 10.1158/1535-7163.MCT-12-0602; Yan MY, 2012, INT J MOL MED, V29, P855, DOI 10.3892/ijmm.2012.908; Zhang FM, 2009, CANCER LETT, V274, P250, DOI 10.1016/j.canlet.2008.09.031; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Ziegelin Maren, 2007, Interact Cardiovasc Thorac Surg, V6, P534, DOI 10.1510/icvts.2007.157941; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	60	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74381	10.1371/journal.pone.0074381	http://dx.doi.org/10.1371/journal.pone.0074381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058556	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400069
J	Colaneri, A; Wang, TY; Pagadala, V; Kittur, J; Staffa, NG; Peddada, SD; Isganaitis, E; Patti, ME; Birnbaumer, L				Colaneri, Alejandro; Wang, Tianyuan; Pagadala, Vijayakanth; Kittur, Jaya; Staffa, Nickolas G., Jr.; Peddada, Shyamal D.; Isganaitis, Elvira; Patti, Mary Elizabeth; Birnbaumer, Lutz			A Minimal Set of Tissue-Specific Hypomethylated CpGs Constitute Epigenetic Signatures of Developmental Programming	PLOS ONE			English	Article							DNA METHYLATION; ISLANDS; REVEALS; METHYLOME; REGIONS; VISUALIZATION; EPIGENOMICS; SEQUENCES; PROFILES; TOOL	Background: Cell specific states of the chromatin are programmed during mammalian development. Dynamic DNA methylation across the developing embryo guides a program of repression, switching off genes in most cell types. Thus, the majority of the tissue specific differentially methylated sites (TS-DMS) must be un-methylated CpGs. Methodology and Principal Findings: Comparison of expanded Methyl Sensitive Cut Counting data (eMSCC) among four tissues (liver, testes, brain and kidney) from three C57BL/6J mice, identified 138,052 differentially methylated sites of which 23,270 contain CpGs un-methylated in only one tissue (TS-DMS). Most of these CpGs were located in intergenic regions, outside of promoters, CpG islands or their shores, and up to 20% of them overlapped reported active enhancers. Indeed, tissue-specific enhancers were up to 30 fold enriched in TS-DMS. Testis showed the highest number of TS-DMS, but paradoxically their associated genes do not appear to be specific to the germ cell functions, but rather are involved in organism development. In the other tissues the differentially methylated genes are associated with tissue-specific physiological or anatomical functions. The identified sets of TS-DMS quantify epigenetic distances between tissues, generated during development. We applied this concept to measure the extent of reprogramming in the liver of mice exposed to in utero or early postnatal nutritional stress. Different protocols of food restriction reprogrammed the liver methylome in different but reproducible ways. Conclusion and Significance: Thus, each identified set of differentially methylated sites constituted an epigenetic signature that traced the developmental programing or the early nutritional reprogramming of each exposed mouse. We propose that our approach has the potential to outline a number of disease-associated epigenetic states. The composition of differentially methylated CpGs may vary with each situation, behaving as a composite variable, which can be used as a pre-symptomatic marker for disease.	[Colaneri, Alejandro; Wang, Tianyuan; Pagadala, Vijayakanth; Kittur, Jaya; Staffa, Nickolas G., Jr.; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Res Triangle Pk, NC 27709 USA; [Peddada, Shyamal D.] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; [Isganaitis, Elvira; Patti, Mary Elizabeth] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Colaneri, A (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	acolaneri_2000@yahoo.com.ar; birnbau1@niehs.nih.gov	Pagadala, Vijayakanth/ABI-8446-2020	Isganaitis, Elvira/0000-0003-3477-0305; Peddada, Shyamal/0000-0002-5014-6513; Pagadala, Vijayakanth/0000-0001-7349-4230	National Institutes of Health [Z01-ES-103006]; American Diabetes Association; Graetz Foundation; Lilly Foundation; Lawson-Wilkins Pediatric Endocrine Society; Joslin DERC [5P30 DK036836-23]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD064793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103006, ZIAES101643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Graetz Foundation; Lilly Foundation; Lawson-Wilkins Pediatric Endocrine Society; Joslin DERC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health [2009 NIH Director's Challenge Award and Project Z01-ES-103006 to L. B.]. The authors gratefully acknowledge research grant support from the American Diabetes Association (research grant and mentored postdoctoral fellowship awards to M. E. P.), the Graetz Foundation (to M. E. P.), the Lilly Foundation (to M. E. P.), and the Lawson-Wilkins Pediatric Endocrine Society (to E. I.). This work was also supported in part by the Joslin DERC [5P30 DK036836-23]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blackledge NP, 2011, EPIGENETICS, V6; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; Colaneri AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059878; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Feinberg AP, 2010, NAT BIOTECHNOL, V28, P1049, DOI 10.1038/nbt1010-1049; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gluckman PD, 2012, NAT REV ENDOCRINOL, V8, P74, DOI 10.1038/nrendo.2011.226; Guo WG, 2010, BIOMETRICS, V66, P485, DOI 10.1111/j.1541-0420.2009.01292.x; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hahn MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018844; Harris RA, 2013, EPIGENETICS-US, V8, P157, DOI 10.4161/epi.23438; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041060; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Quach JM, 2011, J BIOL CHEM, V286, P4186, DOI 10.1074/jbc.M110.178251; Sakamoto H, 2007, GENES CELLS, V12, P1123, DOI 10.1111/j.1365-2443.2007.01120.x; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song F, 2009, GENOMICS, V93, P130, DOI 10.1016/j.ygeno.2008.09.003; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suzuki M, 2007, GENES CELLS, V12, P1305, DOI 10.1111/j.1365-2443.2007.01136.x; Suzuki M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r36; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Wu H, 2010, BIOSTATISTICS OXFORD, DOI [10.1093/biostatistics/kxq005, DOI 10.1093/BI0STATISTICS/KXQ005]	57	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72670	10.1371/journal.pone.0072670	http://dx.doi.org/10.1371/journal.pone.0072670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069155	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100015
J	Barbosa-Desongles, A; Hernandez, C; De Torres, I; Munell, F; Poupon, MF; Simo, R; Selva, DM				Barbosa-Desongles, Anna; Hernandez, Cristina; De Torres, Ines; Munell, Francina; Poupon, Marie-France; Simo, Rafael; Selva, David M.			Diabetes Protects from Prostate Cancer by Downregulating Androgen Receptor: New Insights from LNCaP Cells and PAC120 Mouse Model	PLOS ONE			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; BODY-MASS INDEX; TNF-ALPHA; CIRCULATING LEVELS; RISK; INSULIN; ASSOCIATION; ACTIVATION; PREVENTION	Type 2 diabetes has been associated with decreased risk of prostate cancer in observational studies, and this inverse association has been recently confirmed in several large cohort studies. However the mechanisms involved in this protective effect remain to be elucidated. The aim of the present study was to explore whether different features of type 2 diabetes (hyperinsulinemia, hyperglycemia and tumor necrosis factor alpha [TNF-alpha]) protect against the development of prostate cancer. For this purpose LNCaP cells were used for in vitro experiments and nude mice in which PAC120 (hormone-dependent human prostate cancer) xenografts had been implanted were used for in vivo examinations. We provide evidence that increasing glucose concentrations downregulate androgen receptor (AR) mRNA and protein levels through NF-kappa B activation in LNCaP cells. Moreover, there was a synergic effect of glucose and TNF alpha in downregulating the AR in LNCaP cells. By contrast, insulin had no effect on AR regulation. In vivo experiments showed that streptozotocin-induced diabetes (STZ-DM) produces tumor growth retardation and a significant reduction in AR expression in PAC120 prostate cancer mice. In conclusion, our results suggest that hyperglycemia and TNF-alpha play an important role in protecting against prostate cancer by reducing androgen receptor levels via NF-kappa B.	[Barbosa-Desongles, Anna; Hernandez, Cristina; Simo, Rafael; Selva, David M.] Univ Autonoma Barcelona, Diabet & Metab Res Unit, Vall Hebron Inst Recerca, E-08193 Barcelona, Spain; [Barbosa-Desongles, Anna; Hernandez, Cristina; Simo, Rafael; Selva, David M.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, CIBERDEM, ISCIII, Barcelona, Spain; [De Torres, Ines] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Pathol, E-08193 Barcelona, Spain; [Munell, Francina] Univ Autonoma Barcelona, Vall Hebron Inst Recerca, Pediat Neurol Dept, E-08193 Barcelona, Spain; [Poupon, Marie-France] Inst Curie, Dept Med Oncol, Paris, France	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Simo, R (corresponding author), Univ Autonoma Barcelona, Diabet & Metab Res Unit, Vall Hebron Inst Recerca, E-08193 Barcelona, Spain.	rafael.simo@vhir.org; david.martinez.selva@vhir.org	Selva, David Martínez/O-6444-2016	Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721; Munell Casadesus, Francina/0000-0001-8580-2819	Instituto de Salud Carlos III; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), an initiative of the Instituto de Salud Carlos III; Miguel Servet contract	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), an initiative of the Instituto de Salud Carlos III; Miguel Servet contract	This work was supported by a Grant from the Instituto de Salud Carlos III (DMS) and Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), an initiative of the Instituto de Salud Carlos III (RF, ABD, CH and DMS). DMS is the recipient of a Miguel Servet contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Bansal D, 2012, PROSTATE CANC PROSTA; Chen C, 2005, CANCER, V103, P76, DOI 10.1002/cncr.20727; Chopra DP, 2004, CANCER LETT, V203, P145, DOI 10.1016/j.canlet.2003.09.016; de Pinieux G, 2001, AM J PATHOL, V159, P753, DOI 10.1016/S0002-9440(10)61746-4; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Frayling TM, 2008, DIABETOLOGIA, V51, P1757, DOI 10.1007/s00125-008-1114-9; Fukushima H, 2012, UROLOGY, V79, P1329, DOI 10.1016/j.urology.2012.01.070; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Goldenberg SL, 2011, NAT REV UROL, V8, P365, DOI 10.1038/nrurol.2011.79; Golovchenko I, 2000, CIRC RES, V87, P746, DOI 10.1161/01.RES.87.9.746; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Grossmann M, 2012, ENDOCR-RELAT CANCER, V19, pF47, DOI 10.1530/ERC-12-0067; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hales DB, 2002, J REPROD IMMUNOL, V57, P3, DOI 10.1016/S0165-0378(02)00020-7; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Ismail H, 2004, PROSTATE, V58, P308, DOI 10.1002/pros.10335; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kasper JS, 2008, CANCER CAUSE CONTROL, V19, P703, DOI 10.1007/s10552-008-9133-x; Kasper JS, 2009, INT J CANCER, V124, P1398, DOI 10.1002/ijc.24044; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Li Q, 2010, CANCER CAUSE CONTROL, V21, P977; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Maggio M, 2005, J Endocrinol Invest, V28, P116; Meyer TE, 2012, PROSTATE, V72, P65, DOI 10.1002/pros.21407; Meyer TE, 2010, CANCER EPIDEM BIOMAR, V19, P558, DOI 10.1158/1055-9965.EPI-09-0902; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Mizokami A, 2000, J UROLOGY, V164, P800, DOI 10.1016/S0022-5347(05)67318-1; Morgentaler A, 2011, UROL CLIN N AM, V38, P119, DOI 10.1016/j.ucl.2011.02.002; Muller H, 2009, CANCER EPIDEM BIOMAR, V18, P1350, DOI 10.1158/1055-9965.EPI-08-0794; Olson NC, 2012, J CLIN ENDOCR METAB, V97, P1032, DOI 10.1210/jc.2011-2155; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Pierce BL, 2010, HUM HERED, V69, P193, DOI 10.1159/000289594; POLYCHRONAKOS C, 1991, PROSTATE, V19, P313, DOI 10.1002/pros.2990190405; POUPON MF, 1993, J NATL CANCER I, V85, P2023, DOI 10.1093/jnci/85.24.2023; Rodriguez C, 2005, AM J EPIDEMIOL, V161, P147, DOI 10.1093/aje/kwh334; Rodriguez C, 2007, CANCER EPIDEM BIOMAR, V16, P63, DOI 10.1158/1055-9965.EPI-06-0754; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Seo SI, 2009, APMIS, V117, P623, DOI 10.1111/j.1600-0463.2009.02506.x; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simo R, 2012, MOL ENDOCRINOL, V26, P438, DOI 10.1210/me.2011-1321; Simo R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727; Su LJ, 2011, CANCER EPIDEM BIOMAR, V20, P844, DOI 10.1158/1055-9965.EPI-10-0684; Sun G, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/708183; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Turner EL, 2011, INT J CANCER, V128, P440, DOI 10.1002/ijc.25360; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wallner LP, 2011, UROLOGY, V77, P137, DOI 10.1016/j.urology.2010.07.516; Wang DP, 2009, CANCER RES, V69, P9448, DOI 10.1158/0008-5472.CAN-09-1903; Waters KM, 2009, AM J EPIDEMIOL, V169, P937, DOI 10.1093/aje/kwp003; Wu C, 2011, PROSTATE CANCER P D, V14, P326, DOI 10.1038/pcan.2011.28; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008	57	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74179	10.1371/journal.pone.0074179	http://dx.doi.org/10.1371/journal.pone.0074179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058525	Green Submitted, Green Published, gold			2022-12-27	WOS:000327538600074
J	Ip, YK; Hou, ZS; Chen, XL; Ong, JLY; Chng, YR; Ching, BY; Hiong, KC; Chew, SF				Ip, Yuen K.; Hou, Zhisheng; Chen, Xiu L.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Hiong, Kum C.; Chew, Shit F.			High Brain Ammonia Tolerance and Down-Regulation of Na+:K+:2Cl(-) Cotransporter 1b mRNA and Protein Expression in the Brain of the Swamp Eel, Monopterus albus, Exposed to Environmental Ammonia or Terrestrial Conditions	PLOS ONE			English	Article							K-CL COTRANSPORTER; AIR-BREATHING FISHES; PERIOPHTHALMODON-SCHLOSSERI; NA+-K+-2CL(-) COTRANSPORTER; NA+/K+/2CL(-) COTRANSPORTER; BOLEOPHTHALMUS-BODDAERTI; SEAWATER ACCLIMATION; OXIDATIVE STRESS; GIANT MUDSKIPPER; CLIMBING PERCH	Na+:K+:2Cl(-) cotransporter 1 (NKCC1) has been implicated in mediating ischemia-, trauma-or ammonia-induced astrocyte swelling/brain edema in mammals. This study aimed to determine the effects of ammonia or terrestrial exposure on ammonia concentrations in the plasma and brain, and the mRNA expression and protein abundance of nkcc/Nkcc in the brain, of the swamp eel Monopterus albus. Ammonia exposure led to a greater increase in the ammonia concentration in the brain of M. albus than terrestrial exposure. The brain ammonia concentration of M. albus reached 4.5 mu mol g(-1) and 2.7 mu mol g(-1) after 6 days of exposure to 50 mmol l(-1) NH4Cl and terrestrial conditions, respectively. The full cDNA coding sequence of nkcc1b from M. albus brain comprised 3276 bp and coded for 1092 amino acids with an estimated molecular mass of 119.6 kDa. A molecular characterization indicated that it could be activated through phosphorylation and/or glycosylation by osmotic and/or oxidative stresses. Ammonia exposure for 1 day or 6 days led to significant decreases in the nkcc1b mRNA expression and Nkcc1b protein abundance in the brain of M. albus. In comparison, a significant decrease in nkcc1b mRNA expression was observed in the brain of M. albus only after 6 days of terrestrial exposure, but both 1 day and 6 days of terrestrial exposure resulted in significant decreases in the protein abundance of Nkcc1b. These results are novel because it has been established in mammals that ammonia up-regulates NKCC1 expression in astrocytes and NKCC1 plays an important role in ammonia-induced astrocyte swelling and brain edema. By contrast, our results indicate for the first time that M. albus is able to down-regulate the mRNA and protein expression of nkcc1b/Nkcc1b in the brain when confronted with ammonia toxicity, which could be one of the contributing factors to its extraordinarily high brain ammonia tolerance.	[Ip, Yuen K.; Hou, Zhisheng; Chen, Xiu L.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Hiong, Kum C.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsipyk@nus.edu.sg	Ip, Yuen Kwong/H-8041-2012; Chew, Shit Fun/I-2248-2012	Ip, Yuen Kwong/0000-0001-9124-7911; Chew, Shit Fun/0000-0003-4599-5817	Singapore Ministry of Education [R154-000-470-112]; National Institute of Education [RI 9/08 CSF]	Singapore Ministry of Education(Ministry of Education, Singapore); National Institute of Education	This study was supported in part by the Singapore Ministry of Education through a grant (R154-000-470-112) to YKI and by the National Institute of Education through a grant (RI 9/08 CSF) to SFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], COMP ANIMAL PHYSL, P277; Bergmeyer HU., 1985, METHOD ENZYMAT AN, V8, P454; BINSTOCK L, 1969, J GEN PHYSIOL, V53, P342, DOI 10.1085/jgp.53.3.342; BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brusilow SW, 2002, MEDICINE, V81, P240, DOI 10.1097/00005792-200205000-00007; Chew S. F., 2006, FISH PHYSIOL, V23, P307; Chew SF, 2013, J FISH BIOL IN PRESS; Chew SF, 2007, J EXP ZOOL PART A, V307A, P357, DOI 10.1002/jez.385; Ching BY, 2009, AQUAT TOXICOL, V95, P203, DOI 10.1016/j.aquatox.2009.09.004; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; HAAS M, 1995, J BIOL CHEM, V270, P28955, DOI 10.1074/jbc.270.48.28955; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamann S, 2010, J PHYSIOL-LONDON, V588, P4089, DOI 10.1113/jphysiol.2010.194738; Hermenegildo C, 1996, NEUROCHEM RES, V21, P1237, DOI 10.1007/BF02532401; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2005, J EXP BIOL, V208, P1993, DOI 10.1242/jeb.01586; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P768, DOI 10.1086/422057; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P390, DOI 10.1086/383510; Ip YK, 2004, J EXP BIOL, V207, P787, DOI 10.1242/jeb.00788; Ip YK, 2004, J COMP PHYSIOL B, V174, P565, DOI 10.1007/s00360-004-0445-1; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Ip YK, 2012, J COMP PHYSIOL B, V182, P793, DOI 10.1007/s00360-012-0664-9; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; Jayakumar AR, 2011, J HEPATOL, V54, P272, DOI 10.1016/j.jhep.2010.06.041; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Kaplan MR, 1996, ANNU REV PHYSIOL, V58, P649, DOI 10.1146/annurev.ph.58.030196.003245; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; Kurihara K, 1999, AM J PHYSIOL-CELL PH, V277, pC1184, DOI 10.1152/ajpcell.1999.277.6.C1184; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Lorin-Nebel C, 2006, J EXP BIOL, V209, P4908, DOI 10.1242/jeb.02591; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Minana MD, 1996, J PHARMACOL EXP THER, V279, P194; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; ODonnell ME, 1995, AM J PHYSIOL-CELL PH, V269, pC1513, DOI 10.1152/ajpcell.1995.269.6.C1513; Ott P, 2004, NEUROCHEM INT, V44, P185, DOI 10.1016/S0197-0186(03)00153-0; PAYNE JA, 1995, CURR OPIN CELL BIOL, V7, P493, DOI 10.1016/0955-0674(95)80005-0; Peng KW, 1998, FISH PHYSIOL BIOCHEM, V19, P59, DOI 10.1023/A:1007745003948; Pichili VBR, 2007, GLIA, V55, P801, DOI 10.1002/glia.20499; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; RAICHLE ME, 1981, CIRC RES, V48, P913, DOI 10.1161/01.RES.48.6.913; Randall DJ, 1999, AM J PHYSIOL-REG I, V277, pR1562, DOI 10.1152/ajpregu.1999.277.6.R1562; Reddy PVB, 2009, J NEUROSCI RES, V87, P2677, DOI 10.1002/jnr.22097; Tay ASL, 2003, J EXP BIOL, V206, P2473, DOI 10.1242/jeb.00464; Tay YL, 2006, J EXP BIOL, V209, P4475, DOI 10.1242/jeb.02557; Tng YYM, 2009, J EXP ZOOL PART A, V311A, P676, DOI 10.1002/jez.555; VIGNE P, 1994, J BIOL CHEM, V269, P19925; Wang H, 2003, J NEUROPHYSIOL, V90, P1257, DOI 10.1152/jn.01174.2002; Wee NLJ, 2007, AQUAT TOXICOL, V82, P204, DOI 10.1016/j.aquatox.2007.02.015; Worrell RT, 2008, AM J PHYSIOL-GASTR L, V294, pG429, DOI 10.1152/ajpgi.00251.2006; Yan YP, 2001, J CEREBR BLOOD F MET, V21, P711, DOI 10.1097/00004647-200106000-00009	71	8	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e69512	10.1371/journal.pone.0069512	http://dx.doi.org/10.1371/journal.pone.0069512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069137	gold, Green Submitted, Green Published			2022-12-27	WOS:000324777300001
J	Davis, JM; Keeney, JG; Sikela, JM; Hepburn, S				Davis, Jonathan M.; Keeney, Jonathon G.; Sikela, James M.; Hepburn, Susan			Mode of Genetic Inheritance Modifies the Association of Head Circumference and Autism-Related Symptoms: A Cross-Sectional Study	PLOS ONE			English	Article							1ST YEAR; CHILDREN; GROWTH; CONNECTIVITY; CORTEX; SYNCHRONIZATION; ABNORMALITIES; DISORDER; TODDLERS; NUMBER	Background: Frequently individuals with autism spectrum disorder (ASD) have been noted with a larger head circumference (HC) than their typical developing peers. Biologic hypotheses suggest that an overly rapid brain growth leads to the core symptoms of ASD by impairing connectivity. Literature is divided however where deleterious, protective and null associations of HC with ASD symptoms in individuals with ASD have been found. Method: Individuals (n = 1,416) from the Autism Genetic Resource Exchange with ASD were examined for associations of HC with ASD like symptoms. Mixed models controlling for sex, age, race/ethnicity, simplex/multiplex status and accounting for correlations between siblings were used. Interactions by simplex/multiplex were explored. Adjustments for height in a sub-population with available data were explored as well. Results: A Significant interaction term (p = 0.03) suggested that the effect of HC was dependent on whether the individual was simplex or multiplex. In simplex individuals at mean age (8.9 years) 1 cm increase in head circumference was associated with a 24% increase in the odds of a high social diagnostic score from the Autism Diagnostic Interview - Revised (odds ratio = 1.24, p = 0.01). There was no association in multiplex individuals. Additionally, individuals classified with a non-verbal IQ <70 were 90% simplex and had a significantly increased head circumference (0.7 cm p = 0.03) relative to a mid-range nonverbal IQ group. Interestingly, children classified with a >110 non-verbal IQ also had an increased HC (0.4 cm p = 0.04), relative to a mid-range non-verbal IQ group, and were 90% multiplex. HC effects do not appear to be confounded by height, however, larger samples with height information are needed. Conclusion: The potential link between brain growth and autism like symptoms is complex and could depend on specific etiologies. Further investigations accounting for a likely mode of inheritance will help identify an ASD subtype related to HC.	[Davis, Jonathan M.; Keeney, Jonathon G.; Sikela, James M.] Univ Colorado, Dept Biochem & Mol Genet, Human Med Genet Program, Aurora, CO 80045 USA; [Davis, Jonathan M.; Keeney, Jonathon G.; Sikela, James M.] Univ Colorado, Dept Biochem & Mol Genet, Neurosci Program, Aurora, CO USA; [Hepburn, Susan] Univ Colorado, Dept Psychiat, Aurora, CO USA; [Hepburn, Susan] Univ Colorado, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Davis, JM (corresponding author), Univ Colorado, Dept Biochem & Mol Genet, Human Med Genet Program, Denver Anschutz Med Campus, Aurora, CO 80045 USA.	Jonathan.Davis@UCDenver.edu		Hepburn, Susan/0000-0002-8545-3804	National Institute of Mental Health [1U24MH081810];  [5RO1 MH081203-04 NIMH];  [5RO1AA011853-13 NIAAA]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081203, U24MH081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011853] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded in part by 5RO1 MH081203-04 NIMH, and funding received was also in part from 5RO1AA011853-13 NIAAA. No additional external funding was received for this study. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach R, 2009, J AUTISM DEV DISORD, V39, P188, DOI 10.1007/s10803-008-0612-4; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Bates D, 2011, LINEAR NONLINEAR MIX; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Chaidez V, 2012, AUTISM, V16, P381, DOI 10.1177/1362361311434787; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Deacon TW, 1997, ANNU REV ANTHROPOL, V26, P337, DOI 10.1146/annurev.anthro.26.1.337; Dementieva YA, 2005, PEDIATR NEUROL, V32, P102, DOI 10.1016/j.pediatrneurol.2004.08.005; Deutsch CK, 2003, J AUTISM DEV DISORD, V33, P209, DOI 10.1023/A:1022903913547; Dumas L, 2009, COLD SH Q B, V74, P375, DOI 10.1101/sqb.2009.74.025; Dumas LJ, 2012, AM J HUM GENET, V91, P444, DOI 10.1016/j.ajhg.2012.07.016; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; Fukumoto A, 2008, J AUTISM DEV DISORD, V38, P411, DOI 10.1007/s10803-007-0405-1; Gillberg C, 2002, DEV MED CHILD NEUROL, V44, P296; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V77, P33, DOI 10.1159/000322729; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Lainhart JE, 2006, AM J MED GENET A, V140A, P2257, DOI 10.1002/ajmg.a.31465; Lajonchere CM, 2010, NEURON, V68, P187, DOI 10.1016/j.neuron.2010.10.009; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Miles JH, 2005, AM J MED GENET A, V135A, P171, DOI 10.1002/ajmg.a.30590; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; O'Bleness MS, 2012, G3-GENES GENOM GENET, V2, P977, DOI 10.1534/g3.112.003061; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sell NK, 2012, DISABIL HEALTH J, V5, P9, DOI 10.1016/j.dhjo.2011.08.002; Tek S, 2012, J AUTISM DEV DISORD, V42, P1967, DOI 10.1007/s10803-012-1445-8; Virkud YV, 2009, AM J MED GENET B, V150B, P328, DOI 10.1002/ajmg.b.30810; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548	47	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74940	10.1371/journal.pone.0074940	http://dx.doi.org/10.1371/journal.pone.0074940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058641	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900088
J	Jin, JF; Wang, XQ; Wang, QY; Guo, XR; Cao, JX; Zhang, XY; Zhu, T; Zhang, DL; Wang, WD; Wang, J; Shen, BF; Gao, X; Shi, YC; Zhang, JY				Jin, Jianfeng; Wang, Xiaoqian; Wang, Qingyang; Guo, Xiangrui; Cao, Junxia; Zhang, Xueying; Zhu, Ting; Zhang, Dalin; Wang, Wendie; Wang, Jing; Shen, Beifen; Gao, Xu; Shi, Yanchun; Zhang, Jiyan			Chronic Psychological Stress Induces the Accumulation of Myeloid-Derived Suppressor Cells in Mice	PLOS ONE			English	Article							RESTRAINT STRESS; EXPRESSION; SUSCEPTIBILITY; DIFFERENTIATION; MACROPHAGES; INFECTIONS; ACTIVATION; INHIBITOR; APOPTOSIS; SEVERITY	Chronic psychological stress has been shown to adversely impact immune system functions and compromise host defenses against various infections. However, the underlying mechanisms remain elusive. Recent studies have demonstrated that myeloid-derived suppressor cells (MDSCs) play an important role in regulating immunity. It is of interest to explore whether or not chronic psychological stress plays immunosuppressive functions partially by inducing MDSCs accumulation. In this work, we report that chronic psychological stress led to the accumulation of CD11b+ Gr1+ cells in the bone marrow of BALB/c mice. Repeated beta-agonist infusion showed no such effect. However, beta-adrenergic blockade, but not glucocorticoids blockade, partially reversed the accumulation of CD11b + Gr1+ cells under the condition of chronic psychological stress, suggesting catecholamines collaborate with other factors to induce the accumulation. Further exploration indicates that cyclooxygenase 2 (COX-2)-prostaglandin E-2 (PGE(2)) loop might act downstream to induce the accumulation. A majority of the accumulated CD11b+ Gr1+ cells were Ly6G+ Ly6C(low) immature neutrophils, which inhibited cytokine release of macrophages as well as T cell responsiveness. Moreover, the accumulated CD11b+ Gr1+ cells under the condition of chronic psychological stress expressed multiple inhibitory molecules. Taken together, our data demonstrate for the first time that chronic psychological stress induces MDSCs accumulation in mice, which can contribute to immunosuppression.	[Jin, Jianfeng; Wang, Xiaoqian; Wang, Qingyang; Guo, Xiangrui; Cao, Junxia; Zhang, Xueying; Zhu, Ting; Zhang, Dalin; Wang, Wendie; Wang, Jing; Shen, Beifen; Zhang, Jiyan] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China; [Jin, Jianfeng; Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China; [Wang, Xiaoqian; Shi, Yanchun] Inner Mongolia Med Coll, Res Ctr Mol Biol, Hohhot, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Harbin Medical University; Inner Mongolia Medical University	Zhang, JY (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.	gaoxu_671227@yahoo.com.cn; ycshi5388@yahoo.com.cn; zhangjy@nic.bmi.ac.cn	Z, D/AFG-4813-2022; gao, xu/U-4765-2019	, DALIN/0000-0002-6553-7373; Zhang, Jiyan/0000-0001-8011-8719; Wang, Qingyang/0000-0002-9999-3019; Wang, Jing/0000-0001-9413-2378	National Natural Science Foundation of China [31270960, 31100544]; National Key Technologies R&D Program for New Drugs [2013ZX09103003-010]; National Key Basic Research Program of China [2010CB911904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Natural Science Foundation of China (31270960, 31100544), the National Key Technologies R&D Program for New Drugs (2013ZX09103003-010), and National Key Basic Research Program of China (2010CB911904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2007, J CLIN INVEST, V117, P3339, DOI 10.1172/JCI31726; BENNATHAN D, 1989, ARCH VIROL, V109, P1, DOI 10.1007/BF01310513; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Cacioppo JT, 2002, HORM BEHAV, V42, P32, DOI 10.1006/hbeh.2002.1801; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Feng ZH, 2012, P NATL ACAD SCI USA, V109, P7013, DOI 10.1073/pnas.1203930109; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P3, DOI 10.1016/j.bbi.2004.06.003; Huang M, 1998, CANCER RES, V58, P1208; Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714; Hunzeker J, 2004, BRAIN BEHAV IMMUN, V18, P526, DOI 10.1016/j.bbi.2003.12.010; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Jiang XH, 2002, ONCOGENE, V21, P6113, DOI 10.1038/sj.onc.1205778; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; Kopnisky KL, 2004, BRAIN BEHAV IMMUN, V18, P246, DOI 10.1016/j.bbi.2003.08.003; Lin H, 2001, BIOCHEM J, V353, P299, DOI 10.1042/0264-6021:3530299; Liu X, 2008, J CELL BIOCHEM, V105, P53, DOI 10.1002/jcb.21802; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Mundy-Bosse BL, 2011, CELL IMMUNOL, V270, P80, DOI 10.1016/j.cellimm.2011.04.003; Nicholson LB, 2009, CURR MOL MED, V9, P23, DOI 10.2174/156652409787314499; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ortiz GC, 2003, BRAIN BEHAV IMMUN, V17, P329, DOI 10.1016/S0889-1591(03)00027-8; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Schlachetzki JCM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-2; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Steelman AJ, 2009, BRAIN BEHAV IMMUN, V23, P830, DOI 10.1016/j.bbi.2009.03.010; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; Tanaka K, 2012, J NEUROSCI, V32, P4319, DOI 10.1523/JNEUROSCI.5952-11.2012; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tymen SD, 2013, BRAIN BEHAV IMMUN, V28, P207, DOI 10.1016/j.bbi.2012.07.013; Van Ginderachter JA, 2010, EUR J IMMUNOL, V40, P2976, DOI 10.1002/eji.201040911; Wang J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-6; Yamaoka Y, 2000, IMMUNOPHARMACOLOGY, V48, P35, DOI 10.1016/S0162-3109(00)00176-4; Zhang JY, 2006, MOL CELL BIOL, V26, P1223, DOI 10.1128/MCB.26.4.1223-1234.2006	40	30	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74497	10.1371/journal.pone.0074497	http://dx.doi.org/10.1371/journal.pone.0074497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058577	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900049
J	Park, B; Ko, JH; Lee, JD; Park, HJ				Park, Bumhee; Ko, Jeong Hoon; Lee, Jong Doo; Park, Hae-Jeong			Evaluation of Node-Inhomogeneity Effects on the Functional Brain Network Properties Using an Anatomy-Constrained Hierarchical Brain Parcellation	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; SMALL-WORLD; MODULAR ORGANIZATION; CONNECTIVITY; MODELS; STATES	To investigate functional brain networks, many graph-theoretical studies have defined nodes in a graph using an anatomical atlas with about a hundred partitions. Although use of anatomical node definition is popular due to its convenience, functional inhomogeneity within each node may lead to bias or systematic errors in the graph analysis. The current study was aimed to show functional inhomogeneity of a node defined by an anatomical atlas and to show its effects on the graph topology. For this purpose, we compared functional connectivity defined using 138 resting state fMRI data among 90 cerebral nodes from the automated anatomical labeling (AAL), which is an anatomical atlas, and among 372 cerebral nodes defined using a functional connectivity-based atlas as a ground truth, which was obtained using anatomy-constrained hierarchical modularity optimization algorithm (AHMO) that we proposed to evaluate the graph properties for anatomically defined nodes. We found that functional inhomogeneity in the anatomical parcellation induced significant biases in estimating both functional connectivity and graph-theoretical network properties. We also found very high linearity in major global network properties and nodal strength at all brain regions between anatomical atlas and functional atlas with reasonable network-forming thresholds for graph construction. However, some nodal properties such as betweenness centrality did not show significant linearity in some regions. The current study suggests that the use of anatomical atlas may be biased due to its inhomogeneity, but may generally be used in most neuroimaging studies when a single atlas is used for analysis.	[Park, Bumhee; Lee, Jong Doo; Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med & Radiol, Seoul 120749, South Korea; [Park, Bumhee; Lee, Jong Doo; Park, Hae-Jeong] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120749, South Korea; [Park, Bumhee; Lee, Jong Doo; Park, Hae-Jeong] Yonsei Univ, Coll Med, Project Med Sci BK21, Seoul 120749, South Korea; [Ko, Jeong Hoon] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Duke University	Park, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Nucl Med & Radiol, Seoul 120749, South Korea.	parkhj@yonsei.ac.kr		Park, Hae-Jeong/0000-0002-4633-0756	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20100018839]	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20100018839 for HJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Bickart KC, 2012, J NEUROSCI, V32, P14729, DOI 10.1523/JNEUROSCI.1599-12.2012; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brodmann K, 1909, VERGLEICHENDE LOKALI; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Ji YN, 2009, LECT NOTES COMPUT SC, V5761, P984; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kim DJ, 2013, HUM BRAIN MAPP, V34, P1371, DOI 10.1002/hbm.21517; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Mezer A, 2009, NEUROIMAGE, V45, P1117, DOI 10.1016/j.neuroimage.2008.12.015; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Park B, 2012, NEUROIMAGE, V59, P456, DOI 10.1016/j.neuroimage.2011.07.049; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valencia M, 2009, CHAOS, V19, DOI 10.1063/1.3129783; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	65	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74935	10.1371/journal.pone.0074935	http://dx.doi.org/10.1371/journal.pone.0074935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058640	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900087
J	Ito, S; Miyashita, H; Suzuki, Y; Kobayashi, M; Satomi, S; Sato, Y				Ito, Soichi; Miyashita, Hiroki; Suzuki, Yasuhiro; Kobayashi, Miho; Satomi, Susumu; Sato, Yasufumi			Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene	PLOS ONE			English	Article							NEGATIVE FEEDBACK REGULATOR; TUMOR ANGIOGENESIS; EXPRESSION; ENDOTHELIUM; CARCINOMA; PREDICTOR; PERICYTES	Vasohibin-1 (VASH1) is isolated as an endogenous angiogenesis inhibitor produced by the vascular endothelium. We previously reported that tumor growth and tumor angiogenesis were augmented in VASH1 (-/-) mice. Here we examined whether VASH1 plays any role in cancer metastasis. When Lewis lung carcinoma (LLC) cells were inoculated in the footpad to observe spontaneous metastasis, a significant increase in lung metastasis together with inguinal lymph node metastasis was evident in the VASH1 (-/-) mice. Histological analyses revealed that vessels of the footpad tumor in VASH1 (-/-) mice were more immature, having fewer mural cells. However, when LLC cells were injected into a tail vein, the extent of lung metastasis was unchanged between wild-type mice and VASH1 (-/-) mice. When VASH1 in endothelial cells in culture was knocked-down by siRNA, we observed a decrease in the content of ZO-1, a component of tight junctions, which decrease resulted in increased transmigration of cancer cells across the endothelial cell monolayer. These results indicate that endogenous VASH1 tightens the endothelial barrier and makes tumor vessels resistant to cancer metastasis.	[Ito, Soichi; Miyashita, Hiroki; Suzuki, Yasuhiro; Kobayashi, Miho; Sato, Yasufumi] Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Ito, Soichi; Satomi, Susumu] Tohoku Univ, Sch Med, Dept Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Sato, Y (corresponding author), Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	y-sato@idac.tohoku.ac.jp	Kobayashi, Miho/AAD-1801-2022; Suzuki, Yasuhiro/GOE-4553-2022; Sato, Yasufumi/AAF-3367-2019	Kobayashi, Miho/0000-0003-2548-4120; Suzuki, Yasuhiro/0000-0001-9046-5466; 	"Integrative Research on Cancer Microenvironment Network'' [22112006]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22300323]; Ministry of Health, Labor, and Welfare of Japan	"Integrative Research on Cancer Microenvironment Network''; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grant number 22112006 from the program Grants-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network''; by grant number 22300323 from the program Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by a Health and Labor Sciences research grant (Third Term Comprehensive Control Research for Cancer) from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Cohn ML, 2005, J CUTAN PATHOL, V32, P533, DOI 10.1111/j.0303-6987.2005.00324.x; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Kanomata N, 2013, J CLIN PATHOL, V66, P613, DOI 10.1136/jclinpath-2013-201444; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; MIYAZAKI Y, 2010, CLIN CANCER RES, V18, P4415; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Shen ZL, 2012, MED ONCOL, V29, P2718, DOI 10.1007/s12032-012-0212-1; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tamaki K, 2010, CANCER SCI, V101, P1051, DOI 10.1111/j.1349-7006.2009.01483.x; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Wang QZ, 2012, MED ONCOL, V29, P2727, DOI 10.1007/s12032-011-0106-7; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; YAZDANI S, 2013, HUM PATHOL; Yonenaga Y, 2005, ONCOLOGY-BASEL, V69, P159, DOI 10.1159/000087840; Yoshinaga K, 2008, CANCER SCI, V99, P914, DOI 10.1111/j.1349-7006.2008.00777.x; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Zhao GN, 2012, MED ONCOL, V29, P3325, DOI 10.1007/s12032-012-0313-x	31	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73931	10.1371/journal.pone.0073931	http://dx.doi.org/10.1371/journal.pone.0073931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066086	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000068
J	Kazembe, LN				Kazembe, Lawrence N.			A Bayesian Two Part Model Applied to Analyze Risk Factors of Adult Mortality with Application to Data from Namibia	PLOS ONE			English	Article							MIXED MODELS; CARE; GENDER	Despite remarkable gains in life expectancy and declining mortality in the 21st century, in many places mostly in developing countries, adult mortality has increased in part due to HIV/AIDS or continued abject poverty levels. Moreover many factors including behavioural, socio-economic and demographic variables work simultaneously to impact on risk of mortality. Understanding risk factors of adult mortality is crucial towards designing appropriate public health interventions. In this paper we proposed a structured additive two-part random effects regression model for adult mortality data. Our proposal assumed two processes: (i) whether death occurred in the household (prevalence part), and (ii) number of reported deaths, if death did occur (severity part). The proposed model specification therefore consisted of two generalized linear mixed models (GLMM) with correlated random effects that permitted structured and unstructured spatial components at regional level. Specifically, the first part assumed a GLMM with a logistic link and the second part explored a count model following either a Poisson or negative binomial distribution. The model was used to analyse adult mortality data of 25,793 individuals from the 2006/2007 Namibian DHS data. Inference is based on the Bayesian framework with appropriate priors discussed.	Univ Namibia, Dept Stat & Populat Studies, Windhoek, Namibia	University of Namibia	Kazembe, LN (corresponding author), Univ Namibia, Dept Stat & Populat Studies, Windhoek, Namibia.	lkazembe@unam.na			University of Namibia	University of Namibia	The author acknowledges financial support from the University of Namibia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-31; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2008, NAM DEM HLTH SURV 20; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bendavid E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026607; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Fantahun M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-268; Gelman A, 2006, BAYESIAN ANAL, V1; Houle BC, 2011, THESIS U WASHINGTON, P320; INDEPTH Network, 2004, DEPTH MOD LIF TABL S; Jin XP, 2005, BIOMETRICS, V61, P950, DOI 10.1111/j.1541-0420.2005.00359.x; Kazembe LN, 2012, P 54 C S AFR STAT AS; Namibia Statistics Agency, 2018, NAM HOUS INC EXP SUR; Neelon B, 2013, J R STAT SOC A STAT, V176, P389, DOI 10.1111/j.1467-985X.2012.01039.x; NGOM P, 2003, WORKSH HIV AIDS AD M; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Olsen MK, 2001, J AM STAT ASSOC, V96, P247; Rogers RG., 2000, LIVING DYING US BEHA; Rogers RG, 2002, HDB POPULATION, P283; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Su L, 2009, BIOSTATISTICS, V10, P374, DOI 10.1093/biostatistics/kxn044; Tanser F, 2001, TROP MED INT HEALTH, V6, P826, DOI 10.1046/j.1365-3156.2001.00794.x; Tucker-Seeley RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-313; Turra CM, 2007, J GERONTOL B-PSYCHOL, V62, pS184, DOI 10.1093/geronb/62.3.S184; Winkelmann R, 2004, J APPL ECONOMET, V19, P455, DOI 10.1002/jae.764; Winkelmann R, 2008, ANAL COUNT DATA; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73500	10.1371/journal.pone.0073500	http://dx.doi.org/10.1371/journal.pone.0073500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066052	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000033
J	Tsujimoto, H; Liu, K; Linser, PJ; Agre, P; Rasgon, JL				Tsujimoto, Hitoshi; Liu, Kun; Linser, Paul J.; Agre, Peter; Rasgon, Jason L.			Organ-Specific Splice Variants of Aquaporin Water Channel AgAQP1 in the Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							HARMONIC CONVERGENCE; MALPIGHIAN TUBULES; GENE-EXPRESSION; PERMEABILITY; MEMBRANES; DIURESIS; COMPLEX; DIPTERA; DOMAIN	Background: Aquaporin (AQP) water channels are important for water homeostasis in all organisms. Malaria transmission is dependent on Anopheles mosquitoes. Water balance is a major factor influencing mosquito survival, which may indirectly affect pathogen transmission. Methodology/Principal Findings: We obtained full-length mRNA sequences for Anopheles gambiae aquaporin 1 (AgAQP1) and identified two splice variants for the gene. In vitro expression analysis showed that both variants transported water and were inhibited by Hg2+. One splice variant (AgAQP1A) was exclusively expressed in adult female ovaries indicating a function in mosquito reproduction. The other splice variant (AgAQP1B) was expressed in the midgut, malpighian tubules and the head in adult mosquitoes. Immunolabeling showed that in malpighian tubules, AgAQP1 is expressed in principal cells in the proximal portion and in stellate cells in the distal portion. Moreover, AgAQP1 is expressed in Johnston's organ (the "ear"), which is important for courtship behavior. Conclusions And Significance: These results suggest that AgAQP1 may play roles associated with mating (courtship) and reproduction in addition to water homeostasis in this important African malaria vector.	[Tsujimoto, Hitoshi; Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Tsujimoto, Hitoshi; Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Liu, Kun; Agre, Peter] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA; [Liu, Kun; Agre, Peter] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol, Baltimore, MD USA; [Linser, Paul J.] Univ Florida, Whitney Lab, Gainesville, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University System of Florida; University of Florida	Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu		Rasgon, Jason/0000-0002-4050-8429	Penn State Huck Institutes of the Life Sciences; Bloomberg Family Foundation; National Institutes of Health (NIH) [RO1 HL48268, U19 AI089680]; Johns Hopkins Malaria Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089680] Funding Source: NIH RePORTER	Penn State Huck Institutes of the Life Sciences; Bloomberg Family Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Johns Hopkins Malaria Research Institute Pilot grant and start-up funds from the Penn State Huck Institutes of the Life Sciences to JLR, and funds from the Bloomberg Family Foundation and National Institutes of Health (NIH) grants RO1 HL48268 and U19 AI089680 to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2012, J INSECT PHYSIOL, V58, P523, DOI 10.1016/j.jinsphys.2012.01.007; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x; Boo K, 1975, INT J INSECT MORPHOL; BOO KS, 1975, J INSECT PHYSIOL, V21, P1129, DOI 10.1016/0022-1910(75)90126-2; Cabrero P, 2004, J EXP BIOL, V207, P3299, DOI 10.1242/jeb.01156; Cator LJ, 2011, ANIM BEHAV, V82, P627, DOI 10.1016/j.anbehav.2011.07.013; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Gibson G, 2010, JARO-J ASSOC RES OTO, V11, P527, DOI 10.1007/s10162-010-0243-2; Goto SG, 2011, J INSECT PHYSIOL, V57, P1106, DOI 10.1016/j.jinsphys.2011.03.023; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu K, 2011, P NATL ACAD SCI USA, V108, P6062, DOI 10.1073/pnas.1102629108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Olayemi IK, 2009, J VECTOR DIS, V46, P295; Parish LA, 2011, J PROTEOME RES, V10, P5150, DOI 10.1021/pr2006268; Pietrantonio PV, 2000, INSECT MOL BIOL, V9, P407, DOI 10.1046/j.1365-2583.2000.00201.x; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; STOBBART RH, 1977, J EXP BIOL, V69, P53; 't Hoen PAC, 2011, NUCLEIC ACIDS RES, V39, P556, DOI 10.1093/nar/gkq790; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WILLIAMS JC, 1983, J COMP PHYSIOL, V153, P257, DOI 10.1007/BF00689629; Xiang MHA, 2012, J INSECT PHYSIOL, V58, P570, DOI 10.1016/j.jinsphys.2011.12.009; Yang MY, 2000, GENETICS, V154, P285	34	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75888	10.1371/journal.pone.0075888	http://dx.doi.org/10.1371/journal.pone.0075888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066188	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000170
J	Xiao, DL; Hu, XQ; Huang, XH; Zhou, JJ; Wilson, SM; Yang, SM; Zhang, LB				Xiao, Daliao; Hu, Xiang-Qun; Huang, Xiaohui; Zhou, Jianjun; Wilson, Sean M.; Yang, Shumei; Zhang, Lubo			Chronic Hypoxia during Gestation Enhances Uterine Arterial Myogenic Tone via Heightened Oxidative Stress	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; CAUSES EPIGENETIC REPRESSION; PKC-EPSILON GENE; NADPH-OXIDASE; NITRIC-OXIDE; SMOOTH-MUSCLE; PULMONARY-HYPERTENSION; VASCULAR-TONE; HIGH-ALTITUDE; PREGNANCY	Chronic hypoxia during gestation has profound adverse effects on the adaptation of uteroplacental circulation in pregnancy. Yet, the underlying mechanisms are not fully understood. The present study tested the hypothesis that enhanced production of reactive oxygen species (ROS) in uterine arteries plays a critical role in the maladaptation of uterine circulation associated with chronic hypoxia. Uterine arteries were isolated from nonpregnant and near-term pregnant sheep maintained at sea level (similar to 300 m) or exposed to high-altitude (3801 m) hypoxia for 110 days. Hypoxia significantly increased ROS production in uterine arteries of pregnant, but not nonpregnant, sheep. This was associated with a significant increase in NADPH oxidase (Nox) 2, but not Nox1 or Nox4, protein abundance and total Nox activity in uterine arteries of pregnant animals. Chronic hypoxia significantly increased pressure-dependent uterine arterial myogenic tone in pregnant sheep, which was abrogated by a Nox inhibitor apocynin. Additionally, the hypoxia-induced increase in myogenic reactivity of uterine arteries to phorbol 12,13-dibutyrate in pregnant sheep was blocked by apocynin and tempol. In consistence with the myogenic responses, the hypoxia-mediated down-regulation of BKCa channel activity in uterine arteries of pregnant animals was reversed by apocynin. The findings suggest that heightened oxidative stress in uterine arteries plays a key role in suppressing the BKCa channel activity, resulting in increased myogenic reactivity and maladaptation of uteroplacental circulation caused by chronic hypoxia during gestation.	[Xiao, Daliao; Hu, Xiang-Qun; Huang, Xiaohui; Wilson, Sean M.; Zhang, Lubo] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Div Pharmacol,Dept Basic Sci, Loma Linda, CA 92350 USA; [Zhou, Jianjun] Nanjing Univ, Sch Med, Dept Obstet & Gynecol, Nanjing Drum Tower Hosp, Nanjing, Peoples R China; [Yang, Shumei] Calif State Univ San Bernardino, Dept Chem & Biochem, San Bernardino, CA 92407 USA	Loma Linda University; Nanjing University; California State University System; California State University San Bernardino	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Div Pharmacol,Dept Basic Sci, Loma Linda, CA 92350 USA.	lzhang@llu.edu	Xiao, DaLiao/AAY-1800-2020; wilson, sean/D-1206-2017	Xiao, DaLiao/0000-0003-0147-2758; wilson, sean/0000-0003-4404-1173; Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL110125, HL089012, HD031226, DA032510, HD069746]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD069746, P01HD031226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110125, R01HL089012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants HL110125 (LZ), HL089012 (LZ), HD031226 (LZ), DA032510 (DX), HD069746 (SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brakemeier S, 2003, KIDNEY INT, V64, P199, DOI 10.1046/j.1523-1755.2003.00051.x; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Chang K, 2010, HYPERTENSION, V56, P750, DOI 10.1161/HYPERTENSIONAHA.110.155812; Chang K, 2009, AM J PHYSIOL-HEART C, V296, pH1840, DOI 10.1152/ajpheart.00090.2009; Dasgupta C, 2012, HYPERTENSION, V60, P697, DOI 10.1161/HYPERTENSIONAHA.112.198242; Dennis KE, 2009, AM J PHYSIOL-LUNG C, V297, pL596, DOI 10.1152/ajplung.90568.2008; Dong L, 2009, CLIN EXP PHARMACOL P, V36, pe57, DOI 10.1111/j.1440-1681.2009.05222.x; Fike CD, 2008, AM J PHYSIOL-LUNG C, V295, pL881, DOI 10.1152/ajplung.00047.2008; Gandley RE, 2001, AM J PHYSIOL-REG I, V280, pR1, DOI 10.1152/ajpregu.2001.280.1.R1; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Hu XQ, 2012, HYPERTENSION, V60, P214, DOI 10.1161/HYPERTENSIONAHA.112.196097; Hu XQ, 2011, HYPERTENSION, V58, P1132, DOI 10.1161/HYPERTENSIONAHA.111.179952; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Kublickiene KR, 1997, AM J OBSTET GYNECOL, V177, P1263, DOI 10.1016/S0002-9378(97)70048-6; Kublickiene KR, 1997, AM J OBSTET GYNECOL, V176, P560, DOI 10.1016/S0002-9378(97)70548-9; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Liu YP, 2002, CIRC RES, V91, P1070, DOI 10.1161/01.RES.0000046003.14031.98; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Marshall C, 1996, AM J RESP CELL MOL, V15, P633, DOI 10.1165/ajrcmb.15.5.8918370; Matsubara K, 2010, J OBSTET GYNAECOL RE, V36, P239, DOI 10.1111/j.1447-0756.2009.01128.x; MEYER MC, 1993, AM J OBSTET GYNECOL, V169, P1510, DOI 10.1016/0002-9378(93)90427-K; Meyer MC, 1997, J SOC GYNECOL INVEST, V4, P293, DOI 10.1016/S1071-5576(97)00063-4; Palmer SK, 1999, AM J OBSTET GYNECOL, V180, P1161, DOI 10.1016/S0002-9378(99)70611-3; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Rathore R, 2006, BIOCHEM BIOPH RES CO, V351, P784, DOI 10.1016/j.bbrc.2006.10.116; Rosenfeld CR, 2009, AM J PHYSIOL-HEART C, V296, pH1878, DOI 10.1152/ajpheart.01185.2008; Rosenfeld CR, 2001, AM J PHYSIOL-HEART C, V281, pH422, DOI 10.1152/ajpheart.2001.281.1.H422; Soto MA, 2002, AM J PHYSIOL-CELL PH, V282, pC461, DOI 10.1152/ajpcell.00167.2001; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; THOMAS HM, 1991, BIOCHEM PHARMACOL, V42, pR9, DOI 10.1016/0006-2952(91)90440-G; Veerareddy S, 2002, AM J PHYSIOL-HEART C, V283, pH2226, DOI 10.1152/ajpheart.00593.2002; Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com; Xiao DL, 2006, AM J PHYSIOL-HEART C, V290, pH2337, DOI 10.1152/ajpheart.01238.2005; Xiao DL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.104448; Xiao DL, 2011, BRIT J PHARMACOL, V164, P1400, DOI 10.1111/j.1476-5381.2011.01437.x; Xiao DL, 2009, HYPERTENSION, V54, P352, DOI 10.1161/HYPERTENSIONAHA.109.130781; Xiong FX, 2012, FASEB J, V26, P2753, DOI 10.1096/fj.11-199422; ZAMUDIO S, 1995, J APPL PHYSIOL, V79, P15, DOI 10.1152/jappl.1995.79.1.15; Zhang L, 2007, J HYPERTENS, V25, P407, DOI 10.1097/HJH.0b013e328010beee; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	43	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73731	10.1371/journal.pone.0073731	http://dx.doi.org/10.1371/journal.pone.0073731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066066	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000048
J	Deikumah, JP; McAlpine, CA; Maron, M				Deikumah, Justus P.; McAlpine, Clive A.; Maron, Martine			Matrix Intensification Alters Avian Functional Group Composition in Adjacent Rainforest Fragments	PLOS ONE			English	Article							ECOSYSTEM SERVICES; BIOTIC HOMOGENIZATION; MULTIVARIATE ANALYSES; SPECIES RICHNESS; SEED DISPERSAL; BIRDS; DIVERSITY; HABITAT; LANDSCAPE; BIODIVERSITY	Conversion of farmland land-use matrices to surface mining is an increasing threat to the habitat quality of forest remnants and their constituent biota, with consequences for ecosystem functionality. We evaluated the effects of matrix type on bird community composition and the abundance and evenness within avian functional groups in southwest Ghana. We hypothesized that surface mining near remnants may result in a shift in functional composition of avifaunal communities, potentially disrupting ecological processes within tropical forest ecosystems. Matrix intensification and proximity to the remnant edge strongly influenced the abundance of members of several functional guilds. Obligate frugivores, strict terrestrial insectivores, lower and upper strata birds, and insect gleaners were most negatively affected by adjacent mining matrices, suggesting certain ecosystem processes such as seed dispersal may be disrupted by landscape change in this region. Evenness of these functional guilds was also lower in remnants adjacent to surface mining, regardless of the distance from remnant edge, with the exception of strict terrestrial insectivores. These shifts suggest matrix intensification can influence avian functional group composition and related ecosystem-level processes in adjacent forest remnants. The management of matrix habitat quality near and within mine concessions is important for improving efforts to preserveavian biodiversity in landscapes undergoing intensification such as through increased surface mining.	[Deikumah, Justus P.; McAlpine, Clive A.; Maron, Martine] Univ Queensland, Sch Geog Planning & Environm Management, Landscape Ecol & Conservat Grp, Brisbane, Qld, Australia	University of Queensland	Deikumah, JP (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Landscape Ecol & Conservat Grp, Brisbane, Qld, Australia.	j.deikumah2@uq.edu.au	Maron, Martine/D-9699-2011; Deikumah, Justus P/AGK-9872-2022	Maron, Martine/0000-0002-5563-5789; Deikumah, Justus P/0000-0001-8800-3780; McAlpine, Clive/0000-0003-0457-8144	University of Queensland International Research Tuition Award (UQIRTA); UQ Research Scholarship (UQRS)	University of Queensland International Research Tuition Award (UQIRTA); UQ Research Scholarship (UQRS)	This research was supported by a University of Queensland International Research Tuition Award (UQIRTA) and a UQ Research Scholarship (UQRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy SN, 1998, RESOUR POLICY, V24, P229, DOI 10.1016/S0301-4207(98)00035-X; Agyeman, 2011, IMPACT LOGGING DAMAG; AIROLA DA, 1985, CONDOR, V87, P205, DOI 10.2307/1366884; Amankwah RK, 2003, RESOUR POLICY, V29, P131, DOI 10.1016/j.resourpol.2004.07.002; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Areendran G, 2013, TROP ECOL, V54, P239; Aryee BNA, 2003, J CLEAN PROD, V11, P131, DOI 10.1016/S0959-6526(02)00043-4; ASANTE KA, 2009, INTERDISCIPLINARY ST, P253; Bakker JD, 2008, J APPL ECOL, V45, P1829, DOI 10.1111/j.1365-2664.2008.01571.x; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Bennun Leon, 1998, Journal of East African Natural History, V85, P23, DOI 10.2982/0012-8317(1996)85[23:TFBOKA]2.0.CO;2; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BirdLife International, 2004, STAT WORLDS BIRDS 20; Buckland S.T., 2001, pi; Bueno RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056252; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 1994, CHANGE MARINE COMMUN; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; CROME FHJ, 1978, AUST J ECOL, V3, P195, DOI 10.1111/j.1442-9993.1978.tb01170.x; Cumming GS, 2009, PHILOS T R SOC B, V364, P1683, DOI 10.1098/rstb.2008.0317; Darko G, 2008, CHEMOSPHERE, V72, P21, DOI 10.1016/j.chemosphere.2008.02.052; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; *EPACP, 1994, EP ENV PAN ADV COMM; ESRI, 2011, ARCGIS DESKT REL 10; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Fry CH., 2000, BIRDS AFRICA, VVI; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; GATTER WG, 1998, BIRDS LIBERIA; Githiru M, 2002, OIKOS, V96, P320, DOI 10.1034/j.1600-0706.2002.960214.x; Hammond DS, 2007, AMBIO, V36, P661, DOI 10.1579/0044-7447(2007)36[661:CACOAT]2.0.CO;2; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hawthorne WD, 1995, FOREST PROTECTION GH; Hilson G., 2002, NAT RESOUR FORUM, V26, P3, DOI DOI 10.1111/1477-8947.00002; Holbech LH, 2009, BIRD CONSERV INT, V19, P287, DOI 10.1017/S0959270909007126; Holbech LH, 2005, BIRD CONSERV INT, V15, P27, DOI 10.1017/S0959270905000031; Johnson M, 2007, WILDLIFE RES, V34, P185, DOI 10.1071/WR06103; Keith S., 1992, BIRDS AFRICA, VIV; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lehouck V, 2009, J VEG SCI, V20, P1110, DOI 10.1111/j.1654-1103.2009.01109.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Ntow WJ, 2008, ENVIRON RES, V106, P17, DOI 10.1016/j.envres.2007.05.020; Oksanen J., 2008, COMMUNITY ECOLOGY PA, V190, P254, DOI 10.4135/9781412971874.n145; Perfecto I, 2004, ECOLOGY, V85, P2677, DOI 10.1890/03-3145; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROBERTS DW, 2012, ORDINATION MULTIVARI; Rodewald AD, 2003, WILDLIFE SOC B, V31, P586; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schueler V, 2011, AMBIO, V40, P528, DOI 10.1007/s13280-011-0141-9; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2012, J ORNITHOL, V153, pS153, DOI 10.1007/s10336-012-0869-4; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Swenson JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018875; THRESH JM, 1986, CROP PROT, V5, P41, DOI 10.1016/0261-2194(86)90037-2; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tubelis DP, 2004, OIKOS, V107, P634, DOI 10.1111/j.0030-1299.2004.13420.x; Turner B., 1993, EARTH TRANSFORMED HU, DOI [10.2307/622468, DOI 10.2307/622468]; Umetsu F, 2008, ECOGRAPHY, V31, P359, DOI 10.1111/j.0906-7590.2008.05302.x; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003	81	9	9	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74852	10.1371/journal.pone.0074852	http://dx.doi.org/10.1371/journal.pone.0074852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058634	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400098
J	Fares, E; Pyle, WG; Ray, G; Rose, RA; Denovan-Wright, EM; Chen, RP; Howlett, SE				Fares, Elias; Pyle, W. Glen; Ray, Gibanananda; Rose, Robert A.; Denovan-Wright, Eileen M.; Chen, Robert P.; Howlett, Susan E.			The Impact of Ovariectomy on Calcium Homeostasis and Myofilament Calcium Sensitivity in the Aging Mouse Heart	PLOS ONE			English	Article							AGE-ASSOCIATED CHANGES; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; CARDIAC MYOCYTES; SEX-DIFFERENCES; GENDER-DIFFERENCES; TROPONIN-I; MALE RATS; CONTRACTION; CA2+	This study determined whether deficiency of ovarian estrogen starting very early in life promoted age-associated Ca2+ dysregulation and contractile dysfunction in isolated ventricular myocytes. Myocytes were isolated from anesthetized C57BL/6 female mice. Animals received an ovariectomy or sham-operation at one month and were aged to similar to 24 months. Excitation-contraction coupling parameters were compared in fura-2 loaded myocytes (37 degrees C). While Ca2+ transients were larger and faster in field-stimulated myocytes from ovariectomized mice, ovariectomy had no effect on peak fractional shortening. Similarly, ovariectomy had no effect on fractional shortening measured in vivo by echocardiography (values were 60.5 +/- 2.9 vs. 60.3 +/- 2.5% in sham and ovariectomized, respectively; n=5 mice/group). Ovariectomy did decrease myofilament Ca2+ sensitivity, as evidenced by a 26% increase in the Ca2+ required to activate actomyosin MgATPase in ovariectomized hearts. Larger Ca2+ transients were attributable to a 48% increase in peak Ca2+ current, along with an increase in the amplitude, width and frequency of Ca2+ sparks measured in fluo-4 loaded myocytes. These changes in Ca2+ handling were not due to increased expression of Ca2+ channels (Ca(v)1.2), sarcoplasmic reticulum Ca2+ ATPase (SERCA2) or Na+-Ca2+ exchanger in ovariectomized hearts. However, ovariectomy increased sarcoplasmic reticulum Ca2+ stores by similar to 90% and promoted spontaneous Ca2+ release from the sarcoplasmic reticulum when compared to sham controls. These observations demonstrate that long-term ovariectomy promotes intracellular Ca2+ dysregulation, reduces myofilament Ca2+ sensitivity and increases spontaneous Ca2+ release in the aging female heart.	[Fares, Elias; Denovan-Wright, Eileen M.; Howlett, Susan E.] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Ray, Gibanananda; Rose, Robert A.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Howlett, Susan E.] Dalhousie Univ, Dept Med Geriatr Med, Halifax, NS, Canada; [Pyle, W. Glen] Univ Guelph, Dept Biomed Sci, Cardiovasc Res Grp, Guelph, ON N1G 2W1, Canada; [Chen, Robert P.] IWK Hlth Ctr, Halifax, NS, Canada; [Chen, Robert P.] Dalhousie Univ, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; University of Guelph; Dalhousie University; Dalhousie University	Howlett, SE (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada.	Susan.Howlett@dal.ca		Pyle, Glen/0000-0003-0980-4729; Rose, Robert/0000-0001-9880-3482; Howlett, Susan E/0000-0001-5351-6308	Canadian Institutes for Health Research [MOP 97973]; Heart and Stroke Foundations of New Brunswick	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundations of New Brunswick	This study was supported in part by grants from the Canadian Institutes for Health Research (grant number MOP 97973; http://www.cihr-irsc.gc.ca/e/193.html) and the Heart and Stroke Foundations of New Brunswick (http://www.hsf.ca/research/en/home). Elias Fares was supported by a studentship from the Canadian Institutes for Health Research (Banting and Best Scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagiakrishnan K, 2013, ANN MED, V45, P37, DOI 10.3109/07853890.2012.660493; BASSANI RA, 1995, BIOPHYS J, V68, P2015, DOI 10.1016/S0006-3495(95)80378-4; Bell JR, 2011, ENDOCRINOLOGY, V152, P4937, DOI 10.1210/en.2011-1212; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bupha-Intr T, 2007, AM J PHYSIOL-REG I, V292, pR837, DOI 10.1152/ajpregu.00376.2006; Bupha-Intr T, 2006, AM J PHYSIOL-HEART C, V291, pH1101, DOI 10.1152/ajpheart.00660.2005; Bupha-Intr T, 2011, AM J PHYSIOL-HEART C, V300, pH1661, DOI 10.1152/ajpheart.00411.2010; CAPASSO JM, 1992, AM J PHYSIOL, V262, pH1770, DOI 10.1152/ajpheart.1992.262.6.H1770; Castilla-Cortazar I, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-103; Chu SH, 2006, LIFE SCI, V79, P1257, DOI 10.1016/j.lfs.2006.03.037; Clusin WT, 2003, CRIT REV CL LAB SCI, V40, P337, DOI 10.1080/713609356; Curl CL, 2009, PHYSIOL RES, V58, P293, DOI 10.33549/physiolres.931460; Curl CL, 2003, CLIN EXP PHARMACOL P, V30, P489, DOI 10.1046/j.1440-1681.2003.03864.x; Curl CL, 2001, PFLUG ARCH EUR J PHY, V441, P709, DOI 10.1007/s004240000473; Delbridge LMD, 1996, AM J PHYSIOL-CELL PH, V270, pC192, DOI 10.1152/ajpcell.1996.270.1.C192; Eskin BA, 2003, EXP BIOL MED, V228, P194, DOI 10.1177/153537020322800210; Fares E, 2012, J MOL CELL CARDIOL, V52, P32, DOI 10.1016/j.yjmcc.2011.09.002; Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x; Farrell SR, 2007, MECH AGEING DEV, V128, P566, DOI 10.1016/j.mad.2007.08.003; Farrell SR, 2010, AM J PHYSIOL-HEART C, V299, pH36, DOI 10.1152/ajpheart.00299.2010; FERRIER GR, 1995, J PHYSIOL-LONDON, V484, P107, DOI 10.1113/jphysiol.1995.sp020651; Ferrier GR, 2000, AM J PHYSIOL-HEART C, V278, pH1618, DOI 10.1152/ajpheart.2000.278.5.H1618; Forman DE, 1997, J AM COLL CARDIOL, V30, P1872, DOI 10.1016/S0735-1097(97)00411-7; Golden KL, 2003, AM J PHYSIOL-ENDOC M, V285, pE449, DOI 10.1152/ajpendo.00054.2003; Grandy SA, 2006, AM J PHYSIOL-HEART C, V291, pH2362, DOI 10.1152/ajpheart.00070.2006; Grohe C, 1998, J ENDOCRINOL, V156, pR1, DOI 10.1677/joe.0.156R001; Houser SR, 2010, CIRC RES, V106, P1672, DOI 10.1161/CIRCRESAHA.110.221853; Howlett SE, 2010, AM J PHYSIOL-HEART C, V298, pH659, DOI 10.1152/ajpheart.00214.2009; Kam KWL, 2005, BRIT J PHARMACOL, V144, P972, DOI 10.1038/sj.bjp.0706123; KAMEYAMA M, 1986, PFLUG ARCH EUR J PHY, V407, P123, DOI 10.1007/BF00580662; Katoh H, 2000, CIRC RES, V87, P106, DOI 10.1161/01.RES.87.2.106; Kravtsov GM, 2007, AM J PHYSIOL-CELL PH, V292, pC1625, DOI 10.1152/ajpcell.00368.2006; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lancaster TS, 2012, PHYSIOL GENOMICS, V44, P957, DOI 10.1152/physiolgenomics.00184.2011; Lancaster TS, 2011, AM J PHYSIOL-REG I, V301, pR1242, DOI 10.1152/ajpregu.00851.2010; Lancel S, 2010, CIRC RES, V107, P228, DOI 10.1161/CIRCRESAHA.110.217570; Leblanc N, 1998, J PHYSIOL-LONDON, V511, P533, DOI 10.1111/j.1469-7793.1998.533bh.x; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; Lim CC, 2000, J MOL CELL CARDIOL, V32, P2075, DOI 10.1006/jmcc.2000.1239; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; Ma Y, 2009, BRIT J PHARMACOL, V157, P705, DOI 10.1111/j.1476-5381.2009.00212.x; McIntosh VJ, 2011, AM J PHYSIOL-HEART C, V301, pH1127, DOI 10.1152/ajpheart.00711.2010; Mellor KM, 2012, AM J PHYSIOL-HEART C, V302, pH964, DOI 10.1152/ajpheart.00797.2011; O'Brien JD, 2008, AM J PHYSIOL-HEART C, V294, pH2174, DOI 10.1152/ajpheart.00058.2008; Paigel AS, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-54; Parks RJ, 2013, PFLUG ARCH EUR J PHY, V465, P747, DOI 10.1007/s00424-013-1233-0; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; PRICE T, 1992, J CLIN ENDOCR METAB, V74, P879, DOI 10.1210/jc.74.4.879; Ren J, 2003, AM J PHYSIOL-HEART C, V284, pH1800, DOI 10.1152/ajpheart.00866.2002; Ribeiro RF, 2012, CELL PHYSIOL BIOCHEM, V30, P1, DOI 10.1159/000339041; Rueckschloss U, 2010, EXP GERONTOL, V45, P788, DOI 10.1016/j.exger.2010.05.002; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Sebag IA, 2011, AM J PHYSIOL-HEART C, V301, pH1706, DOI 10.1152/ajpheart.00088.2011; Shutt RH, 2008, AM J PHYSIOL-CELL PH, V295, pC692, DOI 10.1152/ajpcell.00287.2008; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Sipido KR, 2006, HEART RHYTHM, V3, P977, DOI 10.1016/j.hrthm.2006.01.013; SPURGEON HA, 1992, J PHYSIOL-LONDON, V447, P83, DOI 10.1113/jphysiol.1992.sp018992; Takagi G, 2003, AM J PHYSIOL-HEART C, V285, pH527, DOI 10.1152/ajpheart.01034.2002; Thireau J, 2010, ENDOCRINOLOGY, V151, P1837, DOI 10.1210/en.2009-1184; Wu JM, 2005, EXP BIOL MED, V230, P818, DOI 10.1177/153537020523001106; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhao H, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-6; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	67	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74719	10.1371/journal.pone.0074719	http://dx.doi.org/10.1371/journal.pone.0074719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058623	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900077
J	Kalilani-Phiri, L; Thesing, PC; Nyirenda, OM; Mawindo, P; Madanitsa, M; Membe, G; Wylie, B; Masonbrink, A; Makwakwa, K; Kamiza, S; Muehlenbachs, A; Taylor, TE; Laufer, MK				Kalilani-Phiri, Linda; Thesing, Phillip C.; Nyirenda, Osward M.; Mawindo, Patricia; Madanitsa, Mwayi; Membe, Gladys; Wylie, Blair; Masonbrink, Abbey; Makwakwa, Kingsley; Kamiza, Steve; Muehlenbachs, Atis; Taylor, Terrie E.; Laufer, Miriam K.			Timing of Malaria Infection during Pregnancy Has Characteristic Maternal, Infant and Placental Outcomes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; BIRTH-WEIGHT; ANEMIA	We conducted a clinical study of pregnant women in Blantyre, Malawi to determine the effect of the timing of malaria infection during pregnancy on maternal, infant and placental outcomes. Women were enrolled in their first or second trimester of their first or second pregnancy and followed every four weeks until delivery. Three doses of sulfadoxine-pyrimethamine were given for intermittent preventive treatment for malaria, and all episodes of parasitemia were treated according to the national guidelines. Placentas were collected at delivery and examined for malaria parasites and pigment by histology. Pregnant women had 0.6 episodes of malaria per person year of follow up. Almost all episodes of malaria were detected at enrollment and malaria infection during the follow up period was rare. Malaria and anemia at the first antenatal visit were independently associated with an increased risk of placental malaria detected at delivery. When all episodes of malaria were treated with effective antimalarial medication, only peripheral malaria infection at the time of delivery was associated with adverse maternal and infant outcomes. One quarter of the analyzed placentas had evidence of malaria infection. Placental histology was 78% sensitive and 89% specific for peripheral malaria infection during pregnancy. This study suggests that in this setting of high antifolate drug resistance, three doses of sulfadoxine-pyrimethamine maintain some efficacy in suppressing microscopically detectable parasitemia, although placental infection remains frequent. Even in this urban setting, a large proportion of women have malaria infection at the time of their first antenatal care visit. Interventions to control malaria early and aggressive case detection are required to limit the detrimental effects of pregnancy-associated malaria.	[Kalilani-Phiri, Linda] Univ Malawi, Coll Med, Dept Community Heath, Blantyre, Malawi; [Thesing, Phillip C.; Nyirenda, Osward M.; Mawindo, Patricia; Madanitsa, Mwayi; Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Membe, Gladys] Univ Malawi, Coll Med, Dept Obstet & Gynaecol, Blantyre, Malawi; [Wylie, Blair] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Masonbrink, Abbey] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Makwakwa, Kingsley; Kamiza, Steve] Univ Malawi, Coll Med, Dept Histopathol, Blantyre, Malawi; [Muehlenbachs, Atis] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Laufer, Miriam K.] Univ Maryland, Sch Med, Ctr Vaccine Dev HHMI, Baltimore, MD 21201 USA	University of Malawi; University of Malawi; University of Malawi; Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; University of Malawi; University of Washington; University of Washington Seattle; Michigan State University; Michigan State University College of Osteopathic Medicine; University System of Maryland; University of Maryland Baltimore	Laufer, MK (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev HHMI, Baltimore, MD 21201 USA.	mlaufer@medicine.umaryland.edu		Laufer, Miriam/0000-0001-8300-9593; Masonbrink, Abbey/0000-0001-5679-8320	Doris Duke Charitable Foundation [CSDA 081072]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [K23AI059316, R34AI079315, U01AI087624]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R34AI079315, K23AI059316, U01AI087624] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Doris Duke Charitable Foundation (CSDA 081072); National Institute of Allergy and Infectious Diseases, National Institutes of Health (K23AI059316, R34AI079315, U01AI087624; and Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C, P1990; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Bardaji A, 2012, EXPERT OPIN PHARMACO, V13, P1719, DOI 10.1517/14656566.2012.703651; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Kalilani L, 2010, T ROY SOC TROP MED H, V104, P416, DOI 10.1016/j.trstmh.2010.01.013; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Saute F, 2002, TROP MED INT HEALTH, V7, P19, DOI 10.1046/j.1365-3156.2002.00831.x; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71	12	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74643	10.1371/journal.pone.0074643	http://dx.doi.org/10.1371/journal.pone.0074643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058614	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900073
J	Stanley, RRE; deYoung, B; Snelgrove, PVR; Gregory, RS				Stanley, Ryan R. E.; deYoung, Brad; Snelgrove, Paul V. R.; Gregory, Robert S.			Factors Regulating Early Life History Dispersal of Atlantic Cod (Gadus morhua) from Coastal Newfoundland	PLOS ONE			English	Article							HADDOCK MELANOGRAMMUS-AEGLEFINUS; FISH EGGS; TRINITY BAY; SMITH SOUND; POPULATION-STRUCTURE; SPAWNING ORIGINS; CONCEPTION BAY; SURVIVAL RATES; CLASS STRENGTH; NORTHERN COD	To understand coastal dispersal dynamics of Atlantic cod (Gadus morhua), we examined spatiotemporal egg and larval abundance patterns in coastal Newfoundland. In recent decades, Smith Sound, Trinity Bay has supported the largest known overwintering spawning aggregation of Atlantic cod in the region. We estimated spawning and dispersal characteristics for the Smith Sound-Trinity Bay system by fitting ichthyoplankton abundance data to environmentally-driven, simplified box models. Results show protracted spawning, with sharply increased egg production in early July, and limited dispersal from the Sound. The model for the entire spawning season indicates egg export from Smith Sound is 13%.day(-1) with a net mortality of 27%.day(-1). Eggs and larvae are consistently found in western Trinity Bay with little advection from the system. These patterns mirror particle tracking models that suggest residence times of 10-20 days, and circulation models indicating local gyres in Trinity Bay that act in concert with upwelling dynamics to retain eggs and larvae. Our results are among the first quantitative dispersal estimates from Smith Sound, linking this spawning stock to the adjacent coastal waters. These results illustrate the biophysical interplay regulating dispersal and connectivity originating from inshore spawning of coastal northwest Atlantic.	[Stanley, Ryan R. E.; Snelgrove, Paul V. R.] Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada; [Stanley, Ryan R. E.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [deYoung, Brad] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Gregory, Robert S.] Fisheries & Oceans Canada, Ecol Sci Sect, St John, NF, Canada; [Gregory, Robert S.] Fisheries & Oceans Canada, Ctr Expertise Aquat Habitat Res, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Stanley, RRE (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada.	rstanley@mun.ca			Natural Sciences and Engineering Research Council of Canada, major federal government granting agency for natural sciences in Canada	Natural Sciences and Engineering Research Council of Canada, major federal government granting agency for natural sciences in Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada (www.nserc.ca), the major federal government granting agency for natural sciences in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann H, 2003, ICES J MAR SCI, V60, P243, DOI 10.1016/S1054-3139(03)00019-5; Begg GA, 2000, MAR ECOL PROG SER, V202, P193, DOI 10.3354/meps202193; Begg GA, 2002, MAR ECOL PROG SER, V229, P263, DOI 10.3354/meps229263; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Bradbury IR, 2003, MAR ECOL PROG SER, V257, P233, DOI 10.3354/meps257233; Bradbury IR, 2001, FISH OCEANOGR, V10, P342, DOI 10.1046/j.1365-2419.2001.00179.x; Bradbury IR, 2000, SUCCESS FAILURE ATLA; BRANDER KM, 1994, ICES J MAR SCI, V51, P71, DOI 10.1006/jmsc.1994.1007; CAMPANA SE, 1989, CAN J FISH AQUAT SCI, V46, P171, DOI 10.1139/f89-287; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; DAHLBERG MD, 1979, MAR FISH REV, V41, P1; Dalley EL, 2002, ICES J MAR SCI, V59, P929, DOI 10.1006/jmsc.2002.1251; Davidson FJM, 2001, J GEOPHYS RES-OCEANS, V106, P7001, DOI 10.1029/2000JC900052; DEYOUNG B, 1993, J PHYS OCEANOGR, V23, P2636, DOI 10.1175/1520-0485(1993)023<2636:TLANRO>2.0.CO;2; DEYOUNG B, 1993, CAN J FISH AQUAT SCI, V50, P2729, DOI 10.1139/f93-298; DFO, 2008, 2008034 DFO CAN SCI, P1; Harden-Jones FR, 1968, FISH MIGRATION; HEATH MR, 1992, ADV MAR BIOL, V28, P1, DOI 10.1016/S0065-2881(08)60039-5; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; HOUDE ED, 1989, FISH B-NOAA, V87, P471; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Knickle DC, 2012, FISH RES, V129, P8, DOI 10.1016/j.fishres.2012.05.013; Knickle DC, 2010, FISH OCEANOGR, V19, P397, DOI 10.1111/j.1365-2419.2010.00553.x; Knutsen H, 2007, MAR ECOL PROG SER, V333, P249, DOI 10.3354/meps333249; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Maddock Parsons D, 2005, WITCH FLOUNDER POPUL; MARKLE DF, 1985, CAN J ZOOL, V63, P246, DOI 10.1139/z85-038; Mountain D, 2008, MAR ECOL PROG SER, V353, P225, DOI 10.3354/meps07176; Munk P, 2007, MAR ECOL PROG SER, V334, P225, DOI 10.3354/meps334225; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Myksvoll MS, 2013, ICES J MARINE SCI J; Panteleev GG, 2004, J MAR RES, V62, P787, DOI 10.1357/0022240042880846; PEPIN P, 1995, CAN J FISH AQUAT SCI, V52, P1475, DOI 10.1139/f95-142; Pepin P, 2000, MAR ECOL PROG SER, V204, P199, DOI 10.3354/meps204199; Pepin P, 1997, CAN J FISH AQUAT SCI, V54, P2, DOI 10.1139/cjfas-54-S1-2; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Pinsent DL, 1997, CAN J FISH AQUAT SCI, V54, P19, DOI 10.1139/cjfas-54-S1-19; Rideout RM, 2000, J FISH BIOL, V57, P1429, DOI 10.1111/j.1095-8649.2000.tb02222.x; Rose G, 1996, NAFO SCI COUNCIL STU, V96; Rose G. A., 2007, COD ECOLOGICAL HIST; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Rose GA, 2003, ICES J MAR SCI, V60, P453, DOI 10.1016/S1054-3139(03)00044-4; Rose GA, 2011, CAN J FISH AQUAT SCI, V68, P152, DOI 10.1139/F10-135; Ruzzante DE, 2000, J FISH BIOL, V56, P431, DOI 10.1111/j.1095-8649.2000.tb02116.x; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Schillinger DJ, 2000, PHYS BIOL TOW YO DAT; Smedbol RK, 1997, CAN J FISH AQUAT SCI, V54, P177, DOI 10.1139/cjfas-54-S1-177; Smedbol RK, 1998, CAN J FISH AQUAT SCI, V55, P2283, DOI 10.1139/cjfas-55-10-2283; Snelgrove PVR, 2008, CAN J FISH AQUAT SCI, V65, P159, DOI 10.1139/F07-148; St Germain C, 2007, ZOOPLANKTON SPATIAL; Stanley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046266; SUNDBY S, 1989, RAP PROCES, V191, P351; Tittensor D. P., 2002, ANAL PHYS OCEANOGRAP; WROBLEWSKI JS, 1994, CAN J FISH AQUAT SCI, V51, P142, DOI 10.1139/f94-016; Yao T, 1986, ATMOS OCEAN, V24, P235, DOI 10.1080/07055900.1986.9649249	57	10	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75889	10.1371/journal.pone.0075889	http://dx.doi.org/10.1371/journal.pone.0075889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058707	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000324695900130
J	Alsmadi, O; Thareja, G; Alkayal, F; Rajagopalan, R; John, SE; Hebbar, P; Behbehani, K; Thanaraj, TA				Alsmadi, Osama; Thareja, Gaurav; Alkayal, Fadi; Rajagopalan, Ramakrishnan; John, Sumi Elsa; Hebbar, Prashantha; Behbehani, Kazem; Thanaraj, Thangavel Alphonse			Genetic Substructure of Kuwaiti Population Reveals Migration History	PLOS ONE			English	Article							GENOME-WIDE PATTERNS; ASSOCIATION; DIVERSITY; DISORDERS; GENOTYPE; DATABASE; TOOL	The State of Kuwait is characterized by settlers from Saudi Arabia, Iran, and other regions of the Arabian Peninsula. The settlements and subsequent admixtures have shaped the genetics of Kuwait. High prevalence of recessive disorders and metabolic syndromes (that increase risk of diabetes) is seen in the peninsula. Understanding the genetic structure of its population will aid studies designed to decipher the underlying causes of these disorders. In this study, we analyzed 572,366 SNP markers from 273 Kuwaiti natives genotyped using the illumina HumanOmniExpress BeadChip. Model-based clustering identified three genetic subgroups with different levels of admixture. A high level of concordance (Mantel test, p=0.0001 for 9999 repeats) was observed between the derived genetic clusters and the surname-based ancestries. Use of Human Genome Diversity Project (HGDP) data to understand admixtures in each group reveals the following: the first group (Kuwait P) is largely of West Asian ancestry, representing Persians with European admixture; the second group (Kuwait S) is predominantly of city-dwelling Saudi Arabian tribe ancestry, and the third group (Kuwait B) includes most of the tent-dwelling Bedouin surnames and is characterized by the presence of 17% African ancestry. Identity by Descent and Homozygosity analyses find Kuwait's population to be heterogeneous (placed between populations that have large amount of ROH and the ones with low ROH) with Kuwait S as highly endogamous, and Kuwait B as diverse. Population differentiation F-ST estimates place Kuwait P near Asian populations, Kuwait S near Negev Bedouin tribes, and Kuwait B near the Mozabite population. F-ST distances between the groups are in the range of 0.005 to 0.008; distances of this magnitude are known to cause false positives in disease association studies. Results of analysis for genetic features such as linkage disequilibrium decay patterns conform to Kuwait's geographical location at the nexus of Africa, Europe, and Asia.	[Alsmadi, Osama; Thareja, Gaurav; Alkayal, Fadi; Rajagopalan, Ramakrishnan; John, Sumi Elsa; Hebbar, Prashantha; Behbehani, Kazem; Thanaraj, Thangavel Alphonse] Dasman Diabet Inst, Dasman, Kuwait		Thanaraj, TA (corresponding author), Dasman Diabet Inst, Dasman, Kuwait.	Alphonse.Thangavel@dasmaninstitute.org	Rajagopalan, Ramakrishnan/I-4349-2019; Thareja, Gaurav/GRE-8285-2022; Hebbar, Prashantha/S-8748-2019; Rajagopalan, Ramakrishnan/Q-9018-2016	Rajagopalan, Ramakrishnan/0000-0002-5751-9239				ALAWADI SA, 1985, CLIN GENET, V27, P483; Alhyas L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040948; Alsmadi O, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-72; Alwan A, 1995, DIABETIC MED, V12, P1057, DOI 10.1111/j.1464-5491.1995.tb00421.x; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Cabrera VM, 2009, VERTEBR PALEOBIOL PA, P79, DOI 10.1007/978-90-481-2719-1_6; Casey MS, 2007, HIST KUWAIT, P15; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Channanath AM, 2013, DIABETES CARE, V36, pE75, DOI 10.2337/dc12-2451; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu JY, 2011, HUM MOL GENET, V20, pR206, DOI 10.1093/hmg/ddr386; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mohammad T, 2009, HEREDITY, V103, P425, DOI 10.1038/hdy.2009.72; Omberg L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-49; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Shmulewitz D, 2004, HUM HERED, V58, P145, DOI 10.1159/000083541; Slot B, 2003, KUWAIT GROWTH HIST I, Vxiii, P129; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Tadmouri GO, 2006, NUCLEIC ACIDS RES, V34, pD602, DOI 10.1093/nar/gkj015; TEEBI AS, 1994, J MED GENET, V31, P224, DOI 10.1136/jmg.31.3.224; Theyab JB, 2012, HUM BIOL, V84, P379, DOI 10.3378/027.084.0403; Triki-Fendri S, 2010, ANN HUM BIOL, V37, P827, DOI 10.3109/03014461003720296; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	43	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74913	10.1371/journal.pone.0074913	http://dx.doi.org/10.1371/journal.pone.0074913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066156	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000138
J	Biswas, M; Dey, S; Khamrui, S; Sen, U; Dasgupta, J				Biswas, Maitree; Dey, Sanjay; Khamrui, Susmita; Sen, Udayaditya; Dasgupta, Jhimli			Conformational Barrier of CheY3 and Inability of CheY4 to Bind FliM Control the Flagellar Motor Action in Vibrio cholerae	PLOS ONE			English	Article							CHEMOTAXIS SIGNAL-TRANSDUCTION; INTESTINAL EPITHELIAL-CELLS; X-RAY ANALYSIS; RESPONSE REGULATOR; CRYSTAL-STRUCTURE; PROTEIN MODELS; MOTILITY; PHOSPHORYLATION; COMPLEX; DEPHOSPHORYLATION	Vibrio cholerae contains multiple copies of chemotaxis response regulator (VcCheY1-VcCheY4) whose functions are elusive yet. Although previous studies suggested that only VcCheY3 directly switches the flagellar rotation, the involvement of VcCheY4 in chemotaxis could not be ruled out. None of these studies, however, focused on the structure, mechanism of activation or molecular basis of FliM binding of the VcCheYs. From the crystal structures of Ca2+ and Mg2+ bound VcCheY3 we proposed the presence of a conformational barrier composed of the hydrophobic packing of W61, M88 and V106 and a unique hydrogen bond between T90 and Q97 in VcCheY3. Lesser fluorescence quenching and higher Km value of VcCheY3, compared to its mutants VcCheY3-Q97A and VcCheY3-Q97A/E100A supported our proposition. Furthermore, aforesaid biochemical data, in conjunction with the structure of VcCheY3-Q97A, indicated that the coupling of T90 and Q97 restricts the movement of T90 toward the active site reducing the stabilization of the bound phosphate and effectively promoting autodephosphorylation of VcCheY3. The structure of BeF3- activated VcCheY3 insisted us to argue that elevated temperature and/or adequacy of phosphate pool might break the barrier of the free-state VcCheY3 and the conformational changes, required for FliM binding, occur upon phosphorylation. Structure of VcCheY4 has been solved in the free and sulfated states. VcCheY4(sulf), containing a bound sulfate at the active site, appears to be more compact and stable with a longer alpha 4 helix, shorter beta 4 alpha 4 loop and hydrogen bond between T82 and the sulfate compared to VcCheY4 free. While pull down assay of VcCheYs with VcFliM(NM) showed that only activated VcCheY3 can interact with VcFliMNM and VcCheY4 cannot, a knowledge based docking explained the molecular mechanism of the interactions between VcCheY3 and VcFliM and identified the limitations of VcCheY4 to interact with VcFliM even in its phosphorylated state.	[Biswas, Maitree; Dey, Sanjay; Dasgupta, Jhimli] St Xaviers Coll, Dept Biotechnol, Kolkata, India; [Khamrui, Susmita; Sen, Udayaditya] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	St. Xavier's College Kolkata; Saha Institute of Nuclear Physics	Dasgupta, J (corresponding author), St Xaviers Coll, Dept Biotechnol, Kolkata, India.	jhimlidasgupta@yahoo.com		Sen, Udayaditya/0000-0001-5742-2907; Dasgupta, Jhimli/0000-0002-8030-1262	CSIR/37(1381)/09/EMR-II, Govt. of India	CSIR/37(1381)/09/EMR-II, Govt. of India	Partial funding from: CSIR/37(1381)/09/EMR-II, Govt. of India. No additional external funding were received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhaya A, 2009, INNATE IMMUN-LONDON, V15, P131, DOI 10.1177/1753425908100454; Banerjee R, 2002, FEBS LETT, V532, P221, DOI 10.1016/S0014-5793(02)03678-5; Bell CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000306; Berleman JE, 2005, MOL MICROBIOL, V55, P1390, DOI 10.1111/j.1365-2958.2005.04489.x; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Biswas M, 2011, ACTA CRYSTALLOGR F, V67, P1645, DOI 10.1107/S1744309111041972; Black WP, 2010, J BACTERIOL, V192, P4267, DOI 10.1128/JB.00403-10; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Carugo O, 1998, PROTEINS, V31, P201, DOI 10.1002/(SICI)1097-0134(19980501)31:2<201::AID-PROT9>3.0.CO;2-O; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; EISENBACH M, 1990, MOL MICROBIOL, V4, P161, DOI 10.1111/j.1365-2958.1990.tb00584.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRETER R, 1976, INFECT IMMUN, V14, P246, DOI 10.1128/IAI.14.1.246-256.1976; Guhaniyogi J, 2008, J BACTERIOL, V190, P1419, DOI 10.1128/JB.01414-07; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hyakutake A, 2005, J BACTERIOL, V187, P8403, DOI 10.1128/JB.187.24.8403-8410.2005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khamrui S, 2010, ACTA CRYSTALLOGR F, V66, P944, DOI 10.1107/S1744309110022797; Lam KH, 2010, J BACTERIOL, V192, P2324, DOI 10.1128/JB.00603-09; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; Parthasarathy S, 1997, PROTEIN SCI, V6, P2561, DOI 10.1002/pro.5560061208; Pazy Y, 2009, J MOL BIOL, V392, P1205, DOI 10.1016/j.jmb.2009.07.064; Porter SL, 2004, J BIOL CHEM, V279, P54573, DOI 10.1074/jbc.M408855200; Porter SL, 2006, J BIOL CHEM, V281, P32694, DOI 10.1074/jbc.M606016200; Porter SL, 2008, P NATL ACAD SCI USA, V105, P18531, DOI 10.1073/pnas.0808010105; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; Sourjik V, 1998, BIOCHEMISTRY-US, V37, P2327, DOI 10.1021/bi972330a; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; VOLZ K, 1991, J BIOL CHEM, V266, P15511; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhu XY, 1996, J BACTERIOL, V178, P4208, DOI 10.1128/jb.178.14.4208-4215.1996; Zhu XY, 1997, J BIOL CHEM, V272, P23758, DOI 10.1074/jbc.272.38.23758; Zhu XY, 1997, J BIOL CHEM, V272, P5000, DOI 10.1074/jbc.272.8.5000	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73923	10.1371/journal.pone.0073923	http://dx.doi.org/10.1371/journal.pone.0073923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066084	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000066
J	Fan, LJ; Wang, YZ; Jin, XL; Li, JY; Cheng, XQ; Jin, SY				Fan, Lejun; Wang, Yuanzhuo; Jin, Xiaolong; Li, Jingyuan; Cheng, Xueqi; Jin, Shuyuan			Comprehensive Quantitative Analysis on Privacy Leak Behavior	PLOS ONE			English	Article								Privacy information is prone to be leaked by illegal software providers with various motivations. Privacy leak behavior has thus become an important research issue of cyber security. However, existing approaches can only qualitatively analyze privacy leak behavior of software applications. No quantitative approach, to the best of our knowledge, has been developed in the open literature. To fill this gap, in this paper we propose for the first time four quantitative metrics, namely, possibility, severity, crypticity, and manipulability, for privacy leak behavior analysis based on Privacy Petri Net (PPN). In order to compare the privacy leak behavior among different software, we further propose a comprehensive metric, namely, overall leak degree, based on these four metrics. Finally, we validate the effectiveness of the proposed approach using real-world software applications. The experimental results demonstrate that our approach can quantitatively analyze the privacy leak behaviors of various software types and reveal their characteristics from different aspects.	[Fan, Lejun; Wang, Yuanzhuo; Jin, Xiaolong; Li, Jingyuan; Cheng, Xueqi; Jin, Shuyuan] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Computing Technology, CAS	Wang, YZ (corresponding author), Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China.	wangyuanzhuo@ict.ac.cn	Cheng, Xueqi/F-1706-2010; Jin, Xiaolong/B-6626-2011		National Program (973 Program) on Key Basic Research Project of China [2013CB329602, 2012CB316303]; National Natural Science Foundation of China [61173008, 61100175, 61232010, 60933005?61303244]; Beijing Nova Program [Z121101002512063]	National Program (973 Program) on Key Basic Research Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work is supported by National Program (973 Program) on Key Basic Research Project of China (No. 2013CB329602, 2012CB316303) and National Natural Science Foundation of China (No. 61173008, 61100175, 61232010, 60933005?61303244). Y. Wang is supported by Beijing Nova Program (No. Z121101002512063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borders K, 2009, P IEEE S SECUR PRIV, P129, DOI 10.1109/SP.2009.9; COMPARETTI PM, 2010, 31 IEEE S SEC PRIV 2, P61, DOI DOI 10.1109/SP.2010.12; Egele M, 2011, 18 ANN NETW DISTR SY; Egele M, 2007, USENIX ASSOCIATION PROCEEDINGS OF THE 2007 USENIX ANNUAL TECHNICAL CONFERENCE, P233; Fan L, 2012, 17 IEEE S COMP COMM; JUNG J, 2008, 15 ACM C COMP COMM S, P279; Kruegel C., 2004, Proceedings. 20th Annual Computer Security Applications Conference, P91; Lanzi A, 2009, 16 ANN NETW DISTR SY; Moser A, 2007, TWENTY-THIRD ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P421, DOI 10.1109/ACSAC.2007.21; Moser A, 2007, P IEEE S SECUR PRIV, P231, DOI 10.1109/SP.2007.17	10	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73410	10.1371/journal.pone.0073410	http://dx.doi.org/10.1371/journal.pone.0073410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066046	gold, Green Submitted, Green Published			2022-12-27	WOS:000324494000027
J	Jia, M; Chen, SX; Zhang, B; Liang, HP; Feng, JQ; Zong, ZW				Jia, Min; Chen, Sixu; Zhang, Bo; Liang, Huaping; Feng, Jianquan; Zong, Zhaowen			Effects of Constitutive beta-Catenin Activation on Vertebral Bone Growth and Remodeling at Different Postnatal Stages in Mice	PLOS ONE			English	Article							IA RECEPTOR BMPRIA; STEM-CELLS; MASS; OSTEOBLASTS; DKK1; RESORPTION; GENE; LRP5; RATS	Background and Objective: The Wnt/beta-catenin signaling pathway is essential for controlling bone mass; however, little is known about the variable effects of the constitutive activation of beta-catenin (CA-beta-catenin) on bone growth and remodeling at different postnatal stages. The goal of the present study was to observe the effects of CA-beta-catenin on vertebral bone growth and remodeling in mice at different postnatal stages. In particular, special attention was paid to whether CA-beta-catenin has detrimental effects on these processes. Methods: Catnblox(ex 3) mice were crossed with mice expressing the TM-inducible Cre fusion protein, which could be activated at designated time points via injection of tamoxifen. beta-catenin was stabilized by tamoxifen injection 3 days, and 2, 4, 5, and 7 months after birth, and the effects lasted for one month. Radiographic imaging, microcomputed tomography, immunohistochemistry, and safranin O and tartrate-resistant acid phosphatase staining were employed to observe the effects of CA-beta-catenin on vertebral bone growth and remodeling. Results: CA-beta-catenin in both early (3 days after birth) and late stages (2, 4, 5, and 7 months after birth) increased bone formation and decreased bone resorption, which together increased vertebral bone volume. However, when beta-catenin was stabilized in the early stage, vertebral linear growth was retarded, and the mice demonstrated shorter statures. In addition, the newly formed bone was mainly immature and located close to the growth plate. In contrast, when beta-catenin was stabilized in the late stage, vertebral linear growth was unaffected, and the newly formed bone was mainly mature and evenly distributed throughout the vertebral body. Conclusions: CA-beta-catenin in both early and late stages of growth can increase vertebral bone volume, but beta-catenin has differential effects on vertebral growth and remodeling when activated at different postnatal stages.	[Jia, Min; Chen, Sixu; Zhang, Bo; Liang, Huaping; Zong, Zhaowen] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burn & Combined Injury, Dept Trauma Surg, Chongqing, Peoples R China; [Feng, Jianquan; Zong, Zhaowen] Baylor Coll Dent, Texas Agr & Mech Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA	Army Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Feng, JQ (corresponding author), Baylor Coll Dent, Texas Agr & Mech Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA.	JFeng@bcd.tamhsc.edu; zongzhaowen@163.com			Foundation of State Key Laboratory of Trauma, Burns and combined injury [SKLZZ201124]; National Science Foundation of China [81271935]; Special Fund for National Key Project "973" for Development of Basic Research [2011CB964701]	Foundation of State Key Laboratory of Trauma, Burns and combined injury; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for National Key Project "973" for Development of Basic Research(National Basic Research Program of China)	This study was supported by Foundation of State Key Laboratory of Trauma, Burns and combined injury (SKLZZ201124), National Science Foundation of China (81271935), and Special Fund for National Key Project "973" for Development of Basic Research (2011CB964701). The funders' websites are http://202.202.224.96/; http://www.nsfc.gov.cn; and http://www.nsfc.gov.cn, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dela Cruz F, 2012, DIFFERENTIATION, V83, P220, DOI 10.1016/j.diff.2012.01.001; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3; Hoeppner LH, 2011, J BIOL CHEM, V286, P10950, DOI 10.1074/jbc.M110.165100; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huang S, 2012, PLOS ONE, V27, DOI [10.1371/journal.pone.0045904., DOI 10.1371/J0URNAL.P0NE.0045904.PUBMED:23029304]; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI 10.1359/JBMR.080809; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Marsell R, 2012, BONE, V50, P619, DOI 10.1016/j.bone.2011.11.007; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Verkaar F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019185; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]; Zong ZW, 2008, RADIAT RES, V170, P444, DOI 10.1667/RR0744.1	36	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74093	10.1371/journal.pone.0074093	http://dx.doi.org/10.1371/journal.pone.0074093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066100	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000082
J	Morishige, N; Yamada, N; Morita, Y; Kimura, K; Sonoda, KH				Morishige, Naoyuki; Yamada, Naoyuki; Morita, Yukiko; Kimura, Kazuhiro; Sonoda, Koh-Hei			Persistence of Structural Changes at the Anterior Cornea in Bullous Keratopathy Patients after Endothelial Keratoplasty	PLOS ONE			English	Article							GENERATION IMAGING MICROSCOPY; CONFOCAL MICROSCOPY; SUBEPITHELIAL FIBROSIS; EXTRACELLULAR-MATRIX; STROMAL EDEMA	Subepithelial fibrosis (SEF) and the transdifferentiation of keratocytes into fibroblasts or myofibroblasts (Fbs/MFbs) have been detected in the cornea of individuals with bullous keratopathy. We examined the anterior cornea of bullous keratopathy patients for such changes after Descemet's stripping automated endothelial keratoplasty (DSAEK). Twenty-two individuals who underwent unilateral DSAEK at Yamaguchi University Hospital were enrolled in the study. The subjects were divided into groups A (n = 10) and B (n = 12) with a preoperative duration of stromal edema of less than or at least 12 months, respectively. The structure of the anterior stroma was examined by in vivo laser confocal microscopy at various times after surgery. SEF was detected in 1 (10.0%) and 11 (91.7%) cases in groups A and B, respectively, before surgery as well as in 0 (0%) and 7 (58.3%) cases, respectively, at 6 months after DSAEK. Fb/MFb transdifferentiation was detected in 0 (0%) and 8 (66.7%) cases in groups A and B, respectively, before surgery as well as in 0 and 1 (8.3%) case, respectively, at 6 months postsurgery. Anterior stromal scattering (ASS) was detected in 10 (100%) and 12 (100%) cases in groups A and B, respectively, before surgery as well as in 0 (0%) and 6 (50.0%) cases, respectively, at 6 months after DSAEK. Changes in anterior stromal structure apparent before surgery were thus also detected in bullous keratopathy patients after DSAEK. SEF and ASS persisted for more than 6 months in a substantial proportion of individuals with a preoperative duration of stromal edema of at least 12 months.	[Morishige, Naoyuki; Yamada, Naoyuki; Morita, Yukiko; Kimura, Kazuhiro; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan	Yamaguchi University	Morishige, N (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan.	morishig@yamaguchi-u.ac.jp						Awdeh RM, 2012, CORNEA, V31, P761, DOI 10.1097/ICO.0b013e318221d06e; Baratz KH, 2012, ARCH OPHTHALMOL-CHIC, V130, P868, DOI 10.1001/archophthalmol.2012.73; Boimer C, 2011, CAN J OPHTHALMOL, V46, P360, DOI 10.1016/j.jcjo.2011.06.015; Eagle R C Jr, 1989, Trans Am Ophthalmol Soc, V87, P107; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Ham L, 2009, AM J OPHTHALMOL, V148, P521, DOI 10.1016/j.ajo.2009.04.025; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Keenan TDL, 2012, ARCH OPHTHALMOL-CHIC, V130, P621, DOI 10.1001/archophthalmol.2011.2585; KENNEY MC, 1990, CORNEA, V9, P115; Kobayashi A, 2008, AM J OPHTHALMOL, V145, P977, DOI 10.1016/j.ajo.2008.02.009; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039201; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Morishige N, 2012, INVEST OPHTH VIS SCI, V53, P4998, DOI 10.1167/iovs.12-10214; Morishige N, 2012, J CATARACT REFR SURG, V38, P303, DOI 10.1016/j.jcrs.2011.08.032; Morishige N, 2011, CORNEA, V30, P1129, DOI 10.1097/ICO.0b013e318213798d; Morishige N, 2009, CLIN EXP OPHTHALMOL, V37, P249, DOI 10.1111/j.1442-9071.2009.02020.x; Morishige N, 2009, INVEST OPHTH VIS SCI, V50, P3145, DOI 10.1167/iovs.08-3309; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Price MO, 2007, CORNEA, V26, P493, DOI 10.1097/ICO.0b013e318030d274; Price MO, 2006, OPHTHALMOLOGY, V113, P1936, DOI 10.1016/j.ophtha.2006.05.034; Shih CY, 2009, AM J OPHTHALMOL, V148, P837, DOI 10.1016/j.ajo.2009.06.034; Terry Mark A, 2007, Trans Am Ophthalmol Soc, V105, P530	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74279	10.1371/journal.pone.0074279	http://dx.doi.org/10.1371/journal.pone.0074279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066132	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000114
J	Zanetti-Domingues, LC; Tynan, CJ; Rolfe, DJ; Clarke, DT; Martin-Fernandez, M				Zanetti-Domingues, Laura C.; Tynan, Christopher J.; Rolfe, Daniel J.; Clarke, David T.; Martin-Fernandez, Marisa			Hydrophobic Fluorescent Probes Introduce Artifacts into Single Molecule Tracking Experiments Due to Non-Specific Binding	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LATERAL DIFFUSION; MICROSCOPY; INTEGRIN; DOMAIN; EGFR; SPECTROSCOPY; DIMERIZATION; ACTIVATION	Single-molecule techniques are powerful tools to investigate the structure and dynamics of macromolecular complexes; however, data quality can suffer because of weak specific signal, background noise and dye bleaching and blinking. It is less well-known, but equally important, that non-specific binding of probe to substrates results in a large number of immobile fluorescent molecules, introducing significant artifacts in live cell experiments. Following from our previous work in which we investigated glass coating substrates and demonstrated that the main contribution to this non-specific probe adhesion comes from the dye, we carried out a systematic investigation of how different dye chemistries influence the behaviour of spectrally similar fluorescent probes. Single-molecule brightness, bleaching and probe mobility on the surface of live breast cancer cells cultured on a non-adhesive substrate were assessed for anti-EGFR affibody conjugates with 14 different dyes from 5 different manufacturers, belonging to 3 spectrally homogeneous bands (491 nm, 561 nm and 638 nm laser lines excitation). Our results indicate that, as well as influencing their photophysical properties, dye chemistry has a strong influence on the propensity of dye-protein conjugates to adhere non-specifically to the substrate. In particular, hydrophobicity has a strong influence on interactions with the substrate, with hydrophobic dyes showing much greater levels of binding. Crucially, high levels of non-specific substrate binding result in calculated diffusion coefficients significantly lower than the true values. We conclude that the physic-chemical properties of the dyes should be considered carefully when planning single-molecule experiments. Favourable dye characteristics such as photostability and brightness can be offset by the propensity of a conjugate for non-specific adhesion.	[Zanetti-Domingues, Laura C.; Tynan, Christopher J.; Rolfe, Daniel J.; Clarke, David T.; Martin-Fernandez, Marisa] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Clarke, DT (corresponding author), Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England.	dave.clarke@stfc.ac.uk	Zanetti-Domingues, Laura Carolina/AAJ-1387-2021; Zanetti-Domingues, Laura Carolina/GWB-9443-2022	Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Tynan, Christopher/0000-0002-4553-7018; martin-fernandez, marisa/0000-0001-5496-6300; Clarke, David/0000-0002-8776-1341; Rolfe, Daniel/0000-0002-8394-8395	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish; BBSRC [BB/G007160/1, BB/G006911/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was in part funded by the Biotechnology and Biological Sciences Research Council (BB/G006911/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; ATTO-TEC GmbH, 2011, PROD INF ATTO 647N; BENVENISTE M, 1988, J CELL BIOL, V106, P1903, DOI 10.1083/jcb.106.6.1903; Biotium Inc, CF DYES SEL GUID; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clarke DT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3635536; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Friedman M, 2007, PROTEIN ENG DES SEL, V20, P189, DOI 10.1093/protein/gzm011; Haugland RP, 2001, CURR PROTOC CELL BIO; Hovius R, 2006, SINGLE MOL DETECTION; Kannan B, 2007, ANAL CHEM, V79, P4463, DOI 10.1021/ac0624546; Keating E, 2008, EUR BIOPHYS J BIOPHY, V37, P469, DOI 10.1007/s00249-007-0239-y; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; LIVNEH E, 1986, J CELL BIOL, V103, P327, DOI 10.1083/jcb.103.2.327; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Nakao A, 1987, J Biomater Appl, V2, P219, DOI 10.1177/088532828700200203; Needham SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062331; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Qi SB, 2012, BIOCONJUGATE CHEM, V23, P1149, DOI 10.1021/bc200596a; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Tessler LA, 2011, J R SOC INTERFACE, V8, P1400, DOI 10.1098/rsif.2010.0669; Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096; VWR International, CF DYE Q A 3 5; Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084; Yao JZ, 2012, J AM CHEM SOC, V134, P3720, DOI 10.1021/ja208090p; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Yu X, 2000, J CELL SCI, V113, P2139; Zanetti-Domingues LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045655; Zhong H, 2010, COLD SPRING HARBOR P, V2010	38	103	104	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74200	10.1371/journal.pone.0074200	http://dx.doi.org/10.1371/journal.pone.0074200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066121	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000103
J	Choi, HW; Jansen, B; Birrer, D; Kassab, GS				Choi, Hyo Won; Jansen, Benjamin; Birrer, David; Kassab, Ghassan S.			Effect of Saline Injection Mixing on Accuracy of Conductance Lumen Sizing of Peripheral Vessels	PLOS ONE			English	Article							PRESSURE-VOLUME RELATIONSHIPS; AORTIC SEGMENTAL VOLUME; FINITE-ELEMENT MODEL; CORONARY-ARTERIES; BLOOD-FLOW; CATHETER MEASUREMENTS; IMPEDANCE CATHETER; REAL-TIME; IN-VITRO; AREA	Transient displacement of blood in vessel lumen with saline injection is necessary in the conductance method for measurement of arterial cross-sectional area (CSA). The displacement of blood is dictated by the interactions between arterial flow hemodynamics and saline injection dynamics. The objective of the present study is to understand how the accuracy of conductance measurements is affected by the saline injection. Computational simulations were performed to assess the error in predictions of arterial CSA using conductance measurements over a range of peripheral artery diameters (i.e., 4, 7, and 10 mm) with an introducing catheter (6 Fr.) for various blood flow and saline injection rates. The simulation results were validated using the conductance measurements of the phantoms with known diameters (i.e., 7 and 10 mm). The results demonstrated that a minimum ratio of saline injection rate to blood flow rate of 3 is needed to fully displace the blood and result in accurate measurement of CSA for the peripheral artery sizes considered. Furthermore, the error was shown to be minimized as the detection electrodes are positioned between the distal to the mixing zone induced by saline injection and far downstream (4-8 cm from the injection catheter tip). The present study shows that even for the large peripheral arteries (7-10 mm) where mixing can occur, an appropriate injection rate and detection position can produce accurate measurement of lumen size.	[Choi, Hyo Won; Jansen, Benjamin; Birrer, David; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu			3DT Holdings LLC in Indianapolis, IN	3DT Holdings LLC in Indianapolis, IN	This research was funded by 3DT Holdings LLC in Indianapolis, IN and G. S. Kassab is the founder of 3DT Holdings. No authors have received any compensation from 3DT Holdings. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aarnoudse W, 2007, J AM COLL CARDIOL, V50, P2294, DOI 10.1016/j.jacc.2007.08.047; [Anonymous], [No title captured]; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Bragadeesh T, 2005, J AM COLL CARDIOL, V45, P780, DOI 10.1016/j.jacc.2004.11.045; Chen CH, 1997, AM J CARDIOL, V80, P756, DOI 10.1016/S0002-9149(97)00509-2; CHIEN S, 1966, J APPL PHYSIOL, V21, P81, DOI 10.1152/jappl.1966.21.1.81; Choi HW, 2005, BIORHEOLOGY, V42, P493; Choi HW, 2011, J APPL PHYSIOL, V111, P758, DOI 10.1152/japplphysiol.00304.2011; Hermiller J, 2011, CATHETER CARDIO INTE, V78, P202, DOI 10.1002/ccd.22842; Hettrick DA, 1996, ANN BIOMED ENG, V24, P675, DOI 10.1007/BF02684180; Hettrick DA, 1998, ANN BIOMED ENG, V26, P431, DOI 10.1114/1.36; HILAL SK, 1966, RADIOLOGY, V86, P615, DOI 10.1148/86.4.615; Hussain ST, 1996, ULTRASOUND MED BIOL, V22, P287, DOI 10.1016/0301-5629(95)02050-0; Johnson K, 2008, J BIOMECH, V41, P595, DOI 10.1016/j.jbiomech.2007.10.010; KASS DA, 1992, EUR HEART J, V13, P57, DOI 10.1093/eurheartj/13.suppl_E.57; KASS DA, 1988, CATHETER CARDIO DIAG, V15, P192, DOI 10.1002/ccd.1810150314; KASS DA, 1986, CIRCULATION, V73, P586, DOI 10.1161/01.CIR.73.3.586; Kassab GS, 2009, AM J PHYSIOL-HEART C, V297, pH485, DOI 10.1152/ajpheart.01224.2008; Kassab GS, 2005, AM J PHYSIOL-HEART C, V288, pH2014, DOI 10.1152/ajpheart.00508.2004; Kassab GS, 2004, ANN BIOMED ENG, V32, P1642, DOI 10.1007/s10439-004-7817-2; LEVIN DC, 1978, RADIOLOGY, V127, P103, DOI 10.1148/127.1.103; LEVIN DC, 1977, INVEST RADIOL, V12, P116, DOI 10.1097/00004424-197703000-00003; Lieber BB, 2009, MED PHYS, V36, P5064, DOI 10.1118/1.3243079; MABON RF, 1978, RADIOLOGY, V128, P669, DOI 10.1148/128.3.669; Molloi S, 1996, CIRCULATION, V93, P1919, DOI 10.1161/01.CIR.93.10.1919; MOLLOI SY, 1991, INVEST RADIOL, V26, P119, DOI 10.1097/00004424-199102000-00005; MORRIS TW, 1989, INVEST RADIOL, V24, P361, DOI 10.1097/00004424-198905000-00004; WOLF GL, 1978, INVEST RADIOL, V13, P195, DOI 10.1097/00004424-197805000-00004; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6	29	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74622	10.1371/journal.pone.0074622	http://dx.doi.org/10.1371/journal.pone.0074622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058606	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400090
J	Li, WP; Gao, Z; Yang, CH; Li, JH; Li, L; Lv, R; Liu, Z				Li, Wuping; Gao, Zhan; Yang, Chunhui; Li, Jiahu; Li, Ling; Lv, Rong; Liu, Zhong			The Estimation of Prevalence, Incidence, and Residual Risk of Transfusion-Transmitted Human Hepatitis B Infection from Blood Donated at the Anhui Blood Center, China, from 2009 to 2011	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; VIRAL-INFECTIONS; DONORS; IMPACT	Background: The high prevalence of hepatitis B virus (HBV) among the Chinese population poses a threat to blood safety; however, few studies have examined epidemiological data regarding HBV infection of Chinese blood donors. The present study investigated the demographic characteristics of blood donors at the Anhui blood center in China, the prevalence, incidence, and residual risk (RR) associated with hepatitis B surface antigen (HBsAg) expression in terms of transfusion transmitted HBV (TTHBV) infections. Methods: The demographic characteristics and HBV status of people who donated blood at the Anhui blood center between 2009 and 2011 were retrospectively analyzed. The incidence of HBV was estimated through HBsAg yield approach. The window period model was then used to estimate the RR of TTHBV infection. Results: The typical donor at the Anhui blood center was a first-time volunteer, aged less than 25 years, unmarried, of Han ethnicity, and with an education below high school level. The prevalence of HBV infection among repeat donors, first-time donors, and all donors was 28.9, 127.2 and 82.1 per 100,000, respectively. The incidence estimate was 333.9 per 105 person-years. Using an infectious window period of 59 days, the RR for HBV was estimated to be 1 in 1853 between 2009 and 2011. Conclusions: The incidence and RR of HBV in Chinese blood donors are much higher than those of donors in developed countries. This is because sensitive ELISAs and nucleic acid tests are not available in China. Further work is needed to improve both the safety and availability of blood products in China.	[Li, Wuping] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Li, Wuping; Gao, Zhan; Yang, Chunhui; Liu, Zhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Wuping; Gao, Zhan; Yang, Chunhui; Liu, Zhong] Chinese Acad Med Sci, Inst Blood Transfus, Beijing 100730, Peoples R China; [Li, Jiahu; Li, Ling; Lv, Rong; Liu, Zhong] Anhui Blood Ctr, Hefei, Anhui, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS	Li, WP (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	lwpzhr@sina.com; liuzhong@yahoo.cn	Liu, Zhong/ABH-8584-2020	liu, zhong/0000-0001-8173-9656	Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2011IPB106]	Institute of Pathogen Biology, Chinese Academy of Medical Sciences	This study was supported by the basic grant of Institute of Pathogen Biology, Chinese Academy of Medical Sciences (grant NO: 2011IPB106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x; Alter HJ, 2000, NAT MED, V6, P1082, DOI 10.1038/80394; Candotti D, 2009, J HEPATOL, V51, P798, DOI 10.1016/j.jhep.2009.05.020; *DEC INC, 2000, CRYST BALL SOFTW 200; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dodd RY, 2004, INT J HEMATOL, V80, P301, DOI 10.1532/IJH97.04123; Dodd RY, 2002, TRANSFUSION, V42, P1240, DOI 10.1046/j.1537-2995.2002.00231.x; Glynn SA, 1998, TRANSFUSION, V38, P350, DOI 10.1046/j.1537-2995.1998.38498257373.x; Kleinman SH, 2006, J CLIN VIROL, V36, pS23, DOI 10.1016/S1386-6532(06)80005-3; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liu Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-193; Mine H, 2003, J VIROL METHODS, V112, P145, DOI 10.1016/S0166-0934(03)00215-5; Niederhauser C, 2011, J BLOOD MED, V2, P91, DOI 10.2147/JBM.S12899; Ren FR, 2011, TRANSFUSION, V51, P2588, DOI 10.1111/j.1537-2995.2011.03215.x; *SAS I, 1989, SAS STAT US GUID VER; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Seed CR, 2005, INTERN MED J, V35, P592, DOI 10.1111/j.1445-5994.2005.00926.x; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Wang J., 2012, INTERNAL MED, V2, P1, DOI [10.4172/2165-8048.1000113, DOI 10.4172/2165-8048.1000113]; Zou SM, 2009, TRANSFUSION, V49, P1609, DOI 10.1111/j.1537-2995.2009.02195.x	22	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73472	10.1371/journal.pone.0073472	http://dx.doi.org/10.1371/journal.pone.0073472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058476	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400026
J	Sagredo, A; del Campo, L; Martorell, A; Navarro, R; Martin, MC; Blanco-Rivero, J; Ferrer, M				Sagredo, Ana; del Campo, Lara; Martorell, Aina; Navarro, Rocio; Martin, Maria C.; Blanco-Rivero, Javier; Ferrer, Mercedes			Ovariectomy Increases the Participation of Hyperpolarizing Mechanisms in the Relaxation of Rat Aorta	PLOS ONE			English	Article							NITRIC-OXIDE RELEASE; ACETYLCHOLINE-INDUCED RELAXATION; DEPENDENT PROTEIN-KINASE; FEMALE SEX-HORMONES; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; K+ CHANNELS; VASODILATION; METABOLISM; MODULATION	This study examines the downstream NO release pathway and the contribution of different vasodilator mediators in the acetylcholine-induced response in rat aorta 5-months after the loss of ovarian function. Aortic segments from ovariectomized and control female Sprague-Dawley rats were used to measure: the levels of superoxide anion, the superoxide dismutases (SODs) activity, the cGMP formation, the cGMP-dependent protein kinase (PKG) activity and the involvement of NO, cGMP, hydrogen peroxide and hyperpolarizing mechanisms in the ACh-induced relaxation. The results showed that ovariectomy did not alter ACh-induced relaxation; incubation with L-NAME, a NO synthase inhibitor, decreased the ACh-induced response to a lesser extent in aorta from ovariectomized than from control rats, while ODQ, a guanylate cyclase inhibitor, decreased that response to a similar extent; the blockade of hyperpolarizing mechanisms, by precontracting arteries with KCl, decreased the ACh-induced response to a greater extent in aortas from ovariectomized than those from control rats; catalase, that decomposes hydrogen peroxide, decreased the ACh-induced response only in aorta from ovariectomized rats. In addition, ovariectomy increased superoxide anion levels and SODs activity, decreased cGMP formation and increased PKG activity. Despite the increased superoxide anion and decreased cGMP in aorta from ovariectomized rats, ACh-induced relaxation is maintained by the existence of hyperpolarizing mechanisms in which hydrogen peroxide participates. The greater contribution of hydrogen peroxide in ACh-induced relaxation is due to increased SOD activity, in an attempt to compensate for increased superoxide anion formation. Increased PKG activity could represent a redundant mechanism to ensure vasodilator function in the aorta of ovariectomized rats.	[Sagredo, Ana; del Campo, Lara; Martorell, Aina; Navarro, Rocio; Martin, Maria C.; Blanco-Rivero, Javier; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [del Campo, Lara; Blanco-Rivero, Javier; Ferrer, Mercedes] Inst Invest Sanitarias IdiPAZ, Madrid, Spain	Autonomous University of Madrid	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	mercedes.ferrer@uam.es	del Campo, Lara/A-8317-2015; Parra, Mercedes Ferrer/AAE-1746-2020; del Campo Milán, Lara/ABD-4219-2021; Navarro, Rocío/N-5505-2016; Rivero, Javier Blanco/ABE-8749-2020; Ferrer, Mercedes/E-3556-2018; Blanco-Rivero, Javier/J-6118-2014	del Campo, Lara/0000-0002-0394-116X; Parra, Mercedes Ferrer/0000-0002-4670-7146; del Campo Milán, Lara/0000-0002-0394-116X; Navarro, Rocío/0000-0002-0083-7711; Rivero, Javier Blanco/0000-0001-7232-2314; Blanco-Rivero, Javier/0000-0001-7232-2314; Martin, Carmen/0000-0001-8785-4225	Fondo de Investigaciones Sanitarias [PI1100406]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by grants (to MF) from the Fondo de Investigaciones Sanitarias (PI1100406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres S, 1998, AM J PHYSIOL-ENDOC M, V274, pE1002, DOI 10.1152/ajpendo.1998.274.6.E1002; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Castillo C, 2005, BIOGERONTOLOGY, V6, P49, DOI 10.1007/s10522-004-7383-x; Chen GF, 1996, CIRC RES, V79, P827, DOI 10.1161/01.RES.79.4.827; Cornwell TL, 2001, BIOL REPROD, V64, P857, DOI 10.1095/biolreprod64.3.857; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Ferrer M, 1999, CLIN SCI, V97, P625, DOI 10.1042/CS19990102; Ferrer M, 1999, GEN PHARMACOL, V33, P35, DOI 10.1016/S0306-3623(98)00259-6; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; Ghanam K, 1998, BIOCHEM BIOPH RES CO, V249, P858, DOI 10.1006/bbrc.1998.9238; Gorodeski GI, 2000, ENDOCRINOLOGY, V141, P1658, DOI 10.1210/en.141.5.1658; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; KHAN SA, 1993, J PHARMACOL EXP THER, V267, P1327; Kobayashi Seiichi, 2002, J Atheroscler Thromb, V9, P184; Leung SWS, 2007, CLIN EXP PHARMACOL P, V34, P822, DOI 10.1111/j.1440-1681.2007.04686.x; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Meurer S, 2005, J BIOL CHEM, V280, P33149, DOI 10.1074/jbc.M507565200; Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004; Minoves N, 2002, CLIN SCI, V103, P239, DOI 10.1042/cs1030239; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Murad F, 1997, CIRCULATION, V95, P1101; Ng Martin K C, 2007, Heart Lung Circ, V16, P185, DOI 10.1016/j.hlc.2007.02.108; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Oishi A, 2004, BIOCHEM BIOPH RES CO, V324, P193, DOI 10.1016/j.bbrc.2004.09.032; Oury TD, 1996, LAB INVEST, V75, P617; Reyna-Neyra A, 2007, J NEUROENDOCRINOL, V19, P418, DOI 10.1111/j.1365-2826.2007.01546.x; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH815, DOI 10.1152/ajpheart.1986.250.5.H815; Sagredo A, 2011, JOINT M EUR SOC MICR; SAGREDO A, 2007, P 8 C EUR ASS CLIN P; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Tanaka M, 2005, HYPERTENS RES, V28, P67, DOI 10.1291/hypres.28.67; Teede H, 2001, CLIN SCI, V100, P473, DOI 10.1042/CS20000170; Teede HJ, 2007, CLIN EXP PHARMACOL P, V34, P672, DOI 10.1111/j.1440-1681.2007.04658.x; Thengchaisri N, 2003, AM J PHYSIOL-HEART C, V285, pH2255, DOI 10.1152/ajpheart.00487.2003; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Wolin MS, 2002, J VASC RES, V39, P191, DOI 10.1159/000063685	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73474	10.1371/journal.pone.0073474	http://dx.doi.org/10.1371/journal.pone.0073474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058477	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400027
J	Ketelaar, SM; Nieuwenhuijsen, K; Gartner, FR; Bolier, L; Smeets, O; Sluiter, JK				Ketelaar, Sarah M.; Nieuwenhuijsen, Karen; Gartner, Fania R.; Bolier, Linda; Smeets, Odile; Sluiter, Judith K.			Effect of an E-mental Health Approach to Workers' Health Surveillance versus Control Group on Work Functioning of Hospital Employees: A Cluster-RCT	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SUBTHRESHOLD DEPRESSION; ALCOHOL-USE; SELF-HELP; NURSES; QUESTIONNAIRE; CARE; VALIDATION; DISORDERS; PROFESSIONALS	Objective: To evaluate an e-mental health (EMH) approach to workers' health surveillance (WHS) targeting work functioning (WF) and mental health (MH) of healthcare professionals in a randomised controlled trial. Methods: Nurses and allied health professionals (N = 1140) were cluster-randomised at ward level to the intervention (IG) or control group (CG). The intervention consisted of two parts: (a) online screening and personalised feedback on impaired WF and MH, followed by (b) a tailored offer of self-help EMH interventions. CG received none of these parts. Primary outcome was impaired WF (Nurses Work Functioning Questionnaire), assessed at baseline and after three and six months. Analyses were performed in the positively screened subgroup (i) and in all participants (ii). Results: Participation rate at baseline was 32% (N-IG = 178; N-CG = 188). Eighty-two percent screened positive for at least mild impairments in WF and/or MH (N-IG = 139; N-CG = 161). All IG-participants (N = 178) received part (a) of the intervention, nine participants (all positively screened, 6%) followed an EMH intervention to at least some extent. Regarding the subgroup of positively screened participants (i), both IG and CG improved over time regarding WF (non-significant between-group difference). After six months, 36% of positively screened IG-participants (18/50) had a relevant WF improvement compared to baseline, versus 28% (32/115) of positively screened CG-participants (non-significant difference). In the complete sample (ii), IG and CG improved over time but IG further improved between three and six months while CG did not (significant interaction effect). Conclusions: In our study with a full compliance rate of 6% and substantial drop-out leading to a small and underpowered sample, we could not demonstrate that an EMH-approach to WHS is more effective to improve WF and MH than a control group. The effect found in the complete sample of participants is not easily interpreted. Reported results may be useful for future meta-analytic work.	[Ketelaar, Sarah M.; Nieuwenhuijsen, Karen; Gartner, Fania R.; Sluiter, Judith K.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands; [Bolier, Linda; Smeets, Odile] Netherlands Inst Mental Hlth & Addict, Innovat Ctr Mental Hlth & Technol I COM, Trimbos Inst, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Trimbos Institute	Ketelaar, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.M.Ketelaar@amc.uva.nl			Dutch Foundation Institute Gak; The Netherlands Organisation for Health Research and Development (ZonMW) [208010001]	Dutch Foundation Institute Gak; The Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The Mental Vitality @ Work trial was co-financed by a grant from the Dutch Foundation Institute Gak (URL: http://www.instituutgak.nl, PrevBGZ/project D) and a grant from The Netherlands Organisation for Health Research and Development (ZonMW) (URL: http://www.zonmw.nl/en, grant number 208010001). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens J, 2012, INT J NURS STUD, V49, P1411, DOI 10.1016/j.ijnurstu.2012.07.003; [Anonymous], STERK WERK; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Billings DW, 2008, J OCCUP ENVIRON MED, V50, P960, DOI 10.1097/JOM.0b013e31816c435b; Blankers M, 2011, J CONSULT CLIN PSYCH, V79, P330, DOI 10.1037/a0023498; Bolier L, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.1791; Broersen JPJ, 2004, TBV, V12, P100, DOI DOI 10.1007/BF030; Brom D, 1985, NEDERLANDS TIJDSCHRI, V40, P164; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Codony M, 2009, PSYCHIAT SERV, V60, P1051, DOI 10.1176/appi.ps.60.8.1051; De Beurs E., 2006, BRIEF SYMPTOM INVENT; de Beurs E, 2006, MAANDBLAD GEESTELIJK, P120; de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429; Denkena B., 2007, LEISTUNGSOPTIMIERUNG; DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795; Farrer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028099; Fogg B.J., 2009, P 4 INT C PERS TECHN, V40, P7, DOI [DOI 10.1145/1541948.1541999, 10.1145/1541948.1541999]; Gartner FR, 2012, INT ARCH OCC ENV HEA, V85, P125, DOI 10.1007/s00420-011-0649-0; Gartner FR, 2012, J CLIN EPIDEMIOL, V65, P1337, DOI 10.1016/j.jclinepi.2012.06.013; Gartner FR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-290; Gartner FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026565; Gual A, 2002, ALCOHOL ALCOHOLISM, V37, P591, DOI 10.1093/alcalc/37.6.591; Hammig O, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13577; Holier L, 2010, PSYFIT ONLINE GERAND; Hood Joyce, 2007, AAOHN J, V55, P423; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; International Labour Organization, 1998, TECHN ETH GUID WORK; Jahkola, 1998, WORK ABILITY INDEX; Kelders SM, 2012, J MED INTERNET RES, V14, P17, DOI 10.2196/jmir.2104; Ketelaar SM, 2013, J OCCUP ENVIRON MED, V55, P563, DOI 10.1097/JOM.0b013e318289ee3e; Koh D, 2003, OCCUP ENVIRON MED, V60, P705, DOI 10.1136/oem.60.9.705; Kristensen T S, 2005, Occup Environ Med, V62, P205, DOI 10.1136/oem.2004.016097; Letvak S, 2012, CLIN NURSE SPEC, V26, P177, DOI 10.1097/NUR.0b013e3182503ef0; Letvak SA, 2012, AM J NURS, V112, P30, DOI 10.1097/01.NAJ.0000411176.15696.f9; Lexis MAS, 2010, J OCCUP REHABIL, V20, P537, DOI 10.1007/s10926-010-9244-6; Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2; Meijman T.F., 1994, METEN PSYCHOSOCIALE; NVAB, 2005, LEIDR PREV MED OND; Rai D, 2012, J EPIDEMIOL COMMUN H, V66, P586, DOI 10.1136/jech.2010.119644; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; Ritterband LM, 2003, PROF PSYCHOL-RES PR, V34, P527, DOI 10.1037/0735-7028.34.5.527; Schellings R, 2009, J CLIN EPIDEMIOL, V62, P393, DOI 10.1016/j.jclinepi.2008.07.010; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Sluiter JK, 2006, APPL ERGON, V37, P429, DOI 10.1016/j.apergo.2006.04.007; Spek V, 2008, PSYCHOL MED, V38, P635, DOI 10.1017/S0033291707002590; Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Terluin B, 1998, PSYCHOLOOG, V33, P18; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; van Ballegooijen W, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-75; van der Ploeg E., 2003, Occupational and Environmental Medicine, V60, pi40, DOI 10.1136/oem.60.suppl_1.i40; van Rhenen Willem, 2008, J Occup Med Toxicol, V3, P3, DOI 10.1186/1745-6673-3-3; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954	54	20	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72546	10.1371/journal.pone.0072546	http://dx.doi.org/10.1371/journal.pone.0072546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069148	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100009
J	Wertz, AE; German, TC				Wertz, Annie E.; German, Tamsin C.			Theory of Mind in the Wild: Toward Tackling the Challenges of Everyday Mental State Reasoning	PLOS ONE			English	Article							FALSE BELIEF TASK; INTENTIONAL STANCE; YOUNG-CHILDREN; SOCIAL-PERCEPTION; OTHERS BELIEFS; GAZE SHIFTS; INFANTS; GOAL; ATTRIBUTION; EXPLANATION	A complete understanding of the cognitive systems underwriting theory of mind (ToM) abilities requires articulating how mental state representations are generated and processed in everyday situations. Individuals rarely announce their intentions prior to acting, and actions are often consistent with multiple mental states. In order for ToM to operate effectively in such situations, mental state representations should be generated in response to certain actions, even when those actions occur in the presence of mental state content derived from other aspects of the situation. Results from three experiments with preschool children and adults demonstrate that mental state information is indeed generated based on an approach action cue in situations that contain competing mental state information. Further, the frequency with which participants produced or endorsed explanations that include mental states about an approached object decreased when the competing mental state information about a different object was made explicit. This set of experiments provides some of the first steps toward identifying the observable action cues that are used to generate mental state representations in everyday situations and offers insight into how both young children and adults processes multiple mental state representations.	[Wertz, Annie E.; German, Tamsin C.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Wertz, AE (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	annie.wertz@yale.edu		German, Tamsin/0000-0002-4754-8108; Wertz, Annie/0000-0003-2145-5189	UCSB Academic Senate grant	UCSB Academic Senate grant	This research was supported by a UCSB Academic Senate grant to TCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Apperly IA, 2006, PSYCHOL SCI, V17, P841, DOI 10.1111/j.1467-9280.2006.01791.x; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barrett HC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2654; Barrett HC, 2005, EVOL HUM BEHAV, V26, P313, DOI 10.1016/j.evolhumbehav.2004.08.015; BARTSCH K, 1989, CHILD DEV, V60, P946, DOI 10.2307/1131035; Bartsch K, 1998, INT J BEHAV DEV, V22, P423, DOI 10.1080/016502598384450; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Brandone AC, 2009, PSYCHOL SCI, V20, P85, DOI 10.1111/j.1467-9280.2008.02246.x; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Buresh JS, 2007, COGNITION, V104, P287, DOI 10.1016/j.cognition.2006.07.001; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Carlson SM, 1998, CHILD DEV, V69, P672, DOI 10.2307/1132197; Carpenter M, 1998, INFANT BEHAV DEV, V21, P315, DOI 10.1016/S0163-6383(98)90009-1; Cohen AS, 2010, COGNITION, V115, P417, DOI 10.1016/j.cognition.2010.03.001; Cohen AS, 2009, COGNITION, V111, P356, DOI 10.1016/j.cognition.2009.03.004; Csibra G, 2003, COGNITIVE SCI, V27, P111, DOI 10.1207/s15516709cog2701_4; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; Daum MM, 2008, DEVELOPMENTAL SCI, V11, P607, DOI 10.1111/j.1467-7687.2008.00705.x; DAVIDSON D, 1963, J PHILOS, V60, P685, DOI 10.2307/2023177; Friedman O, 2005, DEVELOPMENTAL SCI, V8, P218, DOI 10.1111/j.1467-7687.2005.00410.x; Friedman O, 2004, COGNITIVE SCI, V28, P963, DOI 10.1016/j.cogsci.2004.07.001; Friedman O, 2004, PSYCHOL SCI, V15, P547, DOI 10.1111/j.0956-7976.2004.00717.x; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fritzley VH, 2003, CHILD DEV, V74, P1297; Gao T, 2009, COGNITIVE PSYCHOL, V59, P154, DOI 10.1016/j.cogpsych.2009.03.001; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; German TC, 2012, BRIT J DEV PSYCHOL, V30, P45, DOI 10.1111/j.2044-835X.2011.02055.x; German TP, 2004, J COGNITIVE NEUROSCI, V16, P1805, DOI 10.1162/0898929042947892; GERMAN TP, 1995, THESIS U LONDON; GRAESSER AC, 1993, DISCOURSE PROCESS, V16, P145, DOI 10.1080/01638539309544833; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamlin JK, 2008, DEVELOPMENTAL SCI, V11, P487, DOI 10.1111/j.1467-7687.2008.00694.x; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2009, INFANCY, V14, P579, DOI 10.1080/15250000903144215; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Jastorff J, 2011, CEREB CORTEX, V21, P318, DOI 10.1093/cercor/bhq098; Klein AM, 2009, Q J EXP PSYCHOL, V62, P1189, DOI 10.1080/17470210802384214; Kloo D, 2003, CHILD DEV, V74, P1823, DOI 10.1046/j.1467-8624.2003.00640.x; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Leslie A.M., 2000, NEW COGNITIVE NEUROS, V2nd ed., P1235, DOI 10.5152/npa.2016.12750; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Leslie AM, 1998, DEVELOPMENTAL SCI, V1, P247, DOI 10.1111/1467-7687.00038; Leslie AM, 2005, COGNITIVE PSYCHOL, V50, P45, DOI 10.1016/j.cogpsych.2004.06.002; LESLIE AM, 1994, COGNITION, V50, P211, DOI 10.1016/0010-0277(94)90029-9; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Leuthold H, 2012, SOC COGN AFFECT NEUR, V7, P457, DOI 10.1093/scan/nsr029; Luo Y, 2007, COGNITION, V105, P489, DOI 10.1016/j.cognition.2006.10.007; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Mosconi MW, 2005, NEUROIMAGE, V27, P247, DOI 10.1016/j.neuroimage.2005.03.027; Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306; MOSES LJ, 1990, CHILD DEV, V61, P929, DOI 10.2307/1130866; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Pelphrey KA, 2003, NEUROPSYCHOLOGIA, V41, P156, DOI 10.1016/S0028-3932(02)00146-X; Perner J, 2008, Q J EXP PSYCHOL, V61, P76, DOI 10.1080/17470210701508756; Phillips AT, 2005, COGNITION, V98, P137, DOI 10.1016/j.cognition.2004.11.005; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; ROBINSON EJ, 1995, CHILD DEV, V66, P1022, DOI 10.1111/j.1467-8624.1995.tb00920.x; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schlottmann A, 2010, DEVELOPMENTAL SCI, V13, P1, DOI 10.1111/j.1467-7687.2009.00854.x; Scholl BJ, 2001, CHILD DEV, V72, P696, DOI 10.1111/1467-8624.00308; Schult CA, 1997, COGNITION, V62, P291, DOI 10.1016/S0010-0277(96)00786-X; SMITH MC, 1978, CHILD DEV, V49, P736, DOI 10.2307/1128242; Sommerville JA, 2009, DEVELOPMENTAL SCI, V12, P314, DOI 10.1111/j.1467-7687.2008.00787.x; Song HJ, 2005, COGNITION, V98, pB45, DOI 10.1016/j.cognition.2005.04.004; Song HJ, 2008, COGNITION, V109, P295, DOI 10.1016/j.cognition.2008.08.008; Southgate V, 2009, DEVELOPMENTAL SCI, V12, P1013, DOI 10.1111/j.1467-7687.2009.00861.x; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Surian L, 1999, BRIT J DEV PSYCHOL, V17, P141, DOI 10.1348/026151099165203; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Wang L, 2013, BIENN M SOC RES CHIL; WELLMAN HM, 1988, COGNITION, V30, P239, DOI 10.1016/0010-0277(88)90021-2; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wertz AE, 2009, DISS ABSTR INT B, V70, P7244; Wertz AE, 2007, COGNITION, V105, P184, DOI 10.1016/j.cognition.2006.08.002; WIMMER H, 1994, COGNITION, V53, P45, DOI 10.1016/0010-0277(94)90076-0; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wimmer H, 1998, INT J BEHAV DEV, V22, P403, DOI 10.1080/016502598384441; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x; Yazdi AA, 2006, COGNITION, V100, P343, DOI 10.1016/j.cognition.2005.05.004	90	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72835	10.1371/journal.pone.0072835	http://dx.doi.org/10.1371/journal.pone.0072835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069160	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100020
J	Ashe, E; Wray, J; Picard, CR; Williams, R				Ashe, Erin; Wray, Janie; Picard, Christopher R.; Williams, Rob			Abundance and Survival of Pacific Humpback Whales in a Proposed Critical Habitat Area	PLOS ONE			English	Article							CAPTURE-RECAPTURE; MARKED ANIMALS; PROTECTED AREAS; KILLER WHALES; POPULATION; IDENTIFICATION; CETACEANS; PINNIPEDS; TRENDS; DEATH	Humpback whales (Megaptera novaeangliae) were hunted commercially in Canada's Pacific region until 1966. Depleted to an estimated 1,400 individuals throughout the North Pacific, humpback whales are listed as Threatened under Canada's Species at Risk Act (SARA) and Endangered under the US Endangered Species Act. We conducted an 8-year photo-identification study to monitor humpback whale usage of a coastal fjord system in British Columbia (BC), Canada that was recently proposed as candidate critical habitat for the species under SARA. This participatory research program built collaborations among First Nations, environmental non-governmental organizations and academics. The study site, including the territorial waters of Gitga'at First Nation, is an important summertime feeding destination for migratory humpback whales, but is small relative to the population's range. We estimated abundance and survivorship using mark-recapture methods using photographs of naturally marked individuals. Abundance of humpback whales in the region was large, relative to the site's size, and generally increased throughout the study period. The resulting estimate of adult survivorship (0.979, 95% CI: 0.914, 0.995) is at the high end of previously reported estimates. A high rate of resights provides new evidence for inter-annual site fidelity to these local waters. Habitat characteristics of our study area are considered ecologically significant and unique, and this should be considered as regulatory agencies consider proposals for high-volume crude oil and liquefied natural gas tanker traffic through the area. Monitoring population recovery of a highly mobile, migratory species is daunting for low-cost, community-led science. Focusing on a small, important subset of the animals' range can make this challenge more tractable. Given low statistical power and high variability, our community is considering simpler ecological indicators of population health, such as the number of individuals harmed or killed each year by human activities, including ship strikes and entanglement in fishing gear.	[Ashe, Erin; Williams, Rob] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Ashe, Erin; Williams, Rob] Oceans Initiat, Pearse Isl, BC, Canada; [Wray, Janie] North Coast Cetacean Soc, Hartley Bay, BC, Canada; [Picard, Christopher R.] Gitgaat Lands & Marine Resources Dept, Hartley Bay, BC, Canada	University of St Andrews	Ashe, E (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	ea84@st-andrews.ac.uk	; Williams, Rob/C-5882-2011	Ashe, Erin/0000-0001-9918-1419; Williams, Rob/0000-0001-7496-453X	Julie Walters and Sam Rose, and Fisheries and Oceans Canada (Cetacean Research Program, Species at Risk Program)	Julie Walters and Sam Rose, and Fisheries and Oceans Canada (Cetacean Research Program, Species at Risk Program)	This research was funded through grants to Cetacealab and Gitga'at First Nation from Julie Walters and Sam Rose, and Fisheries and Oceans Canada (Cetacean Research Program, Species at Risk Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ESTIMATION ANIMAL AB; Ashe E, 2010, ANIM CONSERV, V13, P196, DOI 10.1111/j.1469-1795.2009.00321.x; Baird RW, 2003, UPDATE COSEWIC STATU; Barlow J, 2011, MAR MAMMAL SCI, V27, P793, DOI 10.1111/j.1748-7692.2010.00444.x; Berkes F, 2001, OCEAN COAST MANAGE, V44, P451, DOI 10.1016/S0964-5691(01)00060-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham K.P., 1987, DESIGN ANAL METHODS; Burnham K P, 2003, MODEL SELECT MULTIMO; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J., 2008, SPLASH STRUCTURE POP, P1; Canada F. A. O., 2010, REC STRAT N IN PRESS; Clapham PJ, 1997, MAR MAMMAL SCI, V13, P368, DOI 10.1111/j.1748-7692.1997.tb00646.x; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Dalla Rosa L, 2010, MODELING FORAGING HA; Erbe C, 2012, J ACOUST SOC AM, V132, pEL423, DOI 10.1121/1.4758779; Ford JKB, 2006, ASSESSMENT CRITICAL; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Gerber LR, 1999, CONSERV BIOL, V13, P1203, DOI 10.1046/j.1523-1739.1999.98277.x; Hammond P.S., 1986, REP INT WHAL COMM SP, V8, P253; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Nichol LM, 2002, CANADIAN TECHNICAL R, V2396, P82; Nichol LM, 2010, INFORM RELEVANT IDEN; Rambeau AL, 2008, DETERMINING ABUNDANC, P70; Robbins J, 2001, SCI COMM INT WHAL CO; Scheidat Meike, 2004, Journal of Cetacean Research and Management, V6, P63; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Stevens CJ, 2007, LANDSCAPE ECOL, V22, P799, DOI 10.1007/s10980-007-9092-8; Stevick PT, 2011, BIOL LETTERS, V7, P299, DOI 10.1098/rsbl.2010.0717; Stevick PT, 2001, CAN J FISH AQUAT SCI, V58, P1861, DOI 10.1139/cjfas-58-9-1861; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams R., 2007, J CETACEAN RES MANAG, V9, P14; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Williams Rob, 2010, Journal of Cetacean Research and Management, V11, P1; Williams R, 2009, BIOL CONSERV, V142, P1542, DOI 10.1016/j.biocon.2008.12.028; Williams R, 2009, BIOL CONSERV, V142, P709, DOI 10.1016/j.biocon.2008.12.004; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y	42	14	16	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75228	10.1371/journal.pone.0075228	http://dx.doi.org/10.1371/journal.pone.0075228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24058666	Green Published, Green Submitted, gold			2022-12-27	WOS:000326734500138
J	Aupperle, RL; Connolly, CG; Stillman, AN; May, AC; Paulus, MP				Aupperle, Robin L.; Connolly, Colm G.; Stillman, Ashley N.; May, April C.; Paulus, Martin P.			Deployment and Post-Deployment Experiences in OEF/OIF Veterans: Relationship to Gray Matter Volume	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INFERIOR TEMPORAL CORTEX; STRUCTURAL BRAIN ABNORMALITIES; MEDIAL ORBITOFRONTAL CORTEX; HIPPOCAMPAL VOLUME; ANTERIOR CINGULATE; TRAUMA EXPOSURE; AFGHANISTAN VETERANS; COMBAT VETERANS; RISK-FACTORS	Background: Combat-related PTSD has been associated with reduced gray matter volume in regions of the prefrontal and temporal cortex, hippocampus, insula, and amygdala. However, the relationship between gray matter volume and specific deployment and post-deployment experiences has not been investigated. The aim of this study was to delineate how such experiences may contribute to structural brain changes for combat veterans. Methods: Operation Iraqi Freedom/Operation Enduring Freedom veterans (N = 32) completed magnetic resonance imaging, the Deployment Risk and Resilience Inventory, Alcohol Use Disorders Identification Test, and Clinical Administered PTSD Scale. Voxel-wise Huber robust multiple regressions were used to quantify the relationship between gray matter volume and deployment experiences (combat experiences, military social support) and post-deployment symptoms (PTSD, alcohol use). Results: There was an interaction between severity of combat experiences and military social support for orbitofrontal gyrus gray matter volume. Specifically, individuals with more orbitofrontal gyrus gray matter volume reported less combat experiences and higher unit support. Individuals with more severe PTSD symptoms showed reduced gray matter volume within a large temporal region (inferior temporal and parahippocampal gyrus). Conclusions: The identified association between unit support and orbitofrontal gyrus volume supports two potential resilience mechanisms to be delineated with future longitudinal studies. First, individuals with larger orbitofrontal gyrus may engage in greater quality of social interactions and thus experience combat as less stressful. Second, individuals who experience greater unit support may preserve a larger orbitofrontal gyrus, serving to "protect" them from aversive consequences of combat.	[Aupperle, Robin L.; May, April C.; Paulus, Martin P.] VA San Diego Healthcare Syst, Psychiat Serv, La Jolla, CA USA; [Paulus, Martin P.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Aupperle, Robin L.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Aupperle, Robin L.; Stillman, Ashley N.] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Connolly, Colm G.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Missouri System; University of Missouri Kansas City; University of California System; University of California San Francisco	Aupperle, RL (corresponding author), VA San Diego Healthcare Syst, Psychiat Serv, La Jolla, CA USA.	aupperler@umkc.edu	Aupperle, Robin/AAU-8550-2020; Clausen, Ashley N/W-5627-2019; Connolly, Colm G./H-5917-2019	Clausen, Ashley N/0000-0002-1773-7733; Connolly, Colm G./0000-0002-4051-3682; Paulus, Martin/0000-0002-0825-3606	VA Center of Excellence for Stress and Mental Health (CESAMH); VA Merit Award [1I01CX000273-01A2]; Department of Veterans Affairs	VA Center of Excellence for Stress and Mental Health (CESAMH); VA Merit Award(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the VA Center of Excellence for Stress and Mental Health (CESAMH; MPP; http://www.mentalhealth.va.gov/coe/cesamh/) and a VA Merit Award (MPP; 1I01CX000273-01A2), which is supported by the Department of Veterans Affairs (http://www.research.va.gov). CESAMH is affiliated with VISN 22, the Veterans Affairs San Diego Healthcare System (VASDHS) and the University of California, San Diego (UCSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DT, 2012, NEUROPHARMACOLOGY, V62, P674, DOI 10.1016/j.neuropharm.2011.04.029; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; [Anonymous], 2010, R LANG ENV STAT COMP; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Cardenas VA, 2011, PSYCHIAT RES-NEUROIM, V193, P93, DOI 10.1016/j.pscychresns.2011.01.013; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Diekhof EK, 2012, NEUROPSYCHOLOGIA, V50, P1252, DOI 10.1016/j.neuropsychologia.2012.02.007; Diekhof EK, 2011, NEUROPSYCHOLOGIA, V49, P984, DOI 10.1016/j.neuropsychologia.2011.01.032; Donovan BS, 1996, J TRAUMA STRESS, V9, P361, DOI 10.1002/jts.2490090217; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Ekstrom AD, 2011, NEUROIMAGE, V56, P1803, DOI 10.1016/j.neuroimage.2011.02.033; Elman I, 2009, BIOL PSYCHIAT, V66, P1083, DOI 10.1016/j.biopsych.2009.06.006; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fox J, 2002, COX PROPORTIONAL HAZ; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gross CG, 2008, NEUROPSYCHOLOGIA, V46, P841, DOI 10.1016/j.neuropsychologia.2007.11.009; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hadj-Bouziane F, 2012, P NATL ACAD SCI USA, V109, pE3640, DOI 10.1073/pnas.1218406109; Hamame CM, 2012, NEUROIMAGE, V59, P872, DOI 10.1016/j.neuroimage.2011.07.087; Hedges DW, 2010, BIOL PSYCHOL, V84, P163, DOI 10.1016/j.biopsycho.2010.03.002; Heim C, 2009, CNS SPECTRUMS, V14, P13; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hooper JW, 2008, J PSYCHIATR RES, V42, P802, DOI 10.1016/j.jpsychires.2007.10.008; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasahara H, 2011, BRAIN RES, V1423, P30, DOI 10.1016/j.brainres.2011.08.049; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; King DW., 2003, MANUAL DEPLOYMENT RI; Kroes MCW, 2011, EUR PSYCHIAT, V26, P525, DOI 10.1016/j.eurpsy.2011.03.002; Kuhn S, 2011, J AFFECT DISORDERS, V134, P315, DOI 10.1016/j.jad.2011.06.003; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Neigh GN, 2012, NEUROSCIENCE, DOI [DOI 10.1016/J.NEUR0SCIENCE.2012.09.075, 10.1016/j.neuroscience.2012.09.075]; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; Norman SB, 2012, NEUROPHARMACOLOGY, V62, P542, DOI 10.1016/j.neuropharm.2011.04.032; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Scorzin JE, 2008, EPILEPSY RES, V82, P29, DOI 10.1016/j.eplepsyres.2008.06.012; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Van Voorhees EE, 2012, CHILD ABUSE NEGLECT, V36, P423, DOI 10.1016/j.chiabu.2012.03.004; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016; Woloszyn L, 2012, NEURON, V74, P193, DOI 10.1016/j.neuron.2012.01.032; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Woodward SH, 2006, AM J PSYCHIAT, V163, P674, DOI 10.1176/appi.ajp.163.4.674; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Wrase J, 2008, AM J PSYCHIAT, V165, P1179, DOI 10.1176/appi.ajp.2008.07121877; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	76	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75880	10.1371/journal.pone.0075880	http://dx.doi.org/10.1371/journal.pone.0075880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058706	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900129
J	Ghavampour, S; Lange, C; Bottino, C; Gerke, V				Ghavampour, Sharang; Lange, Carsten; Bottino, Cristina; Gerke, Volker			Transcriptional Profiling of Human Monocytes Identifies the Inhibitory Receptor CD300a as Regulator of Transendothelial Migration	PLOS ONE			English	Article							GENE-EXPRESSION; TYROSINE-PHOSPHATASE; BISPECIFIC ANTIBODY; LINEAGE CELLS; IRP60 CD300A; MAST-CELL; ADHESION; MECHANISMS; FAMILY; DEPHOSPHORYLATION	Local inflammatory responses are characterized by the recruitment of circulating leukocytes from the blood to sites of inflammation, a process requiring the directed migration of leukocytes across the vessel wall and hence a penetration of the endothelial lining. To identify underlying signalling events and novel factors involved in these processes we screened for genes differentially expressed in human monocytes following their adhesion to and passage through an endothelial monolayer. Functional annotation clustering of the genes identified revealed an overrepresentation of those associated with inflammation/immune response, in particular early monocyte to macrophage differentiation. Among the gene products so far not implicated in monocyte transendothelial migration was the inhibitory immune receptor CD300a. CD300a mRNA and protein levels were upregulated following transmigration and engagement of the receptor by anti-CD300a antibodies markedly reduced monocyte transendothelial migration. In contrast, siRNA mediated downregulation of CD300a in human monocytes increased their rate of migration. CD300a colocalized and cosedimented with actin filaments and, when activated, caused F-actin cytoskeleton alterations. Thus, monocyte transendothelial migration is accompanied by an elevation of CD300a which serves an inhibitory function possibly required for termination of the actual transmigration.	[Ghavampour, Sharang; Lange, Carsten; Gerke, Volker] Ctr Mol Biol Inflammat, Inst Med Biochem, Munster, Germany; [Bottino, Cristina] Inst Giannina Gaslini, Lab Immunol Clin & Sperimentale, Dipartimento Med Sperimentale, Sez Patol Gen, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini	Gerke, V (corresponding author), Ctr Mol Biol Inflammat, Inst Med Biochem, Munster, Germany.	gerke@uni-muenster.de	Bottino, Cristina/J-9977-2016	Bottino, Cristina/0000-0001-6695-1739	Deutsche Forschungsgemeinschaft [DFG EXC 1003, DFG SFB 1009]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG EXC 1003 and DFG SFB 1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Baba T, 2003, J IMMUNOL, V170, P3762, DOI 10.4049/jimmunol.170.7.3762; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bachelet I, 2008, J IMMUNOL, V180, P6064, DOI 10.4049/jimmunol.180.9.6064; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Briggs RC, 2005, J CELL BIOCHEM, V95, P293, DOI 10.1002/jcb.20435; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Choi EY, 2009, FRONT BIOSCI-LANDMRK, V14, P1596, DOI 10.2741/3327; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; DENHOLM EM, 1991, J IMMUNOL METHODS, V144, P247, DOI 10.1016/0022-1759(91)90092-T; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kielbassa K, 1998, EXP CELL RES, V243, P129, DOI 10.1006/excr.1998.4133; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Lesourne R, 2005, J IMMUNOL, V174, P1365, DOI 10.4049/jimmunol.174.3.1365; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Masilamani M, 2006, J IMMUNOL, V177, P3590, DOI 10.4049/jimmunol.177.6.3590; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Rossetti G, 2002, IMMUNOL REV, V186, P189, DOI 10.1034/j.1600-065X.2002.18616.x; Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Srivastava M, 2005, J IMMUNOL, V175, P1884, DOI 10.4049/jimmunol.175.3.1884; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Tam SW, 2004, ALLERGY, V59, P772, DOI 10.1111/j.1398-9995.2004.00332.x; Thomas-Ecker S, 2007, P NATL ACAD SCI USA, V104, P5539, DOI 10.1073/pnas.0700732104; Toyama-Sorimachi N, 2004, P NATL ACAD SCI USA, V101, P1016, DOI 10.1073/pnas.0305400101; van Buul JD, 2004, ARTERIOSCL THROM VAS, V24, P824, DOI 10.1161/01.ATV.0000122854.76267.5c; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Weber KSC, 1998, EUR J IMMUNOL, V28, P2245, DOI 10.1002/(SICI)1521-4141(199807)28:07<2245::AID-IMMU2245>3.0.CO;2-V; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73981	10.1371/journal.pone.0073981	http://dx.doi.org/10.1371/journal.pone.0073981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058511	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900028
J	Legeai, C; Vigouroux, C; Souberbielle, JC; Bouchaud, O; Boufassa, F; Bastard, JP; Carlier, R; Capeau, J; Goujard, C; Meyer, L; Viard, JP				Legeai, Camille; Vigouroux, Corinne; Souberbielle, Jean-Claude; Bouchaud, Olivier; Boufassa, Faroudy; Bastard, Jean-Philippe; Carlier, Robert; Capeau, Jacqueline; Goujard, Cecile; Meyer, Laurence; Viard, Jean-Paul		ANRS-COPANA Cohort Study Grp	Associations between 25-Hydroxyvitamin D and Immunologic, Metabolic, Inflammatory Markers in Treatment-Naive HIV-Infected Persons: The ANRS CO9 "COPANA" Cohort Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; INTIMA-MEDIA THICKNESS; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; D INSUFFICIENCY; HEART-FAILURE; MORTALITY; RISK; PREVALENCE; RECONSTITUTION	Objectives: Low 25(OH) D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naive HIV-infected persons. Design: We measured plasma 25(OH) D, metabolic, immunologic and inflammatory markers in 355 persons (204 Whites, 151 Blacks) at enrollment in the ANRS COPANA cohort. Methods: 25(OH) D levels were categorized <10 ng/mL (severe deficiency) and <20 ng/mL (deficiency). Statistical analyses were adjusted for sampling season, ethnicity and the interaction between season and ethnicity. Results: 25(OH) D insufficiency (<30 ng/mL), deficiency (<20 ng/mL) and severe deficiency (<10 ng/mL) were highly prevalent (93%, 67% and 24% of patients, respectively). Blacks had significantly lower 25(OH) D than Whites (median: 13 vs. 17 ng/mL, P<0.001), with markedly less pronounced seasonal variation. Smoking and drinking alcohol were associated with having a 25 OHD level<10 ng/mL. In patients with 25(OH)D<10 ng/mL, the proportion of persons with a CD4 count<100/mm(3) was higher than in patients with 25(OH) D >= 10 ng/mL (18.8% vs. 10.7%, P = 0.04). Persons with 25 OHD<10 ng/mL had higher levels of hsCRP (1.60 mg/L [IQR: 0.59-5.76] vs. 1.27 mg/L [0.58-3,39], P = 0.03) and resistin (16.81 ng/L [IQR: 13.82-25.74] vs. 11.56 ng/L [IQR: 8.87-20.46], P = 0.02), and, among Blacks only, sTNFR2 (2.92 ng/mL [2.31-4.13] vs. 2.67 ng/mL, [1.90-3.23], P = 0.04). The strength and significance of the association between CD4<100/mm(3) and 25 OHD, 10 ng/mL were reduced after adjustment on sTNFR1, sTNFR2, and hsCRP levels. In multivariate analysis, a CD4 count <100/mm(3), resistin concentration and smoking were independently associated with 25(OH)D<10 ng/mL. Conclusions: Severe vitamin D deficiency was associated with low CD4 counts and increased markers of inflammation in ARV-naive HIV-infected persons.	[Legeai, Camille; Boufassa, Faroudy; Goujard, Cecile; Meyer, Laurence] INSERM, Unite Mixte Rech & Serv UMRS 1018, Equipe Epidemiol VIH & Infect Sexuellement Transm, Ctr Rech Epidemiol & Sante Populat CESP INSERM U1, F-94275 Le Kremlin Bicetre, France; [Vigouroux, Corinne; Bastard, Jean-Philippe; Capeau, Jacqueline] Assistance Publ Hop Paris, Hop Tenon, Serv Biochim & Hormonol, Paris, France; [Vigouroux, Corinne; Bastard, Jean-Philippe; Capeau, Jacqueline] INSERM, UMRS938, Ctr Rech St Antoine, Paris, France; [Vigouroux, Corinne; Capeau, Jacqueline] Univ Paris 06, Inst Cardiometab & Nutr ICAN, Paris, France; [Souberbielle, Jean-Claude] Assistance Publ Hop Paris, Hop Necker, Serv Explorat Fonct, Paris, France; [Bouchaud, Olivier] Assistance Publ Hop Paris, Hop Avicenne, Serv Malad Infect, Bobigny, France; [Bouchaud, Olivier] Univ Paris 13, Bobigny, France; [Carlier, Robert] Assistance Publ Hop Paris, Hop Raymond Poincare, Serv Radiol & Imagerie Med, Garches, France; [Goujard, Cecile] Assistance Publ Hop Paris, Hop Bicetre, Serv Med Interne, Le Kremlin Bicetre, France; [Legeai, Camille; Goujard, Cecile; Meyer, Laurence] Univ Paris 11, Le Kremlin Bicetre, France; [Meyer, Laurence] Assistance Publ Hop Paris, Hop Bicetre, Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Viard, Jean-Paul] Assistance Publ Hop Paris, Hop Hotel Dieu, Ctr Diagnost & Therapeut, Paris, France; [Viard, Jean-Paul] Univ Paris 05, Equipe Accueil 3620, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris 13; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Viard, JP (corresponding author), INSERM, Unite Mixte Rech & Serv UMRS 1018, Equipe Epidemiol VIH & Infect Sexuellement Transm, Ctr Rech Epidemiol & Sante Populat CESP INSERM U1, F-94275 Le Kremlin Bicetre, France.	jean-paul.viard@htd.aphp.fr	Charles, Marie Aline/F-8567-2017; Charles, Marie Aline/S-1866-2019; Viard, Jean-Paul/O-6467-2017; Bergmann, Jean-Francois/L-6044-2017	Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; Viard, Jean-Paul/0000-0001-5946-8896; Kansau, Imad/0000-0002-1893-6822; Cabie, Andre/0000-0003-0117-3061; Bergmann, Jean-Francois/0000-0001-6861-9748; Dray-Spira, Rosemary/0000-0001-7646-3667	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales), Paris, France	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales), Paris, France(ANRS)	The COPANA cohort study is funded by the ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales), Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Agarwal R, 2011, KIDNEY INT, V80, P1073, DOI 10.1038/ki.2011.207; Allavena C, 2012, J ANTIMICROB CHEMOTH, V67, P2222, DOI 10.1093/jac/dks176; Aziz M, 2013, AIDS, V27, P573, DOI 10.1097/QAD.0b013e32835b9ba1; Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483; Boufassa F, 2012, ANTIVIR THER, V17, P91, DOI 10.3851/IMP1916; Boxer RS, 2008, J AM GERIATR SOC, V56, P454, DOI 10.1111/j.1532-5415.2007.01601.x; Childs K, 2012, AIDS, V26, P253, DOI 10.1097/QAD.0b013e32834f324b; Choi AI, 2011, CLIN INFECT DIS, V52, P941, DOI 10.1093/cid/ciq239; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; FEINGOLD KR, 1993, J CLIN ENDOCR METAB, V76, P1423, DOI 10.1210/jc.76.6.1423; Hammond E, 2012, CLIN ENDOCRINOL, V76, P201, DOI 10.1111/j.1365-2265.2011.04149.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010801; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Lai H, 2012, CLIN INFECT DIS, V54, P1747, DOI 10.1093/cid/cis306; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lin E, 2011, OBESITY, V19, P588, DOI 10.1038/oby.2010.239; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Menendez C, 2001, J ENDOCRINOL, V170, P425, DOI 10.1677/joe.0.1700425; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Norman AW, 2010, EXP BIOL MED, V235, P1034, DOI 10.1258/ebm.2010.010014; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Rosenvinge MM, 2010, J ACQ IMMUN DEF SYND, V54, P1127; Ross AC, 2011, ANTIVIR THER, V16, P555, DOI 10.3851/IMP1784; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Sudfeld CR, 2013, J INFECT DIS, V207, P1370, DOI 10.1093/infdis/jit027; Sudfeld CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040036; Szep Z, 2011, AIDS, V25, P525, DOI 10.1097/QAD.0b013e328342fdfd; Tsuji K, 2010, J BONE MINER RES, V25, P1711, DOI 10.1002/jbmr.65; Vescini F, 2011, JAIDS-J ACQ IMM DEF, V58, P163, DOI 10.1097/QAI.0b013e31822e57e9; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wright NC, 2012, OSTEOPOROSIS INT, V23, P2283, DOI 10.1007/s00198-011-1877-6; Zittermann A, 2009, TRANSPLANTATION, V87, P118, DOI 10.1097/TP.0b013e31818c2708	45	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74868	10.1371/journal.pone.0074868	http://dx.doi.org/10.1371/journal.pone.0074868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058636	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900086
J	Banbura, J; Skwarska, J; Banbura, M; Gladalski, M; Holysz, M; Kalinski, A; Markowski, M; Wawrzyniak, J; Zielinski, P				Banbura, Jerzy; Skwarska, Joanna; Banbura, Miroslawa; Gladalski, Michal; Holysz, Magdalena; Kalinski, Adam; Markowski, Marcin; Wawrzyniak, Jaroslaw; Zielinski, Piotr			Spatial and Temporal Variation in Heterophil-to-Lymphocyte Ratios of Nestling Passerine Birds: Comparison of Blue Tits and Great Tits	PLOS ONE			English	Article							PARUS-MAJOR; PHYSIOLOGICAL STRESS; REPRODUCTIVE SUCCESS; BODY CONDITION; CYANISTES-CAERULEUS; GENETIC-VARIATION; HABITAT QUALITY; BROOD SIZE; LEUKOCYTE PROFILES; PIED FLYCATCHERS	Environmental factors affecting trophic conditions act as stressors on nestling altricial birds. Access of parental birds to a sufficient supply of food in a limited period of the nestling stage differ in time and space, depending on nesting habitat, prey density and weather conditions. Heterophil-to-lymphocyte ratio (H/L) is considered as a reliable indicator of prolonged stress reaction in birds. In this study we examine if variation in H/L shows consistent spatio-temporal patterns in nestlings of two parids, blue tit Cyanistes caeruleus and great tit Parus major. We found that blue tit nestlings had on average higher H/L than great tit nestlings, which corresponds with the ecological sensitivity of these species. In both species H/L was higher in a poor parkland habitat than in a high quality forest habitat. In nestling blue tits, higher H/L values occurred in years characterized by more extreme weather conditions and worse caterpillar availability. Such consistent patterns of variation in the H/L ratio of nestling blue tits and great tits suggest that, when age-dependent effects are controlled, the ratio can be used as an indicator of physiological stress that is generated by food-related stressors differing in space and time. In particular, elevated H/L ratios are indicative of human-induced changes in the structure of breeding habitats.	[Banbura, Jerzy; Skwarska, Joanna; Gladalski, Michal; Holysz, Magdalena; Markowski, Marcin; Wawrzyniak, Jaroslaw] Univ Lodz, Fac Biol & Environm Protect, Dept Expt Zool & Evolutionary Biol, PL-90131 Lodz, Poland; [Banbura, Miroslawa] Univ Lodz, Fac Biol & Environm Protect, Museum Nat Hist, PL-90131 Lodz, Poland; [Kalinski, Adam] Univ Lodz, Fac Biol & Environm Protect, Dept Teacher Training & Biol Divers Studies, PL-90131 Lodz, Poland; [Zielinski, Piotr] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90131 Lodz, Poland	University of Lodz; University of Lodz; University of Lodz; University of Lodz	Banbura, J (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Expt Zool & Evolutionary Biol, PL-90131 Lodz, Poland.	jbanb@biol.uni.lodz.pl	/AAD-1654-2020; Banbura, Jerzy/AAV-7091-2020; Bańbura, Jerzy/U-6197-2017	Banbura, Jerzy/0000-0002-7479-3117; Bańbura, Jerzy/0000-0002-7479-3117; Gladalski, Michal/0000-0002-6471-3080; Zielinski, Piotr/0000-0002-9233-6235; Wawrzyniak, Jaroslaw/0000-0003-3450-9764; Banbura, Miroslawa/0000-0003-1226-0398; Kalinski, Adam/0000-0003-2743-6907; Skwarska, Joanna/0000-0001-7806-3608; Markowski, Marcin/0000-0003-3113-9702	Polish Ministry of Science and Higher Education [N N304 045136]; University of Lodz [506/829]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); University of Lodz	The study was funded by a grant from the Polish Ministry of Science and Higher Education No. N N304 045136 and University of Lodz (No. 506/829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano N, 2012, ARDEOLA, V59, P197; Arriero E, 2008, PHYSIOL BIOCHEM ZOOL, V81, P195, DOI 10.1086/524393; BANBURA J, 1994, OECOLOGIA, V100, P413, DOI 10.1007/BF00317863; Banbura J, 1999, J AVIAN BIOL, V30, P263, DOI 10.2307/3677352; Banbura J, 2001, ARDEA, V89, P517; Banbura J, 2007, COMP BIOCHEM PHYS A, V148, P572, DOI 10.1016/j.cbpa.2007.07.008; Banbura J, 2011, ACTA ORNITHOL, V46, P207, DOI 10.3161/000164511X625991; Banbura J, 2008, ACTA ORNITHOL, V43, P129, DOI 10.3161/000164508X395234; Banbura M, 2010, ACTA ORNITHOL, V45, P121, DOI 10.3161/000164510X551264; Blondel J, 2006, BIOSCIENCE, V56, P661, DOI 10.1641/0006-3568(2006)56[661:ATSOPA]2.0.CO;2; Bradshaw D., 2003, VERTEBRATE ECOPHYSIO; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; Chalfoun AD, 2012, AUK, V129, P589, DOI 10.1525/auk.2012.129.4.589; Cholewa M, 2011, ACTA ORNITHOL, V46, P105, DOI 10.3161/000164511X625874; Norte A, 2009, J AVIAN BIOL, V40, P157, DOI 10.1111/j.1600-048X.2009.04461.x; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Cramp S., 1993, BIRDS W PALEARCTIC, V7; Crawley M. J, 2002, STAT COMPUTING INTRO; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dehnhard N, 2011, J COMP PHYSIOL B, V181, P641, DOI 10.1007/s00360-010-0548-9; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; FRETWELL S D, 1972, P217; Garcia-Navas V, 2011, OECOLOGIA, V165, P639, DOI 10.1007/s00442-010-1858-z; GAVETT AP, 1986, CONDOR, V88, P279, DOI 10.2307/1368873; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Heck RH, 2010, QUANT METH SER, P1; Hinsley SA, 2008, LANDSCAPE ECOL, V23, P615, DOI 10.1007/s10980-008-9225-8; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Horak P, 1999, OECOLOGIA, V121, P316, DOI 10.1007/s004420050934; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Kalinski A, 2009, IBIS, V151, P667, DOI 10.1111/j.1474-919X.2009.00959.x; Kluijver H. N., 1951, ARDEA, V39, P1; Kurowski JK, 2001, SZATA ROSLINNA LASU; Lack D., 1966, POPULATION STUDIES B; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Magi M, 2009, ECOSCIENCE, V16, P145, DOI 10.2980/16-2-3215; Marciniak B, 2007, ACTA ORNITHOL, V42, P53, DOI 10.3161/068.042.0113; Maron M, 2012, BIODIVERS CONSERV, V21, P2509, DOI 10.1007/s10531-012-0314-2; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Martin T.E., 1992, Current Ornithology, V9, P163; MAXWELL MH, 1993, WORLD POULTRY SCI J, V49, P34, DOI 10.1079/WPS19930004; Mazerolle DF, 2002, OECOLOGIA, V130, P356, DOI 10.1007/s00442-001-0818-z; Michalski M, 2011, ACTA ORNITHOL, V46, P164, DOI 10.3161/000164511X625937; Moreno J, 2002, ECOSCIENCE, V9, P434, DOI 10.1080/11956860.2002.11682731; Morrison ML., 2006, WILDLIFE HABITAT REL; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Mueller C, 2011, FUNCT ECOL, V25, P566, DOI 10.1111/j.1365-2435.2010.01816.x; Nadolski J, 2006, COMP BIOCHEM PHYS A, V143, P50, DOI 10.1016/j.cbpa.2005.10.021; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Norte AC, 2008, AUK, V125, P943, DOI 10.1525/auk.2008.07188; Nour N, 1998, OECOLOGIA, V114, P522, DOI 10.1007/s004420050476; O'Connor R.J., 1984, GROWTH DEV BIRDS; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; Owen JC, 2005, AUK, V122, P1261, DOI 10.1642/0004-8038(2005)122[1261:HASDIP]2.0.CO;2; Pap PL, 2003, J AVIAN BIOL, V34, P428, DOI 10.1111/j.0908-8857.2003.03002.x; Payne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045014; Perrins C.M., 1979, BRIT TITS; PERRINS CM, 1991, IBIS, V133, P49, DOI 10.1111/j.1474-919X.1991.tb07668.x; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Potti J, 1999, OECOLOGIA, V120, P1, DOI 10.1007/s004420050826; Radford AN, 2001, BIRD STUDY, V48, P214, DOI 10.1080/00063650109461220; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; RIDDINGTON R, 1995, IBIS, V137, P371, DOI 10.1111/j.1474-919X.1995.tb08035.x; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Sanchez S, 2007, ACTA ORNITHOL, V42, P200, DOI 10.3161/068.042.0204; SIEGEL HS, 1980, BIOSCIENCE, V30, P529, DOI 10.2307/1307973; Simon A, 2005, CAN J ZOOL, V83, P694, DOI 10.1139/Z05-059; Simon A, 2004, PHYSIOL BIOCHEM ZOOL, V77, P492, DOI 10.1086/383512; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Suorsa P, 2003, P ROY SOC B-BIOL SCI, V270, P963, DOI 10.1098/rspb.2002.2326; VANBALEN JH, 1973, ARDEA, V61, P1; Vleck CM, 2000, CONDOR, V102, P392, DOI 10.1650/0010-5422(2000)102[0392:SCAHTL]2.0.CO;2; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilkin TA, 2009, J AVIAN BIOL, V40, P135, DOI 10.1111/j.1600-048X.2009.04362.x; ZANDT HS, 1994, OECOLOGIA, V97, P399, DOI 10.1007/BF00317331; Zanette L, 2003, P ROY SOC B-BIOL SCI, V270, P799, DOI 10.1098/rspb.2002.2311	82	40	41	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74226	10.1371/journal.pone.0074226	http://dx.doi.org/10.1371/journal.pone.0074226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066123	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000105
J	Kalie, E; Razi, M; Tooze, SA				Kalie, Eyal; Razi, Minoo; Tooze, Sharon A.			ULK1 Regulates Melanin Levels in MNT-1 Cells Independently of mTORC1	PLOS ONE			English	Article							LYSOSOME-RELATED ORGANELLES; EARLY MELANOSOMES; AUTOPHAGY; TRAFFICKING; TYROSINASE; MELANOGENESIS; MECHANISMS; PROTEINS; DISEASE; RAB38	Melanosomes are lysosome-related organelles that serve as specialized sites of melanin synthesis and storage in melanocytes. The progression of melanosomes through the different stages of their formation requires trafficking of specific proteins and membrane constituents in a sequential manner, which is likely to deploy ubiquitous cellular machinery along with melanocyte-specific proteins. Recent evidence revealed a connection between melanogenesis and the autophagy machinery, suggesting a novel role for members of the latter in melanocytes. Here we focused on ULK1, a key autophagy protein which is negatively regulated by mTORC1, to assess its potential role in melanogenesis in MNT-1 cells. We found that ULK1 depletion causes an increase in melanin levels, suggesting an inhibitory function for this protein in melanogenesis. Furthermore, this increase was accompanied by increased transcription of MITF (microphthalmia-associated transcription factor) and tyrosinase and by elevated protein levels of tyrosinase, the rate-limiting factor in melanin biogenesis. We also provide evidence to show that ULK1 function in this context is independent of the canonical ULK1 autophagy partners, ATG13 and FIP200. Furthermore we show that regulation of melanogenesis by ULK1 is independent of mTORC1 inhibition. Our data thus provide intriguing insights regarding the involvement of the key regulatory autophagy machinery in melanogenesis.	[Kalie, Eyal; Razi, Minoo; Tooze, Sharon A.] Canc Res UK, London Res Inst, Secretory Pathways Lab, London, England	Cancer Research UK	Tooze, SA (corresponding author), Canc Res UK, London Res Inst, Secretory Pathways Lab, London, England.	sharon.tooze@cancer.org.uk		Tooze, Sharon/0000-0002-2182-3116	London Research Institute Cancer Research UK; Cancer Research UK [15153] Funding Source: researchfish	London Research Institute Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This research was supported by the London Research Institute Cancer Research UK (www.london-research-institute.org.uk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dunlop EA, 2011, AUTOPHAGY, V7, P737, DOI 10.4161/auto.7.7.15491; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Hasegawa T, 2010, INT J MOL SCI, V11, P1082, DOI 10.3390/ijms11031082; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; Ho HA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200543; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Jung CH, 2011, AUTOPHAGY, V7, P1212, DOI 10.4161/auto.7.10.16660; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Murase D, 2013, J INVEST DERMATOL; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Tooze SA, 2010, IUBMB LIFE, V62, P503, DOI 10.1002/iub.334; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323	26	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75313	10.1371/journal.pone.0075313	http://dx.doi.org/10.1371/journal.pone.0075313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066173	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000155
J	King, JD; Buolamwini, J; Cromwell, EA; Panfel, A; Teferi, T; Zerihun, M; Melak, B; Watson, J; Tadesse, Z; Vienneau, D; Ngondi, J; Utzinger, J; Odermatt, P; Emerson, PM				King, Jonathan D.; Buolamwini, Joy; Cromwell, Elizabeth A.; Panfel, Andrew; Teferi, Tesfaye; Zerihun, Mulat; Melak, Berhanu; Watson, Jessica; Tadesse, Zerihun; Vienneau, Danielle; Ngondi, Jeremiah; Utzinger, Juerg; Odermatt, Peter; Emerson, Paul M.			A Novel Electronic Data Collection System for Large-Scale Surveys of Neglected Tropical Diseases	PLOS ONE			English	Article							LYMPHATIC FILARIASIS; IMPLEMENTATION; TRACHOMA; SCHISTOSOMIASIS; PREVALENCE; MALARIA; SMS; SURVEILLANCE; PROGRAMS; NASARAWA	Background: Large cross-sectional household surveys are common for measuring indicators of neglected tropical disease control programs. As an alternative to standard paper-based data collection, we utilized novel paperless technology to collect data electronically from over 12,000 households in Ethiopia. Methodology: We conducted a needs assessment to design an Android-based electronic data collection and management system. We then evaluated the system by reporting results of a pilot trial and from comparisons of two, large-scale surveys; one with traditional paper questionnaires and the other with tablet computers, including accuracy, person-time days, and costs incurred. Principle Findings: The electronic data collection system met core functions in household surveys and overcame constraints identified in the needs assessment. Pilot data recorders took 264 (standard deviation (SD) 152 sec) and 260 sec (SD 122 sec) per person registered to complete household surveys using paper and tablets, respectively (P = 0.77). Data recorders felt a lack of connection with the interviewee during the first days using electronic devices, but preferred to collect data electronically in future surveys. Electronic data collection saved time by giving results immediately, obviating the need for double data entry and cross-correcting. The proportion of identified data entry errors in disease classification did not differ between the two data collection methods. Geographic coordinates collected using the tablets were more accurate than coordinates transcribed on a paper form. Costs of the equipment required for electronic data collection was approximately the same cost incurred for data entry of questionnaires, whereas repeated use of the electronic equipment may increase cost savings. Conclusions/Significance: Conducting a needs assessment and pilot testing allowed the design to specifically match the functionality required for surveys. Electronic data collection using an Android-based technology was suitable for a large-scale health survey, saved time, provided more accurate geo-coordinates, and was preferred by recorders over standard paper-based questionnaires.	[King, Jonathan D.; Cromwell, Elizabeth A.; Emerson, Paul M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [King, Jonathan D.; Vienneau, Danielle; Utzinger, Juerg; Odermatt, Peter] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [King, Jonathan D.; Vienneau, Danielle; Utzinger, Juerg; Odermatt, Peter] Univ Basel, Basel, Switzerland; [Buolamwini, Joy; Panfel, Andrew; Watson, Jessica] Georgia Inst Technol, Dept Comp Sci, Atlanta, GA 30332 USA; [Teferi, Tesfaye; Zerihun, Mulat; Melak, Berhanu; Tadesse, Zerihun] Carter Ctr, Addis Ababa, Ethiopia; [Ngondi, Jeremiah] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	Emory University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University System of Georgia; Georgia Institute of Technology; University of Cambridge	King, JD (corresponding author), Emory Univ, Carter Ctr, Atlanta, GA 30322 USA.	jonathan.king@emory.edu	Odermatt, Peter/K-7727-2015; Odermatt, Peter/AAF-4996-2020; Vienneau, Danielle/L-1558-2019	Odermatt, Peter/0000-0002-0296-2508; Vienneau, Danielle/0000-0002-6309-6439; Ngondi, Jeremiah/0000-0003-4357-4816; Emerson, Paul/0000-0002-6478-8816	Lions Club International Foundation; Carter Center Sight First Initiative	Lions Club International Foundation; Carter Center Sight First Initiative	Funding was provided through Lions Club International Foundation and The Carter Center Sight First Initiative. Staff from The Carter Center were involved in the study design, data collection, analysis, decision to publish, and preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; [Anonymous], 2011, MON EP ASS MASS DRUG; Baker MC, 2010, LANCET, V375, P231, DOI 10.1016/S0140-6736(09)61458-6; Bamani S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000734; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Blaya JA, 2008, INT J TUBERC LUNG D, V12, P921; Brooker S, 2009, PARASITOLOGY, V136, P1707, DOI 10.1017/S0031182009005940; Carroll AE, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P111; Chen CQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000979; Dale O, 2007, J CLIN EPIDEMIOL, V60, P8, DOI 10.1016/j.jclinepi.2006.04.005; Deglise C, 2012, J TELEMED TELECARE, V18, P273, DOI 10.1258/jtt.2012.110810; Dorkenoo AM, 2012, TROP MED INT HEALTH, V17, P896, DOI 10.1111/j.1365-3156.2012.03004.x; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Forrer A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001481; Ghana Statisticalstatistical Serviceservice (GSS), 2006, MULT IND CLUST SURV; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Hanson C, 2012, AM J TROP MED HYG, V86, P508, DOI 10.4269/ajtmh.2012.11-1589; Hillebrand F., 2010, SHORT MESSAGE SERVIC; HOACBP, 2002, PROM COMM RAD HORN A; International Epidemiological Association (IEA), 2007, GOOD EP PRACT IEA GU; Jian WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044462; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kabatereine NB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-232; Kariuki EK, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.437; King JD, 2010, BRIT J OPHTHALMOL, V94, P14, DOI 10.1136/bjo.2009.165282; King JD, 2013, PLOS NEGL T IN PRESS; King JD, 2012, AM J TROP MED HYG, V87, P272, DOI 10.4269/ajtmh.2012.11-0718; King JD, 2011, ACTA TROP, V120, pS48, DOI 10.1016/j.actatropica.2010.08.021; Knopp S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-930; Kuntsche E, 2009, ALCOHOL ALCOHOLISM, V44, P423, DOI 10.1093/alcalc/agp033; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; Madder M, 2012, PARASITOLOGY, V139, P1831, DOI 10.1017/S0031182012000571; Rotondo Lisa A, 2011, Community Eye Health, V24, P22; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Sturrock HJW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000537; USAID, 2012, DEM HLTH SURV TOOLK; WHO, 2012, GUID PREP MAST PLAN; WHO, 2011, 3 GLOB SCI M TRACH B; World Health Organization, 2002, HDB GOOD CLIN RES PR; Yu P, 2009, INT J MED INFORM, V78, P532, DOI 10.1016/j.ijmedinf.2009.03.002; Zhang SY, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2183	42	80	81	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74570	10.1371/journal.pone.0074570	http://dx.doi.org/10.1371/journal.pone.0074570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066147	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324494000129
J	Molnar, B; Ercsey-Ravasz, M				Molnar, Botond; Ercsey-Ravasz, Maria			Asymmetric Continuous-Time Neural Networks without Local Traps for Solving Constraint Satisfaction Problems	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; SATISFIABILITY; COMPUTATION; COMPLEXITY; CHAOS; UNIVERSAL; STABILITY; CNN	There has been a long history of using neural networks for combinatorial optimization and constraint satisfaction problems. Symmetric Hopfield networks and similar approaches use steepest descent dynamics, and they always converge to the closest local minimum of the energy landscape. For finding global minima additional parameter-sensitive techniques are used, such as classical simulated annealing or the so-called chaotic simulated annealing, which induces chaotic dynamics by addition of extra terms to the energy landscape. Here we show that asymmetric continuous-time neural networks can solve constraint satisfaction problems without getting trapped in non-solution attractors. We concentrate on a model solving Boolean satisfiability (k-SAT), which is a quintessential NP-complete problem. There is a one-to-one correspondence between the stable fixed points of the neural network and the k-SAT solutions and we present numerical evidence that limit cycles may also be avoided by appropriately choosing the parameters of the model. This optimal parameter region is fairly independent of the size and hardness of instances, this way parameters can be chosen independently of the properties of problems and no tuning is required during the dynamical process. The model is similar to cellular neural networks already used in CNN computers. On an analog device solving a SAT problem would take a single operation: the connection weights are determined by the k-SAT instance and starting from any initial condition the system searches until finding a solution. In this new approach transient chaotic behavior appears as a natural consequence of optimization hardness and not as an externally induced effect.	[Molnar, Botond; Ercsey-Ravasz, Maria] Univ Babes Bolyai, Fac Phys, RO-400084 Cluj Napoca, Romania	Babes Bolyai University from Cluj	Ercsey-Ravasz, M (corresponding author), Univ Babes Bolyai, Fac Phys, RO-400084 Cluj Napoca, Romania.	ercsey.ravasz@phys.ubbcluj.ro	Molnár, Botond/E-2113-2017; Molnár, Botond/AAP-6227-2021; Ravasz, Maria Ercsey/E-2098-2017	Molnár, Botond/0000-0001-6780-5661; Molnár, Botond/0000-0001-6780-5661; Ravasz, Maria Ercsey/0000-0003-4428-9953	Marie Curie International Incoming Fellowship [FP7-PEOPLE-2011-IIF-299915]	Marie Curie International Incoming Fellowship(European Commission)	This research was supported by a Marie Curie International Incoming Fellowship FP7-PEOPLE-2011-IIF-299915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Hur A, 2002, J COMPLEXITY, V18, P51, DOI 10.1006/jcom.2001.0581; Branicky M. S., 1994, Proceedings. Workshop on Physics and Computation PhysComp '94, P265, DOI 10.1109/PHYCMP.1994.363672; CHEN LN, 1995, NEURAL NETWORKS, V8, P915, DOI 10.1016/0893-6080(95)00033-V; Chen LN, 1997, PHYSICA D, V104, P286, DOI 10.1016/S0167-2789(96)00302-8; CHUA LO, 1988, IEEE T CIRCUITS SYST, V35, P1257, DOI 10.1109/31.7600; CHUA LO, 1993, IEEE T CIRCUITS-I, V40, P289, DOI 10.1109/81.224308; Cook S. A., 1971, Proceedings of the 3rd annual ACM symposium on theory of computing, P151; DOUGLAS R, 1995, ANNU REV NEUROSCI, V18, P255, DOI 10.1146/annurev.ne.18.030195.001351; Ercsey-Ravasz M, 2008, PHYSICA D, V237, P1226, DOI 10.1016/j.physd.2008.03.028; Ercsey-Ravasz M, 2009, PHYSICA A, V388, P1024, DOI 10.1016/j.physa.2008.11.037; Ercsey-Ravasz M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00725; Ercsey-Ravasz M, 2011, NAT PHYS, V7, P966, DOI [10.1038/nphys2105, 10.1038/NPHYS2105]; Ercsey-Ravasz M, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/646975; Forti M, 2012, 13 INT WORKSH CELL N; Garey MR, 1979, SERIES BOOKS MATH SC; GU J, 1994, IEEE T KNOWL DATA EN, V6, P361, DOI 10.1109/69.334864; Gu Jun, 1999, Journal of Computer Science and Technology (English Language Edition), V14, P1, DOI 10.1007/BF02952482; HOPFIELD JJ, 1985, BIOL CYBERN, V52, P141; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Krzakala F, 2007, P NATL ACAD SCI USA, V104, P10318, DOI 10.1073/pnas.0703685104; Krzakala F, 2008, J PHYS CONF SER, V95, DOI 10.1088/1742-6596/95/1/012012; Kwok T, 1999, IEEE T NEURAL NETWOR, V10, P978, DOI 10.1109/72.774279; Lai YC, 2011, APPL MATH SCI, V173, P3, DOI 10.1007/978-1-4419-6987-3; Liu S.-C., 2002, ANALOG VLSI CIRCUITS; Molnar B, 2012, 13 INT WORKSH CELL N; Moore C, 1996, THEOR COMPUT SCI, V162, P23, DOI 10.1016/0304-3975(95)00248-0; Nagamatu M, 1996, NEUROCOMPUTING, V13, P119, DOI 10.1016/0925-2312(95)00087-9; ORPONEN P, 1992, LECT NOTES COMPUT SC, V629, P50; Orponen P, 1997, LECT NOTES COMPUTER, V1338, P86; ROSKA T, 1993, IEEE T CIRCUITS-II, V40, P163, DOI 10.1109/82.222815; SIEGELMANN HT, 1995, SCIENCE, V268, P545, DOI 10.1126/science.268.5210.545; SIEGELMANN HT, 1994, THEOR COMPUT SCI, V131, P331, DOI 10.1016/0304-3975(94)90178-3; Sima J, 2003, NEURAL COMPUT, V15, P2727, DOI 10.1162/089976603322518731; Sima J, 2003, NEURAL COMPUT, V15, P693, DOI 10.1162/089976603321192130; Solomon PM, 2000, ANNU REV MATER SCI, V30, P681, DOI 10.1146/annurev.matsci.30.1.681; Tel T, 2008, PHYS REP, V460, P245, DOI 10.1016/j.physrep.2008.01.001; Wah BW, 1997, J GLOBAL OPTIM, V10, P107, DOI 10.1023/A:1008294209959; Wah BW, 2000, INFORM SCIENCES, V124, P241, DOI 10.1016/S0020-0255(99)00081-X; Wang LP, 2004, IEEE T SYST MAN CY B, V34, P2119, DOI 10.1109/TSMCB.2004.829778; Wang LP, 1998, IEEE T NEURAL NETWOR, V9, P716, DOI 10.1109/72.701185	42	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73400	10.1371/journal.pone.0073400	http://dx.doi.org/10.1371/journal.pone.0073400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066045	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000026
J	Panozzo, CA; Becker-Dreps, S; Pate, V; Funk, MJ; Sturmer, T; Weber, DJ; Brookhart, MA				Panozzo, Catherine A.; Becker-Dreps, Sylvia; Pate, Virginia; Funk, Michele Jonsson; Stuermer, Til; Weber, David J.; Brookhart, M. Alan			Patterns of Rotavirus Vaccine Uptake and Use in Privately-Insured US Infants, 2006-2010	PLOS ONE			English	Article							AGED 19-35 MONTHS; IMMUNIZATION PRACTICES ACIP; UNITED-STATES; ADVISORY-COMMITTEE; CHILDREN; RECOMMENDATIONS; PREVENTION; COVERAGE; GASTROENTERITIS; CARE	Rotavirus vaccines are highly effective at preventing gastroenteritis in young children and are now universally recommended for infants in the US. We studied patterns of use of rotavirus vaccines among US infants with commercial insurance. We identified a large cohort of infants in the MarketScan Research Databases, 2006-2010. The analysis was restricted to infants residing in states without state-funded rotavirus vaccination programs. We computed summary statistics and used multivariable regression to assess the association between patient-, provider-, and ecologic-level variables of rotavirus vaccine receipt and series completion. Approximately 69% of 594,117 eligible infants received at least one dose of rotavirus vaccine from 2006-2010. Most infants received the rotavirus vaccines at the recommended ages, but more infants completed the series for monovalent rotavirus vaccine than pentavalent rotavirus vaccine or a mix of the vaccines (87% versus 79% versus 73%, P < 0.001). In multivariable analyses, the strongest predictors of rotavirus vaccine series initiation and completion were receipt of the diphtheria, tetanus and acellular pertussis vaccine (Initiation: RR = 7.91, 95% CI = 7.69-8.13; Completion: RR = 1.26, 95% CI = 1.23-1.29), visiting a pediatrician versus family physician (Initiation: RR = 1.51, 95% CI = 1.49-1.52; Completion: RR = 1.13, 95% CI = 1.11-1.14), and living in a large metropolitan versus smaller metropolitan, urban, or rural area. We observed rapid diffusion of the rotavirus vaccine in routine practice; however, approximately one-fifth of infants did not receive at least one dose of vaccine as recently as 2010. Interventions to increase rotavirus vaccine coverage should consider targeting family physicians and encouraging completion of the vaccine series.	[Panozzo, Catherine A.; Pate, Virginia; Funk, Michele Jonsson; Stuermer, Til; Weber, David J.; Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Becker-Dreps, Sylvia] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA; [Weber, David J.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Brookhart, MA (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	mabrook@email.unc.edu	Funk, Michele Jonsson/F-6885-2011; Stürmer, Til/AAB-5459-2022	Funk, Michele Jonsson/0000-0002-3756-7540; 	internal funds at the University of North Carolina, Chapel Hill; University of North Carolina Center of Excellence in Pharmacoepidemiology and Public Health; Fogarty International Center at the National Institutes of Health [4K01TW008401-03]; Agency for Healthcare Research and Quality [K02HS017950]; National Institute on Aging at the National Institutes of Health [R01 AG023178]; UNC-DEcIDE center from the Agency for Healthcare Research and Quality; National Institutes of Health; Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017950] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080214] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178] Funding Source: NIH RePORTER	internal funds at the University of North Carolina, Chapel Hill; University of North Carolina Center of Excellence in Pharmacoepidemiology and Public Health; Fogarty International Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UNC-DEcIDE center from the Agency for Healthcare Research and Quality; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by internal funds at the University of North Carolina, Chapel Hill. Ms. Panozzo received support from the University of North Carolina Center of Excellence in Pharmacoepidemiology and Public Health. Dr. Becker-Dreps is supported by 4K01TW008401-03 from the Fogarty International Center at the National Institutes of Health. Dr. Jonsson Funk is supported by K02HS017950 from the Agency for Healthcare Research and Quality. Dr. Sturmer receives investigator-initiated research funding and support as Principal Investigator (R01 AG023178) from the National Institute on Aging at the National Institutes of Health. He also receives research funding as Principal Investigator of the UNC-DEcIDE center from the Agency for Healthcare Research and Quality. Dr. Brookhart receives research support from multiple grants and contracts with National Institutes of Health and the Agency for Healthcare Research and Quality. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black Carla L., 2012, Morbidity and Mortality Weekly Report, V61, P689; Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; Cortes JE, 2011, NEW ENGL J MED, V365, P1108, DOI 10.1056/NEJMoa1000446; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Dennehy PH, 2005, INFECT DIS CLIN N AM, V19, P585, DOI 10.1016/j.idc.2005.05.003; Freed GL, 1996, J FAM PRACTICE, V42, P587; Kempe A, 2009, PEDIATRICS, V124, pE809, DOI 10.1542/peds.2008-3832; Krishnarajah G, 2012, VACCINE, V30, P3717, DOI 10.1016/j.vaccine.2011.12.077; Luman ET, 2008, AM J PREV MED, V34, P463, DOI 10.1016/j.amepre.2008.01.033; Luman ET, 2001, AM J PREV MED, V20, P32, DOI 10.1016/S0749-3797(01)00282-3; National Center for Health Statistics Centers for Medicare and Medicaid Services, 2011, ICD 9 CM OFF GUID CO; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; The Henry J. Kaiser Family Foundation, 2013, STAT HLTH FACTS HLTH; US Census Bureau, 2012, 2012 STAT ABSTR BIRT; US Department of Health and Human Services, 2012, HLTH PEOPL 2020 TOP; Wang FT, 2013, PEDIATR INFECT DIS J, V32, P278, DOI 10.1097/INF.0b013e318275328f; Wendy B, 2012, VACCINE, V30, P5293, DOI 10.1016/j.vaccine.2012.04.071; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171	18	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73825	10.1371/journal.pone.0073825	http://dx.doi.org/10.1371/journal.pone.0073825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066076	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000058
J	Westphal-Fitch, G; Fitch, WT				Westphal-Fitch, Gesche; Fitch, W. Tecumseh			Spatial Analysis of "Crazy Quilts", a Class of Potentially Random Aesthetic Artefacts	PLOS ONE			English	Article							PARTICLE-SIZE DISTRIBUTIONS; POLLOCKS DRIP PAINTINGS; POINT PATTERNS; LOGNORMAL-DISTRIBUTION; R PACKAGE; SYMMETRY; MODEL; PERCEPTION	Human artefacts in general are highly structured and often display ordering principles such as translational, reflectional or rotational symmetry. In contrast, human artefacts that are intended to appear random and non symmetrical are very rare. Furthermore, many studies show that humans find it extremely difficult to recognize or reproduce truly random patterns or sequences. Here, we attempt to model two-dimensional decorative spatial patterns produced by humans that show no obvious order. "Crazy quilts" represent a historically important style of quilt making that became popular in the 1870s, and lasted about 50 years. Crazy quilts are unusual because unlike most human artefacts, they are specifically intended to appear haphazard and unstructured. We evaluate the degree to which this intention was achieved by using statistical techniques of spatial point pattern analysis to compare crazy quilts with regular quilts from the same region and era and to evaluate the fit of various random distributions to these two quilt classes. We found that the two quilt categories exhibit fundamentally different spatial characteristics: The patch areas of crazy quilts derive from a continuous random distribution, while area distributions of regular quilts consist of Gaussian mixtures. These Gaussian mixtures derive from regular pattern motifs that are repeated and we suggest that such a mixture is a distinctive signature of human-made visual patterns. In contrast, the distribution found in crazy quilts is shared with many other naturally occurring spatial patterns. Centroids of patches in the two quilt classes are spaced differently and in general, crazy quilts but not regular quilts are well-fitted by a random Strauss process. These results indicate that, within the constraints of the quilt format, Victorian quilters indeed achieved their goal of generating random structures.	[Westphal-Fitch, Gesche; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna	Westphal-Fitch, G (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	gesche.w.fitch@univie.ac.at		Westphal-Fitch, Gesche/0000-0002-0362-456X	European Research Council [230604]; Austrian Science Fund (FWF) [W1234-G17]	European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding was provided by European Research Council Advanced Grant SOMACCA, grant nr. 230604, to W. Tecumseh Fitch, http://erc.europa.eu/; and Austrian Science Fund (FWF) grant nr. W1234-G17 to W. Tecumseh Fitch, http://www.fwf.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1988, STAT INFERENCE SPATI, DOI DOI 10.1017/CBO9780511624131; [Anonymous], 1890, GOOD HOUSEKEEPING, V11, P310; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2000, AUST NZ J STAT, V42, P283, DOI 10.1111/1467-842X.00128; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Bell ML, 2004, BIOSTATISTICS, V5, P633, DOI 10.1093/biostatistics/kxh014; Benaglia T, 2009, J STAT SOFTW, V32, P1; Besag J, 1975, J R STAT SOC D-STAT, V24, P179, DOI [10.2307/2987782, DOI 10.2307/2987782]; Besag J., 1977, J R STAT SOC SER C A, V26, P327, DOI [10.2307/2346974, DOI 10.2307/2346974]; Besag J, 1977, B INT STAT I, V47, P77, DOI [10.1007/s10661-011-2005-y, DOI 10.1007/S10661-011-2005-Y]; BORNSTEIN MH, 1984, DEV PSYCHOL, V20, P637, DOI 10.1037/0012-1649.20.4.637; Brick C, 2008, CRAZY QUILTS HIST TE; BROWN WK, 1995, J APPL PHYS, V78, P2758, DOI 10.1063/1.360073; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CAMPBELL JW, 1995, J GEOPHYS RES-OCEANS, V100, P13237, DOI 10.1029/95JC00458; Crabtree Caroline, 2007, QUILTING PATCHWORK A; Cunningham J, 2009, AMISH ABSTRACTIONS Q; Delignette-Muller M.L., 2010, Fitdistrplus: help to fit of a parametric distribution to non-censored or censored data, R package version 0.1-3; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Driver P. M., 1988, PROTEAN BEHAV BIOL U; FANG ZG, 1993, MATER CHARACT, V31, P177, DOI 10.1016/1044-5803(93)90058-4; Fechner G. T., 1876, VORSCHULE ASTHETIK, V1-2; FECHNER GT, 1871, EXPT AESTHETIK; Gokhale A, 2011, P SPIE INT SOC OPTIC, V7869; Gombrich E. H., 1984, SENSE ORDER STUDY PS; Gordon B, 2009, AM QUILTS MODERN AGE, P127; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Grunbaum B., 1987, TILINGS PATTERNS; Grunbaum B, 2009, NOT AM MATH SOC, V53, P670; Hanson MF, 2009, AM QUILTS MODERN AGE; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; HIRANO SS, 1982, APPL ENVIRON MICROB, V44, P695, DOI 10.1128/AEM.44.3.695-700.1982; Huber L, 1999, Q J EXP PSYCHOL-B, V52, P351, DOI 10.1080/027249999393040; Hughes JM, 2011, EUR SIGNAL PR CONF, P1244; Ingram JS, 1876, CENTENNIAL EXPOSITIO; Jones-Smith K, 2006, NATURE, V444, pE9, DOI 10.1038/nature05398; Jung KM, 1987, CLOTH TEXT RES J, V5, P18; KELLY FP, 1976, BIOMETRIKA, V63, P357, DOI 10.2307/2335630; Komsta L., 2012, MOMENTS MOMENTS CUMU; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LISANBY SH, 1991, PERCEPTION OF STRUCTURE, P97, DOI 10.1037/10101-005; McManus IC, 2013, PSYCHOL AESTHET CREA, V7, P130, DOI 10.1037/a0030469; McManus IC, 2011, PERCEPTION, V40, P332, DOI 10.1068/p6700; Oxford English Dictionary, DEPLORABLE; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Pham Hoang, 2007, IEEE T RELIABILITY, V56; Salman, 1995, SYMMETRIES ISLAMIC G; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider S, 1999, GENETICS, V152, P1079; Stein A., 2006, CASE STUDIES SPATIAL, P261; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; STRAUSS DJ, 1975, BIOMETRIKA, V62, P467, DOI 10.1093/biomet/62.2.467; Taylor RP, 2006, NATURE, V444, pE10, DOI 10.1038/nature05399; Taylor RP, 1999, NATURE, V399, P422, DOI 10.1038/20833; Thom HCS, 1958, MONTHLY WEATHER REV, V86; Treder MS, 2010, SYMMETRY-BASEL, V2, P1510, DOI 10.3390/sym2031510; van Noortwijk JM, 2009, RELIAB ENG SYST SAFE, V94, P2, DOI 10.1016/j.ress.2007.03.019; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; Wagenaar W. A., 1972, SEQUENTIAL RESPONSE; Washburn D.K., 1988, SYMMETRIES CULTURE T; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Westphal-Fitch G, 2013, PSYCHOL AESTHET CREA, V7, P13, DOI 10.1037/a0031795; Westphal-Fitch G, 2012, PHILOS T R SOC B, V367, P2007, DOI 10.1098/rstb.2012.0098; Wichmann B, 2008, SYMMETRY, V19, P95; Zobeck TM, 1999, EARTH SURF PROC LAND, V24, P943, DOI 10.1002/(SICI)1096-9837(199909)24:10&lt;943::AID-ESP30&gt;3.0.CO;2-9	67	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74055	10.1371/journal.pone.0074055	http://dx.doi.org/10.1371/journal.pone.0074055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066095	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000077
J	Aamir, UB; Alam, MM; Sadia, H; Zaidi, SSZ; Kazi, BM				Aamir, Uzma Bashir; Alam, Muhammad Masroor; Sadia, Hajra; Zaidi, Syed Sohail Zahoor; Kazi, Birjees Mazher			Molecular Characterization of Circulating Respiratory Syncytial Virus (RSV) Genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 Winter Season	PLOS ONE			English	Article							SUBGROUP-A; GENETIC-VARIABILITY; G-GLYCOPROTEIN; GROUP-B; PHYLOGENETIC ANALYSIS; EVOLUTIONARY PATTERN; TRACT INFECTIONS; STRAIN VARIATION; G-PROTEIN; CHILDREN	Respiratory syncytial virus (RSV) is the major cause of acute lower respiratory tract infections in young children, but very little is known about its epidemiology and circulating genotypes in Pakistan. This study analyzed the epidemiological and molecular characteristics of RSV genotypes detected in Pakistani children less than 2 years of age with acute respiratory tract infections (ARIs) in a tertiary care hospital in Gilgit Baltistan (GB) province during 2011-12 winter season. RSV was detected in 75 out of 105 children presenting with acute respiratory infection. Male infants between 2-6 months age made up the highest percentage of RSV positive cases. Epidemiological factors such as pre-maturity, mean weight, clinical features and diagnosis when compared between RSV positive and negative groups were found to be statistically insignificant. Phylogenetic analysis classified all 75 of the RSV strains into 71 strains of subgroups A and 4 strains of subgroup B, respectively. Strains belonging to subgroups A and B were further subdivided into NA1/GA2 and BA, respectively. The nucleotide and deduced amino acid sequence identities were relatively high among these strains (>90%). Both RSV-A and RSV-B isolates had two potential N-glycosylation sites in HVR2 of G protein and with heavy O-glycosylation of serine and threonine residues (G scores of 0.5-0.7). This report highlights the significance of RSV as a dominant viral etiologic agent of pediatric ARIs, and need for continued molecular epidemiological surveys for early detection of prevalent strains and newly emerging genotypes to understand epidemiology of RSV infections in various regions of Pakistan.	[Aamir, Uzma Bashir; Alam, Muhammad Masroor; Zaidi, Syed Sohail Zahoor; Kazi, Birjees Mazher] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Sadia, Hajra] NUST, Atta Ur Rehman Sch Appl BioSci ASAB, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Pk Rd, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Zaidi, Syed Sohail Zahoor/F-7432-2015					ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Boonyasuppayakorn S, 2010, INFLUENZA OTHER RESP, V4, P313, DOI 10.1111/j.1750-2659.2010.00152.x; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1992, VIRUS RES, V25, P15, DOI 10.1016/0168-1702(92)90096-R; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; CANE PA, 1991, J GEN VIROL, V72, P349, DOI 10.1099/0022-1317-72-2-349; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Galiano MC, 2005, J MED VIROL, V77, P311, DOI 10.1002/jmv.20456; GARCIA O, 1994, J VIROL, V68, P5448; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; Goto-Sugai K, 2010, JPN J INFECT DIS, V63, P393; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Martinez I, 1999, J GEN VIROL, V80, P125, DOI 10.1099/0022-1317-80-1-125; MCINTOSH K, 1990, BN FIELDS VIROLOGY, V1, P1045; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Moura FEA, 2003, MEM I OSWALDO CRUZ, V98, P739, DOI 10.1590/S0074-02762003000600005; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Oliveira TFM, 2008, MEM I OSWALDO CRUZ, V103, P417, DOI 10.1590/S0074-02762008000500002; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Queiroz DAO, 2002, BRAZ J MED BIOL RES, V35, P1183, DOI 10.1590/S0100-879X2002001000011; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103; Ruuskanen O, 1993, Curr Probl Pediatr, V23, P50, DOI 10.1016/0045-9380(93)90003-U; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; VATHANOPHAS K, 1990, REV INFECT DIS, V12, pS957; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; *WHO, 2008, GEN PROT EX INC LOW; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	52	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74018	10.1371/journal.pone.0074018	http://dx.doi.org/10.1371/journal.pone.0074018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058513	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400048
J	Schnerch, D; Follo, M; Felthaus, J; Engelhardt, M; Wasch, R				Schnerch, Dominik; Follo, Marie; Felthaus, Julia; Engelhardt, Monika; Waesch, Ralph			The 3 ' Untranslated Region of the Cyclin B mRNA Is Not Sufficient to Enhance the Synthesis of Cyclin B during a Mitotic Block in Human Cells	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; MITOSIS; CANCER; CHECKPOINT; EXIT; PROTEOLYSIS	Antimitotic agents are frequently used to treat solid tumors and hematologic malignancies. However, one major limitation of antimitotic approaches is mitotic slippage, which is driven by slow degradation of cyclin B during a mitotic block. The extent to which cyclin B levels decline is proposed to be governed by an equilibrium between cyclin B synthesis and degradation. It was recently shown that the 3' untranslated region (UTR) of the murine cyclin B mRNA contributes to the synthesis of cyclin B during mitosis in murine cells. Using a novel live-cell imaging-based technique allowing us to study synthesis and degradation of cyclin B simultaneously at the single cell level, we tested here the role of the human cyclin B 3' UTR in regulating cyclin B synthesis during mitosis in human cells. We observed that the cyclin B 3' UTR was not sufficient to enhance cyclin B synthesis in human U2Os, HeLa or hTERT RPE-1 cells. A better understanding of how the equilibrium of cyclin B is regulated in mitosis may contribute to the development of improved therapeutic approaches to prevent mitotic slippage in cancer cells treated with antimitotic agents.	[Schnerch, Dominik; Follo, Marie; Felthaus, Julia; Engelhardt, Monika; Waesch, Ralph] Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany	University of Freiburg	Wasch, R (corresponding author), Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany.	ralph.waesch@uniklinik-freiburg.de	Waesch, Ralph/F-6282-2019	Follo, Marie/0000-0002-3090-7442	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Huang HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015724; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Le Breton M, 2005, BIOCHIMIE, V87, P805, DOI 10.1016/j.biochi.2005.04.014; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Mena AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013037; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Russo AJ, 2006, CANCER RES, V66, P7253, DOI 10.1158/0008-5472.CAN-05-3725; Schnerch D, 2013, HAEMATOLOGICA, DOI [10.3324/haematol.2013.087452, DOI 10.3324/HAEMAT0L.2013.087452.PUBMED:23812934]; Schnerch D, 2012, JOVE-J VIS EXP, DOI 10.3791/4239; Schnerch D, 2012, CELL CYCLE, V11, P310, DOI 10.4161/cc.11.2.18737; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Wasch R, 2011, EXPERT OPIN THER TAR, V15, P785, DOI 10.1517/14728222.2011.577420; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	26	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74379	10.1371/journal.pone.0074379	http://dx.doi.org/10.1371/journal.pone.0074379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058555	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400068
J	Walentek, P; Schneider, I; Schweickert, A; Blum, M				Walentek, Peter; Schneider, Isabelle; Schweickert, Axel; Blum, Martin			Wnt11b Is Involved in Cilia-Mediated Symmetry Breakage during Xenopus Left-Right Development	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; PLANAR CELL POLARITY; LEFT-RIGHT AXIS; GENE-EXPRESSION; KUPFFERS VESICLE; BETA-CATENIN; CONVERGENT EXTENSION; FOXJ1 EXPRESSION; NODAL CILIA; FLOW	Breakage of bilateral symmetry in amphibian embryos depends on the development of a ciliated epithelium at the gastrocoel roof during early neurulation. Motile cilia at the gastrocoel roof plate (GRP) give rise to leftward flow of extracellular fluids. Flow is required for asymmetric gene expression and organ morphogenesis. Wnt signaling has previously been involved in two steps, Wnt/beta-catenin mediated induction of Foxj1, a regulator of motile cilia, and Wnt/planar cell polarity (PCP) dependent cilia polarization to the posterior pole of cells. We have studied Wnt11b in the context of laterality determination, as this ligand was reported to activate canonical and non-canonical Wnt signaling. Wnt11b was found to be expressed in the so-called superficial mesoderm (SM), from which the GRP derives. Surprisingly, Foxj1 was only marginally affected in loss-of-function experiments, indicating that another ligand acts in this early step of laterality specification. Wnt11b was required, however, for polarization of GRP cilia and GRP morphogenesis, in line with the known function of Wnt/PCP in cilia-driven leftward flow. In addition Xnr1 and Coco expression in the lateral-most GRP cells, which sense flow and generate the first asymmetric signal, was attenuated in morphants, involving Wnt signaling in yet another process related to symmetry breakage in Xenopus.	[Walentek, Peter; Schneider, Isabelle; Schweickert, Axel; Blum, Martin] Univ Hohenheim, Inst Zool, Stuttgart, Baden Wurttembe, Germany	University Hohenheim	Blum, M (corresponding author), Univ Hohenheim, Inst Zool, Stuttgart, Baden Wurttembe, Germany.	martin.blum@uni-hohenheim.de		Walentek, Peter/0000-0002-2332-6068	DFG [BL285/9-1]; Landesgraduiertenforderung Baden-Wurttemberg	DFG(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg	This work was supported by DFG Grant BL285/9-1 to MB. PW was recipient of a PhD fellowship from the Landesgraduiertenforderung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Alten L, 2012, DEVELOPMENT, V139, P1276, DOI 10.1242/dev.072728; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Beyer T, 2012, CURR BIOL, V22, P33, DOI 10.1016/j.cub.2011.11.027; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Blum M, 2009, SEMIN CELL DEV BIOL, V20, P464, DOI 10.1016/j.semcdb.2008.11.005; Blum M, 2009, DEV DYNAM, V238, P1215, DOI 10.1002/dvdy.21855; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Garriock RJ, 2007, DEV BIOL, V304, P127, DOI 10.1016/j.ydbio.2006.12.020; Hashimoto M, 2010, CURR OPIN GENET DEV, V20, P433, DOI 10.1016/j.gde.2010.04.002; Hatayama M, 2011, BIOCHEM BIOPH RES CO, V410, P520, DOI 10.1016/j.bbrc.2011.06.014; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Kreiling JA, 2008, MECH DEVELOP, V125, P396, DOI 10.1016/j.mod.2008.02.004; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lin XY, 2009, DEVELOPMENT, V136, P207, DOI 10.1242/dev.029561; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mahaffey JP, 2013, DEVELOPMENT, V140, P1262, DOI 10.1242/dev.085316; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Matthews HK, 2008, DEV DYNAM, V237, P3404, DOI 10.1002/dvdy.21758; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Moulton Jon D, 2008, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2608s83; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nascone N, 1997, DEV BIOL, V189, P68, DOI 10.1006/dbio.1997.8635; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Niehrs C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3134pe26; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Satow R, 2004, BIOCHEM BIOPH RES CO, V321, P487, DOI 10.1016/j.bbrc.2004.06.166; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Schweickert A, 2001, MECH DEVELOP, V107, P191, DOI 10.1016/S0925-4773(01)00461-0; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Schweickert A, 2012, DIFFERENTIATION, V83, pS67, DOI 10.1016/j.diff.2011.11.005; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Shook DR, 2004, DEV BIOL, V270, P163, DOI 10.1016/j.ydbio.2004.02.021; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sykes TG, 1998, DEVELOPMENT, V125, P4595; Tada M, 2000, DEVELOPMENT, V127, P2227; Tahinci E, 2007, DEVELOPMENT, V134, P4095, DOI 10.1242/dev.010272; Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Tetelin S, 2010, DEV DYNAM, V239, P148, DOI 10.1002/dvdy.22012; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435; Zhang Y, 2009, GENESIS, V47, P719, DOI 10.1002/dvg.20551	80	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73646	10.1371/journal.pone.0073646	http://dx.doi.org/10.1371/journal.pone.0073646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058481	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400030
J	Kim, YH; Epting, D; Slanchev, K; Engel, C; Walz, G; Kramer-Zucker, A				Kim, Yun Hee; Epting, Daniel; Slanchev, Krasimir; Engel, Christina; Walz, Gerd; Kramer-Zucker, Albrecht			A Complex of BBS1 and NPHP7 Is Required for Cilia Motility in Zebrafish	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; SYNDROME PROTEINS; ZINC-FINGER; REPRESSOR FUNCTIONS; KUPFFERS VESICLE; NEPHRONOPHTHISIS; GENES; MUTATIONS; GLIS2; DYSKINESIA	Bardet-Biedl syndrome (BBS) and nephronophthisis (NPH) are hereditary autosomal recessive disorders, encoded by two families of diverse genes. BBS and NPH display several overlapping phenotypes including cystic kidney disease, retinitis pigmentosa, liver fibrosis, situs inversus and cerebellar defects. Since most of the BBS and NPH proteins localize to cilia and/or their appendages, BBS and NPH are considered ciliopathies. In this study, we characterized the function of the transcription factor Nphp7 in zebrafish, and addressed the molecular connection between BBS and NPH. The knockdown of zebrafish bbs1 and nphp7.2 caused similar phenotypic changes including convergent extension defects, curvature of the body axis, hydrocephalus, abnormal heart looping and cystic pronephros, all consistent with an altered ciliary function. Immunoprecipitation assays revealed a physical interaction between BBS1 and NPHP7, and the simultaneous knockdown of zbbs1 and znphp7.2 enhanced the cystic pronephros phenotype synergistically, suggesting a genetic interaction between zbbs1 and znphp7.2 in vivo. Deletion of zBbs1 or zNphp7.2 did not compromise cilia formation, but disrupted cilia motility. Although NPHP7 has been shown to act as transcriptional repressor, our studies suggest a crosstalk between BBS1 and NPHP7 in regulating normal function of the cilium.	[Kim, Yun Hee; Epting, Daniel; Slanchev, Krasimir; Engel, Christina; Walz, Gerd; Kramer-Zucker, Albrecht] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Kim, Yun Hee] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Kim, Yun Hee] Univ Freiburg, Fac Biol, Fac Chem Pharm & Earth Sci, D-79106 Freiburg, Germany; [Slanchev, Krasimir] Max Planck Inst, Martinsried, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society	Kramer-Zucker, A (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	albrecht.kramer-zucker@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft [KFO201]; Excellence Initiative of the German Federal Government [GSC-4]; Excellence Initiative of the German State Government [GSC-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This study was supported by Deutsche Forschungsgemeinschaft KFO201 (http://www.dfg.de/foerderung/programme/listen/projektdetails/index.jsp?id=58488057) (AK and GW), Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School, http://www.sgbm.uni-freiburg.de/) (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts HH, 2013, PEDIAT NEPHROL; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Benzing T, 2012, CURR OPIN NEPHROL HY, V21, P272, DOI 10.1097/MNH.0b013e3283520f17; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Boon M, 2013, EUR J PEDIATR, V172, P151, DOI 10.1007/s00431-012-1785-6; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; D'Angelo A., 2009, PATHOGENETICS, V2, P2; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Ebarasi L, 2011, CURR OPIN NEPHROL HY, V20, P416, DOI 10.1097/MNH.0b013e3283477797; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Ferkol T, 2006, SEMIN PERINATOL, V30, P335, DOI 10.1053/j.semperi.2005.11.001; Forsythe E, 2013, EUR J HUM GENET; Fu X, 2008, J AM SOC NEPHROL, V19, P1342, DOI 10.1681/ASN.2007070730; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; GREENSTONE MA, 1983, THORAX, V38, P875, DOI 10.1136/thx.38.11.875; Halbritter J, 2013, HUM GENET; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kobayashi D, 2012, DIFFERENTIATION, V83, pS23, DOI 10.1016/j.diff.2011.11.009; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Mockel A, 2011, PROG RETIN EYE RES, V30, P258, DOI 10.1016/j.preteyeres.2011.03.001; Morillas HN, 2007, RESPIRATION, V74, P252, DOI 10.1159/000101783; Mykytyn K, 2003, AM J HUM GENET, V72, P429, DOI 10.1086/346172; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Patil SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021379; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Price HP, 2012, BBA-MOL CELL RES, V1823, P1178, DOI 10.1016/j.bbamcr.2012.05.007; Putoux A, 2012, PEDIATR NEPHROL, V27, P7, DOI 10.1007/s00467-010-1751-3; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Simms RJ, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/527137; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tayeh MK, 2008, HUM MOL GENET, V17, P1956, DOI 10.1093/hmg/ddn093; Vasanth S, 2011, J BIOL CHEM, V286, P4749, DOI 10.1074/jbc.M110.165951; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Williams CL, 2010, J AM SOC NEPHROL, V21, P782, DOI 10.1681/ASN.2009060597; Wirschell M, 2011, ARCH BIOCHEM BIOPHYS, V510, P93, DOI 10.1016/j.abb.2011.04.003; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Wolf MTF, 2005, J AM SOC NEPHROL, V16, P676, DOI 10.1681/ASN.2003121025; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8	69	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72549	10.1371/journal.pone.0072549	http://dx.doi.org/10.1371/journal.pone.0072549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069149	Green Published, gold			2022-12-27	WOS:000326240100010
J	Butler, DL; Mattingley, JB; Cunnington, R; Suddendorf, T				Butler, David L.; Mattingley, Jason B.; Cunnington, Ross; Suddendorf, Thomas			Different Neural Processes Accompany Self-Recognition in Photographs Across the Lifespan: An ERP Study Using Dizygotic Twins	PLOS ONE			English	Article							OWN-AGE BIAS; EVENT-RELATED POTENTIALS; FACE RECOGNITION; FAMILIAR FACES; EMOTIONAL EXPRESSION; FACIAL RESEMBLANCE; BRAIN; IDENTIFICATION; MECHANISMS; AWARENESS	Our appearance changes over time, yet we can recognize ourselves in photographs from across the lifespan. Researchers have extensively studied self-recognition in photographs and have proposed that specific neural correlates are involved, but few studies have examined self-recognition using images from different periods of life. Here we compared ERP responses to photographs of participants when they were 5-15, 16-25, and 26-45 years old. We found marked differences between the responses to photographs from these time periods in terms of the neural markers generally assumed to reflect (i) the configural processing of faces (i.e., the N170), (ii) the matching of the currently perceived face to a representation already stored in memory (i.e., the P250), and (iii) the retrieval of information about the person being recognized (i.e., the N400). There was no uniform neural signature of visual self-recognition. To test whether there was anything specific to self-recognition in these brain responses, we also asked participants to identify photographs of their dizygotic twins taken from the same time periods. Critically, this allowed us to minimize the confounding effects of exposure, for it is likely that participants have been similarly exposed to each other's faces over the lifespan. The same pattern of neural response emerged with only one exception: the neural marker reflecting the retrieval of mnemonic information (N400) differed across the lifespan for self but not for twin. These results, as well as our novel approach using twins and photographs from across the lifespan, have wide-ranging consequences for the study of self-recognition and the nature of our personal identity through time.	[Butler, David L.; Mattingley, Jason B.; Cunnington, Ross; Suddendorf, Thomas] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Butler, DL (corresponding author), Univ Queensland, Sch Psychol, McElwain Bldg, St Lucia, Qld, Australia.	davidbut@psy.uq.edu.au	Mattingley, Jason/J-1537-2014; Suddendorf, Thomas/A-1631-2017	Mattingley, Jason/0000-0003-0929-9216; Suddendorf, Thomas/0000-0003-3328-7442; Cunnington, Ross/0000-0002-7423-4809; Butler, David/0000-0002-7450-2121				American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; Apps MAJ, 2012, NEUROIMAGE, V63, P1720, DOI 10.1016/j.neuroimage.2012.08.053; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; Brady N, 2004, NEUROPSYCHOLOGIA, V42, P1156, DOI 10.1016/j.neuropsychologia.2004.02.007; Breen N, 2001, NEUROCASE, V7, P239, DOI 10.1093/neucas/7.3.239; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2007, SCHIZOPHR RES, V95, P186, DOI 10.1016/j.schres.2007.06.015; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; DALY M, 1982, ETHOL SOCIOBIOL, V3, P69, DOI 10.1016/0162-3095(82)90002-4; Darwin C., 1877, MIND, V2, P285, DOI [10.1093/mind/os-2.7.285, DOI 10.1093/MIND/OS-2.7.285]; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Debruille JB, 1998, NEUROREPORT, V9, P3349, DOI 10.1097/00001756-199810260-00002; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; DeBruine LM, 2004, EVOL HUM BEHAV, V25, P142, DOI 10.1016/j.evolhumbehav.2004.03.003; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; GALLUP GG, 1985, NEUROSCI BIOBEHAV R, V9, P631, DOI 10.1016/0149-7634(85)90010-7; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; GRANT J, 1828, EDINBURGH J SCI, V9, P1; Greenberg SN, 2009, J EXP PSYCHOL LEARN, V35, P499, DOI 10.1037/a0014640; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; Harrison V, 2009, PSYCHON B REV, V16, P264, DOI 10.3758/PBR.16.2.264; Hehman JA, 2005, SOC COGNITION, V23, P118, DOI 10.1521/soco.23.1.118.59197; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Hills PJ, 2011, Q J EXP PSYCHOL, V64, P17, DOI 10.1080/17470218.2010.537926; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Keenan J., 2004, FACE MIRROR WE KNOW; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Keenan JP, 2003, EUR J NEUROSCI, V18, P2391, DOI 10.1046/j.1460-9568.2003.02958.x; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Keenan JP, 2000, LATERALITY, V5, P259, DOI 10.1080/135765000406102; Keyes H, 2010, Q J EXP PSYCHOL, V63, P840, DOI 10.1080/17470211003611264; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Klein SB, 2010, ANN NY ACAD SCI, V1191, P1, DOI 10.1111/j.1749-6632.2010.05441.x; Ma YN, 2009, J EXP SOC PSYCHOL, V45, P1048, DOI 10.1016/j.jesp.2009.05.008; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Melinder A, 2010, DEVELOPMENTAL SCI, V13, P588, DOI 10.1111/j.1467-7687.2009.00910.x; MITA TH, 1977, J PERS SOC PSYCHOL, V35, P597, DOI 10.1037/0022-3514.35.8.597; Mitchell R, 1997, SELF PSYCHOL SELF RE, P39; Nielsen M, 2006, CHILD DEV, V77, P176, DOI 10.1111/j.1467-8624.2006.00863.x; Phillips M L, 1996, Cogn Neuropsychiatry, V1, P153, DOI 10.1080/135468096396613; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.2307/1131717; Preilowski B, 1977, Act Nerv Super (Praha), V19 Suppl 2, P343; PREYER W, 1889, MIND CHILD 2; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SPERRY RW, 1979, NEUROPSYCHOLOGIA, V17, P153, DOI 10.1016/0028-3932(79)90006-X; Suddendorf T, 1999, J EXP CHILD PSYCHOL, V72, P157, DOI 10.1006/jecp.1998.2485; Suddendorf T, 2001, PSYCHOL BULL, V127, P629, DOI 10.1037//0033-2909.127.5.629; Sugiura M, 2005, NEUROIMAGE, V24, P143, DOI 10.1016/j.neuroimage.2004.07.063; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Sui J, 2006, NEUROREPORT, V17, P423, DOI 10.1097/01.wnr.0000203357.65190.61; Sui J, 2009, SOC NEUROSCI, V4, P402, DOI 10.1080/17470910802674825; Susac A, 2009, HUM BRAIN MAPP, V30, P917, DOI 10.1002/hbm.20557; TANAKA J, 2001, J VISION, V1, P334; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Turk DJ, 2002, NAT NEUROSCI, V5, P841, DOI 10.1038/nn907; Uddin LQ, 2005, CONSCIOUS COGN, V14, P633, DOI 10.1016/j.concog.2005.01.008; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Villarejo A, 2011, NEUROCASE, V17, P276, DOI 10.1080/13554794.2010.498427; Wiese H, 2008, NEUROPSYCHOLOGIA, V46, P2973, DOI 10.1016/j.neuropsychologia.2008.06.007	76	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e72586	10.1371/journal.pone.0072586	http://dx.doi.org/10.1371/journal.pone.0072586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223BC	24069151	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300006
J	Charendoff, MN; Shah, HP; Briggs, JM				Charendoff, Marc N.; Shah, Halie P.; Briggs, James M.			New Insights into the Binding and Catalytic Mechanisms of Bacillus thuringiensis Lactonase: Insights into B-thuringiensis AiiA Mechanism	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MOLECULAR-DYNAMICS; QUORUM; PREDICTION; RATIONALIZATION; SIMULATIONS; HYDROLYSIS; DIFFUSION; VALUES; WATER	The lactonase enzyme (AiiA) produced by Bacillus thuringiensis serves to degrade autoinducer-1 (AI-1) signaling molecules in what is an evolved mechanism by which to compete with other bacteria. Bioassays have been previously performed to determine whether the AI-1 aliphatic tail lengths have any effect on AiiA's bioactivity, however, data to date are conflicting. Additionally, specific residue contributions to the catalytic activity of AiiA provide for some interesting questions. For example, it has been proposed that Y194 serves to provide an oxyanion hole to AI-1 which is curious given the fact the substrate spans two Zn(2+) ions. These ions might conceivably provide enough charge to promote both ligand stability and the carbonyl activation necessary to drive a nucleophilic attack. To investigate these questions, multiple molecular dynamics simulations were performed across a family of seven acylated homoserine lactones (AHL) along with their associated intermediate and product states. Distance analyses and interaction energy analyses were performed to investigate current bioassay data. Our simulations are consistent with experimental studies showing that AiiA degrades AHLs in a tail length independent manner. However, the presence of the tail is required for activity. Also, the putative oxyanion hole function of Y194 toward the substrate is not observed in any of the reactant or product state simulation trajectories, but does seem to show efficacy in stabilizing the intermediate state. Last, we argue through ionization state analyses, that the proton shuttling necessary for catalytic activity might be mediated by both water and substrate-based intra-molecular proton transfer. Based on this argument, an alternate catalytic mechanism is proposed.	[Charendoff, Marc N.; Shah, Halie P.; Briggs, James M.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Briggs, JM (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	jbriggs@uh.edu		Briggs, James/0000-0001-5863-8945	NASA [NNX08BA47A]; Texas Southern University	NASA(National Aeronautics & Space Administration (NASA)); Texas Southern University	Computing resources and support were made available from the University of Houston and the Texas Learning and Computation Center. This research is based upon work supported by NASA under award No. NNX08BA47A through subcontract from Texas Southern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; [Anonymous], 2006, SPART 06 MAC; [Anonymous], 2005, ENZYMES; Antosiewicz J, 1996, J COMPUT CHEM, V17, P1633, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1633::AID-JCC5>3.0.CO;2-M; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Aubert SD, 2004, BIOCHEMISTRY-US, V43, P5707, DOI 10.1021/bi0497805; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Breece RM, 2009, J AM CHEM SOC, V131, P11642, DOI 10.1021/ja902534b; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Dong YH, 2005, J MICROBIOL, V43, P101; FERGUSON DM, 1995, J COMPUT CHEM, V16, P501, DOI 10.1002/jcc.540160413; Frisch MJ, 2004, GAUSSIAN 03, V2004; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; HANSCH C, 1970, J PHARM SCI, V59, P731, DOI 10.1002/jps.2600590602; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Kaminskaia NV, 2000, INORG CHEM, V39, P3365, DOI 10.1021/ic000169d; Kim MH, 2005, P NATL ACAD SCI USA, V102, P17606, DOI 10.1073/pnas.0504996102; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liao RZ, 2009, INORG CHEM, V48, P1442, DOI 10.1021/ic801531n; Liu D, 2008, BIOCHEMISTRY-US, V47, P7706, DOI 10.1021/bi800368y; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Momb J, 2008, BIOCHEMISTRY-US, V47, P7715, DOI 10.1021/bi8003704; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 2001, PHYS CHEM A, V103, P3596; Skindersoe ME, 2008, ANTIMICROB AGENTS CH, V52, P3648, DOI 10.1128/AAC.01230-07; STARKEY R, 1986, J CHEM EDUC, V63, P473, DOI 10.1021/ed063p473; Szeto MWY, 2009, J MOL STRUC-THEOCHEM, V898, P106, DOI 10.1016/j.theochem.2008.06.033; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Willcox MDP, 2008, MICROBIOL-SGM, V154, P2184, DOI 10.1099/mic.0.2008/019281-0	42	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75395	10.1371/journal.pone.0075395	http://dx.doi.org/10.1371/journal.pone.0075395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058683	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900114
J	Guillory, AN; Yin, X; Wijaya, CS; Diaz, ACD; Rababa'h, A; Singh, S; Atrooz, F; Sadayappan, S; McConnell, BK				Guillory, Ashley N.; Yin, Xing; Wijaya, Cori S.; Diaz, Andrea C. Diaz; Rababa'h, Abeer; Singh, Sonal; Atrooz, Fatin; Sadayappan, Sakthivel; McConnell, Bradley K.			Enhanced Cardiac Function in Gravin Mutant Mice Involves Alterations in the beta-Adrenergic Receptor Signaling Cascade	PLOS ONE			English	Article							BINDING-PROTEIN-C; KINASE-ANCHORING PROTEINS; HEART-FAILURE; BETA(2)-ADRENERGIC RECEPTORS; VENTRICULAR MYOCYTES; SCAFFOLD PROTEIN; IN-VIVO; PHOSPHORYLATION; CONTRACTION; DESENSITIZATION	Gravin, an A-kinase anchoring protein, targets protein kinase A (PKA), protein kinase C (PKC), calcineurin and other signaling molecules to the beta2-adrenergic receptor (beta(2)-AR). Gravin mediates desensitization/resensitization of the receptor by facilitating its phosphorylation by PKA and PKC. The role of gravin in beta-AR mediated regulation of cardiac function is unclear. The purpose of this study was to determine the effect of acute beta-AR stimulation on cardiac contractility in mice lacking functional gravin. Using echocardiographic analysis, we observed that contractility parameters such as left ventricular fractional shortening and ejection fraction were increased in gravin mutant (gravin-t/t) animals lacking functional protein compared to wild-type (WT) animals both at baseline and following acute isoproterenol (ISO) administration. In isolated gravin-t/t cardiomyocytes, we observed increased cell shortening fraction and decreased intracellular Ca2+ in response to 1 mu mol/L ISO stimulation. These physiological responses occurred in the presence of decreased beta(2)-AR phosphorylation in gravin-t/t hearts, where PKA-dependent beta(2)-AR phosphorylation has been shown to lead to receptor desensitization. cAMP production, PKA activity and phosphorylation of phospholamban and troponin I was comparable in WT and gravin-t/t hearts both with and without ISO stimulation. However, cardiac myosin binding protein C (cMyBPC) phosphorylation site at position 273 was significantly increased in gravin-t/t versus WT hearts, in the absence of ISO. Additionally, the cardioprotective heat shock protein 20 (Hsp20) was significantly more phosphorylated in gravin-t/t versus WT hearts, in response to ISO. Our results suggest that disruption of gravin's scaffold mediated signaling is able to increase baseline cardiac function as well as to augment contractility in response to acute beta-AR stimulation by decreasing beta(2)-AR phosphorylation and thus attenuating receptor desensitization and perhaps by altering PKA localization to increase the phosphorylation of cMyBPC and the nonclassical PKA substrate Hsp20.	[Guillory, Ashley N.; Yin, Xing; Wijaya, Cori S.; Diaz, Andrea C. Diaz; Rababa'h, Abeer; Singh, Sonal; Atrooz, Fatin; McConnell, Bradley K.] Univ Houston, Texas Med Ctr, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; [Sadayappan, Sakthivel] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; Loyola University Chicago	McConnell, BK (corresponding author), Univ Houston, Texas Med Ctr, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA.	bkmcconn@central.uh.edu	Singh, Sonal/A-4614-2008; singh, sonal/S-5997-2019; Rababah, Abeer/AAH-6902-2019	Singh, Sonal/0000-0003-0912-941X; Rababah, Abeer/0000-0003-4619-2012; Atrooz, Fatin/0000-0002-1358-7926; Diaz Diaz, Andrea Carolina/0000-0002-9619-9143; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health (NIH) [HL085487]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085487] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health (NIH) grant HL085487 (B. K. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Beca S, 2011, CURR OPIN PHARMACOL, V11, P714, DOI 10.1016/j.coph.2011.10.017; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Edwards HV, 2012, BIOCHEM SOC T, V40, P210, DOI 10.1042/BST20110673; Fan GF, 2001, J BIOL CHEM, V276, P24005, DOI 10.1074/jbc.M011199200; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Guggilam A, 2013, J MOL CELL CARDIOL, V57, P47, DOI 10.1016/j.yjmcc.2012.11.013; Guo LW, 2011, J BIOL CHEM, V286, P38356, DOI 10.1074/jbc.M111.258830; Havekes R, 2012, J NEUROSCI, V32, P18137, DOI 10.1523/JNEUROSCI.3612-12.2012; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Jin CZ, 2013, J MOL CELL CARDIOL, V60, P107, DOI 10.1016/j.yjmcc.2013.04.017; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Katz AM, 2000, CIRCULATION, V102, P69; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Knollmann BC, 2008, NATURE, V451, P929, DOI 10.1038/nature06799; Kooij V, 2013, J MOL CELL CARDIOL, V60, P116, DOI 10.1016/j.yjmcc.2013.04.012; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Liao Ronglih, 2007, V139, P251; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pipkin W, 2003, CIRCULATION, V107, P469, DOI 10.1161/01.CIR.0000044386.27444.5A; Pleger ST, 2007, J CARD FAIL, V13, P401, DOI 10.1016/j.cardfail.2007.01.003; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Sin YY, 2011, J MOL CELL CARDIOL, V50, P872, DOI 10.1016/j.yjmcc.2011.02.006; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Tao Jiangchuan, 2008, J Mol Signal, V3, P19, DOI 10.1186/1750-2187-3-19; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; YOSHIDA A, 1992, J BIOCHEM-TOKYO, V111, P186, DOI 10.1093/oxfordjournals.jbchem.a123735	46	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74784	10.1371/journal.pone.0074784	http://dx.doi.org/10.1371/journal.pone.0074784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058627	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900080
J	Angione, SL; Inde, Z; Beck, CM; Artenstein, AW; Opal, SM; Tripathi, A				Angione, Stephanie L.; Inde, Zintis; Beck, Christina M.; Artenstein, Andrew W.; Opal, Steven M.; Tripathi, Anubhav			Microdroplet Sandwich Real-Time RT-PCR for Detection of Pandemic and Seasonal Influenza Subtypes	PLOS ONE			English	Article							A H1N1 VIRUS; INFECTIOUS-DISEASES; GLOBAL MORTALITY; IDENTIFICATION; EMERGENCE; DIAGNOSIS	As demonstrated by the recent 2012/2013 flu epidemic, the continual emergence of new viral strains highlights the need for accurate medical diagnostics in multiple community settings. If rapid, robust, and sensitive diagnostics for influenza subtyping were available, it would help identify epidemics, facilitate appropriate antiviral usage, decrease inappropriate antibiotic usage, and eliminate the extra cost of unnecessary laboratory testing and treatment. Here, we describe a droplet sandwich platform that can detect influenza subtypes using real-time reverse-transcription polymerase chain reaction (rtRT-PCR). Using clinical samples collected during the 2010/11 season, we effectively differentiate between H1N1p (swine pandemic), H1N1s (seasonal), and H3N2 with an overall assay sensitivity was 96%, with 100% specificity for each subtype. Additionally, we demonstrate the ability to detect viral loads as low as 10(4) copies/mL, which is two orders of magnitude lower than viral loads in typical infected patients. This platform performs diagnostics in a miniaturized format without sacrificing any sensitivity, and can thus be easily developed into devices which are ideal for small clinics and pharmacies.	[Angione, Stephanie L.; Beck, Christina M.; Tripathi, Anubhav] Brown Univ, Ctr Biomed Engn, Sch Engn, Providence, RI 02912 USA; [Inde, Zintis] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Artenstein, Andrew W.] Baystate Hlth, Dept Med, Springfield, MA USA; [Artenstein, Andrew W.] Baystate Hlth, Ctr Biodef & Emerging Pathogens, Springfield, MA USA; [Opal, Steven M.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Opal, Steven M.] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA	Brown University; Brown University; Brown University; Brown University	Tripathi, A (corresponding author), Brown Univ, Ctr Biomed Engn, Sch Engn, Providence, RI 02912 USA.	anubhav_tripathi@brown.edu		Inde, Zintis/0000-0001-5564-1698	National Institutes of Health [1R21 A1073808-01 A1]; RISG NASA Graduate Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RISG NASA Graduate Fellowship	The study was partially funded by National Institutes of Health grant 1R21 A1073808-01 A1. SLA acknowledges the support of the RISG NASA Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angione SL, 2012, ANAL CHEM, V84, P2654, DOI 10.1021/ac202532a; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Fang XE, 2011, ANAL CHEM, V83, P690, DOI 10.1021/ac102858j; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Holmes EC, 2005, SCIENCE, V309, P989, DOI 10.1126/science.1117128; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Roa PL, 2011, DIAGN MICR INFEC DIS, V69, P428, DOI 10.1016/j.diagmicrobio.2010.11.007; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ngaosuwankul N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-75; Pabbaraju K, 2009, J CLIN MICROBIOL, V47, P3454, DOI 10.1128/JCM.01103-09; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Pipper J, 2007, NAT MED, V13, P1259, DOI 10.1038/nm1634; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Sun Y, 2011, LAB CHIP, V11, P1457, DOI 10.1039/c0lc00528b; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Viboud C, 2012, LANCET INFECT DIS, V12, P651, DOI 10.1016/S1473-3099(12)70152-4; Wang CH, 2012, MICROFLUID NANOFLUID, V13, P113, DOI 10.1007/s10404-012-0947-1; WHO, 2011, VIR IS CELL CULT MAN, P28; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	32	5	5	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73497	10.1371/journal.pone.0073497	http://dx.doi.org/10.1371/journal.pone.0073497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066051	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000032
J	Dokter, AM; Baptist, MJ; Ens, BJ; Krijgsveld, KL; van Loon, EE				Dokter, Adriaan M.; Baptist, Martin J.; Ens, Bruno J.; Krijgsveld, Karen L.; van Loon, E. Emiel			Bird Radar Validation in the Field by Time-Referencing Line-Transect Surveys	PLOS ONE			English	Article							COLLISION RISK; WIND; MIGRATION; TARGETS; SYSTEM	Track-while-scan bird radars are widely used in ornithological studies, but often the precise detection capabilities of these systems are unknown. Quantification of radar performance is essential to avoid observational biases, which requires practical methods for validating a radar's detection capability in specific field settings. In this study a method to quantify the detection capability of a bird radar is presented, as well a demonstration of this method in a case study. By time-referencing line-transect surveys, visually identified birds were automatically linked to individual tracks using their transect crossing time. Detection probabilities were determined as the fraction of the total set of visual observations that could be linked to radar tracks. To avoid ambiguities in assigning radar tracks to visual observations, the observer's accuracy in determining a bird's transect crossing time was taken into account. The accuracy was determined by examining the effect of a time lag applied to the visual observations on the number of matches found with radar tracks. Effects of flight altitude, distance, surface substrate and species size on the detection probability by the radar were quantified in a marine intertidal study area. Detection probability varied strongly with all these factors, as well as species-specific flight behaviour. The effective detection range for single birds flying at low altitude for an X-band marine radar based system was estimated at similar to 1.5 km. Within this range the fraction of individual flying birds that were detected by the radar was 0.50 +/- 0.06 with a detection bias towards higher flight altitudes, larger birds and high tide situations. Besides radar validation, which we consider essential when quantification of bird numbers is important, our method of linking radar tracks to ground-truthed field observations can facilitate species-specific studies using surveillance radars. The methodology may prove equally useful for optimising tracking algorithms.	[Dokter, Adriaan M.; van Loon, E. Emiel] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Baptist, Martin J.] IMARES Wageningen UR, Den Hoorn, Texel, Netherlands; [Ens, Bruno J.] SOVON Dutch Ctr Field Ornithol, Coastal Ecol Team, Den Burg, Texel, Netherlands; [Krijgsveld, Karen L.] Bur Waardenburg, Culemborg, Netherlands	University of Amsterdam; Wageningen University & Research	Dokter, AM (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	a.m.dokter@uva.nl	van Loon, Emiel/T-3858-2019; Dokter, Adriaan/AAA-9244-2021; Baptist, Martin/O-9479-2019	van Loon, Emiel/0000-0002-8895-0427; Baptist, Martin/0000-0002-3735-676X; Krijgsveld, Karen/0000-0003-0230-0368	Netherlands Organization for Scientific Research (NWO), national programme for sea and coastal research (ZKO)	Netherlands Organization for Scientific Research (NWO), national programme for sea and coastal research (ZKO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Netherlands Organization for Scientific Research (NWO), as part of the national programme for sea and coastal research (ZKO). Bureau Waardenburg received funding from We@Sea/Bsik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Allan JR, 2002, P NAT WILDL RES CTR, P147; Bertram DF, 1999, J FIELD ORNITHOL, V70, P145; Brand M, 2011, INTEGRATION VALIDATI; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P45, DOI 10.1007/s001140050348; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Bunch W, 2010, P 2010 FAA WORLDW AI; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; COOPER BA, 1991, J FIELD ORNITHOL, V62, P367; Cooper BA, 2001, CONDOR, V103, P219, DOI 10.1650/0010-5422(2001)103[0219:RBMOMM]2.0.CO;2; Desholm M, 2006, IBIS, V148, P76, DOI 10.1111/j.1474-919X.2006.00509.x; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Dokter AM, 2011, J R SOC INTERFACE, V8, P30, DOI 10.1098/rsif.2010.0116; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Erni B, 2002, ARDEA, V90, P155; Harmata AR, 1999, WILDLIFE SOC B, V27, P44; KERLINGER P, 1985, AUK, V102, P735; Krijgsveld K, 2011, TECHNICAL REPORT; Krijgsveld KL, 2009, ARDEA, V97, P357, DOI 10.5253/078.097.0311; LACK D, 1945, NATURE, V156, P446, DOI 10.1038/156446a0; Long M.W., 1983, RADAR REFLECTIVITY L, P385; Mateos M, 2010, J FIELD ORNITHOL, V81, P302, DOI 10.1111/j.1557-9263.2010.00286.x; Petersen I, 2006, TECHNICAL REPORT; Plonczkier P, 2012, J APPL ECOL, V49, P1187, DOI 10.1111/j.1365-2664.2012.02181.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronconi RA, 2006, J APPL ECOL, V43, P111, DOI 10.1111/j.1365-2664.2005.01121.x; Schmaljohann H, 2008, IBIS, V150, P342, DOI 10.1111/j.1474-919X.2007.00797.x; Shamoun-Baranes J, 2011, BEHAV ECOL, V22, P1173, DOI 10.1093/beheco/arr102; Shamoun-Baranes J, 2008, ECOL SOC, V13; Taylor Philip D., 2010, BMC Ecology, V10, P22, DOI 10.1186/1472-6785-10-22; Van Belle J, 2007, J APPL ECOL, V44, P864, DOI 10.1111/j.1365-2664.2007.01322.x; Williams R, 2007, J MAR BIOL ASSOC UK, V87, P313, DOI 10.1017/S0025315407055154; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Zakrajsek EJ, 2001, 2001 BIRD STRIK COMM; Zaugg S, 2008, J R SOC INTERFACE, V5, P1041, DOI 10.1098/rsif.2007.1349; Zuur AF, 2007, STAT BIOL HEALTH, P435	38	20	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74129	10.1371/journal.pone.0074129	http://dx.doi.org/10.1371/journal.pone.0074129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066103	gold, Green Published			2022-12-27	WOS:000324494000085
J	Horstmann, A; Kovacs, P; Kabisch, S; Boettcher, Y; Schloegl, H; Tonjes, A; Stumvoll, M; Pleger, B; Villringer, A				Horstmann, Annette; Kovacs, Peter; Kabisch, Stefan; Boettcher, Yvonne; Schloegl, Haiko; Toenjes, Anke; Stumvoll, Michael; Pleger, Burkhard; Villringer, Arno			Common Genetic Variation near MC4R Has a Sex-Specific Impact on Human Brain Structure and Eating Behavior	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBESITY; VARIANTS; HYPOTHALAMUS; AMYGDALAR; NUCLEUS; WEIGHT; RISK; FAT	Obesity is associated with genetic and environmental factors but the underlying mechanisms remain poorly understood. Recent genome-wide association studies (GWAS) identified obesity- and type 2 diabetes-associated genetic variants located within or near genes that modulate brain activity and development. Among the top hits is rs17782313 near MC4R, encoding for the melanocortin-4-receptor, which is expressed in brain regions that regulate eating. Here, we hypothesized rs17782313-associated changes in human brain regions that regulate eating behavior. Therefore, we examined effects of common variants at rs17782313 near MC4R on brain structure and eating behavior. Only in female homozygous carriers of the risk allele we found significant increases of gray matter volume (GMV) in the right amygdala, a region known to influence eating behavior, and the right hippocampus, a structure crucial for memory formation and learning. Further, we found bilateral increases in medial orbitofrontal cortex, a multimodal brain structure encoding the subjective value of reinforcers, and bilateral prefrontal cortex, a higher order regulation area. There was no association between rs17782313 and brain structure in men. Moreover, among female subjects only, we observed a significant increase of 'disinhibition', and, more specifically, on 'emotional eating' scores of the Three Factor Eating Questionnaire in carriers of the variant rs17782313's risk allele. These findings suggest that rs17782313's effect on eating behavior is mediated by central mechanisms and that these effects are sex-specific.	[Horstmann, Annette; Pleger, Burkhard; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Horstmann, Annette; Kovacs, Peter; Boettcher, Yvonne; Stumvoll, Michael; Pleger, Burkhard; Villringer, Arno] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04109 Leipzig, Germany; [Kabisch, Stefan; Schloegl, Haiko; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Pleger, Burkhard; Villringer, Arno] Univ Leipzig, Day Clin Cognit Neurol, D-04109 Leipzig, Germany; [Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, Mind & Brain Inst, D-10099 Berlin, Germany	Max Planck Society; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Humboldt University of Berlin	Horstmann, A (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	horstmann@cbs.mpg.de	Kabisch, Stefan/C-5106-2013; Stumvoll, Michael/ABE-1121-2021; Horstmann, Annette/C-9083-2011	Kabisch, Stefan/0000-0003-1792-1757; Stumvoll, Michael/0000-0001-6225-8240; Horstmann, Annette/0000-0001-6184-8484; Villringer, Arno/0000-0003-2604-2404; Kovacs, Peter/0000-0002-0290-5423	IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01001]; German Research Foundation (DFG) within the framework of the CRC 1052 'Obesity Mechanisms'; Boehringer Ingelheim Foundation	IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) within the framework of the CRC 1052 'Obesity Mechanisms'(German Research Foundation (DFG)); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	The work of AH, BP, MS, AV and YB is supported by the IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01E01001 (http://www.bmbf.de). The work of AH, BP, MS and AV is funded by the German Research Foundation (DFG) (http://www.dfg.de), within the framework of the CRC 1052 'Obesity Mechanisms'. PK is funded by a research grant from the Boehringer Ingelheim Foundation (http://www.bifonds.de/homepage.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman TR, 2009, PHYSIOL BEHAV, V96, P568, DOI 10.1016/j.physbeh.2008.12.007; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Gelez H, 2010, J CHEM NEUROANAT, V40, P310, DOI 10.1016/j.jchemneu.2010.09.002; Grimm O, 2012, APPETITE, V58, P1023, DOI 10.1016/j.appet.2012.02.007; Hasselbalch AL, 2010, J NUTR, V140, P831, DOI 10.3945/jn.109.114439; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Kask A, 2000, BRAIN RES, V887, P460, DOI 10.1016/S0006-8993(00)03034-1; Kvaloy K, 2013, INT J OBESITY, V37, P1221, DOI 10.1038/ijo.2012.220; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Liu GF, 2010, J PEDIATR-US, V156, P598, DOI 10.1016/j.jpeds.2009.10.037; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Petrovich GD, 2005, J NEUROSCI, V25, P8295, DOI 10.1523/JNEUROSCI.2480-05.2005; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rudenga KJ, 2013, INT J OBESITY, V37, P309, DOI 10.1038/ijo.2012.39; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Stutzmann F, 2009, INT J OBESITY, V33, P373, DOI 10.1038/ijo.2008.279; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Xi B, 2012, DIABETOLOGIA, V55, P2660, DOI 10.1007/s00125-012-2655-5; Xi Bo, 2012, PLoS One, V7, pe45731, DOI 10.1371/journal.pone.0045731	29	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74362	10.1371/journal.pone.0074362	http://dx.doi.org/10.1371/journal.pone.0074362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066140	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000122
J	Lamas, V; Alvarado, JC; Carro, J; Merchan, MA				Lamas, Veronica; Alvarado, Juan C.; Carro, Juan; Merchan, Miguel A.			Long-Term Evolution of Brainstem Electrical Evoked Responses to Sound after Restricted Ablation of the Auditory Cortex	PLOS ONE			English	Article							CORTICOFUGAL MODULATION; HOMEOSTATIC PLASTICITY; OLIVOCOCHLEAR NEURONS; CONTRALATERAL SOUND; INFERIOR COLLICULUS; NERVE RESPONSES; HAIR-CELLS; CAT; STIMULATION; INNERVATION	Introduction: This study aimed to assess the top-down control of sound processing in the auditory brainstem of rats. Short latency evoked responses were analyzed after unilateral or bilateral ablation of auditory cortex. This experimental paradigm was also used towards analyzing the long-term evolution of post-lesion plasticity in the auditory system and its ability to self-repair. Method: Auditory cortex lesions were performed in rats by stereotactically guided fine-needle aspiration of the cerebrocortical surface. Auditory Brainstem Responses (ABR) were recorded at post-surgery day (PSD) 1, 7, 15 and 30. Recordings were performed under closed-field conditions, using click trains at different sound intensity levels, followed by statistical analysis of threshold values and ABR amplitude and latency variables. Subsequently, brains were sectioned and immunostained for GAD and parvalbumin to assess the location and extent of lesions accurately. Results: Alterations in ABR variables depended on the type of lesion and post-surgery time of ABR recordings. Accordingly, bilateral ablations caused a statistically significant increase in thresholds at PSD1 and 7 and a decrease in waves amplitudes at PSD1 that recover at PSD7. No effects on latency were noted at PSD1 and 7, whilst recordings at PSD15 and 30 showed statistically significant decreases in latency. Conversely, unilateral ablations had no effect on auditory thresholds or latencies, while wave amplitudes only decreased at PSD1 strictly in the ipsilateral ear. Conclusion: Post-lesion plasticity in the auditory system acts in two time periods: short-term period of decreased sound sensitivity (until PSD7), most likely resulting from axonal degeneration; and a long-term period (up to PSD7), with changes in latency responses and recovery of thresholds and amplitudes values. The cerebral cortex may have a net positive gain on the auditory pathway response to sound.	[Lamas, Veronica] Univ Salamanca, Inst Neurociencias Castilla & Leon, E-37008 Salamanca, Spain; [Alvarado, Juan C.; Carro, Juan; Merchan, Miguel A.] Univ Castilla La Mancha, Fac Med Albacete, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain	University of Salamanca; Universidad de Castilla-La Mancha	Merchan, MA (corresponding author), Univ Castilla La Mancha, Fac Med Albacete, Inst Invest Discapacidades Neurol IDINE, Campus Albacete, Albacete, Spain.	merchan@usal.es	Alvarado, Juan C./G-3379-2015; Merchan, Miguel A/G-3087-2015; Carro, Juan/A-9538-2016	Alvarado, Juan C./0000-0002-3623-4090; Merchan, Miguel A/0000-0002-1334-2822; Carro, Juan/0000-0002-7556-9782	Ministry of Economy and Competitiveness of the Government of Spain [BFU2012-39982-C02]	Ministry of Economy and Competitiveness of the Government of Spain(Spanish Government)	This research was supported by a grant from the Ministry of Economy and Competitiveness of the Government of Spain, BFU2012-39982-C02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; Alvarado JC, 2012, NEUROSCI RES, V73, P302, DOI 10.1016/j.neures.2012.05.001; CHEN TJ, 1991, EXP BRAIN RES, V85, P537; CHURCH MW, 1987, ELECTROEN CLIN NEURO, V67, P570, DOI 10.1016/0013-4694(87)90060-5; Clarkson C, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00086; Clarkson C, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00141; Clarkson C, 2010, J COMP NEUROL, V518, P4261, DOI 10.1002/cne.22453; Clarkson C, 2010, ACTA OTO-LARYNGOL, V130, P326, DOI [10.3109/00016480903150536, 10.1080/00016480903150536]; Coomes DL, 2004, EUR J NEUROSCI, V19, P2188, DOI 10.1111/j.0953-816X.2004.03317.x; CUMMING JF, 1976, ANESTH ANALG, V55, P788; Dallos P, 1997, J NEUROSCI, V17, P2212; Don M, 1998, J ACOUST SOC AM, V104, P2280, DOI 10.1121/1.423741; Evans MG, 2000, CELL CALCIUM, V28, P195, DOI 10.1054/ceca.2000.0145; FELICIANO M, 1995, J NEUROCHEM, V65, P1348; Feliciano M., 1995, AUDIT NEUROSCI, V1, P287; Francis NA, 2010, HEARING RES, V267, P36, DOI 10.1016/j.heares.2010.04.009; GALAMBOS R, 1956, J NEUROPHYSIOL, V19, P424, DOI 10.1152/jn.1956.19.5.424; Groff JA, 2003, J NEUROPHYSIOL, V90, P3178, DOI 10.1152/jn.00537.2003; GUINAN JJ, 1988, HEARING RES, V37, P29, DOI 10.1016/0378-5955(88)90075-5; Guinan JJ, 1996, J ACOUST SOC AM, V100, P1680, DOI 10.1121/1.416066; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Hayton SM, 1999, LAB ANIM-UK, V33, P243, DOI 10.1258/002367799780578219; HUNTER KP, 1993, PHYSIOL BEHAV, V54, P1133, DOI 10.1016/0031-9384(93)90337-F; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; KLINKE R, 1986, HEARING RES, V22, P235, DOI 10.1016/0378-5955(86)90100-0; Leon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036203; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; LIVINGSTON A, 1978, BRIT J PHARMACOL, V64, P63, DOI 10.1111/j.1476-5381.1978.tb08641.x; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Melcher JR, 1996, HEARING RES, V93, P28, DOI 10.1016/0378-5955(95)00179-4; Melcher JR, 1996, HEARING RES, V93, P1, DOI 10.1016/0378-5955(95)00178-6; Mulders WHAM, 2000, HEARING RES, V144, P65, DOI 10.1016/S0378-5955(00)00046-0; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; RASMUSSEN GL, 1953, J COMP NEUROL, V99, P61, DOI 10.1002/cne.900990105; Rosahl SK, 2000, ACTA NEUROCHIR, V142, P1037, DOI 10.1007/s007010070060; Schofield BR, 2005, HEARING RES, V199, P89, DOI 10.1016/j.heares.2004.08.003; Sziklai I, 2001, ACTA OTO-LARYNGOL, V121, P153; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; WARREN EH, 1989, HEARING RES, V37, P89, DOI 10.1016/0378-5955(89)90032-4; WARREN EH, 1989, HEARING RES, V37, P105, DOI 10.1016/0378-5955(89)90033-6; Whiting B, 2009, NEUROSCIENCE, V163, P1264, DOI 10.1016/j.neuroscience.2009.07.049; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786	46	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73585	10.1371/journal.pone.0073585	http://dx.doi.org/10.1371/journal.pone.0073585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066057	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000038
J	Marshall, TC; Bejanyan, K; Ferenczi, N				Marshall, Tara C.; Bejanyan, Kathrine; Ferenczi, Nelli			Attachment Styles and Personal Growth following Romantic Breakups: The Mediating Roles of Distress, Rumination, and Tendency to Rebound	PLOS ONE			English	Article							NONMARITAL RELATIONSHIP DISSOLUTION; POSTTRAUMATIC GROWTH; ADULT ATTACHMENT; LIFE; HEALTH; DEPRESSION; RECOVERY; RELIGION; GENDER; AGENDA	The purpose of this research was to examine the associations of attachment anxiety and avoidance with personal growth following relationship dissolution, and to test breakup distress, rumination, and tendency to rebound with new partners as mediators of these associations. Study 1 (N = 411) and Study 2 (N = 465) measured attachment style, breakup distress, and personal growth; Study 2 additionally measured ruminative reflection, brooding, and proclivity to rebound with new partners. Structural equation modelling revealed in both studies that anxiety was indirectly associated with greater personal growth through heightened breakup distress, whereas avoidance was indirectly associated with lower personal growth through inhibited breakup distress. Study 2 further showed that the positive association of breakup distress with personal growth was accounted for by enhanced reflection and brooding, and that anxious individuals' greater personal growth was also explained by their proclivity to rebound. These findings suggest that anxious individuals' hyperactivated breakup distress may act as a catalyst for personal growth by promoting the cognitive processing of breakup-related thoughts and emotions, whereas avoidant individuals' deactivated distress may inhibit personal growth by suppressing this cognitive work.	[Marshall, Tara C.; Bejanyan, Kathrine; Ferenczi, Nelli] Brunel Univ, Dept Psychol, London, England	Brunel University	Marshall, TC (corresponding author), Brunel Univ, Dept Psychol, London, England.	tara.marshall@brunel.ac.uk		Ferenczi, Nelli/0000-0002-3757-6244; Marshall, Tara/0000-0002-1379-5290				ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Birnbaum GE, 1997, J SOC PERS RELAT, V14, P643, DOI 10.1177/0265407597145004; Boelen PA, 2009, STRESS HEALTH, V25, P11, DOI 10.1002/smi.1219; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bowlby J., 1980, LOSS SADNESS DEPRESS, V3; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Burnette JL, 2009, PERS INDIV DIFFER, V46, P276, DOI 10.1016/j.paid.2008.10.016; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Chan MWC, 2011, PSYCHO-ONCOLOGY, V20, P544, DOI 10.1002/pon.1761; Coan JA, 2010, J SOC PERS RELAT, V27, P210, DOI 10.1177/0265407509360900; Collins NL, 1996, J PERS SOC PSYCHOL, V71, P810, DOI 10.1037/0022-3514.71.4.810; Davis D, 2003, PERS SOC PSYCHOL B, V29, P871, DOI 10.1177/0146167203029007006; Fagundes CP, 2012, PERS RELATIONSHIP, V19, P37, DOI 10.1111/j.1475-6811.2010.01336.x; Field T, 2009, ADOLESCENCE, V44, P705; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Griffin DW, 1994, ATTACHMENT PROCESSES, P17, DOI DOI 10.1037//0022-3514.67.3.430; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Jilek, 2012, INDIVIDUAL DIFFERENC, V10, P202; Kleim B, 2009, J TRAUMA STRESS, V22, P45, DOI 10.1002/jts.20378; Kunst MJJ, 2010, J TRAUMA STRESS, V23, P514, DOI 10.1002/jts.20556; Lepore SJ, 2002, PSYCHOL HEALTH, V17, P547, DOI 10.1080/08870440290025768; Lucas RE, 2005, PSYCHOL SCI, V16, P945, DOI 10.1111/j.1467-9280.2005.01642.x; Marks NF, 1996, J MARRIAGE FAM, V58, P917, DOI 10.2307/353980; Marshall TC, 2013, PERS RELATIONSHIP, V20, P1, DOI 10.1111/j.1475-6811.2011.01393.x; Marshall TC, 2012, CYBERPSYCH BEH SOC N, V15, P521, DOI 10.1089/cyber.2012.0125; MIKULINCER M, 1995, PERS SOC PSYCHOL B, V21, P406, DOI 10.1177/0146167295214011; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Monroe SM, 1999, J ABNORM PSYCHOL, V108, P606, DOI 10.1037/0021-843X.108.4.606; Neimeyer RA, 2000, DEATH STUD, V24, P541, DOI 10.1080/07481180050121480; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nolen-Hoeksema S, 1998, PSYCHOL INQ, V9, P216, DOI 10.1207/s15327965pli0903_5; Proffitt D, 2007, J RELIG HEALTH, V46, P219, DOI 10.1007/s10943-006-9074-1; Rhoades GK, 2011, J FAM PSYCHOL, V25, P366, DOI 10.1037/a0023627; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Russell DW, 1998, J COUNS PSYCHOL, V45, P18, DOI 10.1037/0022-0167.45.1.18; Saffrey C, 2007, PERS RELATIONSHIP, V14, P351, DOI 10.1111/j.1475-6811.2007.00160.x; Salo JA, 2005, ANXIETY STRESS COPIN, V18, P361, DOI 10.1080/10615800500289524; Sbarra DA, 2006, PERS SOC PSYCHOL B, V32, P298, DOI 10.1177/0146167205280913; Sbarra DA, 2005, PERS RELATIONSHIP, V12, P213, DOI 10.1111/j.1350-4126.2005.00112.x; Sbarra DA, 2008, PERS SOC PSYCHOL REV, V12, P141, DOI 10.1177/1088868308315702; Sbarra DA, 2011, PERSPECT PSYCHOL SCI, V6, P454, DOI 10.1177/1745691611414724; Schneller D., 2004, J DIVORCE REMARRIAGE, V42, P1, DOI [10.1300/j087v42n0101, DOI 10.1300/J087V42N01_01]; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SIMPSON JA, 1990, J PERS SOC PSYCHOL, V59, P971, DOI 10.1037/0022-3514.59.5.971; Spielmann SS, 2009, PERS SOC PSYCHOL B, V35, P1382, DOI 10.1177/0146167209341580; Sprecher S, 1998, J SOC PERS RELAT, V15, P791, DOI 10.1177/0265407598156005; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Tashiro TY, 2003, PERS RELATIONSHIP, V10, P113, DOI 10.1111/1475-6811.00039; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Triplett KN, 2012, PSYCHOL TRAUMA-US, V4, P400, DOI 10.1037/a0024204; Wilson T. D., 2003, PSYCHOL EC DECISIONS, VI, P209, DOI DOI 10.1016/j.socec.2003.10.007	53	19	19	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75161	10.1371/journal.pone.0075161	http://dx.doi.org/10.1371/journal.pone.0075161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066169	Green Published, Green Accepted, gold			2022-12-27	WOS:000324494000151
J	Pantzartzi, CN; Drosopoulou, E; Scouras, ZG				Pantzartzi, Chrysoula N.; Drosopoulou, Elena; Scouras, Zacharias G.			Assessment and Reconstruction of Novel HSP90 Genes: Duplications, Gains and Losses in Fungal and Animal Lineages	PLOS ONE			English	Article							HEAT-SHOCK GENE; GENOME DUPLICATION; TRANSPOSABLE ELEMENTS; HEAT-SHOCK-PROTEIN-90 GENE; PHYLOGENETIC ANALYSIS; MOLECULAR CHAPERONE; MAXIMUM-LIKELIHOOD; AMPHIOXUS GENOME; EXPRESSION; YEAST	Hsp90s, members of the Heat Shock Protein class, protect the structure and function of proteins and play a significant task in cellular homeostasis and signal transduction. In order to determine the number of hsp90 gene copies and encoded proteins in fungal and animal lineages and through that key duplication events that this family has undergone, we collected and evaluated Hsp90 protein sequences and corresponding Expressed Sequence Tags and analyzed available genomes from various taxa. We provide evidence for duplication events affecting either single species or wider taxonomic groups. With regard to Fungi, duplicated genes have been detected in several lineages. In invertebrates, we demonstrate key duplication events in certain clades of Arthropoda and Mollusca, and a possible gene loss event in a hymenopteran family. Finally, we infer that the duplication event responsible for the two (a and b) isoforms in vertebrates occurred probably shortly after the split of Hyperoartia and Gnathostomata.	[Pantzartzi, Chrysoula N.; Drosopoulou, Elena; Scouras, Zacharias G.] Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Pantzartzi, Chrysoula N.] Acad Sci Czech Republ, Inst Mol Genet, Dept Transcript Regulat, Prague, Czech Republic	Aristotle University of Thessaloniki; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Pantzartzi, CN (corresponding author), Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece.	chrysap@img.cas.cz	DROSOPOULOU, ELENA/N-2176-2015; Drosopoulou, Elena/AAX-6493-2020	Drosopoulou, Elena/0000-0001-9805-0572	intramural funds of the Aristotle University of Thessaloniki (Greece); Academy of Sciences of the Czech Republic [RVO 68378050]; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University'', from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]	intramural funds of the Aristotle University of Thessaloniki (Greece); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University'', from the European Regional Development Fund	This publication was supported by intramural funds of the Aristotle University of Thessaloniki (Greece) to ZGS and ED and by the Academy of Sciences of the Czech Republic (RVO 68378050) and the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University'' (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund to CNP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aamodt RM, 2008, MECH AGEING DEV, V129, P632, DOI 10.1016/j.mad.2008.07.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Benedict MQ, 1996, INSECT MOL BIOL, V5, P73, DOI 10.1111/j.1365-2583.1996.tb00042.x; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Birnby DA, 2000, GENETICS, V155, P85; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Echeverria PC, 2005, J MOL BIOL, V350, P723, DOI 10.1016/j.jmb.2005.05.031; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Emelyanov VV, 2002, GENE, V299, P125, DOI 10.1016/S0378-1119(02)01021-1; ERKINE AM, 1995, NUCLEIC ACIDS RES, V23, P1822, DOI 10.1093/nar/23.10.1822; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; FARRELLY FW, 1984, J BIOL CHEM, V259, P5745; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galperin MY, 2012, NUCLEIC ACIDS RES, V40, pD1, DOI 10.1093/nar/gkr1196; Gao Q, 2008, FISH SHELLFISH IMMUN, V24, P379, DOI 10.1016/j.fsi.2007.08.008; Gao Q, 2007, COMP BIOCHEM PHYS B, V147, P704, DOI 10.1016/j.cbpb.2007.04.010; Gauthier JP, 2007, BIOINFORMATICS, V23, P783, DOI 10.1093/bioinformatics/btl682; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013; Hofmann GE, 2005, INTEGR COMP BIOL, V45, P247, DOI 10.1093/icb/45.2.247; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Inoue T, 2003, DEV GROWTH DIFFER, V45, P369, DOI 10.1046/j.1440-169X.2003.00706.x; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Konstantopoulou I, 1998, J MOL EVOL, V46, P334, DOI 10.1007/PL00006310; KRONE PH, 1994, BIOCHEM BIOPH RES CO, V204, P746, DOI 10.1006/bbrc.1994.2522; Laksanalamai P, 2004, NAT REV MICROBIOL, V2, P315, DOI 10.1038/nrmicro866; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maere S, 2010, EVOLUTION AFTER GENE DUPLICATION, P31; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Miller M.A., 2010, P GAT COMP ENV WORKS; MINCHIOTTI G, 1991, MOL CELL BIOL, V11, P5624, DOI 10.1128/MCB.11.11.5624; MOORE SK, 1989, J BIOL CHEM, V264, P5343; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Nardi T, 2010, APPL MICROBIOL BIOT, V88, P925, DOI 10.1007/s00253-010-2786-x; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pantzartzi C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000847; Pantzartzi CN, 2009, GENE, V431, P47, DOI 10.1016/j.gene.2008.10.028; PARSONS PA, 1991, ANNU REV ECOL SYST, V22, P1, DOI 10.1146/annurev.es.22.110191.000245; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pugliese L, 2008, GENE, V411, P59, DOI 10.1016/j.gene.2008.01.005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sassi AK, 2005, GENET MOL BIOL, V28, P734, DOI 10.1590/S1415-47572005000500013; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; SPASSKY B, 1971, EVOLUTION, V25, P129, DOI 10.1111/j.1558-5646.1971.tb01866.x; Stechmann A, 2004, J EUKARYOT MICROBIOL, V51, P364, DOI 10.1111/j.1550-7408.2004.tb00580.x; Stechmann A, 2003, J MOL EVOL, V57, P408, DOI 10.1007/s00239-003-2490-x; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; SWOBODA RK, 1995, INFECT IMMUN, V63, P4506, DOI 10.1128/IAI.63.11.4506-4514.1995; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson FJ, 2001, EUR J BIOCHEM, V268, P5808, DOI 10.1046/j.0014-2956.2001.02525.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; van Hoek MJA, 2009, MOL BIOL EVOL, V26, P2441, DOI 10.1093/molbev/msp160; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Versteeg S, 1999, MOL GEN GENET, V261, P582, DOI 10.1007/s004380051004; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wu LT, 2008, MOL REPROD DEV, V75, P952, DOI 10.1002/mrd.20817; Xu PJ, 2010, INSECT MOL BIOL, V19, P593, DOI 10.1111/j.1365-2583.2010.01015.x; Yoshida M, 2011, GENE, V483, P63, DOI 10.1016/j.gene.2011.05.027; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang XY, 2009, COMP BIOCHEM PHYS C, V150, P465, DOI 10.1016/j.cbpc.2009.07.002; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	97	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73217	10.1371/journal.pone.0073217	http://dx.doi.org/10.1371/journal.pone.0073217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066039	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000020
J	Smit, PW; Mabey, D; Changalucha, J; Mngara, J; Clark, B; Andreasen, A; Todd, J; Urassa, M; Zaba, B; Peeling, RW				Smit, Pieter W.; Mabey, David; Changalucha, John; Mngara, Julius; Clark, Benjamin; Andreasen, Aura; Todd, Jim; Urassa, Mark; Zaba, Basia; Peeling, Rosanna W.			The Trade-Off between Accuracy and Accessibility of Syphilis Screening Assays	PLOS ONE			English	Article							PALLIDUM PARTICLE AGGLUTINATION; HUMAN-IMMUNODEFICIENCY-VIRUS; TREPONEMA-PALLIDUM; ENZYME IMMUNOASSAYS; PREGNANCY; TESTS; ANTIBODIES; DIAGNOSIS; MALARIA	The availability of rapid and sensitive methods to diagnose syphilis facilitates screening of pregnant women, which is one of the most cost-effective health interventions available. We have evaluated two screening methods in Tanzania: an enzyme immunoassay (EIA), and a point-of-care test (POCT). We evaluated the performance of each test against the Treponema pallidum particle agglutination assay (TPPA) as the reference method, and the accessibility of testing in a rural district of Tanzania. The POCT was performed in the clinic on whole blood, while the other assays were performed on plasma in the laboratory. Samples were also tested by the rapid plasma Reagin (RPR) test. With TPPA as reference assay, the sensitivity and specificity of EIA were 95.3% and 97.8%, and of the POCT were 59.6% and 99.4% respectively. The sensitivity of the POCT and EIA for active syphilis cases (TPPA positive and RPR titer >= 1/8) were 82% and 100% respectively. Only 15% of antenatal clinic attenders in this district visited a health facility with a laboratory capable of performing the EIA. Although it is less sensitive than EIA, its greater accessibility, and the fact that treatment can be given on the same day, means that the use of POCT would result in a higher proportion of women with syphilis receiving treatment than with the EIA in this district of Tanzania.	[Smit, Pieter W.; Mabey, David; Andreasen, Aura; Todd, Jim; Zaba, Basia; Peeling, Rosanna W.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Changalucha, John; Mngara, Julius; Clark, Benjamin; Todd, Jim; Urassa, Mark] Natl Inst Med Res, Mwanza, Tanzania; [Andreasen, Aura] Mwanza Intervent Trials Unit, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Mabey, D (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	david.mabey@lshtm.ac.uk		Mabey, David/0000-0002-0031-8276; Andreasen, Aura/0000-0003-0664-7342; Todd, Jim/0000-0001-5918-4914	Bill & Melinda Gates Foundation [OPP 47697]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a grant to the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases from the Bill & Melinda Gates Foundation (OPP 47697). The EIA kits were kindly donated by the manufacturer for this evaluation (Lab21 healthcare, Kentford, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas G, 2005, INT J STD AIDS, V16, P294, DOI 10.1258/0956462053654195; Aktas G, 2007, INT J STD AIDS, V18, P255, DOI 10.1258/095646207780658827; AUGENBRAUN MH, 1994, CLIN INFECT DIS, V19, P1040, DOI 10.1093/clinids/19.6.1040; Binnicker MJ, 2011, J CLIN MICROBIOL, V49, P1313, DOI 10.1128/JCM.02555-10; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Cawley C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062212; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Dorigo-Zetsma JW, 2004, SEX TRANSM INFECT, V80, P96, DOI 10.1136/sti.2003.005827; Everett DB, 2007, TROP MED INT HEALTH, V12, P1323, DOI 10.1111/j.1365-3156.2007.01933.x; Fonck K, 2001, AM J PUBLIC HEALTH, V91, P705, DOI 10.2105/AJPH.91.5.705; Gasasira AF, 2006, J CLIN MICROBIOL, V44, P3021, DOI 10.1128/JCM.02207-05; Gift TL, 1999, SEX TRANSM DIS, V26, P232, DOI 10.1097/00007435-199904000-00010; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Kingston M, 2008, INT J STD AIDS, V19, P729, DOI 10.1258/ijsa.2008.008279; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Maple PAC, 2010, CLIN VACCINE IMMUNOL, V17, P1718, DOI 10.1128/CVI.00102-10; Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Oboho IK, 2013, CLIN INFECT DIS; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Smit PW, 2013, BMC INFECT DIS MS ID, V13; TEMMERMAN M, 1993, INT J GYNECOL OBSTET, V41, P182, DOI 10.1016/0020-7292(93)90703-Y; Tsang RSW, 2007, FEMS IMMUNOL MED MIC, V51, P118, DOI 10.1111/j.1574-695X.2007.00289.x; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; World Health Organization, 2012, INV CAS EL MOTH TO C; Young H, 2009, SEX TRANSM INFECT, V85, P19, DOI 10.1136/sti.2008.031872	28	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75327	10.1371/journal.pone.0075327	http://dx.doi.org/10.1371/journal.pone.0075327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066175	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000324494000157
J	Alam, MJ; Arai, S; Saijo, S; Suzuki, K; Mizutani, K; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Iwata, S; Kakinuma, Y; Yamato, I; Murata, T				Alam, Md. Jahangir; Arai, Satoshi; Saijo, Shinya; Suzuki, Kano; Mizutani, Kenji; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Kakinuma, Yoshimi; Yamato, Ichiro; Murata, Takeshi			Loose Binding of the DF Axis with the A(3)B(3) Complex Stimulates the Initial Activity of Enterococcus hirae V-1-ATPase	PLOS ONE			English	Article							ROTATIONAL CATALYSIS; VACUOLAR ATPASE; NA+-ATPASE; ROTOR RING; MECHANISM; RECONSTITUTION; SUBUNITS; DISTINCT; DOMAIN; COLI	Vacuolar ATPases (V-ATPases) function as proton pumps in various cellular membrane systems. The hydrophilic V-1 portion of the V-ATPase is a rotary motor, in which a central-axis DF complex rotates inside a hexagonally arranged catalytic A(3)B(3) complex by using ATP hydrolysis energy. We have previously reported crystal structures of Enterococcus hirae V-ATPase A(3)B(3) and A(3)B(3)DF (V-1) complexes; the result suggested that the DF axis induces structural changes in the A(3)B(3) complex through extensive protein-protein interactions. In this study, we mutated 10 residues at the interface between A(3)B(3) and DF complexes and examined the ATPase activities of the mutated V-1 complexes as well as the binding affinities between the mutated A(3)B(3) and DF complexes. Surprisingly, several V-1 mutants showed higher initial ATPase activities than wild-type V-1-ATPase, whereas these mutated A(3)B(3) and DF complexes showed decreased binding affinities for each other. However, the high ATP hydrolysis activities of the mutants decreased faster over time than the activity of the wild-type V-1 complex, suggesting that the mutants were unstable in the reaction because the mutant A(3)B(3) and DF complexes bound each other more weakly. These findings suggest that strong interaction between the DF complex and A(3)B(3) complex lowers ATPase activity, but also that the tight binding is responsible for the stable ATPase activity of the complex.	[Alam, Md. Jahangir; Arai, Satoshi; Saijo, Shinya; Mizutani, Kenji; Yamato, Ichiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Alam, Md. Jahangir] Shahjalal Univ Sci & Technol, Sch Life Sci, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh; [Arai, Satoshi; Suzuki, Kano; Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan; [Saijo, Shinya] RIKEN, SPring Ctr 8, Hyogo, Japan; [Saijo, Shinya] KEK, High Energy Accelerator Res Org, Struct Biol Res Ctr, Photon Factory,Inst Mat Struct Sci, Ibaraki, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Iwata, So] Kyoto Univ, Fac Med, Dept Cell Biol, Kyoto, Japan; [Kakinuma, Yoshimi] Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 790, Japan; [Murata, Takeshi] PRESTO, JST, Chiba, Japan	Tokyo University of Science; Shahjalal University of Science & Technology (SUST); Chiba University; RIKEN; High Energy Accelerator Research Organization (KEK); RIKEN; Kyoto University; Ehime University; Japan Science & Technology Agency (JST)	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan.	t.murata@faculty.chiba-u.jp	Murata, Takeshi/J-6181-2017; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Murata, Takeshi/0000-0002-5748-4670; Yokoyama, Shigeyuki/0000-0003-3133-7338; 	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government [23370047, 23118705]; Biotechnology and Biological Sciences Research Council [BBS/B/06458] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Targeted Proteins Research Program, grants-in-aid (23370047, 23118705), and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Arai S, 2009, BIOCHEM BIOPH RES CO, V390, P698, DOI 10.1016/j.bbrc.2009.10.032; ARAKAWA T, 2007, PROTEIN EXPRES PURIF, V54, P10116, DOI DOI 10.1016/J.PEP.2007.02.010.PUBMED:17408966; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furutani Y, 2011, J AM CHEM SOC, V133, P2860, DOI 10.1021/ja1116414; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Liberman R, 2013, J BIOL CHEM, V288, P22798, DOI 10.1074/jbc.M113.460295; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Mnatsakanyan N, 2011, J BIOL CHEM, V286, P29788, DOI 10.1074/jbc.M111.254730; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; MOGI T, 1984, J BIOL CHEM, V259, P7797; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Murata T, 2001, J BIOL CHEM, V276, P48337, DOI 10.1074/jbc.M106821200; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; MURATA T, 2000, J BIOL CHEM, V275, P13419, DOI DOI 10.1074/JBC.275.18.13415.PUBMED:10788452; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Nakanishi-Matsui M, 2008, PHILOS T R SOC B, V363, P2135, DOI 10.1098/rstb.2008.2266; NELSON N, 1992, BIOCHIM BIOPHYS ACTA, V1100, P109; Rohl CA, 1999, P NATL ACAD SCI USA, V96, P3682, DOI 10.1073/pnas.96.7.3682; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; STEVENS TH, 1997, ANNU REV CELL DEV BI, V13, P79808, DOI DOI 10.1146/ANNUREV.CELLBI0.13.1.779.PUBMED:9442887; Xie XS, 1996, J BIOL CHEM, V271, P30980; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74291	10.1371/journal.pone.0074291	http://dx.doi.org/10.1371/journal.pone.0074291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058539	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400062
J	Golbabapour, S; Gwaram, NS; Hassandarvish, P; Hajrezaie, M; Kamalidehghan, B; Abdulla, MA; Ali, HM; Hadi, AHA; Majid, NA				Golbabapour, Shahram; Gwaram, Nura Suleiman; Hassandarvish, Pouya; Hajrezaie, Maryam; Kamalidehghan, Behnam; Abdulla, Mahmood Ameen; Ali, Hapipah Mohd; Hadi, A. Hamid A.; Majid, Nazia Abdul			Gastroprotection Studies of Schiff Base Zinc (II) Derivative Complex against Acute Superficial Hemorrhagic Mucosal Lesions in Rats	PLOS ONE			English	Article							INDUCED LIPID-PEROXIDATION; INDUCED GASTRIC-LESIONS; OXIDATIVE DNA-DAMAGE; NF-KAPPA-B; STRUCTURAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; ANTIULCER ACTIVITY; ACID-SECRETION; ULCER; ANTIOXIDANT	Background: The study was carried out to assess the gastroprotective effect of the zinc (II) complex against ethanol-induced acute hemorrhagic lesions in rats. Methodology/Principal Finding: The animals received their respective pre-treatments dissolved in tween 20 (5% v/v), orally. Ethanol (95% v/v) was orally administrated to induce superficial hemorrhagic mucosal lesions. Omeprazole (5.790 x 10(-5) M/kg) was used as a reference medicine. The pre-treatment with the zinc (II) complex (2.181 x 10(-5) and 4.362 x 10(-5) M/kg) protected the gastric mucosa similar to the reference control. They significantly increased the activity levels of nitric oxide, catalase, superoxide dismutase, glutathione and prostaglandin E2, and decreased the level of malondialdehyde. The histology assessments confirmed the protection through remarkable reduction of mucosal lesions and increased the production of gastric mucosa. Immunohistochemistry and western blot analysis indicated that the complex might induced Hsp70 up-regulation and Bax down-regulation. The complex moderately increased the gastroprotectiveness in fine fettle. The acute toxicity approved the non-toxic characteristic of the complex (<87.241 x 10(-5) M/kg). Conclusion/Significance: The gastroprotective effect of the zinc (II) complex was mainly through its antioxidant activity, enzymatic stimulation of prostaglandins E2, and up-regulation of Hsp70. The gastric wall mucus was also a remarkable protective mechanism.	[Golbabapour, Shahram; Hassandarvish, Pouya; Hajrezaie, Maryam; Abdulla, Mahmood Ameen] Univ Malaya, Dept Biomed Sci, Fac Med, Kuala Lumpur, Malaysia; [Gwaram, Nura Suleiman; Ali, Hapipah Mohd; Hadi, A. Hamid A.] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Kamalidehghan, Behnam] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Majid, NA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	nazia@um.edu.my	Gwaram, Nura Suleiman/AEQ-1882-2022; MAJID, NAZIA ABDUL/B-9215-2010; Kamalidehghan, Behnam/B-5401-2013; Gwaram, Nura/F-6667-2011; Hassandarvish, Pouya/K-8112-2012	Gwaram, Nura Suleiman/0000-0002-8423-6111; MAJID, NAZIA ABDUL/0000-0002-6817-8046; Kamalidehghan, Behnam/0000-0001-8530-8124; Hassandarvish, Pouya/0000-0003-0364-5587	University of Malaya (HIR) [UM.C/625/1/HIR/151, PG016/2012B, RG057/11BIO]	University of Malaya (HIR)	This study was funded and supported by the University of Malaya (HIR Grant UM.C/625/1/HIR/151 and PG016/2012B and RG057/11BIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah N, 2012, ACTA ALIMENT HUNG, V41, P334, DOI 10.1556/AAlim.41.2012.3.5; Agte VV, 2004, BIOFACTORS, V20, P139, DOI 10.1002/biof.5520200303; Alam MS, 2012, BIOORGAN MED CHEM, V20, P4103, DOI 10.1016/j.bmc.2012.04.058; Ali RG, 2012, INT J BIOCHEM CELL B, V44, P2065, DOI 10.1016/j.biocel.2012.08.012; Ambike V, 2007, J INORG BIOCHEM, V101, P1517, DOI 10.1016/j.jinorgbio.2007.06.028; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Araki H, 2000, ALIMENT PHARM THERAP, V14, P116, DOI 10.1046/j.1365-2036.2000.014s1116.x; Auld DS, 2011, ZINC ENZYMES ENCY IN; Becker JC, 2006, BIOCHEM BIOPH RES CO, V345, P1014, DOI 10.1016/j.bbrc.2006.04.170; Bhandari SV, 2008, BIOORGAN MED CHEM, V16, P1822, DOI 10.1016/j.bmc.2007.11.014; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; BOLTON JP, 1978, AM J DIG DIS, V23, P359, DOI 10.1007/BF01072421; Bouras EP, 2004, NEUROGASTROENT MOTIL, V16, P729, DOI 10.1111/j.1365-2982.2004.00547.x; Chatterjee A, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/146808; CHEMICALS DOFO, 2005, OECD GUID TEST CHEM; Chen W, 2010, EUR J MED CHEM, V45, P4473, DOI 10.1016/j.ejmech.2010.07.007; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; da Silva LM, 2013, FOOD CHEM TOXICOL, V51, P179, DOI 10.1016/j.fct.2012.09.026; de-Faria FM, 2012, J ETHNOPHARMACOL, V139, P234, DOI 10.1016/j.jep.2011.11.007; Ding YW, 2011, ACTA CRYSTALLOGR E, V67, pM261, DOI 10.1107/S1600536811002753; dos Santos MLP, 1998, J INORG BIOCHEM, V71, P71; Falchuk KH, 1998, MOL CELL BIOCHEM, V188, P41, DOI 10.1023/A:1006808119862; Frassinetti S, 2006, J ENVIRON PATHOL TOX, V25, P597, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i3.40; FUJISAKI H, 1991, BIOCHEM PHARMACOL, V42, P321, DOI 10.1016/0006-2952(91)90719-L; Garber J.C., 2010, COMMITTEE UPDATE GUI, P248; Gawel Stefan, 2004, Wiad Lek, V57, P453; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/974185; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Guslandi M, 2010, DIGEST DIS SCI, V55, P217, DOI 10.1007/s10620-009-1028-5; Gwaram NS, 2012, ARABIAN J CHEM; Gwaram NS, 2012, MOLECULES, V17, P5952, DOI 10.3390/molecules17055952; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Halter F, 2001, GUT, V49, P443, DOI 10.1136/gut.49.3.443; Hegedus L.S., 2010, TRANSITION METALS SY; Hisam EEA, 2012, PHARM BIOL, V50, P1498, DOI 10.3109/13880209.2012.685945; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Kamalidehghan B, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-43; Karatepe M, 2006, CELL BIOCHEM FUNCT, V24, P547, DOI 10.1002/cbf.1266; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Kikuchi K, 2004, CURR OPIN CHEM BIOL, V8, P182, DOI 10.1016/j.cbpa.2004.02.007; Kim JH, 2012, INT J MOL SCI, V13, P5740, DOI 10.3390/ijms13055740; KNECHT KT, 1990, MOL PHARMACOL, V38, P26; Konturek PC, 2010, J PHYSIOL PHARMACOL, V61, P429; Kovacic P, 2003, CURR MED CHEM, V10, P2711, DOI 10.2174/0929867033456369; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Lanas A, 2007, GASTROENTEROLOGY, V132, P490, DOI 10.1053/j.gastro.2006.11.012; Lee SJ, 2011, J BIOL CHEM, V286, P40847, DOI 10.1074/jbc.M111.245993; Li NS, 2012, PLANTA MED, V78, P24, DOI 10.1055/s-0031-1280217; LINDBERG P, 1990, MED RES REV, V10, P1, DOI 10.1002/med.2610100102; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; Maret W, 2001, BIOMETALS, V14, P187, DOI 10.1023/A:1012945110820; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; MIRA L, 1995, ARCH BIOCHEM BIOPHYS, V318, P53, DOI 10.1006/abbi.1995.1203; Mohan S, 2012, PHYTOMEDICINE, V19, P1007, DOI 10.1016/j.phymed.2012.05.012; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nath M, 2010, J ORGANOMET CHEM, V695, P1353, DOI 10.1016/j.jorganchem.2010.02.009; Ng KM, 2008, J PHARM PHARMACOL, V60, P655, DOI 10.1211/jpp.60.5.0012; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; NORDMANN R, 1990, ALCOHOL ALCOHOLISM, V25, P231, DOI 10.1093/oxfordjournals.alcalc.a044996; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Pontiki E, 2006, BIOORG MED CHEM LETT, V16, P2234, DOI 10.1016/j.bmcl.2006.01.045; Qiao WL, 2011, WORLD J GASTROENTERO, V17, P1718, DOI 10.3748/wjg.v17.i13.1718; ROBERT A, 1984, CLIN PHYSIOL BIOCH, V2, P61; Rodrigues PD, 2010, J ETHNOPHARMACOL, V127, P725, DOI 10.1016/j.jep.2009.11.031; Salga MS, 2012, CHEM-BIOL INTERACT, V195, P144, DOI 10.1016/j.cbi.2011.11.008; Salter MH, 2005, INORG CHEM, V44, P2791, DOI 10.1021/ic048705f; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; SAPERAS E, 1991, EUR J PHARMACOL, V209, P1, DOI 10.1016/0014-2999(91)90002-8; SCRUTTON MC, 1971, P NATL ACAD SCI USA, V68, P2497, DOI 10.1073/pnas.68.10.2497; SHAW S, 1981, J LAB CLIN MED, V98, P417; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Suto G, 1996, DIGESTION, V57, P135, DOI 10.1159/000201326; SZABO S, 1991, J CLIN GASTROENTEROL, V13, pS1, DOI 10.1097/00004836-199112002-00001; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; Takayama C, 2011, J ETHNOPHARMACOL, V135, P147, DOI 10.1016/j.jep.2011.03.002; Takeuchi K, 2010, ADV CLIN CHEM, V51, P121, DOI 10.1016/S0065-2423(10)51005-9; Trier JS, 1987, GASTROENTEROLOGY, V92, P13, DOI 10.1016/0016-5085(87)90834-1; Uneyama K., 2008, ORGANOFLUORINE CHEM; VALLEE B L, 1988, Biofactors, V1, P31; Vera-Arzave C, 2012, MOLECULES, V17, P8917, DOI 10.3390/molecules17088917; Wagner III WE, 2012, USING IBM SPSS STAT; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Williams C, 1994, Br J Nurs, V3, P843; Williams R, 1991, BIOL CHEM ELEMENTS I, P315; Xiong Y, 2013, NEUROBIOL AGING, V34, P745, DOI 10.1016/j.neurobiolaging.2012.07.003; You ZL, 2011, POLYHEDRON, V30, P2186, DOI 10.1016/j.poly.2011.05.048	94	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e75036	10.1371/journal.pone.0075036	http://dx.doi.org/10.1371/journal.pone.0075036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058648	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000324408400106
J	Harrison, CF; Kicka, S; Trofimov, V; Berschl, K; Ouertatani-Sakouhi, H; Ackermann, N; Hedberg, C; Cosson, P; Soldati, T; Hilbi, H				Harrison, Christopher F.; Kicka, Sebastien; Trofimov, Valentin; Berschl, Kathrin; Ouertatani-Sakouhi, Hajer; Ackermann, Nikolaus; Hedberg, Christian; Cosson, Pierre; Soldati, Thierry; Hilbi, Hubert			Exploring Anti-Bacterial Compounds against Intracellular Legionella	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; CLPP PROTEASE; PNEUMOPHILA; GROWTH; MULTIPLICATION; VIRULENCE; PATHOGEN; IDENTIFICATION; TUBERCULOSIS; MACROPHAGES	Legionella pneumophila is a ubiquitous fresh-water bacterium which reproduces within its erstwhile predators, environmental amoeba, by subverting the normal pathway of phagocytosis and degradation. The molecular mechanisms which confer resistance to amoeba are apparently conserved and also allow replication within macrophages. Thus, L. pneumophila can act as an 'accidental' human pathogen and cause a severe pneumonia known as Legionnaires' disease. The intracellular localisation of L. pneumophila protects it from some antibiotics, and this fact must be taken into account to develop new anti-bacterial compounds. In addition, the intracellular lifestyle of L. pneumophila may render the bacteria susceptible to compounds diminishing bacterial virulence and decreasing intracellular survival and replication of this pathogen. The development of a single infection cycle intracellular replication assay using GFP-producing L. pneumophila and Acanthamoeba castellanii amoeba is reported here. This fluorescence-based assay allows for continuous monitoring of intracellular replication rates, revealing the effect of bacterial gene deletions or drug treatment. To examine how perturbations of the host cell affect L. pneumophila replication, several known host-targeting compounds were tested, including modulators of cytoskeletal dynamics, vesicle scission and Ras GTPase localisation. Our results reveal a hitherto unrealized potential antibiotic property of the beta-lactone-based Ras depalmitoylation inhibitor palmostatin M, but not the closely related inhibitor palmostatin B. Further characterisation indicated that this compound caused specific growth inhibition of Legionella and Mycobacterium species, suggesting that it may act on a common bacterial target.	[Harrison, Christopher F.; Berschl, Kathrin; Ackermann, Nikolaus; Hilbi, Hubert] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Kicka, Sebastien; Trofimov, Valentin; Soldati, Thierry] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Ouertatani-Sakouhi, Hajer; Cosson, Pierre] Univ Geneva, Fac Med, Geneva, Switzerland; [Hedberg, Christian] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany	University of Munich; University of Geneva; University of Geneva; Max Planck Society	Hilbi, H (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Munich, Germany.	hilbi@mvp.uni-muenchen.de	Trofimov, Valentin/T-3882-2019; SOLDATI, Thierry/A-2902-2009; Hilbi, Hubert/AAU-5815-2020; SOLDATI, Thierry/U-6494-2019; Hill, Andrew/B-4527-2009	Trofimov, Valentin/0000-0002-1823-2171; SOLDATI, Thierry/0000-0002-2056-7931; Hilbi, Hubert/0000-0002-5462-9301; SOLDATI, Thierry/0000-0002-2056-7931; Hill, Andrew/0000-0001-5581-2354	Swiss National Science Foundation (SNF) "Sinergia" [CRSI33_130016]	Swiss National Science Foundation (SNF) "Sinergia"(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation (SNF) "Sinergia" grant CRSI33_130016 (awarded to P. C., T. S., H. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2007, CELL MOL LIFE SCI, V64, P432, DOI 10.1007/s00018-006-6391-1; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Avison MB, 2002, J ANTIMICROB CHEMOTH, V50, P331, DOI 10.1093/jac/dkf135; BACHESON MA, 1981, ANTIMICROB AGENTS CH, V20, P691, DOI 10.1128/AAC.20.5.691; BARKER J, 1995, ANTIMICROB AGENTS CH, V39, P2684, DOI 10.1128/AAC.39.12.2684; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; De Muylder G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001253; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; El Sayed KA, 2006, J NAT PROD, V69, P219, DOI 10.1021/np050372r; Gersch M, 2013, ANGEW CHEM INT EDIT, V52, P3009, DOI 10.1002/anie.201204690; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Hagedorn M, 2007, CELL MICROBIOL, V9, P2716, DOI 10.1111/j.1462-5822.2007.00993.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999; Hedberg C, 2011, ANGEW CHEM INT EDIT, V50, P9832, DOI 10.1002/anie.201102965; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Hoffmann Christine, 2013, Methods Mol Biol, V954, P309, DOI 10.1007/978-1-62703-161-5_18; HORWITZ MA, 1983, J CLIN INVEST, V71, P15, DOI 10.1172/JCI110744; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Imperi F, 2013, ANTIMICROB AGENTS CH, V57, P996, DOI 10.1128/AAC.01952-12; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kolch Walter, 2002, Expert Opin Pharmacother, V3, P709, DOI 10.1517/14656566.3.6.709; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Li XH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-54; Li ZR, 2005, CELL MICROBIOL, V7, P431, DOI 10.1111/j.1462-5822.2004.00472.x; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pedro-Botet L, 2006, CLIN MICROBIOL INFEC, V12, P25, DOI 10.1111/j.1469-0691.2006.01394.x; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Segal G, 1998, MOL MICROBIOL, V30, P197, DOI 10.1046/j.1365-2958.1998.01054.x; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Takemura H, 2000, J ANTIMICROB CHEMOTH, V46, P589, DOI 10.1093/jac/46.4.589; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; Garcia MT, 2007, ENVIRON MICROBIOL, V9, P1267, DOI 10.1111/j.1462-2920.2007.01245.x; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Tiaden Andre N, 2013, Methods Mol Biol, V954, P233, DOI 10.1007/978-1-62703-161-5_14; VILDE JL, 1986, ANTIMICROB AGENTS CH, V30, P743, DOI 10.1128/AAC.30.5.743; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Weber Stephen, 2013, Methods Mol Biol, V954, P367, DOI 10.1007/978-1-62703-161-5_23; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74813	10.1371/journal.pone.0074813	http://dx.doi.org/10.1371/journal.pone.0074813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058631	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400097
J	Pruett, WA; Husband, LD; Husband, G; Dakhlalla, M; Bellamy, K; Coleman, TG; Hester, RL				Pruett, William A.; Husband, Leland D.; Husband, Graham; Dakhlalla, Muhammad; Bellamy, Kyle; Coleman, Thomas G.; Hester, Robert L.			A Population Model of Integrative Cardiovascular Physiology	PLOS ONE			English	Article							CAROTID-SINUS PRESSURE; BODY NEGATIVE-PRESSURE; CARDIAC-OUTPUT; BLOOD-VOLUME; SIMULATION; SYMPATHETICS; TOLERANCE; OCCLUSION; MEN	We present a small integrative model of human cardiovascular physiology. The model is population-based; rather than using best fit parameter values, we used a variant of the Metropolis algorithm to produce distributions for the parameters most associated with model sensitivity. The population is built by sampling from these distributions to create the model coefficients. The resulting models were then subjected to a hemorrhage. The population was separated into those that lost less than 15 mmHg arterial pressure (compensators), and those that lost more (decompensators). The populations were parametrically analyzed to determine baseline conditions correlating with compensation and decompensation. Analysis included single variable correlation, graphical time series analysis, and support vector machine (SVM) classification. Most variables were seen to correlate with propensity for circulatory collapse, but not sufficiently to effect reasonable classification by any single variable. Time series analysis indicated a single significant measure, the stressed blood volume, as predicting collapse in situ, but measurement of this quantity is clinically impossible. SVM uncovered a collection of variables and parameters that, when taken together, provided useful rubrics for classification. Due to the probabilistic origins of the method, multiple classifications were attempted, resulting in an average of 3.5 variables necessary to construct classification. The most common variables used were systemic compliance, baseline baroreceptor signal strength and total peripheral resistance, providing predictive ability exceeding 90%. The methods presented are suitable for use in any deterministic mathematical model.	[Pruett, William A.; Husband, Leland D.; Husband, Graham; Dakhlalla, Muhammad; Bellamy, Kyle; Coleman, Thomas G.; Hester, Robert L.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Pruett, WA (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	wpruett@umc.edu		Hester, Robert/0000-0003-0227-557X	NSF EPSCoR [NSF EPS-090378]; National Institutes of Health [HL-51971]; University of Mississippi Medical Center School of Graduate Studies through the SURE program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER; Office Of The Director [0903787] Funding Source: National Science Foundation	NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi Medical Center School of Graduate Studies through the SURE program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	Drew Pruett, Leland Husband, Kyle Bellamy, Robert Hester: NSF EPSCoR Grant No. NSF EPS-090378 (http://www.msepscor.org/) and National Institutes of Health HL-51971. Grant Husband and Muhammad Dakhlalla were funded by the University of Mississippi Medical Center School of Graduate Studies through the SURE program (http://www.umc.edu/Education/Schools/Graduate_Studies/Undergraduate_Research/SURE.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SR, 2007, ADV PHYSIOL EDUC, V31, P202, DOI 10.1152/advan.00114.2006; BANET M, 1971, AM J PHYSIOL, V220, P662, DOI 10.1152/ajplegacy.1971.220.3.662; Banks HT, 1998, STOHASTIC ANAL CONTR; Bayliss W M, 1894, J Physiol, V16, P159; Beaudouin R, 2010, REGUL TOXICOL PHARM, V57, P103, DOI 10.1016/j.yrtph.2010.01.005; BISHOP VS, 1978, CIRC RES, V43, P840, DOI 10.1161/01.RES.43.6.840; BLOCK MA, 1952, AM J PHYSIOL, V169, P670, DOI 10.1152/ajplegacy.1952.169.3.670; BOLOMEY AA, 1949, J CLIN INVEST, V28, P10, DOI 10.1172/JCI102038; BRAWLEY RK, 1966, AM J PHYSIOL, V211, P347, DOI 10.1152/ajplegacy.1966.211.2.347; Christianini N., 2000, INTRO SUPPORT VECTOR; Convertino VA, 2000, CLIN PHYSIOL, V20, P177; Convertino VA, 1998, AM J PHYSIOL-REG I, V275, pR1909, DOI 10.1152/ajpregu.1998.275.6.R1909; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; COWLEY AW, 1986, FED PROC, V45, P2864; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; GUYTON AC, 1969, CIRC RES, V24, pI1; GUYTON AC, 1971, CIRC RES, V28, pI93; GUYTON AC, 1959, AM J PHYSIOL, V196, P1008, DOI 10.1152/ajplegacy.1959.196.5.1008; GUYTON AC, 1954, AM J PHYSIOL, V179, P261, DOI 10.1152/ajplegacy.1954.179.2.261; Guyton AC, 1973, CIRCULATORY PHYSIOLO; Hester RL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00012; HOSSACK KF, 1982, J APPL PHYSIOL, V53, P799, DOI 10.1152/jappl.1982.53.4.799; KARIM F, 1984, J PHYSIOL-LONDON, V355, P557, DOI 10.1113/jphysiol.1984.sp015438; KARIM F, 1989, J PHYSIOL-LONDON, V417, P295, DOI 10.1113/jphysiol.1989.sp017802; KIRCHHEIM HR, 1976, PHYSIOL REV, V56, P100, DOI 10.1152/physrev.1976.56.1.100; KRIEGER EM, 1967, AM J PHYSIOL, V213, P139, DOI 10.1152/ajplegacy.1967.213.1.139; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nageh MF, 1999, AM J CARDIOL, V84, P1448, DOI 10.1016/S0002-9149(99)00595-0; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; PRATHER JW, 1969, AM J PHYSIOL, V216, P467, DOI 10.1152/ajplegacy.1969.216.3.467; RAKITA L, 1953, CIRC RES, V1, P499, DOI 10.1161/01.RES.1.6.499; SALGADO HC, 1978, AM J PHYSIOL, V234, pH552, DOI 10.1152/ajpheart.1978.234.5.H552; SATHER TM, 1986, AVIAT SPACE ENVIR MD, V57, P413; SHEPHERD AP, 1973, AM J PHYSIOL, V225, P747, DOI 10.1152/ajplegacy.1973.225.3.747; SHIMIZU T, 1979, AM J PHYSIOL, V237, pH528, DOI 10.1152/ajpheart.1979.237.4.H528; SKILLMAN JJ, 1967, ANN SURG, V166, P713, DOI 10.1097/00000658-196711000-00001; Sprandel KA, 2006, DIAGN MICR INFEC DIS, V55, P303, DOI 10.1016/j.diagmicrobio.2006.06.013; Summers RL, 2009, RESUSCITATION, V80, P1405, DOI 10.1016/j.resuscitation.2009.09.001; ULRYCH M, 1969, BRIT HEART J, V31, P570; WANG HH, 1970, AM J PHYSIOL, V218, P1548, DOI 10.1152/ajplegacy.1970.218.6.1548; WEISSLER AM, 1957, CIRCULATION, V15, P875, DOI 10.1161/01.CIR.15.6.875; Wijeysundera DN, 2001, CLIN SCI, V100, P303, DOI 10.1042/CS20000215	42	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74329	10.1371/journal.pone.0074329	http://dx.doi.org/10.1371/journal.pone.0074329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058546	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400064
J	Yimin; Kohanawa, M; Zhao, SJ; Ozaki, M; Haga, S; Nan, GX; Kuge, Y; Tamaki, N				Yimin; Kohanawa, Masashi; Zhao, Songji; Ozaki, Michitaka; Haga, Sanae; Nan, Guangxian; Kuge, Yuji; Tamaki, Nagara			Contribution of Toll-Like Receptor 2 to the Innate Response against Staphylococcus aureus Infection in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; RECOGNITION; CD36; INTERLEUKIN-10; PHAGOCYTOSIS; CELLS; INFLAMMATION; MACROPHAGES	Staphylococcus aureus is a common pathogen that causes a wide range of infectious diseases. The function of TLRs, specifically TLR2, during S. aureus infection is still debated. In this study, we investigated the extent to which TLR2 contributes to the host innate response against the bacterial infection using TLR2-deficient mice. Intravenous inoculation with S. aureus resulted in all TLR2-deficient mice dying within 4 d, along with a high bacterial burden in the livers. However, histological examination showed the same degree of macrophage and neutrophil accumulation in the livers of infected TLR2-deficient mice as that in infected wild-type (WT) mice. TLR2-deficient mouse macrophages also showed normal phagocytic activity, although they failed to express CD36 that appeared on the surface of WT mouse cells upon challenge with heat-killed S. aureus. These data indicate that TLR2, as well as CD36, does not directly affect S. aureus clearance and that CD36 expression on macrophages depends on the presence of TLR2. In vivo infection with S. aureus caused significantly elevated production of TNF-alpha and IL-6 in the livers and blood of TLR2-deficient mice compared with those in WT mice, while the hepatic and serum levels of IL-10 decreased in these mice. In contrast, lower expression of IL-6 and IL-10, but not of TNF-alpha, at both the gene and protein levels was found in TLR2-deficient mouse macrophages compared to that in WT mouse cells, in response to challenge with heat-killed S. aureus. These findings suggest that the S. aureus-induced pro-inflammatory cytokine response is not dependent on macrophages and that TLR2 deficiency results in decreased IL-10 release by macrophages, which contributes to dysregulated cytokine balance, impaired bacterial clearance, and mouse death. Therefore, TLR2 possesses a protective function during S. aureus infection by regulating pro-and anti-inflammatory cytokine responses.	[Yimin; Kohanawa, Masashi] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Kita Ku, Sapporo, Hokkaido, Japan; [Zhao, Songji] Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Kita Ku, Sapporo, Hokkaido, Japan; [Ozaki, Michitaka; Haga, Sanae] Hokkaido Univ, Grad Sch Med, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Nan, Guangxian] Jilin Univ, China Japan Union Hosp, Dept Neurol, Changchun 130023, Peoples R China; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Jilin University; Hokkaido University; Hokkaido University	Yimin (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med, Kita Ku, Sapporo, Hokkaido, Japan.	yimin@med.hokudai.ac.jp	Zhao, Songji/D-5511-2012		ITO Foundation; Akatsuka Company	ITO Foundation; Akatsuka Company	This work was also supported by the ITO Foundation and Akatsuka Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Cheng YL, 2009, INFECT IMMUN, V77, P4002, DOI 10.1128/IAI.00176-09; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Frodermann V, 2011, J INFECT DIS, V204, P253, DOI 10.1093/infdis/jir276; Gillrie MR, 2010, EUR J IMMUNOL, V40, P1639, DOI 10.1002/eji.200939929; Gjertsson I, 2002, CLIN EXP IMMUNOL, V130, P409, DOI 10.1046/j.1365-2249.2002.01999.x; Hattar K, 2006, CRIT CARE MED, V34, P835, DOI 10.1097/01.CCM.0000202204.01230.44; Hawkes M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-299; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Jann NJ, 2011, IMMUNOL LETT, V135, P17, DOI 10.1016/j.imlet.2010.09.007; Jiang WW, 2011, INT IMMUNOPHARMACOL, V11, P1065, DOI 10.1016/j.intimp.2011.02.028; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mae M, 2007, FEMS IMMUNOL MED MIC, V49, P398, DOI 10.1111/j.1574-695X.2007.00218.x; Mal P, 2013, INFLAMM RES, V62, P259, DOI 10.1007/s00011-012-0574-z; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Mattsson E, 2008, FEMS IMMUNOL MED MIC, V52, P110, DOI 10.1111/j.1574-695X.2007.00350.x; Mele T, 2010, INT J BIOCHEM CELL B, V42, P1066, DOI 10.1016/j.biocel.2010.03.021; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; Paik YH, 2006, LAB INVEST, V86, P676, DOI 10.1038/labinvest.3700422; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Yimin, 2008, MICROBES INFECT, V10, P1450, DOI 10.1016/j.micinf.2008.08.013; Yimin, 2006, J IMMUNOL, V177, P642, DOI 10.4049/jimmunol.177.1.642	47	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74287	10.1371/journal.pone.0074287	http://dx.doi.org/10.1371/journal.pone.0074287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058538	gold, Green Published			2022-12-27	WOS:000324408400061
J	Kaitu'u-Lino, TJ; Bambang, K; Onwude, J; Hiscock, R; Konje, J; Tong, S				Kaitu'u-Lino, Tu'uhevaha J.; Bambang, Katerina; Onwude, Joseph; Hiscock, Richard; Konje, Justin; Tong, Stephen			Plasma MIC-1 and PAPP-A Levels Are Decreased among Women Presenting to an Early Pregnancy Assessment Unit, Have Fetal Viability Confirmed but Later Miscarry	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; MATERNAL SERUM; TROPHOBLAST MIGRATION; PROTEIN-A	Background: We have recently shown first trimester Macrophage inhibitory cytokine-1 (MIC-1) and Pregnancy Associated Plasma Protein-A (PAPP-A) serum concentrations are depressed among asymptomatic women destined to miscarry. Here we examined whether plasma levels of MIC-1 and PAPP-A are depressed among women presenting to an Early Pregnancy Assessment Unit (EPAU), noted to have a confirmed viable fetus, but subsequently miscarry. Methods: We performed a prospective cohort study, recruiting 462 women in the first trimester presenting to EPAU and had fetal viability confirmed by ultrasound. We obtained plasma samples on the same day and measured MIC-1, PAPP-A and human chorionic gonadotrophin (hCG), grouping the cohort according to whether they later miscarried or not. To correct for changes in analyte levels across gestation, we expressed the data as Multiples of the normal Median (MoMs). Results: We recruited 462 participants presenting to EPAU at 5-12 weeks gestation. Most (80%) presented with symptoms of threatened miscarriage (e. g. abdominal pain, vaginal bleeding). 34 (7.4%) subsequently miscarried. Median plasma MIC-1 levels among those who miscarried were 50% of those with ongoing pregnancies (Miscarriage cohort MoM 0.50 (25th-75th centiles: 0.29-1.33) vs ongoing pregnancies MoM 1.00 (0.65-1.38); p=0.0025). Median plasma PAPP-A MoMs among those who miscarried was 0.57 (0.00-1.12), significantly lower than those with ongoing pregnancies (MoMs 1.00 (0.59-1.59); p=0.036). Plasma hCG levels were also significantly depressed among those who miscarried compared to those with ongoing pregnancies. However, the performance of MIC-1 as a diagnostic marker to predict miscarriage in this cohort was modest, and not improved with the addition of hCG. Conclusion: MIC-1 and PAPP-A levels are significantly depressed in women presenting to EPAU with ultrasound evidence of fetal viability, but later miscarry. While they are unlikely to be useful as predictive biomarkers in this clinical setting, they probably play important roles in the maintenance of early pregnancy.	[Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia; [Bambang, Katerina; Konje, Justin] Univ Leicester, Dept Canc Studies & Mol Med, Endocannabinoid Res Grp, Leicester, Leics, England; [Onwude, Joseph] Ramsay Springfield Hosp, Chelmsford, Essex, England; [Hiscock, Richard] Mercy Hosp Women, Dept Anaesthesia, Heidelberg, Vic, Australia	University of Melbourne; University of Leicester	Tong, S (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia.	stong@unimelb.edu.au	ONWUDE, JOSEPH Loze/AAH-2903-2022; ONWUDE, JOSEPH Loze/AFM-0527-2022; ONWUDE, JOSEPH LOZE/ABF-7876-2021; ONWUDE, JOSEPH LOZE/ABA-4929-2021	Tong, Stephen/0000-0002-2319-0586; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737	Medical Research Council of UK; National Health and Medical Research Council of Australia [1050765, 490995]	Medical Research Council of UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Medical Research Council of UK and National Health and Medical Research Council of Australia (#1050765 #490995). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gleeson LM, 2001, J CLIN ENDOCR METAB, V86, P2484, DOI 10.1210/jc.86.6.2484; Goddijn M, 2000, BEST PRACT RES CL OB, V14, P855, DOI 10.1053/beog.2000.0124; Habayeb OMH, 2008, JAMA-J AM MED ASSOC, V299, P1135, DOI 10.1001/jama.299.10.1135; Johns J, 2007, REPROD BIOMED ONLINE, V15, P413, DOI 10.1016/S1472-6483(10)60367-7; KNISS DA, 1994, J REPROD MED, V39, P249; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; NESTLER JE, 1990, ENDOCRINOLOGY, V127, P2064, DOI 10.1210/endo-127-5-2064; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Segerer SE, 2011, HUM REPROD; Tong S, 2004, FERTIL STERIL, V82, P1468, DOI 10.1016/j.fertnstert.2004.05.078; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; Wahabi HA, 2011, COCHRANE DB SYST REV; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	18	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72437	10.1371/journal.pone.0072437	http://dx.doi.org/10.1371/journal.pone.0072437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069146	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100007
J	Usha, L; Rao, G; Christopherson, K; Xu, XL				Usha, Lydia; Rao, Geetha; Christopherson, Kent, II; Xu, Xiulong			Mesenchymal Stem Cells Develop Tumor Tropism but Do Not Accelerate Breast Cancer Tumorigenesis in a Somatic Mouse Breast Cancer Model	PLOS ONE			English	Article							STROMAL CELLS; IN-VITRO; DELIVERY; DIFFERENTIATION; RECRUITMENT; VEHICLES; LUNG; VIVO	The role of mesenchymal stem cells (MSCs) on breast cancer progression, growth and tumorigenesis remains controversial or unknown. In the present study, we investigated the role of MSCs on breast tumor induction and growth in a clinically relevant somatic breast cancer model. We first conducted in vitro studies and found that conditioned media (CM) of RCAS-Neu and RCAS-PyMT breast cancer cell lines and tumor cells themselves dramatically increased the proliferation and motility of MSCs and induced morphological changes of MSCs and differentiation into fibroblast-like cells. In contrast, the CM of MSCs inhibited the proliferation of two breast cancer cell lines by arresting the cell cycle at the G0/G1 phase. In vivo studies revealed that fluorescence dye-labeled MSCs migrated into tumor tissues. Unexpectedly, single or multiple intravenous injections of MSCs did not affect the latency of breast cancer in TVA-transgenic mice induced by intraductal injection of the RCAS vector encoding polyoma middle-T antigen (PyMT) or Neu oncogenes. Moreover, MSCs had no effect on RCAS-Neu tumor growth in a syngeneic ectopic breast cancer model. While our studies consistently demonstrated the ability of breast cancer cells to profoundly induce MSCs migration, differentiation, and proliferation, the anti-proliferative effect of MSCs on breast tumor cells observed in vitro could not be translated into an antitumor activity in vivo, probably reflecting the antagonizing or complex effects of MSCs on tumor environment and tumor cells themselves.	[Usha, Lydia; Christopherson, Kent, II] Rush Univ Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL USA; [Rao, Geetha; Xu, Xiulong] Rush Univ Med Ctr, Dept Gen Surg, Chicago, IL USA	Rush University; Rush University	Xu, XL (corresponding author), Rush Univ Med Ctr, Dept Gen Surg, Chicago, IL USA.	xxu@rush.edu			American Cancer Society, Illinois Division; Piccolo Family Foundation	American Cancer Society, Illinois Division(American Cancer Society); Piccolo Family Foundation	Supported in part by the American Cancer Society, Illinois Division (LU) and the Piccolo Family Foundation (XX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Cousin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006278; Doucette T, 2011, NEOPLASIA, V13, P716, DOI 10.1593/neo.101680; Du ZJ, 2007, CELL CYCLE, V6, P823, DOI 10.4161/cc.6.7.4074; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fierro FA, 2004, CLIN EXP METASTAS, V21, P313, DOI 10.1023/B:CLIN.0000046130.79363.33; Ganta C, 2009, CANCER RES, V69, P1815, DOI 10.1158/0008-5472.CAN-08-2750; Gauthaman K, 2013, J CELL BIOCH; Gauthaman K, 2012, J CELL BIOCHEM, V113, P2027, DOI 10.1002/jcb.24073; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hakkarainen T, 2007, HUM GENE THER, V18, P627, DOI 10.1089/hum.2007.034; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Ma Y, 2012, BREAST CANCER RES TR, V133, P473, DOI 10.1007/s10549-011-1774-x; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Molloy AP, 2009, INT J CANCER, V124, P326, DOI 10.1002/ijc.23939; Mosca JD, 2000, CLIN ORTHOP RELAT R, pS71; Poglio S, 2009, AM J PATHOL, V174, P44, DOI 10.2353/ajpath.2009.080505; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Ritter E, 2008, ANN SURG, V247, P310, DOI 10.1097/SLA.0b013e31816401d5; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Secchiero P, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0011140; Sonabend AM, 2008, STEM CELLS, V26, P831, DOI 10.1634/stemcells.2007-0758; Stoff-Khalili MA, 2007, BREAST CANCER RES TR, V105, P157, DOI 10.1007/s10549-006-9449-8; Studeny M, 2002, CANCER RES, V62, P3603; Tyndall A, 2009, BONE MARROW TRANSPLA; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384; Zielske SP, 2009, INT J RADIAT ONCOL, V75, P843, DOI 10.1016/j.ijrobp.2008.06.1953	40	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e67895	10.1371/journal.pone.0067895	http://dx.doi.org/10.1371/journal.pone.0067895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069135	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100002
J	Duttenhoefer, F; Souren, C; Menne, D; Emmerich, D; Schon, R; Sauerbier, S				Duttenhoefer, Fabian; Souren, Cyriel; Menne, Dieter; Emmerich, Dominik; Schoen, Ralf; Sauerbier, Sebastian			Long-Term Survival of Dental Implants Placed in the Grafted Maxillary Sinus: Systematic Review and Meta-Analysis of Treatment Modalities	PLOS ONE			English	Review							ANORGANIC BOVINE BONE; FLOOR AUGMENTATION; AUTOGENOUS BONE; CLINICAL REPORT; MEMBRANE PERFORATION; POSTERIOR MAXILLA; BIO-OSS; ELEVATION; HYDROXYAPATITE; SUCCESS	Background: A prevalent modality to increase the amount of available bone prior to implantation is grafting of the maxillary sinus. Multiple factors such as the surgical technique, moment of implant placement as well as grafting materials and membranes are known to affect implant survival. However, the role of different factor combinations and associated reciprocal effects remain unclear. Conventional statistical methods do not consider inconsistency of study designs and do not take covariables into account. Hence, a systematic research and meta-analysis was conducted to investigate the influence of various treatment modalities on implant survival in the grafted maxillary sinus. Materials and Methods: A meta-analysis was conducted according to the PRISMA guidelines. Articles published from 1980 through January 2013 were electronically and manually searched in MEDLINE (Ovid), the Cochrane Register of Controlled Trials, the Database of Abstracts of Effects, and the Cochrane Database of Systematic Reviews. Clinical reports on single intervention sinus augmentation with root-form implants, a minimum of 10 patients and 6 months of loading were eligible for inclusion if implant survival was stated or calculable. Results were calculated by non-parametric univariate Kaplan-Meier analysis and Bayesian multivariate interval-censored Cox regression. Results: A total of 122 publications on 16268 endosseous implants placed in grafted maxillary sinus were included. The treatment parameters surgical approach, grafting material and implant type showed no selective preference. However, application of membranes showed a significantly reduced hazard-ratio, independent of other co-factors. Conclusions: The use of membranes is the most significant factor to achieve long-term implant survival in sinus augmentation procedures. More data exceeding 3 years follow-up are needed to address prospective confounding and improve clinical evidence.	[Duttenhoefer, Fabian; Souren, Cyriel; Emmerich, Dominik; Sauerbier, Sebastian] Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, Freiburg, Germany; [Menne, Dieter] Menne Biomed Consulting, Tubingen, Germany; [Schoen, Ralf] Malteser Krankenhaus St Josefshosp, Dept Oral & Craniomaxillofacial Surg, Krefeld, Germany	University of Freiburg	Duttenhoefer, F (corresponding author), Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, Freiburg, Germany.	fabian.duttenhoefer@uniklinik-freiburg.de						Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49; ALBREKTSSON T, 1986, DENT CLIN N AM, V30, P151; Ardekian L, 2006, J ORAL MAXIL SURG, V64, P277, DOI 10.1016/j.joms.2005.10.031; Balevi Ben, 2010, Evid Based Dent, V11, P48, DOI 10.1038/sj.ebd.6400721; Barone A, 2006, INT J ORAL MAX IMPL, V21, P81; Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3; Chen L, 2005, J PERIODONTOL, V76, P482, DOI 10.1902/jop.2005.76.3.482; Chiapasco M, 1994, Eur J Prosthodont Restor Dent, V3, P15; Cox D. R, 1972, J R STAT SOC B; Daelemans P, 1997, INT J PERIODONT REST, V17, P26; Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565; Esposito M, 2008, COCHRANE DB SYST REV; Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P7; Ewers R, 2005, J ORAL MAXIL SURG, V63, P1712, DOI 10.1016/j.joms.2005.08.020; Fay MP, 2010, J STAT SOFTW; Ferrigno N, 2006, CLIN ORAL IMPLAN RES, V17, P194, DOI 10.1111/j.1600-0501.2005.01192.x; Fugazzotto PA, 2002, INT J ORAL MAX IMPL, V17, P113; Guarnieri R, 2006, INT J PERIODONT REST, V26, P79; Hallman M, 2004, INT J ORAL MAX IMPL, V19, P222; Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635; Hallman M, 2005, INT J ORAL MAX SURG, V34, P273, DOI 10.1016/j.ijom.2004.09.009; Hallman M, 2002, J ORAL MAXIL SURG, V60, P277, DOI 10.1053/joms.2002.30576; Hising P, 2001, INT J ORAL MAX IMPL, V16, P90; Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013; Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P493, DOI [10.1089/ten.teb.2010.0035, 10.1089/ten.TEB.2010.0035]; Lindenmuller Irene Hitz, 2006, Schweiz Monatsschr Zahnmed, V116, P142; Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23; Mardinger O, 2007, J PERIODONTOL, V78, P1872, DOI 10.1902/jop.2007.070175; Peleg M, 1999, INT J ORAL MAX IMPL, V14, P549; Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397; Peleg M, 2006, INT J ORAL MAX IMPL, V21, P551; Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x; RCT, 2010, R LANG ENV STAT COMP; Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041; Sauerbier S, 2011, TISSUE ENG A; Schwartz-Arad D, 2004, J PERIODONTOL, V75, P511, DOI 10.1902/jop.2004.75.4.511; Schwarzer G, 2012, PACKAGE METAMETAANAL; Shlomi B, 2004, INT J ORAL MAX IMPL, V19, P559; Small SA, 1996, J AM DENT ASSOC, V127, P51, DOI 10.14219/jada.archive.1996.0030; Smiler D G, 1997, Pract Periodontics Aesthet Dent, V9, P885; SMILER D G, 1987, Journal of Oral Implantology, V13, P239; Stelzle F, 2011, CLIN IMPLANT DENT R, V13, P124, DOI 10.1111/j.1708-8208.2009.00190.x; Stricker A, 2003, CLIN ORAL IMPLAN RES, V14, P207, DOI 10.1034/j.1600-0501.2003.140211.x; Strietzel F P, 2004, Mund Kiefer Gesichtschir, V8, P93, DOI 10.1007/s10006-004-0530-3; Summers R B, 1994, Compendium, V15, P154; Tan WC, 2008, J CLIN PERIODONTOL, V35, P241, DOI 10.1111/j.1600-051X.2008.01273.x; Tarnow DP, 2000, INT J PERIODONT REST, V20, P117; TATUM H, 1986, DENT CLIN N AM, V30, P207; Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713; Therneau T.M., 2000, MODELING SURVIVAL DA; Timmenga NM, 1997, J ORAL MAXIL SURG, V55, P936, DOI 10.1016/S0278-2391(97)90063-X; Tong DC, 1998, INT J ORAL MAXILLOF, P13; Tuna T, 2012, J ORAL REHABIL, V39, P226, DOI 10.1111/j.1365-2842.2011.02259.x; Turnbull BW, 1976, EMPIRICAL DISTRIBUTI; Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556; Valentini P, 1997, INT J PERIODONT REST, V17, P233; Vlassis JM, 1999, J PERIODONTOL, V70, P692, DOI 10.1902/jop.1999.70.6.692; Vogel R, 2013, INT J ORAL MAX IMPL, V28, P343, DOI 10.11607/jomi.2921; Wallace SS, 2005, INT J PERIODONT REST, V25, P551; Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328; Wang X, PACKAGE DYNSURV DYNA; Weyant RJ, 2004, J AM GERIATR SOC, V52, P596, DOI 10.1111/j.1532-5415.2004.52168.x; Winter AA, 2002, INT J ORAL MAX IMPL, V17, P687; Yu YH, 2011, J AM GERIATR SOC, V59, P519, DOI 10.1111/j.1532-5415.2010.03311.x; Zitzmann NU, 1998, COMP CRESTAL LATERAL, V85, P8	65	28	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75357	10.1371/journal.pone.0075357	http://dx.doi.org/10.1371/journal.pone.0075357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058679	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900111
J	Kang, L; Janowska, MK; Moriarty, GM; Baum, J				Kang, Lijuan; Janowska, Maria K.; Moriarty, Gina M.; Baum, Jean			Mechanistic Insight into the Relationship between N-Terminal Acetylation of alpha-Synuclein and Fibril Formation Rates by NMR and Fluorescence	PLOS ONE			English	Article							PROTEIN AGGREGATION; SECONDARY STRUCTURE; AMYLOID FORMATION; MUTATIONS; DISEASE; IDENTIFICATION; DETERMINANTS; PROPENSITY; EVOLUTION; DYNAMICS	Aggregation of alpha-synuclein (alpha Syn), the primary protein component in Lewy body inclusions of patients with Parkinson's disease, arises when the normally soluble intrinsically disordered protein converts to amyloid fibrils. In this work, we provide a mechanistic view of the role of N-terminal acetylation on fibrillation by first establishing a quantitative relationship between monomer secondary structural propensity and fibril assembly kinetics, and secondly by demonstrating in the N-terminal acetylated form of the early onset A53T mutation, that N-terminal transient helices formed and/or inhibited by N-terminal acetylation modulate the fibril assembly rates. Using NMR chemical shifts and fluorescence experiments, we report that secondary structural propensity in residues 5-8, 14-31, and 50-57 are highly correlated to fibril growth rate. A four-way comparison of secondary structure propensity and fibril growth rates of N-terminally acetylated A53T and WT alpha Syn with non-acetylated A53T and WT aSyn present novel mechanistic insight into the role of N-terminal acetylation in amyloid fibril formation. We show that N-terminal acetylation inhibits the formation of the "fibrillation promoting" transient helix at residues 14-31 resulting from the A53T mutation in the non-acetylated variant and supports the formation of the "fibrillation inhibiting" transient helix in residues 1-12 thereby resulting in slower fibrillation rates relative to the previously studied non-acetylated A53T variant. Our results highlight the critical interplay of the region-specific transient secondary structure of the N-terminal region with fibrillation, and the inhibitory role of the N-terminal acetyl group in fibril formation.	[Kang, Lijuan; Janowska, Maria K.; Moriarty, Gina M.; Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Baum, Jean] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Baum, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA.	jean.baum@rutgers.edu			NIH [GM087012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087012] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grant GM087012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; ANDERSON VL, 2010, P NATL ACAD SCI US; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bongiovanni MN, 2012, J MOL BIOL, V421, P256, DOI 10.1016/j.jmb.2011.12.020; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; FAUVET B, 2012, J BIOL CHEM; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Meng F, 2007, BIOCHEMISTRY-US, V46, P12091, DOI 10.1021/bi7004834; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; ROCHE J, 2013, CHEMBIOCHEM; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	50	33	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75018	10.1371/journal.pone.0075018	http://dx.doi.org/10.1371/journal.pone.0075018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058647	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900090
J	Wang, JW; Wang, XD; Holz, JD; Rutkowski, T; Wang, YJ; Zhu, ZN; Dong, YF				Wang, Jinwu; Wang, Xudong; Holz, Jonathan D.; Rutkowski, Timothy; Wang, Yongjun; Zhu, Zhenan; Dong, Yufeng			Runx1 Is Critical for PTH-induced Onset of Mesenchymal Progenitor Cell Chondrogenic Differentiation	PLOS ONE			English	Article							PARATHYROID-HORMONE 1-34; EXPRESSION; TRANSCRIPTION; PATHWAY; SOX9; GENE; PROLIFERATION; ACTIVATION; RECEPTOR; DENSITY	Parathyroid hormone (PTH) plays a critical role in the regulation of chondrogenesis. In this study, we have found for the first time that Runt-related transcription factor 1 (Runx1) contributes to PTH-induced chondrogenesis. Upon PTH treatment, limb bud mesenchymal progenitor cells in micromass culture showed an enhanced chondrogenesis, which was associated with a significant increase of chondrogenic marker gene expression, such as type II collagen and type X collagen. Runx1 was also exclusively expressed in cells treated with PTH at the onset stage of chondrogenesis. Knockdown of Runx1 completely blunted PTH-mediated chondrogenesis. Furthermore, PTH induced Runx1 expression and chondrogenesis were markedly reduced by inhibition of protein kinase A (PKA) signaling. Taken together, our present study indicates that chondrogenesis induced by PTH in mesenchymal progenitor cells is mediated by Runx1, which involves the activation of PKA. These data provide a novel insight into understanding the molecular mechanisms behind PTH-enhanced cartilage regeneration.	[Wang, Jinwu; Zhu, Zhenan] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai 200030, Peoples R China; [Wang, Xudong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg,Shanghai Key Lab S, Shanghai 200030, Peoples R China; [Holz, Jonathan D.] DYouville Coll, Dept Math & Nat Sci, Buffalo, NY USA; [Rutkowski, Timothy; Dong, Yufeng] Univ Rochester, Sch Med, Dept Orthopaed & Rehabil, Ctr Musculoskeletal Res, Rochester, NY USA; [Wang, Yongjun] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Spine, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; D'Youville College; University of Rochester; Shanghai University of Traditional Chinese Medicine	Zhu, ZN (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai 200030, Peoples R China.	zhuzhenan2006@126.com; Yufeng_Dong@urmc.rochester.edu	Wang, Jinwu/AAG-4431-2021	Wang, Jinwu/0000-0003-1411-057X; Holz, Jonathan/0000-0003-1486-7230	National Basic Research Program of China (973 Program) [2012CB933604, 2010CB530404]; National Natural Science Foundation of China [81171707]; Fund for Key Disciplines of Shanghai Municipal Education Commission [J50206]; National Natural Foundation Committee of China key [30930111]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053459] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Key Disciplines of Shanghai Municipal Education Commission; National Natural Foundation Committee of China key; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is financially supported by National Basic Research Program of China (973 Program, 2012CB933604), National Natural Science Foundation of China (Grant No. 81171707), Fund for Key Disciplines of Shanghai Municipal Education Commission (J50206), National Basic Research Program of China (973 Program grant 2010CB530404), and National Natural Foundation Committee of China key grant (30930111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Andreassen TT, 1999, J BONE MINER RES, V14, P960, DOI 10.1359/jbmr.1999.14.6.960; Bidwell P, 2010, PROSTAG OTH LIPID M, V91, P18, DOI 10.1016/j.prostaglandins.2009.12.002; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Bukata Susan V, 2010, Curr Osteoporos Rep, V8, P28, DOI 10.1007/s11914-010-0006-3; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Etoh M, 2010, J BONE MINER METAB, V28, P641, DOI 10.1007/s00774-010-0181-4; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Ionescu AM, 2004, J CELL PHYSIOL, V198, P428, DOI 10.1002/jcp.10421; Ito Masako, 2007, Clin Calcium, V17, P1858; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Kudo S, 2011, OSTEOARTHR CARTILAGE, V19, P886, DOI 10.1016/j.joca.2011.04.007; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Lampasso JD, 2006, INT J MOL MED, V17, P1125; Malko AV, 2013, STEM CELL REV REP, V9, P121, DOI 10.1007/s12015-013-9434-7; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Soung DY, 2012, J BONE MINER RES, V27, P1585, DOI 10.1002/jbmr.1601; Tian Y, 2011, MOL CELL BIOCHEM, V355, P211, DOI 10.1007/s11010-011-0856-8; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; Yamashiro T, 2004, J BONE MINER RES, V19, P1671, DOI 10.1359/JBMR.040801	36	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74255	10.1371/journal.pone.0074255	http://dx.doi.org/10.1371/journal.pone.0074255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058535	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900038
J	Cecchini, DA; Laville, E; Laguerre, S; Robe, P; Leclerc, M; Dore, J; Henrissat, B; Remaud-Simeon, M; Monsan, P; Potocki-Veronese, G				Cecchini, Davide A.; Laville, Elisabeth; Laguerre, Sandrine; Robe, Patrick; Leclerc, Marion; Dore, Joel; Henrissat, Bernard; Remaud-Simeon, Magali; Monsan, Pierre; Potocki-Veronese, Gabrielle			Functional Metagenomics Reveals Novel Pathways of Prebiotic Breakdown by Human Gut Bacteria	PLOS ONE			English	Article							HUMAN GASTROINTESTINAL-TRACT; HUMAN FECAL FLORA; BIFIDOBACTERIUM-LONGUM; IN-VITRO; BETA-FRUCTOFURANOSIDASE; LACTOBACILLUS-ACIDOPHILUS; INTESTINAL MICROBIOTA; HUMAN COLON; LARGE-BOWEL; HUMAN-MILK	The human intestine hosts a complex bacterial community that plays a major role in nutrition and in maintaining human health. A functional metagenomic approach was used to explore the prebiotic breakdown potential of human gut bacteria, including non-cultivated ones. Two metagenomic libraries, constructed from ileum mucosa and fecal microbiota, were screened for hydrolytic activities on the prebiotic carbohydrates inulin, fructo-oligosaccharides, xylo-oligosaccharides, galacto-oligosaccharides and lactulose. The DNA inserts of 17 clones, selected from the 167 hits that were identified, were pyrosequenced in-depth, yielding in total 407, 420 bp of metagenomic DNA. From these sequences, we discovered novel prebiotic degradation pathways containing carbohydrate transporters and hydrolysing enzymes, for which we provided the first experimental proof of function. Twenty of these proteins are encoded by genes that are also present in the gut metagenome of at least 100 subjects, whatever are their ages or their geographical origin. The sequence taxonomic assignment indicated that still unknown bacteria, for which neither culture conditions nor genome sequence are available, possess the enzymatic machinery to hydrolyse the prebiotic carbohydrates tested. The results expand the vision on how prebiotics are metabolized along the intestine, and open new perspectives for the design of functional foods.	[Cecchini, Davide A.; Laville, Elisabeth; Laguerre, Sandrine; Remaud-Simeon, Magali; Monsan, Pierre; Potocki-Veronese, Gabrielle] Univ Toulouse 3, Univ Toulouse, Inst Natl Sci Appl, Inst Natl Polytech Ingn Syst Biol & Proc, F-31062 Toulouse, France; [Cecchini, Davide A.; Laville, Elisabeth; Laguerre, Sandrine; Remaud-Simeon, Magali; Monsan, Pierre; Potocki-Veronese, Gabrielle] CNRS, Inst Natl Rech Agron, Ingn Syst Biol & Proc UMR792, UMR5504, Toulouse, France; [Robe, Patrick] LibraGenSA, Toulouse, France; [Leclerc, Marion; Dore, Joel] INRA, Micalis, UMR1319, Jouy En Josas, France; [Henrissat, Bernard] Univ Aix Marseille 1, CNRS, UMR6098, Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13284 Marseille 07, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Potocki-Veronese, G (corresponding author), Univ Toulouse 3, Univ Toulouse, Inst Natl Sci Appl, Inst Natl Polytech Ingn Syst Biol & Proc, F-31062 Toulouse, France.	veronese@insa-toulouse.fr	Henrissat, Bernard/J-2475-2012; Dore, Joel/ABA-8921-2020; Veronese, Gabrielle/GTF-3473-2022; Leclerc, Marion/AAZ-3950-2021	Henrissat, Bernard/0000-0002-3434-8588; Leclerc, Marion/0000-0001-8684-2847	Institut National de la Recherche Agronomique (INRA); French National Agency for Research [ANR/DEDD/PNRA/PROJ/200206-01-01]; Region Midi-Pyrenees, France; European Regional Development Fund; INRA, France	Institut National de la Recherche Agronomique (INRA); French National Agency for Research(French National Research Agency (ANR)); Region Midi-Pyrenees, France(Region Occitanie); European Regional Development Fund(European Commission); INRA, France	This work was carried out with the financial support of Institut National de la Recherche Agronomique (INRA), and of the French National Agency for Research, in the frame of the ANR/DEDD/PNRA/PROJ/200206-01-01 project. ICEO is supported by grants from the Region Midi-Pyrenees, France, the European Regional Development Fund, and INRA, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aider M, 2007, TRENDS FOOD SCI TECH, V18, P356, DOI 10.1016/j.tifs.2007.03.005; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Bird AR, 2010, BENEF MICROBES, V1, P423, DOI 10.3920/BM2010.0041; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; DJOUZI Z, 1995, J APPL BACTERIOL, V79, P117, DOI 10.1111/j.1365-2672.1995.tb00924.x; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Figueroa-Gonzalez I, 2011, J MICROBIAL BIOCH S, VS1, P3, DOI 10.4172/1948-5948.S1-003; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Goh YJ, 2006, APPL ENVIRON MICROB, V72, P7518, DOI 10.1128/AEM.00877-06; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Goulas T, 2009, APPL MICROBIOL BIOT, V84, P899, DOI 10.1007/s00253-009-2009-5; Grabitske HA, 2008, J AM DIET ASSOC, V108, P1677, DOI 10.1016/j.jada.2008.07.010; Gullon B, 2011, LWT-FOOD SCI TECHNOL, V44, P1687, DOI 10.1016/j.lwt.2011.03.006; Herfel TM, 2011, J NUTR, V141, P2139, DOI 10.3945/jn.111.143727; Hopkins MJ, 1998, J APPL MICROBIOL, V85, P381; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; IMAMURA L, 1994, BIOL PHARM BULL, V17, P596, DOI 10.1248/bpb.17.596; Iyer R, 2010, INT DAIRY J, V20, P133, DOI 10.1016/j.idairyj.2009.10.005; Jaskari J, 1998, APPL MICROBIOL BIOT, V49, P175, DOI 10.1007/s002530051155; Jedrzejczak-Krzepkowska M, 2011, PROCESS BIOCHEM, V46, P1963, DOI 10.1016/j.procbio.2011.07.005; KLEEREBEZEM M, 2010, INTESTINAL MICROBIOM, P27; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Kullin B, 2006, APPL MICROBIOL BIOT, V72, P975, DOI 10.1007/s00253-006-0358-x; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lagaert S, 2007, APPL ENVIRON MICROB, V73, P5374, DOI 10.1128/AEM.00722-07; Lagaert S, 2011, APPL MICROBIOL BIOT, V92, P1179, DOI 10.1007/s00253-011-3396-y; Lagaert S, 2010, BIOCHEM BIOPH RES CO, V402, P644, DOI 10.1016/j.bbrc.2010.10.075; Langlands SJ, 2004, GUT, V53, P1610, DOI 10.1136/gut.2003.037580; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Licht TR, 2012, TRENDS FOOD SCI TECH, V23, P70, DOI 10.1016/j.tifs.2011.08.011; Macfarlane S, 2006, ALIMENT PHARM THER, V24, P701, DOI 10.1111/j.1365-2036.2006.03042.x; Majumder A, 2011, PROTEOMICS, V11, P3470, DOI 10.1002/pmic.201100115; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; OHKUSA T, 1995, DIGESTION, V56, P415, DOI 10.1159/000201269; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rhimi M, 2010, RES MICROBIOL, V161, P515, DOI 10.1016/j.resmic.2010.04.011; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Ryan SM, 2005, APPL ENVIRON MICROB, V71, P3475, DOI 10.1128/AEM.71.7.3475-3482.2005; Rycroft CE, 2001, J APPL MICROBIOL, V91, P878, DOI 10.1046/j.1365-2672.2001.01446.x; Santos F, 2008, MICROBIOL-SGM, V154, P81, DOI 10.1099/mic.0.2007/011569-0; Sarbini SR, 2011, APPL ENVIRON MICROB, V77, P5307, DOI 10.1128/AEM.02568-10; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Stabler S. P., 1999, Chemistry and biochemistry of B12., P343; Taras D, 2002, INT J SYST EVOL MICR, V52, P423, DOI 10.1099/00207713-52-2-423; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Temperton B, 2009, ISME J, V3, P792, DOI 10.1038/ismej.2009.32; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P1006, DOI 10.1128/AEM.72.2.1006-1012.2006; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V52, P681, DOI 10.1007/s002530051579; Vlieg JETV, 2011, CURR OPIN BIOTECH, V22, P211, DOI 10.1016/j.copbio.2010.12.004; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	74	58	59	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e72766	10.1371/journal.pone.0072766	http://dx.doi.org/10.1371/journal.pone.0072766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066026	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000007
J	Dimitrov, D; Boily, MC; Marrazzo, J; Beigi, R; Brown, ER				Dimitrov, Dobromir; Boily, Marie-Claude; Marrazzo, Jeannie; Beigi, Richard; Brown, Elizabeth R.			Population-Level Benefits from Providing Effective HIV Prevention Means to Pregnant Women in High Prevalence Settings	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SEXUAL-BEHAVIOR; VIRAL LOAD; INFECTION; AFRICA; IMPACT; RISK; INSIGHTS	Background: HIV prevalence among pregnant women in Southern Africa is extremely high. Epidemiological studies suggest that pregnancy increases the risk of HIV sexual acquisition and that HIV infections acquired during pregnancy carry higher risk of mother-to-child transmission (MTCT). We analyze the potential benefits from extending the availability of effective microbicide to pregnant women (in addition to non-pregnant women) in a wide-scale intervention. Methods and Findings: A transmission dynamic model was designed to assess the impact of microbicide use in high HIV prevalence settings and to estimate proportions of new HIV infections, infections acquired during pregnancy, and MTCT prevented over 10 years. Our analysis suggests that consistent use of microbicide with 70% efficacy by 60% of non-pregnant women may prevent approximately 40% and 15% of new infections in women and men respectively over 10 years, assuming no additional increase in HIV risk to either partner during pregnancy (RRHIV/preg=1). It may also prevent 8-15% MTCT depending on the increase in MTCT risk when HIV is acquired during pregnancy compared to before pregnancy (RRMTCT/preg). Extending the microbicides use during pregnancy may improve the effectiveness of the intervention by 10% (RRHIV/preg=1) to 25% (RRHIV/preg=2) and reduce the number of HIV infections acquired during pregnancy by 40% to 70% in different scenarios. It may add between 6% (RRHIV/preg=1, RRMTCT/preg=1) and 25% (RRHIV/preg=2, RRMTCT/preg=4) to the reduction in the residual MTCT. Conclusion: Providing safe and effective microbicide to pregnant women in the context of wide-scale interventions would be desirable as it would increase the effectiveness of the intervention and significantly reduce the number of HIV infections acquired during pregnancy. The projected benefits from covering pregnant women by the HIV prevention programs is more substantial in communities in which the sexual risk during pregnancy is elevated.	[Dimitrov, Dobromir; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England; [Marrazzo, Jeannie] Univ Washington, Dept Med, Seattle, WA USA; [Beigi, Richard] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA; [Dimitrov, Dobromir] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Imperial College London; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dimitrov, D (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dobromir@scharp.org		Dimitrov, Dobromir/0000-0002-2842-5436; Boily, Marie-Claude/0000-0003-3919-006X; Marrazzo, Jeanne/0000-0002-9277-7364	National Institutes of Health [5 U01 AI068615-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068615, UM1AI069494, U01AI068615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DD and ERB are supported by a grant from the National Institutes of Health (Grant number 5 U01 AI068615-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beigi R, 2011, J INFECT DIS, V204, P1527, DOI 10.1093/infdis/jir562; Bekker L. G., 2012, Southern African Journal of HIV Medicine, V13, P40; Birkhead GS, 2010, OBSTET GYNECOL, V115, P1247, DOI 10.1097/AOG.0b013e3181e00955; Boily MC, 2011, SEX TRANSM INFECT, V87, P646, DOI 10.1136/sextrans-2011-050184; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Centers of Disease Control and Prevention, 2010, CDC TRIAL ANOTHER MA; Chambers CD, 2008, CLIN PHARMACOL THER, V83, P181, DOI 10.1038/sj.clpt.6100448; Dimitrov DT, 2013, JAIDS-J ACQ IMM DEF, V62, P95, DOI 10.1097/QAI.0b013e3182785638; Dimitrov DT, 2010, STAT COMMUNICATIONS, V2; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; FHI, 2011, FHI360; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Garcia PM, 1999, NEW ENGL J MED, V341, P1699; Goldkind SF, 2010, NEW ENGL J MED, V362, P2241, DOI 10.1056/NEJMp1003462; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; HIV Prevention Trials Network, 2006, HPTN 035 PHAS 2 2B S; Jeanne Marrazzo GR, 2013, C RETR OPP INF ATL G; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Latka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031387; Leroy V, 2001, AIDS, V15, P517, DOI 10.1097/00002030-200103090-00011; Lyerly AD, 2009, AM J PUBLIC HEALTH, V99, P1742, DOI 10.2105/AJPH.2009.165498; Macklin R, 2010, LANCET, V375, P632, DOI 10.1016/S0140-6736(10)60257-7; Matthews LT, 2013, PLOS ONE, V8; Microbicide Trials Network, 2008, MTN 003 PHAS 2B SAF; Microbicide Trials Network, 2010, MTN 008 EXP SAF INV; Microbicide Trials Network, 2008, MTN 016 HIV PREV AG; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Padayatch N, 2010, S AFRICAN HLTH REV 2; Patterson KB, 2007, AIDS, V21, P2303, DOI 10.1097/QAD.0b013e3282f155da; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Statistics South Africa, 2010, MID POP EST; UNAIDS/WHO, 2009, AIDS EP UPD NOV 2009	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73770	10.1371/journal.pone.0073770	http://dx.doi.org/10.1371/journal.pone.0073770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066069	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000324494000051
J	Kayigamba, FR; Bakker, MI; Mugisha, V; De Naeyer, L; Gasana, M; Cobelens, F; van der Loeff, MS				Kayigamba, Felix R.; Bakker, Mirjam I.; Mugisha, Veronicah; De Naeyer, Ludwig; Gasana, Michel; Cobelens, Frank; van der Loeff, Maarten Schim			Adherence to Tuberculosis Treatment, Sputum Smear Conversion and Mortality: A Retrospective Cohort Study in 48 Rwandan Clinics	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; POSITIVE TUBERCULOSIS; CULTURE CONVERSION; HIV-INFECTION; RISK-FACTORS; MICROSCOPY; PROGRAM	Background: Adherence to treatment and sputum smear conversion after 2 months of treatment are thought to be important for successful outcome of tuberculosis (TB) treatment. Methods: Retrospective cohort study of new adult TB patients diagnosed in the first quarter of 2007 at 48 clinics in Rwanda. Data were abstracted from TB registers and individual treatment charts. Logistic regression analysis was done to examine associations between baseline demographic and clinical factors and three outcomes adherence, sputum smear conversion at two months, and death. Results: Out of 725 eligible patients the treatment chart was retrieved for 581 (80%). Fifty-six (10%) of these patients took <90% of doses (defined as poor adherence). Baseline demographic characteristics were not associated with adherence to TB treatment, but adherence was lower among HIV patients not taking antiretroviral therapy (ART); p = 0.03). Sputum smear results around 2 months after start of treatment were available for 220 of 311 initially sputum-smear-positive pulmonary TB (PTB+) patients (71%); 175 (80%) had achieved sputum smear conversion. In multivariable analysis, baseline sputum smear grade (odds ratio [OR] = 2.7, 95% Confidence interval [CI] 1.1-6.6 comparing smear 3+ against 1+) and HIV infection (OR 3.0, 95% CI 1.3-6.7) were independent predictors for non-conversion at 2 months. Sixty-nine of 574 patients (12%) with known TB treatment outcomes had died. Besides other known determinants, poor adherence had an independent, strong effect on mortality (OR 3.4, 95% CI 1.4-7.8). Conclusion: HIV infection is an important independent predictor of failure of sputum smear conversion at 2 months among PTB+ patients. Poor adherence to TB treatment is an important independent determinant of mortality.	[Kayigamba, Felix R.; De Naeyer, Ludwig] INTERACT, Kigali, Rwanda; [Bakker, Mirjam I.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Mugisha, Veronicah] Columbia Univ, Mailman Sch Publ Hlth, ICAP, Kigali, Rwanda; [Gasana, Michel] Natl TB Control Program Rwanda PNILT, Kigali, Rwanda; [Cobelens, Frank; van der Loeff, Maarten Schim] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van der Loeff, Maarten Schim] Publ Hlth Serv Amsterdam GGD, Dept Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Kayigamba, FR (corresponding author), INTERACT, Kigali, Rwanda.	fkaigamba@gmail.com		Cobelens, Frank/0000-0002-4367-1133	Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) [W 07.05.201.00, WNA-93-490]	Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO)	This study was funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO), Grant number: W 07.05.201.00; WNA-93-490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; [Anonymous], 2004, COMP IND MON EV NAT; Bwire R, 1999, E AFR MED J, V76, P307; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Horne DJ, 2010, INFECT CONT HOSP EP, V31, P78, DOI 10.1086/649022; Lienhardt C, 1998, INT J TUBERC LUNG D, V2, P712; Measure DHS, 2010, RWAND DEM HLTH SURV; Ministry of Health Rwanda, 2009, HDB TUB TB HIV; Ministry of Health Rwanda, 2007, HDB TUB; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Mwumvaneza M, 2010, HIV AIDS ESTIMATES P; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Rekha VVB, 2007, INDIAN J MED RES, V126, P452; Rieder HL, 1996, TUBERCLE LUNG DIS, V77, P124, DOI 10.1016/S0962-8479(96)90026-X; Senkoro M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-210; Singla R, 2003, INT J TUBERC LUNG D, V7, P58; Somoskovi A, 2001, CHEST, V120, P250, DOI 10.1378/chest.120.1.250; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Su WJ, 2011, EUR RESPIR J, V37, P376, DOI 10.1183/09031936.00007410; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P189; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P1127; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; WHO, 2010, GLOB TUB CONTR REP; World Health Organization, 2011, GLOB TUB CONTR REP 2; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization, 2011, COUNTR TUB PROF RWAN; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169	33	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73501	10.1371/journal.pone.0073501	http://dx.doi.org/10.1371/journal.pone.0073501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066053	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000034
J	Lee, JH; Fulp, W; Wells, KJ; Meade, CD; Calcano, E; Roetzheim, R				Lee, Ji-Hyun; Fulp, William; Wells, Kristen J.; Meade, Cathy D.; Calcano, Ercilia; Roetzheim, Richard			Patient Navigation and Time to Diagnostic Resolution: Results for a Cluster Randomized Trial Evaluating the Efficacy of Patient Navigation among Patients with Breast Cancer Screening Abnormalities, Tampa, FL	PLOS ONE			English	Article							FOLLOW-UP; RACIAL-DIFFERENCES; POPULATION; MAMMOGRAMS; CARE; TIMELINESS; PROGRAM; QUALITY; DELAYS; WOMEN	Objectives: The objective of this study was to evaluate a patient navigation (PN) program that attempts to reduce the time between a breast cancer screening abnormality and definitive diagnosis among medically underserved populations of Tampa Bay, Florida. Methods: The Moffitt Patient Navigation Research Program conducted a cluster randomized design with 10 primary care clinics. Patients were navigated from time of a breast screening abnormality to diagnostic resolution. This paper examined the length of time between breast abnormality and definitive diagnosis, using a shared frailty Cox proportional hazard model to assess PN program effect. Results: 1,039 patients were eligible for the study because of an abnormal breast cancer screening/clinical abnormality (494 navigated; 545 control). Analysis of PN effect by two time periods of resolution (0-3 months and > 3 months) showed a lagged effect of PN. For patients resolving in the first three months, the adjusted Hazard Ratio (aHR) was 0.85 (95% Confidence Interval [CI]: 0.64-1.13) suggesting that PN had no effect on resolution time during this period. Beyond three months, however, navigated patients resolved more quickly to diagnostic resolution compared with the control group (aHR 2.8, 95% CI: 1.30-6.13). The predicted aHR at 3 months was 1.2, which was not statistically significant, while PN had a significant positive effect beyond 4.7 months. Conclusions: PN programs may increase the timeliness of diagnostic resolution for patients with a breast cancer-related abnormality. PN did not speed diagnostic resolution during the initial three months of follow up but started to reduce time to diagnostic resolution after three months and showed a significant effect after 4.7 months.	[Lee, Ji-Hyun; Fulp, William; Meade, Cathy D.; Roetzheim, Richard] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Lee, Ji-Hyun; Meade, Cathy D.; Calcano, Ercilia; Roetzheim, Richard] Univ S Florida, Coll Med, Tampa, FL USA; [Wells, Kristen J.] San Diego State Univ, San Diego, CA 92182 USA; [Wells, Kristen J.] Moores Canc Ctr, San Diego, CA USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; California State University System; San Diego State University	Roetzheim, R (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	rroetzhe@health.usf.edu	Wells, Kristen/J-1838-2012; Roetzheim, Richard/J-4696-2012; Fulp, William/AAD-2369-2022	Fulp, William/0000-0001-6888-0794	National Cancer Institute (NCI), through its Center to Reduce Cancer Health Disparities, National Institutes of Health, Department of Health and Human Services [U01 CA 117281-01]; NCI [R25 CA090314, U01 CA114627, U54 CA153509]; NATIONAL CANCER INSTITUTE [R25CA090314, U54CA153509, P30CA076292, U01CA114627, U01CA117281] Funding Source: NIH RePORTER	National Cancer Institute (NCI), through its Center to Reduce Cancer Health Disparities, National Institutes of Health, Department of Health and Human Services; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute (NCI), through its Center to Reduce Cancer Health Disparities, National Institutes of Health, Department of Health and Human Services (U01 CA 117281-01). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCI. KW's contribution to this study was also funded by a grant from NCI (R25 CA090314; Paul B. Jacobsen, Ph.D., Principal Investigator). CM was also supported by NCI (U01 CA114627 and U54 CA153509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2009, CANCER, V115, P5788, DOI 10.1002/cncr.24633; Allen JD, 2008, PATIENT EDUC COUNS, V72, P283, DOI 10.1016/j.pec.2008.03.024; Angus Jan, 2007, Texto contexto - enferm., V16, P591, DOI 10.1590/S0104-07072007000400002; Arndt V, 2002, BRIT J CANCER, V86, P1034, DOI 10.1038/sj.bjc.6600209; Baquet CR, 2000, CANCER, V88, P1256, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1256::AID-CNCR13>3.0.CO;2-3; Battaglia TA, 2007, CANCER, V109, P359, DOI 10.1002/cncr.22354; Clark CR, 2009, J WOMENS HEALTH, V18, P677, DOI 10.1089/jwh.2008.0972; Dohan D, 2005, CANCER-AM CANCER SOC, V104, P848, DOI 10.1002/cncr.21214; Donner A, 2001, MALADIES CHRONIQUES, V33; Ell K, 2002, J WOMEN HEALTH GEN-B, V11, P639, DOI 10.1089/152460902760360586; Ell K, 2007, PREV MED, V44, P26, DOI 10.1016/j.ypmed.2006.08.001; Fedewa SA, 2011, J HEALTH CARE POOR U, V22, P128, DOI 10.1353/hpu.2011.0006; Ferrante JM, 2008, J URBAN HEALTH, V85, P114, DOI 10.1007/s11524-007-9228-9; Freeman H P, 1995, Cancer Pract, V3, P19; Freeman HP, 2012, CANCER EPIDEM BIOMAR, V21, P1614, DOI 10.1158/1055-9965.EPI-12-0982; Freund KM, 2008, CANCER-AM CANCER SOC, V113, P3391, DOI 10.1002/cncr.23960; Gwyn K, 2004, CANCER, V100, P1595, DOI 10.1002/cncr.20169; Jones BA, 2005, CANCER CAUSE CONTROL, V16, P809, DOI 10.1007/s10552-005-2905-7; Lee JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007265; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; McLaughlin JM, 2012, J CLIN ONCOL; Meade CD, 2011, HEALTH PROMOT PRACT, V12, P456, DOI 10.1177/1524839909341035; Paskett ED, 2011, PATIENT NAVIGATION U; Psooy BJ, 2004, CAN ASSOC RADIOL J, V55, P145; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Richardson LC, 2010, AM J PUBLIC HEALTH, V100, P1769, DOI 10.2105/AJPH.2009.160184; United States Census Bureau, 2011, STAT COUNT QUICK FAC; Wells KJ, 2011, J CANCER EDUC, V26, P1; Wells KJ, 2008, CANCER-AM CANCER SOC, V113, P1999, DOI 10.1002/cncr.23815; Wells KJ, 2012, CANCER EPIDEM BIOMAR, V21, P1664, DOI 10.1158/1055-9965.EPI-12-0448; Wernli KJ, 2011, AM J MANAG CARE, V17, P162; Wujcik D, 2008, CANCER NURS, V31, pE16, DOI 10.1097/01.NCC.0000305764.96732.45; Zapka Jane, 2010, Journal of the National Cancer Institute Monographs, P58, DOI 10.1093/jncimonographs/lgq009	33	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74542	10.1371/journal.pone.0074542	http://dx.doi.org/10.1371/journal.pone.0074542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066145	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000127
J	Santos, MFC; Ribolla, PEM; Alonso, DP; Andrade, JD; Casaril, AE; Ferreira, AMT; Fernandes, CES; Brazil, RP; Oliveira, AG				Santos, Mirella F. C.; Ribolla, Paulo E. M.; Alonso, Diego P.; Andrade-Filho, Jose D.; Casaril, Aline E.; Ferreira, Alda M. T.; Fernandes, Carlos E. S.; Brazil, Reginaldo P.; Oliveira, Alessandra G.			Genetic Structure of Lutzomyia longipalpis Populations in Mato Grosso Do Sul, Brazil, Based on Microsatellite Markers	PLOS ONE			English	Article							MALE SEX-PHEROMONES; SPECIES COMPLEX; VISCERAL LEISHMANIASIS; PERIOD GENE; PSYCHODIDAE; DIPTERA; MITOCHONDRIAL; VECTORS; STATE; DIFFERENTIATION	Background: Lutzomyia longipalpis (Diptera: Psychodidae) is the major vector of Leishmania (Leishmania) infantum and thus plays a crucial role in the epidemiology of American visceral leishmaniasis (AVL). This vector is the best studied species of sand fly in the Neotropical region. Many studies claim that this vector is in fact a species complex; however there is still no consensus regarding the number of species that belong into this complex or the geographical distribution of sibling species. The aim of the present study was to analyze the genetic relationships within Lu. longipalpis populations in the state of Mato Grosso do Sul (MS), Brazil. Methodology/Principal Findings: We collected 30 Lu. longipalpis (15 females and 15 males) from five localities (Campo Grande, Tres Lagoas, Aquidauana, Miranda and Bonito) and 30 Lu. Cruzi from Corumba totaling 180 sandflies from MS, and 30 Lu. longipalpis from Estrela de Alagoas, state of Alagoas (AL), Northeast Brazil. We show that eight previously described microsatellite loci were sufficient in distinguishing Lu. longipalpis from Lu. Cruzi, which is a closely related species, and in differentiating between Lu. longipalpis collected in MS versus Estrela de Alagoas. Analyses of the genotypes revealed introgression between sympatric Lu. longipalpis and Lu. Cruzi. Conclusions/Significance: Our findings support the hypothesis of cryptic species within the Lu. longipalpis complex. Furthermore, our data revealed introgression between Lu. longipalpis and Lu. cruzi. This phenomenon should be further investigated to determine the level and incidence of hybridization between these two species. We also demonstrated that microsatellite markers are a powerful tool for differentiating sand fly populations and species. The present study has elucidated the population structure of Lu. longipalpis in MS and, by extension, the Neotropical Lu. longipalpis complex itself.	[Santos, Mirella F. C.; Casaril, Aline E.; Oliveira, Alessandra G.] Univ Fed Mato Grosso do Sul, UFMS, Fac Med FAMED, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil; [Ribolla, Paulo E. M.; Alonso, Diego P.] Univ Estadual Paulista, UNESP, Dept Parasitol, Sao Paulo, Brazil; [Andrade-Filho, Jose D.] CCPQRR FIOCRUZ, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Ferreira, Alda M. T.] Univ Fed Mato Grosso do Sul, UFMS, Lab Imunol, Campo Grande, MS, Brazil; [Fernandes, Carlos E. S.] Univ Fed Mato Grosso do Sul, UFMS, Lab Patol, Campo Grande, MS, Brazil; [Brazil, Reginaldo P.] Fiocruz MS, Inst Oswaldo Cruz, Lab Doencas Parasitarias, BR-21045900 Rio De Janeiro, Brazil; [Oliveira, Alessandra G.] Univ Fed Mato Grosso do Sul, UFMS, Lab Parasitol, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso do Sul	Santos, MFC (corresponding author), Univ Fed Mato Grosso do Sul, UFMS, Fac Med FAMED, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil.	mirellabio@hotmail.com	Ribolla, Paulo/AAH-3354-2020; Alonso, Diego P/C-1079-2012; Andrade Filho, José Dilermando/B-7852-2013; Brazil, Reginaldo Peçanha/AAF-6777-2019; Alonso, Diego/GRO-4526-2022; Fernandes, Carlos/D-9704-2014; Ribolla, Paulo EM/B-9122-2012	Andrade Filho, José Dilermando/0000-0002-9754-8464; Alonso, Diego/0000-0003-4992-6253; Fernandes, Carlos/0000-0001-5425-1866; Ribolla, Paulo EM/0000-0001-8735-6090	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Secretaria Estadual de Saude de Mato Grosso do Sul (SES/MS) - edital: FUNDECT/MS/CNPq/SES [07/2009]; Secretaria Estadual de Saude de Mato Grosso do Sul (SES/MS) - edital: FUNDECT/CNPq - Programa Primeiros Projetos [08/2009]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Secretaria Estadual de Saude de Mato Grosso do Sul (SES/MS) - edital: FUNDECT/MS/CNPq/SES; Secretaria Estadual de Saude de Mato Grosso do Sul (SES/MS) - edital: FUNDECT/CNPq - Programa Primeiros Projetos; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work relied on financial support of Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Secretaria Estadual de Saude de Mato Grosso do Sul (SES/MS) - edital: FUNDECT/MS/CNPq/SES No 07/2009 and edital: FUNDECT/CNPq No 08/2009 - Programa Primeiros Projetos; also Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Angella AF, 2007, MEM I OSWALDO CRUZ, V102, P953, DOI 10.1590/S0074-02762007000800010; Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Arrivillaga JC, 2001, J MED ENTOMOL, V38, P783, DOI 10.1603/0022-2585-38.6.783; Balbino VD, 2006, ACTA TROP, V98, P15, DOI 10.1016/j.actatropica.2006.01.007; Bauzer LGSR, 2002, INSECT MOL BIOL, V11, P315, DOI 10.1046/j.1365-2583.2002.00340.x; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Day JC, 1999, INSECT MOL BIOL, V8, P575, DOI 10.1046/j.1365-2583.1999.00142.x; de Souza NA, 2002, T ROY SOC TROP MED H, V96, P102, DOI 10.1016/S0035-9203(02)90258-0; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dias Edelberto S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P49, DOI 10.1590/S0036-46651998000100010; Dorval MEMC, 2006, REV SOC BRAS MED TRO, V39, P43, DOI 10.1590/S0037-86822006000100008; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011; Hamilton JGC, 2005, MED VET ENTOMOL, V19, P480, DOI 10.1111/j.1365-2915.2005.00594.x; Hamilton JGC, 1996, J CHEM ECOL, V22, P1477, DOI 10.1007/BF02027726; Hodgkinson VH, 2003, AM J TROP MED HYG, V69, P386, DOI 10.4269/ajtmh.2003.69.386; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lainson R, 2005, TOPLEY WILSONS MICRO, P313; LANZARO GC, 1993, AM J TROP MED HYG, V48, P839, DOI 10.4269/ajtmh.1993.48.839; Lins RMMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044323; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Maingon RDC, 2003, MOL ECOL, V12, P1879, DOI 10.1046/j.1365-294X.2003.01871.x; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; Mangabeira Filho O., 1969, REV BRASILEIRA MALAR, V21, P3; Marcondes CB, 1997, T ROY SOC TROP MED H, V91, P725, DOI 10.1016/S0035-9203(97)90540-X; MARTINS A., 1984, MEM I O CRUZ, V79, P439, DOI DOI 10.1590/S0074-02761984000400007; Mazzoni CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-141; Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242; Minch E., 1996, MICROSAT VERSION 1 5; Molina-Cruz A, 2004, AM J TROP MED HYG, V71, P350, DOI 10.4269/ajtmh.2004.71.350; Mutebi JP, 2002, ANN ENTOMOL SOC AM, V95, P741; Pritchard JK, 2000, GENETICS, V155, P945; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Ward PC, 1983, MEM I O CRUZ, V78, P269; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; Watts PC, 2002, MOL ECOL NOTES, V2, P62, DOI 10.1046/j.1471-8286.2002.00150.x; WEBER JL, 1989, AM J HUM GENET, V44, P388; Yin HZ, 1999, MED VET ENTOMOL, V13, P72, DOI 10.1046/j.1365-2915.1999.00139.x	46	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74268	10.1371/journal.pone.0074268	http://dx.doi.org/10.1371/journal.pone.0074268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066129	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000111
J	Schmitt, S; Safferling, K; Westphal, K; Hrabowski, M; Muller, U; Angel, P; Wiechert, L; Ehemann, V; Muller, B; Holland-Cunz, S; Stichel, D; Harder, N; Rohr, K; Germann, G; Matthaus, F; Schirmacher, P; Grabe, N; Breuhahn, K				Schmitt, Sabrina; Safferling, Kai; Westphal, Kathi; Hrabowski, Manuel; Mueller, Ute; Angel, Peter; Wiechert, Lars; Ehemann, Volker; Mueller, Benedikt; Holland-Cunz, Stefan; Stichel, Damian; Harder, Nathalie; Rohr, Karl; Germann, Guenter; Matthaeus, Franziska; Schirmacher, Peter; Grabe, Niels; Breuhahn, Kai			Stathmin Regulates Keratinocyte Proliferation and Migration during Cutaneous Regeneration	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; IN-VITRO; C-MET; SKIN; PHOSPHORYLATION; REEPITHELIALIZATION; IDENTIFICATION; MORPHOGENESIS; EXPRESSION; GENES	Cutaneous regeneration utilizes paracrine feedback mechanisms to fine-tune the regulation of epidermal keratinocyte proliferation and migration. However, it is unknown how fibroblast-derived hepatocyte growth factor (HGF) affects these mutually exclusive processes in distinct cell populations. We here show that HGF stimulates the expression and phosphorylation of the microtubule-destabilizing factor stathmin in primary human keratinocytes. Quantitative single cell- and cell population-based analyses revealed that basal stathmin levels are important for the migratory ability of keratinocytes in vitro; however, its expression is moderately induced in the migration tongue of mouse skin or organotypic multi-layered keratinocyte 3D cultures after full-thickness wounding. In contrast, clearly elevated stathmin expression is detectable in hyperproliferative epidermal areas. In vitro, stathmin silencing significantly reduced keratinocyte proliferation. Automated quantitative and time-resolved analyses in organotypic cocultures demonstrated a high correlation between Stathmin/phospho-Stathmin and Ki67 positivity in epidermal regions with proliferative activity. Thus, activation of stathmin may stimulate keratinocyte proliferation, while basal stathmin levels are sufficient for keratinocyte migration during cutaneous regeneration.	[Schmitt, Sabrina; Mueller, Ute; Ehemann, Volker; Mueller, Benedikt; Schirmacher, Peter; Breuhahn, Kai] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Safferling, Kai; Westphal, Kathi; Grabe, Niels] Univ Heidelberg Hosp, Sect Med Informat, Inst Med Biometry & Informat, Heidelberg, Germany; [Hrabowski, Manuel; Germann, Guenter] Heidelberg Univ, Dept Hand & Plast Surg, BG Trauma Ctr, Heidelberg, Germany; [Angel, Peter; Wiechert, Lars] Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, Heidelberg, Germany; [Holland-Cunz, Stefan] Univ Heidelberg Hosp, Div Pediat Surg, Heidelberg, Germany; [Stichel, Damian; Matthaeus, Franziska] Heidelberg Univ, Ctr Modeling & Simulat Biosci BIOMS, Heidelberg, Germany; [Harder, Nathalie; Rohr, Karl] Heidelberg Univ, BIOQUANT, Biomed Comp Vis Grp BMCV, Heidelberg, Germany; [Harder, Nathalie; Rohr, Karl] Heidelberg Univ, IPMB, Heidelberg, Germany; [Harder, Nathalie; Rohr, Karl] DKFZ, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Breuhahn, K (corresponding author), Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany.	kai.breuhahn@med.uni-heidelberg.de	Matthäus, Franziska/AAE-5523-2022; Grabe, Niels/I-6214-2016; Grabe, Niels/AAP-6493-2020	Matthäus, Franziska/0000-0001-6042-1366; Harder, Nathalie/0000-0002-6171-6462; Breuhahn, Kai/0000-0002-2462-1229; Grabe, Niels/0000-0003-1732-3706	BMBF (MedSys 'Chronic Wounds') [0315401A/B]	BMBF (MedSys 'Chronic Wounds')(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant from the BMBF (MedSys 'Chronic Wounds', 0315401A/B to PS, KB, NG, GG, and PA). No conflicts of financial interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Belleudi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029159; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christensen JG, 2003, CANCER RES, V63, P7345; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; Factor VM, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0012739; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; JI H, 1993, J BIOL CHEM, V268, P13396; Kinoshita I, 2003, ONCOGENE, V22, P2710, DOI 10.1038/sj.onc.1206371; Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nayeri F, 2002, J DERMATOL TREAT, V13, P81, DOI 10.1080/095466302317584449; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Pommerencke T, 2010, BIOINFORMATICS, V26, P2760, DOI 10.1093/bioinformatics/btq525; Schnickmann S, 2009, J INVEST DERMATOL, V129, P1140, DOI 10.1038/jid.2008.350; Singer S, 2007, HEPATOLOGY, V46, P759, DOI 10.1002/hep.21736; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639	33	13	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75075	10.1371/journal.pone.0075075	http://dx.doi.org/10.1371/journal.pone.0075075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066165	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000147
J	Verma, A; Perumalsamy, V; Shetty, S; Kulm, M; Sundaresan, P				Verma, Anshuman; Perumalsamy, Vijayalakshmi; Shetty, Shashikant; Kulm, Maigi; Sundaresan, Periasamy			Mutational Screening of LCA Genes Emphasizing RPE65 in South Indian Cohort of Patients	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; RETINAL DYSTROPHIES; GENOTYPING MICROARRAY; MODIFIER ALLELES; AIPL1 MUTATIONS; THERAPY; DISEASE; IDENTIFICATION; MODEL	Background: Leber congenital amaurosis (LCA) is the most severe form of inherited retinal visual impairment in children. So far, mutations in more than 20 genes have been known to cause LCA and among them, RPE65 is a suitable candidate for gene therapy. The mutational screenings of RPE65 and other LCA genes are requisite in support of emerging gene specific therapy for LCA. Therefore, we have carried out a comprehensive LCA genes screening using a combined approach of direct sequencing and DNA microarray based Asper chip analysis. Methodology/Principal Findings: Thirty clinically diagnosed index LCA cases from Southern India were screened for coding and flanking intronic regions of RPE65 through direct sequencing. Among thirty, 25 cases excluded from RPE65 mutations were subjected to Asper chip analysis, testing 784 known pathogenic variations in 15 major LCA genes. In RPE65 screening, four different pathogenic variations including two novel (c.361insT & c.939T>A) and two known (c.394G>A & c.361delT) mutations were identified in five index cases. In the chip analysis, seven known pathogenic mutations were identified in six index cases, involving genes GUCY2D, RPGRIP1, AIPL1, CRX and IQCB1. Overall, 11 out of 30 LCA cases (36.6%) revealed pathogenic variations with the involvement of RPE65 (16.6%), GUCY2D (10%), RPGRIP1 (3.3%), AIPL1 (3.3%) and CRX & IQCB1 (3.3%). Conclusions/Significance: Our study suggests that such combined screening approach is productive and cost-effective for mutation detection and can be applied in Indian LCA cohort for molecular diagnosis and genetic counselling.	[Verma, Anshuman; Sundaresan, Periasamy] Aravind Eye Hosp, Aravind Med Res Fdn, Dr G Venkataswamy Eye Res Inst, Dept Genet, Madurai, Tamil Nadu, India; [Perumalsamy, Vijayalakshmi; Shetty, Shashikant] Aravind Eye Hosp, Pediat Eye Clin, Madurai, Tamil Nadu, India; [Kulm, Maigi] Asper Biotech, Tartu, Estonia		Sundaresan, P (corresponding author), Aravind Eye Hosp, Aravind Med Res Fdn, Dr G Venkataswamy Eye Res Inst, Dept Genet, Madurai, Tamil Nadu, India.	sundar@aravind.org	VERMA, ANSHUMAN/AGX-3210-2022; .P, Sundaresan/AAR-8426-2021	VERMA, ANSHUMAN/0000-0003-0948-0154; 	Indian Council of Medical Research (ICMR), New Delhi, India; Aravind Medical Research Foundation (AMRF), Madurai, India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Aravind Medical Research Foundation (AMRF), Madurai, India	This study was supported by the Indian Council of Medical Research (ICMR), New Delhi, India, (http://www.icmr.nic.in) and Aravind Medical Research Foundation (AMRF), Madurai, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Bonilha VL, 2011, INVEST OPHTH VIS SCI, V52, P8381, DOI 10.1167/iovs.11-7973; Booij JC, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035121; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Chen Y, 2013, INVEST OPHTH VIS SCI, V13, P11606; Coppieters F, 2010, HUM MUTAT, V31, pE1709, DOI 10.1002/humu.21336; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Gallon VA, 2004, BBA-MOL BASIS DIS, V1690, P141, DOI 10.1016/j.bbadis.2004.06.012; Gandra M, 2010, 2579A368 US ARVO; Glockle N, 2013, EUR J HUM GENET, DOI [10.1038/ejhg.2013.72, DOI 10.1038/EJHG.2013.72.[]; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; Hufnagel RB, 2012, GRAEF ARCH CLIN EXP, V250, P1117, DOI 10.1007/s00417-012-2028-2; Kaplan J, 2008, OPHTHALMIC GENET, V29, P92, DOI 10.1080/13816810802232768; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Koenekoop RK, 2007, CLIN EXP OPHTHALMOL, V35, P473, DOI 10.1111/j.1442-9071.2007.01534.x; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Kumaramanickavel G, 2002, Community Genet, V5, P182, DOI 10.1159/000066334; Kurg A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Li YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/iovs.08-2589; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mamatha G, 2008, OPHTHALMIC GENET, V29, P73, DOI 10.1080/13816810802008259; Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Mihelec M, 2011, HUM GENE THER, V22, P1179, DOI 10.1089/hum.2011.069; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nichols Lorenzo L, 2010, HUM MUTAT, V31, pe1472; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Sitorus R, 2003, BRIT J OPHTHALMOL, V87, P1065, DOI 10.1136/bjo.87.9.1065; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Stieger K, 2010, DISCOV MED, V10, P425; Sundaresan P, 2009, MOL VIS, V15, P1781; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Testa F, 2011, INVEST OPHTH VIS SCI, V52, P5618, DOI 10.1167/iovs.10-6543; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Xu F, 2012, MOL VIS, V18, P744; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111	46	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73172	10.1371/journal.pone.0073172	http://dx.doi.org/10.1371/journal.pone.0073172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066033	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000014
J	Nayak, S; Dey, S; Kundu, SC				Nayak, Sunita; Dey, Sancharika; Kundu, Subhas C.			Skin Equivalent Tissue-Engineered Construct: Co-Cultured Fibroblasts/Keratinocytes on 3D Matrices of Sericin Hope Cocoons	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; PORE-SIZE; CELL; DELIVERY; PROTEIN; HYDROGELS; GENIPIN; DESIGN; REGENERATION; FIBROBLASTS	The development of effective and alternative tissue-engineered skin replacements to autografts, allografts and xenografts has became a clinical requirement due to the problems related to source of donor tissue and the perceived risk of disease transmission. In the present study 3D tissue engineered construct of sericin is developed using co-culture of keratinocytes on the upper surface of the fabricated matrices and with fibroblasts on lower surface. Sericin is obtained from "Sericin Hope" silkworm of Bombyx mori mutant and is extracted from cocoons by autoclave. Porous sericin matrices are prepared by freeze dried method using genipin as crosslinker. The matrices are characterized biochemically and biophysically. The cell proliferation and viability of co-cultured fibroblasts and keratinocytes on matrices for at least 28 days are observed by live/dead assay, Alamar blue assay, and by dual fluorescent staining. The growth of the fibroblasts and keratinocytes in co-culture is correlated with the expression level of TGF-beta, b-FGF and IL-8 in the cultured supernatants by enzyme-linked immunosorbent assay. The histological analysis further demonstrates a multi-layered stratified epidermal layer of uninhibited keratinocytes in co-cultured constructs. Presence of involucrin, collagen IV and the fibroblast surface protein in immuno-histochemical stained sections of co-cultured matrices indicates the significance of paracrine signaling between keratinocytes and fibroblasts in the expression of extracellular matrix protein for dermal repair. No significant amount of pro inflammatory cytokines (TNF-alpha, IL-1 beta and nitric oxide) production are evidenced when macrophages grown on the sericin matrices. The results all together depict the potentiality of sericin 3D matrices as skin equivalent tissue engineered construct in wound repair.	[Nayak, Sunita; Dey, Sancharika; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Kundu, SC (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	kundu@hijli.iitkgp.ernet.in	Nayak, Sunita/T-2857-2019; Kundu, Subhas C/AAC-1317-2020; Dey, Sanchareeka/AAE-9248-2022	Kundu, Subhas C/0000-0002-7170-2291; Nayak, Sunita/0000-0002-2092-8266	Department of Biotechnology; Department of Science and Technology, Government of India, New Delhi	Department of Biotechnology; Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	This work is supported by Department of Biotechnology and its Bioinformatics facilities (also Senior Research Fellowship to SN) and Department of Science and Technology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramwit P, 2012, WASTE MANAGE RES, V30, P217, DOI 10.1177/0734242X11404733; Ashkenas J, 1996, DEV BIOL, V180, P433, DOI 10.1006/dbio.1996.0317; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Brohem CA, 2011, PIGM CELL MELANOMA R, V24, P35, DOI 10.1111/j.1755-148X.2010.00786.x; Canton I, 2010, BIOTECHNOL BIOENG, V106, P794, DOI 10.1002/bit.22742; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F; Chunthapong J, 2008, EUR CELLS MATER, V16, P1473; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019; Eckes B, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-4; Garland CB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00453; Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x; Harvey KA, 2007, J CELL PHYSIOL, V211, P353, DOI 10.1002/jcp.20939; Hunt Nicola C., 2009, Biotechnology Journal, V4, P730, DOI 10.1002/biot.200800292; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Javaherian A, 1998, CANCER RES, V58, P2200; Kasputis T, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-17; KONIG A, 1992, J CELL BIOL, V117, P679, DOI 10.1083/jcb.117.3.679; Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091; Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024; Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884; Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5; Leon-Villapalos J, 2010, CELL TISSUE BANK, V11, P99, DOI 10.1007/s10561-009-9152-1; Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563; Lim KS, 2012, MACROMOL BIOSCI, V12, P322, DOI 10.1002/mabi.201100292; Lorenti A, 2012, CELL BIOL, V1, P17, DOI DOI 10.4236/cellbio.2012.12003; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026; Mase Keisuke, 2006, Journal of Insect Biotechnology and Sericology, V75, P85; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747; Nayak S, 2012, CELL TISSUE RES, V347, P783, DOI 10.1007/s00441-011-1269-4; Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019; Shaykhiev R, 2007, J LEUKOCYTE BIOL, V82, P1, DOI 10.1189/jlb.0207096; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; WOODLEY DT, 1988, J CELL PHYSIOL, V136, P140, DOI 10.1002/jcp.1041360118; Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869; YANNAS I V, 1992, Clinical Materials, V9, P179, DOI 10.1016/0267-6605(92)90098-E; Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183; Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4	50	47	51	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74779	10.1371/journal.pone.0074779	http://dx.doi.org/10.1371/journal.pone.0074779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058626	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400095
J	Karpati, Z; Knaden, M; Reinecke, A; Hansson, BS				Karpati, Zsolt; Knaden, Markus; Reinecke, Andreas; Hansson, Bill S.			Intraspecific Combinations of Flower and Leaf Volatiles Act Together in Attracting Hawkmoth Pollinators	PLOS ONE			English	Article							MANDUCA-SEXTA; NICOTIANA-ATTENUATA; CONSEQUENCES; PLANTS; MOTH; PHEROMONES; EMISSIONS; BLENDS; CHOICE; CUES	Insects pinpoint mates, food and oviposition sites by olfactory cues. Recognizing and localizing a suitable target by olfaction is demanding. Odor sources emit characteristic blends of compounds that have to be identified against an environmentally derived olfactory background. This background, however, does not necessarily disturb the localization of a source. Rather, the contrary. Sex pheromones become more attractive to male moths when being presented against a relevant plant background. Here we asked whether such olfactory coaction also characterizes foraging cues. The tobacco hornworm Manduca sexta feeds on nectar from wild tobacco Nicotiana attenuata and sacred datura Datura wrightii flowers. We tested how leaf-derived volatile blends as a background affect the moths' approach to flower blends. We found coaction when a flower blend was presented against a conspecific leaf volatile background but not when the blend was presented against volatiles emitted by the other host plant or by a non-host plant. Hence, our results reveal a species-specific coaction between flower blend and leaf volatile background. The ability to integrate information from different odor sources on one plant might provide the moth with a fine-grained analysis of food site quality.	[Karpati, Zsolt; Knaden, Markus; Reinecke, Andreas; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Karpati, Zsolt] Hungarian Acad Sci, Inst Plant Protect, Agr Res Ctr, Budapest, Hungary; [Reinecke, Andreas] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Max Planck Society	Hansson, BS (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	mknaden@ice.mpg.de; hansson@ice.mpg.de	Karpati, Zsolt/AAX-9991-2021; Hansson, Bill S/G-2774-2013; Knaden, Markus/E-2151-2015	Karpati, Zsolt/0000-0002-5767-460X; Hansson, Bill S/0000-0002-4811-1223; Knaden, Markus/0000-0002-6710-1071; Reinecke, Andreas/0000-0002-9336-7324	Max-Planck Society; EU [IEF-255193]; Hungarian Scientific Research Foundation [OTKA PD 1041310]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); EU(European Commission); Hungarian Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Max-Planck Society, Marie Curie IEF-255193 EU Grant and Hungarian Scientific Research (OTKA PD 1041310) Foundation for support of ZK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Baldwin IT, 1997, J CHEM ECOL, V23, P2327, DOI 10.1023/B:JOEC.0000006677.56380.cd; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Bronstein JL, 2009, ANN BOT-LONDON, V103, P1435, DOI 10.1093/aob/mcp053; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Goyret J, 2008, P NATL ACAD SCI USA, V105, P4565, DOI 10.1073/pnas.0708629105; HABER WA, 1984, BIOTROPICA, V16, P269, DOI 10.2307/2387935; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Karpati Z, 2013, P NATL ACAD SCI USA, V110, P7377, DOI 10.1073/pnas.1216145110; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Mechaber W. L., 2002, Journal of Insect Science (Tucson), V2, P1; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2007, J INSECT PHYSIOL, V53, P923, DOI 10.1016/j.jinsphys.2007.03.007; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Schuman MC, 2012, ELIFE, V1, DOI 10.7554/eLife.00007; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Trona F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0267; Varela N, 2011, ENTOMOL EXP APPL, V141, P114, DOI 10.1111/j.1570-7458.2011.01171.x; von Arx M, 2012, P NATL ACAD SCI USA, V109, P9471, DOI 10.1073/pnas.1121624109; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y	26	15	19	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72805	10.1371/journal.pone.0072805	http://dx.doi.org/10.1371/journal.pone.0072805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069159	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000326240100018
J	Turrientes, MC; Baquero, F; Levin, BR; Martinez, JL; Ripoll, A; Gonzalez-Alba, JM; Tobes, R; Manrique, M; Baquero, MR; Rodriguez-Dominguez, MJ; Canton, R; Galan, JC				Turrientes, Maria-Carmen; Baquero, Fernando; Levin, Bruce R.; Martinez, Jose-Luis; Ripoll, Aida; Gonzalez-Alba, Jose-Maria; Tobes, Raquel; Manrique, Marina; Baquero, Maria-Rosario; Rodriguez-Dominguez, Mario-Jose; Canton, Rafael; Galan, Juan-Carlos			Normal Mutation Rate Variants Arise in a Mutator (Mut S) Escherichia coli Population	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; HORIZONTAL TRANSFER; EVOLUTION; RESISTANCE; FREQUENCY; SELECTION; STRESS; MUTAGENESIS; GENES; IDENTIFICATION	The rate at which mutations are generated is central to the pace of evolution. Although this rate is remarkably similar amongst all cellular organisms, bacterial strains with mutation rates 100 fold greater than the modal rates of their species are commonly isolated from natural sources and emerge in experimental populations. Theoretical studies postulate and empirical studies teort the hypotheses that these "mutator'' strains evolved in response to selection for elevated rates of generation of inherited variation that enable bacteria to adapt to novel and/or rapidly changing environments. Less clear are the conditions under which selection will favor reductions in mutation rates. Declines in rates of mutation for established populations of mutator bacteria are not anticipated if such changes are attributed to the costs of augmented rates of generation of deleterious mutations. Here we report experimental evidence of evolution towards reduced mutation rates in a clinical isolate of Escherichia coli with an hyper-mutable phenotype due a deletion in a mismatch repair gene, (Delta mutS). The emergence in a DmutS background of variants with mutation rates approaching those of the normal rates of strains carrying wild-type MutS was associated with increase in fitness with respect to ancestral strain. We postulate that such an increase in fitness could be attributed to the emergence of mechanisms driving a permanent "aerobic style of life'', the negative consequence of this behavior being regulated by the evolution of mechanisms protecting the cell against increased endogenous oxidative radicals involved in DNA damage, and thus reducing mutation rate. Gene expression assays and full sequencing of evolved mutator and normo-mutable variants supports the hypothesis. In conclusion, we postulate that the observed reductions in mutation rate are coincidental to, rather than, the selective force responsible for this evolution.	[Turrientes, Maria-Carmen; Baquero, Fernando; Ripoll, Aida; Gonzalez-Alba, Jose-Maria; Rodriguez-Dominguez, Mario-Jose; Canton, Rafael; Galan, Juan-Carlos] Ramon & Cajal Inst Hlth Res, Dept Microbiol, Madrid, Spain; [Turrientes, Maria-Carmen; Baquero, Fernando; Ripoll, Aida; Gonzalez-Alba, Jose-Maria; Galan, Juan-Carlos] Carlos III Hlth Inst, Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid, Spain; [Baquero, Fernando; Martinez, Jose-Luis; Galan, Juan-Carlos] Joint Unit Res Antibiot Resistance & Virulence, Madrid, Spain; [Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Martinez, Jose-Luis] Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid, Spain; [Tobes, Raquel; Manrique, Marina] Era7 Bioinformat, Res Dept, Granada, Spain; [Baquero, Maria-Rosario; Canton, Rafael] Alfonso X El Sabio Univ, Fac Hlth Sci, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Emory University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Alfonso X el Sabio (UAX)	Baquero, F (corresponding author), Ramon & Cajal Inst Hlth Res, Dept Microbiol, Madrid, Spain.	baquero@bitmailer.net; jgalanm.hrc@salud.madrid.org	Manrique, Marina/GYQ-5538-2022; Martinez, Jose L/A-4725-2013; CANTON, RAFAEL/ABF-6353-2020; Rodriguez-Dominguez, Mario/J-4431-2015; Cantón, Rafael/AAP-8669-2021	Martinez, Jose L/0000-0001-8813-7607; Rodriguez-Dominguez, Mario/0000-0002-1783-9318; Canton, Rafael/0000-0003-1675-3173; Baquero Artigao, Maria Rosario/0000-0001-8825-1696	European Union [LSHM-CT-2005-518152, LSHM-CT-2005-018705, EvoTAR-282004, PAR-241476]; US National Institutes of Health [GM091875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091875] Funding Source: NIH RePORTER	European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sources of funding include Grants LSHM-CT-2005-518152, LSHM-CT-2005-018705, EvoTAR-282004 and PAR-241476 from the European Union as well as the US National Institutes of Health (GM091875, BRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Baquero MR, 2005, ANTIMICROB AGENTS CH, V49, P4754, DOI 10.1128/AAC.49.11.4754-4756.2005; Baquero MR, 2004, J BACTERIOL, V186, P5538, DOI 10.1128/JB.186.16.5538-5542.2004; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V322, P291, DOI 10.1006/abbi.1995.1465; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Boe L, 2000, MUTAT RES-FUND MOL M, V448, P47, DOI 10.1016/S0027-5107(99)00239-0; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; CHAO L, 1983, NATURE, V303, P633, DOI 10.1038/303633a0; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dawson KJ, 1998, J THEOR BIOL, V194, P143, DOI 10.1006/jtbi.1998.0752; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Desai MM, 2011, GENETICS, V188, P997, DOI 10.1534/genetics.111.128116; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; EISENSTARK A, 1992, BIOCHEM BIOPH RES CO, V188, P1054, DOI 10.1016/0006-291X(92)91338-Q; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; Funchain P, 2000, GENETICS, V154, P959; Galan JC, 2007, FEMS MICROBIOL LETT, V275, P263, DOI 10.1111/j.1574-6968.2007.00902.x; Gentile CF, 2011, BIOL LETTERS, V7, P422, DOI 10.1098/rsbl.2010.1036; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; Gould CV, 2007, ANTIMICROB AGENTS CH, V51, P3225, DOI 10.1128/AAC.00336-07; GREENBERG JT, 1988, EMBO J, V7, P2611, DOI 10.1002/j.1460-2075.1988.tb03111.x; Guelfo JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000931; HASSAN HM, 1977, J BACTERIOL, V130, P805, DOI 10.1128/JB.130.2.805-811.1977; Heo M, 2009, P NATL ACAD SCI USA, V106, P1869, DOI 10.1073/pnas.0809852106; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jayaraman R, 2011, J GENET, V90, P383, DOI 10.1007/s12041-011-0086-6; Kaufmann ME, 1988, METHODS MOL MED, V15, P17; Kinnersley MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000713; Kotewicz ML, 2003, TRENDS MICROBIOL, V11, P2, DOI 10.1016/S0966-842X(02)00005-7; Laureti L, 2013, DNA REPAIR, V12, P300, DOI 10.1016/j.dnarep.2013.01.009; Le Chat L, 2006, MICROBIOL-SGM, V152, P67, DOI 10.1099/mic.0.28418-0; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; LEVIN BR, 1981, GENETICS, V99, P1; Levin BR, 2000, P NATL ACAD SCI USA, V97, P6981, DOI 10.1073/pnas.97.13.6981; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Loui C, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-183; Lu S, 2002, INFECT IMMUN, V70, P451, DOI 10.1128/IAI.70.2.451-461.2002; Luria SE, 1943, GENETICS, V28, P491; Maharjan RP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0961; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; McDonald MJ, 2012, CURR BIOL, V22, P1235, DOI 10.1016/j.cub.2012.04.056; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Murphy KC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-26; Neher RA, 2012, GENETICS, V191, P1283, DOI 10.1534/genetics.112.141325; Notley-McRobb L, 2000, GENETICS, V156, P1493; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pareja-Tobes P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049239; ROSENZWEIG RF, 1994, GENETICS, V137, P903; ROSENZWEIG RF, 1994, BIOESSAYS, V16, P715, DOI 10.1002/bies.950161005; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Strohmeier-Gort A, 1998, J BACTERIOL, V180, P1402; Tanaka MM, 2003, GENETICS, V164, P843; Tarassova K, 2009, J BACTERIOL, V191, P3604, DOI 10.1128/JB.01803-08; TROBNER W, 1984, MOL GEN GENET, V198, P177, DOI 10.1007/BF00328720; Vidales LE, 2009, J BACTERIOL, V191, P506, DOI 10.1128/JB.01210-08; Volkert Michael R., 2008, V477, P331, DOI 10.1007/978-1-60327-517-0_25; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Wong SMS, 2007, MOL MICROBIOL, V64, P1375, DOI 10.1111/j.1365-2958.2007.05747.x; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	72	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72963	10.1371/journal.pone.0072963	http://dx.doi.org/10.1371/journal.pone.0072963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069167	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100025
J	Almeida, ST; de Lencastre, H; Sa-Leao, R				Almeida, Sonia T.; de Lencastre, Herminia; Sa-Leao, Raquel			Epidemiology and Population Structure of Serotypes 1, 5 and 7F Carried by Children in Portugal from 1996-2010 before Introduction of the 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPE-1; COLONIZING HEALTHY-CHILDREN; INVASIVE-DISEASE; TEMPORAL TRENDS; VACCINATION; ERA; DIVERSITY; EMERGENCE; COMMUNITY; OUTBREAK	Among the over 90 serotypes of Streptococcus pneumoniae described, serotypes 1, 5, and 7F account for a significant proportion of invasive disease worldwide and are now covered by the most recent 10- and 13-valent pneumococcal conjugate vaccines (PCVs). The epidemiology of these serotypes in carriage remains poorly studied because they are rarely detected. We aimed to gain insights into the epidemiology and population structure of serotypes 1, 5 and 7F carried by children in Portugal before PCV10 and PCV13 became widely used. Isolates obtained in cross-sectional studies carried out over a 15-year period (1996-2010) were retrospectively pooled and characterized. Of 5,123 pneumococci obtained, 70 were associated with serotypes 1 (n = 21), 5 (n = 7), and 7F (n = 42). The highest prevalence detected was 3.3% for serotype 1 in 2006, 1% for serotype 5 in 2009, and 3.3% for serotype 7F in 2006; Serotype 1 was associated with PMEN international clones Sweden(1)-28(ST306) and Sweden(1)-40(ST304); serotype 5 was associated with Colombia(5)-19(ST289); and serotype 7F was associated with Netherlands(7F)-39(ST191). All these isolates were fully susceptible. Most carriers of serotypes 1 (86%), 5 (86%), and 7F (91%) were older than two years but a significant association with older age was only observed for serotype 7F (p = 0.006). Evidence for cross-transmission was obtained. In conclusion, we were able to detect and characterize the rarely carried serotypes 1, 5, and 7F among healthy children in Portugal. These data will constitute an important baseline for upcoming surveillance studies aimed to establish the impact of novel PCVs targeting these serotypes in carriage.	[Almeida, Sonia T.; Sa-Leao, Raquel] Univ Nova Lisboa, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal; [Almeida, Sonia T.; de Lencastre, Herminia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Rockefeller University	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal.	rsaleao@itqb.unl.pt	Sá-Leão, Raquel/A-9341-2011	Sá-Leão, Raquel/0000-0001-9804-827X; /0000-0001-6816-8932; Almeida, Sonia/0000-0002-8143-5254	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/SAU-ESA/65048/2006, PTDC/BIA-BEC/098289/2008, PEst-OE/EQB/LA0004/2011]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was supported by projects PTDC/SAU-ESA/65048/2006, PTDC/BIA-BEC/098289/2008 and PEst-OE/EQB/LA0004/2011 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Balicer RD, 2010, VACCINE, V28, P5591, DOI 10.1016/j.vaccine.2010.06.031; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Carrolo M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-191; CLSI. Performance Standards for Antimocrobial Susceptibility Testing, 2008, M2A9 CLSI S, V28; Cohen R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-52; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Jourdain S, 2013, PEDIATR INFECT DIS J, V32, P86, DOI 10.1097/INF.0b013e3182755cb7; Mato R, 2005, MICROB DRUG RESIST, V11, P309, DOI 10.1089/mdr.2005.11.309; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nunes S, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01871.x; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Romney MG, 2008, CLIN INFECT DIS, V47, P768, DOI 10.1086/591128; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Williams TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026742	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75442	10.1371/journal.pone.0075442	http://dx.doi.org/10.1371/journal.pone.0075442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058686	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900117
J	Chandra, S; Barth, RF; Haider, SA; Yang, WL; Huo, TY; Shaikh, AL; Kabalka, GW				Chandra, Subhash; Barth, Rolf F.; Haider, Syed A.; Yang, Weilian; Huo, Tianyao; Shaikh, Aarif L.; Kabalka, George W.			Biodistribution and Subcellular Localization of an Unnatural Boron-Containing Amino Acid (Cis-ABCPC) by Imaging Secondary Ion Mass Spectrometry for Neutron Capture Therapy of Melanomas and Gliomas	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GLIOBLASTOMA-MULTIFORME; IN-VIVO; INTRACAROTID INJECTION; CULTURED-CELLS; BORONOPHENYLALANINE; MICROSCOPY; TRANSPORTER-1; CALCIUM; CANCER	The development of new boron-delivery agents is a high priority for improving the effectiveness of boron neutron capture therapy. In the present study, 1-amino-3-borono-cyclopentanecarboxylic acid (cis-ABCPC) as a mixture of its L- and D-enantiomers was evaluated in vivo using the B16 melanoma model for the human tumor and the F98 rat glioma as a model for human gliomas. A secondary ion mass spectrometry (SIMS) based imaging instrument, CAMECA IMS 3F SIMS Ion Microscope, was used for quantitative imaging of boron at 500 nm spatial resolution. Both in vivo and in vitro studies in melanoma models demonstrated that boron was localized in the cytoplasm and nuclei with some cell-to-cell variability. Uptake of cis-ABCPC in B16 cells was time dependent with a 7.5: 1 partitioning ratio of boron between cell nuclei and the nutrient medium after 4 hrs. incubation. Furthermore, cis-ABCPC delivered boron to cells in all phases of the cell cycle, including S-phase. In vivo SIMS studies using the F98 rat glioma model revealed an 8: 1 boron partitioning ratio between the main tumor mass and normal brain tissue with a 5: 1 ratio between infiltrating tumor cells and contiguous normal brain. Since cis-ABCPC is water soluble and can cross the blood-brain-barrier via the L-type amino acid transporters (LAT), it may accumulate preferentially in infiltrating tumor cells in normal brain due to up-regulation of LAT in high grade gliomas. Once trapped inside the tumor cell, cis-ABCPC cannot be metabolized and remains either in a free pool or bound to cell matrix components. The significant improvement in boron uptake by both the main tumor mass and infiltrating tumor cells compared to those reported in animal and clinical studies of p-boronophenylalanine strongly suggest that cis-ABCPC has the potential to become a novel new boron delivery agent for neutron capture therapy of gliomas and melanomas.	[Chandra, Subhash; Haider, Syed A.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Barth, Rolf F.; Yang, Weilian; Huo, Tianyao] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Shaikh, Aarif L.; Kabalka, George W.] Univ Tennessee, Dept Radiol, Knoxville, TN 37996 USA; [Shaikh, Aarif L.; Kabalka, George W.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Cornell University; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville	Chandra, S (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	sc40@cornell.edu; rolf.barth@osumc.edu; kabalka@utk.edu			NIH [5R01 CA129326]; Kevin J. Mullin Memorial Fund of Brain Tumor Research; NATIONAL CANCER INSTITUTE [R01CA129326] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kevin J. Mullin Memorial Fund of Brain Tumor Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a NIH grant 5R01 CA129326 to RFB, SC, and GWK. Partial support also was provided to RFB by the Kevin J. Mullin Memorial Fund of Brain Tumor Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkins RD, 2013, NEURO-ONCOLOGY, DOI [10.1093/neuonc/not052, DOI 10.1093/NEU0NC/N0T052]; AOYAGI M, 1988, J NEUROCHEM, V50, P1220, DOI 10.1111/j.1471-4159.1988.tb10596.x; Arlinghaus HF, 2004, SURF INTERFACE ANAL, V36, P698, DOI 10.1002/sia.1739; AUSSERER WA, 1989, ANAL CHEM, V61, P2690, DOI 10.1021/ac00199a002; Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; Barth RF, 1997, CANCER RES, V57, P1129; BARTH RF, 1992, CANCER-AM CANCER SOC, V70, P2995; Barth RF, 2013, APPL RAD IS IN PRESS; Barth RF, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-146; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Chanana AD, 1999, NEUROSURGERY, V44, P1182, DOI 10.1097/00006123-199906000-00013; Chandra S, 2008, J MICROSC-OXFORD, V229, P92, DOI 10.1111/j.1365-2818.2007.01869.x; Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i; Chandra S, 2002, CLIN CANCER RES, V8, P2675; CHANDRA S, 1987, J MICROSC-OXFORD, V148, P223, DOI 10.1111/j.1365-2818.1987.tb02869.x; CHANDRA S, 1986, J MICROSC-OXFORD, V144, P15, DOI 10.1111/j.1365-2818.1986.tb04670.x; Chandra S, 2010, METHODS MOL BIOL, V656, P113, DOI 10.1007/978-1-60761-746-4_6; Chandra S, 2008, APPL SURF SCI, V255, P1273, DOI 10.1016/j.apsusc.2008.05.073; Detta A, 2009, CANCER RES, V69, P2126, DOI 10.1158/0008-5472.CAN-08-2345; Easson MW, 2008, BIOORGAN MED CHEM, V16, P3191, DOI 10.1016/j.bmc.2007.12.020; FAIRCHILD RG, 1985, INT J RADIAT ONCOL, V11, P831, DOI 10.1016/0360-3016(85)90318-9; Fletcher JS, 2011, CURR OPIN CHEM BIOL, V15, P733, DOI 10.1016/j.cbpa.2011.05.016; Gable D, 1987, RADIAT RES, V111, P14; Kabalka GW, 2009, APPL RADIAT ISOTOPES, V67, pS374, DOI 10.1016/j.apradiso.2009.03.104; Kabalka George W., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P111, DOI 10.2174/187152006776119144; Kabalka GW, 2004, APPL RADIAT ISOTOPES, V61, P1111, DOI 10.1016/j.apradiso.2004.05.012; Kobayashi K, 2008, NEUROSURGERY, V62, P493, DOI 10.1227/01.neu.0000316018.51292.19; Kobayashi T, 1987, RADIAT RES, V111, P14; Mcvey WJ, 2008, J INORG BIOCHEM, V102, P943, DOI 10.1016/j.jinorgbio.2007.12.016; Rubakhin SS, 2005, DRUG DISCOV TODAY, V10, P823, DOI 10.1016/S1359-6446(05)03458-6; See also Hosmane N.S., 2012, BORON GADOLINIUM NEU, P41, DOI [10.1142/9789814338684_0004, DOI 10.1142/9789814338684_, DOI 10.1142/9789814338684_0004]; Sibrian-Vazquez M, 2012, BORON SCIENCE: NEW TECHNOLOGIES AND APPLICATIONS, P209; Skold K, 2010, BRIT J RADIOL, V83, P596, DOI 10.1259/bjr/56953620; Skold K, 2010, ACTA NEUROL SCAND, V122, P58, DOI 10.1111/j.1600-0404.2009.01267.x; Smith DR, 1996, CANCER RES, V56, P4302; Smith DR, 2001, CANCER RES, V61, P8179; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Svantesson E, 2002, ANAL CHEM, V74, P5358, DOI 10.1021/ac025798e; Sweet WH, 1983, P 1 INT S NEUTR CAPT, P376; Tiwari R, 2012, INORG CHEM, V51, P629, DOI 10.1021/ic202150b; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Yang W, 2013, APPL RAD IS IN PRESS; Yang WL, 2008, CLIN CANCER RES, V14, P883, DOI 10.1158/1078-0432.CCR-07-1968; Yang WL, 1996, NEUROSURGERY, V38, P985, DOI 10.1097/00006123-199605000-00027; Yinghuai Z, 2005, J AM CHEM SOC, V127, P9875, DOI 10.1021/ja0517116; Yokoyama K, 2007, RADIAT RES, V167, P102, DOI 10.1667/RR0501.1; ZAMENHOF RG, 1992, J NATL CANCER I, V84, P1290, DOI 10.1093/jnci/84.16.1290-a	47	21	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75377	10.1371/journal.pone.0075377	http://dx.doi.org/10.1371/journal.pone.0075377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058680	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900112
J	Hebert, JB; Scheffer, SJ; Hawthorne, DJ				Hebert, Julie B.; Scheffer, Sonja J.; Hawthorne, David J.			Reproductive Isolation between Host Races of Phytomyza glabricola on Ilex coriacea and I. glabra	PLOS ONE			English	Article							EUROSTA-SOLIDAGINIS DIPTERA; COMPARATIVE GENOME SCAN; BEBBIANAE LEAF BEETLES; GENETIC DIFFERENTIATION; ECOLOGICAL SPECIATION; MITOCHONDRIAL-DNA; PHYTOPHAGOUS INSECTS; DIVERGENT SELECTION; PLANT-QUALITY; TEPHRITIDAE	Recently diverged taxa often show discordance in genetic divergence among genomic loci, where some loci show strong divergence and others show none at all. Genetic studies alone cannot distinguish among the possible mechanisms but experimental studies on other aspects of divergence may provide guidance in the inference of causes of observed discordances. In this study, we used no-choice mating trials to test for the presence of reproductive isolation between host races of the leaf-mining fly, Phytomyza glabricola on its two holly host species, Ilex coriacea and I. glabra. These trials inform our effort to determine the cause of significant differences in the degree of divergence of nuclear and mitochondrial loci of flies collected from the two host plants. We present evidence of reproductive isolation between host races in a controlled greenhouse setting: significantly more mate pairs consisting of flies from the same host plant species produced offspring than inter-host mate pairs, which produced no offspring. We also tested whether the presence of the natal or non-natal host plant affects reproductive success. Flies collected from I. coriacea were more likely to produce offspring when in the presence of the natal host, whereas the presence or absence of either the natal or non-natal host had no effect on flies collected from I. glabra. The results indicate discordant patterns of nuclear and mitochondrial divergence among host races of P. glabricola are likely due to incomplete lineage sorting, and the host races may be well on their way to becoming biological species.	[Hebert, Julie B.] Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA; [Hebert, Julie B.; Hawthorne, David J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Scheffer, Sonja J.] USDA ARS, Systemat Entomol Lab, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Smithsonian Institution; United States Department of Agriculture (USDA)	Hebert, JB (corresponding author), Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA.	julie.b.hebert@gmail.com						Abrahamson WG, 2003, J EVOLUTION BIOL, V16, P781, DOI 10.1046/j.1420-9101.2003.00602.x; Al-Siyabi AAK, 1998, OHIO STATE EXTENSION, P165; [Anonymous], 2010, R LANG ENV STAT COMP; Apple JL, 2010, MOL ECOL, V19, P4012, DOI 10.1111/j.1365-294X.2010.04792.x; AVISE JC, 1983, MOL BIOL EVOL, V1, P38; Barman AK, 2012, ENTOMOL EXP APPL, V143, P31, DOI 10.1111/j.1570-7458.2012.01232.x; Brown JM, 1996, EVOLUTION, V50, P777, DOI 10.1111/j.1558-5646.1996.tb03887.x; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; Cook MA, 2011, ENTOMOL EXP APPL, V141, P8, DOI 10.1111/j.1570-7458.2011.01166.x; Dickey AM, 2010, J EVOLUTION BIOL, V23, P945, DOI 10.1111/j.1420-9101.2010.01962.x; Diegisser T, 2006, MOL ECOL, V15, P681, DOI 10.1111/j.1365-294X.2006.02792.x; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Egan SP, 2008, EVOLUTION, V62, P1162, DOI 10.1111/j.1558-5646.2008.00352.x; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; Funk Daniel J., 2012, International Journal of Ecology, P1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Gaston KJ, 2004, J ANIM ECOL, V73, P911, DOI 10.1111/j.0021-8790.2004.00866.x; Gouinguene SPD, 2005, PHYSIOL ENTOMOL, V30, P62, DOI 10.1111/j.0307-6962.2005.00432.x; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; JAENIKE J, 1981, AM NAT, V117, P830, DOI 10.1086/283771; Joyce AL, 2008, ENTOMOL EXP APPL, V127, P39, DOI 10.1111/j.1570-7458.2008.00670.x; Kainulainen P, 1996, J CHEM ECOL, V22, P617, DOI 10.1007/BF02033574; Kempf F, 2009, MOL ECOL, V18, P4450, DOI 10.1111/j.1365-294X.2009.04356.x; Kolaczan CR, 2009, J EVOLUTION BIOL, V22, P1275, DOI 10.1111/j.1420-9101.2009.01742.x; Kulp L., 1968, U MARYLAND AGR EXP A, VA-155, P1; Lonsdale O, 2011, ANN ENTOMOL SOC AM, V104, P1183, DOI 10.1603/AN11008; Mayr E, 1963, ANIMAL SPECIES EVOLU, Vxiv; Nishida R, 1996, J CHEM ECOL, V22, P949, DOI 10.1007/BF02029947; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; PHILLIPS PA, 1975, ANN ENTOMOL SOC AM, V68, P1053, DOI 10.1093/aesa/68.6.1053; Scheffer SJ, 2000, MOL PHYLOGENET EVOL, V17, P244, DOI 10.1006/mpev.2000.0830; Scheffer SJ, 2002, P ENTOMOL SOC WASH, V104, P571; Scheffer SJ, 2007, MOL ECOL, V16, P2627, DOI 10.1111/j.1365-294X.2007.03303.x; Scutareanu P, 2006, J PLANT NUTR, V29, P629, DOI 10.1080/01904160600564345; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; Thorpe WH, 1930, BIOL REV BIOL P CAMB, V5, P177, DOI 10.1111/j.1469-185X.1930.tb00616.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Walsh B, 1864, P ENTOMOL SOC PHILA, V3, P403; WARING GL, 1990, EVOLUTION, V44, P1648, DOI [10.2307/2409344, 10.1111/j.1558-5646.1990.tb03853.x]; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	47	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73976	10.1371/journal.pone.0073976	http://dx.doi.org/10.1371/journal.pone.0073976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058509	gold, Green Published, Green Submitted			2022-12-27	WOS:000324695900026
J	Park, SY; Kim, SM; Sung, JJ; Lee, KM; Park, KS; Kim, SY; Nam, HW; Lee, KW				Park, Su-Yeon; Kim, Sung-Min; Sung, Jung-Joon; Lee, Kyung-Min; Park, Kyung-Seok; Kim, Sang-Yun; Nam, Hyun-woo; Lee, Kwang-Woo			Nocturnal Hypoxia in ALS Is Related to Cognitive Dysfunction and Can Occur as Clusters of Desaturations	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOTHELIAL GROWTH-FACTOR; OXIMETRY; BATTERY; VEGF	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that leads to progressive weakness of the respiratory and limb muscles. Consequently, most patients with ALS exhibit progressive hypoventilation, which worsens during sleep. The aim of this study was to evaluate the relationship between nocturnal hypoxia and cognitive dysfunction and to assess the pattern of nocturnal hypoxia in patients with ALS. Method: Twenty-five patients with definite or probable ALS underwent neuropsychologic testing, nocturnal pulse oximetry, and capnography. Patients were grouped according to the presence of nocturnal hypoxia (SpO(2)<95% for >= 10% of the night) and their clinical characteristics and cognitive function were compared. Results: Compared to patients without nocturnal hypoxia, those with nocturnal hypoxia (n = 10, 40%) had poor memory retention (p = 0.039) and retrieval efficiency (p = 0.045). A cluster-of-desaturation pattern was identified in 7 patients (70%) in the Hypoxia Group. Conclusions: These results suggest that nocturnal hypoxia can be related to cognitive dysfunction in ALS. In addition, a considerable number of patients with ALS may be exposed to repeated episodes of deoxygenation-reoxygenation (a cluster-of-desaturation pattern) during sleep, which could be associated with the generation of reactive oxygen species. Further studies are required to define the exact causal relationships between these phenomena, the exact manifestations of nocturnal cluster-of-desaturation patterns, and the effect of clusters of desaturation on ALS progression.	[Park, Su-Yeon] Korea Canc Ctr Hosp, Dept Neurol, Seoul, South Korea; [Kim, Sung-Min; Sung, Jung-Joon; Lee, Kyung-Min; Lee, Kwang-Woo] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Park, Kyung-Seok; Kim, Sang-Yun] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi, South Korea; [Nam, Hyun-woo] Boramae Hosp, Dept Neurol, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, SM (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	sueh916@gmail.com; jjsaint66@gmail.com			National Research Foundation [2010-0024351]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2010-0011008]; Ministry of Education, Science and Technology	National Research Foundation; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant No. 2010-0024351 from the National Research Foundation and by Grant No. 2010-0011008 from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Adams N, 2001, AM J RESP CRIT CARE, V163, P1626, DOI 10.1164/ajrccm.163.7.2004014; Atalaia A, 2007, AMYOTROPH LATERAL SC, V8, P101, DOI 10.1080/17482960601029883; Bach JR, 2004, CHEST, V126, P1502, DOI 10.1378/chest.126.5.1502; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Brouillette RT, 2000, PEDIATRICS, V105, P405, DOI 10.1542/peds.105.2.405; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; De Carvalho M, 2009, AMYOTROPH LATERAL SC, V10, P154, DOI 10.1080/17482960802382305; Deckersbach T, 2000, J CLIN EXP NEUROPSYC, V22, P640, DOI 10.1076/1380-3395(200010)22:5;1-9;FT640; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fauroux B, 2012, ARCH DIS CHILD, V97, P960, DOI 10.1136/archdischild-2011-300440; Ferguson KA, 1996, CHEST, V110, P664, DOI 10.1378/chest.110.3.664; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Greenberg H, 2006, BIOCHEM BIOPH RES CO, V343, P591, DOI 10.1016/j.bbrc.2006.03.015; Kim H, 2003, NEUROPSYCHOLOGY, V17, P59, DOI 10.1037/0894-4105.17.1.59; Kim SM, 2007, J NEUROL NEUROSUR PS, V78, P1387, DOI 10.1136/jnnp.2006.111195; Kim SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017893; Li BL, 2003, MOL BRAIN RES, V111, P155, DOI 10.1016/S0169-328X(03)00025-1; Lillo P, 2009, J CLIN NEUROSCI, V16, P1131, DOI 10.1016/j.jocn.2009.03.005; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Moreau C, 2011, NEUROSCIENCE, V172, P110, DOI 10.1016/j.neuroscience.2010.10.040; Murakami T, 2003, BRAIN RES, V989, P231, DOI 10.1016/S0006-8993(03)03374-2; Newsom-Davis IC, 2001, J NEUROL NEUROSUR PS, V71, P482, DOI 10.1136/jnnp.71.4.482; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; Vitacca M, 1997, EUR RESPIR J, V10, P1614, DOI 10.1183/09031936.97.10071614	28	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75324	10.1371/journal.pone.0075324	http://dx.doi.org/10.1371/journal.pone.0075324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058674	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900106
J	Sima, N; Cheng, XD; Ye, F; Ma, D; Xie, X; Lu, WG				Sima, Ni; Cheng, Xiaodong; Ye, Feng; Ma, Ding; Xie, Xing; Lu, Weiguo			The Overexpression of Scaffolding Protein NEDD9 Promotes Migration and Invasion in Cervical Cancer via Tyrosine Phosphorylated FAK and SRC	PLOS ONE			English	Article							SUBSTRATE LYMPHOCYTE TYPE; FOCAL ADHESION KINASE; CAS-L; CELL-MIGRATION; GROWTH-FACTOR; EXPRESSION; HEF1; ACTIVATION; APOPTOSIS; DIFFERENTIATION	NEDD9, a focal adhesion scaffolding protein, has been recently proposed to regulate invasion and metastasis in some cancer types, but unknown in cervical cancer. The aim of this study was to determine if NEDD9 was involved in the progression and metastasis of cervical cancer. The experimental results showed NEDD9 protein was overexpressed in cervical cancer compared with normal cervical epithelium tissues. Overexpression of NEDD9 was correlated with histological grading, lymph node metastasis, and FIGO stage of cervical cancer. Silencing NEDD9 resulted in tyrosine dephosphorylation of FAK and SRC oncoproteins, and decreased cell migration and invasion in the cervical carcinoma SiHa and HeLa cells. Overexpression of NEDD9 led to tyrosine phosphorylation of FAK and SRC oncoproteins, and increased cell migration and invasion. Moreover, tyrosine phosphorylation of NEDD9 was significantly decreased via suppressing tyrosine phosphorylation of FAK or SRC, suggesting a positive feedback loop of tyrosine phosphorylation between NEDD9 and FAK or SRC. In addition, our data showed that silencing NEDD9 decreased Vimentin expression and increased E-cadherin expression in cervical cancer cells, and vice versa. E-cadherin was subject to regulation of NEDD9, FAK and SRC, but altered neither tyrosine-phosphorylated nor total NEDD9. Our findings suggest that NEDD9 is overexpressed in cervical cancer tissues and cells, and overexpressed NEDD9 promotes migration and invasion in cervical carcinoma cells, probably via a positive feedback loop of tyrosine phosphorylation between NEDD9 and FAK or SRC.	[Sima, Ni; Cheng, Xiaodong; Ye, Feng; Xie, Xing; Lu, Weiguo] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol,Womens Reprod Hlth Key Lab Zhe, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Ding] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China	Zhejiang University; Huazhong University of Science & Technology	Lu, WG (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol,Womens Reprod Hlth Key Lab Zhe, Hangzhou 310003, Zhejiang, Peoples R China.	lbwg@zju.edu.cn	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	National Natural Science Foundation of China [30801227, 81272862]; Zhejiang Provincial Natural Science Foundation of China [Y2100403, LY12H16020]; National Basic Research Program of China [2009CB521808]; Fundamental Research Funds for the Central Universities of China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	The present study was supported by the National Natural Science Foundation of China (Nos. 30801227; 81272862), the Zhejiang Provincial Natural Science Foundation of China (Nos. Y2100403; LY12H16020), the National Basic Research Program of China (No. 2009CB521808), the Fundamental Research Funds for the Central Universities of China and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino JB, 2009, NEUROSCIENCE, V162, P1106, DOI 10.1016/j.neuroscience.2009.05.035; Aquino JB, 2008, GENE EXPR PATTERNS, V8, P217, DOI 10.1016/j.gep.2008.01.001; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bruna A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2039; Cadron I, 2007, GYNECOL ONCOL, V107, pS113, DOI 10.1016/j.ygyno.2007.07.004; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Du ZW, 2010, METHODS MOL BIOL, V614, P127, DOI 10.1007/978-1-60761-533-0_8; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Inamoto S, 2007, ONCOGENE, V26, P893, DOI 10.1038/sj.onc.1209848; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kondo S, 2012, CLIN CANCER RES, V18, P6326, DOI 10.1158/1078-0432.CCR-11-2162; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Law SF, 1996, MOL CELL BIOL, V16, P3327; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Li YH, 2008, HUM MOL GENET, V17, P759, DOI 10.1093/hmg/ddm348; Little JL, 2013, ONCOGENE; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Malleter M, 2012, GENE, V506, P355, DOI 10.1016/j.gene.2012.06.008; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Miyake-Nishijima R, 2003, ARTHRITIS RHEUM, V48, P1890, DOI 10.1002/art.11047; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2006, CELL CYCLE, V5, P384, DOI 10.4161/cc.5.4.2439; Rasanen K, 2010, J DERMATOL SCI, V58, P97, DOI 10.1016/j.jdermsci.2010.03.002; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sasaki T, 2005, STROKE, V36, P2457, DOI 10.1161/01.STR.0000185672.10390.30; Sima N, 2008, APOPTOSIS, V13, P273, DOI 10.1007/s10495-007-0163-8; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Thao LB, 2009, CANCER BIOL THER, V8, P683, DOI 10.4161/cbt.8.8.7779; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tikhmyanova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022102; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	45	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74594	10.1371/journal.pone.0074594	http://dx.doi.org/10.1371/journal.pone.0074594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058594	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900061
J	Alcalay, Y; Hochhauser, E; Kliminski, V; Dick, J; Zahalka, MA; Parnes, D; Schlesinger, H; Abassi, Z; Shainberg, A; Schindler, RFR; Brand, T; Kessler-Icekson, G				Alcalay, Yifat; Hochhauser, Edith; Kliminski, Vitaly; Dick, Julia; Zahalka, Muayad A.; Parnes, Doris; Schlesinger, Hadassa; Abassi, Zaid; Shainberg, Asher; Schindler, Roland F. R.; Brand, Thomas; Kessler-Icekson, Gania			Popeye Domain Containing 1 (Popdc1/Bves) Is a Caveolae-Associated Protein Involved in Ischemia Tolerance	PLOS ONE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; SKELETAL-MUSCLE; ANGIOTENSIN-II; MEMBRANE RAFTS; BVES FUNCTION; GENE FAMILY; EXPRESSION; HEART; CHANNELS; MYOCYTES	Popeye domain containing1 (Popdc1), also named Bves, is an evolutionary conserved membrane protein. Despite its high expression level in the heart little is known about its membrane localization and cardiac functions. The study examined the hypothesis that Popdc1 might be associated with the caveolae and play a role in myocardial ischemia tolerance. To address these issues, we analyzed hearts and cardiomyocytes of wild type and Popdc1-null mice. Immunoconfocal microscopy revealed co-localization of Popdc1 with caveolin3 in the sarcolemma, intercalated discs and T-tubules and with costameric vinculin. Popdc1 was co-immunoprecipitated with caveolin3 from cardiomyocytes and from transfected COS7 cells and was co-sedimented with caveolin3 in equilibrium density gradients. Caveolae disruption by methyl-beta-cyclodextrin or by ischemia/reperfusion (I/R) abolished the cellular co-localization of Popdc1 with caveolin3 and modified their density co-sedimentation. The caveolin3-rich fractions of Popdc1-null hearts redistributed to fractions of lower buoyant density. Electron microscopy showed a statistically significant 70% reduction in caveolae number and a 12% increase in the average diameter of the remaining caveolae in the mutant hearts. In accordance with these changes, Popdc1-null cardiomyocytes displayed impaired [Ca+2](i) transients, increased vulnerability to oxidative stress and no pharmacologic preconditioning. In addition, induction of I/R injury to Langendorff-perfused hearts indicated a significantly lower functional recovery in the mutant compared with wild type hearts while their infarct size was larger. No improvement in functional recovery was observed in Popdc1-null hearts following ischemic preconditioning. The results indicate that Popdc1 is a caveolae-associated protein important for the preservation of caveolae structural and functional integrity and for heart protection.	[Alcalay, Yifat; Hochhauser, Edith; Kliminski, Vitaly; Dick, Julia; Zahalka, Muayad A.; Parnes, Doris; Schlesinger, Hadassa; Kessler-Icekson, Gania] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel; [Abassi, Zaid] Israel Inst Technol, Rappaport Fac Med, Dept Physiol, Haifa, Israel; [Shainberg, Asher] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Schindler, Roland F. R.; Brand, Thomas] Univ London Imperial Coll Sci Technol & Med, Harefield Heart Sci Ctr, London, England	Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bar Ilan University; Imperial College London	Kessler-Icekson, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel.	icekson@post.tau.ac.il	Brand, Thomas/AAR-7545-2020	Brand, Thomas/0000-0001-7090-5356; Abassi, Zaid/0000-0002-7272-197X	German-Israeli Foundation [I-669-91.2/00]; Israel Science Foundation [611/08]; Niedersachsen-Israeli Research Cooperation Program; Medical Research Council [MR/J010383/1]	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Niedersachsen-Israeli Research Cooperation Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the German-Israeli Foundation (www.gif.org.il) Grant no. I-669-91.2/00 to G.K.-I. and T.B.; the Israel Science Foundation (www.isf.org.il) Grant no. 611/08 to G.K.-I.; the Niedersachsen-Israeli Research Cooperation Program (www.technion.ac.il/research/bio_med.htm) granted in 2005 to T.B. and Z.A.; and the Medical Research Council (www.mrc.ac.uk) Grant no. MR/J010383/1 to T.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; Andree Birgit, 2002, Exp Clin Cardiol, V7, P99; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Ballard-Croft C, 2006, AM J PHYSIOL-HEART C, V291, pH658, DOI 10.1152/ajpheart.01354.2005; Bossuyt J, 2002, ANN NY ACAD SCI, V976, P197; Brand T, 2005, CELL BIOCHEM BIOPHYS, V43, P95, DOI 10.1385/CBB:43:1:095; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Das M, 2008, CELL PHYSIOL BIOCHEM, V21, P325, DOI 10.1159/000129391; Das M, 2007, J MOL CELL CARDIOL, V42, P206, DOI 10.1016/j.yjmcc.2006.08.118; Emanuelov AK, 2010, BIOCHEM PHARMACOL, V79, P180, DOI 10.1016/j.bcp.2009.08.010; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Feng QH, 2008, CANCER EPIDEM BIOMAR, V17, P645, DOI 10.1158/1055-9965.EPI-07-2518; Fixler D, 2002, CELL CALCIUM, V31, P279, DOI 10.1016/S0143-4160(02)00056-8; Froese A, 2012, J CLIN INVEST, V122, P1119, DOI 10.1172/JCI59410; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Garg V, 2009, CARDIOVASC RES, V82, P51, DOI 10.1093/cvr/cvp039; Gingold-Belfer R, 2011, INT J MOL MED, V27, P25, DOI 10.3892/ijmm.2010.558; Hager HA, 2010, EMBO J, V29, P532, DOI 10.1038/emboj.2009.379; Hager HA, 2009, HISTOL HISTOPATHOL, V24, P777, DOI 10.14670/HH-24.777; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Hausenloy DJ, 2010, CARDIOVASC RES, V88, P67, DOI 10.1093/cvr/cvq113; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hirose K, 2011, ANESTHESIOLOGY, V115, P955, DOI 10.1097/ALN.0b013e31822fcede; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Horikawa YT, 2008, J MOL CELL CARDIOL, V44, P123, DOI 10.1016/j.yjmcc.2007.10.003; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Houser SR, 2000, J MOL CELL CARDIOL, V32, P1595, DOI 10.1006/jmcc.2000.1206; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; Kawaguchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002261; Kim KB, 2004, PROTEOMICS, V4, P3527, DOI 10.1002/pmic.200401001; Kim M, 2010, CARCINOGENESIS, V31, P1685, DOI 10.1093/carcin/bgq144; Knight RF, 2003, J BIOL CHEM, V278, P32872, DOI 10.1074/jbc.M301961200; Kostin S, 1998, CELL TISSUE RES, V294, P449, DOI 10.1007/s004410051196; Lim SY, 2008, J CELL MOL MED, V12, P1395, DOI 10.1111/j.1582-4934.2008.00332.x; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Mialet-Perez J, 2011, J MOL CELL CARDIOL; Ofir M, 2008, BIOCHEM PHARMACOL, V75, P1482, DOI 10.1016/j.bcp.2007.12.011; Ortegren U, 2006, FEBS J, V273, P3381, DOI 10.1111/j.1742-4658.2006.05345.x; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Quinlan CL, 2008, AM J PHYSIOL-HEART C, V295, pH953, DOI 10.1152/ajpheart.00520.2008; Reese DE, 1999, DEV BIOL, V209, P159, DOI 10.1006/dbio.1999.9246; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Roth DM, 2011, PEDIATR CARDIOL, V32, P329, DOI 10.1007/s00246-010-9881-8; Russ PK, 2010, INVEST OPHTH VIS SCI, V51, P223, DOI 10.1167/iovs.09-3539; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Shalitin N, 1996, IN VITRO CELL DEV-AN, V32, P573; Simrick S, 2013, TRENDS CARDIOVAS MED, V23, P257, DOI 10.1016/j.tcm.2013.02.002; Smith TK, 2008, P NATL ACAD SCI USA, V105, P8298, DOI 10.1073/pnas.0802345105; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Wada AM, 2001, DEVELOPMENT, V128, P2085; Williams CS, 2011, J CLIN INVEST; Wu M, 2013, INT J MOL MED; Wu YC, 2012, J BIOL CHEM; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Zhou CM, 2006, CIRC RES, V98, P1040, DOI 10.1161/01.RES.0000218989.52072.e7	60	33	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e71100	10.1371/journal.pone.0071100	http://dx.doi.org/10.1371/journal.pone.0071100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066022	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000002
J	Hwang, SH; Park, SH; Choi, J; Lee, DC; Oh, JH; Yeo, UC; Kim, SW; Sun, DI				Hwang, Se Hwan; Park, Sun Hwa; Choi, Jin; Lee, Dong Chang; Oh, Jeong Hoon; Yeo, Un Cheol; Kim, Sung Won; Sun, Dong Il			Age-Related Characteristics of Multipotent Human Nasal Inferior Turbinate-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; MARROW STROMAL CELLS; NEURAL CREST; OSTEOGENIC DIFFERENTIATION; DONOR AGE; IN-VITRO; OSTEOBLASTS; EXPRESSION; MARKERS; CBFA1	Background and Objectives: Multipotent mesenchymal stem cells (MSCs) represent a promising cell-based therapy for a number of degenerative conditions. Understanding the effect of aging on MSCs is crucial for both autologous therapy development and allogenic donors in older subjects whom degenerative diseases typically afflict. In this study, we investigated the influence of donor age on the characteristics, proliferation, and differentiation potential of in vitro cultures of multipotent human turbinated mesenchymal stem cells (hTMSCs) from patients of various age groups. Subjects and Methods: Twelve patients comprised the four age groups: (I) <20 years, (II) 20-39 years, (III) 40-59 years, and (IV) >60 years. Inferior turbinate tissues were discarded from patients undergoing partial turbinectomy. After isolating hTMSCs, the expression of the hTMSC surface markers CD14, CD19, CD34, CD73, CD90, CD105, and HLA-DR was assessed by FACS analysis, and cell proliferation was assessed using a cell counting kit (CCK)-8. The differentiation potential of hTMSCs was evaluated in osteogenic media by histology and determination of osteoblastic gene expression. Results: FACS analysis revealed that hTMSCs were negative for CD14, CD19, CD34, and HLA-DR, and positive for CD73, CD90, and CD105, representing a characteristic MSC phenotype, and showed no significant differences among the age groups. Cellular proliferation and osteogenic differentiation potential of hTMSCs also showed no significant differences among the age groups. Conclusions: We conclude that donor age does not affect the characteristics, proliferation, and osteogenic differentiation potential of hTMSCs. Donor age may be excluded as a criterion in the guidelines for clinical use of the autologous or allogenic transplantation of hTMSCs.	[Hwang, Se Hwan; Park, Sun Hwa; Choi, Jin; Lee, Dong Chang; Oh, Jeong Hoon; Yeo, Un Cheol; Kim, Sung Won; Sun, Dong Il] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Catholic University of Korea	Kim, SW (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kswent@catholic.ac.kr; hnsdi@catholic.ac.kr		Hwang, Se Hwan/0000-0002-2838-7820	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0011249]; Seoul St. Mary's Hospital Clinical Medicine Research Program through the Catholic University of Korea; Catholic Institute of Cell Therapy; Otorhinolaryngology Alumni Fund of the Catholic University of Korea; Research Fund for the Colleague of Catholic University Medical College; Catholic Medical Center Research Foundation	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul St. Mary's Hospital Clinical Medicine Research Program through the Catholic University of Korea; Catholic Institute of Cell Therapy; Otorhinolaryngology Alumni Fund of the Catholic University of Korea; Research Fund for the Colleague of Catholic University Medical College; Catholic Medical Center Research Foundation	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0011249), the Seoul St. Mary's Hospital Clinical Medicine Research Program year of 2013 through the Catholic University of Korea, Catholic Institute of Cell Therapy in 2013, the Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program year of 2013, 2012 Research Fund for the Colleague of Catholic University Medical College, and the Catholic Medical Center Research Foundation made in the program year of 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek Wook-Young, 2011, Front Biosci (Schol Ed), V3, P126, DOI 10.2741/s138; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; Eve DJ, 2010, CELL TRANSPLANT; Fickert S, 2011, J BONE MINER METAB, V29, P224, DOI 10.1007/s00774-010-0215-y; Gala K, 2011, CELL BIOL INT, V35, P1055, DOI 10.1042/CBI20100586; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Hwang SH, 2012, OTOLARYNG HEAD NECK, V147, P568, DOI 10.1177/0194599812447172; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P544; Hwang SH, 2012, OTOLARYNGOL HEAD NEC; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Pinco KA, 2001, MECH DEVELOP, V100, P99, DOI 10.1016/S0925-4773(00)00503-7; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488	27	24	29	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74330	10.1371/journal.pone.0074330	http://dx.doi.org/10.1371/journal.pone.0074330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066137	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000119
J	Ronchi, CL; Sbiera, S; Leich, E; Henzel, K; Rosenwald, A; Allolio, B; Fassnacht, M				Ronchi, Cristina L.; Sbiera, Silviu; Leich, Ellen; Henzel, Katharina; Rosenwald, Andreas; Allolio, Bruno; Fassnacht, Martin			Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; MOLECULAR CLASSIFICATION; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPTOME ANALYSIS; CANDIDATE GENES; BETA-CATENIN; EXPRESSION; CANCER; SERIES; PATHWAYS	Adrenocortical tumors consist of benign adenomas and highly malignant carcinomas with a still incompletely understood pathogenesis. A total of 46 adrenocortical tumors (24 adenomas and 22 carcinomas) were investigated aiming to identify novel genes involved in adrenocortical tumorigenesis. High-resolution single nucleotide polymorphism arrays (Affymetrix) were used to detect copy number alterations (CNAs) and copy neutral losses of heterozygosity (cnLOH). Genomic clustering showed good separation between adenomas and carcinomas, with best partition including only chromosome 5, which was highly amplified in 17/22 malignant tumors. The malignant tumors had more relevant genomic aberrations than benign tumors, such as a higher median number of recurrent CNA (2631 vs 94), CNAs > 100 Kb (62.5 vs 7) and CN losses (72.5 vs 5.5), and a higher percentage of samples with cnLOH (91% vs 29%). Within the carcinoma cohort, a precise genetic pattern (i.e. large gains at chr 5, 7, 12, and 19, and losses at chr 1, 2, 13, 17, and 22) was associated with a better prognosis (overall survival: 72.2 vs 35.4 months, P=0.063). Interestingly, > 70% of gains frequent in beningn were also present in malignant tumors. Notch signaling was the most frequently involved pathway in both tumor entities. Finally, a CN gain at imprinted "IGF2" locus chr 11p15.5 appeared to be an early alteration in a multi-step tumor progression, followed by the loss of one or two alleles, associated with increased IGF2 expression, only in carcinomas. Our study serves as database for the identification of genes and pathways, such as Notch signaling, which could be involved in the pathogenesis of adrenocortical tumors. Using these data, we postulate an adenoma-carcinoma sequence for these tumors.	[Ronchi, Cristina L.; Sbiera, Silviu; Henzel, Katharina; Allolio, Bruno; Fassnacht, Martin] Univ Wurzburg, Endocrine & Diabet Unit, Dept Internal Med 1, Univ Hosp, D-97070 Wurzburg, Germany; [Sbiera, Silviu; Fassnacht, Martin] Univ Munich, Univ Hosp, Dept Internal Med 4, Munich, Germany; [Leich, Ellen; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Munich; University of Wurzburg	Ronchi, CL (corresponding author), Univ Wurzburg, Endocrine & Diabet Unit, Dept Internal Med 1, Univ Hosp, D-97070 Wurzburg, Germany.	cry_ronchi@yahoo.it	Sbiera, Silviu/E-8128-2019; Fassnacht, Martin/N-9614-2019	Sbiera, Silviu/0000-0002-6271-5533; Fassnacht, Martin/0000-0001-6170-6398; Ronchi, Cristina/0000-0001-5020-2071	Alexander von Humboldt Foundation; Wilhelm Sander Foundation [2012.095.1]; Deutsche Krebshilfe [107111]; German Research Foundation (DFG); University of Wuerzburg through the funding programme Open Access Publishing	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Wilhelm Sander Foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg through the funding programme Open Access Publishing	This work was supported by the Alexander von Humboldt Foundation (C.L.R.) and by grants from the Wilhelm Sander Foundation (Grant 2012.095.1 to B.A.) and the Deutsche Krebshilfe (Grant 107111 to M.F.). This publication was also supported by the German Research Foundation (DFG) and the University of Wuerzburg through the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Al-Sohaily S, 2012, J GASTROEN HEPATOL, V27, P1423, DOI 10.1111/j.1440-1746.2012.07200.x; Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Almeida MQ, 2011, J CLIN ENDOCR METAB, V96, pE728, DOI 10.1210/jc.2010-2420; Barreau O, 2012, J CLIN ENDOCR METAB, V97, pE301, DOI 10.1210/jc.2011-1588; Barzon L, 2003, EUR J ENDOCRINOL, V149, P273, DOI 10.1530/eje.0.1490273; Bernard MH, 2003, J CLIN ENDOCR METAB, V88, P998, DOI 10.1210/jc.2002-021117; Berruti A, 2012, ANN ONCOL, V23, P131, DOI 10.1093/annonc/mds231; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; Bhusari S, 2011, PROSTATE, V71, P1621, DOI 10.1002/pros.21379; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Cawood TJ, 2009, EUR J ENDOCRINOL, V161, P513, DOI 10.1530/EJE-09-0234; Demars J, 2011, CURR MED CHEM, V18, P1740, DOI 10.2174/092986711795496764; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Dohna M, 2000, GENE CHROMOSOME CANC, V28, P145, DOI 10.1002/(SICI)1098-2264(200006)28:2<145::AID-GCC3>3.0.CO;2-7; Drelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044171; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; Fassnacht M, 2011, NAT REV ENDOCRINOL, V7, P323, DOI 10.1038/nrendo.2010.235; Fenske W, 2009, ENDOCR-RELAT CANCER, V16, P919, DOI 10.1677/ERC-08-0211; Gicquel C, 2001, ANN ENDOCRINOL-PARIS, V62, P189; Gicquel C, 1997, J CLIN ENDOCR METAB, V82, P2559, DOI 10.1210/jc.82.8.2559; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Gruschwitz T, 2010, WORLD J UROL, V28, P329, DOI 10.1007/s00345-010-0541-7; Haralambieva E, 2002, J PATHOL, V198, P163, DOI 10.1002/path.1197; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Jain M, 2012, J SURG ONCOL, V106, P549, DOI 10.1002/jso.23119; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kjellman M, 1996, CANCER RES, V56, P4219; Koschker AC, 2006, EXP CLIN ENDOCR DIAB, V114, P45, DOI 10.1055/s-2006-923808; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Lehmann T, 2012, CANCER GENET-NY, V205, P131, DOI 10.1016/j.cancergen.2012.02.009; Letouze E, 2012, J CLIN ENDOCR METAB, V97, pE1284, DOI 10.1210/jc.2012-1184; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Nieman LK, 2010, J CLIN ENDOCR METAB, V95, P4106, DOI 10.1210/jc.2010-0457; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ragazzon B, 2011, ENDOCR-RELAT CANCER, V18, pR15, DOI 10.1530/ERC-10-0220; Ragazzon B, 2010, CANCER RES, V70, P8276, DOI 10.1158/0008-5472.CAN-10-2014; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; Ronchi CL, 2009, ENDOCR-RELAT CANCER, V16, P907, DOI 10.1677/ERC-08-0224; Rumi E, 2011, AM J HEMATOL, V86, P974, DOI 10.1002/ajh.22166; Sbiera S, 2010, J CLIN ENDOCR METAB, V95, pE161, DOI 10.1210/jc.2010-0653; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Sidhu S, 2002, J CLIN ENDOCR METAB, V87, P3467, DOI 10.1210/jc.87.7.3467; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Sinha S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-84; Soon PSH, 2008, ANN SURG, V247, P157, DOI 10.1097/SLA.0b013e318153ff55; Stephan EA, 2008, MOL CANCER THER, V7, P425, DOI 10.1158/1535-7163.MCT-07-0267; Szabo PM, 2010, ONCOGENE, V29, P3163, DOI 10.1038/onc.2010.80; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Volante M, 2006, MODERN PATHOL, V19, P1563, DOI 10.1038/modpathol.3800683; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; Zhao JM, 1999, AM J PATHOL, V155, P1039, DOI 10.1016/S0002-9440(10)65205-4; Zhao JM, 2002, GENE CHROMOSOME CANC, V34, P48, DOI 10.1002/gcc.10035; Zsippai A, 2011, AM J CANCER RES, V1, P618	63	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73959	10.1371/journal.pone.0073959	http://dx.doi.org/10.1371/journal.pone.0073959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066089	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000071
J	Groen, Y; Gaastra, GF; Lewis-Evans, B; Tucha, O				Groen, Yvonne; Gaastra, Geraldina F.; Lewis-Evans, Ben; Tucha, Oliver			Risky Behavior in Gambling Tasks in Individuals with ADHD - A Systematic Literature Review	PLOS ONE			English	Review							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; DUAL PATHWAY MODEL; DECISION-MAKING; EXECUTIVE FUNCTIONS; RESPONSE PERSEVERATION; YOUNG-ADULTS; PREFRONTAL CORTEX; CHILDHOOD ADHD; CHILDREN	Objective: The aim of this review was to gain insight into the relationship between Attention deficit hyperactivity disorder (ADHD) and risky performance in gambling tasks and to identify any potential alternate explanatory factors. Methods: PsycINFO, PubMed, and Web of Knowledge were searched for relevant literature comparing individuals with ADHD to normal controls (NCs) in relation to their risky performance on a gambling task. In total, fourteen studies in children/adolescents and eleven studies in adults were included in the review. Results: Half of the studies looking at children/adolescents with ADHD found evidence that they run more risks on gambling tasks when compared to NCs. Only a minority of the studies on adults with ADHD reported aberrant risky behavior. The effect sizes ranged from small to large for both age groups and the outcome pattern did not differ between studies that applied an implicit or explicit gambling task. Two studies demonstrated that comorbid oppositional defiant disorder (ODD) and conduct disorder (CD) increased risky behavior in ADHD. Limited and/or inconsistent evidence was found that comorbid internalizing disorders (IDs), ADHD subtype, methylphenidate use, and different forms of reward influenced the outcomes. Conclusion: The evidence for increased risky performance of individuals with ADHD on gambling tasks is mixed, but is stronger for children/adolescents with ADHD than for adults with ADHD, which may point to developmental changes in reward and/or penalty sensitivity or a publication bias for positive findings in children/adolescents. The literature suggests that comorbid ODD/CD is a risk factor in ADHD for increased risky behavior. Comorbid IDs, ADHD subtype, methylphenidate use, and the form of reward received may affect risky performance in gambling tasks; however, these factors need further examination. Finally, the implications of the findings for ADHD models and the ecological validity of gambling tasks are discussed.	[Groen, Yvonne; Gaastra, Geraldina F.; Lewis-Evans, Ben; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Groningen	Groen, Y (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	y.groen@rug.nl	Tucha, Oliver/AAD-1403-2019	Groen, Yvonne/0000-0002-7242-0317				Agay N, 2010, PSYCHOPHARMACOLOGY, V210, P511, DOI 10.1007/s00213-010-1853-4; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, J INT NEUROPSYCH SOC, V8, P655, DOI 10.1017/S1355617702801345; Barkley RA, 2001, EC NEUROSCI, V3, P64; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Breyer JL, 2009, J GAMBL STUD, V25, P227, DOI 10.1007/s10899-009-9126-z; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Cohen JD, 2005, J ECON PERSPECT, V19, P3, DOI 10.1257/089533005775196750; Cox DJ, 2012, J CLIN PSYCHOPHARM, V32, P225, DOI 10.1097/JCP.0b013e3182496dc5; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115; DAUGHERTY TK, 1991, J CHILD PSYCHOL PSYC, V32, P453, DOI 10.1111/j.1469-7610.1991.tb00323.x; Derevensky JL, 2007, J ADDICT MED, V1, P165, DOI 10.1097/ADM.0b013e318142d081; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; DOUGLAS VI, 1994, J ABNORM CHILD PSYCH, V22, P281, DOI 10.1007/BF02168075; Drechsler R, 2008, J NEURAL TRANSM, V115, P201, DOI 10.1007/s00702-007-0814-5; Drechsler R, 2010, CHILD NEUROPSYCHOL, V16, P145, DOI 10.1080/09297040903190774; Duarte NA, 2012, J PSYCHIATR RES, V46, P492, DOI 10.1016/j.jpsychires.2012.01.006; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Ernst M, 2003, AM J PSYCHIAT, V160, P1061, DOI 10.1176/appi.ajp.160.6.1061; Faraone SV, 2003, J CLIN PSYCHIAT, V64, P9; Faregh N, 2011, J GAMBL STUD, V27, P243, DOI 10.1007/s10899-010-9211-3; Fischer M, 2005, DEV NEUROPSYCHOL, V27, P107, DOI 10.1207/s15326942dn2701_5; Flory K, 2006, J CLIN CHILD ADOLESC, V35, P571, DOI 10.1207/s15374424jccp3504_8; Garon Nancy, 2006, J Atten Disord, V9, P607, DOI 10.1177/1087054705284501; GAYTON WF, 1986, PERCEPT MOTOR SKILL, V63, P801, DOI 10.2466/pms.1986.63.2.801; Geurts HM, 2006, J ABNORM CHILD PSYCH, V34, P813, DOI 10.1007/s10802-006-9059-2; Groen Y, 2009, BIOL PSYCHOL, V82, P45, DOI 10.1016/j.biopsycho.2009.05.004; Halperin JM, 2006, PSYCHOL BULL, V132, P560, DOI 10.1037/0033-2909.132.4.560; Hobson CW, 2011, J CHILD PSYCHOL PSYC, V52, P1035, DOI 10.1111/j.1469-7610.2011.02454.x; Humphreys KL, 2011, J PSYCHOPATHOL BEHAV, V33, P299, DOI 10.1007/s10862-011-9237-6; Iaboni F, 1997, PSYCHOPHYSIOLOGY, V34, P116, DOI 10.1111/j.1469-8986.1997.tb02422.x; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2008, J CHILD PSYCHOL PSYC, V49, P712, DOI 10.1111/j.1469-7610.2008.01910.x; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Malloy-Diniz LF, 2008, REV BRAS PSIQUIATR, V30, P144, DOI 10.1590/S1516-44462008005000009; Mannuzza S, 2004, J ABNORM CHILD PSYCH, V32, P565, DOI 10.1023/B:JACP.0000037784.80885.1a; Mannuzza S, 2008, PSYCHIAT RES, V160, P237, DOI 10.1016/j.psychres.2007.11.003; Mantyla T, 2012, J ATTEN DISORD, V16, P164, DOI 10.1177/1087054709360494; Masunami T, 2009, INT J PSYCHOPHYSIOL, V72, P283, DOI 10.1016/j.ijpsycho.2009.01.007; Matthies S, 2012, J BEHAV THER EXP PSY, V43, P938, DOI 10.1016/j.jbtep.2012.02.002; Matthys W, 1998, J CHILD PSYCHOL PSYC, V39, P643, DOI 10.1017/S0021963098002534; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; PATTERSON CM, 1993, PSYCHOL REV, V100, P716, DOI 10.1037/0033-295X.100.4.716; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Petry NM, 2012, J ABNORM PSYCHOL, V121, P151, DOI 10.1037/a0024782; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rooney M, 2012, J ATTEN DISORD, V16, P221, DOI 10.1177/1087054710392536; Rosenbloom T, 2011, ACCIDENT ANAL PREV, V43, P128, DOI 10.1016/j.aap.2010.08.002; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Scheres A, 2006, NEUROPSYCHOLOGIA, V44, P2092, DOI 10.1016/j.neuropsychologia.2005.10.012; Seguin JR, 2007, COGNITIVE DEV, V22, P530, DOI 10.1016/j.cogdev.2007.08.006; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005; Takahashi T, 2009, NEUROENDOCRINOL LETT, V30, P749; Thompson AL, 2007, J PEDIATR PSYCHOL, V32, P745, DOI 10.1093/jpepsy/jsm002; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Van Duijvenvoorde ACK, 2012, DEV PSYCHOL, V48, P192, DOI 10.1037/a0025601; Weafer J, 2011, DRUG ALCOHOL DEPEN, V113, P139, DOI 10.1016/j.drugalcdep.2010.07.027; White JW, 2012, J FAM VIOLENCE, V27, P123, DOI 10.1007/s10896-012-9411-y; Wiers RW, 1998, J ABNORM CHILD PSYCH, V26, P415, DOI 10.1023/A:1022643617017; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Wilens TE, 2004, J CLIN PSYCHIAT, V65, P1301, DOI 10.4088/JCP.v65n1003	75	60	61	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74909	10.1371/journal.pone.0074909	http://dx.doi.org/10.1371/journal.pone.0074909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058638	gold, Green Published, Green Submitted			2022-12-27	WOS:000324408400100
J	Zhao, H; Liu, JN; Pan, SN; Sun, YW; Li, Q; Li, F; Ma, L; Guo, QY				Zhao, Heng; Liu, Jiani; Pan, Shinong; Sun, Yingwei; Li, Qi; Li, Fei; Ma, Li; Guo, Qiyong			SOD mRNA and MDA Expression in Rectus Femoris Muscle of Rats with Different Eccentric Exercise Programs and Time Points	PLOS ONE			English	Article							PROTECTS VULNERABLE NEURONS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; ISCHEMIC DAMAGE; GENE-EXPRESSION; REACTIVE OXYGEN; FREE-RADICALS; ENDURANCE; OVEREXPRESSION	Purpose: Although superoxide dismutase (SOD) and malondialdehyde (MDA) affect Delayed Onset Muscle Soreness (DOMS), their effects are unclear in rectus femoris muscles (RFM) of rats with different eccentric exercise programs and time points. The purpose of this study is to investigate the effects of the various eccentric exercise programs at different time points on the SOD mRNA expression and MDA using rat as the animal model. Methods: 248 male rats were randomly divided into 4 groups: control group (CTL, n = 8), once-only exercise group (OEG, n = 80), continuous exercise group (CEG, n = 80), and intermittent exercise group (IEG, n = 80). Each exercise group was divided into 10 subgroups that exercised 0.5 h, 6 h, 12 h, 24 h, 48 h, 72 h, 96 h, 120 h, 144 h, or 168 h. Rats were sacrificed and their SOD mRNA expression, and MDA concentrations of skeletal muscle tissue were measured. Results: The specimen in all eccentric exercise programs showed increased RFM SOD1 mRNA expression levels at 0.5 h (P < 0.05), and decreased RFM SOD3 mRNA expression at 0.5 h (P < 0.05). The continuous eccentric exercise (CE) significantly enhanced muscle SOD2 mRNA level at 0.5 h (P < 0.05). After once-only eccentric exercise (OE), SOD1, SOD2, and SOD3 mRNA expression significantly increased at 96 h, whereas MDA concentrations decreased at 96 h. After CE, the correlation coefficients of SOD1, SOD2, SOD3 mRNA expression levels and MDA concentrations were -0.814, -0.763, -0.845 (all P < 0.05) at 12 h. Conclusion: Regular eccentric exercise, especially CE could enhance SOD1 and SOD2 mRNA expression in acute stage and the SOD2 mRNA expression correlates to MDA concentration in vivo, which may improve the oxidative adaption ability of skeletal muscles.	[Zhao, Heng; Liu, Jiani; Pan, Shinong; Sun, Yingwei; Li, Qi; Li, Fei; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China; [Ma, Li] China Med Univ, Shengjing Hosp, Cent Lab, Shenyang, Peoples R China	China Medical University; China Medical University	Pan, SN (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China.	cjr.panshinong@vip.163.com	赵, 衡/AAQ-9925-2021	Zhao, Heng/0000-0001-6549-4644	National Natural Science Foundation of China [30871211, 81271538]; Outstanding Scientific Fund of Shengjing Hospital [201208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Scientific Fund of Shengjing Hospital	This work was supported by National Natural Science Foundation of China(30871211, 81271538), Outstanding Scientific Fund of Shengjing Hospital (NO. 201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Anttila K, 2007, ACTA HISTOCHEM CYTOC, V40, P35, DOI 10.1267/ahc.06028; Atig F, 2012, INT J BIOL SCI, V8, P139, DOI 10.7150/ijbs.8.139; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Cleak MJ, 1992, J SPORT SCI, V10, P325, DOI 10.1080/02640419208729932; Close GL, 2004, EUR J APPL PHYSIOL, V91, P615, DOI 10.1007/s00421-003-1012-2; Pimenta AD, 2007, EUR J APPL PHYSIOL, V102, P119, DOI 10.1007/s00421-007-0542-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Garcia-Lopez D, 2007, MED SCI SPORT EXER, V39, P653, DOI 10.1249/mss.0b013e31802f04f6; Habbout A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056981; Hitomi Y, 2008, REDOX REP, V13, P213, DOI 10.1179/135100008X308894; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Hootman JM, 2002, MED SCI SPORT EXER, V34, P838, DOI 10.1097/00005768-200205000-00017; Itoh M, 2004, AM J PHYSIOL-REG I, V287, pR33, DOI 10.1152/ajpregu.00598.2003; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Jeffcoate W, 2004, DIABETOLOGIA, V47, P1488, DOI 10.1007/s00125-004-1477-5; Ji LL, 2004, FASEB J, V18, P1499, DOI 10.1096/fj.04-1846com; Ji LL, 2002, ANN NY ACAD SCI, V959, P82, DOI 10.1111/j.1749-6632.2002.tb02085.x; Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x; Kerksick C, 2008, MED SCI SPORT EXER, V40, P1772, DOI 10.1249/MSS.0b013e31817d1cce; Koyama H, 2013, MOLECULES, V18, P1383, DOI 10.3390/molecules18021383; KUIPERS H, 1994, INT J SPORTS MED, V15, P132, DOI 10.1055/s-2007-1021034; LAI CC, 1994, FREE RADICAL BIO MED, V16, P613, DOI 10.1016/0891-5849(94)90061-2; Lima-Cabello E, 2010, J APPL PHYSIOL, V108, P575, DOI 10.1152/japplphysiol.00816.2009; Liu WY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/780719; Liu XG, 2009, PHOTOMED LASER SURG, V27, P863, DOI 10.1089/pho.2008.2443; Lustgarten MS, 2009, AM J PHYSIOL-CELL PH, V297, pC1520, DOI 10.1152/ajpcell.00372.2009; McLeay Y, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-19; Molines L, 2010, DIABETES METAB, V36, P251, DOI 10.1016/j.diabet.2010.04.002; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nakao C, 2000, J APPL PHYSIOL, V88, P649, DOI 10.1152/jappl.2000.88.2.649; Noor Rana, 2002, Med Sci Monit, V8, pRA210; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; Papiez MA, 2009, PROG NEURO-PSYCHOPH, V33, P596, DOI 10.1016/j.pnpbp.2009.02.015; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Qiao D, 2006, BRIT J SPORT MED, V40, P214, DOI 10.1136/bjsm.2005.020099; Radak Z, 2012, NITRIC OXIDE-BIOL CH, V26, P89, DOI 10.1016/j.niox.2011.12.005; Ringholm S, 2011, AM J PHYSIOL-ENDOC M, V301, pE649, DOI 10.1152/ajpendo.00230.2011; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; SALMINEN A, 1983, ACTA PHYSIOL SCAND, V117, P109, DOI 10.1111/j.1748-1716.1983.tb07184.x; Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Thau N, 2012, NEUROBIOL DIS, V47, P248, DOI 10.1016/j.nbd.2012.04.008; Tomiya A, 2004, AM J SPORT MED, V32, P503, DOI 10.1177/0095399703258788; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058659; Westerterp M, 2006, J LIPID RES, V47, P1203, DOI 10.1194/jlr.M500434-JLR200; Xu Y, 2009, STROKE, V40, P2512, DOI 10.1161/STROKEAHA.109.548453; Yang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057186; Yu TS, 2010, INT J LEGAL MED, V124, P397, DOI 10.1007/s00414-010-0465-1; Zheng JA, 2010, CLIN EXP PHARMACOL P, V37, P955, DOI 10.1111/j.1440-1681.2010.05415.x	56	13	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73634	10.1371/journal.pone.0073634	http://dx.doi.org/10.1371/journal.pone.0073634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058480	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400029
J	Carozzi, VA; Renn, CL; Bardini, M; Fazio, G; Chiorazzi, A; Meregalli, C; Oggioni, N; Shanks, K; Quartu, M; Serra, MP; Sala, B; Cavaletti, G; Dorsey, SG				Carozzi, Valentina A.; Renn, Cynthia L.; Bardini, Michela; Fazio, Grazia; Chiorazzi, Alessia; Meregalli, Cristina; Oggioni, Norberto; Shanks, Kathleen; Quartu, Marina; Serra, Maria Pina; Sala, Barbara; Cavaletti, Guido; Dorsey, Susan G.			Bortezomib-Induced Painful Peripheral Neuropathy: An Electrophysiological, Behavioral, Morphological and Mechanistic Study in the Mouse	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; SUPERFICIAL DORSAL-HORN; NF-KAPPA-B; MULTIPLE-MYELOMA; NEUROTROPHIC FACTOR; SPINAL-CORD; PROTEASOME INHIBITORS; ROOT GANGLIA; RAT MODEL; NEUROTOXICITY	Bortezomib is the first proteasome inhibitor with significant antineoplastic activity for the treatment of relapsed/refractory multiple myeloma as well as other hematological and solid neoplasms. Peripheral neurological complications manifesting with paresthesias, burning sensations, dysesthesias, numbness, sensory loss, reduced proprioception and vibratory sensitivity are among the major limiting side effects associated with bortezomib therapy. Although bortezomib-induced painful peripheral neuropathy is clinically easy to diagnose and reliable models are available, its pathophysiology remains partly unclear. In this study we used well-characterized immune-competent and immune-compromised mouse models of bortezomib-induced painful peripheral neuropathy. To characterize the drug-induced pathological changes in the peripheral nervous system, we examined the involvement of spinal cord neuronal function in the development of neuropathic pain and investigated the relevance of the immune response in painful peripheral neuropathy induced by bortezomib. We found that bortezomib treatment induced morphological changes in the spinal cord, dorsal roots, dorsal root ganglia (DRG) and peripheral nerves. Neurophysiological abnormalities and specific functional alterations in A delta and C fibers were also observed in peripheral nerve fibers. Mice developed mechanical allodynia and functional abnormalities of wide dynamic range neurons in the dorsal horn of spinal cord. Bortezomib induced increased expression of the neuronal stress marker activating transcription factor-3 in most DRG. Moreover, the immunodeficient animals treated with bortezomib developed a painful peripheral neuropathy with the same features observed in the immunocompetent mice. In conclusion, this study extends the knowledge of the sites of damage induced in the nervous system by bortezomib administration. Moreover, a selective functional vulnerability of peripheral nerve fiber subpopulations was found as well as a change in the electrical activity of wide dynamic range neurons of dorsal horn of spinal cord. Finally, the immune response is not a key factor in the development of morphological and functional damage induced by bortezomib in the peripheral nervous system.	[Carozzi, Valentina A.; Chiorazzi, Alessia; Meregalli, Cristina; Oggioni, Norberto; Sala, Barbara; Cavaletti, Guido] Univ Milano Bicocca, Dept Surg & Translat Med, Monza, Italy; [Renn, Cynthia L.; Shanks, Kathleen; Dorsey, Susan G.] Univ Maryland, Sch Nursing, Ctr Pain Studies, Baltimore, MD 21201 USA; [Bardini, Michela; Fazio, Grazia] Univ Milano Bicocca, Dept Hlth Sci, M Tettamanti Res Ctr, Monza, Italy; [Quartu, Marina; Serra, Maria Pina] Univ Cagliari, Sect Cytomorphol, Dept Biomed Sci, Monserrato, Italy	University of Milano-Bicocca; University System of Maryland; University of Maryland Baltimore; University of Milano-Bicocca; University of Cagliari	Carozzi, VA (corresponding author), Univ Milano Bicocca, Dept Surg & Translat Med, Monza, Italy.	valentina.carozzi1@unmib.it	Serra, Maria Pina/AAG-3721-2021; FAZIO, GRAZIA/K-1523-2016; Cavaletti, Guido/AAA-7063-2022; carozzi, valentina/AAM-1355-2020; QUARTU, MARINA/F-9652-2012	Serra, Maria Pina/0000-0002-3343-7861; FAZIO, GRAZIA/0000-0001-7077-8422; Cavaletti, Guido/0000-0003-4128-2406; Meregalli, Cristina/0000-0002-4281-4577; carozzi, valentina alda/0000-0003-0963-7107; BARDINI, MICHELA/0000-0002-6942-2274; Chiorazzi, Alessia/0000-0002-3469-1829; Renn, Cynthia/0000-0001-6764-9347; QUARTU, MARINA/0000-0002-1884-3597	National Institute of Nursing Research [P30NR011396]; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR011396] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Source of funding for S. Dorsey, C. Renn, K. Shanks: National Institute of Nursing Research, P30NR011396. Source of funding for G. Cavaletti: personal funding for research on chemotherapy-induced peripheral neuropathy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Argyriou AA, 2008, BLOOD, V112, P1593, DOI 10.1182/blood-2008-04-149385; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Back SK, 2003, NEUROREPORT, V14, P1623, DOI 10.1097/00001756-200308260-00016; Badros A, 2007, CANCER-AM CANCER SOC, V110, P1042, DOI 10.1002/cncr.22921; Bonvini P, 2007, LEUKEMIA, V21, P838, DOI 10.1038/sj.leu.2404528; Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-0; Bruna J, 2010, EXP NEUROL, V223, P599, DOI 10.1016/j.expneurol.2010.02.006; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Cata JP, 2008, BRAIN RES, V1230, P91, DOI 10.1016/j.brainres.2008.07.022; Cata JP, 2007, J PAIN, V8, P296, DOI 10.1016/j.jpain.2006.09.014; CAVALETTI G, 1995, EXP NEUROL, V133, P64, DOI 10.1006/exnr.1995.1008; Cavaletti G, 2007, HAEMATOLOGICA, V92, P1308, DOI 10.3324/haematol.11752; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Cavaletti G, 2010, LEUKEMIA LYMPHOMA, V51, P1178, DOI 10.3109/10428194.2010.483303; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016/S0304-3959(96)03165-X; Chaudhry V, 2008, J PERIPHER NERV SYST, V13, P275, DOI 10.1111/j.1529-8027.2008.00193.x; Curran MP, 2009, DRUGS, V69, P859, DOI 10.2165/00003495-200969070-00006; Freimann H, 2007, SWISS MED WKLY, V137, P317; Giannoccaro MP, 2011, NEUROL SCI, V32, P361, DOI 10.1007/s10072-010-0475-2; Glineur S, 2011, IMMUNOBIOLOGY, V216, P213, DOI 10.1016/j.imbio.2010.04.005; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Groth R, 2002, PAIN, V100, P171, DOI 10.1016/S0304-3959(02)00264-6; GUILBAUD G, 1990, J NEUROPHYSIOL, V64, P1537, DOI 10.1152/jn.1990.64.5.1537; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; Jazirehi AR, 2012, MOL CANCER THER, V11, P1332, DOI 10.1158/1535-7163.MCT-11-0814; Jeter A, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-20; Jimenez-Andrade JM, 2006, NEUROSCI LETT, V405, P62, DOI 10.1016/j.neulet.2006.06.043; Joh T, 2009, CASE REP ONCOL, V2, P184, DOI 10.1159/000231996; Kennedy B, 2010, CURR MED CHEM, V17, P4291, DOI 10.2174/092986710793361289; Khasabova IA, 2012, J NEUROSCI, V32, P7091, DOI 10.1523/JNEUROSCI.0403-12.2012; Koga K, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-13; Kortum M, 2011, EXPERT OPIN PHARMACO, V12, P1661, DOI 10.1517/14656566.2011.575780; LAIRD JMA, 1993, J NEUROPHYSIOL, V69, P2072, DOI 10.1152/jn.1993.69.6.2072; Lanzani F, 2008, J PERIPHER NERV SYST, V13, P267, DOI 10.1111/j.1529-8027.2008.00192.x; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lenz HJ, 2003, CANCER TREAT REV, V29, P41, DOI 10.1016/S0305-7372(03)00082-3; Li J, 2012, CURR TOP MED CHEM, V12, P1408, DOI 10.2174/156802612801784434; Linda Hans, 2011, Front Neurol, V2, P30, DOI 10.3389/fneur.2011.00030; Lindwall C, 2004, MOL CELL NEUROSCI, V27, P267, DOI 10.1016/j.mcn.2004.07.001; Lu VB, 2007, J PHYSIOL-LONDON, V584, P543, DOI 10.1113/jphysiol.2007.141267; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; Ma L, 2012, J PHARMACOL SCI, V119, P282, DOI 10.1254/jphs.12080SC; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Mangiacavalli S, 2010, BRIT J HAEMATOL, V149, P916, DOI 10.1111/j.1365-2141.2010.08138.x; Marmiroli P, 2009, CLIN NEUROPATHOL, V28, P263, DOI 10.2379/NP300136; Matsumoto M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-16; Matsumoto M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-25; MCMAHON SB, 1984, PAIN, V19, P235, DOI 10.1016/0304-3959(84)90002-2; Meregalli C, 2010, EUR J PAIN, V14, P343, DOI 10.1016/j.ejpain.2009.07.001; Mitchell K, 2010, MOL PAIN, V17, P694; Motta EM, 2006, EXP BIOL MED, V231, P1141; Muthuraman A, 2011, FOOD CHEM TOXICOL, V49, P2557, DOI 10.1016/j.fct.2011.06.069; Nakano A, 2011, INT J HEMATOL, V93, P727, DOI 10.1007/s12185-011-0850-7; Obata K, 2004, EXP NEUROL, V188, P149, DOI 10.1016/j.expneurol.2004.03.012; Ossipov MH, 1999, PAIN, V79, P127, DOI 10.1016/S0304-3959(98)00187-0; PALECEK J, 1992, J NEUROPHYSIOL, V68, P1951, DOI 10.1152/jn.1992.68.6.1951; Pertovaara A, 2001, EXP NEUROL, V167, P425, DOI 10.1006/exnr.2000.7574; Ravaglia S, 2008, CLIN NEUROPHYSIOL, V119, P2507, DOI 10.1016/j.clinph.2008.08.007; Renn CL, 2011, J NEUROSCI RES, V89, P1551, DOI 10.1002/jnr.22685; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Saade NE, 2002, NEUROSCIENCE, V115, P403, DOI 10.1016/S0306-4522(02)00417-7; Saifee TA, 2010, J PERIPHER NERV SYST, V15, P366, DOI 10.1111/j.1529-8027.2010.00287.x; Schaumburg HH, 2010, J PERIPHER NERV SYST, V15, P128, DOI 10.1111/j.1529-8027.2010.00262.x; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shen H, 1999, MOL BRAIN RES, V64, P186, DOI 10.1016/S0169-328X(98)00314-3; Sotgiu ML, 1997, NEUROSCI LETT, V223, P101, DOI 10.1016/S0304-3940(97)13409-7; Tobinai K, 2007, INT J CLIN ONCOL, V12, P318, DOI 10.1007/s10147-007-0695-5; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Tsuzuki K, 2001, PAIN, V91, P351, DOI 10.1016/S0304-3959(00)00456-5; Ueda Hiroshi, 2008, Folia Pharmacologica Japonica, V131, P367, DOI 10.1254/fpj.131.367; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	77	55	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72995	10.1371/journal.pone.0072995	http://dx.doi.org/10.1371/journal.pone.0072995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069168	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100026
J	Kazemzadeh, A; Ganesan, P; Ibrahim, F; He, SS; Madou, MJ				Kazemzadeh, Amin; Ganesan, Poo; Ibrahim, Fatimah; He, Shuisheng; Madou, Marc J.			The Effect of Contact Angles and Capillary Dimensions on the Burst Frequency of Super Hydrophilic and Hydrophilic Centrifugal Microfluidic Platforms, a CFD Study	PLOS ONE			English	Article							TOTAL ANALYSIS SYSTEMS; MICRO CHECK VALVES; PASSIVE VALVES; STOP VALVES; FABRICATION; DESIGN; BARRIER; PLASMA; FLOW	This paper employs the volume of fluid (VOF) method to numerically investigate the effect of the width, height, and contact angles on burst frequencies of super hydrophilic and hydrophilic capillary valves in centrifugal microfluidic systems. Existing experimental results in the literature have been used to validate the implementation of the numerical method. The performance of capillary valves in the rectangular and the circular microfluidic structures on super hydrophilic centrifugal microfluidic platforms is studied. The numerical results are also compared with the existing theoretical models and the differences are discussed. Our experimental and computed results show a minimum burst frequency occurring at square capillaries and this result is useful for designing and developing more sophisticated networks of capillary valves. It also predicts that in super hydrophilic microfluidics, the fluid leaks consistently from the capillary valve at low pressures which can disrupt the biomedical procedures in centrifugal microfluidic platforms.	[Kazemzadeh, Amin; Ganesan, Poo] Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia; [Kazemzadeh, Amin; Ganesan, Poo; Ibrahim, Fatimah] Univ Malaya, Dept Biomed Engn, Med Informat & Biol Microelectromech Syst MIMEM S, Kuala Lumpur, Malaysia; [He, Shuisheng] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Madou, Marc J.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Madou, Marc J.] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA; [Madou, Marc J.] WCU, UNIST, Ulsan, South Korea	Universiti Malaya; Universiti Malaya; University of Sheffield; University of California System; University of California Irvine; University of California System; University of California Irvine; Ulsan National Institute of Science & Technology (UNIST)	Ganesan, P (corresponding author), Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia.	poo_ganesan@um.edu.my	Kazemzadeh, Amin/K-8960-2013; Ganesan, Poo Balan/H-1804-2014; Madou, Marc J./E-5869-2013; IBRAHIM, FATIMAH/B-8506-2010; SAHU, JAYA NARAYAN/B-8700-2010; He, Shuisheng/J-1741-2014	Kazemzadeh, Amin/0000-0002-2988-6445; Madou, Marc J./0000-0003-4847-3117; IBRAHIM, FATIMAH/0000-0003-1804-4362; He, Shuisheng/0000-0003-0326-2447	University of Malaya, Ministry of Higher Education High Impact Research [UM/HIR/MOHE/ENG/05]; University of Malaya [UMRG: RG023/09AET]; National Institute of Health [1 R01 AI089541-01]; WCU (World Class University) through the National Research Foundation of Korea [R32-2008-000-20054-0]; Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089541] Funding Source: NIH RePORTER	University of Malaya, Ministry of Higher Education High Impact Research; University of Malaya(Universiti Malaya); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WCU (World Class University) through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is financially supported by University of Malaya, Ministry of Higher Education High Impact Research (UM/HIR/MOHE/ENG/05), and University of Malaya Research Grant (UMRG: RG023/09AET). MM would like to acknowledge support of the National Institute of Health (grant 1 R01 AI089541-01). MM also acknowledges support of WCU (World Class University) program (R32-2008-000-20054-0) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2001, SENSOR ACTUAT B-CHEM, V75, P136, DOI 10.1016/S0925-4005(00)00675-4; ANSYS-FLUENT H, 2011, 36 5 4 PHAS INT DIAL; Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Blake TD, 2006, J COLLOID INTERF SCI, V299, P1, DOI 10.1016/j.jcis.2006.03.051; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; CARROZZA MC, 1995, J MICROMECH MICROENG, V5, P177, DOI 10.1088/0960-1317/5/2/032; Chen JM, 2008, MICROFLUID NANOFLUID, V4, P427, DOI 10.1007/s10404-007-0196-x; Cho H, 2004, CAPILLARY PASSIVE VA; Cho H, 2007, J COLLOID INTERF SCI, V306, P379, DOI 10.1016/j.jcis.2006.10.077; Cho YK, 2007, ONE STEP PATHOGEN SP, P387; Danov KD, 2002, J COLLOID INTERF SCI, V251, P18, DOI 10.1006/jcis.2002.8358; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Duffy DC, 1999, ANAL CHEM, V71, P4669, DOI 10.1021/ac990682c; Fang C, 2008, INT J MULTIPHAS FLOW, V34, P690, DOI 10.1016/j.ijmultiphaseflow.2007.08.008; Feng YY, 2003, SENSOR ACTUAT A-PHYS, V108, P138, DOI 10.1016/S0924-4247(03)00363-7; Gliere A, 2006, SENSOR ACTUAT A-PHYS, V130, P601, DOI 10.1016/j.sna.2005.12.011; GRADER L, 1986, COLLOID POLYM SCI, V264, P719, DOI 10.1007/BF01469534; Haeberle S, 2006, LAB CHIP, V6, P776, DOI 10.1039/b604145k; He HY, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3116665; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Hirt CW, 1996, SIMULATION SLIDE COA; Hirt CW, 2001, 4 EUR COAT S BRUSS; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Jeon NL, 2002, BIOMED MICRODEVICES, V4, P117, DOI 10.1023/A:1014683114796; Jia GY, 2006, SENSOR ACTUAT B-CHEM, V114, P173, DOI 10.1016/j.snb.2005.04.043; Kim DS, 2002, J MICROMECH MICROENG, V12, P236, DOI 10.1088/0960-1317/12/3/307; Lee LJ, 2001, BIOMED MICRODEVICES, V3, P339, DOI 10.1023/A:1012469017354; Leu TS, 2004, SENSOR ACTUAT A-PHYS, V115, P508, DOI 10.1016/j.sna.2004.02.036; Li B, 2005, SENSOR ACTUAT A-PHYS, V117, P325, DOI 10.1016/j.sna.2004.06.029; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Madou MJ, 2001, BIOMED MICRODEVICES, V3, P245, DOI 10.1023/A:1011419515576; Man PF, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P45, DOI 10.1109/MEMSYS.1998.659727; Nguyen NT, 2004, J MICROMECH MICROENG, V14, P69, DOI 10.1088/0960-1317/14/1/309; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; Popescu MN, 2008, LANGMUIR, V24, P12710, DOI 10.1021/la801753t; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Rosengarten G, 2006, APPL MATH MODEL, V30, P1033, DOI 10.1016/j.apm.2005.06.011; Saha AA, 2009, J COLLOID INTERF SCI, V339, P461, DOI 10.1016/j.jcis.2009.07.071; Santra S, 2002, SENSOR ACTUAT B-CHEM, V87, P358, DOI 10.1016/S0925-4005(02)00272-1; Shikhmurzaev YD, 1997, PHYS FLUIDS, V9, P266, DOI 10.1063/1.869147; Sim WY, 2003, J MICROMECH MICROENG, V13, P286, DOI 10.1088/0960-1317/13/2/317; Thio THG, 2013, MED BIOL ENG COMPUTI; Tseng FG, 2002, SENSOR ACTUAT A-PHYS, V97-8, P131, DOI 10.1016/S0924-4247(01)00826-3; VANREMOORTERE P, 1991, J COLLOID INTERF SCI, V141, P348, DOI 10.1016/0021-9797(91)90331-2; Xu Z, 2009, J PHYS CONF SER, V188, DOI 10.1088/1742-6596/188/1/012024; Yamahata C, 2005, SENSOR ACTUAT B-CHEM, V110, P1, DOI 10.1016/j.snb.2005.01.005; Yan H, 2008, ELECTROPHORESIS, V29, P1775, DOI 10.1002/elps.200700561; Yang EH, 1996, SENSOR ACTUAT A-PHYS, V57, P75, DOI 10.1016/S0924-4247(97)80097-0; Zeng J, 2000, MESA MG, P579; Zeng J, 2000, FLUIDIC CAPACITANCE, P1; Zoval JV, 2004, P IEEE, V92, P140, DOI 10.1109/JPROC.2003.820541	51	24	24	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73002	10.1371/journal.pone.0073002	http://dx.doi.org/10.1371/journal.pone.0073002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069169	Green Published, gold, Green Accepted			2022-12-27	WOS:000326240100027
J	de Jong, JW; Meijboom, KE; Vanderschuren, LJMJ; Adan, RAH				de Jong, Johannes W.; Meijboom, Karin E.; Vanderschuren, Louk J. M. J.; Adan, Roger A. H.			Low Control over Palatable Food Intake in Rats Is Associated with Habitual Behavior and Relapse Vulnerability: Individual Differences	PLOS ONE			English	Article							ADDICTION-LIKE BEHAVIOR; BODY-COMPOSITION; COCAINE SEEKING; DRUG-ADDICTION; LIMITED ACCESS; D2 RECEPTORS; FAT OPTION; OBESITY; BRAIN; DOPAMINE	The worldwide obesity epidemic poses an enormous and growing threat to public health. However, the neurobehavioral mechanisms of overeating and obesity are incompletely understood. It has been proposed that addiction-like processes may underlie certain forms of obesity, in particular those associated with binge eating disorder. To investigate the role of addiction-like processes in obesity, we adapted a model of cocaine addiction-like behavior in rats responding for highly palatable food. Here, we tested whether rats responding for highly palatable chocolate Ensure would come to show three criteria of addiction-like behavior, i.e., high motivation, continued seeking despite signaled non-availability and persistence of seeking despite aversive consequences. We also investigated whether exposure to a binge model (a diet consisting of alternating periods of limited food access and access to highly palatable food), promotes the appearance of food addiction-like behavior. Our data show substantial individual differences in control over palatable food seeking and taking, but no distinct subgroup of animals showing addiction-like behavior could be identified. Instead, we observed a wide range extending from low to very high control over palatable food intake. Exposure to the binge model did not affect control over palatable food seeking and taking, however. Animals that showed low control over palatable food intake (i.e., scored high on the three criteria for addiction-like behavior) were less sensitive to devaluation of the food reward and more prone to food-induced reinstatement of extinguished responding, indicating that control over palatable food intake is associated with habitual food intake and vulnerability to relapse. In conclusion, we present an animal model to assess control over food seeking and taking. Since diminished control over food intake is a major factor in the development of obesity, understanding its behavioral and neural underpinnings may facilitate improved management of the obesity epidemic.	[de Jong, Johannes W.; Meijboom, Karin E.; Vanderschuren, Louk J. M. J.; Adan, Roger A. H.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Vanderschuren, Louk J. M. J.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Adan, RAH (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	r.a.h.adan@umcutrecht.nl	Vanderschuren, Louk/AAS-4391-2020; de Jong, Johannes/AAM-4842-2020	de Jong, Johannes/0000-0002-0788-9282; Vanderschuren, Louk/0000-0002-5379-0363	NeuroFAST Foundation; European Union [245009]	NeuroFAST Foundation; European Union(European Commission)	Supported by the NeuroFAST Foundation (the integrated neurobiology of food intake, addiction and stress). NeuroFAST is funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2012, NAT REV NEUROSCI, V13, DOI 10.1038/nrn3212-c1; Avena NM, 2012, METHODS MOL BIOL, V829, P351, DOI 10.1007/978-1-61779-458-2_23; Avena Nicole M, 2011, Curr Drug Abuse Rev, V4, P131; Avena NM, 2011, ADDICTION, V106, P1214, DOI 10.1111/j.1360-0443.2011.03373.x; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bello NT, 2003, AM J PHYSIOL-REG I, V284, pR1260, DOI 10.1152/ajpregu.00716.2002; Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Blundell JE, 2011, ADDICTION, V106, P1216, DOI 10.1111/j.1360-0443.2011.03413.x; Braet C, 2007, EUR CHILD ADOLES PSY, V16, P473, DOI 10.1007/s00787-007-0623-2; Brandon TH, 2007, ANNU REV CLIN PSYCHO, V3, P257, DOI 10.1146/annurev.clinpsy.3.022806.091455; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Conason AH, 2006, QJM-INT J MED, V99, P335, DOI 10.1093/qjmed/hcl030; Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041; Corwin RL, 1998, PHYSIOL BEHAV, V65, P545, DOI 10.1016/S0031-9384(98)00201-7; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; de Jong JW, 2012, OBESITY FACTS, V5, P180, DOI 10.1159/000338292; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dimitriou SG, 2000, INT J EAT DISORDER, V28, P436, DOI 10.1002/1098-108X(200012)28:4&lt;436::AID-EAT12&gt;3.0.CO;2-P; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Fetissov SO, 2009, NUTRITION, V25, P132, DOI 10.1016/j.nut.2008.12.001; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fry J, 2005, P NUTR SOC, V64, P359, DOI 10.1079/PNS2005443; Gearhardt AN, 2012, INT J EAT DISORDER, V45, P657, DOI 10.1002/eat.20957; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Hagan MM, 1997, INT J EAT DISORDER, V22, P411, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;411::AID-EAT6&gt;3.0.CO;2-P; Hagan MM, 2002, PHYSIOL BEHAV, V77, P45, DOI 10.1016/S0031-9384(02)00809-0; HOEBEL BG, 1985, AM J CLIN NUTR, V42, P1133, DOI 10.1093/ajcn/42.5.1133; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Jentsch J David, 2008, Drug Discov Today Dis Models, V5, P247; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jonkman S, 2012, J NEUROSCI, V32, P4645, DOI 10.1523/JNEUROSCI.0348-12.2012; Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Kral JG, 2012, OBESITY FACTS, V5, P254, DOI 10.1159/000338566; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Lesscher HMB, 2010, ALCOHOL CLIN EXP RES, V34, P1219, DOI 10.1111/j.1530-0277.2010.01199.x; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Pierce RC, 2010, NEUROSCI BIOBEHAV R, V35, P212, DOI 10.1016/j.neubiorev.2010.01.007; Porrino LJ, 2004, NEUROSCI BIOBEHAV R, V27, P813, DOI 10.1016/j.neubiorev.2003.11.013; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Veeneman MMJ, 2012, PSYCHOPHARMACOLOGY, V220, P771, DOI 10.1007/s00213-011-2525-8; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wojnicki FHE, 2008, PHYSIOL BEHAV, V95, P649, DOI 10.1016/j.physbeh.2008.09.017; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010; Zhang M, 2002, PSYCHOPHARMACOLOGY, V159, P415, DOI 10.1007/s00213-001-0932-y; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	71	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74645	10.1371/journal.pone.0074645	http://dx.doi.org/10.1371/journal.pone.0074645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058616	Green Submitted, gold, Green Published			2022-12-27	WOS:000327538600105
J	Anik, L; Aknin, LB; Norton, MI; Dunn, EW; Quoidbach, J				Anik, Lalin; Aknin, Lara B.; Norton, Michael I.; Dunn, Elizabeth W.; Quoidbach, Jordi			Prosocial Bonuses Increase Employee Satisfaction and Team Performance	PLOS ONE			English	Article							JOB-SATISFACTION; SELF-EFFICACY; PUBLIC-GOODS; PIECE RATES; WORK; PAY; INCENTIVES; ORGANIZATIONS; METAANALYSIS; COOPERATION	In three field studies, we explore the impact of providing employees and teammates with prosocial bonuses, a novel type of bonus spent on others rather than on oneself. In Experiment 1, we show that prosocial bonuses in the form of donations to charity lead to happier and more satisfied employees at an Australian bank. In Experiments 2a and 2b, we show that prosocial bonuses in the form of expenditures on teammates lead to better performance in both sports teams in Canada and pharmaceutical sales teams in Belgium. These results suggest that a minor adjustment to employee bonuses - shifting the focus from the self to others - can produce measurable benefits for employees and organizations.	[Anik, Lalin] Duke Univ, Fuqua Sch Business, Dept Mkt, Durham, NC 27706 USA; [Aknin, Lara B.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Norton, Michael I.] Harvard Univ, Sch Business, Dept Mkt, Boston, MA 02163 USA; [Dunn, Elizabeth W.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Quoidbach, Jordi] Pompeu Fabra Univ, Dept Econ & Business, Barcelona, Spain	Duke University; Simon Fraser University; Harvard University; University of British Columbia; Pompeu Fabra University	Anik, L (corresponding author), Duke Univ, Fuqua Sch Business, Dept Mkt, Durham, NC 27706 USA.	lalin.anik@duke.edu						Adler PS, 2002, ACAD MANAGE REV, V27, P17, DOI 10.2307/4134367; Akerlof GA, 2005, J ECON PERSPECT, V19, P9, DOI 10.1257/0895330053147930; Aknin LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017018; Aknin LB, 2012, PUTTING SOC IN PRESS; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; [Anonymous], 2000, CLOSE RELATIONSHIPS; Ariely D, 2009, AM ECON REV, V99, P544, DOI 10.1257/aer.99.1.544; Ariely D, 2009, REV ECON STUD, V76, P451, DOI 10.1111/j.1467-937X.2009.00534.x; Avery DR, 2007, J APPL PSYCHOL, V92, P1542, DOI 10.1037/0021-9010.92.6.1542; Barry B, 2000, ORGAN SCI, V11, P648, DOI 10.1287/orsc.11.6.648.12537; BATEMAN TS, 1983, ACAD MANAGE J, V26, P587, DOI 10.2307/255908; BEDEIAN AG, 1981, ACAD MANAGE J, V24, P417, DOI 10.2307/255852; Bishop JW, 2000, J APPL PSYCHOL, V85, P439, DOI [10.1037/0021-9010.85.3.439, 10.1037//0021-9010.85.3.439]; Bloom M, 1999, ACAD MANAGE J, V42, P25, DOI 10.2307/256872; Boning B, 2007, J LABOR ECON, V25, P613, DOI 10.1086/519539; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Bradbury H, 2000, ORGAN SCI, V11, P551, DOI 10.1287/orsc.11.5.551.15203; BRAYFIELD AH, 1955, PSYCHOL BULL, V52, P396, DOI 10.1037/h0045899; Bruck CS, 2002, J VOCAT BEHAV, V60, P336, DOI 10.1006/jvbe.2001.1836; Cammann C., 1983, ASSESSING ORG CHANGE, P71, DOI DOI 10.1177/017084068400500420; Carpenter JP, 2007, GAME ECON BEHAV, V60, P31, DOI 10.1016/j.geb.2006.08.011; Chen G, 2001, ORGAN RES METHODS, V4, P62, DOI 10.1177/109442810141004; Chen G, 2001, HUM PERFORM, V14, P209, DOI 10.1207/S15327043HUP1403_1; Chiaburu DS, 2008, J APPL PSYCHOL, V93, P1082, DOI 10.1037/0021-9010.93.5.1082; Cohen SG, 1997, J MANAGE, V23, P239, DOI 10.1177/014920639702300303; Conference Board, 2010, 145909RR C BOARD; COOK TD, 1980, J PERS, V48, P449, DOI 10.1111/j.1467-6494.1980.tb02379.x; DeMatteo JS, 1998, RES ORGAN BEHAV, V20, P141; DRAGO R, 1987, ECON LETT, V23, P301, DOI 10.1016/0165-1765(87)90169-8; Drago R., 1988, J JAPANESE INT EC, V2, P1, DOI DOI 10.1016/0889-1583(88)90023-8; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Dunn EW, 2010, J HEALTH PSYCHOL, V15, P627, DOI 10.1177/1359105309356366; Eisenberger R, 1999, J PERS SOC PSYCHOL, V77, P1026, DOI 10.1037/0022-3514.77.5.1026; Ewing BT, 1996, ECON LETT, V51, P241, DOI 10.1016/0165-1765(95)00775-X; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; FRIED Y, 1987, PERS PSYCHOL, V40, P287, DOI 10.1111/j.1744-6570.1987.tb00605.x; Fuster A, 2010, MANAGE SCI, V56, P57, DOI 10.1287/mnsc.1090.1081; Gardner T, 1999, ACAD MANAGEMENT EXEC, V13, P101, DOI DOI 10.5465/AME.1999.2570559; Gersick CJG, 2000, ACAD MANAGE J, V43, P1026, DOI 10.2307/1556333; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Goldstein NJ, 2011, ADMIN SCI QUART, V56, P441, DOI 10.1177/0001839211435904; Grant AM, 2007, ACAD MANAGE PERSPECT, V21, P51, DOI 10.5465/AMP.2007.26421238; Grant AM, 2007, ACAD MANAGE REV, V32, P393, DOI 10.5465/AMR.2007.24351328; Grant AM., 2008, J POSIT PSYCHOL, V3, P19; Green C, 2008, ECONOMICA, V75, P710, DOI 10.1111/j.1468-0335.2007.00649.x; GREENE CN, 1973, J APPL PSYCHOL, V58, P95, DOI 10.1037/h0035417; Gross N.C., 1958, AM SOCIOL REV, V23, P463; HACKMAN JR, 1971, J APPL PSYCHOL, V55, P259, DOI 10.1037/h0031152; Hamman J, 2007, EXP ECON, V10, P285, DOI 10.1007/s10683-007-9179-8; Harrison DA, 2006, ACAD MANAGE J, V49, P305, DOI [10.2307/20159765, 10.5465/AMJ.2006.20786077]; Haynes K, 1979, ADMIN SOC WORK, V3, P207; Heaphy ED, 2008, ACAD MANAGE REV, V33, P137; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; HOLMSTROM B, 1979, BELL J ECON, V10, P74, DOI 10.2307/3003320; IAFFALDANO MT, 1985, PSYCHOL BULL, V97, P251, DOI 10.1037/0033-2909.97.2.251; IBARRA H, 1993, ACAD MANAGE REV, V18, P56, DOI 10.5465/AMR.1993.3997507; IRONSON GH, 1989, J APPL PSYCHOL, V74, P193, DOI 10.1037/0021-9010.74.2.193; ITOH H, 1992, J LAW ECON ORGAN, V8, P321; ITOH H, 1991, ECONOMETRICA, V59, P611, DOI 10.2307/2938221; Itoh H, 1993, JOB DESIGN INCENTIVE; JOHN G, 1989, J MARKETING RES, V26, P1, DOI 10.2307/3172665; Judge T.A., 2008, SCI SUBJECTIVE WELL, P393; Judge TA, 2000, J APPL PSYCHOL, V85, P751, DOI 10.1037/0021-9010.85.5.751; Judge TA, 2001, PSYCHOL BULL, V127, P376, DOI 10.1037//0033-2909.127.3.376; Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80; JURGENSEN CE, 1978, J APPL PSYCHOL, V63, P267, DOI 10.1037/0021-9010.63.3.267; KAHN WA, 1990, ACAD MANAGE J, V33, P692, DOI 10.2307/256287; Kahn WA, 1998, RES ORGAN BEHAV, V20, P39; Kahneman D, 2006, SCIENCE, V312, P1908, DOI 10.1126/science.1129688; Karau S. J., 1997, GROUP DYN-THEOR RES, V1, P156, DOI DOI 10.1037/1089-2699.1.2.156; Kogut T, 2007, ORGAN BEHAV HUM DEC, V104, P150, DOI 10.1016/j.obhdp.2007.04.006; Kozlowski S.W.J., 2003, HDB PSYCHOL IND ORG, P333, DOI [10.1002/9781118133880.hop212017, DOI 10.1002/0471264385.WEI1214]; Kunin T, 1955, PERS PSYCHOL, V8, P65, DOI 10.1111/j.1744-6570.1955.tb01189.x; LANGSTON CA, 1994, J PERS SOC PSYCHOL, V67, P1112, DOI 10.1037/0022-3514.67.6.1112; LAZEAR EP, 1989, J POLIT ECON, V97, P561, DOI 10.1086/261616; Lazear EP, 2000, PERFORMANCE PAY PROD; Leana C.R., 2000, RELATIONAL WEALTH AD; Locke E. A., 1976, HDB IND ORG PSYCHOL, P1319; MacLeod WB, 1998, RES LAB EC, P177; Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842; MICELI MP, 1991, J APPL PSYCHOL, V76, P508, DOI 10.1037/0021-9010.76.4.508; MOHRMAN SA, 1992, EDUC EVAL POLICY AN, V14, P347, DOI 10.3102/01623737014004347; Morrison R, 2004, NEW ZEAL J PSYCHOL, V33, P114; Mueller C.W., 1990, J BEHAVIORAL EC, V19, P321, DOI [https://doi.org/10.1016/0090-5720(90)90034-5, DOI 10.1016/0090-5720(90)90034-5]; Oettinger GS, 2001, ECON LETT, V73, P117, DOI 10.1016/S0165-1765(01)00472-4; Oishi S, 2011, PSYCHOL SCI, V22, P1095, DOI 10.1177/0956797611417262; Oyer P, 1998, Q J ECON, V113, P149, DOI 10.1162/003355398555559; Paarsch HJ, 2000, INT ECON REV, V41, P59, DOI 10.1111/1468-2354.00055; Parent D, 1999, IND LABOR RELAT REV, V53, P71, DOI 10.2307/2696162; Putnam RD., 2000, BOWLING ALONE COLLAP; Rangan S, 2000, ACAD MANAGE REV, V25, P813, DOI 10.2307/259208; RIZZO JR, 1970, ADMIN SCI QUART, V15, P150, DOI 10.2307/2391486; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rosenthal R, 1991, METAANALYTIC PROCEDU; SAGER JK, 1989, J BUS RES, V18, P303, DOI 10.1016/0148-2963(89)90024-6; Schmidt FL, 2004, J PERS SOC PSYCHOL, V86, P162, DOI 10.1037/0022-3514.86.1.162; Schor J. B., 1991, OVERWORKED AM UNEXPE; Simon LS, 2008, EFFECTS WORK EXPERIE; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; Smith ML, 1980, BENEFITS PSYCHOTHERA; Smith P. L., 1992, APPL HUM RESOUR MANA, V3, P1; Stajkovic AD, 2001, ACAD MANAGE J, V44, P580, DOI 10.2307/3069372; TERRY DJ, 1993, AUST J PSYCHOL, V45, P168, DOI 10.1080/00049539308259135; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Twenge JM, 2002, J PERS SOC PSYCHOL, V83, P606, DOI 10.1037//0022-3514.83.3.606; Vinchur A, 1998, J APPL PSYCHOL, V82, P30; Wageman R, 1997, J ORGAN BEHAV, V18, P139, DOI 10.1002/(SICI)1099-1379(199703)18:2<139::AID-JOB791>3.3.CO;2-I; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEAVER CN, 1980, J APPL PSYCHOL, V65, P364, DOI 10.1037/0021-9010.65.3.364; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Wright T A, 2000, J Occup Health Psychol, V5, P84, DOI 10.1037/1076-8998.5.1.84; Wrzesniewski AC, 2003, RES ORGAN BEHAV, V25, P93, DOI 10.1016/S0191-3085(03)25003-6	115	51	51	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75509	10.1371/journal.pone.0075509	http://dx.doi.org/10.1371/journal.pone.0075509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058691	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900119
J	Kuwabara, H; Yamasue, H; Koike, S; Inoue, H; Kawakubo, Y; Kuroda, M; Takano, Y; Iwashiro, N; Natsubori, T; Aoki, Y; Kano, Y; Kasai, K				Kuwabara, Hitoshi; Yamasue, Hidenori; Koike, Shinsuke; Inoue, Hideyuki; Kawakubo, Yuki; Kuroda, Miho; Takano, Yosuke; Iwashiro, Norichika; Natsubori, Tatsunobu; Aoki, Yuta; Kano, Yukiko; Kasai, Kiyoto			Altered Metabolites in the Plasma of Autism Spectrum Disorder: A Capillary Electrophoresis Time-of-Flight Mass Spectroscopy Study	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT DEFENSES; OXIDATIVE DAMAGE; NITRIC-OXIDE; METABOLOMICS; ASSOCIATION; BIOMARKERS; SCHIZOPHRENIA; INTERVIEW; CHILDREN	Clinical diagnosis and severity of autism spectrum disorders (ASD) are determined by trained clinicians based on clinical evaluations of observed behaviors. As such, this approach is inevitably dependent on the expertise and subjective assessment of those administering the clinical evaluations. There is a need to identify objective biological markers associated with diagnosis or clinical severity of the disorder. To identify novel candidate metabolites as potential biomarkers for ASD, the current study applied capillary electrophoresis time-of-flight mass spectroscopy (CE-TOFMS) for high-throughput profiling of metabolite levels in the plasma of 25 psychotropic-naive adult males with high-functioning ASD and 28 age-matched typically-developed control subjects. Ten ASD participants and ten age-matched controls were assigned in the first exploration set, while 15 ASD participants and 18 controls were included in the second replication set. By CE-TOFMS analysis, a total of 143 metabolites were detected in the plasma of the first set. Of these, 17 metabolites showed significantly different relative areas between the ASD participants and the controls (p<0.05). Of the 17 metabolites, we consistently found that the ASD participants had significantly high plasma levels of arginine (p = 0.024) and taurine (p = 0.018), and significantly low levels of 5-oxoproline (p<0.001) and lactic acid (p = 0.031) compared with the controls in the second sample set. Further confirmatory analysis using quantification of absolute metabolite concentrations supported the robustness of high arginine (p = 0.001) and low lactic acid (p = 0.003) in the combined sample (n = 53). The present study identified deviated plasma metabolite levels associated with oxidative stress and mitochondrial dysfunction in individuals with ASD.	[Kuwabara, Hitoshi; Kawakubo, Yuki; Kuroda, Miho; Kano, Yukiko] Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan; [Yamasue, Hidenori; Koike, Shinsuke; Inoue, Hideyuki; Takano, Yosuke; Iwashiro, Norichika; Natsubori, Tatsunobu; Aoki, Yuta; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan; [Yamasue, Hidenori] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1028666, Japan; [Koike, Shinsuke] Univ Tokyo, Off Mental Hlth Support, Div Counseling & Support, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Miho] Shukutoku Univ, Fac Integrated Human & Social Welf, Dept Psychol, Chiba, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Yamasue, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan.	yamasue-tky@umin.ac.jp	Koike, Shinsuke/AIC-4690-2022	Kasai, Kiyoto/0000-0002-4443-4535; Koike, Shinsuke/0000-0002-3375-236X; aoki, yuta/0000-0001-5617-4948	CREST; Japan Science and Technology Agency; Development of biomarker candidates for social behavior; Grants-in-Aid for Scientific Research [24791199, 25461751] Funding Source: KAKEN	CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Development of biomarker candidates for social behavior; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A part of this study was supported by CREST, Japan Science and Technology Agency, and the "Development of biomarker candidates for social behavior'' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. to funding.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.108; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Cai HL, 2012, J PROTEOME RES, V11, P4338, DOI 10.1021/pr300459d; Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6; Delwing D, 2008, BRAIN RES, V1193, P120, DOI 10.1016/j.brainres.2007.11.052; Emond P, 2013, ANAL BIOANAL CHEM, V405, P5291, DOI 10.1007/s00216-013-6934-x; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; Geier DA, 2009, NEUROCHEM RES, V34, P386, DOI 10.1007/s11064-008-9782-x; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Good P, 2011, MED HYPOTHESES, V77, P1015, DOI 10.1016/j.mehy.2011.08.038; Good P, 2011, NEUROPSYCHOL REV, V21, P66, DOI 10.1007/s11065-011-9157-y; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Iwata K, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-16; Johannesen JK, 2012, SCHIZOPHR B; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kern JK, 2011, MED SCI MONITOR, V17, pCR677, DOI 10.12659/MSM.882125; Kim HW, 2009, AM J MED GENET B, V150B, P300, DOI 10.1002/ajmg.b.30798; Lecavalier L, 2006, AM J MENT RETARD, V111, P199, DOI 10.1352/0895-8017(2006)111[199:VOTADI]2.0.CO;2; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MACCIARDI F, 1990, PSYCHIAT RES, V32, P63, DOI 10.1016/0165-1781(90)90136-S; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuoka K., 2006, JAPANESE ADULT READI; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Ming X, 2012, J PROTEOME RES, V11, P5856, DOI 10.1021/pr300910n; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Pederzolli CD, 2007, METAB BRAIN DIS, V22, P51, DOI 10.1007/s11011-006-9041-2; Pederzolli CD, 2010, METAB BRAIN DIS, V25, P145, DOI 10.1007/s11011-010-9190-1; Pilling S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4082; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; Schicho R, 2012, J PROTEOME RES; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sugimoto M, 2010, ELECTROPHORESIS, V31, P2311, DOI 10.1002/elps.200900584; Suzuki K, 2010, INT J NEUROPSYCHOPH, V13, P529, DOI 10.1017/S1461145709990952; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tsuchiya KJ, 2013, J AUTISM DEV DISORD, V43, P643, DOI 10.1007/s10803-012-1606-9; Tu WJ, 2012, J CLIN BIOCHEM NUTR, V51, P248, DOI 10.3164/jcbn.12-45; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Xu XH, 2012, NEUROSCI BULL, V28, P641, DOI 10.1007/s12264-012-1272-0; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082; Zoroglu SS, 2003, CELL BIOCHEM FUNCT, V21, P55, DOI 10.1002/cbf.989	59	47	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73814	10.1371/journal.pone.0073814	http://dx.doi.org/10.1371/journal.pone.0073814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058493	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900023
J	Lindsey, PA; Balme, GA; Funston, P; Henschel, P; Hunter, L; Madzikanda, H; Midlane, N; Nyirenda, V				Lindsey, Peter Andrew; Balme, Guy Andrew; Funston, Paul; Henschel, Philipp; Hunter, Luke; Madzikanda, Hilary; Midlane, Neil; Nyirenda, Vincent			The Trophy Hunting of African Lions: Scale, Current Management Practices and Factors Undermining Sustainability	PLOS ONE			English	Article							PANTHERA-LEO; CONSERVATION; POPULATION; INDUSTRY; IMPACT	The trophy hunting of lions Panthera leo is contentious due to uncertainty concerning conservation impacts and because of highly polarised opinions about the practice. African lions are hunted across at least similar to 558,000 km(2), which comprises 27-32% of the lion range in countries where trophy hunting of the species is permitted. Consequently, trophy hunting has potential to impart significant positive or negative impacts on lions. Several studies have demonstrated that excessive trophy harvests have driven lion population declines. There have been several attempts by protectionist non-governmental organisations to reduce or preclude trophy hunting via restrictions on the import and export of lion trophies. We document the management of lion hunting in Africa and highlight challenges which need addressing to achieve sustainability. Problems include: unscientific bases for quota setting; excessive quotas and off-takes in some countries; fixed quotas which encourage over-harvest; and lack of restrictions on the age of lions that can be hunted. Key interventions needed to make lion hunting more sustainable, include implementation of: enforced age restrictions; improved trophy monitoring; adaptive management of quotas and a minimum length of lion hunts of at least 21 days. Some range states have made important steps towards implementing such improved management and off-takes have fallen steeply in recent years. For example age restrictions have been introduced in Tanzania and in Niassa in Mozambique, and are being considered for Benin and Zimbabwe, several states have reduced quotas, and Zimbabwe is implementing trophy monitoring. However, further reforms are needed to ensure sustainability and reduce conservation problems associated with the practice while allowing retention of associated financial incentives for conservation.	[Lindsey, Peter Andrew; Balme, Guy Andrew; Funston, Paul; Henschel, Philipp; Hunter, Luke] Panthera, Lion Program, New York, NY USA; [Lindsey, Peter Andrew] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, Gauteng, South Africa; [Balme, Guy Andrew; Midlane, Neil] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, Western Cape, South Africa; [Madzikanda, Hilary] Zimbabwe Parks & Wildlife Management Author, Harare, Mashonaland Eas, Zimbabwe; [Nyirenda, Vincent] Zambia Wildlife Author, Chilanga, Lusaka Province, Zambia	University of Pretoria; University of Cape Town	Lindsey, PA (corresponding author), Panthera, Lion Program, New York, NY USA.	plindsey@Panthera.org	Hunter, Luke T.B./H-3324-2019; Lindsey, Peter A/J-8368-2012	Hunter, Luke T.B./0000-0001-9653-6544; Lindsey, Peter A/0000-0002-9197-2897; Nyirenda, Vincent Raphael/0000-0002-3506-3912	Panthera	Panthera	This research was funded by Panthera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RECREATIONAL HUNTING; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Begg C, 2010, MONITORING LION LEOP; Booth VR, 2009, COMP PRICES HUNTING; Brink H., 2010, THESIS IMPERIAL COLL; CENAGREF, 2013, PLAN ACT CONS LION B; Central African Republic, 1984, ORD 84 045 PORT PROT; Chardonnet P., 2002, CONSERVATION AFRICAN; Chardonnet P., 2011, CONSERVATION STATUS; Chardonnet P, 2009, CONSERVATION STATUS; Croes BM, 2011, BIOL CONSERV, V144, P3064, DOI 10.1016/j.biocon.2011.09.013; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Di Silvestre I., 2002, DENOMBREMENT G UNPUB; Ferreira S, 2010, S AFR J WILDL RES, V40, P1, DOI 10.3957/056.040.0103; Frank L, 2006, LIONS CONFLICT CONSE; Funston PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059044; Group ICS, 2006, CONSERVATION STRATEG; Henschel P., 2012, IMPROVING STATUS LIO; IUCN, 2012, IUCN RED LIST THREAT; IUCN/PACO, 2009, GRAND CHASS AFR OUES; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey P. A., 2010, CURRENT CONSERVATION, V3, P23; Lindsey PA, 2007, CONSERV BIOL, V21, P880, DOI 10.1111/j.1523-1739.2006.00594.x; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2009, RECREATIONAL HUNTING, P108; Mesochina P, 2010, CONSERVATION STATUS; MINFOF/SDIAF/SC, 2012, HUNT AR CAM; Nelson F, 2013, ORYX, V47, P509, DOI 10.1017/S0030605313001178; Norton-Griffiths M., 2007, WORLD ECON, V8, P41; Nowell K, 2004, CAT NEWS, V41, P29; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C, 2006, HUNTERS GUIDE AGING; Pellerin M., 2009, STATUT CONSERVATION; Ray J.C., 2005, 24 WILDL CONS SOC; Riggio J., 2011, AFRICAN LION PANTHER; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Roulet P.A, 2004, CHASSEUR BLANC COEUR; Simasiku P, 2008, IMPACT WILDLIFE MANA; SMUTS GL, 1980, J ZOOL, V190, P365; Tanzania Wildlife Division, 2012, COMM ESA STAT REV AF; Taylor R, 2009, BIODIVERS CONSERV, V18, P2563, DOI 10.1007/s10531-009-9612-8; Weaver C., 2011, CITES CBNRM, P1; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; World Resources Institute, 2010, INT FOR ATL CENTR AF	53	45	45	3	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73808	10.1371/journal.pone.0073808	http://dx.doi.org/10.1371/journal.pone.0073808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058491	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900021
J	Schneps, MH; Thomson, JM; Chen, C; Sonnert, G; Pomplun, M				Schneps, Matthew H.; Thomson, Jenny M.; Chen, Chen; Sonnert, Gerhard; Pomplun, Marc			E-Readers Are More Effective than Paper for Some with Dyslexia	PLOS ONE			English	Article							VISUAL-ATTENTION SPAN; DEVELOPMENTAL DYSLEXIA; EYE-MOVEMENTS; READING-DISABILITY; LETTER RECOGNITION; SACCADIC CONTROL; PERCEPTUAL SPAN; FIXATED WORD; CHILDREN; INFORMATION	E-readers are fast rivaling print as a dominant method for reading. Because they offer accessibility options that are impossible in print, they are potentially beneficial for those with impairments, such as dyslexia. Yet, little is known about how the use of these devices influences reading in those who struggle. Here, we observe reading comprehension and speed in 103 high school students with dyslexia. Reading on paper was compared with reading on a small handheld e-reader device, formatted to display few words per line. We found that use of the device significantly improved speed and comprehension, when compared with traditional presentations on paper for specific subsets of these individuals: Those who struggled most with phoneme decoding or efficient sight word reading read more rapidly using the device, and those with limited VA Spans gained in comprehension. Prior eye tracking studies demonstrated that short lines facilitate reading in dyslexia, suggesting that it is the use of short lines (and not the device per se) that leads to the observed benefits. We propose that these findings may be understood as a consequence of visual attention deficits, in some with dyslexia, that make it difficult to allocate attention to uncrowded text near fixation, as the gaze advances during reading. Short lines ameliorate this by guiding attention to the uncrowded span.	[Schneps, Matthew H.; Chen, Chen; Sonnert, Gerhard] Harvard Smithsonian Ctr Astrophys, Sci Educ Dept, Cambridge, MA 02138 USA; [Thomson, Jenny M.; Chen, Chen] Harvard Univ, Harvard Grad Sch Educ, Cambridge, MA 02138 USA; [Pomplun, Marc] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Harvard University; University of Massachusetts System; University of Massachusetts Boston	Schneps, MH (corresponding author), Harvard Smithsonian Ctr Astrophys, Sci Educ Dept, 60 Garden St, Cambridge, MA 02138 USA.	mschneps@cfa.harvard.edu	Pomplun, Marc/P-8858-2019	Sonnert, Gerhard/0000-0003-4138-2044; Thomson, Jenny/0000-0002-4293-4851	National Science Foundation [HRD-0930962, HRD-1131039]; Youth Access Grant program at the Smithsonian Institution; Direct For Education and Human Resources [1131039] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Youth Access Grant program at the Smithsonian Institution; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This article is based on work supported by the National Science Foundation under Grants No. HRD-0930962 and HRD-1131039, and the Youth Access Grant program at the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi A, 1999, VISION RES, V39, P4412, DOI 10.1016/S0042-6989(99)00154-6; BADDELEY A, 1976, PSYCHOL MEMORY; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Bednarek D, 2009, BRAIN COGNITION, V70, P273, DOI 10.1016/j.bandc.2009.02.010; Bellocchi S, 2013, RES DEV DISABIL, V34, P452, DOI 10.1016/j.ridd.2012.09.002; Binder KS, 1999, J EXP PSYCHOL HUMAN, V25, P1162, DOI 10.1037/0096-1523.25.4.1162; Biscaldi M, 1998, NEUROPSYCHOLOGIA, V36, P1189, DOI 10.1016/S0028-3932(97)00170-X; Biscaldi M, 2000, PERCEPTION, V29, P509, DOI 10.1068/p2666a; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; BOUMA H, 1977, NEUROPSYCHOLOGIA, V15, P69, DOI 10.1016/0028-3932(77)90116-6; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; de Leeuw R, 2010, THESIS U TWENTE TWEN; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2005, ACTA NEUROBIOL EXP, V65, P61; Facoetti A, 2001, EXP BRAIN RES, V138, P46, DOI 10.1007/s002210100700; Facoetti A, 2000, NEUROSCI LETT, V290, P216, DOI 10.1016/S0304-3940(00)01354-9; Facoetti A, 2008, CORTEX, V44, P1221, DOI 10.1016/j.cortex.2007.10.007; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; GEIGER G, 1987, NEW ENGL J MED, V316, P1238, DOI 10.1056/NEJM198705143162003; Gersch TM, 2009, VISION RES, V49, P1256, DOI 10.1016/j.visres.2007.10.030; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hari R, 2001, BRAIN, V124, P1373, DOI 10.1093/brain/124.7.1373; Heim S, 2008, ACTA NEUROBIOL EXP, V68, P73; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; INHOFF AW, 1989, Q J EXP PSYCHOL-A, V41, P63, DOI 10.1080/14640748908402353; Lachmann T, 2007, DEV NEUROPSYCHOL, V31, P61, DOI 10.1207/s15326942dn3101_4; Lallier M, 2010, NEUROPSYCHOLOGIA, V48, P4125, DOI 10.1016/j.neuropsychologia.2010.09.027; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Lum JAG, 2007, BRAIN COGNITION, V63, P287, DOI 10.1016/j.bandc.2006.09.010; MacGinitie H, 2000, GATES MACGINITIE REA; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Moores E, 2011, NEUROPSYCHOLOGIA, V49, P3881, DOI 10.1016/j.neuropsychologia.2011.10.005; Nakayama K., 1990, VISION CODING EFFICI, P411; O'Brien BA, 2005, J RES READ, V28, P332, DOI 10.1111/j.1467-9817.2005.00273.x; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.i; Petrov Y, 2011, J VISION, V11, DOI 10.1167/11.4.1; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; POLLATSEK A, 1981, BRAIN LANG, V14, P174, DOI 10.1016/0093-934X(81)90073-0; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1989, COGNITIVE NEUROPSYCH, V6, P357, DOI 10.1080/02643298908253288; RAYNER K, 1983, ANN DYSLEXIA, V33, P163, DOI 10.1007/BF02648003; RAYNER K, 1980, PERCEPT PSYCHOPHYS, V27, P537, DOI 10.3758/BF03198682; RAYNER K, 1979, SCIENCE, V206, P468, DOI 10.1126/science.504987; Reichle ED, 1999, VISION RES, V39, P4403, DOI 10.1016/S0042-6989(99)00152-2; Schneps MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071161; Schneps MH, 2010, J SPEC EDUC TECHNOL, V25, P21, DOI 10.1177/016264341002500304; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; SNOWLING MJ, 1980, J EXP CHILD PSYCHOL, V29, P294, DOI 10.1016/0022-0965(80)90021-1; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; Starr MS, 2004, EUR J COGN PSYCHOL, V16, P203, DOI 10.1080/09541440340000150; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Warschauer M, 2012, JALT CALL J, P1; Wechsler D., 1997, WECHSLER ADULT INTEL; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	68	41	43	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75634	10.1371/journal.pone.0075634	http://dx.doi.org/10.1371/journal.pone.0075634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058697	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000324695900123
J	Wang, H; Xie, JZ; Shreeve, TG; Ma, JM; Pallett, DW; King, LA; Possee, RD				Wang, Hui; Xie, Jiazheng; Shreeve, Tim G.; Ma, Jinmin; Pallett, Denise W.; King, Linda A.; Possee, Robert D.			Sequence Recombination and Conservation of Varroa destructor Virus-1 and Deformed Wing Virus in Field Collected Honey Bees (Apis mellifera)	PLOS ONE			English	Article							PICORNA-LIKE VIRUS; VARROA-DESTRUCTOR; RNA INTERFERENCE; GENOME SEQUENCE; GC PREFERENCE; KAKUGO-VIRUS; INFECTION; PREVALENCE; REPLICATION; DISCOVERY	We sequenced small (s) RNAs from field collected honeybees (Apis mellifera) and bumblebees (Bombus pascuorum) using the Illumina technology. The sRNA reads were assembled and resulting contigs were used to search for virus homologues in GenBank. Matches with Varroa destructor virus-1 (VDV1) and Deformed wing virus (DWV) genomic sequences were obtained for A. mellifera but not B. pascuorum. Further analyses suggested that the prevalent virus population was composed of VDV-1 and a chimera of 5'-DWV-VDV1-DWV-3'. The recombination junctions in the chimera genomes were confirmed by using RT-PCR, cDNA cloning and Sanger sequencing. We then focused on conserved short fragments (CSF, size > 25 nt) in the virus genomes by using GenBank sequences and the deep sequencing data obtained in this study. The majority of CSF sites confirmed conservation at both between-species (GenBank sequences) and within-population (dataset of this study) levels. However, conserved nucleotide positions in the GenBank sequences might be variable at the within-population level. High mutation rates (Pi>10%) were observed at a number of sites using the deep sequencing data, suggesting that sequence conservation might not always be maintained at the population level. Virus-host interactions and strategies for developing RNAi treatments against VDV1/DWV infections are discussed.	[Wang, Hui; Pallett, Denise W.; Possee, Robert D.] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Xie, Jiazheng; Ma, Jinmin] Beijing Genome Inst, Shenzhen, Peoples R China; [Shreeve, Tim G.; King, Linda A.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Beijing Genomics Institute (BGI); Oxford Brookes University	Wang, H (corresponding author), NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England.	huw@ceh.ac.uk	Ma, Jinmin/L-8470-2019; Pallett, Denise W/E-8741-2010; Wang, Hui/E-6764-2012	Ma, Jinmin/0000-0002-7993-7001; Pallett, Denise W/0000-0002-3981-6547; 	Natural Environment Research Council (United Kingdom) [NE/I000593/1]; Oxford Brookes University and Ministry of Science and Technology of the Peoples Republic of China [2011DFA33220]; NERC [NE/I000593/1] Funding Source: UKRI; Natural Environment Research Council [CEH010021, NE/I000593/1] Funding Source: researchfish	Natural Environment Research Council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Oxford Brookes University and Ministry of Science and Technology of the Peoples Republic of China; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by Natural Environment Research Council (United Kingdom, grant no. NE/I000593/1), Oxford Brookes University and Ministry of Science and Technology of the Peoples Republic of China (China, grant no. 2011DFA33220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antunez K, 2012, RES VET SCI, V93, P1441, DOI 10.1016/j.rvsc.2012.03.006; Bacandritsos N, 2010, J INVERTEBR PATHOL, V105, P335, DOI 10.1016/j.jip.2010.08.004; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Barriga GP, 2012, VIRUS GENES, V45, P606, DOI 10.1007/s11262-012-0791-0; Berkhout B, 2011, ANTIVIR RES, V92, P7, DOI 10.1016/j.antiviral.2011.04.002; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Choe SE, 2012, J INVERTEBR PATHOL, V109, P330, DOI 10.1016/j.jip.2012.01.003; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Dainat B, 2011, J VIROL METHODS, V174, P150, DOI 10.1016/j.jviromet.2011.03.029; Davis BK, 1999, PROG BIOPHYS MOL BIO, V72, P157, DOI 10.1016/S0079-6107(99)00006-1; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Desai SD, 2012, INSECT MOL BIOL, V21, P446, DOI 10.1111/j.1365-2583.2012.01150.x; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Ding SW, 2011, CURR OPIN VIROL, V1, P533, DOI 10.1016/j.coviro.2011.10.028; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Francis RM, 2013, J GEN VIROL, V94, P668, DOI 10.1099/vir.0.047019-0; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Ho T, 2010, PROTEIN CELL, V1, P847, DOI 10.1007/s13238-010-0100-4; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kojima Y, 2011, MICROB ECOL, V62, P895, DOI 10.1007/s00248-011-9947-z; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martinez F, 2012, MOL BIOL EVOL, V29, P3297, DOI 10.1093/molbev/mss135; Meeus I, 2010, J INVERTEBR PATHOL, V105, P200, DOI 10.1016/j.jip.2010.06.012; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Pallett DW, 2010, J VIROL METHODS, V168, P223, DOI 10.1016/j.jviromet.2010.06.003; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Rortais A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-61; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanpa S, 2009, J INVERTEBR PATHOL, V100, P116, DOI 10.1016/j.jip.2008.11.010; Santillan-Galicia MT, 2008, J GEN VIROL, V89, P1685, DOI 10.1099/vir.0.83223-0; Schroeder DC, 2012, VIRULENCE, V3, P589, DOI 10.4161/viru.22219; Seetin Matthew G, 2012, Methods Mol Biol, V905, P99, DOI 10.1007/978-1-61779-949-5_8; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Terio V, 2008, NEW MICROBIOL, V31, P439; Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Williams GR, 2009, J INVERTEBR PATHOL, V101, P77, DOI 10.1016/j.jip.2009.01.004; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	81	33	39	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74508	10.1371/journal.pone.0074508	http://dx.doi.org/10.1371/journal.pone.0074508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058580	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324695900051
J	Bacon, AP; Carter, RE; Ogle, EA; Joyner, MJ				Bacon, Andrew P.; Carter, Rickey E.; Ogle, Eric A.; Joyner, Michael J.			VO(2)max Trainability and High Intensity Interval Training in Humans: A Meta-Analysis	PLOS ONE			English	Article							BETA-ALANINE SUPPLEMENTATION; AEROBIC POWER; SKELETAL-MUSCLE; ENDURANCE PERFORMANCE; METABOLIC RESPONSES; CARDIAC GROWTH; OXYGEN-UPTAKE; BLOOD-FLOW; O-2 UPTAKE; EXERCISE	Endurance exercise training studies frequently show modest changes in VO(2)max with training and very limited responses in some subjects. By contrast, studies using interval training (IT) or combined IT and continuous training (CT) have reported mean increases in VO(2)max of up to similar to 1.0 L . min(-1). This raises questions about the role of exercise intensity and the trainability of VO(2)max. To address this topic we analyzed IT and IT/CT studies published in English from 1965-2012. Inclusion criteria were: 1)>= 3 healthy sedentary/3recreationally active humans <45 yrs old, 2) training duration 6-13 weeks, 3) >= 3 days/3week, 4) >= 10 minutes of high intensity work, 5) >= 1:1 work/rest ratio, and 6) results reported as mean +/- SD or SE, ranges of change, or individual data. Due to heterogeneity (I-2 value of 70), statistical synthesis of the data used a random effects model. The summary statistic of interest was the change in VO2max. A total of 334 subjects (120 women) from 37 studies were identified. Participants were grouped into 40 distinct training groups, so the unit of analysis was 40 rather than 37. An increase in VO(2)max of 0.51 L . min(-1) (95% CI: 0.43 to 0.60 L . min(-1)) was observed. A subset of 9 studies, with 72 subjects, that featured longer intervals showed even larger (similar to 0.8-0.9 L . min(-1)) changes in VO(2)max with evidence of a marked response in all subjects. These results suggest that ideas about trainability and VO(2)max should be further evaluated with standardized IT or IT/CT training programs.	[Bacon, Andrew P.; Joyner, Michael J.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Carter, Rickey E.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Ogle, Eric A.] Creighton Univ, Sch Med, Omaha, NE USA	Mayo Clinic; Mayo Clinic; Creighton University	Joyner, MJ (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.	joyner.michael@mayo.edu			National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; Mayo Foundation; Caywood Professorship	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; Caywood Professorship	This publication was partially supported by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), the Mayo Foundation, and Caywood Professorship to MJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger NJA, 2006, MED SCI SPORT EXER, V38, P504, DOI 10.1249/01.mss.0000191418.37709.81; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; BURKE J, 1994, BRIT J SPORT MED, V28, P18, DOI 10.1136/bjsm.28.1.18; CLAUSEN JP, 1977, PHYSIOL REV, V57, P779, DOI 10.1152/physrev.1977.57.4.779; COGGAN AR, 1993, J APPL PHYSIOL, V75, P70, DOI 10.1152/jappl.1993.75.1.70; COGGAN AR, 1990, J APPL PHYSIOL, V68, P990, DOI 10.1152/jappl.1990.68.3.990; COGGAN AR, 1993, AM J PHYSIOL, V264, pE215, DOI 10.1152/ajpendo.1993.264.2.E215; COX ML, 1986, J APPL PHYSIOL, V61, P926, DOI 10.1152/jappl.1986.61.3.926; CUNNINGHAM DA, 1979, EUR J APPL PHYSIOL O, V41, P187, DOI 10.1007/BF00430011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duffield R, 2006, J SCI MED SPORT, V9, P249, DOI 10.1016/j.jsams.2006.03.014; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edge J, 2006, J APPL PHYSIOL, V101, P918, DOI 10.1152/japplphysiol.01534.2005; FOX EL, 1977, MED SCI SPORT EXER, V9, P191; GAESSER GA, 1988, INT J SPORTS MED, V9, P417, DOI 10.1055/s-2007-1025043; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; GYNTELBERG F, 1977, J APPL PHYSIOL, V43, P302, DOI 10.1152/jappl.1977.43.2.302; HICKSON RC, 1985, J APPL PHYSIOL, V58, P492, DOI 10.1152/jappl.1985.58.2.492; HICKSON RC, 1981, MED SCI SPORT EXER, V13, P13; HICKSON RC, 1982, J APPL PHYSIOL, V53, P225, DOI 10.1152/jappl.1982.53.1.225; HICKSON RC, 1981, MED SCI SPORT EXER, V13, P17; HICKSON RC, 1977, J APPL PHYSIOL, V42, P372, DOI 10.1152/jappl.1977.42.3.372; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432; Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89; KNUTTGEN HG, 1973, MED SCI SPORT EXER, V5, P220; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; Laursen PB, 2002, SPORTS MED, V32, P53, DOI 10.2165/00007256-200232010-00003; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; OVEREND TJ, 1992, CAN J SPORT SCI, V17, P129; POOLE DC, 1990, EUR J APPL PHYSIOL, V59, P421, DOI 10.1007/BF02388623; POOLE DC, 1985, J APPL PHYSIOL, V58, P1115, DOI 10.1152/jappl.1985.58.4.1115; Proctor DN, 2001, J APPL PHYSIOL, V91, P2619, DOI 10.1152/jappl.2001.91.6.2619; RAY CA, 1991, J APPL PHYSIOL, V71, P596, DOI 10.1152/jappl.1991.71.2.596; ROCA J, 1992, J APPL PHYSIOL, V73, P1067; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; SIEGEL W, 1970, CIRCULATION, V41, P19, DOI 10.1161/01.CIR.41.1.19; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Slordahl SA, 2004, MED SCI SPORT EXER, V36, P1871, DOI 10.1249/01.MSS.0000145444.01292.3D; Smith AE, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-5; SPINA RJ, 1992, J APPL PHYSIOL, V72, P307, DOI 10.1152/jappl.1992.72.1.307; Walter AA, 2010, J STRENGTH COND RES, V24, P1199, DOI 10.1519/JSC.0b013e3181d82f8b; Warburton DER, 2004, MED SCI SPORT EXER, V36, P991, DOI 10.1249/01.MSS.0000128163.88298.CB; Weltman A, 1997, MED SCI SPORT EXER, V29, P669, DOI 10.1097/00005768-199705000-00013; WINDER WW, 1979, J APPL PHYSIOL, V46, P766, DOI 10.1152/jappl.1979.46.4.766; WOMACK CJ, 1995, J APPL PHYSIOL, V79, P838, DOI 10.1152/jappl.1995.79.3.838	53	174	178	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73182	10.1371/journal.pone.0073182	http://dx.doi.org/10.1371/journal.pone.0073182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066036	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000017
J	Castro, B; Sanchez, P; Torres, JM; Ortega, E				Castro, Beatriz; Sanchez, Pilar; Torres, Jesus M.; Ortega, Esperanza			Effects of Adult Exposure to Bisphenol A on Genes Involved in the Physiopathology of Rat Prefrontal Cortex	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; STEROID 5-ALPHA-REDUCTASE ISOZYMES; DENDRITIC SPINE DENSITY; NF-KAPPA-B; NEUROACTIVE STEROIDS; RECEPTOR EXPRESSION; PERINATAL EXPOSURE; NEONATAL EXPOSURE; BRAIN; MICE	Several neurological and behavioral dysfunctions have been reported in animals exposed to bisphenol A (BPA). However, little is known about the impact of adult exposure to BPA on brain physiopathology. Here, we focused on prefrontal cortex (PFC) of rats, because it is an important area for cognitive control, complex behaviors and is altered in many psychopathologies. Gamma-aminobutyric acid (GABA) and serotonin (5-HT) systems are essential for PFC function. Therefore, we examined the effects of adult exposure to BPA on 5 alpha-Reductase (5 alpha-R) and cytochrome P450 aromatase (P450arom), enzymes that synthesize GABA(A) receptor modulators, and tryptophan hydroxylase (Tph), the rate-limiting enzyme in 5-HT biosynthesis. To gain better understanding of BPA's action in the adult PFC, 84 genes involved in neurotoxicity were also analysed. Adult male and female rats were subcutaneously injected for 4 days with 50 mu g/kg/day, the current reference safe dose for BPA. mRNA and protein levels of 5 alpha-R, P450arom and Tph were quantified by real-time RT-PCR and Western blot. Genes linked to neurotoxicity were analyzed by PCR-Array technology. Adult exposure to BPA increased both P450arom and Tph2 expression in PFC of male and female, but decreased 5 alpha-R1 expression in female. Moreover, we identified 17 genes related to PFC functions such as synaptic plasticity and memory, as potential targets of BPA. Our results provided new insights on the molecular mechanisms underlying BPA action in the physiopathology of PFC, but also raise the question about the safety of short-term exposure to it in the adulthood.	[Castro, Beatriz; Sanchez, Pilar; Torres, Jesus M.; Ortega, Esperanza] Univ Granada, Fac Med, Dept Biochem & Mol Biol, Granada, Spain; [Torres, Jesus M.; Ortega, Esperanza] Univ Granada, Fac Med, Inst Neurosci, Granada, Spain	University of Granada; University of Granada	Torres, JM (corresponding author), Univ Granada, Fac Med, Dept Biochem & Mol Biol, Granada, Spain.	torrespi@ugr.es; esortega@ugr.es	Torres, Jesus M/B-3634-2011		Ministerio de Ciencia e Innovacion [BFU2008-05340]; Junta de Andalucia [CTS202-Endocronologia y Metabolismo]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia)	This research was supported by grants from Ministerio de Ciencia e Innovacion (BFU2008-05340) and by the Junta de Andalucia (CTS202-Endocronologia y Metabolismo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avissar S, 2004, AM J PSYCHIAT, V161, P2066, DOI 10.1176/appi.ajp.161.11.2066; Barbaccia ML, 2001, INT REV NEUROBIOL, V46, P243; Batista TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033814; Birzniece V, 2006, BRAIN RES REV, V51, P212, DOI 10.1016/j.brainresrev.2005.11.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JS, 2009, SCHIZOPHRENIA BULL, V35, P256, DOI 10.1093/schbul/sbm147; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calza A, 2010, J NEUROCHEM, V113, P1285, DOI 10.1111/j.1471-4159.2010.06696.x; Castro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055905; Chen GL, 2012, AM J MED GENET B, V159B, P152, DOI 10.1002/ajmg.b.32023; Chen Y, 2008, NEURON GLIA BIOL, V4, P211, DOI 10.1017/S1740925X09990287; Chung E, 2011, P NATL ACAD SCI USA, V108, P17732, DOI 10.1073/pnas.1115187108; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; Derijck AAHA, 2010, TRENDS CELL BIOL, V20, P568, DOI 10.1016/j.tcb.2010.06.007; Eilam-Stock T, 2012, BEHAV NEUROSCI, V126, P175, DOI 10.1037/a0025959; Emery AC, 2010, J BIOL CHEM, V285, P26041, DOI 10.1074/jbc.M110.139899; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Hiroi R, 2006, BIOL PSYCHIAT, V60, P288, DOI 10.1016/j.biopsych.2005.10.019; Igarashi A, 2006, BIOL PHARM BULL, V29, P2120, DOI 10.1248/bpb.29.2120; Inagaki T, 2012, ENDOCRINOLOGY, V153, P3357, DOI 10.1210/en.2012-1121; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Klotz DM, 2000, ENDOCRINOLOGY, V141, P3430, DOI 10.1210/en.141.9.3430; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu XB, 2012, EPILEPSIA, V53, P45, DOI 10.1111/j.1528-1167.2012.03474.x; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Mahendroo MS, 1997, MOL ENDOCRINOL, V11, P917, DOI 10.1210/me.11.7.917; Martini M, 2010, J NEUROENDOCRINOL, V22, P1004, DOI 10.1111/j.1365-2826.2010.02043.x; Matsuda S, 2010, CHEMOSPHERE, V78, P894, DOI 10.1016/j.chemosphere.2009.11.010; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Murphy DD, 1998, J NEUROSCI, V18, P2550; Nadal A, 2013, NAT REV ENDOCRINOL, V9, P9, DOI 10.1038/nrendo.2012.205; Nakamura K, 2010, NEUROSCI LETT, V484, P66, DOI 10.1016/j.neulet.2010.08.021; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pjevac M, 2012, PSYCHIAT DANUB, V24, pS336; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; Pulgar R, 2000, ENVIRON HEALTH PERSP, V108, P21, DOI 10.2307/3454291; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Snyder SH, 2011, P NATL ACAD SCI USA, V108, P8923, DOI 10.1073/pnas.1106103108; St Onge JR, 2011, J NEUROSCI, V31, P8625, DOI 10.1523/JNEUROSCI.1020-11.2011; Torres JM, 2006, J MOL ENDOCRINOL, V36, P239, DOI 10.1677/jme.1.01907; Torres JM, 2003, FASEB J, V17, P1428, DOI 10.1096/fj.02-1119com; Torres JM, 2001, NEUROCHEM RES, V26, P555, DOI 10.1023/A:1010925331768; Turkmen S, 2011, BRIT J PHARMACOL, V162, P311, DOI 10.1111/j.1476-5381.2010.01059.x; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Viberg H, 2012, NEUROTOXICOLOGY, V33, P1390, DOI 10.1016/j.neuro.2012.09.002; Waider J, 2013, HISTOCHEM CELL BIOL, V139, P267, DOI 10.1007/s00418-012-1029-x; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xu XH, 2010, ENVIRON TOXICOL CHEM, V29, P176, DOI 10.1002/etc.18; Xu XH, 2013, HORM BEHAV, V63, P766, DOI 10.1016/j.yhbeh.2013.03.004; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001; Zhou R, 2009, NEUROSCIENCE, V159, P161, DOI 10.1016/j.neuroscience.2008.12.028	61	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73584	10.1371/journal.pone.0073584	http://dx.doi.org/10.1371/journal.pone.0073584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066056	gold, Green Published			2022-12-27	WOS:000324494000037
J	Choi, S; Choi, HJ; Cheong, Y; Lim, YJ; Park, HK				Choi, Samjin; Choi, Hyuk Jai; Cheong, Youjin; Lim, Young-Jin; Park, Hun-Kuk			Internal-Specific Morphological Analysis of Sciatic Nerve Fibers in a Radiofrequency-Induced Animal Neuropathic Pain Model	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; PULSED RADIOFREQUENCY; EXTRACELLULAR-MATRIX; PERIPHERAL-NERVE; TRANSMISSION ELECTRON; COLLAGEN; EXPRESSION; CELLS; DISTINCT; LESIONS	This study investigated the reversible effects of pulsed radiofrequency (PRF) treatment at 42 degrees C on the ultrastructural and biological changes in nerve and collagen fibers in the progression of neuropathic pain after rat sciatic nerve injury. Assessments of morphological changes in the extracellular matrices by atomic force microscopy and hematoxylin-eosin, Masson's trichrome and picrosirius-red staining as well as the expressions of two fibril-forming collagens, types-I and -III, and two inflammatory cytokines, TNF-alpha and IL-6, were evaluated on day 30 after RF exposure. There were four groups for different RF thermal treatments: no treatment, no current, PRF, and continuous RF (CRF). An RF procedure similar to that used in human clinical trials was used in this study. The CRF treatment at 82 degrees C led to neural and collagen damage by the permanent blockage of sensory nociceptors. The PRF treatment led to excellent performance and high expandability compared to CRF, with effects including slight damage and swelling of myelinated axons, a slightly decreased amount of collagen fibers, swelling of collagen fibril diameters, decreased immunoreactivity of collagen types-I and -III, presence of newly synthesized collagen, and recovery of inflammatory protein immunoreactivity. These evidence-based findings suggest that PRF-based pain relief is responsible for the temporary blockage of nerve signals as well as the preferential destruction of pain-related principal sensory fibers like the Ad and C fibers. This suggestion can be supported by the interaction between the PRF-induced electromagnetic field and cell membranes; therefore, PRF treatment provides pain relief while allowing retention of some tactile sensation.	[Choi, Samjin; Cheong, Youjin; Park, Hun-Kuk] Kyung Hee Univ, Dept Biomed Engn, Seoul, South Korea; [Choi, Samjin; Cheong, Youjin; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Choi, Hyuk Jai] Hallym Univ, Dept Neurosurg, Chunchon, South Korea; [Lim, Young-Jin] Kyung Hee Univ, Dept Neurosurg, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Dept Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Hallym University; Kyung Hee University; Kyung Hee University	Park, HK (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Seoul, South Korea.	sigmoidus@khu.ac.kr	Choi, Hyukjai/GSE-1138-2022	Choi, Samjin/0000-0003-3498-0652	Bio R&D Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0092562]	Bio R&D Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Bio R&D Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology (Grant 2009-0092562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benazzoug Y, 1998, EXP GERONTOL, V33, P445, DOI 10.1016/S0531-5565(98)00015-1; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; Bradley JL, 2000, ACTA NEUROPATHOL, V99, P539, DOI 10.1007/s004010051158; Chernousov MA, 2006, J NEUROSCI, V26, P508, DOI 10.1523/JNEUROSCI.2544-05.2006; Choi S, 2012, LASER MED SCI, V27, P923, DOI 10.1007/s10103-011-1016-9; Cohen Steven P, 2003, Urology, V61, P645, DOI 10.1016/S0090-4295(02)02423-8; Cosman ER, 2005, PAIN MED, V6, P405, DOI 10.1111/j.1526-4637.2005.00076.x; de Louw AJA, 2001, EUR J PAIN-LONDON, V5, P169; Dubovy P, 2010, NEURON GLIA BIOL, V6, P73, DOI 10.1017/S1740925X10000074; Erdine S, 2005, EUR J PAIN, V9, P251, DOI 10.1016/j.ejpain.2004.07.002; Erdine S, 2009, PAIN PRACT, V9, P407, DOI 10.1111/j.1533-2500.2009.00317.x; Esposito E, 2013, MINI-REV MED CHEM, V13, P237; Fehrenbacher JC, 2005, PAIN, V113, P113, DOI 10.1016/j.pain.2004.09.031; Gess B, 2011, J NEUROSCI, V31, P17180, DOI 10.1523/JNEUROSCI.3457-11.2011; Geurts JWM, 2003, LANCET, V361, P21, DOI 10.1016/S0140-6736(03)12115-0; Grimal S, 2010, GLIA, V58, P1977, DOI 10.1002/glia.21066; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kiguchi N, 2009, ANESTH ANALG, V109, P1305, DOI 10.1213/ane.0b013e3181b1dca2; Kwak HW, 2013, MICROSC RES TECHNIQ, V76, P219, DOI 10.1002/jemt.22119; Layton BE, 2004, J BIOMECH ENG-T ASME, V126, P803, DOI 10.1115/1.1824118; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Maeda T, 2009, P NATL ACAD SCI USA, V106, P13076, DOI 10.1073/pnas.0903524106; Micera S, 2009, INT REV NEUROBIOL, V86, P23, DOI 10.1016/S0074-7742(09)86002-9; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; MYERS DB, 1977, ACTA NEUROPATHOL, V37, P7, DOI 10.1007/BF00684533; NASH TP, 1986, PAIN, V24, P67, DOI 10.1016/0304-3959(86)90027-8; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Plumb DA, 2007, J BIOL CHEM, V282, P12791, DOI 10.1074/jbc.C700021200; Podhajsky RJ, 2005, SPINE, V30, P1008, DOI 10.1097/01.brs.0000161005.31398.58; Protasoni M, 2009, EUR SPINE J, V18, P473, DOI 10.1007/s00586-008-0870-z; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shah RV, 2004, ARCH PHYS MED REHAB, V85, P1013, DOI 10.1016/j.apmr.2003.07.017; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Slappendel R, 1997, PAIN, V73, P159, DOI 10.1016/S0304-3959(97)00094-8; Sluijter M, 2002, Pain Pract, V2, P195, DOI 10.1046/j.1533-2500.2002.02023.x; Sluijter ME, 1998, PAIN CLINIC, V11, P109; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Tun K, 2009, SURG NEUROL, V72, P496, DOI 10.1016/j.surneu.2008.11.016; Tun K, 2006, NEUROL RES, V28, P841, DOI 10.1179/016164106X110409; USHIKI T, 1990, CELL TISSUE RES, V260, P175, DOI 10.1007/BF00297503; van Wijk RMAW, 2001, J NEUROSURG, V94, P227, DOI 10.3171/spi.2001.94.2.0227; Van Zundert J, 2002, Pain Pract, V2, P269, DOI 10.1046/j.1533-2500.2002.02036.x; Van Zundert J, 2003, PAIN, V104, P449, DOI 10.1016/S0304-3959(03)00066-6; Vatansever D, 2008, CLIN J PAIN, V24, P717, DOI 10.1097/AJP.0b013e318173c27a; Wang H, 2003, DIABETES-METAB RES, V19, P288, DOI 10.1002/dmrr.372; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Williams PE, 2000, HISTOPATHOLOGY, V36, P551, DOI 10.1046/j.1365-2559.2000.00897.x; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	49	14	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73913	10.1371/journal.pone.0073913	http://dx.doi.org/10.1371/journal.pone.0073913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066083	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000065
J	Ghosh, S; Pandey, NK; Roy, AS; Tripathy, DR; Dinda, AK; Dasgupta, S				Ghosh, Sudeshna; Pandey, Nitin Kumar; Roy, Atanu Singha; Tripathy, Debi Ranjan; Dinda, Amit Kumar; Dasgupta, Swagata			Prolonged Glycation of Hen Egg White Lysozyme Generates Non Amyloidal Structures	PLOS ONE			English	Article							NATIVE-LIKE AGGREGATION; END-PRODUCTS; D-RIBOSE; NONENZYMATIC GLYCATION; MOLECULAR-MECHANISM; MAILLARD REACTION; HIGH CYTOTOXICITY; IN-VITRO; PROTEIN; FIBRILS	Glycation causes severe damage to protein structure that could lead to amyloid formation in special cases. Here in this report, we have shown for the first time that hen egg white lysozyme (HEWL) does not undergo amyloid formation even after prolonged glycation in the presence of D-glucose, D-fructose and D-ribose. Cross-linked oligomers were formed in all the cases and ribose was found to be the most potent among the three sugars. Ribose mediated oligomers, however, exhibit Thioflavin T binding properties although microscopic images clearly show amorphous and globular morphology of the aggregates. Our study demonstrates that the structural damage of hen egg white lysozyme due to glycation generates unstructured aggregates.	[Ghosh, Sudeshna; Pandey, Nitin Kumar; Roy, Atanu Singha; Tripathy, Debi Ranjan; Dinda, Amit Kumar; Dasgupta, Swagata] Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Dasgupta, S (corresponding author), Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India.	swagata@chem.iitkgp.ernet.in	Pandey, Nitin K./AAP-1523-2021; GHOSH, SUDESHNA/B-8927-2018	Pandey, Nitin K./0000-0001-6124-4090; GHOSH, SUDESHNA/0000-0002-8776-8041; Dasgupta, Swagata/0000-0003-2074-1247; Tripathy, Debi Ranjan/0000-0002-6842-0138	Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, New Delhi; IIT Kharagpur	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); IIT Kharagpur	SD is grateful to the Department of Science and Technology, Government of India for financial assistance for the chemicals and reagents. SG, ASR, DRT and AKD thank Council of Scientific and Industrial Research, New Delhi and NKP thank IIT Kharagpur for their senior research fellowship respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1992, CLIN CHEM, V38, P1301; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Bathaie SZ, 2011, PROTEIN J, V30, P480, DOI 10.1007/s10930-011-9353-x; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chaudhary N, 2009, MOL CELL BIOCHEM, V328, P209, DOI 10.1007/s11010-009-0091-8; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009052; Chen L, 2009, CELL MOL LIFE SCI, V66, P2559, DOI 10.1007/s00018-009-0058-7; Chevalier F, 2002, NAHRUNG, V46, P58, DOI [10.1002/1521-3803(20020301)46:2<58::AID-FOOD58>3.0.CO;2-Y, 10.1002/1521-3803(20020301)46:2&lt;58::AID-FOOD58&gt;3.0.CO;2-Y]; Cloos PAC, 2002, MATRIX BIOL, V21, P39, DOI 10.1016/S0945-053X(01)00188-3; Coussons PJ, 1997, FREE RADICAL BIO MED, V22, P1217, DOI 10.1016/S0891-5849(96)00557-6; Das BK, 1998, INVEST OPHTH VIS SCI, V39, P2058; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; GhoshMoulick R, 2007, BBA-PROTEINS PROTEOM, V1774, P233, DOI 10.1016/j.bbapap.2006.11.018; Gustot A, 2013, CELL MOL LIFE SCI, V70, P2999, DOI 10.1007/s00018-012-1245-5; Han CSA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024623; Handl M, 2007, PHYSIOL RES, V56, P235, DOI 10.33549/physiolres.930934; HARVEY SC, 1986, J AM CHEM SOC, V108, P6128, DOI 10.1021/ja00280a004; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Jackson GS, 2000, CURR OPIN STRUC BIOL, V10, P69, DOI 10.1016/S0959-440X(99)00051-2; Kapurniotu A, 1998, EUR J BIOCHEM, V251, P208, DOI 10.1046/j.1432-1327.1998.2510208.x; Khan TA, 2011, INT J PEPT RES THER, V17, P271, DOI 10.1007/s10989-011-9267-7; Kikuchi S, 2003, BRAIN RES REV, V41, P306, DOI 10.1016/S0165-0173(02)00273-4; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kong FL, 2011, CHEM-BIOL INTERACT, V194, P69, DOI 10.1016/j.cbi.2011.08.003; Lapolla A, 2005, CLIN BIOCHEM, V38, P103, DOI 10.1016/j.clinbiochem.2004.09.007; Lapolla A, 1996, RAPID COMMUN MASS SP, V10, P1512, DOI 10.1002/(SICI)1097-0231(199609)10:12<1512::AID-RCM667>3.0.CO;2-O; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Lopez-Jaramillo FJ, 2005, ACTA CRYSTALLOGR F, V61, P435, DOI 10.1107/S1744309105008869; LUTHRA M, 1993, J BIOL CHEM, V268, P18119; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; MONNIER VM, 1990, J GERONTOL, V45, pB105, DOI 10.1093/geronj/45.4.B105; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Muthenna P, 2012, BIOCHEM J, V442, P221, DOI 10.1042/BJ20110846; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Oliveira LMA, 2013, BBA-PROTEINS PROTEOM, V1834, P1010, DOI 10.1016/j.bbapap.2012.12.001; Oliveira LMA, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-41; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Roth Ziv, 2012, International Journal of Carbohydrate Chemistry, DOI 10.1155/2012/640923; Sasaki N, 2002, NEUROSCI LETT, V326, P117, DOI 10.1016/S0304-3940(02)00310-5; Sattarahmady N, 2008, CARBOHYD RES, V343, P2229, DOI 10.1016/j.carres.2008.04.036; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Seneff S, 2011, EUR J INTERN MED, V22, P134, DOI 10.1016/j.ejim.2010.12.017; Seo S, 2013, LWT-FOOD SCI TECHNOL, V53, P44, DOI 10.1016/j.lwt.2013.02.001; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tagami U, 2000, J MASS SPECTROM, V35, P131, DOI 10.1002/(SICI)1096-9888(200002)35:2<131::AID-JMS920>3.0.CO;2-0; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; Vaney MC, 1996, ACTA CRYSTALLOGR D, V52, P505, DOI 10.1107/S090744499501674X; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; VO-DINH T, 1982, APPL SPECTROSC, V36, P576, DOI 10.1366/0003702824639510; Wei Y, 2012, BBA-GEN SUBJECTS, V1820, P488, DOI 10.1016/j.bbagen.2012.01.005; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yamamoto Y, 2002, NEPHROL DIAL TRANSPL, V17, P630, DOI 10.1093/ndt/17.4.630; Yeboah FK, 2000, J AGR FOOD CHEM, V48, P2766, DOI 10.1021/jf990978j; Zheng F, 2001, MOL MED, V7, P737, DOI 10.1007/BF03401963	63	41	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74336	10.1371/journal.pone.0074336	http://dx.doi.org/10.1371/journal.pone.0074336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066139	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000121
J	Hoekstra, EJ; von Oerthel, L; van der Heide, LP; Kouwenhoven, WM; Veenvliet, JV; Wever, I; Jin, YR; Yoon, JK; van der Linden, AJA; Holstege, FCP; Koerkamp, MJG; Smidt, MP				Hoekstra, Elisa J.; von Oerthel, Lars; van der Heide, Lars P.; Kouwenhoven, Willemieke M.; Veenvliet, Jesse V.; Wever, Iris; Jin, Yong-Ri; Yoon, Jeong K.; van der Linden, Annemarie J. A.; Holstege, Frank C. P.; Koerkamp, Marian J. Groot; Smidt, Marten P.			Lmx1a Encodes a Rostral Set of Mesodiencephalic Dopaminergic Neurons Marked by the Wnt/B-Catenin Signaling Activator R-spondin 2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; VENTRAL MIDBRAIN; GENE-EXPRESSION; SUBSTANTIA-NIGRA; LENTIVIRAL DELIVERY; DREHER GENE; PITX3; DIFFERENTIATION; PATHWAY; NURR1	Recent developments in molecular programming of mesodiencephalic dopaminergic (mdDA) neurons have led to the identification of many transcription factors playing a role in mdDA specification. LIM homeodomain transcription factor Lmx1a is essential for chick mdDA development, and for the efficient differentiation of ES-cells towards a dopaminergic phenotype. In this study, we aimed towards a more detailed understanding of the subtle phenotype in Lmx1a-deficient (dreher) mice, by means of gene expression profiling. Transcriptome analysis was performed, to elucidate the exact molecular programming underlying the neuronal deficits after loss of Lmx1a. Subsequent expression analysis on brain sections, confirmed that Nurr1 is regulated by Lmx1a, and additional downstream targets were identified, like Pou4f1, Pbx1, Pitx2, C130021l20Rik, Calb2 and Rspo2. In line with a specific, rostral-lateral (prosomer 2/3) loss of expression of most of these genes during development, Nurr1 and C130021l20Rik were affected in the SNc of the mature mdDA system. Interestingly, this deficit was marked by the complete loss of the Wnt/b-catenin signaling activator Rspo2 in this domain. Subsequent analysis of Rspo2-/- embryos revealed affected mdDA neurons, partially phenocopying the Lmx1a mutant. To conclude, our study revealed that Lmx1a is essential for a rostral-lateral subset of the mdDA neuronal field, where it might serve a critical function in modulating proliferation and differentiation of mdDA progenitors through the regulation of the Wnt activator Rspo2.	[Hoekstra, Elisa J.; von Oerthel, Lars; van der Heide, Lars P.; Kouwenhoven, Willemieke M.; Veenvliet, Jesse V.; Smidt, Marten P.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hoekstra, Elisa J.; von Oerthel, Lars; Wever, Iris; van der Linden, Annemarie J. A.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Holstege, Frank C. P.; Koerkamp, Marian J. Groot] Univ Med Ctr Utrecht, Mol Canc Res, Utrecht, Netherlands; [Jin, Yong-Ri; Yoon, Jeong K.] Maine Med Ctr Res Inst, Ctr Mol Med, Portland, ME USA	University of Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maine Medical Center	Smidt, MP (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl	Holstege, Frank/AAM-9944-2021	Groot Koerkamp, Marian JA/0000-0002-0867-0821; van der Heide, Lars P./0000-0003-1779-425X; Smidt, Marten/0000-0002-8815-747X	National Institute of Health [R01 AR055278, P20 GM103465]; TIPharma grant (Netherlands) [T5-207]; NWO VICI grant (Netherlands) [865.09.002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103465] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TIPharma grant (Netherlands); NWO VICI grant (Netherlands); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of Health grants (R01 AR055278 and P20 GM103465) to J.K.Y., a TIPharma grant (T5-207, Netherlands) and an NWO VICI grant (865.09.002, Netherlands) to M.P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Chizhikov V, 2006, MAMM GENOME, V17, P1025, DOI 10.1007/s00335-006-0033-7; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; Hoekstra EJ, 2013, EUR J NEUROSCI, V37, P23, DOI 10.1111/ejn.12022; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Jin YR, 2011, DEV BIOL, V352, P1, DOI 10.1016/j.ydbio.2011.01.004; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klauzinska M, 2012, J CELL PHYSIOL, V227, P1960, DOI 10.1002/jcp.22924; Megason SG, 2002, DEVELOPMENT, V129, P2087; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Petros TJ, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00030, 10.3389/fnmol.2011.00030]; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Sanchez-Danes A, 2012, HUM GENE THER, V23, P56, DOI 10.1089/hum.2011.054; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smits SM, 2006, J NEURAL TRANSM-SUPP, P57; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Wu Thomas D, 2002, Brief Bioinform, V3, P7, DOI 10.1093/bib/3.1.7; Yamada W, 2009, BIOCHEM BIOPH RES CO, V381, P453, DOI 10.1016/j.bbrc.2009.02.066; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Zou HL, 2009, BRAIN RES BULL, V78, P306, DOI 10.1016/j.brainresbull.2008.12.001	52	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74049	10.1371/journal.pone.0074049	http://dx.doi.org/10.1371/journal.pone.0074049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066094	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000076
J	Saliba, J; Hamidi, S; Lenglet, G; Langlois, T; Yin, JK; Cabagnols, X; Secardin, L; Legrand, C; Galy, A; Opolon, P; Benyahia, B; Solary, E; Bernard, OA; Chen, LY; Debili, N; Raslova, H; Norol, F; Vainchenker, W; Plo, I; Di Stefano, A				Saliba, Joseph; Hamidi, Sofiane; Lenglet, Gaelle; Langlois, Thierry; Yin, Jingkui; Cabagnols, Xenia; Secardin, Lise; Legrand, Celine; Galy, Anne; Opolon, Paule; Benyahia, Baya; Solary, Eric; Bernard, Olivier A.; Chen, Longyun; Debili, Najet; Raslova, Hana; Norol, Francoise; Vainchenker, William; Plo, Isabelle; Di Stefano, Antonio			Heterozygous and Homozygous JAK2(V617F) States Modeled by Induced Pluripotent Stem Cells from Myeloproliferative Neoplasm Patients	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; JAK2 MUTATION; BONE-MARROW; IN-VITRO; T-CELLS; GENERATION; INHIBITOR; HEMATOPOIESIS	JAK2(V617F) is the predominant mutation in myeloproliferative neoplasms (MPN). Modeling MPN in a human context might be helpful for the screening of molecules targeting JAK2 and its intracellular signaling. We describe here the derivation of induced pluripotent stem (iPS) cell lines from 2 polycythemia vera patients carrying a heterozygous and a homozygous mutated JAK2(V617F), respectively. In the patient with homozygous JAK2(V617F), additional ASXL1 mutation and chromosome 20 allowed partial delineation of the clonal architecture and assignation of the cellular origin of the derived iPS cell lines. The marked difference in the response to erythropoietin (EPO) between homozygous and heterozygous cell lines correlated with the constitutive activation level of signaling pathways. Strikingly, heterozygous iPS cells showed thrombopoietin (TPO)-independent formation of megakaryocytic colonies, but not EPO-independent erythroid colony formation. JAK2, PI3K and HSP90 inhibitors were able to block spontaneous and EPO-induced growth of erythroid colonies from GPA(+)CD41(+) cells derived from iPS cells. Altogether, this study brings the proof of concept that iPS can be used for studying MPN pathogenesis, clonal architecture, and drug efficacy.	[Saliba, Joseph; Hamidi, Sofiane; Lenglet, Gaelle; Langlois, Thierry; Cabagnols, Xenia; Secardin, Lise; Legrand, Celine; Solary, Eric; Debili, Najet; Raslova, Hana; Norol, Francoise; Vainchenker, William; Plo, Isabelle; Di Stefano, Antonio] INSERM, UMR 1009, Lab Excellence, Globule Rouge Excellence GR Ex, Villejuif, France; [Saliba, Joseph; Hamidi, Sofiane; Lenglet, Gaelle; Langlois, Thierry; Cabagnols, Xenia; Secardin, Lise; Legrand, Celine; Solary, Eric; Bernard, Olivier A.; Debili, Najet; Raslova, Hana; Norol, Francoise; Vainchenker, William; Plo, Isabelle; Di Stefano, Antonio] Univ Paris 11, Le Kremlin Bicetre, France; [Saliba, Joseph; Hamidi, Sofiane; Lenglet, Gaelle; Langlois, Thierry; Cabagnols, Xenia; Secardin, Lise; Legrand, Celine; Opolon, Paule; Solary, Eric; Bernard, Olivier A.; Debili, Najet; Raslova, Hana; Norol, Francoise; Vainchenker, William; Plo, Isabelle; Di Stefano, Antonio] Inst Gustave Roussy, Villejuif, France; [Galy, Anne] Univ Evry Val dEssonne, UMR 951, INSERM, Evry, France; [Benyahia, Baya] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet, Unite Fonct Genet Chromosom, F-75634 Paris, France; [Bernard, Olivier A.] INSERM, UMR 985, Villejuif, France; [Yin, Jingkui; Chen, Longyun] BGI, Shenzhen, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Beijing Genomics Institute (BGI)	Vainchenker, W (corresponding author), INSERM, UMR 1009, Lab Excellence, Globule Rouge Excellence GR Ex, Villejuif, France.	verpre@igr.fr	hamidi, sofiane/AAP-1789-2021; Bernard, Olivier A./E-5721-2016; Plo, Isabelle/C-9056-2017; Plo, Isabelle/AAT-6742-2021; Galy, Anne HM/J-4439-2013; hamidi, sofiane/GQA-3848-2022; Raslova, Hana/N-3562-2018; Di Stefano, Antonio/M-1478-2018	Plo, Isabelle/0000-0002-5915-6910; Galy, Anne HM/0000-0002-0153-4392; Raslova, Hana/0000-0001-8846-5299; Vainchenker, William/0000-0003-4705-202X; Hamidi, Sofiane/0000-0002-1189-843X; Bernard, Olivier/0000-0002-0463-9747; Solary, Eric/0000-0002-8629-1341	Agence Nationale de la Recherche (ANR); Association pour la Recherche sur le Cancer (ARC); program "Investissements d'avenir"; ANR-blanc Megon; Ile de France Canceropole; Institut National du Cancer (INCA); Ile de France region (Canceropole); Ile de France region (Departement d'information medicale (DIM) cellule souche); Ile de France region (Fondation pour la Recherche Medicale (FRM)); Centre Hospitalier Universitaire (CHU Bordeaux)-INSERM; Assistance Publique-Hopitaux de Paris (AP-HP)-INSERM; Institut Gustave Roussy (IGR)-INSERM	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); program "Investissements d'avenir"(French National Research Agency (ANR)); ANR-blanc Megon(French National Research Agency (ANR)); Ile de France Canceropole(Region Ile-de-France); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Ile de France region (Canceropole)(Region Ile-de-France); Ile de France region (Departement d'information medicale (DIM) cellule souche)(Region Ile-de-France); Ile de France region (Fondation pour la Recherche Medicale (FRM))(Region Ile-de-France); Centre Hospitalier Universitaire (CHU Bordeaux)-INSERM; Assistance Publique-Hopitaux de Paris (AP-HP)-INSERM; Institut Gustave Roussy (IGR)-INSERM	This work was supported by grants from Agence Nationale de la Recherche (ANR) (ANR-blanc Megon 2009 and thrombocytosis 2011; ANR-Blanc 2010 Epigenome) and from the Association pour la Recherche sur le Cancer (ARC) (ontogenese et megacaryopoiese normale et pathologique, and ARC libre 2012). Labex GR-Ex (IP, VW) is funded by the program "Investissements d'avenir". TL was supported by a fellowship from ANR-blanc Megon. GL was supported by a postdoctoral fellowship from the Ile de France Canceropole and Institut National du Cancer (INCA). LS and JS were supported by PhD grants from the Ile de France region (Canceropole, Departement d'information medicale (DIM) cellule souche, Fondation pour la Recherche Medicale (FRM)). ND, HR and WV are recipients of a research fellowship from Centre Hospitalier Universitaire (CHU Bordeaux)-INSERM, Assistance Publique-Hopitaux de Paris (AP-HP)-INSERM and Institut Gustave Roussy (IGR)-INSERM (contrats d'interface). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Bogani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054826; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Davies C, 2013, BR J HAEMATOL; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guglielmelli P, 2011, BLOOD, V118, P2069, DOI 10.1182/blood-2011-01-330563; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jedidi A, 2009, BLOOD, V114, P1842, DOI 10.1182/blood-2008-09-176875; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Mead AJ, 2012, NEW ENGL J MED, V366, P967, DOI 10.1056/NEJMc1200349; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Reddy MM, 2012, EXPERT OPIN THER TAR, V16, P313, DOI 10.1517/14728222.2012.662956; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Verstovsek S, 2012, BLOOD, V120, P1202, DOI 10.1182/blood-2012-02-414631; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406	40	26	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74257	10.1371/journal.pone.0074257	http://dx.doi.org/10.1371/journal.pone.0074257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066127	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000109
J	Sappok, T; Budczies, J; Bolte, S; Dziobek, I; Dosen, A; Diefenbacher, A				Sappok, Tanja; Budczies, Jan; Bolte, Sven; Dziobek, Isabel; Dosen, Anton; Diefenbacher, Albert			Emotional Development in Adults with Autism and Intellectual Disabilities: A Retrospective, Clinical Analysis	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; SPECTRUM DISORDERS; ADAPTIVE-BEHAVIOR; MENTAL-HEALTH; PSYCHIATRIC-ASSESSMENT; FUNCTIONING AUTISM; CHILDREN; ABILITIES; INDIVIDUALS; COMMUNICATION	Individuals with intellectual disability (ID) are at risk for additional autism spectrum disorders (ASD). A large amount of research reveals deficits in emotion-related processes that are relevant to social cognition in ASD. However, studies on the structure and level of emotional development (ED) assessing emotional maturity according to the normative trajectory in typically developing children are scares. The level of ED can be evaluated by the 'Scheme of Appraisal of Emotional Development' (SAED), a semi-structured interview with a close caregiver. The SAED assesses the level of emotional developmental based on a five stage system in 10 domains, for example, 'interaction with peers' or 'object permanence', which are conducive to the overall emotional developmental level. This study examined the ED as measured by the SAED in 289 adults (mean age: 36 years) with ID with and without additional ASD. A lower level in ED was observed in ASD/ID combined that corresponded to the ED of typically developing children aged 1.5-3 years versus an ED with a corresponding age of 3-7 years in ID individuals without ASD. Moreover, distinct strengths in 'object permanence', and weaknesses in 'interaction', 'verbal communication', 'experience of self', 'affect differentiation', 'anxiety', and 'handling of material objects' led to a characteristic pattern of ED in ASD. SAED domains with highest discriminative power between ID individuals with and without ASD (5/10) were used to predict ASD group membership. The classification using a selection of SAED domains revealed a sensitivity of 77.5% and a specificity of 76.4%. ASD risk increased 2.7-fold with every SAED level. The recognition of delayed and uneven pattern of ED contributes to our understanding of the emotion-related impairments in adults with ID and ASD these individuals. Assessment of intra-individual ED could add value to the standard diagnostic procedures in ID, a population at risk for underdiagnosed ASD.	[Sappok, Tanja; Diefenbacher, Albert] Evangel Krankenhaus Konigin Elisabeth Herzberge, Dept Psychiat, Berlin, Germany; [Budczies, Jan] Charite, Inst Pathol, Berlin, Germany; [Bolte, Sven] Karolinska Inst KIND, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders, Stockholm, Sweden; [Dziobek, Isabel] Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany; [Dosen, Anton] Radboud Univ Nijmegen, Univ Hosp, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Karolinska Institutet; Free University of Berlin; Radboud University Nijmegen	Sappok, T (corresponding author), Evangel Krankenhaus Konigin Elisabeth Herzberge, Dept Psychiat, Berlin, Germany.	t.sappok@keh-berlin.de	Sappok, Tanja/AAF-5530-2019; Budczies, Jan/AAG-8122-2020; Bölte, Sven/AAH-8675-2019; Dziobek, isabel/ABB-4928-2020	Bölte, Sven/0000-0002-4579-4970; 	von Bodelschwinghsche Stiftungen Bethel; Swedish Research Council [523-2009-7054]	von Bodelschwinghsche Stiftungen Bethel; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the "von Bodelschwinghsche Stiftungen Bethel.'' Sven Bolte was supported by the Swedish Research Council (grant nr. 523-2009-7054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2012, BEHAV RES THER, V50, P493, DOI 10.1016/j.brat.2012.04.004; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aminabadi NA, 2011, ACTA ODONTOL SCAND, V69, P292, DOI 10.3109/00016357.2011.568959; Anckarsater H, 2008, NORD J PSYCHIAT, V62, P160, DOI 10.1080/08039480801957269; Barnard L, 2008, AUTISM, V12, P125, DOI 10.1177/1362361307088486; Barnhill LJ, 2008, PSYCHIAT QUART, V79, P157, DOI 10.1007/s11126-008-9076-0; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Beadle-Brown J, 2005, AM J MENT RETARD, V110, P1, DOI 10.1352/0895-8017(2005)110<1:LOFPWS>2.0.CO;2; Begeer S, 2008, DEV REV, V28, P342, DOI 10.1016/j.dr.2007.09.001; Bergmann T., 2011, MED MENSCHEN GEISTIG, V8, P14; Bernabel P, 2003, PERCEPT MOTOR SKILL, V96, P1107, DOI 10.2466/PMS.96.4.1107-1116; Bertin E, 2006, INFANT BEHAV DEV, V29, P294, DOI 10.1016/j.infbeh.2005.12.003; Bolte S, 2008, J AUTISM DEV DISORD, V38, P776, DOI 10.1007/s10803-007-0443-8; Bolte S, 2003, PSYCHOL MED, V33, P907, DOI 10.1017/S0033291703007438; Bolte S, 2002, CHILD PSYCHIAT HUM D, V33, P165, DOI 10.1023/A:1020734325815; Bolte S, 2002, COMPR PSYCHIAT, V43, P325, DOI 10.1053/comp.2002.33490; Boucher J, 2012, AUTISM, V16, P226, DOI 10.1177/1362361311430403; Bowlby B., 1969, ATTACHMENT LOSS; Bradley S. J., 2000, AFFECT REGULATION DE; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Budczies J, CANCERCLASS R PACKAG; Buitelaar JK, 1997, J AUTISM DEV DISORD, V27, P539, DOI 10.1023/A:1025878026569; CAPPS L, 1992, J CHILD PSYCHOL PSYC, V33, P1169, DOI 10.1111/j.1469-7610.1992.tb00936.x; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; CHARLOT LR, 1998, MENTAL HLTH ASPECTS, V1, P29; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; Cicchetti D, 1990, ISSUES DEV APPROACH, P115; Cicchetti DV, 1995, CHILD NEUROPSYCHOL, V1, P26, DOI 10.1080/09297049508401340; CURCIO F, 1978, J AUTISM CHILD SCHIZ, V8, P281, DOI 10.1007/BF01539631; Damasio A, 2010, SELF COMES MIND CONS; de Bildt A, 2005, J INTELL DISABIL RES, V49, P672, DOI 10.1111/j.1365-2788.2005.00711.x; de Bildt A, 2005, J INTELL DISABIL RES, V49, P317, DOI 10.1111/j.1365-2788.2005.00655.x; Denham SA, 2002, J CHILD PSYCHOL PSYC, V43, P901, DOI 10.1111/1469-7610.00139; Denham SA, 2012, J GENET PSYCHOL, V173, P246, DOI 10.1080/00221325.2011.597457; Dilling H, 2004, KLIN DIAGNOSTISCHE L, V3rd; Dosen A, 2005, J INTELL DISABIL RES, V49, P1, DOI 10.1111/j.1365-2788.2005.00656.x; Dosen A, 2007, J INTELL DISABIL RES, V51, P66, DOI 10.1111/j.1365-2788.2006.00868.x; Dosen A, 1997, PSYCHISCHE STORUNGEN; Dosen A, 2004, MENT HLTH DEV DISABI, V7, P1; Dosen A, 2010, PSYCHISCHE STORUNGEN; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; GOULD J, 1977, J MENT DEFIC RES, V21, P213; Gowen E, 2013, J AUTISM DEV DISORD, V43, P323, DOI 10.1007/s10803-012-1574-0; Greenspan S, 1985, COMPREHENSIVE TXB PS, P1102; Greenspan S.I., 1997, DEV BASED PSYCHOTHER; Greenspan SI, 2009, ENGAGING AUTISM; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hobson RP, 2010, AUTISM, V14, P391, DOI 10.1177/1362361310364142; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Hodapp R.M., 1995, DEV PSYCHOPATHOL, P299; Howlin P., 2004, AUTISM ASPERGER SYND, P270; HOWLIN P, 2004, AUTISM ASPERGER SYND, P19; Izard C. E., 2006, DEV PSYCHOPATHOL, V1, P244; IZARD CE, 1993, PSYCHOL REV, V100, P68; Jackson M, 2001, BRIT J DEV PSYCHOL, V19, P349, DOI 10.1348/026151001166146; Joseph RM, 2002, J CHILD PSYCHOL PSYC, V43, P807, DOI 10.1111/1469-7610.00092; Kanne SM, 2011, J AUTISM DEV DISORD, V41, P926, DOI 10.1007/s10803-010-1118-4; Kanner L, 1943, NERV CHILD, V2, P217; Kasari C, 1996, EMOTIONAL DEVELOPMENT IN ATYPICAL CHILDREN, P109; KASARI C, 1990, J AUTISM DEV DISORD, V20, P87, DOI 10.1007/BF02206859; Kasari C. L., 2011, OXFORD HDB INTELLECT; Kernberg O.F., 2012, INSEPARABLE NATURE L; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Kraijer D, 2000, J AUTISM DEV DISORD, V30, P39, DOI 10.1023/A:1005460027636; Kraijer D., 2003, SKALA ERFASSUNG AUTI; La Malfa G, 2004, J INTELL DISABIL RES, V48, P262, DOI 10.1111/j.1365-2788.2003.00567.x; La Malfa G, 2009, RES DEV DISABIL, V30, P1406, DOI 10.1016/j.ridd.2009.06.008; LANE RD, 1987, AM J PSYCHIAT, V144, P133; LINCOLN AJ, 1988, J AUTISM DEV DISORD, V18, P505, DOI 10.1007/BF02211870; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luteijn E, 2000, J AUTISM DEV DISORD, V30, P317, DOI 10.1023/A:1005527300247; Matson JL, 2007, RES AUTISM SPECT DIS, V1, P330, DOI 10.1016/j.rasd.2007.01.001; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; Matson JL, 2009, RES DEV DISABIL, V30, P1317, DOI 10.1016/j.ridd.2009.05.008; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; MCDONALD MA, 1989, J CHILD PSYCHOL PSYC, V30, P599, DOI 10.1111/j.1469-7610.1989.tb00271.x; MEINS W, 1993, SOC PSYCH PSYCH EPID, V28, P201, DOI 10.1007/BF00797324; Menolascino FJ, 1970, PSYCHIAT APPROACHES; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; MORGAN SB, 1989, J CHILD PSYCHOL PSYC, V30, P857, DOI 10.1111/j.1469-7610.1989.tb00287.x; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Papazoglou A, 2013, J INT NEUROPSYCH SOC, V8, P1; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Piaget J., 1953, CHILDS CONSTRUCTION; Punshon C, 2009, AUTISM, V13, P265, DOI 10.1177/1362361309103795; Rieffe C, 2005, INFANT CHILD DEV, V14, P259, DOI 10.1002/icd.391; Rutter M, 2001, SOCIAL COMMUNICATION; Sappok T, 2012, FORTSCHR NEUROL PSYC, V80, P154, DOI 10.1055/s-0031-1273382; Sappok T, 2010, NERVENARZT, V81, P1333, DOI 10.1007/s00115-010-3098-1; Sappok T, 2012, PSYCHIAT PRAX, V39, P228, DOI 10.1055/s-0032-1305078; Schuengel C, 2009, J CONSULT CLIN PSYCH, V77, P291, DOI 10.1037/a0014274; Seltzer MM, 2010, J AUTISM DEV DISORD, V40, P457, DOI 10.1007/s10803-009-0887-0; Shetreat-Klein M, 2012, BRAIN DEV; SIGMAN M, 1981, J ABNORM CHILD PSYCH, V9, P149, DOI 10.1007/BF00919111; Soulieres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025372; Sparrow S, 1997, HDB AUTISM PERVASIVE, P411; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; Sroufe L.A., 2005, POWER LONGITUDINAL A, P48; Sroufe LA, 2009, CHILD DEV PERSPECT, V3, P178, DOI 10.1111/j.1750-8606.2009.00103.x; Stern D., 2007, LEBENSERFAHRUNG SAUG, V9th; Totsika V, 2011, J CHILD PSYCHOL PSYC, V52, P91, DOI 10.1111/j.1469-7610.2010.02295.x; Trevarthen C., 1980, SOCIAL FDN LANGUAGE, P316; Underwood L, 2010, CURR OPIN PSYCHIATR, V23, P421, DOI 10.1097/YCO.0b013e32833cfc18; UZGIRIS I, 1975, ASSESSMENT INFANCY; Warren ZE, 2010, AM J PSYCHIAT, V167, P1299, DOI 10.1176/appi.ajp.2010.09091281; WEBSTER TG, 1963, AM J PSYCHIAT, V120, P37, DOI 10.1176/ajp.120.1.37; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Williams BT, 2012, J CHILD PSYCHOL PSYC, V53, P1268, DOI 10.1111/j.1469-7610.2012.02593.x; Winberg J, 2005, DEV PSYCHOBIOL, V47, P217, DOI 10.1002/dev.20094; Wong CS, 2002, LEADERSHIP QUART, V13, P243, DOI 10.1016/S1048-9843(02)00099-1	114	25	25	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74036	10.1371/journal.pone.0074036	http://dx.doi.org/10.1371/journal.pone.0074036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066092	Green Submitted, gold, Green Published			2022-12-27	WOS:000324494000074
J	Sun, WJ; Jia, CP; Huang, T; Sheng, WQ; Li, GC; Zhang, HL; Jing, FX; Jin, QH; Zhao, JL; Li, G; Zhang, Z				Sun, Wenjie; Jia, Chunping; Huang, Ting; Sheng, Weiqi; Li, Guichao; Zhang, Honglian; Jing, Fengxiang; Jin, Qinghui; Zhao, Jianlong; Li, Gang; Zhang, Zhen			High-Performance Size-Based Microdevice for the Detection Of Circulating Tumor Cells from Peripheral Blood in Rectal Cancer Patients	PLOS ONE			English	Article							ADHESION MOLECULE; EXPRESSION; GUIDELINES	Since individualized therapy becomes more and more important in the treatment of rectal cancer, an accurate and effective approach should be established in the clinical settings to help physicians to make their decisions. Circulating tumor cells (CTCs), originated from either primary or metastatic cancer, could provide important information for diagnosis and monitoring of cancer. However, the implication and development of CTCs are limited due to the extreme rarity of these tumor cells. In this study we fabricated a simple and high-performance microfluidic device, which exploited numerous filtered microchannels in it to enrich the large-sized target tumor cells from whole blood. A very high CTC capture efficiency (average recovery rate: 94%) was obtained in this device at the optimum flow rate of 0.5 mL/h and channel height of 5 mm. Additionally, we used this device for detecting CTCs in 60 patients with rectal cancer. The CTC counts of rectal cancer patients were significantly higher than those in healthy subjects. Furthermore, the CTC counts detected by this device were significantly higher than those by EpCAM bead-based method for rectal cancer patients with various stage. Especially, for localized rectal cancer patients, the positive rates of samples with more than 3 CTCs per 5 mL blood by use of microdevice vs. EpCAM-based ones were 100% vs. 47%, respectively. Thus, this device provides a new and effective tool for accurate identification and measurement of CTCs in patients with rectal cancer, and has broad potential in clinical practice.	[Sun, Wenjie; Li, Guichao; Zhang, Zhen] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Sun, Wenjie; Sheng, Weiqi; Li, Guichao; Zhang, Zhen] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Jia, Chunping; Zhang, Honglian; Jing, Fengxiang; Jin, Qinghui; Zhao, Jianlong; Li, Gang] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Key Labs Transducer Technol, Shanghai, Peoples R China; [Jia, Chunping; Zhang, Honglian; Jing, Fengxiang; Jin, Qinghui; Zhao, Jianlong; Li, Gang] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Sci & Technol Microsyst Lab, Shanghai, Peoples R China; [Huang, Ting] Nantong Univ, Affiliated Hosp, Dept Tumor Chemotherapy, Nantong, Jiangsu, Peoples R China; [Sheng, Weiqi] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Microsystem & Information Technology, CAS; Chinese Academy of Sciences; Shanghai Institute of Microsystem & Information Technology, CAS; Nantong University; Fudan University	Li, G (corresponding author), Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Key Labs Transducer Technol, Shanghai, Peoples R China.	gang_li@mail.sim.ac.cn; zhenzhang6@hotmail.com	Jin, Qinghui/S-8451-2016; Li, Gang/AGO-1240-2022; Li, Gang/F-9143-2015	Li, Gang/0000-0001-9805-4354; Li, Gang/0000-0001-9805-4354	National Basic Research Program of China (973 Program) [2012CB933303]; Key Clinical Project of the Ministry of Health; Fudan University Radiation Medicine Research 3rd phase "985 project" [985III-YPT06]; National Natural Science Foundation of China [81101645, 61271162]; Shanghai Municipal Commission for Science and Technology [12nm0503702, 11JC1414400]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Clinical Project of the Ministry of Health; Fudan University Radiation Medicine Research 3rd phase "985 project"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology	This study was supported by some scientific research funds as follows: 1. National Basic Research Program of China (973 Program No. 2012CB933303) 2. The Key Clinical Project of the Ministry of Health (2010-2012) 3. Fudan University Radiation Medicine Research 3rd phase "985 project" (Grant No. 985III-YPT06) 4. The National Natural Science Foundation of China (No. 81101645, 61271162) 5. Shanghai Municipal Commission for Science and Technology (No. 12nm0503702, 11JC1414400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Allen-Mersh TG, 2007, BRIT J SURG, V94, P96, DOI 10.1002/bjs.5526; Bhagat AAS, 2011, LAB CHIP, V11, P1870, DOI 10.1039/c0lc00633e; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Crnic I, 2004, INT J DEV BIOL, V48, P573, DOI 10.1387/ijdb.041809ic; FLEISCHE.RL, 1972, SCIENCE, V178, P255, DOI 10.1126/science.178.4058.255; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Kuo JS, 2010, LAB CHIP, V10, P837, DOI 10.1039/b922301k; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Mocellin S, 2006, TRENDS MOL MED, V12, P130, DOI 10.1016/j.molmed.2006.01.006; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Rao CG, 2005, INT J ONCOL, V27, P49; ROSS AA, 1993, BLOOD, V82, P2605; Rostagno P, 1997, ANTICANCER RES, V17, P2481; Sastre J, 2008, ANN ONCOL, V19, P935, DOI 10.1093/annonc/mdm583; Sheng WA, 2012, ANAL CHEM, V84, P4199, DOI 10.1021/ac3005633; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yen LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179; Zhao MX, 2013, ANAL CHEM, V85, P2465, DOI 10.1021/ac400193b; Zhe XN, 2011, AM J CANCER RES, V1, P740; Zheng S, 2007, J CHROMATOGR A, V1162, P154, DOI 10.1016/j.chroma.2007.05.064	36	18	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75865	10.1371/journal.pone.0075865	http://dx.doi.org/10.1371/journal.pone.0075865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066187	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000169
J	Asano, Y; Trojanowska, M				Asano, Yoshihide; Trojanowska, Maria			Fli1 Represses Transcription of the Human alpha 2(I) Collagen Gene by Recruitment of the HDAC1/p300 Complex	PLOS ONE			English	Article							PROTEIN-ASSOCIATED FACTOR; GROWTH-FACTOR; HISTONE DEACETYLASE; DERMAL FIBROBLASTS; SIGNALING PATHWAY; ETS FAMILY; ACETYLTRANSFERASE; PHOSPHORYLATION; ACTIVATION; INDUCTION	Fli1, a member of the Ets transcription factor family, is a key repressor of the human alpha 2(I) collagen (COL1A2) gene. Although our previous studies have delineated that TGF-beta induces displacement of Fli1 from the COL1A2 promoter through sequential post-translational modifications, the detailed mechanism by which Fli1 functions as a potent transcriptional repressor of the COL1A2 gene has not been fully investigated. To address this issue, we carried out a series of experiments especially focusing on protein-protein interaction and epigenetic transcriptional regulation. The combination of tandem affinity purification and mass spectrometry identified HDAC1 as a Fli1 interacting protein. Under quiescent conditions, HDAC1 induced deacetylation of Fli1 resulting in an increase of Fli1 DNA binding ability and p300 enhanced this process by promoting the formation of a Fli1-HDAC1-p300 complex. TGF-beta-induced phosphorylation of Fli1 at threonine 312 led to disassembly of this protein complex. In quiescent dermal fibroblasts Fli1, HDAC1, and p300 occupied the -404 to -237 region, including the Fli1 binding site, of the COL1A2 promoter. TGF-beta induced Fli1 and HDAC1 dissociation from the COL1A2 promoter, while promoting Ets1 and p300 recruitment. Furthermore, acetylation levels of histone H3 around the Fli1 binding site in the COL1A2 promoter inversely correlated with the DNA occupancy of Fli1 and HDAC1, while positively correlating with that of Ets1 and p300. In the functional studies, HDAC1 overexpression magnified the inhibitory effect of Fli1 on the COL1A2 promoter. Moreover, pharmacological blockade of HDAC1 by entinostat enhanced collagen production in dermal fibroblasts. Collectively, these results indicate that under quiescent conditions Fli1 recruits HDAC1/p300 to the COL1A2 promoter and suppresses the expression of the COL1A2 gene by chromatin remodeling through histone deacetylation. TGF-beta-dependent phosphorylation of Fli1 at threonine 312 is a critical step regulating the remodeling of the Fli1 transcription repressor complex, leading to transcriptional activation of the COL1A2 gene.	[Asano, Yoshihide] Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 113, Japan; [Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA	University of Tokyo; Boston University	Asano, Y (corresponding author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 113, Japan.	yasano-tky@umin.ac.jp			NIH [AR42334]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042334, P50AR060780] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the NIH grant AR42334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Baran CP, AM J RESP CELL MOL B, V45, P999; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; Bujor AM, 2011, ARTHRITIS RHEUM-US, V63, P1729, DOI 10.1002/art.30284; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Huber LC, 2007, ARTHRITIS RHEUM, V56, P2755, DOI 10.1002/art.22759; Jinnin M, 2006, J CELL PHYSIOL, V206, P718, DOI 10.1002/jcp.20527; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P1337, DOI 10.1093/nar/gki275; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Mager AM, 1998, INT J DEV BIOL, V42, P561; Masuya M, 2005, BLOOD, V105, P95, DOI 10.1182/blood-2003-12-4345; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Noda S, 2012, BRIT J DERMATOL, V167, P1098, DOI 10.1111/j.1365-2133.2012.11055.x; Noda S, 2013, RHEUMATOLOGY; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032272; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Simone C, 2004, ONCOGENE, V23, P2177, DOI 10.1038/sj.onc.1207327; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003	34	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74930	10.1371/journal.pone.0074930	http://dx.doi.org/10.1371/journal.pone.0074930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058639	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400101
J	Hadas, K; Randriamboavonjy, V; Elgheznawy, A; Mann, A; Fleming, I				Hadas, Karin; Randriamboavonjy, Voahanginirina; Elgheznawy, Amro; Mann, Alexander; Fleming, Ingrid			Methylglyoxal Induces Platelet Hyperaggregation and Reduces Thrombus Stability by Activating PKC and Inhibiting PI3K/Akt Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; MYOSIN PHOSPHORYLATION; SHAPE CHANGE; IN-VITRO; AGGREGATION; SYNTHASE; 3-KINASE; RELEASE; BETA; AKT	Diabetes is characterized by a dysregulation of glucose homeostasis and platelets from patients with diabetes are known to be hyper-reactive and contribute to the accelerated development of vascular diseases. Since many of the deleterious effects of glucose have been attributed to its metabolite methylgyloxal (MG) rather than to hyperglycemia itself, the aim of the present study was to characterize the effects of MG on platelet function. Washed human platelets were pre-incubated for 15 min with MG and platelet aggregation, adhesion on matrix-coated slides and signaling (Western blot) were assessed ex vivo. In vivo, the effect of MG on thrombus formation was determined using the FeCl3-induced carotid artery injury model. MG potentiated thrombin-induced platelet aggregation and dense granule release, but inhibited platelet spreading on fibronectin and collagen. In vivo, MG accelerated thrombus formation but decreased thrombus stability. At the molecular level, MG increased intracellular Ca2+ and activated classical PKCs at the same time as inhibiting PI3K/Akt and the beta 3-integrin outside-in signaling. In conclusion, these findings indicate that the enhanced MG concentration measured in diabetic patients can directly contribute to the platelet dysfunction associated with diabetes characterized by hyperaggregability and reduced thrombus stability.	[Hadas, Karin; Randriamboavonjy, Voahanginirina; Elgheznawy, Amro; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, D-60054 Frankfurt, Germany; [Mann, Alexander] Endokrinologikum Frankfurt, Frankfurt, Germany	Goethe University Frankfurt	Randriamboavonjy, V (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, D-60054 Frankfurt, Germany.	voahangy@vrc.uni-frankfurt.de	Randriamboavonjy, Voahanginirina/AAU-3655-2020; Fleming, Ingrid/AAB-6123-2022; Fleming, Ingrid/L-1225-2014; Randriamboavonjy, Voahanginirina/AAY-7031-2021	Randriamboavonjy, Voahanginirina/0000-0002-3542-6672; Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; 	Deutsche Forschungsgemeinschaft [SFB 815/A16]; Deutsche Forschungsgemeinschaft (Exzellenzcluster 147 "Cardio-Pulmonary System")	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Exzellenzcluster 147 "Cardio-Pulmonary System")	This study was supported by the Deutsche Forschungsgemeinschaft (SFB 815/A16 and the Exzellenzcluster 147 "Cardio-Pulmonary System"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assert R, 2001, DIABETOLOGIA, V44, P188, DOI 10.1007/s001250051598; Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Bierhaus A, 2012, NAT MED; Brouwers O, 2010, DIABETOLOGIA, V53, P989, DOI 10.1007/s00125-010-1677-0; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; DANIEL JL, 1984, J BIOL CHEM, V259, P9826; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Distler MG, 2012, J CLIN INVEST, V122, P2306, DOI 10.1172/JCI61319; Fiory F, 2011, DIABETOLOGIA, V54, P2941, DOI 10.1007/s00125-011-2280-8; Fleming I, 2003, THROMB HAEMOSTASIS, V90, P863, DOI 10.1160/TH03-04-0228; Gawlowski T, 2007, THROMB RES, V121, P117, DOI 10.1016/j.thromres.2007.03.002; Gresele P, 2003, ACUTE SHORT TERM HYP; Harper MT, 2010, J THROMB HAEMOST, V8, P454, DOI 10.1111/j.1538-7836.2009.03722.x; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Leoncini G, 1996, CELL BIOCHEM FUNCT, V14, P89, DOI 10.1002/cbf.655; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Nemet I, 2005, CLIN BIOCHEM, V38, P379, DOI 10.1016/j.clinbiochem.2004.12.008; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Payrastre B, 2000, BIOCHEM PHARMACOL, V60, P1069, DOI 10.1016/S0006-2952(00)00417-2; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Randriamboavonjy V, 2004, J EXP MED, V199, P347, DOI 10.1084/jem.20030694; Randriamboavonjy V, 2012, BLOOD, V120, P415, DOI 10.1182/blood-2011-12-399980; Randriamboavonjy V, 2010, BLOOD, V116, P2134, DOI 10.1182/blood-2010-04-279612; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74401	10.1371/journal.pone.0074401	http://dx.doi.org/10.1371/journal.pone.0074401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058557	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400070
J	Peng, YF; Shi, YH; Shen, YH; Ding, ZB; Ke, AW; Zhou, J; Qiu, SJ; Fan, J				Peng, Yuan-Fei; Shi, Ying-Hong; Shen, Ying-Hao; Ding, Zhen-Bin; Ke, Ai-Wu; Zhou, Jian; Qiu, Shuang-Jian; Fan, Jia			Promoting Colonization in Metastatic HCC Cells by Modulation of Autophagy	PLOS ONE			English	Article							OVEREXPRESSION; APOPTOSIS; PROGNOSIS; GFP-LC3; CANCER; ASSAYS	Background: Autophagy is an important adaptive survival mechanism, which has been postulated to be involved in cancer metastasis. The purpose of this study was to investigate autophagy in metastasis of hepatocellular carcinoma (HCC). Methods: Immunohistochemical analysis of autophagic activity in metastatic and paired primary HCC tissues using LC3 as autophagosome marker was performed in samples from 216 HCC patients diagnosed with metastasis (including 158 intravascular, 42 intrabiliary, 8 lymph node, 4 bone and 4 lung metastases). Then a mouse model of pulmonary metastasis was established using a highly metastatic HCC cell line (HCCLM3). Autophagy in pulmonary metastases and paired primary tumors were analyzed by LC3 immunohistochemistry, transmission electron microscopy (TEM) and western blot analysis. Further, mouse model of pulmonary metastasis and in vitro cell migration, invasion and detachment models were established using a stable GFP-LC3-expressing HCCLM3 cell line (HCCLM3-GFP-LC3). Autophagic alterations during metastatic colonization, migration, invasion and detachment were determined by GFP-LC3 analysis and western blot analysis. Results: LC3 immunohistochemistry of metastases and primary tumors from HCC patients revealed significantly higher LC3 expression in metastases than primary HCC, which suggested a higher level of autophagy in HCC metastases. Further immunohistochemical, TEM, western blot and in vivo GFP-LC3 analyses of lung metastases and primary tumors in mouse model of pulmonary metastasis confirmed that metastatic colonies displayed higher level of autophagy than primary tumors and the early metastatic colonies displayed highest level. The dynamic monitoring of autophagy in cell migration, invasion and detachment showed that autophagy did not significantly alter in those processes. Conclusions: Autophagy is activated in metastatic colonization but not in invasion, migration and detachment of HCC cells. Autophagy may play a role in HCC metastasis via promoting metastatic colonization of HCC cells.	[Peng, Yuan-Fei; Shi, Ying-Hong; Shen, Ying-Hao; Ding, Zhen-Bin; Ke, Ai-Wu; Zhou, Jian; Qiu, Shuang-Jian; Fan, Jia] Fudan Univ, Liver Canc Inst, Zhongshan Hosp,Minist Educ, Dept Liver Surg,Key Lab Carcinogenesis & Canc Inv, Shanghai 200032, Peoples R China; [Fan, Jia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Fan, J (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp,Minist Educ, Dept Liver Surg,Key Lab Carcinogenesis & Canc Inv, Shanghai 200032, Peoples R China.	fan.jia@zs-hosptal.sh.cn	Shi, Ying-Hong/B-7063-2017; shen, ying/HHS-5635-2022; Fan, Jia/C-6689-2017	Ke, Ai-Wu/0000-0002-7964-6909; Zhou, Jian/0000-0002-7650-7540	National Natural Science Foundation of China [81030038, 81001060, 81272389]; National Key Sci-Tech Project [2012ZX10002011-002]; China Postdoctoral Science Foundation [20100470639, 201104240]; Shanghai Postdoctoral Science Foundation [11R21410300]; Shanghai Health Bureau scientific research found projects [2008Y082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Health Bureau scientific research found projects	This work was supported by the grants from National Natural Science Foundation of China (No. 81030038, 81001060, 81272389), National Key Sci-Tech Project (2012ZX10002011-002), China Postdoctoral Science Foundation (No. 20100470639, 201104240), Shanghai Postdoctoral Science Foundation (No. 11R21410300) and Shanghai Health Bureau scientific research found projects (No. 2008Y082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Debnath J, 2008, AUTOPHAGY, V4, P351, DOI 10.4161/auto.5523; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Han CR, 2011, TOHOKU J EXP MED, V223, P243, DOI 10.1620/tjem.223.243; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He CC, 2010, AUTOPHAGY, V6, P642, DOI 10.4161/auto.6.5.12092; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lazova R, 2012, CLIN CANCER RES, V18, P370, DOI 10.1158/1078-0432.CCR-11-1282; Lazova R, 2010, J CUTAN PATHOL, V37, P256, DOI 10.1111/j.1600-0560.2009.01359.x; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Martinet W, 2006, AUTOPHAGY, V2, P55, DOI 10.4161/auto.2217; Martinet W, 2006, J HISTOCHEM CYTOCHEM, V54, P85, DOI 10.1369/jhc.5A6743.2005; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Stipanuk MH, 2009, NUTR REV, V67, P677, DOI 10.1111/j.1753-4887.2009.00252.x; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Terada M, 2010, CIRC J, V74, P203, DOI 10.1253/circj.CJ-09-0589; Tian FF, 2010, AUTOPHAGY, V6, P1107, DOI 10.4161/auto.6.8.13427; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023	33	47	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74407	10.1371/journal.pone.0074407	http://dx.doi.org/10.1371/journal.pone.0074407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058558	gold, Green Submitted, Green Published			2022-12-27	WOS:000324408400071
J	Hamner, S; McInnerney, K; Williamson, K; Franklin, MJ; Ford, TE				Hamner, Steve; McInnerney, Kate; Williamson, Kerry; Franklin, Michael J.; Ford, Timothy E.			Bile Salts Affect Expression of Escherichia coli O157: H7 Genes for Virulence and Iron Acquisition, and Promote Growth under Iron Limiting Conditions	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; PORIN CHANNELS; RESISTANCE; ADHERENCE; BACTERIAL; EVOLUTION; PATHOGENESIS; INDUCTION; SECRETION; FLAGELLA	Bile salts exhibit potent antibacterial properties, acting as detergents to disrupt cell membranes and as DNA-damaging agents. Although bacteria inhabiting the intestinal tract are able to resist bile's antimicrobial effects, relatively little is known about how bile influences virulence of enteric pathogens. Escherichia coli O157:H7 is an important pathogen of humans, capable of causing severe diarrhea and more serious sequelae. In this study, the transcriptome response of E. coli O157: H7 to bile was determined. Bile exposure induced significant changes in mRNA levels of genes related to virulence potential, including a reduction of mRNA for the 41 genes making up the locus of enterocyte effacement (LEE) pathogenicity island. Bile treatment had an unusual effect on mRNA levels for the entire flagella-chemotaxis regulon, resulting in two-to four-fold increases in mRNA levels for genes associated with the flagella hook-basal body structure, but a two-fold decrease for "late" flagella genes associated with the flagella filament, stator motor, and chemotaxis. Bile salts also caused increased mRNA levels for seventeen genes associated with iron scavenging and metabolism, and counteracted the inhibitory effect of the iron chelating agent 2,2'-dipyridyl on growth of E. coli O157: H7. These findings suggest that E. coli O157: H7 may use bile as an environmental signal to adapt to changing conditions associated with the small intestine, including adaptation to an iron-scarce environment.	[Hamner, Steve; McInnerney, Kate; Williamson, Kerry; Franklin, Michael J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [McInnerney, Kate] Montana State Univ, Funct Genom Core Facil, Bozeman, MT 59717 USA; [Ford, Timothy E.] Univ New England, Biddeford, ME USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of New England - Maine	Hamner, S (corresponding author), Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.	shiva_dancing@yahoo.com		Ford, Timothy/0000-0001-5194-5459	Montana INBRE program of the National Center for Research Resources (NCRR) a component of the National Institutes of Health (NIH) [P20 RR016455]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER	Montana INBRE program of the National Center for Research Resources (NCRR) a component of the National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was made possible by Grant Number P20 RR016455 from the Montana INBRE program of the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). This publication's contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bernstein C, 1999, CURR MICROBIOL, V39, P68, DOI 10.1007/s002849900420; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; De Paepe M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002107; Degen LP, 1996, GUT, V39, P299, DOI 10.1136/gut.39.2.299; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Ebel F, 1996, INFECT IMMUN, V64, P4472, DOI 10.1128/IAI.64.11.4472-4479.1996; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; KANDELL RL, 1991, NUTR CANCER, V16, P227, DOI 10.1080/01635589109514161; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kus JV, 2011, J BACTERIOL, V193, P4509, DOI 10.1128/JB.00200-11; LEVITT MD, 1980, ANNU REV MED, V31, P127, DOI 10.1146/annurev.me.31.020180.001015; Low AS, 2006, INFECT IMMUN, V74, P2233, DOI 10.1128/IAI.74.4.2233-2244.2006; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Martinez MB, 2001, BIOCHEMISTRY-US, V40, P11965, DOI 10.1021/bi0109515; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Pomares MF, 2008, J BACTERIOL, V190, P4328, DOI 10.1128/JB.00183-08; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Pyle BH, 1999, APPL ENVIRON MICROB, V65, P1966; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reid SD, 1999, J BACTERIOL, V181, P153, DOI 10.1128/JB.181.1.153-160.1999; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Torres AG, 2005, INFECT IMMUN, V73, P4766, DOI 10.1128/IAI.73.8.4766-4776.2005; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; Torres AG, 2009, ANAEROBE, V15, P1, DOI 10.1016/j.anaerobe.2008.05.002; Vazquez-Juarez RC, 2008, INFECT IMMUN, V76, P5072, DOI 10.1128/IAI.00677-08; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; WU Z, 2004, WORKING PAPERS J HOP; Yin XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017424	58	50	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74647	10.1371/journal.pone.0074647	http://dx.doi.org/10.1371/journal.pone.0074647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058617	Green Submitted, gold, Green Published			2022-12-27	WOS:000327538600106
J	Burns, JC; Herzog, L; Fabri, O; Tremoulet, AH; Rodo, X; Uehara, R; Burgner, D; Bainto, E; Pierce, D; Tyree, M; Cayan, D				Burns, Jane C.; Herzog, Lauren; Fabri, Olivia; Tremoulet, Adriana H.; Rodo, Xavier; Uehara, Ritei; Burgner, David; Bainto, Emelia; Pierce, David; Tyree, Mary; Cayan, Daniel		Kawasaki Dis Global Climate Consor	Seasonality of Kawasaki Disease: A Global Perspective	PLOS ONE			English	Article								Background: Understanding global seasonal patterns of Kawasaki disease (KD) may provide insight into the etiology of this vasculitis that is now the most common cause of acquired heart disease in children in developed countries worldwide. Methods: Data from 1970-2012 from 25 countries distributed over the globe were analyzed for seasonality. The number of KD cases from each location was normalized to minimize the influence of greater numbers from certain locations. The presence of seasonal variation of KD at the individual locations was evaluated using three different tests: time series modeling, spectral analysis, and a Monte Carlo technique. Results: A defined seasonal structure emerged demonstrating broad coherence in fluctuations in KD cases across the Northern Hemisphere extra-tropical latitudes. In the extra-tropical latitudes of the Northern Hemisphere, KD case numbers were highest in January through March and approximately 40% higher than in the months of lowest case numbers from August through October. Datasets were much sparser in the tropics and the Southern Hemisphere extra-tropics and statistical significance of the seasonality tests was weak, but suggested a maximum in May through June, with approximately 30% higher number of cases than in the least active months of February, March and October. The seasonal pattern in the Northern Hemisphere extra-tropics was consistent across the first and second halves of the sample period. Conclusion: Using the first global KD time series, analysis of sites located in the Northern Hemisphere extra-tropics revealed statistically significant and consistent seasonal fluctuations in KD case numbers with high numbers in winter and low numbers in late summer and fall. Neither the tropics nor the Southern Hemisphere extra-tropics registered a statistically significant aggregate seasonal cycle. These data suggest a seasonal exposure to a KD agent that operates over large geographic regions and is concentrated during winter months in the Northern Hemisphere extratropics.	[Burns, Jane C.; Herzog, Lauren; Fabri, Olivia; Tremoulet, Adriana H.] Rady Childrens Hosp San Diego, Dept Pediat, La Jolla, CA USA; [Burns, Jane C.; Herzog, Lauren; Fabri, Olivia; Tremoulet, Adriana H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Rodo, Xavier] ICREA, Barcelona, Catalonia, Spain; [Rodo, Xavier] Inst Catala Ciencies Clima IC3, Barcelona, Catalonia, Spain; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bainto, Emelia; Pierce, David; Tyree, Mary; Cayan, Daniel] UCSD, Scripps Inst Oceanog, La Jolla, CA USA; [Bainto, Emelia; Pierce, David; Tyree, Mary; Cayan, Daniel] Water Resources Discipline, La Jolla, CA USA; [Cayan, Daniel] US Geol Survey, La Jolla, CA USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; ICREA; Institut Catala de Ciencies del Clima (IC3); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of the Interior; United States Geological Survey	Burns, JC (corresponding author), Rady Childrens Hosp San Diego, Dept Pediat, La Jolla, CA USA.	jcburns@ucsd.edu	Anton, Jordi/A-9848-2017; Ciftci, Ergin/W-2756-2017; Burns, Jane C/J-6167-2015; Özdemir, Halil/AAP-1702-2020; Rodó, Xavier/F-7663-2017; Cheung, Yiu Fai/C-4240-2009	Anton, Jordi/0000-0002-8792-4219; Ciftci, Ergin/0000-0002-4955-160X; Özdemir, Halil/0000-0002-7318-1688; Rodó, Xavier/0000-0003-4843-6180; Ricart, Silvia/0000-0002-0651-8180; Cheung, Yiu Fai/0000-0002-7279-4992; Burgner, David/0000-0002-8304-4302; Tulloh, Robert/0000-0002-3180-6993	National Institutes of Health; National Heart, Lung, Blood Institute [HL69413, iDASH U54-HL108460]; La Marato de TV3 Foundation; National Oceanographic and Atmospheric Administration Regional Integrated Sciences; Assessments through the California Nevada Applications Program, through the National Oceanographic; Atmospheric Administration Regional Integrated Science Assessments program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460, R01HL069413] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); La Marato de TV3 Foundation; National Oceanographic and Atmospheric Administration Regional Integrated Sciences; Assessments through the California Nevada Applications Program, through the National Oceanographic; Atmospheric Administration Regional Integrated Science Assessments program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	This work was supported in part by grants from the National Institutes of Health, National Heart, Lung, Blood Institute (HL69413 and iDASH U54-HL108460) awarded to JCB, by La Marato de TV3 Foundation ('Malaties cardiovasculars 2007') to XR, and by the National Oceanographic and Atmospheric Administration Regional Integrated Sciences and Assessments through the California Nevada Applications Program, through the National Oceanographic and Atmospheric Administration Regional Integrated Science Assessments program, awarded to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaisdell LL, 2011, PEDIATR CARDIOL, V32, P1023, DOI 10.1007/s00246-011-0045-2; Box G.E., 2011, TIME SERIES ANAL FOR; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; Burns JC, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e27; Du ZD, 2007, PEDIATR INFECT DIS J, V26, P449, DOI 10.1097/01.inf.0000261196.79223.18; Friedland-Little J, 2013, PEDIATR TRANSPLANT, V17, pE1, DOI 10.1111/petr.12014; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; Harnden A, 2009, PEDIATR INFECT DIS J, V28, P21, DOI 10.1097/INF.0b013e3181812ca4; Hata A, 2009, J HUM GENET, V54, P67, DOI 10.1038/jhg.2008.9; Holman Robert C, 2010, Hawaii Med J, V69, P194; Jawad NH, 1997, ANN TROP PAEDIATR, V17, P33, DOI 10.1080/02724936.1997.11747860; Jenkins G. M., 1969, SPECTRAL ANAL ITS AP; Kao AS, 2008, PEDIATR INFECT DIS J, V27, P981, DOI 10.1097/INF.0b013e31817acf4f; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Nakamura Y, 1987, Prog Clin Biol Res, V250, P19; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Onouchi Y, 2009, PEDIATR RES, V65, p46R, DOI 10.1203/PDR.0b013e31819dba60; PARRY RC, 1990, J ANAL TOXICOL, V14, P39, DOI 10.1093/jat/14.1.39; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Rowley AH, 2008, NAT REV MICROBIOL, V6, P394, DOI 10.1038/nrmicro1853; Straface E, 2012, ANTIOXID REDOX SIGN, V17, P1441, DOI 10.1089/ars.2012.4660; WALTER SD, 1980, J EPIDEMIOL COMMUN H, V34, P147, DOI 10.1136/jech.34.2.147; YANAGAWA H, 1995, ARCH PEDIAT ADOL MED, V149, P779, DOI 10.1001/archpedi.1995.02170200069011	24	100	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74529	10.1371/journal.pone.0074529	http://dx.doi.org/10.1371/journal.pone.0074529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058585	Green Published, gold			2022-12-27	WOS:000324695900054
J	Hu, LX; He, J; Hou, L; Wang, H; Li, J; Xie, CS; Duan, Z; Sun, LK; Wang, X; Zhu, C				Hu, Li-Xia; He, Jing; Hou, Li; Wang, Hong; Li, Jun; Xie, Changsheng; Duan, Zhuo; Sun, Li-Kui; Wang, Xin; Zhu, Changhong			Biological Evaluation of the Copper/Low-density Polyethylene Nanocomposite Intrauterine Device	PLOS ONE			English	Article							SIMULATED UTERINE SOLUTION; PIG MAXIMIZATION TEST; IN-VIVO EXPERIMENTS; ARRIVE GUIDELINES; METALLIC COPPER; CUPRIC ION; COMPOSITES; BEHAVIOR; RELEASE; CONTRACEPTION	Devices and materials intended for clinical applications as medical and implant devices should be evaluated to determine their biocompatibility in physiological systems. This article presents results from cytotoxicity assay of L929 mouse fibroblasts culture, tests for skin irritation, intracutaneous reactivity and sensitization, and material implantation tests for the novel copper/low-density polyethylene nanocomposite intrauterine device (nano-Cu/LDPE IUD) with potential for future clinical utilization. Cytotoxicity test in vitro was conducted to evaluate the change in morphology, growth and proliferation of cultured L929 mouse fibroblasts, which in vivo examination for skin irritation (n = 6) and intracutaneous reactivity (n = 6) were carried out to explore the irritant behavior in New Zealand White rabbits. Skin sensitization was implemented to evaluate the potential skin sensitizing in Hartley guinea pigs (n = 35). The materials were implanted into the spinal muscle of rabbits (n = 9). The cytotoxicity grade of the nano-Cu/LDPE IUD was 0-1, suggested that the composite was nontoxic or mildly cytotoxic; no irritation reaction and skin sensitization were identified in any animals of specific extracts prepared from the material under test; similarly to the control sides, the inflammatory reaction was observed in the rabbits living tissue of the implanted material in intramuscular implantation assay. They indicated that the novel composite intrauterine device presented potential for this type of application because they meet the requirements of the standard practices recommended for evaluating the biological reactivity. The nano-Cu/LDPE IUD has good biocompatibility, which is biologically safe for the clinical research as a novel contraceptive device.	[Hu, Li-Xia; He, Jing; Wang, Hong; Zhu, Changhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China; [He, Jing] Cent Hosp Wuhan, Wuhan, Peoples R China; [Hou, Li; Sun, Li-Kui; Wang, Xin] Shandong Qual Inspect Ctr Med Devices, Jinan, Peoples R China; [Hou, Li; Sun, Li-Kui; Wang, Xin] Shandong Prov Key Lab Biol Evaluat Med Devices, Jinan, Peoples R China; [Li, Jun] Wuchang Dist Maternal & Child Hlth Hosp, Wuhan, Peoples R China; [Xie, Changsheng] Huazhong Univ Sci & Technol, Dept Mat Sci, Wuhan 430074, Peoples R China; [Duan, Zhuo] Dayu Med Devices Co Ltd, Jinzhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhu, C (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China.	reprodcentre@163.com	xie, chang/GYJ-2493-2022	Xie, Changsheng/0000-0001-5123-3195	National Eleven Five-Year Key Technologies R&D Programme, China [2006BAI03B01]	National Eleven Five-Year Key Technologies R&D Programme, China	This research was supported by grant 2006BAI03B01 from the National Eleven Five-Year Key Technologies R&D Programme, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins-Gynecology, 2005, Obstet Gynecol, V105, P223; Andersson K, 1998, CONTRACEPTION, V57, P251, DOI 10.1016/S0010-7824(98)00029-8; [Anonymous], 2010, J PHYSIOL-LONDON, V588, P2519, DOI 10.1113/jphysiol.2010.192278; [Anonymous], 2007, 109936 ISO; [Anonymous], 2007, 1099312 ISO; Arancibia V, 2003, CLIN CHIM ACTA, V332, P69, DOI 10.1016/S0009-8981(03)00124-4; Bastidas JM, 2000, CONTRACEPTION, V61, P395, DOI 10.1016/S0010-7824(00)00124-4; Cai SZ, 2007, J BIOMED MATER RES B, V80B, P220, DOI 10.1002/jbm.b.30587; Cai SZ, 2005, BIOMATERIALS, V26, P2671, DOI 10.1016/j.biomaterials.2004.08.003; Colli E, 1999, CONTRACEPTION, V59, P227, DOI 10.1016/S0010-7824(99)00027-X; Grillo CA, 2010, CONTRACEPTION, V81, P343, DOI 10.1016/j.contraception.2009.12.003; International Organization for Standardization, 2006, 109932 ISO; International Organization for Standardization, 2009, TESTS CYT IN VITR ME, VThird, P42; ISO, 2010, 10993102010 ISO; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Liu HF, 2007, CONTRACEPTION, V75, P157, DOI 10.1016/j.contraception.2006.09.012; MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42; Mirshahpanah P, 2007, CUTAN OCUL TOXICOL, V26, P375, DOI 10.1080/15569520701662775; Mishell DR, 1998, CONTRACEPTION, V58, p45S, DOI 10.1016/S0010-7824(98)00082-1; Patai K, 2003, FERTIL STERIL, V80, P1281, DOI 10.1016/S0015-0282(03)01171-3; POLYZOIS GL, 1994, J PROSTHET DENT, V71, P500, DOI 10.1016/0022-3913(94)90190-2; Silva VV, 2002, J BIOMED MATER RES, V63, P583, DOI 10.1002/jbm.10308; Sitruk-Ware R, 2013, CONTRACEPTION, V87, P319, DOI 10.1016/j.contraception.2012.08.002; Stanback J, 1998, CONTRACEPTION, V58, P357, DOI 10.1016/S0010-7824(98)00126-7; Stanford JB, 2002, AM J OBSTET GYNECOL, V187, P1699, DOI 10.1067/mob.2002.128091; Sun L, 2011, FERTIL STERIL, V95, P1416, DOI 10.1016/j.fertnstert.2010.04.041; Thiery M, 2000, EUR J OBSTET GYN R B, V90, P145, DOI 10.1016/S0301-2115(00)00262-1; Wen F, 2006, ELECTROCHIM ACTA, V51, P5606, DOI 10.1016/j.electacta.2006.02.034; Westhoff CL, 1996, J NURSE-MIDWIFERY, V41, P218, DOI 10.1016/0091-2182(96)00015-8; Xia XP, 2007, FERTIL STERIL, V88, P472, DOI 10.1016/j.fertnstert.2006.11.122; Xia XP, 2006, MAT SCI ENG A-STRUCT, V429, P329, DOI 10.1016/j.msea.2006.05.045; Xia XP, 2011, J MATER SCI-MATER M, V22, P1773, DOI 10.1007/s10856-011-4347-y; Xu T, 2004, CONTRACEPTION, V70, P153, DOI 10.1016/j.contraception.2004.02.018; Yang ZH, 2009, COLLOID SURFACE B, V69, P276, DOI 10.1016/j.colsurfb.2008.11.027; Yu J, 2008, CONTRACEPTION, V78, P319, DOI 10.1016/j.contraception.2008.05.008; ZIPPER JA, 1969, AM J OBSTET GYNECOL, V105, P1274, DOI 10.1016/0002-9378(69)90302-0	37	10	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74128	10.1371/journal.pone.0074128	http://dx.doi.org/10.1371/journal.pone.0074128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058521	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900032
J	Kenward, B; Gredeback, G				Kenward, Ben; Gredeback, Gustaf			Infants Help a Non-Human Agent	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; PREVERBAL INFANTS; SOCIAL-DOMINANCE; MOTOR COGNITION; YOUNG-CHILDREN; EMPATHY; MIRROR; OTHERS; PERCEPTION; IMITATION	Young children can be motivated to help adults by sympathetic concern based upon empathy, but the underlying mechanisms are unknown. One account of empathy-based sympathetic helping in adults states that it arises due to direct-matching mirror-system mechanisms which allow the observer to vicariously experience the situation of the individual in need of help. This mechanism could not account for helping of a geometric-shape agent lacking human-isomorphic bodyparts. Here 17-month-olds observed a ball-shaped non-human agent trying to reach a goal but failing because it was blocked by a barrier. Infants helped the agent by lifting it over the barrier. They performed this action less frequently in a control condition in which the barrier could not be construed as blocking the agent. Direct matching is therefore not required for motivating helping in infants, indicating that at least some of our early helpful tendencies do not depend on human-specific mechanisms. Empathy-based mechanisms that do not require direct-matching provide one plausible basis for the observed helping. A second possibility is that rather than being based on empathy, the observed helping occurred as a result of a goal-contagion process in which the infants were primed with the unfulfilled goal.	[Kenward, Ben; Gredeback, Gustaf] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Uppsala University	Kenward, B (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	ben.kenward@wolfson.oxon.org	Gredebäck, Gustaf/C-1676-2009	Gredebäck, Gustaf/0000-0003-3046-0043	Riksbankens Jubileumsfond (Bank of Sweden Tercentenary Fund) [P2008-01039:1]	Riksbankens Jubileumsfond (Bank of Sweden Tercentenary Fund)	This work was supported by Riksbankens Jubileumsfond (Bank of Sweden Tercentenary Fund) Grant P2008-01039:1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2004, J PERS SOC PSYCHOL, V87, P23, DOI 10.1037/0022-3514.87.1.23; Baird AD, 2011, SOC NEUROSCI-UK, V6, P327, DOI 10.1080/17470919.2010.547085; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Biro S, 2007, PROG BRAIN RES, V164, P303, DOI 10.1016/S0079-6123(07)64017-5; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Brownell CA, 2013, INFANCY, V18, P1, DOI 10.1111/infa.12004; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Csibra G., 2008, SENSORIMOTOR FDN HIG, P435; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Decety J, 2010, EMOT REV, V2, P204, DOI 10.1177/1754073910361981; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Elsner C, 2013, NEUROPSYCHOLOGIA, V51, P488, DOI 10.1016/j.neuropsychologia.2012.12.007; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; Fawcett C, 2012, INFANT CHILD DEV, V21, P239, DOI 10.1002/icd.739; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Good P, 2005, PERMUTATION PARAMETR; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Hepach R, 2013, INFANCY, V18, P67, DOI 10.1111/j.1532-7078.2012.00130.x; Hepach R, 2012, PSYCHOL SCI, V23, P967, DOI 10.1177/0956797612440571; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Kartner J, 2010, DEV PSYCHOL, V46, P905, DOI 10.1037/a0019718; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liszkowski U, 2008, COGNITION, V108, P732, DOI 10.1016/j.cognition.2008.06.013; Mascaro O, 2012, P NATL ACAD SCI USA, V109, P6862, DOI 10.1073/pnas.1113194109; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Molnar-Szakacs I, 2011, J ECON BEHAV ORGAN, V77, P76, DOI 10.1016/j.jebo.2010.02.019; Nystrom P, 2008, SOC NEUROSCI-UK, V3, P334, DOI 10.1080/17470910701563665; Over H, 2009, PSYCHOL SCI, V20, P1189, DOI 10.1111/j.1467-9280.2009.02419.x; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; RHEINGOLD HL, 1982, CHILD DEV, V53, P114, DOI 10.2307/1129643; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sartori L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00033; Scarf D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042698; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Southgate V, 2013, PSYCHOL SCI IN PRESS; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Thompson RA, 2013, INFANCY, V18, P120, DOI 10.1111/j.1532-7078.2012.00139.x; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2008, DEV PSYCHOL, V44, P1785, DOI 10.1037/a0013860; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	62	32	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75130	10.1371/journal.pone.0075130	http://dx.doi.org/10.1371/journal.pone.0075130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058657	Green Published, Green Submitted, gold			2022-12-27	WOS:000324695900096
J	Moore, KA; Plant, JJ; Gaddam, D; Craft, J; Hollien, J				Moore, Kristin A.; Plant, Joshua J.; Gaddam, Deepika; Craft, Jonathan; Hollien, Julie			Regulation of Sumo mRNA during Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; TRANSLATIONAL CONTROL; GENE-EXPRESSION; ER STRESS; KINASE; DECAY; XBP-1	The unfolded protein response (UPR) is a collection of pathways that maintains the protein secretory pathway during the many physiological and pathological conditions that cause stress in the endoplasmic reticulum (ER). The UPR is mediated in part by Ire1, an ER transmembrane kinase and endoribonuclease that is activated when misfolded proteins accumulate in the ER. Ire1's nuclease initiates the cytosolic splicing of the mRNA encoding X-box binding protein (Xbp1), a potent transcription factor that then upregulates genes responsible for restoring ER function. This same nuclease is responsible for the degradation of many other mRNAs that are localized to the ER, through Regulated Ire1 Dependent Decay (RIDD). Here we show that Smt3, a homolog of small ubiquitin-like modifier (sumo), is a non-canonical RIDD target in Drosophila S2 cells. Unlike other RIDD targets, the sumo transcript does not stably associate with the ER membrane, but instead relies on an Xbp1-like stem loop and a second UPR mediator, Perk, for its degradation during stress.	[Hollien, Julie] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Hollien, J (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	hollien@biology.utah.edu		Hollien, Julie/0000-0003-0649-1261	NIH [GM081255]; NSF [0841233]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was funded by NIH R00 (GM081255) to JH and an NSF GK-12 award (0841233) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gaddam D, 2013, MOL BIOL CELL, V24, P14, DOI 10.1091/mbc.E12-06-0491; Garrey JL, 2010, J VIROL, V84, P1124, DOI 10.1128/JVI.02006-09; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jiang Z, 2012, CELL CYCLE, V11, P1118, DOI 10.4161/cc.11.6.19529; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; MORI K, 1993, CELL, V74, P743; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	34	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75723	10.1371/journal.pone.0075723	http://dx.doi.org/10.1371/journal.pone.0075723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058701	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900126
J	Camacho, L; Guerrero, P; Marchetti, D				Camacho, Laura; Guerrero, Paola; Marchetti, Dario			MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived Exosomes	PLOS ONE			English	Article							PROMOTE TUMOR-GROWTH; BREAST-CANCER; PROTEOMIC ANALYSIS; EXPRESSION; APOPTOSIS; VESICLES; ADHESION; GENE; SUPPRESSION; FIBRONECTIN	Exosomes are small membrane vesicles released by most cell types including tumor cells. The intercellular exchange of proteins and genetic material via exosomes is a potentially effective approach for cell-to-cell communication and it may perform multiple functions aiding to tumor survival and metastasis. We investigated microRNA and protein profiles of brain metastatic (BM) versus non-brain metastatic (non-BM) cell-derived exosomes. We studied the cargo of exosomes isolated from brain-tropic 70W, MDA-MB-231BR, and circulating tumor cell brain metastasis-selected markers (CTC1BMSM) variants, and compared them with parental non-BM MeWo, MDA-MB-231P and CTC1P cells, respectively. By performing microRNA PCR array we identified one up-regulated (miR-210) and two down-regulated miRNAs (miR-19a and miR-29c) in BM versus non-BM exosomes. Second, we analyzed the proteomic content of cells and exosomes isolated from these six cell lines, and detected high expression of proteins implicated in cell communication, cell cycle, and in key cancer invasion and metastasis pathways. Third, we show that BM cell-derived exosomes can be internalized by non-BM cells and that they effectively transport their cargo into cells, resulting in increased cell adhesive and invasive potencies. These results provide a strong rationale for additional investigations of exosomal proteins and miRNAs towards more profound understandings of exosome roles in brain metastasis biogenesis, and for the discovery and application of non-invasive biomarkers for new therapies combating brain metastasis.	[Camacho, Laura; Guerrero, Paola; Marchetti, Dario] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Camacho, Laura; Guerrero, Paola; Marchetti, Dario] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Marchetti, Dario] Baylor Coll Med, Dept Mol Biol, Houston, TX 77030 USA; [Marchetti, Dario] Baylor Coll Med, Dept Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Marchetti, D (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	marchett@bcm.edu	Camacho, Laura/M-2071-2015	Camacho, Laura/0000-0002-5911-1616	US Department of Defense [W81XWH-12-0281]; NIH [5R01-CA160335]; NATIONAL CANCER INSTITUTE [R01CA160335] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the US Department of Defense (W81XWH-12-0281) and NIH (5R01-CA160335) to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartsch JE, 2003, J SURG RES, V110, P287, DOI 10.1016/S0022-4804(03)00004-0; Denzer K, 2000, J CELL SCI, V113, P3365; Duncavage E, 2010, J THORAC ONCOL, V5, P1755, DOI 10.1097/JTO.0b013e3181f3909d; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Frederick MJ, 2011, AM J PATHOL, V178, P548, DOI 10.1016/j.ajpath.2010.10.044; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hong L, 2012, GENE, V507, P135, DOI 10.1016/j.gene.2012.07.025; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Krymskaya VP, 2003, CELL SIGNAL, V15, P729, DOI 10.1016/S0898-6568(03)00040-8; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; MARCHETTI D, 1993, INT J CANCER, V55, P692, DOI 10.1002/ijc.2910550430; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Palazzolo G, 2012, ANTICANCER RES, V32, P847; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Ridgway LD, 2012, MOL CANCER RES, V10, P689, DOI 10.1158/1541-7786.MCR-11-0534; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Rubio N, 2001, LAB INVEST, V81, P725, DOI 10.1038/labinvest.3780281; RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Srivastava M, 2004, CLIN CANCER RES, V10, P2344, DOI 10.1158/1078-0432.CCR-03-0278; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006376; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	58	85	92	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73790	10.1371/journal.pone.0073790	http://dx.doi.org/10.1371/journal.pone.0073790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066071	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000053
J	de Paula, JJ; Bertola, L; Avila, RT; Moreira, L; Coutinho, G; de Moraes, EN; Bicalho, MAC; Nicolato, R; Diniz, BS; Malloy-Diniz, LF				de Paula, Jonas Jardim; Bertola, Laiss; Avila, Rafaela Teixeira; Moreira, Lafaiete; Coutinho, Gabriel; de Moraes, Edgar Nunes; Camargos Bicalho, Maria Aparecida; Nicolato, Rodrigo; Diniz, Breno Satler; Malloy-Diniz, Leandro Fernandes			Clinical Applicability and Cutoff Values for an Unstructured Neuropsychological Assessment Protocol for Older Adults with Low Formal Education	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VERBAL-LEARNING TEST; ALZHEIMERS-DISEASE; LANGUAGE COMPREHENSION; ECOLOGICAL VALIDITY; DEMENTIA; BATTERY; VERSION; TESTS; CHILDREN	Background and Objectives: The neuropsychological exam plays a central role in the assessment of elderly patients with cognitive complaints. It is particularly relevant to differentiate patients with mild dementia from those subjects with mild cognitive impairment. Formal education is a critical factor in neuropsychological performance; however, there are few studies that evaluated the psychometric properties, especially criterion related validity, neuropsychological tests for patients with low formal education. The present study aims to investigate the validity of an unstructured neuropsychological assessment protocol for this population and develop cutoff values for clinical use. Methods and Results: A protocol composed by the Rey-Auditory Verbal Learning Test, Frontal Assessment Battery, Category and Letter Fluency, Stick Design Test, Clock Drawing Test, Digit Span, Token Test and TN-LIN was administered to 274 older adults (96 normal aging, 85 mild cognitive impairment and 93 mild Alzheimer's disease) with predominantly low formal education. Factor analysis showed a four factor structure related to Executive Functions, Language/Semantic Memory, Episodic Memory and Visuospatial Abilities, accounting for 65% of explained variance. Most of the tests showed a good sensitivity and specificity to differentiate the diagnostic groups. The neuropsychological protocol showed a significant ecological validity as 3 of the cognitive factors explained 31% of the variance on Instrumental Activities of Daily Living. Conclusion: The study presents evidence of the construct, criteria and ecological validity for this protocol. The neuropsychological tests and the proposed cutoff values might be used for the clinical assessment of older adults with low formal education.	[de Paula, Jonas Jardim; Bertola, Laiss; Avila, Rafaela Teixeira; Moreira, Lafaiete; Malloy-Diniz, Leandro Fernandes] Univ Fed Minas Gerais, Lab Neuropsychol Invest LIN, Belo Horizonte, MG, Brazil; [de Paula, Jonas Jardim; Bertola, Laiss; Avila, Rafaela Teixeira; Moreira, Lafaiete; Nicolato, Rodrigo; Diniz, Breno Satler; Malloy-Diniz, Leandro Fernandes] Univ Fed Minas Gerais, Fac Med, INCT Med Mol, Belo Horizonte, MG, Brazil; [Coutinho, Gabriel] DOr Inst Res & Educ IDOr, Rio De Janeiro, Brazil; [Coutinho, Gabriel] Univ Fed Rio de Janeiro, Programa Posgrad Ciencias Morfol, Rio De Janeiro, Brazil; [de Moraes, Edgar Nunes; Camargos Bicalho, Maria Aparecida] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil; [Nicolato, Rodrigo; Diniz, Breno Satler; Malloy-Diniz, Leandro Fernandes] Univ Fed Minas Gerais, Fac Med, Dept Saude Mental, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Paula, JJ (corresponding author), Univ Fed Minas Gerais, Lab Neuropsychol Invest LIN, Belo Horizonte, MG, Brazil.	jonasjardim@gmail.com	de Paula, Jonas J/I-8066-2012; Malloy-Diniz, Leandro/D-7829-2013; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021; Bertola, Laiss/G-8235-2016; Diniz, Breno/H-8381-2019	Malloy-Diniz, Leandro/0000-0002-6606-1354; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354; Bertola, Laiss/0000-0001-5771-2576; Diniz, Breno/0000-0003-0653-1905; de Paula, Jonas/0000-0001-5530-2346; Moraes, Edgar Nunes de/0000-0002-8923-1029	FAPEMIG [CBB-APQ-00075-09, APQ-01972/12-10, APQ-02755-10]; CNPq [573646/2008-2]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the following grants: CBB-APQ-00075-09 from FAPEMIG, 573646/2008-2 from CNPq, and APQ-01972/12-10, APQ-02755-10 from FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprahamian I, 2011, INT J GERIATR PSYCH, V26, P403, DOI 10.1002/gps.2540; Baiyewu O, 2005, J INT NEUROPSYCH SOC, V11, P598, DOI 10.1017/S135561770505071X; Brucki SMD, 1997, ARQ NEURO-PSIQUIAT, V55, P56, DOI 10.1590/S0004-282X1997000100009; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Cotta MF, 2012, CONTEXTOS CLIN, V5, P10; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Davies SR, 2011, J CLIN EXP NEUROPSYC, V33, P820, DOI 10.1080/13803395.2011.574608; de Paula JJ, 2010, REV PSIQUIATR CLIN, V37, P251; de Paula JJ, 2013, INT PSYCHOGERIATR; de Paula JJ, 2012, ARQ NEURO-PSIQUIAT, V70, P435, DOI 10.1590/S0004-282X2012000600010; de Paula JJ, 2012, PSYCHOL REP, V110, P477, DOI 10.2466/03.10.13.PR0.110.2.477-488; de Paula JJ, 2012, REV PSIQ CLIN-BRAZIL, V39, P19; Diniz BS, 2008, REV BRAS PSIQUIATR, V30, P316, DOI 10.1590/S1516-44462008000400003; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Farley KL, 2011, ARCH CLIN NEUROPSYCH, V26, P728, DOI 10.1093/arclin/acr069; Fontanari J, 1989, NEUROBIOLOGIA, V52, P167; Forlenza OV, 2010, REV BRAS PSIQUIATR, V32, P216, DOI 10.1590/S1516-44462010005000002; Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314; IBM Corp, 2010, REL 2010 IBM SPSS ST; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kessels RPC, 2008, ASSESSMENT, V15, P426, DOI 10.1177/1073191108315611; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Malloy-Diniz LF, 2007, REV NEUROLOGIA, V44, P275, DOI 10.33588/rn.4405.2006089; Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ministerio do Planejamento Orcamento e Gestao. (Instituto Brasileiro de Geografia e Estatistica IBGE), CONT POP; Moreira L, 2011, REV PSIQ CLIN-BRAZIL, V38, P97, DOI 10.1590/S0101-60832011000300003; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062; Paula J.J., 2013, REV PSICOLOGIA PESQU, V7, P89, DOI [https://doi.org/10.24879/201300700100258, DOI 10.24879/201300700100258, 10.5327/Z1982-1247201300010010, DOI 10.5327/Z1982-1247201300010010]; Paula Jonas Jardim de, 2013, Estud. psicol. (Natal), V18, P117, DOI 10.1590/S1413-294X2013000100019; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Porto CS, 2003, ARQ NEURO-PSIQUIAT, V61, P339, DOI 10.1590/S0004-282X2003000300004; Salmon DP, 2009, ANNU REV PSYCHOL, V60, P257, DOI 10.1146/annurev.psych.57.102904.190024; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Schmand B, 2011, J AM GERIATR SOC, V59, P1705, DOI 10.1111/j.1532-5415.2011.03539.x; Senhorini MCT, 2006, J CLIN EXP NEUROPSYC, V28, P1191, DOI 10.1080/13803390500350969; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Tuokko H, 2000, ARCH CLIN NEUROPSYCH, V15, P137, DOI 10.1016/S0887-6177(99)00003-7; Unverzagt FW, 1999, J INT NEUROPSYCH SOC, V5, P255, DOI 10.1017/S1355617799003082; Zhang D, 2011, PLOS ONE, V7	42	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73167	10.1371/journal.pone.0073167	http://dx.doi.org/10.1371/journal.pone.0073167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219GJ	24066031	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000012
J	Huesgen, PF; Alami, M; Lange, PF; Foster, LJ; Schroder, WP; Overall, CM; Green, BR				Huesgen, Pitter F.; Alami, Meriem; Lange, Philipp F.; Foster, Leonard J.; Schroder, Wolfgang P.; Overall, Christopher M.; Green, Beverley R.			Proteomic Amino-Termini Profiling Reveals Targeting Information for Protein Import into Complex Plastids	PLOS ONE			English	Article							CHLOROPLAST TRANSIT PEPTIDES; PROCESSING PEPTIDASE; PROTEOLYTIC EVENTS; DIATOM PLASTIDS; GLOBAL ANALYSIS; CLEAVAGE SITES; N-TERMINI; IDENTIFICATION; STABILITY; EVOLUTION	In organisms with complex plastids acquired by secondary endosymbiosis from a photosynthetic eukaryote, the majority of plastid proteins are nuclear-encoded, translated on cytoplasmic ribosomes, and guided across four membranes by a bipartite targeting sequence. In-depth understanding of this vital import process has been impeded by a lack of information about the transit peptide part of this sequence, which mediates transport across the inner three membranes. We determined the mature N-termini of hundreds of proteins from the model diatom Thalassiosira pseudonana, revealing extensive N-terminal modification by acetylation and proteolytic processing in both cytosol and plastid. We identified 63 mature N-termini of nucleus-encoded plastid proteins, deduced their complete transit peptide sequences, determined a consensus motif for their cleavage by the stromal processing peptidase, and found evidence for subsequent processing by a plastid methionine aminopeptidase. The cleavage motif differs from that of higher plants, but is shared with other eukaryotes with complex plastids.	[Huesgen, Pitter F.; Lange, Philipp F.; Schroder, Wolfgang P.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Huesgen, Pitter F.; Lange, Philipp F.; Schroder, Wolfgang P.; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Huesgen, Pitter F.; Lange, Philipp F.; Foster, Leonard J.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Alami, Meriem; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Schroder, Wolfgang P.] Umea Univ, Dept Chem, Umea, Sweden; [Schroder, Wolfgang P.] Umea Univ, Umea Plant Sci Ctr, Umea, Sweden	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Umea University; Umea University	Green, BR (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	brgreen@mail.ubc.ca	Huesgen, Pitter/E-9246-2019; Green, Beverley R./AAJ-5199-2021; Lange, Philipp F/E-5752-2011; Lange, Philipp F/AAB-9073-2020	Huesgen, Pitter/0000-0002-0335-2242; Green, Beverley R./0000-0002-4021-9387; Lange, Philipp F/0000-0003-1171-5864; Lange, Philipp F/0000-0003-1171-5864; Schroder, Wolfgang/0000-0001-9831-1533	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; German Academic Exchange Service (DAAD); Michael Smith Foundation for Health Research (MSFHR); MSFHR; Breast Cancer Society of Canada; Alexander von Humboldt Foundation; German Federal Ministry of Education and Research; Wenner Gren Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Breast Cancer Society of Canada; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Wenner Gren Foundation	The experimental research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (BRG, LJF), the Canadian Institutes of Health Research (CMO), an Infrastructure Grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research) and by the British Columbia Proteomics Network. PFH was supported by postdoctoral fellowships of the German Academic Exchange Service (DAAD) and the Michael Smith Foundation for Health Research (MSFHR). PFL acknowledged support by the MSFHR, the Breast Cancer Society of Canada, the Alexander von Humboldt Foundation and the German Federal Ministry of Education and Research. CMO is a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology and LJF is a Canada Research Chair in Quantitative Proteomics. WPS acknowledges the Wenner Gren Foundation for the support of a sabbatical research visit at the University of British Columbia, Vancouver, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2011, PLANT CELL, V23, P3745, DOI 10.1105/tpc.111.087239; Apel W, 2010, PLANT J, V63, P636, DOI 10.1111/j.1365-313X.2010.04268.x; Apt KE, 2002, J CELL SCI, V115, P4061, DOI 10.1242/jcs.00092; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Bienvenut WV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015131; Bienvenut WV, 2011, PROTEOMICS, V11, P1734, DOI 10.1002/pmic.201000634; Bolte K, 2009, J EUKARYOT MICROBIOL, V56, P9, DOI 10.1111/j.1550-7408.2008.00370.x; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Chaal BK, 2005, PLANT MOL BIOL, V57, P333, DOI 10.1007/s11103-004-7848-y; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Felsner G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-223; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; Green BR, 2011, PHOTOSYNTH RES, V107, P103, DOI 10.1007/s11120-010-9584-2; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; Hirakawa Y, 2010, PLANT J, V64, P402, DOI 10.1111/j.1365-313X.2010.04334.x; Huesgen PF, 2012, PHYSIOL PLANTARUM, V145, P5, DOI 10.1111/j.1399-3054.2011.01536.x; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lange PF, 2013, CURR OPIN CHEM BIOL, V17, P73, DOI 10.1016/j.cbpa.2012.11.025; Lange PF, 2011, NAT METHODS, V8, P703, DOI 10.1038/nmeth.1669; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Meinnel T, 2008, PROTEOMICS, V8, P626, DOI 10.1002/pmic.200700592; Moog D, 2011, GENOME BIOL EVOL, V3, P375, DOI 10.1093/gbe/evr031; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Patron NJ, 2007, BIOESSAYS, V29, P1048, DOI 10.1002/bies.20638; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Richter S, 2005, PHYSIOL PLANTARUM, V123, P362, DOI 10.1111/j.1399-3054.2005.00476.x; Sheiner L, 2013, BBA-MOL CELL RES, V1833, P352, DOI 10.1016/j.bbamcr.2012.05.030; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	45	30	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74483	10.1371/journal.pone.0074483	http://dx.doi.org/10.1371/journal.pone.0074483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066144	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000126
J	Joosten, SA; Fletcher, HA; Ottenhoff, THM				Joosten, Simone A.; Fletcher, Helen A.; Ottenhoff, Tom H. M.			A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis	PLOS ONE			English	Article							IMMUNE-RESPONSE; BCG VACCINATION; CELL FREQUENCY; MYELOID CELLS; B-CELLS; TUBERCULOSIS; INFECTION; DIAGNOSIS; METALLOPROTEINASES; INFLAMMATION	Biomarker host genetic signatures are considered key tools for improved early diagnosis of tuberculosis (TB) disease (development). The analysis of gene expression changes based on a limited number of genes or single study designs, however, may not be sufficient for the identification of universal diagnostic biomarker profiles. Here we propose that biological pathway and process based analyses from multiple data sets may be more relevant for identification of key pathways in TB pathogenesis, and may reveal novel candidate diagnostic TB biomarkers. A number of independent genome-wide gene expression studies have recently been performed to study expression of biomarkers for TB disease. We have integrated the results from these independent studies and performed pathway- as well as biological process-based analysis on the total data set. Interestingly, IFN alpha/beta signalling is not the single dominant pathway in the analysis of the total dataset, but combined, functional, analysis of biomarkers suggests a strong dominant role for myeloid cell involvement in inflammation.	[Joosten, Simone A.; Ottenhoff, Tom H. M.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Fletcher, Helen A.] Univ Oxford, Jenner Inst, Oxford, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Jenner Institute	Joosten, SA (corresponding author), Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands.	sajoosten@lumc.nl	Joosten, Simone A/F-1357-2011; Joosten, Simone/E-4731-2011	Joosten, Simone A/0000-0002-9878-0863; Fletcher, Helen/0000-0002-0435-1006	European Commission [LSHP-CT-2003-503367, HEALTH F3-2009-241745, HEALTH.2011.1.4-4 280873]; Netherlands Organization for Scientific Research (VENI grant) [916.86.115]; Gisela Thier foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (VENI grant)(Netherlands Organization for Scientific Research (NWO)); Gisela Thier foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation	The authors acknowledge European Commission Framework Programme 6 TBVAC contract no. LSHP-CT-2003-503367, European Commission Framework Programme 7 NEWTBVAC contract no. HEALTH F3-2009-241745 and European Commission Framework Programme 7 ADITEC contract no. HEALTH.2011.1.4-4 280873 (the text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), The Netherlands Organization for Scientific Research (VENI grant 916.86.115), the Gisela Thier foundation of the Leiden University Medical Center and the Netherlands Leprosy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Britten CM, 2012, IMMUNITY, V37, P1, DOI 10.1016/j.immuni.2012.07.010; Chan MC, 2007, RESPIROLOGY, V12, P333, DOI 10.1111/j.1440-1843.2007.01056.x; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Dai Guixiang, 1998, Frontiers in Bioscience, V3, pE110; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Dockrell HM, 2012, EXPERT REV VACCINES, V11, P121, DOI [10.1586/erv.11.186, 10.1586/ERV.11.186]; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Geijtenbeek TBH, 2013, NAT IMMUNOL, V14, P309, DOI 10.1038/ni.2574; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Maurice J, 2011, LANCET, V378, P1209, DOI 10.1016/S0140-6736(11)61527-4; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Piccaluga PP, 2007, CANCER RES, V67, P10703, DOI 10.1158/0008-5472.CAN-07-1708; Porcel JM, 2009, EUR RESPIR J, V34, P1383, DOI 10.1183/09031936.00197208; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Richeldi L, 2004, EUR RESPIR J, V24, P247, DOI 10.1183/09031936.04.00014204; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Smith SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007972; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Tintinger GR, 2012, EUR J CLIN MICROBIOL, V31, P73, DOI 10.1007/s10096-011-1278-y; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; *WHO, 2004, GLOB TUB CONTR; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; World Health Organization, 2011, COLL FRAM CAR CONTR	56	73	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73230	10.1371/journal.pone.0073230	http://dx.doi.org/10.1371/journal.pone.0073230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066041	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324494000022
J	Kiiru, J; Mutreja, A; Mohamed, AA; Kimani, RW; Mwituria, J; Sanaya, RO; Muyodi, J; Revathi, G; Parkhill, J; Thomson, N; Dougan, G; Kariuki, S				Kiiru, John; Mutreja, Ankur; Mohamed, Ahmed Abade; Kimani, Racheal W.; Mwituria, Joyce; Sanaya, Robert Onsare; Muyodi, Jane; Revathi, Gunturu; Parkhill, Julian; Thomson, Nicholas; Dougan, Gordon; Kariuki, Samuel			A Study on the Geophylogeny of Clinical and Environmental Vibrio cholerae in Kenya	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; WESTERN KENYA; O1; TRANSMISSION; EPIDEMIC; OUTBREAKS; EVOLUTION; SEQUENCES; SPREAD	Cholera remains a significant public health challenge in many sub-Saharan countries including Kenya. We have performed a combination of phylogenetic and phenotypic analysis based on whole genome DNA sequences derived from 40 environmental and 57 clinical V. cholerae from different regions of Kenya isolated between 2005 and 2010. Some environmental and all clinical isolates mapped back onto wave three of the monophyletic seventh pandemic V. cholerae El Tor phylogeny but other environmental isolates were phylogenetically very distinct. Thus, the genomes of the Kenyan V. cholerae O1 El Tor isolates are clonally related to other El Tor V. cholerae isolated elsewhere in the world and similarly harbour antibiotic resistance-associated STX elements. Further, the Kenyan O1 El Tor isolates fall into two distinct clades that may have entered Kenya independently.	[Kiiru, John; Kimani, Racheal W.; Mwituria, Joyce; Sanaya, Robert Onsare; Muyodi, Jane; Kariuki, Samuel] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Revathi, Gunturu] Aga Khan Univ Hosp, Dept Pathol, Div Microbiol, Nairobi, Kenya; [Mohamed, Ahmed Abade] Ctr Dis Control & Prevent, Nairobi, Kenya; [Mutreja, Ankur; Parkhill, Julian; Thomson, Nicholas; Dougan, Gordon; Kariuki, Samuel] Wellcome Trust Sanger Inst, Cambridge, England	Kenya Medical Research Institute; Wellcome Trust Sanger Institute	Kariuki, S (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.	skariuki@kemri.org	Parkhill, Julian/G-4703-2011; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Thomson, Nicholas/0000-0002-4432-8505; KIMANI, RACHEAL/0000-0002-1614-4637	Wellcome Trust [098051]; UBS-Optimus Grant [70:493]	Wellcome Trust(Wellcome TrustEuropean Commission); UBS-Optimus Grant	This work was supported by The Wellcome Trust grant 098051 and UBS-Optimus Grant 70:493. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Constantin de Magny Guillaume, 2009, Trans Am Clin Climatol Assoc, V120, P119; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hashizume M, 2010, EPIDEMIOLOGY, V21, P706, DOI 10.1097/EDE.0b013e3181e5b053; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; HUQ A, 2006, CURRENT PROTOCOLS MI, pCH6; Kendall EA, 2010, J BACTERIOL, V192, P4367, DOI 10.1128/JB.00698-10; Kiiru JN, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-275; Mohamed AA, 2012, EMERG INFECT DIS, V18, P925, DOI 10.3201/eid1806.111774; Mugoya I, 2008, AM J TROP MED HYG, V78, P527, DOI 10.4269/ajtmh.2008.78.527; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Mwansa JCL, 2007, EPIDEMIOL INFECT, V135, P847, DOI 10.1017/S0950268806007254; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Rashed SM, 2012, J MED MICROBIOL, V61, P1736, DOI 10.1099/jmm.0.049635-0; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Scrascia M, 2006, J CLIN MICROBIOL, V44, P3401, DOI 10.1128/JCM.00611-06; Scrascia M, 2009, INT J MED MICROBIOL, V299, P367, DOI 10.1016/j.ijmm.2008.10.004; Scrascia M, 2009, INT J MED MICROBIOL, V299, P203, DOI 10.1016/j.ijmm.2008.07.003; Shapiro RL, 1999, AM J TROP MED HYG, V60, P271, DOI 10.4269/ajtmh.1999.60.271; Shikanga OT, 2009, AM J TROP MED HYG, V81, P1085, DOI 10.4269/ajtmh.2009.09-0400; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAUXE RV, 1995, EMERG INFECT DIS, V1, P141, DOI 10.3201/eid0104.950408; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74829	10.1371/journal.pone.0074829	http://dx.doi.org/10.1371/journal.pone.0074829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066154	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000136
J	Ono, M; Cheng, Y; Kimura, H; Watanabe, H; Matsumura, K; Yoshimura, M; Iikuni, S; Okamoto, Y; Ihara, M; Takahashi, R; Saji, H				Ono, Masahiro; Cheng, Yan; Kimura, Hiroyuki; Watanabe, Hiroyuki; Matsumura, Kenji; Yoshimura, Masashi; Iikuni, Shimpei; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Saji, Hideo			Development of Novel I-123-Labeled Pyridyl Benzofuran Derivatives for SPECT Imaging of beta-Amyloid Plaques in Alzheimer's Disease	PLOS ONE			English	Article							BRAINS; PROBES; AGENTS; BIODISTRIBUTION; RADIOLIGAND; DOSIMETRY; DIAGNOSIS; MODEL; IMPY	Imaging of beta-amyloid (A beta) plaques in the brain may facilitate the diagnosis of cerebral beta-amyloidosis, risk prediction of Alzheimer's disease (AD), and effectiveness of anti-amyloid therapies. The purpose of this study was to evaluate novel I-123-labeled pyridyl benzofuran derivatives as SPECT probes for A beta imaging. The formation of a pyridyl benzofuran backbone was accomplished by Suzuki coupling. [I-123/I-125]-labeled pyridyl benzofuran derivatives were readily prepared by an iododestannylation reaction. In vitro A beta binding assays were carried out using A beta(1-42) aggregates and postmortem human brain sections. Biodistribution experiments were conducted in normal mice at 2, 10, 30, and 60 min postinjection. A beta labeling in vivo was evaluated by small-animal SPECT/CT in Tg2576 transgenic mice injected with [I-123]8. Ex vivo autoradiography of the brain sections was performed after SPECT/CT. Iodinated pyridyl benzofuran derivatives showed excellent affinity for A beta(1-42) aggregates (2.4 to 10.3 nM) and intensely labeled A beta plaques in autoradiographs of postmortem AD brain sections. In biodistribution experiments using normal mice, all these derivatives displayed high initial uptake (4.03-5.49% ID/g at 10 min). [I-125]8 displayed the quickest clearance from the brain (1.30% ID/g at 60 min). SPECT/CT with [I-123]8 revealed higher uptake of radioactivity in the Tg2576 mouse brain than the wild-type mouse brain. Ex vivo autoradiography showed in vivo binding of [I-123]8 to Ab plaques in the Tg2576 mouse brain. These combined results warrant further investigation of [I-123]8 as a SPECT imaging agent for visualizing A beta plaques in the AD brain.	[Ono, Masahiro; Cheng, Yan; Kimura, Hiroyuki; Watanabe, Hiroyuki; Matsumura, Kenji; Yoshimura, Masashi; Iikuni, Shimpei; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Kyoto, Japan; [Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurosci, Kyoto, Japan	Kyoto University; Kyoto University	Ono, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Kyoto, Japan.	ono@pharm.kyoto-u.ac.jp	Ihara, Masafumi/O-5020-2019; IIKUNI, Shimpei/AAU-7810-2020	Ihara, Masafumi/0000-0002-7102-4048; IIKUNI, Shimpei/0000-0002-7073-9084	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research is granted by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program),'' initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheng Y, 2012, J MED CHEM, V55, P2279, DOI 10.1021/jm201513c; Cheng Y, 2010, ACS MED CHEM LETT, V1, P321, DOI 10.1021/ml100082x; Cheng Y, 2010, BIOORG MED CHEM LETT, V20, P6141, DOI 10.1016/j.bmcl.2010.08.016; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Cselenyi Z, 2012, J NUCL MED, V53, P415, DOI 10.2967/jnumed.111.094029; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klunk WE, 1998, NEUROBIOL AGING, V19, P145, DOI 10.1016/S0197-4580(98)00013-X; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; Kung MP, 2004, EUR J NUCL MED MOL I, V31, P1136, DOI 10.1007/s00259-004-1487-z; Kung MP, 2002, BRAIN RES, V956, P202, DOI 10.1016/S0006-8993(02)03436-4; Lin KJ, 2010, NUCL MED BIOL, V37, P497, DOI 10.1016/j.nucmedbio.2010.02.003; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Mathis CA, 2004, CURR PHARM DESIGN, V10, P1469, DOI 10.2174/1381612043384772; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Newberg AB, 2006, J NUCL MED, V47, P748; Nordberg A, 2004, LANCET NEUROL, V3, P519, DOI 10.1016/S1474-4422(04)00853-1; Ono M, 2002, NUCL MED BIOL, V29, P633, DOI 10.1016/S0969-8051(02)00326-8; Ono M, 2008, BIOORGAN MED CHEM, V16, P6867, DOI 10.1016/j.bmc.2008.05.054; Ono Masahiro, 2011, Int J Mol Imaging, V2011, P543267, DOI 10.1155/2011/543267; Ono M, 2012, J PHARMACOL SCI, V118, P338, DOI 10.1254/jphs.11R08FM; Ono M, 2011, J MED CHEM, V54, P2971, DOI 10.1021/jm200057u; Ono M, 2009, CHEM PHARM BULL, V57, P1029, DOI 10.1248/cpb.57.1029; Poisnel G, 2012, NEUROBIOL AGING, V33, P2561, DOI 10.1016/j.neurobiolaging.2011.12.024; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Snellman A, 2012, EUR J NUCL MED MOL I, V39, P1784, DOI 10.1007/s00259-012-2178-9; Toyama H, 2005, EUR J NUCL MED MOL I, V32, P593, DOI 10.1007/s00259-005-1780-5; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Zhang W, 2007, NUCL MED BIOL, V34, P89, DOI 10.1016/j.nucmedbio.2006.10.003	33	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74104	10.1371/journal.pone.0074104	http://dx.doi.org/10.1371/journal.pone.0074104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058519	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400051
J	Portella, L; Vitale, R; De Luca, S; D'Alterio, C; Ierano, C; Napolitano, M; Riccio, A; Polimeno, MN; Monfregola, L; Barbieri, A; Luciano, A; Ciarmiello, A; Arra, C; Castello, G; Amodeo, P; Scala, S				Portella, Luigi; Vitale, Rosamaria; De Luca, Stefania; D'Alterio, Crescenzo; Ierano, Caterina; Napolitano, Maria; Riccio, Anna; Polimeno, Maria Neve; Monfregola, Luca; Barbieri, Antonio; Luciano, Antonio; Ciarmiello, Andrea; Arra, Claudio; Castello, Giuseppe; Amodeo, Pietro; Scala, Stefania			Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; INHIBITION; MOBILIZATION; MIGRATION; AMD3100; LIGAND; CELLS; STEM; IDENTIFICATION; EXPRESSION	The CXCR4/CXCL12 axis plays a role in cancer metastases, stem cell mobilization and chemosensitization. Proof of concept for efficient CXCR4 inhibition has been demonstrated in stem cell mobilization prior to autologous transplantation in hematological malignancies. Nevertheless CXCR4 inhibitors suitable for prolonged use as required for anticancer therapy are not available. To develop new CXCR4 antagonists a rational, ligand-based approach was taken, distinct from the more commonly used development strategy. A three amino acid motif (Ar-Ar-X) in CXCL12, also found in the reverse orientation (X-Ar-Ar) in the vMIP-II inhibitory chemokine formed the core of nineteen cyclic peptides evaluated for inhibition of CXCR4-dependent migration, binding, P-ERK1/2-induction and calcium efflux. Peptides R, S and I were chosen for evaluation in in vivo models of lung metastases (B16-CXCR4 and KTM2 murine osteosarcoma cells) and growth of a renal cells xenograft. Peptides R, S, and T significantly reduced the association of the 12G5-CXCR4 antibody to the receptor and inhibited CXCL12-induced calcium efflux. The four peptides efficiently inhibited CXCL12-dependent migration at concentrations as low as 10 nM and delayed CXCL12-mediated wound healing in PES43 human melanoma cells. Intraperitoneal treatment with peptides R, I or S drastically reduced the number of B16-CXCR4-derived lung metastases in C57/BL mice. KTM2 osteosarcoma lung metastases were also reduced in Balb/C mice following CXCR4 inhibition. All three peptides significantly inhibited subcutaneous growth of SN12C-EGFP renal cancer cells. A novel class of CXCR4 inhibitory peptides was discovered. Three peptides, R, I and S inhibited lung metastases and primary tumor growth and will be evaluated as anticancer agents.	[Portella, Luigi; D'Alterio, Crescenzo; Ierano, Caterina; Napolitano, Maria; Riccio, Anna; Polimeno, Maria Neve; Scala, Stefania] Fdn Giovanni Pascale IRCCS Italia, Ist Nazl Studio & Cura Tumori, Dept Oncol Immunol, Naples, Italy; [Barbieri, Antonio; Luciano, Antonio; Arra, Claudio] Fdn Giovanni Pascale IRCCS Italia, Ist Nazl Studio & Cura Tumori, Anim Facil, Naples, Italy; [Vitale, Rosamaria; Amodeo, Pietro] CNR, ICB CNR, Pozzuoli, Italy; [De Luca, Stefania; Monfregola, Luca] CNR, IBB CNR, I-80125 Naples, Italy; [Castello, Giuseppe] CROM, Mercogliano, AV, Italy; [Ciarmiello, Andrea] Azienda Sanit Locale 5 Spezzino, La Spezia, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Scala, S (corresponding author), Fdn Giovanni Pascale IRCCS Italia, Ist Nazl Studio & Cura Tumori, Dept Oncol Immunol, Naples, Italy.	scalaste@unina.it	Ieranò, Caterina/K-1676-2016; Scala, Stefania/K-1380-2016; Barbieri, Antonio/AAG-8961-2019; Vitale, Rosa Maria/AAY-1522-2020; Riccio, Anna/HHC-2105-2022; Portella, Luigi/AAA-6967-2019; D'Alterio, Crescenzo/AAB-9098-2019; Amodeo, Pietro/P-1800-2015; napolitano, maria/K-1615-2016	Ieranò, Caterina/0000-0003-3138-1873; Scala, Stefania/0000-0001-9524-2616; Barbieri, Antonio/0000-0002-7788-6167; Vitale, Rosa Maria/0000-0001-9243-1307; Riccio, Anna/0000-0002-1140-1366; Portella, Luigi/0000-0002-8679-3309; D'Alterio, Crescenzo/0000-0003-0275-3367; Amodeo, Pietro/0000-0002-6439-7575; napolitano, maria/0000-0002-8996-3297; Ciarmiello, Andrea/0000-0002-6579-656X; Luciano, Antonio/0000-0003-0183-6574; DE LUCA, STEFANIA/0000-0002-7078-1696; Arra, Claudio/0000-0003-3162-2091; Castello, Giuseppe/0000-0002-0924-6248	Alleanza Contro il Cancro [ACC9]; Associazione Italiana per la Ricerca sul Cancro [IG 13192]; FIRB [RBAP11884M-008]	Alleanza Contro il Cancro; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by Alleanza Contro il Cancro (ACC9), Associazione Italiana per la Ricerca sul Cancro IG 13192, and FIRB RBAP11884M-008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham M, 2007, STEM CELLS, V25, P2158, DOI 10.1634/stemcells.2007-0161; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Amodeo P, 2010, [Italian patent, international patent], Patent No. [MI2010A 000093, WO2011/092575 A., 2010000093]; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Beider K, 2011, EXP HEMATOL, V39, P282, DOI 10.1016/j.exphem.2010.11.010; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Booth V, 2003, J MOL BIOL, V327, P329, DOI 10.1016/S0022-2836(03)00094-9; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Crump MP, 2001, FEBS LETT, V489, P171, DOI 10.1016/S0014-5793(00)02393-0; D'Alterio C, 2012, CANCER IMMUNOL IMMUN, V61, P1713, DOI 10.1007/s00262-012-1223-7; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P302, DOI 10.1073/pnas.1016917108; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Kwong J, 2009, MOL CANCER THER, V8, P1893, DOI 10.1158/1535-7163.MCT-08-0966; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; MASUDA M, 1992, BIOCHEM BIOPH RES CO, V189, P845, DOI 10.1016/0006-291X(92)92280-B; Mori T, 2004, MOL CANCER THER, V3, P29; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2002, CANCER RES, V62, P7328; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Rao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033005; Rettig MP, 2012, LEUKEMIA, V26, P34, DOI 10.1038/leu.2011.197; Richert MM, 2009, ONCOL REP, V21, P761, DOI 10.3892/or_00000282; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Scotton CJ, 2002, CANCER RES, V62, P5930; Shan LX, 2000, BIOCHEM BIOPH RES CO, V268, P938, DOI 10.1006/bbrc.2000.2235; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Tavor S, 2010, SEMIN CANCER BIOL, V20, P178, DOI 10.1016/j.semcancer.2010.07.001; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vose JM, 2009, LEUKEMIA LYMPHOMA, V50, P1412, DOI 10.1080/10428190903096701; Wu XS, 2009, CURR PHARM DESIGN, V15, P742, DOI 10.2174/138161209787582165; Xu L, 2009, CANCER RES, V69, P7905, DOI 10.1158/0008-5472.CAN-09-2099; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	48	61	65	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74548	10.1371/journal.pone.0074548	http://dx.doi.org/10.1371/journal.pone.0074548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058588	Green Published, Green Submitted, gold			2022-12-27	WOS:000324408400084
J	Fukuhara, S; Wakita, T; Yamada, M; Hiratsuka, Y; Green, J; Oki, K				Fukuhara, Shunichi; Wakita, Takafumi; Yamada, Masakazu; Hiratsuka, Yoshimune; Green, Joseph; Oki, Kotaro			Development of a Short Version of the Visual Function Questionnaire Using Item-Response Theory	PLOS ONE			English	Article							QUALITY-OF-LIFE; CLINICAL DIAGNOSTIC-TESTS; ASSOCIATION; NEI-VFQ-25	Purpose: In clinical ophthalmology as in other fields, measuring patient-reported outcomes imposes a burden on patients. To decrease that burden, we used item-response theory (IRT) to develop and test a short version of the National Eye Institute's Visual Function Questionnaire (VFQ). Methods: We analyzed VFQ data from 276 adults in Japan. Most of them had glaucoma, cataract, or macular degeneration. Their visual acuity (Snellen fraction) averaged 20/120 (range: 20/13 to 20/2000) for the better eye, and 20/200 (range: 20/13 to 20/2000) for the worse eye. We used a polytomous IRT model, the Generalized Partial Credit Model as implemented in software for parameter scaling of rating data (PARSCALE). To select items for inclusion in the short version we examined each item's location on the latent-trait continuum, its slope, and its frequency of missing data. We also ensured representation of all 7 domains that are important in Japan. To examine the characteristics of the resulting scale, we computed its test information (an index of precision that can vary with the value of the latent trait), and carried out validation testing. Results: From 32 of the original VFQ items, we selected 11. The scale comprising those 11 items (the VFQ-J11) had test information greater than 9 for values of the latent trait between -2.0 and +0.8. The item thresholds were well-targeted for patients with vision problems. Scores on the VFQ-J11 correlated strongly and in the expected direction with measures of visual field and corrected visual acuity. As expected for a valid measure, those scores also improved by a large amount (almost one standard deviation) after cataract surgery. Conclusion: This 11-item instrument can provide reliable and the valid data on visual functioning in patients with ophthalmic problems. It is expected to be less of a burden on respondents, while it maintains good psychometric properties.	[Fukuhara, Shunichi] Kyoto Univ, Dept Epidemiol & Healthcare Res, Grad Sch Med, Kyoto, Japan; [Fukuhara, Shunichi] Kyoto Univ, Fac Med, Kyoto, Japan; [Fukuhara, Shunichi; Green, Joseph; Oki, Kotaro] iHope Int, Kyoto, Japan; [Fukuhara, Shunichi; Green, Joseph; Oki, Kotaro] iHope Int, Tokyo, Japan; [Wakita, Takafumi] Kansai Univ, Fac Sociol, Osaka, Japan; [Yamada, Masakazu] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Vis Res, Tokyo, Japan; [Hiratsuka, Yoshimune] Juntendo Univ, Dept Ophthalmol, Tokyo, Japan; [Green, Joseph] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Green, Joseph] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Oki, Kotaro] Oki Eye Surg Ctr, Tokyo, Japan	Kyoto University; Kyoto University; Kansai University; Juntendo University; University of Tokyo; University of Tokyo	Fukuhara, S (corresponding author), Kyoto Univ, Dept Epidemiol & Healthcare Res, Grad Sch Med, Kyoto, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp		Wakita, Takafumi/0000-0003-2293-5918				Cohen J.E., 1988, STAT POWER ANAL BEHA; Embretson S. E., 2013, ITEM RESPONSE THEORY; Japanese EuroQol Translation Team, 1998, J HLTH CARE SOC, V8, P109, DOI DOI 10.4091/IKEN1991.8.1_109]; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; Mizuno Y, 2010, JPN J OPHTHALMOL, V54, P259, DOI 10.1007/s10384-010-0812-2; MURAKI E, 1992, APPL PSYCH MEAS, V16, P159, DOI 10.1177/014662169201600206; Muraki E, 2003, PARSCALE PARAMETER S; Nichols KK, 2002, ADV EXP MED BIOL, V506, P1177; Nichols KK, 2002, CORNEA, V21, P578, DOI 10.1097/00003226-200208000-00009; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2009, AM J OPHTHALMOL, V147, P869, DOI 10.1016/j.ajo.2008.11.018; Oshika Tetsuro, 2005, Nippon Ganka Gakkai Zasshi, V109, P753; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; Tatematsu-Ogawa Y, 2008, EYE CONTACT LENS, V34, P13, DOI 10.1097/ICL.0b013e3180515282; Varma R, 2006, OPHTHALMOLOGY, V113, P1846, DOI 10.1016/j.ophtha.2006.04.028; Vitale Susan, 2004, Health Qual Life Outcomes, V2, P44, DOI 10.1186/1477-7525-2-44; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yamada M, 2009, JPN J OPHTHALMOL, V53, P470, DOI 10.1007/s10384-009-0709-0	22	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73084	10.1371/journal.pone.0073084	http://dx.doi.org/10.1371/journal.pone.0073084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069172	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100029
J	Lee, IT; Lin, CC; Cheng, SE; Hsiao, LD; Hsiao, YC; Yang, CM				Lee, I-Ta; Lin, Chih-Chung; Cheng, Shin-Ei; Hsiao, Li-Der; Hsiao, Yu-Chun; Yang, Chuen-Mao			RETRACTED: TNF-alpha Induces Cytosolic Phospholipase A(2) Expression in Human Lung Epithelial Cells via JNK1/2-and p38 MAPK-Dependent AP-1 Activation (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; CYCLOOXYGENASE-2 EXPRESSION; AIRWAY INFLAMMATION; ARACHIDONIC-ACID; PATHWAYS; KINASE; INDUCTION; P300; HYPERRESPONSIVENESS	Background: Cytosolic phospholipase A(2) (cPLA(2)) plays a pivotal role in mediating agonist-induced arachidonic acid (AA) release for prostaglandin (PG) synthesis during inflammation triggered by tumor necrosis factor-alpha (TNF-alpha). However, the mechanisms underlying TNF-alpha-induced cPLA2 expression in human lung epithelial cells (HPAEpiCs) were not completely understood. Principal Findings: We demonstrated that TNF-a induced cPLA2 mRNA and protein expression, promoter activity, and PGE(2) secretion in HPAEpiCs. These responses induced by TNF-a were inhibited by pretreatment with the inhibitor of MEK1/2 (PD98059), p38 MAPK (SB202190), JNK1/2 (SP600125), or AP-1 (Tanshinone IIA) and transfection with siRNA of TNFR1, p42, p38, JNK2, c-Jun, c-Fos, or ATF2. We showed that TNF-alpha markedly stimulated p42/p44 MAPK, p38 MAPK, and JNK1/2 phosphorylation which were attenuated by their respective inhibitors. In addition, TNF-alpha also stimulated c-Jun and ATF2 phosphorylation which were inhibited by pretreatment with SP600125 and SB202190, respectively, but not PD98059. Furthermore, TNF-alpha-induced cPLA2 promoter activity was abrogated by transfection with the point-mutated AP-1 cPLA2 construct. Finally, we showed that TNF-alpha time-dependently induced p300/c-Fos/c-Jun/ATF2 complex formation in HPAEpiCs. On the other hand, TNF-alpha induced in vivo binding of c-Jun, c-Fos, ATF2, and p300 to the cPLA2 promoter in these cells. In an in vivo study, we found that TNF-alpha induced leukocyte count in BAL fluid of mice and cPLA2 mRNA levels in lung tissues via MAPKs and AP-1. Significance: Taken together, these results demonstrated that TNF-alpha-induced cPLA2 expression was mediated through p38 MAPK-and JNK1/2-dependent p300/c-Fos/c-Jun/ATF2 complex formation in HPAEpiCs.	[Lee, I-Ta; Lin, Chih-Chung] Chang Gung Mem Hosp, Dept Anesthet, Linkou, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lee, I-Ta; Cheng, Shin-Ei; Hsiao, Li-Der; Hsiao, Yu-Chun; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Lee, I-Ta; Cheng, Shin-Ei; Hsiao, Li-Der; Hsiao, Yu-Chun; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan.	chuenmao@mail.cgu.edu.tw			Ministry of Education, Taiwan [EMRPD1C0261, EMRPD1C0271]; National Science Council, Taiwan [NSC101-2321-B-182-013, NSC101-2320-B-182-039-MY3, NSC99-2321-B182-003, NSC98-2320-B-255-001-MY3]; Chang Gung Medical Research Foundation [CMRPD180373, CMRPD1B0381, CMRPG391033, CMRPG3B1091]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Foundation	This work was supported by the Ministry of Education, Taiwan, grant numbers EMRPD1C0261 and EMRPD1C0271; National Science Council, Taiwan, grant numbers NSC101-2321-B-182-013, NSC101-2320-B-182-039-MY3, NSC99-2321-B182-003, and NSC98-2320-B-255-001-MY3; and Chang Gung Medical Research Foundation, grant numbers CMRPD180373, CMRPD1B0381, CMRPG391033, and CMRPG3B1091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Byeon HE, 2012, LIFE SCI, V90, P396, DOI 10.1016/j.lfs.2011.12.017; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Cheng SE, 2009, FREE RADICAL BIO MED, V46, P948, DOI 10.1016/j.freeradbiomed.2009.01.006; Chi PL, 2012, ARTHRITIS RHEUM-US, V64, P2114, DOI 10.1002/art.34371; Choi IW, 2005, J ALLERGY CLIN IMMUN, V116, P537, DOI 10.1016/j.jaci.2005.05.034; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Dieter P, 2002, CELL SIGNAL, V14, P199, DOI 10.1016/S0898-6568(01)00243-1; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; Goodman RH, 2000, GENE DEV, V14, P1553; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Hsieh HL, 2006, J CELL PHYSIOL, V206, P246, DOI 10.1002/jcp.20457; HULKOWER KI, 1994, ARTHRITIS RHEUM-US, V37, P653, DOI 10.1002/art.1780370508; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Joo M, 2007, AM J PHYSIOL-LUNG C, V292, pL1219, DOI 10.1152/ajplung.00474.2006; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee CW, 2011, J CELL PHYSIOL, V226, P2103, DOI 10.1002/jcp.22537; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lee SH, 2010, ONCOGENE, V29, P5182, DOI 10.1038/onc.2010.251; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lin CC, 2004, CELL SIGNAL, V16, P597, DOI 10.1016/j.cellsig.2003.10.002; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Luo SF, 2006, CELL SIGNAL, V18, P1201, DOI 10.1016/j.cellsig.2005.09.011; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Pascual RM, 2006, AM J PHYSIOL-LUNG C, V290, pL501, DOI 10.1152/ajplung.00420.2005; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Van Putten V, 2001, J BIOL CHEM, V276, P1226, DOI 10.1074/jbc.M003581200; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Wang YN, 2006, MOL PHARMACOL, V69, P85, DOI 10.1124/mol.105.016220; Yang CM, 2002, CELL SIGNAL, V14, P899, DOI 10.1016/S0898-6568(02)00037-2	42	29	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e72783	10.1371/journal.pone.0072783	http://dx.doi.org/10.1371/journal.pone.0072783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069158	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300007
J	Glass, TJ; Hui, SK; Blazar, BR; Lund, TC				Glass, Tiffany J.; Hui, Susanta K.; Blazar, Bruce R.; Lund, Troy C.			Effect of Radiation Dose-Rate on Hematopoietic Cell Engraftment in Adult Zebrafish	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; INDUCED DNA-DAMAGE; GENE-EXPRESSION; IN-VIVO; CHEMOKINE RECEPTOR; IONIZING-RADIATION; ENDOTHELIAL-CELLS; STEM-CELLS; THERAPY	Although exceptionally high radiation dose-rates are currently attaining clinical feasibility, there have been relatively few studies reporting the biological consequences of these dose-rates in hematopoietic cell transplant (HCT). In zebrafish models of HCT, preconditioning before transplant is typically achieved through radiation alone. We report the comparison of outcomes in adult zebrafish irradiated with 20Gy at either 25 or 800 cGy/min in the context of experimental HCT. In non-transplanted irradiated fish we observed no substantial differences between dose-rate groups as assessed by fish mortality, cell death in the kidney, endogenous hematopoietic reconstitution, or gene expression levels of p53 and ddb2 (damage-specific DNA binding protein 2) in the kidney. However, following HCT, recipients conditioned with the higher dose rate showed significantly improved donor-derived engraftment at 9 days post transplant (p <= 0.0001), and improved engraftment persisted at 31 days post transplant. Analysis for sdf-1a expression, as well as transplant of hematopoietic cells from cxcr4b -/- zebrafish, (odysseus), cumulatively suggest that the sdf-1a/cxcr4b axis is not required of donor-derived cells for the observed dose-rate effect on engraftment. Overall, the adult zebrafish model of HCT indicates that exceptionally high radiation dose-rates can impact HCT outcome, and offers a new system for radiobiological and mechanistic interrogation of this phenomenon. Key words: Radiation dose rate, Total Marrow Irradiation (TMI), Total body irradiation (TBI), SDF-1, Zebrafish, hematopoietic cell transplant.	[Glass, Tiffany J.] Univ Minnesota, Sch Med, Dept Mol Cellular Dev Biol & Genet, Minneapolis, MN 55455 USA; [Hui, Susanta K.] Univ Minnesota, Sch Med, Dept Therapeut Radiol Radiat Oncol, Minneapolis, MN 55455 USA; [Blazar, Bruce R.; Lund, Troy C.] Univ Minnesota, Sch Med, Dept Pediat, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA.	lundx072@umn.edu			National Institutes of Health from the University of Minnesota [1R01CA154491]; Brainstorm translational grant from the University of Minnesota; Joseph E. Wargo cancer research fund from the University of Minnesota; NIH/NHLBI [K08 HL108998]; PHS Cancer Center Support Grant [P30 CA77398]; NATIONAL CANCER INSTITUTE [R01CA154491, R01CA077398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL108998] Funding Source: NIH RePORTER	National Institutes of Health from the University of Minnesota; Brainstorm translational grant from the University of Minnesota(University of Minnesota System); Joseph E. Wargo cancer research fund from the University of Minnesota; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health (grant #1R01CA154491), Brainstorm translational grant, Joseph E. Wargo cancer research fund from the University of Minnesota; K08 HL108998 NIH/NHLBI; PHS Cancer Center Support Grant P30 CA77398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; [Anonymous], 2011, THOMAS HEMATOPOIETIC; Bastianutto C, 2007, CANCER RES, V67, P10112, DOI 10.1158/0008-5472.CAN-07-2192; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Collis SJ, 2004, RADIAT RES, V162, P48, DOI 10.1667/RR3197; DOWN JD, 1991, BLOOD, V77, P661; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Gaugler MH, 2001, BRIT J HAEMATOL, V113, P940, DOI 10.1046/j.1365-2141.2001.02852.x; Gillette-Ferguson I, 2003, ADV SPACE RES-SERIES, V32, P1641, DOI 10.1016/S0273-1177(03)90405-4; Glass T, 2011, BLOOD; Hui SK, 2007, ACTA ONCOL, V46, P250, DOI 10.1080/02841860601042449; Hwang M, 2007, CURR GENOMICS, V8, P360, DOI 10.2174/138920207783406497; Khaled S, 2012, RADIAT RES, V177, P594, DOI 10.1667/RR2557.1; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kobayashi I, 2010, BLOOD, V115, pE1, DOI 10.1182/blood-2009-07-232322; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; LEHNERT S, 1985, BRIT J RADIOL, V58, P745, DOI 10.1259/0007-1285-58-692-745; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; McAleer MF, 2005, INT J RADIAT ONCOL, V61, P10, DOI 10.1016/j.ijrobp.2004.09.046; Nagasawa T, 2000, INT J HEMATOL, V72, P408; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pei DS, 2012, MUTAT RES; PETERS LJ, 1979, RADIOLOGY, V131, P243, DOI 10.1148/131.1.243; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Somlo G, 2011, CLIN CANCER RES, V17, P174, DOI 10.1158/1078-0432.CCR-10-1912; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Stachura DL, 2011, BLOOD, V118, P1274, DOI 10.1182/blood-2011-01-331199; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; TRAVIS EL, 1985, RADIOTHER ONCOL, V4, P341, DOI 10.1016/S0167-8140(85)80122-5; VANOS R, 1993, INT J RADIAT BIOL, V64, P761, DOI 10.1080/09553009314552011; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wong JYC, 2006, BIOL BLOOD MARROW TR, V12, P306, DOI 10.1016/j.bbmt.2005.10.026; Zeng ZQ, 2009, ZEBRAFISH, V6, P405, DOI 10.1089/zeb.2009.0611	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73745	10.1371/journal.pone.0073745	http://dx.doi.org/10.1371/journal.pone.0073745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058487	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900018
J	Jeong, IS; Aksoy, E; Fukudome, A; Akhter, S; Hiraguri, A; Fukuhara, T; Bahk, JD; Koiwa, H				Jeong, In Sil; Aksoy, Emre; Fukudome, Akihito; Akhter, Salina; Hiraguri, Akihiro; Fukuhara, Toshiyuki; Bahk, Jeong Dong; Koiwa, Hisashi			Arabidopsis C-Terminal Domain Phosphatase-Like 1 Functions in miRNA Accumulation and DNA Methylation	PLOS ONE			English	Article							RNA-BINDING PROTEIN; DOUBLE-STRANDED-RNA; GLYCOSYLASE/LYASE ROS1; ABSCISIC-ACID; SIRNA PATHWAY; DICER-LIKE; STRESS; THALIANA; HYL1; RESPONSES	Arabidopsis CTD-PHOSPHATASE-LIKE 1 (CPL1) is a protein phosphatase that can dephosphorylate RNA polymerase II C-terminal domain (CTD). Unlike typical CTD-phosphatases, CPL1 contains a double-stranded (ds) RNA-binding motif (dsRBM) and has been implicated for gene regulation mediated by dsRNA-dependent pathways. We investigated the role of CPL1 and its dsRBMs in various gene silencing pathways. Genetic interaction analyses revealed that cpl1 was able to partially suppress transcriptional gene silencing and DNA hypermethylation phenotype of ros1 suggesting CPL1 is involved in the RNA-directed DNA methylation pathway without reducing siRNA production. By contrast, cpl1 reduced some miRNA levels at the level of processing. Indeed, CPL1 protein interacted with proteins important for miRNA biogenesis, suggesting that CPL1 regulates miRNA processing. These results suggest that CPL1 regulates DNA methylation via a miRNA-dependent pathway.	[Jeong, In Sil; Akhter, Salina; Bahk, Jeong Dong] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci, Program BK21, Jinju, Gyeongsangnam D, South Korea; [Jeong, In Sil; Aksoy, Emre; Fukudome, Akihito; Koiwa, Hisashi] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Hiraguri, Akihiro; Fukuhara, Toshiyuki] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan	Gyeongsang National University; Texas A&M University System; Texas A&M University College Station; Tokyo University of Agriculture & Technology	Bahk, JD (corresponding author), Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci, Program BK21, Jinju, Gyeongsangnam D, South Korea.	jdbahk@gnu.ac.kr; koiwa@neo.tamu.edu	Hiraguri, Akihiro/O-4584-2014; Fukuhara, T./C-3208-2013; Koiwa, Hisashi/AAA-8182-2019; Koiwa, Hisashi/AAO-6512-2020; Aksoy, Emre/ABB-6969-2020; Fukudome, Akihito/X-5091-2019	Koiwa, Hisashi/0000-0002-7421-340X; Fukudome, Akihito/0000-0001-8924-1035	BK21 program of the Ministry of Education and Science Technology of Korea; National Science Foundation [MCB0950459]; USDA-CSREES [2009-34402-19831]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24570044]; Direct For Biological Sciences [0950459] Funding Source: National Science Foundation	BK21 program of the Ministry of Education and Science Technology of Korea(Ministry of Education (MOE), Republic of Korea); National Science Foundation(National Science Foundation (NSF)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the BK21 program of the Ministry of Education and Science Technology of Korea, the National Science Foundation (MCB0950459), USDA-CSREES (2009-34402-19831) "Designing Food for Health", and Grant-in-Aid for Scientific Research (number 24570044) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Aksoy E, 2013, PLANT PHYSIOL, V161, P330, DOI 10.1104/pp.112.207043; Bang WY, 2008, BIOCHEM BIOPH RES CO, V372, P907, DOI 10.1016/j.bbrc.2008.05.161; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; DOELLING JH, 1993, PLANT CELL REP, V12, P241, DOI 10.1007/BF00237127; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Gehl C, 2011, PLANT J, V67, P542, DOI 10.1111/j.1365-313X.2011.04607.x; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; He XJ, 2009, CELL, V137, P498, DOI 10.1016/j.cell.2009.04.028; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; James P, 1996, GENETICS, V144, P1425; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Koiwa H, 2002, P NATL ACAD SCI USA, V99, P10893, DOI 10.1073/pnas.112276199; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Liu QP, 2009, FUNCT INTEGR GENOMIC, V9, P277, DOI 10.1007/s10142-009-0111-5; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Milla MAR, 2006, FEBS LETT, V580, P904, DOI 10.1016/j.febslet.2006.01.013; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; SCHWARTZ BW, 1994, DEVELOPMENT, V120, P3235; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Wierzbicki AT, 2012, GENE DEV, V26, P1825, DOI 10.1101/gad.197772.112; Wu L, 2012, PLANT PHYSIOL, V160, P990, DOI 10.1104/pp.112.200279; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zhang CJ, 2013, EMBO J, V32, P1128, DOI 10.1038/emboj.2013.49; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	48	13	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74739	10.1371/journal.pone.0074739	http://dx.doi.org/10.1371/journal.pone.0074739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058624	Green Submitted, Green Published, gold			2022-12-27	WOS:000324695900078
J	Liu, P; Xue, C; Wu, TT; Heng, W; Jia, B; Ye, ZF; Liu, L; Zhu, LW				Liu, Pu; Xue, Cheng; Wu, Ting-ting; Heng, Wei; Jia, Bing; Ye, Zhenfeng; Liu, Li; Zhu, Liwu			Molecular Analysis of the Processes of Surface Brown Spot (SBS) Formation in Pear Fruit (Pyrus bretschneideri Rehd. cv. Dangshansuli) by De Novo Transcriptome Assembly	PLOS ONE			English	Article							CHLOROGENIC ACID QUINONE; PHENOLIC-COMPOUNDS; LOW-TEMPERATURE; ABSCISIC-ACID; COMMUNIS L.; QUALITY; STORAGE; DISORDERS; FLESH; POLYPHENOLOXIDASE	Browning disorder, which usually occurs post-harvest in pears subjected to long-term storage, can cause browning of the pear flesh and/or core. In 2011, investigators in China found a novel type of brown spot (designated as surface brown spot, SBS) in pre-harvest 'Dangshansuli' pears (Pyrus bretschneideri Rehd.). SBS has a large impact on the exterior quality of the pears. Interestingly, the brown coloration was only found on the peel and not the flesh or the core. In this paper, de novo transcriptome analysis of the exocarp of pears with SBS using Illumina sequencing showed that SBS up-regulated the expression of genes related to oxidative phosphorylation, phenolic compound synthesis and polyphenoloxidase (PPO), and SBS was associated with inhibition of primary and secondary metabolism genes. Ca2+-sensor proteins might be involved in the signal transduction that occurs during the process of SBS formation, and this signaling is likely to be regulated by H2O2, abscisic acid (ABA) and gibberellic acid (GA(3)). Phytohormone and mineral element analyses confirmed that GA(3), ABA, H2O2 and Ca2+ contribute to SBS formation. In addition to the seasonal characteristics, low levels of O-2 and Ca2+ in the fruit are potential causes of the browning response due to exposure to oxidative stress, oxidative-reductive imbalance and the accumulation of reactive oxygen species (ROS), which affected the membrane integrity. Disruption of the membranes allows for PPO and phenolic compounds to come into contact, and the phenolic compounds are oxidized to form the browning pigments.	[Liu, Pu; Xue, Cheng; Wu, Ting-ting; Heng, Wei; Jia, Bing; Ye, Zhenfeng; Liu, Li; Zhu, Liwu] Anhui Agr Univ, Sch Hort, Key Lab Pomol, Hefei, Peoples R China	Anhui Agricultural University	Zhu, LW (corresponding author), Anhui Agr Univ, Sch Hort, Key Lab Pomol, Hefei, Peoples R China.	zhuliwu@ahau.edu.cn		Liu, Pu/0000-0002-2624-7998	China Agriculture Research System [CARS-29-14]; Special Fund for Agro-scientific Research in the Public Interest [201203034]	China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest	The research was financially supported by China Agriculture Research System (CARS-29-14) and Special Fund for Agro-scientific Research in the Public Interest (201203034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka JP, 2013, FOOD CHEM, V138, P1289, DOI 10.1016/j.foodchem.2012.10.083; Amaki K, 2011, BIOSCI BIOTECH BIOCH, V75, P829, DOI 10.1271/bbb.100444; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Cascia G, 2013, PHYSIOL PLANTARUM, V147, P121, DOI 10.1111/j.1399-3054.2012.01641.x; Chen CS, 2012, SCI HORTIC-AMSTERDAM, V142, P68, DOI 10.1016/j.scienta.2012.05.001; Chen JL, 2007, FOOD CHEM, V104, P268, DOI 10.1016/j.foodchem.2006.11.038; Christopoulos MV, 2012, POSTHARVEST BIOL TEC, V73, P80, DOI 10.1016/j.postharvbio.2012.06.001; Franck C, 2007, POSTHARVEST BIOL TEC, V43, P1, DOI 10.1016/j.postharvbio.2006.08.008; Gong XinMing, 2010, Acta Horticulturae Sinica, V37, P375; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He Y, 2009, PLANT CELL TISS ORG, V98, P11, DOI 10.1007/s11240-009-9533-y; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Herremans E, 2013, POSTHARVEST BIOL TEC, V75, P114, DOI 10.1016/j.postharvbio.2012.08.008; Ho QT, 2010, J EXP BOT, V61, P2071, DOI 10.1093/jxb/erq026; Hudina M, 2012, CAN J PLANT SCI, V92, P67, DOI [10.4141/cjps2011-095, 10.4141/CJPS2011-095]; Hutzler P, 1998, J EXP BOT, V49, P953, DOI 10.1093/jexbot/49.323.953; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; LEE CY, 1990, J AGR FOOD CHEM, V38, P99, DOI 10.1021/jf00091a019; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; Lu XH, 2011, SCI HORTIC-AMSTERDAM, V130, P97, DOI 10.1016/j.scienta.2011.06.017; MALDINEY R, 1986, J IMMUNOL METHODS, V90, P151, DOI 10.1016/0022-1759(86)90070-0; Manganaris GA, 2007, FOOD CHEM, V100, P1385, DOI 10.1016/j.foodchem.2005.11.036; Murata M, 2002, BIOSCI BIOTECH BIOCH, V66, P2525, DOI 10.1271/bbb.66.2525; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pedreschi R, 2009, POSTHARVEST BIOL TEC, V51, P123, DOI 10.1016/j.postharvbio.2008.05.019; Pedreschi R, 2008, POSTHARVEST BIOL TEC, V50, P110, DOI 10.1016/j.postharvbio.2008.04.004; Pei ZM, 2005, J PLANT GROWTH REGUL, V24, P296, DOI 10.1007/s00344-005-0095-x; Pusittigul I, 2012, SCI HORTIC-AMSTERDAM, V146, P45, DOI 10.1016/j.scienta.2012.08.008; RichardForget FC, 1997, J AGR FOOD CHEM, V45, P2472, DOI 10.1021/jf970042f; Rupasinghe HPV, 2007, J FOOD COMPOS ANAL, V20, P133, DOI 10.1016/j.jfca.2006.06.008; Veltman RH, 2003, POSTHARVEST BIOL TEC, V28, P295, DOI 10.1016/S0925-5214(02)00198-9; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang YingTao, 2011, Acta Horticulturae Sinica, V38, P1507; Waterman PG, 1994, ANAL PHENOLICS PLANT, V83; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wu Tao, 2012, African Journal of Agricultural Research, V7, P3701; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Xuan H, 2001, J HORTIC SCI BIOTECH, V76, P133, DOI 10.1080/14620316.2001.11511339; Yin R, 2012, J EXP BOT, V63, P2465, DOI 10.1093/jxb/err416; Yun Z, 2012, J EXP BOT, V63, P2873, DOI 10.1093/jxb/err390	41	14	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74217	10.1371/journal.pone.0074217	http://dx.doi.org/10.1371/journal.pone.0074217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058529	gold, Green Submitted, Green Published			2022-12-27	WOS:000324695900034
J	Zi, J; Zhang, JY; Wang, QH; Zhou, BJ; Zhong, JY; Zhang, CL; Qiu, XM; Wen, B; Zhang, SY; Fu, XQ; Lin, L; Liu, SQ				Zi, Jin; Zhang, Jiyuan; Wang, Quanhui; Zhou, Baojin; Zhong, Junyan; Zhang, Chaoliang; Qiu, Xuemei; Wen, Bo; Zhang, Shenyan; Fu, Xiqin; Lin, Liang; Liu, Siqi			Stress Responsive Proteins Are Actively Regulated during Rice (Oryza sativa) Embryogenesis as Indicated by Quantitative Proteomics Analysis	PLOS ONE			English	Article							LIPID TRANSFER PROTEIN; 2-DIMENSIONAL GEL-ELECTROPHORESIS; SEED DEVELOPMENT; SOMATIC EMBRYOGENESIS; EXPRESSION; GENES; IDENTIFICATION; RESISTANCE; DISCOVERY; OVEREXPRESSION	Embryogenesis is the initial step in a plant's life, and the molecular changes that occur during embryonic development are largely unknown. To explore the relevant molecular events, we used the isobaric tags for relative and absolute quantification (iTRAQ) coupled with the shotgun proteomics technique (iTRAQ/Shotgun) to study the proteomic changes of rice embryos during embryogenesis. For the first time, a total of 2 165 unique proteins were identified in rice embryos, and the abundances of 867 proteins were actively changed based on the statistical evaluation of the quantitative MS/MS signals. The quantitative data were then confirmed using multiple reactions monitoring (MRM) and were also supported by our previous study based on two-dimensional gel electrophoresis (2 DE). Using the proteome at 6 days after pollination (DAP) as a reference, cluster analysis of these differential proteins throughout rice embryogenesis revealed that 25% were up-regulated and 75% were down-regulated. Gene Ontology (GO) analysis implicated that most of the up-regulated proteins were functionally categorized as stress responsive, mainly including heat shock-, lipid transfer-, and reactive oxygen species-related proteins. The stress-responsive proteins were thus postulated to play an important role during seed maturation.	[Zi, Jin; Wang, Quanhui; Zhou, Baojin; Zhong, Junyan; Zhang, Chaoliang; Qiu, Xuemei; Wen, Bo; Zhang, Shenyan; Lin, Liang; Liu, Siqi] BGI Shenzhen, Prote Div, Shenzhen, Peoples R China; [Zi, Jin; Zhang, Jiyuan; Wang, Quanhui; Zhang, Shenyan; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Zhang, Jiyuan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Fu, Xiqin] Hunan Hybrid Rice Res Ctr, Changsha, Hunan, Peoples R China	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; China Agricultural University; Hunan Academy of Agricultural Sciences	Lin, L (corresponding author), BGI Shenzhen, Prote Div, Shenzhen, Peoples R China.	linl@genomics.cn; siqiliu@genomics.cn	Zi, Jin/AAH-8620-2020; Wen, Bo/I-1259-2019	Wen, Bo/0000-0003-2261-3150; Zhou, Baojin/0000-0002-8255-3439	National High Technology 863 Research and Development Program of China [2012AA020204]; National Key Basic Research 973 Program of China [2010CB912703]; Natural Science Foundation of China [91131009]; Guangdong Innovative Research Team Program [2009010016]	National High Technology 863 Research and Development Program of China(National High Technology Research and Development Program of China); National Key Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program	This work was supported by the National High Technology 863 Research and Development Program of China 2012AA020204, the National Key Basic Research 973 Program of China 2010CB912703, the Natural Science Foundation of China 91131009 and the Guangdong Innovative Research Team Program 2009010016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON ED, 1976, J EMBRYOL EXP MORPH, V35, P355; Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Agrawal GK, 2011, PROTEOMICS, V11, P1630, DOI 10.1002/pmic.201000696; BRITT DG, 1974, J DAIRY SCI, V57, P416, DOI 10.3168/jds.S0022-0302(74)84906-4; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; Dam S, 2009, PLANT PHYSIOL, V149, P1325, DOI 10.1104/pp.108.133405; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; George S, 2010, PLANT MOL BIOL REP, V28, P32, DOI 10.1007/s11105-009-0127-y; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jayaraj J, 2007, PLANT CELL REP, V26, P1539, DOI 10.1007/s00299-007-0368-x; KADER JC, 1975, BIOCHIM BIOPHYS ACTA, V380, P31, DOI 10.1016/0005-2760(75)90042-9; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lilley KS, 2002, CURR OPIN CHEM BIOL, V6, P46, DOI 10.1016/S1367-5931(01)00275-7; Liu Wanfei, 2010, Genomics Proteomics & Bioinformatics, V8, P229, DOI 10.1016/S1672-0229(10)60024-1; Maghuly F, 2009, TREE PHYSIOL, V29, P437, DOI 10.1093/treephys/tpn036; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; MCDONALD TL, 1975, CAN J MICROBIOL, V21, P675, DOI 10.1139/m75-097; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Moore JP, 2009, TRENDS PLANT SCI, V14, P110, DOI 10.1016/j.tplants.2008.11.007; Ono K, 2001, PLANT SCI, V160, P455, DOI 10.1016/S0168-9452(00)00412-X; Owiti J, 2011, PLANT J; Pan ZY, 2009, PLANT CELL REP, V28, P281, DOI 10.1007/s00299-008-0633-7; Qin XY, 2011, EUPHYTICA, V177, P33, DOI 10.1007/s10681-010-0246-4; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Saltzmann KD, 2010, PLANT PHYSIOL BIOCH, V48, P54, DOI 10.1016/j.plaphy.2009.10.004; Sarowar S, 2009, PLANT CELL REP, V28, P419, DOI 10.1007/s00299-008-0653-3; Scarpeci TE, 2008, PLANT SIGNAL BEHAV, V3, P856, DOI 10.4161/psb.3.10.6021; Sheoran IS, 2005, PROTEOMICS, V5, P3752, DOI 10.1002/pmic.200401209; Shi JS, 2010, J EXP BOT, V61, P2367, DOI 10.1093/jxb/erq066; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Sugino M, 1999, PLANT SCI, V146, P81, DOI 10.1016/S0168-9452(99)00086-2; Takac T, 2011, J PROTEOMICS, V74, P577, DOI 10.1016/j.jprot.2011.02.002; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; WALKER PR, 1974, LIFE SCI, V15, P1507, DOI 10.1016/0024-3205(74)90125-8; Wittmann-Liebold B, 2006, PROTEOMICS, V6, P4688, DOI 10.1002/pmic.200500874; Wu GH, 2004, J PLANT PHYSIOL, V161, P449, DOI 10.1078/0176-1617-01259; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu H, 2012, PLANTA, V235, P687, DOI 10.1007/s00425-011-1535-4; Yubero-Serrano EM, 2003, J EXP BOT, V54, P1865, DOI 10.1093/jxb/erg211; Zhang SY, 2013, J PROTEOME RES, V12, P2022, DOI 10.1021/pr301153z; Zi J, 2013, GIGASCIENCE DATABASE; Zi J, 2012, ELECTROPHORESIS, V33, P1129, DOI 10.1002/elps.201100398; Zottich U, 2011, BBA-GEN SUBJECTS, V1810, P375, DOI 10.1016/j.bbagen.2010.12.002	51	56	61	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e74229	10.1371/journal.pone.0074229	http://dx.doi.org/10.1371/journal.pone.0074229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058531	Green Submitted, gold, Green Published			2022-12-27	WOS:000324695900035
J	Eickbush, DG; Burke, WD; Eickbush, TH				Eickbush, Danna G.; Burke, William D.; Eickbush, Thomas H.			Evolution of the R2 Retrotransposon Ribozyme and Its Self-Cleavage Site	PLOS ONE			English	Article							HEPATITIS-DELTA-VIRUS; NON-LTR RETROTRANSPOSONS; RIBOSOMAL-RNA GENES; IN-VITRO; REVERSE TRANSCRIPTION; CRYSTAL-STRUCTURE; SEQUENCE; ELEMENTS; IDENTIFICATION; DIVERSITY	R2 is a non-long terminal repeat retrotransposon that inserts site-specifically in the tandem 28S rRNA genes of many animals. Previously, R2 RNA from various species of Drosophila was shown to self-cleave from the 28S rRNA/R2 co-transcript by a hepatitis D virus (HDV)-like ribozyme encoded at its 5' end. RNA cleavage was at the precise 5' junction of the element with the 28S gene. Here we report that RNAs encompassing the 5' ends of R2 elements from throughout its species range fold into HDV-like ribozymes. In vitro assays of RNA self-cleavage conducted in many R2 lineages confirmed activity. For many R2s, RNA self-cleavage was not at the 5' end of the element but at 28S rRNA sequences up to 36 nucleotides upstream of the junction. The location of cleavage correlated well with the types of endogenous R2 5' junctions from different species. R2 5' junctions were uniform for most R2s in which RNA cleavage was upstream in the rRNA sequences. The 28S sequences remaining on the first DNA strand synthesized during retrotransposition are postulated to anneal to the target site and uniformly prime second strand DNA synthesis. In species where RNA cleavage occurred at the R2 5' end, the 5' junctions were variable. This junction variation is postulated to result from the priming of second strand DNA synthesis by chance microhomologies between the target site and the first DNA strand. Finally, features of R2 ribozyme evolution, especially changes in cleavage site and convergence on the same active site sequences, are discussed.	[Eickbush, Danna G.; Burke, William D.; Eickbush, Thomas H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Eickbush, TH (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	thomas.eickbush@rochester.edu			National Institutes of Health [R01GM42790]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant number R01GM42790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEN MD, 1992, BIOCHEMISTRY-US, V31, P11843, DOI 10.1021/bi00162a024; Been MD, 1997, EUR J BIOCHEM, V247, P741, DOI 10.1111/j.1432-1033.1997.00741.x; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J BIOL CHEM, V277, P34836, DOI 10.1074/jbc.M204345200; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; BURKE WD, 1995, NUCLEIC ACIDS RES, V23, P4628, DOI 10.1093/nar/23.22.4628; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Chadalavada DM, 2000, J MOL BIOL, V301, P349, DOI 10.1006/jmbi.2000.3953; Chen JH, 2010, BIOCHEMISTRY-US, V49, P6508, DOI 10.1021/bi100670p; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; Christensen SM, 2005, MOL CELL BIOL, V25, P6617, DOI 10.1128/MCB.25.15.6617-6628.2005; Eickbush DG, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-10; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Eickbush DG, 2000, MOL CELL BIOL, V20, P213, DOI 10.1128/MCB.20.1.213-223.2000; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Friedlander TP, 1998, MOL PHYLOGENET EVOL, V9, P131, DOI 10.1006/mpev.1997.9999; George JA, 1996, GENETICS, V142, P853; Gladyshev EA, 2009, GENE, V448, P145, DOI 10.1016/j.gene.2009.08.016; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kojima KK, 2006, MOL BIOL EVOL, V23, P1984, DOI 10.1093/molbev/msl067; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Legiewicz M, 2006, NUCLEIC ACIDS RES, V34, P1270, DOI 10.1093/nar/gkl018; Levesque D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040309; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luchetti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057076; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nishikawa F, 1996, EUR J BIOCHEM, V237, P712, DOI 10.1111/j.1432-1033.1996.0712p.x; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; PERROTTA AT, 1990, NUCLEIC ACIDS RES, V18, P6821, DOI 10.1093/nar/18.23.6821; Ruminski DJ, 2011, J BIOL CHEM, V286, P41286, DOI 10.1074/jbc.M111.297283; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Stage DE, 2010, INSECT MOL BIOL, V19, P37, DOI 10.1111/j.1365-2583.2009.00949.x; Stage DE, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r49; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; THILL G, 1993, BIOCHEMISTRY-US, V32, P4254, DOI 10.1021/bi00067a013; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; XIONG Y, 1993, NUCLEIC ACIDS RES, V21, P1318, DOI 10.1093/nar/21.5.1318; XIONG Y, 1988, NUCLEIC ACIDS RES, V16, P10561, DOI 10.1093/nar/16.22.10561	47	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e66441	10.1371/journal.pone.0066441	http://dx.doi.org/10.1371/journal.pone.0066441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066021	Green Submitted, Green Published, gold			2022-12-27	WOS:000324494000001
J	Grailer, JJ; Steeber, DA				Grailer, Jamison J.; Steeber, Douglas A.			Vascular Endothelial Growth Factor Receptor Inhibitor SU5416 Suppresses Lymphocyte Generation and Immune Responses in Mice by Increasing Plasma Corticosterone	PLOS ONE			English	Article							ANTIANGIOGENIC AGENT SU5416; B-CELL ACTIVATION; PHASE-II; ANGIOGENESIS; MIGRATION; POTENT; DIFFERENTIATION; GLUCOCORTICOIDS; SUBPOPULATIONS; DEXAMETHASONE	Inhibitors of vascular endothelial growth factor and its receptors (VEGFRs) are attractive therapeutic candidates for cancer treatment. One such small molecule VEGFR inhibitor, SU5416, limits angiogenesis in vivo and is widely used for investigating VEGFR signaling in tumor pathophysiology. Herein, we describe novel actions of SU5416 on the immune system. Treatment of mice with SU5416 for 3 days induced significant reductions in size and cellularity of peripheral lymph nodes. Interestingly, SU5416 did not affect initial lymphocyte localization to peripheral lymph nodes but did reduce lymphocyte accumulation during long-term migration assays. Treatment with SU5416 also induced severe loss of double-positive thymocytes resulting in thymic atrophy and a reduction in peripheral B cells. Furthermore, immune responses following immunization were reduced in mice treated with SU5416. Findings of thymic atrophy and reduced weight gain during SU5416 treatment suggested elevated corticosterone levels. Indeed, a significant 5-fold increase in serum corticosterone was found 4 hours after treatment with SU5416. Importantly, adrenalectomy negated the effects of SU5416 treatment on primary immune tissues, and partial reversal of SU5416-induced changes was observed following blockade of glucocorticoid receptors. SU5416 has been reported to inhibit the activation of latent transforming growth factor (TGF)-beta, a cytokine involved in the regulation of glucocorticoid release by the adrenal glands. Interestingly, treatment with a TGF-beta receptor inhibitor, showed a similar phenotype as SU5416 treatment, including elevated serum corticosterone levels and thymic atrophy. Therefore, these results suggest that SU5416 induces glucocorticoid release directly from the adrenal glands, possibly by inhibition of TGF-beta activation.	[Grailer, Jamison J.; Steeber, Douglas A.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Steeber, DA (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	steeber@uwm.edu			UWM Chancellor's Office; UWM Graduate School Research Growth Initiative (RGI) program; UWM Graduate School	UWM Chancellor's Office; UWM Graduate School Research Growth Initiative (RGI) program; UWM Graduate School	This work was supported in part by grants from the UWM Chancellor's Office and the UWM Graduate School Research Growth Initiative (RGI) program (to DAS). The UWM Graduate School provided support through a Dissertator Fellowship (to JJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Author not listed, 2002, EXPERT REV ANTICANC, V2, P5; Basu A, 2010, J IMMUNOL, V184, P545, DOI 10.4049/jimmunol.0900397; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; BETTENS F, 1984, J IMMUNOL, V132, P261; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; BOWEN DL, 1984, J IMMUNOL, V133, P1885; Caldwell CW, 2000, EVALUATION PERIPHERA; Chernoguz A, 2012, J PEDIATR SURG, V47, P347, DOI 10.1016/j.jpedsurg.2011.11.028; CUPPS TR, 1985, J CLIN INVEST, V75, P754, DOI 10.1172/JCI111757; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; FEIGE JJ, 1991, ENDOCR RES, V17, P267, DOI 10.1080/07435809109027201; Fong TAT, 1999, CANCER RES, V59, P99; GARDINER PF, 1980, AM J PHYSIOL, V238, pE124, DOI 10.1152/ajpendo.1980.238.2.E124; GILLIS S, 1979, J IMMUNOL, V123, P1624; Haroon ZA, 2002, CANCER BIOL THER, V1, P121, DOI 10.4161/cbt.55; Heymach JV, 2004, CLIN CANCER RES, V10, P5732, DOI 10.1158/1078-0432.CCR-04-0157; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Islam Z, 2003, TOXICOL APPL PHARM, V187, P69, DOI 10.1016/S0041-008X(02)00031-5; Itokawa T, 2002, MOL CANCER THER, V1, P295; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Kodera M, 2008, MICROSC MICROANAL, V14, P211, DOI 10.1017/S1431927608080215; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Lack G, 1996, J PEDIATR-US, V129, P898, DOI 10.1016/S0022-3476(96)70035-5; Lanza L, 1996, CLIN EXP IMMUNOL, V103, P482; Lara PN, 2003, CLIN CANCER RES, V9, P4772; LARSSON EL, 1980, J IMMUNOL, V124, P2828; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; MAO J, 1992, MOL CELL BIOCHEM, V109, P1; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mulligan JK, 2010, J IMMUNOTHER, V33, P126, DOI 10.1097/CJI.0b013e3181b91c9c; Overmoyer B, 2007, CLIN CANCER RES, V13, P5862, DOI 10.1158/1078-0432.CCR-07-0688; Peterson AC, 2004, CLIN CANCER RES, V10, P4048, DOI 10.1158/1078-0432.CCR-03-0766; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; SCREPANTI I, 1989, J IMMUNOL, V142, P3378; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; SPRENT J, 1973, CELL IMMUNOL, V7, P10, DOI 10.1016/0008-8749(73)90180-9; Stadler WM, 2004, CLIN CANCER RES, V10, P3365, DOI 10.1158/1078-0432.CCR-03-0404; Steeber DA, 1996, J IMMUNOL, V157, P1096; Steeber DA, 1996, J IMMUNOL, V157, P4899; Steer JH, 1998, ANN RHEUM DIS, V57, P732, DOI 10.1136/ard.57.12.732; STENZELPOORE M, 1993, ENDOCRINOLOGY, V132, P1313, DOI 10.1210/en.132.3.1313; Stojic-Vukanic Z, 2009, EXP BIOL MED, V234, P1067, DOI 10.3181/0902-RM-63; Vajkoczy Peter, 1999, Neoplasia (New York), V1, P31, DOI 10.1038/sj.neo.7900006; Woodrum C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-14; Yao ZL, 2008, J PHARM SCI-US, V97, P2820, DOI 10.1002/jps.21167; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873; Zangari M, 2004, CLIN CANCER RES, V10, P88, DOI 10.1158/1078-0432.CCR-0221-3	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75390	10.1371/journal.pone.0075390	http://dx.doi.org/10.1371/journal.pone.0075390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066177	Green Published, gold, Green Submitted			2022-12-27	WOS:000324494000159
J	Jiang, ZY; Chu, HX; Xi, MY; Yang, TT; Jia, JM; Huang, JJ; Guo, XK; Zhang, XJ; You, QD; Sun, HP				Jiang, Zheng-Yu; Chu, Hong-Xi; Xi, Mei-Yang; Yang, Ting-Ting; Jia, Jian-Min; Huang, Jing-Jie; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng			Insight into the Intermolecular Recognition Mechanism between Keap1 and IKK beta Combining Homology Modelling, Protein-Protein Docking, Molecular Dynamics Simulations and Virtual Alanine Mutation	PLOS ONE			English	Article							HEME OXYGENASE-1 EXPRESSION; CUL3-BASED E3 LIGASE; PARTICLE MESH EWALD; UBIQUITIN LIGASE; SHAPE COMPLEMENTARITY; CRYSTAL-STRUCTURE; NRF2 ACTIVATION; SUBSTRATE; ADAPTER; CANCER	Degradation of certain proteins through the ubiquitin-proteasome pathway is a common strategy taken by the key modulators responsible for stress responses. Kelch-like ECH-associated protein-1(Keap1), a substrate adaptor component of the Cullin3 (Cul3)-based ubiquitin E3 ligase complex, mediates the ubiquitination of two key modulators, NF-E2-related factor 2 (Nrf2) and I kappa B kinase beta (IKK beta), which are involved in the redox control of gene transcription. However, compared to the Keap1-Nrf2 protein-protein interaction (PPI), the intermolecular recognition mechanism of Keap1 and IKK beta has been poorly investigated. In order to explore the binding pattern between Keap1 and IKK beta, the PPI model of Keap1 and IKK beta was investigated. The structure of human IKK beta was constructed by means of the homology modeling method and using reported crystal structure of Xenopus laevis IKK beta as the template. A protein-protein docking method was applied to develop the Keap1-IKK beta complex model. After the refinement and visual analysis of docked proteins, the chosen pose was further optimized through molecular dynamics simulations. The resulting structure was utilized to conduct the virtual alanine mutation for the exploration of hot-spots significant for the intermolecular interaction. Overall, our results provided structural insights into the PPI model of Keap1-IKK beta and suggest that the substrate specificity of Keap1 depend on the interaction with the key tyrosines, namely Tyr525, Tyr574 and Tyr334. The study presented in the current project may be useful to design molecules that selectively modulate Keap1. The selective recognition mechanism of Keap1 with IKK beta or Nrf2 will be helpful to further know the crosstalk between NF-kappa B and Nrf2 signaling.	[Jiang, Zheng-Yu; Chu, Hong-Xi; Xi, Mei-Yang; Yang, Ting-Ting; Jia, Jian-Min; Huang, Jing-Jie; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Jiang, Zheng-Yu; Chu, Hong-Xi; Xi, Mei-Yang; Yang, Ting-Ting; Jia, Jian-Min; Huang, Jing-Jie; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng] China Pharmaceut Univ, Jiang Su Key Lab Drug Design & Optimizat, Nanjing, Jiangsu, Peoples R China; [Sun, Hao-Peng] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiao-Jin] China Pharmaceut Univ, Sch Sci, Dept Organ Chem, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University	Sun, HP (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	sunhaopeng@163.com	Sun, Haopeng/M-3063-2018	Sun, Haopeng/0000-0002-5109-0304; Jiang, Zhengyu/0000-0002-1671-1582	National Natural Science Foundation of China [81230078, 81202463, 91129732]; 863 of the State Key Program; Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University [JKGQ201103]; National Major Science and Technology Project of China (Innovation and Development of New Drugs) [2008ZX09401-001, 2009ZX09501-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 of the State Key Program(National High Technology Research and Development Program of China); Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University; National Major Science and Technology Project of China (Innovation and Development of New Drugs)	This work is supported by the project 81230078 (key program), 81202463 (youth foundation) and 91129732 of National Natural Science Foundation of China, 863 of the State Key Program, Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGQ201103), 2008ZX09401-001 and 2009ZX09501-003 of National Major Science and Technology Project of China (Innovation and Development of New Drugs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Anwar AA, 2005, FREE RADICAL BIO MED, V39, P227, DOI 10.1016/j.freeradbiomed.2005.03.012; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Grosdidier S, 2012, CURR PHARM DESIGN, V18, P4607, DOI 10.2174/138161212802651599; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Knorr-Wittmann C, 2005, FREE RADICAL BIO MED, V39, P1438, DOI 10.1016/j.freeradbiomed.2005.07.003; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Meyer B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001514; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; NITURE SK, 2011, J BIOL CHEM; Niture SK, 2010, J BIOL CHEM, V285, P36865, DOI 10.1074/jbc.M110.175802; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Spasser L, 2012, ANGEW CHEM INT EDIT, V51, P6840, DOI 10.1002/anie.201200020; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	68	30	32	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e75076	10.1371/journal.pone.0075076	http://dx.doi.org/10.1371/journal.pone.0075076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066166	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000148
J	Spears, D; Ghosh, A; Cumming, O				Spears, Dean; Ghosh, Arabinda; Cumming, Oliver			Open Defecation and Childhood Stunting in India: An Ecological Analysis of New Data from 112 Districts	PLOS ONE			English	Article							SOLAR DISINFECTION; DRINKING-WATER; RANDOMIZED INTERVENTION; PREVENTION; DYSENTERY; ENTEROPATHY; DIARRHEA; BAD	Poor sanitation remains a major public health concern linked to several important health outcomes; emerging evidence indicates a link to childhood stunting. In India over half of the population defecates in the open; the prevalence of stunting remains very high. Recently published data on levels of stunting in 112 districts of India provide an opportunity to explore the relationship between levels of open defecation and stunting within this population. We conducted an ecological regression analysis to assess the association between the prevalence of open defecation and stunting after adjustment for potential confounding factors. Data from the 2011 HUNGaMA survey was used for the outcome of interest, stunting; data from the 2011 Indian Census for the same districts was used for the exposure of interest, open defecation. After adjustment for various potential confounding factors - including socio-economic status, maternal education and calorie availability - a 10 percent increase in open defecation was associated with - a 0.7 percentage point increase in both stunting and severe stunting. Differences in open defecation can statistically account for 35 to 55 percent of the average difference in stunting between districts identified as low-performing and high-performing in the HUNGaMA data. In addition, using a Monte Carlo simulation, we explored the effect on statistical power of the common practice of dichotomizing continuous height data into binary stunting indicators. Our simulation showed that dichotomization of height sacrifices statistical power, suggesting that our estimate of the association between open defecation and stunting may be a lower bound. Whilst our analysis is ecological and therefore vulnerable to residual confounding, these findings use the most recently collected large-scale data from India to add to a growing body of suggestive evidence for an effect of poor sanitation on human growth. New intervention studies, currently underway, may shed more light on this important issue.	[Spears, Dean] Delhi Sch Econ, Ctr Dev Econ, Delhi, India; [Ghosh, Arabinda] Indian Adm Serv, Nadia, W Bengal, India; [Cumming, Oliver] Univ London London Sch Hyg & Trop Med, Environm Hlth Grp, Dept Dis Control, Fac Infect & Trop Dis, London WC1E 7HT, England	Delhi School of Economics; University of London; London School of Hygiene & Tropical Medicine	Spears, D (corresponding author), Delhi Sch Econ, Ctr Dev Econ, Delhi, India.	dean@riceinstitute.org		Cumming, Oliver/0000-0002-5074-8709	UK aid from the Department for International Development (DfID), as part of the SHARE research programme; Bill and Melinda Gates Foundation	UK aid from the Department for International Development (DfID), as part of the SHARE research programme; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	There are no current external funding sources specifically for this study. Oliver Cumming's time was in part funded by UK aid from the Department for International Development (DfID), as part of the SHARE research programme. Dean Spears's time was in part funded by the Bill and Melinda Gates Foundation, as part of r.i.c.e.'s sanitation policy research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 6351 WORLD BANK; Arnold BF, 2012, ENVIRON SCI TECHNOL, V46, P3031, DOI 10.1021/es204193j; Bank World, 2008, ENV HLTH CHILD SURV; Boschi-Pinto C, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P225, DOI 10.1007/b106524_13; Bozzoli C, 2009, DEMOGRAPHY, V46, P647; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Deaton A., 2009, Economic and Political Weekly, V44, P42; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; du Preez M, 2011, ENVIRON SCI TECHNOL, V45, P9315, DOI 10.1021/es2018835; du Preez M, 2010, ENVIRON SCI TECHNOL, V44, P8744, DOI 10.1021/es103328j; Gopalan C, 1980, NUTR VALUES INDIAN F; Haghighi P, 1997, CRIT REV CL LAB SCI, V34, P313, DOI 10.3109/10408369708998096; Hammer J., 2013, Policy Research Working Paper - World Bank; Headey D., 2011, IFPRI - Discussion Papers; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Hunter PR, 2012, ENVIRON SCI TECHNOL, V46, P3035, DOI 10.1021/es204500c; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; McGuigan KG, 2011, ENVIRON SCI TECHNOL, V45, P7862, DOI 10.1021/es201313x; Naandi, 2011, FDN HUNGAMA HYD FIGH; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Pruss-Ustun A, 2008, SAFE WATER BETTER HL; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; UNICEF, 2008, MULT IND CLUST SURV; UNICEF, 1990, UNICEF POL REV; UNICEF and WHO, 2013, PROGR DRINK WAT SAN; Waddington H., 2009, INT INITIATIVE IMPAC, V1, P1; WEINBERG CR, 1995, EPIDEMIOLOGY, V6, P345; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	31	197	196	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73784	10.1371/journal.pone.0073784	http://dx.doi.org/10.1371/journal.pone.0073784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24066070	Green Published, Green Accepted, gold			2022-12-27	WOS:000324494000052
J	Hans, N; Singh, S; Pandey, AK; Reddy, KS; Gaur, D; Chauhan, VS				Hans, Nidhi; Singh, Shailja; Pandey, Alok K.; Reddy, K. Sony; Gaur, Deepak; Chauhan, Virander S.			Identification and Characterization of a Novel Plasmodium falciparum Adhesin Involved in Erythrocyte Invasion	PLOS ONE			English	Article							MALARIA PARASITES; BINDING ANTIGEN; APICAL ORGANELLES; PROTEIN; RECEPTOR; FAMILY; MICRONEMES; HOMOLOG; LOCALIZATION; POLYMORPHISM	Malaria remains a major health problem worldwide. All clinical symptoms of malaria are attributed to the asexual blood stages of the parasite life cycle. Proteins resident in apical organelles and present on the surface of P. falciparum merozoites are considered promising candidates for the development of blood stage malaria vaccines. In the present study, we have identified and characterized a microneme associated antigen, PfMA [PlasmoDB Gene ID: PF3D7_0316000, PFC0700c]. The gene was selected by applying a set of screening criteria such as transcriptional upregulation at late schizogony, inter-species conservation and the presence of signal sequence or transmembrane domains. The gene sequence of PfMA was found to be conserved amongst various Plasmodium species. We experimentally demonstrated that the transcript for PfMA was expressed only in the late blood stages of parasite consistent with a putative role in erythrocyte invasion. PfMA was localized by immunofluorescence and immunoelectron microscopy to be in the micronemes, an apical organelle of merozoites. The functional role of the PfMA protein in erythrocyte invasion was identified as a parasite adhesin involved in direct attachment with the target erythrocyte. PfMA was demonstrated to bind erythrocytes in a sialic acid independent, chymotrypsin and trypsin resistant manner and its antibodies inhibited P. falciparum erythrocyte invasion. Invasion of erythrocytes is a complex multistep process that involves a number of redundant ligand-receptor interactions many of which still remain unknown and even uncharacterized. Our work has identified and characterized a novel P. falciparum adhesin involved in erythrocyte invasion.	[Hans, Nidhi; Singh, Shailja; Pandey, Alok K.; Reddy, K. Sony; Gaur, Deepak; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi, India.	virander@icgeb.res.in	Reddy, K Sony/AAR-6285-2020; Chauhan, Virander S./K-5276-2019; Gaur, Deepak/AAF-4379-2019; Pandey, Alok Kumar/ABD-9897-2021	Reddy, K. Sony/0000-0002-8437-5250	Department of Biotechnology, Government of India [BT/01/CEIB/11/V/01]; Bill and Melinda Gates Foundation; Department of Biotechnology (DBT), Government of India; Council of Scientific and Industrial Research (CSIR)	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The work and the establishment of the super-resolution and confocal imaging facility in the Malaria group, ICGEB has been funded by grants from the Department of Biotechnology, Government of India through the Program Support Grant [BT/01/CEIB/11/V/01]. Deepak Gaur is the recipient of the Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation. Deepak Gaur and Shailja Singh are recipients of the Ramalingaswami Fellowship and Innovative Young Biotechnologist Award, respectively, from the Department of Biotechnology (DBT), Government of India. Nidhi Hans and K. Sony Reddy received financial support from Council of Scientific and Industrial Research (CSIR) in the form of Junior and Senior Research Fellowships. AKP received support as a Research Associate from Department of Biotechnology (DBT), Government of India under the GLUE and Vaccine Grand Challenge Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; [Anonymous], 2000, METHODS MALARIA RES; Arumugam TU, 2011, INFECT IMMUN, V79, P4523, DOI 10.1128/IAI.05412-11; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2003, INFECT IMMUN, V71, P6742, DOI 10.1128/IAI.71.12.6742-6746.2003; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Haase S, 2008, INFECT IMMUN, V76, P879, DOI 10.1128/IAI.00144-07; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hinds L, 2009, EUKARYOT CELL, V8, P1869, DOI 10.1128/EC.00218-09; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; Ord RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030251; Pandey AK, 2013, INFECT IMMUN, V81, P441, DOI 10.1128/IAI.01107-12; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Siddiqui FA, 2013, CELL MICROBIOL, V15, P1341, DOI 10.1111/cmi.12118; SIM BKL, 1992, MOL BIOCHEM PARASIT, V51, P157, DOI 10.1016/0166-6851(92)90211-2; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Srivastava A, 2010, MOL BIOCHEM PARASIT, V174, P66, DOI 10.1016/j.molbiopara.2010.06.003; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002075; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991	55	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e74790	10.1371/journal.pone.0074790	http://dx.doi.org/10.1371/journal.pone.0074790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058628	Green Submitted, Green Published, gold			2022-12-27	WOS:000324408400096
J	Monaghan, TM; Robins, A; Knox, A; Sewell, HF; Mahida, YR				Monaghan, Tanya M.; Robins, Adrian; Knox, Alan; Sewell, Herbert F.; Mahida, Yashwant R.			Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis	PLOS ONE			English	Article							PERIPHERAL-BLOOD MONOCYTES; CLOSTRIDIUM-DIFFICILE; ASYMPTOMATIC CARRIAGE; INFECTION; COLONIZATION; MACROPHAGES; LYMPHOCYTES; PROTECTION	C. difficile infection (CDI) is rarely reported in cystic fibrosis (CF) patients despite frequent hospitalisations and antibiotic usage. Conversely, the prevalence of CDI in inflammatory bowel disease (IBD) has received increased attention. We investigated components of the IgG-specific humoral immune response to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea (CDAD), IBD patients with CDI, CF patients and healthy controls. Serum anti-toxin IgG was determined by ELISA. Circulating antigen-activated B-cells were investigated using Alexa Fluor 488-labelled toxin A and assessed by flow cytometry. Following induction of differentiation of memory B-cells, toxin A-and B-specific antibody secreting cells (ASCs) were quantified using ELISpot. We present the first data showing levels of serum anti-toxin A and B antibodies were significantly higher in patients with CF (without a history of CDI) than in CDAD patients and were stably maintained over time. Notably, the CDAD patients were significantly older than the CF patients. We also show that circulating toxin A-specific memory B-cells (IgD-negative) can be detected in CDAD patients [0.92 (0.09-1.78)%], and were prominent (5.64%, 1.14%) in two CF patients who were asymptomatic carriers of C. difficile. There was correlation between toxin A-and B-specific ASCs, with significantly higher proportions of the latter seen. In some with CDAD, high serum antibody levels were seen to only one of the two toxins. Mucosal secretion of toxin-specific IgG was detected in an additional group of IBD patients with no history of CDI. We conclude that enhanced and stable humoral immune responses to toxins A and B may protect CF and some IBD patients against CDI. The impaired ability to generate strong and/or sustained toxin-specific antibody and memory B-cell responses may increase susceptibility of older patients to CDI and highlight the need to investigate the role of immune senescence in future studies.	[Monaghan, Tanya M.; Mahida, Yashwant R.] Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England; [Monaghan, Tanya M.; Knox, Alan; Mahida, Yashwant R.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Robins, Adrian; Sewell, Herbert F.] Univ Nottingham, Div Immunol, Nottingham NG7 2RD, England; [Knox, Alan] Univ Nottingham, Div Resp, Nottingham NG7 2RD, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham	Mahida, YR (corresponding author), Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England.	yash.mahida@nottingham.ac.uk		Knox, Alan/0000-0002-5906-4143; Monaghan, Tanya/0000-0001-7622-3997	Wellcome Trust [086735/Z/08/Z]; National Institute for Health Research Biomedical Research Units in Gastrointestinal Disease and Respiratory Disease; National Institute for Health Research [ACF-2006-12-005] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Units in Gastrointestinal Disease and Respiratory Disease; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the Wellcome Trust (Ref 086735/Z/08/Z), via a Research Training Fellowship to Dr Monaghan. Some of the technical assistance and Research Nurse support was funded by the National Institute for Health Research Biomedical Research Units in Gastrointestinal Disease and Respiratory Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; BORRIELLO SP, 1986, J MED MICROBIOL, V21, P299, DOI 10.1099/00222615-21-4-299; Clayton EM, 2009, AM J GASTROENTEROL, V104, P1162, DOI 10.1038/ajg.2009.4; Goodhand JR, 2011, ALIMENT PHARM THER, V33, P428, DOI 10.1111/j.1365-2036.2010.04548.x; Johal SS, 2004, J INFECT DIS, V189, P2110, DOI 10.1086/386287; Johal SS, 2004, GUT, V53, P673, DOI 10.1136/gut.2003.028803; KAMIYA S, 1989, J MED MICROBIOL, V30, P69, DOI 10.1099/00222615-30-1-69; Koon HW, 2013, ANTIMICROB AGENTS CH, V57, P3214, DOI 10.1128/AAC.02633-12; Kurosaki T, 2010, IMMUNOL REV, V237, P104, DOI 10.1111/j.1600-065X.2010.00939.x; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Mahida YR, 1998, INFECT IMMUN, V66, P5462, DOI 10.1128/IAI.66.11.5462-5469.1998; Mahida YR, 1997, CLIN EXP IMMUNOL, V109, P377, DOI 10.1046/j.1365-2249.1997.4481346.x; Mayne CG, 2013, INFLAMM BOWEL DIS, V19, P1772, DOI 10.1097/MIB.0b013e318281f5a3; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Mekker A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002850; Modi N, 2011, SCAND J IMMUNOL, V74, P264, DOI 10.1111/j.1365-3083.2011.02578.x; Monaghan T, 2008, GUT, V57, P850, DOI 10.1136/gut.2007.128157; Mullan N, 2011, INFECT IMMUN, V79, P1623, DOI 10.1128/IAI.00686-10; PEACH SL, 1986, J CLIN PATHOL, V39, P1013, DOI 10.1136/jcp.39.9.1013; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994; WELKON CJ, 1985, AM J DIS CHILD, V139, P805, DOI 10.1001/archpedi.1985.02140100067032	30	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74452	10.1371/journal.pone.0074452	http://dx.doi.org/10.1371/journal.pone.0074452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058568	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600094
J	Petrosova, H; Pospisilova, P; Strouhal, M; Cejkova, D; Zobanikova, M; Mikalova, L; Sodergren, E; Weinstock, GM; Smajs, D				Petrosova, Helena; Pospisilova, Petra; Strouhal, Michal; Cejkova, Darina; Zobanikova, Marie; Mikalova, Lenka; Sodergren, Erica; Weinstock, George M.; Smajs, David			Resequencing of Treponema pallidum ssp pallidum Strains Nichols and SS14: Correction of Sequencing Errors Resulted in Increased Separation of Syphilis Treponeme Subclusters	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MACROLIDE RESISTANCE; GENETIC DIVERSITY; TPRK GENE; PROTEIN; IDENTIFICATION; EXPRESSION; EVOLUTION; SOFTWARE; ANTIGEN	Background: Treponema pallidum ssp. pallidum (TPA), the causative agent of syphilis, is a highly clonal bacterium showing minimal genetic variability in the genome sequence of individual strains. Nevertheless, genetically characterized syphilis strains can be clearly divided into two groups, Nichols-like strains and SS14-like strains. TPA Nichols and SS14 strains were completely sequenced in 1998 and 2008, respectively. Since publication of their complete genome sequences, a number of sequencing errors in each genome have been reported. Therefore, we have resequenced TPA Nichols and SS14 strains using next-generation sequencing techniques. Methodology/Principal Findings: The genomes of TPA strains Nichols and SS14 were resequenced using the 454 and Illumina sequencing methods that have a combined average coverage higher than 90x. In the TPA strain Nichols genome, 134 errors were identified (25 substitutions and 109 indels), and 102 of them affected protein sequences. In the TPA SS14 genome, a total of 191 errors were identified (85 substitutions and 106 indels) and 136 of them affected protein sequences. A set of new intrastrain heterogenic regions in the TPA SS14 genome were identified including the tprD gene, where both tprD and tprD2 alleles were found. The resequenced genomes of both TPA Nichols and SS14 strains clustered more closely with related strains (i.e. strains belonging to same syphilis treponeme subcluster). At the same time, groups of Nichols-like and SS14-like strains were found to be more distantly related. Conclusion/Significance: We identified errors in 11.5% of all annotated genes and, after correction, we found a significant impact on the predicted proteomes of both Nichols and SS14 strains. Corrections of these errors resulted in protein elongations, truncations, fusions and indels in more than 11% of all annotated proteins. Moreover, it became more evident that syphilis is caused by treponemes belonging to two separate genetic subclusters.	[Petrosova, Helena; Pospisilova, Petra; Strouhal, Michal; Cejkova, Darina; Zobanikova, Marie; Mikalova, Lenka; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Cejkova, Darina; Sodergren, Erica; Weinstock, George M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Strouhal, Michal; Cejkova, Darina; Mikalova, Lenka; Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Inst, St Louis, MO 63110 USA	Masaryk University Brno; Baylor College of Medicine; Washington University (WUSTL)	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.muni.cz	Cejkova, Darina/AAA-5820-2022; Smajs, David/I-3479-2016; Pospisilova, Petra/L-8212-2018; Weinstock, George M/C-6314-2013; Mikalová, Lenka/AAM-1068-2020	Cejkova, Darina/0000-0002-6989-6330; Weinstock, George M/0000-0002-2997-4592; 	Ministry of Health of the Czech Republic [NT11159-5/2010]; Grant Agency of the Czech Republic [P302/12/0574]; Program of Employment of Newly Graduated Doctors of Science for Scientific Excellence [CZ.1.07/2.3.00/30.0009]; European Social Fund; state budget of the Czech Republic	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Program of Employment of Newly Graduated Doctors of Science for Scientific Excellence; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by a grant from the Ministry of Health of the Czech Republic (NT11159-5/2010), and by the Grant Agency of the Czech Republic (P302/12/0574) to DS. This work was also supported by the Program of Employment of Newly Graduated Doctors of Science for Scientific Excellence (grant number CZ.1.07/2.3.00/30.0009) co-financed from European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Cejkova D, 2012, J MED MICROBIOL; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Centurion-Lara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002222; Dai T, 2012, J CLIN MICROBIOL; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Giacani L, 2012, J BACTERIOL, V194, P4208, DOI 10.1128/JB.00863-12; Giacani L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001698; Giacani L, 2010, J BACTERIOL, V192, P2645, DOI 10.1128/JB.00159-10; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Nichols HJ, 1914, J EXP MED, V19, P362, DOI 10.1084/jem.19.4.362; Petrosova H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001832; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Rao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064129; Rozen S, 2000, BIOINFORMATICS METHO, P365; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Smajs David, 2004, Methods Mol Biol, V255, P47; STAMM LV, 1983, INFECT IMMUN, V41, P709, DOI 10.1128/IAI.41.2.709-721.1983; Stamm LV, 2000, INFECT IMMUN, V68, P6482, DOI 10.1128/IAI.68.11.6482-6486.2000; STAMM LV, 1988, ANTIMICROB AGENTS CH, V32, P164, DOI 10.1128/AAC.32.2.164; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Sun ES, 2004, MICROBES INFECT, V6, P725, DOI 10.1016/j.micinf.2004.04.001; Tipple C, 2011, SEX TRANSM INFECT, V87, P486, DOI 10.1136/sextrans-2011-050082; Wu H, 2012, J CLIN MICROBIOL, V50, P2299, DOI 10.1128/JCM.00341-12; Zhuo Y, 2012, J BACTERIOL, V194, P4749, DOI 10.1128/JB.00931-12; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838	45	46	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74319	10.1371/journal.pone.0074319	http://dx.doi.org/10.1371/journal.pone.0074319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24058545	Green Published, gold, Green Submitted			2022-12-27	WOS:000327538600088
J	Lu, HD; Lv, LL; Dai, YH; Wu, G; Zhao, HQ; Zhang, FC				Lu, Huading; Lv, Lulu; Dai, Yuhu; Wu, Gang; Zhao, Huiqing; Zhang, Fucheng			Porous Chitosan Scaffolds with Embedded Hyaluronic Acid/Chitosan/Plasmid-DNA Nanoparticles Encoding TGF-beta 1 Induce DNA Controlled Release, Transfected Chondrocytes, and Promoted Cell Proliferation	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; MESENCHYMAL STEM-CELLS; IN-VITRO; PLASMID DNA; TRANSFORMING GROWTH-FACTOR-BETA-1; ACTIVATED MATRIX; MOLECULAR-WEIGHT; CARTILAGE; REGENERATION; EFFICIENCY	Cartilage defects resulting from traumatic injury or degenerative diseases have very limited spontaneous healing ability. Recent progress in tissue engineering and local therapeutic gene delivery systems has led to promising new strategies for successful regeneration of hyaline cartilage. In the present study, tissue engineering and local therapeutic gene delivery systems are combined with the design of a novel gene-activated matrix (GAM) embedded with hybrid hyaluronic acid(HA)/chitosan(CS)/plasmid-DNA nanoparticles encoding transforming growth factor (TGF)-beta 1. A chitosan scaffold functioned as the three-dimensional carrier for the nanoparticles. Results demonstrated that scaffold-entrapped plasmid DNA was released in a sustained and steady manner over 120 days, and was effectively protected in the HA/CS/pDNA nanoparticles. Culture results demonstrated that chondrocytes grown in the novel GAM were highly proliferative and capable of filling scaffold micropores with cells and extracellular matrix. Confocal laser scanning microscopy indicated that chondrocytes seeded in the GAM expressed exogenous transgenes labeled with green fluorescent protein. ELISA results demonstrated detectable TGF-beta 1 expression in the supernatant of GAM cultures, which peaked at the sixth day of culture and afterwards showed a moderate decline. Histological results and biochemical assays confirmed promotion of chondrocyte proliferation. Cell culture indicated no affects on phenotypic expression of ECM molecules, such as GAG. The results of this study indicate the suitability of this novel GAM for enhanced in vitro cartilage tissue engineering.	[Lu, Huading; Lv, Lulu; Dai, Yuhu; Zhao, Huiqing] Sun Yat Sen Univ, Dept Orthoped, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Gang] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Fucheng] Sun Yat Sen Univ, Cent Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology; Sun Yat Sen University	Lu, HD (corresponding author), Sun Yat Sen Univ, Dept Orthoped, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	johnniehuading@163.com	Wu, Gang/A-1149-2009	Wu, Gang/0000-0002-4730-4971; ZHU, Chao-Dong/0000-0002-9347-3178	National Natural Science Foundation of China [30600632]; Basic Research Project of China [2012CB619105]; Natural Science Foundation of Guangdong Province, China [S2011010004808]; Science and Technology Projects of Guangdong Province, China [2010B060900029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30600632); the Basic Research Project of China (No. 2012CB619105); the Natural Science Foundation of Guangdong Province, China (No. S2011010004808); and the Science and Technology Projects of Guangdong Province, China (No. 2010B060900029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi MA, 2009, BIOMATERIALS, V30, P5260, DOI 10.1016/j.biomaterials.2009.07.018; Bachmann G, 2004, RADIOLOGE, V44, P773, DOI 10.1007/s00117-004-1084-y; Bachrach G, 2006, J BIOMED MATER RES A, V77A, P811, DOI 10.1002/jbm.a.30675; Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077; Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]; Duceppe N, 2009, BIOMATERIALS, V30, P2625, DOI 10.1016/j.biomaterials.2009.01.017; Elder SH, 2003, METH MOL B, V238, P41; Elisseeff J, 2001, J ORTHOP RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7; Endo M, 2006, TISSUE ENG, V12, P489, DOI 10.1089/ten.2006.12.489; Gao Y, 2008, INT J PHARMACEUT, V359, P241, DOI 10.1016/j.ijpharm.2008.03.037; Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547; Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kumar MNVR, 2004, EXPERT OPIN BIOL TH, V4, P1213, DOI 10.1517/14712598.4.8.1213; Kuo YC, 2011, COLLOID SURFACE B, V84, P63, DOI 10.1016/j.colsurfb.2010.12.021; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Lu HD, 2011, INT J PHARMACEUT, V420, P358, DOI 10.1016/j.ijpharm.2011.08.046; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083; Peng L, 2009, J BIOMED MATER RES A, V90A, P564, DOI 10.1002/jbm.a.32117; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; Sezer AD, 2009, AAPS PHARMSCITECH, V10, P1193, DOI 10.1208/s12249-009-9324-0; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Shi DH, 2005, CHINESE MED J-PEKING, V118, P1436; Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080; Trentin D, 2005, J CONTROL RELEASE, V102, P263, DOI 10.1016/j.jconrel.2004.09.029; Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4; Wang S, 2000, J DENT RES, V79, P701, DOI 10.1177/00220345000790020201; Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013; Zhang XL, 2006, BIOCHEM BIOPH RES CO, V341, P202, DOI 10.1016/j.bbrc.2005.12.171; Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106; Zhao QQ, 2009, BIOL PHARM BULL, V32, P706, DOI 10.1248/bpb.32.706; Zhao X, 2006, J CONTROL RELEASE, V112, P223, DOI 10.1016/j.jconrel.2006.01.016; Zheng F, 2007, LIFE SCI, V80, P388, DOI 10.1016/j.lfs.2006.09.040	42	80	85	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69950	10.1371/journal.pone.0069950	http://dx.doi.org/10.1371/journal.pone.0069950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894564	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000167
J	Li, ZR; Gao, L; Tang, H; Yin, Y; Xiang, XX; Li, Y; Zhao, J; Mulholland, M; Zhang, WZ				Li, Ziru; Gao, Ling; Tang, Hong; Yin, Yue; Xiang, Xinxin; Li, Yin; Zhao, Jing; Mulholland, Michael; Zhang, Weizhen			Peripheral Effects of Nesfatin-1 on Glucose Homeostasis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INSULIN-SECRETION; ENERGY-BALANCE; GHRELIN; OBESITY	Aims/hypothesis: The actions of peripherally administered nesfatin-1 on glucose homeostasis remain controversial. The aim of this study was to characterize the mechanisms by which peripheral nesfatin-1 regulates glucose metabolism. Methods: The effects of nesfatin-1 on glucose metabolism were examined in mice by continuous infusion of the peptide via osmotic pumps. Changes in AKT phosphorylation and Glut4 were investigated by Western blotting and immnuofluorescent staining. Primary myocytes, adipocytes and hepatocytes were isolated from male mice. Results: Continuous peripheral infusion of nesfatin-1 altered glucose tolerance and insulin sensitivity in mice fed either normal or high fat diet, while central administration of nesfatin-1 demonstrated no effect. Nesfatin-1 increases insulin secretion in vivo, and in vitro in cultured min6 cells. In addition, nesfatin-1 up-regulates the phosphorylation of AKT in pancreas and min6 islet cells. In mice fed normal diet, peripheral nesfatin-1 significantly increased insulin-stimulated phosphorylation of AKT in skeletal muscle, adipose tissue and liver; similar effects were observed in skeletal muscle and adipose tissue in mice fed high fat diet. At basal conditions and after insulin stimulation, peripheral nesfatin-1 markedly increased GLUT4 membrane translocation in skeletal muscle and adipose tissue in mice fed either diet. In vitro studies showed that nesfatin-1 increased both basal and insulin-stimulated levels of AKT phosphorylation in cells derived from skeletal muscle, adipose tissue and liver. Conclusions: Our studies demonstrate that nesfatin-1 alters glucose metabolism by mechanisms which increase insulin secretion and insulin sensitivity via altering AKT phosphorylation and GLUT 4 membrane translocation in the skeletal muscle, adipose tissue and liver.	[Li, Ziru; Tang, Hong; Yin, Yue; Xiang, Xinxin; Li, Yin; Zhao, Jing; Zhang, Weizhen] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Gao, Ling] Coll Binzhou Polytech, Binzhou, Shandong, Peoples R China; [Mulholland, Michael; Zhang, Weizhen] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA	Peking University; University of Michigan System; University of Michigan	Zhang, WZ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	weizhenzhang@bjmu.edu.cn	Li, Yin/P-9296-2016; zhang, weizhen/K-1484-2018; Li, Zhonghai/N-6670-2018	Li, Yin/0000-0002-4019-3391; zhang, weizhen/0000-0001-8791-2798; Li, Zhonghai/0000-0003-4735-1193; Li, Ziru/0000-0002-2755-9299	National Natural Science Foundation of China [81030012]; Major National Basic Research Program of P. R. China [2010CB912504]; American Diabetes Association [1-13-BS-225]; Visiting Scholar Project Fund for Outstanding Junior Faculties from Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Program of P. R. China(National Basic Research Program of China); American Diabetes Association(American Diabetes Association); Visiting Scholar Project Fund for Outstanding Junior Faculties from Shandong Province	This work was supported by grants from the National Natural Science Foundation of China (81030012), the Major National Basic Research Program of P. R. China (No. 2010CB912504), American Diabetes Association grant #1-13-BS-225, and the Visiting Scholar Project Fund for Outstanding Junior Faculties from Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelone T, 2012, CELL MOL LIFE SCI; Atsuchi K, 2010, NEUROREPORT, V21, P1008, DOI 10.1097/WNR.0b013e32833f7b96; CAMPBELL PJ, 1993, DIABETES, V42, P405, DOI 10.2337/diabetes.42.3.405; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Li ZR, 2012, CELL PHYSIOL BIOCHEM, V29, P493, DOI 10.1159/000338503; LUDVIK B, 1995, DIABETES, V44, P1121, DOI 10.2337/diabetes.44.9.1121; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nakata M, 2011, ENDOCR J, V58, P305, DOI 10.1507/endocrj.K11E-056; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Riva M, 2011, CELL TISSUE RES, V346, P393, DOI 10.1007/s00441-011-1268-5; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; Tagaya Y, 2012, PROTEIN PEPTIDE LETT, V19, P997, DOI 10.2174/092986612802084546; Xia ZF, 2012, AM J PHYSIOL-GASTR L, V303, pG570, DOI 10.1152/ajpgi.00178.2012; Xu GY, 2009, ENDOCRINOLOGY, V150, P3637, DOI 10.1210/en.2009-0372; Yamawaki H, 2012, BIOCHEM BIOPH RES CO, V418, P676, DOI 10.1016/j.bbrc.2012.01.076; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Yosten GLC, 2012, J NEUROENDOCRINOL, V24, P1078, DOI 10.1111/j.1365-2826.2012.02304.x; Zhang Z, 2012, EXP CLIN ENDOCR DIAB, V120, P91, DOI 10.1055/s-0031-1286339	28	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71513	10.1371/journal.pone.0071513	http://dx.doi.org/10.1371/journal.pone.0071513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967220	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000055
J	Zheng, SQ; Ding, AJ; Li, GP; Wu, GS; Luo, HR				Zheng, Shan-Qing; Ding, Ai-Jun; Li, Guo-Ping; Wu, Gui-Sheng; Luo, Huai-Rong			Drug Absorption Efficiency in Caenorhbditis elegans Delivered by Different Methods	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; CALORIC RESTRICTION; DIETARY RESTRICTION; SMALL MOLECULES; MODEL; IDENTIFICATION; INCREASE; WORM; BIOACTIVITY	Background: Caenorhbditis elegans has being vigorously used as a model organism in many research fields and often accompanied by administrating with various drugs. The methods of delivering drugs to worms are varied from one study to another, which make difficult in comparing results between studies. Methodology/Principal Findings: We evaluated the drug absorption efficiency in C. elegans using five frequently used methods with resveratrol with low aqueous solubility and water-soluble 5-Fluoro-2'-deoxyuridine (FUDR) as positive compounds. The drugs were either applied to the LB medium with bacteria OP50, before spreading onto Nematode Growth Medium (NGM) plates (LB medium method), or to the NGM with live (NGM live method) or dead bacteria (NGM dead method), or spotting the drug solution to the surface of plates directly (spot dead method), or growing the worms in liquid medium (liquid growing method). The concentration of resveratrol and FUDR increased gradually within C. elegans and reached the highest during 12 hours to one day and then decreased slowly. At the same time point, the higher the drug concentration, the higher the metabolism rate. The drug concentrations in worms fed with dead bacteria were higher than with live bacteria at the same time point. Consistently, the drug concentration in medium with live bacteria decreased much faster than in medium with dead bacteria, reach to about half of the original concentration within 12 hours. Conclusion: Resveratrol with low aqueous solubility and water-soluble FUDR have the same absorption and metabolism pattern. The drug metabolism rate in worms was both dosage and time dependent. NGM dead method and liquid growing method achieved the best absorption efficiency in worms. The drug concentration within worms was comparable with that in mice, providing a bridge for dose translation from worms to mammals.	[Zheng, Shan-Qing; Ding, Ai-Jun; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Zheng, Shan-Qing; Ding, Ai-Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Inst Geriatr, Minist Hlth, Beijing, Peoples R China; [Wu, Gui-Sheng] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology	Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	luohuairong@mail.kib.ac.cn	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Yunnan provincial government [20080A007]; 100 Talents Program of the Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany [P2008-ZZ21, T2009-KF05]	Yunnan provincial government; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany	This work was partially supported by the Yunnan provincial government (20080A007), the 100 Talents Program of the Chinese Academy of Sciences, and the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany (P2008-ZZ21 and T2009-KF05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AT, 2010, RAPID COMMUN MASS SP, V24, P1447, DOI 10.1002/rcm.4535; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Anastassopoulou CG, 2011, CURR PHARM DESIGN, V17, P1225, DOI 10.2174/138161211795703753; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Dexter PM, 2012, NEUROTHERAPEUTICS, V9, P393, DOI 10.1007/s13311-012-0109-x; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Kim S, 2008, BIOCHEM BIOPH RES CO, V368, P588, DOI 10.1016/j.bbrc.2008.01.131; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2003, GENETICS, V163, P159; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Masuda M, 2004, ANAL CHEM, V76, P728, DOI 10.1021/ac034840i; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nass R, 2001, PARKINSONISM RELAT D, V7, P185, DOI 10.1016/S1353-8020(00)00056-0; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Sellers WR, 2011, CELL, V147, P26, DOI 10.1016/j.cell.2011.09.016; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stiernagle Theresa, 2006, WormBook, P1; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wypijewska A, 2010, FEBS J, V277, P3003, DOI 10.1111/j.1742-4658.2010.07709.x; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zheng J, 2012, INT J OBESITY, V36, P186, DOI 10.1038/ijo.2011.93	50	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56877	10.1371/journal.pone.0056877	http://dx.doi.org/10.1371/journal.pone.0056877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24058503	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500039
J	Ding, Y; Song, LR; Sedmak, B				Ding, Yi; Song, Lirong; Sedmak, Bojan			UVB Radiation as a Potential Selective Factor Favoring Microcystin Producing Bloom Forming Cyanobacteria	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; LIGHT; SOLAR; BIOSYNTHESIS; AERUGINOSA; EVOLUTION; GROWTH; DAMAGE; GENES	Due to the stratospheric ozone depletion, several organisms will become exposed to increased biologically active UVB (280-320nm) radiation, not only at polar but also at temperate and tropical latitudes. Bloom forming cyanobacteria are exposed to UVB radiation on a mass scale, particularly during the surface bloom and scum formation that can persist for long periods of time. All buoyant species of cyanobacteria are at least periodically exposed to higher irradiation during their vertical migration to the surface that usually occurs several times a day. The aim of this study is to assess the influence on cyanobacteria of UVB radiation at realistic environmental intensities. The effects of two UVB intensities of 0.5 and 0.99 W/m(2) in up to 0.5 cm water depth were studied in vitro on Microcystis aeruginosa strains, two microcystin producing and one non-producing. After UVB exposure their ability to proliferate was estimated by cell counting, while cell fitness and integrity were evaluated using light microscopy, autofluorescence and immunofluorescence. Gene damage was assessed by TUNEL assay and SYBR Green staining of the nucleoide area. We conclude that UVB exposure causes damage to the genetic material, cytoskeletal elements, higher sedimentation rates and consequent cell death. In contrast to microcystin producers (PCC7806 and FACHB905), the microcystin non-producing strain PCC7005 is more susceptible to the deleterious effects of radiation, with weak recovery ability. The ecological relevance of the results is discussed using data from eleven years' continuous UVB radiation measurements within the area of Ljubljana city (Slovenia, Central Europe). Our results suggest that increased solar radiation in temperate latitudes can have its strongest effect during cyanobacterial bloom formation in spring and early summer. UVB radiation in this period may significantly influence strain composition of cyanobacterial blooms in favor of microcystin producers.	[Ding, Yi; Song, Lirong] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Ding, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sedmak, Bojan] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute of Biology - Slovenia	Sedmak, B (corresponding author), Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia.	bojan.sedmak@nib.si	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), Research Program P1-0245ARRS: Ecotoxicology, Toxicogenomics and Carcinogenesis - (BS salary, reagents, materials, analysis tools), and Ministry of Defence Administration for Civil Protection and Dosaster Relief (Contract No URSZR 4300-1117/2009-1) "Cyanobacterial toxins in surface waters,'' which co-financed the Laminar Flow Cabinet. Chinese grants from the Natural Science Foundation of China-Yunnan Project (U0833604) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and '973' Program (2008CB418000) funded the nine-month stay of Ding Yi at the National Institute of Biology in Ljubljana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Codd GA, 2000, ECOL ENG, V16, P51, DOI 10.1016/S0925-8574(00)00089-6; Ding Y, 2012, PHYCOLOGIA, V51, P567, DOI 10.2216/11-107.1; DONKOR V, 1991, FEMS MICROBIOL ECOL, V86, P159; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; EKELUND NGA, 1991, J PLANT PHYSIOL, V138, P274, DOI 10.1016/S0176-1617(11)80287-7; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gan NQ, 2012, ENVIRON MICROBIOL, V14, P730, DOI 10.1111/j.1462-2920.2011.02624.x; Gumbo JR, 2011, AFR J BIOTECHNOL, V10, P8054; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Harel M, 2012, ENV MICROBIOL REP, V4, P342, DOI 10.1111/j.1758-2229.2012.00339.x; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P73, DOI 10.1016/S1011-1344(01)00278-0; Hessen DO, 2008, SOLAR RAD HUMAN HLTH, P123, DOI DOI 10.1038/NRG2897; Jungblut AD, 2006, ARCH MICROBIOL, V185, P107, DOI 10.1007/s00203-005-0073-5; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kulandaivelu G, 1989, PHOTOSYNTHESIS MOL B, P305; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Ma ZL, 2009, ENVIRON EXP BOT, V66, P265, DOI 10.1016/j.envexpbot.2009.02.006; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Phelan RR, 2011, J PHYCOL, V47, P1241, DOI 10.1111/j.1529-8817.2011.01056.x; QUESADA A, 1995, J PHYCOL, V31, P242, DOI 10.1111/j.0022-3646.1995.00242.x; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; SCHERER S, 1988, PLANT PHYSIOL, V88, P1055, DOI 10.1104/pp.88.4.1055; Schopf JW., 2000, ECOLOGY CYANOBACTERI, P13; Sedmak B, 2005, MICROB ECOL, V50, P298, DOI 10.1007/s00248-004-0189-1; Sedmak B, 1998, J PLANKTON RES, V20, P691, DOI 10.1093/plankt/20.4.691; Sedmak B, 2009, J PLANKTON RES, V31, P1321, DOI 10.1093/plankt/fbp076; Shi L, 1999, J BIOL CHEM, V274, P10039, DOI 10.1074/jbc.274.15.10039; Sinha RP, 1998, J PHOTOCH PHOTOBIO B, V47, P83, DOI 10.1016/S1011-1344(98)00198-5; UTKILEN H, 1992, APPL ENVIRON MICROB, V58, P1321, DOI 10.1128/AEM.58.4.1321-1325.1992; WALSBY AE, 1987, CYANOBACTERIA, P377; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	36	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73919	10.1371/journal.pone.0073919	http://dx.doi.org/10.1371/journal.pone.0073919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058503	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400043
J	Silva-Cavalcante, MD; Correia-Oliveira, CR; Santos, RA; Lopes-Silva, JP; Lima, HM; Bertuzzi, R; Duarte, M; Bishop, DJ; Lima-Silva, AE				Silva-Cavalcante, Marcos David; Correia-Oliveira, Carlos Rafaell; Santos, Ralmony Alcantara; Lopes-Silva, Joao Paulo; Lima, Hessel Marani; Bertuzzi, Romulo; Duarte, Marcos; Bishop, David John; Lima-Silva, Adriano Eduardo			Caffeine Increases Anaerobic Work and Restores Cycling Performance following a Protocol Designed to Lower Endogenous Carbohydrate Availability	PLOS ONE			English	Article							GLYCOGEN DEPLETION PATTERN; HIGH-INTENSITY EXERCISE; PERCEIVED EXERTION; MUSCLE GLYCOGEN; TIME-TRIAL; NEUROMUSCULAR FUNCTION; FATIGUE DEVELOPMENT; PACING STRATEGY; OXYGEN-UPTAKE; POWER OUTPUT	The purpose this study was to examine the effects of caffeine ingestion on performance and energy expenditure (anaerobic and aerobic contribution) during a 4-km cycling time trial (TT) performed after a carbohydrate (CHO) availability-lowering exercise protocol. After preliminary and familiarization trials, seven amateur cyclists performed three 4-km cycling TT in a double-blind, randomized and crossover design. The trials were performed either after no previous exercise (CON), or after a CHO availability-lowering exercise protocol (DEP) performed in the previous evening, followed by either placebo (DEP-PLA) or 5 mg.kg(-1) of caffeine intake (DEP-CAF) 1 hour before the trial. Performance was reduced (22.1%) in DEP-PLA vs CON (421.0 +/- 12.3 vs 412.4 +/- 9.7 s). However, performance was restored in DEP-CAF (404.6 +/- 17.1 s) compared with DEP-PLA, while no differences were found between DEP-CAF and CON. The anaerobic contribution was increased in DEP-CAF compared with both DEP-PLA and CON (67.4 +/- 14.91, 47. 3 +/- 14.6 and 55.3 +/- 14.0 W, respectively), and this was more pronounced in the first 3 km of the trial. Similarly, total anaerobic work was higher in DEP-CAF than in the other conditions. The integrated electromyographic activity, plasma lactate concentration, oxygen uptake, aerobic contribution and total aerobic work were not different between the conditions. The reduction in performance associated with low CHO availability is reversed with caffeine ingestion due to a higher anaerobic contribution, suggesting that caffeine could access an anaerobic "reserve'' that is not used under normal conditions.	[Silva-Cavalcante, Marcos David; Correia-Oliveira, Carlos Rafaell; Santos, Ralmony Alcantara; Lopes-Silva, Joao Paulo; Lima, Hessel Marani; Lima-Silva, Adriano Eduardo] Univ Fed Alagoas, Fac Nutr, Sports Sci Res Grp, Maceio, Alagoas, Brazil; [Silva-Cavalcante, Marcos David; Correia-Oliveira, Carlos Rafaell; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil; [Santos, Ralmony Alcantara] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Duarte, Marcos] Fed Univ ABC, Fac Biomed Engn, Sao Paulo, Brazil; [Bishop, David John] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia	Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); Victoria University	Lima-Silva, AE (corresponding author), Univ Fed Alagoas, Fac Nutr, Sports Sci Res Grp, Maceio, Alagoas, Brazil.	adrianosilva@usp.br	Duarte, Marcos/D-1854-2011; Correia-Oliveira, Carlos/K-5574-2013; Bishop, David John/X-9826-2019; Lopes-Silva, João/R-6909-2016; Lima-Silva, Adriano Eduardo/C-2800-2013; Kiss, Maria Augusta/H-5902-2012; Lima-Silva, Adriano/Y-2404-2019; Bertuzzi, Romulo/E-7048-2012; Silva, João Paulo/L-4396-2017; Silva-Cavalcante, Marcos/E-9980-2012	Duarte, Marcos/0000-0002-0344-7460; Bishop, David John/0000-0002-6956-9188; Lopes-Silva, João/0000-0002-2033-365X; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Lima-Silva, Adriano/0000-0002-0613-5104; Silva, João Paulo/0000-0002-2033-365X; Silva-Cavalcante, Marcos/0000-0003-3943-3420	Coordination of Improvement of Personnel of Superior Level (CAPES-PRODOC) [MEC/CAPES 29/2010]	Coordination of Improvement of Personnel of Superior Level (CAPES-PRODOC)	This project was supported by Coordination of Improvement of Personnel of Superior Level (CAPES-PRODOC, MEC/CAPES 29/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiss CR, 2008, J APPL PHYSIOL, V104, P1021, DOI 10.1152/japplphysiol.00683.2007; Aisbett B, 2009, J SPORT SCI, V27, P1201, DOI 10.1080/02640410903114372; Albertus-Kajee Y, 2010, J ELECTROMYOGR KINES, V20, P1036, DOI 10.1016/j.jelekin.2010.07.011; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Astorino TA, 2012, NUTR RES, V32, P78, DOI 10.1016/j.nutres.2011.12.001; Atkinson G, 2007, SPORTS MED, V37, P647, DOI 10.2165/00007256-200737080-00001; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bazzucchi I, 2011, MUSCLE NERVE, V43, P839, DOI 10.1002/mus.21995; Bell DG, 2001, MED SCI SPORT EXER, V33, P1399, DOI 10.1097/00005768-200108000-00024; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; Billat VL, 2006, J PHYSIOL SCI, V56, P103, DOI 10.2170/physiolsci.R2028; Blomstrand E, 1999, J PHYSIOL-LONDON, V514, P293, DOI 10.1111/j.1469-7793.1999.293af.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bridge CA, 2006, J SPORT SCI, V24, P433, DOI 10.1080/02640410500231496; COLLOMP K, 1991, INT J SPORTS MED, V12, P439, DOI 10.1055/s-2007-1024710; Corbett J, 2012, MED SCI SPORT EXER, V44, P509, DOI 10.1249/MSS.0b013e31823378b1; CRAIG NP, 1993, EUR J APPL PHYSIOL, V67, P150, DOI 10.1007/BF00376659; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Doherty M, 2004, J SPORT SCI, V22, P637, DOI 10.1080/02640410310001655741; Doherty M, 1998, INT J SPORT NUTR, V8, P95, DOI 10.1123/ijsn.8.2.95; Fredholm BB, 1999, PHARMACOL REV, V51, P83; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P615, DOI 10.1152/jappl.1973.34.5.615; GREENHAFF PL, 1987, EUR J APPL PHYSIOL O, V56, P331, DOI 10.1007/BF00690901; HEIGENHAUSER GJF, 1983, J APPL PHYSIOL, V54, P470, DOI 10.1152/jappl.1983.54.2.470; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hettinga FJ, 2007, MED SCI SPORT EXER, V39, P2212, DOI 10.1249/mss.0b013e318156e8d4; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hulston CJ, 2010, MED SCI SPORT EXER, V42, P2046, DOI 10.1249/MSS.0b013e3181dd5070; Joseph T, 2008, MED SCI SPORT EXER, V40, P381, DOI 10.1249/mss.0b013e31815a83f6; Kalmar JM, 1999, J APPL PHYSIOL, V87, P801, DOI 10.1152/jappl.1999.87.2.801; Kilding AE, 2012, INT J SPORT NUTR EXE, V22, P175, DOI 10.1123/ijsnem.22.3.175; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lander PJ, 2009, BRIT J SPORT MED, V43, P789, DOI 10.1136/bjsm.2008.056085; Langfort J, 1997, EUR J APPL PHYSIOL, V76, P128, DOI 10.1007/s004210050224; Lima-Silva AE, 2011, PSYCHOPHYSIOLOGY, V48, P277, DOI 10.1111/j.1469-8986.2010.01059.x; Lima-Silva AE, 2013, INT J SPORT IN PRESS; Magkos F, 2003, CURR OPIN CLIN NUTR, V6, P539, DOI 10.1097/00075197-200309000-00007; MAUGHAN RJ, 1981, EUR J APPL PHYSIOL O, V46, P211, DOI 10.1007/BF00423397; Meyers BM, 2005, J APPL PHYSIOL, V99, P1056, DOI 10.1152/japplphysiol.00937.2004; Miura A, 2000, ERGONOMICS, V43, P133, DOI 10.1080/001401300184693; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Racinais S, 2010, CHRONOBIOL INT, V27, P855, DOI 10.3109/07420521003668412; Rosser JI, 2009, AM J PHYSIOL-REG I, V296, pR1512, DOI 10.1152/ajpregu.90901.2008; Simmonds MJ, 2010, EUR J APPL PHYSIOL, V109, P287, DOI 10.1007/s00421-009-1351-8; Stone MR, 2011, EUR J APPL PHYSIOL, V111, P1807, DOI 10.1007/s00421-010-1818-7; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687; Yeo WK, 2008, J APPL PHYSIOL, V105, P1462, DOI 10.1152/japplphysiol.90882.2008; Yeo WK, 2010, EXP PHYSIOL, V95, P351, DOI 10.1113/expphysiol.2009.049353	50	54	55	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72025	10.1371/journal.pone.0072025	http://dx.doi.org/10.1371/journal.pone.0072025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	24058684	Green Published, gold, Green Accepted			2022-12-27	WOS:000323425700122
J	Santos, RD; Kiss, MAPD; Silva-Cavalcante, MD; Correia-Oliveira, CR; Bertuzzi, R; Bishop, DJ; Lima-Silva, AE				Santos, Ralmony de Alcantara; Peduti Dal Molin Kiss, Maria Augusta; Silva-Cavalcante, Marcos David; Correia-Oliveira, Carlos Rafaell; Bertuzzi, Romulo; Bishop, David John; Lima-Silva, Adriano Eduardo			Caffeine Alters Anaerobic Distribution and Pacing during a 4000-m Cycling Time Trial	PLOS ONE			English	Article							ENERGY-EXPENDITURE; PERFORMANCE; EXERCISE; INGESTION; STRATEGY; MUSCLE; FATIGUE; EMG; BRAIN; FORCE	The purpose of the present study was to investigate the effects of caffeine ingestion on pacing strategy and energy expenditure during a 4000-m cycling time-trial (TT). Eight recreationally-trained male cyclists volunteered and performed a maximal incremental test and a familiarization test on their first and second visits, respectively. On the third and fourth visits, the participants performed a 4000-m cycling TT after ingesting capsules containing either caffeine (5 mg.kg(-1) of body weight, CAF) or cellulose (PLA). The tests were applied in a double-blind, randomized, repeated-measures, cross-over design. When compared to PLA, CAF ingestion increased mean power output [219.1 +/- 18.6 vs. 232.8 +/- 21.4 W; effect size (ES) = 0.60 (95% CI = 0.05 to 1.16), p = 0.034] and reduced the total time [419 +/- 13 vs. 409 +/- 12 s; ES = -0.71 (95% CI = -0.09 to -1.13), p = 0.026]. Furthermore, anaerobic contribution during the 2200-, 2400-, and 2600-m intervals was significantly greater in CAF than in PLA (p<0.05). However, the mean anaerobic [64.9 +/- 20.1 vs. 57.3 +/- 17.5 W] and aerobic [167.9 +/- 4.3 vs. 161.8 +/- 11.2 W] contributions were similar between conditions (p>0.05). Similarly, there were no significant differences between CAF and PLA for anaerobic work (26363 +/- 7361 vs. 23888 +/- 6795 J), aerobic work (68709 +/- 2118 vs. 67739 +/- 3912 J), or total work (95245 +/- 8593 vs. 91789 +/- 7709 J), respectively. There was no difference for integrated electromyography, blood lactate concentration, heart rate, and ratings of perceived exertion between the conditions. These results suggest that caffeine increases the anaerobic contribution in the middle of the time trial, resulting in enhanced overall performance.	[Santos, Ralmony de Alcantara; Silva-Cavalcante, Marcos David; Correia-Oliveira, Carlos Rafaell; Lima-Silva, Adriano Eduardo] Univ Fed Pernambuco, Dept Phys Educ & Sports Sci CAV, Sports Sci Res Grp, Vitoria De Santo Anta, PE, Brazil; [Santos, Ralmony de Alcantara] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Peduti Dal Molin Kiss, Maria Augusta; Silva-Cavalcante, Marcos David; Correia-Oliveira, Carlos Rafaell; Bertuzzi, Romulo] Univ Fed Sao Paulo, Sch Phys Educ & Sport, Endurance Sports Res Grp, Sao Paulo, Brazil; [Bishop, David John] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia	Universidade Federal de Pernambuco; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Victoria University	Lima-Silva, AE (corresponding author), Univ Fed Pernambuco, Dept Phys Educ & Sports Sci CAV, Sports Sci Res Grp, Vitoria De Santo Anta, PE, Brazil.	adrianosilva@usp.br	Duarte, Marcos/D-1854-2011; Correia-Oliveira, Carlos/K-5574-2013; Bishop, David John/X-9826-2019; Lopes-Silva, João/R-6909-2016; Lima-Silva, Adriano Eduardo/C-2800-2013; Kiss, Maria Augusta/H-5902-2012; Lima-Silva, Adriano/Y-2404-2019; Bertuzzi, Romulo/E-7048-2012; Silva, João Paulo/L-4396-2017; Silva-Cavalcante, Marcos/E-9980-2012	Duarte, Marcos/0000-0002-0344-7460; Bishop, David John/0000-0002-6956-9188; Lopes-Silva, João/0000-0002-2033-365X; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Lima-Silva, Adriano/0000-0002-0613-5104; Silva, João Paulo/0000-0002-2033-365X; Silva-Cavalcante, Marcos/0000-0003-3943-3420	Coordination of Improvement of Personnel of Superior Level (CAPES-PRODOC) [58]	Coordination of Improvement of Personnel of Superior Level (CAPES-PRODOC)	This study was supported by a grant from the Coordination of Improvement of Personnel of Superior Level (CAPES-PRODOC, call MEC/CAPES 029/2010; grant number 58). Website: www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisbett B, 2009, J SPORT SCI, V27, P1201, DOI 10.1080/02640410903114372; Albertus-Kajee Y, 2010, J ELECTROMYOGR KINES, V20, P1036, DOI 10.1016/j.jelekin.2010.07.011; Astorino TA, 2012, PHYSIOL BEHAV, V106, P211, DOI 10.1016/j.physbeh.2012.02.006; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Bell DG, 2001, MED SCI SPORT EXER, V33, P1399, DOI 10.1097/00005768-200108000-00024; Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002; Bertuzzi RCM, 2010, INT J SPORTS MED, V31, P477, DOI 10.1055/s-0030-1253375; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bridge CA, 2006, J SPORT SCI, V24, P433, DOI 10.1080/02640410500231496; Cohen J., 1998, STAT POWER ANAL BEHA; Conger SA, 2011, INT J SPORT NUTR EXE, V21, P71, DOI 10.1123/ijsnem.21.1.71; Corbett J, 2012, MED SCI SPORT EXER, V44, P509, DOI 10.1249/MSS.0b013e31823378b1; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; CRAIG NP, 1993, EUR J APPL PHYSIOL, V67, P150, DOI 10.1007/BF00376659; de Koning J J, 1999, J Sci Med Sport, V2, P266, DOI 10.1016/S1440-2440(99)80178-9; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Doherty M, 1998, INT J SPORT NUTR, V8, P95, DOI 10.1123/ijsn.8.2.95; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; HAKKINEN K, 1993, INT J SPORTS MED, V14, P53, DOI 10.1055/s-2007-1021146; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hettinga FJ, 2007, MED SCI SPORT EXER, V39, P2212, DOI 10.1249/mss.0b013e318156e8d4; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Hunter AM, 2003, INT J SPORTS MED, V24, P83, DOI 10.1055/s-2003-38196; Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Kalmar JM, 1999, J APPL PHYSIOL, V87, P801, DOI 10.1152/jappl.1999.87.2.801; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lima-Silva AE, 2012, INT J SPORTS MED, V33, P813, DOI 10.1055/s-0032-1311581; Lima-Silva AE, 2010, EUR J APPL PHYSIOL, V108, P1045, DOI 10.1007/s00421-009-1300-6; LINDINGER MI, 1993, J APPL PHYSIOL, V74, P1149, DOI 10.1152/jappl.1993.74.3.1149; MCCALL AL, 1982, LIFE SCI, V31, P2709, DOI 10.1016/0024-3205(82)90715-9; Myers DE, 1997, HEADACHE, V37, P654, DOI 10.1046/j.1526-4610.1997.3710654.x; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Schneiker KT, 2006, MED SCI SPORT EXER, V38, P578, DOI 10.1249/01.mss.0000188449.18968.62; Simmonds MJ, 2010, EUR J APPL PHYSIOL, V109, P287, DOI 10.1007/s00421-009-1351-8; Stone MR, 2011, EUR J APPL PHYSIOL, V111, P1807, DOI 10.1007/s00421-010-1818-7; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Walker GJ, 2008, J SPORT SCI, V26, P611, DOI 10.1080/02640410701654306; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687; WILLIAMS JH, 1987, AM J PHYS MED REHAB, V66, P169	50	54	55	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75399	10.1371/journal.pone.0075399	http://dx.doi.org/10.1371/journal.pone.0075399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058684	Green Published, gold, Green Accepted			2022-12-27	WOS:000324695900115
J	Wang, S; Lee, Y; Kim, J; Hyun, J; Lee, K; Kim, Y; Jung, Y				Wang, Sihyung; Lee, Youngjae; Kim, Jieun; Hyun, Jeongeun; Lee, Keumju; Kim, Younghwa; Jung, Youngmi			Potential Role of Hedgehog Pathway in Liver Response to Radiation	PLOS ONE			English	Article							HEPATITIS-C; IONIZING-RADIATION; VIRUS COINFECTION; CELLS; PROGENITORS; INFECTION; CIRRHOSIS; TARGET	Radiation-induced fibrosis constitutes a major problem that is commonly observed in the patients undergoing radiotherapy; therefore, understanding its pathophysiological mechanism is important. The Hedgehog (Hh) pathway induces the proliferation of progenitors and myofibroblastic hepatic stellate cells (MF-HSCs) and promotes the epithelial-to-mesenchymal transition (EMT), thereby regulating the repair response in the damaged liver. We examined the response of normal liver to radiation injury. Male mice were sacrificed at 6 weeks and 10 weeks after exposure to a single dose of 6 Gy and the livers were collected for biochemical analysis. Irradiated (IR) and control mice were compared for progenitors, fibrosis, Hh pathway, and EMT at 6 and 10 weeks post irradiation. Fatty hepatocytes were observed and the expressions of Hh ligand, Indian Hh. were greater in the livers at 6 weeks, whereas expression of another Hh ligand, Sonic Hh, increased at 10 weeks post irradiation. Both Smoothened, Hh receptor, and Gli2, Hh-target gene, were up-regulated at 6 and 10 weeks after irradiation. Accumulation of progenitors (CD44, Pan-cytokeratin, and Sox9) was significant in IR livers at 6 and 10 weeks. RNA analysis showed enhanced expression of the EMT-stimulating factor, tgf-beta, in the IR livers at 6 weeks and the upregulation of mesenchymal markers (alpha-SMA, collagen, N-cadherin, and s100a4), but down-regulation of EMT inhibitors, in IR mouse livers at 6 and 10 weeks. Increased fibrosis was observed in IR mouse livers at 10 weeks. Treatment of mice with Hh inhibitor, GDC-0449, suppressed Hh activity and block the proliferation of hepatic progenitor and expression of EMT-stimulating genes in irradiated mice. Therefore, those results demonstrated that the Hh pathway increased in response to liver injury by radiation and promoted a compensatory proliferation of MF-HSCs and progenitors, thereby regulating liver remodeling.	[Wang, Sihyung; Lee, Youngjae; Kim, Jieun; Hyun, Jeongeun; Lee, Keumju; Jung, Youngmi] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Kim, Younghwa] Kyungil Univ, Dept Emergency Med Technol, Gyongsan, South Korea	Pusan National University; Kyungil University	Jung, Y (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea.	y.jung@pusan.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012-0007141]; Korea government (MEST) [2011-0019037]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-0007141) and National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0019037) awarded to Youngmi Jung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2012, HEPATOLOGY, V56, P1681, DOI 10.1002/hep.25867; Bar-Gal GK, 2012, HEPATOLOGY, V56, P1671, DOI 10.1002/hep.25852; Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Giusti AM, 1998, INT J RADIAT BIOL, V74, P595, DOI 10.1080/095530098141177; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Jung YM, 2007, HEPATOLOGY, V45, P1091, DOI 10.1002/hep.21660; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Lo Re V, 2012, HEPATOLOGY, V56, P1688, DOI 10.1002/hep.25866; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; McMillan TJ, 2002, BASIC CLIN RADIOBIOL, P71; Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619; Philips GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023943; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Sarkar M, 2012, HEPATOLOGY, V56, P1699, DOI 10.1002/hep.25859; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V290, pG859, DOI 10.1152/ajpgi.00456.2005; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang S, 2012, RADIAT RES, V179, P69; Yamao J, 2012, J HEPATOBILIARY PANC, P1; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032	25	80	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e74141	10.1371/journal.pone.0074141	http://dx.doi.org/10.1371/journal.pone.0074141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24023915	gold, Green Published, Green Submitted			2022-12-27	WOS:000324494000090
J	Xue, H; Zheng, J; Cui, ZP; Bai, XF; Li, G; Zhang, CD; He, SH; Li, WH; Lajud, SA; Duan, YZ; Zhou, H				Xue, Hui; Zheng, Jun; Cui, Ziping; Bai, Xiufeng; Li, Gang; Zhang, Caidi; He, Sanhu; Li, Weihong; Lajud, Shayanne A.; Duan, Yinzhong; Zhou, Hong			Low-Intensity Pulsed Ultrasound Accelerates Tooth Movement via Activation of the BMP-2 Signaling Pathway	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; IN-VITRO; OSTEOBLASTIC DIFFERENTIATION; PERIODONTAL TISSUE; PROSTAGLANDIN E-2; HEALING-PROCESS; BONE-FORMATION; CELLS; EXPRESSION; MODEL	The present study was designed to determine the underlying mechanism of low-intensity pulsed ultrasound (LIPUS) induced alveolar bone remodeling and the role of BMP-2 expression in a rat orthodontic tooth movement model. Orthodontic appliances were placed between the homonymy upper first molars and the upper central incisors in rats under general anesthesia, followed by daily 20-min LIPUS or sham LIPUS treatment beginning at day 0. Tooth movement distances and molecular changes were evaluated at each observation point. In vitro and in vivo studies were conducted to detect HGF (Hepatocyte growth factor)/Runx2/BMP-2 signaling pathways and receptor activator of NFkB ligand (RANKL) expression by quantitative real time PCR (qRT-PCR), Western blot and immunohistochemistry. At day 3, LIPUS had no effect on the rat orthodontic tooth movement distance and BMP-2-induced alveolar bone remodeling. However, beginning at day 5 and for the following time points, LIPUS significantly increased orthodontic tooth movement distance and BMP-2 signaling pathway and RANKL expression compared with the control group. The qRT-PCR and Western blot data in vitro and in vivo to study BMP-2 expression were consistent with the immunohistochemistry observations. The present study demonstrates that LIPUS promotes alveolar bone remodeling by stimulating the HGF/Runx2/BMP-2 signaling pathway and RANKL expression in a rat orthodontic tooth movement model, and LIPUS increased BMP-2 expression via Runx2 regulation.	[Xue, Hui; Duan, Yinzhong] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China; [Xue, Hui] Hegang Peoples Hosp, Dept Dent, Hegang, Peoples R China; [Zheng, Jun; Bai, Xiufeng; Li, Gang; He, Sanhu] Xi An Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Stomatol Hosp, Xian 710049, Peoples R China; [Cui, Ziping] Hegang Peoples Hosp, Dept Digest Dis, Hegang, Peoples R China; [Zhang, Caidi; Zhou, Hong] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Orthodont, Xian 710049, Peoples R China; [Li, Weihong] Wenzhou Med Coll, Stomatol Hosp, Dept Orthodont, Wenzhou, Peoples R China; [Lajud, Shayanne A.] Univ Penn, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA	Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University; Wenzhou Medical University; University of Pennsylvania	Duan, YZ (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China.	duanyz@fmmu.edu.cn; zhouhongdean@126.com	Huang, Yu/K-2866-2017	Huang, Yu/0000-0002-1277-6784; Wang, Rui/0000-0003-3825-3620; SHEN, YANG/0000-0002-2448-8405	National Natural Science Foundation of China [30973359]; Scientific and Technological Project of Shaanxi Province of China [2008K14-03]; Kwang-Hua Education Foundation; Zhejiang Provincial Natural Science Foundation of China [Y2110400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shaanxi Province of China; Kwang-Hua Education Foundation; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by grants from the National Natural Science Foundation of China (Project No. 30973359) (to Dr. Zhou), the Scientific and Technological Project of Shaanxi Province of China (2008K14-03) (to Dr. Duan), and partially supported by Kwang-Hua Education Foundation and Zhejiang Provincial Natural Science Foundation of China (Project No. Y2110400) (to Dr. Weihong Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Borsje MA, 2010, ANGLE ORTHOD, V80, P498, DOI 10.2319/060809-318.1; Chan CW, 2006, J ORTHOP RES, V24, P263, DOI 10.1002/jor.20015; Coords M, 2011, J ORTHOP RES, V29, P181, DOI 10.1002/jor.21223; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7; El-Bialy T, 2004, AM J ORTHOD DENTOFAC, V126, P186, DOI 10.1016/j.ajodo.2004.02.010; El-Bialy T, 2011, J DENT, V39, P693, DOI 10.1016/j.jdent.2011.08.001; El-Bialy T, 2006, AM J ORTHOD DENTOFAC, V130; Fujita S, 2008, ORTHOD CRANIOFAC RES, V11, P143, DOI 10.1111/j.1601-6343.2008.00423.x; Fung CH, 2012, ULTRASOUND MED BIOL, V38, P745, DOI 10.1016/j.ultrasmedbio.2012.01.022; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Hadjiargyrou M, 1998, CLIN ORTHOP RELAT R, pS216, DOI 10.1097/00003086-199810001-00022; Hayton MJ, 2005, ULTRASOUND MED BIOL, V31, P1131, DOI 10.1016/j.ultrasmedbio.2005.04.017; Hsieh PCH, 2006, J VASC SURG, V43, P150, DOI 10.1016/j.jvs.2005.08.008; Iglesias-Linares A, 2011, ORTHOD CRANIOFAC RES, V14, P138, DOI 10.1111/j.1601-6343.2011.01519.x; Iino S, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.08.014; Inubushi T, 2008, J PERIODONTOL, V79, P1984, DOI [10.1902/jop.2008.080081, 10.1902/jop.2008.080081 ]; Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x; Kanzaki H, 2006, GENE THER, V13, P678, DOI 10.1038/sj.gt.3302707; Katano M, 2011, EXP ANIM TOKYO, V60, P385, DOI 10.1538/expanim.60.385; Kawasaki K, 2000, LASER SURG MED, V26, P282, DOI 10.1002/(SICI)1096-9101(2000)26:3<282::AID-LSM6>3.0.CO;2-X; Khanna A, 2009, BRIT MED BULL, V89, P169, DOI 10.1093/bmb/ldn040; Kim SJ, 2009, LASER SURG MED, V41, P524, DOI 10.1002/lsm.20792; Kim SJ, 2009, ANGLE ORTHOD, V79, P284, DOI 10.2319/020308-60.1; King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801; Kobayashi Y, 1998, ANGLE ORTHOD, V68, P259; Kohno T, 2002, J Orthod, V29, P129, DOI 10.1093/ortho/29.2.129; Lee W, 2008, J DENT RES, V87, P861, DOI 10.1177/154405910808700904; Li JK, 2003, BIOMATERIALS, V24, P2379, DOI 10.1016/S0142-9612(03)00033-4; LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738; Malizos KN, 2006, BONE, V38, P530, DOI 10.1016/j.bone.2005.10.012; de Albornoz PM, 2011, BRIT MED BULL, V100, P39, DOI 10.1093/bmb/ldr006; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Oshiro T, 2002, ANAT REC, V266, P218, DOI 10.1002/ar.10061; Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Sant'Anna EF, 2005, J ORTHOP RES, V23, P646, DOI 10.1016/j.orthres.2004.09.007; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Shiraishi R, 2011, J PERIODONTOL, V82, P1498, DOI 10.1902/jop.2011.100627; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Spadaro JA, 1997, BIOELECTROMAGNETICS, V18, P193, DOI 10.1002/(SICI)1521-186X(1997)18:3<193::AID-BEM1>3.0.CO;2-Y; Strippoli Julien, 2012, Orthod Fr, V83, P155, DOI 10.1051/orthodfr/2012015; Sun JS, 2001, J BIOMED MATER RES, V57, P449, DOI 10.1002/1097-4636(20011205)57:3<449::AID-JBM1188>3.0.CO;2-0; Suzuki Akito, 2009, J Oral Sci, V51, P29; Suzuki A, 2009, ACTA BIOCH BIOPH SIN, V41, P108, DOI 10.1093/abbs/gmn012; Takiguchi T, 1999, J PERIODONTAL RES, V34, P431; Tsai SY, 2012, INT IMMUNOPHARMACOL, V13, P156, DOI 10.1016/j.intimp.2012.03.026; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang Y, 2011, ARCH ORAL BIOL, V56, P177, DOI 10.1016/j.archoralbio.2010.09.009; Wijdicks CA, 2009, ULTRASOUND MED BIOL, V35, P1629, DOI 10.1016/j.ultrasmedbio.2009.04.017; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	52	77	83	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68926	10.1371/journal.pone.0068926	http://dx.doi.org/10.1371/journal.pone.0068926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	24058553	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000063
J	Huang, ZG; Jin, Q; Fan, M; Cong, XL; Han, SF; Gao, H; Shan, Y				Huang, Zhi Gang; Jin, Qun; Fan, Min; Cong, Xiao Liang; Han, Shu Fang; Gao, Hai; Shan, Yi			Myocardial Remodeling in Diabetic Cardiomyopathy Associated with Cardiac Mast Cell Activation	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE ACTIVITY; HYPERTENSIVE HEART-DISEASE; NECROSIS-FACTOR-ALPHA; ANGIOTENSIN-II; MEDIATOR RELEASE; TNF-ALPHA; INFLAMMATION; INHIBITION; FIBROSIS; CHYMASE	Diabetic cardiomyopathy is a specific disease process distinct from coronary artery disease and hypertension. The disease features cardiac remodeling stimulated by hyperglycemia of the left ventricle wall and disrupts contractile functions. Cardiac mast cells may be activated by metabolic byproducts resulted from hyperglycermia and then participate in the remodeling process by releasing a multitude of cytokines and bioactive enzymes. Nedocromil, a pharmacologic stabilizer of mast cells, has been shown to normalize cytokine levels and attenuate cardiac remodeling. In this study, we describe the activation of cardiac mast cells by inducing diabetes in normal mice using streptozotocin (STZ). Next, we treated the diabetic mice with nedocromil for 12 weeks and then examined their hearts for signs of cardiac remodeling and quantified contractile function. We observed significantly impaired heart function in diabetic mice, as well as increased cardiac mast cell density and elevated mast cell secretions that correlated with gene expression and aberrant cytokine levels associated with cardiac remodeling. Nedocromil treatment halted contractile dysfunction in diabetic mice and reduced cardiac mast cell density, which correlated with reduced bioactive enzyme secretions, reduced expression of extracellular matrix remodeling factors and collagen synthesis, and normalized cytokine levels. However, the results showed nedocromil treatments did not return diabetic mice to a normal state. We concluded that manipulation of cardiac mast cell function is sufficient to attenuate cardiomyopathy stimulated by diabetes, but other cellular pathways also contribute to the disease process.	[Huang, Zhi Gang; Fan, Min; Cong, Xiao Liang] Second Mil Med Univ, Chang Zheng Hosp, Dept Cardiol, Shanghai, Peoples R China; [Jin, Qun; Han, Shu Fang] Gen Hosp Jinan Mil Reg, Dept Cardiol, Jinan, Peoples R China; [Gao, Hai] Third Peoples Hosp Haiyang, Haiyang, Shandong, Peoples R China; [Shan, Yi] Second Mil Med Univ, Chang Zheng Hosp, Dept Emergency Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Gao, H (corresponding author), Third Peoples Hosp Haiyang, Haiyang, Shandong, Peoples R China.	doctorhd@126.com; shanyikxy@126.com		Qiao, Lei/0000-0003-1626-1769				Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Andrzejczak D, 2006, PHARMACOL REP, V58, P711; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Asghar O, 2009, CLIN SCI, V116, P741, DOI 10.1042/CS20080500; Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brower GL, 2002, AM J PHYSIOL-HEART C, V283, pH518, DOI 10.1152/ajpheart.00218.2000; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; DORING HJ, 1990, PHYSIOL BOHEMOSLOV, V39, P481; DVORAK AM, 1986, NEW ENGL J MED, V315, P969; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Levick SP, 2008, J MOL CELL CARDIOL, V45, P56, DOI 10.1016/j.yjmcc.2008.04.010; Levick SP, 2009, HYPERTENSION, V53, P1041, DOI 10.1161/HYPERTENSIONAHA.108.123158; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Liu JW, 2012, BIOCHEM BIOPH RES CO, V427, P441, DOI 10.1016/j.bbrc.2012.09.058; Marshall JS, 1996, J CLIN INVEST, V97, P1122, DOI 10.1172/JCI118506; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; Matsumoto T, 2003, CIRCULATION, V107, P2555, DOI 10.1161/01.CIR.0000074041.81728.79; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miki T, 2012, HEART FAIL REV; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Murray DB, 2010, J MOL CELL CARDIOL, V49, P245, DOI 10.1016/j.yjmcc.2010.04.005; Nelson N, 1996, J IMMUNOL, V156, P3711; Oyamada S, 2011, J PHARMACOL EXP THER, V339, P143, DOI 10.1124/jpet.111.179697; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; PANIZO A, 1995, J HYPERTENS, V13, P1201, DOI 10.1097/00004872-199510000-00015; PATELLA V, 1995, INT ARCH ALLERGY IMM, V106, P386, DOI 10.1159/000236871; Patella V, 1997, INFLAMM RES, V46, pS31, DOI 10.1007/s000110050041; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Rottem M, 2005, AUTOIMMUN REV, V4, P21, DOI 10.1016/j.autrev.2004.05.001; Shiota N, 2003, J HYPERTENS, V21, P1935, DOI 10.1097/00004872-200310000-00022; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2011, TRENDS PHARMACOL SCI, V32, P534, DOI 10.1016/j.tips.2011.05.005; URATA H, 1990, CIRC RES, V66, P883, DOI 10.1161/01.RES.66.4.883; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu QL, 2006, HYPERTENSION, V48, P98, DOI 10.1161/01.HYP.0000227247.27111.B2; Zhao XY, 2008, MOL CELL BIOCHEM, V310, P159, DOI 10.1007/s11010-007-9676-2	42	75	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60827	10.1371/journal.pone.0060827	http://dx.doi.org/10.1371/journal.pone.0060827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	24058605	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900082
J	Tang, CK; Aoshi, T; Jounai, N; Ito, J; Ohata, K; Kobiyama, K; Dessailly, BH; Kuroda, E; Akira, S; Mizuguchi, K; Coban, C; Ishii, KJ				Tang, Choon Kit; Aoshi, Taiki; Jounai, Nao; Ito, Junichi; Ohata, Keiichi; Kobiyama, Kouji; Dessailly, Benoit H.; Kuroda, Etsushi; Akira, Shizuo; Mizuguchi, Kenji; Coban, Cevayir; Ishii, Ken J.			The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant	PLOS ONE			English	Article							VASCULAR DISRUPTING AGENT; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; INNATE; ACTIVATION; IMMUNOGENICITY; CARBOPLATIN; PACLITAXEL; ASA404; PLAYS; CELLS	5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent type I interferon (IFN) inducer, was evaluated as a chemotherapeutic agent in mouse cancer models and proved to be well tolerated in human cancer clinical trials. Despite its multiple biological functions, DMXAA has not been fully characterized for the potential application as a vaccine adjuvant. In this report, we show that DMXAA does act as an adjuvant due to its unique property as a soluble innate immune activator. Using OVA as a model antigen, DMXAA was demonstrated to improve on the antigen specific immune responses and induce a preferential Th2 (Type-2) response. The adjuvant effect was directly dependent on the IRF3-mediated production of type-I-interferon, but not IL-33. DMXAA could also enhance the immunogenicity of influenza split vaccine which led to significant increase in protective responses against live influenza virus challenge in mice compared to split vaccine alone. We propose that DMXAA can be used as an adjuvant that targets a specific innate immune signaling pathway via IRF3 for potential applications including vaccines against influenza which requires a high safety profile.	[Tang, Choon Kit] Agcy Sci & Technol Res, Singapore Immunol Network, Singapore, Singapore; [Tang, Choon Kit; Ohata, Keiichi; Coban, Cevayir] Osaka Univ, Immunol Frontier Res Ctr IFReC, Malaria Immunol Lab, Suita, Osaka 565, Japan; [Tang, Choon Kit; Akira, Shizuo] Osaka Univ, IFReC, Host Def Lab, Suita, Osaka 565, Japan; [Tang, Choon Kit; Aoshi, Taiki; Kobiyama, Kouji; Kuroda, Etsushi; Ishii, Ken J.] Osaka Univ, IFReC, Vaccine Sci Lab, Suita, Osaka 565, Japan; [Aoshi, Taiki; Jounai, Nao; Kobiyama, Kouji; Kuroda, Etsushi; Ishii, Ken J.] NIBIO, Lab Adjuvant Innovat, Osaka, Japan; [Ito, Junichi; Dessailly, Benoit H.; Mizuguchi, Kenji] Natl Inst Biomed Innovat NIBIO, Lab Bioinformat, Osaka, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Osaka University; Osaka University; Osaka University	Ishii, KJ (corresponding author), Osaka Univ, IFReC, Vaccine Sci Lab, Suita, Osaka 565, Japan.	kenishii@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Ishii, Ken J/B-1685-2012; Mizuguchi, Kenji/GVS-5857-2022; COBAN, Cevayir/P-1928-2019; Coban, Cevayir/B-2129-2012	Ishii, Ken J/0000-0002-6728-3872; Mizuguchi, Kenji/0000-0003-3021-7078; COBAN, Cevayir/0000-0002-4467-7799; Ohata, Keiichi/0000-0002-5635-4292	Japanese Ministry of Health, Labour and Welfare; A*STAR, Singapore	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a Health and Labour Sciences Research Grant 'Adjuvant database Project' of the Japanese Ministry of Health, Labour and Welfare. CKT was funded by A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer R, 2010, NEOPLASIA, V12, P755, DOI 10.1593/neo.10636; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; LAWS AL, 1995, BRIT J CANCER, V71, P1204, DOI 10.1038/bjc.1995.234; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Peng SW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-21; Perkins DJ, 2012, J IMMUNOL; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Tang CK, 2009, BIOMATERIALS, V30, P1389, DOI 10.1016/j.biomaterials.2008.11.010; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhao LL, 2005, INT J CANCER, V116, P322, DOI 10.1002/ijc.21005	30	124	128	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60038	10.1371/journal.pone.0060038	http://dx.doi.org/10.1371/journal.pone.0060038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	24066172	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400077
J	Li, X; Xu, F; Xie, L; Ji, YJ; Cheng, K; Zhou, QM; Wang, T; Shively, C; Wu, QY; Gong, W; Fang, L; Zhan, QL; Melgiri, ND; Xie, P				Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Shively, Carol; Wu, Qingyuan; Gong, Wei; Fang, Liang; Zhan, Qunlin; Melgiri, N. D.; Xie, Peng			Depression-Like Behavioral Phenotypes by Social and Social Plus Visual Isolation in the Adult Female Macaca fascicularis	PLOS ONE			English	Article							ANIMAL-MODELS; BODY-IMAGE; MACAQUES; THERMOREGULATION; ACTIVATION; ATTACHMENT; DISORDER; BRAIN; US	Major depressive disorder (MDD) is a debilitating psychiatric mood disorder that affects millions of individuals globally. Our understanding of the biological basis of MDD is poor, and current treatments are ineffective in a significant proportion of cases. This current situation may relate to the dominant rodent animal models of depression, which possess translational limitations due to limited homologies with humans. Therefore, a more homologous primate model of depression is needed to advance investigation into the pathophysiological mechanisms underlying depression and to conduct pre-clinical therapeutic trials. Here, we report two convenient methods - social isolation and social plus visual isolation - which can be applied to construct a non-human primate model of depression in the adult female cynomolgus monkey (Macaca fascicularis). Both social and social plus visual isolation were shown to be effective in inducing depression-like behavior by significantly reducing socially dominant aggressive conflict behavior, communicative behavior, sexual behavior, and parental behavior. The addition of visual isolation produced more profound behavioral changes than social isolation alone by further reducing parental behavior and sexual behavior. Thus, the degree of behavioral pathology may be manipulated by the degree of isolation. These methods can be applied to construct a non-human primate model of depression in order to assess physiological, behavioral, and social phenomena in a controlled laboratory setting.	[Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhan, Qunlin] Fifth Peoples Hosp, Dept Neurol, Chongqing, Peoples R China; [Shively, Carol] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA	Chongqing Medical University; Chongqing Medical University; Wake Forest University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Cheng, Ke/HCH-8846-2022; Shively, Carol/L-2921-2019	Wong, Frank Y./0000-0001-5835-9938	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]; Chongqing Postdoctoral Science Foundation [XM20120010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Science Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Grant NO. 2009CB918300), the National Natural Science Foundation of China (Grant NO. 31271189), the Chongqing Postdoctoral Science Foundation (Grant No. XM20120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifulco A, 2004, BRIT J PSYCHIAT, V184, pS31, DOI 10.1192/bjp.184.46.s31; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Canales JZ, 2010, REV BRAS PSIQUIATR, V32, P375, DOI 10.1590/S1516-44462010000400010; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; Clarke AS, 2005, AM J PRIMATOL, V14, P37; Ehlers CL, 1989, ANIMAL MODELS DEPRES; Ellgring H, 1989, NONVERBAL COMMUNICAT, P168; Fava M, 1997, J NERV MENT DIS, V185, P140, DOI 10.1097/00005053-199703000-00002; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GOTTMAN JM, 1977, CHILD DEV, V48, P513, DOI 10.1111/j.1467-8624.1977.tb01191.x; Grippo AJ, 2007, PSYCHOSOM MED, V69, P149, DOI 10.1097/PSY.0b013e31802f054b; Hanya G, 2007, AM J PRIMATOL, V69, P802, DOI 10.1002/ajp.20397; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Hayward BA, 2007, INT J MENT HEALTH NU, V16, P15, DOI 10.1111/j.1447-0349.2006.00439.x; Helms CM, 2012, PSYCHOPHARMACOLOGY, V224, P133, DOI 10.1007/s00213-012-2707-z; Kennedy SH, 2009, J CLIN PSYCHOPHARM, V29, P157, DOI 10.1097/JCP.0b013e31819c76e9; Kim JW, 1996, BIOL PSYCHIAT, V40, P918, DOI 10.1016/0006-3223(95)00546-3; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; Maestripieri D., 2005, GESTURE, V5, P57, DOI [DOI 10.1075/GEST.5.1.06MAE, 10.1075/gest.5.1.06mae]; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Malkesman O, 2006, BEHAV BRAIN RES, V175, P408, DOI 10.1016/j.bbr.2006.09.017; Masayuki Nakamichi FC, 1990, PRIMATES, V31, P213; MAXIM PE, 1972, BRAIN RES, V42, P243, DOI 10.1016/0006-8993(72)90529-X; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; NOLES SW, 1985, J CONSULT CLIN PSYCH, V53, P88, DOI 10.1037/0022-006X.53.1.88; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Rahaman H., 1968, Primates, V9, P259, DOI 10.1007/BF01730973; Reding K, 2012, HORM BEHAV, V62, P612, DOI 10.1016/j.yhbeh.2012.09.010; RUBIN KH, 1989, J PERS, V57, P237, DOI 10.1111/j.1467-6494.1989.tb00482.x; Rubin KH, 1998, SOCIAL NONSOCIAL PLA; Scaccianoce S, 2006, BEHAV BRAIN RES, V168, P323, DOI 10.1016/j.bbr.2005.04.024; SCHINO G, 1990, PHYSIOL BEHAV, V47, P1125, DOI 10.1016/0031-9384(90)90362-8; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Smolmsky AN, 2009, MOOD ANXIETY RELATED; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SWARTZ KB, 1982, J HUM EVOL, V11, P237, DOI 10.1016/S0047-2484(82)80039-0; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Vollmayr B, 2007, EUR ARCH PSY CLIN N, V257, P300, DOI 10.1007/s00406-007-0734-2; Watson SL, 1998, ATHEROSCLEROSIS, V137, P259, DOI 10.1016/S0021-9150(97)00277-3; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486	50	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73293	10.1371/journal.pone.0073293	http://dx.doi.org/10.1371/journal.pone.0073293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24086565	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600094
